Citrus Sinensis ID: 001253
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1114 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LVP0 | 1102 | Probable leucine-rich rep | yes | no | 0.955 | 0.965 | 0.708 | 0.0 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.976 | 0.967 | 0.641 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.940 | 0.951 | 0.549 | 0.0 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.925 | 0.908 | 0.382 | 0.0 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.896 | 0.875 | 0.384 | 0.0 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.905 | 0.805 | 0.377 | 0.0 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.885 | 0.789 | 0.379 | 0.0 | |
| Q9SSL9 | 1123 | Leucine-rich repeat recep | no | no | 0.903 | 0.896 | 0.371 | 1e-179 | |
| Q9FZ59 | 1088 | Leucine-rich repeat recep | no | no | 0.896 | 0.918 | 0.377 | 1e-176 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.919 | 0.923 | 0.371 | 1e-175 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1497 bits (3876), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 759/1071 (70%), Positives = 873/1071 (81%), Gaps = 7/1071 (0%)
Query: 27 QTKGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLT 86
+T GL N+EGQ LL IKSK VD L NWN NDS PCGW GV C+ V SLNL+
Sbjct: 23 ETTGL-NLEGQYLLEIKSKFVDAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLS 81
Query: 87 KMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKEL 146
M LSG LSP+IGGLVHL LDLS+N LS IPKEIGNCSSLE+L LNNN+ + IP E+
Sbjct: 82 SMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEI 141
Query: 147 GNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAG 206
G L SL L IYNNRISG P EIG L +LSQLV YSNNISG LP ++GNLKRL SFRAG
Sbjct: 142 GKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAG 201
Query: 207 QNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKEL 266
QN+ISGSLPSEIGGCESL LGLAQNQLSGE+PKEIGMLK L+ VILW N+ SG IP+E+
Sbjct: 202 QNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREI 261
Query: 267 GNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFS 326
NCTSLETLALY N+ VG +PKELG + SL++LY+YRN LNGTIPREIG LS A+EIDFS
Sbjct: 262 SNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFS 321
Query: 327 ENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGF 386
EN+L GEIP+EL I GLELLYLFEN+LTG IPVEL+TLKNL+KLDLSIN+LTG IPLGF
Sbjct: 322 ENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGF 381
Query: 387 QYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLE 446
QYL L MLQLF NSL G IP +LG YS LWV+D+SDNHL+G+IP ++C ++++I LNL
Sbjct: 382 QYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLG 441
Query: 447 TNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEI 506
TN L+G+IPTG+T CK+LVQLRL N+ G FPS+LCK N++ +EL QN+F G IP E+
Sbjct: 442 TNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREV 501
Query: 507 GNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLS 566
GNC+ALQRL L+DN FTGELPRE+G LS L T N+SSN LTG +P EIF+CKMLQRLD+
Sbjct: 502 GNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMC 561
Query: 567 WNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAEL 626
N F G LP E+GSL+QLELLKLS N LSG+IPV +GNLSRLTELQMGGN F+G IP EL
Sbjct: 562 CNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPREL 621
Query: 627 GSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNF 686
GSL+ LQIALNLSYN L+G IPPEL NL++LE+LLLNNN+LSGEIP SF NLSSLLG NF
Sbjct: 622 GSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNF 681
Query: 687 SYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPSSLPFPSGTNSPTARLGKL 746
SYN+LTGPIP +N+S++SF G++GLCG PL C Q P S R K+
Sbjct: 682 SYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKI 738
Query: 747 VAIIAAAIGGVSLVLITVIIYFLRQPVEVVA-PLQDKQLSSTVSDIYFPPKEGFTFKDLV 805
+AI AA IGGVSL+LI +I+Y +R+PV VA QD Q S DIYFPPKEGFTF+DLV
Sbjct: 739 IAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLV 798
Query: 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREG--NNNVDNSFRAEILTLG 863
ATDNFDE FV+GRGACGTVY+AVL G+T+AVKKLASN EG NNNVDNSFRAEILTLG
Sbjct: 799 AATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLG 858
Query: 864 KIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLS 923
IRHRNIVKL+GFC HQGSNLL+YEYM +GSLGE+LH S LDW RF IALGAA+GL+
Sbjct: 859 NIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLA 918
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP SKSMSAIAGSYGYIAPE
Sbjct: 919 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPE 978
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043
YAYTMKVTEK DIYSYGVVLLELLTG+APVQP+DQGGD+V WVR++IR ++L SG+LDAR
Sbjct: 979 YAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDAR 1038
Query: 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFE 1094
L L+DE+ VSHM+TVLKIA+LCT++SP RP+MR+VVLML ES R +G E
Sbjct: 1039 LTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIESERSEGEQE 1089
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 1351 bits (3497), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 711/1108 (64%), Positives = 866/1108 (78%), Gaps = 20/1108 (1%)
Query: 3 MGRISYSYRLFSAS----ILAIICLLVHQTKGLVNIEGQILLLIKSK-LVDNSNYLGNWN 57
MG + ++ S S +L ++ LLV ++ L N +GQ LL +K++ D+ N L NWN
Sbjct: 1 MGWWIFEFKKESKSMFVGVLFLLTLLVWTSESL-NSDGQFLLELKNRGFQDSLNRLHNWN 59
Query: 58 PNDSTPCGWIGVNCTTNDFGA-----VVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFN 112
D TPC WIGVNC++ + VV SL+L+ MNLSG +SP+IGGLV+L L+L++N
Sbjct: 60 GIDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYN 119
Query: 113 QLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGK 172
L+ +IP+EIGNCS LEV+ LNNN+ IP E+ LS L NI NN++SGP P+EIG
Sbjct: 120 ALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGD 179
Query: 173 LSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQN 232
L L +LVAY+NN++G LP +LGNL +L +FRAGQN SG++P+EIG C +L+ LGLAQN
Sbjct: 180 LYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQN 239
Query: 233 QLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGS 292
+SGE+PKEIGML L +VILW N+ SG IPK++GN TSLETLALY N VG +P E+G+
Sbjct: 240 FISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGN 299
Query: 293 IGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFEN 352
+ SLK LY+Y+N+LNGTIP+E+GKLS +EIDFSEN L GEIPVELSKI L LLYLF+N
Sbjct: 300 MKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQN 359
Query: 353 KLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGA 412
KLTG+IP EL+ L+NL KLDLSINSLTG IP GFQ LT++ LQLF NSL G IPQ LG
Sbjct: 360 KLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGL 419
Query: 413 YSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGN 472
YS LWVVD S+N L+GKIP IC+ ++LI LNL +N++ G+IP GV RCKSL+QLR+ GN
Sbjct: 420 YSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGN 479
Query: 473 SFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGN 532
TG FP++LCKL NLS +ELDQN+FSGP+P EIG C LQRLHL+ N F+ LP E+
Sbjct: 480 RLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISK 539
Query: 533 LSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSEN 592
LSNLVTFNVSSN LTG IP EI +CKMLQRLDLS N F+G+LP E+GSL QLE+L+LSEN
Sbjct: 540 LSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSEN 599
Query: 593 ELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELG 652
SG+IP IGNL+ LTELQMGGN FSG IP +LG LSSLQIA+NLSYN+ SG IPPE+G
Sbjct: 600 RFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIG 659
Query: 653 NLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGS 712
NL LL YL LNNNHLSGEIP +F NLSSLLGCNFSYNNLTG +P +Q FQNM++ SF G+
Sbjct: 660 NLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGN 719
Query: 713 KGLCGGPLQNCTQPPSSLPFPSGTNSPTARLGKLVAIIAAAIGGVSLVLITVIIYFLRQP 772
KGLCGG L++C SS P S + +AR G+++ I+++ IGG+SL+LI ++++FLR P
Sbjct: 720 KGLCGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNP 779
Query: 773 VEVVAP-LQDKQLSSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLR 831
VE AP + DK+ SDIYF PKE FT KD++ AT F + +++GRGACGTVY+AV+
Sbjct: 780 VEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMP 839
Query: 832 TGHTVAVKKL----ASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG--SNLL 885
+G T+AVKKL N +NN DNSFRAEILTLGKIRHRNIV+LY FCYHQG SNLL
Sbjct: 840 SGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLL 899
Query: 886 MYEYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNIL 944
+YEYM+RGSLGELLHG S ++DW TRF IALGAAEGL+YLHHDCKPRI HRDIKSNNIL
Sbjct: 900 LYEYMSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNIL 959
Query: 945 LDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLL 1004
+D+ FEAHVGDFGLAKVIDMP SKS+SA+AGSYGYIAPEYAYTMKVTEKCDIYS+GVVLL
Sbjct: 960 IDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLL 1019
Query: 1005 ELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL-NLQDEKTVSHMITVLKIAM 1063
ELLTG+APVQPL+QGGDL TW RN IR++SL S +LD L ++D+ ++HMITV KIA+
Sbjct: 1020 ELLTGKAPVQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAV 1079
Query: 1064 LCTNISPFDRPTMREVVLMLSESNRRQG 1091
LCT SP DRPTMREVVLML ES R G
Sbjct: 1080 LCTKSSPSDRPTMREVVLMLIESGERAG 1107
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 1091 bits (2822), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 582/1059 (54%), Positives = 736/1059 (69%), Gaps = 11/1059 (1%)
Query: 32 VNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLS 91
+N EG++LL K+ L D++ YL +WN DS PC W G+ CT V S++L MNLS
Sbjct: 24 LNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACT---HLRTVTSVDLNGMNLS 80
Query: 92 GYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSS 151
G LSP I L L L++S N +S IP+++ C SLEVL+L NR IP +L + +
Sbjct: 81 GTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIIT 140
Query: 152 LTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLIS 211
L L + N + G P++IG LS+L +LV YSNN++G +PP++ L++L+ RAG+N S
Sbjct: 141 LKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFS 200
Query: 212 GSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTS 271
G +PSEI GCESL+ LGLA+N L G +PK++ L+ LTD+ILW N+LSG IP +GN +
Sbjct: 201 GVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISR 260
Query: 272 LETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLI 331
LE LAL++N G +P+E+G + +K LY+Y N+L G IPREIG L A EIDFSEN L
Sbjct: 261 LEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLT 320
Query: 332 GEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTN 391
G IP E IL L+LL+LFEN L G IP EL L L KLDLSIN L GTIP Q+L
Sbjct: 321 GFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPY 380
Query: 392 LIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLT 451
L+ LQLFDN L G IP +G YS V+D+S N L+G IP H CR +LI L+L +NKL+
Sbjct: 381 LVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLS 440
Query: 452 GSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNA 511
G+IP + CKSL +L LG N TGS P +L L NL+ +EL QN SG I ++G
Sbjct: 441 GNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKN 500
Query: 512 LQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFV 571
L+RL L++N FTGE+P E+GNL+ +V FN+SSN LTG IP E+ SC +QRLDLS NKF
Sbjct: 501 LERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFS 560
Query: 572 GALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSS 631
G + +E+G L LE+L+LS+N L+G IP G+L+RL ELQ+GGN S IP ELG L+S
Sbjct: 561 GYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTS 620
Query: 632 LQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNL 691
LQI+LN+S+NNLSG IP LGNL +LE L LN+N LSGEIP S NL SLL CN S NNL
Sbjct: 621 LQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNL 680
Query: 692 TGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQP--PSSLPFPSGTNSPTARLGKLVAI 749
G +P + FQ M ++F+G+ GLC +C QP P S + + + R K++ I
Sbjct: 681 VGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHC-QPLVPHSDSKLNWLINGSQR-QKILTI 738
Query: 750 IAAAIGGVSLVLITVIIYFLRQPVEVVAPLQDKQLSSTVSDIYFPPKEGFTFKDLVVATD 809
IG V L+ + + +++ L+D Q V D Y+ PK+GFT++ LV AT
Sbjct: 739 TCIVIGSVFLITFLGLCWTIKRREPAFVALED-QTKPDVMDSYYFPKKGFTYQGLVDATR 797
Query: 810 NFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN 869
NF E V+GRGACGTVY+A + G +AVKKL S EG ++ DNSFRAEI TLGKIRHRN
Sbjct: 798 NFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASS-DNSFRAEISTLGKIRHRN 856
Query: 870 IVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASST--LDWQTRFMIALGAAEGLSYLHH 927
IVKLYGFCYHQ SNLL+YEYM++GSLGE L LDW R+ IALGAAEGL YLHH
Sbjct: 857 IVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHH 916
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
DC+P+I HRDIKSNNILLD++F+AHVGDFGLAK+ID+ SKSMSA+AGSYGYIAPEYAYT
Sbjct: 917 DCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYT 976
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047
MKVTEKCDIYS+GVVLLEL+TG+ PVQPL+QGGDLV WVR IRN M DARL+
Sbjct: 977 MKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTN 1036
Query: 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086
D++TV M VLKIA+ CT+ SP RPTMREVV M++E+
Sbjct: 1037 DKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEA 1075
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 679 bits (1751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/1090 (38%), Positives = 602/1090 (55%), Gaps = 59/1090 (5%)
Query: 13 FSASILAIICLLVHQTKGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNCT 72
FS ++ + + T N ++ + S + WNP+DS PC W + C+
Sbjct: 18 FSITLSLFLAFFISSTSASTNEVSALISWLHSSNSPPPSVFSGWNPSDSDPCQWPYITCS 77
Query: 73 TNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLN 132
++D +V +N+ + L+ PNI L L +S L+ I EIG+CS L V++
Sbjct: 78 SSD-NKLVTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVID 136
Query: 133 LNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPP 192
L++N L IP LG L +L L + +N ++G P E+G +L L + N +S +LP
Sbjct: 137 LSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPL 196
Query: 193 TLGNLKRLKSFRAGQNL-ISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDV 251
LG + L+S RAG N +SG +P EIG C +L+ LGLA ++SG +P +G L L +
Sbjct: 197 ELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSL 256
Query: 252 ILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIP 311
++ LSG IPKELGNC+ L L LYDN G LPKELG + +L+ + +++N L+G IP
Sbjct: 257 SVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIP 316
Query: 312 REIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKL 371
EIG + S ID S N G IP + L+ L L N +TG IP L+ L +
Sbjct: 317 EEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQF 376
Query: 372 DLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIP 431
+ N ++G IP L L + + N L G IP L L +DLS N+LTG +P
Sbjct: 377 QIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLP 436
Query: 432 RHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTV 491
+ + +L L L +N ++G IP + C SLV+LRL N TG P + L NLS +
Sbjct: 437 AGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFL 496
Query: 492 ELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIP 551
+L +N SGP+P EI NC LQ L+LS+N G LP + +L+ L +VSSN LTG+IP
Sbjct: 497 DLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIP 556
Query: 552 LEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTEL 611
+ L RL LS N F G +P +G L+LL LS N +SG+
Sbjct: 557 DSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGT-------------- 602
Query: 612 QMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEI 671
IP EL + L IALNLS+N+L G IP + L L L +++N LSG++
Sbjct: 603 ----------IPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDL 652
Query: 672 PGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPSSLP 731
+ L +L+ N S+N +G +P S+ F+ + G+ GLC ++C
Sbjct: 653 -SALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSC-------- 703
Query: 732 FPSGTNSPTARLGKLVAIIAAAIG---GVSLVLITVIIYFLRQPVEVVAPLQDKQLSSTV 788
F S ++ T + G + AIG V+ VL + + + + +++ D + +
Sbjct: 704 FVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENL 763
Query: 789 SDIYFPP--KEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLA---- 842
F P K FT + ++ E VIG+G G VY+A + +AVKKL
Sbjct: 764 WTWQFTPFQKLNFTVEHVLKC---LVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTV 820
Query: 843 ---SNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL 899
+ + ++ V +SF AE+ TLG IRH+NIV+ G C+++ + LLMY+YM+ GSLG LL
Sbjct: 821 PNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLL 880
Query: 900 HGAS--STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957
H S +L W+ R+ I LGAA+GL+YLHHDC P I HRDIK+NNIL+ FE ++GDFG
Sbjct: 881 HERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFG 940
Query: 958 LAKVIDMPQ-SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQP- 1015
LAK++D ++S + IAGSYGYIAPEY Y+MK+TEK D+YSYGVV+LE+LTG+ P+ P
Sbjct: 941 LAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPT 1000
Query: 1016 LDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPT 1075
+ G +V WV+ IR+ ++ L AR E V M+ L +A+LC N P DRPT
Sbjct: 1001 IPDGLHIVDWVKK-IRDIQVIDQGLQAR----PESEVEEMMQTLGVALLCINPIPEDRPT 1055
Query: 1076 MREVVLMLSE 1085
M++V MLSE
Sbjct: 1056 MKDVAAMLSE 1065
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 665 bits (1717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/1064 (38%), Positives = 596/1064 (56%), Gaps = 65/1064 (6%)
Query: 55 NWNPNDSTPCG-WIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQ 113
NWN D+TPC W + C++ F + +++ + L L N+ L L +S
Sbjct: 60 NWNSIDNTPCNNWTFITCSSQGF---ITDIDIESVPLQLSLPKNLPAFRSLQKLTISGAN 116
Query: 114 LSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKL 173
L+ +P+ +G+C L+VL+L++N L IP L L +L L + +N+++G P +I K
Sbjct: 117 LTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKC 176
Query: 174 SALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNL-ISGSLPSEIGGCESLQYLGLAQN 232
S L L+ + N ++GS+P LG L L+ R G N ISG +PSEIG C +L LGLA+
Sbjct: 177 SKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAET 236
Query: 233 QLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGS 292
+SG +P +G LK L + ++ +SG IP +LGNC+ L L LY+N G +P+E+G
Sbjct: 237 SVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQ 296
Query: 293 IGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFEN 352
+ L+ L++++N L G IP EIG S+ ID S N L G IP + ++ LE + +N
Sbjct: 297 LTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDN 356
Query: 353 KLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGA 412
K +G IP ++ +L +L L N ++G IP LT L + + N L G IP L
Sbjct: 357 KFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLAD 416
Query: 413 YSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGN 472
+ L +DLS N LTG IP + +L L L +N L+G IP + C SLV+LRLG N
Sbjct: 417 CTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFN 476
Query: 473 SFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGN 532
TG PS + L ++ ++ N+ G +P EIG+C+ LQ + LS+N G LP V +
Sbjct: 477 RITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSS 536
Query: 533 LSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSEN 592
LS L +VS+N +G+IP + L +L LS N F G++P +G L+LL L N
Sbjct: 537 LSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSN 596
Query: 593 ELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELG 652
ELSG IP+ELG + +L+IALNLS N L+G IP ++
Sbjct: 597 ELSGE------------------------IPSELGDIENLEIALNLSSNRLTGKIPSKIA 632
Query: 653 NLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGS 712
+L L L L++N L G++ N+ +L+ N SYN+ +G +P ++ F+ +S G+
Sbjct: 633 SLNKLSILDLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGN 691
Query: 713 KGLCGGPLQNCTQPPSSLPFPSGT----NSPTARLGKLVAIIAAAIGGVSLVLITVIIYF 768
K LC + TQ L + G + +R KL +A I +++I +
Sbjct: 692 KKLC-----SSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAV 746
Query: 769 LRQPVEVVAPLQDKQLSSTVSDIY---FPPKEGFTFK-DLVVATDNFDERFVIGRGACGT 824
+R + D + S + + Y F P + F D ++ E VIG+G G
Sbjct: 747 IRARRNI-----DNERDSELGETYKWQFTPFQKLNFSVDQIIRC--LVEPNVIGKGCSGV 799
Query: 825 VYRAVLRTGHTVAVKKL------ASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCY 878
VYRA + G +AVKKL + E NV +SF AE+ TLG IRH+NIV+ G C+
Sbjct: 800 VYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCW 859
Query: 879 HQGSNLLMYEYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRD 937
++ + LLMY+YM GSLG LLH S+LDW R+ I LGAA+GL+YLHHDC P I HRD
Sbjct: 860 NRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRD 919
Query: 938 IKSNNILLDDKFEAHVGDFGLAKVIDMPQ-SKSMSAIAGSYGYIAPEYAYTMKVTEKCDI 996
IK+NNIL+ FE ++ DFGLAK++D + + +AGSYGYIAPEY Y+MK+TEK D+
Sbjct: 920 IKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDV 979
Query: 997 YSYGVVLLELLTGRAPVQP-LDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHM 1055
YSYGVV+LE+LTG+ P+ P + +G LV WV R N +LD+ L + E M
Sbjct: 980 YSYGVVVLEVLTGKQPIDPTVPEGIHLVDWV----RQNRGSLEVLDSTLRSRTEAEADEM 1035
Query: 1056 ITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMD 1099
+ VL A+LC N SP +RPTM++V ML E +Q E++ +D
Sbjct: 1036 MQVLGTALLCVNSSPDERPTMKDVAAMLKEI--KQEREEYAKVD 1077
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 665 bits (1716), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/1065 (37%), Positives = 605/1065 (56%), Gaps = 56/1065 (5%)
Query: 70 NCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLE 129
NCT+ A F+ L+G L + L +L L+L N S IP ++G+ S++
Sbjct: 214 NCTSLALFAAAFN------RLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQ 267
Query: 130 VLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGS 189
LNL N+L+ IPK L L++L L++ +N ++G +E +++ L LV N +SGS
Sbjct: 268 YLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGS 327
Query: 190 LPPTL-GNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYL 248
LP T+ N LK + +SG +P+EI C+SL+ L L+ N L+G+IP + L L
Sbjct: 328 LPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVEL 387
Query: 249 TDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNG 308
T++ L N L G + + N T+L+ LY N G++PKE+G +G L+ +Y+Y N +G
Sbjct: 388 TNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSG 447
Query: 309 TIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNL 368
+P EIG + EID+ N L GEIP + ++ L L+L EN+L G IP L +
Sbjct: 448 EMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQM 507
Query: 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTG 428
T +DL+ N L+G+IP F +LT L + +++NSL G +P L L ++ S N G
Sbjct: 508 TVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNG 567
Query: 429 KIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANL 488
I +C ++S + ++ N G IP + + +L +LRLG N FTG P K++ L
Sbjct: 568 SI-SPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISEL 626
Query: 489 STVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTG 548
S +++ +N SG IP E+G C L + L++NY +G +P +G L L +SSN G
Sbjct: 627 SLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVG 686
Query: 549 RIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRL 608
+P EIFS + L L N G++P+EIG+L L L L EN+LSG +P IG LS+L
Sbjct: 687 SLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKL 746
Query: 609 TELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLS 668
EL++ N+ +G IP E+G L LQ AL+LSYNN +G IP + L LE L L++N L
Sbjct: 747 FELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLV 806
Query: 669 GEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPS 728
GE+PG ++ SL N SYNNL G + + F ++F G+ GLCG PL +C +
Sbjct: 807 GEVPGQIGDMKSLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAGLCGSPLSHCNR--- 861
Query: 729 SLPFPSGTNSPTARLGKLVAIIAA--AIGGVSLVLITVIIYFLRQPVEVVAPLQDKQLSS 786
+G+ + + K V II+A ++ ++L+++ VII F +Q ++ ++ +
Sbjct: 862 -----AGSKNQRSLSPKTVVIISAISSLAAIALMVL-VIILFFKQNHDLFKKVRGGNSAF 915
Query: 787 TVSDIYFP--------PKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAV 838
+ + K + D++ AT +E F+IG G G VY+A L+ G T+AV
Sbjct: 916 SSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAV 975
Query: 839 KKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLLMYEYMARGSLG 896
KK+ + +N SF E+ TLG IRHR++VKL G+C + G NLL+YEYMA GS+
Sbjct: 976 KKILWKDDLMSN--KSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVW 1033
Query: 897 ELLHGASST-----LDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEA 951
+ LH +T L W+TR IALG A+G+ YLH+DC P I HRDIKS+N+LLD EA
Sbjct: 1034 DWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEA 1093
Query: 952 HVGDFGLAKVID---MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 1008
H+GDFGLAK++ ++S + AGSYGYIAPEYAY++K TEK D+YS G+VL+E++T
Sbjct: 1094 HLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVT 1153
Query: 1009 GRAPVQPL-DQGGDLVTWVRNFIRN-------NSLVSGMLDARLNLQDEKTVSHMITVLK 1060
G+ P + + D+ D+V WV + L+ L + L ++E VL+
Sbjct: 1154 GKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQ----VLE 1209
Query: 1061 IAMLCTNISPFDRPTMREVV-LMLSESNRRQGHFEFSPMDHDSDQ 1104
IA+ CT P +RP+ R+ +L+ N R + M D+D+
Sbjct: 1210 IALQCTKSYPQERPSSRQASEYLLNVFNNRAASYR--EMQTDTDK 1252
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 647 bits (1668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/1037 (37%), Positives = 583/1037 (56%), Gaps = 51/1037 (4%)
Query: 90 LSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNL 149
L+G + +G L +L L+L+ N L+ IP ++G S L+ L+L N+L+ IPK L +L
Sbjct: 227 LNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADL 286
Query: 150 SSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTL-GNLKRLKSFRAGQN 208
+L L++ N ++G P+E +S L LV +N++SGSLP ++ N L+
Sbjct: 287 GNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGT 346
Query: 209 LISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGN 268
+SG +P E+ C+SL+ L L+ N L+G IP+ + L LTD+ L N L G + + N
Sbjct: 347 QLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISN 406
Query: 269 CTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSEN 328
T+L+ L LY N G+LPKE+ ++ L+ L++Y N +G IP+EIG +S ID N
Sbjct: 407 LTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGN 466
Query: 329 SLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQY 388
GEIP + ++ L LL+L +N+L G +P L L LDL+ N L+G+IP F +
Sbjct: 467 HFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGF 526
Query: 389 LTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETN 448
L L L L++NSL G +P L + L ++LS N L G I +C ++S + ++ N
Sbjct: 527 LKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTI-HPLCGSSSYLSFDVTNN 585
Query: 449 KLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGN 508
IP + ++L +LRLG N TG P L K+ LS +++ N +G IP ++
Sbjct: 586 GFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVL 645
Query: 509 CNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWN 568
C L + L++N+ +G +P +G LS L +SSN +P E+F+C L L L N
Sbjct: 646 CKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGN 705
Query: 569 KFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGS 628
G++P+EIG+L L +L L +N+ SGS+P +G LS+L EL++ NS +G IP E+G
Sbjct: 706 SLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQ 765
Query: 629 LSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSY 688
L LQ AL+LSYNN +G IP +G L LE L L++N L+GE+PGS ++ SL N S+
Sbjct: 766 LQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSF 825
Query: 689 NNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPSSLPFPSGTNSPTARLGKLVA 748
NNL G + + F +SF G+ GLCG PL C + S N+ L
Sbjct: 826 NNLGGKL--KKQFSRWPADSFLGNTGLCGSPLSRCNRVRS--------NNKQQGLSARSV 875
Query: 749 IIAAAIGGVSLV--LITVIIYFLRQPVEVVAPLQDKQLSST-----VSDIYFP------P 795
+I +AI ++ + +I VI F +Q + + + T + P
Sbjct: 876 VIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGAS 935
Query: 796 KEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSF 855
K ++D++ AT N E F+IG G G VY+A L G TVAVKK+ + +N SF
Sbjct: 936 KSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSN--KSF 993
Query: 856 RAEILTLGKIRHRNIVKLYGFC--YHQGSNLLMYEYMARGSLGELLH-------GASSTL 906
E+ TLG+IRHR++VKL G+C +G NLL+YEYM GS+ + LH L
Sbjct: 994 SREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLL 1053
Query: 907 DWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM-- 964
DW+ R IA+G A+G+ YLHHDC P I HRDIKS+N+LLD EAH+GDFGLAKV+
Sbjct: 1054 DWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENC 1113
Query: 965 -PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPL-DQGGDL 1022
+ S + A SYGYIAPEYAY++K TEK D+YS G+VL+E++TG+ P + D+
Sbjct: 1114 DTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDM 1173
Query: 1023 VTWVRNFIR-----NNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMR 1077
V WV + + L+ L L +++ VL+IA+ CT SP +RP+ R
Sbjct: 1174 VRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQ----VLEIALQCTKTSPQERPSSR 1229
Query: 1078 EVV--LMLSESNRRQGH 1092
+ L+ +NR G+
Sbjct: 1230 QACDSLLHVYNNRTAGY 1246
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 629 bits (1623), Expect = e-179, Method: Compositional matrix adjust.
Identities = 399/1075 (37%), Positives = 590/1075 (54%), Gaps = 68/1075 (6%)
Query: 57 NPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSR 116
N +++TPC W G+ C D V SLN T+ +SG L P IG L L LDLS N S
Sbjct: 57 NASEATPCNWFGITC---DDSKNVASLNFTRSRVSGQLGPEIGELKSLQILDLSTNNFSG 113
Query: 117 NIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSAL 176
IP +GNC+ L L+L+ N IP L +L L +L +Y N ++G P+ + ++ L
Sbjct: 114 TIPSTLGNCTKLATLDLSENGFSDKIPDTLDSLKRLEVLYLYINFLTGELPESLFRIPKL 173
Query: 177 SQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSG 236
L NN++G +P ++G+ K L N SG++P IG SLQ L L +N+L G
Sbjct: 174 QVLYLDYNNLTGPIPQSIGDAKELVELSMYANQFSGNIPESIGNSSSLQILYLHRNKLVG 233
Query: 237 EIPKEIGM------------------------LKYLTDVILWGNQLSGVIPKELGNCTSL 272
+P+ + + K L + L N+ G +P LGNC+SL
Sbjct: 234 SLPESLNLLGNLTTLFVGNNSLQGPVRFGSPNCKNLLTLDLSYNEFEGGVPPALGNCSSL 293
Query: 273 ETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIG 332
+ L + G +P LG + +L L + N L+G+IP E+G SS + ++N L+G
Sbjct: 294 DALVIVSGNLSGTIPSSLGMLKNLTILNLSENRLSGSIPAELGNCSSLNLLKLNDNQLVG 353
Query: 333 EIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNL 392
IP L K+ LE L LFEN+ +G IP+E+ ++LT+L + N+LTG +P+ + L
Sbjct: 354 GIPSALGKLRKLESLELFENRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVEMTEMKKL 413
Query: 393 IMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTG 452
+ LF+NS G IP LG S L VD N LTG+IP ++C L LNL +N L G
Sbjct: 414 KIATLFNNSFYGAIPPGLGVNSSLEEVDFIGNKLTGEIPPNLCHGRKLRILNLGSNLLHG 473
Query: 453 SIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNAL 512
+IP + CK++ + L N+ +G P + + +LS ++ + N F GPIP +G+C L
Sbjct: 474 TIPASIGHCKTIRRFILRENNLSGLLP-EFSQDHSLSFLDFNSNNFEGPIPGSLGSCKNL 532
Query: 513 QRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVG 572
++LS N FTG++P ++GNL NL N+S N L G +P ++ +C L+R D+ +N G
Sbjct: 533 SSINLSRNRFTGQIPPQLGNLQNLGYMNLSRNLLEGSLPAQLSNCVSLERFDVGFNSLNG 592
Query: 573 ALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSL 632
++P + L L LSEN SG IP + L +L+ LQ+ N+F G IP+ +G + L
Sbjct: 593 SVPSNFSNWKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSSIGLIEDL 652
Query: 633 QIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692
L+LS N L+G IP +LG+LI L L ++NN+L+G + L+SLL + S N T
Sbjct: 653 IYDLDLSGNGLTGEIPAKLGDLIKLTRLNISNNNLTGSL-SVLKGLTSLLHVDVSNNQFT 711
Query: 693 GPIPSSQTFQNMSV-NSFSGSKGLCGGPLQNCTQPPSSLPFPSGTNSPTARLGKLVAIIA 751
GPIP + Q +S +SFSG+ LC P S S +N+ + L
Sbjct: 712 GPIPDNLEGQLLSEPSSFSGNPNLC---------IPHSF---SASNNSRSALKYCKDQSK 759
Query: 752 AAIGGVSLVLITVIIYFLRQPVEVVAP------LQDKQLSSTVSDIYFPPKEG--FTFKD 803
+ G+S I +I V VV L+ ++ F +EG
Sbjct: 760 SRKSGLSTWQIVLIAVLSSLLVLVVVLALVFICLRRRKGRPEKDAYVFTQEEGPSLLLNK 819
Query: 804 LVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKL--ASNREGNNNVDNSFRAEILT 861
++ ATDN +E++ IGRGA G VYRA L +G AVK+L AS+ N S EI T
Sbjct: 820 VLAATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVKRLVFASHIRAN----QSMMREIDT 875
Query: 862 LGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGAS---STLDWQTRFMIALGA 918
+GK+RHRN++KL GF + L++Y YM +GSL ++LHG S + LDW R+ +ALG
Sbjct: 876 IGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDWSARYNVALGV 935
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG 978
A GL+YLH+DC P I HRDIK NIL+D E H+GDFGLA+++D + S + + G+ G
Sbjct: 936 AHGLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLD-DSTVSTATVTGTTG 994
Query: 979 YIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNS--- 1034
YIAPE A+ + D+YSYGVVLLEL+T RA + + D+V+WVR+ + +++
Sbjct: 995 YIAPENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSFPESTDIVSWVRSALSSSNNNV 1054
Query: 1035 --LVSGMLDARL--NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+V+ ++D L L D ++ V ++A+ CT P RPTMR+ V +L +
Sbjct: 1055 EDMVTTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPTMRDAVKLLED 1109
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 620 bits (1599), Expect = e-176, Method: Compositional matrix adjust.
Identities = 397/1051 (37%), Positives = 576/1051 (54%), Gaps = 52/1051 (4%)
Query: 57 NPNDSTPCG--WIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQL 114
N +++TPC W GV C + G VV +LNL+ LSG L IG L L LDLS N
Sbjct: 55 NTSETTPCNNNWFGVICDLS--GNVVETLNLSASGLSGQLGSEIGELKSLVTLDLSLNSF 112
Query: 115 SRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLS 174
S +P +GNC+SLE L+L+NN +P G+L +LT L + N +SG P +G L
Sbjct: 113 SGLLPSTLGNCTSLEYLDLSNNDFSGEVPDIFGSLQNLTFLYLDRNNLSGLIPASVGGLI 172
Query: 175 ALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQL 234
L L NN+SG++P LGN +L+ N ++GSLP+ + E+L L ++ N L
Sbjct: 173 ELVDLRMSYNNLSGTIPELLGNCSKLEYLALNNNKLNGSLPASLYLLENLGELFVSNNSL 232
Query: 235 SGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIG 294
G + K L + L N G +P E+GNC+SL +L + G +P +G +
Sbjct: 233 GGRLHFGSSNCKKLVSLDLSFNDFQGGVPPEIGNCSSLHSLVMVKCNLTGTIPSSMGMLR 292
Query: 295 SLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKL 354
+ + + N L+G IP+E+G SS + ++N L GEIP LSK+ L+ L LF NKL
Sbjct: 293 KVSVIDLSDNRLSGNIPQELGNCSSLETLKLNDNQLQGEIPPALSKLKKLQSLELFFNKL 352
Query: 355 TGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYS 414
+G IP+ + +++LT++ + N+LTG +P+ L +L L LF+N G IP LG
Sbjct: 353 SGEIPIGIWKIQSLTQMLVYNNTLTGELPVEVTQLKHLKKLTLFNNGFYGDIPMSLGLNR 412
Query: 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSF 474
L VDL N TG+IP H+C L L +N+L G IP + +CK+L ++RL N
Sbjct: 413 SLEEVDLLGNRFTGEIPPHLCHGQKLRLFILGSNQLHGKIPASIRQCKTLERVRLEDNKL 472
Query: 475 TGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLS 534
+G P + + +LS V L N F G IP +G+C L + LS N TG +P E+GNL
Sbjct: 473 SGVLP-EFPESLSLSYVNLGSNSFEGSIPRSLGSCKNLLTIDLSQNKLTGLIPPELGNLQ 531
Query: 535 NLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENEL 594
+L N+S N+L G +P ++ C L D+ N G++P S L L LS+N
Sbjct: 532 SLGLLNLSHNYLEGPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRSWKSLSTLVLSDNNF 591
Query: 595 SGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNL 654
G+IP + L RL++L++ N+F G IP+ +G L SL+ L+LS N +G IP LG L
Sbjct: 592 LGAIPQFLAELDRLSDLRIARNAFGGKIPSSVGLLKSLRYGLDLSANVFTGEIPTTLGAL 651
Query: 655 ILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKG 714
I LE L ++NN L+G + +L SL + SYN TGPIP VN S S
Sbjct: 652 INLERLNISNNKLTGPL-SVLQSLKSLNQVDVSYNQFTGPIP---------VNLLSNSSK 701
Query: 715 LCGGPLQNCTQPPSSL------PFPSGTNSPTARLGKLVAIIAAAIGGVSLVLITVIIYF 768
G P C Q S+ F S K +A+IAA G SL ++ ++
Sbjct: 702 FSGNP-DLCIQASYSVSAIIRKEFKSCKGQVKLSTWK-IALIAA---GSSLSVLALLFAL 756
Query: 769 LRQPVEVVAPLQDKQLSSTVSDIYFPPKEGFT--FKDLVVATDNFDERFVIGRGACGTVY 826
+ + D +EG + ++ ATDN D++++IGRGA G VY
Sbjct: 757 FLVLCRC-------KRGTKTEDANILAEEGLSLLLNKVLAATDNLDDKYIIGRGAHGVVY 809
Query: 827 RAVLRTGHTVAVKKL--ASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884
RA L +G AVKKL A + N N+ + EI T+G +RHRN+++L F + L
Sbjct: 810 RASLGSGEEYAVKKLIFAEHIRANQNM----KREIETIGLVRHRNLIRLERFWMRKEDGL 865
Query: 885 LMYEYMARGSLGELLH---GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSN 941
++Y+YM GSL ++LH + LDW RF IALG + GL+YLHHDC P I HRDIK
Sbjct: 866 MLYQYMPNGSLHDVLHRGNQGEAVLDWSARFNIALGISHGLAYLHHDCHPPIIHRDIKPE 925
Query: 942 NILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGV 1001
NIL+D E H+GDFGLA+++D + S + + G+ GYIAPE AY +++ D+YSYGV
Sbjct: 926 NILMDSDMEPHIGDFGLARILD-DSTVSTATVTGTTGYIAPENAYKTVRSKESDVYSYGV 984
Query: 1002 VLLELLTG-RAPVQPLDQGGDLVTWVRNFIRN----NSLVSGMLDARL--NLQDEKTVSH 1054
VLLEL+TG RA + + ++V+WVR+ + + + ++D +L L D K
Sbjct: 985 VLLELVTGKRALDRSFPEDINIVSWVRSVLSSYEDEDDTAGPIVDPKLVDELLDTKLREQ 1044
Query: 1055 MITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
I V +A+ CT+ P +RP+MR+VV L++
Sbjct: 1045 AIQVTDLALRCTDKRPENRPSMRDVVKDLTD 1075
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 617 bits (1592), Expect = e-175, Method: Compositional matrix adjust.
Identities = 398/1072 (37%), Positives = 579/1072 (54%), Gaps = 48/1072 (4%)
Query: 50 SNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDL 109
S+ +WN +DSTPC W+GV C F V +LNL+ +SG P I L HL + L
Sbjct: 43 SDITQSWNASDSTPCSWLGVECDRRQF---VDTLNLSSYGISGEFGPEISHLKHLKKVVL 99
Query: 110 SFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKE 169
S N +IP ++GNCS LE ++L++N +IP LG L +L L+++ N + GPFP+
Sbjct: 100 SGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQNLRNLSLFFNSLIGPFPES 159
Query: 170 ------------------------IGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRA 205
IG +S L+ L N SG +P +LGN+ L+
Sbjct: 160 LLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSGPVPSSLGNITTLQELYL 219
Query: 206 GQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKE 265
N + G+LP + E+L YL + N L G IP + K + + L NQ +G +P
Sbjct: 220 NDNNLVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPG 279
Query: 266 LGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDF 325
LGNCTSL + G +P G + L LY+ N +G IP E+GK S +++
Sbjct: 280 LGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHFSGRIPPELGKCKSMIDLQL 339
Query: 326 SENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG 385
+N L GEIP EL + L+ L+L+ N L+G +P+ + +++L L L N+L+G +P+
Sbjct: 340 QQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIWKIQSLQSLQLYQNNLSGELPVD 399
Query: 386 FQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNL 445
L L+ L L++N G IPQ LGA S L V+DL+ N TG IP ++C L L L
Sbjct: 400 MTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLL 459
Query: 446 ETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTE 505
N L GS+P+ + C +L +L L N+ G P D + NL +L N F+GPIP
Sbjct: 460 GYNYLEGSVPSDLGGCSTLERLILEENNLRGGLP-DFVEKQNLLFFDLSGNNFTGPIPPS 518
Query: 506 IGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDL 565
+GN + ++LS N +G +P E+G+L L N+S N L G +P E+ +C L LD
Sbjct: 519 LGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEHLNLSHNILKGILPSELSNCHKLSELDA 578
Query: 566 SWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAE 625
S N G++P +GSL +L L L EN SG IP + ++L LQ+GGN +G IP
Sbjct: 579 SHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGDIPP- 637
Query: 626 LGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCN 685
+G+L +L+ +LNLS N L+G +P +LG L +LE L +++N+LSG + + SL N
Sbjct: 638 VGALQALR-SLNLSSNKLNGQLPIDLGKLKMLEELDVSHNNLSGTL-RVLSTIQSLTFIN 695
Query: 686 FSYNNLTGPIPSSQT-FQNMSVNSFSGSKGLC-GGPLQNCTQPPSSLPFPSGTNSPTARL 743
S+N +GP+P S T F N S SFSG+ LC P P SS+ P S T +
Sbjct: 696 ISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLCINCPADGLACPESSILRPCNMQSNTGKG 755
Query: 744 GKLVAIIAAAIGGVSLVLITVIIYFLRQPVEVVAPLQDKQLSSTVSDIYFPPKEGFTFKD 803
G IA + G L +I + ++ + +Q+ +S+ D G
Sbjct: 756 GLSTLGIAMIVLGALLFIICLFLFSAFLFLHCKKSVQEIAISAQEGD-------GSLLNK 808
Query: 804 LVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLG 863
++ AT+N ++++VIG+GA GT+Y+A L AVKKL N +V S EI T+G
Sbjct: 809 VLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKLVFTGIKNGSV--SMVREIETIG 866
Query: 864 KIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGAS--STLDWQTRFMIALGAAEG 921
K+RHRN++KL F + L++Y YM GSL ++LH + LDW TR IA+G A G
Sbjct: 867 KVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNPPKPLDWSTRHNIAVGTAHG 926
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS-AIAGSYGYI 980
L+YLH DC P I HRDIK NILLD E H+ DFG+AK++D + S + G+ GY+
Sbjct: 927 LAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKLLDQSATSIPSNTVQGTIGYM 986
Query: 981 APEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG-GDLVTWVRNFIRNNSLVSGM 1039
APE A+T + + D+YSYGVVLLEL+T + + P G D+V WVR+ + +
Sbjct: 987 APENAFTTVKSRESDVYSYGVVLLELITRKKALDPSFNGETDIVGWVRSVWTQTGEIQKI 1046
Query: 1040 LDARL--NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089
+D L L D + + L +A+ C RPTMR+VV L+ + R
Sbjct: 1047 VDPSLLDELIDSSVMEQVTEALSLALRCAEKEVDKRPTMRDVVKQLTRWSIR 1098
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1114 | ||||||
| 224144663 | 1071 | predicted protein [Populus trichocarpa] | 0.959 | 0.998 | 0.741 | 0.0 | |
| 255562043 | 1123 | Leucine-rich repeat receptor protein kin | 0.993 | 0.985 | 0.738 | 0.0 | |
| 224123638 | 1106 | predicted protein [Populus trichocarpa] | 0.973 | 0.980 | 0.720 | 0.0 | |
| 359477838 | 1105 | PREDICTED: probable leucine-rich repeat | 0.941 | 0.949 | 0.732 | 0.0 | |
| 15237562 | 1102 | leucine-rich repeat protein kinase-like | 0.955 | 0.965 | 0.708 | 0.0 | |
| 297793985 | 1102 | hypothetical protein ARALYDRAFT_496585 [ | 0.945 | 0.955 | 0.713 | 0.0 | |
| 255554244 | 1112 | BRASSINOSTEROID INSENSITIVE 1 precursor, | 0.970 | 0.972 | 0.686 | 0.0 | |
| 224072618 | 1106 | predicted protein [Populus trichocarpa] | 0.983 | 0.990 | 0.666 | 0.0 | |
| 224057652 | 1106 | predicted protein [Populus trichocarpa] | 0.983 | 0.990 | 0.678 | 0.0 | |
| 147843348 | 1066 | hypothetical protein VITISV_039668 [Viti | 0.903 | 0.943 | 0.704 | 0.0 |
| >gi|224144663|ref|XP_002325367.1| predicted protein [Populus trichocarpa] gi|222862242|gb|EEE99748.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1571 bits (4067), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 795/1072 (74%), Positives = 911/1072 (84%), Gaps = 3/1072 (0%)
Query: 20 IICLLVHQTKGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAV 79
++ LL HQ+ GL N EGQ LL IKS++ D N+L NWNPNDS PCGW GVNCT+ D+ V
Sbjct: 3 VVSLLFHQSMGL-NAEGQYLLDIKSRIGDTYNHLSNWNPNDSIPCGWKGVNCTS-DYNPV 60
Query: 80 VFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLE 139
V+ L+L+ MNLSG LSP+IGGLVHLT LDLSFN LS+NIP EIGNCSSLE L LNNN E
Sbjct: 61 VWRLDLSSMNLSGSLSPSIGGLVHLTLLDLSFNALSQNIPSEIGNCSSLESLYLNNNLFE 120
Query: 140 AHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKR 199
+ +P EL LS LT LN+ NNRISGPFP +IG LS+LS L+AYSNNI+GSLP +LGNLK
Sbjct: 121 SQLPVELAKLSCLTALNVANNRISGPFPDQIGNLSSLSLLIAYSNNITGSLPASLGNLKH 180
Query: 200 LKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLS 259
L++FRAGQNLISGSLPSEIGGCESL+YLGLAQNQLSGEIPKEIGML+ LT +IL NQLS
Sbjct: 181 LRTFRAGQNLISGSLPSEIGGCESLEYLGLAQNQLSGEIPKEIGMLQNLTALILRSNQLS 240
Query: 260 GVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSS 319
G IP EL NCT LETLALYDNK VG +PKELG++ LK Y+YRN LNGTIPREIG LSS
Sbjct: 241 GPIPMELSNCTYLETLALYDNKLVGPIPKELGNLVYLKRFYLYRNNLNGTIPREIGNLSS 300
Query: 320 ALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLT 379
ALEIDFSEN L GEIP+EL I GL LLY+FEN LTGVIP ELTTL+NLTKLD+SIN+LT
Sbjct: 301 ALEIDFSENELTGEIPIELKNIAGLSLLYIFENMLTGVIPDELTTLENLTKLDISINNLT 360
Query: 380 GTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTS 439
GTIP+GFQ++ LIMLQLFDNSL G IP+ LG Y +LWVVD+S+NHLTG+IPRH+CRN +
Sbjct: 361 GTIPVGFQHMKQLIMLQLFDNSLSGVIPRGLGVYGKLWVVDISNNHLTGRIPRHLCRNEN 420
Query: 440 LIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFS 499
LI LN+ +N LTG IPTGVT C+ LVQL L N GSFPSDLCKLANLS++ELDQN F+
Sbjct: 421 LILLNMGSNNLTGYIPTGVTNCRPLVQLHLAENGLVGSFPSDLCKLANLSSLELDQNMFT 480
Query: 500 GPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKM 559
GPIP EIG C+ LQRLHLS N+FTGELP+E+G LS LV FNVS+NFLTG IP EIF+CKM
Sbjct: 481 GPIPPEIGQCHVLQRLHLSGNHFTGELPKEIGKLSQLVFFNVSTNFLTGVIPAEIFNCKM 540
Query: 560 LQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS 619
LQRLDL+ N FVGALP EIG+L QLE+LKLSEN+LS IPV++GNLSRLT+LQMGGNSFS
Sbjct: 541 LQRLDLTRNNFVGALPSEIGALSQLEILKLSENQLSEHIPVEVGNLSRLTDLQMGGNSFS 600
Query: 620 GGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLS 679
G IPAELG +SSLQIALNLSYNNL+G IP ELGNL+LLE+LLLN+NHLSGEIP +F LS
Sbjct: 601 GEIPAELGGISSLQIALNLSYNNLTGAIPAELGNLVLLEFLLLNDNHLSGEIPDAFDKLS 660
Query: 680 SLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPSSLPFPSGTNSP 739
SLLGCNFS N+LTGP+PS FQ ++SF G+KGLCGG L NC + P P T
Sbjct: 661 SLLGCNFSNNDLTGPLPSLPLFQKTGISSFLGNKGLCGGTLGNCNEFPHLSSHPPDTEGT 720
Query: 740 TARLGKLVAIIAAAIGGVSLVLITVIIYFLRQPVEVVAPLQDKQLSSTVSDIYFPPKEGF 799
+ R+GK++AII+A IGG SL+LI VIIYF+R+PV ++A L DK SS VSDIYF PK+GF
Sbjct: 721 SVRIGKIIAIISAVIGGSSLILIIVIIYFMRRPVAIIASLPDKPSSSPVSDIYFSPKDGF 780
Query: 800 TFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEI 859
TF+DLVVATDNFD+ FV+GRGACGTVY+AVLR G +AVK+LASNREG NN+DNSFRAEI
Sbjct: 781 TFQDLVVATDNFDDSFVLGRGACGTVYKAVLRCGRIIAVKRLASNREG-NNIDNSFRAEI 839
Query: 860 LTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAA 919
LTLG IRHRNIVKLYGFC HQGSNLL+YEY+ARGSLGELLHG+S LDW+TRF IALGAA
Sbjct: 840 LTLGNIRHRNIVKLYGFCNHQGSNLLLYEYLARGSLGELLHGSSCGLDWRTRFKIALGAA 899
Query: 920 EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGY 979
+GL+YLHHDCKPRIFHRDIKSNNILLD+KFEAHVGDFGLAKVIDMPQ KSMSA+AGSYGY
Sbjct: 900 QGLAYLHHDCKPRIFHRDIKSNNILLDEKFEAHVGDFGLAKVIDMPQWKSMSAVAGSYGY 959
Query: 980 IAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039
IAPEYAYTMKVTEKCDIYSYGVVLLELLTGR PVQ LDQGGDLV+WVRN+I+ +SL GM
Sbjct: 960 IAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQSLDQGGDLVSWVRNYIQVHSLSPGM 1019
Query: 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091
LD R+NLQD+ T+ HMITV+KIA++CT++SP DRPTMREVV ML ESN+ +G
Sbjct: 1020 LDDRINLQDQNTIPHMITVMKIALVCTSMSPLDRPTMREVVSMLMESNKLEG 1071
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562043|ref|XP_002522030.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] gi|223538834|gb|EEF40434.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1557 bits (4032), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 821/1112 (73%), Positives = 928/1112 (83%), Gaps = 5/1112 (0%)
Query: 3 MGRISYSYRLFSASILAIICLLVHQTKGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDST 62
MGRI SY S S+L +I LL HQ+ GL N +GQ LL IKS+LVDNSN+L +WNPNDST
Sbjct: 1 MGRIRISYGSISISVL-VIFLLFHQSFGL-NADGQFLLDIKSRLVDNSNHLTDWNPNDST 58
Query: 63 PCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEI 122
PCGW GVNCT + + VV+SL+L+ NLSG LSP+IGGL L LDLSFN LS++IPKEI
Sbjct: 59 PCGWKGVNCTYDYYNPVVWSLDLSFKNLSGSLSPSIGGLTGLIYLDLSFNGLSQDIPKEI 118
Query: 123 GNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAY 182
G CSSLEVL LNNN+ E IP E+ LSSLTI NI NNRISG FP+ IG+ S+LSQL+A+
Sbjct: 119 GYCSSLEVLCLNNNQFEGQIPIEIVKLSSLTIFNISNNRISGSFPENIGEFSSLSQLIAF 178
Query: 183 SNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEI 242
SNNISG LP + GNLKRL FRAGQNLISGSLP EIGGCESLQ LGLAQNQLSGEIP+EI
Sbjct: 179 SNNISGQLPASFGNLKRLTIFRAGQNLISGSLPQEIGGCESLQILGLAQNQLSGEIPREI 238
Query: 243 GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIY 302
GMLK L DV+LW NQLSG IPKEL NC+ L LALYDN VG +PKELG + LK LY+Y
Sbjct: 239 GMLKNLKDVVLWSNQLSGSIPKELSNCSKLGILALYDNNLVGAIPKELGGLVFLKSLYLY 298
Query: 303 RNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVEL 362
RN LNGTIP+E+G LSSA+EIDFSEN L GEIPVEL+KI GL LLYLFENKLTGVIP EL
Sbjct: 299 RNHLNGTIPKELGNLSSAIEIDFSENMLTGEIPVELAKITGLRLLYLFENKLTGVIPNEL 358
Query: 363 TTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLS 422
TTL NLTKLDLSIN+LTGTIP+GFQYL L+MLQLF+NSL G IPQ LG Y +LWVVDLS
Sbjct: 359 TTLVNLTKLDLSINNLTGTIPVGFQYLKQLVMLQLFNNSLSGSIPQGLGVYGKLWVVDLS 418
Query: 423 DNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDL 482
+N+LTG+IP H+CRN SL LNL +N L G IP GV CK+L QL L GN+ TGSFP+DL
Sbjct: 419 NNYLTGRIPPHLCRNGSLFLLNLGSNSLVGYIPNGVITCKTLGQLYLAGNNLTGSFPTDL 478
Query: 483 CKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVS 542
CKL NLS++ELDQN+F+G IP EIG C L+RLHLS+NY GELPRE+GNLS LV FN+S
Sbjct: 479 CKLVNLSSIELDQNKFTGTIPPEIGYCRGLKRLHLSNNYLYGELPREIGNLSQLVIFNIS 538
Query: 543 SNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQI 602
SN L+G IP EIF+CKMLQRLDLS N FVGALP EIG L QLELLKLS+NE SG IP+++
Sbjct: 539 SNRLSGMIPPEIFNCKMLQRLDLSRNNFVGALPSEIGGLSQLELLKLSDNEFSGIIPMEV 598
Query: 603 GNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLL 662
GNLS LTELQMGGN FSG IPAELG LSSLQIALNLSYNNLSG IP E+GNL+LLE+LLL
Sbjct: 599 GNLSHLTELQMGGNLFSGAIPAELGDLSSLQIALNLSYNNLSGSIPEEIGNLVLLEFLLL 658
Query: 663 NNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQN 722
NNN+LSGEIPGS +LSSLL CNFSYN+LTGP+PS F N ++SF G+KGLCGG L N
Sbjct: 659 NNNNLSGEIPGSLKSLSSLLVCNFSYNDLTGPLPSLPLFLNTGISSFLGNKGLCGGSLGN 718
Query: 723 CTQPPSSLPFPSGTNSPTARLGKLVAIIAAAIGGVSLVLITVIIYFLRQPVEVVAPLQDK 782
C++ PSS P GT +ARLGK++AIIAA IGG+S +LI VIIYF+R+PVE+VAP+QDK
Sbjct: 719 CSESPSS-NLPWGTQGKSARLGKIIAIIAAVIGGISFILIVVIIYFMRRPVEIVAPVQDK 777
Query: 783 QLSSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLA 842
SS +SDIYF P+EGFTF+DLV AT+NFD FVIGRGACGTVYRAVL G T+AVKKLA
Sbjct: 778 LFSSPISDIYFSPREGFTFQDLVAATENFDNSFVIGRGACGTVYRAVLPCGRTIAVKKLA 837
Query: 843 SNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGA 902
SNREG + +DNSFRAEILTLGKIRHRNIVKL+GFCYHQGSNLL+YEYMA+GSLGE+LHG
Sbjct: 838 SNREG-STIDNSFRAEILTLGKIRHRNIVKLFGFCYHQGSNLLLYEYMAKGSLGEMLHGE 896
Query: 903 SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962
SS LDW TRF IALGAA+GL+YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI
Sbjct: 897 SSCLDWWTRFNIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 956
Query: 963 DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDL 1022
DMPQSKSMSA+AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGR PVQPLDQGGDL
Sbjct: 957 DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDQGGDL 1016
Query: 1023 VTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082
VTWVRN+I+ ++L GMLDARL+L DE TV+HMITV+KIA+LCTN+SP DRPTMRE VLM
Sbjct: 1017 VTWVRNYIQVHTLSPGMLDARLDLDDENTVAHMITVMKIALLCTNMSPMDRPTMREAVLM 1076
Query: 1083 LSES-NRRQGHFEFSPMDHDSDQKLENEFQST 1113
L ES N+R G E SP + F S+
Sbjct: 1077 LIESHNKRVGQSESSPSSRHGNSSEGAHFDSS 1108
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123638|ref|XP_002319129.1| predicted protein [Populus trichocarpa] gi|222857505|gb|EEE95052.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1546 bits (4004), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 787/1092 (72%), Positives = 913/1092 (83%), Gaps = 8/1092 (0%)
Query: 3 MGRISYSYRLFSASILAIICLLVHQTKGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDST 62
M RISYS + +I L HQ+ GL N EGQ LL IKS++ D N+L NWNPNDST
Sbjct: 1 MERISYSML-----TVFVISLSFHQSMGL-NAEGQYLLDIKSRIGDAYNHLSNWNPNDST 54
Query: 63 PCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEI 122
PCGW GVNCT+ D+ VV+ L+L MNLSG LSP+IGGLVHLT L++SFN LS+NIP EI
Sbjct: 55 PCGWKGVNCTS-DYNQVVWRLDLNSMNLSGSLSPSIGGLVHLTLLNVSFNFLSKNIPSEI 113
Query: 123 GNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAY 182
GNCSSLEVL L+NN +P EL LS LT LNI NNRISGP P +IG LS+LS L+AY
Sbjct: 114 GNCSSLEVLYLDNNLFVGQLPVELAKLSCLTDLNIANNRISGPLPDQIGNLSSLSLLIAY 173
Query: 183 SNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEI 242
SNNI+G LP +LGNLK L++FRAGQNLISGSLPSEIGGCESL+YLGLAQNQLS EIPKEI
Sbjct: 174 SNNITGPLPASLGNLKNLRTFRAGQNLISGSLPSEIGGCESLEYLGLAQNQLSEEIPKEI 233
Query: 243 GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIY 302
GML+ LTD+ILW NQLSG IP+ELGNCT+L TLALY NK G +P+ELG++ L+ LY+Y
Sbjct: 234 GMLQNLTDLILWSNQLSGSIPEELGNCTNLGTLALYHNKLEGPMPQELGNLLFLRKLYLY 293
Query: 303 RNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVEL 362
N LNG IP+EIG LS A+EIDFSEN L GEIP+EL+KI GL+LLY+FEN+L GVIP EL
Sbjct: 294 GNNLNGAIPKEIGNLSFAVEIDFSENELTGEIPIELTKISGLQLLYIFENELNGVIPDEL 353
Query: 363 TTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLS 422
TTL+NLTKLDLSIN L+GTIP+GFQ++ L+MLQLF+NSL G IPQ LG YS+LWVVDLS
Sbjct: 354 TTLENLTKLDLSINYLSGTIPMGFQHMKQLVMLQLFNNSLGGIIPQALGVYSKLWVVDLS 413
Query: 423 DNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDL 482
+NHLTG+IPRH+CRN +LI LNL +N LTG IPTGVT CK LVQL L N GSFPS L
Sbjct: 414 NNHLTGEIPRHLCRNENLILLNLGSNNLTGYIPTGVTNCKPLVQLHLAANGLVGSFPSGL 473
Query: 483 CKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVS 542
CK+ NLS+ ELDQN+F+GPIP EIG C+ L+RLHLS NYF GELPR++G LS LV FNVS
Sbjct: 474 CKMVNLSSFELDQNKFTGPIPPEIGQCHVLKRLHLSGNYFNGELPRQIGKLSQLVIFNVS 533
Query: 543 SNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQI 602
SNFLTG IP EIFSCKMLQRLDL+ N FVGA+P EIG+L QLE+L LSEN+LSG+IPV++
Sbjct: 534 SNFLTGVIPAEIFSCKMLQRLDLTRNSFVGAIPSEIGALSQLEILMLSENQLSGNIPVEV 593
Query: 603 GNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLL 662
GNLSRLT LQMGGN FSG IP LG + SLQIALNLSYNNLSG IP ELGNL+LLE+LLL
Sbjct: 594 GNLSRLTYLQMGGNLFSGEIPVTLGGILSLQIALNLSYNNLSGPIPTELGNLVLLEFLLL 653
Query: 663 NNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQN 722
NNNHLSGEIPGSF LSSLLGCNFS N+LTGP+PS FQ + SF G+KGLCGGP N
Sbjct: 654 NNNHLSGEIPGSFEKLSSLLGCNFSNNDLTGPLPSLSLFQKTGIGSFFGNKGLCGGPFGN 713
Query: 723 CTQPPSSLPFPSGTNSPTARLGKLVAIIAAAIGGVSLVLITVIIYFLRQPVEVVAPLQDK 782
C PS PS + R+GK++AII+A IGG+SL+LI VI+YF+R+PV++VAPLQD+
Sbjct: 714 CNGSPSFSSNPSDAEGRSLRIGKIIAIISAVIGGISLILILVIVYFMRRPVDMVAPLQDQ 773
Query: 783 QLSSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLA 842
SS +SDIYF PK+ FTF+DLVVAT+NFD+ FVIGRGACGTVYRA L G +AVK+LA
Sbjct: 774 SSSSPISDIYFSPKDEFTFQDLVVATENFDDSFVIGRGACGTVYRADLPCGRIIAVKRLA 833
Query: 843 SNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGA 902
SNREG +N+DNSFRAEI TLG IRHRNIVKLYGFCYHQGSNLL+YEY+A+GSLGELLHG+
Sbjct: 834 SNREG-SNIDNSFRAEIQTLGNIRHRNIVKLYGFCYHQGSNLLLYEYLAKGSLGELLHGS 892
Query: 903 SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962
S+LDW+TRF IALG+A GL+YLHHDCKPRIFHRDIKSNNILLD+KF+A VGDFGLAKVI
Sbjct: 893 PSSLDWRTRFKIALGSAHGLAYLHHDCKPRIFHRDIKSNNILLDEKFDARVGDFGLAKVI 952
Query: 963 DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDL 1022
DMP SKSMSA+AGSYGYIAPEYAYT+KVTEKCDIYSYGVVLLELLTGR PVQPLDQGGDL
Sbjct: 953 DMPHSKSMSAVAGSYGYIAPEYAYTLKVTEKCDIYSYGVVLLELLTGRTPVQPLDQGGDL 1012
Query: 1023 VTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082
V+WVRN+I+ +SL GMLD R+N+QD+ T+ HMITV+KIA+LCT++SP DRPTMREVVLM
Sbjct: 1013 VSWVRNYIQVHSLSPGMLDDRVNVQDQNTIPHMITVMKIALLCTSMSPVDRPTMREVVLM 1072
Query: 1083 LSESNRRQGHFE 1094
L ESN+ +GH +
Sbjct: 1073 LIESNKLEGHLD 1084
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477838|ref|XP_002283031.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At2g33170-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1504 bits (3894), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 771/1052 (73%), Positives = 890/1052 (84%), Gaps = 3/1052 (0%)
Query: 48 DNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTAL 107
D N+L NWNP+D TPCGWIGVNCT D VV SL+L MNLSG LSP+IGGL +LT L
Sbjct: 48 DQFNHLYNWNPSDQTPCGWIGVNCTGYD--PVVISLDLNSMNLSGTLSPSIGGLSYLTYL 105
Query: 108 DLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFP 167
D+S N L+ NIPKEIGNCS LE L LN+N+ + IP E +LS LT LN+ NN++SGPFP
Sbjct: 106 DVSHNGLTGNIPKEIGNCSKLETLCLNDNQFDGSIPAEFCSLSCLTDLNVCNNKLSGPFP 165
Query: 168 KEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYL 227
+EIG L AL +LVAY+NN++G LP + GNLK LK+FRAGQN ISGSLP+EIGGC SL+YL
Sbjct: 166 EEIGNLYALVELVAYTNNLTGPLPRSFGNLKSLKTFRAGQNAISGSLPAEIGGCRSLRYL 225
Query: 228 GLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLP 287
GLAQN L+GEIPKEIGML+ LTD+ILWGNQLSG +PKELGNCT LETLALY N VG++P
Sbjct: 226 GLAQNDLAGEIPKEIGMLRNLTDLILWGNQLSGFVPKELGNCTHLETLALYQNNLVGEIP 285
Query: 288 KELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELL 347
+E+GS+ LK LYIYRNELNGTIPREIG LS A EIDFSEN L G IP E SKI GL+LL
Sbjct: 286 REIGSLKFLKKLYIYRNELNGTIPREIGNLSQATEIDFSENYLTGGIPTEFSKIKGLKLL 345
Query: 348 YLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIP 407
YLF+N+L+GVIP EL++L+NL KLDLSIN+LTG IP+GFQYLT + LQLFDN L G IP
Sbjct: 346 YLFQNELSGVIPNELSSLRNLAKLDLSINNLTGPIPVGFQYLTQMFQLQLFDNRLTGRIP 405
Query: 408 QRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQL 467
Q LG YS LWVVD S NHLTG IP HICR ++LI LNLE+NKL G+IP GV +CKSLVQL
Sbjct: 406 QALGLYSPLWVVDFSQNHLTGSIPSHICRRSNLILLNLESNKLYGNIPMGVLKCKSLVQL 465
Query: 468 RLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELP 527
RL GNS TGSFP +LC+L NLS +ELDQN+FSG IP EI NC LQRLHL++NYFT ELP
Sbjct: 466 RLVGNSLTGSFPLELCRLVNLSAIELDQNKFSGLIPPEIANCRRLQRLHLANNYFTSELP 525
Query: 528 REVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELL 587
+E+GNLS LVTFN+SSNFLTG+IP I +CKMLQRLDLS N FV ALP+E+G+L QLELL
Sbjct: 526 KEIGNLSELVTFNISSNFLTGQIPPTIVNCKMLQRLDLSRNSFVDALPKELGTLLQLELL 585
Query: 588 KLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLI 647
KLSEN+ SG+IP +GNLS LTELQMGGN FSG IP ELG+LSSLQIA+NLSYNNL G I
Sbjct: 586 KLSENKFSGNIPAALGNLSHLTELQMGGNLFSGEIPPELGALSSLQIAMNLSYNNLLGRI 645
Query: 648 PPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVN 707
PPELGNLILLE+LLLNNNHLSGEIP +F NLSSL+GCNFSYN+LTGP+PS FQNM +
Sbjct: 646 PPELGNLILLEFLLLNNNHLSGEIPSTFGNLSSLMGCNFSYNDLTGPLPSIPLFQNMVSS 705
Query: 708 SFSGSKGLCGGPLQNCTQPPSSLPFPSGTNSPTARLGKLVAIIAAAIGGVSLVLITVIIY 767
SF G++GLCGG L NC PS P S A GK++ ++AA +GG+SL+LI +I+Y
Sbjct: 706 SFIGNEGLCGGRLSNCNGTPSFSSVPPSLESVDAPRGKIITVVAAVVGGISLILIVIILY 765
Query: 768 FLRQPVEVVAPLQDKQLSSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYR 827
F+R+PVEVVA LQDK++ S+VSDIYFPPKEGFTF+DLV AT+NF + +V+GRGACGTVY+
Sbjct: 766 FMRRPVEVVASLQDKEIPSSVSDIYFPPKEGFTFQDLVEATNNFHDSYVVGRGACGTVYK 825
Query: 828 AVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887
AV+ +G T+AVKKLASNREG N++DNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL+Y
Sbjct: 826 AVMHSGQTIAVKKLASNREG-NSIDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLLY 884
Query: 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947
EYMARGSLGELLHGAS +L+WQTRF IALGAAEGL+YLHHDCKPRI HRDIKSNNILLD
Sbjct: 885 EYMARGSLGELLHGASCSLEWQTRFTIALGAAEGLAYLHHDCKPRIIHRDIKSNNILLDS 944
Query: 948 KFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 1007
FEAHVGDFGLAKV+DMPQSKSMSA+AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL
Sbjct: 945 NFEAHVGDFGLAKVVDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 1004
Query: 1008 TGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTN 1067
TGR PVQPLDQGGDLV+WVRN+IR++SL S + D RLNL+DE TV HMI VLKIA+LCTN
Sbjct: 1005 TGRTPVQPLDQGGDLVSWVRNYIRDHSLTSEIFDTRLNLEDENTVDHMIAVLKIAILCTN 1064
Query: 1068 ISPFDRPTMREVVLMLSESNRRQGHFEFSPMD 1099
+SP DRP+MREVVLML ESN +G++ SP++
Sbjct: 1065 MSPPDRPSMREVVLMLIESNEHEGYYISSPIN 1096
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15237562|ref|NP_201198.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|75264278|sp|Q9LVP0.1|Y5639_ARATH RecName: Full=Probable leucine-rich repeat receptor-like protein kinase At5g63930; Flags: Precursor gi|8777306|dbj|BAA96896.1| receptor-like protein kinase [Arabidopsis thaliana] gi|224589747|gb|ACN59405.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332010434|gb|AED97817.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1497 bits (3876), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 759/1071 (70%), Positives = 873/1071 (81%), Gaps = 7/1071 (0%)
Query: 27 QTKGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLT 86
+T GL N+EGQ LL IKSK VD L NWN NDS PCGW GV C+ V SLNL+
Sbjct: 23 ETTGL-NLEGQYLLEIKSKFVDAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLS 81
Query: 87 KMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKEL 146
M LSG LSP+IGGLVHL LDLS+N LS IPKEIGNCSSLE+L LNNN+ + IP E+
Sbjct: 82 SMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEI 141
Query: 147 GNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAG 206
G L SL L IYNNRISG P EIG L +LSQLV YSNNISG LP ++GNLKRL SFRAG
Sbjct: 142 GKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAG 201
Query: 207 QNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKEL 266
QN+ISGSLPSEIGGCESL LGLAQNQLSGE+PKEIGMLK L+ VILW N+ SG IP+E+
Sbjct: 202 QNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREI 261
Query: 267 GNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFS 326
NCTSLETLALY N+ VG +PKELG + SL++LY+YRN LNGTIPREIG LS A+EIDFS
Sbjct: 262 SNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFS 321
Query: 327 ENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGF 386
EN+L GEIP+EL I GLELLYLFEN+LTG IPVEL+TLKNL+KLDLSIN+LTG IPLGF
Sbjct: 322 ENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGF 381
Query: 387 QYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLE 446
QYL L MLQLF NSL G IP +LG YS LWV+D+SDNHL+G+IP ++C ++++I LNL
Sbjct: 382 QYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLG 441
Query: 447 TNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEI 506
TN L+G+IPTG+T CK+LVQLRL N+ G FPS+LCK N++ +EL QN+F G IP E+
Sbjct: 442 TNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREV 501
Query: 507 GNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLS 566
GNC+ALQRL L+DN FTGELPRE+G LS L T N+SSN LTG +P EIF+CKMLQRLD+
Sbjct: 502 GNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMC 561
Query: 567 WNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAEL 626
N F G LP E+GSL+QLELLKLS N LSG+IPV +GNLSRLTELQMGGN F+G IP EL
Sbjct: 562 CNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPREL 621
Query: 627 GSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNF 686
GSL+ LQIALNLSYN L+G IPPEL NL++LE+LLLNNN+LSGEIP SF NLSSLLG NF
Sbjct: 622 GSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNF 681
Query: 687 SYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPSSLPFPSGTNSPTARLGKL 746
SYN+LTGPIP +N+S++SF G++GLCG PL C Q P S R K+
Sbjct: 682 SYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKI 738
Query: 747 VAIIAAAIGGVSLVLITVIIYFLRQPVEVVA-PLQDKQLSSTVSDIYFPPKEGFTFKDLV 805
+AI AA IGGVSL+LI +I+Y +R+PV VA QD Q S DIYFPPKEGFTF+DLV
Sbjct: 739 IAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLV 798
Query: 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREG--NNNVDNSFRAEILTLG 863
ATDNFDE FV+GRGACGTVY+AVL G+T+AVKKLASN EG NNNVDNSFRAEILTLG
Sbjct: 799 AATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLG 858
Query: 864 KIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLS 923
IRHRNIVKL+GFC HQGSNLL+YEYM +GSLGE+LH S LDW RF IALGAA+GL+
Sbjct: 859 NIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLA 918
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP SKSMSAIAGSYGYIAPE
Sbjct: 919 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPE 978
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043
YAYTMKVTEK DIYSYGVVLLELLTG+APVQP+DQGGD+V WVR++IR ++L SG+LDAR
Sbjct: 979 YAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDAR 1038
Query: 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFE 1094
L L+DE+ VSHM+TVLKIA+LCT++SP RP+MR+VVLML ES R +G E
Sbjct: 1039 LTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIESERSEGEQE 1089
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793985|ref|XP_002864877.1| hypothetical protein ARALYDRAFT_496585 [Arabidopsis lyrata subsp. lyrata] gi|297310712|gb|EFH41136.1| hypothetical protein ARALYDRAFT_496585 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1479 bits (3830), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 756/1060 (71%), Positives = 871/1060 (82%), Gaps = 7/1060 (0%)
Query: 27 QTKGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLT 86
+T GL N+EGQ LL IKSK VD+ L NWN NDS PCGW GV C+ V SLNL+
Sbjct: 23 ETTGL-NLEGQYLLDIKSKFVDDMQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLS 81
Query: 87 KMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKEL 146
M LSG LSP+IGGLVHL LDLS+N LS +IPKEIGNCSSLE+L LNNN+ + IP E+
Sbjct: 82 SMVLSGKLSPSIGGLVHLKQLDLSYNGLSGSIPKEIGNCSSLEILKLNNNQFDGEIPVEI 141
Query: 147 GNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAG 206
G L SL L IYNNRISG P EIG + +LSQLV YSNNISG LP ++GNLKRL SFRAG
Sbjct: 142 GKLVSLENLIIYNNRISGSLPVEIGNILSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAG 201
Query: 207 QNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKEL 266
QN+ISGSLPSEIGGCESL LGLAQNQLSGE+PKEIGMLK L+ VILW N+ SG IP+E+
Sbjct: 202 QNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREI 261
Query: 267 GNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFS 326
NC+SLETLALY N+ VG +PKELG + SL+YLY+YRN LNGTIPREIG LS+A+EIDFS
Sbjct: 262 SNCSSLETLALYKNQLVGPIPKELGDLQSLEYLYLYRNVLNGTIPREIGNLSNAIEIDFS 321
Query: 327 ENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGF 386
EN+L GEIP+EL I GLELL+LFEN+LTG IPVEL+TLKNL+KLDLSIN+LTG IPLGF
Sbjct: 322 ENALTGEIPLELGNIEGLELLHLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGF 381
Query: 387 QYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLE 446
QYL L MLQLF NSL G IP +LG YS LWV+DLSDNHL G+IP ++C ++++I LNL
Sbjct: 382 QYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDLSDNHLRGRIPSYLCLHSNMIILNLG 441
Query: 447 TNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEI 506
TN L+G+IPTGVT CK+LVQLRL N+ G FPS+LCKL NL+ +EL QN+F G IP E+
Sbjct: 442 TNNLSGNIPTGVTTCKTLVQLRLARNNLVGRFPSNLCKLVNLTAIELGQNRFRGSIPREV 501
Query: 507 GNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLS 566
GNC+ALQRL L+DN FTGELPRE+G LS L T N+SSN LTG +P EIF+CKMLQRLD+
Sbjct: 502 GNCSALQRLQLADNDFTGELPREIGTLSQLGTLNISSNSLTGEVPFEIFNCKMLQRLDMC 561
Query: 567 WNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAEL 626
N F G LP E+GSL+QLELLKLS N LSG+IPV +GNLSRLTELQMGGN F+G IP EL
Sbjct: 562 CNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPREL 621
Query: 627 GSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNF 686
GSL+ LQIALNLSYN L+G IPPEL NL++LE+LLLNNN+LSGEIP SF NLSSLLG NF
Sbjct: 622 GSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNF 681
Query: 687 SYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPSSLPFPSGTNSPTARLGKL 746
SYN+LTGPIP +N+S++SF G++GLCG PL C Q S P S R K+
Sbjct: 682 SYNSLTGPIP---LLRNISISSFIGNEGLCGPPLNQCIQTQPSAPSQSTVKPGGMRSSKI 738
Query: 747 VAIIAAAIGGVSLVLITVIIYFLRQPVEVV-APLQDKQLSSTVSDIYFPPKEGFTFKDLV 805
+AI AAAIGGVSL+LI +I+Y +R+PV V + QD Q S DIYFPPKEGFTF+DLV
Sbjct: 739 IAITAAAIGGVSLMLIALIVYLMRRPVRTVSSSAQDGQQSEMSLDIYFPPKEGFTFQDLV 798
Query: 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREG--NNNVDNSFRAEILTLG 863
ATDNFDE FV+GRGACGTVY+AVL G+T+AVKKLASN EG NNNVDNSFRAEILTLG
Sbjct: 799 AATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLG 858
Query: 864 KIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLS 923
IRHRNIVKL+GFC HQGSNLL+YEYM +GSLGE+LH S LDW RF IALGAA+GL+
Sbjct: 859 NIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSGNLDWSKRFKIALGAAQGLA 918
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP SKSMSAIAGSYGYIAPE
Sbjct: 919 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPE 978
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043
YAYTMKVTEK DIYSYGVVLLELLTG+APVQP+DQGGD+V WVR++IR ++L SG+LD R
Sbjct: 979 YAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDPR 1038
Query: 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
L L+DE+ VSHM+TVLKIA+LCT++SP RP+MR+VVLML
Sbjct: 1039 LTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255554244|ref|XP_002518162.1| BRASSINOSTEROID INSENSITIVE 1 precursor, putative [Ricinus communis] gi|223542758|gb|EEF44295.1| BRASSINOSTEROID INSENSITIVE 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1452 bits (3760), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 752/1095 (68%), Positives = 891/1095 (81%), Gaps = 14/1095 (1%)
Query: 9 SYRLFS--ASILAIICLLVHQTKGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCGW 66
S R F A +I +LV ++GL N EGQ LL +K+ D N L NW D TPCGW
Sbjct: 15 SRRAFEVFAGFWLVITVLVSTSEGL-NSEGQYLLDLKNGFHDEFNRLENWKSIDQTPCGW 73
Query: 67 IGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCS 126
IGVNCTT D+ VV SLNL+ MNLSG LSP+IGGLV+L LDLS+N L+ NIP IGNCS
Sbjct: 74 IGVNCTT-DYEPVVQSLNLSLMNLSGILSPSIGGLVNLRYLDLSYNMLAENIPNTIGNCS 132
Query: 127 SLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNI 186
L L LNNN +P ELGNLS L LNI NNRISG FP+E G +++L ++VAY+NN+
Sbjct: 133 MLLSLYLNNNEFSGELPAELGNLSLLQSLNICNNRISGSFPEEFGNMTSLIEVVAYTNNL 192
Query: 187 SGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLK 246
+G LP ++GNLK LK+FRAG+N ISGS+P+EI GC+SL+ LGLAQN + GE+PKEIGML
Sbjct: 193 TGPLPHSIGNLKNLKTFRAGENKISGSIPAEISGCQSLELLGLAQNAIGGELPKEIGMLG 252
Query: 247 YLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNEL 306
LTD+ILW NQL+G IPKE+GNCT LETLALY N VG +P ++G++ L LY+YRN L
Sbjct: 253 SLTDLILWENQLTGFIPKEIGNCTKLETLALYANNLVGPIPADIGNLKFLTKLYLYRNAL 312
Query: 307 NGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLK 366
NGTIPREIG LS +EIDFSEN L GEIP+E+SKI GL LLYLFEN+LTGVIP EL++L+
Sbjct: 313 NGTIPREIGNLSMVMEIDFSENYLTGEIPIEISKIKGLHLLYLFENQLTGVIPNELSSLR 372
Query: 367 NLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHL 426
NLTKLDLS N+L+G IP GFQYLT ++ LQLFDN L GG+PQ LG YS+LWVVD SDN L
Sbjct: 373 NLTKLDLSSNNLSGPIPFGFQYLTEMVQLQLFDNFLTGGVPQGLGLYSKLWVVDFSDNAL 432
Query: 427 TGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLA 486
TG+IP H+CR+++L+ LN+E+NK G+IPTG+ CKSLVQLRL GN TG FPS+LC+L
Sbjct: 433 TGRIPPHLCRHSNLMLLNMESNKFYGNIPTGILNCKSLVQLRLVGNRLTGGFPSELCRLV 492
Query: 487 NLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFL 546
NLS +ELDQN+FSGPIP IG+C LQRLH+++NYFT ELP+E+GNLS LVTFNVSSN L
Sbjct: 493 NLSAIELDQNKFSGPIPQAIGSCQKLQRLHIANNYFTNELPKEIGNLSQLVTFNVSSNLL 552
Query: 547 TGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLS 606
GRIP EI +CKMLQRLDLS N FV ALP E+G+L QLELLKLSEN+ SG+IP +GNLS
Sbjct: 553 KGRIPPEIVNCKMLQRLDLSHNSFVDALPDELGTLLQLELLKLSENKFSGNIPPALGNLS 612
Query: 607 RLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNH 666
LTELQMGGN FSG IP +LGSLSSLQIA+NLS NNL+G IPPELGNL LLE+LLLNNNH
Sbjct: 613 HLTELQMGGNFFSGEIPRQLGSLSSLQIAMNLSNNNLTGAIPPELGNLNLLEFLLLNNNH 672
Query: 667 LSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQP 726
L+GEIP +F NLSSLLGCNFS+NNLTGP+P FQNM+V+SF G+ GLCGG L C
Sbjct: 673 LTGEIPDTFENLSSLLGCNFSFNNLTGPLPPVPLFQNMAVSSFLGNDGLCGGHLGYCNGD 732
Query: 727 PSSLPFPSGTN----SPTARLGKLVAIIAAAIGGVSLVLITVIIYFLRQPVEVVAPLQDK 782
SG+N S A G+++ +AAA+GGVSL+LI V++YF+R+P E V ++D
Sbjct: 733 SF-----SGSNASFKSMDAPRGRIITTVAAAVGGVSLILIAVLLYFMRRPAETVPSVRDT 787
Query: 783 QLSSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLA 842
+ SS SDIYF PKEGF+ +DLV AT+NF + +V+GRGACGTVY+AV+ TG T+AVKKLA
Sbjct: 788 ESSSPDSDIYFRPKEGFSLQDLVEATNNFHDSYVVGRGACGTVYKAVMHTGQTIAVKKLA 847
Query: 843 SNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGA 902
SNREG +N++NSF+AEILTLG IRHRNIVKL+GFCYHQGSNLL+YEYMARGSLGE LHG
Sbjct: 848 SNREG-SNIENSFQAEILTLGNIRHRNIVKLFGFCYHQGSNLLLYEYMARGSLGEQLHGP 906
Query: 903 SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962
S +L+W TRFMIALGAAEGL+YLHHDCKPRI HRDIKSNNILLDD FEAHVGDFGLAK+I
Sbjct: 907 SCSLEWPTRFMIALGAAEGLAYLHHDCKPRIIHRDIKSNNILLDDNFEAHVGDFGLAKII 966
Query: 963 DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDL 1022
DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTG PVQPLDQGGDL
Sbjct: 967 DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGLTPVQPLDQGGDL 1026
Query: 1023 VTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082
VTWV+N++RN+SL SG+LD+RL+L+D+ V HM+TVLKIA++CT +SPFDRP+MREVVLM
Sbjct: 1027 VTWVKNYVRNHSLTSGILDSRLDLKDQSIVDHMLTVLKIALMCTTMSPFDRPSMREVVLM 1086
Query: 1083 LSESNRRQGHFEFSP 1097
L ESN R+ F SP
Sbjct: 1087 LIESNEREESFISSP 1101
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224072618|ref|XP_002303809.1| predicted protein [Populus trichocarpa] gi|222841241|gb|EEE78788.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1433 bits (3710), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 737/1106 (66%), Positives = 894/1106 (80%), Gaps = 10/1106 (0%)
Query: 5 RISYSYRLFSASILAIICLLVHQTKGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPC 64
R S + L A IL + LL+ T+GL N +G LL +K+ L D N+L NW D TPC
Sbjct: 6 RSSGVFELGLAGILLVTFLLIFTTEGL-NSDGHHLLELKNALHDEFNHLQNWKSTDQTPC 64
Query: 65 GWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGN 124
W GV+CT D+ +V+SL+L MNLSG LSP IGGLV+L DLS N+++ +IPK IGN
Sbjct: 65 SWTGVSCTL-DYEPLVWSLDLNSMNLSGTLSPGIGGLVNLRYFDLSHNEITGDIPKAIGN 123
Query: 125 CSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSN 184
CS L+ LNNN+L IP ELG LS L LNI NN+ISG P+E G+LS+L + VAY+N
Sbjct: 124 CSLLQYFYLNNNQLSGEIPAELGRLSFLERLNICNNQISGSLPEEFGRLSSLVEFVAYTN 183
Query: 185 NISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGM 244
++G LP ++ NLK LK+ RAGQN ISGS+P+EI GC+SL+ LGLAQN++ GE+PKE+ M
Sbjct: 184 KLTGPLPRSIRNLKNLKTIRAGQNQISGSIPAEISGCQSLKLLGLAQNKIGGELPKELAM 243
Query: 245 LKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRN 304
L LT++ILW NQ+SG+IPKELGNCT+LETLALY N G +P E+G++ LK LY+YRN
Sbjct: 244 LGNLTELILWENQISGLIPKELGNCTNLETLALYANALAGPIPMEIGNLKFLKKLYLYRN 303
Query: 305 ELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTT 364
LNGTIPREIG LS A EIDFSEN L G+IP E SKI GL LLYLF+N+LTGVIP EL+
Sbjct: 304 GLNGTIPREIGNLSMATEIDFSENFLTGKIPTEFSKIKGLRLLYLFQNQLTGVIPNELSI 363
Query: 365 LKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDN 424
L+NLTKLDLSIN LTG IP GFQYLT ++ LQLF+NSL GGIPQRLG YSQLWVVD SDN
Sbjct: 364 LRNLTKLDLSINHLTGPIPFGFQYLTEMLQLQLFNNSLSGGIPQRLGLYSQLWVVDFSDN 423
Query: 425 HLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCK 484
LTG+IP H+CR+++LI LNL++N+L G+IPTGV C++LVQLRL GN FTG FPS+LCK
Sbjct: 424 DLTGRIPPHLCRHSNLILLNLDSNRLYGNIPTGVLNCQTLVQLRLVGNKFTGGFPSELCK 483
Query: 485 LANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSN 544
L NLS +EL+QN F+GP+P E+GNC LQRLH+++NYFT ELP+E+GNLS LVTFN SSN
Sbjct: 484 LVNLSAIELNQNMFTGPLPPEMGNCRRLQRLHIANNYFTSELPKELGNLSQLVTFNASSN 543
Query: 545 FLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGN 604
LTG+IP E+ +CKMLQRLDLS N F ALP E+G+L QLELL+LSEN+ SG+IP+ +GN
Sbjct: 544 LLTGKIPPEVVNCKMLQRLDLSHNSFSDALPDELGTLLQLELLRLSENKFSGNIPLALGN 603
Query: 605 LSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNN 664
LS LTELQMGGNSFSG IP LG LSSLQI +NLSYN+L+G IPPELGNL LLE+LLLNN
Sbjct: 604 LSHLTELQMGGNSFSGRIPPSLGLLSSLQIGMNLSYNSLTGSIPPELGNLNLLEFLLLNN 663
Query: 665 NHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCT 724
NHL+GEIP +F NLSSLLGCNFSYN LTG +PS FQNM+++SF G+KGLCGGPL C+
Sbjct: 664 NHLTGEIPKTFENLSSLLGCNFSYNELTGSLPSGSLFQNMAISSFIGNKGLCGGPLGYCS 723
Query: 725 QPPSSLPFPSGTNSPTARLGKLVAIIAAAIGGVSLVLITVIIYFLRQPVEVVAPLQDKQL 784
SS P + A G+++ I+AA +GGVSL+LI VI+YF+R P + + DK+
Sbjct: 724 GDTSSGSVPQ--KNMDAPRGRIITIVAAVVGGVSLILIIVILYFMRHPTATASSVHDKEN 781
Query: 785 SSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASN 844
S S+IYFP K+G TF+DLV AT+NF + +V+GRGACGTVY+AV+R+G T+AVKKLAS+
Sbjct: 782 PSPESNIYFPLKDGITFQDLVQATNNFHDSYVVGRGACGTVYKAVMRSGKTIAVKKLASD 841
Query: 845 REGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASS 904
REG ++++NSF+AEILTLGKIRHRNIVKLYGFCYH+GSNLL+YEY+ARGSLGELLHG S
Sbjct: 842 REG-SSIENSFQAEILTLGKIRHRNIVKLYGFCYHEGSNLLLYEYLARGSLGELLHGPSC 900
Query: 905 TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964
+L+W TRFM+ALGAAEGL+YLHHDCKP I HRDIKSNNILLDD FEAHVGDFGLAKVIDM
Sbjct: 901 SLEWSTRFMVALGAAEGLAYLHHDCKPIIIHRDIKSNNILLDDNFEAHVGDFGLAKVIDM 960
Query: 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVT 1024
PQSKSMSA+AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTG+ PVQPLDQGGDLVT
Sbjct: 961 PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGKTPVQPLDQGGDLVT 1020
Query: 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084
W R+++R++SL SG+LD RL+L+D+ TV+HMI+ LKIA+LCT++SPFDRP+MREVVLML
Sbjct: 1021 WARHYVRDHSLTSGILDDRLDLEDQSTVAHMISALKIALLCTSMSPFDRPSMREVVLMLI 1080
Query: 1085 ESNRRQGHFEFS-----PMDHDSDQK 1105
ESN R+G+ S P D +K
Sbjct: 1081 ESNEREGNLTLSSTYDFPWKDDISRK 1106
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224057652|ref|XP_002299290.1| predicted protein [Populus trichocarpa] gi|222846548|gb|EEE84095.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1431 bits (3703), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 750/1106 (67%), Positives = 895/1106 (80%), Gaps = 10/1106 (0%)
Query: 5 RISYSYRLFSASILAIICLLVHQTKGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPC 64
R + L A IL + LL+ T+ L N EGQ LL +K+ L D N+L NW D TPC
Sbjct: 6 RSKRVFELRLAGILLVSILLICTTEAL-NSEGQRLLELKNSLHDEFNHLQNWKSTDQTPC 64
Query: 65 GWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGN 124
W GVNCT+ + VV+SLN++ MNLSG LSP+IGGLV+L DLS+N ++ +IPK IGN
Sbjct: 65 SWTGVNCTSG-YEPVVWSLNMSSMNLSGTLSPSIGGLVNLQYFDLSYNLITGDIPKAIGN 123
Query: 125 CSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSN 184
CS L++L LNNN+L IP ELG LS L LNI NNRISG P+E G+LS+L + VAY+N
Sbjct: 124 CSLLQLLYLNNNQLSGEIPAELGELSFLERLNICNNRISGSLPEEFGRLSSLVEFVAYTN 183
Query: 185 NISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGM 244
++G LP ++GNLK LK+ RAGQN ISGS+PSEI GC+SL+ LGLAQN++ GE+PKE+GM
Sbjct: 184 KLTGPLPHSIGNLKNLKTIRAGQNEISGSIPSEISGCQSLKLLGLAQNKIGGELPKELGM 243
Query: 245 LKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRN 304
L LT+VILW NQ+SG IPKELGNCT+LETLALY N G +PKE+G++ LK LY+YRN
Sbjct: 244 LGNLTEVILWENQISGFIPKELGNCTNLETLALYSNTLTGPIPKEIGNLRFLKKLYLYRN 303
Query: 305 ELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTT 364
LNGTIPREIG LS A EIDFSEN L GEIP E SKI GL LLYLF+N+LT VIP EL++
Sbjct: 304 GLNGTIPREIGNLSMAAEIDFSENFLTGEIPTEFSKIKGLRLLYLFQNQLTSVIPKELSS 363
Query: 365 LKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDN 424
L+NLTKLDLSIN LTG IP GFQYLT ++ LQLFDNSL GGIPQ G +S+LWVVD SDN
Sbjct: 364 LRNLTKLDLSINHLTGPIPSGFQYLTEMLQLQLFDNSLSGGIPQGFGLHSRLWVVDFSDN 423
Query: 425 HLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCK 484
LTG+IP H+C+ ++LI LNL++N+L G+IPTGV C++LVQLRL GN+FTG FPS+LCK
Sbjct: 424 DLTGRIPPHLCQLSNLILLNLDSNRLYGNIPTGVLNCQTLVQLRLVGNNFTGGFPSELCK 483
Query: 485 LANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSN 544
L NLS +ELDQN F+GP+P EIGNC LQRLH+++NYFT ELP+E+GNL LVTFN SSN
Sbjct: 484 LVNLSAIELDQNSFTGPVPPEIGNCQRLQRLHIANNYFTSELPKEIGNLFQLVTFNASSN 543
Query: 545 FLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGN 604
LTGRIP E+ +CKMLQRLDLS N F ALP +G+L QLELL+LSEN+ SG+IP +GN
Sbjct: 544 LLTGRIPPEVVNCKMLQRLDLSHNSFSDALPDGLGTLLQLELLRLSENKFSGNIPPALGN 603
Query: 605 LSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNN 664
LS LTELQMGGNSFSG IP LGSLSSLQIA+NLSYNNL+G IPPELGNL LLE+LLLNN
Sbjct: 604 LSHLTELQMGGNSFSGQIPPALGSLSSLQIAMNLSYNNLTGSIPPELGNLNLLEFLLLNN 663
Query: 665 NHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCT 724
NHL+GEIP +F NLSSLLGCNFSYN LTGP+PS FQNM+ +SF G+KGLCGGPL C+
Sbjct: 664 NHLNGEIPITFENLSSLLGCNFSYNELTGPLPSIPLFQNMATSSFLGNKGLCGGPLGYCS 723
Query: 725 QPPSSLPFPSGTNSPTARLGKLVAIIAAAIGGVSLVLITVIIYFLRQPVEVVAPLQDKQL 784
PSS + A G+++ I+AA +GGVSLVLI VI+YF+R+P E + D++
Sbjct: 724 GDPSSGSVVQ--KNLDAPRGRIITIVAAIVGGVSLVLIIVILYFMRRPTETAPSIHDQEN 781
Query: 785 SSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASN 844
ST SDIYFP K+G TF+DLV AT+NF + +V+GRGACGTVY+AV+R+G +AVKKLASN
Sbjct: 782 PSTESDIYFPLKDGLTFQDLVEATNNFHDSYVLGRGACGTVYKAVMRSGKIIAVKKLASN 841
Query: 845 REGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASS 904
REG ++++NSFRAEILTLGKIRHRNIVKLYGFCYH+GSNLL+YEYMARGSLGELLH S
Sbjct: 842 REG-SDIENSFRAEILTLGKIRHRNIVKLYGFCYHEGSNLLLYEYMARGSLGELLHEPSC 900
Query: 905 TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964
L+W TRF++ALGAAEGL+YLHHDCKPRI HRDIKSNNILLDD FEAHVGDFGLAKVIDM
Sbjct: 901 GLEWSTRFLVALGAAEGLAYLHHDCKPRIIHRDIKSNNILLDDNFEAHVGDFGLAKVIDM 960
Query: 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVT 1024
PQSKSMSA+AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTG+ PVQPLDQGGDLVT
Sbjct: 961 PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGKTPVQPLDQGGDLVT 1020
Query: 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084
W R ++R +SL SG+LD RL+L+D+ TV+HMI VLKIA+LCT++SP DRP+MREVVLML
Sbjct: 1021 WARQYVREHSLTSGILDERLDLEDQSTVAHMIYVLKIALLCTSMSPSDRPSMREVVLMLI 1080
Query: 1085 ESNRRQGHFEFS-----PMDHDSDQK 1105
ESN R+G+ S P+ D+ +K
Sbjct: 1081 ESNEREGNLTLSSTYVFPLKDDASRK 1106
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147843348|emb|CAN79986.1| hypothetical protein VITISV_039668 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1429 bits (3700), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 741/1052 (70%), Positives = 850/1052 (80%), Gaps = 46/1052 (4%)
Query: 48 DNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTAL 107
D N+L NWNP+D TPCGWIGVNCT D VV SL+L MNLSG LSP+IGGL +LT L
Sbjct: 52 DQFNHLYNWNPSDQTPCGWIGVNCTGYD--PVVISLDLNSMNLSGTLSPSIGGLSYLTYL 109
Query: 108 DLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFP 167
D+S N L+ NIPKEIGNCS LE L LN+N+ + IP E +LS LT LN+ NN++SGPFP
Sbjct: 110 DVSHNGLTGNIPKEIGNCSKLETLCLNDNQFDGSIPAEFCSLSCLTDLNVCNNKLSGPFP 169
Query: 168 KEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYL 227
+EIG L AL +LVAY+NN++G LP + GNLK LK+FRAGQN ISGSLP+EIGGC SL+YL
Sbjct: 170 EEIGNLYALVELVAYTNNLTGPLPRSFGNLKSLKTFRAGQNAISGSLPAEIGGCRSLRYL 229
Query: 228 GLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLP 287
GLAQN L+GEIPKEIGML+ LTD+ILWGNQLSG +PKELGNCT LETLALY N VG++P
Sbjct: 230 GLAQNDLAGEIPKEIGMLRNLTDLILWGNQLSGFVPKELGNCTHLETLALYQNNLVGEIP 289
Query: 288 KELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELL 347
+E+GS+ LK LYIYRNELNGTIPREIG LS A EIDFSEN L G IP E SKI GL+LL
Sbjct: 290 REIGSLKFLKKLYIYRNELNGTIPREIGNLSQATEIDFSENYLTGGIPTEFSKIKGLKLL 349
Query: 348 YLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIP 407
YLF+N+L+GVIP EL++L+NL KLDLSIN+LTG IP+GFQYLT + LQLFDN L G IP
Sbjct: 350 YLFQNELSGVIPNELSSLRNLAKLDLSINNLTGPIPVGFQYLTQMFQLQLFDNRLTGRIP 409
Query: 408 QRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQL 467
Q LG YS LWVVD S NHLTG IP HICR ++LI LNLE+NKL G+IP GV +CKSLVQL
Sbjct: 410 QALGLYSPLWVVDFSQNHLTGSIPSHICRRSNLILLNLESNKLYGNIPMGVLKCKSLVQL 469
Query: 468 RLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELP 527
RL GNS TGSFP +LC+L NLS +ELDQN+FSG IP EI NC LQRLHL++NYFT ELP
Sbjct: 470 RLVGNSLTGSFPLELCRLVNLSAIELDQNKFSGLIPPEIANCRRLQRLHLANNYFTSELP 529
Query: 528 REVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELL 587
+E+GNLS LVTFN+SSNFLTG+IP I +CKMLQRLDLS N FV ALP+E+G+L QLELL
Sbjct: 530 KEIGNLSELVTFNISSNFLTGQIPPTIVNCKMLQRLDLSRNSFVDALPKELGTLLQLELL 589
Query: 588 KLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLI 647
KLSEN+ SG+IP +GNLS LTELQMGGN FSG IP ELG+LSSLQIA+NLSYNNL G I
Sbjct: 590 KLSENKFSGNIPAALGNLSHLTELQMGGNLFSGEIPPELGALSSLQIAMNLSYNNLLGRI 649
Query: 648 PPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVN 707
PPELGNLILLE+LLLNNNHLSGEIP +F NLSSL+GCNFSYN+LTGP+PS FQNM +
Sbjct: 650 PPELGNLILLEFLLLNNNHLSGEIPSTFGNLSSLMGCNFSYNDLTGPLPSIPLFQNMVSS 709
Query: 708 SFSGSKGLCGGPLQNCTQPPSSLPFPSGTNSPTARLGKLVAIIAAAIGGVSLVLITVIIY 767
SF G++GLCGG L NC PS P S A GK++ ++AA
Sbjct: 710 SFIGNEGLCGGRLSNCNGTPSFSSVPPSLESVDAPRGKIITVVAAV-------------- 755
Query: 768 FLRQPVEVVAPLQDKQLSSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYR 827
EGFTF+DLV AT+NF + +V+GRGACGTVY+
Sbjct: 756 -----------------------------EGFTFQDLVEATNNFHDSYVVGRGACGTVYK 786
Query: 828 AVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887
AV+ +G T+AVKKLASNREG N++DNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL+Y
Sbjct: 787 AVMHSGQTIAVKKLASNREG-NSIDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLLY 845
Query: 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947
EYMARGSLGELLHGAS +L+WQTRF IALGAAEGL+YLHHDCKPRI HRDIKSNNILLD
Sbjct: 846 EYMARGSLGELLHGASCSLEWQTRFTIALGAAEGLAYLHHDCKPRIIHRDIKSNNILLDS 905
Query: 948 KFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 1007
FEAHVGDFGLAKV+DMPQSKSMSA+AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL
Sbjct: 906 NFEAHVGDFGLAKVVDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 965
Query: 1008 TGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTN 1067
TGR PVQPLDQGGDLV+WVRN+IR++SL S + D RLNL+DE TV HMI VLKIA+LCTN
Sbjct: 966 TGRTPVQPLDQGGDLVSWVRNYIRDHSLTSEIFDTRLNLEDENTVDHMIAVLKIAILCTN 1025
Query: 1068 ISPFDRPTMREVVLMLSESNRRQGHFEFSPMD 1099
+SP DRP+MREVVLML ESN +G++ SP++
Sbjct: 1026 MSPPDRPSMREVVLMLIESNEHEGYYISSPIN 1057
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1114 | ||||||
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.965 | 0.976 | 0.658 | 0.0 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.964 | 0.955 | 0.612 | 0.0 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.967 | 0.979 | 0.505 | 6.6e-271 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.911 | 0.810 | 0.356 | 5.4e-166 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.919 | 0.897 | 0.351 | 1e-162 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.892 | 0.795 | 0.355 | 2e-159 | |
| UNIPROTKB|P93194 | 1109 | INRPK1 "Receptor-like protein | 0.930 | 0.935 | 0.344 | 2.3e-158 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.601 | 0.598 | 0.365 | 4.2e-158 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.868 | 0.851 | 0.352 | 3.5e-155 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.486 | 0.540 | 0.348 | 4.9e-155 |
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3584 (1266.7 bits), Expect = 0., P = 0.
Identities = 716/1087 (65%), Positives = 820/1087 (75%)
Query: 12 LFSASILAIICLLVHQTKGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNC 71
+F S+L I LL+ +T GL N+EGQ LL IKSK VD L NWN NDS PCGW GV C
Sbjct: 10 VFFISLLLI--LLISETTGL-NLEGQYLLEIKSKFVDAKQNLRNWNSNDSVPCGWTGVMC 66
Query: 72 TTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSXXXX 131
+ V SLNL+ M LSG LSP+IGGLVHL LDLS+N LS IPKEIGNCSS
Sbjct: 67 SNYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEIL 126
Query: 132 XXXXXXXXAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLP 191
IP E+G L SL L IYNNRISG P EIG L +LSQLV YSNNISG LP
Sbjct: 127 KLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLP 186
Query: 192 PTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDV 251
++GNLKRL SFRAGQN+ISGSLPSEIGGCESL LGLAQNQLSGE+PKEIGMLK L+ V
Sbjct: 187 RSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQV 246
Query: 252 ILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIP 311
ILW N+ SG IP+E+ NCTSLETLALY N+ VG +PKELG + SL++LY+YRN LNGTIP
Sbjct: 247 ILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIP 306
Query: 312 REIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVEXXXXXXXXXX 371
REIG LS A+EIDFSEN+L GEIP+EL I GLELLYLFEN+LTG IPVE
Sbjct: 307 REIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKL 366
Query: 372 XXSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIP 431
SIN+LTG IPLGFQYL L MLQLF NSL G IP +LG YS LWV+D+SDNHL+G+IP
Sbjct: 367 DLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIP 426
Query: 432 RHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTV 491
++C ++++I LNL TN L+G+IPTG+T CK+LVQLRL N+ G FPS+LCK N++ +
Sbjct: 427 SYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAI 486
Query: 492 ELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIP 551
EL QN+F G IP E+GNC+ALQRL L+DN FTGELPRE+G LS L T N+SSN LTG +P
Sbjct: 487 ELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVP 546
Query: 552 LEIFSCKMLQRLDLSWNKFVGALPREIGSLFQXXXXXXXXXXXXXXIPVQIGNLSRLTEL 611
EIF+CKMLQRLD+ N F G LP E+GSL+Q IPV +GNLSRLTEL
Sbjct: 547 SEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTEL 606
Query: 612 QMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPEXXXXXXXXXXXXXXXXXSGEI 671
QMGGN F+G IP ELGSL+ LQIALNLSYN L+G IPPE SGEI
Sbjct: 607 QMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEI 666
Query: 672 PGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPSSLP 731
P SF NLSSLLG NFSYN+LTGPIP +N+S++SF G++GLCG PL C Q P
Sbjct: 667 PSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAP 723
Query: 732 FPSGTNSPTA-RXXXXXXXXXXXXXXXXXXLITVIIYFLRQPVEVVAP-LQDKQLSSTVS 789
S T P R LI +I+Y +R+PV VA QD Q S
Sbjct: 724 SQS-TGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSL 782
Query: 790 DIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREG-- 847
DIYFPPKEGFTF+DLV ATDNFDE FV+GRGACGTVY+AVL G+T+AVKKLASN EG
Sbjct: 783 DIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGN 842
Query: 848 NNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLD 907
NNNVDNSFRAEILTLG IRHRNIVKL+GFC HQGSNLL+YEYM +GSLGE+LH S LD
Sbjct: 843 NNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLD 902
Query: 908 WQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967
W RF IALGAA+GL+YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP S
Sbjct: 903 WSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHS 962
Query: 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR 1027
KSMSAIAGSYGYIAPEYAYTMKVTEK DIYSYGVVLLELLTG+APVQP+DQGGD+V WVR
Sbjct: 963 KSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVR 1022
Query: 1028 NFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087
++IR ++L SG+LDARL L+DE+ VSHM+TVLKIA+LCT++SP RP+MR+VVLML ES
Sbjct: 1023 SYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIESE 1082
Query: 1088 RRQGHFE 1094
R +G E
Sbjct: 1083 RSEGEQE 1089
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3334 (1178.7 bits), Expect = 0., P = 0.
Identities = 668/1090 (61%), Positives = 803/1090 (73%)
Query: 17 ILAIICLLVHQTKGLVNIEGQILLLIKSK-LVDNSNYLGNWNPNDSTPCGWIGVNCTTND 75
+L ++ LLV ++ L N +GQ LL +K++ D+ N L NWN D TPC WIGVNC++
Sbjct: 19 VLFLLTLLVWTSESL-NSDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQG 77
Query: 76 FGA-----VVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSXXX 130
+ VV SL+L+ MNLSG +SP+IGGLV+L L+L++N L+ +IP+EIGNCS
Sbjct: 78 SSSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEV 137
Query: 131 XXXXXXXXXAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSL 190
IP E+ LS L NI NN++SGP P+EIG L L +LVAY+NN++G L
Sbjct: 138 MFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPL 197
Query: 191 PPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTD 250
P +LGNL +L +FRAGQN SG++P+EIG C +L+ LGLAQN +SGE+PKEIGML L +
Sbjct: 198 PRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQE 257
Query: 251 VILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTI 310
VILW N+ SG IPK++GN TSLETLALY N VG +P E+G++ SLK LY+Y+N+LNGTI
Sbjct: 258 VILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTI 317
Query: 311 PREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVEXXXXXXXXX 370
P+E+GKLS +EIDFSEN L GEIPVELSKI L LLYLF+NKLTG+IP E
Sbjct: 318 PKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAK 377
Query: 371 XXXSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKI 430
SINSLTG IP GFQ LT++ LQLF NSL G IPQ LG YS LWVVD S+N L+GKI
Sbjct: 378 LDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKI 437
Query: 431 PRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLST 490
P IC+ ++LI LNL +N++ G+IP GV RCKSL+QLR+ GN TG FP++LCKL NLS
Sbjct: 438 PPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSA 497
Query: 491 VELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRI 550
+ELDQN+FSGP+P EIG C LQRLHL+ N F+ LP E+ LSNLVTFNVSSN LTG I
Sbjct: 498 IELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPI 557
Query: 551 PLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQXXXXXXXXXXXXXXIPVQIGNLSRLTE 610
P EI +CKMLQRLDLS N F+G+LP E+GSL Q IP IGNL+ LTE
Sbjct: 558 PSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTE 617
Query: 611 LQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPEXXXXXXXXXXXXXXXXXSGE 670
LQMGGN FSG IP +LG LSSLQIA+NLSYN+ SG IPPE SGE
Sbjct: 618 LQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGE 677
Query: 671 IPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPSSL 730
IP +F NLSSLLGCNFSYNNLTG +P +Q FQNM++ SF G+KGLCGG L++C SS
Sbjct: 678 IPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSW 737
Query: 731 PFPSGTNSPTARXXXXXXXXXXXXXXXXXXLITVIIYFLRQPVEVVAP-LQDKQLSSTVS 789
P S + +AR LI ++++FLR PVE AP + DK+ S
Sbjct: 738 PHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQES 797
Query: 790 DIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNN 849
DIYF PKE FT KD++ AT F + +++GRGACGTVY+AV+ +G T+AVKKL SNREGNN
Sbjct: 798 DIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNN 857
Query: 850 N----VDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN--LLMYEYMARGSLGELLHGAS 903
N DNSFRAEILTLGKIRHRNIV+LY FCYHQGSN LL+YEYM+RGSLGELLHG
Sbjct: 858 NNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGK 917
Query: 904 S-TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962
S ++DW TRF IALGAAEGL+YLHHDCKPRI HRDIKSNNIL+D+ FEAHVGDFGLAKVI
Sbjct: 918 SHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVI 977
Query: 963 DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDL 1022
DMP SKS+SA+AGSYGYIAPEYAYTMKVTEKCDIYS+GVVLLELLTG+APVQPL+QGGDL
Sbjct: 978 DMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDL 1037
Query: 1023 VTWVRNFIRNNSLVSGMLDARLN-LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081
TW RN IR++SL S +LD L ++D+ ++HMITV KIA+LCT SP DRPTMREVVL
Sbjct: 1038 ATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVL 1097
Query: 1082 MLSESNRRQG 1091
ML ES R G
Sbjct: 1098 MLIESGERAG 1107
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2605 (922.1 bits), Expect = 6.6e-271, P = 6.6e-271
Identities = 554/1096 (50%), Positives = 699/1096 (63%)
Query: 18 LAIICLLVHQTKGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNCTTNDFG 77
+ I+C +N EG++LL K+ L D++ YL +WN DS PC W G+ CT
Sbjct: 10 IVILCSFSFILVRSLNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTHL--- 66
Query: 78 AVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSXXXXXXXXXX 137
V S++L MNLSG LSP I L L L++S N +S IP+++ C S
Sbjct: 67 RTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNR 126
Query: 138 XXAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNL 197
IP +L + +L L + N + G P++IG LS+L +LV YSNN++G +PP++ L
Sbjct: 127 FHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKL 186
Query: 198 KRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQ 257
++L+ RAG+N SG +PSEI GCESL+ LGLA+N L G +PK++ L+ LTD+ILW N+
Sbjct: 187 RQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNR 246
Query: 258 LSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKL 317
LSG IP +GN + LE LAL++N G +P+E+G + +K LY+Y N+L G IPREIG L
Sbjct: 247 LSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNL 306
Query: 318 SSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVEXXXXXXXXXXXXSINS 377
A EIDFSEN L G IP E IL L+LL+LFEN L G IP E SIN
Sbjct: 307 IDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINR 366
Query: 378 LTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN 437
L GTIP Q+L L+ LQLFDN L G IP +G YS V+D+S N L+G IP H CR
Sbjct: 367 LNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRF 426
Query: 438 TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQ 497
+LI L+L +NKL+G+IP + CKSL +L LG N TGS P +L L NL+ +EL QN
Sbjct: 427 QTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNW 486
Query: 498 FSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSC 557
SG I ++G L+RL L++N FTGE+P E+GNL+ +V FN+SSN LTG IP E+ SC
Sbjct: 487 LSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSC 546
Query: 558 KMLQRLDLSWNKFVGALPREIGSLFQXXXXXXXXXXXXXXIPVQIGNLSRLTELQMGGNS 617
+QRLDLS NKF G + +E+G L IP G+L+RL ELQ+GGN
Sbjct: 547 VTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNL 606
Query: 618 FSGGIPAELGSLSSLQIALNLSYNNLSGLIPPEXXXXXXXXXXXXXXXXXSGEIPGSFVN 677
S IP ELG L+SLQI+LN+S+NNLSG IP SGEIP S N
Sbjct: 607 LSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGN 666
Query: 678 LSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQP--PSSLPFPSG 735
L SLL CN S NNL G +P + FQ M ++F+G+ GLC +C QP P S S
Sbjct: 667 LMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHC-QPLVPHS---DSK 722
Query: 736 TNSPTARXXXXXXXXXXXXXXXXXXLITVI--IYFLRQPVEVVAPLQDKQLSSTVSDIYF 793
N LIT + + +++ L+D Q V D Y+
Sbjct: 723 LNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALED-QTKPDVMDSYY 781
Query: 794 PPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDN 853
PK+GFT++ LV AT NF E V+GRGACGTVY+A + G +AVKKL S EG ++ DN
Sbjct: 782 FPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASS-DN 840
Query: 854 SFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASST--LDWQTR 911
SFRAEI TLGKIRHRNIVKLYGFCYHQ SNLL+YEYM++GSLGE L LDW R
Sbjct: 841 SFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNAR 900
Query: 912 FMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 971
+ IALGAAEGL YLHHDC+P+I HRDIKSNNILLD++F+AHVGDFGLAK+ID+ SKSMS
Sbjct: 901 YRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMS 960
Query: 972 AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIR 1031
A+AGSYGYIAPEYAYTMKVTEKCDIYS+GVVLLEL+TG+ PVQPL+QGGDLV WVR IR
Sbjct: 961 AVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIR 1020
Query: 1032 NNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091
N M DARL+ D++TV M VLKIA+ CT+ SP RPTMREVV M++E+ +G
Sbjct: 1021 NMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEA---RG 1077
Query: 1092 HFEFSPMDHDSDQKLE 1107
S S+ LE
Sbjct: 1078 SSSLSSSSITSETPLE 1093
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1615 (573.6 bits), Expect = 5.4e-166, P = 5.4e-166
Identities = 379/1064 (35%), Positives = 564/1064 (53%)
Query: 67 IGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCS 126
IG NCT+ A F+ L+G L + L +L L+L N S IP ++G+
Sbjct: 212 IG-NCTSLALFAAAFN------RLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLV 264
Query: 127 SXXXXXXXXXXXXAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNI 186
S IPK L L++L L++ +N ++G +E +++ L LV N +
Sbjct: 265 SIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRL 324
Query: 187 SGSLPPTL-GNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGML 245
SGSLP T+ N LK + +SG +P+EI C+SL+ L L+ N L+G+IP + L
Sbjct: 325 SGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQL 384
Query: 246 KYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNE 305
LT++ L N L G + + N T+L+ LY N G++PKE+G +G L+ +Y+Y N
Sbjct: 385 VELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENR 444
Query: 306 LNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVEXXXX 365
+G +P EIG + EID+ N L GEIP + ++ L L+L EN+L G IP
Sbjct: 445 FSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNC 504
Query: 366 XXXXXXXXSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNH 425
+ N L+G+IP F +LT L + +++NSL G +P L L ++ S N
Sbjct: 505 HQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNK 564
Query: 426 LTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKL 485
G I +C ++S + ++ N G IP + + +L +LRLG N FTG P K+
Sbjct: 565 FNGSISP-LCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKI 623
Query: 486 ANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNF 545
+ LS +++ +N SG IP E+G C L + L++NY +G +P +G L L +SSN
Sbjct: 624 SELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNK 683
Query: 546 LTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQXXXXXXXXXXXXXXIPVQIGNL 605
G +P EIFS + L L N G++P+EIG+L +P IG L
Sbjct: 684 FVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKL 743
Query: 606 SRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPEXXXXXXXXXXXXXXX 665
S+L EL++ N+ +G IP E+G L LQ AL+LSYNN +G IP
Sbjct: 744 SKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHN 803
Query: 666 XXSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQ 725
GE+PG ++ SL N SYNNL G + + F ++F G+ GLCG PL +C +
Sbjct: 804 QLVGEVPGQIGDMKSLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAGLCGSPLSHCNR 861
Query: 726 PPSSLPFPSGTNSPTARXXXXXXXXXXXXXXXXXXLITVIIYFLRQPVEVVAPLQ--DKQ 783
S N + ++ VII F +Q ++ ++ +
Sbjct: 862 AGSK-------NQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSA 914
Query: 784 LSSTVSDIYFP------PKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVA 837
SS S P K + D++ AT +E F+IG G G VY+A L+ G T+A
Sbjct: 915 FSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIA 974
Query: 838 VKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLLMYEYMARGSL 895
VKK+ + +N SF E+ TLG IRHR++VKL G+C + G NLL+YEYMA GS+
Sbjct: 975 VKKILWKDDLMSN--KSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSV 1032
Query: 896 GELLHGASST-----LDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE 950
+ LH +T L W+TR IALG A+G+ YLH+DC P I HRDIKS+N+LLD E
Sbjct: 1033 WDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIE 1092
Query: 951 AHVGDFGLAKVIDM---PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 1007
AH+GDFGLAK++ ++S + AGSYGYIAPEYAY++K TEK D+YS G+VL+E++
Sbjct: 1093 AHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIV 1152
Query: 1008 TGRAPVQPL-DQGGDLVTWVRNFIRN---NSLVSGMLDARLN--LQDEKTVSHMITVLKI 1061
TG+ P + + D+ D+V WV + + ++D+ L L E+ ++ VL+I
Sbjct: 1153 TGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQ--VLEI 1210
Query: 1062 AMLCTNISPFDRPTMREVV-LMLSESNRRQGHFEFSPMDHDSDQ 1104
A+ CT P +RP+ R+ +L+ N R + M D+D+
Sbjct: 1211 ALQCTKSYPQERPSSRQASEYLLNVFNNRAASYR--EMQTDTDK 1252
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1584 (562.7 bits), Expect = 1.0e-162, P = 1.0e-162
Identities = 373/1061 (35%), Positives = 559/1061 (52%)
Query: 57 NPNDSTPCGWIGVNCTTNDFGAVVF---SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQ 113
NP S W+ + T +F S++ T N +++ + G + T +D+
Sbjct: 36 NPEASILYSWLHSSSPTPS-SLSLFNWNSIDNTPCNNWTFITCSSQGFI--TDIDIESVP 92
Query: 114 LSRNIPKEIGNCSSXXXXXXXXXXXXAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKL 173
L ++PK + S +P+ LG+ L +L++ +N + G P + KL
Sbjct: 93 LQLSLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKL 152
Query: 174 SALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQN- 232
L L+ SN ++G +PP + +LKS NL++GS+P+E+G L+ + + N
Sbjct: 153 RNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNK 212
Query: 233 QLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGS 292
++SG+IP EIG LT + L +SG +P LG LETL++Y G++P +LG+
Sbjct: 213 EISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGN 272
Query: 293 IGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFEN 352
L L++Y N L+G+IPREIG+L+ ++ +NSL+G IP E+ L+++ L N
Sbjct: 273 CSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLN 332
Query: 353 KLTGVIPVEXXXXXXXXXXXXSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGA 412
L+G IP S N +G+IP ++L+ LQL N + G IP LG
Sbjct: 333 LLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGT 392
Query: 413 YSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGN 472
++L + N L G IP + T L L+L N LTG+IP+G+ ++L +L L N
Sbjct: 393 LTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISN 452
Query: 473 SFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGN 532
S +G P ++ ++L + L N+ +G IP+ IG+ + L S N G++P E+G+
Sbjct: 453 SLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGS 512
Query: 533 LSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQXXXXXXXXX 592
S L ++S+N L G +P + S LQ LD+S N+F G +P +G L
Sbjct: 513 CSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKN 572
Query: 593 XXXXXIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPEXX 652
IP +G S L L +G N SG IP+ELG + +L+IALNLS N L+G IP +
Sbjct: 573 LFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIA 632
Query: 653 XXXXXXXXXXXXXXXSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGS 712
G++ N+ +L+ N SYN+ +G +P ++ F+ +S G+
Sbjct: 633 SLNKLSILDLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGN 691
Query: 713 KGLCGGPLQNCTQPPSSLPFPSGTNSPTARXXXXXXXXXXXXXXXXXXLITVIIYFLRQP 772
K LC +C L + G +TV++ L
Sbjct: 692 KKLCSSTQDSCF-----LTYRKGNG--LGDDGDASRTRKLRLTLALLITLTVVLMILGAV 744
Query: 773 VEVVAPLQ-DKQLSSTVSDIY---FPPKEGFTFK-DLVVATDNFDERFVIGRGACGTVYR 827
+ A D + S + + Y F P + F D ++ E VIG+G G VYR
Sbjct: 745 AVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRC--LVEPNVIGKGCSGVVYR 802
Query: 828 AVLRTGHTVAVKKL------ASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881
A + G +AVKKL + E NV +SF AE+ TLG IRH+NIV+ G C+++
Sbjct: 803 ADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRN 862
Query: 882 SNLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKS 940
+ LLMY+YM GSLG LLH S+LDW R+ I LGAA+GL+YLHHDC P I HRDIK+
Sbjct: 863 TRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKA 922
Query: 941 NNILLDDKFEAHVGDFGLAKVIDMPQ-SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSY 999
NNIL+ FE ++ DFGLAK++D + + +AGSYGYIAPEY Y+MK+TEK D+YSY
Sbjct: 923 NNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSY 982
Query: 1000 GVVLLELLTGRAPVQP-LDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITV 1058
GVV+LE+LTG+ P+ P + +G LV WVR SL +LD+ L + E M+ V
Sbjct: 983 GVVVLEVLTGKQPIDPTVPEGIHLVDWVRQ--NRGSLE--VLDSTLRSRTEAEADEMMQV 1038
Query: 1059 LKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMD 1099
L A+LC N SP +RPTM++V ML E +Q E++ +D
Sbjct: 1039 LGTALLCVNSSPDERPTMKDVAAMLKEI--KQEREEYAKVD 1077
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1553 (551.7 bits), Expect = 2.0e-159, P = 2.0e-159
Identities = 367/1032 (35%), Positives = 540/1032 (52%)
Query: 90 LSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSXXXXXXXXXXXXAHIPKELGNL 149
L+G + +G L +L L+L+ N L+ IP ++G S IPK L +L
Sbjct: 227 LNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADL 286
Query: 150 SSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTL-GNLKRLKSFRAGQN 208
+L L++ N ++G P+E +S L LV +N++SGSLP ++ N L+
Sbjct: 287 GNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGT 346
Query: 209 LISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGN 268
+SG +P E+ C+SL+ L L+ N L+G IP+ + L LTD+ L N L G + + N
Sbjct: 347 QLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISN 406
Query: 269 CTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSEN 328
T+L+ L LY N G+LPKE+ ++ L+ L++Y N +G IP+EIG +S ID N
Sbjct: 407 LTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGN 466
Query: 329 SLIGEIPVELSKILGLELLYLFENKLTGVIPVEXXXXXXXXXXXXSINSLTGTIPLGFQY 388
GEIP + ++ L LL+L +N+L G +P + N L+G+IP F +
Sbjct: 467 HFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGF 526
Query: 389 LTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETN 448
L L L L++NSL G +P L + L ++LS N L G I +C ++S + ++ N
Sbjct: 527 LKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTI-HPLCGSSSYLSFDVTNN 585
Query: 449 KLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGN 508
IP + ++L +LRLG N TG P L K+ LS +++ N +G IP ++
Sbjct: 586 GFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVL 645
Query: 509 CNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWN 568
C L + L++N+ +G +P +G LS L +SSN +P E+F+C L L L N
Sbjct: 646 CKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGN 705
Query: 569 KFVGALPREIGSLFQXXXXXXXXXXXXXXIPVQIGNLSRLTELQMGGNSFSGGIPAELGS 628
G++P+EIG+L +P +G LS+L EL++ NS +G IP E+G
Sbjct: 706 SLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQ 765
Query: 629 LSSLQIALNLSYNNLSGLIPPEXXXXXXXXXXXXXXXXXSGEIPGSFVNLSSLLGCNFSY 688
L LQ AL+LSYNN +G IP +GE+PGS ++ SL N S+
Sbjct: 766 LQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSF 825
Query: 689 NNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPSSLPFPSGTNSPTARXXXXXX 748
NNL G + + F +SF G+ GLCG PL C + S+ + +AR
Sbjct: 826 NNLGGKL--KKQFSRWPADSFLGNTGLCGSPLSRCNRVRSN----NKQQGLSARSVVIIS 879
Query: 749 XXXXXXXXXXXXLITVIIYFLRQPVEVVAPLQDKQL----SSTVSDIYFPP-------KE 797
+I VI F +Q + + SS+ S P K
Sbjct: 880 AISALTAIGL--MILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKS 937
Query: 798 GFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRA 857
++D++ AT N E F+IG G G VY+A L G TVAVKK+ + +N SF
Sbjct: 938 DIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSN--KSFSR 995
Query: 858 EILTLGKIRHRNIVKLYGFCYH--QGSNLLMYEYMARGSLGELLHG-------ASSTLDW 908
E+ TLG+IRHR++VKL G+C +G NLL+YEYM GS+ + LH LDW
Sbjct: 996 EVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDW 1055
Query: 909 QTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM---P 965
+ R IA+G A+G+ YLHHDC P I HRDIKS+N+LLD EAH+GDFGLAKV+
Sbjct: 1056 EARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDT 1115
Query: 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG-DLVT 1024
+ S + A SYGYIAPEYAY++K TEK D+YS G+VL+E++TG+ P + D+V
Sbjct: 1116 NTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVR 1175
Query: 1025 WVRNFIR-NNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV-LM 1082
WV + S ++D +L VL+IA+ CT SP +RP+ R+ +
Sbjct: 1176 WVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235
Query: 1083 LSESNRRQGHFE 1094
L N R ++
Sbjct: 1236 LHVYNNRTAGYK 1247
|
|
| UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)] | Back alignment and assigned GO terms |
|---|
Score = 1543 (548.2 bits), Expect = 2.3e-158, P = 2.3e-158
Identities = 374/1086 (34%), Positives = 543/1086 (50%)
Query: 32 VNIEGQILLLIKSKLVD-NSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNL 90
+N +G LL + S+ +WN +DSTPC W+GV C F V +LNL+ +
Sbjct: 24 LNSDGAALLSLTRHWTSIPSDITQSWNASDSTPCSWLGVECDRRQF---VDTLNLSSYGI 80
Query: 91 SGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSXXXXXXXXXXXXAHIPKELGNLS 150
SG P I L HL + LS N +IP ++GNCS +IP LG L
Sbjct: 81 SGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQ 140
Query: 151 SLTILNIYNNRISGPFPKE------------------------IGKLSALSQLVAYSNNI 186
+L L+++ N + GPFP+ IG +S L+ L N
Sbjct: 141 NLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQF 200
Query: 187 SGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLK 246
SG +P +LGN+ L+ N + G+LP + E+L YL + N L G IP + K
Sbjct: 201 SGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFVSCK 260
Query: 247 YLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNEL 306
+ + L NQ +G +P LGNCTSL + G +P G + L LY+ N
Sbjct: 261 QIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHF 320
Query: 307 NGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVEXXXXX 366
+G IP E+GK S +++ +N L GEIP EL + L+ L+L+ N L+G +P+
Sbjct: 321 SGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIWKIQ 380
Query: 367 XXXXXXXSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHL 426
N+L+G +P+ L L+ L L++N G IPQ LGA S L V+DL+ N
Sbjct: 381 SLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLTRNMF 440
Query: 427 TGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLA 486
TG IP ++C L L L N L GS+P+ + C +L +L L N+ G P D +
Sbjct: 441 TGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGLP-DFVEKQ 499
Query: 487 NLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFL 546
NL +L N F+GPIP +GN + ++LS N +G +P E+G+L L N+S N L
Sbjct: 500 NLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEHLNLSHNIL 559
Query: 547 TGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQXXXXXXXXXXXXXXIPVQIGNLS 606
G +P E+ +C L LD S N G++P +GSL + IP + +
Sbjct: 560 KGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLFQSN 619
Query: 607 RLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPEXXXXXXXXXXXXXXXX 666
+L LQ+GGN +G IP +G+L +L+ +LNLS N L+G +P +
Sbjct: 620 KLLNLQLGGNLLAGDIPP-VGALQALR-SLNLSSNKLNGQLPIDLGKLKMLEELDVSHNN 677
Query: 667 XSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQT-FQNMSVNSFSGSKGLC-GGPLQNCT 724
SG + + SL N S+N +GP+P S T F N S SFSG+ LC P
Sbjct: 678 LSGTLR-VLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLCINCPADGLA 736
Query: 725 QPPSSLPFPSGTNSPTARXXXXXXXXXXXXXXXXXXLITVIIYFLRQPVEVVAPLQDKQL 784
P SS+ P S T + +I + ++ + +Q+ +
Sbjct: 737 CPESSILRPCNMQSNTGKGGLSTLGIAMIVLGALLFIICLFLFSAFLFLHCKKSVQEIAI 796
Query: 785 SSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASN 844
S+ D G ++ AT+N ++++VIG+GA GT+Y+A L AVKKL
Sbjct: 797 SAQEGD-------GSLLNKVLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKLVFT 849
Query: 845 REGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGAS- 903
N +V S EI T+GK+RHRN++KL F + L++Y YM GSL ++LH +
Sbjct: 850 GIKNGSV--SMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNP 907
Query: 904 -STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962
LDW TR IA+G A GL+YLH DC P I HRDIK NILLD E H+ DFG+AK++
Sbjct: 908 PKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKLL 967
Query: 963 DMPQSKSMS-AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG- 1020
D + S + G+ GY+APE A+T + + D+YSYGVVLLEL+T + + P G
Sbjct: 968 DQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALDPSFNGET 1027
Query: 1021 DLVTWVRNFIRNNSLVSGMLDARL--NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMRE 1078
D+V WVR+ + ++D L L D + + L +A+ C RPTMR+
Sbjct: 1028 DIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEALSLALRCAEKEVDKRPTMRD 1087
Query: 1079 VVLMLS 1084
VV L+
Sbjct: 1088 VVKQLT 1093
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1025 (365.9 bits), Expect = 4.2e-158, Sum P(2) = 4.2e-158
Identities = 252/690 (36%), Positives = 348/690 (50%)
Query: 35 EGQILLLIKSKLVDNSNYLGNW----NPNDSTPC-GWIGVNCTTNDFGAVVFSLNLTKMN 89
E LL KS NS+ L +W N N S C W GV+C N G++ LNLT
Sbjct: 33 EANALLKWKSTFT-NSSKLSSWVHDANTNTSFSCTSWYGVSC--NSRGSIE-ELNLTNTG 88
Query: 90 LSGYLS--PNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSXXXXXXXXXXXXAHIPKELG 147
+ G P I L +L +DLS N LS IP + GN S I LG
Sbjct: 89 IEGTFQDFPFIS-LSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLG 147
Query: 148 NLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQ 207
NL +LT+L ++ N ++ P E+G + +++ L N ++GS+P +LGNLK L +
Sbjct: 148 NLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYE 207
Query: 208 NLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELG 267
N ++G +P E+G ES+ L L+QN+L+G IP +G LK L + L+ N L+GVIP E+G
Sbjct: 208 NYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIG 267
Query: 268 NCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSE 327
N S+ LAL NK G +P LG++ +L L +++N L G IP ++G + S ++++ S
Sbjct: 268 NMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSN 327
Query: 328 NSLIGEIPVELSKILGLELLYLFENKLTGVIPVEXXXXXXXXXXXXSINSLTGTIPLGFQ 387
N L G IP L + L +LYL+EN LTGVIP E + N LTG+IP F
Sbjct: 328 NKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFG 387
Query: 388 YLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLET 447
L NL L L+ N L G IPQ LG + +DLS N LTG +P T L L L
Sbjct: 388 NLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRV 447
Query: 448 NKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIG 507
N L+G+IP GV L L L N+FTG FP +CK L + LD N GPIP +
Sbjct: 448 NHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLR 507
Query: 508 NCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSW 567
+C +L R N FTG++ G +L + S N G I L L +S
Sbjct: 508 DCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSN 567
Query: 568 NKFVGALPREIGSLFQXXXXXXXXXXXXXXIPVQIGNLSRLTELQMGGNSFSGGIPAELG 627
N GA+P EI ++ Q +P IGNL+ L+ L++ GN SG +PA L
Sbjct: 568 NNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLS 627
Query: 628 SLSSLQIALNLSYNNLSGLIPPEXXXXXXXXXXXXXXXXXSGEIPGSFVNLSSLLGCNFS 687
L++L+ +L+LS NN S IP G IP L+ L + S
Sbjct: 628 FLTNLE-SLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLS 685
Query: 688 YNNLTGPIPSS-QTFQNM-----SVNSFSG 711
+N L G IPS + Q++ S N+ SG
Sbjct: 686 HNQLDGEIPSQLSSLQSLDKLDLSHNNLSG 715
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1513 (537.7 bits), Expect = 3.5e-155, P = 3.5e-155
Identities = 351/997 (35%), Positives = 531/997 (53%)
Query: 104 LTALDLSFNQLSRNIPKEIGNCSSXXXXXXXXXXXXAHIPKELGNLSSLTILNIYNNRIS 163
+T +++ QL+ P I + +S I E+G+ S L ++++ +N +
Sbjct: 84 VTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSLV 143
Query: 164 GPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCES 223
G P +GKL L +L SN ++G +PP LG+ LK+ N +S +LP E+G +
Sbjct: 144 GEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKIST 203
Query: 224 LQYLGLAQN-QLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQ 282
L+ + N +LSG+IP+EIG + L + L ++SG +P LG + L++L++Y
Sbjct: 204 LESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTML 263
Query: 283 VGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKIL 342
G++PKELG+ L L++Y N+L+GT+P+E+GKL + ++ +N+L G IP E+ +
Sbjct: 264 SGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMK 323
Query: 343 GLELLYLFENKLTGVIPVEXXXXXXXXXXXXSINSLTGTIPLGFQYLTNLIMLQLFDNSL 402
L + L N +G IP S N++TG+IP T L+ Q+ N +
Sbjct: 324 SLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQI 383
Query: 403 VGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCK 462
G IP +G +L + N L G IP + +L L+L N LTGS+P G+ + +
Sbjct: 384 SGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLR 443
Query: 463 SLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYF 522
+L +L L N+ +G P ++ +L + L N+ +G IP IG L L LS+N
Sbjct: 444 NLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNL 503
Query: 523 TGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLF 582
+G +P E+ N L N+S+N L G +PL + S LQ LD+S N G +P +G L
Sbjct: 504 SGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLI 563
Query: 583 QXXXXXXXXXXXXXXIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNN 642
IP +G+ + L L + N+ SG IP EL + L IALNLS+N+
Sbjct: 564 SLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNS 623
Query: 643 LSGLIPPEXXXXXXXXXXXXXXXXXSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQ 702
L G IP SG++ + L +L+ N S+N +G +P S+ F+
Sbjct: 624 LDGFIPERISALNRLSVLDISHNMLSGDL-SALSGLENLVSLNISHNRFSGYLPDSKVFR 682
Query: 703 NMSVNSFSGSKGLCGGPLQNCTQPPSS-LPFPSGTNSPTARXXXXXXXXXXXXXXXXXXL 761
+ G+ GLC ++C SS L G +S R L
Sbjct: 683 QLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVL 742
Query: 762 ITVIIYFLRQPVEVVAPLQDKQLSSTVSDIYFPP--KEGFTFKDLVVATDNFDERFVIGR 819
+ + +++ D + + F P K FT + ++ E VIG+
Sbjct: 743 AVI------RAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKC---LVEGNVIGK 793
Query: 820 GACGTVYRAVLRTGHTVAVKKL-------ASNREGNNNVDNSFRAEILTLGKIRHRNIVK 872
G G VY+A + +AVKKL + + ++ V +SF AE+ TLG IRH+NIV+
Sbjct: 794 GCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVR 853
Query: 873 LYGFCYHQGSNLLMYEYMARGSLGELLHGASS--TLDWQTRFMIALGAAEGLSYLHHDCK 930
G C+++ + LLMY+YM+ GSLG LLH S +L W+ R+ I LGAA+GL+YLHHDC
Sbjct: 854 FLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCV 913
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ-SKSMSAIAGSYGYIAPEYAYTMK 989
P I HRDIK+NNIL+ FE ++GDFGLAK++D ++S + IAGSYGYIAPEY Y+MK
Sbjct: 914 PPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMK 973
Query: 990 VTEKCDIYSYGVVLLELLTGRAPVQP-LDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048
+TEK D+YSYGVV+LE+LTG+ P+ P + G +V WV+ IR+ ++ L AR
Sbjct: 974 ITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKK-IRDIQVIDQGLQAR----P 1028
Query: 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
E V M+ L +A+LC N P DRPTM++V MLSE
Sbjct: 1029 ESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSE 1065
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 774 (277.5 bits), Expect = 4.9e-155, Sum P(2) = 4.9e-155
Identities = 193/554 (34%), Positives = 278/554 (50%)
Query: 148 NLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQ 207
+L +T L++ +SG ++ L L L +N ISG +PP + NL L+
Sbjct: 67 SLRHVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSN 126
Query: 208 NLISGSLPSEIG-GCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKEL 266
N+ +GS P E+ G +L+ L L N L+G++P + L L + L GN SG IP
Sbjct: 127 NVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATY 186
Query: 267 GNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYI-YRNELNGTIPREIGKLSSALEIDF 325
G LE LA+ N+ G++P E+G++ +L+ LYI Y N +P EIG LS + D
Sbjct: 187 GTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDA 246
Query: 326 SENSLIGEIPVELSKILGLELLYLFENKLTGVIPVEXXXXXXXXXXXXSINSLTGTIPLG 385
+ L GEIP E+ K+ L+ L+L N TG I E S N TG IP
Sbjct: 247 ANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTS 306
Query: 386 FQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNL 445
F L NL +L LF N L G IP+ +G +L V+ L +N+ TG IP+ + N L+ L+L
Sbjct: 307 FSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDL 366
Query: 446 ETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTE 505
+NKLTG++P + L+ L GN GS P L K +L+ + + +N +G IP E
Sbjct: 367 SSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKE 426
Query: 506 IGNCNALQRLHLSDNYFTGELPREVGNLS-NLVTFNVSSNFLTGRIPLEIFSCKMLQRLD 564
+ L ++ L DNY TGELP G +S +L ++S+N L+G +P I + +Q+L
Sbjct: 427 LFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLL 486
Query: 565 LSWNKFVGALPREIGSLFQXXXXXXXXXXXXXXIPVQIGNLSRLTELQMGGNSFSGGIPA 624
L NKF G++P EIG L Q I +I LT + + N SG IP
Sbjct: 487 LDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPN 546
Query: 625 ELGSLSSLQIALNLSYNNLSGLIPPEXXXXXXXXXXXXXXXXXSGEIPG----SFVNLSS 680
EL + L LNLS N+L G IP SG +P S+ N +S
Sbjct: 547 ELTGMKILNY-LNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTS 605
Query: 681 LLGCNFSYNNLTGP 694
+G N ++L GP
Sbjct: 606 FVG-N---SHLCGP 615
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LVP0 | Y5639_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7086 | 0.9551 | 0.9655 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.XIX.729.1 | hypothetical protein (1071 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1114 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-159 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-24 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 498 bits (1283), Expect = e-159
Identities = 349/1062 (32%), Positives = 532/1062 (50%), Gaps = 146/1062 (13%)
Query: 35 EGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYL 94
E ++LL KS + D YL NWN + + C W G+ C + + V S++L+ N+SG +
Sbjct: 30 ELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNS---SRVVSIDLSGKNISGKI 85
Query: 95 SPNIGGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNRLEAHIPKELGNLSSLT 153
S I L ++ ++LS NQLS IP +I SSL LNL+NN IP+ G++ +L
Sbjct: 86 SSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLE 143
Query: 154 ILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGS 213
L++ NN +SG P +IG S+L L N + G +P +L NL
Sbjct: 144 TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLT--------------- 188
Query: 214 LPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLE 273
SL++L LA NQL G+IP+E+G +K L + L N LSG IP E+G TSL
Sbjct: 189 ---------SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239
Query: 274 TLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGE 333
L L N G +P LG++ +L+YL++Y+N+L+G IP I L + +D S+NSL GE
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299
Query: 334 IPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLI 393
IP + ++ LE+L+LF N TG IPV LT+L L
Sbjct: 300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQ------------------------ 335
Query: 394 MLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGS 453
+LQL+ N G IP+ LG ++ L V+DLS N+LTG+IP +C + +L L L +N L G
Sbjct: 336 VLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGE 395
Query: 454 IPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQ 513
IP KSL G C +L+
Sbjct: 396 IP------KSL------------------------------------------GACRSLR 407
Query: 514 RLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGA 573
R+ L DN F+GELP E L + ++S+N L GRI + LQ L L+ NKF G
Sbjct: 408 RVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG 467
Query: 574 LPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQ 633
LP GS +LE L LS N+ SG++P ++G+LS L +L++ N SG IP EL S L
Sbjct: 468 LPDSFGSK-RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKL- 525
Query: 634 IALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTG 693
++L+LS+N LSG IP + +L L L+ N LSGEIP + N+ SL+ N S+N+L G
Sbjct: 526 VSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585
Query: 694 PIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPSSLPFPSGTNSPTARLGKLVA---II 750
+PS+ F ++ ++ +G+ LCGG S LP P R+ K + I
Sbjct: 586 SLPSTGAFLAINASAVAGNIDLCGG------DTTSGLP-------PCKRVRKTPSWWFYI 632
Query: 751 AAAIGGVSLVLITVIIYFLRQPVEVVAPLQDKQLSSTVSDIYFPPK--EGFTFKDLVVAT 808
+G ++ + + + + + + T +F K + T D++ +
Sbjct: 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSL 692
Query: 809 DNFDERFVIGRGACGTVYRA-VLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
E VI RG G Y+ ++ G VK++ N+V++ +EI +GK++H
Sbjct: 693 ---KEENVISRGKKGASYKGKSIKNGMQFVVKEI-------NDVNSIPSSEIADMGKLQH 742
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
NIVKL G C + L++EY+ +L E+L L W+ R IA+G A+ L +LH
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHC 798
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
C P + ++ I++D K E H+ L ++ +S+ Y+APE T
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYVAPETRET 852
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG-GDLVTWVRNFIRNNSLVSGMLDARLNL 1046
+TEK DIY +G++L+ELLTG++P G +V W R + ++ + +D +
Sbjct: 853 KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR-YCYSDCHLDMWIDPSIRG 911
Query: 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088
+ ++ V+ +A+ CT P RP +V+ L ++R
Sbjct: 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 4e-49
Identities = 87/269 (32%), Positives = 120/269 (44%), Gaps = 23/269 (8%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
+G G+ GTVY+A + TG VAVK L R + D + R EI L ++ H NIV+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKIL-KKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+ L+ EY G L + L L IAL GL YLH + I
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSN---GII 120
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE-YAYTMKVTEK 993
HRD+K NILLD+ + DFGLAK + S S++ G+ Y+APE K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSS-SLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 994 CDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVS 1053
D++S GV+L ELLTG+ P + L L+ +L L + K S
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQ-----------LIRRILGPPLEFDEPKWSS 228
Query: 1054 HMITVLKIA--MLCTNISPFDRPTMREVV 1080
+ L + P RPT E++
Sbjct: 229 GSEEAKDLIKKCLNKD--PSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 5e-45
Identities = 74/193 (38%), Positives = 99/193 (51%), Gaps = 9/193 (4%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G GTVY A + TG VA+K + +E ++++ EI L K+ H NIVKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ L+ EY GSL +LL L I L EGL YLH I H
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS-NG--IIH 115
Query: 936 RDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE-YAYTMKVTEK 993
RD+K NILLD D + + DFGL+K++ + I G+ Y+APE +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 994 CDIYSYGVVLLEL 1006
DI+S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 9e-44
Identities = 77/280 (27%), Positives = 116/280 (41%), Gaps = 39/280 (13%)
Query: 816 VIGRGACGTVYRAVLRTGH-----TVAVKKLASNREGNNNVDN-SFRAEILTLGKIRHRN 869
+G GA G VY+ L+ VAVK L +EG + + F E + K+ H N
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTL---KEGASEEEREEFLEEASIMKKLSHPN 62
Query: 870 IVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
IV+L G C ++ EYM G L + L L + +AL A+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE--- 119
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM-----PQSKSMSAIAGSYGYIAPEY 984
HRD+ + N L+ + + DFGL++ I + I ++APE
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPES 175
Query: 985 AYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043
K T K D++S+GV+L E+ T G P + V + + L
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-----NEEVLELLEDG----YRLPRP 226
Query: 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
N DE + ++ + C P DRPT E+V L
Sbjct: 227 ENCPDE--------LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 78/269 (28%), Positives = 113/269 (42%), Gaps = 31/269 (11%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
+G G+ G VY A +TG VA+K + ++ EI L K++H NIV+LY
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVI--KKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+ L+ EY G L +LL + + RF L YLH I
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF-YLRQILSALEYLH---SKGIV 119
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
HRD+K NILLD+ + DFGLA+ +D + ++ G+ Y+APE +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGE--KLTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 995 DIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRN----FIRNNSLVSGMLDARLNLQDEK 1050
DI+S GV+L ELLTG+ P DQ +L + F +S
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS------------P 225
Query: 1051 TVSHMITVLKIAMLCTNISPFDRPTMREV 1079
+I +L + P R T E
Sbjct: 226 EAKDLIR----KLLVKD--PEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 8e-43
Identities = 76/277 (27%), Positives = 115/277 (41%), Gaps = 34/277 (12%)
Query: 816 VIGRGACGTVYRAVLR-----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
+G GA G VY+ L+ VAVK L + + F E + K+ H N+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE--FLREARIMRKLDHPNV 63
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
VKL G C + ++ EYM G L L L AL A G+ YL K
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES--K 121
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS---YGYIAPEYAYT 987
I HRD+ + N L+ + + DFGL++ + G ++APE
Sbjct: 122 NFI-HRDLAARNCLVGENLVVKISDFGLSRDLY---DDDYYRKRGGKLPIRWMAPESLKE 177
Query: 988 MKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046
K T K D++S+GV+L E+ T G P + +++ +++N R L N
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLKNGYR--------LPQPPNC 228
Query: 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
E + + + C P DRPT E+V +L
Sbjct: 229 PPE--------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 74/285 (25%), Positives = 111/285 (38%), Gaps = 42/285 (14%)
Query: 816 VIGRGACGTVYRAVLRTG----HTVAVKKLASNREGNNNVDNS-FRAEILTLGKIRHRNI 870
+G GA G VY+ L+ VAVK L +E + + F E + K+ H N+
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTL---KEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSL--------GELLHGASSTLDWQTRFMIALGAAEGL 922
V+L G C + L+ EYM G L STL + A+ A+G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-- 980
YL + HRD+ + N L+ + + DFGL++ + I
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL--PIRW 173
Query: 981 -APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038
APE T K D++S+GV+L E+ T G P L N V
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---------------NEEVLE 218
Query: 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
L L + + ++ + C + P DRPT E+V L
Sbjct: 219 YLRKGYRLPKPEYCPDELY--ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 77/279 (27%), Positives = 117/279 (41%), Gaps = 37/279 (13%)
Query: 816 VIGRGACGTVYRAVLR-----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
+G GA G VY+ L+ VAVK L + + F E + K+ H NI
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE--FLREARIMRKLDHPNI 63
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASST-LDWQTRFMIALGAAEGLSYLHHDC 929
VKL G C + +++ EYM G L + L L AL A G+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES-- 121
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID----MPQSKSMSAIAGSYGYIAPEYA 985
K I HRD+ + N L+ + + DFGL++ + I ++APE
Sbjct: 122 KNFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESL 176
Query: 986 YTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044
K T K D++S+GV+L E+ T G P + +++ +++ R L
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLKKGYR--------LPKPP 227
Query: 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
N E + K+ + C P DRPT E+V +L
Sbjct: 228 NCPPE--------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 69/201 (34%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 816 VIGRGACGTVYRA-VLRTGHTVAVKKLA--SNREGNNNVDNSFRAEILTLGKIRHRNIVK 872
IG+G G VY+A RTG VA+K + S + + EI L K +H NIVK
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII-----NEIQILKKCKHPNIVK 61
Query: 873 LYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
YG Y + L ++ E+ + GSL +LL + TL + +GL YLH
Sbjct: 62 YYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SN 117
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVT 991
I HRDIK+ NILL E + DFGL+ + +K+ + + G+ ++APE
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 992 EKCDIYSYGVVLLELLTGRAP 1012
K DI+S G+ +EL G+ P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
++GRG+ G+VY A+ + TG +AVK + + + ++ + EI L ++H NIV+ Y
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE-ALEREIRILSSLQHPNIVRYY 65
Query: 875 GFCYHQGS---NLLMYEYMARGSLGELLHGASSTLDWQTR---FMIALGAAEGLSYLHHD 928
G + N+ + EY++ GSL LL + R I EGL+YLH
Sbjct: 66 GSERDEEKNTLNIFL-EYVSGGSLSSLLKKFGKLPEPVIRKYTRQI----LEGLAYLH-- 118
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAIAGSYGYIAPEYAYT 987
I HRDIK NIL+D + DFG AK + D+ + ++ G+ ++APE
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAP 1012
+ DI+S G ++E+ TG+ P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 77/275 (28%), Positives = 122/275 (44%), Gaps = 42/275 (15%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
V+G+G+ G VY+ + TG A+KK+ + G+ E+ TL +VK Y
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVD--GDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 875 GFCYHQGS-NLLMYEYMARGSLGELLHGASSTLDWQTRFM--IALGAAEGLSYLHHDCKP 931
G Y +G ++++ EYM GSL +LL + IA +GL YLH K
Sbjct: 66 GAFYKEGEISIVL-EYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHT--KR 119
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE------YA 985
I HRDIK +N+L++ K E + DFG++KV++ + + + G+ Y++PE Y+
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYS 178
Query: 986 YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG--DLVTWVRNFIRNNSLVSGMLDAR 1043
Y DI+S G+ LLE G+ P P Q +L+ +
Sbjct: 179 Y------AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPP 220
Query: 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMRE 1078
+L E+ + C P RP+ E
Sbjct: 221 PSLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (323), Expect = 5e-32
Identities = 84/278 (30%), Positives = 111/278 (39%), Gaps = 22/278 (7%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH-RNIVKLY 874
+G G+ G VY A R VA+K LA E + F EI L + H NIVKLY
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLH--GASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
F +GS L+ EY+ GSL +LL G L I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 933 IFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKS-----MSAIAGSYGYIAPEYAY 986
I HRDIK NILLD D + DFGLAK++ P S S S G+ GY+APE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 987 TM---KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043
+ + DI+S G+ L ELLTG P + ++ + +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL-----A 236
Query: 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081
L + P +R + +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 85/306 (27%), Positives = 127/306 (41%), Gaps = 59/306 (19%)
Query: 811 FDERFV-----IGRGACGTVYRAVL-----RTGHTVAVKKLASNREGNNNVDNSFRAEIL 860
F++R + +G G G V TG VAVK L N G + F EI
Sbjct: 1 FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIE 58
Query: 861 TLGKIRHRNIVKLYGFCYHQGSN--LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGA 918
L + H NIVK G C G L+ EY+ GSL + L ++ + + +
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG 978
+G+ YL R HRD+ + NIL++ + + DFGLAKV+ P+ K Y
Sbjct: 119 CKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL--PEDK-------DYY 166
Query: 979 YI-----------APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPL---------D 1017
Y+ APE T K + D++S+GV L EL T G P
Sbjct: 167 YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA 226
Query: 1018 QGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMR 1077
QG +VT + ++ L + DE V ++ LC P DRP+
Sbjct: 227 QGQMIVTRLLELLKEG----ERLPRPPSCPDE--VYDLMK------LCWEAEPQDRPSFA 274
Query: 1078 EVVLML 1083
+++L++
Sbjct: 275 DLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 8/214 (3%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
D+ + +G G G V + + R TG +AVK + E N + E+ L K
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNS 58
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
IV YG Y+ G + EYM GSL ++L + + IA+ +GL+YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
K I HRD+K +NIL++ + + + DFG++ + S + G+ Y+APE
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQ--LVNSLAK-TFVGTSSYMAPERIQG 173
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD 1021
+ K DI+S G+ L+EL TGR P P + D
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 73/225 (32%), Positives = 104/225 (46%), Gaps = 20/225 (8%)
Query: 796 KEGFTFKDLVVA---TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNV 851
+ KD+V + + IG GA G VY+A R TG VA+KK+ ++ +
Sbjct: 3 ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI 62
Query: 852 DNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM-YEYMARGSLGELLHGASSTLDWQT 910
N EIL + +H NIV Y Y G L + EYM GSL +++ +
Sbjct: 63 IN----EILIMKDCKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRM---N 114
Query: 911 RFMIALGAAE---GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967
IA E GL YLH + HRDIKS+NILL + DFG A + +S
Sbjct: 115 EPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171
Query: 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
K S + G+ ++APE K DI+S G++ +E+ G P
Sbjct: 172 KRNS-VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 66/202 (32%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
+IGRGA G VY+ + L TG VA+K+++ + + S EI L ++H NIVK
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL-KSIMQEIDLLKNLKHPNIVKYI 65
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLH---GASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
G S ++ EY GSL +++ +L ++ + +GL+YLH +
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL--VAVYVYQV--LQGLAYLH---EQ 118
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMSAIAGSYGYIAPEYAYTMKV 990
+ HRDIK+ NIL + DFG+A K+ D+ SK +++ G+ ++APE
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGTPYWMAPEVIEMSGA 176
Query: 991 TEKCDIYSYGVVLLELLTGRAP 1012
+ DI+S G ++ELLTG P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 73/210 (34%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG G G VY AV L TG +AVK++ + E+ L ++H N+VK YG
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLKHPNLVKYYG 66
Query: 876 FCYHQGSNLLMYEYMARGSLGELL-HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
H+ + EY + G+L ELL HG + + L EGL+YLH I
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHGIV 121
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK---SMSAIAGSYGYIAPEYAYTMKVT 991
HRDIK NI LD +GDFG A + + + ++AG+ Y+APE K
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 992 EK---CDIYSYGVVLLELLTGRAPVQPLDQ 1018
DI+S G V+LE+ TG+ P LD
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN 869
FD +G G+ G+VY+A+ + TG VA+K + E + EI L +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-EDLQEIIK----EISILKQCDSPY 59
Query: 870 IVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
IVK YG Y + ++L ++ EY GS+ +++ + TL + I +GL YLH
Sbjct: 60 IVKYYG-SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH-- 116
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM 988
+ HRDIK+ NILL+++ +A + DFG++ + +K + I G+ ++APE +
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 174
Query: 989 KVTEKCDIYSYGVVLLELLTGRAP 1012
K DI+S G+ +E+ G+ P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 77/267 (28%), Positives = 117/267 (43%), Gaps = 35/267 (13%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
IG+G G V R G VAVK L + ++ +F AE + +RH N+V+L G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCL----KDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 877 CYHQGSNLLMYEYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
++ EYMA+GSL + L + + + AL EG+ YL H
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 995
RD+ + N+L+ + A V DFGLAK Q + + APE K + K D
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK----WTAPEALREKKFSTKSD 181
Query: 996 IYSYGVVLLELLT-GRAPV--QPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052
++S+G++L E+ + GR P PL D+V V R ++A E
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLK---DVVPHVEKGYR--------MEAPEGCPPE--- 227
Query: 1053 SHMITVLKIAMLCTNISPFDRPTMREV 1079
V K+ C + P RPT +++
Sbjct: 228 -----VYKVMKDCWELDPAKRPTFKQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 817 IGRGACGTVYRA-VLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG GA G V++A TG TVA+KK+A R + N EI L +H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRR-LEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTL-DWQTR-FMIALGAAEGLSYLHHDCKPRI 933
H +L+ EYM L E+L L + Q + +M L +G++Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMH---ANGI 120
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY-TMKVTE 992
HRD+K N+L+ + DFGLA++ + + S + Y APE Y K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 993 KCDIYSYGVVLLELLTGRA 1011
D+++ G + ELL G
Sbjct: 181 GVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G G VY+A +TG VA+KK+ + E + R EI L +++H NIVKL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPNIVKLLD 65
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQT--RFMIALGAAEGLSYLHHDCKPRI 933
+ + L++EY L + L L M L GL+Y H RI
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQL--LRGLAYCHSH---RI 119
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE-----YAYTM 988
HRD+K NIL++ + DFGLA+ +P + + Y APE Y+
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW-YRAPEILLGSKHYST 178
Query: 989 KVTEKCDIYSYGVVLLELLTGRA 1011
V DI+S G + E++TG+
Sbjct: 179 AV----DIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 65/205 (31%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G+G+ G V + TG A+K L + E L +I H IVKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 876 FCYHQGSNLLM-YEYMARGSLGELLHGASSTLDWQTRFMIALGAAE---GLSYLHHDCKP 931
+ + L + EY G L L + + RF AAE L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY----AAEIVLALEYLH---SL 112
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY----AYT 987
I +RD+K NILLD + DFGLAK + S++ + G+ Y+APE Y
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYG 171
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAP 1012
V D +S GV+L E+LTG+ P
Sbjct: 172 KAV----DWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 817 IGRGACGTVYRAVLRTGHT-VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G G V+ G T VAVK L + G + +F E + K+RH +V+LY
Sbjct: 14 LGAGQFGEVWMGTWN-GTTKVAVKTL---KPGTMSP-EAFLQEAQIMKKLRHDKLVQLYA 68
Query: 876 FCYHQGSNLLMYEYMARGSLGELLH-GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
C + ++ EYM++GSL + L G L +A AEG++YL
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
HRD+ + NIL+ + + DFGLA++I+ + + + APE A + T K
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 995 DIYSYGVVLLELLT-GRAP 1012
D++S+G++L E++T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 21/219 (9%)
Query: 810 NFDERFVIGRGACGTVYRAVLRT-GHTVAVKKL----ASNREGNNNVDNSFRAEILTLGK 864
+F+ IG+G+ G V++ V + A+K++ + RE +D E L K
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-----EARVLAK 55
Query: 865 IRHRNIVKLY-GFCYHQGSNLLMYEYMARGSLGELLH---GASSTLDWQTRFMIALGAAE 920
+ I++ Y F N++M EY G L +LL G D RF I
Sbjct: 56 LDSSYIIRYYESFLDKGKLNIVM-EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQ--ILL 112
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI 980
GL++LH +I HRDIKS N+ LD +GD G+AK++ + + I G+ Y+
Sbjct: 113 GLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYL 168
Query: 981 APEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
+PE EK D+++ GVVL E TG+ P +QG
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
VIG GA VY A+ L VA+K++ + E + R E+ + + H N+VK Y
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 875 G-FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIAL---GAAEGLSYLHHDCK 930
F L+M Y++ GSL +++ + +IA +GL YLH
Sbjct: 66 TSFVVGDELWLVM-PYLSGGSLLDIMKSSYPR-GGLDEAIIATVLKEVLKGLEYLH---S 120
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP---QSKSMSAIAGSYGYIAPE---- 983
HRDIK+ NILL + + DFG++ + K G+ ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 984 -YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ Y K DI+S+G+ +EL TG AP
Sbjct: 181 VHGY----DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 71/210 (33%), Positives = 100/210 (47%), Gaps = 11/210 (5%)
Query: 810 NFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
F++ IG G G VYRA +G VA+KK+ + E + +S R EI L +RH
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 869 NIVKLYGFCY--HQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH 926
NIV+L H S L+ EY + L LL + + L GL YLH
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY 986
+ I HRD+K +N+LL DK + DFGLA+ +P K M+ + Y APE
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKVVTLWYRAPELLL 181
Query: 987 TMKV-TEKCDIYSYGVVLLELLTGRAPVQP 1015
T D+++ G +L ELL + P+ P
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHK-PLLP 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 67/206 (32%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG G G VY+A +TG VA+KK+ E + R EI L K+RH NIV+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPNIVRLKE 65
Query: 876 FC--YHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRI 933
+GS +++EYM G L + Q + EGL YLH + I
Sbjct: 66 IVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC-YMKQLLEGLQYLHSN---GI 121
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY-----AYTM 988
HRDIK +NIL+++ + DFGLA+ S + + Y PE Y
Sbjct: 122 LHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGP 181
Query: 989 KVTEKCDIYSYGVVLLELLTGRAPVQ 1014
+V D++S G +L EL G+ Q
Sbjct: 182 EV----DMWSVGCILAELFLGKPIFQ 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
IG+G+ G VY+A+ RT VA+K + E + +++ + EI L + R I K Y
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQ-EIQFLSQCRSPYITKYY 65
Query: 875 GFCYHQGSNL--LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
G + +GS L +M EY GS +LL LD I GL YLH + K
Sbjct: 66 G-SFLKGSKLWIIM-EYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYLHEEGK-- 119
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
HRDIK+ NILL ++ + + DFG++ + SK + G+ ++APE E
Sbjct: 120 -IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-RNTFVGTPFWMAPEVIKQSGYDE 177
Query: 993 KCDIYSYGVVLLELLTGRAPVQPLD 1017
K DI+S G+ +EL G P+ L
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDLH 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G G G V+ + + VA+K L S+ + F+ E+ L ++RH++++ L+
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 877 CYHQGSNLLMYEYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
C ++ E M +GSL L L + +A AEG++YL H
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIH 127
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMP-QSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
RD+ + NIL+ + V DFGLA++I S I Y + APE A + K
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKS 185
Query: 995 DIYSYGVVLLELLT-GRAP 1012
D++S+G++L E+ T G+ P
Sbjct: 186 DVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
IG+G+ G VY G +K++ + +++ E+ L K+ H NI+K Y
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNIIKYY 65
Query: 875 GFCYHQGS-NLLMYEYMARGSLGELLHGASST---------LDWQTRFMIALGAAEGLSY 924
+G ++M EY G L + + LDW + + L L Y
Sbjct: 66 ESFEEKGKLCIVM-EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA----LKY 118
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAIAGSYGYIAP 982
LH +I HRDIK NI L +GDFG++KV+ + +K++ G+ Y++P
Sbjct: 119 LH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV---VGTPYYLSP 172
Query: 983 EYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
E K DI+S G VL EL T + P
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG G G VY+A TG VA+KK+ E + R EI L ++ H NI+KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLD--------WQTRFMIALGAAEGLSYLHH 927
H+G L++E+M L +L+ L +Q +GL++ H
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQL--------LQGLAFCH- 115
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
I HRD+K N+L++ + + DFGLA+ P + + Y APE
Sbjct: 116 --SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-YRAPELLLG 172
Query: 988 MKV-TEKCDIYSYGVVLLELLTGRAPVQP----LDQ 1018
K + DI+S G + ELL+ R P+ P +DQ
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR-PLFPGKSEIDQ 207
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 69/214 (32%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVK--KLASNREGNNNVDNSFRAEILTLGKI 865
++++ IG G G VY+A + TG VA+K KL E ++ + + EI L +
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKL----EPGDDFE-IIQQEISMLKEC 57
Query: 866 RHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE---G 921
RH NIV +G Y + L ++ EY GSL ++ L + IA E G
Sbjct: 58 RHPNIVAYFG-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL---SELQIAYVCRETLKG 113
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIA 981
L+YLH K HRDIK NILL + + + DFG++ + +K S I Y ++A
Sbjct: 114 LAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY-WMA 169
Query: 982 PEYA---YTMKVTEKCDIYSYGVVLLELLTGRAP 1012
PE A KCDI++ G+ +EL + P
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 71/211 (33%), Positives = 108/211 (51%), Gaps = 21/211 (9%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDN-------SFRAEILTLGKIRH 867
+IG+G G VY A+ + TG +AVK++ D+ + R+EI TL + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
NIV+ GF + + EY+ GS+G L + RF EGL+YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVLEGLAYLH- 125
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK----VIDMPQSKSMSAIAGSYGYIAPE 983
I HRD+K++N+L+D + DFG++K + D Q+ SM GS ++APE
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---GSVFWMAPE 180
Query: 984 --YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
++Y+ + K DI+S G V+LE+ GR P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 74/294 (25%), Positives = 114/294 (38%), Gaps = 49/294 (16%)
Query: 816 VIGRGACGTVYRAVLRTG------HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN 869
+G GA G V+ VAVK L + D AE+LT +H N
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLT--NFQHEN 69
Query: 870 IVKLYGFCYHQGSNLLMYEYMARGSLGELL--HG---ASSTLDWQTRF--------MIAL 916
IVK YG C ++++EYM G L + L HG A IA+
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS 976
A G+ YL HRD+ + N L+ +GDFG+++ + + + G
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV---YTTDYYRVGGH 183
Query: 977 ----YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIR 1031
++ PE K T + D++S+GVVL E+ T G+ P W +
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP------------W---YGL 228
Query: 1032 NNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+N V + LQ +T V I + C P R ++++ L +
Sbjct: 229 SNEEVIECITQGRLLQRPRTCPS--EVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 6e-22
Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 45/288 (15%)
Query: 817 IGRGACGTVYRAVL-RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G G VY V + TVAVK L +E V+ F E + +I+H N+V+L G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 69
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
C + ++ E+M G+L + L + ++ +A + + YL K
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 126
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS---YGYIAPEYAYTMKVT 991
HRD+ + N L+ + V DFGL++++ + +A AG+ + APE K +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 992 EKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEK 1050
K D++++GV+L E+ T G +P G DL S V +L+ + E+
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPY----PGIDL-----------SQVYELLEKGYRM--ER 226
Query: 1051 TVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPM 1098
V ++ C +P DRP+ E+ H F M
Sbjct: 227 PEGCPPKVYELMRACWQWNPSDRPSFAEI------------HQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 7e-22
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLA---SNREGNNNVDNSFRAEILTLGKIRHRNIVK 872
+G+GA G VY + TG +AVK++ + E V N+ EI L ++H IV+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV-NALECEIQLLKNLQHERIVQ 68
Query: 873 LYGFCYHQGSNLLMYEYMARGSLGELL--HGA-SSTLDWQTRFMIALGAAEGLSYLHHDC 929
YG + + EYM GS+ + L +GA + T+ + I EG+ YLH +
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN- 123
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--MSAIAGSYGYIAPEYAYT 987
I HRDIK NIL D +GDFG +K + S M ++ G+ +++PE
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAP 1012
K D++S G ++E+LT + P
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G G G V+ + VAVK L + G + + F AE + K+RH +++LY
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL---KPGTMDPKD-FLAEAQIMKKLRHPKLIQLYAV 69
Query: 877 CYHQGSNLLMYEYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
C + ++ E M GSL E L G A L +A A G++YL H
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIH 126
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 995
RD+ + N+L+ + V DFGLA+VI ++ + APE A + + K D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 996 IYSYGVVLLELLT-GRAP---------VQPLDQG 1019
++S+G++L E++T GR P +Q +DQG
Sbjct: 187 VWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 68/218 (31%), Positives = 100/218 (45%), Gaps = 39/218 (17%)
Query: 817 IGRGACGTVYRAVL------RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
+G GA G VY+ L + +VA+K L N E V FR E + ++H NI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSDLQHPNI 70
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLD--------------WQTRFM-IA 915
V L G C + +++EY+A G L E L S D + F+ IA
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 916 LGAAEGLSYL--HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP-----QSK 968
+ A G+ YL HH HRD+ + N L+ + + DFGL++ I QSK
Sbjct: 131 IQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLEL 1006
S+ + ++ PE K T + DI+S+GVVL E+
Sbjct: 186 SLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 16/199 (8%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDN-SFRAEILTLGKIRHRNIVKLYG 875
IG+G G VY+ VL+ VAVK + R F E L + H NIVKL G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVK---TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
C + ++ E + GSL L + L + ++L AA G+ YL H
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEYAYTMKV 990
RD+ + N L+ + + DFG+++ + + ++ I APE +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 991 TEKCDIYSYGVVLLELLTG 1009
T + D++SYG++L E +
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 92/300 (30%), Positives = 131/300 (43%), Gaps = 47/300 (15%)
Query: 811 FDERFVI-----GRGACGTV----YRAVL-RTGHTVAVKKLASNREGNNNVDNSFRAEIL 860
F+ER + G+G G+V Y + TG VAVKKL + + F EI
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR---DFEREIE 57
Query: 861 TLGKIRHRNIVKLYGFCYHQGS-NL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGA 918
L ++H NIVK G CY G NL L+ EY+ GSL + L LD + + A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI----A 974
+G+ YL R HRD+ + NIL++ + +GDFGL KV+ PQ K +
Sbjct: 118 CKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL--PQDKEYYKVREPGE 172
Query: 975 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT----GRAP-------VQPLDQGGDLV 1023
+ APE K + D++S+GVVL EL T +P + QG +V
Sbjct: 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232
Query: 1024 TWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
+ ++NN G L A E + I C N P RP+ E+ L +
Sbjct: 233 YHLIELLKNN----GRLPAPPGCPAE--------IYAIMKECWNNDPSQRPSFSELALQV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 66/199 (33%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+IG G G V + TG VAVK + + +F E + K+ H+N+V+L G
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQ-----AFLEETAVMTKLHHKNLVRLLG 66
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFM-IALGAAEGLSYLHHDCKPRIF 934
H G ++M E M++G+L L L + + +L AEG+ YL ++
Sbjct: 67 VILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLV 122
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
HRD+ + NIL+ + A V DFGLA+V M S + + APE K + K
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALKHKKFSSKS 178
Query: 995 DIYSYGVVLLELLT-GRAP 1012
D++SYGV+L E+ + GRAP
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 68/269 (25%), Positives = 118/269 (43%), Gaps = 25/269 (9%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
IG G G V+ VA+K + REG + + F E + K+ H +V+LYG
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI---REGAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 877 CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHR 936
C + L++E+M G L + L +T + L EG++YL + HR
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 937 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDI 996
D+ + N L+ + V DFG+ + + Q S + + +PE K + K D+
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 997 YSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHM 1055
+S+GV++ E+ + G+ P + R+NS V ++A L + S
Sbjct: 185 WSFGVLMWEVFSEGKTPYEN---------------RSNSEVVETINAGFRLYKPRLASQ- 228
Query: 1056 ITVLKIAMLCTNISPFDRPTMREVVLMLS 1084
+V ++ C P DRP+ ++ L+
Sbjct: 229 -SVYELMQHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 816 VIGRGACGTVYRAVLRT-GHT----VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
V+G GA GTVY+ V G VA+K L N E + + H ++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN--KEILDEAYVMASVDHPHV 71
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
V+L G C L+ + M G L + + + Q + A+G+SYL +
Sbjct: 72 VRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---E 127
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY--GYIAPEYAYTM 988
R+ HRD+ + N+L+ + DFGLAK++D K A G ++A E
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD-VDEKEYHAEGGKVPIKWMALESILHR 186
Query: 989 KVTEKCDIYSYGVVLLELLT-GRAP 1012
T K D++SYGV + EL+T G P
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLA----SNREGNNNVDNSFRAEILTLGKIRHRNI 870
IG+G+ GTV + G + K++ + +E V +E+ L +++H NI
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV-----SEVNILRELKHPNI 61
Query: 871 VKLYGFCYHQGSNLLMY---EYMARGSLGELLHGASSTLD-------WQTRFMIALGAAE 920
V+ Y SN +Y EY G L +L+ W+ + L
Sbjct: 62 VRYYDR-IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA--- 117
Query: 921 GLSYLHH--DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG 978
L H+ D + HRD+K NI LD +GDFGLAK++ S + + + Y
Sbjct: 118 -LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY- 175
Query: 979 YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQ 1014
Y++PE M EK DI+S G ++ EL P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 9e-21
Identities = 65/229 (28%), Positives = 96/229 (41%), Gaps = 33/229 (14%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVK---KLASNREGNNNVDNSFRAEILTLGK 864
D+F +IG G+ TV A + T A+K K +E V E L +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE--KKVKYVKI-EKEVLTR 57
Query: 865 I-RHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGL 922
+ H I+KLY + + NL + EY G L + + S + TRF A L
Sbjct: 58 LNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAE-ILLAL 115
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS--------------- 967
YLH I HRD+K NILLD + DFG AKV+D S
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 968 KSMSAIAGSY-G---YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ S+ G Y++PE + D+++ G ++ ++LTG+ P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG GA GTVY+ + R TG A+K + N E + V EI L + H N+VK +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFM--IALGAAEGLSYLHHDCKPRI 933
H G ++ E+M GSL T +F+ +A G++YLH + I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSL-------EGTHIADEQFLADVARQILSGIAYLH---RRHI 189
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT-----M 988
HRDIK +N+L++ + DFG+++++ S++ G+ Y++PE T
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGA 248
Query: 989 KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD 1021
DI+S GV +LE GR P + + GD
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGD 280
|
Length = 353 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 816 VIGRGACGTVYRAVL----RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
VIG G G V R L + VA+K L + +D F E +G+ H NI+
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD--FLTEASIMGQFDHPNII 68
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
+L G +++ EYM GSL + L + G A G+ YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEYAY 986
HRD+ + NIL++ V DFGL++ ++ + + G I APE
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE----ATYTTKGGKIPIRWTAPEAIA 181
Query: 987 TMKVTEKCDIYSYGVVLLELLT 1008
K T D++S+G+V+ E+++
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 69/210 (32%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVK--KLASNREGNNNVDNSFRAEILTLGKIRHRNIVKL 873
+G G+ G+VY + L G AVK LA + + EI L K++H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 874 YGFCYHQGSNLLMY-EYMARGSLGELLHGASSTLDWQ----TRFMIALGAAEGLSYLHHD 928
G + NL ++ E + GSL +LL S + TR ++ GL YLH
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHDR 121
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAIAGSYGYIAPEY--- 984
HRDIK NIL+D + DFG+AK V++ +KS GS ++APE
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK---GSPYWMAPEVIAQ 175
Query: 985 --AYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y + DI+S G +LE+ TG+ P
Sbjct: 176 QGGYGLAA----DIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 40/230 (17%)
Query: 807 ATDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI 865
T F+ VIG G G VY+A +TG VA+K + + + + E L K
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKY 59
Query: 866 -RHRNIVKLYGFCYHQGSNL-------LMYEYMARGSLGELLHGASSTLDWQTRF---MI 914
H NI YG + + + L+ E GS+ +L+ G R I
Sbjct: 60 SNHPNIATFYG-AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG---LRKKGKRLKEEWI 115
Query: 915 AL---GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 971
A GL+YLH + ++ HRDIK NILL E + DFG++ +D + +
Sbjct: 116 AYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 972 AIAGSYGYIAPE---------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
I Y ++APE +Y + D++S G+ +EL G+ P
Sbjct: 173 FIGTPY-WMAPEVIACDEQPDASYDA----RSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH---RNIV 871
+IGRGA G VYR + TG VA+K + + ++ D + E+ L ++R NI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD--IQREVALLSQLRQSQPPNIT 65
Query: 872 KLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
K YG Y +G L ++ EY GS+ L+ + + + +I L Y+H
Sbjct: 66 KYYG-SYLKGPRLWIIMEYAEGGSVRTLMK--AGPIAEKYISVIIREVLVALKYIHKV-- 120
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY-----A 985
+ HRDIK+ NIL+ + + DFG+A +++ SK S G+ ++APE
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFVGTPYWMAPEVITEGKY 178
Query: 986 YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018
Y K DI+S G+ + E+ TG P +D
Sbjct: 179 YDTKA----DIWSLGITIYEMATGNPPYSDVDA 207
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 71/295 (24%), Positives = 119/295 (40%), Gaps = 57/295 (19%)
Query: 817 IGRGACGTVYRAVLRT------GHTVAVKKL---ASNREGNNNVDNSFRAEILTLGKIRH 867
+G+G+ G VY + + VA+K + AS RE F E + +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-----FLNEASVMKEFNC 68
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMI---------ALGA 918
++V+L G L++ E MA+G L L + A
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-----MPQSKSMSAI 973
A+G++YL + HRD+ + N ++ + +GDFG+ + I K + +
Sbjct: 129 ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 974 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPL--DQGGDLVTWVRNFI 1030
++APE T K D++S+GVVL E+ T P Q L ++ V F+
Sbjct: 186 R----WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFV 234
Query: 1031 RNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ G LD N D+ +L++ +C +P RPT E+V L +
Sbjct: 235 IDG----GHLDLPENCPDK--------LLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 73/293 (24%), Positives = 123/293 (41%), Gaps = 40/293 (13%)
Query: 810 NFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLG 863
N E +GRG G V+ A + V VK L ++ N+ + FR E+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFR 63
Query: 864 KIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASST--------LDWQTRFMIA 915
K+ H+N+V+L G C + ++ EY G L + L S L + + +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 916 LGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAIA 974
A G+ +L R HRD+ + N L+ + E V L+K V + K +A+
Sbjct: 124 TQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180
Query: 975 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNN 1033
++APE + K D++S+GV++ E+ T G P L +
Sbjct: 181 -PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--------------DE 225
Query: 1034 SLVSGMLDARLNL-QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+++ + +L L E S + K+ C ++P DRP+ E+V L E
Sbjct: 226 EVLNRLQAGKLELPVPEGCPS---RLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 67/278 (24%), Positives = 116/278 (41%), Gaps = 37/278 (13%)
Query: 817 IGRGACGTVYRAVLRTGH----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVK 872
+G G G+V + V VAVK L F E + ++ H IV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG--KKEFLREASVMAQLDHPCIVR 60
Query: 873 LYGFCYHQGSNLLMYEYMAR-GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
L G C +G L++ +A G L + L + + A A G++YL
Sbjct: 61 LIGVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL-AHQVAMGMAYLE---SK 114
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY--GYIAPEYAYTMK 989
HRD+ + N+LL ++ +A + DFG+++ + + AG + + APE K
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 990 VTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA--RLNL 1046
+ K D++SYGV L E + G P ++ +++ ML++ RL
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGE--------------MKGAEVIA-MLESGERLP- 218
Query: 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084
+ E+ + +++ + C P DRPT E+
Sbjct: 219 RPEECPQEIYSIM---LSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 61/223 (27%), Positives = 92/223 (41%), Gaps = 34/223 (15%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
+ E +G GA G+V + L+ + K + N ++ E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSP 59
Query: 869 NIVKLYGFCY--HQGSNLLMYEYMARGSL--------------GELLHGASSTLDWQTRF 912
IVK YG S + EY GSL GE + G
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK---------- 109
Query: 913 MIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972
IA +GLSYLH +I HRDIK +NILL K + + DFG++ ++ S + +
Sbjct: 110 -IAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTF 163
Query: 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQP 1015
S+ Y+APE + D++S G+ LLE+ R P P
Sbjct: 164 TGTSF-YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLA---SNREGNNNVDNSFRAEILTLGKIRHRNIVK 872
V+G+GA GTVY + G +AVK++ SN + E+ L ++H NIV+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 873 LYGFCYHQGSNLLMYEYMARGSLGELLH--GA--SSTLDWQTRFMIALGAAEGLSYLHHD 928
G C + + E++ GS+ +L+ G T+ ++ +G++YLH++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHNN 121
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM-----PQSKSMSAIAGSYGYIAPE 983
C + HRDIK NN++L + DFG A+ + S + ++ G+ ++APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018
K DI+S G + E+ TG+ P+ +D+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G+G G V+ VA+K L + G + + +F E + K+RH +V+LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAV 69
Query: 877 CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFM-IALGAAEGLSYLHHDCKPRIFH 935
+ ++ EYM++GSL + L G + + +A A G++Y+ + H
Sbjct: 70 VSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 125
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 995
RD+++ NIL+ + V DFGLA++I+ + + + APE A + T K D
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 996 IYSYGVVLLELLT-GRAP 1012
++S+G++L EL T GR P
Sbjct: 186 VWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG+G G V R G+ VAVK + N+ +F AE + ++RH N+V+L G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIK-----NDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 876 FCYHQGSNL-LMYEYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRI 933
+ L ++ EYMA+GSL + L S L +L E + YL +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEK 993
HRD+ + N+L+ + A V DFGL K Q + + APE K + K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTK 179
Query: 994 CDIYSYGVVLLELLT-GRAP 1012
D++S+G++L E+ + GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 66/221 (29%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRA--EILTLGKIRHRNIVKL 873
+G G VY+A TG VA+KK+ +F A EI L +++H NI+ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 874 YGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE----------GL 922
+ SN+ L++E+M L +++ S I L A+ GL
Sbjct: 68 LD-VFGHKSNINLVFEFME-TDLEKVIKDKS----------IVLTPADIKSYMLMTLRGL 115
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAP 982
YLH + I HRD+K NN+L+ + DFGLA+ P K M+ + Y AP
Sbjct: 116 EYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-MTHQVVTRWYRAP 171
Query: 983 EYAY-TMKVTEKCDIYSYGVVLLELLTGRAPVQP----LDQ 1018
E + D++S G + ELL R P P +DQ
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQ 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 8/197 (4%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G G G V+ R VA+K + REG + D+ F E + K+ H N+V+LYG
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI---REGAMSEDD-FIEEAKVMMKLSHPNLVQLYGV 67
Query: 877 CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHR 936
C Q ++ EYMA G L L L + + E + YL + HR
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 937 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDI 996
D+ + N L+ + V DFGLA+ + Q S + PE + + K D+
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 997 YSYGVVLLELLT-GRAP 1012
+S+GV++ E+ + G+ P
Sbjct: 185 WSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG G+ G VY A +RT VA+KK++ + + +N E+ L ++RH N ++ Y
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81
Query: 876 FCY-HQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
CY + + L+ EY GS ++L L I GA +GL+YLH +
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---I 137
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM---KVT 991
HRDIK+ NILL + + DFG A ++ S G+ ++APE M +
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILAMDEGQYD 192
Query: 992 EKCDIYSYGVVLLELLTGRAP 1012
K D++S G+ +EL + P
Sbjct: 193 GKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
+F+ VIG+GA G V R T A+K + + + E L ++ H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 869 NIVKL-YGFCYHQGSNLLMYEYMARGSLG-ELLHGASSTLDWQTRFMIA-LGAAEGLSYL 925
+V L Y F + L++ + + G L L + + Q +F I + A L YL
Sbjct: 61 FLVNLWYSFQDEENMYLVV-DLLLGGDLRYHLSQKVKFSEE-QVKFWICEIVLA--LEYL 116
Query: 926 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYA 985
H I HRDIK +NILLD++ H+ DF +A + ++ +G+ GY+APE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIA--TKVTPDTLTTSTSGTPGYMAPEVL 171
Query: 986 YTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ D +S GV E L G+ P
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 59/204 (28%), Positives = 85/204 (41%), Gaps = 21/204 (10%)
Query: 817 IGRGACGTVYRA-VLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G G V V T A+K + +E L + H IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ ++ EY G L +L ++ RF IA YLH+ I +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLHNR---GIIY 116
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS-AIAGSYGYIAPE------YAYTM 988
RD+K N+LLD + DFG AK + +S + G+ Y+APE Y ++
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKGYDFS- 172
Query: 989 KVTEKCDIYSYGVVLLELLTGRAP 1012
D +S G++L ELLTGR P
Sbjct: 173 -----VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 71/231 (30%), Positives = 98/231 (42%), Gaps = 38/231 (16%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G G VY+A ++TG VA+KK+ + E + + R EI L K++H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74
Query: 876 FCY-----HQGSNLLMY---EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
+ +Y YM L LL S L L EG++YLH
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH- 132
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS---YG------ 978
+ I HRDIK+ NIL+D++ + DFGLA+ D P G Y
Sbjct: 133 --ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190
Query: 979 -YIAPEYA-----YTMKVTEKCDIYSYGVVLLELLTGRAPVQP----LDQG 1019
Y PE YT V DI+ G V E+ T R P+ +DQ
Sbjct: 191 WYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR-PILQGKSDIDQL 236
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDN---SFRAEILTLGKIRHRNIV 871
+G GA + Y+A ++TG +AVK++ R ++ + + R EI + ++ H +I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELLH--GASSTLDWQTRFMIA--LGAAEGLSYLHH 927
++ G L E+MA GS+ LL GA ++ +I GLSYLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA-----FKEAVIINYTEQLLRGLSYLHE 121
Query: 928 DCKPRIFHRDIKSNNILLDDKFE-AHVGDFGLAKVIDMPQSKS---MSAIAGSYGYIAPE 983
+ +I HRD+K N+L+D + + DFG A + + + + G+ ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ CD++S G V++E+ T + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-19
Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 16/215 (7%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKL------ASNREGNNNVDNSFRAEILTLGKIRHR 868
+IG G+ G+VY + +G +AVK++ AS+++ ++ ++ EI L +++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
NIV+ G + EY+ GS+ LL+ + + R + +GL+YLH+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR-QILKGLNYLHNR 125
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-----VIDMPQSKSMSAIAGSYGYIAPE 983
I HRDIK NIL+D+K + DFG++K + + + ++ GS ++APE
Sbjct: 126 ---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018
T K DI+S G +++E+LTG+ P Q
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 67/269 (24%), Positives = 111/269 (41%), Gaps = 25/269 (9%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G G G V+ R VA+K + EG + ++ F E + K+ H +V+LYG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEED-FIEEAKVMMKLSHPKLVQLYGV 67
Query: 877 CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHR 936
C Q ++ E+M G L L L + EG+ YL + HR
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 937 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDI 996
D+ + N L+ V DFG+ + + + S S + PE K + K D+
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 997 YSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHM 1055
+S+GV++ E+ T G+ P + ++N V M+ L K S
Sbjct: 185 WSFGVLMWEVFTEGKMPFEK---------------KSNYEVVEMISRGFRLYRPKLASM- 228
Query: 1056 ITVLKIAMLCTNISPFDRPTMREVVLMLS 1084
TV ++ C + P RPT E++ ++
Sbjct: 229 -TVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 7e-19
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G GA G VY+A + A K+ D F EI L + +H NIV LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED--FMVEIDILSECKHPNIVGLYEA 70
Query: 877 CYHQGSNLLMYEYMARGSLGELLHGASSTLDW-QTRFMIALGAAEGLSYLHHDCKPRIFH 935
+++ ++ E+ G+L ++ L Q R+ + E L++LH ++ H
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIH 126
Query: 936 RDIKSNNILLDDKFEAHVGDFGL-AKVIDMPQSKSMSAIAGSYGYIAPEYAY--TMKVTE 992
RD+K+ NILL + + DFG+ AK Q + + I Y ++APE T K
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD-TFIGTPY-WMAPEVVACETFKDNP 184
Query: 993 ---KCDIYSYGVVLLELLTGRAP 1012
K DI+S G+ L+EL P
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 80/276 (28%), Positives = 117/276 (42%), Gaps = 35/276 (12%)
Query: 816 VIGRGACGTVYRAVLRTGHT----VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
VIG+G G VY L AVK L NR + F E + + H N++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 872 KLYGFCY-HQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
L G C +GS L++ YM G L + + + L A+G+ YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---AS 116
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-----DMPQSKSMSAIAGSYGYIAPEYA 985
+ HRD+ + N +LD+ F V DFGLA+ I + + + + ++A E
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PVKWMALESL 174
Query: 986 YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045
T K T K D++S+GV+L EL+T AP P D+ + +L R
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY-------------LLQGRRL 221
Query: 1046 LQDEKTVSHMITVLKIAML-CTNISPFDRPTMREVV 1080
LQ E + V ML C + P RPT E+V
Sbjct: 222 LQPEYCPDPLYEV----MLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 67/223 (30%), Positives = 100/223 (44%), Gaps = 37/223 (16%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
D ER V+G+G G VY A L T +A+K++ E ++ EI ++
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIP---ERDSRYVQPLHEEIALHSYLK 63
Query: 867 HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAA--EGLSY 924
HRNIV+ G G + E + GSL LL L + +I EGL Y
Sbjct: 64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKY 123
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI-------AGSY 977
LH + +I HRDIK +N+L++ G+ K+ D SK ++ I G+
Sbjct: 124 LHDN---QIVHRDIKGDNVLVNTY-------SGVVKISDFGTSKRLAGINPCTETFTGTL 173
Query: 978 GYIAPEYAYTMKVTEK--------CDIYSYGVVLLELLTGRAP 1012
Y+APE V +K DI+S G ++E+ TG+ P
Sbjct: 174 QYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 12/204 (5%)
Query: 816 VIGRGACGTVYRAVLRTG----HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
VIG G G V+R +L+ VA+K L D F +E +G+ H NI+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD--FLSEASIMGQFSHHNII 69
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
+L G +++ EYM G+L + L + G A G+ YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDM 126
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG--YIAPEYAYTMK 989
HRD+ + NIL++ E V DFGL++V++ + + G + APE K
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 990 VTEKCDIYSYGVVLLELLT-GRAP 1012
T D++S+G+V+ E+++ G P
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 71/215 (33%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 811 FDERF-----VIGRGACGTV--YR---AVLRTGHTVAVKKLASNREGNNNVDNSFRAEIL 860
F +R+ V+G G G V Y A TG VAVK L RE + ++ EI
Sbjct: 1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--KRECGQQNTSGWKKEIN 58
Query: 861 TLGKIRHRNIVKLYGFCYHQGSN--LLMYEYMARGSLGELLHGASSTLDWQTRFMI-ALG 917
L + H NIVK G C QG L+ EY+ GSL + L L + ++ A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL---AQLLLFAQQ 115
Query: 918 AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA--- 974
EG++YLH HRD+ + N+LLD+ +GDFGLAK + P+ +
Sbjct: 116 ICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV--PEGHEYYRVREDG 170
Query: 975 -GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 1008
+ A E K + D++S+GV L ELLT
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
I +GA G V+ A TG A+K + N + E L + + +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 876 FCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+ + NL L+ EY+ G L LL S + R IA L YLH I
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLH---SNGII 115
Query: 935 HRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSA-------IAGSYGYIAPEYA 985
HRD+K +NIL+D H+ DFGL+KV + + +++ I G+ YIAPE
Sbjct: 116 HRDLKPDNILIDS--NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 986 YTMKVTEKCDIYSYGVVLLELLTGRAP 1012
++ D +S G +L E L G P
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 817 IGRGACGTVYRAVLRT--GHT--VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVK 872
+G G+ G V R T G VAVK L S++ + D F E + + H N+++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD--FLKEAAIMHSLDHENLIR 60
Query: 873 LYGFCYHQGSNLLMYEYMARGSLGELLH-GASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
LYG +++ E GSL + L A T A+ A G+ YL
Sbjct: 61 LYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS----YGYIAPEYAYT 987
R HRD+ + NILL + +GDFGL + +PQ++ + + + APE T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRA--LPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 988 MKVTEKCDIYSYGVVLLELLT-GRAP 1012
+ D++ +GV L E+ T G P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 68/267 (25%), Positives = 115/267 (43%), Gaps = 27/267 (10%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G G G V R + VA+K + +EG+ + D F E + K+ H +V+LYG
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDE-FIEEAKVMMKLSHEKLVQLYGV 67
Query: 877 CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHR 936
C Q ++ EYM+ G L L + EG++YL + HR
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHR 124
Query: 937 DIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 995
D+ + N L+DD+ V DFGL++ V+D + S+ + + PE K + K D
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVLLYSKFSSKSD 183
Query: 996 IYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSH 1054
++++GV++ E+ + G+ P + NNS + L L S
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERF---------------NNSETVEKVSQGLRLYRPHLASE 228
Query: 1055 MITVLKIAMLCTNISPFDRPTMREVVL 1081
V I C + +RPT ++++
Sbjct: 229 --KVYAIMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-18
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G G G V+ VAVK L + G + + SF E + K+RH +V+LY
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL---KPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAV 69
Query: 877 CYHQGSNLLMYEYMARGSLGELLH-GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ ++ EYM++GSL + L G L +A A G++Y+ + H
Sbjct: 70 VSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 995
RD++S NIL+ D + DFGLA++I+ + + + APE A + T K D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 996 IYSYGVVLLELLT-GRAP 1012
++S+G++L EL+T GR P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 61/204 (29%), Positives = 88/204 (43%), Gaps = 23/204 (11%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKL-ASNREGNNNVDNSFRAEILTLGKIRHR-NIVKL 873
I +GA G+VY A R TG A+K L S+ N V N +AE + + KL
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVAKL 62
Query: 874 YGFCYHQGSNL-LMYEYMARGSLGELLHGASS-TLDWQTRFMIALGAAE---GLSYLHHD 928
Y + + L L+ EY+ G L+ DW ++ AE G+ LH
Sbjct: 63 Y-YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY-----IAEVVLGVEDLHQR 116
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM 988
I HRDIK N+L+D + DFGL++ + G+ Y+APE +
Sbjct: 117 ---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGV 168
Query: 989 KVTEKCDIYSYGVVLLELLTGRAP 1012
+ D +S G V+ E L G P
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 64/198 (32%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG+GA GTVY A+ + TG VA+K++ ++ + EIL + + +H NIV Y
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKHPNIVN-YL 82
Query: 876 FCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
Y G L ++ EY+A GSL +++ + +D + + L +LH + ++
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
HRDIKS+NILL + DFG I QSK + + Y ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKV 196
Query: 995 DIYSYGVVLLELLTGRAP 1012
DI+S G++ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG G+ G VY A +R VA+KK++ + + +N E+ L K+RH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ + L+ EY GS +LL L + GA +GL+YLH + H
Sbjct: 83 CYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIH 138
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE--- 992
RD+K+ NILL + +GDFG A ++ G+ ++APE M +
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMDEGQYDG 193
Query: 993 KCDIYSYGVVLLELLTGRAPV 1013
K D++S G+ +EL + P+
Sbjct: 194 KVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 810 NFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN 869
+++ V+GRGA G V+ + + + K + + + + E L + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 870 IVKLYGFCYHQGSNLLMYEYMARGSLGELLHG-------ASSTLDWQTRFMIALGAAEGL 922
I++ Y + +++ EY G+L E + + L + + ++A
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------- 113
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDMPQSKS-MSAIAGSYGYI 980
LHH I HRD+K+ NILLD K +GDFG++K++ SKS + G+ YI
Sbjct: 114 --LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYI 168
Query: 981 APEYAYTMKVTEKCDIYSYGVVLLELLT 1008
+PE +K DI++ G VL EL +
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G G VY+A L TG AVK + + ++ + EI + + +H NIV +G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL---IQQEIFMVKECKHCNIVAYFG 73
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ + EY GSL ++ H + Q ++ +GL+YLH K H
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYV-CRETLQGLAYLHSKGK---MH 129
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMK---VTE 992
RDIK NILL D + + DFG+A I +K S I Y ++APE A K +
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY-WMAPEVAAVEKNGGYNQ 188
Query: 993 KCDIYSYGVVLLELLTGRAPVQP 1015
CDI++ G+ +EL A +QP
Sbjct: 189 LCDIWAVGITAIEL----AELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 75/289 (25%), Positives = 126/289 (43%), Gaps = 44/289 (15%)
Query: 816 VIGRGACGTVYRAVLRTG---HTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIV 871
VIG G G V +A ++ A+K++ +++ D F E+ L K+ H NI+
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD--FAGELEVLCKLGHHPNII 71
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELL---------------HGASSTLDWQTRFMIAL 916
L G C H+G L EY G+L + L + +STL Q A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS 976
A G+ YL + + HRD+ + NIL+ + + A + DFGL++ ++ K+M +
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL--P 186
Query: 977 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLV 1036
++A E T D++SYGV+L E+++ GG + L
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LGGTPYCGMTCAELYEKLP 237
Query: 1037 SGM-LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084
G L+ LN DE V + C P++RP+ ++++ L+
Sbjct: 238 QGYRLEKPLNCDDE--------VYDLMRQCWREKPYERPSFAQILVSLN 278
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 59/182 (32%), Positives = 87/182 (47%), Gaps = 9/182 (4%)
Query: 831 RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN--LLMYE 888
TG VAVK L GN+ D + EI L + H NIVK G C G N L+ E
Sbjct: 31 NTGEQVAVKSLKPESGGNHIAD--LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88
Query: 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK 948
++ GSL E L + ++ + + A+ +G+ YL + HRD+ + N+L++ +
Sbjct: 89 FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESE 145
Query: 949 FEAHVGDFGLAKVI--DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLEL 1006
+ +GDFGL K I D + + APE K D++S+GV L EL
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL 205
Query: 1007 LT 1008
LT
Sbjct: 206 LT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-17
Identities = 62/211 (29%), Positives = 108/211 (51%), Gaps = 11/211 (5%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
D+F++ +G G G V++ + + +KL + E + N E+ L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLI-HLEIKPAIRNQIIRELQVLHECNSP 63
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
IV YG Y G + E+M GSL ++L A + Q +++ +GL+YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSIAVIKGLTYLRE- 121
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMS-AIAGSYGYIAPEYAY 986
K +I HRD+K +NIL++ + E + DFG++ ++ID SM+ + G+ Y++PE
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQ 175
Query: 987 TMKVTEKCDIYSYGVVLLELLTGRAPVQPLD 1017
+ + DI+S G+ L+E+ GR P+ P D
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 66/228 (28%), Positives = 96/228 (42%), Gaps = 30/228 (13%)
Query: 806 VATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEI 859
V D+ +G GA G VY + R VAVK L + + D F E
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD--FLMEA 60
Query: 860 LTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLH------GASSTLDWQTRFM 913
L + K H+NIV+L G + + ++ E MA G L L S+L +
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 914 IALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE---AHVGDFGLAKVIDMPQ---- 966
A A+G YL + HRDI + N LL K A + DFG+A+ I
Sbjct: 121 CARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 967 -SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
++M I ++ PE T K D++S+GV+L E+ + G P
Sbjct: 178 GGRAMLPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 68/209 (32%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLA---SNREGNNNVDNSFRAEILTLGKIRHRNIV 871
++GRGA G VY TG +AVK++ ++E + V N+ EI L +RH IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV-NALECEIQLLKNLRHDRIV 67
Query: 872 KLYGFCY--HQGSNLLMY-EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
+ YG C + L ++ EYM GS+ + L + + TR +G+SYLH +
Sbjct: 68 QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLHSN 125
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS-----AIAGSYGYIAPE 983
I HRDIK NIL D +GDFG +K I Q+ MS ++ G+ +++PE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRI---QTICMSGTGIKSVTGTPYWMSPE 179
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
K D++S ++E+LT + P
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKK--LASNREGNNNVDNSFRAEILTLGKIRHRNIVKL 873
IG G GTV++A R T VA+K+ L + EG V +S EI L +++H+NIV+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIVRL 64
Query: 874 YGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQT--RFMIALGAAEGLSYLHHDCKP 931
Y + L++EY + L + + +D + FM L +GL++ H
Sbjct: 65 YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQL--LKGLAFCHSH--- 118
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKV- 990
+ HRD+K N+L++ E + DFGLA+ +P + SA + Y P+ + K+
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLY 177
Query: 991 TEKCDIYSYGVVLLELLTGRAPVQP 1015
+ D++S G + EL P+ P
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 816 VIGRGACGTVYRA-VLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
V+G GA G V + TG VA+KK + E + +V + E+ L ++RH NIV L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKES-EDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+G L++EY+ R +L ELL + L + ++Y H I
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNII 122
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE-----YAYTMK 989
HRDIK NIL+ + + DFG A+ + + ++ + Y APE Y
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182
Query: 990 VTEKCDIYSYGVVLLELLTGRAPVQP----LDQ 1018
V D+++ G ++ ELL G P+ P +DQ
Sbjct: 183 V----DVWAIGCIMAELLDGE-PLFPGDSDIDQ 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 11/212 (5%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
D+F++ +G G G V + + R + +KL + E + N E+ L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLI-HLEIKPAIRNQIIRELKVLHECNSP 59
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
IV YG Y G + E+M GSL ++L A + I++ GL+YL
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPENILGKISIAVLRGLTYLRE- 117
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMS-AIAGSYGYIAPEYAY 986
K +I HRD+K +NIL++ + E + DFG++ ++ID SM+ + G+ Y++PE
Sbjct: 118 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQ 171
Query: 987 TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018
T + DI+S G+ L+E+ GR P+ P D
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G G G V+ VAVK L + G +V +F E + ++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL---KPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAV 69
Query: 877 CYHQGSNLLMYEYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ ++ EYMA+GSL + L + + AEG++Y+ + H
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 995
RD+++ N+L+ + + DFGLA+VI+ + + + APE T K D
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 996 IYSYGVVLLELLT-GRAP 1012
++S+G++L E++T G+ P
Sbjct: 187 VWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 8e-17
Identities = 63/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG+GA GTVY A+ + TG VA+K++ ++ + EIL + + ++ NIV Y
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKNPNIVN-YL 82
Query: 876 FCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
Y G L ++ EY+A GSL +++ + +D + + L +LH + ++
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
HRDIKS+NILL + DFG I QSK + + Y ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKV 196
Query: 995 DIYSYGVVLLELLTGRAP 1012
DI+S G++ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-17
Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI- 865
TD ++ IG+G G VY+ + G AVK L + VD AE L +
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLP 76
Query: 866 RHRNIVKLYGFCYHQ-----GSNLLMYEYMARGSLGELLHG---ASSTLDWQTRFMIALG 917
H N+VK YG Y G L+ E GS+ EL+ G LD I G
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 918 AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY 977
A GL +LH++ RI HRD+K NNILL + + DFG++ + + + +++ G+
Sbjct: 137 ALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTP 192
Query: 978 GYIAPEY-----AYTMKVTEKCDIYSYGVVLLELLTGRAPV 1013
++APE Y +CD++S G+ +EL G P+
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 11/204 (5%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVD--NSFRAEILTLGKIRHRNIVK 872
++G+GA G VY + TG +A K++ + E ++ EI L ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 873 LYGFCYHQGSNLL--MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
YG + L EYM GS+ + L + + TR EG+SYLH +
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLHSN-- 125
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM--PQSKSMSAIAGSYGYIAPEYAYTM 988
I HRDIK NIL D +GDFG +K + + ++ G+ +++PE
Sbjct: 126 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 989 KVTEKCDIYSYGVVLLELLTGRAP 1012
K D++S G ++E+LT + P
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 26/212 (12%)
Query: 816 VIGRGACGTVYRAVLRTG---HTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIV 871
VIG G G V RA+++ A+K L N++ D F E+ L K+ H NI+
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD--FAGELEVLCKLGHHPNII 66
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELL---------------HGASSTLDWQTRFMIAL 916
L G C ++G + EY G+L + L HG +STL Q A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS 976
A G+ YL + + HRD+ + N+L+ + + + DFGL++ ++ K+M +
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL--P 181
Query: 977 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 1008
++A E T K D++S+GV+L E+++
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 17/213 (7%)
Query: 809 DNFDERFV----IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLG 863
D+ +E FV IG G+ G VY A T VAVKK++ + + N E+ L
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 864 KIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLS 923
+++H N ++ G + + L+ EY GS +LL L I GA +GL+
Sbjct: 77 QLKHPNTIEYKGCYLKEHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 135
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
YLH HRDIK+ NILL + + + DFG A S ++ G+ ++APE
Sbjct: 136 YLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASK-----SSPANSFVGTPYWMAPE 187
Query: 984 YAYTMKVTE---KCDIYSYGVVLLELLTGRAPV 1013
M + K D++S G+ +EL + P+
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 73/224 (32%), Positives = 107/224 (47%), Gaps = 23/224 (10%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
D FD IG G G VY+A + TG VA+KK+ + E + R EI L ++ H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNH 65
Query: 868 RNIVKLY----------GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTR-FMIAL 916
RNIV L F +G+ L++EYM +G L G + + FM L
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS 976
EGL+Y H K HRDIK +NILL++K + + DFGLA++ + +S+ + +
Sbjct: 126 --LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 977 YGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
Y PE + D++S G +L EL T + P+ Q
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK----PIFQA 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G+G G V+ VA+K L + + +F E + K+RH +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL----KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 877 CYHQGSNLLMYEYMARGSLGELL-HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ ++ E+M +GSL + L G L +A A+G++Y+ + H
Sbjct: 70 VSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 995
RD+++ NIL+ D + DFGLA++I+ + + + APE A + T K D
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 996 IYSYGVVLLELLT-GRAP 1012
++S+G++L EL+T GR P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVD--NSFRAEILTLGKIRHRNIVK 872
++G+GA G VY TG +AVK++ + E N+ EI L + H IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 873 LYGFCYHQGSNLL--MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
YG L E+M GS+ + L + + TR EG+SYLH +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLHSN-- 125
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP--QSKSMSAIAGSYGYIAPEYAYTM 988
I HRDIK NIL D +GDFG +K + M ++ G+ +++PE
Sbjct: 126 -MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 989 KVTEKCDIYSYGVVLLELLTGRAP 1012
K DI+S G ++E+LT + P
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 816 VIGRGACGTVYRAV-LRTGHTV----AVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
V+G GA GTVY+ + + G TV A+K L NV+ F E L + + H ++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPHL 71
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
V+L G C L+ + M G L + +H + Q + A+G+ YL +
Sbjct: 72 VRLLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---E 127
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY--GYIAPEYAYTM 988
R+ HRD+ + N+L+ + DFGLA++++ + K +A G ++A E +
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-KEYNADGGKMPIKWMALECIHYR 186
Query: 989 KVTEKCDIYSYGVVLLELLT 1008
K T + D++SYGV + EL+T
Sbjct: 187 KFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-16
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 11/211 (5%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
D+F+ +G G G V + + + +KL + E + N E+ L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLI-HLEIKPAIRNQIIRELQVLHECNSP 63
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
IV YG Y G + E+M GSL ++L A + + +++ GL+YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSIAVLRGLAYLRE- 121
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMS-AIAGSYGYIAPEYAY 986
K +I HRD+K +NIL++ + E + DFG++ ++ID SM+ + G+ Y++PE
Sbjct: 122 -KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQ 175
Query: 987 TMKVTEKCDIYSYGVVLLELLTGRAPVQPLD 1017
+ + DI+S G+ L+EL GR P+ P D
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 9/207 (4%)
Query: 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN 869
F + V+G+G G V +R TG A KKL R ++ E L K+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 870 IVKLYGFCYHQGSNL-LMYEYMARGSLG-ELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
+V L + Y L L+ M G L + H + + A GL LH
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
+ RI +RD+K NILLDD + D GLA + +P+ +++ G+ GY+APE
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKN 175
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAPVQ 1014
+ T D ++ G +L E++ G++P Q
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-16
Identities = 44/123 (35%), Positives = 65/123 (52%), Gaps = 10/123 (8%)
Query: 56 WNPNDSTPCG-----WIGVNCTTNDFGA--VVFSLNLTKMNLSGYLSPNIGGLVHLTALD 108
WN + PC W G +C + + L L L G++ +I L HL +++
Sbjct: 392 WNGD---PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSIN 448
Query: 109 LSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPK 168
LS N + NIP +G+ +SLEVL+L+ N IP+ LG L+SL ILN+ N +SG P
Sbjct: 449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA 508
Query: 169 EIG 171
+G
Sbjct: 509 ALG 511
|
Length = 623 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 63/198 (31%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG+GA GTVY A+ + TG VA++++ ++ + EIL + + ++ NIV Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNPNIVN-YL 83
Query: 876 FCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
Y G L ++ EY+A GSL +++ + +D + + L +LH + ++
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
HRDIKS+NILL + DFG I QSK S + G+ ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKV 197
Query: 995 DIYSYGVVLLELLTGRAP 1012
DI+S G++ +E++ G P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
IG+G+ G V++ + V K+ E + +++ + EI L + + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYVTKYYG- 69
Query: 877 CYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE---GLSYLHHDCKPR 932
Y +G+ L ++ EY+ GS +LL F IA E GL YLH + K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFD-----EFQIATMLKEILKGLDYLHSEKK-- 122
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
HRDIK+ N+LL ++ + + DFG+A + Q K + G+ ++APE
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIQQSAYDS 180
Query: 993 KCDIYSYGVVLLELLTGRAP 1012
K DI+S G+ +EL G P
Sbjct: 181 KADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG G+ G VY A +RT VA+KK++ + + +N E+ L +I+H N ++ G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ + L+ EY GS +LL L I GA +GL+YLH + H
Sbjct: 93 CYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIH 148
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE--- 992
RDIK+ NILL + + + DFG A + S G+ ++APE M +
Sbjct: 149 RDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVILAMDEGQYDG 203
Query: 993 KCDIYSYGVVLLELLTGRAPV 1013
K D++S G+ +EL + P+
Sbjct: 204 KVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 27/215 (12%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G GA G V A TG VA+KKL+ + + ++R E+ L + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 876 FCYHQGSNL-------LMYEYMARGSLGELLHGASSTL-DWQTRFMIALGAAEGLSYLHH 927
+ S+L L+ M L ++ L D +F++ GL Y+H
Sbjct: 82 -VFTPASSLEDFQDVYLVTHLMGA-DLNNIV--KCQKLSDDHIQFLV-YQILRGLKYIH- 135
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
I HRD+K +NI +++ E + DFGLA+ D M+ + Y APE
Sbjct: 136 --SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLN 189
Query: 988 -MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD 1021
M + DI+S G ++ ELLTG+ L G D
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGK----TLFPGSD 220
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNR----EGNNNVDNSFRAEILTLGKIRHRNIV 871
V+G G+ G RA+L H + +K A + ++ V++S R E + L K++H NIV
Sbjct: 7 VVGEGSFG---RALL-VQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIV 61
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGE-------LLHGASSTLDWQTRFMIALGAAEGLSY 924
G ++ EY G L + L + L W + + G+ +
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQH 115
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
+H + R+ HRDIKS NI L + +GDFG A+++ P + + + + Y Y+ PE
Sbjct: 116 IH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY-YVPPEI 171
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAPVQ 1014
M K DI+S G +L EL T + P Q
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 70/279 (25%), Positives = 111/279 (39%), Gaps = 36/279 (12%)
Query: 816 VIGRGACGTVYRAVLRTGH----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
IG G G VY+ V + VAVK + + V F E + + H +IV
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS--VREKFLQEAYIMRQFDHPHIV 70
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
KL G ++M E G L L +LD + + + + L+YL
Sbjct: 71 KLIGVITENPVWIVM-ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVT 991
R HRDI + N+L+ +GDFGL++ ++ S ++APE + T
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 992 EKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD--ARLNLQD 1048
D++ +GV + E+L G P Q V+ N+ V G ++ RL +
Sbjct: 187 SASDVWMFGVCMWEILMLGVKPFQ----------GVK-----NNDVIGRIENGERLPMPP 231
Query: 1049 E--KTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
T+ ++T C P RP E+ LS+
Sbjct: 232 NCPPTLYSLMT------KCWAYDPSKRPRFTELKAQLSD 264
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 5e-16
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG+GA GTV+ A+ + TG VA+K++ ++ + EIL + ++++ NIV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMKELKNPNIVNFLD 83
Query: 876 FCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+ G L ++ EY+A GSL +++ + +D + + L +LH + ++
Sbjct: 84 -SFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
HRDIKS+N+LL + DFG I QSK + + Y ++APE K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKV 196
Query: 995 DIYSYGVVLLELLTGRAP 1012
DI+S G++ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G G G V+ VA+K L ++G+ + + +F AE + +++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL---KQGSMSPE-AFLAEANLMKQLQHPRLVRLYAV 69
Query: 877 CYHQGSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ ++ EYM GSL + L L +A AEG++++ + H
Sbjct: 70 VTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 995
RD+++ NIL+ + + DFGLA++I+ + + + APE T K D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 996 IYSYGVVLLELLT-GRAP 1012
++S+G++L E++T GR P
Sbjct: 186 VWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 810 NFDERFVIGRGACGTVYRA-VLRTGHTVAVKKL----ASNREGNNNVDNSFRAEILTLGK 864
D IG G+ G V A TG VAVKK+ RE N E++ +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-------EVVIMRD 72
Query: 865 IRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLS 923
+H NIV++Y Y G L ++ E++ G+L +++ + ++ + + L + LS
Sbjct: 73 YQHPNIVEMYS-SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLAVLKALS 129
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAIAGSYGYIA 981
+LH + HRDIKS++ILL + DFG + ++P+ KS+ G+ ++A
Sbjct: 130 FLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMA 183
Query: 982 PEYAYTMKVTEKCDIYSYGVVLLELLTGRAP---VQPL 1016
PE + + DI+S G++++E++ G P PL
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 34/224 (15%)
Query: 814 RFVIGRGACGTVYRAVL------RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
++ +G GA G V+ A + VAVK L +E + + F+ E L ++H
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTVLQH 66
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELL--HGASSTLDWQTR------------FM 913
++IV+ YG C L+++EYM G L L HG + +
Sbjct: 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 914 IALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI 973
IA A G+ YL HRD+ + N L+ +GDFG+++ I S +
Sbjct: 127 IASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRV 180
Query: 974 AGS----YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
G ++ PE K T + DI+S+GVVL E+ T G+ P
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 72/275 (26%), Positives = 116/275 (42%), Gaps = 34/275 (12%)
Query: 816 VIGRGACG--TVYRAVLRT--GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
V+G+GA G T+YR RT V K++ R ++ EI+ L ++H NI+
Sbjct: 7 VLGKGAFGEATLYR---RTEDDSLVVWKEVNLTRLSEKERRDALN-EIVILSLLQHPNII 62
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGE-LLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
Y + L+ EY G+L + ++ + + +SY+H K
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---K 119
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKV 990
I HRDIK+ NI L +GDFG++K++ S + + + Y Y++PE +K
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY-YMSPELCQGVKY 178
Query: 991 TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN--SLVSGMLDARLNLQD 1048
K DI++ G VL ELLT + R F N +LV ++
Sbjct: 179 NFKSDIWALGCVLYELLTLK----------------RTFDATNPLNLVVKIVQGNYTPVV 222
Query: 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
S +I+++ P RPT EV+
Sbjct: 223 SVYSSELISLVH---SLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 33/213 (15%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKK----LASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
+G+G+ G+VY+ L A+K+ S +E + V+ EI L + H NI+
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-----EIRILASVNHPNII 62
Query: 872 KLYGFCYHQG---SNLL--MYEYMARGSLGELLHGASST---LDWQTRFMIALGAAEGLS 923
Y + N L + EY G L + + + Q + I + GL
Sbjct: 63 -----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA--IAGSYGYIA 981
LH +I HRD+KS NILL +GD G++KV+ K A G+ Y+A
Sbjct: 118 ALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL-----KKNMAKTQIGTPHYMA 169
Query: 982 PEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQ 1014
PE + K DI+S G +L E+ T P +
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 816 VIGRGACGTVYRAVLRTG---HTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIV 871
VIG G G V +A ++ A+K++ +++ D F E+ L K+ H NI+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD--FAGELEVLCKLGHHPNII 59
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELL---------------HGASSTLDWQTRFMIAL 916
L G C H+G L EY G+L + L + +STL Q A
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS 976
A G+ YL + + HRD+ + NIL+ + + A + DFGL++ ++ K+M +
Sbjct: 120 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL--P 174
Query: 977 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 1008
++A E T D++SYGV+L E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG G G VY+A + TG A+K + E + + EI+ + +H NIV +G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI--KLEPGEDFA-VVQQEIIMMKDCKHSNIVAYFG 73
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ + E+ GSL ++ H + Q + ++ +GL YLH K H
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-VSRETLQGLYYLHSKGK---MH 129
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMK---VTE 992
RDIK NILL D + DFG++ I +K S I Y ++APE A + +
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPY-WMAPEVAAVERKGGYNQ 188
Query: 993 KCDIYSYGVVLLELLTGRAPV 1013
CDI++ G+ +EL + P+
Sbjct: 189 LCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 49/290 (16%)
Query: 817 IGRGACGTVYRAVL------RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
+G GA G V+ A + VAVK L ++ ++N F E L ++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLTNLQHEHI 69
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELL--HGASSTLD---------WQTRFM-IALGA 918
VK YG C ++++EYM G L + L HG + L Q++ + IA
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAG--- 975
A G+ YL HRD+ + N L+ + +GDFG+++ + S + G
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV---YSTDYYRVGGHTM 183
Query: 976 -SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNN 1033
++ PE K T + D++S GVVL E+ T G+ P W + + NN
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP------------WYQ--LSNN 229
Query: 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
++ + R+ LQ +T V + + C P R ++E+ +L
Sbjct: 230 EVIECITQGRV-LQRPRTCPK--EVYDLMLGCWQREPHMRLNIKEIHSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 69/278 (24%), Positives = 127/278 (45%), Gaps = 36/278 (12%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+I ++Y+ + V ++ +G+ + + EI L +I NI+K+YG
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 876 FCYHQGSNL----LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH-HDCK 930
F +L L+ EY RG L E+L L ++T+ +A+ +GL L+ + K
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD-LSFKTKLDMAIDCCKGLYNLYKYTNK 144
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM-- 988
P ++++ S + L+ + ++ + GL K++ P K+++ + Y + + +
Sbjct: 145 P---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFS 197
Query: 989 KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG--DLVTWVRNFIRNNSLVSGMLDARLNL 1046
+ T K DIYS GVVL E+ TG+ P + L DL+ I N+ + LD L +
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNNSLKLPLDCPLEI 251
Query: 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084
+ I CT+ RP ++E++ LS
Sbjct: 252 KC------------IVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 11/202 (5%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G+G G V ++ TG A KKL R + E L K+ R IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 876 FCYHQGSNL-LMYEYMARGSLGELL--HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
+ + +L L+ M G L + G + + F A GL +LH R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLHQR---R 115
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
I +RD+K N+LLDD + D GLA +++ K + AG+ GY+APE
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 993 KCDIYSYGVVLLELLTGRAPVQ 1014
D ++ G L E++ GR+P +
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 18/213 (8%)
Query: 810 NFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN 869
++ IG G+ G +Y A ++ V K + + + E++ L K++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 870 IVKLYGFCYHQGSNLLMYEYMARGSLGE-------LLHGASSTLDWQTRFMIALGAAEGL 922
IV + G ++ EY G L + +L L W + I+LG
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ--ISLG----- 113
Query: 923 SYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIA 981
L H +I HRDIKS NI L + A +GDFG+A+ ++ + + + Y Y++
Sbjct: 114 --LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY-YLS 170
Query: 982 PEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQ 1014
PE K DI+S G VL EL T + P +
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 37/222 (16%)
Query: 817 IGRGACGTVYRAVL------RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
IG+GA G V++A VAVK L E + ++ F+ E + + H NI
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEFDHPNI 70
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASST---------------------LDWQ 909
VKL G C L++EYMA G L E L S L
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 910 TRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI---DMPQ 966
+ IA A G++YL + HRD+ + N L+ + + DFGL++ I D +
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 1008
+ AI ++ PE + + T + D+++YGVVL E+ +
Sbjct: 188 ASENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 810 NFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
NF + IG G G VY+A TG VA+KK+ + E + R EI L ++ H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 59
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASST---LDWQTRFMIALGAAEGLSYL 925
NIVKL + + L++E++ + L + + + + L ++ L +GL++
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFC 116
Query: 926 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYA 985
H R+ HRD+K N+L++ + + DFGLA+ +P ++ + + Y APE
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPEIL 172
Query: 986 YTMKV-TEKCDIYSYGVVLLELLTGRA 1011
K + DI+S G + E++T RA
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 69/219 (31%), Positives = 107/219 (48%), Gaps = 22/219 (10%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
D +++ I G G VYRA +TG VA+KKL +E S R EI L K++H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 868 RNIVKLYGFCYHQGSNL----LMYEYMARG--SLGELLHGASSTLDWQTRFMIALGAAEG 921
NIV + GSNL ++ EY+ SL E + + + M+ L G
Sbjct: 64 PNIVTVKEVVV--GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC-LMLQL--LSG 118
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIA 981
+++LH + I HRD+K++N+LL+++ + DFGLA+ P K + + + Y A
Sbjct: 119 VAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLVVTLWYRA 174
Query: 982 PEYAY-TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
PE + + D++S G + ELLT + PL G
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK----PLFPG 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVK---KLASNREGNNNVDNSFRA---EILTLGKIRHR 868
++G G GTV++ + + G ++ + K +R G +F+ +L +G + H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQ----TFQEITDHMLAMGSLDHA 69
Query: 869 NIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
IV+L G C G++L L+ + GSL + + +LD Q + A+G+ YL
Sbjct: 70 YIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM--SAIAGSYGYIAPEYA 985
+ HR++ + NILL + DFG+A ++ P K S ++A E
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLL-YPDDKKYFYSEHKTPIKWMALESI 183
Query: 986 YTMKVTEKCDIYSYGVVLLELLT 1008
+ T + D++SYGV + E+++
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 74/265 (27%), Positives = 115/265 (43%), Gaps = 26/265 (9%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
IG+G+ G VY+ + V K+ E + +++ + EI L + I + YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYITRYYG- 69
Query: 877 CYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
Y +G+ L ++ EY+ GS +LL L+ I +GL YLH + R H
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSE---RKIH 124
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 995
RDIK+ N+LL ++ + + DFG+A + Q K + G+ ++APE K D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 996 IYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHM 1055
I+S G+ +EL G P L V I NS + L Q K
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHP-----MRVLFLIPKNSPPT------LEGQYSKPFKEF 232
Query: 1056 ITVLKIAMLCTNISPFDRPTMREVV 1080
+ C N P RPT +E++
Sbjct: 233 VEA------CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G TVY+ R TG VA+K++ + E + R EI + +++H NIV+L+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIR-EISLMKELKHENIVRLHD 65
Query: 876 FCYHQGSNLLMYEYMARGSLGELL--HGASSTLDWQT--RFMIALGAAEGLSYLHHDCKP 931
+ + +L++EYM L + + HG LD T F L +G+++ H +
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAFCHEN--- 119
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKV- 990
R+ HRD+K N+L++ + E + DFGLA+ +P + + + + Y AP+ +
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLW-YRAPDVLLGSRTY 178
Query: 991 TEKCDIYSYGVVLLELLTGRA 1011
+ DI+S G ++ E++TGR
Sbjct: 179 STSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 75/277 (27%), Positives = 118/277 (42%), Gaps = 25/277 (9%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
++G G+ G V + + TG VA+KK E + V EI L ++RH N+V L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFL-ESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+ L++E++ L +L + LD G+ + H I
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSH---NII 122
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY-TMKVTEK 993
HRDIK NIL+ + DFG A+ + P +A + Y APE K
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW-YRAPELLVGDTKYGRA 181
Query: 994 CDIYSYGVVLLELLTGRAPVQP----LDQ-------GGDLVTWVRNFIRNNSLVSGM--- 1039
DI++ G ++ E+LTG P+ P +DQ G+L+ + + N L +GM
Sbjct: 182 VDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240
Query: 1040 -LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPT 1075
+ L +++ VL +A C I P DRP+
Sbjct: 241 EVKEIEPL-EKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 7/196 (3%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
IG+G+ G V++ + V K+ E + +++ + EI L + + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYVTKYYGS 70
Query: 877 CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHR 936
++ EY+ GS +LL LD I +GL YLH + K HR
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKK---IHR 125
Query: 937 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDI 996
DIK+ N+LL + E + DFG+A + Q K + G+ ++APE K DI
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSAYDSKADI 184
Query: 997 YSYGVVLLELLTGRAP 1012
+S G+ +EL G P
Sbjct: 185 WSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G GA G VY+A + +A K+ + D + EI L H IVKL G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED--YMVEIEILATCNHPYIVKLLGA 77
Query: 877 CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHR 936
Y G +M E+ G++ ++ L +I E L YLH +I HR
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHR 134
Query: 937 DIKSNNILLDDKFEAHVGDFGL-AKVIDMPQSKSMSAIAGSYGYIAPEYAY--TMKVTE- 992
D+K+ N+LL + + DFG+ AK + Q + S I Y ++APE TMK T
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD-SFIGTPY-WMAPEVVMCETMKDTPY 192
Query: 993 --KCDIYSYGVVLLELLTGRAPVQP 1015
K DI+S G+ L+E+ A ++P
Sbjct: 193 DYKADIWSLGITLIEM----AQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR----NIVK 872
+G G G+V + TV KK+ + +S R +IL +I H IV
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVV-----HIGAKSSVRKQILRELQIMHECRSPYIVS 67
Query: 873 LYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
YG ++ + + E+M GSL + + + IA+ EGL+YL++ R
Sbjct: 68 FYGAFLNENNICMCMEFMDCGSLDRIYKKGGP-IPVEILGKIAVAVVEGLTYLYN--VHR 124
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA----GSYGYIAPEYAYTM 988
I HRDIK +NIL++ + + + DFG++ + +++IA G+ Y++PE
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVS-------GELINSIADTFVGTSTYMSPERIQGG 177
Query: 989 KVTEKCDIYSYGVVLLELLTGRAP 1012
K T K D++S G+ ++EL G+ P
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
V+G+G G V +R TG A KKL R + E L K+ R +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL- 65
Query: 875 GFCYHQGSNL-LMYEYMARGSLG-ELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
+ Y L L+ M G L + + + D Q A GL L + R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RER 122
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
I +RD+K NILLDD+ + D GLA + +P+ +++ G+ GY+APE K T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180
Query: 993 KCDIYSYGVVLLELLTGRAP 1012
D + G ++ E++ G++P
Sbjct: 181 SPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 73/288 (25%), Positives = 127/288 (44%), Gaps = 45/288 (15%)
Query: 817 IGRGACGTVY--RAVLRTGHTVAVKKLA----SNREGNNNVDNSFR---AEILTLGK-IR 866
+G GA G VY R + +A+K++ + + D S +E+ + + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 867 HRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFM------IALGAA 919
H NIV+ Y + + L ++ + + LGE +S + + RF I +
Sbjct: 68 HPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHF---NSLKEKKQRFTEERIWNIFVQMV 123
Query: 920 EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGY 979
L YLH + RI HRD+ NNI+L + + + DFGLAK P+SK ++++ G+ Y
Sbjct: 124 LALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESK-LTSVVGTILY 179
Query: 980 IAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN--SLVS 1037
PE EK D++++G +L ++ T + P F N SL +
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP----------------FYSTNMLSLAT 223
Query: 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+++A E S +T + C RP + +V M+S+
Sbjct: 224 KIVEAVYEPLPEGMYSEDVTDV--ITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH-RNIVKLY 874
IGRGA GTV + + + +G +AVK++ S + ++ + + IVK Y
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ--KRLLMDLDVVMRSSDCPYIVKFY 69
Query: 875 GFCYHQGSNLLMYEYM--ARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
G + +G + E M + + ++ S + + IA+ + L+YL + K
Sbjct: 70 GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK- 128
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMSAIAGSYGYIAPEY------ 984
I HRD+K +NILLD + DFG++ +++D S + + AG Y+APE
Sbjct: 129 -IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSAR 184
Query: 985 -AYTMKVTEKCDIYSYGVVLLELLTGRAPVQ----PLDQ 1018
Y + + D++S G+ L E+ TG+ P DQ
Sbjct: 185 DGYDV----RSDVWSLGITLYEVATGKFPYPKWNSVFDQ 219
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-14
Identities = 80/316 (25%), Positives = 140/316 (44%), Gaps = 31/316 (9%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
D + + +G GA GTV A+ RTG VA+KKL + ++R E+ L ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKH 73
Query: 868 RNIVKLYGFCYHQGSNL-------LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE 920
N++ L + +L L+ +M LG+L+ + D + +F++ +
Sbjct: 74 ENVIGLLD-VFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSED-RIQFLV-YQMLK 129
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI 980
GL Y+H I HRD+K N+ +++ E + DFGLA+ D M+ + Y
Sbjct: 130 GLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTRWYR 182
Query: 981 APEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039
APE M T+ DI+S G ++ E+LTG+ PL +G D + + ++ S
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK----PLFKGHDHLDQLMEIMKVTGTPSKE 238
Query: 1040 LDARLNLQDEKT-VSHMITVLK--IAMLCTNISPFDRPTMREVVLMLSESNRRQGH---F 1093
+L +D K V + K L N +P + +++++ +ES
Sbjct: 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298
Query: 1094 EFSPMDHDSDQKLENE 1109
+ HD + + E
Sbjct: 299 PYFEEFHDPEDETEAP 314
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 39/211 (18%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLA--SNREGNNNVDNSFRAEILTLGKIR---HRNI 870
IG GA GTVY+A L TG VA+KK+ + EG + S EI L ++ H NI
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG---IPLSTLREIALLKQLESFEHPNI 63
Query: 871 VKLYGFCY-HQGSN----LLMYEYMARGSLGELLHGASSTLD-WQTRFMIA--LGAAEGL 922
V+L C+ + L++E++ + L L + ++ L G+
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR---GV 120
Query: 923 SYLH-HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIA 981
+LH H RI HRD+K NIL+ + + DFGLA++ + S + + Y A
Sbjct: 121 DFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMALTSVVVTLW-YRA 174
Query: 982 PE------YAYTMKVTEKCDIYSYGVVLLEL 1006
PE YA D++S G + EL
Sbjct: 175 PEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 71/291 (24%), Positives = 123/291 (42%), Gaps = 52/291 (17%)
Query: 817 IGRGACGTVYRAVLRT------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRN 869
+G GA G V +A TVAVK L + + D +E+ + I +H+N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD--LVSEMEMMKMIGKHKN 77
Query: 870 IVKLYGFCYHQGSNLLMYEYMARGSLGELLHG-------ASSTLDWQTRFMI-------- 914
I+ L G C +G ++ EY A G+L + L AS +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 915 ALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAI 973
A A G+ +L + HRD+ + N+L+ + + DFGLA+ I + + +
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 974 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQ--PLDQGGDLVTWVRNFI 1030
++APE + T + D++S+GV+L E+ T G +P P+++ L ++
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---LFKLLKEGY 251
Query: 1031 RNNSLVSGMLDARLNLQDEKTVSHMITVLKIAML-CTNISPFDRPTMREVV 1080
R ++ N E + H+ M C + P RPT +++V
Sbjct: 252 R--------MEKPQNCTQE--LYHL-------MRDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVK-----KLASNREGNNNVDNSFRAEILTL 862
D+F+ +G G+ G V + +G A+K K+ ++ V++ E L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ----VEHVL-NEKRIL 55
Query: 863 GKIRHRNIVKLYGFCYHQGSNLLM-YEYMARGSLGELLHGASSTLDWQTRFMIALGAAE- 920
IRH +V LYG + SNL + EY+ G L L + + RF AA+
Sbjct: 56 QSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY----AAQV 110
Query: 921 --GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG 978
L YLH I +RD+K N+LLD + DFG AK + + G+
Sbjct: 111 VLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GRTYTLCGTPE 163
Query: 979 YIAPEY----AYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y+APE Y V D ++ G+++ E+L G P
Sbjct: 164 YLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 817 IGRGACGTVYRA-VLRTGHTVAVKKLA--SNREGNNNVDNSFRAEILTLGKIRHR--NIV 871
IG G CG VY+ +TGH +AVK++ N+E N + + + H IV
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS-----HDCPYIV 77
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
K YG+ + E M+ L +LL + + + + L YL K
Sbjct: 78 KCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KH 134
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMSAIAGSYGYIAPEYAYTMKV 990
+ HRD+K +NILLD + DFG++ +++D SK+ + AG Y+APE
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAYMAPERIDPPDP 191
Query: 991 TEKCDI----YSYGVVLLELLTGRAP 1012
K DI +S G+ L+EL TG+ P
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 64/219 (29%), Positives = 93/219 (42%), Gaps = 31/219 (14%)
Query: 817 IGRGACGTVYRAVLRT-------GHTVAVKKLASNREGNNNVDNS-FRAEILTLGKIRHR 868
+G GA G VY VAVK L R+G + + F E + H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFNHP 59
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASST------LDWQTRFMIALGAAEGL 922
NIVKL G C ++ E M G L L A L + I L A+G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEA-----HVGDFGLAKVI---DMPQSKSMSAIA 974
YL + HRD+ + N L+ +K +GDFGLA+ I D + + +
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL- 175
Query: 975 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
++APE K T + D++S+GV++ E+LT G+ P
Sbjct: 176 -PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-14
Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 33/229 (14%)
Query: 813 ERFVIGR----GACGTVYRAVL------RTGH--TVAVKKLASNREGNNNVDNSFRAEIL 860
+R V+G+ G G V RA R TVAVK L N + D E++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 861 TLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHG---------------ASST 905
L +H+NI+ L G C +G ++ EY A+G+L E L
Sbjct: 72 KLIG-KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 906 LDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDM 964
L ++ A A G+ YL R HRD+ + N+L+ + + DFGLA+ V D+
Sbjct: 131 LSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
Query: 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
K S ++APE + T + D++S+G+++ E+ T G +P
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 27/204 (13%)
Query: 817 IGRGACGTVYRAVL----RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVK 872
IG G+ G +A+L G +K++ ++ + S R E+ L ++H NIV+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQ 63
Query: 873 LYGFCYHQGSNL-LMYEYMARGSLGELLHG-------ASSTLDWQTRFMIALGAAEGLSY 924
Y + + NL ++ +Y G L + ++ LDW + +AL
Sbjct: 64 -YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV----- 117
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
HD K I HRDIKS NI L +GDFG+A+V++ + + I Y Y++PE
Sbjct: 118 --HDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPY-YLSPEI 172
Query: 985 AYTMKVTEKCDIYSYGVVLLELLT 1008
K DI++ G VL E+ T
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 816 VIGRGACGTVYRAVL----RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
VIG G G V R L + VA+K L S D F +E +G+ H NI+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD--FLSEASIMGQFDHPNII 68
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
L G +++ E+M G+L L + G A G+ YL +
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEM 125
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--MSAIAGSYG--YIAPEYAYT 987
HRD+ + NIL++ V DFGL++ ++ S S++ G + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 988 MKVTEKCDIYSYGVVLLELLT-GRAP 1012
K T D++SYG+V+ E+++ G P
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 817 IGRGACGTVYRA------VLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
+G GA G V+ A + VAVK L ++ F+ E L ++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQHEHI 69
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELL--HGASSTL--DWQTR-----------FMIA 915
VK YG C ++++EYM G L + L HG + + D Q R IA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 916 LGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAG 975
A G+ YL HRD+ + N L+ +GDFG+++ + S + G
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV---YSTDYYRVGG 183
Query: 976 ----SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
++ PE K T + D++S+GV+L E+ T G+ P
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG G+ G V A + TG VAVKK+ ++ + E++ + H N+V +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL---LFNEVVIMRDYHHENVVDMYN 86
Query: 876 FCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
Y G L ++ E++ G+L +++ + ++ + + L LSYLH+ +
Sbjct: 87 -SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQ---GVI 140
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
HRDIKS++ILL + DFG + ++P+ KS+ G+ ++APE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL---VGTPYWMAPEVISRLPYGT 197
Query: 993 KCDIYSYGVVLLELLTGRAP 1012
+ DI+S G++++E++ G P
Sbjct: 198 EVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKK--LASNREGNNNVDNSFRAEILTLGKIRHRNIVKL 873
IG G G VY+A TG VA+KK L + EG V ++ EI L ++ H NIV+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG---VPSTAIREISLLKELNHPNIVRL 63
Query: 874 YGFCYHQGSNL-LMYEYMARGSLGELLHGASST-LDWQ--TRFMIALGAAEGLSYLHHDC 929
H + L L++E++ L + + + T LD ++ L +G++Y H
Sbjct: 64 LDV-VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQL--LQGIAYCHSH- 118
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY----- 984
R+ HRD+K N+L+D + + DFGLA+ +P + + Y APE
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW-YRAPEILLGSR 175
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLD 1017
Y+ V DI+S G + E++ R P+ P D
Sbjct: 176 QYSTPV----DIWSIGCIFAEMVN-RRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 5e-14
Identities = 77/246 (31%), Positives = 99/246 (40%), Gaps = 59/246 (23%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKL------ASNREGNNNVDNSFRAEILT 861
D+F+ VIGRGA G V+ + TG A+K L N+ + RAE
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH------VRAERDI 54
Query: 862 LGKIRHRNIVKLYGFCYHQGSN---LLMYEYMARGSLGELL-HGASSTLDWQTRFMIA-L 916
L IVKLY Q L+M EYM G L LL + RF IA L
Sbjct: 55 LADADSPWIVKLY--YSFQDEEHLYLVM-EYMPGGDLMNLLIRKDVFPEET-ARFYIAEL 110
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVI------------ 962
A L +H K HRDIK +NIL+D H+ DFGL K +
Sbjct: 111 VLA--LDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLND 163
Query: 963 ---------------DMPQSKSMS-AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLEL 1006
D Q + + + G+ YIAPE +CD +S GV+L E+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223
Query: 1007 LTGRAP 1012
L G P
Sbjct: 224 LYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 65/249 (26%), Positives = 123/249 (49%), Gaps = 24/249 (9%)
Query: 811 FDERFVIGRGACGTVYRAVLRT-GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN 869
D IG G+ G V A +++ G VAVKK+ ++ + E++ + +H N
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHEN 78
Query: 870 IVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
+V++Y Y G L ++ E++ G+L +++ + ++ + + L + LS LH
Sbjct: 79 VVEMYN-SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAIAGSYGYIAPEYAY 986
+ HRDIKS++ILL + DFG + ++P+ KS+ G+ ++APE
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPELIS 189
Query: 987 TMKVTEKCDIYSYGVVLLELLTGRAPV---QPLDQ----GGDLVTWVRNFIRNNSLVSGM 1039
+ + DI+S G++++E++ G P PL +L ++N + + + G
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGF 249
Query: 1040 LDARLNLQD 1048
LD RL ++D
Sbjct: 250 LD-RLLVRD 257
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 8e-14
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G GA G V A TG VA+KK+ ++R E+ L +RH NI+ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFM--IALGAAEGLSYLHHDCKPRI 933
++ Y LG LH ++ + +F+ GL Y+H +
Sbjct: 77 IFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---SAGV 129
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTE 992
HRD+K +NIL+++ + + DFGLA+ Q M+ + Y APE T K
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLAR----IQDPQMTGYVSTRYYRAPEIMLTWQKYDV 185
Query: 993 KCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023
+ DI+S G + E+L G+ PL G D V
Sbjct: 186 EVDIWSAGCIFAEMLEGK----PLFPGKDHV 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 23/221 (10%)
Query: 817 IGRGACGTVYRAVLRTGHT---VAVKKLASNREGNNNVDNSFRAEILTLGKIRHR----N 869
+G G G V + V + VA+K L + E S R E++ +I H+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE------KSVRDEMMREAEIMHQLDNPY 56
Query: 870 IVKLYGFCYHQGSNLLMYEYMAR-GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
IV++ G C + L++ MA G L + L G + + + G+ YL
Sbjct: 57 IVRMIGVC--EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE-- 112
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY--GYIAPEYAY 986
HRD+ + N+LL ++ A + DFGL+K + S + AG + + APE
Sbjct: 113 -GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 987 TMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWV 1026
K + + D++SYG+ + E + G+ P + + +G ++++++
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFI 211
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-13
Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 24/198 (12%)
Query: 832 TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY--GFCYHQGSNLL--MY 887
TGH VA+K L ++ + FR E ++ H NIV L G LL ++
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAVF 58
Query: 888 EYMARGSLGELL--HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL 945
EY+ +L E+L GA + R M L + L+ H+ I HRD+K NI++
Sbjct: 59 EYVPGRTLREVLAADGALPAGE-TGRLM--LQVLDALACAHNQ---GIVHRDLKPQNIMV 112
Query: 946 ---DDKFEAHVGDFGL------AKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDI 996
+ A V DFG+ + D+ + + G+ Y APE VT D+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 997 YSYGVVLLELLTGRAPVQ 1014
Y++G++ LE LTG+ VQ
Sbjct: 173 YAWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR----NIV 871
+G+G G+VY+ + R TG T+A+K++ + ++ F I+ L I H+ IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-----ESKFNQIIMEL-DILHKAVSPYIV 62
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELLHGASST--LDWQTRFMIALGAAEGLSYLHHDC 929
YG + +G+ + EYM GSL +L G +T + I +GL +L +
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMK 989
I HRD+K N+L++ + + DFG++ ++ S + + I G Y+APE +
Sbjct: 123 N--IIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNI-GCQSYMAPERIKSGG 177
Query: 990 VTE------KCDIYSYGVVLLELLTGRAPVQP 1015
+ + D++S G+ +LE+ GR P P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-13
Identities = 37/84 (44%), Positives = 50/84 (59%)
Query: 546 LTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNL 605
L G IP +I + LQ ++LS N G +P +GS+ LE+L LS N +GSIP +G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 606 SRLTELQMGGNSFSGGIPAELGSL 629
+ L L + GNS SG +PA LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 76/253 (30%), Positives = 108/253 (42%), Gaps = 64/253 (25%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR--TGHTVAVKKLASN----REGNNNVDNSFRAEILTL 862
D+F+ VIGRGA G V R V + TGH A+KKL + +E +V RAE L
Sbjct: 1 DDFESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHV----RAERDIL 55
Query: 863 GKIRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMI-----AL 916
+ + +VKLY + + + L L+ EY+ G + LL + + +TRF I A+
Sbjct: 56 AEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAI 114
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK---------------- 960
+ L Y+H RDIK +N+LLD K + DFGL
Sbjct: 115 DSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165
Query: 961 --------VIDMPQSKSMSA-------------IAGSYGYIAPEYAYTMKVTEKCDIYSY 999
I P S A G+ YIAPE ++CD +S
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225
Query: 1000 GVVLLELLTGRAP 1012
GV++ E+L G P
Sbjct: 226 GVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 2e-13
Identities = 68/232 (29%), Positives = 99/232 (42%), Gaps = 53/232 (22%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNS-------FRAEILTLGKIRH 867
IG GA G V AV RTG VA+KK+ +NV + R EI L +RH
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILR-EIKLLRHLRH 58
Query: 868 RNIVKLYGFCYHQGSN-----LLMYEYMARGSLGELLHGASSTLDWQTRFMI--ALGAAE 920
NI+ L ++ E M L +++ D ++ + L
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQIL---R 114
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--MSAIAGSY- 977
GL YLH + HRD+K +NIL++ + + DFGLA+ +D + + ++ Y
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT----EYV 167
Query: 978 ---GYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD 1021
Y APE YT + DI+S G + ELLT + PL G D
Sbjct: 168 VTRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK----PLFPGRD 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 64/242 (26%), Positives = 99/242 (40%), Gaps = 52/242 (21%)
Query: 809 DNFDERFV-----IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRA----- 857
+ ER++ +G G G V +A TG VA+KK+ E +N+V +
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCG 62
Query: 858 -------EILTLGKIRHRNIVKLYG-FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQ 909
E+ + +I+H NI+ L + NL+M + MA +L +D +
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVM-DIMA----SDL----KKVVDRK 113
Query: 910 TRFM------IALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA---- 959
R I L GL+ LH K HRD+ NI ++ K + DFGLA
Sbjct: 114 IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYG 170
Query: 960 ---------KVIDMPQSKSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTG 1009
K M + + M++ + Y APE K D++S G + ELLTG
Sbjct: 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
Query: 1010 RA 1011
+
Sbjct: 231 KP 232
|
Length = 335 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 48/224 (21%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKK--LASNREGNNNVDNSFRAEILTLGKIRHRNIVKL 873
IG G G VY+ +TG VA+KK L S EG V ++ EI L +++H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG---VPSTAIREISLLKELQHPNIVCL 64
Query: 874 YGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGL------SYLHH 927
+ L++E++ ++D + +++ +L + + SYL+
Sbjct: 65 QDVLMQESRLYLIFEFL--------------SMDLK-KYLDSLPKGQYMDAELVKSYLYQ 109
Query: 928 D------C-KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI 980
C R+ HRD+K N+L+D+K + DFGLA+ +P + + Y
Sbjct: 110 ILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLW-YR 168
Query: 981 APEY-----AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
APE Y+ V DI+S G + E+ T + PL G
Sbjct: 169 APEVLLGSPRYSTPV----DIWSIGTIFAEMATKK----PLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 816 VIGRGACGTVYRAVLRTGH----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
VIG G G V L+ VA+K L + D F +E +G+ H NI+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD--FLSEASIMGQFDHPNII 68
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELL--HGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
L G +++ EYM GSL L H T+ Q M+ G A G+ YL
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV-IQLVGMLR-GIASGMKYL---S 123
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG--YIAPEYAYT 987
HRD+ + NIL++ V DFGL++V++ + + G + APE
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 988 MKVTEKCDIYSYGVVLLELLT-GRAP 1012
K T D++SYG+V+ E+++ G P
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 56/205 (27%), Positives = 105/205 (51%), Gaps = 17/205 (8%)
Query: 813 ERFV-IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
E ++ IG G+ G V A + +G VAVK + ++ + E++ + +H+N+
Sbjct: 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVIMRDYQHQNV 80
Query: 871 VKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
V++Y Y G L ++ E++ G+L +++ + + L+ + + + L YLH
Sbjct: 81 VEMYK-SYLVGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLHSQ- 136
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAIAGSYGYIAPEYAYT 987
+ HRDIKS++ILL + DFG I D+P+ KS+ G+ ++APE
Sbjct: 137 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPYWMAPEVISR 191
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAP 1012
+ DI+S G++++E++ G P
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 46/221 (20%)
Query: 817 IGRGACGTVYRAVLRTGHT---VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKL 873
IGRG G VY+A + G A+KK ++E + S EI L +++H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 874 YGFCYH--QGSNLLMYEYMARGSLGELLHGASST------------LDWQTRFMIALGAA 919
S L+++Y A L +++ L WQ
Sbjct: 68 VEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI--------L 118
Query: 920 EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMPQSKSMSAIAG 975
G+ YLH + + HRD+K NIL+ + +GD GLA++ + P K ++ +
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-LKPLADLDP 174
Query: 976 ---SYGYIAPEYA-----YTMKVTEKCDIYSYGVVLLELLT 1008
+ Y APE YT + DI++ G + ELLT
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-13
Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 835 TVAVKKLASNREGNNNVDNSFRAEILTL-GKIRHRNIVKLYGFCYHQGSNLLMYEYMARG 893
TVAVK L + + D E++ + GK H+NI+ L G C G ++ EY ++G
Sbjct: 46 TVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKG 103
Query: 894 SLGELLHG---------------ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDI 938
+L E L L ++ A A G+ YL + HRD+
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDL 160
Query: 939 KSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIY 997
+ N+L+ + + DFGLA+ V ++ K + ++APE + T + D++
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220
Query: 998 SYGVVLLELLT-GRAP 1012
S+GV+L E+ T G +P
Sbjct: 221 SFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-13
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G GA G+V A +TG VAVKKL+ + + ++R E+ L ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 876 F-----CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
+ +++ + ++ L ++ T D +F+I GL Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQFLI-YQILRGLKYIH---S 138
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT-MK 989
I HRD+K +N+ +++ E + DFGLA+ D M+ + Y APE M
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMH 194
Query: 990 VTEKCDIYSYGVVLLELLTGR 1010
+ DI+S G ++ ELLTGR
Sbjct: 195 YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 41/226 (18%)
Query: 816 VIGRGACGTVYRAVL-----RTGHT-VAVKKLASNREGNNNVD-NSFRAEILTLGKIRHR 868
+G G G V +A R G+T VAVK L +E ++ + +E L ++ H
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHP 63
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSL---------------GELLHGASSTLDWQTRFM 913
+++KLYG C G LL+ EY GSL G + SS LD
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 914 IALG--------AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--- 962
+ +G + G+ YL + ++ HRD+ + N+L+ + + + DFGL++ +
Sbjct: 124 LTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 963 DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 1008
D +S I ++A E + T + D++S+GV+L E++T
Sbjct: 181 DSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG G G VY+A R T T+A+KK+ +E + R EI L +++H NIV+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQD 68
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTR------FMIALGAAEGLSYLHHDC 929
+ + L++EY+ +L S+ D+ ++ + G++Y H
Sbjct: 69 VVHSEKRLYLVFEYLDL----DLKKHMDSSPDFAKNPRLIKTYLYQI--LRGIAYCHSH- 121
Query: 930 KPRIFHRDIKSNNILLDDKFEA-HVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE----- 983
R+ HRD+K N+L+D + A + DFGLA+ +P ++ + + Y APE
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-VRTFTHEVVTLWYRAPEILLGS 178
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLD 1017
Y+ V DI+S G + E++ + P+ P D
Sbjct: 179 RHYSTPV----DIWSVGCIFAEMVNQK-PLFPGD 207
|
Length = 294 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 816 VIGRGACGTVYRAVLRTGH---------TVAVKKLASNREGNNNVDNSFRAEILTLGKI- 865
+G GA G V A T + VAVK L +S R +++ KI
Sbjct: 42 TLGAGAFGKVVEA---TAYGLSKSDAVMKVAVKMLKPT------AHSSEREALMSELKIM 92
Query: 866 ----RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLH-GASSTLDWQTRFMIALGAAE 920
H NIV L G C G L++ EY G L L S L + + A+
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 921 GLSYL-HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS--- 976
G+++L +C HRD+ + N+LL + DFGLA+ I + S + G+
Sbjct: 153 GMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDI---MNDSNYVVKGNARL 205
Query: 977 -YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 1008
++APE + T + D++SYG++L E+ +
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 7/204 (3%)
Query: 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN 869
F + V+G+G G V +R TG A K+L R ++ E L K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 870 IVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
+V L + Y L L+ M G L ++ + + R + AAE L L
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY--AAEILCGLEDL 118
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM 988
+ +RD+K NILLDD + D GLA + +P+ +S+ G+ GY+APE
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQ 176
Query: 989 KVTEKCDIYSYGVVLLELLTGRAP 1012
+ T D + G ++ E++ G++P
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-13
Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 13/208 (6%)
Query: 816 VIGRGACGTV-YRAVLRTGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKIRHRNIVKL 873
V+G GA GTV + G AVK + + EG + D N +AE+ L +IVK
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVV--DMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 874 Y-GFCYHQGSN-------LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYL 925
+ F N L+ +Y G L + + + T L + L +
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156
Query: 926 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS-AIAGSYGYIAPEY 984
HH + HRDIKS NILL +GDFG +K+ S + G+ Y+APE
Sbjct: 157 HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
++K D++S GV+L ELLT + P
Sbjct: 217 WRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G G G V+ A VAVK + + G+ +V+ +F AE + ++H +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVE-AFLAEANVMKTLQHDKLVKLHAV 69
Query: 877 CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGA--AEGLSYLHHDCKPRIF 934
+ ++ E+MA+GSL + L + +I A AEG++++ +
Sbjct: 70 VTKE-PIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIE---QRNYI 124
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
HRD+++ NIL+ + DFGLA+VI+ + + + APE T K
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 995 DIYSYGVVLLELLT-GRAP 1012
D++S+G++L+E++T GR P
Sbjct: 185 DVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 9e-13
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 9/202 (4%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
V+G+G G V +R TG A KKL R + E L K+ R +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 65
Query: 875 GFCYHQGSNL-LMYEYMARGSLG-ELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
+ Y L L+ M G L + + + D + A GL LH + R
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---R 122
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
I +RD+K NILLDD + D GLA +++P+ +++ G+ GY+APE + T
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180
Query: 993 KCDIYSYGVVLLELLTGRAPVQ 1014
D + G ++ E++ G++P +
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 59/206 (28%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAE--ILTLGKIRHRNIVKL 873
+G+G G V+ A + TG VA+K++ + N E ILT K +VKL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVKL 66
Query: 874 YGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMI-----ALGAAEGLSYLHH 927
+ + L L EY+ G LL+ + RF + A+ A L Y+H
Sbjct: 67 L-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHR 125
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAIAGSYGYIAPEYAY 986
D KP N L+D + DFGL+K ++ S + GS Y+APE
Sbjct: 126 DLKP---------ENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLR 171
Query: 987 TMKVTEKCDIYSYGVVLLELLTGRAP 1012
D +S G +L E L G P
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 7/194 (3%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
++G+G G V++ L+ VAVK + + F +E L + H NIVKL G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIG 59
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH-HDCKPRIF 934
C + ++ E + G L L + AL AA G++YL +C
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC----I 115
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
HRD+ + N L+ + + DFG+++ D S + APE + + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 995 DIYSYGVVLLELLT 1008
D++SYG++L E +
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 811 FDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI 865
R+ IG GA G V A+ R+G VA+KK+ + + R E+ L
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHF 61
Query: 866 RHRNIVKLYGFCYHQGSNL----LMYEYMARGSLGELLHGASS-TLDWQTRFMIALGAAE 920
+H NI+ + G++ ++ + M L ++H T + F+ L
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQL--LR 118
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS---MSAIAGSY 977
GL Y+H + HRD+K +N+L+++ E +GDFG+A+ + ++ M+ +
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 978 GYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQP 1015
Y APE ++ + T D++S G + E+L GR + P
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFP 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 38/220 (17%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKL 873
V+G G G VY+ ++TG A+K + + + + + EI L K HRNI
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVM----DVTEDEEEEIKLEINMLKKYSHHRNIATY 78
Query: 874 YGFCY------HQGSNLLMYEYMARGSLGELLH---GASSTLDWQTRFMIALGAAEGLSY 924
YG H L+ E+ GS+ +L+ G + DW I GL++
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAH 136
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE- 983
LH ++ HRDIK N+LL + E + DFG++ +D + + I Y ++APE
Sbjct: 137 LHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY-WMAPEV 192
Query: 984 ----------YAYTMKVTEKCDIYSYGVVLLELLTGRAPV 1013
Y Y + DI+S G+ +E+ G P+
Sbjct: 193 IACDENPDATYDY------RSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 10/201 (4%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G TVY+ + T + VA+K++ E + E+ L ++H NIV L+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ + S L++EY+ + L + L ++++ + GL+Y H + ++ H
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLH 127
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY-TMKVTEKC 994
RD+K N+L++++ E + DFGLA+ +P +K+ S + Y P+ + + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIP-TKTYSNEVVTLWYRPPDILLGSTDYSTQI 186
Query: 995 DIYSYGVVLLELLTGRAPVQP 1015
D++ G + E+ TGR P+ P
Sbjct: 187 DMWGVGCIFYEMSTGR-PLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-12
Identities = 68/220 (30%), Positives = 105/220 (47%), Gaps = 48/220 (21%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLA---SNREGNNNVDNSFRAEILTLGKIR-HRNIV 871
+G+GA G V++A+ RT VA+KK+ N + +FR EI+ L ++ H NIV
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA---TDAQRTFR-EIMFLQELGDHPNIV 70
Query: 872 KLYGFCYHQGSN----LLMYEYMARGSLGEL-LHG---ASSTLDWQTRFMI--ALGAAEG 921
KL + N L++EYM E LH A+ D R+++ L A
Sbjct: 71 KLLNV--IKAENDKDIYLVFEYM------ETDLHAVIRANILEDVHKRYIMYQLLKA--- 119
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-MPQSKSMSA----IAGS 976
L Y+H + HRD+K +NILL+ + DFGLA+ + + ++ +A
Sbjct: 120 LKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 977 YGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRA 1011
+ Y APE YT V D++S G +L E+L G+
Sbjct: 177 W-YRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNRE-GNNNVDNSF-RAEILTLGKIRHRNIVK 872
V+G+G+ G V A L+ T A+K L + +++V+ + +L L H +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTH 60
Query: 873 LYGFCYHQGSNLLMY--EYMARGSLGELLHGASSTLDW---QTRFMIALGAAE---GLSY 924
L FC Q L + EY+ + G+L+ S+ + + RF AAE GL +
Sbjct: 61 L--FCTFQTKEHLFFVMEYL---NGGDLMFHIQSSGRFDEARARFY----AAEIICGLQF 111
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
LH K I +RD+K +N+LLD + DFG+ K +M S G+ YIAPE
Sbjct: 112 LH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEI 167
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
K E D +S+GV+L E+L G++P
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G+ TVY+ + R G VA+K ++ E V + E L ++H NIV L+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTR-FMIALGAAEGLSYLHHDCKPRIF 934
+ + + ++EYM ++ + R FM L GL+Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL--LRGLAYIHGQ---HIL 125
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY-TMKVTEK 993
HRD+K N+L+ E + DFGLA+ +P S++ S+ + Y P+ +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIP-SQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 994 CDIYSYGVVLLELLTGRAPVQP 1015
DI+ G + +E+L G+ P P
Sbjct: 185 LDIWGAGCIFIEMLQGQ-PAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLY 874
IG+G G V++ + + G AVK L + +++D AE L + H N+VK Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL----DPIHDIDEEIEAEYNILKALSDHPNVVKFY 81
Query: 875 GFCYHQ----GSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
G Y + G L L+ E GS+ +L+ G + +IA E L L H
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY----- 984
+ HRD+K NNILL + + DFG++ + + + +++ G+ ++APE
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 200
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPL 1016
+CD++S G+ +EL G P+ L
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY- 874
+G GA G+V A+ RTG VA+KKL+ + ++R E+ L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 875 ----GFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
+ + L+ YM + L +++ S + + ++++ GL Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLS--EDKVQYLV-YQMLCGLKYIH--- 134
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT-M 988
I HRD+K N+ +++ E + DFGLA+ D M+ + Y APE M
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILNWM 190
Query: 989 KVTEKCDIYSYGVVLLELLTGR 1010
+ DI+S G ++ E+LTG+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 69/287 (24%), Positives = 114/287 (39%), Gaps = 38/287 (13%)
Query: 816 VIGRGACGTVYRAVLRTGHT----VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
++G G G+V L VAVK + + + ++ F +E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEE-FLSEAACMKDFDHPNVM 64
Query: 872 KLYGFCYHQGSN------LLMYEYMARGSLGELL-----HGASSTLDWQTRFMIALGAAE 920
KL G C+ S +++ +M G L L G L QT + A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAG-SYGY 979
G+ YL + HRD+ + N +L + V DFGL+K I IA +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 980 IAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038
IA E T K D++++GV + E+ T G+ P P + ++ ++R+
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY-PGVENHEIYDYLRH---------- 230
Query: 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
RL Q E + + + C P DRPT ++ +L
Sbjct: 231 --GNRLK-QPEDCLDE---LYDLMYSCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-12
Identities = 66/222 (29%), Positives = 91/222 (40%), Gaps = 22/222 (9%)
Query: 802 KDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAE--- 858
L + ++FD VIGRGA G V ++ V KL S E D++F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 859 ILTLGKIRHRN---IVKLYGFCYHQGSNLLM-YEYMARGSLGELLHGASSTLDWQTRFMI 914
I+ H N IV+L+ + + L M EYM G L L+ W RF
Sbjct: 96 IMA-----HANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW-ARFYT 148
Query: 915 ALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA 974
A L +H HRD+K +N+LLD + DFG +D
Sbjct: 149 A-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204
Query: 975 GSYGYIAPEYAYTMKVT----EKCDIYSYGVVLLELLTGRAP 1012
G+ YI+PE + +CD +S GV L E+L G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRA----EILTL 862
NF IG+G VY+A+ L G VA+KK+ + +D R EI L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV----QIFEMMDAKARQDCLKEIDLL 56
Query: 863 GKIRHRNIVKLY-GFCYHQGSNLLMYEYMARGSLGELLHGASS---TLDWQTRFMIALGA 918
++ H N++K F + N+++ E G L ++ + +T + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVL-ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA--IAGS 976
L ++H RI HRDIK N+ + +GD GL + SK+ +A + G+
Sbjct: 116 CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGT 169
Query: 977 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y++PE + K DI+S G +L E+ ++P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 49/280 (17%)
Query: 816 VIGRGACGTVYRAVLRT-GHTVAVKKL----ASNREGNNNVDNSFRAEILTLGKIRHRNI 870
V+G+G+ G V RT G +KKL AS RE + E L +++H NI
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRE-----RKAAEQEAQLLSQLKHPNI 61
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHG----------ASSTLDWQTRFMIALGAAE 920
V Y + +G + L+Y M G+L H + ++W + +AL
Sbjct: 62 V-AYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL---- 115
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI 980
YLH I HRD+K+ N+ L VGD G+A+V++ Q S + G+ Y+
Sbjct: 116 --QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYM 169
Query: 981 APEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040
+PE K D+++ G + E+ T + D NSLV ++
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--------------NSLVYRII 215
Query: 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV 1080
+ +L + + ++ ML P RP+++ ++
Sbjct: 216 EGKLPPMPKDYSPELGELIA-TMLSKR--PEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 816 VIGRGACGTVY--RAVLRT--GHTVAVKKLASNREGNNNVDNSFRA--EILTLGKIRHRN 869
V+G+G+ G V+ R + G A+K L ++ V + R E L ++ H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVL---KKATLKVRDRVRTKMERDILAEVNHPF 59
Query: 870 IVKL-YGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
IVKL Y F +G L+ +++ G L L + +F +A A L +LH
Sbjct: 60 IVKLHYAF-QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLH-- 115
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAIAGSYGYIAPEYAYT 987
I +RD+K NILLD++ + DFGL+K ID K + G+ Y+APE
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNR 172
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018
T+ D +S+GV++ E+LTG P Q D+
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDR 203
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-12
Identities = 67/227 (29%), Positives = 99/227 (43%), Gaps = 35/227 (15%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG GA G V+ R G VA+KK+ + + + FR E+ L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHG---------ASSTLDWQTRFMIALGAAEGLSYLH 926
Q ++ +E + + EL+ + D F+ + GL YLH
Sbjct: 67 IL--QPPHIDPFEEIY--VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQI--LRGLKYLH 120
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYA- 985
I HRDIK N+L++ + DFGLA+V + +SK M+ + Y APE
Sbjct: 121 ---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177
Query: 986 ----YTMKVTEKCDIYSYGVVLLELLTGR------APVQPLDQGGDL 1022
YT V DI+S G + ELL R +P+Q LD DL
Sbjct: 178 GSRHYTSAV----DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDL 220
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAE---ILTLGKIRHRNIV 871
V+GRG G V A + TG A+K L + S E T RH +V
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 872 KLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDW-QTRFMIALGAAE---GLSYLH 926
L+ C+ ++ + EY A G L ++H + + F AA GL YLH
Sbjct: 66 NLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFY----AACVVLGLQYLH 118
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY 986
+ +I +RD+K +N+LLD + + DFGL K M S G+ ++APE
Sbjct: 119 ---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFGDRTSTFCGTPEFLAPEVLT 174
Query: 987 TMKVTEKCDIYSYGVVLLELLTGRAP 1012
T D + GV++ E+L G +P
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 10/201 (4%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G TV++ + T + VA+K++ E + E+ L ++H NIV L+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ + L++EY+ L + L + + + GLSY H +I H
Sbjct: 71 IIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILH 126
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY-TMKVTEKC 994
RD+K N+L+++K E + DFGLA+ +P +K+ S + Y P+ + + +
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 995 DIYSYGVVLLELLTGRAPVQP 1015
D++ G +L E+ TGR P+ P
Sbjct: 186 DMWGVGCILYEMATGR-PMFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
D+ + +G G G V+ R + H A+K +A + E L ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 868 RNIVKLYGFCYHQGSNLLM-YEYMARGSLGELLHGASSTLDWQTRFMIALGAAE---GLS 923
I++L+ + H L M EY+ G L L + + F A+E L
Sbjct: 61 PFIIRLF-WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY----ASEIVCALE 115
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAIAGSYGYIAP 982
YLH I +RD+K NILLD + + DFG AK + D + + G+ Y+AP
Sbjct: 116 YLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPEYLAP 167
Query: 983 EYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
E + + D ++ G+++ E+L G P
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 817 IGRGACGTVYRAVLRTGHT-VAVKKLASNREG-NNNVDNSFRAEILTLGKIRHRNIVKLY 874
IGRG G V+ LR +T VAVK S RE ++ F E L + H NIV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK---SCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
G C + ++ E + G L L + + AA G+ YL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEYAYTMK 989
HRD+ + N L+ +K + DFG+++ + + A G I APE +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 990 VTEKCDIYSYGVVLLELLT-GRAP 1012
+ + D++S+G++L E + G P
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVP 196
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 68/273 (24%), Positives = 105/273 (38%), Gaps = 48/273 (17%)
Query: 836 VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL 895
VAVK L + ++N F E+ L ++ NI +L G C ++ EYM G L
Sbjct: 49 VAVKVLRPD--ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 896 GELLHGA----------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF-HRDIKSNNIL 944
+ L S +L + T +A A G+ YL + F HRD+ + N L
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL----ESLNFVHRDLATRNCL 162
Query: 945 LDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----------APEYAYTMKVTEK 993
+ + + DFG+ S + + Y + A E K T K
Sbjct: 163 VGKNYTIKIADFGM----------SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK 212
Query: 994 CDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052
D++++GV L E+LT R QP + D V I N ++ L
Sbjct: 213 SDVWAFGVTLWEILTLCRE--QPYEHLTD--QQV---IENAGHFFRDDGRQIYLPRPPNC 265
Query: 1053 SHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ ++ + C DRPT RE+ L L
Sbjct: 266 PK--DIYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKL 873
++G G G VY+ ++TG A+K + + + + + EI L K HRNI
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVM----DVTGDEEEEIKQEINMLKKYSHHRNIATY 68
Query: 874 YG-FCYHQGSNL-----LMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLH 926
YG F + L+ E+ GS+ +L+ +TL + I GLS+LH
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 128
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY 986
++ HRDIK N+LL + E + DFG++ +D + + I Y ++APE
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY-WMAPEVIA 184
Query: 987 TMKVTE-----KCDIYSYGVVLLELLTGRAPV 1013
+ + K D++S G+ +E+ G P+
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 74/292 (25%), Positives = 119/292 (40%), Gaps = 44/292 (15%)
Query: 816 VIGRGACGTVYRAV-LRTGHT----VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
V+G GA GTVY+ + + G VA+K L N N E + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPYV 71
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLH------GASSTLDWQTRFMIALGAAEGLSY 924
+L G C L+ + M G L + + G+ L+W + A+G+SY
Sbjct: 72 CRLLGICLTSTVQLVT-QLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSY 124
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY--GYIAP 982
L + R+ HRD+ + N+L+ + DFGLA+++D+ + A G ++A
Sbjct: 125 LE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE-TEYHADGGKVPIKWMAL 180
Query: 983 EYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041
E + T + D++SYGV + EL+T G P + R + +L+
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--------ARE-------IPDLLE 225
Query: 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHF 1093
L + I V I + C I RP RE+V S R F
Sbjct: 226 KGERLPQPPICT--IDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRF 275
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-12
Identities = 67/220 (30%), Positives = 100/220 (45%), Gaps = 24/220 (10%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRA--EILTLGKIRHRNIVK 872
VIG+G+ G V A+ TG VA+KK+ E +V ++ R EI L +RH +IV+
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVE 63
Query: 873 LYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTR-----FMIALGAAEGLSYLHH 927
+ Y+ + LH D T F+ L L Y+H
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQL--LRALKYIH- 120
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAIAGSYGYIAPEY- 984
+FHRD+K NIL + + + DFGLA+V D P + + + Y APE
Sbjct: 121 --TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 985 -AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023
++ K T DI+S G + E+LTG+ PL G ++V
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGK----PLFPGKNVV 214
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 817 IGRGACGTVYRA-VLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLY 874
IG G V +A +TG A+K + + + V+N EI L ++ H NI++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL--REIQALRRLSPHPNILRLI 64
Query: 875 GFCYHQ--GSNLLMYEYMARGSLGELLHGASSTLDWQT--RFMIALGAAEGLSYLHHDCK 930
+ + G L++E M +L EL+ G L + +M L + L ++H +
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL--LKSLDHMHRN-- 119
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKV 990
IFHRDIK NIL+ D + DFG + I + I+ + Y APE T
Sbjct: 120 -GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYT-EYISTRW-YRAPECLLTDGY 175
Query: 991 -TEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
K DI++ G V E+L+ + PL G
Sbjct: 176 YGPKMDIWAVGCVFFEILS----LFPLFPG 201
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 25/206 (12%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRA--EILTLGKIRHRNIVK 872
+G G+ TVY+ + TG VA+K++ E F A E L ++H NIV
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA----PFTAIREASLLKDLKHANIVT 67
Query: 873 LYGFCYHQGSNLLMYEYMARGSLGELL--HGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
L+ + + + L++EY+ L + + G ++ F+ L GL+Y H
Sbjct: 68 LHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQL--LRGLAYCHQR-- 122
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY-----A 985
R+ HRD+K N+L+ ++ E + DFGLA+ +P SK+ S + Y P+
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLARAKSVP-SKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 986 YTMKVTEKCDIYSYGVVLLELLTGRA 1011
Y+ + D++ G + E+ TGR
Sbjct: 181 YSTSL----DMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 9e-12
Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVK----KLASNREGNNNVDNSFRAEILTLGKI-RHRNI 870
+G G G+VY A + TG VA+K K S E N R E+ +L K+ H NI
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-----LR-EVKSLRKLNEHPNI 60
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELL-HGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
VKL ++EYM G+L +L+ I +GL+++H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS---AIAGSYGYIAPEY-- 984
K FHRD+K N+L+ + DFGLA+ I +S + Y APE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREI-----RSRPPYTDYVSTRWYRAPEILL 171
Query: 985 ---AYTMKVTEKCDIYSYGVVLLELLTGR 1010
+Y+ V DI++ G ++ EL T R
Sbjct: 172 RSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 11/206 (5%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
+G GA G VY+A + +A K+ + D + EI L H NIVKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED--YMVEIDILASCDHPNIVKLLDA 70
Query: 877 CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHR 936
Y++ + ++ E+ A G++ ++ L ++ E L+YLH + +I HR
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 937 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE---- 992
D+K+ NIL + + DFG++ + S I Y ++APE +
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRPYD 186
Query: 993 -KCDIYSYGVVLLELLTGRAPVQPLD 1017
K D++S G+ L+E+ P L+
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 74/293 (25%), Positives = 126/293 (43%), Gaps = 46/293 (15%)
Query: 811 FDERFVIGRGACGTVYRAV-LRTGHT----VAVKKLASNREGNN-NVDNSFRAEILTLGK 864
F + V+G GA GTVY+ + + G VA+K+L RE + + E +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVMAS 65
Query: 865 IRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLH------GASSTLDWQTRFMIALGA 918
+ + ++ +L G C L+ + M G L + + G+ L+W +
Sbjct: 66 VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 118
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY- 977
A+G++YL + R+ HRD+ + N+L+ + DFGLAK++ + K A G
Sbjct: 119 AKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE-KEYHAEGGKVP 174
Query: 978 -GYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSL 1035
++A E T + D++SYGV + EL+T G P + S
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---------------SE 219
Query: 1036 VSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088
+S +L+ L + I V I + C I RP RE+++ S+ R
Sbjct: 220 ISSILEKGERLPQPPICT--IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 78/293 (26%), Positives = 123/293 (41%), Gaps = 53/293 (18%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG G+ G V++ R TG VA+KK + + + R EI L +++H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR-EIRMLKQLKHPNLVNLIE 67
Query: 876 FCYHQGSNLLMYEYMARGSLGEL---LHGASS----TLDWQTRFMIALGAAEGLSYLH-H 927
+ L++EY L EL G + WQT + +++ H H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT--------LQAVNFCHKH 119
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY--- 984
+C HRD+K NIL+ + + + DFG A+++ P +A + Y APE
Sbjct: 120 NC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW-YRAPELLVG 174
Query: 985 --AYTMKVTEKCDIYSYGVVLLELLTGRAPVQP----LDQ-------GGDLVTWVRNFIR 1031
Y V D+++ G V ELLTG P+ P +DQ GDL+ +
Sbjct: 175 DTQYGPPV----DVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229
Query: 1032 NNSLVSGML----DARLNLQD--EKTVSHMITVLKIAMLCTNISPFDRPTMRE 1078
N G+ + R L+ S ++ LK C + P +R + E
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKG---CLQMDPTERLSCEE 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 17/193 (8%)
Query: 835 TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGS 894
TVAVK L + + D E++ + +H+NI+ L G C G ++ EY ++G+
Sbjct: 49 TVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGN 107
Query: 895 LGELLHGASSTLDWQTRFMIALGAAEGLSY-------------LHHDCKPRIFHRDIKSN 941
L E L A + + IA E +++ + + + HRD+ +
Sbjct: 108 LREYLR-ARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166
Query: 942 NILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYG 1000
N+L+ + + DFGLA+ V ++ K + ++APE + T + D++S+G
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 1001 VVLLELLT-GRAP 1012
V++ E+ T G +P
Sbjct: 227 VLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSF-----RAEILTLGKIRHRN 869
V+G+G+ G V A L+ T AVK L ++ D+ +L L +H
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVL---KKDVILQDDDVECTMTEKRVLALAG-KHPF 57
Query: 870 IVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE---GLSYL 925
+ +L+ C+ L + EY+ G L + + + + RF AAE GL +L
Sbjct: 58 LTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY----AAEIVLGLQFL 112
Query: 926 HHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
H + I +RD+K +N+LLD E H+ DFG+ K + + S G+ YIAPE
Sbjct: 113 H---ERGIIYRDLKLDNVLLDS--EGHIKIADFGMCKE-GILGGVTTSTFCGTPDYIAPE 166
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
D ++ GV+L E+L G++P
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 83/284 (29%), Positives = 134/284 (47%), Gaps = 35/284 (12%)
Query: 110 SFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKE 169
+ +P + SL++L+ + + L NL L L++ NR+ E
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSPSGISSL-DGSENLLNLLPLPSLDLNLNRLRS-NISE 111
Query: 170 IGKLSALSQLVAYSNNISGSLPPTLGNLK-RLKSFRAGQNLISGSLPSEIGGCESLQYLG 228
+ +L+ L+ L +NNI+ +PP +G LK LK N I SLPS + +L+ L
Sbjct: 112 LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD 169
Query: 229 LAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPK 288
L+ N LS ++PK + L L ++ L GN++S +P E+ ++LE L L +N + +L
Sbjct: 170 LSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLS 226
Query: 289 ELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLY 348
L ++ +L L + N+L +P IG LS+ +D S N ++S I L
Sbjct: 227 SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNN--------QISSISSLG--- 274
Query: 349 LFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNL 392
+L NL +LDLS NSL+ +PL L L
Sbjct: 275 ---------------SLTNLRELDLSGNSLSNALPLIALLLLLL 303
|
Length = 394 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRA-----EILTLGKIRHRNI 870
IGRGA G V A T VA+KK+A N DN A EI L + H N+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIA------NAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 871 VKLYGF----CYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYL 925
+ + +++ ++YE M L +++ + + D ++ + GL Y+
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFL-YQLLRGLKYI 124
Query: 926 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY- 984
H + HRD+K +N+LL+ + + DFGLA+ + M+ + Y APE
Sbjct: 125 H---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-EKGDFMTEYVVTRWYRAPELL 180
Query: 985 ----AYTMKVTEKCDIYSYGVVLLELLTGRAPVQP 1015
YT + D++S G + ELL GR P+ P
Sbjct: 181 LNCSEYTTAI----DVWSVGCIFAELL-GRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-11
Identities = 33/103 (32%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 443 LNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPI 502
L L+ L G IP +++ + L + L GNS G+ P L + +L ++L N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 503 PTEIGNCNALQRLHLSDNYFTGELPREVGN-LSNLVTFNVSSN 544
P +G +L+ L+L+ N +G +P +G L + +FN + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 3/136 (2%)
Query: 515 LHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGAL 574
L L + G +P ++ L +L + N+S N + G IP + S L+ LDLS+N F G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 575 PREIGSLFQLELLKLSENELSGSIPVQIGN-LSRLTELQMGGNSFSGGIPA--ELGSLSS 631
P +G L L +L L+ N LSG +P +G L N+ GIP G S
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLS 542
Query: 632 LQIALNLSYNNLSGLI 647
+ + +++ +
Sbjct: 543 VGAKIGIAFGVSVAFL 558
|
Length = 623 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR-----NI 870
+GRGA G V + TG +AVK++ + V++ + +L I R
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRAT------VNSQEQKRLLMDLDISMRSVDCPYT 62
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGEL-----LHGASSTLDWQTRFMIALGAAEGLSYL 925
V YG + +G + E M SL + G + D + IA+ + L YL
Sbjct: 63 VTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYL 119
Query: 926 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG--------LAKVIDMPQSKSMSAIAGSY 977
H + HRD+K +N+L++ + + DFG +AK ID AG
Sbjct: 120 HSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID----------AGCK 167
Query: 978 GYIAPE--------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y+APE Y + K D++S G+ ++EL TGR P
Sbjct: 168 PYMAPERINPELNQKGYDV----KSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 9/199 (4%)
Query: 817 IGRGACGTVYRA-VLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G+G G V V TG A KKL R + + E L K+ IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 876 FCYHQGSNL-LMYEYMARGSLG-ELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRI 933
+ + ++L L+ M G L + + L+ + + G+ +LH I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDI 116
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEK 993
+RD+K N+LLDD+ + D GLA +++ K+++ AG+ GY+APE +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 994 CDIYSYGVVLLELLTGRAP 1012
D ++ G + E++ GR P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 836 VAVKKLASNREGNNNVDNSFRAEILTL-GKIRHRNIVKLYGFCYHQGSNLLMYEYMARGS 894
VAVK L S+ + D E++ + GK H+NI+ L G C G ++ EY ++G+
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 895 LGELL---------------HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIK 939
L E L L ++ A A G+ YL + HRD+
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLA 167
Query: 940 SNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYS 998
+ N+L+ + + DFGLA+ I + K + ++APE + T + D++S
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 227
Query: 999 YGVVLLELLT-GRAP 1012
+GV+L E+ T G +P
Sbjct: 228 FGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 33/221 (14%)
Query: 814 RFV--IGRGACGTVYRAVL------RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI 865
RF+ +G G VY+ L VA+K L EG + F+ E + ++
Sbjct: 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP--LREEFKHEAMMRSRL 65
Query: 866 RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL---------------HGASSTLDWQT 910
+H NIV L G + +++ Y + L E L STL+
Sbjct: 66 QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 911 RFMIALGAAEGLSYL--HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQS 967
I A G+ +L HH H+D+ + N+L+ DK + D GL + V
Sbjct: 126 FVHIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYAADYY 180
Query: 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 1008
K M +++PE K + DI+SYGVVL E+ +
Sbjct: 181 KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 37/223 (16%)
Query: 814 RFV--IGRGACGTVYRAVL-----RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
RF+ +G A G +Y+ L VA+K L + F+ E + ++
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE--FQQEASLMAELH 65
Query: 867 HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL-----H---GAS--------STLDWQT 910
H NIV L G + +++EY+ +G L E L H G S S+LD
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 911 RFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP----- 965
IA+ A G+ YL H+D+ + NIL+ ++ + D GL++ I
Sbjct: 126 FLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182
Query: 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 1008
Q KS+ I ++ PE K + DI+S+GVVL E+ +
Sbjct: 183 QPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 22/222 (9%)
Query: 802 KDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILT 861
+ L + +++D VIGRGA G V ++ V KL S E D++F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 862 LGKIRHRN-IVKLYGFCYHQGSNLL--MYEYMARGSLGELLHGASSTLDWQTRF----MI 914
+ + +V+L FC Q L + EYM G L L+ W + ++
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL 153
Query: 915 ALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA 974
AL A + + HRD+K +N+LLD + DFG +D
Sbjct: 154 ALDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204
Query: 975 GSYGYIAPEYAYTMK----VTEKCDIYSYGVVLLELLTGRAP 1012
G+ YI+PE + +CD +S GV L E+L G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNRE-GNNNVDNSF-RAEILTLGKIRHRNIVK 872
++G+G+ G V+ A L+ T A+K L + +++V+ + +L+L H +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTH 60
Query: 873 LYGFCYHQGSNLLMY--EYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHDC 929
LY C Q L + EY+ G L + H S D A GL +LH
Sbjct: 61 LY--CTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLH--- 113
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMK 989
I +RD+K +NILLD + DFG+ K + +K+ G+ YIAPE K
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT-CTFCGTPDYIAPEILLGQK 172
Query: 990 VTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018
D +S+GV+L E+L G++P D+
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-11
Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 8/151 (5%)
Query: 858 EILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALG 917
E + L + H +++++ ++ + L L S L +I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 918 AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS-AIAGS 976
EGL YLH RI HRD+K+ NI ++D + +GD G A+ P +AG+
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ---FPVVAPAFLGLAGT 219
Query: 977 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 1007
APE K K DI+S G+VL E+L
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-11
Identities = 69/246 (28%), Positives = 103/246 (41%), Gaps = 53/246 (21%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR--TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
D+F+ VIGRGA G V R V + TGH A+K L RAE L +
Sbjct: 1 DDFESLKVIGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD 59
Query: 867 HRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMI-----ALGAAE 920
+VK++ + + NL L+ E++ G + LL + + T+F I A+ A
Sbjct: 60 GAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH 118
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA-------------KVIDMPQS 967
L ++H RDIK +N+LLD K + DFGL + P S
Sbjct: 119 QLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 968 ----KSMS-----------------AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLEL 1006
++M+ + G+ YIAPE + CD +S GV++ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 1007 LTGRAP 1012
L G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 66/202 (32%), Positives = 89/202 (44%), Gaps = 13/202 (6%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGK-IRHRNIVKL 873
VIG+G+ G V A + G AVK L AE L K ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 874 -YGFCYHQGSNLLMY--EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
Y F Q ++ L + +Y+ G L L S + + RF A A L YLH
Sbjct: 62 HYSF---QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---S 114
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKV 990
I +RD+K NILLD + + DFGL K + SK+ S G+ Y+APE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 991 TEKCDIYSYGVVLLELLTGRAP 1012
D + G VL E+L G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-11
Identities = 43/108 (39%), Positives = 64/108 (59%), Gaps = 6/108 (5%)
Query: 620 GGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLS 679
G IP ++ L LQ ++NLS N++ G IPP LG++ LE L L+ N +G IP S L+
Sbjct: 432 GFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 680 SLLGCNFSYNNLTGPIPSS---QTFQNMSVNSFSGSKGLCGGP-LQNC 723
SL N + N+L+G +P++ + S N F+ + GLCG P L+ C
Sbjct: 491 SLRILNLNGNSLSGRVPAALGGRLLHRASFN-FTDNAGLCGIPGLRAC 537
|
Length = 623 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 5e-11
Identities = 48/155 (30%), Positives = 71/155 (45%), Gaps = 26/155 (16%)
Query: 867 HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLH--GASSTLDWQTRFMIALGAAEGLSY 924
+ N +KLY ++L+ +Y+ G L +LL G S + + I E L+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA--EVKK-IIRQLVEALND 124
Query: 925 LHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
LH K I H DIK N+L D K ++ D+GL K+I P S G+ Y +PE
Sbjct: 125 LH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPE 176
Query: 984 ------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y + D ++ GV+ ELLTG+ P
Sbjct: 177 KIKGHNYDVSF------DWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-11
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G GA G+V A R VAVKKL+ + + ++R E+ L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81
Query: 876 FCYHQGSNLLMYE-YMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
S E Y+ +G L+ D +F+I GL Y+H
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI-YQLLRGLKYIH---SA 137
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT-MKV 990
I HRD+K +N+ +++ E + DFGLA+ D M+ + Y APE M
Sbjct: 138 GIIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWYRAPEIMLNWMHY 193
Query: 991 TEKCDIYSYGVVLLELLTGRA 1011
+ DI+S G ++ ELL G+A
Sbjct: 194 NQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 49/201 (24%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G TV++ + T + VA+K++ E + E+ L ++H NIV L+
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ S L++EY+ + L + + + + + GL+Y H + ++ H
Sbjct: 72 IVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLH 127
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY-TMKVTEKC 994
RD+K N+L++++ E + DFGLA+ +P +K+ S + Y P+ + + + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 995 DIYSYGVVLLELLTGRAPVQP 1015
D++ G + E+ +GR P+ P
Sbjct: 187 DMWGVGCIFFEMASGR-PLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-11
Identities = 31/85 (36%), Positives = 48/85 (56%)
Query: 467 LRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGEL 526
L L G P+D+ KL +L ++ L N G IP +G+ +L+ L LS N F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 527 PREVGNLSNLVTFNVSSNFLTGRIP 551
P +G L++L N++ N L+GR+P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-11
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 817 IGRGACGTVYRAVLRT-GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG GA G V A G VAVKKL+ + + ++R E++ L + H+NI+ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87
Query: 876 FCYHQGS-----NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
Q S ++ + + +L +++H LD + + G+ +LH
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLH---S 141
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKV 990
I HRD+K +NI++ + DFGLA+ + M+ + Y APE M
Sbjct: 142 AGIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEVILGMGY 199
Query: 991 TEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018
E DI+S G ++ EL+ G Q D
Sbjct: 200 KENVDIWSVGCIMGELVKGSVIFQGTDH 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-11
Identities = 60/227 (26%), Positives = 90/227 (39%), Gaps = 37/227 (16%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG+G G VY A VA+KK+ + N + F E + H IV +Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 876 FC-----------YHQGSNL--LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGL 922
C Y +G L L+ + SL + L +S I +
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV---GAFLSIFHKICATI 126
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV----------IDMPQSKSMSA 972
Y+H + HRD+K +NILL E + D+G A ID+ + +
Sbjct: 127 EYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 973 -------IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
I G+ Y+APE + +E DIY+ GV+L ++LT P
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-10
Identities = 42/104 (40%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 306 LNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTL 365
L G IP +I KL I+ S NS+ G IP L I LE+L L N G IP L L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 366 KNLTKLDLSINSLTGTIP--LGFQYLTNLIMLQLFDNSLVGGIP 407
+L L+L+ NSL+G +P LG + L DN+ + GIP
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASF-NFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-10
Identities = 35/83 (42%), Positives = 48/83 (57%)
Query: 330 LIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYL 389
L G IP ++SK+ L+ + L N + G IP L ++ +L LDLS NS G+IP L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 390 TNLIMLQLFDNSLVGGIPQRLGA 412
T+L +L L NSL G +P LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 90/342 (26%), Positives = 151/342 (44%), Gaps = 43/342 (12%)
Query: 33 NIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSG 92
N+ LLL+ S + L +P+ + ++ +LN + N+S
Sbjct: 53 NLSSNTLLLLPS-SLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS- 110
Query: 93 YLSPNIGGLVHLTALDLSFNQLSRNIPKEIGN-CSSLEVLNLNNNRLEAHIPKELGNLSS 151
+ L +LT+LDL N ++ IP IG S+L+ L+L++N++E +P L NL +
Sbjct: 111 ----ELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPN 164
Query: 152 LTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLIS 211
L L++ N +S PK + LS L+ L N IS LPP + L L+ N I
Sbjct: 165 LKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII 222
Query: 212 GSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTS 271
L S + ++L L L+ N+L +P+ +GN ++
Sbjct: 223 -ELLSSLSNLKNLSGLELSNNKLED-------------------------LPESIGNLSN 256
Query: 272 LETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLI 331
LETL L +N Q+ + LGS+ +L+ L + N L+ I L LE+ + +
Sbjct: 257 LETLDLSNN-QISSISS-LGSLTNLRELDLSGNSLS-NALPLIALLLLLLELLLNLLLTL 313
Query: 332 GEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDL 373
+ ++L+ I L + N T P L+ L++L L
Sbjct: 314 KALELKLNSI--LLNNNILSNGET-SSPEALSILESLNNLWT 352
|
Length = 394 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-10
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G+ G V+ AV VAVKK+ +V ++ R EI + ++ H NIVK+Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALR-EIKIIRRLDHDNIVKVYE 69
Query: 876 FCYHQGSNL--------------LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEG 921
GS+L ++ EYM L +L + + FM L G
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQL--LRG 126
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKS--MSAIAGSYG 978
L Y+H + HRD+K N+ ++ + +GDFGLA+++D S +S +
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 979 YIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGR 1010
Y +P + T+ D+++ G + E+LTG+
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-10
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 22/222 (9%)
Query: 802 KDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILT 861
+DL + ++++ VIGRGA G V ++ V KL S E D++F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 862 LGKIRHRN-IVKLYGFCYHQGSNLLM-YEYMARGSLGELLHGASSTLDWQTRF-----MI 914
+ + +V+L+ + + L M EYM G L L+ W RF ++
Sbjct: 96 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-ARFYTAEVVL 153
Query: 915 ALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA 974
AL A + ++H RD+K +N+LLD + DFG ++
Sbjct: 154 ALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204
Query: 975 GSYGYIAPEYAYTMK----VTEKCDIYSYGVVLLELLTGRAP 1012
G+ YI+PE + +CD +S GV L E+L G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 48/156 (30%), Positives = 66/156 (42%), Gaps = 6/156 (3%)
Query: 858 EILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALG 917
EI L I HR I+ L Y S + M + L + S L + I
Sbjct: 136 EIDILKTISHRAIINLI-HAYRWKSTVCMVMPKYKCDLFTYVDR-SGPLPLEQAITIQRR 193
Query: 918 AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMSAIAGS 976
E L+YLH I HRD+K+ NI LD+ A +GDFG A K+ P + +G+
Sbjct: 194 LLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 977 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+PE K DI+S G+VL E+
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNS-FRAEILTLGKIRH 867
++F+ VIGRGA G V L+ V K+ + E + + FR E L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 868 RNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTL-DWQTRFMIA--LGAAEGLS 923
+ I L+ + + +NL L+ +Y G L LL L + RF +A + A + +
Sbjct: 61 QWITTLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
LH+ HRDIK +NIL+D + DFG + + S G+ YI+PE
Sbjct: 120 QLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 984 YAYTM-----KVTEKCDIYSYGVVLLELLTGRAP 1012
M K +CD +S GV + E+L G P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 43/241 (17%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR--TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
++F+ VIGRGA G V R V + TGH A+K L RAE L +
Sbjct: 1 EDFESLKVIGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD 59
Query: 867 HRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYL 925
+VK++ + + NL L+ E++ G + LL + + +T+F IA + +
Sbjct: 60 SLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSI 117
Query: 926 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--------------DMPQSKSMS 971
H + HRDIK +N+LLD K + DFGL + +P +
Sbjct: 118 H---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 972 --------------------AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRA 1011
+ G+ YIAPE + CD +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 1012 P 1012
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 42/110 (38%), Positives = 62/110 (56%), Gaps = 1/110 (0%)
Query: 227 LGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQL 286
LGL L G IP +I L++L + L GN + G IP LG+ TSLE L L N G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 287 PKELGSIGSLKYLYIYRNELNGTIPREIG-KLSSALEIDFSENSLIGEIP 335
P+ LG + SL+ L + N L+G +P +G +L +F++N+ + IP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 30/90 (33%), Positives = 48/90 (53%)
Query: 131 LNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSL 190
L L+N L IP ++ L L +N+ N I G P +G +++L L N+ +GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 191 PPTLGNLKRLKSFRAGQNLISGSLPSEIGG 220
P +LG L L+ N +SG +P+ +GG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 59/198 (29%), Positives = 84/198 (42%), Gaps = 4/198 (2%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKL-Y 874
+G+G G V +R TG A KKL R E L K+ R IV L Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
F L+M M G L ++ A+ +S L H + RI
Sbjct: 61 AFQTKTDLCLVM-TIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
+RD+K N+LLD+ + D GLA + QSK+ AG+ G++APE +
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT-KGYAGTPGFMAPELLQGEEYDFSV 178
Query: 995 DIYSYGVVLLELLTGRAP 1012
D ++ GV L E++ R P
Sbjct: 179 DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHT--VAVKKLASNREGNNNVDNS-FRAEILTLGKI 865
D+F+ VIGRGA G V AV++ HT + K+ + E + + FR E L
Sbjct: 1 DDFEIIKVIGRGAFGEV--AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG 58
Query: 866 RHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTL-DWQTRFMIALGAAEGLS 923
+ I L+ + + + L L+ +Y G L LL L + RF IA E +
Sbjct: 59 DCQWITTLH-YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA----EMVL 113
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
+H + HRDIK +N+LLD + DFG ++ + S G+ YI+PE
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 984 YAYTM-----KVTEKCDIYSYGVVLLELLTGRAP 1012
M K +CD +S GV + E+L G P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-10
Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 858 EILTLGKIRHRNIVKL--------YGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQ 909
EIL LG++ H NI+K+ + Q + +Y +M + L Q
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF----DWKDRPLLKQ 268
Query: 910 TR-FMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968
TR M L A + Y+H ++ HRDIK NI L+ + +GDFG A + +
Sbjct: 269 TRAIMKQLLCA--VEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 1008
G+ +PE E DI+S G++LL++L+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-10
Identities = 76/238 (31%), Positives = 112/238 (47%), Gaps = 8/238 (3%)
Query: 420 DLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFP 479
DL+ N L I + T+L L+L+ N +T P +L +L L N S P
Sbjct: 99 DLNLNRLRSNIS-ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLP 156
Query: 480 SDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTF 539
S L L NL ++L N S +P + N + L L LS N + +LP E+ LS L
Sbjct: 157 SPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEEL 214
Query: 540 NVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIP 599
++S+N + + + + K L L+LS NK LP IG+L LE L LS N++S
Sbjct: 215 DLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SI 270
Query: 600 VQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILL 657
+G+L+ L EL + GNS S +P L L++ LNL + + L
Sbjct: 271 SSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNN 328
|
Length = 394 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 8/207 (3%)
Query: 810 NFDERFVIGRGACGTVYRAVLRTGHT-VAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
NF IGRG VYRA VA+KK+ + EI L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELLH---GASSTLDWQTRFMIALGAAEGLSYL 925
N++K Y ++ E G L ++ + +T + + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 926 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYA 985
H R+ HRDIK N+ + +GD GL + + + S + Y Y++PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPERI 178
Query: 986 YTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ K DI+S G +L E+ ++P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 816 VIGRGACGTVYRA-VLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
++G G GTVY+A L T +AVK + + + +E+ L K I+ Y
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
G + + + E+M GSL + IA+ +GL+YL +I
Sbjct: 66 GAFFVENRISICTEFMDGGSLD-----VYRKIPEHVLGRIAVAVVKGLTYL---WSLKIL 117
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY----GYIAPEYAYTMKV 990
HRD+K +N+L++ + + + DFG++ ++ +++IA +Y Y+APE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVS-------TQLVNSIAKTYVGTNAYMAPERISGEQY 170
Query: 991 TEKCDIYSYGVVLLELLTGRAP 1012
D++S G+ +EL GR P
Sbjct: 171 GIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 816 VIGRGACGTVYRAVLRTGHTV-AVKKLASNR-EGNNNVDNSF-RAEILTLGKIRHRNIVK 872
V+G+G+ G V A L+ + AVK L + +++V+ + IL+L + H + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60
Query: 873 LYGFCYHQGSNLL-MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
LY C+ L + E++ G L + + + + RF AAE S L
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY----AAEITSALMFLHDK 115
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVT 991
I +RD+K +N+LLD + + DFG+ K + K+ S G+ YIAPE M
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 992 EKCDIYSYGVVLLELLTGRAPVQ 1014
D ++ GV+L E+L G AP +
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 21/222 (9%)
Query: 817 IGRGACGTVYRAVL---RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR----N 869
+G G GTV + + ++ TVAVK L N+N D + + E+L + +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILK-----NDNNDPALKDELLREANVMQQLDNPY 57
Query: 870 IVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
IV++ G C + L+M E G L + L + ++ + G+ YL
Sbjct: 58 IVRMIGICEAESWMLVM-ELAELGPLNKFLQKNKHVTEKNITELVH-QVSMGMKYLEET- 114
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY--GYIAPEYAYT 987
HRD+ + N+LL + A + DFGL+K + ++ + G + + APE
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 988 MKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRN 1028
K + K D++S+GV++ E + G+ P + + +G ++ + +
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGM-KGNEVTQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVK--KLASNREGNNNVDNSFRAEILTLGKIR---HRNI 870
IG GA GTVY+A +GH VA+K ++ +N +G + S E+ L ++ H NI
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG---LPLSTVREVALLKRLEAFDHPNI 64
Query: 871 VKLYGFCYHQGSN-----LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYL 925
V+L C ++ L++E++ + L L +T + GL +L
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 926 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYA 985
H +C I HRD+K NIL+ + + DFGLA++ +++ + + Y APE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLWYRAPEVL 179
Query: 986 YTMKVTEKCDIYSYGVVLLELLTGRAPV 1013
D++S G + E+ R P+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 36/214 (16%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH----RNIV 871
IG+G G VY+ + T A+K L+ + EI+ ++ H RNI+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS-------------KKEIVAKKEVAHTIGERNIL 47
Query: 872 K---------LYG--FCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAA 919
+ G F + S+L L+ +YM+ G L L + + +F IA
Sbjct: 48 VRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA---- 103
Query: 920 EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGY 979
E + L H K I +RD+K NILLD + DFGL+K ++ +K+ + G+ Y
Sbjct: 104 ELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEY 162
Query: 980 IAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAP 1012
+APE K T+ D +S GV++ E+ G +P
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-10
Identities = 31/89 (34%), Positives = 48/89 (53%)
Query: 155 LNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSL 214
L + N + G P +I KL L + N+I G++PP+LG++ L+ N +GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 215 PSEIGGCESLQYLGLAQNQLSGEIPKEIG 243
P +G SL+ L L N LSG +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-10
Identities = 30/78 (38%), Positives = 50/78 (64%)
Query: 354 LTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAY 413
L G IP +++ L++L ++LS NS+ G IP +T+L +L L NS G IP+ LG
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 414 SQLWVVDLSDNHLTGKIP 431
+ L +++L+ N L+G++P
Sbjct: 490 TSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-10
Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 4/98 (4%)
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI 980
GL +LH I +RD+K +N++LD + DFG+ K +++ S G+ YI
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA-STFCGTPDYI 163
Query: 981 APEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018
APE +K T D +S+GV+L E+L G++P D+
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-10
Identities = 61/212 (28%), Positives = 88/212 (41%), Gaps = 12/212 (5%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
+FD + ++GRG G V + TG A+K + + + F E L
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 868 RNIVKL-YGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH 926
I +L Y F L+M EY G L LL+ D M AE + +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVM-EYQPGGDLLSLLNRYEDQFDED---MAQFYLAELVLAIH 116
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY 986
+ HRDIK N+L+D + DFG A + + + G+ YIAPE
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 987 TMKVTEK------CDIYSYGVVLLELLTGRAP 1012
TM K CD +S GV+ E++ GR+P
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 65/292 (22%), Positives = 118/292 (40%), Gaps = 51/292 (17%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNS--------FRAEILTLGKIRHR 868
+G+G+ G VY + + VK R V+ + F E + +
Sbjct: 14 LGQGSFGMVYEGIAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELL-------HGASSTLDWQTRFMIALGA--A 919
++V+L G L++ E M RG L L + MI + A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 920 EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG- 978
+G++YL+ + + HRD+ + N ++ + F +GDFG+ + D+ ++ G G
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR--KGGKGL 182
Query: 979 ----YIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNN 1033
+++PE T D++S+GVVL E+ T P Q + V F+
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQVLRFV--- 234
Query: 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ G+LD N D + ++ +C +P RP+ E++ + E
Sbjct: 235 -MEGGLLDKPDNCPD--------MLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 23/188 (12%)
Query: 836 VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL 895
VAVK L + + N F EI + ++++ NI++L G C ++ EYM G L
Sbjct: 47 VAVKMLRA--DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 896 GELLHGAS-----------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNIL 944
+ L ++ +A+ A G+ YL HRD+ + N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161
Query: 945 LDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS----YGYIAPEYAYTMKVTEKCDIYSYG 1000
+ + + + DFG+++ + S I G ++A E K T D++++G
Sbjct: 162 VGNHYTIKIADFGMSRNL---YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218
Query: 1001 VVLLELLT 1008
V L E+ T
Sbjct: 219 VTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 9e-10
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 7/204 (3%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
D++++ +G G+ TVY+ + + K+ +E + R L G ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKG-LKHA 63
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
NIV L+ + + + L++EY+ L + + L + + GLSY+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH-- 120
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM 988
+ I HRD+K N+L+ D E + DFGLA+ +P S + S + Y P+
Sbjct: 121 -QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLLGS 178
Query: 989 KVTEKC-DIYSYGVVLLELLTGRA 1011
C D++ G + +E++ G A
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVA 202
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-10
Identities = 67/217 (30%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI 865
D+F+ VIGRGA G V AV++ TG A+K L FR E L
Sbjct: 1 DDFEILKVIGRGAFGEV--AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG 58
Query: 866 RHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTL-DWQTRFMIA--LGAAEG 921
R I L+ + + +NL L+ +Y G L LL L + RF +A + A +
Sbjct: 59 DRRWITNLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDS 117
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA-GSYGYI 980
+ L + HRDIK +N+LLD + DFG + + S +A G+ YI
Sbjct: 118 VHQLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRL-LADGTVQSNVAVGTPDYI 170
Query: 981 APEYAYTM-----KVTEKCDIYSYGVVLLELLTGRAP 1012
+PE M + +CD +S GV + E+L G P
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 32/100 (32%), Positives = 53/100 (53%), Gaps = 4/100 (4%)
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG 978
A GL +LH I +RD+K +N++LD + + DFG+ K ++ K+ G+
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTFCGTPD 166
Query: 979 YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018
YIAPE + D +++GV+L E+L G+ P D+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 816 VIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
++G+G G+V A L+ + VAVK L ++ +++++ R E + + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFDHPNVI 64
Query: 872 KLYGFCYHQGSN------LLMYEYMARGSLGELLHGAS-----STLDWQT--RFMIALGA 918
KL G + +++ +M G L L + TL QT RFMI +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI-- 122
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI---DMPQSKSMSAIAG 975
A G+ YL HRD+ + N +L++ V DFGL+K I D + S +
Sbjct: 123 ASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL-- 177
Query: 976 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
++A E T D++++GV + E++T G+ P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 10/212 (4%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
+ F+ V+G GA G V + + T VA+KK + E N V + E+ L ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQ 59
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
NIV+L +G L++EY+ + L L + + R I + + + H
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCH- 117
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
K I HRDIK N+L+ + DFG A+ + + + + + Y +PE
Sbjct: 118 --KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
+ D++S G +L EL G QPL G
Sbjct: 176 APYGKAVDMWSVGCILGELSDG----QPLFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 14/210 (6%)
Query: 810 NFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
NF IGRG VYRA L VA+KK+ + EI L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 869 NIVK-LYGFCYHQGSNLLMYEYMARGSLGELL---HGASSTLDWQT--RFMIALGAAEGL 922
N++K L F N+++ E G L +++ + +T ++ + L +A
Sbjct: 63 NVIKYLDSFIEDNELNIVL-ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--- 118
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAP 982
+ H R+ HRDIK N+ + +GD GL + + + S + Y Y++P
Sbjct: 119 --VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSP 175
Query: 983 EYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
E + K DI+S G +L E+ ++P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
+ IG GA G V A TG VA+KK+ S E + R EI L + +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRTLR-EIKILRRFKH 62
Query: 868 RNIVKLYGFCYHQGSNL-------LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE 920
NI+ + + + ++ E M L +L+ + D F+ +
Sbjct: 63 ENIIGILDI--IRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQI--LR 117
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS---MSAIAGSY 977
GL Y+H + HRD+K +N+LL+ + + DFGLA++ D P+ ++ +
Sbjct: 118 GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD-PEHDHTGFLTEYVATR 173
Query: 978 GYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPVQP----LDQ 1018
Y APE K T+ DI+S G +L E+L+ R P+ P L Q
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGKDYLHQ 218
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 52/209 (24%), Positives = 83/209 (39%), Gaps = 46/209 (22%)
Query: 830 LRTGHT--VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887
+R G VAVK L + N N N F E+ L +++ NI++L G C + ++
Sbjct: 41 VRKGRPLLVAVKILRP--DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMIT 98
Query: 888 EYMARGSLGELLH------------------GASSTLDWQTRFMIALGAAEGLSYLHHDC 929
EYM G L + L + + + +AL A G+ YL
Sbjct: 99 EYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---S 155
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY-----------G 978
HRD+ + N L+ + + DFG+ S + AG Y
Sbjct: 156 SLNFVHRDLATRNCLVGENLTIKIADFGM----------SRNLYAGDYYRIQGRAVLPIR 205
Query: 979 YIAPEYAYTMKVTEKCDIYSYGVVLLELL 1007
++A E K T D++++GV L E+L
Sbjct: 206 WMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 65/209 (31%), Positives = 90/209 (43%), Gaps = 13/209 (6%)
Query: 816 VIGRGACGTVYRAVLRT-GHTVAVKKLASNREGNNNVDNSFRAEILTLGK-IRHRNIVKL 873
VIG+G+ G V A ++ G AVK L N AE L K ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 874 -YGFCYHQGSNLLMY--EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
Y F Q + L + +Y+ G L L L+ + RF A A + YLH
Sbjct: 62 HYSF---QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAA-EVASAIGYLH---S 114
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKV 990
I +RD+K NILLD + + DFGL K + ++ S G+ Y+APE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 991 TEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
D + G VL E+L G P D
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVS 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 810 NFDERFVIGRGACGTVYRAVLRTGH------TVAVKKLASNREGNNNVDNSFRAEILTLG 863
NF+ V+G GA G V+ +GH + V K A+ + +++ R E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLE 59
Query: 864 KIRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFM---IALGAA 919
IR + + + + L L+ +Y+ G L + L + RF + + +
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGEL-------FTHLSQRERFKEQEVQIYSG 112
Query: 920 EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGY 979
E + L H K I +RDIK NILLD + DFGL+K + + + G+ Y
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172
Query: 980 IAPEYAYTMKV--TEKCDIYSYGVVLLELLTGRAP 1012
+AP+ + D +S GV++ ELLTG +P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 64/202 (31%), Positives = 88/202 (43%), Gaps = 13/202 (6%)
Query: 816 VIGRGACGTVYRAVL-RTGHTVAVKKLASNREGNNNVDNSFRAEI-LTLGKIRHRNIVKL 873
VIG+G+ G V A G AVK L N AE + L ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 874 -YGFCYHQGSNLLMY--EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
Y F Q + L + +++ G L L S + + RF A A L YLH
Sbjct: 62 HYSF---QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---S 114
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKV 990
I +RD+K NILLD + + DFGL K + QS + + G+ Y+APE
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 991 TEKCDIYSYGVVLLELLTGRAP 1012
D + G VL E+L G P
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 75/297 (25%), Positives = 119/297 (40%), Gaps = 61/297 (20%)
Query: 817 IGRGACGTVYRAVLR------TGHTVAVKKL---ASNREGNNNVDNSFRAEILTLGKIRH 867
+G+G+ G VY R VAVK + AS RE R E L +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE---------RIEFLNEASVMK 64
Query: 868 ----RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQT-------RFMIAL 916
++V+L G L++ E MA G L L + + MI +
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 917 GA--AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA 974
A A+G++YL+ + HRD+ + N ++ F +GDFG+ + D+ ++
Sbjct: 125 AAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR--K 177
Query: 975 GSYG-----YIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRN 1028
G G ++APE T D++S+GVVL E+ + P Q L V
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLK 232
Query: 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
F+ + G LD N + V + +C +P RPT E+V +L +
Sbjct: 233 FVMD----GGYLDQPDNCPER--------VTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG+G G V++A + T VA+KK+ E + R EI L ++H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 78
Query: 876 FCY--------HQGSNLLMYEYMARGSLGELLHGASS--TLDWQTRFMIALGAAEGLSYL 925
C ++GS L++E+ L LL + TL + M L GL Y+
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML--LNGLYYI 135
Query: 926 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965
H + +I HRD+K+ NIL+ + DFGLA+ +
Sbjct: 136 HRN---KILHRDMKAANILITKDGILKLADFGLARAFSLS 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-09
Identities = 35/88 (39%), Positives = 46/88 (52%)
Query: 371 LDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKI 430
L L L G IP L +L + L NS+ G IP LG+ + L V+DLS N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 431 PRHICRNTSLIFLNLETNKLTGSIPTGV 458
P + + TSL LNL N L+G +P +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 49/187 (26%), Positives = 80/187 (42%), Gaps = 22/187 (11%)
Query: 836 VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL 895
VAVK L + N N N F EI + +++ NI++L C ++ EYM G L
Sbjct: 49 VAVKMLRE--DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 896 GELL----------HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL 945
+ L T+ + T +A A G+ YL HRD+ + N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 946 DDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS----YGYIAPEYAYTMKVTEKCDIYSYGV 1001
+ + DFG+++ + S I G +++ E K T D++++GV
Sbjct: 164 GKNYTIKIADFGMSRNL---YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220
Query: 1002 VLLELLT 1008
L E+LT
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGN----NNVDNSFRAEILTLGKIRHRNIVK 872
IG+G+ G V + +R T + L + R+ + + V ++ AE L ++ IV
Sbjct: 1 IGKGSFGKVMQ--VRKRDTQRIYALKTIRKAHIVSRSEVTHTL-AERTVLAQVNCPFIVP 57
Query: 873 LYGFCYHQGSNLLMYEYMARGSLGELLH-----GASSTLDWQTRFMIALGAAEGLSYLHH 927
L F + L Y +A + GEL H G + RF A E L L +
Sbjct: 58 L-KFSFQSPEKL--YLVLAFINGGELFHHLQREGRFDL--SRARFYTA----ELLCALEN 108
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVG--DFGLAKVIDMPQSKSMSAIAGSYGYIAPEYA 985
K + +RD+K NILLD ++ H+ DFGL K ++M + G+ Y+APE
Sbjct: 109 LHKFNVIYRDLKPENILLD--YQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELL 165
Query: 986 YTMKVTEKCDIYSYGVVLLELLTGRAP 1012
T+ D ++ GV+L E+LTG P
Sbjct: 166 LGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNR-EGNNNVDNSF-RAEILTLGKIRHRNIVK 872
V+G+G+ G V A L+ T A+K L + +++VD + IL L +H +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTA 60
Query: 873 LYGFCYHQGSNLLMY--EYMARGSLGELLHGASSTLDWQTRFMIALGAAE---GLSYLH- 926
L+ C Q + L + EY+ G L + + + ++RF AAE L +LH
Sbjct: 61 LH--CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFY----AAEVTLALMFLHR 114
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY 986
H + +RD+K +NILLD + + DFG+ K + + + G+ YIAPE
Sbjct: 115 HG----VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQ 169
Query: 987 TMKVTEKCDIYSYGVVLLELLTGRAPVQ 1014
++ D ++ GV++ E++ G+ P +
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-09
Identities = 30/80 (37%), Positives = 44/80 (55%)
Query: 188 GSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKY 247
G +P + L+ L+S N I G++P +G SL+ L L+ N +G IP+ +G L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 248 LTDVILWGNQLSGVIPKELG 267
L + L GN LSG +P LG
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 62/228 (27%), Positives = 97/228 (42%), Gaps = 37/228 (16%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKK--LASNREGNNNVDNSFRAEILTLGKI 865
D +++ IG G G VY+A TG VA+KK L + EG + + EI L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG---IPPTALREISLLQML 57
Query: 866 RHRN-IVKLYGFCYHQGSN-----LLMYEYMA---RGSLGELLHGASSTLDWQT--RFMI 914
IV+L + + N L++EY+ + + G L +T FM
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 915 ALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEA-HVGDFGLAKVIDMPQSKSMSAI 973
L +G+++ H K + HRD+K N+L+D + + D GL + +P I
Sbjct: 118 QL--LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 974 AGSYGYIAPEY-----AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPL 1016
+ Y APE Y+ V DI+S G + E+ QPL
Sbjct: 173 VTLW-YRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRK----QPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 9/200 (4%)
Query: 816 VIGRGACGTVYRAVLRTGHTV-AVKKLASNREGNNNVDNSFRAEI-LTLGKIRHRNIVKL 873
VIG+G+ G V A + AVK L + +E + L ++H +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 874 YGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
+ F + L + +Y+ G L L L+ + RF A A L YLH
Sbjct: 62 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLH---SLN 116
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
I +RD+K NILLD + + DFGL K ++ + + S G+ Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 993 KCDIYSYGVVLLELLTGRAP 1012
D + G VL E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 918 AAE---GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA 974
AAE GL +LH + I +RD+K +N++LD + + DFG+ K M +
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-HMVDGVTTRTFC 162
Query: 975 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018
G+ YIAPE + D ++YGV+L E+L G+ P D+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 817 IGRGACGTVYRA--VLRTGHTVAVKKLASNREGNNNVDNSFR--AEILTLGKIRHRNIVK 872
IG GA G V++A + G VA+K++ ++ R A + L H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 873 LYGFCYHQGSN-----LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
L+ C ++ L++E++ + L + +T + GL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
R+ HRD+K NIL+ + + DFGLA++ +++++ + Y APE
Sbjct: 129 H---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQ 183
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
D++S G + E+ + PL +G
Sbjct: 184 SSYATPVDLWSVGCIFAEMFRRK----PLFRG 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-09
Identities = 29/80 (36%), Positives = 42/80 (52%)
Query: 212 GSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTS 271
G +P++I LQ + L+ N + G IP +G + L + L N +G IP+ LG TS
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 272 LETLALYDNKQVGQLPKELG 291
L L L N G++P LG
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-09
Identities = 34/94 (36%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 417 WVVD---LSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNS 473
W +D L + L G IP I + L +NL N + G+IP + SL L L NS
Sbjct: 418 WFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS 477
Query: 474 FTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIG 507
F GS P L +L +L + L+ N SG +P +G
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 8e-09
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRA--EILTLGKIRHRNIVK 872
IG GA G V A TG VA+KKL+ + NV ++ RA E++ + + H+NI+
Sbjct: 23 PIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVNHKNIIG 79
Query: 873 LYGFCYHQGSNL-------LMYEYMARGSLG-----ELLHGASSTLDWQTRFMIALGAAE 920
L + +L L+ E M +L +L H S L +Q M+
Sbjct: 80 LLN-VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQ---MLC----- 129
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI 980
G+ +LH I HRD+K +NI++ + DFGLA+ S M+ + Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYR 184
Query: 981 APEYAYTMKVTEKCDIYSYGVVLLELLTGR 1010
APE M E DI+S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 9e-09
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 817 IGRGACGTVYRAV---LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR------- 866
+G+GA G V A TVA+KK + N F +IL +R
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKK----------ITNVFSKKILAKRALRELKLLRH 57
Query: 867 ---HRNIVKLYGF---CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE 920
H+NI LY + L +YE + L +++ D + I
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQILC 116
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS---MSAIAGSY 977
GL Y+H + HRD+K N+L++ E + DFGLA+ ++ M+ +
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 978 GYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPV 1013
Y APE + + T+ D++S G +L ELL GR PV
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 65/241 (26%), Positives = 92/241 (38%), Gaps = 51/241 (21%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG GA G V + T A+K L N +AE L + + +VKLY
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 876 FCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIA-LGAAEGLSYLHHDCKPRI 933
+ + NL + +Y+ G + LL + RF IA L A + +H K
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCA--IESVH---KMGF 122
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVI------------DMPQSKSMS---------- 971
HRDIK +NIL+D + DFGL D + SM
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 972 --------------------AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRA 1011
++ G+ YIAPE T+ CD +S GV+L E+L G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 1012 P 1012
P
Sbjct: 243 P 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 810 NFDERFVIGRGACGTVYRAVLRTGH------TVAVKKLASNREGNNNVDNSFRAEILTLG 863
NF+ V+G GA G V+ GH + V K A+ + +++ R E L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVLE 59
Query: 864 KIRHRN-IVKL-YGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEG 921
+R +V L Y F +L++ +Y+ G L L+ + + R I AE
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLIL-DYVNGGELFTHLYQREHFTESEVRVYI----AEI 114
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYGY 979
+ L H + I +RDIK NILLD E HV DFGL+K + + + G+ Y
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDS--EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172
Query: 980 IAPEYAYTMKV--TEKCDIYSYGVVLLELLTGRAP 1012
+APE + D +S GV+ ELLTG +P
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 817 IGRGACGTV---YRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKL 873
IG GA G V Y A+L VA+KKL+ + + ++R E++ + + H+NI+ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 874 YGFCYHQGS-----NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
Q S ++ + + +L +++ LD + + G+ +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLH-- 143
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM 988
I HRD+K +NI++ + DFGLA+ S M+ + Y APE M
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 200
Query: 989 KVTEKCDIYSYGVVLLELLTGR 1010
E DI+S G ++ E++ G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 50/166 (30%), Positives = 72/166 (43%), Gaps = 13/166 (7%)
Query: 856 RAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRF--- 912
R+E+ L H IVK + LL+ EY GS G+L L F
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY---GSGGDLNKQIKQRLKEHLPFQEY 169
Query: 913 ---MIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSK 968
++ L +H + HRD+KS NI L +GDFG +K D
Sbjct: 170 EVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226
Query: 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQ 1014
S+ G+ Y+APE + ++K D++S GV+L ELLT P +
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 918 AAE---GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA 974
AAE GL +LH I +RD+K +N++LD + + DFG+ K +M +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFC 162
Query: 975 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018
G+ YIAPE + D +++GV+L E+L G+AP + D+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 23/202 (11%)
Query: 817 IGRGACGTVYRAV---LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKL 873
+G+G+ GTVY + V K E N N E L K+ H IVK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 874 YGFCYHQGSNLLMYEYMARGSLG----ELLHGA-----SSTLDWQTRFMIALGAAEGLSY 924
+ + + ++ EY L EL H + +W + ++ G+ Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
+H + RI HRD+K+ NI L + +GDFG+++++ M + G+ Y++PE
Sbjct: 122 MH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEA 176
Query: 985 AYTMKVTEKCDIYSYGVVLLEL 1006
K DI+S G +L E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 810 NFDERFVIGRGACGTVYRAVLRTGH------TVAVKKLASNREGNNNVDNSFRAEILTLG 863
NF+ V+G GA G V+ TGH + V + A+ + V+++ R E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHT-RTERNVLE 59
Query: 864 KIRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGL 922
+R + + + + L L+ +Y++ G + L+ + + + RF + E +
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY----SGEII 115
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAP 982
L H K I +RDIK NILLD + + DFGL+K + + + G+ Y+AP
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 983 EYAYTMKVTEKC-DIYSYGVVLLELLTGRAP 1012
E K D +S G+++ ELLTG +P
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 68/285 (23%), Positives = 105/285 (36%), Gaps = 36/285 (12%)
Query: 817 IGRGACGTVYRAVLRTGHTVA---VKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKL 873
IG G G V G + A VK+L ++ + F E+ ++ H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 874 YGFCYHQGSNLLMYEYMARGSLGELLHG--ASSTLDWQTRFM--IALGAAEGLSYLHHDC 929
G C LL+ E+ G L L Q + +A A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI---DMPQSKSMSAIAGSYGYIAPEYA- 985
+ H D+ N L +GD+GLA D +K A+ ++APE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP--LRWLAPELVE 175
Query: 986 ------YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039
T+K +I+S GV + EL T A QP D ++ +R +
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT--AADQPYPDLSDEQV-LKQVVREQDIKLPK 232
Query: 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084
L D ++ C + P RPT EV +L+
Sbjct: 233 PQLDLKYSDR--------WYEVMQFCW-LDPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 9/200 (4%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKI-RHRNIVKL 873
VIGRG+ V L+ + K+ N++ D + + E + H +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 874 YGFCYHQGSNLL-MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
+ C+ S L + EY+ G L + + RF A + L+YLH +
Sbjct: 62 HS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERG 116
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
I +RD+K +N+LLD + + D+G+ K P + S G+ YIAPE
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 993 KCDIYSYGVVLLELLTGRAP 1012
D ++ GV++ E++ GR+P
Sbjct: 176 SVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 16/206 (7%)
Query: 816 VIGRGACGTVYRA-VLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN--IVK 872
+IGRG G VY TG A+K L R + E + L + + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 873 LYGFCYHQGSNL-LMYEYMARGSLGELL--HGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
+ +H L + + M G L L HG S + RF A E + L H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKE--MRFY----ATEIILGLEHMH 114
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMK 989
+ +RD+K NILLD+ + D GLA D + K +++ G++GY+APE
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTHGYMAPEVLQKGT 171
Query: 990 VTE-KCDIYSYGVVLLELLTGRAPVQ 1014
+ D +S G +L +LL G +P +
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-08
Identities = 78/254 (30%), Positives = 118/254 (46%), Gaps = 19/254 (7%)
Query: 462 KSLVQLRLGGNSFTGSFPSDLCKLANLSTV----ELDQNQFSGPI-PTEIGNCNALQRLH 516
S + L + + S S L NL + LD N +E+ L L
Sbjct: 63 PSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLD 122
Query: 517 LSDNYFTGELPREVGNL-SNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALP 575
L +N T ++P +G L SNL ++S N + +P + + L+ LDLS+N + LP
Sbjct: 123 LDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND-LSDLP 179
Query: 576 REIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSL--Q 633
+ + +L L L LS N++S +P +I LS L EL + NS I L SLS+L
Sbjct: 180 KLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS----IIELLSSLSNLKNL 234
Query: 634 IALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTG 693
L LS NN +P +GNL LE L L+NN +S S +L++L + S N+L+
Sbjct: 235 SGLELS-NNKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSN 291
Query: 694 PIPSSQTFQNMSVN 707
+P +
Sbjct: 292 ALPLIALLLLLLEL 305
|
Length = 394 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 44/151 (29%), Positives = 69/151 (45%), Gaps = 18/151 (11%)
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSL----GELLHGASSTLD-WQTRFMIALGAAEGLS 923
N+V L+ + + S L+ ++ G L + L+ + W ++AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
LH + I RD+ NNILLDD+ + F + ++ S A+ Y APE
Sbjct: 101 -LHRE---GIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAV--ENMYCAPE 152
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQ 1014
+ TE CD +S G +L ELLTG+ V+
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 5e-08
Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 817 IGRGACGTV---YRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKL 873
IG GA G V Y AVL VA+KKL+ + + ++R E++ + + H+NI+ L
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 874 YGFCYHQGSNLLMYEYMARGSLGELLHG-----ASSTLDWQTRFMIALGAAEGLSYLHHD 928
Q S + E+ + EL+ LD + + G+ +LH
Sbjct: 82 LNVFTPQKS---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 136
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM 988
I HRD+K +NI++ + DFGLA+ S M+ + Y APE M
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 193
Query: 989 KVTEKCDIYSYGVVLLELL 1007
E DI+S G ++ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-08
Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 12/203 (5%)
Query: 816 VIGRGACGTVYRAVLRTGH----TVAVKKLASNREGNNNVDNSF-RAEILTLGKIRHRNI 870
V+G+G G V++ TG A+K L N D + +AE L ++H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 871 VKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
V L + + G L L+ EY++ G L L ++ F ++ E L H
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS----EISLALEHLH 117
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMK 989
+ I +RD+K NILLD + + DFGL K + + G+ Y+APE
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEILMRSG 176
Query: 990 VTEKCDIYSYGVVLLELLTGRAP 1012
+ D +S G ++ ++LTG P
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 54/224 (24%), Positives = 84/224 (37%), Gaps = 46/224 (20%)
Query: 816 VIGR----GACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSF-RAEILTLGKIRHRNI 870
+IG+ + + T VAVKK+ N + + D + EI+T +++H NI
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKI--NLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 871 VKLYGFCYHQGSNL-LMYEYMARGSLGELL-----HGASSTLDWQTRFMIAL---GAAEG 921
+ Y + S L ++ MA GS +LL G IA
Sbjct: 62 LP-YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA-------IAFILKDVLNA 113
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV-----------GDFGLAKVIDMPQSKSM 970
L Y+H HR +K+++ILL + + V D P+S
Sbjct: 114 LDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS--- 167
Query: 971 SAIAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRAP 1012
+ +++PE EK DIYS G+ EL G P
Sbjct: 168 --SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 877 CYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE---GLSYLHHDCKPR 932
C+ S L L+ EY+ G L + + RF AAE L++LH +
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFY----AAEICIALNFLH---ERG 116
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
I +RD+K +N+LLD + D+G+ K P + S G+ YIAPE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 993 KCDIYSYGVVLLELLTGRAPVQPLDQGGDLVT 1024
D ++ GV++ E++ GR+P + D+ T
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNT 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-07
Identities = 33/88 (37%), Positives = 44/88 (50%)
Query: 395 LQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSI 454
L L + L G IP + L ++LS N + G IP + TSL L+L N GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 455 PTGVTRCKSLVQLRLGGNSFTGSFPSDL 482
P + + SL L L GNS +G P+ L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 858 EILTLGKIRHRNIVKLYG-FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIAL 916
E L I H +I++L G F Y++ + L++ Y + L L A + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYL-AAKRNIAICDILAIER 189
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV-IDMPQSKSMSAIAG 975
+ YLH + RI HRDIK+ NI ++ + +GDFG A +D+ +K AG
Sbjct: 190 SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWAG 245
Query: 976 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGR 1010
+ APE DI+S G+VL E+ T
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 20/212 (9%)
Query: 817 IGRGACGTVYRAVLRTGHT---VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKL 873
+G G G+V L + VAVK + + +++ F +E + + + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED-FLSEAVCMKEFDHPNVMRL 65
Query: 874 YGFCYHQGSN------LLMYEYMARGSLGELL-----HGASSTLDWQTRFMIALGAAEGL 922
G C + +++ +M G L L L Q A G+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAG-SYGYIA 981
YL HRD+ + N +L++ V DFGL+K I IA +IA
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 982 PEYAYTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
E T K D++S+GV + E+ T G+ P
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 918 AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY 977
AAE + L H + +RD+K NILLD+ + D GLA D + K +++ G++
Sbjct: 103 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTH 159
Query: 978 GYIAPE-YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQ 1014
GY+APE + D +S G +L +LL G +P +
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-07
Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 8/159 (5%)
Query: 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
I RGA G VY + AVK + N N+ + +AE L + IV LY
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY- 70
Query: 876 FCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+ +N+ L+ EY+ G + LLH + I+ A L YLH + I
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLH---RHGII 126
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI 973
HRD+K +N+L+ ++ + DFGL+KV + + +M I
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV-TLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 30/91 (32%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIA 981
L YLH C + +RD+K N++LD + DFGL K + +M G+ Y+A
Sbjct: 108 LGYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLA 163
Query: 982 PEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
PE D + GVV+ E++ GR P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 813 ERFVIGRGACGTVYRAVL----RTGHTVAVKKLASNREG-NNNVDNSFRAEILTLGKIRH 867
ER ++G G G + R L + VA+ L R G ++ F AE LTLG+ H
Sbjct: 10 ER-ILGTGRFGELCRGCLKLPSKRELPVAIHTL---RAGCSDKQRRGFLAEALTLGQFDH 65
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
NIV+L G + +++ EYM+ G+L L L + G A G+ YL
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL-- 123
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG------YIA 981
+ H+ + ++ +L++ + F Q AI + + A
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFRRL------QEDKSEAIYTTMSGKSPVLWAA 176
Query: 982 PEYAYTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
PE + D++S+G+V+ E+++ G P
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-07
Identities = 18/39 (46%), Positives = 21/39 (53%), Gaps = 1/39 (2%)
Query: 35 EGQILLLIKSKLV-DNSNYLGNWNPNDSTPCGWIGVNCT 72
+ LL KS L D S L +WNP+ S PC W GV C
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 34/104 (32%), Positives = 50/104 (48%), Gaps = 5/104 (4%)
Query: 909 QTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968
+TRF A L YLH +I +RD+K N++LD + DFGL K + +
Sbjct: 96 RTRFYGA-EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE-GITDAA 150
Query: 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+M G+ Y+APE D + GVV+ E++ GR P
Sbjct: 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG- 875
+GRG G VY+A + G K+ A + + S EI L +++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDE--KEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 876 FCYHQGSNL-LMYEYMARGSLGELL--HGASSTLDWQTRFMIALGAA------EGLSYLH 926
F H + L+++Y A L ++ H AS + ++ + +G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 927 HDCKPRIFHRDIKSNNILL----DDKFEAHVGDFGLAKVIDMPQS--KSMSAIAGSYGYI 980
+ + HRD+K NIL+ ++ + D G A++ + P + + ++ Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 981 APEYAYTMK-VTEKCDIYSYGVVLLELLT 1008
APE + T+ DI++ G + ELLT
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 29/224 (12%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHT-VAVKKLASNREG---NNNVDNSF-RAEILTLG 863
++F+ +I GA G VY + A+KK+ N++ N + F +ILT
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKI--NKQNLILRNQIQQVFVERDILTFA 58
Query: 864 KIRHRNIVKLYGFCYHQGSNLLM-YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGL 922
+ + +V ++ + +L M EY+ G LL + R A L
Sbjct: 59 E--NPFVVSMFC-SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVLAL 114
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM------------ 970
YLH+ I HRD+K +N+L+ + DFGL+K+ M + ++
Sbjct: 115 EYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 971 --SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ G+ YIAPE + D ++ G++L E L G P
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-07
Identities = 66/262 (25%), Positives = 97/262 (37%), Gaps = 60/262 (22%)
Query: 817 IGRGACGTVYRA-VLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G GA G V A + T A+K L N +AE L + + +V+LY
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLY- 67
Query: 876 FCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIA--LGAAEGLSYLHHDCKPR 932
+ + NL + +Y+ G + LL + RF IA A E + K
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH------KMG 121
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVI------------DMPQSKSMS--------- 971
HRDIK +NIL+D + DFGL D + SM
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181
Query: 972 -------------------------AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLEL 1006
++ G+ YIAPE T+ CD +S GV+L E+
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 1007 LTGRAPV---QPLDQGGDLVTW 1025
L G+ P PL+ ++ W
Sbjct: 242 LVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGH--TVAVKKLASNRE-GNNNVDNSFRAEILTLGKI 865
++F+ +G G+ G V A + VA+K+ ++ VD+ F +E L I
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYI 88
Query: 866 RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALG---AAEGL 922
H V LYG + L+ E++ G L RF +G AA+ +
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-------NKRFPNDVGCFYAAQIV 141
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAP 982
+ I +RD+K N+LLD + DFG AKV+D + G+ YIAP
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAP 197
Query: 983 EYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
E + + D ++ G+ + E+L G P
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 6e-07
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 817 IGRGACGTVYRAVLRTGHT---VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKL 873
+GRG G VY+A + G A+K++ EG + S EI L +++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTG-ISMSACREIALLRELKHPNVISL 63
Query: 874 YG-FCYHQGSNL-LMYEYMARGSLGELL--HGASSTLDWQTRFMIALGAA------EGLS 923
F H + L+++Y A L ++ H AS + + + +G+
Sbjct: 64 QKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 924 YLHHDCKPRIFHRDIKSNNILL----DDKFEAHVGDFGLAKVIDMPQS--KSMSAIAGSY 977
YLH + + HRD+K NIL+ ++ + D G A++ + P + + ++
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 978 GYIAPEYAYTMK-VTEKCDIYSYGVVLLELLT 1008
Y APE + T+ DI++ G + ELLT
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 40/173 (23%), Positives = 80/173 (46%), Gaps = 29/173 (16%)
Query: 919 AEGLSYL-HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS- 976
A+G+ +L +C HRD+ + N+LL D A + DFGLA+ I + S + G+
Sbjct: 222 AQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDI---MNDSNYVVKGNA 274
Query: 977 ---YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRN 1032
++APE + T + D++SYG++L E+ + G++P + N
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP-------------GILVN 321
Query: 1033 NSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ + + + + +++K +C N+ P +RPT ++ ++
Sbjct: 322 SKFYKMVKRGYQMSRPDFAPPEIYSIMK---MCWNLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 9e-07
Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 29/203 (14%)
Query: 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYL-HHDCKPRIFHRDIKSNNILLDD 947
Y+ + E+L LD + + A+G+S+L +C HRD+ + NILL
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTH 249
Query: 948 KFEAHVGDFGLAKVIDMPQSKSMSAIAGS----YGYIAPEYAYTMKVTEKCDIYSYGVVL 1003
+ DFGLA+ I ++ S + G+ ++APE + T + D++SYG++L
Sbjct: 250 GRITKICDFGLARDI---RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILL 306
Query: 1004 LELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIA 1062
E+ + G +P + ++ R S E S M ++K
Sbjct: 307 WEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS-------------PECAPSEMYDIMKS- 352
Query: 1063 MLCTNISPFDRPTMREVVLMLSE 1085
C + P RPT +++V ++ +
Sbjct: 353 --CWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-07
Identities = 56/200 (28%), Positives = 83/200 (41%), Gaps = 9/200 (4%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNR-EGNNNVDNSFRAEILTLGKIRHRNIVKL 873
++G+G G V + TG A+K L + V ++ E L RH + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFLTAL 60
Query: 874 -YGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
Y F H +M EY G L L + + RF A L YLH +
Sbjct: 61 KYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSE--KN 116
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
+ +RD+K N++LD + DFGL K + +M G+ Y+APE
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 993 KCDIYSYGVVLLELLTGRAP 1012
D + GVV+ E++ GR P
Sbjct: 176 AVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 30/91 (32%), Positives = 43/91 (47%), Gaps = 4/91 (4%)
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIA 981
L YLH + +RDIK N++LD + DFGL K + +M G+ Y+A
Sbjct: 108 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLA 163
Query: 982 PEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
PE D + GVV+ E++ GR P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 65/245 (26%), Positives = 95/245 (38%), Gaps = 55/245 (22%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G GA G V A + T A+K L N N +AE L + + +VKLY
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY- 67
Query: 876 FCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIA-LGAAEGLSYLHHDCKPRI 933
+ + NL + +Y+ G + LL + RF IA L A + +H K
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLA--IESVH---KMGF 122
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLA---------------------------------- 959
HRDIK +NIL+D + DFGL
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 960 -------KVIDMPQSKSMS-----AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 1007
K ++ +K ++ G+ YIAPE T+ CD +S GV+L E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 1008 TGRAP 1012
G+ P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-06
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
+IG G+ G VY A+ + T VA+KK+ + + N E+L + + H NI+ L
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-------ELLIMKNLNHINIIFLK 125
Query: 875 GFCYHQGS---------NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE---GL 922
+ Y + N++M E++ + + H A + F++ L + + L
Sbjct: 126 DYYYTECFKKNEKNIFLNVVM-EFIPQTVHKYMKHYARNNHALPL-FLVKLYSYQLCRAL 183
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEA-HVGDFGLAKVIDMPQSKSMSAIAGSYGYIA 981
+Y+H I HRD+K N+L+D + DFG AK + + +S+S I + Y A
Sbjct: 184 AYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL-LAGQRSVSYICSRF-YRA 238
Query: 982 PEYAY-TMKVTEKCDIYSYGVVLLELLTG 1009
PE T D++S G ++ E++ G
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
+F+ +G G+ G V A + TG A+K L E L ++ H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 869 NIVKLYGFCYHQGSNLL--MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE---GLS 923
IV + C Q N + + E++ G L L A + +F AE
Sbjct: 79 FIVNMM--CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFY----HAELVLAFE 132
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
YLH I +RD+K N+LLD+K V DFG AK + + G+ Y+APE
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE 185
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ + D ++ GV+L E + G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 848 NNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLH--GASST 905
++ +F + ++ H+++VKLYG C N+++ EY+ G L LH + +
Sbjct: 41 DHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVS 99
Query: 906 LDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL---DDKFE----AHVGDFGL 958
L W + +A A L YL ++ H ++ NIL+ + D G+
Sbjct: 100 LHW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154
Query: 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAY--TMKVTEKCDIYSYGVVLLELLT-GRAPVQP 1015
+ + + + + I +IAPE +T D +S+G LLE+ + G P+
Sbjct: 155 PITV-LSREERVERIP----WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209
Query: 1016 LD 1017
L
Sbjct: 210 LS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 57/244 (23%), Positives = 106/244 (43%), Gaps = 36/244 (14%)
Query: 858 EILTLGKIRHRNIVKLYGFCYHQGSN-LLMYEYMARGSLGELLH-------GASSTLDWQ 909
E L + H+NI+ + C G ++Y YM G+L L L Q
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 910 TRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969
+A+ A G+SYLH K + H+DI + N ++D++ + + D L++ D+
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR--DLFPMDY 172
Query: 970 MSAIAGSY---GYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTW 1025
++A E + + D++S+GV+L EL+T G+ P +D ++ +
Sbjct: 173 HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMAAY 231
Query: 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCT-NISPFDRPTMREVVLMLS 1084
+++ R L +N DE + V M C + P +RP+ ++V L+
Sbjct: 232 LKDGYR--------LAQPINCPDE-----LFAV----MACCWALDPEERPSFSQLVQCLT 274
Query: 1085 ESNR 1088
+ +
Sbjct: 275 DFHA 278
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-06
Identities = 23/64 (35%), Positives = 34/64 (53%)
Query: 635 ALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGP 694
L L L G IP ++ L L+ + L+ N + G IP S +++SL + SYN+ G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 695 IPSS 698
IP S
Sbjct: 482 IPES 485
|
Length = 623 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 817 IGRGACG--TVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
IGRG C +VY A T+ ++ + + E++ RH NI+ +
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 875 GFCYHQGSNL-LMYEYMARGSLGELL-----HGASSTLDWQTRFMIALGAAEGLSYLHHD 928
+ GS L ++ +MA GS LL G S L I GA GL+YLH +
Sbjct: 66 TV-FTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGALRGLNYLHQN 120
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG--------YI 980
HR+IK+++IL+ + V GL+ + + ++ + + + ++
Sbjct: 121 ---GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL 175
Query: 981 APE------YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQ 1014
+PE Y Y +K DIYS G+ EL TGR P Q
Sbjct: 176 SPELLRQDLYGYNVK----SDIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 8e-06
Identities = 25/79 (31%), Positives = 42/79 (53%)
Query: 284 GQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILG 343
G +P ++ + L+ + + N + G IP +G ++S +D S NS G IP L ++
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 344 LELLYLFENKLTGVIPVEL 362
L +L L N L+G +P L
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-06
Identities = 67/255 (26%), Positives = 98/255 (38%), Gaps = 59/255 (23%)
Query: 809 DNFDERFVIGRGACGTVYRAV--LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
++F VIG+GA G V R V TG A+K L + + +AE L +
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59
Query: 867 HRNIVKLY-GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIA--LGAAEGLS 923
+V LY F Q L+M E++ G L +L + + TRF +A + A E +
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIM-EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA----------------------KV 961
L HRDIK +NIL+D + DFGL+
Sbjct: 119 KLGF------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172
Query: 962 IDMPQSKSMSAI------------------------AGSYGYIAPEYAYTMKVTEKCDIY 997
ID S ++ +I G+ YIAPE ++CD +
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232
Query: 998 SYGVVLLELLTGRAP 1012
S G ++ E L G P
Sbjct: 233 SLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-05
Identities = 21/61 (34%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 103 HLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNR 161
+L +LDLS N+L IP +L+VL+L+ N L + P+ L SL L++ N
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 162 I 162
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIA 981
L++LH + I +RD+K +N+LLD + + D+G+ K + + S G+ YIA
Sbjct: 109 LNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIA 164
Query: 982 PEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
PE D ++ GV++ E++ GR+P
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 19/161 (11%)
Query: 864 KIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLS 923
++ H++IV LYG C N+++ E++ G L +H S L +F +A A LS
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 924 YLHHDCKPRIFHRDIKSNNILL-DDKFEAHVGDFGLAKVID-------MPQSKSMSAIAG 975
YL + H ++ + NILL + + G F K+ D + + + + I
Sbjct: 120 YLE---DKDLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITVLSRQECVERIP- 173
Query: 976 SYGYIAPEYAYTMKV-TEKCDIYSYGVVLLEL-LTGRAPVQ 1014
+IAPE K + D +S+G L E+ G P++
Sbjct: 174 ---WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAIAGS 976
A G+ +L + HRD+ + NILL + + DFGLA+ I D + A
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-P 238
Query: 977 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSL 1035
++APE + T + D++S+GV+L E+ + G +P + + L
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC---------RRL 289
Query: 1036 VSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
G R+ + T + I + C + +P DRPT E+V +L +
Sbjct: 290 KEG---TRMRAPEYATPE----IYSIMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 8e-05
Identities = 64/250 (25%), Positives = 92/250 (36%), Gaps = 65/250 (26%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
+F + ++G+G G V+ L+ TG A+K L N E L + H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 868 RNIVKLYG-----FCYHQGSNLLMYEYMARGSLGELLHGAS-STLDWQT-RFMIALGAAE 920
+ LY L+M +Y G L LL L + RF AAE
Sbjct: 61 PFLPTLYASFQTETYLC----LVM-DYCPGGELFRLLQRQPGKCLSEEVARFY----AAE 111
Query: 921 ---GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAK--------------- 960
L YLH I +RD+K NILL + H+ DF L+K
Sbjct: 112 VLLALEYLH--LLG-IVYRDLKPENILLHE--SGHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 961 --------------VIDMPQSKSMSAIAGSYGYIAPE----YAYTMKVTEKCDIYSYGVV 1002
+ P +S S + G+ YIAPE + V D ++ G++
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFV-GTEEYIAPEVISGDGHGSAV----DWWTLGIL 221
Query: 1003 LLELLTGRAP 1012
L E+L G P
Sbjct: 222 LYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-05
Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 5/96 (5%)
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAIAGSY 977
A+G+ +L + HRD+ + NILL + + DFGLA+ + P
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 978 GYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
++APE + T + D++S+GV+L E+ + G +P
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 56/202 (27%), Positives = 76/202 (37%), Gaps = 39/202 (19%)
Query: 511 ALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKF 570
+L+ L LS N TG +PR + +L G C LQ LDLS N
Sbjct: 52 SLKELCLSLN-ETGRIPRGLQSLL--------QGLTKG--------CG-LQELDLSDNAL 93
Query: 571 VGALPREIGSLFQ---LELLKLSENELSGSIPVQIG-----NLSRLTELQMGGNSFSGGI 622
+ SL + L+ LKL+ N L + L +L +G N G
Sbjct: 94 GPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGAS 153
Query: 623 PAELGSL----SSLQIALNLSYNNLSG----LIPPELGNLILLEYLLLNNNHLSGE---- 670
L L+ LNL+ N + + L LE L LNNN L+ E
Sbjct: 154 CEALAKALRANRDLKE-LNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASA 212
Query: 671 IPGSFVNLSSLLGCNFSYNNLT 692
+ + +L SL N NNLT
Sbjct: 213 LAETLASLKSLEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 1e-04
Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 21/112 (18%)
Query: 932 RIFHRDIKSNNILLDDKFE-----------------AHVGDFGLAKVIDMPQSKSMSAIA 974
R+ HRD+K NI L A +GDFGL+K I + +S + S +
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI-ESMAHSCVG 203
Query: 975 GSYGYIAPEYAY--TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVT 1024
Y Y +PE T +K D+++ G ++ EL +G+ P + L++
Sbjct: 204 TPY-YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLIS 254
|
Length = 1021 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-04
Identities = 31/91 (34%), Positives = 44/91 (48%), Gaps = 7/91 (7%)
Query: 916 LGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS-AIA 974
L A + Y+H + I HRDIK+ N+L++ + +GDFG A S IA
Sbjct: 270 LSAID---YIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 975 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLE 1005
G+ APE T DI+S G+V+ E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 39/169 (23%), Positives = 73/169 (43%), Gaps = 21/169 (12%)
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAIAGSY 977
A G+ +L + HRD+ + NILL + + DFGLA+ I P +
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 978 GYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLV 1036
++APE + T + D++S+GV+L E+ + G +P + + +++
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-------- 292
Query: 1037 SGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
R+ + T + +I + C P +RPT +V +L +
Sbjct: 293 ----GTRMRAPENATPE----IYRIMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 42/150 (28%), Positives = 61/150 (40%), Gaps = 12/150 (8%)
Query: 817 IGRGACGTVYRAVLRTGHT---VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKL 873
IG G G V + +G+T V VK+L + + F E ++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLLQC 60
Query: 874 YGFCYHQGSNLLMYEYMARGSLGELLHGA----SSTLDWQTRFMIALGAAEGLSYLHHDC 929
G C LL+ E+ G L L T D T +A A GL +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959
K H D+ N LL +GD+GL+
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 44/154 (28%), Positives = 64/154 (41%), Gaps = 23/154 (14%)
Query: 817 IGRGACGTVYRAVLRTGHTVA---VKKL---ASNREGNNNVDNSFRAEILTLGKIRHRNI 870
IG G G V + + T VA VK+L AS++E N + IL +H NI
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-----QHPNI 57
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLG------ELLHGASSTLDWQTRFMIALGAAEGLSY 924
++ G C LL++EY G L + S L Q +A A G+++
Sbjct: 58 LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTH 114
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 958
+H K H D+ N L VGD+G+
Sbjct: 115 MH---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 27/99 (27%), Positives = 35/99 (35%), Gaps = 17/99 (17%)
Query: 914 IALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI 973
+ L L LH K NILL ++ + G QS+
Sbjct: 22 VCLQCLGALRELHRQAKSG---------NILL--TWDGLLKLDGSVAFKTPEQSRPDPY- 69
Query: 974 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
++APE TEK DIYS G+ L E L P
Sbjct: 70 -----FMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 7e-04
Identities = 19/61 (31%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 127 SLEVLNLNNNRLEAHIPKE-LGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNN 185
+L+ L+L+NNRL IP L +L +L++ N ++ P+ L +L L NN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 186 I 186
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 31/154 (20%), Positives = 55/154 (35%), Gaps = 16/154 (10%)
Query: 812 DERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
++ G VY + +K S +G + E+ L + + +
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDED-YVLKINPSREKGAD-----REREVAILQLLARKGLP 54
Query: 872 --KLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
K+ G + L+ E++ GE L + + + IA AE L+ LH
Sbjct: 55 VPKVLASGESDGWSYLLMEWIE----GETL----DEVSEEEKEDIAEQLAELLAKLHQLP 106
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963
+ H D+ NIL+DD + D+ A
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 24/60 (40%), Positives = 30/60 (50%)
Query: 343 GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSL 402
L+ L L N+LT + L NL LDLS N+LT P F L +L L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 919 AEGLSYL-HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS- 976
A G+ +L +C HRD+ + N+L+ + + DFGLA+ I M S +S GS
Sbjct: 249 ANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI-MRDSNYISK--GST 301
Query: 977 ---YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 1008
++APE + T D++S+G++L E+ T
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1114 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.44 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.23 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.11 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.07 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.07 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.06 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.02 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.0 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.99 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.94 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.91 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.86 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.67 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.67 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.64 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.53 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.39 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-114 Score=1125.22 Aligned_cols=923 Identities=36% Similarity=0.579 Sum_probs=658.2
Q ss_pred CcchHHHHHHhHhhccCCCCCCCCCCCCCCCCCccceEEEecCCCccEEEEEeecCCCcCcccCCCCCCCCccCEEEecC
Q 001253 32 VNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSF 111 (1114)
Q Consensus 32 ~~~~~~~ll~~k~~~~~~~~~~~~W~~~~~~~C~w~gv~C~~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~ 111 (1114)
.++|++||++||+++.+|.+.+++|+.. .+||.|.||+|+.. .+|+.|+|+++++.|.+++.+..+++|+.|+|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~gv~c~~~---~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~ 102 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNS---SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSN 102 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCcceecCCC---CcEEEEEecCCCccccCChHHhCCCCCCEEECCC
Confidence 3479999999999998888888999754 56999999999742 4688999999999999988899999999999999
Q ss_pred CcccCCCCcccC-CCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCC
Q 001253 112 NQLSRNIPKEIG-NCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSL 190 (1114)
Q Consensus 112 n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~ 190 (1114)
|++++.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+|++|.+.+.+|..++++++|++|++++|.+.+
T Consensus 103 n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~-- 178 (968)
T PLN00113 103 NQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG-- 178 (968)
T ss_pred CccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccc--
Confidence 999888887765 888888888888888877774 456777777777777776666666555555555555555544
Q ss_pred CCCccccccccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCcccccccccc
Q 001253 191 PPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCT 270 (1114)
Q Consensus 191 p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 270 (1114)
.+|..++++++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..+++++
T Consensus 179 ----------------------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 236 (968)
T PLN00113 179 ----------------------KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT 236 (968)
T ss_pred ----------------------cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCC
Confidence 4555555556666666666666666666666666777776666666665565555555
Q ss_pred ccchhhcccccccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecc
Q 001253 271 SLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLF 350 (1114)
Q Consensus 271 ~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~ 350 (1114)
+|++|++++|.+.+.+|..|+++++|++|+|++|.+
T Consensus 237 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l-------------------------------------------- 272 (968)
T PLN00113 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL-------------------------------------------- 272 (968)
T ss_pred CCCEEECcCceeccccChhHhCCCCCCEEECcCCee--------------------------------------------
Confidence 555555554444444444444444444443333333
Q ss_pred cccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCC
Q 001253 351 ENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKI 430 (1114)
Q Consensus 351 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 430 (1114)
++..|..+..+++|+.|+|++|.+.+.+|..+..+++|+.|++++|.+.+..|..+..+++
T Consensus 273 ----~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~--------------- 333 (968)
T PLN00113 273 ----SGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR--------------- 333 (968)
T ss_pred ----eccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCC---------------
Confidence 3333444555677888888888887777766666666666666666555555555554444
Q ss_pred CccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccc
Q 001253 431 PRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCN 510 (1114)
Q Consensus 431 ~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 510 (1114)
|+.|++++|.+++.+|..+..+++|+.|++++|++++.+|..++.+++|+.|++++|++.+.+|..++.++
T Consensus 334 ---------L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~ 404 (968)
T PLN00113 334 ---------LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404 (968)
T ss_pred ---------CCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCC
Confidence 44555555555555555555556666666666666666666666666666666666666666666666677
Q ss_pred cCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeecc
Q 001253 511 ALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLS 590 (1114)
Q Consensus 511 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 590 (1114)
+|+.|+|++|++++.+|..|..+++|+.|++++|.+++.+|..+..+++|+.|+|++|++.+.+|..++ .++|+.|+++
T Consensus 405 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls 483 (968)
T PLN00113 405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLS 483 (968)
T ss_pred CCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECc
Confidence 777777777777766677777777777777777777766666666677777777777777776666553 4678888888
Q ss_pred CccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccC
Q 001253 591 ENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGE 670 (1114)
Q Consensus 591 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 670 (1114)
+|++++.+|..+.++++|+.|+|++|++.+.+|..+..+++|+ .|+|++|+++|.+|..++.+++|+.|||++|+++|.
T Consensus 484 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 562 (968)
T PLN00113 484 RNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV-SLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGE 562 (968)
T ss_pred CCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCC-EEECCCCcccccCChhHhCcccCCEEECCCCccccc
Confidence 8888888888888888888888888888888888888888888 789999999999999999999999999999999999
Q ss_pred CCCccccccccceEEeccCcccCCCCCcccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccCchhhhH
Q 001253 671 IPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPSSLPFPSGTNSPTARLGKLVAII 750 (1114)
Q Consensus 671 ip~~~~~l~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lc~~p~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~i 750 (1114)
+|..+.++++|+.+++++|+++|.+|..++|.++.+.++.||+++||.+.... .++|... .....++.+++
T Consensus 563 ~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~---~~~c~~~------~~~~~~~~~~~ 633 (968)
T PLN00113 563 IPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG---LPPCKRV------RKTPSWWFYIT 633 (968)
T ss_pred CChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC---CCCCccc------cccceeeeehh
Confidence 99999999999999999999999999999999999999999999999753221 1222210 01111111222
Q ss_pred HHhHhhHHHHHHhhhhheecccc-eeecccccccccCcccccccCC--CCCCCHHHHHHHhcCCcCCceecccCCeEEEE
Q 001253 751 AAAIGGVSLVLITVIIYFLRQPV-EVVAPLQDKQLSSTVSDIYFPP--KEGFTFKDLVVATDNFDERFVIGRGACGTVYR 827 (1114)
Q Consensus 751 ~~~~~~~~l~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~ 827 (1114)
+++.+++++++++++++++|+++ ......+.... ......+.. ...++++++ ...|+..++||+|+||+||+
T Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~ 708 (968)
T PLN00113 634 CTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDG--TWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYK 708 (968)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcccccccccccc--cccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEE
Confidence 22222222222222222222221 11111111000 000001111 112333333 35678888999999999999
Q ss_pred EEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCHHHHhccCCCCC
Q 001253 828 AVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTL 906 (1114)
Q Consensus 828 ~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l 906 (1114)
|+++ +|..||||++...... ...|++.+++++|||||+++++|.+++..|+||||+++|+|.++++ .+
T Consensus 709 ~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l 777 (968)
T PLN00113 709 GKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NL 777 (968)
T ss_pred EEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cC
Confidence 9974 7899999998643321 1346888999999999999999999999999999999999999996 38
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccccccccccCccccc
Q 001253 907 DWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY 986 (1114)
Q Consensus 907 ~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~ 986 (1114)
+|.++..++.|+|+||+|||..+.++|+||||||+||+++.++.+++. ||.+..... .....+++.|||||++.
T Consensus 778 ~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~ 851 (968)
T PLN00113 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRE 851 (968)
T ss_pred CHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----CCCccccccccCccccc
Confidence 999999999999999999997666799999999999999999888875 665543221 12236889999999999
Q ss_pred cCCCCcccchHHHHHHHHHHHhCCCCCCCCC-CCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhc
Q 001253 987 TMKVTEKCDIYSYGVVLLELLTGRAPVQPLD-QGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLC 1065 (1114)
Q Consensus 987 ~~~~~~~~DvwslGvil~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 1065 (1114)
+..++.++|||||||++|||++|+.||.... ......+|.+....... ...+.++.+........+...++.+++.+|
T Consensus 852 ~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C 930 (968)
T PLN00113 852 TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHC 930 (968)
T ss_pred CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc-hhheeCccccCCCCccHHHHHHHHHHHHhh
Confidence 9999999999999999999999999996433 23456666654433322 233344444433344556677899999999
Q ss_pred cCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1066 TNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1066 l~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
|+.||++||||+||+++|+++.+..
T Consensus 931 l~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 931 TATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred CcCCchhCcCHHHHHHHHHHhhccc
Confidence 9999999999999999999986643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-61 Score=629.69 Aligned_cols=515 Identities=36% Similarity=0.539 Sum_probs=418.4
Q ss_pred ccceeccccccccccCCCCCCCCccceeeccccccCCCCccccc-ccccccEEEecCCcccCccccccccccccchhhcc
Q 001253 200 LKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIG-MLKYLTDVILWGNQLSGVIPKELGNCTSLETLALY 278 (1114)
Q Consensus 200 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 278 (1114)
++.|++++|.+++.+|..+..+++|++|+|++|++++.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|+
T Consensus 71 v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls 148 (968)
T PLN00113 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLS 148 (968)
T ss_pred EEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECc
Confidence 44444444444444444455555555555555555544554433 555555555555555554443 335556666666
Q ss_pred cccccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccCcc
Q 001253 279 DNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVI 358 (1114)
Q Consensus 279 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 358 (1114)
+|.+.+.+|..++.+++|++|+|++|.+.+.+|..++++++|++|++++|.+.+.+|..+.++++|+.|+|++|++++.+
T Consensus 149 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~ 228 (968)
T PLN00113 149 NNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228 (968)
T ss_pred CCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcC
Confidence 66665566666666666666666666666666666666666666666666666666666777777777777777777777
Q ss_pred cccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccC
Q 001253 359 PVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNT 438 (1114)
Q Consensus 359 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 438 (1114)
|..+..+++|++|++++|.+++.+|..|..+++|++|++++|++.+.+|..+..+++|++|+|++|++.+.+|..+..++
T Consensus 229 p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~ 308 (968)
T PLN00113 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ 308 (968)
T ss_pred ChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCC
Confidence 77777777788888888877777777788888888888888888877888888888899999999999888898899999
Q ss_pred ccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEec
Q 001253 439 SLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLS 518 (1114)
Q Consensus 439 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 518 (1114)
+|++|++++|.+++.+|..+..+++|+.|++++|.+.+.+|..++.+++|+.|++++|++++.+|..+..+++|+.|+++
T Consensus 309 ~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~ 388 (968)
T PLN00113 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILF 388 (968)
T ss_pred CCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcc
Q 001253 519 DNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSI 598 (1114)
Q Consensus 519 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 598 (1114)
+|.+.+.+|..+..+++|+.|++++|++++.+|..+..++.|+.|++++|++++.+|..+..+++|+.|++++|++.+.+
T Consensus 389 ~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~ 468 (968)
T PLN00113 389 SNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468 (968)
T ss_pred CCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccc
Q 001253 599 PVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNL 678 (1114)
Q Consensus 599 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l 678 (1114)
|..++ .++|+.|++++|++++.+|..+.++++|+ .|+|++|+++|.+|..++++++|++|+|++|+++|.+|.+|.++
T Consensus 469 p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 546 (968)
T PLN00113 469 PDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELM-QLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546 (968)
T ss_pred Ccccc-cccceEEECcCCccCCccChhhhhhhccC-EEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCc
Confidence 98764 58999999999999999999999999998 79999999999999999999999999999999999999999999
Q ss_pred cccceEEeccCcccCCCCCc-ccccccccccccCCCCCCCC
Q 001253 679 SSLLGCNFSYNNLTGPIPSS-QTFQNMSVNSFSGSKGLCGG 718 (1114)
Q Consensus 679 ~~l~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~lc~~ 718 (1114)
++|+.|||++|+++|.+|.. ..+..+......+|.-.+.-
T Consensus 547 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~ 587 (968)
T PLN00113 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587 (968)
T ss_pred ccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeC
Confidence 99999999999999999964 22333444445566544433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=426.98 Aligned_cols=289 Identities=46% Similarity=0.781 Sum_probs=250.0
Q ss_pred CCCCCCHHHHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEE
Q 001253 795 PKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874 (1114)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 874 (1114)
+...|+++++..|+++|...++||+|+||+||+|...+|+.||||++....... .++|..|+.++.+++|||+|+++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEE
Confidence 566799999999999999999999999999999999989999999876554432 34599999999999999999999
Q ss_pred eEEEecC-ceEEEEecCCCCCHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeE
Q 001253 875 GFCYHQG-SNLLMYEYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH 952 (1114)
Q Consensus 875 ~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 952 (1114)
|||.+.+ +.++|||||++|+|.++++.... .++|.+|++||.++|+||+|||+.+.+.|+|||||++|||+|+++++|
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9999988 59999999999999999997666 899999999999999999999999988999999999999999999999
Q ss_pred EeeccCceecCCCCCCccccc-cccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--CCCCHHHHHHHH
Q 001253 953 VGDFGLAKVIDMPQSKSMSAI-AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLD--QGGDLVTWVRNF 1029 (1114)
Q Consensus 953 l~DfG~a~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~--~~~~~~~~~~~~ 1029 (1114)
|+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+... ....+..|++..
T Consensus 218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999764321 2222222 79999999999999999999999999999999999998887543 334488998888
Q ss_pred HhcCCcccccccccccCCCccc-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1030 IRNNSLVSGMLDARLNLQDEKT-VSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
+.++ ....++|+++.. ...+ .+....+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 297 ~~~~-~~~eiiD~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCc-chhheeCCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 8776 556666887653 2233 26777899999999999999999999999999776543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=385.66 Aligned_cols=252 Identities=28% Similarity=0.435 Sum_probs=212.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-ceEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG-SNLLM 886 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv 886 (1114)
++.+..+.||+|..|+||+++++ +++.+|+|++... .++...+++.+|+++++..+||+||+++|+|...+ ...++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 34556678999999999999987 7899999999433 34456788999999999999999999999999998 49999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
||||++|+|+++++.. +.+++....+++.+|++||.|||.. .+||||||||+|||++..|.|||||||.++.+-..
T Consensus 157 mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999999844 6799999999999999999999963 29999999999999999999999999999876432
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPL-DQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
...+++||..|||||.+.+..|+.++||||||++++|+++|+.||.+. ....+..+.+...+.+. .
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p---------p-- 299 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP---------P-- 299 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC---------C--
Confidence 557889999999999999999999999999999999999999999875 22233333333322221 1
Q ss_pred CCCcccH-HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTV-SHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+..+. ....++..|+..|+++||.+||+++|+++
T Consensus 300 --P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 --PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred --CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11222 35678999999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=405.81 Aligned_cols=263 Identities=35% Similarity=0.546 Sum_probs=218.5
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-ceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG-SNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 887 (1114)
.++...+.||+|+||+||+|.|+....||||++......... .++|.+|+.++.+++|||||+++|+|.+.. ..++||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 344455569999999999999994444999999877665544 778999999999999999999999999887 789999
Q ss_pred ecCCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCCCeEECCCC-CeEEeeccCceecCC
Q 001253 888 EYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLHHDCKPR-IFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDM 964 (1114)
Q Consensus 888 E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~~~~ 964 (1114)
|||++|+|.++++. ....+++..++.++.+||+||.|||++ + |||||||++|||++.++ ++||+|||+++....
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999987 467999999999999999999999998 6 99999999999999997 999999999987542
Q ss_pred CCCCccccccccccccCccccc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAY--TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
.. ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||..... ...... .+..+
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~---v~~~~--------- 262 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASA---VVVGG--------- 262 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHH---HHhcC---------
Confidence 21 3344478999999999999 66999999999999999999999999987664 222111 11111
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCC
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGH 1092 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 1092 (1114)
.++..+......+..++.+||+.||++||++.|++..|+.++.....
T Consensus 263 ---~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 263 ---LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ---CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 01122222455788999999999999999999999999998775443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=403.97 Aligned_cols=266 Identities=27% Similarity=0.426 Sum_probs=225.7
Q ss_pred HHHHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec
Q 001253 801 FKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ 880 (1114)
Q Consensus 801 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 880 (1114)
.+.+++..+.++..+.||+|.||+||.|.++....||+|.++..... .++|.+|+++|++++|++||+++++|..+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 44455556677788899999999999999997779999999875432 46788999999999999999999999998
Q ss_pred CceEEEEecCCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 881 GSNLLMYEYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
+..|||||||+.|+|.++++. .+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..|||+|||+|
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccc
Confidence 999999999999999999986 566899999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1114)
+...+..........-+..|.|||.+....++.|||||||||+||||+| |+.||..... .+..+.+ ..+
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-~ev~~~l----e~G----- 420 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-EEVLELL----ERG----- 420 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-HHHHHHH----hcc-----
Confidence 9766555555555667889999999999999999999999999999999 8888875543 2222222 221
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
.+-+.|..++..++++|..||+.+|++||||+.+...++++....
T Consensus 421 -------yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 421 -------YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred -------CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 112234446668999999999999999999999999999986643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=394.09 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=220.2
Q ss_pred cCCcCCceecccCCeEEEEEEe-CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVL-RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.+|...+.||+|+|++||+++. .+|+.||+|++.+.........+.+.+|+++.+.++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999998 789999999999877766677888999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|+|+.++|.++++ .++.+++.+++.+.+||+.||.|||+. +|+|||||..|++++++.+|||+|||+|..+..+ .
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-G 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc-c
Confidence 9999999999998 677999999999999999999999999 9999999999999999999999999999988643 4
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
+...+.+|||.|.|||++.....+..+||||+||++|.|++|++||.... ++.....+..+++
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vkety~~Ik~~~Y------------ 235 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKETYNKIKLNEY------------ 235 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHHHHHHHhcCc------------
Confidence 55678899999999999999999999999999999999999999997432 1222222332222
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..|.....+..++|.++|+.||.+|||+++|+.
T Consensus 236 -~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 -SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 122244557889999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=378.55 Aligned_cols=255 Identities=28% Similarity=0.384 Sum_probs=214.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChh----hHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNN----VDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
.+.|.+.+.||+|+||.|-+|..+ +|+.||||++.+....... ....+++|+++|++++|||||+++++|+..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 367888999999999999999965 8999999999876544321 23446799999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC---CCeEEeeccCc
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK---FEAHVGDFGLA 959 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfG~a 959 (1114)
.|+|||||+||+|.+.+-. .+.+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|
T Consensus 251 ~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred eEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999999999873 44677788899999999999999999 99999999999999766 67999999999
Q ss_pred eecCCCCCCccccccccccccCccccccCCCC---cccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVT---EKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLV 1036 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1114)
+..+ ....+.+.||||.|.|||++.+..+. .++|+||+||++|-+++|.+||........+.+.+
T Consensus 327 K~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI---------- 394 (475)
T KOG0615|consen 327 KVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI---------- 394 (475)
T ss_pred hccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH----------
Confidence 9865 55677899999999999999876533 47899999999999999999998655444333332
Q ss_pred cccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1037 SGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+++...+....+...+..++|.+||..||++|||+.|+++
T Consensus 395 ---~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 ---LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ---hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 233444444455566778999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=370.43 Aligned_cols=202 Identities=29% Similarity=0.475 Sum_probs=182.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|...+.||+|+||+||+|+++ ++..||||.+.+..- .....+.+..|+++++.++|||||++++++..++..|+||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 67888889999999999999976 689999999987654 2334566788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC------CCeEEeeccCcee
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK------FEAHVGDFGLAKV 961 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~------~~~kl~DfG~a~~ 961 (1114)
|||.||+|.++++.. +.+++.....++.|+|.||++||++ +||||||||.|||++.. -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999999844 4899999999999999999999999 99999999999999865 4689999999998
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLD 1017 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~ 1017 (1114)
+. ......+.+|++.|||||++....|+.|+|+||+|+++||+++|+.||....
T Consensus 165 L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 165 LQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred CC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 75 4455678899999999999999999999999999999999999999997543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=357.16 Aligned_cols=267 Identities=21% Similarity=0.319 Sum_probs=221.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+.|+...++|+|+||+||+|+.+ +|+.||||++.... +++...+-..+|++++++++|||+|.++++|......++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 46788889999999999999987 79999999997544 44566677789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||++. ++.+-+......++.+.+.+++.|++.|+.|+|++ +++||||||+|||++.+|.+||||||+|+.... ..
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 99988 66666666778899999999999999999999999 999999999999999999999999999998763 44
Q ss_pred CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH----------HHHhcCCcc
Q 001253 968 KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR----------NFIRNNSLV 1036 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~----------~~~~~~~~~ 1036 (1114)
...+.++.|..|+|||.+.+ ..|+..+||||+||++.||++|.+-|++..+.+.+....+ +.+..+.+.
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 45567789999999999987 7899999999999999999999999987766555544433 334455555
Q ss_pred cccccccccCCCc---ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1037 SGMLDARLNLQDE---KTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1037 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.++.-+......+ ..+.....+.+++..|++.||.+|++-+|++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 5553333221111 12233346889999999999999999998874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=368.63 Aligned_cols=270 Identities=24% Similarity=0.309 Sum_probs=220.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
-++|++.++||+|+||+||.++.+ +++.+|+|++++...-.....+...+|..++.+++||+||+++-.|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 478999999999999999999965 7899999999987765555567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
+||+.||.|.-++++ .+.+++..+.-++..|+.||.|||+. +|||||+||+|||+|++|+++|+|||+++..- ..
T Consensus 104 ld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~-~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL-KD 178 (357)
T ss_pred EeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc-cC
Confidence 999999999999984 45788888888889999999999999 99999999999999999999999999998542 23
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.....+++||+.|||||++.+.+|+.++|.||+|+++|||++|.+||...+ ..++.+...... ..
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~----~~~~~~~I~~~k----------~~- 243 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED----VKKMYDKILKGK----------LP- 243 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc----HHHHHHHHhcCc----------CC-
Confidence 445567899999999999999999999999999999999999999997543 233333322221 11
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCCccc
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDSDQK 1105 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~~ 1105 (1114)
..+.-...+..+++.+.++.||++|..+. .+.+.-..+.++..++|+.-..
T Consensus 244 --~~p~~ls~~ardll~~LL~rdp~~RLg~~------~d~~~ik~HpfF~~inW~~l~~ 294 (357)
T KOG0598|consen 244 --LPPGYLSEEARDLLKKLLKRDPRQRLGGP------GDAEEIKRHPFFKGINWEKLLA 294 (357)
T ss_pred --CCCccCCHHHHHHHHHHhccCHHHhcCCC------CChHHhhcCcccccCCHHHHHh
Confidence 11111334678899999999999997511 2222244566777777765433
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=387.05 Aligned_cols=484 Identities=28% Similarity=0.367 Sum_probs=394.0
Q ss_pred CccccccccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCcccccccccccc
Q 001253 193 TLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSL 272 (1114)
Q Consensus 193 ~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 272 (1114)
..++-..|+.|.+++|.+. .+-+.+.++..|.+|++.+|+++ ..|.+++.+..+..|+.++|+++ .+|++++.+.+|
T Consensus 40 ~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l 116 (565)
T KOG0472|consen 40 NWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISL 116 (565)
T ss_pred hhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhh
Confidence 4444556777777777776 45556777888888888888888 78888888888888888888888 678888888888
Q ss_pred chhhcccccccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccc
Q 001253 273 ETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFEN 352 (1114)
Q Consensus 273 ~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N 352 (1114)
..|+.++|.+. .+|+.++.+..|..|+..+|+++ ..|..++.+.++..+++.+|.+....|..+. ++.|+.|+..+|
T Consensus 117 ~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N 193 (565)
T KOG0472|consen 117 VKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSN 193 (565)
T ss_pred hhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchh
Confidence 88888888754 56777888888888888899888 7888888889999999999998866555555 889999999999
Q ss_pred cccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCc
Q 001253 353 KLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPR 432 (1114)
Q Consensus 353 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 432 (1114)
.++ .+|..++.+.+|..|+|..|+|. ..| .|.+++.|++|+++.|+|.....+....++++.+|||.+|+++ ..|+
T Consensus 194 ~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pd 269 (565)
T KOG0472|consen 194 LLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPD 269 (565)
T ss_pred hhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCch
Confidence 887 66778899999999999999998 566 7999999999999999998555555668999999999999999 8899
Q ss_pred cccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccc--cccEeec--ccccCC---C-----
Q 001253 433 HICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLA--NLSTVEL--DQNQFS---G----- 500 (1114)
Q Consensus 433 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L--~~N~l~---~----- 500 (1114)
.+|-+.+|.+||+|+|.|+ ..|..++++ .|+.|-+.||.+..+-.+.+.+-+ -|++|.= ..-.++ |
T Consensus 270 e~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~ 347 (565)
T KOG0472|consen 270 EICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETA 347 (565)
T ss_pred HHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccccc
Confidence 9999999999999999999 578889999 999999999998743332222211 1222221 001111 0
Q ss_pred -C-ccc---cccccccCcEEEecCceeccCCCccccCCCC---cceeecccccccccccccccccccceE-EECcccccc
Q 001253 501 -P-IPT---EIGNCNALQRLHLSDNYFTGELPREVGNLSN---LVTFNVSSNFLTGRIPLEIFSCKMLQR-LDLSWNKFV 571 (1114)
Q Consensus 501 -~-~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~ 571 (1114)
. .+. ......+.+.|++++=+++ .+|+.....-+ ....+++.|++. .+|..+..++.+.+ +++++|.+.
T Consensus 348 ~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is 425 (565)
T KOG0472|consen 348 MTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS 425 (565)
T ss_pred CCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc
Confidence 1 111 1234567899999999999 56665544433 788999999999 89999888887765 556666554
Q ss_pred CCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccc
Q 001253 572 GALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPEL 651 (1114)
Q Consensus 572 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~ 651 (1114)
.+|..++.+++|..|+|++|-+. .+|..++.+..|+.||+|.|+|. .+|..+..+..++ .+-.++|++....|..+
T Consensus 426 -fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lE-tllas~nqi~~vd~~~l 501 (565)
T KOG0472|consen 426 -FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLE-TLLASNNQIGSVDPSGL 501 (565)
T ss_pred -cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHH-HHHhccccccccChHHh
Confidence 99999999999999999999998 89999999999999999999998 8999999999998 57677899998878889
Q ss_pred cchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCC
Q 001253 652 GNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPS 697 (1114)
Q Consensus 652 ~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~ 697 (1114)
++|.+|..|||.+|.|. .||+.++++++|++|++++|++. .|.
T Consensus 502 ~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr 544 (565)
T KOG0472|consen 502 KNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPR 544 (565)
T ss_pred hhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC--CCH
Confidence 99999999999999999 88999999999999999999997 454
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=392.48 Aligned_cols=516 Identities=28% Similarity=0.382 Sum_probs=353.9
Q ss_pred cCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCcccccccc
Q 001253 122 IGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLK 201 (1114)
Q Consensus 122 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~ 201 (1114)
.+.-..|+.|.+++|.+.. +-..+.+|..|.+|++.+|++. .+|.+++.+..++.|+.++|+++ .+|+.++.+.+|+
T Consensus 41 wW~qv~l~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~ 117 (565)
T KOG0472|consen 41 WWEQVDLQKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLV 117 (565)
T ss_pred hhhhcchhhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhh
Confidence 4455678888999998884 5556788888899999999988 78888888888888888888888 7888888888888
Q ss_pred ceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhhccccc
Q 001253 202 SFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNK 281 (1114)
Q Consensus 202 ~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 281 (1114)
.|+.++|.+. .+|+.++.+..|+.|+..+|+++ ..|..+..+.+|..|++.+|.++.. |+..-+++.|++||...|.
T Consensus 118 ~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~ 194 (565)
T KOG0472|consen 118 KLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNL 194 (565)
T ss_pred hhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhh
Confidence 8888888887 77778888888888888888888 6888888888888888888888844 4444448888888888774
Q ss_pred ccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccCccccc
Q 001253 282 QVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVE 361 (1114)
Q Consensus 282 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 361 (1114)
.+.+|..++.+.+|..|||.+|++. .+| +|+.++.|.++.++.|++.-........+.++..|+|++|+++ ..|..
T Consensus 195 -L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde 270 (565)
T KOG0472|consen 195 -LETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDE 270 (565)
T ss_pred -hhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchH
Confidence 5677888888888888888888887 566 7778888888888888877333333447777888888888877 55677
Q ss_pred ccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcC--ccceEEEeecccccCCCCccccccCc
Q 001253 362 LTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAY--SQLWVVDLSDNHLTGKIPRHICRNTS 439 (1114)
Q Consensus 362 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~~~~ 439 (1114)
++-+++|++||+|+|.|+ ..|..++++ +|+.|.+.+|.+..+-.+.+..= .-|++|.= .++.-.+..- .-.+
T Consensus 271 ~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs---~~~~dglS~s-e~~~ 344 (565)
T KOG0472|consen 271 ICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS---KIKDDGLSQS-EGGT 344 (565)
T ss_pred HHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH---hhccCCCCCC-cccc
Confidence 777777888888888877 455667777 77777777776643211111100 00111100 0000000000 0000
Q ss_pred cceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhcccc---ccEeecccccCCCCccccccccccCcE-E
Q 001253 440 LIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLAN---LSTVELDQNQFSGPIPTEIGNCNALQR-L 515 (1114)
Q Consensus 440 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~~-L 515 (1114)
-..-+ ... ........+.+.+.|++++-+++ .+|+......+ ...++++.|++. .+|..+..++.+.+ +
T Consensus 345 e~~~t----~~~-~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l 417 (565)
T KOG0472|consen 345 ETAMT----LPS-ESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDL 417 (565)
T ss_pred cccCC----CCC-Ccccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHH
Confidence 00000 000 11112334566777777777777 66666655544 777888888887 67777776666554 4
Q ss_pred EecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCC
Q 001253 516 HLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELS 595 (1114)
Q Consensus 516 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 595 (1114)
++++|.+. -+|..++.+++|..|+|++|.+. .+|.+++.+..|+.||+|.|+|. .+|..+..+..|+.+-.++|++.
T Consensus 418 ~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~ 494 (565)
T KOG0472|consen 418 VLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIG 494 (565)
T ss_pred HhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccc
Confidence 55555554 67777777888888888888777 77888888877888888888877 77777777777777777778887
Q ss_pred CcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcc
Q 001253 596 GSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNH 666 (1114)
Q Consensus 596 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 666 (1114)
...|..+.+|.+|++|||.+|.+. .||+.++++++|+ .|.|++|.|+ ..+..+-.......|..-+++
T Consensus 495 ~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~-hLeL~gNpfr-~Pr~~iLmkgT~aiL~ylrdr 562 (565)
T KOG0472|consen 495 SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLR-HLELDGNPFR-QPRHQILMKGTAAILSYLRDR 562 (565)
T ss_pred ccChHHhhhhhhcceeccCCCchh-hCChhhcccccee-EEEecCCccC-CCHHHHhccChHHHHHHhccc
Confidence 555555777788888888888776 6777777777776 6777777777 323333222334444433443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=350.29 Aligned_cols=258 Identities=23% Similarity=0.354 Sum_probs=209.6
Q ss_pred cCCcCCceecccCCeEEEEEEe-CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEe-EEEecCc-eEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVL-RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG-FCYHQGS-NLL 885 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l 885 (1114)
.+|++.++||+|.||+||+++. .+|..||.|.+.-.. .+....++...|+.++++++|||||++++ .+.++.. .++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 4577888999999999999995 489999999998433 34455778899999999999999999998 4444444 899
Q ss_pred EEecCCCCCHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 886 MYEYMARGSLGELLH---GASSTLDWQTRFMIALGAAEGLSYLHHDCKPR--IFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
||||++.|+|.++++ +....+++..+++++.|+++||..+|+.. +. |+||||||.||+++.+|.|||+|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999986 34568999999999999999999999942 24 9999999999999999999999999999
Q ss_pred ecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.+.. ......+.+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.+. .+.. +.+.+.++++.
T Consensus 177 ~l~s-~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~-L~~KI~qgd~~---- 246 (375)
T KOG0591|consen 177 FLSS-KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLS-LCKKIEQGDYP---- 246 (375)
T ss_pred Hhcc-hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHH-HHHHHHcCCCC----
Confidence 8753 333445679999999999999999999999999999999999999999754 2332 23333333221
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
+-.....+..+..+|..|+.+||+.||+...+++.++.
T Consensus 247 -------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 -------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11123455678999999999999999996555554443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=396.36 Aligned_cols=264 Identities=28% Similarity=0.438 Sum_probs=221.0
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCY 878 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 878 (1114)
.+...+....+.||+|+||+||+|+.. +...||||.++..... ...++|++|+.+++.++|||||+++|+|.
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 455677788889999999999999943 3467999999866543 35789999999999999999999999999
Q ss_pred ecCceEEEEecCCCCCHHHHhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE
Q 001253 879 HQGSNLLMYEYMARGSLGELLHGA-------------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL 945 (1114)
Q Consensus 879 ~~~~~~lv~E~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 945 (1114)
+++..|+|+|||..|||.++|.-. ...++..+.+.||.|||.||+||.++ .+|||||.++|+||
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLV 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhcee
Confidence 999999999999999999999621 12388999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeeccCceecCCCCCCccc-cccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHH
Q 001253 946 DDKFEAHVGDFGLAKVIDMPQSKSMS-AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLV 1023 (1114)
Q Consensus 946 ~~~~~~kl~DfG~a~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~ 1023 (1114)
.++..|||+|||+++.+-..+++... ...-+.+|||||.+..++|+.+||||||||++||+++ |+.||......
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---- 712 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---- 712 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH----
Confidence 99999999999999975444443333 4456789999999999999999999999999999999 99999865532
Q ss_pred HHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1024 TWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
.+-+.++.+... +.+..++.+++++|..||+..|.+||+++||-..|++.....
T Consensus 713 -EVIe~i~~g~lL------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 713 -EVIECIRAGQLL------------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred -HHHHHHHcCCcc------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 233334433321 223344567999999999999999999999999999987654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=368.77 Aligned_cols=263 Identities=25% Similarity=0.346 Sum_probs=221.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 885 (1114)
..+|..++.||+|+|++||+|+.+ +++.||||++.+.....+...+.+..|-.+|.++ .||.|++++-.|.++...|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 367999999999999999999966 7899999999887766666677788899999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|+||+++|+|.+++++. +.+++...+.++.+|+.|++|||+. |||||||||+|||+|+||++||+|||.|+.+...
T Consensus 152 vLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999999854 6899999999999999999999999 9999999999999999999999999999877532
Q ss_pred CC----------C--ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 966 QS----------K--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 966 ~~----------~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
.. . ....++||..|.+||++.....++.+|+|+||||+|+|+.|.+||.+..+. -.+++...
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----liFqkI~~-- 301 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----LIFQKIQA-- 301 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----HHHHHHHH--
Confidence 11 1 124589999999999999999999999999999999999999999765432 22222111
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCC
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDS 1102 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~ 1102 (1114)
-. .+.+......+.+++.+.|..||.+|+|..||. .+.+|..+||+.
T Consensus 302 --------l~----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk----------~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 302 --------LD----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIK----------AHPFFEGVDWEN 348 (604)
T ss_pred --------hc----ccCCCCCCHHHHHHHHHHHccCccccccHHHHh----------hCcccccCChhh
Confidence 11 222333335688999999999999999996543 356778888876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.31 Aligned_cols=268 Identities=23% Similarity=0.335 Sum_probs=211.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|...+++|+|.||.||+|++. +|+.||||+++.....+ .......+|++.++.++|+||+.++++|.+.+...+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46788889999999999999964 89999999998764432 23445678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|||+. +|+..+++....++..++..++.++++|++|+|++ .|+|||+||.|+|++++|.+||+|||+|+.+..+..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 99987 99999998888999999999999999999999999 999999999999999999999999999999875544
Q ss_pred CccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHh--cCCc--ccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIR--NNSL--VSGMLDA 1042 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~ 1042 (1114)
... ..+-|..|+|||.+.+. .|+..+||||.||++.||+-|.+-|++..+-+++...++-.-. .+.+ +..+-|-
T Consensus 157 ~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 157 IQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred ccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 332 33789999999999875 5999999999999999999998777655544444333332110 0000 0000000
Q ss_pred -cccCC-----CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1043 -RLNLQ-----DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1043 -~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
.+... ..........+.+++..++..||.+|+++.|+++.
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00000 00122334567999999999999999999998753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.94 Aligned_cols=267 Identities=21% Similarity=0.282 Sum_probs=214.9
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecC-ce
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQG-SN 883 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~ 883 (1114)
..++|.++++||.|.||.||+|+.+ +|+.||||++++.....++. .-.+|++.++++. |||||++.+++.+.+ ..
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3478999999999999999999965 78999999998776653322 2347999999998 999999999999888 89
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|+|||||+. +|++++++++..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.+.
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 999999987 99999999989999999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCccccccccccccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC---ccc-c
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS---LVS-G 1038 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~-~ 1038 (1114)
.. ...+.++.|..|+|||++. ..-|+.+.||||+|||++|+.+-++-|++..+.+++.+... .+.... +.. .
T Consensus 162 Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~-VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE-VLGTPDKDSWPEGY 238 (538)
T ss_pred cC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH-HhCCCccccchhHH
Confidence 33 3345678999999999875 56689999999999999999999999987766555444332 221111 000 0
Q ss_pred cccccccCCCc----c-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1039 MLDARLNLQDE----K-----TVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1039 ~~~~~~~~~~~----~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
-....+..+.+ . ......+..+++.+|+.|||.+||||+|.++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00111111111 1 11255678999999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=354.83 Aligned_cols=266 Identities=27% Similarity=0.347 Sum_probs=215.4
Q ss_pred hcCCcCCceecccCCeEEEEEEe-CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--CceE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVL-RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNL 884 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 884 (1114)
.+.|+.+++||+|.||.||+|++ .+|+.||+|++..+..... ......+||.++++++||||+++.+...+. +..|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 35688888999999999999996 4899999999987664332 244567899999999999999999998876 6899
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
||+|||+. ||.-++....-.+++.++..++.|+++||+|+|++ ||+|||||.+|||||.+|.+||+|||+|+++..
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999988 99999987777999999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc--
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD-- 1041 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1041 (1114)
......+..+-|..|+|||.+.+. .|+.++|+||.|||+.||+.|++.|.+..+.+.+..+++-. +...+..+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc---GSP~e~~W~~~ 347 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC---GSPTEDYWPVS 347 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh---CCCChhccccc
Confidence 666667888999999999999875 59999999999999999999999998766544444333321 111111111
Q ss_pred -----ccccCCCcc-------cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 -----ARLNLQDEK-------TVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 -----~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+...... ........++++..+|..||.+|.||.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 011111111 1112246788999999999999999998874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=374.34 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=221.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
....+.++||.|.||.||+|+++ ....||||.++..... ....+|..|+.+|.+++||||+++.|+.......+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte--kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH--HHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 44567789999999999999986 2457999999876654 44778999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+|.|||++|+|+.+|+.+++.+++.+...|.++||.||.||..+ ++|||||.++|||++.+-.+|++|||+++...+
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999999999999999999999999999999999998 999999999999999999999999999998754
Q ss_pred CCCCccccc--cccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 965 PQSKSMSAI--AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 965 ~~~~~~~~~--~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
+.....++. .-+.+|.|||.+...+++.+||||||||++||.++ |..||.++.. .+..+.+.+.
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~g------------ 850 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQG------------ 850 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhc------------
Confidence 443333332 34579999999999999999999999999999877 9999986553 2222332221
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1091 (1114)
.+-+.+.+++..+.++|..||++|-.+||.+.||+..|.++.+.-.
T Consensus 851 ----yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 851 ----YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred ----cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 1233455666789999999999999999999999999999865433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=347.28 Aligned_cols=261 Identities=25% Similarity=0.363 Sum_probs=211.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++..+||.|..++||+|+.. .++.||||++.-+..... .+.+++|+..++.++||||++++..|..+...|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 478999999999999999999964 789999999987665443 67899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 887 YEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|.||.+|++.++++.. ...+++..+..|.+++++||.|||.+ |.||||||+.|||++++|.|||+|||.+..+...
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999999743 44799999999999999999999999 9999999999999999999999999988755433
Q ss_pred CCCc---cccccccccccCccccc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 966 QSKS---MSAIAGSYGYIAPEYAY--TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 966 ~~~~---~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..+. ..+++||+.|||||++. ...|+.|+||||||++..|+.+|..||...++-..+...+ ......-.+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL----qn~pp~~~t- 254 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL----QNDPPTLLT- 254 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh----cCCCCCccc-
Confidence 2211 15679999999999954 3569999999999999999999999998766433222222 221110000
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
-....+........+.+++..|++.||.+|||++++++
T Consensus 255 ---~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 ---SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ---ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00111222233447889999999999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=363.50 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=212.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
...|+...+||+|+.|.||.|+.. +++.||||++....... .+-+..|+.+|+..+|+|||.+++.|..++..++|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 356888889999999999999954 78899999997655443 45678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
||||+||+|.|.+.. ..+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 349 MEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred EeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999999973 4599999999999999999999999 99999999999999999999999999999875333
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
....+.+|||+|||||++....|++|+||||||++++||+.|++||-.... .+.+.-...++. +
T Consensus 424 -~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----lrAlyLIa~ng~-------P---- 487 (550)
T KOG0578|consen 424 -SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYLIATNGT-------P---- 487 (550)
T ss_pred -CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----HHHHHHHhhcCC-------C----
Confidence 356788999999999999999999999999999999999999999974322 222222222211 1
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+...+......+.+|+.+||..||++||+++|+++
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 12234445568999999999999999999999985
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=391.35 Aligned_cols=269 Identities=29% Similarity=0.445 Sum_probs=220.8
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC--CCc----EEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR--TGH----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ 880 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 880 (1114)
.....+..+.||+|+||.||+|... +|. .||||.+++... .....+|.+|..+|+.++|||||+++|+|.+.
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~--~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS--EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 3566777889999999999999965 343 488888876554 34477899999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEe
Q 001253 881 GSNLLMYEYMARGSLGELLHGA------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG 954 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 954 (1114)
...++++|||++|+|..++++. ...++..+.+.++.+||+|+.||+++ ++|||||.++|+|+++...|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence 9999999999999999999976 56899999999999999999999999 99999999999999999999999
Q ss_pred eccCceecCCCCCCccc-cccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhc
Q 001253 955 DFGLAKVIDMPQSKSMS-AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRN 1032 (1114)
Q Consensus 955 DfG~a~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 1032 (1114)
|||+|+.+......... ...-+.+|||||.+..+.++.|+|||||||++||++| |..||......+-+..+.+ .
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~----g 920 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE----G 920 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh----C
Confidence 99999954333333322 2345689999999999999999999999999999999 8899986654332222222 1
Q ss_pred CCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCccccc
Q 001253 1033 NSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSP 1097 (1114)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~ 1097 (1114)
.++ +.+..+...++++|..||+.+|++||++..+++.+.++.......+..+
T Consensus 921 ---------gRL----~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~ 972 (1025)
T KOG1095|consen 921 ---------GRL----DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGP 972 (1025)
T ss_pred ---------Ccc----CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccc
Confidence 122 2333445578899999999999999999999999998866554444333
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=351.94 Aligned_cols=258 Identities=30% Similarity=0.410 Sum_probs=207.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC--ceEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG--SNLL 885 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 885 (1114)
.++...+.||+|+||+||++... +|+..|||.+....... .+.+++|+.++++++|||||+.+|...... ..++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 45777889999999999999976 58999999987653221 566889999999999999999999855544 5889
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCCeEEeeccCceecCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~~~~~ 964 (1114)
.|||+++|+|.+++.+.+..+++..+...++||++||+|||++ |||||||||+|||++. ++.+||+|||+++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999999997666899999999999999999999999 9999999999999999 79999999999987652
Q ss_pred --CCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 965 --PQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 965 --~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
........+.||+.|||||++... ....++||||+||++.||+||++||... .....++-...... .
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~-~------ 240 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGRED-S------ 240 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccC-C------
Confidence 222334567899999999999953 3345999999999999999999999753 11222222211111 0
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
.+..+........+|+.+|+..||++||||+++++----..
T Consensus 241 -----~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 241 -----LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred -----CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 01223334557889999999999999999999988665443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=362.20 Aligned_cols=277 Identities=28% Similarity=0.407 Sum_probs=224.0
Q ss_pred HHHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 802 KDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 802 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
+++++..+++.+...||+|.||+||+|+|. ..||||++.......+ ..+.|+.|+.++++-+|.||+-+.|||..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 566677788888999999999999999997 3699999987766544 6789999999999999999999999999877
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
. .+|+.||+|.+|+.+++.....++..+.+.||+|||+||.|||.+ +|||||+|..||++.++++|||+|||++..
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence 7 999999999999999998888999999999999999999999999 999999999999999999999999999975
Q ss_pred cCCC-CCCccccccccccccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 001253 962 IDMP-QSKSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 962 ~~~~-~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1114)
...- .........|...|||||+++ ..+|++.+||||||+++|||++|..||.. . ..+..-|.. ..+-.
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~-~~dqIifmV---GrG~l-- 610 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-Q-NRDQIIFMV---GRGYL-- 610 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-C-ChhheEEEe---ccccc--
Confidence 4322 122233445788999999986 45799999999999999999999999982 2 222211111 11100
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccC
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPM 1098 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~ 1098 (1114)
.++. ......+..++.+++..||..++++||.+.+|+..|+++.....+...+++
T Consensus 611 ---~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S 665 (678)
T KOG0193|consen 611 ---MPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSAS 665 (678)
T ss_pred ---Cccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcC
Confidence 1111 111223445788999999999999999999999999999776545444443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=331.97 Aligned_cols=264 Identities=22% Similarity=0.281 Sum_probs=215.6
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|+..+.||.|+||+|.+++.+ +|..+|+|++.+...-.....+....|..+++.+.||+++++++.|.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56888899999999999999987 78999999998776555445566778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||++||.|..++++ .+++++..++-+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||+|+.+.
T Consensus 124 eyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~---- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS---- 195 (355)
T ss_pred eccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec----
Confidence 99999999999984 45789999999999999999999999 99999999999999999999999999999864
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
....+.||||.|+|||++...+|..++|.|||||++|||+.|.+||.....-.. .+.+- .+.
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i-----Y~KI~---------~~~---- 257 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI-----YEKIL---------EGK---- 257 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH-----HHHHH---------hCc----
Confidence 235678999999999999999999999999999999999999999986543111 11111 111
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhhccCCCcccccCCCCCcc
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRP-TMREVVLMLSESNRRQGHFEFSPMDHDSDQ 1104 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~~~~~~~~~~~~~~~ 1104 (1114)
-.++......+.+++...++.|-.+|- ++. ...+..-.+.++..++|+.--
T Consensus 258 v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlk------nG~~dIk~H~wF~~v~W~~i~ 309 (355)
T KOG0616|consen 258 VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLK------NGVEDIKNHPWFKGVDWEAIL 309 (355)
T ss_pred ccCCcccCHHHHHHHHHHHhhhhHhhhcCcC------CCccccccCcccccccHHHHh
Confidence 223334445678899999999988882 211 123334455566666665433
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=367.72 Aligned_cols=269 Identities=26% Similarity=0.374 Sum_probs=220.6
Q ss_pred HHHHHhcCCcCCceecccCCeEEEEEEeCC--C---cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEE
Q 001253 803 DLVVATDNFDERFVIGRGACGTVYRAVLRT--G---HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFC 877 (1114)
Q Consensus 803 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 877 (1114)
.|+...++....++||+|+||.||+|+++. + ..||||..+...........+|..|+++++.++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344556677777899999999999999762 2 23899998865555566788899999999999999999999999
Q ss_pred EecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeecc
Q 001253 878 YHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957 (1114)
Q Consensus 878 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 957 (1114)
..+...++|||+|.||+|.+++++....++..++..++.++|+||+|||++ +++||||.++|+|++.++.+||+|||
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccc
Confidence 999999999999999999999998887899999999999999999999999 99999999999999999999999999
Q ss_pred CceecCCCCCCccc-cccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 001253 958 LAKVIDMPQSKSMS-AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSL 1035 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1114)
+++... ...... ...-+.+|+|||.+....|+.++|||||||++||+++ |..||.+.... .++..+..+.+
T Consensus 308 Ls~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----~v~~kI~~~~~ 380 (474)
T KOG0194|consen 308 LSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----EVKAKIVKNGY 380 (474)
T ss_pred cccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----HHHHHHHhcCc
Confidence 998643 111111 2236789999999999999999999999999999999 88899865532 23333311111
Q ss_pred ccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCC
Q 001253 1036 VSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGH 1092 (1114)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 1092 (1114)
. -..+......+..++.+||..+|++||+|.++.+.++.+......
T Consensus 381 r-----------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 381 R-----------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred c-----------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1 111223344677888899999999999999999999998666443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=351.49 Aligned_cols=275 Identities=26% Similarity=0.305 Sum_probs=218.2
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
..++|+...+||+|+||.||.|+-+ +|+.+|+|++++.........+.++.|-.+|...++|.||+++-.|++.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999966 799999999998876655567778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC-
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM- 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~- 964 (1114)
||||++||++..+|. ..+.+++..+...+.+.+-|++.+|.. |+|||||||+|+|||..|++||+|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999998 455888888888888999999999999 999999999999999999999999999852210
Q ss_pred ---------------------CCCC------------------------ccccccccccccCccccccCCCCcccchHHH
Q 001253 965 ---------------------PQSK------------------------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSY 999 (1114)
Q Consensus 965 ---------------------~~~~------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl 999 (1114)
+... .....+|||.|||||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 0112479999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 001253 1000 GVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079 (1114)
Q Consensus 1000 Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1079 (1114)
|||+|||+.|.+||.+....+.+...+.- ..-+. .+.......+..++|.+|+. ||++|.....+
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nw------------r~~l~--fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNW------------RETLK--FPEEVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHH------------hhhcc--CCCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 99999999999999865543332222111 11111 22222333678899999999 99999873221
Q ss_pred HHHHHhhhccCCCcccccCCCCCccccc
Q 001253 1080 VLMLSESNRRQGHFEFSPMDHDSDQKLE 1107 (1114)
Q Consensus 1080 l~~L~~i~~~~~~~~~~~~~~~~~~~~~ 1107 (1114)
++ .-.+.+|..++|+.--+.+
T Consensus 440 ----~E---IK~HPfF~~v~W~~l~~~~ 460 (550)
T KOG0605|consen 440 ----EE---IKKHPFFKGVDWDHLREMP 460 (550)
T ss_pred ----HH---HhcCCccccCCcchhhcCC
Confidence 11 1245677777777655444
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=363.51 Aligned_cols=398 Identities=23% Similarity=0.181 Sum_probs=340.5
Q ss_pred cccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCC
Q 001253 321 LEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDN 400 (1114)
Q Consensus 321 ~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 400 (1114)
+.||+++|.+...-+..|.++++|+.++|.+|.++ .+|.......+|+.|+|.+|.|+..-.+.+..++.|+.|||+.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 45888888888777888888888888888888888 55655555667888888888888777778888888888888888
Q ss_pred cccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCc
Q 001253 401 SLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPS 480 (1114)
Q Consensus 401 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 480 (1114)
.|+.+.-..|..-.++++|+|++|.|+..-...|..+.+|..|.|++|+++...+..|.++++|+.|+|..|+|.-..--
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~l 239 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGL 239 (873)
T ss_pred hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhh
Confidence 88877777787778899999999999988888888888999999999999977777888899999999999998855467
Q ss_pred hhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccc
Q 001253 481 DLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKML 560 (1114)
Q Consensus 481 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 560 (1114)
.|.+|++|+.|.|..|.|+..--..|..|.++++|+|+.|+++..-..++-+|+.|+.|+||+|.|...-++.+.-+++|
T Consensus 240 tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL 319 (873)
T KOG4194|consen 240 TFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKL 319 (873)
T ss_pred hhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccc
Confidence 88999999999999999997778889999999999999999998888899999999999999999997777888889999
Q ss_pred eEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCC---hhhcCcchhhHHhh
Q 001253 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIP---AELGSLSSLQIALN 637 (1114)
Q Consensus 561 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~~L~ 637 (1114)
++||||+|+|+...+.+|..|.+|++|+|++|.++-.-...|..+++|++|||++|.|++.|- ..|..|++|+ .|.
T Consensus 320 ~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lr-kL~ 398 (873)
T KOG4194|consen 320 KELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLR-KLR 398 (873)
T ss_pred eeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhh-hee
Confidence 999999999998888999999999999999999997667788999999999999999987653 4577899998 799
Q ss_pred cccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCCcccccccccccccCC-CCCC
Q 001253 638 LSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGS-KGLC 716 (1114)
Q Consensus 638 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n-~~lc 716 (1114)
|-+|+|....-..|..+..||+|||.+|.|-.+-|..|..+ .|+.|-++.-++-|.+-..|-.+|+-...+... ...|
T Consensus 399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~qWl~~~~lq~sv~a~C 477 (873)
T KOG4194|consen 399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQWLYRRKLQSSVIAKC 477 (873)
T ss_pred ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHHHHHhcccccceeeec
Confidence 99999997766799999999999999999999999999999 899999988888888877776666655444322 3578
Q ss_pred CCCCC
Q 001253 717 GGPLQ 721 (1114)
Q Consensus 717 ~~p~~ 721 (1114)
+.|-.
T Consensus 478 ayPe~ 482 (873)
T KOG4194|consen 478 AYPEP 482 (873)
T ss_pred cCCcc
Confidence 87754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=349.73 Aligned_cols=249 Identities=27% Similarity=0.387 Sum_probs=209.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
..|+....||+|+||.||+|.+. +++.||+|++.-....+ ...++++|+.++..++++||.++|+.|..+...+++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 45777789999999999999965 78999999997655433 3667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|||.||++.+.++ .+..+++.....+.+++..|+.|+|++ +.+|||||+.||++..+|.||++|||.+........
T Consensus 91 ey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 91 EYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999999998 334558888889999999999999999 999999999999999999999999999988754433
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.. .+++|||.|||||++.+..|+.|+||||+|++.+||.+|.+|+....+-.-+ .+..+. ..
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl---------------flIpk~--~P 228 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL---------------FLIPKS--AP 228 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE---------------EeccCC--CC
Confidence 33 7899999999999999999999999999999999999999999865541110 000111 11
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+.........+.+|+..|++.||+.||+|+++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1112244557889999999999999999998865
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=353.95 Aligned_cols=242 Identities=32% Similarity=0.486 Sum_probs=204.8
Q ss_pred CcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecC
Q 001253 811 FDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYM 890 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 890 (1114)
+...+-||.|+.|.||.|+++ ++.||||+++.-. +.+++-+++++||||+.+.|+|.....+|+|||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 334456999999999999998 7899999985332 35888999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcc
Q 001253 891 ARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 970 (1114)
Q Consensus 891 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 970 (1114)
..|-|...++ .+..++......+..+||.||.|||.+ +|||||||.-||||..+..|||+|||-++.... ....
T Consensus 195 a~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~--~STk 268 (904)
T KOG4721|consen 195 AQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD--KSTK 268 (904)
T ss_pred ccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh--hhhh
Confidence 9999999998 456788899999999999999999999 999999999999999999999999999987653 2455
Q ss_pred ccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcc
Q 001253 971 SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEK 1050 (1114)
Q Consensus 971 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1114)
..++||+.|||||++...+.+.|+|||||||++|||+||..||...+...- + -++-.-. +.-..
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----I----------wGVGsNs--L~Lpv 332 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----I----------WGVGSNS--LHLPV 332 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----E----------EeccCCc--ccccC
Confidence 678999999999999999999999999999999999999999976553211 0 0110111 12334
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1051 TVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1051 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
+..+...+.-+++.||+..|..||+|++++.-|+-
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 45566678889999999999999999999988854
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.93 Aligned_cols=365 Identities=22% Similarity=0.210 Sum_probs=305.7
Q ss_pred cchhhcccccccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeeccc
Q 001253 272 LETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFE 351 (1114)
Q Consensus 272 L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~ 351 (1114)
-+.|++++|++...-+..|.++++|+++++.+|.++ .||...+...+++.|+|.+|.|...-...+..++.|++|||+.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 356888888888888888888999999999999987 7888777777899999999998888888888899999999999
Q ss_pred ccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCC
Q 001253 352 NKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIP 431 (1114)
Q Consensus 352 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 431 (1114)
|.|+.+.-..|..-.++++|+|++|+|+..-...|..+.+|..|.|+.|+++...+..|..+++|+.|||..|+|.-.--
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ 238 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG 238 (873)
T ss_pred chhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence 99998777888887889999999999998888889999999999999999988888888889999999999998874445
Q ss_pred ccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCcccccccccc
Q 001253 432 RHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNA 511 (1114)
Q Consensus 432 ~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 511 (1114)
-.|.++++|+.|.|..|.+...-...|..+.++++|+|+.|++...-..++.+|+.|+.|+||+|.|..+-++.+..+++
T Consensus 239 ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftqk 318 (873)
T KOG4194|consen 239 LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQK 318 (873)
T ss_pred hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccc
Confidence 67888889999999999888777777888899999999999988777888888999999999999998888888888889
Q ss_pred CcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCch---hhhhcccCCeee
Q 001253 512 LQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPR---EIGSLFQLELLK 588 (1114)
Q Consensus 512 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~ 588 (1114)
|+.||||+|+|+...+++|..|..|+.|+|++|++...-...|..+++|+.|||++|.+++.+.+ .|..|++|+.|+
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~ 398 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR 398 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence 99999999999888888888888899999999988854455566788888888888888876543 466678888888
Q ss_pred ccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcc
Q 001253 589 LSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLS 639 (1114)
Q Consensus 589 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls 639 (1114)
|.+|+|..+...+|..+..|+.|||.+|.|...-|..|..+ .|+ .|-++
T Consensus 399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk-~Lv~n 447 (873)
T KOG4194|consen 399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELK-ELVMN 447 (873)
T ss_pred ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhh-hhhhc
Confidence 88888886666778888888888888888877777777777 666 45543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=363.04 Aligned_cols=246 Identities=26% Similarity=0.330 Sum_probs=209.6
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 884 (1114)
.-++|...++||+|+||+|+++..+ +++.+|||++++...-..+..+..+.|.+++... +||.++.++.+|+..++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3478999999999999999999987 7889999999998776666677788888888777 5999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||+.||++..+.+ .+.+++..+.-+|..|+.||+|||++ +|||||||.+|||+|.+|.+||+|||+++.. +
T Consensus 446 fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~-m 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG-M 519 (694)
T ss_pred EEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc-C
Confidence 9999999999544443 56899999999999999999999999 9999999999999999999999999999863 2
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
.......+++|||.|||||++.+..|+.++|.|||||++|||+.|..||++.++.+. .+. .+
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-Fds-----------------I~ 581 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-FDS-----------------IV 581 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHH-----------------Hh
Confidence 344567889999999999999999999999999999999999999999986543221 111 11
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTM 1076 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1076 (1114)
.....++.-...+...++++++..+|++|..+
T Consensus 582 ~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11223444455678899999999999999877
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=351.35 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=212.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|.+.+.||+|+||+||||+.+ +.+.||+|.+.+...... ..+.+++|++++++++|||||.++++|+...+.++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k-~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEK-ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchH-HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 46777888999999999999977 789999999987765443 3567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+.| +|..++. ..+.++++.+..++.+++.||.|||+. +|.|||+||+|||++..+++|+||||+|+.+.. ..
T Consensus 81 e~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 99988 9999998 456899999999999999999999999 999999999999999999999999999998653 33
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......|||.|||||.+.+.+|+..+|+||+||++||+++|++||... .+.+.++....+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~I~~d~-------------- 216 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR----SITQLVKSILKDP-------------- 216 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH----HHHHHHHHHhcCC--------------
Confidence 4445678999999999999999999999999999999999999999742 2233333322221
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+..++...+..||.+|.+..+++.
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1223355667889999999999999999998763
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=348.42 Aligned_cols=266 Identities=24% Similarity=0.388 Sum_probs=217.6
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
.+.....++++||+|.||.|.+|....+..||||+++..... ...++|.+|+++|.+++|||||.++|+|..++..++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 455677788899999999999999987899999999876543 336889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 886 MYEYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
|+|||++|+|.+++..+.. ..+.....+|+.|||.||+||.+. ++||||+.++|+|++.++++||+|||+++.+-.
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999999986533 235666778999999999999998 999999999999999999999999999995433
Q ss_pred CCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 965 PQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT--GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 965 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
.+. +.....+-+.+|||||.+.-++++.++|||+||+++||+++ ...||....+ ++.++-...+.+......
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~~~~---- 764 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQGRQV---- 764 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCCcce----
Confidence 333 33445677889999999999999999999999999999876 7889975543 222233333333322111
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
....+.-+...++++|.+||+.|.++||+++++...|++.
T Consensus 765 -----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 -----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1223344556788999999999999999999999988764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=354.05 Aligned_cols=258 Identities=25% Similarity=0.359 Sum_probs=212.9
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCC-C-hhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCc
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREG-N-NNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 882 (1114)
..+.|.+.+.||+|+||+||.|+.. +|+.||+|++.+.... . ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3478999999999999999999865 7899999977664221 1 133556778999999999 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-CCeEEeeccCcee
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK-FEAHVGDFGLAKV 961 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG~a~~ 961 (1114)
.|+||||+.||+|.+++.. ...+.+.....+++|+++|++|+|+. ||+||||||+||+++.+ +++||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999996 67899999999999999999999999 99999999999999999 9999999999997
Q ss_pred cCCCCCCccccccccccccCccccccCC-CC-cccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMK-VT-EKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
.. .......+.+|++.|+|||++.+.. |+ .++||||+||++|.|++|+.||.... .....+. +..+
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~----~~~l~~k-i~~~------ 238 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN----VPNLYRK-IRKG------ 238 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc----HHHHHHH-HhcC------
Confidence 64 3445667889999999999999987 86 78999999999999999999998622 2222222 2221
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
.+..+.... ..++..++.+|+..||.+|+++.+++ .-.-++
T Consensus 239 ---~~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 239 ---EFKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred ---CccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 111111111 55788999999999999999999999 433333
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=362.26 Aligned_cols=262 Identities=25% Similarity=0.423 Sum_probs=206.8
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCY 878 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 878 (1114)
+..++|++.++||+|+||.||+|.+. +++.||||++..... ....+.+..|+.+++.+ +||||++++++|.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 45678999999999999999999742 356899999875432 22345688999999999 8999999999987
Q ss_pred ecC-ceEEEEecCCCCCHHHHhccCC------------------------------------------------------
Q 001253 879 HQG-SNLLMYEYMARGSLGELLHGAS------------------------------------------------------ 903 (1114)
Q Consensus 879 ~~~-~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------------ 903 (1114)
..+ ..++||||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 644 5789999999999999986421
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC-Cccccccc
Q 001253 904 -------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAG 975 (1114)
Q Consensus 904 -------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g 975 (1114)
..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++....... .......+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 2477888999999999999999998 999999999999999999999999999986532221 12223456
Q ss_pred cccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHH
Q 001253 976 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSH 1054 (1114)
Q Consensus 976 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1114)
++.|+|||++.+..++.++|||||||++|||++ |..||.......... .....+.. .. .+...
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~----~~~~~~~~--------~~----~~~~~ 302 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC----QRLKDGTR--------MR----APENA 302 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH----HHHhcCCC--------CC----CCCCC
Confidence 788999999999999999999999999999997 999997544322211 11111111 00 11122
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1055 MITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1055 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
...+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3468899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=323.54 Aligned_cols=264 Identities=24% Similarity=0.287 Sum_probs=210.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe--cCceEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH--QGSNLL 885 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 885 (1114)
++|+..++|++|+||.||+|+++ +++.||+|+++...+...-.. ...+|+.++.+++|||||.+.++... -+..|+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 56888899999999999999976 789999999987765433322 34579999999999999999998764 357899
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|||||+. +|..+++.....+...++..+..|+++|++|||.. .|+|||+|++|+|++..|.+||+|||+|+.++.+
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999998 99999998888999999999999999999999999 9999999999999999999999999999998754
Q ss_pred CCCccccccccccccCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc-
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR- 1043 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1043 (1114)
....+..+-|..|+|||.+.+.+ |+.+.||||+|||+.||+++++-|++...-+.+...++.. +-..+.++.+-
T Consensus 231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll---GtPte~iwpg~~ 306 (419)
T KOG0663|consen 231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL---GTPSEAIWPGYS 306 (419)
T ss_pred -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh---CCCccccCCCcc
Confidence 34556678899999999998754 8999999999999999999999998766544444443321 11111111110
Q ss_pred ---------ccCC------CcccHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 ---------LNLQ------DEKTVS-HMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ---------~~~~------~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+... ..+... ....-++++...+..||.+|.||.|.++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0000 001111 2246788999999999999999999764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.45 Aligned_cols=270 Identities=27% Similarity=0.353 Sum_probs=212.5
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHH--HhcCCCCceeeEEeEEEecC-
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILT--LGKIRHRNIVKLYGFCYHQG- 881 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~- 881 (1114)
.....+.++.+.||+|.||.||+|+|+ |+.||||+|....+. .+.+|.++ ..-++|+||+.+++.-..+.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~------SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER------SWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccchh------hhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 345678999999999999999999999 999999999765542 34444444 44569999999998765433
Q ss_pred ---ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCeEECCCCCeEE
Q 001253 882 ---SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD-----CKPRIFHRDIKSNNILLDDKFEAHV 953 (1114)
Q Consensus 882 ---~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlk~~Nill~~~~~~kl 953 (1114)
..+||++|.+.|||+|++. ...++....++++..+|.||++||.. .+|.|+|||||++||||..++.+.|
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~--r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLN--RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHh--hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 5689999999999999998 46899999999999999999999985 4889999999999999999999999
Q ss_pred eeccCceecCCCC---CCccccccccccccCccccccCC----C--CcccchHHHHHHHHHHHhC----------CCCCC
Q 001253 954 GDFGLAKVIDMPQ---SKSMSAIAGSYGYIAPEYAYTMK----V--TEKCDIYSYGVVLLELLTG----------RAPVQ 1014 (1114)
Q Consensus 954 ~DfG~a~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~----~--~~~~DvwslGvil~el~tg----------~~p~~ 1014 (1114)
+|+|+|....... .......+||.+|||||++...- + -..+||||||.++||++-+ +.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 9999998764332 12345678999999999986421 1 1368999999999999752 37888
Q ss_pred CCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1015 PLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
+..+.+...+..++.+-...+ .+.+. ......+....+.++|+.||..+|.-|-|+--+.+.|.++...
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~-----RP~ip-nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKL-----RPNIP-NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred cCCCCCCCHHHHhcceeeccc-----CCCCC-cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 777666655555543332111 11111 1234566778899999999999999999999999999988653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.49 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=214.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+-|+.++.||.|+.|.|..|++. +|+.+|||++.+...-.+.....+++|+-+|+.+.||||++++++++...+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45788889999999999999964 89999999998876555555677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||++||.|.+++-. .+.+++.++.+++.||+.|+.|+|+. +|+|||+||+|+|+|..+.+||+|||+|..- ...
T Consensus 92 Eyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe--~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE--VPG 165 (786)
T ss_pred EecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc--cCC
Confidence 99999999999974 45788888999999999999999999 9999999999999999999999999999863 355
Q ss_pred CccccccccccccCccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVT-EKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
....+.||.|+|.|||++.+.+|+ .++||||+|||+|.+++|+-||++ +. .+.+-..++.+.+
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dN-ir~LLlKV~~G~f----------- 229 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DN-IRVLLLKVQRGVF----------- 229 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----cc-HHHHHHHHHcCcc-----------
Confidence 667788999999999999999986 589999999999999999999972 22 2233333443332
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
+.+-....++.+++.+|+..||++|.|++||++-
T Consensus 230 --~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 --EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2233344578899999999999999999999763
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=312.98 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=216.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
-++|++.+.||+|.||.||.|+.+ ++-.||+|++.+..........++++|+++...++||||++++++|.++...|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 368999999999999999999966 6789999999988776666788899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 887 YEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
+||.++|++...+... ...+++.....+..|+|.|+.|+|.. +|+||||||+|+|++.++.+|++|||.+...
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~--- 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA--- 174 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec---
Confidence 9999999999999743 44688899999999999999999998 9999999999999999999999999999863
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
+.....+.+||..|.|||+..+..++..+|+|++|++.||++.|.+||......+ ..+.++. .+
T Consensus 175 p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-tYkrI~k-------------~~-- 238 (281)
T KOG0580|consen 175 PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-TYKRIRK-------------VD-- 238 (281)
T ss_pred CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-HHHHHHH-------------cc--
Confidence 2556678899999999999999999999999999999999999999998655322 2222222 00
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.++|.+|+..+|.+|.+..|++.
T Consensus 239 --~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 239 --LKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred --ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1122333456889999999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.82 Aligned_cols=262 Identities=24% Similarity=0.398 Sum_probs=222.0
Q ss_pred HHHHHHhcCCcCCceecccCCeEEEEEEeCC-CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec
Q 001253 802 KDLVVATDNFDERFVIGRGACGTVYRAVLRT-GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ 880 (1114)
Q Consensus 802 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 880 (1114)
++|+....++.+.++||-|.||.||.|.|+. .-.||||.++.+... ..+|..|+.+|+.++|||+|+++|+|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 4566667788899999999999999999983 567999999765443 67899999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 881 GSNLLMYEYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
..+|+|+|||..|+|.++++.... .++.-..+.||.||++||+||... ++||||+.++|+||.++..||++|||++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999999986543 677778899999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1114)
+.+..+....+....-+..|.|||.+....++.|+|||+|||++||+.| |-.||++.+- ..+.+.+.++-.
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----SqVY~LLEkgyR--- 484 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYGLLEKGYR--- 484 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----HHHHHHHhcccc---
Confidence 9886555555555566789999999999999999999999999999998 8899975542 233333333211
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
-+.+..+...++++|+.||+|.|.+||+++|+-+.++.+.
T Consensus 485 ---------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 485 ---------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ---------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 2234455668999999999999999999999999997763
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=342.14 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=203.8
Q ss_pred ceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe----cCceEEEEecC
Q 001253 815 FVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH----QGSNLLMYEYM 890 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~ 890 (1114)
..||+|++|.||+|.+. |+.||||++...........+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 67999999999999984 89999999987655554445778899999999999999999999877 34678999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcc
Q 001253 891 ARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 970 (1114)
Q Consensus 891 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 970 (1114)
++|+|.++++.. ..+++.....++.+++.|++|+|+.. +++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---- 177 (283)
T PHA02988 105 TRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---- 177 (283)
T ss_pred CCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence 999999999853 47899999999999999999999732 78899999999999999999999999998654222
Q ss_pred ccccccccccCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 971 SAIAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 971 ~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..........+. +.
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----~~~~~~i~~~~~--------~~---- 241 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----KEIYDLIINKNN--------SL---- 241 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhcCC--------CC----
Confidence 23468899999999876 6799999999999999999999999975432 222222211111 11
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
..+......+.+++.+||+.||++|||++|+++.|++...
T Consensus 242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111234468899999999999999999999999998754
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=343.50 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=203.2
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEec
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
|+..+.||+|+||+||+|..+ +|+.||+|++.............+.+|+.++++++|++|+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677889999999999999975 7899999998765433333345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 890 MARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 890 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
+++|+|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++..... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GE 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC--CC
Confidence 9999999887643 34689999999999999999999998 999999999999999999999999999987532 22
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
......|++.|+|||++.+..++.++||||+||++|||++|+.||............ ...+... . .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~-~~~~~~~---------~----~ 222 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV-DRRVKED---------Q----E 222 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH-HHHhhcc---------c----c
Confidence 233457999999999999999999999999999999999999999865432221111 1111110 0 0
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPT-----MREVVL 1081 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1081 (1114)
..+......+.+++.+||+.||++||+ ++++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111122346788999999999999997 677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=380.94 Aligned_cols=504 Identities=32% Similarity=0.373 Sum_probs=296.1
Q ss_pred EEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhccccc
Q 001253 107 LDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNI 186 (1114)
Q Consensus 107 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i 186 (1114)
+|+|..++. .||..+-+-..++.|+++.|.+-...-....+.-+|+.|||++|++. .+|..+..+.+|+.|.++.|-|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 566666664 56666655555777777777665432233444445777777777776 6666666666666666666665
Q ss_pred CCCCCCCccccccccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCcccccc
Q 001253 187 SGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKEL 266 (1114)
Q Consensus 187 ~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l 266 (1114)
. ..|.+..++.+|++|.|.+|++. ..|.++..+++|+.|+++.|.+. .+|..+
T Consensus 81 ~-------------------------~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i 133 (1081)
T KOG0618|consen 81 R-------------------------SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVI 133 (1081)
T ss_pred h-------------------------hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhH
Confidence 5 34445555556666666666665 56666666666666666666665 456667
Q ss_pred ccccccchhhcccccccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccce
Q 001253 267 GNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLEL 346 (1114)
Q Consensus 267 ~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~ 346 (1114)
..++.++.+..++|.....+ +... ++.+++..|.+.+.++..+..+.. .|||++|.++ -..+..+.+|+.
T Consensus 134 ~~lt~~~~~~~s~N~~~~~l----g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~ 203 (1081)
T KOG0618|consen 134 EVLTAEEELAASNNEKIQRL----GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEV 203 (1081)
T ss_pred HhhhHHHHHhhhcchhhhhh----cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhh
Confidence 77777777777777322222 2222 777777777777777777776666 6788888776 234666777888
Q ss_pred eecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccc
Q 001253 347 LYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHL 426 (1114)
Q Consensus 347 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 426 (1114)
+....|++....- .-++|+.|+.++|.++...+ . ..-.+|+++++++|++++. |++++.+.+|+.|+..+|+|
T Consensus 204 l~c~rn~ls~l~~----~g~~l~~L~a~~n~l~~~~~-~-p~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l 276 (1081)
T KOG0618|consen 204 LHCERNQLSELEI----SGPSLTALYADHNPLTTLDV-H-PVPLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRL 276 (1081)
T ss_pred hhhhhcccceEEe----cCcchheeeeccCcceeecc-c-cccccceeeecchhhhhcc-hHHHHhcccceEecccchhH
Confidence 8888888764321 23678888888888773222 1 1234566667777766643 36666667777777777777
Q ss_pred cCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchh-hcccc-ccEeecccccCCCCccc
Q 001253 427 TGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDL-CKLAN-LSTVELDQNQFSGPIPT 504 (1114)
Q Consensus 427 ~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~-L~~L~L~~N~l~~~~p~ 504 (1114)
+ .+|..+...++|++|.+.+|.+. .+|.....+++|++|+|..|+|. .+|+.+ ..+.. |+.|+.+.|+++.....
T Consensus 277 ~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~ 353 (1081)
T KOG0618|consen 277 V-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSY 353 (1081)
T ss_pred H-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccc
Confidence 4 56666666667777777777766 55666666667777777777666 444432 22222 55555566665522211
Q ss_pred cccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccc-cccccccceEEECccccccCCCchhhhhccc
Q 001253 505 EIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPL-EIFSCKMLQRLDLSWNKFVGALPREIGSLFQ 583 (1114)
Q Consensus 505 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 583 (1114)
.=...+.|+.|+|.+|+++...-..+.+.++|+.|+|++|+|. .+|+ .+.++..|+.|+||+|+++ .+|..+..+..
T Consensus 354 ~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~ 431 (1081)
T KOG0618|consen 354 EENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGR 431 (1081)
T ss_pred cchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhh
Confidence 1113344555555555555444444555555555555555554 3332 2334555555555555554 44455555555
Q ss_pred CCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccC-CccccchhhhHhhhc
Q 001253 584 LELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLI-PPELGNLILLEYLLL 662 (1114)
Q Consensus 584 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L 662 (1114)
|++|...+|+|. ..| .+..++.|+.+|+|.|+|+ ... |.... -++|++|||
T Consensus 432 L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~-------------------------~~~l~~~~p-~p~LkyLdl 483 (1081)
T KOG0618|consen 432 LHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLS-------------------------EVTLPEALP-SPNLKYLDL 483 (1081)
T ss_pred hHHHhhcCCcee-ech-hhhhcCcceEEecccchhh-------------------------hhhhhhhCC-Ccccceeec
Confidence 555555555554 344 4444555555555555444 322 22222 156777777
Q ss_pred cCcccccCCCCccccccccceEEeccC
Q 001253 663 NNNHLSGEIPGSFVNLSSLLGCNFSYN 689 (1114)
Q Consensus 663 s~N~l~g~ip~~~~~l~~l~~l~ls~N 689 (1114)
++|.-.-.--..|..+.++..+++.-|
T Consensus 484 SGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 484 SGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred cCCcccccchhhhHHhhhhhheecccC
Confidence 777643344455666666767776666
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=329.62 Aligned_cols=273 Identities=26% Similarity=0.372 Sum_probs=201.6
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHh--cCCCCceeeEEeEEEecC----c
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLG--KIRHRNIVKLYGFCYHQG----S 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~----~ 882 (1114)
...+..+.||+|.||.||||.++ ++.||||++.... .+.|..|-++.+ .++|+||++++++-+..+ +
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 34455568999999999999998 5999999996543 455666666655 558999999999877655 7
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCeEECCCCCeEEeec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC------KPRIFHRDIKSNNILLDDKFEAHVGDF 956 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlk~~Nill~~~~~~kl~Df 956 (1114)
+++|+||.+.|+|.++++ ...++|....+|+..+++||+|||+.. +|+|+|||||.+||||..|+++.|+||
T Consensus 283 ywLVt~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eeEEeeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 899999999999999998 567999999999999999999999864 679999999999999999999999999
Q ss_pred cCceecCCCCC-CccccccccccccCccccccCC-CC-----cccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 001253 957 GLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMK-VT-----EKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNF 1029 (1114)
Q Consensus 957 G~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~-~~-----~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 1029 (1114)
|+|..+..... ......+||.+|||||++.+.- +. .+.||||+|.++|||+++...+.+ ....++.--....
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAE 439 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHH
Confidence 99998763322 2233478999999999987543 22 368999999999999997654432 1111110001111
Q ss_pred HhcCCccccccc----cccc--CC-CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 001253 1030 IRNNSLVSGMLD----ARLN--LQ-DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1030 ~~~~~~~~~~~~----~~~~--~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1091 (1114)
+...+-.+.+.+ .+.+ .+ ....-..+..+.+.+..||+.||+.|.|+.=|-+.+.+++....
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 111111111110 0000 00 01111345578889999999999999999999999988866544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=329.01 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=216.0
Q ss_pred cCCcCCceecccCCeEEEEEEe-CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVL-RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.+|++.+.||+|.||.|-+|.. ..|+.||||.+++....++...-.+++|+++|..++||||++++++|+..+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 6788889999999999999996 589999999999988877777778899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||..+|.|+|++.. .+.+++.+...+++||.+|+.|+|.+ +++|||+|.+|||+|+++++||+|||++-.+. ..
T Consensus 133 EYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~--~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA--DK 206 (668)
T ss_pred EecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc--cc
Confidence 99999999999984 45899999999999999999999999 99999999999999999999999999998865 45
Q ss_pred CccccccccccccCccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVT-EKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
...++++|+|-|.+||++.+.+|. +.+|-||+||++|.++.|..||++.+. ...+++ +..+.+.+
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQ-Is~GaYrE--------- 272 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQ-ISRGAYRE--------- 272 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHH-hhcccccC---------
Confidence 567889999999999999999986 689999999999999999999975442 222322 23332211
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1083 (1114)
+ +......-+|++|+..+|++|.|..+|..-.
T Consensus 273 -P----~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 -P----ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -C----CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1 1112456789999999999999999987654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=354.34 Aligned_cols=261 Identities=25% Similarity=0.401 Sum_probs=207.1
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEe------CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVL------RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFC 877 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 877 (1114)
....++|++.++||+|+||+||+|++ .++..||||+++..... ...+.+.+|+.+++.+ +||||++++++|
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34456899999999999999999974 24568999998754332 2345688899999999 899999999999
Q ss_pred EecCceEEEEecCCCCCHHHHhccCC------------------------------------------------------
Q 001253 878 YHQGSNLLMYEYMARGSLGELLHGAS------------------------------------------------------ 903 (1114)
Q Consensus 878 ~~~~~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------------ 903 (1114)
.+.+..++||||+++|+|.++++...
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999986321
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 904 --------------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 904 --------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 1478889999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCCc-cccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 964 MPQSKS-MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 964 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
...... .....++..|+|||++.+..++.++|||||||++|||++ |..||..........+++.. +..
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~----~~~------ 335 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE----GYR------ 335 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh----Ccc------
Confidence 322211 122345678999999999999999999999999999998 88888755433333332221 100
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
...+.....++.+++.+||+.||++||+++|+++.|++.
T Consensus 336 ------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 ------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 000111124688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=338.33 Aligned_cols=257 Identities=20% Similarity=0.333 Sum_probs=207.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.++|++.+.||+|+||.||+|.++ .+..||+|+++.... ......+.+|+..++.++||||+++++++..++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 357889999999999999999864 356899999876533 23345788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++|+|.+++......+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999999986666889999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
...........++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ...++. +.....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~----~~~~~~-~~~~~~------- 226 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG----QDVIKA-VEDGFR------- 226 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHH-HHCCCC-------
Confidence 222112222345678999999999999999999999999999775 9999975432 112221 111100
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
.+.+......+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 227 -----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 -----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011122334688899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.30 Aligned_cols=261 Identities=24% Similarity=0.380 Sum_probs=221.6
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC---CCc--EEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR---TGH--TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH 879 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~---~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 879 (1114)
++.++.....+.||+|-||.||+|.+. .|+ .||||..+.+...+. .+.|..|+.+++.++|||||+++|+|.+
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 445566777789999999999999964 233 488898887655433 6779999999999999999999999975
Q ss_pred cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 880 QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
...++|||.++-|.|..+++.+...++......++.||..||+|||+. .+|||||.++|||+.....||++|||++
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred -cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 568999999999999999998888999999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1114)
+.+.+......+...-+..|||||.+.-.+++.++|||.|||.+||+++ |..||......+- ..
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------------I~- 603 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------------IG- 603 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------------EE-
Confidence 9988777766666667889999999999999999999999999999887 9999986554221 11
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
.-.-..+.+.++.++..++.++.+||..||.+||++.|+...|.++..
T Consensus 604 --~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 --HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 111122234455667789999999999999999999999999988744
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=334.88 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=205.7
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
++|++.+.||+|+||.||+|+++++..+|+|.+...... .+.+..|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 468888999999999999999988889999998644322 4568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++|+|.++++.....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||.++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999999999986556789999999999999999999998 9999999999999999999999999999865332222
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.+.........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~~~~i~~~~~~------------ 220 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEMISRGFRL------------ 220 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHCCCCC------------
Confidence 2223345678999999998889999999999999999999 8999864432 2222222111100
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
..+......+.+++.+||+++|++||+++|+++.|.
T Consensus 221 -~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 -YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001112346889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.60 Aligned_cols=264 Identities=27% Similarity=0.338 Sum_probs=203.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-----c
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG-----S 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 882 (1114)
-.|...+++|.|+||.||+|... +++.||||++..+.... .+|+++|+.++|||||++.-+|.... .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 35777889999999999999976 67999999997666533 36899999999999999999986532 2
Q ss_pred eEEEEecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-CCeEEeeccC
Q 001253 883 NLLMYEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK-FEAHVGDFGL 958 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG~ 958 (1114)
..+|||||+. +|.+.++. ....++.-.+.-+..|+.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence 3589999988 99999874 356788888899999999999999998 99999999999999976 8999999999
Q ss_pred ceecCCCCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHH-------H
Q 001253 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNF-------I 1030 (1114)
Q Consensus 959 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------~ 1030 (1114)
|+..... ........+..|+|||.+.+. .|+.+.||||.||++.||+-|++-|++....+.++.+++-+ +
T Consensus 173 AK~L~~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 173 AKVLVKG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ceeeccC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9987533 233455678899999998864 59999999999999999999999998766555555554421 1
Q ss_pred hc--CCcccccccccccCCCc---ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhh
Q 001253 1031 RN--NSLVSGMLDARLNLQDE---KTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSES 1086 (1114)
Q Consensus 1031 ~~--~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1086 (1114)
.. ..+.+.. .+.+..... .......+..+++.+++..+|.+|.++.|++. .+.++
T Consensus 251 ~~mn~~y~~~~-~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 251 KSMNPNYTEFK-FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred hhcCccccccc-CcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 11 1111111 111111110 22334457899999999999999999999874 34444
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=339.96 Aligned_cols=263 Identities=22% Similarity=0.384 Sum_probs=204.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeCC-----------------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRT-----------------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 870 (1114)
.++|++.++||+|+||.||+|++++ +..||+|++..... .....++.+|+.++++++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCCe
Confidence 4678899999999999999998642 33699999875432 3345678899999999999999
Q ss_pred eeEEeEEEecCceEEEEecCCCCCHHHHhccCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 001253 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGAS------------------STLDWQTRFMIALGAAEGLSYLHHDCKPR 932 (1114)
Q Consensus 871 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 932 (1114)
+++++++.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence 999999999999999999999999999985321 2468889999999999999999998 9
Q ss_pred eEecCCCCCCeEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh--C
Q 001253 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT--G 1009 (1114)
Q Consensus 933 ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t--g 1009 (1114)
|+||||||+||++++++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 99999999999999999999999999986532222 11223456789999999988889999999999999999987 5
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1010 RAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1010 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
..||..... ......+....+....... ...+......+.+++.+||+.||++|||+.||.+.|++
T Consensus 239 ~~p~~~~~~-~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 239 EQPYGELTD-EQVIENAGEFFRDQGRQVY---------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCcCCH-HHHHHHHHHHhhhcccccc---------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 567764432 2222222222221110000 00111223468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=314.22 Aligned_cols=252 Identities=25% Similarity=0.360 Sum_probs=204.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|.|+.||++... +|+.+|+|++....... ...+++.+|+.+.+.++|||||++.+.+...+..|+|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 367888889999999999999865 79999999887554332 2467899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC---CCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK---FEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfG~a~~~~ 963 (1114)
+|+|+|++|..-+-. +...++..+-..++||++|+.|+|.+ +|||||+||+|+++-.. .-+|++|||+|..++
T Consensus 89 Fe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999665432 24678888889999999999999999 99999999999999543 459999999999876
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
.......++|||+|||||++...+|+..+|||+.||++|-++.|..||.+.+.. ++.+.+ ..+.+
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~I----~~g~y-------- 229 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQI----KAGAY-------- 229 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHH----hcccc--------
Confidence 445556789999999999999999999999999999999999999999854332 222222 22211
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV 1080 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1080 (1114)
....+.-.....+..+++++|+..||.+|.|+.|.+
T Consensus 230 -d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 230 -DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred -CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 111222223344677899999999999999998765
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.19 Aligned_cols=279 Identities=24% Similarity=0.328 Sum_probs=210.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe-----cC
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH-----QG 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 881 (1114)
...|...+.||+|+||.|+.|..+ +|+.||||++.......- ..++..+|++.+++++|+||+.+.+++.. -.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~-~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQI-DAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchH-HHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 355666789999999999999976 899999999975544332 34556679999999999999999999865 24
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..|+|+|+|+- +|...++ .+..++......+..|+++|+.|+|+. +|+|||+||.|++++.+..+||+|||+|+.
T Consensus 100 DvYiV~elMet-DL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHHhh-HHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceee
Confidence 67999999955 9999998 344599999999999999999999999 999999999999999999999999999998
Q ss_pred cCCC-CCCccccccccccccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH----------HH
Q 001253 962 IDMP-QSKSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR----------NF 1029 (1114)
Q Consensus 962 ~~~~-~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~----------~~ 1029 (1114)
.... ....++..+.|..|+|||++. ...|+.+.||||.|||+.||++|++-|++.+....+..... ..
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 7532 234456788999999999875 56799999999999999999999999986654332211111 00
Q ss_pred Hhc---CCccccccc-ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhhhccCCCc
Q 001253 1030 IRN---NSLVSGMLD-ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSESNRRQGHF 1093 (1114)
Q Consensus 1030 ~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~~~~~~ 1093 (1114)
+.. ..+....-. ++..+ ....+.......+++.+|+..||.+|+|++|.++ .++.......-.
T Consensus 255 i~s~~ar~yi~slp~~p~~~f-~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPF-SSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCH-HHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 110 001111100 00000 0011233457889999999999999999999875 455555444443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=351.31 Aligned_cols=262 Identities=26% Similarity=0.430 Sum_probs=207.8
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFC 877 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 877 (1114)
....++|++.++||+|+||.||+|++. ++..||+|+++..... .....+.+|+.+++.+ +||||++++++|
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 345578999999999999999999853 3457999999755432 2345688899999999 899999999999
Q ss_pred EecCceEEEEecCCCCCHHHHhccCC------------------------------------------------------
Q 001253 878 YHQGSNLLMYEYMARGSLGELLHGAS------------------------------------------------------ 903 (1114)
Q Consensus 878 ~~~~~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------------ 903 (1114)
...+..++||||+++|+|.++++...
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999885321
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 904 ---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 904 ---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
..+++.++.+++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 2468888999999999999999998 9999999999999999999999999999865432221
Q ss_pred -ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 969 -SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 969 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
......+++.|||||++.+..++.++|||||||++|||++ |+.||............+. .. . ..
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~----~~-~-----~~---- 334 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK----RG-Y-----QM---- 334 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH----cc-c-----Cc----
Confidence 1122345678999999998899999999999999999997 9999976543322222211 11 0 00
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
..+.....++.+++.+||+.||.+|||+.++++.|+++.
T Consensus 335 --~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 --SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 001111346889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=326.56 Aligned_cols=258 Identities=24% Similarity=0.272 Sum_probs=201.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCCh-----------hhHHHHHHHHHHHhcCCCCceeeEEe
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNN-----------NVDNSFRAEILTLGKIRHRNIVKLYG 875 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~~ 875 (1114)
-++|++.+.||+|.||.|-+|+.. +++.||||++.+...... ...+..++|+.++++++|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 378999999999999999999965 789999999976532111 11247889999999999999999999
Q ss_pred EEEec--CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEE
Q 001253 876 FCYHQ--GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 953 (1114)
Q Consensus 876 ~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 953 (1114)
+..+. +..|||+|||..|.+.+.=.. ...++..++++++++++.||+|||.+ ||+||||||+|+|++++|+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEe
Confidence 98764 578999999999887654431 22389999999999999999999999 9999999999999999999999
Q ss_pred eeccCceecCCC----CCCccccccccccccCccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHH
Q 001253 954 GDFGLAKVIDMP----QSKSMSAIAGSYGYIAPEYAYTMK----VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTW 1025 (1114)
Q Consensus 954 ~DfG~a~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~ 1025 (1114)
+|||.+...... ........+|||.|+|||...+.. .+.+.||||+||++|.++.|+.||.+... ..
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-----~~ 326 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-----LE 326 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-----HH
Confidence 999999865211 111223468999999999987633 34688999999999999999999964321 11
Q ss_pred HHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
..+.+. ...+.. +...+....+.++|.++|.+||++|.+..+|..-..-
T Consensus 327 l~~KIv---------n~pL~f--P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 327 LFDKIV---------NDPLEF--PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HHHHHh---------cCcccC--CCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 111121 222221 1222445678899999999999999999998655443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=343.74 Aligned_cols=247 Identities=23% Similarity=0.287 Sum_probs=202.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+.+ +|+.||+|++...........+.+.+|+.++++++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999976 78999999997544333334566888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--- 153 (291)
T cd05612 81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--- 153 (291)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC---
Confidence 99999999999974 34688999999999999999999998 999999999999999999999999999986532
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
......|++.|+|||++.+..++.++||||+||++|||++|+.||..... ....+..... . ..
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~----~~~~~~i~~~-~---------~~-- 216 (291)
T cd05612 154 -RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP----FGIYEKILAG-K---------LE-- 216 (291)
T ss_pred -CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC-C---------cC--
Confidence 12345799999999999999999999999999999999999999975332 2222221111 1 11
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPT-----MREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1081 (1114)
.+......+.+++.+||+.||.+||+ ++|+++
T Consensus 217 --~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 217 --FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred --CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 11112346789999999999999995 777663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=347.30 Aligned_cols=244 Identities=21% Similarity=0.238 Sum_probs=199.5
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARG 893 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 893 (1114)
+.||+|+||+||+|+.+ +|+.||+|+++............+.+|+.++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999975 78999999998654333333456778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccc
Q 001253 894 SLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI 973 (1114)
Q Consensus 894 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 973 (1114)
+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... ........
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTF 155 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCcccce
Confidence 99999874 35789999999999999999999998 999999999999999999999999999875321 22233456
Q ss_pred cccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHH
Q 001253 974 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVS 1053 (1114)
Q Consensus 974 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1114)
+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ........... . . ..+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~~~~~~~-~---------~----~~p~~ 217 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELILME-E---------I----RFPRT 217 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC----HHHHHHHHHcC-C---------C----CCCCC
Confidence 79999999999999999999999999999999999999996432 12222211111 1 0 11112
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1054 HMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1054 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 234678999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=374.14 Aligned_cols=439 Identities=27% Similarity=0.354 Sum_probs=309.5
Q ss_pred cceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhhcccccccCCchhhhcCCCccceeeecc
Q 001253 224 LQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYR 303 (1114)
Q Consensus 224 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~ 303 (1114)
|+.||+++|+++ ..|..+..+.+|+.|.++.|.|. ..|.+.+++.+|++|.|..|. ....|.++..+++|++|+++.
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~-l~~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNR-LQSLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccch-hhcCchhHHhhhcccccccch
Confidence 444444444443 34444444444444444444444 334444444455555554442 334455555555555555555
Q ss_pred cccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCCEEEccccccccccc
Q 001253 304 NELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIP 383 (1114)
Q Consensus 304 n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 383 (1114)
|++. .+|..+..+..++.++.++|...... +.. .++.++|..|.+.+.++.++..+.. .|||++|.+. -
T Consensus 124 N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~l----g~~-~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~ 192 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEVLTAEEELAASNNEKIQRL----GQT-SIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---V 192 (1081)
T ss_pred hccC-CCchhHHhhhHHHHHhhhcchhhhhh----ccc-cchhhhhhhhhcccchhcchhhhhe--eeecccchhh---h
Confidence 5554 55666666666666666666222111 111 1666667777776666666665555 6777777765 2
Q ss_pred CccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCc
Q 001253 384 LGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKS 463 (1114)
Q Consensus 384 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~ 463 (1114)
.....+.+|+.|....|++.... -.-++|+.|+.++|.++...+. ....+|+++++++|+++ .+|++++.+.+
T Consensus 193 ~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~n 265 (1081)
T KOG0618|consen 193 LDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACAN 265 (1081)
T ss_pred hhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhccc
Confidence 23455666777777777665321 1346777888888888733221 22357888888888888 46688888999
Q ss_pred ceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCcc-ccCCCC-cceeec
Q 001253 464 LVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPRE-VGNLSN-LVTFNV 541 (1114)
Q Consensus 464 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~-L~~L~L 541 (1114)
|+.|...+|+++ .+|..+....+|+.|.+.+|.++ .+|.....++.|++|||..|+|. ..|+. |.-+.. |..|+.
T Consensus 266 le~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~ 342 (1081)
T KOG0618|consen 266 LEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNV 342 (1081)
T ss_pred ceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhh
Confidence 999999999986 78888888899999999999998 67778888999999999999998 45543 333333 788888
Q ss_pred cccccccccccc-ccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCC
Q 001253 542 SSNFLTGRIPLE-IFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSG 620 (1114)
Q Consensus 542 s~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 620 (1114)
+.|++. ..|.. -...+.|+.|++.+|.++...-+.+.+...|+.|+|++|+|.......+.++..|++|+||||+|+
T Consensus 343 s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~- 420 (1081)
T KOG0618|consen 343 SSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT- 420 (1081)
T ss_pred hhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-
Confidence 888887 45522 224778999999999999887778888999999999999999555566889999999999999999
Q ss_pred CCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcc
Q 001253 621 GIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNL 691 (1114)
Q Consensus 621 ~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l 691 (1114)
.+|.++.++..|+ +|..-+|+|... | .+.++++|+.+|+|.|+|+-..-..-...+.|++|||++|..
T Consensus 421 ~Lp~tva~~~~L~-tL~ahsN~l~~f-P-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 421 TLPDTVANLGRLH-TLRAHSNQLLSF-P-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhHHHHhhhhhH-HHhhcCCceeec-h-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 8899999999999 799999999954 7 899999999999999999976655555668999999999984
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.44 Aligned_cols=267 Identities=22% Similarity=0.283 Sum_probs=205.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+++ +++.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 36889999999999999999986 6889999999765432 233456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||++++.+..+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 80 EYVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred ecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9999977765544 445789999999999999999999998 999999999999999999999999999987643333
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHH-----------HHHHhcCCcc
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWV-----------RNFIRNNSLV 1036 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~-----------~~~~~~~~~~ 1036 (1114)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||......+...... +.......+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 33345678999999999998889999999999999999999999997543222111110 0000110000
Q ss_pred cccccccccCCC----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1037 SGMLDARLNLQD----EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1037 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
... .+...... .........+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLR-FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccc-cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00000000 000112346899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=348.00 Aligned_cols=246 Identities=22% Similarity=0.271 Sum_probs=202.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+++ +++.||+|++...........+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999986 68999999997654333334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred cCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 99999999999974 34688899999999999999999998 9999999999999999999999999999875322
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||..... .+..+. +..+ .....
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~-i~~~---------~~~~p 235 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIYEK-ILAG---------RLKFP 235 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----HHHHHH-HhcC---------CcCCC
Confidence 2345799999999999999999999999999999999999999964321 222222 1111 11111
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPT-----MREVV 1080 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl 1080 (1114)
. .....+.+++.+||+.||.+||+ +++++
T Consensus 236 ~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 236 N----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred C----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 1 12235778999999999999997 56665
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=339.60 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=215.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc-eEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS-NLLM 886 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 886 (1114)
++|..++++|+|+||.++.++.+ +++.||+|.+.-....... .+....|+.++++++|||||.+.+.+.+++. .++|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 57888999999999999999977 6789999999866654433 4467789999999999999999999999888 8999
Q ss_pred EecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 887 YEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|+|++||++.+.+.+.. ..++++.+..++.|++.|+.|||+. .|+|||||+.||+++.++.|||+|||+|+....+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999997655 6899999999999999999999988 9999999999999999999999999999987643
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
. ....+.+||+.||.||.+.+.+|..|+||||+||++|||++-+++|.+.+. ..-+.+..+..
T Consensus 160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m----~~Li~ki~~~~------------ 222 (426)
T KOG0589|consen 160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM----SELILKINRGL------------ 222 (426)
T ss_pred h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch----HHHHHHHhhcc------------
Confidence 3 355678999999999999999999999999999999999999999975443 22222222211
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
..+.+.....++..+|..|++.+|+.||++.+++..
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 022333445678899999999999999999999876
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=337.06 Aligned_cols=264 Identities=21% Similarity=0.318 Sum_probs=202.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+.+ +++.||+|+++...... ....+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 56899999999999999999976 78999999987543222 2345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++ +|.+++......+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 99986 99999876666789999999999999999999998 99999999999999999999999999998653222
Q ss_pred CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc------------CC
Q 001253 968 KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN------------NS 1034 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------~~ 1034 (1114)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+...... ..... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF-RLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHhCCCChHHhhccccchh
Confidence 22334568999999998865 568999999999999999999999997543222111111 11110 00
Q ss_pred cccccccccccCCC--cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1035 LVSGMLDARLNLQD--EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1035 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+.... .+...... ........+..+++.+|+++||.+|||++|+++
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYL-FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccc-cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 00000000 000112346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.78 Aligned_cols=254 Identities=22% Similarity=0.272 Sum_probs=212.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
-++|+..+.||+|.-|+||+|+.+ ++..+|+|++.+..........+.+.|-++++.++||.++.+|+.++.+...|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 467888889999999999999987 4689999999887766555667788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC-
Q 001253 887 YEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM- 964 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~- 964 (1114)
||||+||+|..+.+++ ...+++..+.-++..|+-||+|||.. |||+|||||+||||.++|++.|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999854 45789999999999999999999999 999999999999999999999999998753311
Q ss_pred ------------------------------------------------------CCCCccccccccccccCccccccCCC
Q 001253 965 ------------------------------------------------------PQSKSMSAIAGSYGYIAPEYAYTMKV 990 (1114)
Q Consensus 965 ------------------------------------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~ 990 (1114)
+.......++||-.|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00011234689999999999999999
Q ss_pred CcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCC
Q 001253 991 TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISP 1070 (1114)
Q Consensus 991 ~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 1070 (1114)
+.++|.|+|||++|||+.|..||.+......+...+.+ .+.. +.....+..+.++|++.|.+||
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~--------------~l~F--p~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ--------------PLKF--PEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC--------------CCcC--CCCCcchhHHHHHHHHHhccCh
Confidence 99999999999999999999999887766655554432 1111 1122455678999999999999
Q ss_pred CCCCC----HHHHH
Q 001253 1071 FDRPT----MREVV 1080 (1114)
Q Consensus 1071 ~~RPs----~~evl 1080 (1114)
++|.. |.||.
T Consensus 377 ~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIK 390 (459)
T ss_pred hhhhccccchHHhh
Confidence 99998 66554
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.93 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=208.3
Q ss_pred HhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
..++|++.++||+|+||+||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 3478999999999999999999988888999999865332 246788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 887 YEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|||+++++|.++++.. ...+++..+..++.|+++|++|||+. +++||||||+||++++++.++|+|||.+......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999999743 45688999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
.........++..|+|||++.+..++.++|||||||++|+|++ |+.||...... ..... +.... . .
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~-~~~~~------~--~ 223 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMSA-LQRGY------R--M 223 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHHH-HHcCC------C--C
Confidence 2222233446778999999988889999999999999999998 99998643321 11111 11110 0 0
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
+........+.+++.+|++.+|++||+++++.+.|+++
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 ----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01111234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.17 Aligned_cols=271 Identities=23% Similarity=0.326 Sum_probs=208.7
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCc-eeeEEeEEEecC-----
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN-IVKLYGFCYHQG----- 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 881 (1114)
..|+..++||+|+||+||+|+.+ +|+.||+|++.-.... +.......+|+.+++.++|+| ||.+++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45677778999999999999966 7899999999876553 223344568999999999999 999999998877
Q ss_pred -ceEEEEecCCCCCHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeecc
Q 001253 882 -SNLLMYEYMARGSLGELLHGAS---STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957 (1114)
Q Consensus 882 -~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 957 (1114)
..++||||++. +|..++.... ..++...+..++.|+++||+|||++ +|+||||||.||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 78999999987 9999998655 4678889999999999999999999 99999999999999999999999999
Q ss_pred CceecCCCCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc---C
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN---N 1033 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~ 1033 (1114)
+|+.+..+. ......++|..|+|||++.+. .|+...||||+|||++||++++.-|++..+.+.+....+- +.. .
T Consensus 166 lAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~-lGtP~e~ 243 (323)
T KOG0594|consen 166 LARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL-LGTPNEK 243 (323)
T ss_pred hHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH-cCCCCcc
Confidence 999765433 334566899999999999876 6999999999999999999999888765543222222221 111 1
Q ss_pred Ccc--cccccccccCCCcc-c-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhh
Q 001253 1034 SLV--SGMLDARLNLQDEK-T-------VSHMITVLKIAMLCTNISPFDRPTMREVVLM--LSES 1086 (1114)
Q Consensus 1034 ~~~--~~~~~~~~~~~~~~-~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 1086 (1114)
.+. ..+.+-........ + ........+++.+|++.+|.+|.|++.+++. +.+.
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111 11111110111111 0 1111368889999999999999999998875 5544
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=345.46 Aligned_cols=256 Identities=22% Similarity=0.234 Sum_probs=206.7
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||.||+|+++ +++.||+|++...........+.+..|+.+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999986 68999999998654333334566888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999999974 34688999999999999999999998 999999999999999999999999999986532
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
......|++.|+|||++.+..++.++||||+||++|||++|+.||..... .+............. .+..
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~---~~~~--- 222 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP----NETWENLKYWKETLQ---RPVY--- 222 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH----HHHHHHHHhcccccc---CCCC---
Confidence 23455799999999999999999999999999999999999999975432 111111111100000 0000
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
..........+.+++.+|++.+|.+||+++|+++.
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=336.45 Aligned_cols=267 Identities=22% Similarity=0.333 Sum_probs=202.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|+.+ +++.||+|++....... ....+.+|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 478999999999999999999986 78999999987544322 234567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||++ +++.+++......+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~- 156 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP- 156 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC-
Confidence 99996 588888876666789999999999999999999998 9999999999999999999999999999764322
Q ss_pred CCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc---c-----c
Q 001253 967 SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL---V-----S 1037 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~-----~ 1037 (1114)
........|++.|+|||++.+ ..++.++||||+||++|||++|+.||............+......... . .
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 222344568999999998865 457889999999999999999999997543322111111111110000 0 0
Q ss_pred ccccccccCCCcccH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1038 GMLDARLNLQDEKTV-------SHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
............... .....+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000000 01235778999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=329.96 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=208.6
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
+..++|++.+.||+|++|.||+|.+.+++.||+|.++..... .+.+.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 345679999999999999999999887889999998754322 4568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 886 MYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
||||+++++|.+++.... ..+++..+..++.|++.|+.|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999999997543 4689999999999999999999998 999999999999999999999999999987653
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
...........+..|+|||+..+..++.++||||||+++|||++ |+.||..... ..... .+.....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~-~~~~~~~-------- 222 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AEVLQ-QVDQGYR-------- 222 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHH-HHHcCCC--------
Confidence 32222222234568999999998899999999999999999999 9999864332 11111 1111100
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
. ..+......+.+++.+|++.+|++||++.++++.|++.
T Consensus 223 ~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 M----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred C----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 01112234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=345.73 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=208.9
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFC 877 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 877 (1114)
....++|++.++||+|+||+||+|++. .+..||||++..... ....+.+.+|+.+++++. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 344678999999999999999999863 234799999965433 233567889999999996 99999999999
Q ss_pred EecCceEEEEecCCCCCHHHHhccCC------------------------------------------------------
Q 001253 878 YHQGSNLLMYEYMARGSLGELLHGAS------------------------------------------------------ 903 (1114)
Q Consensus 878 ~~~~~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------------ 903 (1114)
.+.+..|+||||+++|+|.++++...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999999886321
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 001253 904 -----------------------------------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNN 942 (1114)
Q Consensus 904 -----------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 942 (1114)
..+++..+..++.|+++|++|||+. +|+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence 2467888899999999999999998 99999999999
Q ss_pred eEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 001253 943 ILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGG 1020 (1114)
Q Consensus 943 ill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~ 1020 (1114)
|++++++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999999986532222 12233457788999999999899999999999999999997 999987543322
Q ss_pred CHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1021 DLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
.....+ .... +. ..+......+.+++.+||+.||++||++.+|.+.|+++..
T Consensus 348 ~~~~~~----~~~~--------~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 TFYNKI----KSGY--------RM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHH----hcCC--------CC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 222211 1110 00 1111233568899999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=300.26 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=211.3
Q ss_pred HHhcCCcCCceecccCCeEEEEEE-eCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC---
Q 001253 806 VATDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG--- 881 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 881 (1114)
+..++|++.+.+|+|+|+-||.+. ..+++.||+|++..... +..+...+|++..++++||||++++++...+.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 445789999999999999999999 45789999999976553 23566788999999999999999999875433
Q ss_pred --ceEEEEecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeec
Q 001253 882 --SNLLMYEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 956 (1114)
Q Consensus 882 --~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 956 (1114)
..|++++|...|+|.+.+.. .+..+++.+.++|+.++++||++||+. .++++||||||.||++.+++.+++.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 47999999999999998863 445899999999999999999999997 346999999999999999999999999
Q ss_pred cCceecCCCCCCc--------cccccccccccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHH
Q 001253 957 GLAKVIDMPQSKS--------MSAIAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTW 1025 (1114)
Q Consensus 957 G~a~~~~~~~~~~--------~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~ 1025 (1114)
|.++......... ......|..|+|||.+. +...+.++|||||||++|+|+.|..||+...+.+
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G----- 248 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG----- 248 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-----
Confidence 9997653221111 11234688999999885 4457789999999999999999999997433222
Q ss_pred HHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
+...-++..+.+......+ .+..+.+++++|++.||.+||+..+++..++++
T Consensus 249 -------gSlaLAv~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 -------GSLALAVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------CeEEEeeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 2333334444444333333 556789999999999999999999999998875
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=316.10 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=212.6
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+-|.++.+||+|+||.||+|.++ +|..+|||++..... .+++..|+.++++++.|+||++||.|......++||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 34777889999999999999977 799999999876544 677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|||.-|+..|+++-+.+.+++.++..+.+..++||+|||-. .-+|||||+.|||++.+|.+|++|||.|..+.+ .-
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TM 183 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TM 183 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh-hH
Confidence 99999999999998889999999999999999999999998 889999999999999999999999999987642 23
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
....++.|||.|||||++..-.|+.++||||+|++..||..|++||.+..+-.. -.+........
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------------IFMIPT~PPPT 248 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------------IFMIPTKPPPT 248 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------------eEeccCCCCCC
Confidence 445678899999999999999999999999999999999999999975543110 01111111111
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+.....++-++++.|+-..|++|.|+.++++
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 2335566678999999999999999999987764
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=328.23 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=204.8
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
++|++.+.||+|+||+||+|.++++..||+|.+...... ...+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 568888999999999999999887778999998744322 4568899999999999999999999998889999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++|+|.+++......+++.++..++.|++.|++|||+. +++|+||||+||++++++.+||+|||.++....+...
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 9999999999986556789999999999999999999998 9999999999999999999999999999865433222
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
......++..|+|||...+..++.++|||||||++|||++ |..||..... ...... +..... .
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~-~~~~~~-----~------ 220 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----SETVEK-VSQGLR-----L------ 220 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHH-HhcCCC-----C------
Confidence 2222345678999999988889999999999999999998 9999864332 111111 111110 0
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
..+......+.+++.+||+.+|++||++.++++.++
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112356889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=349.87 Aligned_cols=268 Identities=22% Similarity=0.285 Sum_probs=218.8
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCC-cEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeE-EEe---
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTG-HTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGF-CYH--- 879 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~--- 879 (1114)
+...++++.++|.+|||+.||.|++..+ ..||+|++... ++...+.+++|+.+|+.++ |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 5567888999999999999999998755 99999998765 3455788999999999997 9999999993 321
Q ss_pred ---cCceEEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEee
Q 001253 880 ---QGSNLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 955 (1114)
Q Consensus 880 ---~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 955 (1114)
.-++++.||||.||.|-|++..+ ...+++.++++|+.++++|+++||.. +++|||||||-+|||++.++..||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 13567999999999999999733 33699999999999999999999986 78899999999999999999999999
Q ss_pred ccCceecCCCCCCc--c------ccccccccccCcccc---ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHH
Q 001253 956 FGLAKVIDMPQSKS--M------SAIAGSYGYIAPEYA---YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVT 1024 (1114)
Q Consensus 956 fG~a~~~~~~~~~~--~------~~~~g~~~y~aPE~~---~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~ 1024 (1114)
||.|...-...... . -...-|+.|+|||++ .+.+++.|+||||+||+||-++....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 99997432222111 0 123578999999987 478899999999999999999999999975422
Q ss_pred HHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCccccc
Q 001253 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSP 1097 (1114)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~ 1097 (1114)
-++....+.+ +........+.++|+.||++||.+||++.||+..+.+++.+.-+....+
T Consensus 264 ------------laIlng~Y~~--P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 264 ------------LAILNGNYSF--PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred ------------eeEEeccccC--CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 1223333332 2234566789999999999999999999999999999988877776655
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=344.61 Aligned_cols=248 Identities=21% Similarity=0.267 Sum_probs=202.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeCC--CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRT--GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.++||+|+||.||+|.++. +..||+|++...........+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999998652 36899999976543333345668889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 99999999999999743 4689999999999999999999998 999999999999999999999999999987542
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+..... . ..
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~i~~~-~---------~~ 246 (340)
T PTZ00426 184 ---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLIYQKILEG-I---------IY 246 (340)
T ss_pred ---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HHHHHHHhcC-C---------CC
Confidence 12345799999999999998899999999999999999999999974332 1112221111 1 11
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
.+......+.+++.+|++.||++|+ +++|+++
T Consensus 247 ----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 247 ----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 1111223577899999999999995 7888764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.97 Aligned_cols=261 Identities=21% Similarity=0.312 Sum_probs=212.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||.||+|+.+ +++.||||++.............+..|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999975 78999999987654444555667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 888 EYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 888 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
||+++|+|.+++.. ....+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988852 234688999999999999999999998 999999999999999999999999999887542
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
.. .......|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... +...+... +..... +
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~~~~-~~~~~~------~-- 226 (267)
T cd08228 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLCQK-IEQCDY------P-- 226 (267)
T ss_pred hh-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc--cHHHHHHH-HhcCCC------C--
Confidence 22 122345688899999999888899999999999999999999999864322 22222222 111110 0
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
..........+.+++.+||+.+|++||++.++++.+++++
T Consensus 227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1111223356889999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=341.34 Aligned_cols=241 Identities=23% Similarity=0.270 Sum_probs=196.4
Q ss_pred ecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCH
Q 001253 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL 895 (1114)
Q Consensus 817 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 895 (1114)
||+|+||+||+|+.. +++.||+|++.............+.+|+.++++++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 6889999999765433333456678899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccccc
Q 001253 896 GELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAG 975 (1114)
Q Consensus 896 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 975 (1114)
.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.... .........|
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~g 155 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK-DDDKTNTFCG 155 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCcc-CCCccccccC
Confidence 999974 34689999999999999999999998 999999999999999999999999999985322 2223345679
Q ss_pred cccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHH
Q 001253 976 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHM 1055 (1114)
Q Consensus 976 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1114)
|+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+..+...... . ..+....
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~----~~~~~~~~~~~~----------~----~~~~~~~ 217 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN----VNEMYRKILQEP----------L----RFPDGFD 217 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC----HHHHHHHHHcCC----------C----CCCCcCC
Confidence 999999999999999999999999999999999999997432 223333322211 1 1111223
Q ss_pred HHHHHHHhhccCCCCCCCCC---HHHHH
Q 001253 1056 ITVLKIAMLCTNISPFDRPT---MREVV 1080 (1114)
Q Consensus 1056 ~~l~~li~~cl~~dP~~RPs---~~evl 1080 (1114)
..+.+++.+||+.||.+||+ +.|++
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 46789999999999999985 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=341.40 Aligned_cols=244 Identities=21% Similarity=0.255 Sum_probs=199.8
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARG 893 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 893 (1114)
++||+|+||+||+|+.+ +|+.||+|++.............+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999976 78999999998654444444567788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccc
Q 001253 894 SLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI 973 (1114)
Q Consensus 894 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 973 (1114)
+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ........
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~-~~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKTF 155 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCC-cccccccc
Confidence 99998874 34789999999999999999999998 999999999999999999999999999875322 22223456
Q ss_pred cccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHH
Q 001253 974 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVS 1053 (1114)
Q Consensus 974 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1114)
+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+..... .. ..+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~~~~~~~~~~----------~~----~~p~~ 217 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILME----------DI----KFPRT 217 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH----HHHHHHhccC----------Cc----cCCCC
Confidence 799999999999998999999999999999999999999964321 2222221111 00 11112
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1054 HMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1054 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
....+.+++.+||+.||++|| ++.|+++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 234678899999999999997 8898875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=338.70 Aligned_cols=264 Identities=23% Similarity=0.358 Sum_probs=205.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||.||+|+++ +|..||+|++..... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999976 688999999875432 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++|+|.+++.. ...+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 156 (331)
T cd06649 82 MEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156 (331)
T ss_pred eecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc--
Confidence 999999999999974 346889999999999999999999852 699999999999999999999999999976532
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc--c--------
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL--V-------- 1036 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~-------- 1036 (1114)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||...+. ..+...+......... .
T Consensus 157 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred -cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhcccccccccCCccccCcccc
Confidence 222345799999999999999999999999999999999999999964332 1111111100000000 0
Q ss_pred -----------------------cccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1037 -----------------------SGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1037 -----------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
+.+...... .........++.+++.+||++||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPP--KLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCc--CCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 00011234568899999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.85 Aligned_cols=253 Identities=26% Similarity=0.318 Sum_probs=203.4
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
.|++.++||+|+||+||++... +++.||+|++.............+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999975 789999999976543333334557789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 889 YMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||++..... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~--~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--G 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCC--C
Confidence 99999999988643 34689999999999999999999998 999999999999999999999999999986532 2
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||......... ..+...+....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~------------- 221 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-EEVERRVKEDQ------------- 221 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-HHHHHHhhhcc-------------
Confidence 2223457899999999999888999999999999999999999999754432211 11222111110
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
...+......+.+++.+||+.||++|| +++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 111122344678999999999999999 7777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=340.61 Aligned_cols=261 Identities=25% Similarity=0.402 Sum_probs=216.9
Q ss_pred CCcCCceecccCCeEEEEEEeC-CC----cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TG----HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
..+..++||+|+||+||+|.|- .| -+||||++...... ....++.+|+..|.+++|||+++++++|.... ..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 4566789999999999999974 34 36899998765443 33567899999999999999999999998766 78
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+|++||+.|+|.|+++.++..+..+..+.|..|||+||.|||.+ ++|||||.++||||.+-..+|+.|||+|+....
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999999999899999999999999999999999998 999999999999999999999999999997653
Q ss_pred CCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 965 PQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 965 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
... .......-++.|||-|.+....|+.++|||||||++||++| |..||..... +.+.+.++.++-
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----~eI~dlle~geR------- 918 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----EEIPDLLEKGER------- 918 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----HHhhHHHhcccc-------
Confidence 322 23333445678999999999999999999999999999998 9999976543 334444444321
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCc
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHF 1093 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 1093 (1114)
-..++-...+++.++.+||..|+..||+|+++..++.+..+--.++
T Consensus 919 -----LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqry 964 (1177)
T KOG1025|consen 919 -----LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRY 964 (1177)
T ss_pred -----CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceE
Confidence 2234445667899999999999999999999999999875544443
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=341.26 Aligned_cols=244 Identities=22% Similarity=0.249 Sum_probs=198.7
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARG 893 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 893 (1114)
+.||+|+||.||+|+.+ +|+.||+|++.............+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999975 78999999998654433334556778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccc
Q 001253 894 SLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI 973 (1114)
Q Consensus 894 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 973 (1114)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..... ........
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~-~~~~~~~~ 155 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTF 155 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccC-CCCccccc
Confidence 99998874 34789999999999999999999998 999999999999999999999999999875321 22233446
Q ss_pred cccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHH
Q 001253 974 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVS 1053 (1114)
Q Consensus 974 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1114)
.|++.|+|||++.+..++.++||||+||++|||++|+.||..... ....+...... .. .+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~~~~~~----------~~----~p~~ 217 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEE----------IR----FPRT 217 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCC----------CC----CCCC
Confidence 799999999999999999999999999999999999999964332 11122211110 00 1112
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1054 HMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1054 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
....+.+++.+||+.||.+|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 234678999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=334.40 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=216.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 885 (1114)
.+.|++.+.||+|.||.||+|+.+ +|+.+|+|++.+...........+.+|+.+++++. |||||.++++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 367888899999999999999987 59999999998877655445678999999999998 9999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC----CCeEEeeccCcee
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK----FEAHVGDFGLAKV 961 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~DfG~a~~ 961 (1114)
|||+++||.|.+.+... .+++..+..++.|++.|+.|||+. ||+|||+||+|+|+... +.+|++|||+|..
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999998755 399999999999999999999998 99999999999999643 5799999999998
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
... .......+||+.|+|||++...+|+..+||||+||++|.|++|.+||.+......... +..+
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-----i~~~-------- 253 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-----ILRG-------- 253 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-----HHcC--------
Confidence 764 5567788999999999999999999999999999999999999999986554333221 1111
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+....+........+.+++++|+..||.+|+|+.++++
T Consensus 254 -~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 254 -DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 112223333344567889999999999999999999998
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=330.15 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=206.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
..+|++.++||+|+||.||+|.++ +++.||+|++..... ....+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 356888899999999999999976 588999999864322 245688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 887 YEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|||+++++|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999998743 34689999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
.........++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+..+.. ... + .
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~~~-~~~-~-----~--- 223 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELL-EKG-Y-----R--- 223 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH-HCC-C-----C---
Confidence 2222222335678999999998999999999999999999998 8899864322 2222221 110 0 0
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
...+......+.+++.+||+.||++||++.+++++|+.+
T Consensus 224 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 ---MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111122235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=348.17 Aligned_cols=255 Identities=28% Similarity=0.331 Sum_probs=207.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+.. +|+.||||++.............+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999976 78999999998654333344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC-
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ- 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 966 (1114)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999854 6789999999999999999999998 99999999999999999999999999998654332
Q ss_pred ---------------------------CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001253 967 ---------------------------SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019 (1114)
Q Consensus 967 ---------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~ 1019 (1114)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~- 235 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL- 235 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH-
Confidence 1123345799999999999999999999999999999999999999975432
Q ss_pred CCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 001253 1020 GDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPT-MREVVLM 1082 (1114)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 1082 (1114)
........... ....... .......+.+++.+|+. ||.+||+ ++|+++.
T Consensus 236 ---~~~~~~i~~~~--------~~~~~p~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 ---QETYNKIINWK--------ESLRFPP--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ---HHHHHHHhccC--------CcccCCC--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11222211100 0000001 11124568889999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=330.36 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=210.5
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
.+..+|++.++||+|+||+||+|.+++++.+|+|++...... ....+..|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 345679999999999999999999988999999998754432 24568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 886 MYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
||||+++++|.++++.. ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999999753 34689999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
.... .....++..|+|||...+..++.++||||||+++|+|++ |+.||...... +..+...... +
T Consensus 157 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~~---------~ 222 (261)
T cd05148 157 DVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----EVYDQITAGY---------R 222 (261)
T ss_pred cccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHHHHhCC---------c
Confidence 2222 223446778999999988889999999999999999998 89999654321 1111111110 0
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
...+......+.+++.+||+.||++|||++++++.|+.+
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111122334688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=347.87 Aligned_cols=256 Identities=22% Similarity=0.264 Sum_probs=204.4
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
..++|++.++||+|+||+||+|+.+ +++.||+|++...........+.+..|+.+++.++||||+++++++.++...|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3468999999999999999999976 689999999975433222334557789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999974 3578888999999999999999998 9999999999999999999999999999876433
Q ss_pred CCCccccccccccccCccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTM----KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
.........||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ............
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~------- 264 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMDHKN------- 264 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH----HHHHHHHHcCCC-------
Confidence 22233456799999999998653 378899999999999999999999975332 222222221110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFD--RPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1081 (1114)
.+. .+........+.+++.+|++.+|.+ ||++.|+++
T Consensus 265 -~~~--~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 265 -SLT--FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred -cCC--CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 011 0111122346788999999999988 999999965
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=334.42 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=209.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.-|...+.||+|+||.||-|++. +.+.||||++.-......+.-+++..|+..+++++|||++.+.|+|..+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34666788999999999999965 78899999998776666677788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|||-| +-.|++.-..+++.+.++..|+.+.+.||+|||+. +.||||||+.|||+++.|.|||+|||.|....
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---- 177 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA---- 177 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC----
Confidence 99966 99999887778899999999999999999999999 99999999999999999999999999998754
Q ss_pred CccccccccccccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
...+++|||+|||||++. .+.|+-|+||||+|++..|+..+++|+..+..-..++.+ ..+. .+.+
T Consensus 178 -PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI----AQNe-------sPtL 245 (948)
T KOG0577|consen 178 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNE-------SPTL 245 (948)
T ss_pred -chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH----HhcC-------CCCC
Confidence 235679999999999985 567999999999999999999999998755432222211 1111 1111
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+....+..|+..|++.-|.+|||.+++++
T Consensus 246 -----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 -----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 13345567889999999999999999987764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=345.66 Aligned_cols=258 Identities=22% Similarity=0.276 Sum_probs=204.0
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
...++|++.++||+|+||.||+|+.+ +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++..|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999976 68899999997543333333556788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|.....
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999999974 3578899999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCccccccccccccCccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMK----VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.........+||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... ............
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~----~~~~~~i~~~~~------ 264 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL----VGTYSKIMDHKN------ 264 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCc------
Confidence 3333334567999999999987543 77899999999999999999999975432 222222221110
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFD--RPTMREVVLM 1082 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1082 (1114)
.+. .+........+.+++.+|+..+|.+ ||++.|+++.
T Consensus 265 --~~~--~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 --SLN--FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --ccC--CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 011 1111223345778888999855543 8899998774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=325.95 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=203.7
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
.+|++.+.||+|+||.||+|.++++..+|+|++...... ...+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 457888999999999999999887788999998644322 3467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++++|.+++......+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999999999986666789999999999999999999998 9999999999999999999999999999865432222
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
......++..|+|||.+.+..++.++||||||+++||+++ |+.||...... +.... +.... .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~-~~~~~------~------ 219 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVVES-VSAGY------R------ 219 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HHHHH-HHcCC------c------
Confidence 2222234568999999998899999999999999999999 78888643321 11111 11110 0
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1083 (1114)
...+......+.+++.+||+.+|++|||+.|+++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011112344688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=341.24 Aligned_cols=255 Identities=22% Similarity=0.248 Sum_probs=207.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+.+ +|+.||+|+++..........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999976 78999999998665444445667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 99999999999987667899999999999999999999998 999999999999999999999999999987643333
Q ss_pred CccccccccccccCccccc------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAY------TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~------~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
.......||+.|+|||++. ...++.++||||+||++|||++|+.||..... ..............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~~~~i~~~~~~~----- 228 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS----AKTYNNIMNFQRFL----- 228 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH----HHHHHHHHcCCCcc-----
Confidence 2333457999999999986 45678899999999999999999999964332 22222222211110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. .+........+.+++.+|++ +|.+||++.++++
T Consensus 229 ---~--~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 ---K--FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ---C--CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 01111223467889999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=338.49 Aligned_cols=254 Identities=23% Similarity=0.240 Sum_probs=202.3
Q ss_pred CCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCC-CChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCce
Q 001253 810 NFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNRE-GNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 883 (1114)
+|++.++||+|+||+||+|+.. +++.||+|++.+... ......+.+..|+.+++.+ +||+|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999999853 688999999975432 1222345678899999999 589999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999999874 34689999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||.............+...... .
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------~ 228 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--------P 228 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--------C
Confidence 3333333456799999999998865 478899999999999999999999975443333333222222111 1
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
..+......+.+++.+||+.||++|| +++++++
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 229 ------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11112234678899999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=346.28 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=199.4
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
.|+.+++||+|+||+||+|+.+ +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888899999999999999975 788999999976544444445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC-
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS- 967 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 967 (1114)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++++||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999999999743 4688899999999999999999998 999999999999999999999999999754311000
Q ss_pred ---------------------------------------------CccccccccccccCccccccCCCCcccchHHHHHH
Q 001253 968 ---------------------------------------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVV 1002 (1114)
Q Consensus 968 ---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvi 1002 (1114)
......+||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123579999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhh--ccCCCCCCCCCHHHHH
Q 001253 1003 LLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAML--CTNISPFDRPTMREVV 1080 (1114)
Q Consensus 1003 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl 1080 (1114)
+|||++|+.||........ ........ .... .+.......++.+++.+ |+..+|.+||+++|++
T Consensus 238 l~elltG~~Pf~~~~~~~~----~~~i~~~~--------~~~~--~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTET----QLKVINWE--------NTLH--IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHhCCCCCcCCCHHHH----HHHHHccc--------cccC--CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999975432111 11111100 0000 01111123456677777 5566677799999997
Q ss_pred H
Q 001253 1081 L 1081 (1114)
Q Consensus 1081 ~ 1081 (1114)
+
T Consensus 304 ~ 304 (381)
T cd05626 304 A 304 (381)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.53 Aligned_cols=249 Identities=34% Similarity=0.542 Sum_probs=195.2
Q ss_pred CCceecccCCeEEEEEEeC-----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 813 ERFVIGRGACGTVYRAVLR-----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 813 ~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
..+.||.|+||.||+|.++ .+..|+||+++.. ...+..+.+.+|++.+++++||||++++|++...+..++||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 4568999999999999976 3568999999543 23334678899999999999999999999999888899999
Q ss_pred ecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 888 EYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
||+++|+|.++++.. ...+++.++..|+.|+++||+|||+. +++|+||+++||++++++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999999876 66899999999999999999999998 99999999999999999999999999998762221
Q ss_pred C-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 967 S-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 967 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
. ...........|+|||.+.+..++.++||||||+++||+++ |+.||... ...+..... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~----~~~~~~~~~-~~~~~~-------- 224 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY----DNEEIIEKL-KQGQRL-------- 224 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS----CHHHHHHHH-HTTEET--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccccc-cccccc--------
Confidence 1 22233457789999999999889999999999999999999 67888643 222333332 221111
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1083 (1114)
..+......+.+++.+||+.||++||++.++++.|
T Consensus 225 ----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 ----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11112234688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.26 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=207.7
Q ss_pred cCCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
++|++.+.||+|+||+||+|.++ +...||||+++.... ......+.+|+..++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 57899999999999999999975 245799999865432 233567888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||+++++|.+++......+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||+++....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999999987666899999999999999999999998 999999999999999999999999999987642
Q ss_pred CCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 965 PQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 965 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .+.. ..+.....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----~~~~-~~~~~~~~------- 226 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVI-KAVEDGYR------- 226 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----HHHH-HHHHcCCC-------
Confidence 2211 1122345678999999998899999999999999999998 9999864332 1111 11111100
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
.+.+......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 227 -----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 -----LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=339.54 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=206.4
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCY 878 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 878 (1114)
+..++|++.++||+|+||.||+|+.. +++.||+|++..... ....+.+..|+.++.++ +|+||++++++|.
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 44578999999999999999999742 357899999875432 22345677899999999 8999999999886
Q ss_pred ec-CceEEEEecCCCCCHHHHhccCC------------------------------------------------------
Q 001253 879 HQ-GSNLLMYEYMARGSLGELLHGAS------------------------------------------------------ 903 (1114)
Q Consensus 879 ~~-~~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------------ 903 (1114)
.. ...+++|||+++++|.+++....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 54 56789999999999999985321
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC-Ccccccccc
Q 001253 904 ------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGS 976 (1114)
Q Consensus 904 ------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~ 976 (1114)
..+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||+++.+..... .......++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 2678999999999999999999998 999999999999999999999999999986532222 122234567
Q ss_pred ccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHH
Q 001253 977 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHM 1055 (1114)
Q Consensus 977 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1114)
..|+|||++.+..++.++||||+||++|||++ |..||......+.....+ ..... ...+....
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~----~~~~~------------~~~~~~~~ 302 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL----KEGTR------------MRAPEYAT 302 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH----hccCC------------CCCCccCC
Confidence 78999999999999999999999999999998 999997543322222221 11110 00111223
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1056 ITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1056 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 468899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.13 Aligned_cols=247 Identities=23% Similarity=0.272 Sum_probs=197.0
Q ss_pred ecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCH
Q 001253 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL 895 (1114)
Q Consensus 817 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 895 (1114)
||+|+||+||+|.++ +|+.||+|++...........+.+..|+.+++.++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999976 7899999998765433333345677899999999999999999999999999999999999999
Q ss_pred HHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 896 GELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 896 ~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-ccccc
Confidence 988743 334689999999999999999999998 99999999999999999999999999998654322 22334
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..|++.|+|||++.+..++.++||||+||++|||++|+.||.............+. ... .. ...+.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~---------~~----~~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR-ILN---------DS----VTYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh-hcc---------cC----CCCcc
Confidence 57899999999999999999999999999999999999999754432221111111 110 00 11112
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1053 SHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
.....+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2334688999999999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=301.96 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=208.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCC--C---hhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecC
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREG--N---NNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 881 (1114)
..|.-.+.+|+|..++|.++..+ +|..+|+|++...... . .+..++-..|+.+++++ .||+|+++.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 45677788999999999999876 7889999998644322 1 12234456789999988 6999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..++|+|.|+.|.|.|++. ..-.++++...+|++|+.+|++|||.. .|||||+||+|||++++.++||+|||+|+.
T Consensus 97 F~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeec
Confidence 9999999999999999997 344789999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCccccccccccccCcccccc------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYT------MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL 1035 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1114)
+. ........+|||+|.|||.+.. ..|+..+|+||+||++|.++.|.+||.+..+- . +
T Consensus 173 l~--~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-----l---------M 236 (411)
T KOG0599|consen 173 LE--PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-----L---------M 236 (411)
T ss_pred cC--CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-----H---------H
Confidence 64 5566678899999999998853 45788999999999999999999999643321 0 1
Q ss_pred ccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1036 VSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...++.+.+.+..+.-.....++.++|.+|++.||++|.|++|+++
T Consensus 237 LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1112233334444444556667889999999999999999999975
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=337.79 Aligned_cols=247 Identities=25% Similarity=0.319 Sum_probs=196.8
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHH---hcCCCCceeeEEeEEEecCceEEE
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTL---GKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
|++.+.||+|+||+||+|.++ +|+.||||+++..........+.+..|+.++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999976 7899999999765432223344566666554 567899999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++|+|..+++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... .
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~-~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG-F 154 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC-C
Confidence 99999999999886 34689999999999999999999998 999999999999999999999999999875321 2
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.......+|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......... .
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~----~~~~~~i~~~~~----------~- 219 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----EEVFDSIVNDEV----------R- 219 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCC----------C-
Confidence 2233456799999999999999999999999999999999999999974332 222222221110 0
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPT-----MREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1081 (1114)
.+......+.+++.+||+.||.+||+ +.++++
T Consensus 220 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 ---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11112345788999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=340.74 Aligned_cols=260 Identities=21% Similarity=0.241 Sum_probs=198.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
..+|++.++||+|+||.||+|++. +++.||+|+.. .+.+.+|+.++++++||||+++++++......++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 467999999999999999999975 78999999743 22367899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
||++. ++|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+......
T Consensus 162 ~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 162 LPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 99996 5888888643 4688999999999999999999998 99999999999999999999999999997543223
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC---CHHHHHHHHHhcCC-----c---
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG---DLVTWVRNFIRNNS-----L--- 1035 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~-----~--- 1035 (1114)
........||+.|+|||++.+..++.++||||+||++|||++|+.||....... +....++..+.... +
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 333445679999999999999999999999999999999999998875432111 11111111111000 0
Q ss_pred ----ccccc-------cccccCCC--cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1036 ----VSGML-------DARLNLQD--EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1036 ----~~~~~-------~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....+ ........ .........+.+++.+||++||++|||++|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00000000 001123446889999999999999999999984
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=335.18 Aligned_cols=199 Identities=28% Similarity=0.375 Sum_probs=173.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CC-----ceeeEEeEEEec
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HR-----NIVKLYGFCYHQ 880 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 880 (1114)
..+|.+.+.||+|+||.|.+|.+. +++.||||+++..... .++-..|+.++..++ |. |+|+++++|...
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f----~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF----LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH----HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 348999999999999999999965 7999999999866543 445567999999997 53 899999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC--CeEEeecc
Q 001253 881 GSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF--EAHVGDFG 957 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~DfG 957 (1114)
++.|+|+|.++. +|+++++.+. ..++...+..++.||+.||.+||+. +|||+||||+|||+.+.+ .|||+|||
T Consensus 261 ~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 999999999976 9999998543 4789999999999999999999998 999999999999997644 69999999
Q ss_pred CceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~ 1018 (1114)
.|+... ....+...+..|+|||++.+.+|+.+.||||||||++||++|.+.|++...
T Consensus 337 SSc~~~----q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 337 SSCFES----QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cccccC----CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 999743 223367889999999999999999999999999999999999777765443
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.92 Aligned_cols=244 Identities=22% Similarity=0.296 Sum_probs=195.5
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
+.||+|+||+||+|+.+ +++.||+|++++.........+.+..|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 6889999999876544444455677888888776 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~-~~~~~~~ 155 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTST 155 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccC-CCCcccc
Confidence 999998864 34789999999999999999999998 999999999999999999999999999875322 2222345
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC----CCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG----GDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....++.+.+.... .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---------~---- 222 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---------I---- 222 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------C----
Confidence 67999999999999999999999999999999999999999643211 112223322222111 0
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPTM 1076 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1076 (1114)
..+......+.+++.+||+.||++||++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1112223467899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=338.53 Aligned_cols=248 Identities=28% Similarity=0.419 Sum_probs=195.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|+..++||+|+||+||+|+++ +|+.||||++..... ....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 45667789999999999999976 789999999865432 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+.. ..++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 152 e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 152 EFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred ecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 999999987532 356778889999999999999998 99999999999999999999999999998754221
Q ss_pred CccccccccccccCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAYT-----MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
.......|+..|+|||++.. ...+.++|||||||++|||++|+.||..... .++...........
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~~--------- 292 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-GDWASLMCAICMSQ--------- 292 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccHHHHHHHHhccC---------
Confidence 22234579999999998743 2345689999999999999999999973322 22222222111110
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...........+.+++.+||+.||++||++.|+++
T Consensus 293 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred ----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111223346889999999999999999999986
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=323.98 Aligned_cols=254 Identities=27% Similarity=0.438 Sum_probs=205.3
Q ss_pred HhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
..++|++.++||+|+||.||+|.++++..||+|.+...... .+.+.+|+.++++++|++++++++++. ....++|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 34678999999999999999999888889999998764432 356889999999999999999999875 4568999
Q ss_pred EecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 887 YEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|||+++++|.++++.. ...+++.++..++.+++.|++|||+. +++||||||+||++++++.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999999753 34689999999999999999999998 9999999999999999999999999999875433
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
.........++..|+|||+..+..++.++||||||+++|||++ |..||..... .+..........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~~~~---------- 221 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN----REVLEQVERGYR---------- 221 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCC----------
Confidence 2222223345678999999988889999999999999999999 8888864332 122222111100
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
.+.+......+.+++.+|++.+|.+|||++++.+.|++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 ---MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=323.86 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=206.5
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
+..++|++.++||+|+||+||+|..++++.||+|.+...... ..++.+|+.++++++|||++++++++. .+..++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 345789999999999999999999988999999998754432 456889999999999999999999874 457899
Q ss_pred EEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 886 MYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
||||+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999998643 34789999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
..........++..|+|||++.+..++.++||||||+++||+++ |+.||..... ....+.. .... .
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~-~~~~--------~ 221 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEVIQNL-ERGY--------R 221 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----HHHHHHH-HcCC--------C
Confidence 22222233456788999999998889999999999999999999 9999975432 1112111 1110 0
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
. +.+......+.+++.+||+.+|++||+++++++.|+.
T Consensus 222 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 M----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0 0111123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=324.38 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=205.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.++|++.++||+|+||+||+|+++++..||+|++...... .+.+.+|++++++++||||+++++++. .+..++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence 4679999999999999999999887778999998753321 356889999999999999999999875 45679999
Q ss_pred ecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 888 EYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
||+++|+|.+++... ...+++..+..++.|+++||+|+|+. +++||||||+||++++++.++|+|||.++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999753 34689999999999999999999998 99999999999999999999999999998765333
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
........++..|+|||+..+..++.++||||+|+++|||++ |..||...... ..... ..... .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~~-~~~~~--------~-- 221 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQ-VERGY--------R-- 221 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHHH-HhcCC--------C--
Confidence 222233456778999999988899999999999999999999 78888643321 11111 11100 0
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
..........+.+++.+|++.||++||++.++++.|++.
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011123345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=337.02 Aligned_cols=248 Identities=21% Similarity=0.293 Sum_probs=199.2
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
++||+|+||+||+|+++ +++.||+|+++..........+.+..|..+++.+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999976 6899999999876544444456678899999888 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTST 155 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCcccc
Confidence 999998863 35789999999999999999999998 999999999999999999999999999875321 2223345
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC----CCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG----GDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....++..+.+.... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~~--- 223 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ---------IR--- 223 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC---------CC---
Confidence 67999999999999999999999999999999999999999643221 122223332222211 11
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCC------HHHHH
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPT------MREVV 1080 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl 1080 (1114)
.+......+.+++.+|++.||.+||+ +++++
T Consensus 224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 11122346788999999999999998 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=335.34 Aligned_cols=241 Identities=24% Similarity=0.304 Sum_probs=191.7
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhc-CCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGK-IRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
++||+|+||+||+|+.+ +++.||+|+++..........+.+..|..++.. .+||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 688999999986543322233445556666654 4899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~-~~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG-EGKAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC-CCcccc
Confidence 9999998743 4689999999999999999999998 9999999999999999999999999999864322 233345
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+......... ...+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~~--------------~~~~~ 217 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----DELFDSILNDR--------------PHFPR 217 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCC--------------CCCCC
Confidence 6799999999999999999999999999999999999999975432 22222211110 01111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHH
Q 001253 1053 SHMITVLKIAMLCTNISPFDRPTMRE 1078 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RPs~~e 1078 (1114)
.....+.+++.+||+.||++||++.+
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChH
Confidence 12345778999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=328.25 Aligned_cols=256 Identities=30% Similarity=0.474 Sum_probs=206.5
Q ss_pred cCCcCCceecccCCeEEEEEEeCC------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRT------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
++|++.+.||+|+||.||+|.... ...||+|.+..... ......+.+|+..+++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 468888999999999999998652 25799999864432 3345678899999999999999999999999899
Q ss_pred eEEEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 001253 883 NLLMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 947 (1114)
.+++|||+++|+|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence 999999999999999986431 4578899999999999999999998 9999999999999999
Q ss_pred CCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHH
Q 001253 948 KFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTW 1025 (1114)
Q Consensus 948 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~ 1025 (1114)
++.++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... +.
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-~~--- 235 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-EV--- 235 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-HH---
Confidence 99999999999986532221 22233457889999999988889999999999999999998 99998754321 11
Q ss_pred HHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
...+..... ...+......+.+++.+||+.||.+||+++||++.|+.+
T Consensus 236 -~~~i~~~~~------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 -IEMIRSRQL------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -HHHHHcCCc------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111221111 111223345789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=339.62 Aligned_cols=244 Identities=21% Similarity=0.248 Sum_probs=198.0
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARG 893 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 893 (1114)
+.||+|+||+||+|+.+ +|+.||+|++.............+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999975 78999999998654433334556778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 894 SLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 894 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~-~~~~~~~ 155 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT 155 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCC-CCccccc
Confidence 99998874 3478999999999999999999997 6 899999999999999999999999999875321 2222344
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+..... ... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~----~~~~~~i~~~----------~~~----~p~ 217 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILME----------EIR----FPR 217 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----HHHHHHHhcC----------CCC----CCC
Confidence 5799999999999999999999999999999999999999964332 1222211111 001 111
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1053 SHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
.....+.+++.+||+.||++|+ +++++++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 1234678899999999999996 8998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=344.44 Aligned_cols=254 Identities=27% Similarity=0.340 Sum_probs=202.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+.+ +|+.||||++.............+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999976 68999999997653333334556788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999999743 4689999999999999999999998 999999999999999999999999999875421110
Q ss_pred C-------------------------------------ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCC
Q 001253 968 K-------------------------------------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGR 1010 (1114)
Q Consensus 968 ~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~ 1010 (1114)
. .....+||+.|+|||++.+..++.++||||+||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 111346999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 001253 1011 APVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPT---MREVVL 1081 (1114)
Q Consensus 1011 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1081 (1114)
.||..... ....+...... ..+.. .........+.+++.+|+. +|.+|++ ++|+++
T Consensus 237 ~Pf~~~~~----~~~~~~i~~~~--------~~~~~--~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNP----QETYRKIINWK--------ETLQF--PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCH----HHHHHHHHcCC--------CccCC--CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99975432 22222221110 00110 0111123467788999996 9999998 888766
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=333.85 Aligned_cols=262 Identities=25% Similarity=0.439 Sum_probs=208.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCc----EEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGH----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
..+|+..+.||+|+||+||+|++. +|+ .||+|++..... ....+++..|+.+++.++||||++++++|... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 357999999999999999999964 333 489999864322 23356788999999999999999999998764 5
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.++|+||+++|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 7899999999999999987667789999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 963 DMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 963 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
...... ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+ +........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----~~-~~~~~~~~~------ 228 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SE-ISSILEKGE------ 228 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HH-HHHHHhCCC------
Confidence 432221 1122335678999999999999999999999999999997 9999864321 11 122222111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCC
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGH 1092 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 1092 (1114)
... .+......+.+++.+||+.+|.+||++.+++..+.++.+...+
T Consensus 229 --~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~ 274 (316)
T cd05108 229 --RLP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 274 (316)
T ss_pred --CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence 000 1111234678999999999999999999999999988665443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=325.03 Aligned_cols=250 Identities=24% Similarity=0.290 Sum_probs=197.9
Q ss_pred ecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCH
Q 001253 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL 895 (1114)
Q Consensus 817 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 895 (1114)
||+|+||+||+++.+ +|+.||+|++...........+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999976 6899999999754333222344556799999999999999999999999999999999999999
Q ss_pred HHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccccc
Q 001253 896 GELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA 974 (1114)
Q Consensus 896 ~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 974 (1114)
.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence 9888643 33688999999999999999999998 9999999999999999999999999999865422 2223456
Q ss_pred ccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHH
Q 001253 975 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSH 1054 (1114)
Q Consensus 975 g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1114)
|++.|+|||++.+..++.++||||+||++|||++|+.||.............+..... ..... ....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~---~~~~ 222 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED----------EVKFE---HQNF 222 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc----------ccccc---cccC
Confidence 8999999999998889999999999999999999999997543322222222221111 00000 0112
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1055 MITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1055 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
..++.+++.+||+.||++||+++|+++...
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 345789999999999999999988764444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=339.27 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=208.6
Q ss_pred HHHHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeE
Q 001253 804 LVVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGF 876 (1114)
Q Consensus 804 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 876 (1114)
+.+..++|.+.++||+|+||.||+|+++ .++.||+|+++..... ...+.+..|+.++.++. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4566678999999999999999999964 3468999999754332 22456888999999997 9999999999
Q ss_pred EEecCceEEEEecCCCCCHHHHhccCC-----------------------------------------------------
Q 001253 877 CYHQGSNLLMYEYMARGSLGELLHGAS----------------------------------------------------- 903 (1114)
Q Consensus 877 ~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------- 903 (1114)
+...+..++||||+++|+|.++++...
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986421
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 001253 904 --------------------------------------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIK 939 (1114)
Q Consensus 904 --------------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 939 (1114)
..+++.....++.|++.||+|||+. +++|||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlk 266 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLA 266 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCC
Confidence 1357778889999999999999988 99999999
Q ss_pred CCCeEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 001253 940 SNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLD 1017 (1114)
Q Consensus 940 ~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~ 1017 (1114)
|+||++++++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999986532211 12223457889999999998889999999999999999998 888986543
Q ss_pred CCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1018 QGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
..+ .....+..+.. ...+......+.+++.+||+.+|.+||+++|+++.|+++.
T Consensus 347 ~~~----~~~~~~~~~~~------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 MNE----QFYNAIKRGYR------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred chH----HHHHHHHcCCC------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 222 11121211110 0111122357889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=340.09 Aligned_cols=204 Identities=28% Similarity=0.390 Sum_probs=177.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+.+ +++.||+|++.............+..|+.++.+++||+|+++++++.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999976 68999999997654333334567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999999974 35789999999999999999999998 999999999999999999999999999875431110
Q ss_pred ----------------------------------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCC
Q 001253 968 ----------------------------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPV 1013 (1114)
Q Consensus 968 ----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~ 1013 (1114)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0112457999999999999999999999999999999999999999
Q ss_pred CCC
Q 001253 1014 QPL 1016 (1114)
Q Consensus 1014 ~~~ 1016 (1114)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=353.93 Aligned_cols=263 Identities=24% Similarity=0.314 Sum_probs=208.6
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|++. +|+.||+|++.......+...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999976 68999999998665554555677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeecc
Q 001253 888 EYMARGSLGELLHGA----------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 957 (1114)
||++||+|.++++.. ....++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998631 12456778899999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCC-----------------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 001253 958 LAKVIDMPQS-----------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG 1020 (1114)
Q Consensus 958 ~a~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~ 1020 (1114)
+++....... ......+||+.|||||++.+..++.++||||+||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 11123569999999999999999999999999999999999999997532211
Q ss_pred CHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhhcc
Q 001253 1021 DLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRP-TMREVVLMLSESNRR 1089 (1114)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~ 1089 (1114)
.. ...... ++.. ..........+.+++.+|++.||++|| +++++++.|+.....
T Consensus 239 i~---~~~~i~---------~P~~---~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 IS---YRDVIL---------SPIE---VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh---hhhhcc---------Chhh---ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 000000 0000 000112234578899999999999995 678888888887553
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=336.07 Aligned_cols=239 Identities=24% Similarity=0.319 Sum_probs=193.2
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
++||+|+||+||+|+.+ +++.||+|++...........+.+..|..++... +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 6889999999765432233345567788888766 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~-~~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTST 155 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc-CCCcccc
Confidence 9999998743 4689999999999999999999998 999999999999999999999999999875421 2223345
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+..... .. ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~~~~i~~~-~~-------------~~~~ 217 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----DDLFEAILND-EV-------------VYPT 217 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHHHHHHhcC-CC-------------CCCC
Confidence 6799999999999999999999999999999999999999974332 2222222211 10 0111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCH
Q 001253 1053 SHMITVLKIAMLCTNISPFDRPTM 1076 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RPs~ 1076 (1114)
.....+.+++.+|++.||++||++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCC
Confidence 123467899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=335.88 Aligned_cols=244 Identities=23% Similarity=0.295 Sum_probs=196.7
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC-CceeeEEeEEEecCceEEEE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH-RNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 887 (1114)
+|++.+.||+|+||+||+|+.+ +++.||+|++...........+.+..|..++..++| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788899999999999999976 678999999986543333335567789999999976 56889999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++..... ..
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~-~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF-GG 155 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC-CC
Confidence 99999999999874 34688999999999999999999998 999999999999999999999999999875321 12
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... . .
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~~~-~---------~--- 218 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQSIMEH-N---------V--- 218 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHcC-C---------C---
Confidence 233456799999999999999999999999999999999999999975432 1222221111 0 0
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTM 1076 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1076 (1114)
..+......+.+++.+|++.||.+|++.
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 -SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1111223467889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=318.45 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=216.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+-|...+.||+|.|++|-+|++- +|+.||||++.+.+.+.-. ...+.+|++.|+.++|||||++|++.......|+|.
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45788889999999999999965 8999999999887765433 445667999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE-CCCCCeEEeeccCceecCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL-DDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|.=++|+|+|++.++...+.+....+++.||+.|+.|+|+. .+||||+||+||.+ ..-|-|||+|||++-.+. +
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--P 171 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC--C
Confidence 99999999999998889999999999999999999999998 89999999999875 567899999999998764 5
Q ss_pred CCccccccccccccCccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVT-EKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.....+.+|+..|-|||++.+..|+ +++||||+|||+|-+++|+.||....+.+.+- .++|+.+
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT--------------mImDCKY- 236 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT--------------MIMDCKY- 236 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh--------------hhhcccc-
Confidence 5667888999999999999999988 47899999999999999999998766544332 2334443
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+.....+..++|..|+..||.+|.+.+||+.
T Consensus 237 ---tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 ---TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ---cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 345556678899999999999999999999864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=321.50 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=205.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCc----EEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGH----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
++|++.+.||+|+||+||+|.+. +++ .+|+|.+.... ......++..|+..+++++||||+++++++. +...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence 57888899999999999999975 444 47777764322 1223456778888999999999999999875 4567
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++++||+++|+|.+++......+++..+..++.|++.||+|+|+. +++||||||+||++++++.+||+|||.++...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 899999999999999987677899999999999999999999998 99999999999999999999999999998653
Q ss_pred CCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 964 MPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 964 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
.... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ....+.+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~~~~~---- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----HEVPDLLEKGERLA---- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCCCcCC----
Confidence 2221 22234457788999999998899999999999999999998 9999865432 11222222221110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1091 (1114)
.+......+.+++.+||..||++|||+.|+++.|..+.+..+
T Consensus 232 --------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 232 --------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence 000112356789999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=332.40 Aligned_cols=244 Identities=27% Similarity=0.436 Sum_probs=205.8
Q ss_pred eecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCC
Q 001253 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGS 894 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 894 (1114)
++|+|.||+||-|++. +...+|||.+....... .+-+.+|+...++++|.|||+++|.+..++.+-+.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~---~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE---VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchh---hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 7999999999999976 57789999986544322 4557889999999999999999999999999899999999999
Q ss_pred HHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCCeEEeeccCceecCCCCCCccc
Q 001253 895 LGELLHGASSTL--DWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMS 971 (1114)
Q Consensus 895 L~~~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~ 971 (1114)
|.++++..-+++ .+.+.-...+||++||.|||.. .|||||||-+||||+ -.|.+||+|||-++... .......
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TE 734 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTE 734 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc-cCCcccc
Confidence 999998776777 6777888999999999999999 999999999999996 57899999999998764 2334557
Q ss_pred cccccccccCccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCc
Q 001253 972 AIAGSYGYIAPEYAYTM--KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDE 1049 (1114)
Q Consensus 972 ~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1114)
++.||..|||||++..+ .|+.++|||||||++.||.||++||....... ...++ -+-++..++
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFk-------------VGmyKvHP~ 799 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFK-------------VGMYKVHPP 799 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhh-------------hcceecCCC
Confidence 78999999999999765 48889999999999999999999998655322 11111 122233456
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1050 KTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1050 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+.+...+...+|.+|+.+||.+||+|++++.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 77788889999999999999999999999975
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=332.21 Aligned_cols=202 Identities=27% Similarity=0.470 Sum_probs=176.4
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
..++|++.++||+|+||+||+|.++ ++..+|+|++..... ......+.+|+++++.++||||++++++|.+++..++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3478999999999999999999987 688899998875432 2335678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+++|+|.++++. ...+++.....++.+++.|++|||+.. +++||||||+||++++++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999999974 346889999999999999999999741 7999999999999999999999999998754321
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPL 1016 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~ 1016 (1114)
......|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 223456899999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.41 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=203.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.++|.+.++||+|++|.||+|.++.+..+|+|++..... ..+.+.+|+.++++++|||++++++++. .+..++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 356888999999999999999988777899998765432 2456888999999999999999999875 45689999
Q ss_pred ecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 888 EYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
||+++++|.++++... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||.++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999997533 3589999999999999999999998 99999999999999999999999999998754332
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
........++..|+|||...+..++.++||||+|+++|||++ |+.||...... ...........
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~----------- 221 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQVERGYR----------- 221 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcCCC-----------
Confidence 222223346778999999988889999999999999999999 88998753321 11111111100
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
...+......+.+++.+||+.||++||+++++++.|++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01111233568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=341.60 Aligned_cols=262 Identities=21% Similarity=0.257 Sum_probs=205.2
Q ss_pred HHHHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec
Q 001253 802 KDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ 880 (1114)
Q Consensus 802 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 880 (1114)
.++....++|++.+.||+|+||.||+|+.+ +++.||+|++...........+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344556689999999999999999999976 6889999998754333333345678899999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 881 GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
+..|+||||+++|+|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999999974 3578888999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccccccCccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMK----VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLV 1036 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1114)
..............||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... ....+........
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~- 265 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMNHKNS- 265 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCc-
Confidence 76433333334567999999999987543 78899999999999999999999975332 2222222221110
Q ss_pred cccccccccCCCcccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 001253 1037 SGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFD--RPTMREVVLM 1082 (1114)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1082 (1114)
.. ..........+.+++.+|++.++.+ ||++.|+++.
T Consensus 266 -------~~--~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 -------LT--FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -------cc--CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00 0111123346778999999844433 7888888774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=322.05 Aligned_cols=261 Identities=22% Similarity=0.320 Sum_probs=211.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||.||+|+.+ +++.||||.+...........+++..|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46788889999999999999964 78999999887654444444567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 888 EYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 888 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
||+++++|.++++. ....+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 234689999999999999999999998 999999999999999999999999999886542
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
.. .......|+..|+|||.+.+..++.++||||+|+++|+|++|..||..... +.....+.. .... .+
T Consensus 159 ~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~-~~~~------~~-- 226 (267)
T cd08229 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKI-EQCD------YP-- 226 (267)
T ss_pred CC-cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc--hHHHHhhhh-hcCC------CC--
Confidence 22 222345688999999999988899999999999999999999999864322 112222211 1100 00
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
..........+.+++.+||+.||++|||+.+|++.++++.
T Consensus 227 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 ---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0111123446889999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=322.67 Aligned_cols=256 Identities=26% Similarity=0.448 Sum_probs=208.7
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
+..++|++.++||+|+||+||+|..++++.||||.+...... .+++.+|+..+++++|||++++++++..+...++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 345789999999999999999999888889999998754332 4568899999999999999999999998899999
Q ss_pred EEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 886 MYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
||||+++++|.+++.... ..+++.++..++.+++.|++|||+. +++|+||||+||++++++.+|++|||.+.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999999997543 4789999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
..........++..|+|||.+.+..++.++||||+|+++||+++ |+.||..... ............
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~~~~~~~~--------- 222 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----REVLEQVERGYR--------- 222 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCC---------
Confidence 22222223345678999999998889999999999999999998 9999864332 112222111100
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
...+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 ----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00111113468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=327.71 Aligned_cols=258 Identities=23% Similarity=0.409 Sum_probs=203.6
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH 879 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 879 (1114)
+.+++|++.+.||+|+||+||+|.++ +++.||+|++..... .....++.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 45678999999999999999999854 356799999864332 2234568899999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC
Q 001253 880 QGSNLLMYEYMARGSLGELLHGAS---------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE 950 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 950 (1114)
+...++||||+++|+|.++++... ..+++..+..++.|+++|++|||+. +++||||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence 999999999999999999986422 2457888999999999999999998 9999999999999999999
Q ss_pred eEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHH
Q 001253 951 AHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRN 1028 (1114)
Q Consensus 951 ~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 1028 (1114)
++|+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||..... ....+
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~----~~~~~- 232 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----EQVLR- 232 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH-
Confidence 999999998754322211 1122345788999999998889999999999999999999 6888864332 12222
Q ss_pred HHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
.+...... ..+......+.+++.+||+.||++|||+.|+++.|++
T Consensus 233 ~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGGLL------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCcC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111110 0111123468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=335.69 Aligned_cols=244 Identities=22% Similarity=0.302 Sum_probs=196.3
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
++||+|+||+||+|+.+ +++.||+|++...........+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999976 6789999999765433333345567788888765 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~-~~~~~~~ 155 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL-NGVTTTT 155 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceeccc-CCccccc
Confidence 999998874 34688999999999999999999998 999999999999999999999999999976432 2222345
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..|++.|+|||++.+..++.++||||+||++|||++|+.||..... ....+...... . ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~----~~~~~~i~~~~-~-------------~~p~ 217 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE----DDLFESILHDD-V-------------LYPV 217 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH----HHHHHHHHcCC-C-------------CCCC
Confidence 6799999999999998999999999999999999999999975432 22222222111 0 0111
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 001253 1053 SHMITVLKIAMLCTNISPFDRP-------TMREVVL 1081 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RP-------s~~evl~ 1081 (1114)
.....+.+++.+|++.||++|| ++.++++
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1234678899999999999999 7777763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=334.93 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=196.5
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEEE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+|++.+.||+|+||+||+|+.+ +++.||+|++.+.........+.+..|..++... +|++|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999976 6789999999865433333344566677777777 5899999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.... ..
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~-~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-DG 155 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC-CC
Confidence 999999999998743 4688999999999999999999998 999999999999999999999999999975432 12
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+..... . .
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~-~---------~--- 218 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEH-N---------V--- 218 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHHHHHHHhC-C---------C---
Confidence 223456799999999999999999999999999999999999999975332 1122221111 1 0
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTM 1076 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1076 (1114)
..+......+.+++.+|++.||++|++.
T Consensus 219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111223467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.09 Aligned_cols=264 Identities=25% Similarity=0.424 Sum_probs=209.8
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCc----EEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGH----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
.++|+..++||+|+||+||+|++. +|+ +||+|++..... ....+.+..|+..++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 467899999999999999999864 444 589999865432 3335678889999999999999999999875 45
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.+++|||+++|+|.++++.....+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 7899999999999999986666899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 963 DMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 963 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
...... ......+++.|+|||...+..++.++|||||||++|||++ |..||..... ..... .+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~----~~~~~~~----- 229 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-REIPD----LLEKGER----- 229 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH----HHHCCCc-----
Confidence 432221 1122235678999999998899999999999999999998 8898864332 11111 2221110
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFE 1094 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 1094 (1114)
...+......+.+++.+||+.||++||++.|+++.++++.+..+++.
T Consensus 230 -------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~~ 276 (279)
T cd05109 230 -------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFV 276 (279)
T ss_pred -------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCeE
Confidence 00111223468899999999999999999999999999977765543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=317.80 Aligned_cols=261 Identities=22% Similarity=0.324 Sum_probs=212.7
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||.||+|..+ +|+.||+|.++..........+.+.+|++++++++|++++++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999987 89999999987544444444667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 888 EYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 888 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
||+++|+|.+++.. ....+++.++..++.+++.|++|||+. +++||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998863 234689999999999999999999998 999999999999999999999999999886542
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
.. .......+++.|+|||.+.+..++.++||||+||++|+|++|+.||.... ....+.... ...+.. .
T Consensus 159 ~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~-~~~~~~-----~--- 226 (267)
T cd08224 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCKK-IEKCDY-----P--- 226 (267)
T ss_pred CC-cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC--ccHHHHHhh-hhcCCC-----C---
Confidence 22 22234568889999999998889999999999999999999999986432 222222221 111100 0
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
..........+.+++.+||+.+|++|||+.++++++++++
T Consensus 227 ---~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 ---PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0011133446889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=328.09 Aligned_cols=260 Identities=26% Similarity=0.439 Sum_probs=207.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
.++|.+.+.||+|+||+||++... ++..+|+|.+.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 467899999999999999999852 34568999886432 233567889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 001253 882 SNLLMYEYMARGSLGELLHGAS------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF 949 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 949 (1114)
..++||||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||++++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 9999999999999999986332 2589999999999999999999998 999999999999999999
Q ss_pred CeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHH
Q 001253 950 EAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVR 1027 (1114)
Q Consensus 950 ~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~ 1027 (1114)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... .....
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~----~~~~~ 233 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NEVIE 233 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH
Confidence 999999999986532221 11223345778999999998889999999999999999998 8888864432 11111
Q ss_pred HHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1028 NFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
. +..+... . .+......+.+++.+||+.||.+|||+.|+.+.|+++.+..
T Consensus 234 ~-i~~~~~~--------~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 234 C-ITQGRVL--------Q----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred H-HHcCCcC--------C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 1 2221110 0 00112246889999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=343.59 Aligned_cols=255 Identities=23% Similarity=0.291 Sum_probs=200.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+.+ +++.||||++...........+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999975 78999999987654333344567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999999974 35688999999999999999999998 999999999999999999999999999864321000
Q ss_pred ------------C----------------------------------ccccccccccccCccccccCCCCcccchHHHHH
Q 001253 968 ------------K----------------------------------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGV 1001 (1114)
Q Consensus 968 ------------~----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGv 1001 (1114)
. .....+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCC---CCHHH
Q 001253 1002 VLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDR---PTMRE 1078 (1114)
Q Consensus 1002 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~e 1078 (1114)
++|||++|+.||..... ....+...... ..+.. +........+.+++.+|+. +|.+| +++.|
T Consensus 237 il~elltG~~Pf~~~~~----~~~~~~i~~~~--------~~~~~--p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 237 IMFECLIGWPPFCSENS----HETYRKIINWR--------ETLYF--PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhcCCCCCCCCCH----HHHHHHHHccC--------CccCC--CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 99999999999965332 11122211100 00110 0111123467789999997 66665 69998
Q ss_pred HHHH
Q 001253 1079 VVLM 1082 (1114)
Q Consensus 1079 vl~~ 1082 (1114)
+++.
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 8764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=335.90 Aligned_cols=266 Identities=25% Similarity=0.340 Sum_probs=196.8
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-----ce
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG-----SN 883 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 883 (1114)
+|++.++||+|+||.||+|+.+ +|+.||||++....... .....+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV-SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc-hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5788899999999999999976 78999999987543222 22346788999999999999999999886432 47
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|+||||++ ++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 80 ~lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 80 YVVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 99999996 589998874 34689999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCC--CccccccccccccCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc-------
Q 001253 964 MPQS--KSMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN------- 1032 (1114)
Q Consensus 964 ~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 1032 (1114)
.... .......|++.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....+......
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLLGTPSPETIS 233 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH
Confidence 2211 12234579999999999865 678999999999999999999999996543211 11111110000
Q ss_pred ----C---CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1033 ----N---SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1033 ----~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
. .+...+..................+.+++.+||+.||++|||++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 0000000000000000001122457899999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=334.45 Aligned_cols=244 Identities=25% Similarity=0.310 Sum_probs=196.5
Q ss_pred ceecccCCeEEEEEEeC----CCcEEEEEEecccCC-CChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEec
Q 001253 815 FVIGRGACGTVYRAVLR----TGHTVAVKKLASNRE-GNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
++||+|+||+||+++.. +++.||+|++..... ........+..|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999853 578999999975432 1122245577899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCc
Q 001253 890 MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 969 (1114)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 156 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTV 156 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCc
Confidence 999999999974 34678888899999999999999998 9999999999999999999999999998754322 222
Q ss_pred cccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCc
Q 001253 970 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDE 1049 (1114)
Q Consensus 970 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1114)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||..... .......... ...
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~----~~~~~~~~~~----------~~~---- 218 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR----KKTIDKILKG----------KLN---- 218 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH----HHHHHHHHcC----------CCC----
Confidence 3345799999999999988899999999999999999999999975332 2222222211 111
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1050 KTVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1050 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
.+......+.+++.+||+.||++|| ++.++++
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1111234678999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.29 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=198.7
Q ss_pred eecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCC
Q 001253 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGS 894 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 894 (1114)
.||+|+||+||+|+++ +++.||+|.+.... ..+....+.+|+++++.++||||+++++++......++||||+++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 6999999999999975 78999999876433 23345678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcc-ccc
Q 001253 895 LGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM-SAI 973 (1114)
Q Consensus 895 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-~~~ 973 (1114)
|.+++......+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||.+........... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9999976666789999999999999999999998 999999999999999999999999999876432111111 111
Q ss_pred cccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 974 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 974 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..+..|+|||.+.+..++.++||||+|+++|||++ |..||..... ........... . ...+.
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----~~~~~~~~~~~--------~----~~~~~ 219 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----QQTREAIEQGV--------R----LPCPE 219 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----HHHHHHHHcCC--------C----CCCcc
Confidence 23567999999998889999999999999999998 8888864322 11111111110 0 01111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1053 SHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
.....+.+++.+|++.+|++|||+.|++++|++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=343.29 Aligned_cols=253 Identities=23% Similarity=0.258 Sum_probs=197.6
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
.|+..++||+|+||+||+|+.+ +++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999975 688999999976543333445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC--
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ-- 966 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-- 966 (1114)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999999743 4688899999999999999999998 99999999999999999999999999975321000
Q ss_pred --------------------------------------------CCccccccccccccCccccccCCCCcccchHHHHHH
Q 001253 967 --------------------------------------------SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVV 1002 (1114)
Q Consensus 967 --------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvi 1002 (1114)
.......+||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 001123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCC---HHHH
Q 001253 1003 LLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPT---MREV 1079 (1114)
Q Consensus 1003 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev 1079 (1114)
+|||++|+.||...... ......... ..... .+........+.+++.+++ .+|++|++ +.|+
T Consensus 238 l~elltG~~Pf~~~~~~----~~~~~i~~~--------~~~~~--~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 238 LYEMLVGQPPFLAQTPL----ETQMKVINW--------QTSLH--IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHhCCCCCCCCCHH----HHHHHHHcc--------CCCcC--CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999754321 111111110 00011 0111112345667777765 49999987 7776
Q ss_pred HH
Q 001253 1080 VL 1081 (1114)
Q Consensus 1080 l~ 1081 (1114)
++
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 64
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=334.04 Aligned_cols=258 Identities=23% Similarity=0.265 Sum_probs=201.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+.+ +++.||+|++.+.........+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999976 68999999997543333333566888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.+....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999999986566789999999999999999999998 999999999999999999999999999976543332
Q ss_pred CccccccccccccCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAYT-----MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||.... ..+...........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~----~~~~~~~i~~~~~~------- 226 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHKEH------- 226 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC----HHHHHHHHHcCCCc-------
Confidence 22333569999999999863 457889999999999999999999996432 22222222211110
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCC--CCCCHHHHHHH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPF--DRPTMREVVLM 1082 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 1082 (1114)
... ..........+.+++.+|+..+++ .||++.++++.
T Consensus 227 -~~~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 -FQF-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -ccC-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000 011111234567788887755433 37899888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=326.73 Aligned_cols=265 Identities=20% Similarity=0.327 Sum_probs=196.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC--CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC---CCCceeeEEeEEEe----
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR--TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI---RHRNIVKLYGFCYH---- 879 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 879 (1114)
++|++.+.||+|+||+||+|+.. +++.||+|++........ ....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 36889999999999999999973 468899999875543222 223455676666655 69999999999853
Q ss_pred -cCceEEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeecc
Q 001253 880 -QGSNLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957 (1114)
Q Consensus 880 -~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 957 (1114)
....++||||++ ++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346799999997 4899988643 34689999999999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC---C
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN---S 1034 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~ 1034 (1114)
+++..... .......|++.|+|||++.+..++.++||||+||++|||++|++||......+.....+ +..... .
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~-~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL-DVIGLPGEED 232 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH-HHhCCCChhh
Confidence 99875422 23345578999999999998899999999999999999999999997654322222211 111100 0
Q ss_pred cccc--cccccccCCCccc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1035 LVSG--MLDARLNLQDEKT-----VSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1035 ~~~~--~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+... .....+......+ ......+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 0000000001111 112345678999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=332.16 Aligned_cols=263 Identities=24% Similarity=0.378 Sum_probs=211.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC--CC--cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR--TG--HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.++....++||+|.||+||+|.|+ .| ..||||.++...... ...+|.+|+.+|.+++|||++++||+..+ ...
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 345566678999999999999987 34 369999998776543 47889999999999999999999999987 778
Q ss_pred EEEEecCCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 884 LLMYEYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.+|||.++.|+|.+.+++ ....+-......++.|||.||.||.++ ++||||+.++|+++-....|||+|||+.+.+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence 899999999999999987 455788888899999999999999999 9999999999999999999999999999977
Q ss_pred CCCCCCc-c-ccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 963 DMPQSKS-M-SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 963 ~~~~~~~-~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
+...... + ....-+..|+|||.+....++.++|||+|||++|||+| |..||.+... .+.++. +..
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----~qIL~~-iD~------- 330 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----IQILKN-IDA------- 330 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----HHHHHh-ccc-------
Confidence 5332221 1 12234568999999999999999999999999999999 7899976543 222222 111
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH--HhhhccCCCc
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML--SESNRRQGHF 1093 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L--~~i~~~~~~~ 1093 (1114)
. .+-+.+..+...++++++.||..+|++||||..+.+.+ .+........
T Consensus 331 ---~--erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~a~~ 381 (1039)
T KOG0199|consen 331 ---G--ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVARE 381 (1039)
T ss_pred ---c--ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCceeee
Confidence 1 11233445667899999999999999999999998544 4443333333
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=348.36 Aligned_cols=250 Identities=23% Similarity=0.276 Sum_probs=202.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC-C-CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-T-GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
..|.+.+.||+|+||.||+|... + ++.||+|.+.... ......++.|+.+++.++|||||++++++..++..|+|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 34889999999999999999865 3 6788888764332 23345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|||+++|+|.++++. ....+++.++..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999999998853 234688999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 964 MPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 964 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ........... .. .
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~----~~~~~~~~~~~-~~-----~- 289 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----QREIMQQVLYG-KY-----D- 289 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhC-CC-----C-
Confidence 3222 22345679999999999999999999999999999999999999996432 22222222111 10 0
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+......+.+++.+||+.||++||++++++.
T Consensus 290 ------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 ------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011122346889999999999999999999864
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=326.42 Aligned_cols=269 Identities=24% Similarity=0.388 Sum_probs=209.4
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH 879 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 879 (1114)
+..++|++.++||+|+||.||+|..+ .+..||+|.+..... ......+.+|+.++++++||||+++++++.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 45688999999999999999999754 245899998764432 2224457889999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC
Q 001253 880 QGSNLLMYEYMARGSLGELLHGAS---------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE 950 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 950 (1114)
.+..++||||+++|+|.++++... ...++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence 999999999999999999996421 2456778899999999999999998 9999999999999999999
Q ss_pred eEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHH
Q 001253 951 AHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRN 1028 (1114)
Q Consensus 951 ~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 1028 (1114)
++++|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+..+
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----~~~~~- 232 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----EQVLK- 232 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH-
Confidence 99999999985432221 11222345778999999998889999999999999999998 7888864332 12222
Q ss_pred HHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCC
Q 001253 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDH 1100 (1114)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~ 1100 (1114)
.+..+... ..+......+.+++.+|++.||++|||+.++++.+++... ..+.++||
T Consensus 233 ~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~----~~~~~~~~ 288 (288)
T cd05061 233 FVMDGGYL------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH----PSFPEVSF 288 (288)
T ss_pred HHHcCCCC------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC----CCCCCCCC
Confidence 22111110 0011123468899999999999999999999999988642 35555554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=343.93 Aligned_cols=255 Identities=23% Similarity=0.260 Sum_probs=198.7
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.+|++.++||+|+||+||+|+.+ +++.||||++...........+.+.+|+.++++++||||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999975 68999999987543322233566888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC-
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ- 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 966 (1114)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999999743 4688888999999999999999998 99999999999999999999999999975321000
Q ss_pred -----------------------------------------CCccccccccccccCccccccCCCCcccchHHHHHHHHH
Q 001253 967 -----------------------------------------SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLE 1005 (1114)
Q Consensus 967 -----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~e 1005 (1114)
.......+||+.|||||++.+..++.++||||+||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 001123579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCC---CHHHHHHH
Q 001253 1006 LLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRP---TMREVVLM 1082 (1114)
Q Consensus 1006 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~ 1082 (1114)
|++|+.||...... .......... .... ..........+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 237 ll~G~~Pf~~~~~~----~~~~~i~~~~--------~~~~--~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPA----ETQLKVINWE--------TTLH--IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHH----HHHHHHhccC--------cccc--CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999754321 1111111100 0000 0011112335667777766 4999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=333.00 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=196.9
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
+.||+|+||+||+|+++ +++.||+|++++...........+..|..+++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 6789999999865433333345667788888877 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+++... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.... .......
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL-GGVTTST 155 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCc-CCCcccc
Confidence 9999998743 4789999999999999999999998 999999999999999999999999999875321 2222334
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
.+|++.|+|||++.+..++.++||||+||++|||++|+.||.... ........... .. ..+.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~----~~~~~~~i~~~-~~-------------~~~~ 217 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----EDELFQSILED-EV-------------RYPR 217 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC----HHHHHHHHHcC-CC-------------CCCC
Confidence 579999999999999999999999999999999999999996433 12222221111 10 0111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 001253 1053 SHMITVLKIAMLCTNISPFDRPTM-----REVVL 1081 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 1081 (1114)
.....+.+++.+||+.||.+||++ .++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 223467899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=334.95 Aligned_cols=244 Identities=21% Similarity=0.271 Sum_probs=196.0
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
+.||+|+||+||+|+.+ +++.||+|++...........+.+..|+.++.++ +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 6789999999876544444456688899998888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+++.. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG-PGDTTST 155 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccC-CCCceec
Confidence 999998863 34689999999999999999999998 999999999999999999999999999875321 2223345
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC--CHHHHHHHHHhcCCcccccccccccCCCcc
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG--DLVTWVRNFIRNNSLVSGMLDARLNLQDEK 1050 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1114)
.+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....++........ .. .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~----~ 222 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP---------IR----I 222 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC---------CC----C
Confidence 679999999999999999999999999999999999999996433221 12222222222111 11 1
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCH
Q 001253 1051 TVSHMITVLKIAMLCTNISPFDRPTM 1076 (1114)
Q Consensus 1051 ~~~~~~~l~~li~~cl~~dP~~RPs~ 1076 (1114)
+......+.+++.+|++.||.+|+++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11122457789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=323.53 Aligned_cols=266 Identities=27% Similarity=0.362 Sum_probs=201.7
Q ss_pred CcCCceecccCCeEEEEEEe-----CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--Cce
Q 001253 811 FDERFVIGRGACGTVYRAVL-----RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSN 883 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 883 (1114)
|+..+.||+|+||+||++.. .+++.||+|+++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 48889999999999988763 2578899999875432 12356688899999999999999999988754 357
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||+++...
T Consensus 84 ~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 899999999999999974 3589999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCC--ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC--Cccccc
Q 001253 964 MPQSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN--SLVSGM 1039 (1114)
Q Consensus 964 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 1039 (1114)
..... ......++..|+|||...+..++.++||||||+++|||++|..||...... ............ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh
Confidence 32211 112234567799999998888999999999999999999999998643321 111100000000 000000
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
.+.... ...+......+.+++.+||+++|++|||++++++.|++++
T Consensus 237 ~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMR--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCC--CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000000 1112223457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=317.54 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=200.7
Q ss_pred eecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCH
Q 001253 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL 895 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 895 (1114)
+||+|+||.||+|..++++.||+|++..... ......+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 6899999999999988889999999875432 23345688899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccccc
Q 001253 896 GELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAG 975 (1114)
Q Consensus 896 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 975 (1114)
.+++......+++..+..++.+++.|+.|+|+. +++||||||+||++++++.+|++|||++...............+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 999976666789999999999999999999998 99999999999999999999999999997643222222222345
Q ss_pred cccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHH
Q 001253 976 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSH 1054 (1114)
Q Consensus 976 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1114)
+..|+|||++.+..++.++||||||+++||+++ |..||..... .. ....+..... ...+...
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~----~~-~~~~~~~~~~------------~~~~~~~ 219 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN----QQ-AREQVEKGYR------------MSCPQKC 219 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH----HH-HHHHHHcCCC------------CCCCCCC
Confidence 678999999998889999999999999999998 9999864432 11 1111111110 0111122
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1055 MITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1055 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
...+.+++.+|++.+|++||++.|++++|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=325.03 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=205.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
.++|.+.+.||+|+||.||+|+.. +++.||+|+++.... .+..+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 356888899999999999999864 347899999875433 223567899999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC
Q 001253 882 SNLLMYEYMARGSLGELLHGAS-------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK 948 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 948 (1114)
..++||||+++++|.++++... ..+++.++..++.|++.|++|+|+. +++||||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence 9999999999999999996432 3578899999999999999999998 99999999999999999
Q ss_pred CCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHH
Q 001253 949 FEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWV 1026 (1114)
Q Consensus 949 ~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~ 1026 (1114)
+.+||+|||.++....... .......+++.|+|||++.+..++.++||||+||++|||++ |..||...... ..+
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----~~~ 234 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----EVI 234 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHH
Confidence 9999999999986432221 11223346788999999999999999999999999999998 99998654321 111
Q ss_pred HHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1027 RNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
.. +..+.. . ..+......+.+++.+||+.||++||++.|+++.|++
T Consensus 235 ~~-~~~~~~---------~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 EC-ITQGRL---------L---QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH-HHcCCc---------C---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11 111111 0 0111223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=330.79 Aligned_cols=243 Identities=25% Similarity=0.338 Sum_probs=192.9
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhc-CCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGK-IRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
+.||+|+||+||+|+++ +++.||||+++..........+.+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 578999999976532222223445667777765 4899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENML-GDAKTCT 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCC-CCCceee
Confidence 999999974 34688999999999999999999998 999999999999999999999999999875321 1222345
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+. +.... .. .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~~~~-i~~~~-------~~------~~~ 217 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----EELFQS-IRMDN-------PC------YPR 217 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH----HHHHHH-HHhCC-------CC------CCc
Confidence 5799999999999998999999999999999999999999975332 122222 11110 00 011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 001253 1053 SHMITVLKIAMLCTNISPFDRPTMR-EVV 1080 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RPs~~-evl 1080 (1114)
.....+.+++.+||+.||++||++. ++.
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1223578899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=335.41 Aligned_cols=240 Identities=26% Similarity=0.292 Sum_probs=191.5
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHH-HHhcCCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEIL-TLGKIRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
+.||+|+||+||+|+.+ +|+.||+|++...........+.+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999976 78999999997653322222334444444 56889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTTST 155 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCcccc
Confidence 999999874 45788999999999999999999998 999999999999999999999999999875321 2223345
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+..+..... .... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~----------~~~~----~~ 217 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----TAEMYDNILNK----------PLRL----KP 217 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC----HHHHHHHHHcC----------CCCC----CC
Confidence 679999999999999999999999999999999999999997432 22222222211 1111 11
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHH
Q 001253 1053 SHMITVLKIAMLCTNISPFDRPTMR 1077 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RPs~~ 1077 (1114)
.....+.+++.+|++.||.+||+++
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1234678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=335.20 Aligned_cols=246 Identities=23% Similarity=0.256 Sum_probs=193.0
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHH-HHHhcCCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEI-LTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
+.||+|+||+||+|+++ +++.||+|++.............+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999976 6788999999754322222233344444 456788999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+++.. ...+.+.....++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~-~~~~~~~ 155 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTTST 155 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccccc-CCCCccc
Confidence 999999974 34677888889999999999999998 999999999999999999999999999975422 2223345
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..|++.|+|||++.+..++.++||||+||++|||++|+.||..... .+..+...... .. ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~----------~~----~~~ 217 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNILNKP----------LQ----LKP 217 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH----HHHHHHHHhCC----------cC----CCC
Confidence 6799999999999999999999999999999999999999974332 22222222110 11 111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001253 1053 SHMITVLKIAMLCTNISPFDRPTMREVVLML 1083 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1083 (1114)
.....+.+++.+|++.||.+||++.+.+.++
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 2234678899999999999999987654443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=325.97 Aligned_cols=258 Identities=25% Similarity=0.428 Sum_probs=206.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
++|.+.+.||+|+||.||+|... ++..+|+|.+..... ...+.+.+|+..+++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 56888899999999999999853 345688888754332 234678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 001253 883 NLLMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 947 (1114)
.++||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 999999999999999986432 3478999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHH
Q 001253 948 KFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTW 1025 (1114)
Q Consensus 948 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~ 1025 (1114)
++.++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~ 234 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EV 234 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HH
Confidence 99999999999976532221 11223456788999999999999999999999999999999 99998654321 11
Q ss_pred HHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
+.. ...+.... .+......+.+++.+||+.||++||++.+|+++|+++.+.
T Consensus 235 ~~~-~~~~~~~~------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IEC-ITQGRVLE------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHH-HhCCCCCC------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111 11111110 0111234688999999999999999999999999999664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=328.69 Aligned_cols=265 Identities=19% Similarity=0.333 Sum_probs=202.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+.+ +++.||+|++....... ....+.+|+.++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 56889999999999999999976 68899999987554322 2345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++ ++.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 99986 89888876666789999999999999999999998 99999999999999999999999999998653222
Q ss_pred CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC------c--ccc
Q 001253 968 KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS------L--VSG 1038 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~--~~~ 1038 (1114)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+......+ ...... . ...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR-LLGTPTEETWPGISSNDE 237 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCHHHHhhhcchhh
Confidence 22234568899999998865 4588999999999999999999999975443222111111 110000 0 000
Q ss_pred cccccccCCC-----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1039 MLDARLNLQD-----EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1039 ~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+....... .........+.+++.+|++.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 001112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.28 Aligned_cols=252 Identities=24% Similarity=0.298 Sum_probs=201.4
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEec
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
|+..+.||+|+||+||+|++. +++.||+|++.............+.+|+.+++.++|++++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999975 7899999998765443333345577899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 890 MARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 890 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++..... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~--~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GE 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCC--CC
Confidence 9999999988643 34699999999999999999999998 999999999999999999999999999976432 12
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
......|+..|+|||++.+..++.++|+||+||++|||++|+.||........... +...+.....
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~-~~~~~~~~~~------------- 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE-VDRRVLETEE------------- 222 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhhhcccc-------------
Confidence 22345789999999999988999999999999999999999999975433211111 1111111100
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPT-----MREVVL 1081 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1081 (1114)
.........+.+++.+|++.||++||+ +.++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 011122335788999999999999999 556655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=320.51 Aligned_cols=257 Identities=25% Similarity=0.450 Sum_probs=206.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CC---cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TG---HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.++|+..+.||+|+||.||+|+.+ ++ ..+|+|.+..... ....+.+..|+.++++++|||++++.+++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 457888899999999999999975 33 3799998865432 23356788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++++|.+++......+++.++..++.|++.|++|+|+. +++||||||+||++++++.+|++|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999999986667889999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCCcc--ccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 964 MPQSKSM--SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 964 ~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
....... .....+..|+|||++.+..++.++|||||||++||+++ |+.||..... ....+.. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~~~~~i-~~~~------ 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVMKAI-NDGF------ 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHH-hcCC------
Confidence 3222111 11223567999999988889999999999999999997 9999965432 1222221 1110
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
. .+........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 --~----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 --R----LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --C----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 011112234688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=330.50 Aligned_cols=243 Identities=25% Similarity=0.317 Sum_probs=192.9
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhc-CCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGK-IRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
++||+|+||.||+|+++ +|+.||+|+++..........+.+..|..++.. .+||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999986 689999999976533222224455667777765 4899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-GDNRAST 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeeccc-CCCceec
Confidence 999999874 34688999999999999999999998 999999999999999999999999999875321 1223345
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..|++.|+|||++.+..++.++||||+||++|||++|+.||..... ....+. +.... . ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~----~~~~~~-~~~~~-------~------~~~~ 217 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE----DELFES-IRVDT-------P------HYPR 217 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHH-HHhCC-------C------CCCC
Confidence 6799999999999999999999999999999999999999964332 122221 11110 0 0111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 001253 1053 SHMITVLKIAMLCTNISPFDRPTMR-EVV 1080 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RPs~~-evl 1080 (1114)
....++.+++.+||+.||++||++. +++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1234678899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=326.87 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=207.9
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFC 877 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 877 (1114)
.+..++|+..+.||+|+||.||+|.++ ....+|+|++..... ......+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345678999999999999999999864 236799999875432 22345688899999999 899999999999
Q ss_pred EecCceEEEEecCCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 001253 878 YHQGSNLLMYEYMARGSLGELLHGA---------------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNN 942 (1114)
Q Consensus 878 ~~~~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 942 (1114)
..++..++||||+++|+|.++++.. ...+++..+..++.|++.|++|||+. +|+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence 9999999999999999999998632 34689999999999999999999998 99999999999
Q ss_pred eEECCCCCeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 001253 943 ILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGG 1020 (1114)
Q Consensus 943 ill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~ 1020 (1114)
|++++++.+||+|||.++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |..||.....
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 240 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 240 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence 99999999999999999865432211 1122345678999999998899999999999999999997 8899864332
Q ss_pred CHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1021 DLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
.+.. +....... ...+......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 241 --~~~~-~~~~~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 --EELF-KLLKEGYR------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHH-HHHHcCCc------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111 11111110 0111222346889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.76 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=205.4
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|+..+.||+|++|.||+|+.+ +++.||+|.+...... ....+.+..|+.+++.++|||++++++++..++..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 4777889999999999999976 6899999998754332 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 889 YMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|+++++|.++++.. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~- 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT- 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc-
Confidence 99999999999754 45789999999999999999999998 99999999999999999999999999998764322
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......|++.|+|||+..+..++.++||||||+++|||++|+.||..... ....+.... +..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-~~~------------ 218 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GALILKIIR-GVF------------ 218 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHc-CCC------------
Confidence 222345688999999999999999999999999999999999999964431 111221111 110
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 0111123346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=324.67 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=207.6
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCY 878 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 878 (1114)
...++|.+.+.||+|+||.||+|.+. ++..||+|+++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 34467999999999999999999742 355899999875433 22346788999999999 7999999999999
Q ss_pred ecCceEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeecc
Q 001253 879 HQGSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957 (1114)
Q Consensus 879 ~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 957 (1114)
..+..++||||+++|+|.++++... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++++|||
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999997533 3489999999999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 001253 958 LAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSL 1035 (1114)
Q Consensus 958 ~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1114)
.++....... .......++..|+|||.+.+..++.++||||+||++|||++ |..||............ ......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~----~~~~~~ 262 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL----IKEGYR 262 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH----HHcCCc
Confidence 9986532221 11222346788999999999899999999999999999998 99998754432222111 111100
Q ss_pred ccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1036 VSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
...+......+.+++.+|++++|++|||+.|+++.|++.
T Consensus 263 ------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 ------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000111234688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=337.43 Aligned_cols=266 Identities=23% Similarity=0.289 Sum_probs=200.7
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-----ce
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG-----SN 883 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 883 (1114)
+|+..++||+|+||+||+|+.. +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788899999999999999975 7899999998654322 223456788999999999999999999998776 78
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|+||||+.+ +|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 80 ~lv~e~~~~-~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 80 YVVTELMQS-DLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEeecccc-CHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 999999975 88887763 45789999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcc------
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLV------ 1036 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 1036 (1114)
...........+++.|+|||++.+. .++.++||||+||++|||++|+.||........ ...+.+........
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-LDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHHHhh
Confidence 3333334445688999999998774 478999999999999999999999975442211 11111111100000
Q ss_pred ----cccc-----cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1037 ----SGML-----DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1037 ----~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
..+. .+...............+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 000000000011123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=345.35 Aligned_cols=255 Identities=25% Similarity=0.295 Sum_probs=204.9
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC----
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG---- 881 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 881 (1114)
..++|++.++||+|+||+||+|+.. +|+.||||++...... ......+.+|+..+..++|+|++++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3478999999999999999999965 7899999999765432 233556788999999999999999988775432
Q ss_pred ----ceEEEEecCCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEe
Q 001253 882 ----SNLLMYEYMARGSLGELLHGA---SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG 954 (1114)
Q Consensus 882 ----~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 954 (1114)
..++||||+++|+|.++++.. ...+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 257999999999999998642 34689999999999999999999998 99999999999999999999999
Q ss_pred eccCceecCCCC-CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 955 DFGLAKVIDMPQ-SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 955 DfG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||... .....+......
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~----~~~~~~~~~~~~- 260 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE----NMEEVMHKTLAG- 260 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHhcC-
Confidence 999998654322 22234567999999999999999999999999999999999999999643 222333322211
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
.. ...+......+.+++.+||+.||.+||++.++++.
T Consensus 261 ~~------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RY------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 10 01112233468899999999999999999998763
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=333.41 Aligned_cols=264 Identities=26% Similarity=0.331 Sum_probs=199.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-----
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG----- 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 881 (1114)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++...... ......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 478999999999999999999975 6899999999755332 233456778999999999999999999986543
Q ss_pred -ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 882 -SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 882 -~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
..|+||||+++ ++.+.++ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 46999999976 6666664 3478889999999999999999998 99999999999999999999999999997
Q ss_pred ecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHH--------------
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWV-------------- 1026 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~-------------- 1026 (1114)
.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+....+....
T Consensus 172 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 6432 222344578999999999999999999999999999999999999997554221111111
Q ss_pred ----HHHHhcCCcccccc------cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1027 ----RNFIRNNSLVSGML------DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1027 ----~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+.+........... +................+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111100000000 00000000011112346789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.75 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=206.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC-C---CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-T---GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
++|++.+.||+|+||.||+|+++ + +..+|+|.++.... ....+.+..|+.++++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 57888999999999999999864 2 34799999865432 233567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||+++++|.+++......+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999999987666789999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCcc--ccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 965 PQSKSM--SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 965 ~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
...... ....++..|+|||.+.+..++.++||||||+++||+++ |..||...... +....+ ....
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~~~~----~~~~------- 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIKAI----EEGY------- 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHHHHH----hCCC-------
Confidence 322211 11233568999999998889999999999999999886 99998654321 111111 1110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
+ .+.+......+.+++.+|++.+|.+||++.++++.|+++
T Consensus 227 -~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 -R----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -c----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 011112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.91 Aligned_cols=254 Identities=25% Similarity=0.368 Sum_probs=203.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGN--NNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
++|++.+.||+|++|.||+|... +++.||+|++....... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999975 68999999987543322 1224568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+++++|.+++... ..+++.....++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++.....
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999998743 4688899999999999999999998 9999999999999999999999999999865422
Q ss_pred CCCcc--ccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 966 QSKSM--SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 966 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
..... ....++..|+|||++.+..++.++||||+|+++|||++|+.||..... . ........... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~-~~~~~~~~~~~--------~ 225 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---M-AAIFKIATQPT--------N 225 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---H-HHHHHHhccCC--------C
Confidence 21111 334678899999999998899999999999999999999999864322 1 11111111100 0
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
...+......+.+++.+||+.+|.+|||+.|+++.
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11112233467889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=326.52 Aligned_cols=261 Identities=26% Similarity=0.458 Sum_probs=204.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCc--EEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGH--TVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 884 (1114)
++|++.+.||+|+||+||+|+++ ++. .+|+|.+.... .....+.+.+|+.++.++ +||||+++++++..++..|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 57888999999999999999975 454 45777765332 223356788899999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 001253 885 LMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF 949 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 949 (1114)
+||||+++|+|.++++... ..+++.++..++.|++.|++|||+. +++||||||+||++++++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence 9999999999999996432 2578999999999999999999998 999999999999999999
Q ss_pred CeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHH
Q 001253 950 EAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRN 1028 (1114)
Q Consensus 950 ~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 1028 (1114)
.+||+|||++..... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... .+..+.
T Consensus 162 ~~kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~ 235 (303)
T cd05088 162 VAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEK 235 (303)
T ss_pred cEEeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh----HHHHHH
Confidence 999999999864221 111112234678999999988889999999999999999998 9999864332 111111
Q ss_pred HHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCc
Q 001253 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHF 1093 (1114)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 1093 (1114)
..... . ...+......+.+++.+||+.+|++||++.++++.++++...+..+
T Consensus 236 -~~~~~--------~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 236 -LPQGY--------R----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred -HhcCC--------c----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 11100 0 0011112346789999999999999999999999999885554433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.97 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=198.1
Q ss_pred eecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 816 VIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
.||+|+||.||+|.++ ++..||+|++..... ....+.+.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999864 355799999865432 334567889999999999999999999885 4578999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCc--c
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--M 970 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~--~ 970 (1114)
++|.+++......+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......... .
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999999986667899999999999999999999998 99999999999999999999999999998654322211 1
Q ss_pred ccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCc
Q 001253 971 SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDE 1049 (1114)
Q Consensus 971 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1114)
....++..|+|||.+.+..++.++|||||||++||+++ |..||...... ... ..+..+.. ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~-~~~~~~~~------------~~ 218 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----EVM-SFIEQGKR------------LD 218 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----HHH-HHHHCCCC------------CC
Confidence 12234578999999988889999999999999999996 99999754321 111 22222110 11
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1050 KTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1050 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
.+.....++.+++.+||..+|++||++.+|.+.|+++
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=330.96 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=204.3
Q ss_pred HHhcCCcCCceecccCCeEEEEEEe------CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVL------RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCY 878 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 878 (1114)
...++|++.++||+|+||+||+|++ .+++.||||+++..... ...+.+.+|+.++.++ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 3457899999999999999999974 25788999999754322 2345678899999999 6899999999886
Q ss_pred ec-CceEEEEecCCCCCHHHHhccCC------------------------------------------------------
Q 001253 879 HQ-GSNLLMYEYMARGSLGELLHGAS------------------------------------------------------ 903 (1114)
Q Consensus 879 ~~-~~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------------ 903 (1114)
.. ...++||||+++|+|.++++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 46789999999999999986321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC-Ccc
Q 001253 904 ------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-KSM 970 (1114)
Q Consensus 904 ------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~ 970 (1114)
..+++.++..++.|+++|++|||+. +|+||||||+||++++++.+||+|||++........ ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 2367888899999999999999998 999999999999999999999999999986532221 112
Q ss_pred ccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCc
Q 001253 971 SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDE 1049 (1114)
Q Consensus 971 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1114)
....+++.|+|||.+.+..++.++||||||+++|||++ |..||.......... .....+.. ..
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~~~~~--------~~---- 302 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC----RRLKEGTR--------MR---- 302 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH----HHHhccCC--------CC----
Confidence 22345678999999988899999999999999999997 899986543221111 11111110 00
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1050 KTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1050 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
.+......+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0011123588999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=331.65 Aligned_cols=258 Identities=22% Similarity=0.258 Sum_probs=201.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+++.+ +++.||+|++.+...........+..|+.++..++|++|+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999976 57889999986543322333456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++++....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999986566789999999999999999999998 999999999999999999999999999976533222
Q ss_pred CccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+..........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~~~~-------- 225 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHKE-------- 225 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC----HHHHHHHHhCCCc--------
Confidence 2333457999999999986 3457889999999999999999999997432 2222222221110
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFD--RPTMREVVLM 1082 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1082 (1114)
+... ..........+.+++.+|+..+|.+ |++++|+++.
T Consensus 226 ~~~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RFQF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 1111122346778888888654444 7899988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.13 Aligned_cols=252 Identities=23% Similarity=0.419 Sum_probs=204.7
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
.+|++.+.||+|+||.||+|.+.+++.+|+|++...... ...+.+|++++++++||+++++++++......++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 467888999999999999999887889999998654332 3568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++++|.+++......+++..+..++.+++.|++|||+. +++||||||+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 9999999999986666789999999999999999999998 9999999999999999999999999999865432222
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
......++..|+|||.+.+..++.++||||+|+++|||++ |+.||..... ...+... ..+. ....
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~~-~~~~---~~~~------ 222 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----SEVVETI-NAGF---RLYK------ 222 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHH-hCCC---CCCC------
Confidence 2223345678999999998889999999999999999998 8999864321 2222221 1110 0000
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
+......+.+++.+||+.+|++||++.|+++.|.
T Consensus 223 ---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 ---PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 0112346889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=331.53 Aligned_cols=257 Identities=23% Similarity=0.252 Sum_probs=201.6
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+.+ +++.||+|++.............+.+|..++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999976 68899999987543322333456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++......+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999986566789999999999999999999998 999999999999999999999999999987653333
Q ss_pred CccccccccccccCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAYT-----MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
.......|++.|+|||++.+ ..++.++||||+||++|||++|+.||..... .+......... .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~--------~ 225 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHE--------E 225 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH----HHHHHHHHcCC--------C
Confidence 33334579999999999875 4678899999999999999999999974332 22222222111 0
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFD--RPTMREVVL 1081 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1081 (1114)
+... +.........+.+++.+|+..++.+ |++++++++
T Consensus 226 ~~~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 226 RFQF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cccC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0100 0111112346778899998865544 467887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=319.00 Aligned_cols=252 Identities=26% Similarity=0.333 Sum_probs=202.1
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEec
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
|+..+.||+|+||+||+|.++ +++.||+|.+...........+.+..|+.++++++|++++++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999976 7899999998765443333345577899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 890 MARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 890 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
+++++|.+++... ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++..... ..
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~--~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQ 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCC--Cc
Confidence 9999999988643 34689999999999999999999998 999999999999999999999999999876432 22
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
......|+..|+|||++.+..++.++||||+||++|||++|+.||......... ........... .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~~~-------~------ 222 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKEVQ-------E------ 222 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhhhh-------h------
Confidence 223457899999999999999999999999999999999999999754322111 11111111100 0
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPT-----MREVVL 1081 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1081 (1114)
.........+.+++.+||+.||++||| ++|+++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011112345789999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=323.26 Aligned_cols=263 Identities=24% Similarity=0.394 Sum_probs=202.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeCC---------------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceee
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRT---------------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVK 872 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 872 (1114)
.++|++.++||+|+||.||+|+... ...||+|++..... ......+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCe
Confidence 4679999999999999999998642 23589999875432 233567889999999999999999
Q ss_pred EEeEEEecCceEEEEecCCCCCHHHHhccCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 001253 873 LYGFCYHQGSNLLMYEYMARGSLGELLHGAS-----------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSN 941 (1114)
Q Consensus 873 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 941 (1114)
+++++......++||||+++++|.+++.... ..+++..+..++.|+++|++|||+. +++||||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence 9999999999999999999999999986432 2468899999999999999999998 9999999999
Q ss_pred CeEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh--CCCCCCCCCC
Q 001253 942 NILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT--GRAPVQPLDQ 1018 (1114)
Q Consensus 942 Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t--g~~p~~~~~~ 1018 (1114)
||++++++.+||+|||++........ .......++..|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 99999999999999999976432221 11223345778999999998889999999999999999998 5567764332
Q ss_pred CCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1019 GGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
......+......... .. . ...+......+.+++.+||+.||++||++++|++.|++
T Consensus 239 -~~~~~~~~~~~~~~~~--~~----~---~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 -EQVIENTGEFFRNQGR--QI----Y---LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHHHHHhhhhccc--cc----c---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111211111111000 00 0 00011123478999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=319.68 Aligned_cols=261 Identities=29% Similarity=0.409 Sum_probs=202.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe--cC
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH--QG 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 881 (1114)
.+|++.+.||+|+||+||+|..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 57888999999999999999853 57899999986543 2335678899999999999999999998754 34
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..++||||+++|+|.+++......+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 67899999999999999986666789999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCCc--cccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC-----------CHHHHHHH
Q 001253 962 IDMPQSKS--MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG-----------DLVTWVRN 1028 (1114)
Q Consensus 962 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~-----------~~~~~~~~ 1028 (1114)
........ .....++..|+|||+..+..++.++||||+||++|||++|..|+....... .......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 54322111 112234456999999998889999999999999999999887654321100 00000001
Q ss_pred HHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
..... .. ...+......+.+++.+||+.+|++|||+.|+++.|++++
T Consensus 238 ~~~~~----------~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 238 LLKNN----------GR--LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHhcC----------Cc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 11100 00 0111122346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=333.99 Aligned_cols=246 Identities=27% Similarity=0.295 Sum_probs=194.5
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHH-HHhcCCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEIL-TLGKIRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
+.||+|+||+||+|+.+ +|+.||+|++.............+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999975 78999999997654333233344555554 56789999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.... .......
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~-~~~~~~~ 155 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTT 155 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCC-CCCCccc
Confidence 999998873 45789999999999999999999998 999999999999999999999999999875321 2223345
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..|++.|+|||++.+..++.++||||+||++|||++|+.||...+ ..+..+..... . ... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~----~~~~~~~~~~~-~---------~~~----~~ 217 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD----VAEMYDNILHK-P---------LVL----RP 217 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC----HHHHHHHHHcC-C---------ccC----CC
Confidence 679999999999999999999999999999999999999997533 22222222211 0 110 11
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001253 1053 SHMITVLKIAMLCTNISPFDRPTMREVVLML 1083 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1083 (1114)
.....+.+++.+|++.+|.+||++++.++.+
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 1234577899999999999999986544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.79 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=204.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCc--EEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGH--TVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 884 (1114)
++|++.+.||+|+||.||+|..+ ++. .+|+|.++.... ....+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS--ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC--HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 57889999999999999999976 333 478888763222 22346688899999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 001253 885 LMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF 949 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 949 (1114)
+||||+++|+|.++++... ..+++..+..++.|++.|++|||+. +++||||||+||++++++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence 9999999999999996432 2588899999999999999999998 999999999999999999
Q ss_pred CeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHH
Q 001253 950 EAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRN 1028 (1114)
Q Consensus 950 ~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 1028 (1114)
.+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||..... ......
T Consensus 157 ~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~----~~~~~~ 230 (297)
T cd05089 157 ASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC----AELYEK 230 (297)
T ss_pred eEEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH
Confidence 9999999998743211 11111233567999999998889999999999999999997 9999965432 122222
Q ss_pred HHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCc
Q 001253 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHF 1093 (1114)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 1093 (1114)
.... . . ...+......+.+++.+||+.+|.+||+++++++.|+++..+...+
T Consensus 231 ~~~~-~----------~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 231 LPQG-Y----------R--MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred HhcC-C----------C--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 1111 0 0 0011122346889999999999999999999999999987665443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=336.85 Aligned_cols=385 Identities=28% Similarity=0.387 Sum_probs=317.5
Q ss_pred CCCCccCEEEecCCccc-CCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccc
Q 001253 99 GGLVHLTALDLSFNQLS-RNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALS 177 (1114)
Q Consensus 99 ~~l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 177 (1114)
+-|+.++..|+|+|.++ +..|.....+++++.|.|....+. .+|..++.|.+|++|.+++|++. .+-+++..|+.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 34567788888888887 467888888888888888888887 58888888888888888888887 5667778888888
Q ss_pred hhhhcccccCC-CCCCCccccccccceeccccccccccCCCCCCCCccceeeccccccCCCCccc-ccccccccEEEecC
Q 001253 178 QLVAYSNNISG-SLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKE-IGMLKYLTDVILWG 255 (1114)
Q Consensus 178 ~L~l~~n~i~~-~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~L~~ 255 (1114)
.+.+..|++.. -+|+.+..|..|..|+|++|++. ..|..+..-+++-.|+||+|+|. .||.. |-+|+.|-.|||++
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~ 159 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSN 159 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcccc
Confidence 88888888854 37888888899999999999888 78888888888999999999998 56655 55888889999999
Q ss_pred CcccCccccccccccccchhhcccccccCCchhhhcCCCccceeeecccccc-cccCccccccccccccccccccCCCCC
Q 001253 256 NQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELN-GTIPREIGKLSSALEIDFSENSLIGEI 334 (1114)
Q Consensus 256 N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~ls~N~l~~~~ 334 (1114)
|++. .+|+.+..+..|++|+|++|.+...--..+..+++|+.|.+++.+-+ ..+|.++..+.+|.++|+|.|++. .+
T Consensus 160 NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~v 237 (1255)
T KOG0444|consen 160 NRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IV 237 (1255)
T ss_pred chhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cc
Confidence 9998 67778899999999999999865544444556788888888887644 568999999999999999999987 78
Q ss_pred chhhhcccccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCccc-CCCCCCCCcC
Q 001253 335 PVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLV-GGIPQRLGAY 413 (1114)
Q Consensus 335 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l 413 (1114)
|..+.++.+|+.|+|++|+|+. .........+|++|+||.|+++ ..|.+++.+++|+.|.+.+|++. ..+|..++.+
T Consensus 238 Pecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL 315 (1255)
T KOG0444|consen 238 PECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKL 315 (1255)
T ss_pred hHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhh
Confidence 9999999999999999999984 3444566789999999999999 78999999999999999999986 4588889999
Q ss_pred ccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeec
Q 001253 414 SQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVEL 493 (1114)
Q Consensus 414 ~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 493 (1114)
.+|+++..++|++. ..|..+|++..|+.|.|++|++. .+|+++.-++.|+.|+|..|.----.|..-..-++|+.-++
T Consensus 316 ~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 316 IQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred hhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeec
Confidence 99999999999998 88999999999999999999998 68999999999999999998754233333222244554443
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.34 Aligned_cols=255 Identities=24% Similarity=0.412 Sum_probs=205.7
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
+..++|++.++||+|+||.||+|.+.++..+|+|.+..... ..+.+.+|+.++++++|+||+++++++.+ ...++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 34578999999999999999999988788899998864322 24568889999999999999999999887 77899
Q ss_pred EEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 886 MYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+|||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999999753 34678999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
..........++..|+|||++....++.++|||||||++|++++ |+.||...... +...+ +.....
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~----~~~~~~-------- 221 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRA----LERGYR-------- 221 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HHHHH----HhCCCC--------
Confidence 22222223346678999999998889999999999999999999 89998753321 11111 111110
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
. +........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 ~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 M----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred C----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 0111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=332.34 Aligned_cols=240 Identities=25% Similarity=0.288 Sum_probs=190.8
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHH-HHHhcCCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEI-LTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
++||+|+||+||+|+.+ +|+.||+|++.+...........+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999986 6889999999755432222234444454 467889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+.+.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE-PEETTST 155 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCC-CCCcccc
Confidence 999988863 35688888999999999999999998 999999999999999999999999999875322 2223345
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..|++.|+|||++.+..++.++||||+||++|||++|+.||...+ ........... .. ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~----------~~----~~~~ 217 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----VSQMYDNILHK----------PL----QLPG 217 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC----HHHHHHHHhcC----------CC----CCCC
Confidence 679999999999999899999999999999999999999997532 22222222111 11 1111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHH
Q 001253 1053 SHMITVLKIAMLCTNISPFDRPTMR 1077 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RPs~~ 1077 (1114)
.....+.+++.+|++.||.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2234678999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=318.58 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=201.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+++|+.++++++||||+++++++..++..++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 367999999999999999999975 7889999998654322 245678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.++++. ...+++..+..++.|++.|++|||+. +|+|||++|+||++++++.++|+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 85 MEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999999874 34689999999999999999999998 99999999999999999999999999998654221
Q ss_pred CCccccccccccccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
.......|++.|+|||.+. ...++.++||||+||++|||++|+.||...........+ ... ....+.
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-----~~~----~~~~~~ 230 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----SKS----NFQPPK 230 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-----ecC----CCCCCC
Confidence 2223456889999999874 345778999999999999999999998643321111000 000 000011
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
. .........+.+++.+||+.+|++||+++++++.
T Consensus 231 ~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 231 L----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred C----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 1 0111223578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=321.33 Aligned_cols=261 Identities=21% Similarity=0.379 Sum_probs=208.4
Q ss_pred HhcCCcCCceecccCCeEEEEEEeCC-----CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe-c
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLRT-----GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH-Q 880 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 880 (1114)
..++|++.+.||+|+||.||+|.+.. +..||+|++.... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 45789999999999999999999765 6889999886433 23345668889999999999999999998876 4
Q ss_pred CceEEEEecCCCCCHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEE
Q 001253 881 GSNLLMYEYMARGSLGELLHGAS-------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 953 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 953 (1114)
...++++||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+|+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence 67899999999999999986432 4689999999999999999999998 9999999999999999999999
Q ss_pred eeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHh
Q 001253 954 GDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIR 1031 (1114)
Q Consensus 954 ~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 1031 (1114)
+|||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||..... .++. ....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~-~~~~ 233 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMA-AYLK 233 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH----HHHH-HHHH
Confidence 999999865322221 1122346678999999998889999999999999999999 9999965322 1221 1122
Q ss_pred cCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1032 NNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
.... . .........+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 234 ~~~~--------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 234 DGYR--------L----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred cCCC--------C----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1110 0 01111234688999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.37 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=203.6
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|++.++||+|+||.||++.+. +++.||+|.+...... ...+.+..|+.+++.++||||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4788899999999999999976 7899999998654322 235667889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 889 YMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 889 ~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|+++|++.+++.. ....+++.....++.|++.|+.|||+. +++|+||||+||++++++.++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 9999999998864 334678999999999999999999998 99999999999999999999999999998654322
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.... ....... +..+...
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~----~~~~~~~-~~~~~~~----------- 218 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS----WKNLILK-VCQGSYK----------- 218 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC----HHHHHHH-HhcCCCC-----------
Confidence 22234568899999999998889999999999999999999999996432 2222221 1111110
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
..+......+.+++.+||+.||++||++.|++..
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0111223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=322.36 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=202.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.+|++.+.||+|+||.||+|... +++.||+|.+....... .+.+.+|+.+++.++||||+++++.+..+...|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 57889999999999999999965 68999999987544332 456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.++++. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||.+.......
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~- 170 (296)
T cd06654 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (296)
T ss_pred cccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence 99999999999963 3578999999999999999999998 99999999999999999999999999987643221
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......... ........ +..
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~----~~~~~~~~-------~~~--- 236 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----YLIATNGT-------PEL--- 236 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH----HHHhcCCC-------CCC---
Confidence 2223446889999999999888999999999999999999999999654321111 11111100 000
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+......+.+++.+||..||++||++.|+++
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 111223346788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=326.36 Aligned_cols=263 Identities=25% Similarity=0.389 Sum_probs=207.5
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC--------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR--------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGF 876 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 876 (1114)
+..++|.+.+.||+|+||.||+|++. ++..+|+|.+..... ......+..|+.+++.+ +||||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 33478999999999999999999853 235699999875432 22345678899999999 79999999999
Q ss_pred EEecCceEEEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 001253 877 CYHQGSNLLMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSN 941 (1114)
Q Consensus 877 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 941 (1114)
+...+..|+||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 169 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 169 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHH
Confidence 999999999999999999999997432 2588999999999999999999998 9999999999
Q ss_pred CeEECCCCCeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 001253 942 NILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQG 1019 (1114)
Q Consensus 942 Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~ 1019 (1114)
||++++++.+||+|||.++........ ......+++.|+|||++.+..++.++||||+||++|||++ |..||....
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-- 247 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-- 247 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC--
Confidence 999999999999999998765321111 1112234578999999998889999999999999999998 888885432
Q ss_pred CCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1020 GDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
..+. ...+..... .+.+......+.+++.+||+.+|++||++.|+++.|+++....
T Consensus 248 --~~~~-~~~~~~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 248 --VEEL-FKLLKEGHR------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred --HHHH-HHHHHcCCC------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1222 222222110 0111223347888999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=329.52 Aligned_cols=244 Identities=23% Similarity=0.300 Sum_probs=195.8
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEEEE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+|+..+.||+|+||+||+|+.+ +|+.||+|++...........+.+..|..+++.+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999976 68999999998654333333456777888888875 578889999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..... .
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-G 155 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC-C
Confidence 99999999999874 34689999999999999999999998 9999999999999999999999999998754322 2
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+...... .
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~~~~----------~--- 218 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSIMEHN----------V--- 218 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCC----------C---
Confidence 223345699999999999999999999999999999999999999975432 12222222111 0
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTM 1076 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1076 (1114)
..+......+.+++.+|++.+|.+|++.
T Consensus 219 -~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111123467889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.40 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=203.3
Q ss_pred cCCcCCceecccCCeEEEEEEe-----CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 809 DNFDERFVIGRGACGTVYRAVL-----RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
++|++.+.||+|+||+||+|++ .++..||+|.+..... ......+.+|+.++++++||||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4688889999999999999985 2467899999875332 23346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 001253 884 LLMYEYMARGSLGELLHGA----------------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 947 (1114)
|+||||+++++|.+++... ...+++.+...++.|++.||+|||+. +++||||||+||++++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 9999999999999998522 12578899999999999999999998 9999999999999999
Q ss_pred CCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHH
Q 001253 948 KFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTW 1025 (1114)
Q Consensus 948 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~ 1025 (1114)
++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-----~~ 234 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-----QE 234 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----HH
Confidence 99999999999986532221 22233456778999999988889999999999999999998 8888864321 11
Q ss_pred HHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
+.+.+...... . .+......+.+++.+||+.||++||++.++.+.|+.
T Consensus 235 ~~~~~~~~~~~--------~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLL--------P----CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcC--------C----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 22222221111 0 111123467889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=322.43 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=204.3
Q ss_pred CCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 810 NFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
+|++.+.||+|+||+||+|+.. ....+|+|.+..... ....+.+..|+.+++.++||||+++++.+..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4778899999999999999863 235688888865443 22346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 001253 884 LLMYEYMARGSLGELLHGA-----------------------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKS 940 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 940 (1114)
++||||+.+|+|.+++... ...+++.++..++.|++.|++|||+. +++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 9999999999999998632 12478899999999999999999998 999999999
Q ss_pred CCeEECCCCCeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 001253 941 NNILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQ 1018 (1114)
Q Consensus 941 ~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~ 1018 (1114)
+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999865322211 1223346778999999988889999999999999999998 9999864321
Q ss_pred CCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1019 GGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
.. +........ . ...+......+.+++.+||+.+|++||+++|+++.|+++..+
T Consensus 236 -~~----~~~~~~~~~------~------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 -ER----LFNLLKTGY------R------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -HH----HHHHHhCCC------C------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11 112121110 0 011112234688999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.58 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=206.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeCC----CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRT----GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.++|++.++||+|+||.||+|.+.+ ...||+|....... ....+.+..|+.++++++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 4568888999999999999999653 24689998865432 2345678899999999999999999998875 557
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++|+|.+++......+++..+..++.+++.|++|+|+. +++||||||+||+++.++.++++|||+++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 899999999999999986666789999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
...........++..|+|||.+....++.++||||||+++||+++ |..||......+ .... +....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~~~----~~~~~-------- 225 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-VIGR----IENGE-------- 225 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHH----HHcCC--------
Confidence 332222223345578999999988889999999999999999986 999997544321 1111 11111
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
.. ..+......+.+++.+|+.++|.+|||+.++++.|+++...
T Consensus 226 ~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 RL----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 01112234688899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=341.45 Aligned_cols=264 Identities=20% Similarity=0.304 Sum_probs=195.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec------
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ------ 880 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 880 (1114)
.++|++.++||+|+||+||+|+.. +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 467999999999999999999975 68999999885432 1235699999999999999999987432
Q ss_pred --CceEEEEecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-CeEEe
Q 001253 881 --GSNLLMYEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVG 954 (1114)
Q Consensus 881 --~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~ 954 (1114)
...++||||+++ ++.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence 135689999986 77776642 345789999999999999999999998 999999999999999665 79999
Q ss_pred eccCceecCCCCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 955 DFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 955 DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
|||+|+.+.. ........||+.|+|||++.+. .++.++||||+||++|||++|.+||........+...++. ....
T Consensus 214 DFGla~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~-~~~p 290 (440)
T PTZ00036 214 DFGSAKNLLA--GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV-LGTP 290 (440)
T ss_pred ccccchhccC--CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCC
Confidence 9999986542 2223345789999999998754 6899999999999999999999999765432222222211 1000
Q ss_pred ----------Cccccccccccc---CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHH--HHHHhh
Q 001253 1034 ----------SLVSGMLDARLN---LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV--LMLSES 1086 (1114)
Q Consensus 1034 ----------~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl--~~L~~i 1086 (1114)
.+....++ ... .....+.....++.+++.+||+.||.+|||+.|++ ..++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFP-DVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred CHHHHHHhchhhhcccCC-ccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 00000000 000 00001111234688999999999999999999998 344544
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.99 Aligned_cols=249 Identities=27% Similarity=0.433 Sum_probs=200.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEE-ecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCY-HQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv 886 (1114)
.++|++.+.||+|+||.||+|..+ |+.||+|.+.... ..+.+.+|+.++++++|+|++++++++. .+...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 357889999999999999999876 7889999985432 2456889999999999999999999765 45678999
Q ss_pred EecCCCCCHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 887 YEYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|||+++++|.++++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999999975443 589999999999999999999998 9999999999999999999999999998864322
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ....... +..+. .
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~----~~~~~~~-~~~~~------~--- 217 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPR-VEKGY------K--- 217 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC----HHHHHHH-HhcCC------C---
Confidence 1 22345678999999998889999999999999999997 999886432 2222221 11110 0
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
...+......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 218 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 ---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 011112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.33 Aligned_cols=364 Identities=24% Similarity=0.359 Sum_probs=219.9
Q ss_pred ccccceeccccccc-cccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhh
Q 001253 198 KRLKSFRAGQNLIS-GSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLA 276 (1114)
Q Consensus 198 ~~L~~L~l~~n~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 276 (1114)
+-.+-.++++|.++ +.+|.....++++++|-|...++. .+|++++.+++|++|.+++|++. .+-..++.++.|+.++
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 33445566666666 566777777777777777777776 67777777777777777777777 3445677777777777
Q ss_pred cccccccCC-chhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeeccccccc
Q 001253 277 LYDNKQVGQ-LPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLT 355 (1114)
Q Consensus 277 Ls~N~~~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 355 (1114)
+.+|++... +|..+..+..|+.|+|++|++. ..|..+...+++..|+||+|+|....-..|.+++.|-.|+|++|++.
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 777776543 6666777777777777777776 66766666667777777777766554455666666666666666666
Q ss_pred CcccccccccccCCEEEcccccccccccCccccccceeeeeccCCccc-CCCCCCCCcCccceEEEeecccccCCCCccc
Q 001253 356 GVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLV-GGIPQRLGAYSQLWVVDLSDNHLTGKIPRHI 434 (1114)
Q Consensus 356 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 434 (1114)
. .|..+..+..|++|+|++|.+...--..+-.++.|..|.+++.+-+ ..+|.++..+.+|..+|||.|.+. ++|+.+
T Consensus 164 ~-LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecl 241 (1255)
T KOG0444|consen 164 M-LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECL 241 (1255)
T ss_pred h-cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHH
Confidence 3 3445566666666666666654322222333445555555554322 345555555666666666666665 555555
Q ss_pred cccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCC-CCccccccccccCc
Q 001253 435 CRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFS-GPIPTEIGNCNALQ 513 (1114)
Q Consensus 435 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~ 513 (1114)
..+++|+.|+||+|+|+ .+.-+.....+|++|+||.|+++ .+|+.+++|++|+.|++.+|+++ .-+|+.++.+.+|+
T Consensus 242 y~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Le 319 (1255)
T KOG0444|consen 242 YKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLE 319 (1255)
T ss_pred hhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhH
Confidence 55555666666666555 33444455555555555555555 55555555555555555555554 22455555555555
Q ss_pred EEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccc
Q 001253 514 RLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKF 570 (1114)
Q Consensus 514 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 570 (1114)
.+..++|.+. ..|+.++.+..|+.|.|+.|++. .+|..+.-++.|+.|||..|.-
T Consensus 320 vf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 320 VFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred HHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence 5555555554 45555555555555555555554 4555555555555555555543
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.55 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=202.3
Q ss_pred HhcCCcCCceecccCCeEEEEEEeCC------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLRT------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ 880 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 880 (1114)
..++|++.+.||+|+||.||+|.+.. +..||+|.+..... ......+..|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34679999999999999999999753 56789998764432 22345688899999999999999999999998
Q ss_pred CceEEEEecCCCCCHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC---Ce
Q 001253 881 GSNLLMYEYMARGSLGELLHGAS------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF---EA 951 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~ 951 (1114)
+..++||||+++++|.++++... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++ .+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence 99999999999999999987443 2589999999999999999999998 999999999999998754 59
Q ss_pred EEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHH
Q 001253 952 HVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNF 1029 (1114)
Q Consensus 952 kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 1029 (1114)
||+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |..||..... ..... .
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~----~~~~~-~ 233 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----QEVME-F 233 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH-H
Confidence 99999999865322111 1112234568999999998899999999999999999997 9999874332 11111 1
Q ss_pred HhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1030 IRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
+..... ...+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 234 ~~~~~~------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 234 VTGGGR------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHcCCc------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 211110 01111223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=324.90 Aligned_cols=262 Identities=23% Similarity=0.399 Sum_probs=208.3
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC--------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR--------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGF 876 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 876 (1114)
+..++|++.+.||+|+||.||+|++. ++..||+|.+..... ....+.+.+|+.+++.+ +||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 44578999999999999999999742 245799999864432 23356788999999999 89999999999
Q ss_pred EEecCceEEEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 001253 877 CYHQGSNLLMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSN 941 (1114)
Q Consensus 877 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 941 (1114)
+......++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +++||||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence 999999999999999999999987432 3578889999999999999999998 9999999999
Q ss_pred CeEECCCCCeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 001253 942 NILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQG 1019 (1114)
Q Consensus 942 Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~ 1019 (1114)
||++++++.+||+|||.++........ ......+++.|+|||++.+..++.++||||||+++||+++ |..||....
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-- 244 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-- 244 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--
Confidence 999999999999999999876432221 1223346678999999998889999999999999999998 778875432
Q ss_pred CCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1020 GDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
..+..+. +...... ..+......+.+++.+||+.+|.+||++.|+++.|+++..-
T Consensus 245 --~~~~~~~-~~~~~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 --VEELFKL-LKEGHRM------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred --HHHHHHH-HHcCCcC------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 2222222 2221110 01112334688899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.16 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=204.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--C
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--G 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 881 (1114)
..|++.+.||+|+||.||+|+++ ++..||+|.++.... ......+.+|+.+++.++|||++++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 34788899999999999999842 578899999865432 23356789999999999999999999998775 5
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..++||||+++++|.+++......+++.++..++.|++.||+|+|+. +++||||||+||+++.++.++|+|||+++.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 67899999999999999976555789999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCC--ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----------CCCHHHHHHHH
Q 001253 962 IDMPQSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ----------GGDLVTWVRNF 1029 (1114)
Q Consensus 962 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~----------~~~~~~~~~~~ 1029 (1114)
....... ......++..|+|||+..+..++.++|||||||++|||++++.|...... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 5432221 12234577789999999888899999999999999999998766432110 00011111111
Q ss_pred HhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1030 IRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
...... .+.+......+.+++.+||+.+|++||++.++++.++++
T Consensus 239 ~~~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKR------------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCcc------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111100 011112345789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=332.99 Aligned_cols=240 Identities=25% Similarity=0.285 Sum_probs=194.3
Q ss_pred ceecccCCeEEEEEEe----CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecC
Q 001253 815 FVIGRGACGTVYRAVL----RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYM 890 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 890 (1114)
+.||+|+||+||+++. .+|+.||+|++....... .....+..|++++++++||||+++++++.+++..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999985 368899999997644321 22345678999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcc
Q 001253 891 ARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 970 (1114)
Q Consensus 891 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 970 (1114)
++|+|.+++.+ ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..... ....
T Consensus 81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~ 155 (318)
T cd05582 81 RGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKA 155 (318)
T ss_pred CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CCce
Confidence 99999999974 34689999999999999999999998 9999999999999999999999999999865322 1223
Q ss_pred ccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcc
Q 001253 971 SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEK 1050 (1114)
Q Consensus 971 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1114)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... .......... . .. .
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~~~~i~~~-~---------~~----~ 217 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----KETMTMILKA-K---------LG----M 217 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----HHHHHHHHcC-C---------CC----C
Confidence 456799999999999988899999999999999999999999964321 2222221111 1 11 1
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 001253 1051 TVSHMITVLKIAMLCTNISPFDRPTMRE 1078 (1114)
Q Consensus 1051 ~~~~~~~l~~li~~cl~~dP~~RPs~~e 1078 (1114)
+......+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1122346788999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=334.75 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=197.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|+..+.||+|+||+||+|+.+ +++.||+|++.............++.|+.++..++||+|+++++++.+++..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 68999999997654333344567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999974 34689999999999999999999998 999999999999999999999999999875421100
Q ss_pred ----------------------------------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCC
Q 001253 968 ----------------------------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPV 1013 (1114)
Q Consensus 968 ----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~ 1013 (1114)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0112357999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCC---HHHHH
Q 001253 1014 QPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPT---MREVV 1080 (1114)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 1080 (1114)
..... ........... ......... .....+.+++.+++ .||.+|++ +.|++
T Consensus 237 ~~~~~----~~~~~~i~~~~--------~~~~~p~~~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 237 CSETP----QETYRKVMNWK--------ETLVFPPEV--PISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCCCH----HHHHHHHHcCC--------CceecCCCC--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 75432 11222211100 001100111 12235667777766 49999986 45544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=331.66 Aligned_cols=266 Identities=23% Similarity=0.304 Sum_probs=200.8
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC----
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG---- 881 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 881 (1114)
..++|++.+.||+|+||.||+|... +++.||||++....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh-HHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4478999999999999999999975 68899999987654322 33456778999999999999999999986433
Q ss_pred --ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 882 --SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 882 --~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
..|+||||+++ ++.+.+. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 46999999976 6777665 3578899999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH------------
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR------------ 1027 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~------------ 1027 (1114)
+.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||............++
T Consensus 167 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCC--ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 86532 2223445789999999999999999999999999999999999999975432211111111
Q ss_pred ------HHHhcCCcccccc------cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1028 ------NFIRNNSLVSGML------DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1028 ------~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
.+........... +................+.+++.+|++.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 1111100000000 000000011111223467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=320.85 Aligned_cols=263 Identities=24% Similarity=0.406 Sum_probs=204.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeCC-----------------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRT-----------------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 870 (1114)
..+|++.++||+|+||.||+|+... +..||+|++...... ...+.+.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence 4678999999999999999998642 245899998755432 335678899999999999999
Q ss_pred eeEEeEEEecCceEEEEecCCCCCHHHHhccCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 001253 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGAS----------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKS 940 (1114)
Q Consensus 871 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 940 (1114)
+++++++..++..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence 999999999999999999999999999987433 2689999999999999999999998 999999999
Q ss_pred CCeEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh--CCCCCCCCC
Q 001253 941 NNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT--GRAPVQPLD 1017 (1114)
Q Consensus 941 ~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t--g~~p~~~~~ 1017 (1114)
+||+++.++.++|+|||.++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999986532221 12233456788999999988889999999999999999998 667775433
Q ss_pred CCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1018 QGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
.. ............... .. ....+.....++.+++.+||+.||++|||+.|+++.|++
T Consensus 239 ~~-~~~~~~~~~~~~~~~-------~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQ-QVIENAGHFFRDDGR-------QI--YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hH-HHHHHHHhccccccc-------cc--cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 21 111111111111000 00 001111223468999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=315.73 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=201.2
Q ss_pred CcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc----
Q 001253 811 FDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS---- 882 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 882 (1114)
|++.+.||+|+||+||+|.+. .+..||+|+++..... ......+..|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 567889999999999999964 2368999998754332 2334578899999999999999999999876554
Q ss_pred --eEEEEecCCCCCHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEee
Q 001253 883 --NLLMYEYMARGSLGELLHGA-----SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 955 (1114)
Q Consensus 883 --~~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 955 (1114)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|+|+. +++||||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 68999999999999988532 23689999999999999999999998 999999999999999999999999
Q ss_pred ccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 956 FGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 956 fG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
||.++........ ......++..|+|||+..+..++.++|||||||++|||++ |..||..... .+.... ...+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~~~-~~~~ 231 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIYDY-LRHG 231 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH-HHcC
Confidence 9999865432221 1122345678999999988889999999999999999999 8888864332 112211 1111
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
.. . ..+......+.+++.+||+.||.+||++.|+++.|+++
T Consensus 232 ~~--------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NR--------L----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC--------C----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 0 11112334788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=319.94 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=202.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
..+|+..++||+|+||+||+|... ++..+|+|.+.... ......+.+|+++++.++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 356888899999999999999742 35688999876433 233567899999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 001253 882 SNLLMYEYMARGSLGELLHGAS--------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 947 (1114)
..++||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence 9999999999999999987432 2578999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHH
Q 001253 948 KFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTW 1025 (1114)
Q Consensus 948 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~ 1025 (1114)
++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~ 233 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT----EA 233 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH----HH
Confidence 99999999999976532221 11223345788999999999999999999999999999998 88998643321 11
Q ss_pred HHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
.......... ..+......+.+++.+||+.||.+||++.||++.|++
T Consensus 234 ~~~~~~~~~~-------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 IECITQGREL-------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHcCccC-------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111111000 0111223457899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=314.06 Aligned_cols=248 Identities=23% Similarity=0.380 Sum_probs=197.3
Q ss_pred eecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 816 VIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
+||+|+||+||+|.++ +++.+|+|+++.... .....+.+..|+.+++.++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 5899999999999753 578899999864433 3344567889999999999999999999885 4567899999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCc--c
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--M 970 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~--~ 970 (1114)
|+|.+++.. ...+++..+..++.|++.|++|+|+. +++||||||+||+++.++.+||+|||.++......... .
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 80 GPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999999974 34689999999999999999999998 99999999999999999999999999998654332211 1
Q ss_pred ccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCc
Q 001253 971 SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDE 1049 (1114)
Q Consensus 971 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1114)
....++..|+|||.+....++.++|||||||++|||++ |+.||..... . ... ..+..+.. .+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~---~~~-~~i~~~~~------------~~ 218 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-N---EVT-QMIESGER------------ME 218 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-H---HHH-HHHHCCCC------------CC
Confidence 22234678999999988889999999999999999998 9999975432 1 111 12222110 01
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1050 KTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1050 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
.+......+.++|.+||+.||++||++.+|++.|++.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1112334688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.49 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=202.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
.+|++.++||+|+||+||+|++. ++..||+|++..... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 34677789999999999999864 247899999875432 2335668899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 001253 883 NLLMYEYMARGSLGELLHGA---------------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 947 (1114)
.++++||+++++|.+++... ...+++..+..++.|++.||+|+|+. +++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence 99999999999999998521 23578888999999999999999998 9999999999999999
Q ss_pred CCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHH
Q 001253 948 KFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTW 1025 (1114)
Q Consensus 948 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~ 1025 (1114)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||+||++|||++ |..||..... .++
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~ 235 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDV 235 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence 99999999999886532221 11233456789999999988889999999999999999998 7888864322 222
Q ss_pred HHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
... +...... ..+......+.+++.+||+.+|.+||+++||++.|+.
T Consensus 236 ~~~-i~~~~~~------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEM-IRNRQVL------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH-HHcCCcC------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222 2221110 0111233458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=312.94 Aligned_cols=250 Identities=29% Similarity=0.459 Sum_probs=205.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.++|++.+.||+|+||.||+|... |+.||+|++..... ..+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 467888999999999999999986 88999999975543 3567888999999999999999999999989999999
Q ss_pred ecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 888 EYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
||+++++|.++++... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||.++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999997543 3689999999999999999999998 99999999999999999999999999998653211
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
....++..|+|||++.+..++.++||||+|+++||+++ |+.||..... . .+...+.... .
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~-~~~~~~~~~~--------~-- 217 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----K-DVVPHVEKGY--------R-- 217 (256)
T ss_pred ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----H-HHHHHHhcCC--------C--
Confidence 12345678999999988889999999999999999997 9999864321 1 1222222110 0
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
...+......+.+++.+|++.+|++||++.|++++|+.+
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 --MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 011112235688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=319.28 Aligned_cols=257 Identities=24% Similarity=0.388 Sum_probs=205.0
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ 880 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 880 (1114)
..++|++.+.||+|+||.||+|.++ ++..||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 3578999999999999999999975 236899999864432 22345688899999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCe
Q 001253 881 GSNLLMYEYMARGSLGELLHGAS---------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEA 951 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 951 (1114)
...++||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 99999999999999999986322 2478889999999999999999998 99999999999999999999
Q ss_pred EEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHH
Q 001253 952 HVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNF 1029 (1114)
Q Consensus 952 kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 1029 (1114)
||+|||+++....... .......++..|+|||.+.+..++.++|||||||++||+++ |..||..... ....+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~~- 233 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----EEVLKF- 233 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH----HHHHHH-
Confidence 9999999986543222 12233456789999999988889999999999999999998 8888864332 122221
Q ss_pred HhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1030 IRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
...... . ..+......+.+++.+||+.+|++|||+.++++.|++
T Consensus 234 ~~~~~~--------~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGGH--------L----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCCC--------C----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111 0 0111124568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=312.33 Aligned_cols=249 Identities=26% Similarity=0.427 Sum_probs=205.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|+..++||+|+||.||+|+++ +++.||+|.+..... .+++.+|++++++++||||+++++++.++...|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 67888999999999999999987 478999999864432 567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.+++......+++..+..++.|+++|+.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 99999999999986677899999999999999999999998 99999999999999999999999999998654322
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||........... ..... ...
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~------~~~---- 218 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNKP------PPT---- 218 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-----hccCC------CCC----
Confidence 122344588899999999988999999999999999999999999975433211110 00000 000
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.+++.+||+.||++|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1112223346889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=314.93 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=199.7
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|+..++||+|+||+||+|++. +++.||+|++..... ....+.+..|+.++++++||||+++++++..++..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36788899999999999999965 789999999865432 233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||++++++..+. .+++..+..++.|++.|++|+|+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 79 EFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred ecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 999999997653 467888999999999999999998 9999999999999999999999999999865322
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHH--HHHHHhcCCccccccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTW--VRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
......|+..|+|||++.+..++.++||||+|+++|+|++|+.||............ ......... ....
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~- 220 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVL- 220 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCC-
Confidence 223457899999999999989999999999999999999999999754322211111 111111100 0000
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
........+.+++.+|++.+|++||+++|+++.
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 ----PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ----CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011123467899999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=325.74 Aligned_cols=193 Identities=26% Similarity=0.360 Sum_probs=167.7
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
....+|++.+.||+|+||+||+|+.+ +++.||+|+..... ...|+.++++++||||+++++++......+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 44568999999999999999999976 57889999753221 245899999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||+. ++|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++...
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~- 208 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV- 208 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc-
Confidence 9999996 589998876677899999999999999999999998 99999999999999999999999999997532
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCC
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPV 1013 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~ 1013 (1114)
.........||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 -VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 122223457999999999999999999999999999999999865554
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=312.46 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=198.3
Q ss_pred ceecccCCeEEEEEEeC-C---CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecC
Q 001253 815 FVIGRGACGTVYRAVLR-T---GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYM 890 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 890 (1114)
++||+|+||.||+|.+. . +..||+|.+...... ...+.+..|+.+++.++||||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999864 2 268999998755443 33567889999999999999999999876 45679999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcc
Q 001253 891 ARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 970 (1114)
Q Consensus 891 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 970 (1114)
++|+|.+++.... .+++..+..++.|++.|++|||.. +++||||||+||+++.++.+||+|||.++..........
T Consensus 78 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 78 PLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999998544 789999999999999999999998 999999999999999999999999999986643322111
Q ss_pred --ccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 971 --SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 971 --~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
....++..|+|||...+..++.++||||||+++|||++ |..||..... .+...+ +......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~~~~----~~~~~~~----------- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIAM----LESGERL----------- 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHHHHH----HHcCCcC-----------
Confidence 11223568999999998899999999999999999998 9999865432 112222 2111100
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
..+......+.+++.+||+.+|++||++.++++.|+++.
T Consensus 218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111122346889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=315.66 Aligned_cols=255 Identities=23% Similarity=0.386 Sum_probs=198.6
Q ss_pred CcCCceecccCCeEEEEEEeCC-Cc--EEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec------C
Q 001253 811 FDERFVIGRGACGTVYRAVLRT-GH--TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ------G 881 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 881 (1114)
|.+.++||+|+||.||+|++.+ +. .||+|.++.... .....+.+..|+.+++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3466789999999999999764 33 689998876533 223356788899999999999999999987532 2
Q ss_pred ceEEEEecCCCCCHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeec
Q 001253 882 SNLLMYEYMARGSLGELLHG-----ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 956 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 956 (1114)
..++||||+++|+|.+++.. ....+++.....++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 46899999999999998742 234589999999999999999999998 9999999999999999999999999
Q ss_pred cCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCC
Q 001253 957 GLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNS 1034 (1114)
Q Consensus 957 G~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1034 (1114)
|+++.+...... ......+++.|+|||...+..++.++||||||+++|||++ |+.||..... .. ..+.+..+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~-~~~~~~~~~ 231 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----SE-IYDYLRQGN 231 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----HH-HHHHHHcCC
Confidence 999875432211 1122346778999999999899999999999999999999 7888864322 11 122222211
Q ss_pred cccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1035 LVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
.. ..+......+.+++.+||+.||++|||+.++++.|+++
T Consensus 232 ~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10 01112234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=317.51 Aligned_cols=263 Identities=23% Similarity=0.385 Sum_probs=202.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-----------------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-----------------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 870 (1114)
.++|++.++||+|+||+||++.+. ++..||+|++..... .....++.+|+.+++.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence 357999999999999999998643 234689999875432 2335678899999999999999
Q ss_pred eeEEeEEEecCceEEEEecCCCCCHHHHhccCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 001253 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGAS----------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKS 940 (1114)
Q Consensus 871 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 940 (1114)
+++++++..++..++||||+++|+|.+++.... ..+++.++..++.|++.|++|||+. +++||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp 158 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT 158 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence 999999999999999999999999999986432 2467889999999999999999998 999999999
Q ss_pred CCeEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh--CCCCCCCCC
Q 001253 941 NNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT--GRAPVQPLD 1017 (1114)
Q Consensus 941 ~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t--g~~p~~~~~ 1017 (1114)
+||++++++.++|+|||+++.+..... .......+++.|+|||...+..++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 999999999999999999986532221 11222345678999999888889999999999999999998 677886443
Q ss_pred CCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1018 QGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
... ............... . . .+.+......+.+++.+||+.||.+||++.||++.|++
T Consensus 239 ~~~-~~~~~~~~~~~~~~~--~---~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 DEQ-VIENTGEFFRDQGRQ--V---Y----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hHH-HHHHHHHHHhhcccc--c---c----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 221 111111111111000 0 0 01111223568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=318.61 Aligned_cols=264 Identities=22% Similarity=0.313 Sum_probs=194.8
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC---CCCceeeEEeEEEec-----
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI---RHRNIVKLYGFCYHQ----- 880 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~----- 880 (1114)
+|++.+.||+|+||+||+|+.+ +++.||+|.++....... ....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 4788899999999999999976 689999999875433221 123445666666555 799999999998642
Q ss_pred CceEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 881 GSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
...++||||+++ ++.+++.... ..+++..+..++.|++.||+|+|+. +++||||||+||+++.++.+||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 357899999985 8988886433 4589999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC---Ccc
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN---SLV 1036 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 1036 (1114)
+.... ........|+..|+|||++.+..++.++||||+||++|||++|++||......+....... ..... .+.
T Consensus 156 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (288)
T cd07863 156 RIYSC--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD-LIGLPPEDDWP 232 (288)
T ss_pred ccccC--cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHH-HhCCCChhhCc
Confidence 86542 2222345689999999999988999999999999999999999999965433222222111 11000 000
Q ss_pred ccc--ccccccCCC-----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1037 SGM--LDARLNLQD-----EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1037 ~~~--~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
... ......... .........+.+++.+|++.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000000000 001122346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=316.58 Aligned_cols=263 Identities=26% Similarity=0.456 Sum_probs=210.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCc----EEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGH----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
..+|++.+.||+|+||+||+|.++ +|+ .||+|+...... ......+.+|+..+++++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 467889999999999999999975 333 589998765543 2335678899999999999999999999987 78
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.++||||+++|+|.++++.....+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++..
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 8999999999999999987667799999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCc-cccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 963 DMPQSKS-MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 963 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
....... .....++..|+|||.+....++.++||||||+++||+++ |+.||..... .+ +...+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~-~~~~~~~~~~----- 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VE-IPDLLEKGER----- 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HH-HHHHHhCCCC-----
Confidence 4222211 112234578999999988889999999999999999998 9999865432 11 2222221110
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHF 1093 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 1093 (1114)
. ..+......+.+++.+||..||.+||++.++++.|+++.+...++
T Consensus 230 ---~----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 275 (279)
T cd05057 230 ---L----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRY 275 (279)
T ss_pred ---C----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcce
Confidence 0 011112236788999999999999999999999999987765554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=318.80 Aligned_cols=265 Identities=25% Similarity=0.392 Sum_probs=202.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||.||+|.+. ++..||+|.+..... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36889999999999999999976 688899998865432 233556888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.++++.. ..+++..+..++.|+++||+|||+.+ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 79 EHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 999999999999744 56889999999999999999999732 8999999999999999999999999998754322
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccc---c-----
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG---M----- 1039 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~----- 1039 (1114)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... .....+............. .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCCC
Confidence 22345789999999999888899999999999999999999999864431 1111111110000000000 0
Q ss_pred -----------ccccccC-CCcc-cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1040 -----------LDARLNL-QDEK-TVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1040 -----------~~~~~~~-~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
.+..... .... .......+.+++.+||+.+|++||+++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0000 00123468899999999999999999998876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=330.67 Aligned_cols=264 Identities=22% Similarity=0.299 Sum_probs=199.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec------
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ------ 880 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 880 (1114)
.++|++.+.||+|+||.||+|... +++.||||++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-hhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 478999999999999999999975 68899999997654322 2345677899999999999999999987543
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 881 GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
...|+||||+++ ++.+.+. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 356999999976 7777775 3578899999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH------------
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRN------------ 1028 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~------------ 1028 (1114)
.... ........|++.|+|||++.+..++.++||||+||++|||++|+.||...+..+.....++.
T Consensus 175 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCC--CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 6532 22234457899999999999999999999999999999999999999754432211111110
Q ss_pred ------HHhcCCcccc-----ccc-ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1029 ------FIRNNSLVSG-----MLD-ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1029 ------~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.......... ... ................+.+++.+|++.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 000 0000000111112346789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=318.90 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=199.7
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+.|++.++||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.+++.++|||++++++++..+...++||
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence 34677789999999999999976 57788999885432 233566888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.+++......+++..+..++.|+++||+|||+. +++||||||+||+++.++.+|++|||++..... ..
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~-~~ 157 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-TI 157 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccc-cc
Confidence 99999999998876566799999999999999999999998 999999999999999999999999999876432 12
Q ss_pred CccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
.......+++.|+|||++. +..++.++||||+||++|||++|+.||..... .+.......... .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~~~~~~~-------~ 226 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP----MRVLLKIAKSEP-------P 226 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH----HHHHHHHhhcCC-------C
Confidence 2233456899999999873 45577899999999999999999999865332 111111111100 0
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.. ..+......+.+++.+||+.||++||++.++++
T Consensus 227 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 227 TL----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CC----CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 011122346889999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=315.25 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=204.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CC---cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TG---HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
.+|++.+.||+|+||.||+|+++ ++ ..||||++.... .....+.|..|+..++.++||||+++++++..+...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 35788899999999999999975 33 369999986543 2334567999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||+++++|.+++......+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999999986667789999999999999999999998 999999999999999999999999999876532
Q ss_pred CCCCc-cc-cc--cccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 965 PQSKS-MS-AI--AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 965 ~~~~~-~~-~~--~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
..... .. .. ..+..|+|||++.+..++.++||||+||++||+++ |..||..... ....+. +....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~~~~~-i~~~~----- 228 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVINA-IEQDY----- 228 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HHHHHH-HHcCC-----
Confidence 22111 11 11 12457999999998899999999999999999886 9999865432 111111 11110
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
.. ..+......+.+++.+||+.+|.+||++.+++..|+++
T Consensus 229 ---~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ---RL----PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---cC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 11112234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=313.60 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=199.8
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
.+++.+.....||+|+||+||+|+++ ++..||+|.+..... ...+.+.+|+.++++++|+||+++++++..++..+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 44566666778999999999999965 678899998865432 23567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCCeEEeeccCcee
Q 001253 885 LMYEYMARGSLGELLHGASSTL--DWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKV 961 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~~ 961 (1114)
+||||+++++|.+++......+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++|+|||.+..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999998554445 8888899999999999999998 9999999999999976 67999999999876
Q ss_pred cCCCCCCccccccccccccCccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMK--VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
..... .......|++.|+|||++.+.. ++.++||||+|+++|+|++|+.||........ ..+.......
T Consensus 159 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~~~~~~~~------- 229 (268)
T cd06624 159 LAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMFKVGMFKI------- 229 (268)
T ss_pred cccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHhhhhhhcc-------
Confidence 53211 2223346889999999986543 78899999999999999999999965332111 1111100000
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....+......+.+++.+||+.+|.+|||+.|+++
T Consensus 230 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 -------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 01112223346889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=313.17 Aligned_cols=238 Identities=24% Similarity=0.404 Sum_probs=188.5
Q ss_pred eecccCCeEEEEEEeCC-------------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 816 VIGRGACGTVYRAVLRT-------------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
.||+|+||.||+|++.+ ...||+|++..... .....+.+|+..++.++||||+++++++..+..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR---DISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh---hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 68999999999998542 23588888765432 234568889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC-------eEEee
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE-------AHVGD 955 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-------~kl~D 955 (1114)
.++||||+++|+|..+++.....+++..+..++.|+++||+|||+. +|+||||||+||+++.++. ++++|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999999999886666799999999999999999999998 9999999999999987664 89999
Q ss_pred ccCceecCCCCCCccccccccccccCccccc-cCCCCcccchHHHHHHHHHHH-hCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 956 FGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELL-TGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 956 fG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
||.+..... .....++..|+|||.+. +..++.++|||||||++|||+ +|..||...... . ...+...
T Consensus 156 ~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~-~~~~~~~- 224 (262)
T cd05077 156 PGIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA----E-KERFYEG- 224 (262)
T ss_pred CCCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh----H-HHHHHhc-
Confidence 999875421 12345788999999886 566889999999999999998 478877543211 1 1111111
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1083 (1114)
.. .. .......+.+++.+||+.||++||++.++++.+
T Consensus 225 ~~---------~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QC---------ML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Cc---------cC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 00 001124678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=322.60 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=205.2
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC--------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR--------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFC 877 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 877 (1114)
..++|.+.++||+|+||.||+|+.. .+..||+|++..... ......+..|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 3467889999999999999999752 245799999875433 22355688899999999 699999999999
Q ss_pred EecCceEEEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 001253 878 YHQGSNLLMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNN 942 (1114)
Q Consensus 878 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 942 (1114)
.+.+..++||||+++|+|.+++.... ..+++.++..++.|++.||+|+|+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 99999999999999999999996432 3588999999999999999999998 99999999999
Q ss_pred eEECCCCCeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 001253 943 ILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGG 1020 (1114)
Q Consensus 943 ill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~ 1020 (1114)
|++++++.+||+|||.++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-- 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-- 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999999865422211 1112234567999999998889999999999999999999 8888864321
Q ss_pred CHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1021 DLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
.. +.+........ ..+......+.+++.+||+.+|++||++.|+++.|+++...
T Consensus 243 --~~-~~~~~~~~~~~------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 --EE-LFKLLREGHRM------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred --HH-HHHHHHcCCCC------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11 11112211110 01112233677899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.62 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=204.5
Q ss_pred cCCcCCceecccCCeEEEEEEeCC-CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRT-GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+.|.++..||.|+||.||+|..++ +-..|.|++.... ++...+|.-|+.++..++||+||++++.|..++..+++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 556777889999999999999773 4456677775433 334678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|||.||-.+.++-.-+..+++.++..+++|++.||.|||++ +|||||+|+.|||++-+|.++|+|||.+.... ...
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~ 184 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STR 184 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHH
Confidence 99999999999887788999999999999999999999999 99999999999999999999999999876422 233
Q ss_pred CccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
.....+.|||+|||||++. ..+|++++||||||+++.||..+.+|-..... +...++- ... ++
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---MRVllKi--aKS-------eP 252 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKI--AKS-------EP 252 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---HHHHHHH--hhc-------CC
Confidence 4456789999999999874 57899999999999999999999998754332 1111111 110 11
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.. --.+......+.+|+.+|+..+|..||+++++++
T Consensus 253 PT---LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 253 PT---LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred Cc---ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11 1123344567889999999999999999999874
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=312.48 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=195.2
Q ss_pred ceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEE-ecCceEEEEec
Q 001253 815 FVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCY-HQGSNLLMYEY 889 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~ 889 (1114)
+.||+|+||+||+|.+. ++..||+|++..... ....+.+.+|+.+++.++||||+++++++. .++..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC--HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 36899999999999864 245799998754322 223567888999999999999999999875 45568999999
Q ss_pred CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC--
Q 001253 890 MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-- 967 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-- 967 (1114)
+.+|+|.+++.......++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999999986666678888899999999999999998 999999999999999999999999999975432211
Q ss_pred -CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 968 -KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTG-RAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 968 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.......++..|+|||.+.+..++.++|||||||++|||++| .+||.... .....+....... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~~~~~~~~~~~~---------~- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----SFDITVYLLQGRR---------L- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHhcCCC---------C-
Confidence 111233467789999999888899999999999999999995 45554322 1222222111100 0
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
..+......+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 222 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 ---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0011123468899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=319.77 Aligned_cols=257 Identities=28% Similarity=0.469 Sum_probs=204.8
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ 880 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 880 (1114)
..++|+..+.||+|+||.||+|..+ ++..||+|++..... ....+++.+|+.++++++||||+++++++.++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 3578999999999999999999864 467899999865432 23356788999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 001253 881 GSNLLMYEYMARGSLGELLHGAS---------------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIK 939 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 939 (1114)
+..++||||+++|+|.+++.... ..+++.++..++.|++.||+|+|+. +++|||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 99999999999999999986321 2478888999999999999999998 99999999
Q ss_pred CCCeEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 001253 940 SNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLD 1017 (1114)
Q Consensus 940 ~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~ 1017 (1114)
|+||++++++.++|+|||.+........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876432221 11222345678999999998899999999999999999997 888886433
Q ss_pred CCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1018 QGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
. .+..+. +..+... ..+......+.+++.+||+.||++|||+.|+++.|++
T Consensus 238 ~----~~~~~~-~~~~~~~------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 H----EEVIYY-VRDGNVL------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H----HHHHHH-HhcCCCC------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2 222222 2221110 0011123468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=348.48 Aligned_cols=262 Identities=19% Similarity=0.344 Sum_probs=203.0
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--C
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--G 881 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 881 (1114)
....++|++.++||+|+||+||+|++. ++..||+|++...... ......+..|+.+++.++|||||+++++|.+. .
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 344578999999999999999999976 6788999998755432 23356788899999999999999999988653 4
Q ss_pred ceEEEEecCCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCeEECC-------
Q 001253 882 SNLLMYEYMARGSLGELLHGA---SSTLDWQTRFMIALGAAEGLSYLHHDCK----PRIFHRDIKSNNILLDD------- 947 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlk~~Nill~~------- 947 (1114)
..|+||||+++|+|.+++... ...+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999999999998642 3478999999999999999999998521 25999999999999964
Q ss_pred ----------CCCeEEeeccCceecCCCCCCccccccccccccCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001253 948 ----------KFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRAPVQP 1015 (1114)
Q Consensus 948 ----------~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~p~~~ 1015 (1114)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 335899999999865422 22334579999999999864 4588999999999999999999999964
Q ss_pred CCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHH--HHHHhh
Q 001253 1016 LDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV--LMLSES 1086 (1114)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl--~~L~~i 1086 (1114)
.. .....+.. +.... .+. .......+.++|.+||+.+|.+||++.|++ ..+..+
T Consensus 246 ~~---~~~qli~~-lk~~p--------~lp-----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 AN---NFSQLISE-LKRGP--------DLP-----IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CC---cHHHHHHH-HhcCC--------CCC-----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 33 22222222 11110 000 011234688999999999999999999998 445444
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=318.23 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=201.6
Q ss_pred CHHHHHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 001253 800 TFKDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFC 877 (1114)
Q Consensus 800 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 877 (1114)
.++.+..+.++|++.+.||+|+||+||+|..+ +++.+|+|++..... ....+..|+.+++.+ +||||+++++++
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 34445556789999999999999999999975 688999998764322 235677899999999 699999999988
Q ss_pred E-----ecCceEEEEecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 001253 878 Y-----HQGSNLLMYEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF 949 (1114)
Q Consensus 878 ~-----~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 949 (1114)
. .++..++||||+++++|.++++. ....+++..+..++.|+++|+.|||+. +++||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 4 34568999999999999998752 335688999999999999999999998 999999999999999999
Q ss_pred CeEEeeccCceecCCCCCCccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHH
Q 001253 950 EAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVT 1024 (1114)
Q Consensus 950 ~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~ 1024 (1114)
.++|+|||+++..... ........|++.|+|||++. +..++.++||||+||++|||++|+.||.........
T Consensus 162 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-- 238 (286)
T cd06638 162 GVKLVDFGVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-- 238 (286)
T ss_pred CEEEccCCceeecccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--
Confidence 9999999999865422 22223456899999999875 345788999999999999999999999754321111
Q ss_pred HHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
....... ..... .+......+.+++.+||+.||++|||+.|+++.
T Consensus 239 --~~~~~~~-------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 --FKIPRNP-------PPTLH----QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --hhccccC-------CCccc----CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1100000 00000 011112358899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=311.77 Aligned_cols=254 Identities=26% Similarity=0.381 Sum_probs=206.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||.||+|... +++.+|+|++...... ..+.+.+|+.++++++||||+++++++.+.+..+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 367899999999999999999975 6789999999755432 356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++......+++.++..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~- 154 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT- 154 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh-
Confidence 999999999999986656899999999999999999999998 9999999999999999999999999998765422
Q ss_pred CCccccccccccccCccccccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTM---KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
........++..|+|||.+.+. .++.++||||+|+++|||++|+.||........... .....+ ....
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-----~~~~~~----~~~~ 225 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-----ISKSNF----PPPK 225 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhccC----CCcc
Confidence 1122345688899999998877 889999999999999999999999975432111111 111100 0000
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..........+.+++.+||+.+|.+|||+.+++.
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 ----LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ----ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112233456889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=331.84 Aligned_cols=261 Identities=21% Similarity=0.216 Sum_probs=198.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
...|.+.++||+|+||.||+|.+. +++.||||... ...+.+|++++++++|+|||++++++..++..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 346999999999999999999976 57899999632 12356799999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
||++. ++|.+++......+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 99996 589998876666799999999999999999999998 99999999999999999999999999998654222
Q ss_pred C-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC---CCHHHHHHHHHhcCCcccccccc
Q 001253 967 S-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG---GDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 967 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
. .......||+.|+|||++.+..++.++|||||||++|||++|..|+...... ......+...+.........+..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 1 1223457999999999999999999999999999999999988765432211 11122222222211110000000
Q ss_pred ------------------cccCCCcc---cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1043 ------------------RLNLQDEK---TVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1043 ------------------~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
........ .......+.+++.+||+.||.+|||+.|+++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00000000 0011236788999999999999999999986
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=313.25 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=190.4
Q ss_pred ceecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCC
Q 001253 815 FVIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMA 891 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 891 (1114)
+.||+|+||.||+|.+. ++..+|+|.+...... .....+.+|+.++++++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 35899999999999865 3467999988655432 234568889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 892 RGSLGELLHGAS----STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 892 ~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
+|+|.++++... ...++..+..++.|+++|++|||+. +++||||||+||+++.++.+|++|||.++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 999999986422 2567788889999999999999998 999999999999999999999999999975432211
Q ss_pred -CccccccccccccCccccccC-------CCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 001253 968 -KSMSAIAGSYGYIAPEYAYTM-------KVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038 (1114)
Q Consensus 968 -~~~~~~~g~~~y~aPE~~~~~-------~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1114)
.......++..|+|||++.+. .++.++||||||+++|||++ |+.||........ ....+..... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~----~~~~~~~~~~--~ 229 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV----LTYTVREQQL--K 229 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH----HHHHhhcccC--C
Confidence 112234578899999988642 35789999999999999996 9999965432211 1111111000 0
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
...+. ........+.+++.+|| .+|++|||++||++.|+
T Consensus 230 ~~~~~------~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPR------LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCc------cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00111 01112235677899999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=316.82 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=202.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.+.|++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 367899999999999999999976 58899999986432 23356788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||++++++..++......+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 999999999998876666789999999999999999999998 9999999999999999999999999998754321
Q ss_pred CCccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
........+++.|+|||++. ...++.++|||||||++|||++|+.||..... ........... .
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~-------~ 232 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAKSE-------P 232 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH----HHHHHHHhcCC-------C
Confidence 22223456889999999884 34578899999999999999999999864332 11111111110 0
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+.. ..+......+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTL----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccC----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 111223346888999999999999999999865
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.06 Aligned_cols=261 Identities=29% Similarity=0.431 Sum_probs=207.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe--cC
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH--QG 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 881 (1114)
++|+..+.||+|+||+||+|++. +++.||||++...... ...+.+.+|++.++.++||||+++++++.. +.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 56788899999999999999864 3688999999765443 345679999999999999999999999887 55
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..++||||+++++|.+++......+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 78999999999999999986666799999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCC--ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC----------CHHHHHHHH
Q 001253 962 IDMPQSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG----------DLVTWVRNF 1029 (1114)
Q Consensus 962 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~----------~~~~~~~~~ 1029 (1114)
....... ......++..|+|||...+..++.++||||||+++|||++|+.|+....... .....+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6422111 1112345667999999988899999999999999999999999886432211 001111111
Q ss_pred HhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1030 IRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
..... + ...+......+.+++.+||+.+|++|||+.||+++|+++
T Consensus 239 ~~~~~--------~----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE--------R----LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC--------c----CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11110 0 011112235688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=313.35 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=202.5
Q ss_pred CCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCC---ChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 810 NFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREG---NNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
+|+..+.||+|+||+||+|...+|+.+|+|.+...... .....+.+.+|+..+++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999999888999999998754322 122345688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC-
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP- 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~- 965 (1114)
|||+++++|.+++... ..+++..+..++.|++.|++|+|+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999999743 4678999999999999999999998 9999999999999999999999999998754211
Q ss_pred ----CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 966 ----QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 966 ----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
.........|+..|+|||++.+..++.++||||+||++|+|++|+.||........ . ......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~-~~~~~~~~~-----~ 227 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---M-FYIGAHRGL-----M 227 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---H-HHhhhccCC-----C
Confidence 11122345688999999999988899999999999999999999999975432111 1 110000000 0
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.+++.+||+.+|.+||++.|+++
T Consensus 228 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 ------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111123346789999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.20 Aligned_cols=254 Identities=29% Similarity=0.460 Sum_probs=202.5
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEec
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
|++++.||+|+||+||+|+.. +++.||+|++......... .....+|+.++++++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 667889999999999999987 5678999999876543222 22334599999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCc
Q 001253 890 MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 969 (1114)
+++++|.+++. ....+++..+..++.|+++||++||+. +++|+||||+||++++++.++|+|||.+.... .....
T Consensus 80 ~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 80 CPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp ETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred ccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence 99999999997 445789999999999999999999999 99999999999999999999999999998641 23334
Q ss_pred cccccccccccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 970 MSAIAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 970 ~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
.....++..|+|||++. +..++.++||||+|+++|+|++|..||..... .+............ . ... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-~~~~~~~~~~~~~~-~-----~~~----~ 223 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-DDQLEIIEKILKRP-L-----PSS----S 223 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-HHHHHHHHHHHHTH-H-----HHH----T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-hhhhhhhhhccccc-c-----ccc----c
Confidence 45567899999999998 88899999999999999999999999975411 11111121111110 0 000 0
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.........+.+++.+||+.||++||++.++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011257999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=314.44 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=198.5
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEec----
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQ---- 880 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---- 880 (1114)
+++.|+..+.||+|+||+||+|..+ +++.||+|++...... ...+..|+.+++++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 4577888899999999999999976 6889999998654322 45678899999988 799999999998753
Q ss_pred --CceEEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeecc
Q 001253 881 --GSNLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957 (1114)
Q Consensus 881 --~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 957 (1114)
...|+||||+++++|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 3578999999999999999853 34689999999999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCCCccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN 1032 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1032 (1114)
++...... ........|++.|+|||++. +..++.++||||+||++|||++|+.||....... .... ...
T Consensus 157 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~---~~~~--~~~ 230 (272)
T cd06637 157 VSAQLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFL--IPR 230 (272)
T ss_pred Cceecccc-cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH---HHHH--Hhc
Confidence 99865322 22334567899999999986 3457889999999999999999999996433211 1111 011
Q ss_pred CCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1033 NSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.. .... ........+.+++.+||+.+|.+|||+.|+++
T Consensus 231 ~~------~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NP------APRL-----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC------CCCC-----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 0000 01112346889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=324.47 Aligned_cols=264 Identities=24% Similarity=0.396 Sum_probs=208.1
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC--------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR--------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGF 876 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 876 (1114)
+...+|++.+.||+|+||.||+|++. .+..||+|++..... ....+.+.+|+.+++++ +||||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC--HHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 44467999999999999999999853 123689998864432 22356788999999999 79999999999
Q ss_pred EEecCceEEEEecCCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 001253 877 CYHQGSNLLMYEYMARGSLGELLHGA---------------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSN 941 (1114)
Q Consensus 877 ~~~~~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 941 (1114)
+..++..+++|||+++|+|.+++... ...+++.++..++.|++.||+|||+. +++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 99999999999999999999998642 23578899999999999999999998 9999999999
Q ss_pred CeEECCCCCeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 001253 942 NILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQG 1019 (1114)
Q Consensus 942 Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~ 1019 (1114)
||++++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-- 241 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-- 241 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--
Confidence 999999999999999999865422211 1122334568999999999999999999999999999998 888886432
Q ss_pred CCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 001253 1020 GDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1091 (1114)
..+..+. +..... .+.+......+.+++.+||+.+|++||++.|+++.|+++.....
T Consensus 242 --~~~~~~~-~~~~~~------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 242 --VEELFKL-LKEGHR------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred --HHHHHHH-HHcCCC------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 2222222 111110 01111223468899999999999999999999999999975544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.99 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=200.8
Q ss_pred ceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCC
Q 001253 815 FVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGS 894 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 894 (1114)
++||+|+||.||+|.+.+++.||+|++...... .....+..|++++++++||||+++++++.+....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 369999999999999877999999998755433 335678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcc-ccc
Q 001253 895 LGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM-SAI 973 (1114)
Q Consensus 895 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-~~~ 973 (1114)
|.+++......+++..+..++.+++.|++|||+. +++||||+|+||+++.++.+||+|||.+........... ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9999976666789999999999999999999998 999999999999999999999999999986432111111 122
Q ss_pred cccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 974 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 974 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
.++..|+|||.+.+..++.++||||+||++|||++ |..||...... . ....+.... . ...+.
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-~----~~~~~~~~~--------~----~~~~~ 218 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-Q----TRERIESGY--------R----MPAPQ 218 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-H----HHHHHhcCC--------C----CCCCc
Confidence 34667999999988889999999999999999999 78888644321 1 111111110 0 01111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1053 SHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
.....+.+++.+||+.+|.+||++.|+++.|++
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=317.47 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=202.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.+|++.+.||.|+||+||+|... +++.||+|.+...... ..+.+.+|+..++.++|||++++++++...+..++||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 46899999999999999999964 7899999998654332 2456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~- 169 (296)
T cd06655 96 EYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ- 169 (296)
T ss_pred EecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc-
Confidence 99999999999873 3589999999999999999999998 99999999999999999999999999987653222
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......++..|+|||.+.+..++.++|||||||++|++++|+.||....... .......... +..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~----~~~~~~~~~~-------~~~--- 235 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----ALYLIATNGT-------PEL--- 235 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCC-------ccc---
Confidence 22234568899999999998889999999999999999999999996543211 1111111100 000
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+......+.+++.+||..||++||++.+++.
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111122346788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=319.53 Aligned_cols=265 Identities=21% Similarity=0.347 Sum_probs=201.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||.||+|+.+ +++.||+|.+....... ....+.+|+..++.++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 57899999999999999999976 68899999987544322 2345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++ +|.+++......+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+|||++.....+.
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 99975 99999886666789999999999999999999998 99999999999999999999999999997643222
Q ss_pred CccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC--Ccccccccc--
Q 001253 968 KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN--SLVSGMLDA-- 1042 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-- 1042 (1114)
.......+++.|+|||++.+. .++.++||||+||++|||++|+.||....... ....+....... .....+.+.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChhhchhhhcccc
Confidence 222334678999999988653 47889999999999999999999997543211 111111111100 000000000
Q ss_pred --cccCCC-------cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1043 --RLNLQD-------EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1043 --~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...... .........+.+++.+|++.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 001112346789999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=317.38 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=203.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|+++ +++.||+|++.... ....+.+..|++++++++||||+++++++..+...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 467888899999999999999975 68999999986432 23356788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++......+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST- 156 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc-
Confidence 999999999999986666899999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
........+++.|+|||.+. +..++.++||||+|+++|||++|+.||...... +........ ..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-~~------ 225 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVLLKILKS-EP------ 225 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHHHHHhcC-CC------
Confidence 22223456899999999874 345778999999999999999999999754321 111111111 00
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
+.+ ..+......+.+++.+||+.+|.+||++.++++.
T Consensus 226 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 PTL----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCc----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 0111223467889999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=327.74 Aligned_cols=263 Identities=22% Similarity=0.269 Sum_probs=201.0
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
+...+|++.++||+|+||+||+|... .++.||+|.+.... ...+|+.+++.++||||+++++++.....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 34568999999999999999999854 45789999875432 24579999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.|+|||++. ++|.+++. ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++..
T Consensus 161 ~~lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEEEehhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999999996 58888884 456789999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHh---cCCcc--
Q 001253 963 DMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIR---NNSLV-- 1036 (1114)
Q Consensus 963 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~-- 1036 (1114)
..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......... ..++..++ .....
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS-SQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH-HHHHHHHHHhccCccccC
Confidence 43222 2223467999999999999999999999999999999999999999765433211 11111111 00000
Q ss_pred c--------cc--ccccccCCCccc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1037 S--------GM--LDARLNLQDEKT-----VSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1037 ~--------~~--~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
. .. ...........+ ......+.+++.+|++.||++|||+.|++..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00 000000000000 0112457789999999999999999998865
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=318.32 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=202.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.+|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 67999999999999999999964 7899999998754432 2456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.+++.. ..+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 96 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~- 169 (297)
T cd06656 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (297)
T ss_pred cccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc-
Confidence 99999999999863 4578999999999999999999998 99999999999999999999999999998653222
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......+++.|+|||...+..++.++||||+||++|++++|+.||............ .. .....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~----~~---------~~~~~-- 234 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----AT---------NGTPE-- 234 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee----cc---------CCCCC--
Confidence 2223456889999999999888999999999999999999999999654321111000 00 00000
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112223345788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=312.58 Aligned_cols=267 Identities=22% Similarity=0.357 Sum_probs=203.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|+..+.||+|+||.||+|+++ +|+.||+|++...... ....+.+.+|+.++++++|||++++++++..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 46888999999999999999987 6899999998754332 223456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||++++++..+... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 80 EYCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred eccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99999888887763 44689999999999999999999998 999999999999999999999999999987643221
Q ss_pred CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHH----------HhcCCcc
Q 001253 968 KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNF----------IRNNSLV 1036 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~ 1036 (1114)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||......+......+.. .....+.
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 2234467889999999875 557899999999999999999999997544322211111100 0001111
Q ss_pred cccccccccCCCc---ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1037 SGMLDARLNLQDE---KTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1037 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.....+....... ........+.+++.+||+.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 1110111000000 00112356889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=313.57 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=199.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||.||+|+.. +++.||+|+++..... ....+.+|+.+++.++||||+++++++..++..++||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 56788889999999999999975 6889999998654322 2345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.+++.. ...+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.+...... .
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~ 160 (267)
T cd06645 86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-I 160 (267)
T ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-c
Confidence 99999999999874 34789999999999999999999998 9999999999999999999999999998765422 2
Q ss_pred CccccccccccccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
.......|++.|+|||++. ...++.++||||+||++|||++|+.||............ .. .... ....
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~----~~-~~~~----~~~~ 231 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM----TK-SNFQ----PPKL 231 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh----hc-cCCC----CCcc
Confidence 2233457899999999874 455888999999999999999999998654322211111 01 1100 0000
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. ........+.+++.+|++.+|++||+++++++
T Consensus 232 ~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 K----DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred c----ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 01112235788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=310.62 Aligned_cols=251 Identities=27% Similarity=0.400 Sum_probs=201.8
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCCh------hhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNN------NVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
+|.+...||+|++|.||+|... +++.||+|.+........ ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999975 688999999876544322 223568889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999999743 5688999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCC-----CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 001253 963 DMPQS-----KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 963 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1114)
..... .......|+..|+|||.+.+..++.++||||+||++|+|++|+.||...... ..+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~----- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QAIFKIGEN----- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HHHHHHhcc-----
Confidence 42111 1122345888999999999888999999999999999999999999754321 111111010
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.. ...+......+.+++.+||+.||.+||++.|+++
T Consensus 228 --~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 --AS------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --CC------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 1111223346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=314.49 Aligned_cols=239 Identities=21% Similarity=0.351 Sum_probs=187.8
Q ss_pred eecccCCeEEEEEEeCC-------------------------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCce
Q 001253 816 VIGRGACGTVYRAVLRT-------------------------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 870 (1114)
.||+|+||.||+|.+.. +..||+|++..... .....+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 59999999999998521 13588888864332 234567889999999999999
Q ss_pred eeEEeEEEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-
Q 001253 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF- 949 (1114)
Q Consensus 871 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~- 949 (1114)
+++++++.+....++||||+++|+|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999999976667889999999999999999999998 999999999999997643
Q ss_pred ------CeEEeeccCceecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHH-hCCCCCCCCCCCCC
Q 001253 950 ------EAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELL-TGRAPVQPLDQGGD 1021 (1114)
Q Consensus 950 ------~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~-tg~~p~~~~~~~~~ 1021 (1114)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 3899999988643211 22357788999998865 56889999999999999985 6899886543211
Q ss_pred HHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1022 LVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
...+ ..... .... .....+.+++.+||+.+|++|||+.++++.|+
T Consensus 230 ~~~~----~~~~~----------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERF----YEKKH----------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHH----HHhcc----------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111 11100 0001 11235788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=315.98 Aligned_cols=263 Identities=22% Similarity=0.317 Sum_probs=199.0
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|++.+.||+|++|+||+|+.+ +++.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 4788899999999999999976 7899999998754332 2234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 889 YMARGSLGELLHGAS--STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|++ +++.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.....+.
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 998 58988886433 5789999999999999999999998 99999999999999999999999999998654322
Q ss_pred CCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc-----
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML----- 1040 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1040 (1114)
.......+++.|+|||++.+. .++.++||||+||++|||++|+.||.............+.... .....+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT---PTEDVWPGVTS 231 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC---CChhhhhcchh
Confidence 222334578899999988654 4788999999999999999999999754322111111111000 000000
Q ss_pred ----cccccC-----CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 ----DARLNL-----QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 ----~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...... ..........++.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 00001112346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=317.53 Aligned_cols=195 Identities=24% Similarity=0.421 Sum_probs=161.2
Q ss_pred CceecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe--cCceEEEEe
Q 001253 814 RFVIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH--QGSNLLMYE 888 (1114)
Q Consensus 814 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E 888 (1114)
.++||+|+||+||+|+.+ +++.||+|++..... ...+.+|+.++++++||||+++++++.. +...++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 358999999999999965 467899999865432 3346789999999999999999999864 456789999
Q ss_pred cCCCCCHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----CCCCCeEEeec
Q 001253 889 YMARGSLGELLHGA--------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL----DDKFEAHVGDF 956 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Df 956 (1114)
|+++ ++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9975 888877521 23588999999999999999999998 99999999999999 46678999999
Q ss_pred cCceecCCCCC--CccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 001253 957 GLAKVIDMPQS--KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLD 1017 (1114)
Q Consensus 957 G~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~ 1017 (1114)
|+++....... .......||+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 99987643221 223456789999999998764 58899999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.82 Aligned_cols=248 Identities=29% Similarity=0.459 Sum_probs=203.7
Q ss_pred ceecccCCeEEEEEEeCC----CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecC
Q 001253 815 FVIGRGACGTVYRAVLRT----GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYM 890 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 890 (1114)
++||+|+||.||+|.... +..||+|++....... ..+.+.+|++.++.++|+|++++++++..+...++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 369999999999999763 7899999997655433 3567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 891 ARGSLGELLHGA--------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 891 ~~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
++++|.++++.. ...+++..+..++.|+++|++|||+. +++||||+|+||++++++.++|+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence 999999999865 46899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 963 DMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 963 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..... .......++..|+|||.+....++.++||||+|+++|||++ |..||..... ...... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~-~~~~~~----- 225 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EEVLEY-LRKGYR----- 225 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH-HHcCCC-----
Confidence 43221 22334567889999999988889999999999999999999 6899875521 122222 221110
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
...+......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 226 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 -------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111222457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=321.48 Aligned_cols=265 Identities=20% Similarity=0.220 Sum_probs=196.0
Q ss_pred CCceeccc--CCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEec
Q 001253 813 ERFVIGRG--ACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 813 ~~~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
+.++||+| +|++||+++.+ +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 35679999 68899999975 7899999998765432 23355678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC-
Q 001253 890 MARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS- 967 (1114)
Q Consensus 890 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 967 (1114)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999999643 34689999999999999999999998 999999999999999999999999986543211110
Q ss_pred -----CccccccccccccCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc--------
Q 001253 968 -----KSMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN-------- 1032 (1114)
Q Consensus 968 -----~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 1032 (1114)
.......++..|+|||++.+ ..++.++||||+||++|||++|+.||...................
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 01122356778999999876 458899999999999999999999997543322111111100000
Q ss_pred -CC-------------cccccc-cccc-----cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1033 -NS-------------LVSGML-DARL-----NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1033 -~~-------------~~~~~~-~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.. ...... .... .............+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 000000 0000 0000011123457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=311.62 Aligned_cols=247 Identities=28% Similarity=0.490 Sum_probs=194.2
Q ss_pred eecccCCeEEEEEEeC-CCc--EEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEEEecCC
Q 001253 816 VIGRGACGTVYRAVLR-TGH--TVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMYEYMA 891 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 891 (1114)
.||+|+||.||+|+++ ++. .+|+|.++.... ....+.+..|+.++.++ +||||+++++++...+..++||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC--HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 5899999999999976 343 468888764322 23345788899999999 79999999999999999999999999
Q ss_pred CCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeec
Q 001253 892 RGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 956 (1114)
Q Consensus 892 ~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 956 (1114)
+|+|.++++... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence 999999986432 2478999999999999999999998 9999999999999999999999999
Q ss_pred cCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 001253 957 GLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSL 1035 (1114)
Q Consensus 957 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1114)
|++..... .........+..|+|||++....++.++|||||||++|||++ |..||..... ....+.. ....
T Consensus 157 gl~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~~~-~~~~- 228 (270)
T cd05047 157 GLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKL-PQGY- 228 (270)
T ss_pred CCccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH----HHHHHHH-hCCC-
Confidence 99863221 111111234567999999988889999999999999999997 9999864332 1222221 1110
Q ss_pred ccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1036 VSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
.. +.+......+.+++.+||+.+|.+|||+.|+++.|+++
T Consensus 229 -------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 229 -------RL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred -------CC----CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 01111234678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.51 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=205.8
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|+..+.||+|+||.||.++.. +++.+|+|.+....... ...+++.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 5888999999999999999965 68999999986544322 335668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 889 YMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|+++++|.+++... ...+++.++..++.|+++|++|||+. +++||||+|+||++++++.+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999999754 45689999999999999999999998 999999999999999999999999999987643332
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
......+++.|+|||...+..++.++||||+|+++|||++|+.||.... ..+....... +.. .
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~~~~~~~~~-~~~---------~-- 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN----PLNLVVKIVQ-GNY---------T-- 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHc-CCC---------C--
Confidence 2344568999999999998889999999999999999999999986432 2222222211 111 0
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 -PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0111223468889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=309.27 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=205.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||.|+||+||+|... ++..+|+|++....... ..+.+.+|+..++.++|+|++++++.+..+...++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 46889999999999999999965 68899999986544332 3567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 888 EYMARGSLGELLHGA--SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||+++++|.++++.. ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999999743 24689999999999999999999998 9999999999999999999999999998765433
Q ss_pred CCC---ccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 966 QSK---SMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 966 ~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
... ......|+..|+|||++... .++.++|||||||++|||++|+.||..........+.. ... .
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~----~~~-------~ 224 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL----QND-------P 224 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh----cCC-------C
Confidence 222 22345689999999998776 78999999999999999999999997544322222211 111 0
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+.. ..........+.+++.+||+.||++||++.++++
T Consensus 225 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLET-GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCC-ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11110 0001123456789999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.69 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=200.3
Q ss_pred ceecccCCeEEEEEEeCC--C--cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecC
Q 001253 815 FVIGRGACGTVYRAVLRT--G--HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYM 890 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 890 (1114)
++||+|++|+||+|.+.+ + ..||+|++...... ...+.+..|+..+++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999753 3 36999998765543 446778999999999999999999999988 8889999999
Q ss_pred CCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC-
Q 001253 891 ARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK- 968 (1114)
Q Consensus 891 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 968 (1114)
++++|.+++.... ..+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9999999997654 5789999999999999999999998 9999999999999999999999999999876432211
Q ss_pred -ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 969 -SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 969 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
......++..|+|||++.+..++.++||||+||++|||++ |+.||..... .+..+........ .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~~~~~--------~-- 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----SQILKKIDKEGER--------L-- 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHhcCCc--------C--
Confidence 1123457788999999998899999999999999999998 9999864322 2222222111100 0
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
..+......+.+++.+|++.+|++||++.++++.|.+
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 0111223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=316.21 Aligned_cols=266 Identities=24% Similarity=0.373 Sum_probs=200.3
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|+..+.||+|+||+||+|+++ +|+.||+|++...... +.....+.+|+.++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 4788899999999999999976 7899999998754322 2223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++ ++.+++......+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++...... .
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~ 154 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-R 154 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-C
Confidence 9975 88888875566799999999999999999999998 99999999999999999999999999998654322 2
Q ss_pred ccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc-----cccccc-
Q 001253 969 SMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL-----VSGMLD- 1041 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~- 1041 (1114)
......++..|+|||++.+. .++.++||||+||++|||++|+.|+..........+.+......... .....+
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 22344678899999988764 47899999999999999999998875433322222211111110000 000000
Q ss_pred ccccCCC------cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQD------EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....... .........+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 001122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=338.58 Aligned_cols=263 Identities=19% Similarity=0.231 Sum_probs=191.9
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC------CCceeeEEeEE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR------HRNIVKLYGFC 877 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~ 877 (1114)
....++|++.++||+|+||+||+|.+. +++.||||+++.... ..+.+..|+.+++.++ |.+++++++++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 345688999999999999999999975 678999999864322 1334455666666654 45689999988
Q ss_pred Eec-CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCC------
Q 001253 878 YHQ-GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH-DCKPRIFHRDIKSNNILLDDKF------ 949 (1114)
Q Consensus 878 ~~~-~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~------ 949 (1114)
... +..|+|||++ +++|.+++.+. ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccc
Confidence 764 4678999988 66888888643 578999999999999999999997 5 899999999999998765
Q ss_pred ----------CeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001253 950 ----------EAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019 (1114)
Q Consensus 950 ----------~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~ 1019 (1114)
.+||+|||.+.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999886422 2234568999999999999999999999999999999999999999754432
Q ss_pred CCHHHHHHHHHhcCC----------cccccccccccC---------------CCcccHHHHHHHHHHHhhccCCCCCCCC
Q 001253 1020 GDLVTWVRNFIRNNS----------LVSGMLDARLNL---------------QDEKTVSHMITVLKIAMLCTNISPFDRP 1074 (1114)
Q Consensus 1020 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~cl~~dP~~RP 1074 (1114)
+.+ ..+......-. ....+++..... ...........+.+++.+||++||++||
T Consensus 352 ~~~-~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 352 EHL-HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHH-HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 111 11111100000 000000000000 0000011234577999999999999999
Q ss_pred CHHHHHH
Q 001253 1075 TMREVVL 1081 (1114)
Q Consensus 1075 s~~evl~ 1081 (1114)
|++|+++
T Consensus 431 ta~e~L~ 437 (467)
T PTZ00284 431 NARQMTT 437 (467)
T ss_pred CHHHHhc
Confidence 9999986
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=307.10 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=201.6
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec-CceEEEE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ-GSNLLMY 887 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 887 (1114)
+|++.+.||+|++|.||++..+ +++.||+|++...... ....+.+..|+.++++++|+|++++++.+... ...++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 4788899999999999999976 6789999998654332 22355688899999999999999999987644 4578999
Q ss_pred ecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 888 EYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
||+++++|.+++... ...+++.++..++.+++.|++|+|+. +++||||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999999753 34689999999999999999999998 99999999999999999999999999998764322
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.......+++.|+|||+..+..++.++||||+|+++|++++|+.||...+ .......... +..
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~----~~~~~~~~~~-~~~----------- 219 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD----MNSLVYRIIE-GKL----------- 219 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHh-cCC-----------
Confidence 22344568899999999999999999999999999999999999986432 2222222111 110
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.+++.+|++.+|++||++.++++
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111223356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=315.02 Aligned_cols=261 Identities=25% Similarity=0.438 Sum_probs=205.8
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCc----EEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGH----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
..++|+..+.||+|+||.||+|.+. +|+ .||+|.+..... .....++.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 3467888999999999999999964 444 578888764432 22344688899999999999999999998654
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..++++||+++|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 56799999999999999986666789999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 962 IDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 962 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
....... ......++..|+|||++.+..++.++|||||||++||+++ |+.||..... ....+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~~~---- 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-----REIPDLLEKGER---- 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHCCCC----
Confidence 5422211 1223345778999999998899999999999999999997 8899864321 112222222111
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
.. .+......+.+++.+||..+|++||+++++++.++++....
T Consensus 230 ----~~----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 230 ----LP----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ----CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 00 01112346788999999999999999999999999985543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=311.05 Aligned_cols=249 Identities=29% Similarity=0.425 Sum_probs=203.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|+..+.||.|++|.||+|++. +++.||+|++..... ......+.+|+.+++.++|+|++++++++.++...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 36888889999999999999976 689999999875432 223456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||.++......
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred EeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999999999743 789999999999999999999998 99999999999999999999999999998765332
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......+++.|+|||+..+..++.++||||||+++|+|++|+.||...... ..... +.... .+...
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----~~~~~-~~~~~------~~~~~-- 219 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----RVLFL-IPKNN------PPSLE-- 219 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----HHHHH-hhhcC------CCCCc--
Confidence 2233456888999999999888999999999999999999999999654321 11111 11110 00000
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.. .....+.+++.+||..+|++|||++++++
T Consensus 220 -~~--~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 -GN--KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -cc--ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00 02346788999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=311.50 Aligned_cols=256 Identities=26% Similarity=0.453 Sum_probs=204.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
++|+..+.||+|+||+||+|+.+ +.+.||+|.+..... ....+.+..|++++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 67889999999999999999964 246799998754332 2245678999999999999999999999999899
Q ss_pred eEEEEecCCCCCHHHHhccCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEe
Q 001253 883 NLLMYEYMARGSLGELLHGAS--------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG 954 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 954 (1114)
.++||||+++|+|.++++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence 999999999999999997433 1589999999999999999999998 99999999999999999999999
Q ss_pred eccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 955 DFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 955 DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
|||++...............++..|+|||.+.+..++.++||||+|+++|++++ |..||...... ..+.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~----~~~~~-~~~~ 234 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE----EVLNR-LQAG 234 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH----HHHHH-HHcC
Confidence 999987543223333344467788999999988888999999999999999999 78888643321 11111 1111
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
... .. ........+.+++.+||+.+|++||++.|+++.|++
T Consensus 235 ~~~-------~~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KLE-------LP----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CcC-------CC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 100 00 011122468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=285.44 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=198.8
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEEEe
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
.+.+..||.|.-|+||+++.+ +|...|||.+.+... .+..+++...+.++... ++|+||+.+|||..+...++.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N--kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC--HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 344556999999999999977 689999999976543 23345566667665544 58999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
.|.- ..+.+++.-.+.+++..+-++...+++||.||.+++ +|+|||+||+|||+|+.|.+|+||||++..+- .+.
T Consensus 172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv--dSk 246 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV--DSK 246 (391)
T ss_pred HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee--ccc
Confidence 9965 777787766778999999999999999999998764 99999999999999999999999999998764 334
Q ss_pred ccccccccccccCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 969 SMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
..+..+|-+.|||||.+.- ..|+.++||||||++++|+.||+.||...+...+....+ ..+. .+.+.
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv---ln~e-------PP~L~ 316 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV---LNEE-------PPLLP 316 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH---HhcC-------CCCCC
Confidence 4455678999999999863 468899999999999999999999998755433322222 2211 11111
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
........+.+++..|++.|+.+||.+.++++
T Consensus 317 ----~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 ----GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ----cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11124567899999999999999999998875
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=326.63 Aligned_cols=243 Identities=24% Similarity=0.243 Sum_probs=187.4
Q ss_pred ecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC---CCCceeeEEeEEEecCceEEEEecCCC
Q 001253 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI---RHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 817 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
||+|+||+||+|+.+ +++.||+|++.............+..|..++... +||+|+++++++......|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999976 6899999999654332222233344566666554 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~-~~~~~~~ 155 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLT-DNKTTNT 155 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCC-CCCCccC
Confidence 999999874 45789999999999999999999998 999999999999999999999999999875322 2223345
Q ss_pred ccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCccc
Q 001253 973 IAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKT 1051 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1114)
.+||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+..+.. ..+.. ....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~----~~~~~~~i-~~~~~---------~~~~--- 218 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED----TQQMYRNI-AFGKV---------RFPK--- 218 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC----HHHHHHHH-HcCCC---------CCCC---
Confidence 6799999999998754 48899999999999999999999996432 22222221 11110 0000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 001253 1052 VSHMITVLKIAMLCTNISPFDRPT----MREVVL 1081 (1114)
Q Consensus 1052 ~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 1081 (1114)
......+.+++.+||+.||.+||+ +.|+++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 012335778999999999999985 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=313.51 Aligned_cols=259 Identities=29% Similarity=0.430 Sum_probs=201.6
Q ss_pred CHHHHHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 001253 800 TFKDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFC 877 (1114)
Q Consensus 800 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 877 (1114)
+..++..+.++|++.+.||+|+||.||+|..+ +++.+|+|++..... ....+.+|+.+++++ +|||++++++++
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 33444456788999999999999999999975 688999999864322 245577899999988 899999999998
Q ss_pred Eec-----CceEEEEecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 001253 878 YHQ-----GSNLLMYEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF 949 (1114)
Q Consensus 878 ~~~-----~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 949 (1114)
... +..++||||+++++|.++++. ....+++..+..++.|++.||+|||+. +++||||||+||++++++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 754 357999999999999998863 345789999999999999999999998 999999999999999999
Q ss_pred CeEEeeccCceecCCCCCCccccccccccccCccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHH
Q 001253 950 EAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM-----KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVT 1024 (1114)
Q Consensus 950 ~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~ 1024 (1114)
.+||+|||.+....... .......|+..|+|||++... .++.++||||+||++|||++|+.||.........
T Consensus 166 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-- 242 (291)
T cd06639 166 GVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-- 242 (291)
T ss_pred CEEEeecccchhccccc-ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--
Confidence 99999999988654222 122334688999999987543 3678999999999999999999999754322111
Q ss_pred HHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....+. .. ... ..+......+.+++.+||+.+|++||++.|+++
T Consensus 243 --~~~~~~-~~------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 --FKIPRN-PP------PTL----LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --HHHhcC-CC------CCC----CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 00 000 011122346889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=298.18 Aligned_cols=245 Identities=24% Similarity=0.270 Sum_probs=204.4
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
.-++|+..++||+|.||+|-.++.+ +|+.||+|++++...-..+....-..|-++++..+||.+..+.-.|+..++.|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4478899999999999999999976 799999999998876554445556678899999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||..||.|.-++.+ ...+++......-..|+.||.|||++ +||+||+|.+|.|+|.||++||+|||+++.- ..
T Consensus 246 VMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I~ 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE-IK 320 (516)
T ss_pred EEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc-cc
Confidence 9999999999999974 45677777777888999999999998 9999999999999999999999999999853 34
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
......+++|||.|.|||++....|+.++|.|.+||++|||++|+.||...+... +.+. +....++
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-LFeL-------------Il~ed~k 386 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-LFEL-------------ILMEDLK 386 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-HHHH-------------HHhhhcc
Confidence 5566788999999999999999999999999999999999999999998655422 1111 1111122
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCC
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRP 1074 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1074 (1114)
++.....+...++...+..||.+|.
T Consensus 387 ----FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 ----FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ----CCccCCHHHHHHHHHHhhcChHhhc
Confidence 2222334566778889999999995
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=342.46 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=215.4
Q ss_pred HHHHhcCCcCCceecccCCeEEEEEEeC----C----CcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEE
Q 001253 804 LVVATDNFDERFVIGRGACGTVYRAVLR----T----GHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLY 874 (1114)
Q Consensus 804 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 874 (1114)
+++..++..+.+.+|+|+||.||+|..+ . ...||||.++..... ...+.+..|+++++.+ +||||+.++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 3445566667779999999999999843 1 357999999876654 3467899999999999 699999999
Q ss_pred eEEEecCceEEEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 001253 875 GFCYHQGSNLLMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIK 939 (1114)
Q Consensus 875 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 939 (1114)
|+|..++..++|+||+..|+|.++++..+ ..++..+...++.|||.||+||++. ++||||+.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLA 445 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLA 445 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhh
Confidence 99999999999999999999999998666 3489999999999999999999999 99999999
Q ss_pred CCCeEECCCCCeEEeeccCceecCCCCCCcccccc--ccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 001253 940 SNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA--GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPL 1016 (1114)
Q Consensus 940 ~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~ 1016 (1114)
++|||+.++..+||+|||+|+.............. -+..|||||.+....|+.++|||||||++||++| |..||+..
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999965443333322222 3567999999999999999999999999999999 88999864
Q ss_pred CCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1017 DQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
....++.+++++ +.- .+.+..+..+++++|+.||+.+|++||++.|+++.++..
T Consensus 526 ~~~~~l~~~l~~----G~r------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 PPTEELLEFLKE----GNR------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CcHHHHHHHHhc----CCC------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 433444333332 211 122333456789999999999999999999999999995
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=309.05 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=203.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
..|+..++||+|+||.||+|.++ +++.||+|++..... ......+.+|+.++++++||||+++++++.++...++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45777889999999999999976 688999999875432 233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ..+++.+...++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 82 e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 82 EYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred ecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 99999999999873 4688899999999999999999998 99999999999999999999999999997654222
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......++..|+|||++.+..++.++|||||||++|||++|..||....... ... ..... ..
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~-~~~~~------------~~ 218 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLF-LIPKN------------NP 218 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hhh-hhhcC------------CC
Confidence 22233468889999999998889999999999999999999999987543211 111 01100 01
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12223445678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.26 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=204.2
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|++.+.||+|+||+||+++.+ +|+.||+|++....... ...+++.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 5888899999999999999975 68999999987543322 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 889 YMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|+++++|.+++.... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 999999999987533 3678999999999999999999998 99999999999999999999999999998654322
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......|++.|+|||+..+..++.++|||||||++|+|++|+.||.... ....+....... .
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~~~~~~~~~~~-~------------ 218 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN----MKNLVLKIIRGS-Y------------ 218 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC----HHHHHHHHhcCC-C------------
Confidence 12223468889999999998889999999999999999999999986432 222332222211 0
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.+++.+||+.+|.+||++.+|++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0111223446889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.68 Aligned_cols=270 Identities=25% Similarity=0.274 Sum_probs=214.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.+.|+.-++||+|+||.||-++.+ +|+-||.|++.+.+........-...|-.++.++..+.||.+--+|+..+..|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 466888899999999999999976 7999999988766544333344556789999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 887 YEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
+..|.||+|.-++...+ ..++++.+...+.+|+.||++||+. +||+||+||+|||+|+.|+|+|+|.|+|..+.
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~-- 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP-- 338 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC--
Confidence 99999999999887544 4789999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
........+||.+|||||++.+..|+...|.||+||++|||+.|+.||.......... .+...+..
T Consensus 339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e-Evdrr~~~------------- 404 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE-EVDRRTLE------------- 404 (591)
T ss_pred CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH-HHHHHHhc-------------
Confidence 4444555699999999999999999999999999999999999999997544322111 12221111
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCC
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHD 1101 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~ 1101 (1114)
...+.+...+.+..++.+..++.||++|...+.- .......+.++..++|.
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~-----ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGE-----GAQEVKEHPFFKDLNWR 455 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhccCCCc-----CcchhhhCcccccCCHh
Confidence 1122333445567888889999999999766531 33333344455555554
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=313.19 Aligned_cols=239 Identities=20% Similarity=0.386 Sum_probs=188.8
Q ss_pred eecccCCeEEEEEEeCC--------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 816 VIGRGACGTVYRAVLRT--------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.||+|+||+||+|..+. ...||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 69999999999998642 2348888875432 223456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC--------eEEeeccCc
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE--------AHVGDFGLA 959 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--------~kl~DfG~a 959 (1114)
||+++|+|.++++.....+++..+..++.|++.|++|||+. +|+||||||+||+++.++. ++++|||.+
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999999987666789999999999999999999998 9999999999999987765 699999988
Q ss_pred eecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCC-CCCCCCCCCCCHHHHHHHHHhcCCccc
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGR-APVQPLDQGGDLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1114)
..... .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+..... .... ......
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~----~~~~-~~~~~~---- 221 (258)
T cd05078 156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS----QKKL-QFYEDR---- 221 (258)
T ss_pred cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH----HHHH-HHHHcc----
Confidence 75431 223467889999999886 45789999999999999999985 55543221 1111 111110
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
. ..+.....++.+++.+||+.||++|||++++++.|+
T Consensus 222 ------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ------H----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------c----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 011112246889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=312.56 Aligned_cols=266 Identities=26% Similarity=0.317 Sum_probs=204.0
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|++.+.||+|+||.||+|++. +|+.||+|++...... ......+.+|+.++++++|||++++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 4788899999999999999975 7899999998765432 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+ +++|.+++......+++.++..++.|+++||+|||+. +++|+||||+||+++.++.++++|||.+.........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99 9999999976667899999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc--------cccc
Q 001253 969 SMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL--------VSGM 1039 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 1039 (1114)
......|+..|+|||++.+. .++.++||||+|+++|||++|.+||........ ...+......... ....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ-LAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH-HHHHHHHcCCCChHHHhhccCcchh
Confidence 33445789999999988654 468899999999999999999877754332111 1111111110000 0000
Q ss_pred ccccccCCC-----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1040 LDARLNLQD-----EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1040 ~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
......... ....+....+.+++.+|++.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000 001122367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=312.22 Aligned_cols=266 Identities=21% Similarity=0.347 Sum_probs=199.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|++|+||+|..+ +++.||+|.+....... ....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 67889999999999999999976 68999999987544322 1234667999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++ +|.+++......+++.....++.|+++||.|||+. +++||||||+||++++++.+||+|||.++....+.
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 157 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS- 157 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-
Confidence 99985 99999886666889999999999999999999998 99999999999999999999999999987543222
Q ss_pred CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC---Cccc-----c
Q 001253 968 KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN---SLVS-----G 1038 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~-----~ 1038 (1114)
.......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.......+....+.+..... .+.. .
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 12223356889999998875 4578999999999999999999999965432111111111111000 0000 0
Q ss_pred cccccccCCCcc-------cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1039 MLDARLNLQDEK-------TVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1039 ~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
............ .......+.+++.+|++++|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000000 0111146788999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=306.46 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=197.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--Cce
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREG--NNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSN 883 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 883 (1114)
.+|+..+.||+|+||.||+|... +++.||+|++...... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999975 6899999998754322 222345688899999999999999999998753 567
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
+++|||+++++|.+++... ..+++.....++.|++.||+|||+. +++||||+|+||+++.++.++|+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 8999999999999999743 3588999999999999999999998 99999999999999999999999999997653
Q ss_pred CCC--CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 964 MPQ--SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 964 ~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
... ........++..|+|||.+.+..++.++||||+||++||+++|+.||..... ...+........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~~~~~~~~------~ 227 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQPT------N 227 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHHHHhcCCC------C
Confidence 211 1112234588899999999988899999999999999999999999975432 122222111100 0
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.+++ +||..+|++||+++|+++
T Consensus 228 ------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 ------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111222233456666 788899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=316.13 Aligned_cols=258 Identities=22% Similarity=0.260 Sum_probs=203.7
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||.||+|..+ +++.||+|.+...........+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999976 67899999987654333333556788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.+++... ..+++..+..++.|++.|++|+|+. +++||||||+||+++.++.++++|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999999744 4689999999999999999999998 999999999999999999999999999874211100
Q ss_pred --------------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 968 --------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 968 --------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
.......++..|+|||.+.+..++.++|||||||++||+++|..||..... .+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~----~~~~~~~~~~- 231 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP----EELFGQVISD- 231 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhc-
Confidence 011224578899999999888899999999999999999999999964321 2222221111
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
... .+ .........+.+++.+||+.||++||++.++.+.++.
T Consensus 232 ~~~----~~------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 DIE----WP------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccC----CC------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000 00 0001223467899999999999999997766666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=311.24 Aligned_cols=259 Identities=24% Similarity=0.382 Sum_probs=206.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|... +|+.||+|++..... ....+.+.+|+++++.++||||+++++++......++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 357888899999999999999976 688999998865432 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++.. .+.+++..+..++.+++.|+.|||+.. +++||||+|+||++++++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999999999874 346899999999999999999999731 8999999999999999999999999998754221
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCC-------HHHHHHHHHhcCCccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD-------LVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 1039 (1114)
......|+..|+|||++.+..++.++|||||||++|++++|+.||.......+ ...++.......
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence 12245789999999999888899999999999999999999999975443211 112222222110
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
.+.+ ........+.+++.+|++.||++|||+.|+++...-+
T Consensus 230 -~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 230 -PPRL-----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred -CCCC-----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 0000 0111334688999999999999999999999864333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=308.93 Aligned_cols=256 Identities=29% Similarity=0.448 Sum_probs=199.8
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCC-------hhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGN-------NNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
+|...+.||+|+||.||+|... +|+.||+|.++...... ....+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999865 68999999886432211 112346788999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..++||||+++++|.++++.. ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999999754 5789999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCC-CccccccccccccCccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 001253 962 IDMPQS-KSMSAIAGSYGYIAPEYAYTMK--VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038 (1114)
Q Consensus 962 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1114)
...... .......|+..|+|||...... ++.++||||+|+++||+++|..||..... . ....+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~-~~~~~~~~~~~---- 229 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---I-AAMFKLGNKRS---- 229 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---H-HHHHHhhcccc----
Confidence 432211 1223456889999999987654 78999999999999999999999863322 1 11111111100
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.. .............+.+++.+||+.+|++||+++++++
T Consensus 230 --~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 --AP--PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred --CC--cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00 0001111223457888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=308.16 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=187.0
Q ss_pred eecccCCeEEEEEEeCCCc---EEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 816 VIGRGACGTVYRAVLRTGH---TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~~g~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
.||+|+||+||+|...++. .+++|.+..... ....+.+.+|+..++.++||||+++++.+.+....|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 5999999999999865433 456666554332 23356788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC-CC
Q 001253 893 GSLGELLHGAS---STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ-SK 968 (1114)
Q Consensus 893 gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~ 968 (1114)
|+|.++++... ...++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999997432 3466777889999999999999998 99999999999999999999999999986422111 11
Q ss_pred ccccccccccccCcccccc-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 969 SMSAIAGSYGYIAPEYAYT-------MKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
......++..|+|||+... ..++.++|||||||++|||++ |..||..... .+........... ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~~~~~~--~~~ 230 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD----REVLNHVIKDQQV--KLF 230 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHhhccc--ccC
Confidence 2234568899999998753 345779999999999999997 5667754332 2222222222111 011
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
++.. .......+.+++..|| .+|++||+++||++.|.
T Consensus 231 ~~~~------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQL------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCcc------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1111 1112345777889999 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.17 Aligned_cols=238 Identities=24% Similarity=0.440 Sum_probs=190.4
Q ss_pred ceecccCCeEEEEEEeCCCc-----------EEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 815 FVIGRGACGTVYRAVLRTGH-----------TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
+.||+|+||.||+|.++... .|++|++...... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999986322 4777776543321 5678899999999999999999999988 778
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-------CeEEeec
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-------EAHVGDF 956 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-------~~kl~Df 956 (1114)
++||||+++|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|++||
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 999999999999999986655789999999999999999999998 999999999999999887 7999999
Q ss_pred cCceecCCCCCCccccccccccccCccccccC--CCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 957 GLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM--KVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 957 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
|++..... .....++..|+|||++.+. .++.++||||+|+++||+++ |..||..... .....+. ...
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~~~~~~~----~~~ 222 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-SEKERFY----QDQ 222 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-hhHHHHH----hcC
Confidence 99986532 2234567789999998876 78999999999999999999 5777765432 1111111 110
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
. ... ......+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 223 ~--------~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H--------RLP------MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C--------CCC------CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 000 001157889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=307.23 Aligned_cols=246 Identities=28% Similarity=0.466 Sum_probs=198.5
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
++|++.+.||+|+||.||+|.. +++.||+|++..... .+.+.+|+.++++++|||++++++++... ..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 5688999999999999999975 578899999864322 45688999999999999999999998754 4799999
Q ss_pred cCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 889 YMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|+++++|.+++.... ..+++..+..++.|++.|++|+|+. +++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999997543 3689999999999999999999998 9999999999999999999999999999764321
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
......+..|+|||.+.+..++.++||||+|+++|||++ |+.||..... .... ....... +
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~-~~~~~~~--------~--- 215 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL----KEVK-ECVEKGY--------R--- 215 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH----HHHH-HHHhCCC--------C---
Confidence 122334678999999988889999999999999999998 8999865432 1111 1121110 0
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
...+......+.+++.+||+.+|++||+++++++.|++
T Consensus 216 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 -MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00111223467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=308.68 Aligned_cols=256 Identities=22% Similarity=0.374 Sum_probs=202.3
Q ss_pred CCcCCceecccCCeEEEEEEeCC--CcEEEEEEecccCC-------CChhhHHHHHHHHHHHhc-CCCCceeeEEeEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLRT--GHTVAVKKLASNRE-------GNNNVDNSFRAEILTLGK-IRHRNIVKLYGFCYH 879 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 879 (1114)
+|++.+.||+|+||+||+|.++. ++.+|+|.+..... .......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999764 68899998864321 122234556678887764 799999999999999
Q ss_pred cCceEEEEecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeec
Q 001253 880 QGSNLLMYEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 956 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 956 (1114)
++..++||||+++++|.+++.. ....+++..+..++.|++.|+.|||+. .+++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998742 345789999999999999999999963 18999999999999999999999999
Q ss_pred cCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 001253 957 GLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLV 1036 (1114)
Q Consensus 957 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1114)
|.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ....... ......
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~ 231 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM----LSLATKI-VEAVYE 231 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH----HHHHHHH-hhccCC
Confidence 9998754322 33455688999999999988899999999999999999999999864321 2222211 111110
Q ss_pred cccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1037 SGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
+ .........+.+++.+||+.||++||++.|+.+++++
T Consensus 232 -----~------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 232 -----P------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred -----c------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0 0001123468899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=315.07 Aligned_cols=254 Identities=23% Similarity=0.306 Sum_probs=204.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|+..+.||+|+||+||+|... +++.||+|.+...........+.+..|+++++.++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999976 58999999998765443344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 888 EYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
||+.+++|.++++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999999753 35789999999999999999999998 99999999999999999999999999987543211
Q ss_pred C----------------------------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 001253 967 S----------------------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018 (1114)
Q Consensus 967 ~----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~ 1018 (1114)
. .......|+..|+|||++.+..++.++||||+|+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 1 011234688999999999988899999999999999999999999975443
Q ss_pred CCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 001253 1019 GGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPT----MREVVL 1081 (1114)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 1081 (1114)
... ....... .... .........+.+++.+||..||++||+ +.|++.
T Consensus 238 ~~~----~~~~~~~----------~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DET----FSNILKK----------EVTF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHH----HHHHhcC----------CccC--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 211 1111111 0000 011113457899999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=311.13 Aligned_cols=265 Identities=23% Similarity=0.318 Sum_probs=199.5
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
++++|++.+.||+|+||.||+|..+ +|+.||+|++....... ....+.+|+.+++.++|+||+++++++..++..|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 3478999999999999999999975 68999999987554322 23456789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+. +++.+++......+.+..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 999996 577777765556678888999999999999999998 9999999999999999999999999999764322
Q ss_pred CCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHh-------------
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIR------------- 1031 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~------------- 1031 (1114)
. .......+++.|+|||++.+. .++.++||||+||++|||++|+.||...... .+.+.+...
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 S-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV---FEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred C-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH---HHHHHHHHHHcCCCChhhhhhh
Confidence 2 222344578999999998754 5788999999999999999999999754432 111111111
Q ss_pred --cCCcccccccccccCC---CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1032 --NNSLVSGMLDARLNLQ---DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1032 --~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+............ ..........+.+++.+|++.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000 0000111346788999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=323.69 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=196.6
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec-----
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ----- 880 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 880 (1114)
..++|++.+.||+|+||+||+|... +++.||||++....... ...+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4578999999999999999999975 78899999987543221 2244567899999999999999999987543
Q ss_pred -CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 881 -GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 881 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
...|+++|++ +++|.++++ ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence 3468999998 669998886 34689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc--c
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL--V 1036 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 1036 (1114)
+.... ......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||...........+. ........ .
T Consensus 166 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (343)
T cd07878 166 RQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM-EVVGTPSPEVL 240 (343)
T ss_pred eecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-HHhCCCCHHHH
Confidence 86542 2234578999999999876 568899999999999999999999997543211111111 10000000 0
Q ss_pred ccc-------ccccccCCCccc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1037 SGM-------LDARLNLQDEKT-----VSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1037 ~~~-------~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+ ....+....... ......+.+++.+|++.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000000000000 011234678999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=314.21 Aligned_cols=267 Identities=25% Similarity=0.395 Sum_probs=202.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||.||+|.++ +++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 46888899999999999999986 68999999987544332 33556788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||++++++.++... ...+++.++..++.|+++|++|||+. +++|||++|+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 80 EFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred ecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999999887763 34589999999999999999999998 99999999999999999999999999998654322
Q ss_pred CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH----------HHHhcCCcc
Q 001253 968 KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR----------NFIRNNSLV 1036 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~----------~~~~~~~~~ 1036 (1114)
.......++..|+|||+..+ ..++.++||||||+++|||++|+.||.............. .........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22334568899999998875 4477899999999999999999998864332111111100 000000000
Q ss_pred cccccccccCCC---cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1037 SGMLDARLNLQD---EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1037 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+..+...... .........+.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000000 001122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=308.57 Aligned_cols=252 Identities=27% Similarity=0.451 Sum_probs=206.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|+..+.||+|+||.||+|.++ +++.||+|++...... ...+.+.+|+..+++++||||+++++++..+...++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 35778889999999999999987 6899999998765432 34567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
||+++++|.+++......+++.....++.|+++|++|+|+ . +++|+||||+||++++++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999999998655788999999999999999999999 7 99999999999999999999999999987553221
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC-CCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG-GDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
. ....++..|+|||...+..++.++||||+|+++|+|++|+.||...... ....+.++.......
T Consensus 156 ~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 221 (265)
T cd06605 156 A---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP----------- 221 (265)
T ss_pred h---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-----------
Confidence 1 1266889999999999989999999999999999999999999754321 222333333222110
Q ss_pred CCCcccHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVS-HMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+.. ....+.++|.+||..||++|||+.|++.
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 --PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 001111 3456889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=308.26 Aligned_cols=256 Identities=21% Similarity=0.338 Sum_probs=200.8
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 884 (1114)
+....|++.++||+||.+.||++...+.+.||+|++..... +.....-|..|+..+.+++ |.+||++++|-..++..|
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34567999999999999999999988888899998765443 3445678999999999994 899999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||=+- +|..++++.......-.++.+..|++.|+.++|.+ ||||.||||.|+|+-. |.+||+|||+|..+..
T Consensus 437 mvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 437 MVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred EEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 99998654 99999987666555347788899999999999999 9999999999999864 5899999999998764
Q ss_pred CCCC-ccccccccccccCccccccCC-----------CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc
Q 001253 965 PQSK-SMSAIAGSYGYIAPEYAYTMK-----------VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN 1032 (1114)
Q Consensus 965 ~~~~-~~~~~~g~~~y~aPE~~~~~~-----------~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1032 (1114)
+... .....+||+.||+||.+.... .+.++||||+|||+|+|+.|++||.. +...+.++.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~------~~n~~aKl~-- 583 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ------IINQIAKLH-- 583 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH------HHHHHHHHH--
Confidence 4332 345678999999999886433 45689999999999999999999963 222222211
Q ss_pred CCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1033 NSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+.++.-....+.. ....++.++|+.||.+||.+||+..|+++
T Consensus 584 -----aI~~P~~~Iefp~~-~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 584 -----AITDPNHEIEFPDI-PENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -----hhcCCCccccccCC-CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 12222111001111 11123889999999999999999999875
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=306.40 Aligned_cols=251 Identities=28% Similarity=0.443 Sum_probs=201.7
Q ss_pred CcCCceecccCCeEEEEEEeCC-----CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 811 FDERFVIGRGACGTVYRAVLRT-----GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
|++.+.||+|+||.||+|++.. +..||+|++...... ...+.+..|+..++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 4567899999999999999763 388999998655432 135678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 886 MYEYMARGSLGELLHGASST-LDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+|||+++++|.+++...... +++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||.+.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999999754444 89999999999999999999998 999999999999999999999999999987653
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
..........+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||.... .....+.. .....
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~----~~~~~~~~-~~~~~-------- 222 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS----NEEVLEYL-KKGYR-------- 222 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHH-hcCCC--------
Confidence 32222212337789999999988889999999999999999998 778876422 12222221 11110
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1083 (1114)
...+......+.+++.+|++.||++|||+.|+++.|
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011111344688899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=312.42 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=201.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+.|+..+.||+|+||.||+|.+. +++.||+|.+..... ....+.+.+|+..+++++||||+++++++..+...++||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 34666778999999999999875 678999999864432 233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.+++. ...+++..+..++.|+++|++|+|+. +++|+||+|+||++++++.++++|||++.......
T Consensus 82 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 82 EYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred EccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 9999999999986 34688999999999999999999998 99999999999999999999999999997654221
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ... ...... .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~----~~~~~~------~------ 218 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-VLF----LIPKNS------P------ 218 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-HHh----hhhcCC------C------
Confidence 12233468889999999998889999999999999999999999986443211 111 111110 0
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..........+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0111123346889999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=312.40 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=201.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+.|+..+.||+|+||+||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 55888899999999999999976 68999999987554444444567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++ ++.+++......+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 99975 78787765556799999999999999999999998 9999999999999999999999999998764321
Q ss_pred CccccccccccccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
....+++.|+|||++. ...++.++||||||+++|||++|+.||..... ............ +.
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~----~~~~~~~~~~~~-------~~- 233 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNDS-------PT- 233 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH----HHHHHHHhcCCC-------CC-
Confidence 2346888999999874 45688899999999999999999999864332 111111111100 00
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
.........+.+++.+||+.+|++||++.+++..
T Consensus 234 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 ----LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0111234568899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=312.70 Aligned_cols=267 Identities=24% Similarity=0.353 Sum_probs=203.7
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||.||+|.++ +++.||+|+++..... ....+.+.+|++++++++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 36888999999999999999976 6889999998754332 233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||++++.+..+.. ....+++.++..++.|++.|++|||+. +++|||++|+||++++++.+||+|||.+........
T Consensus 80 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 80 EYVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred ecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9999877766655 345689999999999999999999998 999999999999999999999999999987654333
Q ss_pred CccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc-----------CCc
Q 001253 968 KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN-----------NSL 1035 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~ 1035 (1114)
.......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+.. ......... ...
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL-YLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHhhhcccCcc
Confidence 233445688999999999888 7899999999999999999999998754321111 111111000 000
Q ss_pred ccccccccccC----CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1036 VSGMLDARLNL----QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1036 ~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
........... ....+.....++.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000000 00011112467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=312.39 Aligned_cols=266 Identities=24% Similarity=0.332 Sum_probs=201.5
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREG--NNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
+|+..+.||+|+||.||+|..+ +|+.||||++...... .......+..|+.++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999976 6899999999765433 122345577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+ +|+|.+++......+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 8899999985545799999999999999999999998 99999999999999999999999999998764322
Q ss_pred CCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc-----ccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL-----VSGML 1040 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 1040 (1114)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||......+......+ ....... .....
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 -RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFE-ALGTPTEENWPGVTSLP 234 (298)
T ss_pred -ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHH-HcCCCchhhhhhccccc
Confidence 22233456788999998864 4578899999999999999999777764332211111111 1100000 00000
Q ss_pred cc-cccCCCc-----ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 DA-RLNLQDE-----KTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 ~~-~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+. ....... ........+.+++.+||++||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00 0000000 01122457889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=308.64 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=188.0
Q ss_pred eecccCCeEEEEEEeCC---CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 816 VIGRGACGTVYRAVLRT---GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
.||+|+||+||+|...+ ...+|+|.+.... .......+.+|+..++.++||||+++++++......++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999999999998543 3568888765432 223355678899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC-
Q 001253 893 GSLGELLHGASS----TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS- 967 (1114)
Q Consensus 893 gsL~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 967 (1114)
|+|.+++..... ..++.....++.|++.|++|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999975432 346788889999999999999998 999999999999999999999999999875322111
Q ss_pred CccccccccccccCccccc-------cCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAY-------TMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~-------~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
.......++..|+|||+.. ...++.++||||+||++|||++ |..||...... +........... ..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~~~~~~~~~~--~~ 230 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE----QVLKQVVREQDI--KL 230 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHHHHHhhccCc--cC
Confidence 1122335677899999874 3456789999999999999999 77888644321 122222222110 00
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
.. ..........+.+++..|| .||++|||++||++.|.
T Consensus 231 ~~------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PK------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CC------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 00 0111123345667888898 49999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=304.73 Aligned_cols=253 Identities=31% Similarity=0.442 Sum_probs=203.4
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|+..+.||+|+||.||+|... +++.||+|+++..... ....+.+..|+.++++++|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 5788899999999999999975 7899999998766543 3456778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++++|.+++... ..+++..+..++.++++|++|||+. +++|+||+|+||++++++.+||+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999999743 4578999999999999999999998 9999999999999999999999999999876433322
Q ss_pred cc---ccccccccccCccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 969 SM---SAIAGSYGYIAPEYAYTMK---VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 969 ~~---~~~~g~~~y~aPE~~~~~~---~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
.. ....+++.|+|||++.+.. ++.++||||||+++||+++|+.||...+... ..... ..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~~~-~~~~~------~~ 225 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIMFH-VGAGH------KP 225 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHHHH-HhcCC------CC
Confidence 21 2356889999999998766 8899999999999999999999997543211 11111 01000 00
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.. +........+.+++.+||+.+|++||++.|++.
T Consensus 226 ~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PI----PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CC----CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01 011112446778999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=304.31 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=202.0
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|+..+.||+|+||.||+|... +++.+|+|++....... ...+.+..|+.++++++|||++++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 4788899999999999999975 78899999987654322 335678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-CeEEeeccCceecCCCC
Q 001253 889 YMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~ 966 (1114)
|+++++|.+++... ...+++..+..++.++++|++|||+. +++||||+|+||++++++ .+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC-
Confidence 99999999999754 34589999999999999999999998 999999999999998654 5899999999875422
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.......++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... .......... ..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~~~~~~-~~----------- 218 (256)
T cd08220 156 -SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL----PALVLKIMSG-TF----------- 218 (256)
T ss_pred -ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch----HHHHHHHHhc-CC-----------
Confidence 222345688999999999988899999999999999999999999865432 1222221111 00
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.+++.+||+++|.+|||+.|+++
T Consensus 219 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 -APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0011112346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=312.25 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=202.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||.||+|.+. +++.||+|++...........+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999976 68999999997654433344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999999744 5789999999999999999999998 9999999999999999999999999999875432
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.....+++.|+|||.+.+..++.++||||+|+++|+|++|+.||..... ....+... .+. ..
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-~~~---------~~-- 216 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQIYEKIL-EGK---------VR-- 216 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHh-cCC---------cc--
Confidence 2345688999999999888899999999999999999999999964331 11112111 111 00
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVV 1080 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl 1080 (1114)
.+......+.+++.+||..||.+|| +++|++
T Consensus 217 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 --FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1111234678899999999999999 556554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=312.72 Aligned_cols=193 Identities=24% Similarity=0.424 Sum_probs=159.7
Q ss_pred ceecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe--cCceEEEEec
Q 001253 815 FVIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH--QGSNLLMYEY 889 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~ 889 (1114)
.+||+|+||+||+|+.+ ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 57999999999999975 457899999865432 3456789999999999999999999854 4567899999
Q ss_pred CCCCCHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----CCCCCeEEeecc
Q 001253 890 MARGSLGELLHG--------ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL----DDKFEAHVGDFG 957 (1114)
Q Consensus 890 ~~~gsL~~~l~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfG 957 (1114)
+++ ++.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 976 78777642 123588999999999999999999998 99999999999999 566799999999
Q ss_pred CceecCCCCC--CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 001253 958 LAKVIDMPQS--KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPL 1016 (1114)
Q Consensus 958 ~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~ 1016 (1114)
+++....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9987643322 22334578999999999876 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=310.47 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=200.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+++ +|+.||+|.+..... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46888899999999999999986 789999999865422 223456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 888 EYMARGSLGELLHGA--SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||+++++|.++++.. ...+++..+..++.|++.|+.|||+.. +++||||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999998753 237899999999999999999999632 8999999999999999999999999999765322
Q ss_pred CCCccccccccccccCccccccCC------CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMK------VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~------~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||...... .....+...... .
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~-~----- 226 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-NIFAQLSAIVDG-D----- 226 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-hHHHHHHHHhhc-C-----
Confidence 223346888999999886543 478999999999999999999999653321 111111111111 0
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....+......+.+++.+||+.+|++||++.+++.
T Consensus 227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 -------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 01112224456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=310.37 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=200.6
Q ss_pred CHHHHHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 001253 800 TFKDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFC 877 (1114)
Q Consensus 800 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 877 (1114)
+..++..+.+.|++.+.||+|+||+||+|+.. +++.||+|++..... ....+..|+.+++++ +||||+++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 33444456678999999999999999999975 688999999864322 245677899999888 699999999998
Q ss_pred Ee------cCceEEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC
Q 001253 878 YH------QGSNLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE 950 (1114)
Q Consensus 878 ~~------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 950 (1114)
.. ....|++|||+++|+|.+++... ...+++..+..++.|+++|++|||+. +++||||+|+||++++++.
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 53 45679999999999999999753 34588888999999999999999998 9999999999999999999
Q ss_pred eEEeeccCceecCCCCCCccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHH
Q 001253 951 AHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTW 1025 (1114)
Q Consensus 951 ~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~ 1025 (1114)
++|+|||++....... .......|++.|+|||.+. +..++.++||||+||++|||++|+.||..........
T Consensus 160 ~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-- 236 (282)
T cd06636 160 VKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-- 236 (282)
T ss_pred EEEeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--
Confidence 9999999987653221 2233456899999999875 3467889999999999999999999996543211111
Q ss_pred HHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. ..... ... .........+.+++.+||+.||.+||++.|+++
T Consensus 237 --~-~~~~~------~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 --L-IPRNP------PPK-----LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --h-HhhCC------CCC-----CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00000 000 011122346889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=303.86 Aligned_cols=250 Identities=27% Similarity=0.371 Sum_probs=202.3
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCC--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNRE--GNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
+|+..+.||+|+||+||+|..+ +++.||+|.+..... ..++..+.+.+|+.+++.++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999986 789999999865432 2233456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++... ..+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999999743 4688999999999999999999998 99999999999999999999999999988653222
Q ss_pred CCccccccccccccCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
......|+..|+|||.+.... ++.++|+||+|+++|++++|+.||..... .............
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~---------- 220 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFKIGRSKEL---------- 220 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHHHHhcccC----------
Confidence 234456889999999987766 89999999999999999999999965431 1111111110000
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.+++.+||+.+|.+||++.+++.
T Consensus 221 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 --PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0111122346788999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=304.45 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=203.4
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGN---NNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
+|+..+.||+|+||.||+|... +++.||+|++....... ....+.+..|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778889999999999999964 78999999987544322 2235678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-CeEEeeccCceecCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDM 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~~~~ 964 (1114)
||||+++++|.+++.. ...+++..+..++.|++.|++|||+. +++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 9999999999999974 34688999999999999999999998 999999999999998776 599999999976543
Q ss_pred CCCC---ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 965 PQSK---SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 965 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
.... ......++..|+|||.+.+..++.++||||+|+++|++++|..||........ ...+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~--------- 226 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIFKIASA--------- 226 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHHHHhcc---------
Confidence 2111 12234688999999999888899999999999999999999999964432221 2221111110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
......+......+.+++.+|++.+|.+||++.|++.
T Consensus 227 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ---TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011222334457889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=309.06 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=200.3
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecC---
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQG--- 881 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--- 881 (1114)
+.++|++.+.||+|++|+||+|..+ +++.+|+|++..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 4578999999999999999999986 678999999865433 245688999999999 7999999999997644
Q ss_pred ---ceEEEEecCCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEee
Q 001253 882 ---SNLLMYEYMARGSLGELLHGA---SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 955 (1114)
Q Consensus 882 ---~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 955 (1114)
..++||||+++++|.++++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 479999999999999998643 35789999999999999999999998 999999999999999999999999
Q ss_pred ccCceecCCCCCCccccccccccccCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 001253 956 FGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT-----MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFI 1030 (1114)
Q Consensus 956 fG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 1030 (1114)
||.+...... ........|+..|+|||++.. ..++.++||||+||++|+|++|+.||........ .....
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~ 231 (275)
T cd06608 157 FGVSAQLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA----LFKIP 231 (275)
T ss_pred Cccceecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH----HHHhh
Confidence 9999865322 222334568899999998753 3467899999999999999999999964332111 11111
Q ss_pred hcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1031 RNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.. . ... ...+......+.+++.+||..||++|||+.|+++
T Consensus 232 ~~-~------~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RN-P------PPT----LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cc-C------CCC----CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 0 000 1111223456889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=303.97 Aligned_cols=252 Identities=26% Similarity=0.343 Sum_probs=198.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--Cce
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREG--NNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSN 883 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 883 (1114)
.+|++.+.||+|+||.||+|..+ +|+.||+|++...... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999975 6899999998643322 222345788899999999999999999998764 457
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++++|.+++... ..+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999998743 4578889999999999999999998 99999999999999999999999999987643
Q ss_pred CCC--CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 964 MPQ--SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 964 ~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
... ........|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~-------- 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQP-------- 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHHHHHHhcCC--------
Confidence 211 1122335688999999999888899999999999999999999999964321 11111111110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.....+......+.+++.+|+. +|++||+++|+++
T Consensus 226 ----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0011233344567889999995 9999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=345.26 Aligned_cols=252 Identities=29% Similarity=0.380 Sum_probs=206.8
Q ss_pred cCCcCCceecccCCeEEEEEEe-CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVL-RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
-+++...+||.|.||.||-|.. .+|+-.|+|.++-.... ....+.+.+|+.++..++|||+|+++|+-.+++..++.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4677778999999999999995 58999999998765544 455677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC-
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ- 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 966 (1114)
|||++|+|.+++. .+...++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|+.+..+.
T Consensus 1314 EyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 9999999999997 455677777788899999999999999 99999999999999999999999999999775432
Q ss_pred --CCccccccccccccCccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 967 --SKSMSAIAGSYGYIAPEYAYTMK---VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 967 --~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
........||+.|||||++.+.. ...++||||+||++.||+||+.||...+..- +.... +
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~-V----------- 1454 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYH-V----------- 1454 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhH-H-----------
Confidence 12234568999999999997543 5568999999999999999999998665421 11111 1
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.....+..+.....+-.+|+.+|+..||++|.++.|+++
T Consensus 1455 -~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1455 -AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred -hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 111223445556677889999999999999998886553
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=307.96 Aligned_cols=249 Identities=29% Similarity=0.453 Sum_probs=196.4
Q ss_pred ceecccCCeEEEEEEeCC-------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 815 FVIGRGACGTVYRAVLRT-------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+.||+|+||.||+|++++ ++.+|+|.+...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 368999999999999652 257999988654321 23556888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-----CeEEeec
Q 001253 888 EYMARGSLGELLHGA------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-----EAHVGDF 956 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~Df 956 (1114)
||+++++|.+++... ...+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .++++||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 999999999998642 23578899999999999999999998 999999999999999887 8999999
Q ss_pred cCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCC
Q 001253 957 GLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNS 1034 (1114)
Q Consensus 957 G~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1034 (1114)
|+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.... +..+.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~~~~~~-~~~~~ 230 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQH-VTAGG 230 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----HHHHHH-HhcCC
Confidence 99976532221 11223345678999999999999999999999999999998 9999864332 111111 11110
Q ss_pred cccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1035 LVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
.. ..+......+.+++.+||..+|.+||+++++++.|++
T Consensus 231 --------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 --------RL----QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------cc----CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 1112233568899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=306.06 Aligned_cols=250 Identities=23% Similarity=0.287 Sum_probs=205.7
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|++.+.||.|+||.||+|+++ +++.||+|++...........+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999986 689999999986654443456788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999754 5789999999999999999999998 99999999999999999999999999988654221
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ............ ..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-------------~~ 219 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQETA-------------DV 219 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhccc-------------cc
Confidence 223456888999999999888999999999999999999999999765432 122222211110 01
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPTM--REVV 1080 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 1080 (1114)
..+......+.+++.+||+.||.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1122233578899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=301.82 Aligned_cols=245 Identities=25% Similarity=0.317 Sum_probs=199.5
Q ss_pred ecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCH
Q 001253 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL 895 (1114)
Q Consensus 817 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 895 (1114)
||.|+||+||+|+.. +++.||+|++...........+.+..|+.+++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999976 5899999999866554444567799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccccc
Q 001253 896 GELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAG 975 (1114)
Q Consensus 896 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 975 (1114)
.+++.+. ..+++..+..++.|++.|++|+|+. +++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 9999743 4589999999999999999999998 99999999999999999999999999998654321 2233468
Q ss_pred cccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHH
Q 001253 976 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHM 1055 (1114)
Q Consensus 976 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1114)
++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... +..+..+....... . ...+....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~--------~----~~~~~~~~ 220 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE--DPMEIYNDILKGNG--------K----LEFPNYID 220 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC--CHHHHHHHHhccCC--------C----CCCCcccC
Confidence 8999999999888899999999999999999999999975442 22233332221100 0 11111224
Q ss_pred HHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 001253 1056 ITVLKIAMLCTNISPFDRPT-----MREVVL 1081 (1114)
Q Consensus 1056 ~~l~~li~~cl~~dP~~RPs-----~~evl~ 1081 (1114)
..+.+++.+||+.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 57899999999999999999 555543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=337.92 Aligned_cols=273 Identities=24% Similarity=0.259 Sum_probs=218.1
Q ss_pred HHHHHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 001253 801 FKDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH 879 (1114)
Q Consensus 801 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 879 (1114)
..++....++|.++++||+|+||.|..++++ +++.||.|++.+...-......-|+.|-.+|..-+.+-|++++-+|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455567789999999999999999999986 789999999987433222235568899999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 880 QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
+.+.|+|||||+||+|-.++.+.. .+++..+..++..|+-||..+|+. |+|||||||+|||+|..|++||+|||.+
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 999999999999999999998776 899999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccccccCccccc----c-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAY----T-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS 1034 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1034 (1114)
..++.+..-.....+|||.|.+||++. + +.|+..+|.||+||++|||+.|..||+...-.+.+..+. ..
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm----~h-- 296 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM----NH-- 296 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh----ch--
Confidence 887766666667789999999999985 3 568899999999999999999999998533222221111 11
Q ss_pred cccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHHHHhhhccCCCcccccCCCCC
Q 001253 1035 LVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPT---MREVVLMLSESNRRQGHFEFSPMDHDS 1102 (1114)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L~~i~~~~~~~~~~~~~~~~ 1102 (1114)
...+.++ .....+.+..++|++.+. +|+.|.. +.++ ..+.+|..+||++
T Consensus 297 ------k~~l~FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedi----------k~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 297 ------KESLSFP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDI----------KNHPFFEGIDWDN 348 (1317)
T ss_pred ------hhhcCCC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHH----------HhCccccCCChhh
Confidence 1122222 222345567788887776 7778877 5543 3466777777754
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=317.63 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=196.3
Q ss_pred CCceecccCCeEEEEEEeC-CCcEEEEEEecc-cCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc--eEEEEe
Q 001253 813 ERFVIGRGACGTVYRAVLR-TGHTVAVKKLAS-NREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS--NLLMYE 888 (1114)
Q Consensus 813 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~E 888 (1114)
...+||+|+|-+||+|.+. +|..||--.++- .....+...+.|..|+.+++.++||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3457999999999999976 577776433321 122233445789999999999999999999999987665 678999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCCeEEeeccCceecCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~~~~~~~~ 967 (1114)
.+..|+|..|.++. +.++......|++||++||.|||++ +|+|+|||||-+||+|+. .|.|||+|.|+|........
T Consensus 124 L~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred cccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 99999999999844 4788899999999999999999998 889999999999999985 58999999999998653322
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
..+.|||.|||||+.. ..|+..+||||||+.+.||+|+..||.........++.+-. ++....+..-
T Consensus 202 ---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S---------GiKP~sl~kV 268 (632)
T KOG0584|consen 202 ---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS---------GIKPAALSKV 268 (632)
T ss_pred ---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc---------CCCHHHhhcc
Confidence 3378999999999876 77999999999999999999999999866543333332221 1212222111
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.-+++.+||.+|+.. .++|||+.|++.
T Consensus 269 ------~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 ------KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 123688999999998 899999999975
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=313.07 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=198.7
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
.|.....||+|+||.||++... +++.||||++..... ...+.+.+|+..++.++||||+++++.+..++..++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3444567999999999999975 688999999864332 235568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||++....... .
T Consensus 100 ~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~ 173 (292)
T cd06658 100 FLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-P 173 (292)
T ss_pred CCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-c
Confidence 9999999999863 4588999999999999999999998 99999999999999999999999999987543222 2
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
......|+..|+|||...+..++.++||||+|+++|||++|+.||..... .......... . ....
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~~~~~--~-----~~~~---- 238 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQAMRRIRDN--L-----PPRV---- 238 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhc--C-----CCcc----
Confidence 22345689999999999888899999999999999999999999974332 1111111110 0 1111
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
.........+.+++.+||..||.+|||++|+++.
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111123357789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=301.76 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=202.2
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe--cCceEEE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH--QGSNLLM 886 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 886 (1114)
+|++.+.||.|+||.||+|... +++.||+|++...... ....+.+..|+++++.++||||+++++++.. +...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 4788899999999999999965 7889999998754432 3335668889999999999999999998764 3457899
Q ss_pred EecCCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCeEECCCCCeEEeeccC
Q 001253 887 YEYMARGSLGELLHGA---SSTLDWQTRFMIALGAAEGLSYLH-----HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 958 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 958 (1114)
|||+++++|.+++... ...+++..+..++.|++.|++|+| +. +++|+||+|+||++++++.+|++|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999998643 457899999999999999999999 65 999999999999999999999999999
Q ss_pred ceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 001253 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038 (1114)
Q Consensus 959 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1114)
+........ ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.... ... +...+.....
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~-~~~~~~~~~~--- 227 (265)
T cd08217 157 AKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----QLQ-LASKIKEGKF--- 227 (265)
T ss_pred cccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----HHH-HHHHHhcCCC---
Confidence 987643221 1234568999999999998889999999999999999999999997543 111 2222222111
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.+++.+|++.+|++||++.+|++
T Consensus 228 ---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 ---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1112233457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=303.62 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=201.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--CceEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLL 885 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 885 (1114)
++|...++||.|++|.||+|..+ +++.+|+|.+...... .....+.+|++++++++||||++++++|.+. +..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 36788899999999999999985 6889999998754332 3356688999999999999999999998654 46899
Q ss_pred EEecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 886 MYEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 9999999999988652 345688999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC-CCHHHHHHHHHhcCCccccccc
Q 001253 963 DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG-GDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 963 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
.... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ....+.... ......
T Consensus 156 ~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~------ 225 (287)
T cd06621 156 VNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPN------ 225 (287)
T ss_pred cccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCc------
Confidence 3221 12345788999999999889999999999999999999999999755321 111122211 111000
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+.............+.+++.+||+.+|++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000001111123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=309.17 Aligned_cols=254 Identities=27% Similarity=0.370 Sum_probs=203.8
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
.|+..+.||+|+||+||+|+.. ++..||+|++........+....+..|+.+++.++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677789999999999999975 688999999876544444455678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+.+ ++.+++......+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 9975 88888865566799999999999999999999998 999999999999999999999999999875432
Q ss_pred ccccccccccccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 969 SMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.....|++.|+|||++. ...++.++|||||||++|||++|+.||....... .......... .
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~~~~~~~~---------~- 242 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQNES---------P- 242 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHHhccC---------C-
Confidence 12346888999999874 4568899999999999999999999986543211 1111111110 0
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
..........+.+++.+||+.+|.+||++.++++.......
T Consensus 243 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 243 --TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred --CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 01111223468899999999999999999999987655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=311.62 Aligned_cols=248 Identities=22% Similarity=0.374 Sum_probs=198.7
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEec
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
|+...+||+|+||.||+|..+ +++.||+|++...... ..+.+.+|+..++.++|||++++++++..++..++||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 334457999999999999975 6899999998654322 245678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCc
Q 001253 890 MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 969 (1114)
+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~ 173 (297)
T cd06659 100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PK 173 (297)
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cc
Confidence 999999998863 4689999999999999999999998 99999999999999999999999999987543222 22
Q ss_pred cccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCc
Q 001253 970 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDE 1049 (1114)
Q Consensus 970 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1114)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||..... ....+. +..... ... .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~-~~~~~~------~~~----~ 238 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAMKR-LRDSPP------PKL----K 238 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH-HhccCC------CCc----c
Confidence 2345689999999999988899999999999999999999999974332 111111 111100 000 0
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1050 KTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1050 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
........+.+++.+||+.+|++||+++++++.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 011122357889999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=309.53 Aligned_cols=266 Identities=24% Similarity=0.317 Sum_probs=201.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--CceEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLL 885 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 885 (1114)
++|+..+.||+|+||.||+|.++ +++.+|+|.++..... ......+.+|+.++++++||||+++++++... ...|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 46888899999999999999986 6889999999755433 22234567899999999999999999999877 78999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+++ +|.+++......+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999985 99999876666799999999999999999999998 9999999999999999999999999999876533
Q ss_pred CCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc------------
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN------------ 1032 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------ 1032 (1114)
. .......+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||.............. ....
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 160 L-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK-LLGTPTEKIWPGFSEL 237 (293)
T ss_pred c-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCchHHHHHhhcc
Confidence 2 222334578899999988754 468899999999999999999999975432211111110 0000
Q ss_pred CCcc-ccccccccc-CCCcccHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1033 NSLV-SGMLDARLN-LQDEKTVS-HMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1033 ~~~~-~~~~~~~~~-~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.... ......... .....+.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 000000000 00001111 2446789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.77 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=198.8
Q ss_pred CcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-----
Q 001253 811 FDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG----- 881 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 881 (1114)
|++.++||+|+||+||+|.++ +++.||||++....... ...+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 566789999999999999864 46889999997654333 33566888999999999999999999886532
Q ss_pred -ceEEEEecCCCCCHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEee
Q 001253 882 -SNLLMYEYMARGSLGELLHG-----ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 955 (1114)
Q Consensus 882 -~~~lv~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 955 (1114)
..++++||+.+|+|.+++.. ....+++.....++.|++.|++|||+. +|+||||||+||+++.++.+|++|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 23788999999999988742 123578899999999999999999998 999999999999999999999999
Q ss_pred ccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 956 FGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 956 fG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
||.++....... .......+++.|++||...+..++.++||||||+++|||++ |+.||..... ... ...+...
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~-~~~~~~~ 231 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEI-YNYLIKG 231 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHH-HHHHHcC
Confidence 999986532221 11223346678999999998889999999999999999999 8888864332 111 1111111
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
.. .. .+......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 232 ~~--------~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR--------LK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc--------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 00 0112234688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.48 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=193.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHH-HhcCCCCceeeEEeEEEecCceEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILT-LGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
++|++.+.||+|+||.||+|+++ +|+.||+|++........ ...+..|+.. ++..+||||+++++++..++..|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 46888999999999999999976 699999999876543221 2344445554 6667899999999999999999999
Q ss_pred EecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|||++ |+|.+++.. ....+++..+..++.|++.|++|||+++ +++||||||+||+++.++.+||+|||.+....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99997 588887753 3357899999999999999999999742 79999999999999999999999999998653
Q ss_pred CCCCCccccccccccccCcccccc----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYT----MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
.. .......++..|+|||.+.+ ..++.++|+||+||++|||++|+.||...... .+..........
T Consensus 156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~----- 225 (283)
T cd06617 156 DS--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQLKQVVEEPS----- 225 (283)
T ss_pred cc--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHHHHHHHhcCC-----
Confidence 22 12233468889999998864 45688999999999999999999999643221 122222111100
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
... ........+.+++.+||..+|++||++.++++
T Consensus 226 --~~~-----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 --PQL-----PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCC-----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00112346889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=308.66 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=202.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|... +++.||+|.+...... ..+.+..|+.+++.++||||+++++++...+..|+|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 67899999999999999999865 6889999998643322 2456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.+++.+ ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~- 169 (293)
T cd06647 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (293)
T ss_pred ecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc-
Confidence 99999999999973 3578999999999999999999998 99999999999999999999999999887654222
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......+++.|+|||.+.+..++.++||||||+++|++++|+.||............ .. .+...
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~----~~---------~~~~~-- 234 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----AT---------NGTPE-- 234 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh----hc---------CCCCC--
Confidence 2233456889999999998888999999999999999999999999754322111100 00 00000
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
..........+.+++.+||+.+|++||++.+++..
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111223467889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.14 Aligned_cols=270 Identities=20% Similarity=0.333 Sum_probs=219.3
Q ss_pred HHHHHHHhcCCcCCceecccCCeEEEEEEeCC------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEE
Q 001253 801 FKDLVVATDNFDERFVIGRGACGTVYRAVLRT------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874 (1114)
Q Consensus 801 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 874 (1114)
.+++.+...+++....+-+|.||.||.|.|++ .+.|.+|.++...... ....+..|.-.+..+.|||+.++.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~i--Qv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQI--QVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHH--HHHHHHHHHHHHhcCcCCCcccee
Confidence 44566777888888899999999999998763 3457788877655433 245677888889999999999999
Q ss_pred eEEEec-CceEEEEecCCCCCHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC
Q 001253 875 GFCYHQ-GSNLLMYEYMARGSLGELLHG-------ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD 946 (1114)
Q Consensus 875 ~~~~~~-~~~~lv~E~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 946 (1114)
+++.++ +..++++.++.-|+|..++.. ..+.++..+...++.|++.|++|||++ +|||.||.++|++||
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 998654 567889999999999999972 234678888999999999999999999 999999999999999
Q ss_pred CCCCeEEeeccCceecCCCCCCc-cccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHH
Q 001253 947 DKFEAHVGDFGLAKVIDMPQSKS-MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVT 1024 (1114)
Q Consensus 947 ~~~~~kl~DfG~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~ 1024 (1114)
+.-.|||+|=.+++..-+.+.+. ......+..||+||.+....|+.++|||||||++|||+| |+.||...++ .++..
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-fEm~~ 509 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-FEMEH 509 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-HHHHH
Confidence 99999999999999765444433 344557789999999999999999999999999999999 9999986654 33344
Q ss_pred HHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCC
Q 001253 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGH 1092 (1114)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 1092 (1114)
++++..+ -..+..++.+++.+|..||..+|++||+++|++..|++...+-++
T Consensus 510 ylkdGyR----------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~ 561 (563)
T KOG1024|consen 510 YLKDGYR----------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTR 561 (563)
T ss_pred HHhccce----------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhh
Confidence 4443221 123334556899999999999999999999999999998765443
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=299.55 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=208.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|++|.||+|+.+ +++.||+|++...... ...+.+..|+..+.+++|+|++++++++......++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 36888899999999999999987 5999999998765432 34677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
||+++++|.+++... ..+++..+..++.|+++|++|+|+ . +++||||+|+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 79 EYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999999744 678999999999999999999999 8 99999999999999999999999999998764322
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+..+....... .
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~-------~---- 221 (264)
T cd06623 155 D-QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAICDGPP-------P---- 221 (264)
T ss_pred C-cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHhcCCC-------C----
Confidence 2 22345688999999999988899999999999999999999999976543 223333333221110 0
Q ss_pred CCcccHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1047 QDEKTVS-HMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1047 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
..+.. ....+.+++.+|++++|++||++.|+++.
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 --SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01111 33468899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=284.45 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=201.3
Q ss_pred hcCCcCC-ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEe----c
Q 001253 808 TDNFDER-FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYH----Q 880 (1114)
Q Consensus 808 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~ 880 (1114)
+++|++. ++||-|-.|.|-.+..+ +|+++|+|++.... ..++|++..-.. .|||||.++++|+. .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 4556554 57999999999999976 89999999986432 245677765444 69999999999864 3
Q ss_pred CceEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCCeEEeec
Q 001253 881 GSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD---KFEAHVGDF 956 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Df 956 (1114)
....+|||.|+||.|...+++++ ..+++.++..|+.||+.|+.|||+. .|.||||||+|+|... +..+||+||
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 45679999999999999998654 4799999999999999999999999 9999999999999974 456999999
Q ss_pred cCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 001253 957 GLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLV 1036 (1114)
Q Consensus 957 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1114)
|+|+... ......+.+-||.|.|||++...+|+..+|+||+||++|-|++|.+||+.... ..+..-.+..++.+
T Consensus 209 GFAK~t~--~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispgMk~rI~~g--- 282 (400)
T KOG0604|consen 209 GFAKETQ--EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKRRIRTG--- 282 (400)
T ss_pred ccccccC--CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChhHHhHhhcc---
Confidence 9999743 34556677899999999999999999999999999999999999999986553 22222233333332
Q ss_pred cccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1037 SGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+.+..+.-...+....++|+.+++.+|++|.|..|++.
T Consensus 283 ------qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 ------QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ------CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 223333444455667888999999999999999999875
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=303.13 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=201.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+-|+..++||+|+||.||+|.++ +++.||+|++..... ....+.+.+|+..+++++||||+++++++..++..++||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 34778889999999999999875 688999999864332 223467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.+++.. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++...... .
T Consensus 82 e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~-~ 155 (277)
T cd06641 82 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-Q 155 (277)
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc-h
Confidence 99999999999873 4689999999999999999999998 9999999999999999999999999998765422 1
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......++..|+|||.+.+..++.++||||+||++|+|++|..||..... ...... +.....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~-~~~~~~------------ 218 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVLFL-IPKNNP------------ 218 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHHHH-HhcCCC------------
Confidence 222334688899999999888899999999999999999999999864322 111111 111100
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
..........+.+++.+||+.+|.+||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01111223467889999999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=305.97 Aligned_cols=265 Identities=26% Similarity=0.349 Sum_probs=201.6
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--CceEEEE
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLLMY 887 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 887 (1114)
|++.+.||+|+||.||+|+.. +++.+|+|++.... ......+.+.+|+.+++.++|||++++++++.+. +..++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 567789999999999999977 58899999998664 2223345688899999999999999999999888 7899999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++ +|.+++......+++..+..++.|+++|++|||+. +++|+||+|+||++++++.+||+|||.+........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 99985 89999876556899999999999999999999998 999999999999999999999999999987654432
Q ss_pred CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC---c--cccc-c
Q 001253 968 KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS---L--VSGM-L 1040 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~--~~~~-~ 1040 (1114)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...+.+...... + ...+ .
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccccchh
Confidence 22334467888999998765 4578999999999999999999999975442111 111111111000 0 0000 0
Q ss_pred cccccCCCcc-------cHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 DARLNLQDEK-------TVS-HMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 ~~~~~~~~~~-------~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.......... ... ....+.+++.+||+++|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000 001 1457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=307.95 Aligned_cols=266 Identities=24% Similarity=0.354 Sum_probs=198.8
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|+..+.||+|++|.||+|+.+ +|+.||||++...... ....+.+..|++++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 4788899999999999999976 6899999998754432 2234568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 889 YMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|+. ++|.+++... ...+++..+..++.|+++|++|||+. +++||||+|+||++++++.+||+|||.+.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 996 5898888643 35789999999999999999999998 99999999999999999999999999987654222
Q ss_pred CccccccccccccCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcc----cccc--
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLV----SGML-- 1040 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~-- 1040 (1114)
.......+++.|+|||.+.+.. ++.++||||||+++|||+||+.||..........+..+..-...... ....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2223345788999999887644 58899999999999999999999975432222222111100000000 0000
Q ss_pred cccccCC-C----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 DARLNLQ-D----EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 ~~~~~~~-~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....... . .........+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000 0 000112345778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.53 Aligned_cols=265 Identities=23% Similarity=0.317 Sum_probs=198.8
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEec
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
|++.+.||.|++|+||+|.++ +|+.||+|++...... ......+.+|+.++++++|||++++++++.+++..++||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 567889999999999999976 7999999998755432 22345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 890 MARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
++ ++|.+++.... ..+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||.++.......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 96 58999987543 4689999999999999999999998 999999999999999999999999999976542221
Q ss_pred ccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC-----------Ccc
Q 001253 969 SMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN-----------SLV 1036 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~ 1036 (1114)
......++..|+|||++.+. .++.++||||+|+++|+|++|+.||..........+..+...... .+.
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 12233568899999987654 578899999999999999999999975433222222211100000 000
Q ss_pred cccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1037 SGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.....................+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000001112246889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=304.46 Aligned_cols=265 Identities=23% Similarity=0.374 Sum_probs=199.8
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|+..++||+|++|+||+|+.+ +|+.||||++...... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4788899999999999999986 6899999998755432 224556789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 889 YMARGSLGELLHGAS--STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|+++ ++.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.++++|||.+.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9986 8888886443 4689999999999999999999998 99999999999999999999999999997654322
Q ss_pred CCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC-ccccc-----
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS-LVSGM----- 1039 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~----- 1039 (1114)
.......++..|+|||++.+. .++.++||||+||++|+|++|+.||......+......+....... ....+
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 222334578899999988654 4688999999999999999999999755432221111111000000 00000
Q ss_pred ccccccCCC-----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1040 LDARLNLQD-----EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1040 ~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
......... .........+.+++.+|++.||.+||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 001122456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=304.32 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=199.9
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
.|...++||+|++|.||+|..+ +++.+|+|++..... ...+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4555679999999999999965 788999998854322 224567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+....... .
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~ 170 (285)
T cd06648 97 FLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-P 170 (285)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-c
Confidence 9999999999975 5689999999999999999999998 99999999999999999999999999887543222 2
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
......|++.|+|||...+..++.++||||+|+++|||++|+.||..... ....+...... .+..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~~~~~~~~~-------~~~~---- 235 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQAMKRIRDNL-------PPKL---- 235 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHHHHHHHhcC-------CCCC----
Confidence 22345689999999999888899999999999999999999999864322 22222211110 0000
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.........+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 011112346889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=302.65 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=199.0
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC---CCceeeEEeEEEecCceEE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR---HRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 885 (1114)
.|+..+.||+|+||.||+|.+. +++.||+|.+...... ...+.+.+|+.+++.++ |||++++++++..+...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4777889999999999999975 7899999998754332 22456788999998886 9999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+++++|.++++. ..+++.....++.|+++|++|||+. +++||||+|+||++++++.++++|||.+......
T Consensus 80 v~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 80 IMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999999999874 3789999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
. .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ..... .... ..+.+
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~-~~~~------~~~~~ 222 (277)
T cd06917 155 S-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF----RAMML-IPKS------KPPRL 222 (277)
T ss_pred c-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh----hhhhc-cccC------CCCCC
Confidence 2 22334568899999998865 45788999999999999999999999654321 11110 0000 01111
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. . ......+.+++.+||+.||++||++.|+++
T Consensus 223 ~--~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 E--D---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred C--c---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1 0 013346889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=302.94 Aligned_cols=243 Identities=25% Similarity=0.299 Sum_probs=193.4
Q ss_pred ecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCH
Q 001253 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL 895 (1114)
Q Consensus 817 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 895 (1114)
||+|+||+||+|..+ +|+.||+|++.............+..|+.++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 6899999998754433223345567899999999999999999999999999999999999999
Q ss_pred HHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccccc
Q 001253 896 GELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA 974 (1114)
Q Consensus 896 ~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 974 (1114)
.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence 99987543 3689999999999999999999998 999999999999999999999999999876532 22223456
Q ss_pred ccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHH
Q 001253 975 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSH 1054 (1114)
Q Consensus 975 g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1114)
++..|+|||++.+..++.++||||+||++|+|++|+.||.............+. .. ... ...+...
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~---------~~~----~~~~~~~ 221 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-TL---------EMA----VEYPDKF 221 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc-cc---------ccc----ccCCccC
Confidence 788999999998888999999999999999999999999754432221111111 00 000 1111122
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHH
Q 001253 1055 MITVLKIAMLCTNISPFDRPTMRE 1078 (1114)
Q Consensus 1055 ~~~l~~li~~cl~~dP~~RPs~~e 1078 (1114)
...+.+++.+||+.||++||+++|
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCc
Confidence 446889999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=297.82 Aligned_cols=249 Identities=29% Similarity=0.425 Sum_probs=204.6
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|+..+.||+|++|.||+|..+ +++.+|+|++..... ...+.+.+|+..++.++||+++++++++..+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4778889999999999999986 788999999976554 235678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++++|.+++......+++..+..++.|++.|++|||.. +++||||+|+||++++++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 9999999999986656899999999999999999999998 999999999999999999999999999987543221
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
.....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ......... .. ...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-~~------~~~---- 217 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM----KALFKIATN-GP------PGL---- 217 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH----HHHHHHHhc-CC------CCc----
Confidence 34557889999999998888999999999999999999999998754321 111111110 00 000
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.........+.+++.+||+.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011111346889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=302.39 Aligned_cols=261 Identities=23% Similarity=0.280 Sum_probs=195.2
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEec--CceEEE
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQ--GSNLLM 886 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 886 (1114)
|++.++||+|+||.||+|..+ +++.||+|+++....... ......|+..++++. |||++++++++.++ +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 567789999999999999975 689999999876543222 223446888888885 99999999999987 889999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++ ++.+.+......+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.++......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 999975 88888876556789999999999999999999998 9999999999999999 999999999998654222
Q ss_pred CCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc-----------CC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN-----------NS 1034 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------~~ 1034 (1114)
......++..|+|||++.. ..++.++||||+||++|||++|..||...... +...+..+.... ..
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 --PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-DQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred --CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-HHHHHHHHHcCCCCHHHHHhhcccc
Confidence 2233467899999997654 55788999999999999999999999654321 111222111110 00
Q ss_pred cccccccccccC-CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1035 LVSGMLDARLNL-QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1035 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
............ ...........+.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000 00001123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=301.73 Aligned_cols=244 Identities=23% Similarity=0.238 Sum_probs=188.7
Q ss_pred eecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHH---hcCCCCceeeEEeEEEecCceEEEEecCC
Q 001253 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTL---GKIRHRNIVKLYGFCYHQGSNLLMYEYMA 891 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 891 (1114)
.||+|+||.||+|+.. +++.||+|.+.............+.+|..++ ...+||+|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 6899999998765433222223334444333 34479999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccc
Q 001253 892 RGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 971 (1114)
Q Consensus 892 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 971 (1114)
+|+|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||++....... ..
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 99999998743 4689999999999999999999998 99999999999999999999999999997653221 22
Q ss_pred cccccccccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcc
Q 001253 972 AIAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEK 1050 (1114)
Q Consensus 972 ~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1114)
...|+..|+|||... +..++.++||||+||++|||++|..||....... . ..+....... . ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~-~~~~~~~~~~-------~------~~~ 218 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-K-HEIDRMTLTV-------N------VEL 218 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-H-HHHHHHhhcC-------C------cCC
Confidence 346899999999886 4568899999999999999999999997544322 1 1122111100 0 111
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1051 TVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1051 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
+......+.+++.+|++.||.+|| +++|+++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 222345688999999999999999 5888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=328.91 Aligned_cols=269 Identities=20% Similarity=0.232 Sum_probs=190.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC--CCcEEEEEE--------------ecccCCCChhhHHHHHHHHHHHhcCCCCcee
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR--TGHTVAVKK--------------LASNREGNNNVDNSFRAEILTLGKIRHRNIV 871 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 871 (1114)
.++|++.++||+|+||+||+|..+ ++..+++|. +.+...........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 478999999999999999999864 222233321 1111112223355688999999999999999
Q ss_pred eEEeEEEecCceEEEEecCCCCCHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 001253 872 KLYGFCYHQGSNLLMYEYMARGSLGELLHGAS----STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947 (1114)
Q Consensus 872 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 947 (1114)
++++++.+.+..|+|+|++.+ ++.+++.... ......+...++.|++.||+|||+. +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 999999999999999999965 7777764321 2334566778999999999999998 9999999999999999
Q ss_pred CCCeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 001253 948 KFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR 1027 (1114)
Q Consensus 948 ~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~ 1027 (1114)
++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|..++........ ...+.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~-~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP-GKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH-HHHHH
Confidence 99999999999987654333333456799999999999999999999999999999999998754432222111 11111
Q ss_pred HHHhcCCc-cccccc-----------ccccCCCcc------cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1028 NFIRNNSL-VSGMLD-----------ARLNLQDEK------TVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1028 ~~~~~~~~-~~~~~~-----------~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+.+..-.. ...+.+ ..+...... .......+.+++.+|+++||.+|||+.|+++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11111000 000000 000000000 0001234667899999999999999999986
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=304.94 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=204.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
++.|+..+.||+|++|.||+|.++ +++.||+|++..... ..+.+..|+..++.++|+|++++++++...+..++|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 456778889999999999999987 789999999975443 256688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
+||+++++|.+++......+++..+..++.|++.||+|||+. +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999999986555899999999999999999999998 99999999999999999999999999887553222
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.......+++.|+|||++.+..++.++|||||||++|+|++|+.||...... ......... ... .
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----~~~~~~~~~-~~~-----~---- 235 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----RALFLITTK-GIP-----P---- 235 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhc-CCC-----C----
Confidence 1223445788999999998888999999999999999999999998643321 111111111 000 0
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..........+.+++.+||+.+|.+||++.++++
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 -LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0011112346889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=308.84 Aligned_cols=266 Identities=29% Similarity=0.396 Sum_probs=199.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--CceEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLL 885 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 885 (1114)
++|++.+.||+|+||+||+|.++ +|+.||+|+++...... .....+.+|+.++++++|+|++++++++... +..++
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 67999999999999999999976 68999999987544322 2223456799999999999999999998765 46799
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+++ +|.+++......+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999975 89998876567799999999999999999999998 9999999999999999999999999999876533
Q ss_pred CCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC--Cccccc---
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN--SLVSGM--- 1039 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~--- 1039 (1114)
. .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...+....... ......
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 162 A-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-LDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred c-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChhhchhhhcc
Confidence 2 22233346788999999865 4578999999999999999999999975432211 11111111100 000000
Q ss_pred -ccccccC--CCc-----ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1040 -LDARLNL--QDE-----KTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1040 -~~~~~~~--~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....... ... ........+.+++.+|+++||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 000 00112456788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=282.43 Aligned_cols=202 Identities=26% Similarity=0.427 Sum_probs=172.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC---C--CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe-cCc
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR---T--GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH-QGS 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~---~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 882 (1114)
..|+..++||+|.||.||+|.-+ + .+.+|+|+++.......- ....-+|+.+++.++|||++.+..++.. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-S~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-SMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-CHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 57899999999999999999643 2 237999999877664433 3445679999999999999999999877 788
Q ss_pred eEEEEecCCCCCHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC----CCeEEe
Q 001253 883 NLLMYEYMARGSLGELLHGA----SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK----FEAHVG 954 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~ 954 (1114)
.++++||.+. +|.++++.. ...++...+..|..||+.|+.|||++ -|+|||+||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999988 999988632 34788999999999999999999999 89999999999999877 899999
Q ss_pred eccCceecCCCCC--CccccccccccccCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCC
Q 001253 955 DFGLAKVIDMPQS--KSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPVQP 1015 (1114)
Q Consensus 955 DfG~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~p~~~ 1015 (1114)
|||+|+.+..+-. .....++-|..|+|||.+.+.+ |+.+.||||.|||+.||++-++-|..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999998875533 2345678899999999998754 89999999999999999998877753
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=315.58 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=199.7
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec-----
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ----- 880 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 880 (1114)
..++|+..+.||+|+||+||+|+.. +|+.||+|++....... .....+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh-hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3478999999999999999999975 78999999986543322 2345567899999999999999999998643
Q ss_pred -CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 881 -GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 881 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
...|+||||+.+ +|.+.+.. .++...+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 346999999975 88888863 288999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH------------
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR------------ 1027 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~------------ 1027 (1114)
+..... .......++..|+|||.+.+..++.++||||+||++|+|++|+.||...+........++
T Consensus 166 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 875432 223345688999999999999999999999999999999999999975442111111110
Q ss_pred ------HHHhcCCcc-----cccccccc-cCC-CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1028 ------NFIRNNSLV-----SGMLDARL-NLQ-DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1028 ------~~~~~~~~~-----~~~~~~~~-~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
......... ........ ... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00000000 000 00011234467899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=311.96 Aligned_cols=280 Identities=25% Similarity=0.326 Sum_probs=213.9
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC------ce
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG------SN 883 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 883 (1114)
+...+.||+|+||.||+|+.+ +|+.||||.+...... ...+...+|++++++++|||||+++++-+... ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 445668999999999999965 8999999999875533 23566788999999999999999999865443 56
Q ss_pred EEEEecCCCCCHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC--CCCC--eEEeecc
Q 001253 884 LLMYEYMARGSLGELLHGA--SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD--DKFE--AHVGDFG 957 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~--~kl~DfG 957 (1114)
.+|||||.||||...+.+. ...+++.+.+.+..++..||.|||++ +|+||||||.||++- ++|+ -||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 8999999999999999853 34799999999999999999999998 999999999999983 4444 6999999
Q ss_pred CceecCCCCCCccccccccccccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH-HHhcCCc
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRN-FIRNNSL 1035 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~ 1035 (1114)
.|+..+ +.......+||..|.+||+.. .+.|+..+|.|||||++|+.+||..||.+-............ ..+...-
T Consensus 170 ~Arel~--d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 170 AARELD--DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccccCC--CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 999875 344667889999999999998 588999999999999999999999999866554332222222 2222111
Q ss_pred cccccc----------ccccCCCcccHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHhhhccCCCccccc
Q 001253 1036 VSGMLD----------ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRP--TMREVVLMLSESNRRQGHFEFSP 1097 (1114)
Q Consensus 1036 ~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i~~~~~~~~~~~ 1097 (1114)
...... ..+.....-.......+-.....++.++|.+|. .+.+....+.+|....-...+.-
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhiFs~ 321 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHIFSM 321 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEEEee
Confidence 111111 111111112233334566778889999999999 88888888888876654444433
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=305.46 Aligned_cols=270 Identities=26% Similarity=0.352 Sum_probs=201.8
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC---
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG--- 881 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 881 (1114)
...++|++.++||+|+||+||+|..+ +|+.||+|++....... .....+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45678999999999999999999986 68999999987553322 22456778999999999999999999987654
Q ss_pred -------ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEe
Q 001253 882 -------SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG 954 (1114)
Q Consensus 882 -------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 954 (1114)
..++|+||+++ ++.+.+......+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999987 77777775556799999999999999999999998 99999999999999999999999
Q ss_pred eccCceecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 955 DFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 955 DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
|||.+...............++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...+.......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~-~~~~~~~~~~~ 237 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ-LELISRLCGSP 237 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCC
Confidence 999998764333222233456788999998764 4578899999999999999999999974332111 11122211110
Q ss_pred Ccc--cccc--------cccccCC---CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1034 SLV--SGML--------DARLNLQ---DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1034 ~~~--~~~~--------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
... ..+. +...... ..........+.+++.+||+.||.+||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0000 0000000 0000112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=300.93 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=201.8
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|+..+.||+|+||.||+|..+ +|..||+|.+....... ...+.+.+|+.+++.++|+||+++++.+...+..++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4778889999999999999976 68899999987643322 224567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC-eEEeeccCceecCCCC
Q 001253 889 YMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE-AHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~DfG~a~~~~~~~ 966 (1114)
|+++++|.+++.... ..+++..+..++.|+++|++|||+. +++|+||||+||++++++. +|++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999987533 3579999999999999999999998 9999999999999998864 6999999998654322
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.......|++.|+|||+..+..++.++||||+|+++|||++|+.||.... ..+++...... .. .
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~-----~----- 220 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN----LHQLVLKICQG-YF-----A----- 220 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHhcc-cC-----C-----
Confidence 22233468899999999988889999999999999999999999986432 22333322211 10 0
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.........+.+++.+||+.+|++|||+.|+++
T Consensus 221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 --PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 011122346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=285.67 Aligned_cols=256 Identities=28% Similarity=0.406 Sum_probs=200.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhc-CCCCceeeEEeEEEecCceEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGK-IRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv 886 (1114)
++.+....||.|+||+|+|..++ .|+..|||++..... +..++++..|.....+ -+.||||+++|++..++..++.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 44455567999999999999977 799999999987655 3335667778876544 4789999999999999999999
Q ss_pred EecCCCCCHHHHhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 887 YEYMARGSLGELLH----GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
||.|+- +++.+.+ .....+++...-.|+...+.||.||-+.. +|+|||+||+|||++..|.+||||||++..+
T Consensus 142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 999976 7776543 13457888888999999999999998764 8999999999999999999999999999865
Q ss_pred CCCCCCccccccccccccCccccc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 963 DMPQSKSMSAIAGSYGYIAPEYAY--TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 963 ~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.. +...+.-+|-..|||||.+. +..|+.+|||||+|+++||+.||..||...+. ..+.+...+..
T Consensus 219 v~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~g-------- 285 (361)
T KOG1006|consen 219 VD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIG-------- 285 (361)
T ss_pred HH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcC--------
Confidence 42 22233446888899999986 34589999999999999999999999975543 33333333332
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
++..-.......+....+.++|.-|+..|-.+||.+.++.+.
T Consensus 286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 222222233334566789999999999999999999988653
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=299.16 Aligned_cols=247 Identities=24% Similarity=0.275 Sum_probs=191.3
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHH-HhcCCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILT-LGKIRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
+.||+|+||.||+|+.. +|+.||+|++.............+..|... ....+|+|++++++++..++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999975 689999999875433222223334445444 4455899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
++|.++++.. ..+++..+..++.|++.||.|+|+. +++||||+|+||++++++.++|+|||++..... ...
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 9999999743 4688999999999999999999998 999999999999999999999999999875432 223
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..+++.|+|||...+..++.++||||+|+++|||++|..||..... .......... . .........
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~-~---------~~~~~~~~~ 218 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----DAVFDNILSR-R---------INWPEEVKE 218 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhc-c---------cCCCCcccc
Confidence 4688899999999888889999999999999999999999964332 1222221111 0 000011111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1053 SHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1053 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
.....+.+++.+||+.+|++||++.++.+.+.
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 23356889999999999999998876655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=303.36 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=196.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 886 (1114)
++|+..++||+|+||+||++... +++.||+|++...... .....+.+|+..+.++. ||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 45666778999999999999976 6899999998754433 33566888999999996 99999999999999999999
Q ss_pred EecCCCCCHHHHhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 887 YEYMARGSLGELLH----GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
|||++. ++.++.. .....+++..+..++.+++.||+|||+.. +++||||||+||+++.++.++|+|||+++..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 999875 6655432 12357899999999999999999999732 8999999999999999999999999999765
Q ss_pred CCCCCCccccccccccccCccccccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 963 DMPQSKSMSAIAGSYGYIAPEYAYTM---KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 963 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
.... ......|+..|+|||++.+. .++.++||||+||++|||++|+.||.... .....+.......
T Consensus 159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~------ 227 (288)
T cd06616 159 VDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVKGD------ 227 (288)
T ss_pred ccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcCCC------
Confidence 3222 22334688899999998766 68899999999999999999999996433 1122222211110
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
.+.+. ..........+.+++.+||+.||++|||+.+|++.
T Consensus 228 -~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILS--NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCC--CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111 11112234568899999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=306.83 Aligned_cols=268 Identities=22% Similarity=0.314 Sum_probs=197.6
Q ss_pred CCcCCceecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--CceE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNL 884 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 884 (1114)
+|++.++||+|+||.||+|..+ +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778889999999999999975 4789999999875432233345677899999999999999999999988 7899
Q ss_pred EEEecCCCCCHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC----CCCeEEeec
Q 001253 885 LMYEYMARGSLGELLHGA----SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD----KFEAHVGDF 956 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~Df 956 (1114)
+||||+++ ++.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 677666422 23688999999999999999999998 9999999999999999 999999999
Q ss_pred cCceecCCCCC--CccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCC-----HHHHHHH
Q 001253 957 GLAKVIDMPQS--KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD-----LVTWVRN 1028 (1114)
Q Consensus 957 G~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~-----~~~~~~~ 1028 (1114)
|++........ .......++..|+|||++.+. .++.++|||||||++|||++|+.||........ ....+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 122345688999999988764 578999999999999999999999975443220 0000000
Q ss_pred HHh---------------cCCccccc-ccccccCCCccc-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1029 FIR---------------NNSLVSGM-LDARLNLQDEKT-------VSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1029 ~~~---------------~~~~~~~~-~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+. ...+.... ............ ......+.+++.+|+++||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 00000000 000000000000 022346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=301.38 Aligned_cols=261 Identities=19% Similarity=0.259 Sum_probs=188.8
Q ss_pred HhcCCcCCceecccCCeEEEEEEeCC----CcEEEEEEecccCCCChhh--------HHHHHHHHHHHhcCCCCceeeEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLRT----GHTVAVKKLASNREGNNNV--------DNSFRAEILTLGKIRHRNIVKLY 874 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~ 874 (1114)
..++|++.++||+|+||+||+|.+.+ +..+|+|+........... ......+...+..++|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34689999999999999999999764 3456666543222211000 01112233455677899999999
Q ss_pred eEEEecC----ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC
Q 001253 875 GFCYHQG----SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE 950 (1114)
Q Consensus 875 ~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 950 (1114)
+++.... ..++++|++.. ++.+.++. ....++..+..++.|+++||+|||+. +|+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 9876543 34688888755 67777653 23457888899999999999999998 9999999999999999999
Q ss_pred eEEeeccCceecCCCCC------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHH
Q 001253 951 AHVGDFGLAKVIDMPQS------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVT 1024 (1114)
Q Consensus 951 ~kl~DfG~a~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~ 1024 (1114)
++|+|||+|+.+..... .......||+.|+|||+..+..++.++||||+||++|||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999986532211 112234699999999999999999999999999999999999999986644333322
Q ss_pred HHH-HHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001253 1025 WVR-NFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083 (1114)
Q Consensus 1025 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1083 (1114)
..+ +++.. +....... ......+.+++..|++.+|++||++.++++.+
T Consensus 245 ~~~~~~~~~------~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKR------LHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHHHH------hhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 221 11111 00111110 11135688999999999999999999999876
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=304.73 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=200.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
..|+..+.||+|+||+||+|+.+ +++.+|+|.+...........+++.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44777788999999999999976 67899999987544333344566788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+. |++.+++......+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9997 588888765556789999999999999999999998 9999999999999999999999999998765321
Q ss_pred CccccccccccccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
....+++.|+|||.+. ...++.++|||||||++|||++|+.||....... ........ .. +
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~-~~------~-- 232 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQN-ES------P-- 232 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH----HHHHHhhc-CC------C--
Confidence 2346888999999874 3457889999999999999999999986433211 11111111 00 0
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
..........+.+++.+||+.+|++||++.++++.-..
T Consensus 233 ---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 233 ---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred ---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 00111233467899999999999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=327.88 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=192.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe-------
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH------- 879 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 879 (1114)
..+|+....||+||||.||+++.+ ||+.||||++.-.. .......+.+|+..+++++|||||+++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 367888889999999999999988 89999999998765 33445668889999999999999988652100
Q ss_pred ------------------------------------------------c-------------------------------
Q 001253 880 ------------------------------------------------Q------------------------------- 880 (1114)
Q Consensus 880 ------------------------------------------------~------------------------------- 880 (1114)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 001253 881 ---------------------------------GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927 (1114)
Q Consensus 881 ---------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~ 927 (1114)
...|+-||||+..++.++++++...-.....++++++|++||+|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 11378899999988888887443322577888999999999999999
Q ss_pred CCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC-----------------CCCCCccccccccccccCccccccC--
Q 001253 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-----------------MPQSKSMSAIAGSYGYIAPEYAYTM-- 988 (1114)
Q Consensus 928 ~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~-----------------~~~~~~~~~~~g~~~y~aPE~~~~~-- 988 (1114)
+ |||||||||.||+++++..|||+|||+|.... .+.....+..+||.-|+|||++.+.
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 99999999999999999999999999998621 0111234567899999999998754
Q ss_pred -CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccC
Q 001253 989 -KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTN 1067 (1114)
Q Consensus 989 -~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 1067 (1114)
+|+.|+||||+||+++||+. ||....+ .+..+.. ++ ++.+.............=.++|+++++
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsME---Ra~iL~~-LR---------~g~iP~~~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSME---RASILTN-LR---------KGSIPEPADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHH---HHHHHHh-cc---------cCCCCCCcccccccchHHHHHHHHHhc
Confidence 49999999999999999985 4643322 1112221 12 222332222233344455689999999
Q ss_pred CCCCCCCCHHHHHH
Q 001253 1068 ISPFDRPTMREVVL 1081 (1114)
Q Consensus 1068 ~dP~~RPs~~evl~ 1081 (1114)
.||.+||||.|++.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999875
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=304.94 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=208.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
...|.+.+.||+|.|++|..|++. ++..||||.+.+..-.... .+.+.+|++++..+.|||||+++.+.+.+...|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 356888999999999999999976 7999999999887765443 34488899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+.+|.+++++...+ ...+.....++.|+.+|++|+|++ .|||||||++||+++.+.++||+|||++..+. .
T Consensus 134 ~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--Y 207 (596)
T ss_pred EEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--c
Confidence 99999999999998554 455588889999999999999999 99999999999999999999999999999876 4
Q ss_pred CCccccccccccccCccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVT-EKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.....+++|++.|.|||++.+..|+ +.+|+||+|+++|-++.|.-||++..-.+- +. ..+...++
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----r~---------rvl~gk~r 273 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----RP---------RVLRGKYR 273 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----cc---------hheeeeec
Confidence 5566788999999999999988865 689999999999999999999975432111 10 01111111
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1083 (1114)
. +.....+.-+++++++-.+|.+|++.+++.+.-
T Consensus 274 I----p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 274 I----PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred c----cceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 1 111223456789999999999999999987654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=302.56 Aligned_cols=258 Identities=23% Similarity=0.238 Sum_probs=203.9
Q ss_pred CCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCC-CChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCce
Q 001253 810 NFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNRE-GNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 883 (1114)
+|++.+.||+|+||.||+|+.. +++.||||+++.... ......+.+..|+.++.++ +||+|+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778889999999999999853 578899999875432 1222345678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++++|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999999874 34688999999999999999999998 99999999999999999999999999988654
Q ss_pred CCCCCccccccccccccCccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMK--VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
...........|+..|+|||...+.. .+.++||||+|+++|||++|..||.............+......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------- 228 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-------- 228 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--------
Confidence 33322233456889999999987655 78899999999999999999999964332222223323222211
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
...+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 229 ------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 ------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01111123467889999999999999999988887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=302.89 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=196.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|++|+||+|+++ +|+.||+|++...... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 46888999999999999999976 7899999998654332 223456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCCeEEeeccCceecCCC
Q 001253 888 EYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~~~~~~ 965 (1114)
||+++ ++.+++.... ...++..+..++.|++.||+|||+. +++||||+|+||+++. ++.+||+|||++......
T Consensus 81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99965 7888775433 3468888889999999999999998 9999999999999985 557999999999765432
Q ss_pred CCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc---
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD--- 1041 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 1041 (1114)
........+++.|+|||++.+ ..++.++||||+||++|+|++|+.||......+........ ... . ....++
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~-~~~-~-~~~~~~~~~ 232 (294)
T PLN00009 157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRI-LGT-P-NEETWPGVT 232 (294)
T ss_pred -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCC-C-Chhhccccc
Confidence 122233467889999998866 45788999999999999999999999754332211111110 000 0 000000
Q ss_pred -------ccccCCCc----ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 -------ARLNLQDE----KTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 -------~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
........ ........+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 01122345789999999999999999999986
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=302.14 Aligned_cols=246 Identities=27% Similarity=0.394 Sum_probs=197.7
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEec
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
|...++||+|+||+||+|+.. +|+.||+|++...........+.+..|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666678999999999999975 6889999999765554444456788899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCc
Q 001253 890 MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 969 (1114)
+.+ ++.+++......+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+.... .
T Consensus 103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~ 173 (313)
T cd06633 103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----P 173 (313)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC-----C
Confidence 964 88888876666789999999999999999999998 99999999999999999999999999886432 1
Q ss_pred cccccccccccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 970 MSAIAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 970 ~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.....|+..|+|||++. ...++.++|||||||++|||++|..||...... ........... +.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~~~~-------~~--- 239 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNDS-------PT--- 239 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCC-------CC---
Confidence 23456889999999974 456888999999999999999999998654321 11221111100 00
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.........+.+++.+||+.+|++||++.++++
T Consensus 240 --~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 240 --LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001112235788999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-32 Score=300.57 Aligned_cols=254 Identities=24% Similarity=0.261 Sum_probs=199.6
Q ss_pred CCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCce
Q 001253 810 NFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREG-NNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 883 (1114)
+|++.+.||+|+||.||+|+.. +|+.||+|++...... .....+.+..|+.+++++ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999863 6899999998754322 222345678899999999 589999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|+||||+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||++++++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999999743 4688999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCCCccccccccccccCccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTM--KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
...........|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||.............+.......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 229 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------- 229 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC-------
Confidence 3333333345688999999998753 4678999999999999999999999644333333333322211110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
..+......+.+++.+||+.||++|| ++.+++.
T Consensus 230 -------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 -------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11112234678999999999999997 5565543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=301.10 Aligned_cols=248 Identities=26% Similarity=0.347 Sum_probs=199.8
Q ss_pred ecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCH
Q 001253 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL 895 (1114)
Q Consensus 817 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 895 (1114)
||+|+||.||+|++. +|+.||+|++...........+.+.+|++.+++++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 5999999999766544444567788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC-------C
Q 001253 896 GELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-------K 968 (1114)
Q Consensus 896 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-------~ 968 (1114)
.++++... .+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99997543 789999999999999999999998 999999999999999999999999999875432211 1
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
......++..|+|||...+..++.++||||||+++||+++|..||..... ......... .. .. .
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~-~~---------~~--~ 220 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP----EEIFQNILN-GK---------IE--W 220 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhc-CC---------cC--C
Confidence 22345688899999999888899999999999999999999999964432 222222111 10 00 0
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
.........+.+++.+||+.+|.+|||+.++.+.++
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 001112456889999999999999999966666555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=311.33 Aligned_cols=270 Identities=23% Similarity=0.342 Sum_probs=199.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-----
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG----- 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 881 (1114)
.++|++.++||+|+||+||+|++. +|+.||+|++..... ......+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 468999999999999999999975 789999999864322 223456778999999999999999999876543
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..|+|+||+++ ++.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 82 ~~~lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 82 DVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred eEEEEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 47999999975 8888886 34689999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCC--CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc--c
Q 001253 962 IDMPQS--KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL--V 1036 (1114)
Q Consensus 962 ~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 1036 (1114)
...... .......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+... ....+......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHH
Confidence 543221 11233568999999998754 468899999999999999999999996533211 11111111111000 0
Q ss_pred ccccc-------ccccCCCcc-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhh
Q 001253 1037 SGMLD-------ARLNLQDEK-----TVSHMITVLKIAMLCTNISPFDRPTMREVVLM--LSES 1086 (1114)
Q Consensus 1037 ~~~~~-------~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 1086 (1114)
..+.+ ......... .......+.+++.+||+.||++|||+.|+++. ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00000 000000000 01124568899999999999999999999876 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=294.54 Aligned_cols=273 Identities=22% Similarity=0.272 Sum_probs=213.9
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCce
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 883 (1114)
+...+|....+||+|+||.|-+|..+ +.+.||||+++++.....+..+--..|-++++.. +-|.+++++.+|+.-++.
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 44567999999999999999999977 5788999999887654333233334577777766 568999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|+||||+.||+|--.+++. +.+.+..+...|..||-||-+||++ ||++||+|.+|||++.+|++||+|||+++.-
T Consensus 426 yFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn- 500 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN- 500 (683)
T ss_pred eeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc-
Confidence 9999999999999888744 4677888888999999999999999 9999999999999999999999999999852
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
.-......+++|||.|+|||++...+|+.++|.|||||++|||+.|++||++.++.+ +.+.+.+ .
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-lF~aI~e-------------h- 565 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LFQAIME-------------H- 565 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHH-------------c-
Confidence 234455678999999999999999999999999999999999999999998655422 2222221 1
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCCcccc
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDSDQKL 1106 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~~~ 1106 (1114)
....+...+.+...++...+...|.+|...-- +.-+....+.++..+||+.-...
T Consensus 566 ---nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~-----~ge~di~~H~FFR~iDWek~E~~ 620 (683)
T KOG0696|consen 566 ---NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGP-----EGERDIREHPFFRRIDWEKLERR 620 (683)
T ss_pred ---cCcCcccccHHHHHHHHHHhhcCCccccCCCC-----ccccchhhCcchhhccHHHHhhc
Confidence 12234445567888999999999999954321 11123334566777777654433
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=291.80 Aligned_cols=252 Identities=28% Similarity=0.404 Sum_probs=206.4
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--CceEEE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLLM 886 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 886 (1114)
+|+..+.||+|++|.||+|..+ +++.|++|++...... ....+.+.+|+..+++++||||+++++.+.+. ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 4777889999999999999987 7899999998765532 34467788999999999999999999999988 889999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++.... .+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 99999999999998544 889999999999999999999998 99999999999999999999999999998765332
Q ss_pred CC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.. ......++..|+|||...+..++.++||||+|+++|+|++|+.||.... +........... ..
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~-~~---------- 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG---NPMAALYKIGSS-GE---------- 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHhcccc-CC----------
Confidence 21 1234568899999999988889999999999999999999999997554 111111111100 00
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....+......+.+++.+|++.+|.+||++.|++.
T Consensus 222 -~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 -PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 01112222457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=301.20 Aligned_cols=264 Identities=24% Similarity=0.326 Sum_probs=202.7
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEec
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
|++.+.||+|++|.||+|... +++.+|+|++...... ......+..|+.++++++|+||+++++++.+++..++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 567789999999999999975 7899999998765433 23356778899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCc
Q 001253 890 MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 969 (1114)
+++ ++.+++......+++.++..++.|+++|++|||+. +++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 976 88888876556899999999999999999999998 99999999999999999999999999998765332 22
Q ss_pred cccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC--cccccc------
Q 001253 970 MSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS--LVSGML------ 1040 (1114)
Q Consensus 970 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~------ 1040 (1114)
.....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+.... +.+...... ......
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK-IFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHcCCCchHhcccchhhhhhh
Confidence 2334678899999998776 789999999999999999999999965442211111 111100000 000000
Q ss_pred -----cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 -----DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 -----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.................+.+++.+||++||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000111223467899999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=295.23 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=206.4
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|++.+.||+|+||.||++.+. +++.||+|++...... ....+.+.+|+++++.++|||++++.+.+..++..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 4788899999999999999976 6899999999765442 2335678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 889 YMARGSLGELLHGA---SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|+++++|.+++... ...+++..+..++.+++.|++|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999999754 36899999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
. .......|++.|+|||...+..++.++||||+|+++|+|++|+.||.... ............ . .
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~~~~-~-----~---- 221 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN----LLELALKILKGQ-Y-----P---- 221 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc----HHHHHHHHhcCC-C-----C----
Confidence 2 22334578899999999988889999999999999999999999986443 222222222211 0 0
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+......+.+++.+||+.+|++|||+.|+++
T Consensus 222 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 ---PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 011122346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=257.35 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=200.1
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|...++||+|.||+||+|+.+ +++.||+|++.-+..+. .......+|+-+++.++|.|||+++++...+....+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 4666778999999999999955 78999999998665543 334456689999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
||.. +|..+.....+.++.+....++.|+++|+.|+|++ ++.|||+||.|.+++.+|++|++|||+|+.++.+. .
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv-r 156 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-R 156 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce-E
Confidence 9977 99999988888999999999999999999999999 99999999999999999999999999999887554 3
Q ss_pred ccccccccccccCccccccCC-CCcccchHHHHHHHHHHHhC-CCCCCCCCCCCCHHHHHHHHHhcCCcccccccc----
Q 001253 969 SMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTG-RAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA---- 1042 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 1042 (1114)
.....+-|..|++|+++.+.+ |+...|+||.||++.|+... ++.|++.+..+.+.+.++. + +...+.-+..
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~-l--g~p~ed~wps~t~l 233 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL-L--GTPTEDQWPSMTKL 233 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHH-h--CCCccccCCccccC
Confidence 345567899999999999866 88899999999999999984 4445543332222222221 1 1111111111
Q ss_pred -cccCCCccc---------HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1043 -RLNLQDEKT---------VSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1043 -~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+...+..+ +.....=.+++.+.+.-+|.+|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111111 111123345666777778999999987654
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=304.70 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=196.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.++||+|+||+||+|.++ +++.||||+++..... .....+..|+.++.+. .||||+++++++.++...|+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 367888999999999999999987 4899999999754332 2234455677666666 59999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+++ ++.+++......+++..+..++.|++.|++|||+. .+++||||+|+||++++++.+||+|||++..+...
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9999865 88888775556889999999999999999999973 18999999999999999999999999999765422
Q ss_pred CCCccccccccccccCccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMK----VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
. ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+..........
T Consensus 169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~------- 236 (296)
T cd06618 169 K--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQEEP------- 236 (296)
T ss_pred C--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHHhcCCC-------
Confidence 2 222335788999999987554 788999999999999999999999643221 122222121110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
+... ........+.+++.+||+.||++||++.++++.
T Consensus 237 ~~~~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSLP----PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 001123468899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=302.37 Aligned_cols=264 Identities=20% Similarity=0.280 Sum_probs=196.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCc----
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGS---- 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~---- 882 (1114)
++|++.+.||+|+||+||+|++. +++.||+|++....... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46888999999999999999976 68999999986543322 22356778999999995 6999999999987665
Q ss_pred -eEEEEecCCCCCHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCCeEEeec
Q 001253 883 -NLLMYEYMARGSLGELLHGA----SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDF 956 (1114)
Q Consensus 883 -~~lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Df 956 (1114)
.|+||||+++ ++.+++... ...+++..+..++.|++.||+|||+. +++||||+|+||+++. ++.+||+||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999986 888887632 23589999999999999999999998 9999999999999998 889999999
Q ss_pred cCceecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 001253 957 GLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL 1035 (1114)
Q Consensus 957 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1114)
|.++.+..+.. ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.............+. ....
T Consensus 156 g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~-- 231 (295)
T cd07837 156 GLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL-LGTP-- 231 (295)
T ss_pred ccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH-hCCC--
Confidence 99986543221 2223357888999998865 45789999999999999999999999754322111111110 0000
Q ss_pred ccccccc-----c---ccC-CC----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1036 VSGMLDA-----R---LNL-QD----EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1036 ~~~~~~~-----~---~~~-~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....... . ... .. .........+.++|.+||++||.+||+++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 0 000 00 001123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=294.53 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=199.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCC--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--Cce
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNRE--GNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSN 883 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 883 (1114)
.+|++.+.||+|+||.||+|+.+ +++.||+|++..... ........+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999975 689999998754321 2233456788999999999999999999998764 457
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++++|.+++... ..+++.....++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 8999999999999998743 3578999999999999999999998 99999999999999999999999999998653
Q ss_pred CCC--CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 964 MPQ--SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 964 ~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
... ........++..|+|||.+.+..++.++|||||||++||+++|+.||..... ...+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~-------- 225 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFKIATQP-------- 225 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHHHHcCC--------
Confidence 211 1122345688999999999988899999999999999999999999964322 11122211110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.....+......+.+++.+|++ +|.+||++.+++.
T Consensus 226 ----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0011222334568899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=308.86 Aligned_cols=280 Identities=24% Similarity=0.342 Sum_probs=206.2
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC----
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG---- 881 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 881 (1114)
..++|++.+.||+|+||+||+|... +|+.||||++..... .......+.+|+.++++++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 4578999999999999999999965 789999999865432 2223456778999999999999999999987654
Q ss_pred --ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 882 --SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 882 --~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
..++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++++|||++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 358999999 6699988863 4689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc-c-
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL-V- 1036 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~- 1036 (1114)
..... ......+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||....... ...+....... .
T Consensus 166 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~ 237 (343)
T cd07880 166 RQTDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD----QLMEIMKVTGTPSK 237 (343)
T ss_pred ccccc----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCCH
Confidence 86432 1233467889999998875 458889999999999999999999997543211 11111110000 0
Q ss_pred ---ccc--------ccccccCCC----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHH--HHHHhhhccCCCcccccCC
Q 001253 1037 ---SGM--------LDARLNLQD----EKTVSHMITVLKIAMLCTNISPFDRPTMREVV--LMLSESNRRQGHFEFSPMD 1099 (1114)
Q Consensus 1037 ---~~~--------~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl--~~L~~i~~~~~~~~~~~~~ 1099 (1114)
..+ ......... .........+.+++.+|++.||++|||+.+++ ..++...........++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~~ 317 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYD 317 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCcc
Confidence 000 000000000 00011234578999999999999999999998 5566554444444444444
Q ss_pred CC
Q 001253 1100 HD 1101 (1114)
Q Consensus 1100 ~~ 1101 (1114)
.+
T Consensus 318 ~~ 319 (343)
T cd07880 318 DS 319 (343)
T ss_pred cc
Confidence 33
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=292.50 Aligned_cols=249 Identities=28% Similarity=0.429 Sum_probs=204.0
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|++.+.||+|++|.||+|+.+ +++.||+|.+...... ....+.+.+|++++++++|||++++++++.++...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 4778899999999999999976 6789999999866543 2345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence 99999999999744 5789999999999999999999998 999999999999999999999999999987643222
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
......++..|+|||...+..++.++||||+|+++|+|++|+.||..... .....+ .... . . .
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~-~~~~-~------~------~ 217 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFR-IVQD-D------H------P 217 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHH-Hhcc-C------C------C
Confidence 22345688999999999888889999999999999999999999874432 111111 1110 0 0 0
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+......+.+++.+|++.+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111122346789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=297.73 Aligned_cols=264 Identities=24% Similarity=0.321 Sum_probs=196.8
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC---CCCceeeEEeEEEecCc----
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI---RHRNIVKLYGFCYHQGS---- 882 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~---- 882 (1114)
|++.+.||+|+||.||+|+++ +++.||+|+++...... .....+..|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 567889999999999999987 58999999997554422 2234556677766655 69999999999988776
Q ss_pred -eEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 883 -NLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 883 -~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
.+++|||+.+ +|.+++.... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||.+.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 8998887543 3689999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC--Ccccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN--SLVSG 1038 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 1038 (1114)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||......+....+........ .+...
T Consensus 156 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 156 IYSFE--MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eccCC--cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 76432 222334578899999999999999999999999999999999999875433222222211100000 00000
Q ss_pred c------ccccc-cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1039 M------LDARL-NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1039 ~------~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. ..... .............+.+++.+||+.||.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 00000 0000111223456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=296.24 Aligned_cols=244 Identities=23% Similarity=0.223 Sum_probs=188.4
Q ss_pred eecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHH---HHHhcCCCCceeeEEeEEEecCceEEEEecCC
Q 001253 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEI---LTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMA 891 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 891 (1114)
.||+|+||+||+|+.. +++.||+|++.............+..|. ..++...||+|+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999975 6899999998765432222122233333 34455679999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccc
Q 001253 892 RGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 971 (1114)
Q Consensus 892 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 971 (1114)
||+|.+++.. ...+++.++..++.|+++|++|||+. +++||||||+||+++.++.++|+|||++...... ...
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~ 153 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPH 153 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCc
Confidence 9999998874 45799999999999999999999998 9999999999999999999999999998755322 123
Q ss_pred cccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcc
Q 001253 972 AIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEK 1050 (1114)
Q Consensus 972 ~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1114)
...|+..|+|||.+.+. .++.++||||+||++|||++|+.||........ .. +....... . ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~-~~~~~~~~-------~------~~~ 218 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HE-IDRMTLTM-------A------VEL 218 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HH-HHHHhhcc-------C------CCC
Confidence 44789999999998744 688999999999999999999999975432221 11 11111100 0 011
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1051 TVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1051 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
+......+.+++.+|++.+|.+|| ++.++++
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111235688999999999999999 8998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=302.40 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=204.6
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 886 (1114)
++|.+.+.||+|+||.||+|+.+ +|+.||+|++...........+.+..|+.++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999976 78999999997654444444567888999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999999754 4799999999999999999999998 99999999999999999999999999998654322
Q ss_pred C-------------------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 001253 967 S-------------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR 1027 (1114)
Q Consensus 967 ~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~ 1027 (1114)
. .......++..|+|||...+..++.++||||+|++++++++|+.||..... ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~ 232 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YLTFQ 232 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----HHHHH
Confidence 1 222345678999999999888899999999999999999999999975442 11122
Q ss_pred HHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCH----HHHH
Q 001253 1028 NFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTM----REVV 1080 (1114)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl 1080 (1114)
..... . ...+......+.+++.+||+.+|++||++ ++++
T Consensus 233 ~~~~~----------~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 233 KILKL----------E----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HHHhc----------C----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 21111 0 01111223468899999999999999999 6655
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=308.21 Aligned_cols=267 Identities=25% Similarity=0.350 Sum_probs=198.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEec--Cce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQ--GSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 883 (1114)
.++|++.+.||+|+||.||+|.++ +|+.||+|++....... .....+.+|+.+++++ +||||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 467888999999999999999976 68899999986543222 2234567899999999 999999999998654 357
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++ +|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 85 ~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 999999975 999998743 788999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCC----CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc------
Q 001253 964 MPQS----KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN------ 1032 (1114)
Q Consensus 964 ~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~------ 1032 (1114)
.... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||............ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI-IEVIGPPSAEDI 237 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhCCCCHHHH
Confidence 3221 12234568999999998765 45788999999999999999999999654322111111 000000
Q ss_pred ----CCccccccc----ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1033 ----NSLVSGMLD----ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1033 ----~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
......+.+ ................+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000 00000000111134568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=302.71 Aligned_cols=265 Identities=21% Similarity=0.340 Sum_probs=197.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC------
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG------ 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 881 (1114)
++|++.++||+|+||.||+|+.+ +++.||||++....... .....+.+|+.++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 57999999999999999999976 68999999986543322 22334567999999999999999999987654
Q ss_pred --ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 882 --SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 882 --~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
..++||||+++ ++.+++......+++.++..++.|+++||+|||+. +++|+||||+||+++.++.+||+|||.+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 34999999975 88888876656789999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCC---CccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 001253 960 KVIDMPQS---KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL 1035 (1114)
Q Consensus 960 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1114)
........ .......++..|+|||.+.+. .++.++||||+|+++|||++|+.||..... ......+...... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-~~~~~~~~~~~~~--~ 243 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-QHQLTLISQLCGS--I 243 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCC--C
Confidence 86543221 122334678899999988664 378899999999999999999999865332 1111222221110 0
Q ss_pred ccccccc--------cccCCCcc---------cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1036 VSGMLDA--------RLNLQDEK---------TVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1036 ~~~~~~~--------~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+... ........ .......+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000 00000000 0001235678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=304.35 Aligned_cols=256 Identities=24% Similarity=0.299 Sum_probs=192.9
Q ss_pred eeccc--CCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 816 VIGRG--ACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 816 ~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
.||+| +||+||+|++. +|+.||+|++....... ...+.+++|+.+++.++||||+++++++..++..++||||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 46666 99999999975 79999999987554332 3346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC---
Q 001253 893 GSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK--- 968 (1114)
Q Consensus 893 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--- 968 (1114)
+++.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998754 23689999999999999999999998 9999999999999999999999999865432111100
Q ss_pred ---ccccccccccccCccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc--------
Q 001253 969 ---SMSAIAGSYGYIAPEYAYTM--KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL-------- 1035 (1114)
Q Consensus 969 ---~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 1035 (1114)
......++..|+|||++.+. .++.++||||+||++|||++|+.||............. ....+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 236 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKL----KGPPYSPLDITTF 236 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHh----cCCCCCCcccccc
Confidence 01112356679999998763 47889999999999999999999997544221111111 00000
Q ss_pred --------------c----c---------ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1036 --------------V----S---------GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1036 --------------~----~---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. + .+.... ............+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSER--LRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred chhhhhhccchhhhhcccccchhcccccccccccc--ccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 0 000000 011122345567899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=300.19 Aligned_cols=243 Identities=23% Similarity=0.378 Sum_probs=195.4
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCC
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARG 893 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 893 (1114)
.+||+|+||.||+|..+ +++.||+|++..... .....+.+|+.+++.++|+|++++++++...+..++||||++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccch---hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 57999999999999975 789999998753322 23566888999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccc
Q 001253 894 SLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI 973 (1114)
Q Consensus 894 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 973 (1114)
+|.+++.. ..+++.....++.|++.|++|+|+. +++||||+|+||++++++.++|+|||.+....... ......
T Consensus 103 ~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 103 ALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred cHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 99998863 3578999999999999999999998 99999999999999999999999999987653222 222345
Q ss_pred cccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHH
Q 001253 974 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVS 1053 (1114)
Q Consensus 974 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1114)
.|++.|+|||.+.+..++.++||||+|+++|+|++|..||..... .......... ...... ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----~~~~~~~~~~-------~~~~~~----~~~~ 241 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIRDN-------LPPKLK----NLHK 241 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhh-------CCcccC----Cccc
Confidence 688999999999888899999999999999999999999864322 1111111110 011110 0111
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1054 HMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1054 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2335778999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=309.43 Aligned_cols=270 Identities=22% Similarity=0.322 Sum_probs=200.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-----
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG----- 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 881 (1114)
.++|...+.||+|+||+||+|++. +|+.||+|++...... +.....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 478999999999999999999975 7899999998754322 223456778999999999999999999987543
Q ss_pred -ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 882 -SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 882 -~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
..++|+||+.. ++.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred ceEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 45899999975 7777653 4688999999999999999999998 99999999999999999999999999987
Q ss_pred ecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc----
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL---- 1035 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 1035 (1114)
.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.........
T Consensus 166 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~ 237 (342)
T cd07879 166 HADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD----QLTQILKVTGVPGPE 237 (342)
T ss_pred CCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCCHH
Confidence 6432 2234467889999999876 468899999999999999999999997543211 11111110000
Q ss_pred -c--------cccccccccCCCcc----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhhhccCCCc
Q 001253 1036 -V--------SGMLDARLNLQDEK----TVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSESNRRQGHF 1093 (1114)
Q Consensus 1036 -~--------~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~~~~~~ 1093 (1114)
. .............. .......+.+++.+||++||++||+++|++. .+++.+......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~ 310 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence 0 00000000000000 0112346789999999999999999999994 477765543333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=298.61 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=196.6
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEEEEe
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 888 (1114)
|++.+.||+|++|+||+|+.. +++.||||++........ .....+|+..+++++ |||++++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 567789999999999999986 578999999875543221 233456889999998 9999999999999999999999
Q ss_pred cCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 889 YMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|+ +|++.+++.... ..+++.++..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-- 152 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-- 152 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC--
Confidence 99 779999887544 5789999999999999999999998 9999999999999999999999999999865422
Q ss_pred CccccccccccccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc--------CCcccc
Q 001253 968 KSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN--------NSLVSG 1038 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 1038 (1114)
.......++..|+|||++. ...++.++||||||+++|||++|+.||......+...... ..... ......
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKIC-SVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHH-HhcCCCChhhhhhHhhhhc
Confidence 2223456888999999875 4557899999999999999999999986543211111110 00000 000000
Q ss_pred cccccccCCCcc-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1039 MLDARLNLQDEK-----TVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1039 ~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+......... .......+.+++.+||+.||++|||++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000 0111356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=293.71 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=203.5
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|++.++||+|+||.||++..+ +++.+|+|++....... .....+.+|+..++.++|+||+++++++.+....++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 4788899999999999999865 78899999987654332 334567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 889 YMARGSLGELLHGA---SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|+++++|.+++.+. ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999998642 35689999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||..... ... ...+....+
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~-~~~~~~~~~---------- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----QDL-RYKVQRGKY---------- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHH-HHHHhcCCC----------
Confidence 22334688999999999999999999999999999999999999965432 111 111111111
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+.....++.+++.+|++.+|++||++.|+++
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 --PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1112234456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=306.46 Aligned_cols=267 Identities=21% Similarity=0.321 Sum_probs=199.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe----cCc
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH----QGS 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~ 882 (1114)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++....... ...+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc-cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 378999999999999999999976 69999999987643322 234567789999999999999999998763 346
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.++||||+. ++|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 799999996 5899998743 4589999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCC---CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC--cc
Q 001253 963 DMPQS---KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS--LV 1036 (1114)
Q Consensus 963 ~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 1036 (1114)
..... .......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......... ..+........ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~-~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL-KLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH-HHHHHHhCCChhHhh
Confidence 43222 11234578899999998765 45889999999999999999999999754322111 11111000000 00
Q ss_pred ccccc-------ccccCCCcc-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1037 SGMLD-------ARLNLQDEK-----TVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1037 ~~~~~-------~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..... ......... .......+.+++.+||+.+|++||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000 000000000 1123457899999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-31 Score=289.95 Aligned_cols=242 Identities=23% Similarity=0.279 Sum_probs=189.6
Q ss_pred HhcCCcCCcee--cccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCc
Q 001253 807 ATDNFDERFVI--GRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 807 ~~~~~~~~~~l--G~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 882 (1114)
..++|++.+.+ |+|+||.||+++.+ +++.+|+|++....... . |+.....+ +|||++++++++...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~--e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------I--EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------h--hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34567776666 99999999999975 68899999986543211 1 22222212 79999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-CeEEeeccCcee
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKV 961 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~ 961 (1114)
.++||||+++++|.+++.... .+++.++..++.|+++|++|||+. +++||||||+||+++.++ .++|+|||.+..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 999999999999999997543 889999999999999999999998 999999999999999998 999999999886
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC-CHHHHHHHHHhcCCcccccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG-DLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.... ....++..|+|||++.+..++.++||||+|+++|||++|+.||....... +...+.... ..
T Consensus 160 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-------- 225 (267)
T PHA03390 160 IGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK-------- 225 (267)
T ss_pred cCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc--------
Confidence 5422 23468899999999999899999999999999999999999997443222 111221111 00
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCC-HHHHH
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPT-MREVV 1080 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl 1080 (1114)
. ..........+.+++.+||+.+|.+||+ ++|++
T Consensus 226 --~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 226 --K----LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred --c----CCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 0 1111133456889999999999999996 58876
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=306.70 Aligned_cols=273 Identities=22% Similarity=0.305 Sum_probs=202.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec-----C
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ-----G 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 881 (1114)
.++|++.+.||+|+||+||+|+.. +++.||||++....... .....+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 357899999999999999999975 78999999987543322 2244567899999999999999999988654 3
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 4799999996 589988874 35789999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc--------
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN-------- 1032 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 1032 (1114)
..... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||....... ....+......
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhhh
Confidence 54322 22334568889999998764 468899999999999999999999996532111 11111110000
Q ss_pred ---CCc---ccccc-cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhhcc
Q 001253 1033 ---NSL---VSGML-DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM--LSESNRR 1089 (1114)
Q Consensus 1033 ---~~~---~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~~ 1089 (1114)
... ..... ...... ..........+.+++.+||+++|++|||++|+++. ++.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred cCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 000 00000 000000 00011234568899999999999999999999876 6665433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=295.13 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=202.2
Q ss_pred CceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCC
Q 001253 814 RFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 814 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
.++||.|.||+||-|+++ +|+.||||++.+.+.... ....++.|+.+++.++||.||.+...|+..+..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 368999999999999965 899999999987765443 347799999999999999999999999999999999999987
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC---CCeEEeeccCceecCCCCCCc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK---FEAHVGDFGLAKVIDMPQSKS 969 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfG~a~~~~~~~~~~ 969 (1114)
.=|+-++....+++++..-..+..||+.||.|||-+ +|+|+|+||+|||+.+. ..+||||||+|++++ ....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--EksF 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--EKSF 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc--hhhh
Confidence 555556666677899999999999999999999998 99999999999999754 369999999999976 3344
Q ss_pred cccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCc
Q 001253 970 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDE 1049 (1114)
Q Consensus 970 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1114)
...++|||.|.|||++..+.|...-||||.|||+|--++|..||... ++..+.++ ...+.....
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd---EdIndQIQ-------------NAaFMyPp~ 786 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED---EDINDQIQ-------------NAAFMYPPN 786 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc---cchhHHhh-------------ccccccCCC
Confidence 56789999999999999999999999999999999999999999643 33333322 223333344
Q ss_pred ccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 001253 1050 KTVSHMITVLKIAMLCTNISPFDRPTMREV 1079 (1114)
Q Consensus 1050 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1079 (1114)
.-.+......++|...++..=.+|-+..+-
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 445566678888888888888888877543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=299.54 Aligned_cols=261 Identities=20% Similarity=0.238 Sum_probs=190.4
Q ss_pred eecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCH
Q 001253 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL 895 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 895 (1114)
.+|.|+++.||++.. +++.||||++...... ....+.+..|+..++.++||||+++++++.+.+..+++|||+++|++
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 344444444444444 6899999999765322 23456789999999999999999999999999999999999999999
Q ss_pred HHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC------C
Q 001253 896 GELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS------K 968 (1114)
Q Consensus 896 ~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~------~ 968 (1114)
.+++... ...+++.....++.|+++||+|||+. +|+||||||+||+++.++.+|++|||.+........ .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999753 34688999999999999999999998 999999999999999999999999998875432111 1
Q ss_pred ccccccccccccCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHh----cCCccc---cc
Q 001253 969 SMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIR----NNSLVS---GM 1039 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~---~~ 1039 (1114)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||..........+....... ...... .+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1233457788999999875 35888999999999999999999999764432222111111000 000000 00
Q ss_pred -------ccc--cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1040 -------LDA--RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1040 -------~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+. ...............+.+++.+||++||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 000001112233457889999999999999999999876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=301.44 Aligned_cols=268 Identities=26% Similarity=0.353 Sum_probs=196.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-----
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG----- 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 881 (1114)
.++|++.++||+|+||.||+|+++ +++.||+|++........ ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 378999999999999999999976 689999999875433221 2335678999999999999999999875433
Q ss_pred ---ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccC
Q 001253 882 ---SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 958 (1114)
Q Consensus 882 ---~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 958 (1114)
..++||||+++ ++...+......+++.++..++.|+++||+|||+. +++||||||+||++++++.++|+|||+
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46999999976 78887776666899999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCC----------ccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 001253 959 AKVIDMPQSK----------SMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR 1027 (1114)
Q Consensus 959 a~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~ 1027 (1114)
++........ ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9765322211 1123457888999998765 4578999999999999999999999865433211111111
Q ss_pred HHHhcC---Cc-----ccccccccccCCCcc-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1028 NFIRNN---SL-----VSGMLDARLNLQDEK-----TVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1028 ~~~~~~---~~-----~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..... .+ .....+......... .......+.+++.+|++.||++|||+.|++.
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 -LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred -HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000 00 000000000000000 0112246889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=301.47 Aligned_cols=263 Identities=24% Similarity=0.339 Sum_probs=199.0
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe-cCce
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH-QGSN 883 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 883 (1114)
..+++|++.++||+|+||.||+|..+ +++.||+|++...... ....+.+..|+.+++.++||||+++.+++.. ....
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 45688999999999999999999966 7899999998654332 2234567789999999999999999999875 5578
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+. ++|.++++. ..+++.....++.|+++||+|||+. +++||||+|+||++++++.++|+|||.+....
T Consensus 86 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 86 YFVTELLG-TDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEeehhc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 99999995 589998863 4578888899999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc----------
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN---------- 1032 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------- 1032 (1114)
. ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||......... ..+.+....
T Consensus 160 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 160 P----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF-SIITDLLGTPPDDVINTIC 234 (328)
T ss_pred C----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHhcc
Confidence 2 2233467889999998765 56899999999999999999999999654321111 111111000
Q ss_pred -CCcccccccccccCCCccc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1033 -NSLVSGMLDARLNLQDEKT-----VSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1033 -~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
....... .........+ ......+.++|.+|++.+|++||++.+++..
T Consensus 235 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFV--QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHH--hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000001111 1123578899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=295.75 Aligned_cols=264 Identities=24% Similarity=0.354 Sum_probs=200.6
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEec
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
|+..+.||+|++|.||+|+.. +++.||+|++..... .....+.+..|+.++++++|+|++++++++.+.+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 556778999999999999976 589999999986542 223345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCc
Q 001253 890 MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 969 (1114)
+++ +|.+++......+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 985 99999986546799999999999999999999998 999999999999999999999999999986543221 2
Q ss_pred cccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc-----cccc--cc
Q 001253 970 MSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL-----VSGM--LD 1041 (1114)
Q Consensus 970 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--~~ 1041 (1114)
.....++..|+|||.+.+. .++.++||||+||++||+++|+.||......+.... +.+....... ...+ .+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK-IFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HHHHhCCCcHHHHHhhccccccc
Confidence 2334567889999998766 789999999999999999999999865332111111 1111100000 0000 00
Q ss_pred ccccCCC-----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQD-----EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....... .........+.+++.+||+.||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 001112457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=275.47 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=198.5
Q ss_pred ceecccCCeEEEEEE-eCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
+.||+|+|+.|--+. ..+|..||||++.+... .....+-+|++++.+. .|+||++++++|++++.+|+|||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 479999999999998 67899999999976632 3356677899999988 599999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC---eEEeeccCceecCCCC---
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE---AHVGDFGLAKVIDMPQ--- 966 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfG~a~~~~~~~--- 966 (1114)
|.|...+++ ...+++.++.++.++|+.||.|||.+ ||.|||+||+|||-.+... ||||||.+..-.....
T Consensus 161 GplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 161 GPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred chHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999999984 45789999999999999999999998 9999999999999876543 8999999876432111
Q ss_pred ---CCccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCC------CCCCHHHHHHHHHhc
Q 001253 967 ---SKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLD------QGGDLVTWVRNFIRN 1032 (1114)
Q Consensus 967 ---~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~------~~~~~~~~~~~~~~~ 1032 (1114)
.....+.+|+..|||||++. ...|+.++|.||+|||+|-|++|.+||.+.= +.+..-...++
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~---- 312 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN---- 312 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH----
Confidence 12234567999999999864 3458899999999999999999999996432 11221111111
Q ss_pred CCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1033 NSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+.+.++.+.++...-.....+..+++...+..|+.+|-++.+++.
T Consensus 313 -~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 313 -KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred -HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 122223334444334444445556778888999999999999998876
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=286.41 Aligned_cols=262 Identities=23% Similarity=0.291 Sum_probs=201.8
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-C-C----ceeeEEeEEEe
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-H-R----NIVKLYGFCYH 879 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~ 879 (1114)
.+.+|.++..+|+|.||.|-++.++ ++..||||+++..... .+.-+-|+++++++. + | -+|++.++|..
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY----reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY----REAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH----hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 3688999999999999999999976 5789999999765443 344556899999993 3 3 48999999999
Q ss_pred cCceEEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-----------
Q 001253 880 QGSNLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD----------- 947 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~----------- 947 (1114)
.++.|+|+|.+ |-++.+++..+ ..+++...+..|+.|++++++|||+. +++|.|+||+||++.+
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence 99999999998 44999999853 44789999999999999999999999 9999999999999842
Q ss_pred ---------CCCeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 001253 948 ---------KFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018 (1114)
Q Consensus 948 ---------~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~ 1018 (1114)
...++++|||.|+.- .....+.+.|..|+|||++.+.+++.++||||+|||++|+.+|...|+.-++
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~----~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFD----HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccceeccCCCcceEEEecCCccee----ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 235899999999863 2334678899999999999999999999999999999999999999976554
Q ss_pred CCCHHHHHHHHH-----------------hcCCcc--cccccc--c--------ccCCCcccHHHHHHHHHHHhhccCCC
Q 001253 1019 GGDLVTWVRNFI-----------------RNNSLV--SGMLDA--R--------LNLQDEKTVSHMITVLKIAMLCTNIS 1069 (1114)
Q Consensus 1019 ~~~~~~~~~~~~-----------------~~~~~~--~~~~~~--~--------~~~~~~~~~~~~~~l~~li~~cl~~d 1069 (1114)
.+.+ ...+..+ ..+.+. +.-.++ + +.........+..++++++++|+..|
T Consensus 315 ~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 315 LEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred HHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 3333 1111111 111000 000000 0 00001112234457999999999999
Q ss_pred CCCCCCHHHHHH
Q 001253 1070 PFDRPTMREVVL 1081 (1114)
Q Consensus 1070 P~~RPs~~evl~ 1081 (1114)
|.+|+|++|++.
T Consensus 394 P~~RiTl~EAL~ 405 (415)
T KOG0671|consen 394 PARRITLREALS 405 (415)
T ss_pred ccccccHHHHhc
Confidence 999999999874
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=304.27 Aligned_cols=268 Identities=24% Similarity=0.318 Sum_probs=205.5
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-----ce
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG-----SN 883 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 883 (1114)
+|++.+.||+|++|.||+|+.. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5788899999999999999976 589999999876542 1233567888999999999999999999988765 78
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|+||||+++ +|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+....
T Consensus 80 ~lv~e~~~~-~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 80 YIVTELMET-DLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEEecchhh-hHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 999999985 899998743 3899999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCC--CccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc-CCcccc-
Q 001253 964 MPQS--KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN-NSLVSG- 1038 (1114)
Q Consensus 964 ~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~- 1038 (1114)
.... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... ...+..... +.....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI----DQLNLIVEVLGTPSEED 230 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHHhcCCCChhH
Confidence 3321 123345688899999999887 7899999999999999999999999754421 111111110 000000
Q ss_pred -----------cccccccCCCc-----ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhhc
Q 001253 1039 -----------MLDARLNLQDE-----KTVSHMITVLKIAMLCTNISPFDRPTMREVVLM--LSESNR 1088 (1114)
Q Consensus 1039 -----------~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~ 1088 (1114)
.... ...... ........+.+++.+||+++|.+||++.++++. ++++..
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 231 LKFITSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhccccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000 000000 011134568899999999999999999999873 665543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=303.46 Aligned_cols=271 Identities=24% Similarity=0.306 Sum_probs=200.1
Q ss_pred HHHHHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 001253 801 FKDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH 879 (1114)
Q Consensus 801 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 879 (1114)
..++....++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3455667799999999999999999999964 78999999987543222 224557789999999999999999998864
Q ss_pred c------CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEE
Q 001253 880 Q------GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 953 (1114)
Q Consensus 880 ~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 953 (1114)
. ...|++++++ +++|.++++. ..+++..+..++.|+++|++|||+. +++||||||+||++++++.+||
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEE
Confidence 3 3467888887 6799988863 3589999999999999999999998 9999999999999999999999
Q ss_pred eeccCceecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc
Q 001253 954 GDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN 1032 (1114)
Q Consensus 954 ~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1032 (1114)
+|||+++.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.............+.....
T Consensus 162 ~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 162 LDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred ecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999886432 2234568889999998866 568889999999999999999999996543322111111100000
Q ss_pred C-Cccccccc-------ccccCCCcc-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1033 N-SLVSGMLD-------ARLNLQDEK-----TVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1033 ~-~~~~~~~~-------~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
. .....+.+ ..+...... .......+.+++.+|++.||.+||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 00000000 000000000 00123467899999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=300.45 Aligned_cols=267 Identities=22% Similarity=0.287 Sum_probs=197.0
Q ss_pred cCCc-CCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChh-----------hHHHHHHHHHHHhcCCCCceeeEEe
Q 001253 809 DNFD-ERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNN-----------VDNSFRAEILTLGKIRHRNIVKLYG 875 (1114)
Q Consensus 809 ~~~~-~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 875 (1114)
++|. +.+.||+|+||+||+|+++ +++.||||++......... ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 4567999999999999976 6899999998754332210 1124678999999999999999999
Q ss_pred EEEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEee
Q 001253 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 955 (1114)
Q Consensus 876 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 955 (1114)
++..++..++||||++ |+|.+++.. ...+++.....++.|++.||+|||+. +++||||+|+||+++.++.++++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECC
Confidence 9999999999999997 599999863 44689999999999999999999998 999999999999999999999999
Q ss_pred ccCceecCCCC-------------CCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 001253 956 FGLAKVIDMPQ-------------SKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD 1021 (1114)
Q Consensus 956 fG~a~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~ 1021 (1114)
||.+.....+. ........++..|+|||.+.+. .++.++||||+||++|||++|+.||......+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99997654111 1112233567889999998764 468899999999999999999999975543221
Q ss_pred HHHHHHHHHhcCC---cccccccccc---cCC-C----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1022 LVTWVRNFIRNNS---LVSGMLDARL---NLQ-D----EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1022 ~~~~~~~~~~~~~---~~~~~~~~~~---~~~-~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. ..+........ +......+.. ... . .........+.+++.+|++.+|++||+++|++.
T Consensus 243 ~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 L-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1 11211111110 0000000000 000 0 001112346889999999999999999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=323.76 Aligned_cols=148 Identities=30% Similarity=0.381 Sum_probs=134.6
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|++. +++.||||+++............+..|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999987 78999999998665544455577889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
||+.+++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999974 34688999999999999999999998 99999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=289.57 Aligned_cols=250 Identities=23% Similarity=0.307 Sum_probs=196.4
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCC--ChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREG--NNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
+|.+.++||+|+||+||++++. .+..+++|+++..... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999976 3455667766543221 112234566789999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|||+++++|.+++.. ....+++.++..++.|+++|++|||+. +++|+||+|+||++++ +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998863 345789999999999999999999998 9999999999999975 579999999998654
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
.. ........|++.|+|||...+..++.++||||+|+++|+|++|..||.... ........... .
T Consensus 157 ~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~~~~~~~~~~-~--------- 221 (260)
T cd08222 157 GS-CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVLRIVEG-P--------- 221 (260)
T ss_pred CC-cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHcC-C---------
Confidence 22 222334568889999999988889999999999999999999999986322 22222221111 0
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....+......+.+++.+||+.+|++||++.|+++
T Consensus 222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 ---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 01112233457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=283.48 Aligned_cols=239 Identities=26% Similarity=0.297 Sum_probs=196.7
Q ss_pred ecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCH
Q 001253 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL 895 (1114)
Q Consensus 817 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 895 (1114)
||+|+||.||++..+ +++.||+|++.............+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999976 5899999999876554444566788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccccc
Q 001253 896 GELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAG 975 (1114)
Q Consensus 896 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 975 (1114)
.+++... ..+++.....++.|+++|+.|+|+. +++|+||+|+||+++.++.++|+|||.+....... .......+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 9999744 3689999999999999999999998 99999999999999999999999999998754221 22344568
Q ss_pred cccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHH
Q 001253 976 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHM 1055 (1114)
Q Consensus 976 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1114)
+..|+|||...+..++.++|+||||+++|++++|+.||...+. ....+..... . . ..+....
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~-~---------~----~~~~~~~ 217 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILKD-P---------L----RFPEFLS 217 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhcC-C---------C----CCCCCCC
Confidence 8899999999888899999999999999999999999964432 2222221111 0 0 1111113
Q ss_pred HHHHHHHhhccCCCCCCCCCHHH
Q 001253 1056 ITVLKIAMLCTNISPFDRPTMRE 1078 (1114)
Q Consensus 1056 ~~l~~li~~cl~~dP~~RPs~~e 1078 (1114)
..+.+++.+||..||++||++++
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 46789999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=274.48 Aligned_cols=276 Identities=21% Similarity=0.281 Sum_probs=214.6
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCce
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 883 (1114)
..-.+|+..++||+|+|++|..++++ +.+.||+|++++....+.+..+-.+.|-.+.... +||.+|.++.+|..+...
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 44578999999999999999999976 7889999999988666555566677788777766 699999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++|.||++||+|--.+++ ...++++.+......|.-||.|||+. ||++||+|.+|||+|..|++|++|+|+++.-
T Consensus 327 ffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~- 401 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG- 401 (593)
T ss_pred EEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC-
Confidence 999999999999888874 44678888888888999999999999 9999999999999999999999999999863
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC---CCCCHHHHHHHHHhcCCcccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLD---QGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
........+++|||.|.|||++.+..|...+|.|++||+++||+.|+.||+... +...-.+++-+.+-+
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile-------- 473 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE-------- 473 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--------
Confidence 234556678999999999999999999999999999999999999999997433 112223333322221
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCCc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDSD 1103 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~ 1103 (1114)
..++ .+.........+++.-++.||.+|..-.--. ....-.++.++..+|||.-
T Consensus 474 -kqir----iprslsvkas~vlkgflnkdp~erlgc~~~~----g~~dik~h~ffr~idwd~l 527 (593)
T KOG0695|consen 474 -KQIR----IPRSLSVKASHVLKGFLNKDPKERLGCRPQT----GFSDIKSHAFFRSIDWDLL 527 (593)
T ss_pred -hccc----ccceeehhhHHHHHHhhcCCcHHhcCCCccc----chhhhhcchhhhhCCHHHH
Confidence 1111 1122223455677788999999985321100 2223345566667777753
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=300.80 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=207.1
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEe----
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYH---- 879 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 879 (1114)
..++-|++..+||.|.+|.||+++.+ +|+.+|||+....... ..+++.|.++++.. .|||++.++|+|..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 34567888999999999999999954 7899999998766654 34567788888877 69999999999864
Q ss_pred -cCceEEEEecCCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeecc
Q 001253 880 -QGSNLLMYEYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957 (1114)
Q Consensus 880 -~~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 957 (1114)
++..++|||||.+|+.-|+++. .+..+.|..+..|++.++.|+.+||.. .++|||||-.|||+++++.||++|||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeee
Confidence 5678999999999999999974 255899999999999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCCCccccccccccccCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYT-----MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN 1032 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1032 (1114)
.+...+ .......+..|||.|||||++.. ..|+.++|+||+|++..||.-|.+|+.++..-..+...
T Consensus 169 vSaQld-sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I------- 240 (953)
T KOG0587|consen 169 VSAQLD-STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------- 240 (953)
T ss_pred eeeeee-cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-------
Confidence 998875 34455677899999999999864 34778999999999999999999999866542211100
Q ss_pred CCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1033 NSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...++.. -..+.....++-++|..|+..|.++||++.++++
T Consensus 241 ------pRNPPPk--Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 ------PRNPPPK--LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------CCCCCcc--ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0111111 2234556678999999999999999999987653
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=303.42 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=197.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc----
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS---- 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 882 (1114)
.++|++.+.||+|++|+||+|+.. +++.||+|++....... ...+.+.+|+.+++.++|||++++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 578999999999999999999986 68899999987543222 234556789999999999999999998876554
Q ss_pred --eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 883 --NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 883 --~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
.++|+||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +++||||||+||++++++.++|+|||++.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 5699999873 4689999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc-CCcccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN-NSLVSG 1038 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1038 (1114)
..... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||...... ..++..... +...+.
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~----~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI----DQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHhcCCCCHH
Confidence 65322 234467889999998865 46788999999999999999999999754321 111111110 000000
Q ss_pred cc------------cc-cccCCCc---ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1039 ML------------DA-RLNLQDE---KTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1039 ~~------------~~-~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+. .. ....+.. ........+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 00 0000000 00112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=298.97 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=193.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec-------
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ------- 880 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 880 (1114)
.+|++.+.||+|+||+||+|..+ +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 67999999999999999999975 689999999865543 2246678899999999999999999876543
Q ss_pred -------CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCCeE
Q 001253 881 -------GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAH 952 (1114)
Q Consensus 881 -------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~k 952 (1114)
...|+||||+++ +|.+++.. ..+++..+..++.|+++||+|||+. +++||||||+||+++ +++.+|
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 82 VGSLTELNSVYIVQEYMET-DLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccccceEEEEeecccc-cHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 346899999975 99988863 4688999999999999999999998 999999999999997 456789
Q ss_pred EeeccCceecCCCCCC--ccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 001253 953 VGDFGLAKVIDMPQSK--SMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNF 1029 (1114)
Q Consensus 953 l~DfG~a~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 1029 (1114)
++|||.+......... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||................
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999865422211 1123357889999998654 567889999999999999999999997543221111111100
Q ss_pred Hhc---------CCcccccccccccCCC---cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1030 IRN---------NSLVSGMLDARLNLQD---EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1030 ~~~---------~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
... ................ .........+.+++.+|+++||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 0000000000000000 001112346789999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=295.25 Aligned_cols=272 Identities=22% Similarity=0.267 Sum_probs=195.4
Q ss_pred CCcCCceecccCCeEEEEEEeC-C--CcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEec----C
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-T--GHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQ----G 881 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~ 881 (1114)
+|++.+.||+|+||.||+|+.. + +..||+|++...... ....+.+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 4778889999999999999976 4 789999998654322 22345677899999999 599999999875432 3
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..++++||++ ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.++.
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred cEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 5688999986 589998863 45789999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCC---CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH----------
Q 001253 962 IDMPQS---KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR---------- 1027 (1114)
Q Consensus 962 ~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~---------- 1027 (1114)
...... .......|+..|+|||+..+ ..++.++||||+||++|++++|+.||...+........+.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 542211 12234578999999998765 4688999999999999999999999875432111111000
Q ss_pred -HHHhcC--CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhhh
Q 001253 1028 -NFIRNN--SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSESN 1087 (1114)
Q Consensus 1028 -~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1087 (1114)
...... ........................+.+++.+|++.||++|||+.|++. .+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 000000 000000000000000000112346889999999999999999999864 344443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=291.84 Aligned_cols=245 Identities=23% Similarity=0.295 Sum_probs=205.6
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCc-EEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGH-TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.+++.+..||-|+||.|=++..+..+ .+|+|++++...-+....+.+..|-.+|...+.|.||++|..|.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566678999999999999876433 48999998877666566677888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|-|-||.+...++++ +.++..+...++..+++|++|||++ +||+||+||+|.+++.+|-+||.|||+|+.+. ..
T Consensus 500 EaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--SG 573 (732)
T ss_pred HhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc--cC
Confidence 999999999999854 4778888888888999999999999 99999999999999999999999999999875 55
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
...-+++|||.|.|||++..+..+.++|.||+|+++||+++|.+||.+.++-..+...++. +..
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-id~--------------- 637 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-IDK--------------- 637 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-hhh---------------
Confidence 6667899999999999999999999999999999999999999999876653333333332 111
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCC
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPT 1075 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs 1075 (1114)
...+........++|++....+|.+|..
T Consensus 638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1223334456778888888999999976
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=294.23 Aligned_cols=239 Identities=24% Similarity=0.276 Sum_probs=193.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 885 (1114)
+++|.....+|.|+|++|-.+... +++..+||++.+.... -.+|+.+.... +||||+++.+.+.++.+.|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 356777778999999999999965 7889999999776332 23456454444 79999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE-CCCCCeEEeeccCceecCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL-DDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~DfG~a~~~~~ 964 (1114)
|||.+.|+-+.+.+..... .. ..+..|+.+++.|+.|||++ ||||||+||+|||+ ++.++++|+|||.++....
T Consensus 394 v~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999999988887763332 22 67778999999999999998 99999999999999 6999999999999997653
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
. ..+-+-|..|.|||+.....|+.++|+||+|+++|+|++|+.||...+.. ..+...+..+.
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~~~---------- 530 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQMPK---------- 530 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcCCc----------
Confidence 3 33446788999999999999999999999999999999999999865543 12222222221
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+....+....+++.+||+.||.+||+|.++..
T Consensus 531 -----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 -----FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -----cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 12344557889999999999999999999754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=268.59 Aligned_cols=265 Identities=21% Similarity=0.345 Sum_probs=197.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe--------
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH-------- 879 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 879 (1114)
..|....+||+|.||.||+|+.+ +|+.||+|++.-..+.... -....+|++++..++|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGf-pitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGF-PITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCC-cHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 45666778999999999999966 6888999876543222212 2234579999999999999999998853
Q ss_pred cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 880 QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
...+|+||++|+. +|.-++......++..++.+++.++..||.|+|+. .|+|||+||.|+||+.+|.+||+|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 2347999999988 99999987777899999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC---CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 001253 960 KVIDMPQS---KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL 1035 (1114)
Q Consensus 960 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1114)
+.+..+.. ...+..+-|..|++||.+.+ ..|+++.|||+.||++.||++|.+-+..... ......+...... .
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte-qqql~~Is~LcGs--~ 248 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE-QQQLHLISQLCGS--I 248 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH-HHHHHHHHHHhcc--C
Confidence 86643322 22345567999999999876 4599999999999999999999887764332 2222333322211 1
Q ss_pred cccccc--------cc-----ccCCC-cccHHH------HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1036 VSGMLD--------AR-----LNLQD-EKTVSH------MITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1036 ~~~~~~--------~~-----~~~~~-~~~~~~------~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....+. .. +.... ..-... ..+..+++..++..||.+|+++++++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 111110 00 00000 000111 126788999999999999999998764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=280.13 Aligned_cols=261 Identities=26% Similarity=0.346 Sum_probs=201.5
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhH----HHHHHHHHHHhcCCCCceeeEEeEEEe-
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVD----NSFRAEILTLGKIRHRNIVKLYGFCYH- 879 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~- 879 (1114)
...++|-....||+|+|+.||+|.+- ..+.||||+-.....+.++.. +...+|..+.+.++||.||++++++.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 34467888889999999999999954 578899998766655544333 334579999999999999999999974
Q ss_pred cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC---CCCCeEEeec
Q 001253 880 QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD---DKFEAHVGDF 956 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Df 956 (1114)
.+.+|-|.|||+|.+|+-+++. ...+++.++..|+.||+.||.||.+. +++|+|-|+||.|||+. .-|.+||+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 5678999999999999999984 45789999999999999999999986 78999999999999984 4578999999
Q ss_pred cCceecCCCCCC------ccccccccccccCcccccc----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 001253 957 GLAKVIDMPQSK------SMSAIAGSYGYIAPEYAYT----MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWV 1026 (1114)
Q Consensus 957 G~a~~~~~~~~~------~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~ 1026 (1114)
|++++++..... .....+||+.|.+||.+.- .+++.|+||||+|||+|+.+.|+.||.......+.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI---- 693 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI---- 693 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH----
Confidence 999988654332 2345689999999998753 34678999999999999999999999754432222
Q ss_pred HHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 001253 1027 RNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV 1080 (1114)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1080 (1114)
+..+.+..+ .... .+..+....+...||++|+...-++|....++.
T Consensus 694 ---LqeNTIlkA---tEVq--FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 ---LQENTILKA---TEVQ--FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ---Hhhhchhcc---eecc--CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 122222111 1111 111222334677899999999999998887764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=251.29 Aligned_cols=217 Identities=23% Similarity=0.364 Sum_probs=175.4
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCc
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 882 (1114)
++..++...+..||+|+||.|-+.++. +|...|+|.++...... ..++...|+.+..+. .+|.+|.++|.+.+.+.
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q--~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ--EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH--HHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 344556666678999999999999865 89999999998766532 245566777765544 79999999999999999
Q ss_pred eEEEEecCCCCCHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 883 NLLMYEYMARGSLGELLH---GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
.++.||.|+- +|+.+-+ +.+..+++...-+||..+.+||.|||++. .++|||+||+|||++.+|+||+||||.+
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 9999999976 8877654 35678999999999999999999999975 8999999999999999999999999999
Q ss_pred eecCCCCCCccccccccccccCccccc----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHh
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAY----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIR 1031 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1031 (1114)
..+.+.... +-..|-..|||||.+. ...|+.|+||||+|+++.||.+++.||+.... -.+.+++.+.
T Consensus 197 G~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t---pF~qLkqvVe 267 (282)
T KOG0984|consen 197 GYLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT---PFQQLKQVVE 267 (282)
T ss_pred eeehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC---HHHHHHHHhc
Confidence 876433222 2245778899999875 34789999999999999999999999975443 3344444443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=276.07 Aligned_cols=220 Identities=25% Similarity=0.247 Sum_probs=175.7
Q ss_pred cCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCHHHH
Q 001253 820 GACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGEL 898 (1114)
Q Consensus 820 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~ 898 (1114)
|.+|+||+++++ +++.||+|++..... +..|...+....||||+++++++.+.+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999976 789999999975432 22344445556799999999999999999999999999999999
Q ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccccccccc
Q 001253 899 LHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG 978 (1114)
Q Consensus 899 l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~ 978 (1114)
+... ..+++..+..++.|+++||+|+|+. +++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 76 l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 76 ISKF-LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred HHHh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 8743 4689999999999999999999998 9999999999999999999999999988654321 223356778
Q ss_pred ccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHH
Q 001253 979 YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITV 1058 (1114)
Q Consensus 979 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1058 (1114)
|+|||...+..++.++||||+|+++|||++|+.|+....... .. ..... .+......+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------~~--------~~~~~----~~~~~~~~~ 205 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------NT--------HTTLN----IPEWVSEEA 205 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------cc--------ccccC----CcccCCHHH
Confidence 999999988889999999999999999999998875322100 00 00000 111123467
Q ss_pred HHHHhhccCCCCCCCCCHH
Q 001253 1059 LKIAMLCTNISPFDRPTMR 1077 (1114)
Q Consensus 1059 ~~li~~cl~~dP~~RPs~~ 1077 (1114)
.+++.+|++.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 8899999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=254.23 Aligned_cols=260 Identities=19% Similarity=0.277 Sum_probs=199.0
Q ss_pred HhcCCcCCceecccCCeEEEEEEe-CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecC--c
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVL-RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQG--S 882 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 882 (1114)
..++|++.+++|+|.|+.||.|.. .+.++++||++++.+ .+.+.+|+.+++.++ ||||++++++..+.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 347899999999999999999994 568899999998655 466899999999997 999999999998754 5
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-CCeEEeeccCcee
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK-FEAHVGDFGLAKV 961 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG~a~~ 961 (1114)
..+|+||+.+.+...+.. .++...+.....+++.||.|+|++ ||+|||+||.|||+|.. ..++|+|+|+|.+
T Consensus 110 paLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred chhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 679999999987776654 677788889999999999999999 99999999999999965 5699999999998
Q ss_pred cCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC------
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS------ 1034 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------ 1034 (1114)
+.. .......+.+..|--||.+.. ..|++.-|+|||||++..|+..+.||....++.+....+...+...+
T Consensus 183 YHp--~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 183 YHP--GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred cCC--CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 753 233344567788899998865 45899999999999999999999999876655544333332222110
Q ss_pred --------cccccccc----cccCC-CcccH-HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1035 --------LVSGMLDA----RLNLQ-DEKTV-SHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1035 --------~~~~~~~~----~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+.++.. ++... ..... -...++.+++.+.+..|-.+|||++|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01111000 00000 00000 11257889999999999999999999753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=272.20 Aligned_cols=280 Identities=22% Similarity=0.284 Sum_probs=206.5
Q ss_pred CcccccccCCCCCCCHHHHHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhc
Q 001253 786 STVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGK 864 (1114)
Q Consensus 786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~ 864 (1114)
++...-|-|...+-.|. ..+|.+.++||.|.|+|||+|.+. +.+.||+|+.+..... .+....|++++++
T Consensus 60 dY~kGGYHpV~IGD~F~-----~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY----tEaAlDEIklL~~ 130 (590)
T KOG1290|consen 60 DYRKGGYHPVRIGDVFN-----GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY----TEAALDEIKLLQQ 130 (590)
T ss_pred hhhcCCCceeecccccc-----CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH----HHHHHHHHHHHHH
Confidence 33334444555555543 378999999999999999999965 6789999999865543 3455679999988
Q ss_pred CC-----C---CceeeEEeEEEec----CceEEEEecCCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 001253 865 IR-----H---RNIVKLYGFCYHQ----GSNLLMYEYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931 (1114)
Q Consensus 865 l~-----h---~niv~l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 931 (1114)
++ | .+||+++++|... .+.|||+|++.. +|..++.. ..+.++...+..|++||+.||.|||+.|
T Consensus 131 v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-- 207 (590)
T KOG1290|consen 131 VREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-- 207 (590)
T ss_pred HHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--
Confidence 84 3 3799999999764 478999999955 77777753 4568999999999999999999999998
Q ss_pred CeEecCCCCCCeEECCC---------------------------------------------------------------
Q 001253 932 RIFHRDIKSNNILLDDK--------------------------------------------------------------- 948 (1114)
Q Consensus 932 ~ivH~Dlk~~Nill~~~--------------------------------------------------------------- 948 (1114)
||||.||||+|||+..+
T Consensus 208 gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~ 287 (590)
T KOG1290|consen 208 GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEAS 287 (590)
T ss_pred CccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhh
Confidence 99999999999999400
Q ss_pred --------------------------------------------------------------------------------
Q 001253 949 -------------------------------------------------------------------------------- 948 (1114)
Q Consensus 949 -------------------------------------------------------------------------------- 948 (1114)
T Consensus 288 l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s 367 (590)
T KOG1290|consen 288 LAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSS 367 (590)
T ss_pred hcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccC
Confidence
Q ss_pred -----------------------CCeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHH
Q 001253 949 -----------------------FEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLE 1005 (1114)
Q Consensus 949 -----------------------~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~e 1005 (1114)
.+|||+|||-|+.+. ...+.-..|..|+|||++.+.+|+..+||||++|++||
T Consensus 368 ~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FE 443 (590)
T KOG1290|consen 368 PSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFE 443 (590)
T ss_pred cCCccccccccccCCCCCCCccceeEEEeeccchhhhh----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHH
Confidence 014566666665432 22233357889999999999999999999999999999
Q ss_pred HHhCCCCCCCCCC------CCCHHHHHH-------HHHhcCCccccccccc-----------------ccCCCcccHHHH
Q 001253 1006 LLTGRAPVQPLDQ------GGDLVTWVR-------NFIRNNSLVSGMLDAR-----------------LNLQDEKTVSHM 1055 (1114)
Q Consensus 1006 l~tg~~p~~~~~~------~~~~~~~~~-------~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~ 1055 (1114)
++||...|.+-.. .+++...+. .+...+.+...+++.+ +......+.+..
T Consensus 444 LaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A 523 (590)
T KOG1290|consen 444 LATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDA 523 (590)
T ss_pred hhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHH
Confidence 9999998875432 112222221 2222333333332221 111123466777
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1056 ITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1056 ~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.++.+|+.-||+.+|++||||.+.++
T Consensus 524 ~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 524 QQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHHHHHHHHhcCccccccHHHHhc
Confidence 89999999999999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=299.55 Aligned_cols=260 Identities=18% Similarity=0.209 Sum_probs=169.1
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-C----CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeE-----
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-T----GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF----- 876 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~----- 876 (1114)
..++|+..++||+|+||+||+|++. + +..||||++...... +....| .++...+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 4578999999999999999999976 4 689999987643221 111111 1111122222222111
Q ss_pred -EEecCceEEEEecCCCCCHHHHhccCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 001253 877 -CYHQGSNLLMYEYMARGSLGELLHGASST-------------------LDWQTRFMIALGAAEGLSYLHHDCKPRIFHR 936 (1114)
Q Consensus 877 -~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 936 (1114)
...+...++||||+++++|.++++..... .....+..++.|++.||+|||+. +|+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 24556789999999999999998743211 12334567999999999999998 99999
Q ss_pred CCCCCCeEECC-CCCeEEeeccCceecCCCCCCccccccccccccCccccccC----------------------CCCcc
Q 001253 937 DIKSNNILLDD-KFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM----------------------KVTEK 993 (1114)
Q Consensus 937 Dlk~~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~ 993 (1114)
||||+|||+++ ++.+||+|||+|+..............+++.|||||.+... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999986 57999999999986543334444567899999999965321 23456
Q ss_pred cchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccc---ccccccCC----CcccHHHHHHHHHHHhhcc
Q 001253 994 CDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM---LDARLNLQ----DEKTVSHMITVLKIAMLCT 1066 (1114)
Q Consensus 994 ~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~----~~~~~~~~~~l~~li~~cl 1066 (1114)
+||||+||++|||+++..|+. .....+.+.....+.....+ ..+..... .+..........+++.+|+
T Consensus 360 ~DVwSlGviL~el~~~~~~~~-----~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSD-----SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCc-----hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 799999999999999766543 11222211111110000000 00000000 0000001123458999999
Q ss_pred CCCCCCCCCHHHHHH
Q 001253 1067 NISPFDRPTMREVVL 1081 (1114)
Q Consensus 1067 ~~dP~~RPs~~evl~ 1081 (1114)
+.||++|||++|+++
T Consensus 435 ~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 435 RFKGRQRISAKAALA 449 (566)
T ss_pred cCCcccCCCHHHHhC
Confidence 999999999999886
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=265.99 Aligned_cols=239 Identities=30% Similarity=0.390 Sum_probs=193.9
Q ss_pred CCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCHHHHh
Q 001253 821 ACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL 899 (1114)
Q Consensus 821 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l 899 (1114)
+||.||+|.++ +|+.+|+|++........ .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999987 589999999976554322 567899999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccccccccc
Q 001253 900 HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGY 979 (1114)
Q Consensus 900 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y 979 (1114)
.... .+++..+..++.+++++++|||+. +++|+||+|+||++++++.++++|||.+....... ......++..|
T Consensus 79 ~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 79 KKRG-RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred Hhcc-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 7443 389999999999999999999998 99999999999999999999999999998765322 33445688899
Q ss_pred cCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHH
Q 001253 980 IAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVL 1059 (1114)
Q Consensus 980 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1059 (1114)
+|||...+..++.++||||+|+++|++++|..||..........+. ........ ..........+.
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~----~~~~~~~~----------~~~~~~~~~~~~ 218 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKK----IGKPKPPF----------PPPEWKISPEAK 218 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH----HhccCCCC----------ccccccCCHHHH
Confidence 9999998888999999999999999999999999753322222221 11111100 000000234688
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 001253 1060 KIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1060 ~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=275.16 Aligned_cols=209 Identities=26% Similarity=0.326 Sum_probs=176.1
Q ss_pred cCCcCCceecccCCeEEEEEEe-CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVL-RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.-|..++.||-|+||.|.+++- ++...||.|.+.+...-.......++.|-.+++.-+.+-||+++-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4588888999999999999984 456789999987665444444556788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec-----
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI----- 962 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~----- 962 (1114)
||++||++-.+|-+ .+.+.+..+..++..+..|+++.|.. |+|||||||+|||||.||++||+|||++.-+
T Consensus 709 dYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999999873 44677777777788999999999999 9999999999999999999999999998522
Q ss_pred ----CCCCC--------------------------------CccccccccccccCccccccCCCCcccchHHHHHHHHHH
Q 001253 963 ----DMPQS--------------------------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLEL 1006 (1114)
Q Consensus 963 ----~~~~~--------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el 1006 (1114)
..... ......+||+.|+|||++....|+..+|.||.|||+|||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 10000 001134799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCC
Q 001253 1007 LTGRAPVQPLDQGGD 1021 (1114)
Q Consensus 1007 ~tg~~p~~~~~~~~~ 1021 (1114)
+.|+.||.+....+.
T Consensus 865 ~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGET 879 (1034)
T ss_pred hhCCCCccCCCCCcc
Confidence 999999987665554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=283.87 Aligned_cols=264 Identities=20% Similarity=0.228 Sum_probs=179.0
Q ss_pred HhcCCcCCceecccCCeEEEEEEe-----------------CCCcEEEEEEecccCCCCh-----------hhHHHHHHH
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVL-----------------RTGHTVAVKKLASNREGNN-----------NVDNSFRAE 858 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~-----------~~~~~~~~E 858 (1114)
..++|++.++||+|+||+||+|.+ ..++.||||++........ ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2356899999865332110 011223346
Q ss_pred HHHHhcCCCCc-----eeeEEeEEEe--------cCceEEEEecCCCCCHHHHhccCC----------------------
Q 001253 859 ILTLGKIRHRN-----IVKLYGFCYH--------QGSNLLMYEYMARGSLGELLHGAS---------------------- 903 (1114)
Q Consensus 859 ~~~l~~l~h~n-----iv~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~---------------------- 903 (1114)
+.++.+++|.+ +++++++|.. ++..++||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 77777776654 4677777753 356799999999999999987421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccccccccccCc
Q 001253 904 -STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAP 982 (1114)
Q Consensus 904 -~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aP 982 (1114)
..+++..+..++.|+++||+|+|+. +|+||||||+||+++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1346778889999999999999998 999999999999999999999999999976543222222223457899999
Q ss_pred cccccCC--------------------C--CcccchHHHHHHHHHHHhCCC-CCCCCCCCCCHHHHH---HHHHhcCCcc
Q 001253 983 EYAYTMK--------------------V--TEKCDIYSYGVVLLELLTGRA-PVQPLDQGGDLVTWV---RNFIRNNSLV 1036 (1114)
Q Consensus 983 E~~~~~~--------------------~--~~~~DvwslGvil~el~tg~~-p~~~~~~~~~~~~~~---~~~~~~~~~~ 1036 (1114)
|.+.... + ..+.||||+||++|||++|.. ||............. ...++.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~---- 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM---- 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh----
Confidence 9875322 1 124799999999999999874 664322111000000 000000
Q ss_pred cccccccccCCCcccHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 001253 1037 SGMLDARLNLQDEKTVSHMITVLKIAMLCTNISP---FDRPTMREVVL 1081 (1114)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 1081 (1114)
....... ............+++.+++..+| .+|+|++|+++
T Consensus 456 --~~~~~~~--~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 456 --YKGQKYD--FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred --hcccCCC--cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000111 01111233467889999998765 68999999874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=256.76 Aligned_cols=267 Identities=23% Similarity=0.292 Sum_probs=200.4
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-----ceE
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG-----SNL 884 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 884 (1114)
.+-.+.||-|+||.||.+++. +|+.||.|++...... -...+.+-+|++++..++|.|++..+++..-.. +.|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~-L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN-LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHH-HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 344568999999999999975 8999999998654322 223456778999999999999999888765432 468
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+++|.|.. +|..++- ....++...+.-+.+||++||.|||+. +|.||||||.|.|++.+..+||||||+|+..+.
T Consensus 134 V~TELmQS-DLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHh-hhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 89999965 8888876 456788899999999999999999999 999999999999999999999999999998766
Q ss_pred CCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccc-----
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG----- 1038 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1038 (1114)
.....++..+-|..|+|||++.+. .|+.+.||||.||++.|++.++..|......+. .+.+.+.+........
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ-L~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ-LQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH-HHHHHHHhCCCcHHHHHHHhh
Confidence 666667777889999999999875 589999999999999999999988875443222 2222222221111000
Q ss_pred -----cccccccCC-------CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1039 -----MLDARLNLQ-------DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1039 -----~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
+.....+.. ...+.....+...+.+.++.+||.+|.+..+.+...-
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000000000 0011223345677888999999999999998876653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=280.86 Aligned_cols=264 Identities=27% Similarity=0.348 Sum_probs=198.8
Q ss_pred CcCCceecccCCe-EEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEEEe
Q 001253 811 FDERFVIGRGACG-TVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 811 ~~~~~~lG~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
|.-.+++|.|+.| .||+|... |+.||||++-.... ....+|+..++.- +|||||++++.-.++...|+..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 3444578999988 57999987 88999999865442 3456899999888 59999999998888999999999
Q ss_pred cCCCCCHHHHhccCCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---C--CCeEEeeccCce
Q 001253 889 YMARGSLGELLHGASS---TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD---K--FEAHVGDFGLAK 960 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~--~~~kl~DfG~a~ 960 (1114)
.|.. +|+++++.... .........+..|+++|+++||+. +|||||+||.||||+. + .+++|+|||+++
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9976 99999985311 111134567889999999999997 9999999999999975 3 468999999999
Q ss_pred ecCCCCC--CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 001253 961 VIDMPQS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTG-RAPVQPLDQGGDLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 961 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1114)
..+.... ....+..||.+|+|||++....-+.++||||+||++|+.++| .+||...-.. .. ..+..+.-..
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~----NIl~~~~~L~ 733 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QA----NILTGNYTLV 733 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hh----hhhcCcccee
Confidence 8754332 234567899999999999998888999999999999999995 8999643221 11 1111111111
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHH---------HHHHhhhccCCCcccccCCCCC
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV---------LMLSESNRRQGHFEFSPMDHDS 1102 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl---------~~L~~i~~~~~~~~~~~~~~~~ 1102 (1114)
.+ .+. .++ ...++|.+|+++||..||+|.+|+ ++|+-++...++.|....+++.
T Consensus 734 ~L-------~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r~~~s 796 (903)
T KOG1027|consen 734 HL-------EPL--PDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENRDSPS 796 (903)
T ss_pred ee-------ccC--chH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhccCch
Confidence 11 011 111 678999999999999999999997 3556666666666666655554
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=247.42 Aligned_cols=262 Identities=24% Similarity=0.292 Sum_probs=199.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec------C
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ------G 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 881 (1114)
.+|...+.+|.|+- .|..|.+. .+++||+|+........ ...+...+|...+..+.|+||++++.+|.-. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~-~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQ-THAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccC-ccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 56778888999988 67767655 68999999987774443 3345566799999999999999999998643 3
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..|+|||+|.. +|...+. ..++-.....+..|++.|+.|+|+. +|+|||+||+||++..+..+||.|||+|+.
T Consensus 95 e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 56999999976 8988886 4577888999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH--------------
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR-------------- 1027 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~-------------- 1027 (1114)
.+.. -..+..+.+..|+|||++.+..+...+||||.||++.||++|+.-|.+.+.-+.+.+.+.
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 5422 456677899999999999999999999999999999999999998875443222221111
Q ss_pred ----HHHhcCCc------ccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1028 ----NFIRNNSL------VSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1028 ----~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+++..+. ...+.|..+....+........+.+++.+|+-.||++|-+++++++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 11111000 0011111111111122233446788999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-29 Score=275.89 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=203.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|....++|.|.||.||||+++ +++..|||+++-...++ .+-.+.|+-+++..+|||||.++|.|...+..++.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 478899999999999999999976 79999999998665544 45567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+.+|+|++.-+ ....+++.++..+++...+|++|+|++ +-+|||||-.||++++.|.+|++|||.+..+.. .
T Consensus 91 MEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita-t 165 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-T 165 (829)
T ss_pred EEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-h
Confidence 99999999999887 456899999999999999999999999 889999999999999999999999999887642 2
Q ss_pred CCccccccccccccCcccc---ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYA---YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~---~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
-.....+.||+.|||||+. +...|...+|||+.|+...|+-.-++|.....+-. +-...... ....+.
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-----~l~LmTkS----~~qpp~ 236 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-----ALFLMTKS----GFQPPT 236 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-----HHHHhhcc----CCCCCc
Confidence 2344667899999999986 35678999999999999999988777754332211 11111111 111111
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV 1080 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1080 (1114)
+ +........+.+|++.|+..+|.+||+++.++
T Consensus 237 l----kDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 237 L----KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred c----cCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 1 12223445688999999999999999997643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=263.76 Aligned_cols=199 Identities=25% Similarity=0.340 Sum_probs=172.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChh-----hHHHHHHHHHHHhcCC---CCceeeEEeEEEe
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNN-----VDNSFRAEILTLGKIR---HRNIVKLYGFCYH 879 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 879 (1114)
.+|...+.+|+|+||.|+.|.++ +...|+||.+.+.+.-... ..-.+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 56899999999999999999987 4567999999876532111 1123557999999997 9999999999999
Q ss_pred cCceEEEEecCC-CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccC
Q 001253 880 QGSNLLMYEYMA-RGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 958 (1114)
Q Consensus 880 ~~~~~lv~E~~~-~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 958 (1114)
++.+|++||-.. |-+|.+++. ....+++.+...|++||+-|+++||.+ +|||||||-+||.++.+|-+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence 999999999765 448999997 445899999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCccccccccccccCccccccCCCC-cccchHHHHHHHHHHHhCCCCCC
Q 001253 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVT-EKCDIYSYGVVLLELLTGRAPVQ 1014 (1114)
Q Consensus 959 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~p~~ 1014 (1114)
|.... ......++||..|.|||++.+.+|- ..-|||++|+++|.++....||+
T Consensus 717 aa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98653 4455678999999999999998875 46799999999999999999986
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-28 Score=260.42 Aligned_cols=265 Identities=22% Similarity=0.256 Sum_probs=205.9
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC------CceeeEEeEE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH------RNIVKLYGFC 877 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~ 877 (1114)
+....+|.+....|+|-|++|..|.+. .|..||||++...... .+.=..|+++++++.. -|+++++-.|
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 445678999999999999999999976 5789999999765443 2334569999999952 3899999999
Q ss_pred EecCceEEEEecCCCCCHHHHhccCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-CeEEe
Q 001253 878 YHQGSNLLMYEYMARGSLGELLHGASS--TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVG 954 (1114)
Q Consensus 878 ~~~~~~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~ 954 (1114)
....+.|||||.+.- +|.+++++.+. .+....+..++.|+.-||..|-.. +|+|.||||+||||++.. .+|||
T Consensus 504 ~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeec
Confidence 999999999999976 99999986554 678889999999999999999987 999999999999999765 57999
Q ss_pred eccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHH--------
Q 001253 955 DFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWV-------- 1026 (1114)
Q Consensus 955 DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~-------- 1026 (1114)
|||.|...... ..+.+.-+..|+|||++.+.+|++..|+||+||++||+.||+..|++......+ ...
T Consensus 580 DfGSA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML-rl~me~KGk~p 655 (752)
T KOG0670|consen 580 DFGSASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML-RLFMELKGKFP 655 (752)
T ss_pred cCccccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH-HHHHHhcCCCc
Confidence 99999875422 233344567899999999999999999999999999999999999866543322 221
Q ss_pred HHHHhcCCcccccccccccCC-----------------------------------CcccHHHHHHHHHHHhhccCCCCC
Q 001253 1027 RNFIRNNSLVSGMLDARLNLQ-----------------------------------DEKTVSHMITVLKIAMLCTNISPF 1071 (1114)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~cl~~dP~ 1071 (1114)
..+++.+.+.++-+|..+.+. +.........+.+++..|+..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 123333333322222221110 112234456788999999999999
Q ss_pred CCCCHHHHHH
Q 001253 1072 DRPTMREVVL 1081 (1114)
Q Consensus 1072 ~RPs~~evl~ 1081 (1114)
+|.|..++++
T Consensus 736 KRit~nqAL~ 745 (752)
T KOG0670|consen 736 KRITVNQALK 745 (752)
T ss_pred hcCCHHHHhc
Confidence 9999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=238.74 Aligned_cols=211 Identities=36% Similarity=0.553 Sum_probs=184.6
Q ss_pred ecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCH
Q 001253 817 IGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL 895 (1114)
Q Consensus 817 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 895 (1114)
||+|.+|.||++... +++.+++|++....... ..+.+.+|+..++.++|++++++++++......+++|||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999986 48999999997655432 246788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCCeEEeeccCceecCCCCCCcccccc
Q 001253 896 GELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDMPQSKSMSAIA 974 (1114)
Q Consensus 896 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~ 974 (1114)
.+++......+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++++|||.+........ ......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 999985545789999999999999999999998 9999999999999999 89999999999987643221 223356
Q ss_pred ccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHH
Q 001253 975 GSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVS 1053 (1114)
Q Consensus 975 g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1114)
+...|++||..... .++.+.|+|++|++++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999998877 788999999999999999
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1054 HMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1054 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 257789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=237.96 Aligned_cols=200 Identities=35% Similarity=0.470 Sum_probs=174.1
Q ss_pred CcCCceecccCCeEEEEEEeCC-CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEec
Q 001253 811 FDERFVIGRGACGTVYRAVLRT-GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
|+..+.||+|++|+||+|.... ++.+|+|.+...... ...+.+.+|+..+++++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 5667899999999999999874 899999999765443 2356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCc
Q 001253 890 MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 969 (1114)
+++++|.+++......+++.....++.+++.++.++|+. +++|+|++|.||+++.++.++|+|||.+..........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999999999985443389999999999999999999998 99999999999999999999999999998765432123
Q ss_pred cccccccccccCcccc-ccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 001253 970 MSAIAGSYGYIAPEYA-YTMKVTEKCDIYSYGVVLLELLTGRAPVQP 1015 (1114)
Q Consensus 970 ~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslGvil~el~tg~~p~~~ 1015 (1114)
.....++..|++||.. ....++.++|||++|++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 3445678899999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=227.63 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=185.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeE-EEecCceEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGF-CYHQGSNLL 885 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~l 885 (1114)
+.|.+.+.+|+|.||.+-+|+++ +.+.+|+|.+.+.... .++|.+|...--.+ .|.||+.-++. |+..+..++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 67899999999999999999987 6788999999876553 67788888765555 58999987765 566777889
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC--CCCCeEEeeccCceecC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD--DKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~DfG~a~~~~ 963 (1114)
++||++.|+|.+-+. ...+.+....+++.|+++|+.|+|+. .+||||||.+||||- +..+||+||||..+..+
T Consensus 100 ~qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eeccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999999999887 35688888999999999999999999 999999999999983 34589999999988644
Q ss_pred CCCCCccccccccccccCccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCC-CCCHHHHHHHHHhcCCccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTM-----KVTEKCDIYSYGVVLLELLTGRAPVQPLDQ-GGDLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslGvil~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 1037 (1114)
. .....-.+..|.|||..... ...+.+|||.||++++.++||..||..... ....++|.+=.-+...
T Consensus 175 ~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~--- 247 (378)
T KOG1345|consen 175 T----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP--- 247 (378)
T ss_pred c----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc---
Confidence 2 22223345679999977532 356789999999999999999999984432 2233333321111110
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+. +.........++++.++-+.++|++|--..++.+
T Consensus 248 -----~~---P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 248 -----AL---PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred -----cC---chhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 11 1111122345777888999999999944444433
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-27 Score=247.82 Aligned_cols=407 Identities=23% Similarity=0.254 Sum_probs=209.7
Q ss_pred cCEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceecccc-ccccCCCCcccccCcccchhhhc
Q 001253 104 LTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYN-NRISGPFPKEIGKLSALSQLVAY 182 (1114)
Q Consensus 104 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~ 182 (1114)
-+.++|..|+|+...|.+|+.+++|++||||+|.|+.+-|++|.+|.+|..|-+.+ |+|+......|++|..|+.|.+.
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 37778888888766677788888888888888888877788888887776666555 77875545667778888888777
Q ss_pred ccccCCCCCCCccccccccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCcc
Q 001253 183 SNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVI 262 (1114)
Q Consensus 183 ~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 262 (1114)
-|++.-...++|..|++|..|.+-+|.+...--..|..+.+++.+.+..|.+- ...+++.+.. +....
T Consensus 149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~-------~~a~~ 216 (498)
T KOG4237|consen 149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLAD-------DLAMN 216 (498)
T ss_pred hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-----cccccchhhh-------HHhhc
Confidence 77777666677777777777777777777333336777777777777777632 1111211111 00012
Q ss_pred ccccccccccchhhcccccccCCchhhhcC-CCccceeeecccccccccCc-cccccccccccccccccCCCCCchhhhc
Q 001253 263 PKELGNCTSLETLALYDNKQVGQLPKELGS-IGSLKYLYIYRNELNGTIPR-EIGKLSSALEIDFSENSLIGEIPVELSK 340 (1114)
Q Consensus 263 p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~-l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~ls~N~l~~~~~~~l~~ 340 (1114)
|.+++...-..-..+.++++...-+..|.. +..+..=..+.+...+..|. .|..+++|+.|+|++|++++.-+.+|..
T Consensus 217 ~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~ 296 (498)
T KOG4237|consen 217 PIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEG 296 (498)
T ss_pred hhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcc
Confidence 222333333333333333322222222211 11111111111212222221 2444444445555555554444445555
Q ss_pred ccccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCC-CCCCC--------
Q 001253 341 ILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGI-PQRLG-------- 411 (1114)
Q Consensus 341 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~-------- 411 (1114)
+..++.|+|..|+|..+....|..+..|+.|+|.+|+|+...|..|..+..|.+|+|..|.+.-.. -.+++
T Consensus 297 ~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~ 376 (498)
T KOG4237|consen 297 AAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSV 376 (498)
T ss_pred hhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCC
Confidence 555555555555555444455555555555555555555555555555555555555555442110 00010
Q ss_pred -------cCccceEEEeecccccCC---CCccccccCccceeeeccCCccCCcCcccccCCcceEEe-eccceeeccCCc
Q 001253 412 -------AYSQLWVVDLSDNHLTGK---IPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLR-LGGNSFTGSFPS 480 (1114)
Q Consensus 412 -------~l~~L~~L~Ls~N~l~~~---~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~-L~~N~l~~~~p~ 480 (1114)
.-..++.++++++.+... .|+..+- . ..+.+-..++-+.+.. .|++.+. .+|.
T Consensus 377 ~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~--------------~-~s~~cP~~c~c~~tVvRcSnk~lk-~lp~ 440 (498)
T KOG4237|consen 377 VGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGC--------------L-TSSPCPPPCTCLDTVVRCSNKLLK-LLPR 440 (498)
T ss_pred CCCCCCCCCchhccccchhccccccccCCccccCC--------------C-CCCCCCCCcchhhhhHhhcccchh-hcCC
Confidence 011223333333332211 0000000 0 0011112223333222 2233332 4443
Q ss_pred hhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccc
Q 001253 481 DLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSN 544 (1114)
Q Consensus 481 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 544 (1114)
.+- ....+|++++|.++ .+|.. .+..| .+|+|+|+|+......|.++++|.+|-|++|
T Consensus 441 ~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 441 GIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred CCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 332 23556777777777 55555 55666 7777777777555556677777777766665
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=236.53 Aligned_cols=263 Identities=25% Similarity=0.367 Sum_probs=194.9
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecC
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 881 (1114)
..+.|..+++||+|.|++||+|++. ..+.||+|.+...... ..+..|++++..+ .+.||+++.+++...+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4567899999999999999999954 3678999999876653 4578899999999 5899999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCCeEEeeccCce
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAK 960 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~ 960 (1114)
...+|+||++..+..++.. .++..++....+.+..||+++|.. |||||||||.|++.+. .++-.|+|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999888886 466889999999999999999999 9999999999999974 5678999999996
Q ss_pred ecCC----------------C-----------------CC----------CccccccccccccCcccccc-CCCCcccch
Q 001253 961 VIDM----------------P-----------------QS----------KSMSAIAGSYGYIAPEYAYT-MKVTEKCDI 996 (1114)
Q Consensus 961 ~~~~----------------~-----------------~~----------~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv 996 (1114)
..+. + .. ......+||++|+|||++.. ..-+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 2210 0 00 01123469999999999875 446789999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCC-HHHHHHHH----Hhc-----CC--ccc--c---c---------cc-cccc----
Q 001253 997 YSYGVVLLELLTGRAPVQPLDQGGD-LVTWVRNF----IRN-----NS--LVS--G---M---------LD-ARLN---- 1045 (1114)
Q Consensus 997 wslGvil~el~tg~~p~~~~~~~~~-~~~~~~~~----~~~-----~~--~~~--~---~---------~~-~~~~---- 1045 (1114)
||.|||+.-+++++.||....+.-+ +.+.+.-+ +++ +. +.+ . + ++ ....
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999864443322 22222100 000 11 000 0 0 00 0000
Q ss_pred ---CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 ---LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
............+++++.+|+..||.+|.|+++.++
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000111112236889999999999999999998764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-26 Score=241.53 Aligned_cols=416 Identities=22% Similarity=0.188 Sum_probs=252.1
Q ss_pred CCcccccccccccEEEecCCcccCccccccccccccchhhcccccccCCchhhhcCCCccceeeecc-cccccccCcccc
Q 001253 237 EIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYR-NELNGTIPREIG 315 (1114)
Q Consensus 237 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~l~ 315 (1114)
.+|..+. ..-++++|..|+|+.+.|.+|+.+.+|+.||||+|.|..+-|++|..+.+|..|-+.+ |+|+......|+
T Consensus 60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~ 137 (498)
T KOG4237|consen 60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG 137 (498)
T ss_pred cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence 4554432 2456778888888877777888888888888888888878888888777777776666 677644444566
Q ss_pred ccccccccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeee
Q 001253 316 KLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIML 395 (1114)
Q Consensus 316 ~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 395 (1114)
.+.+++.|.+.-|++.-.....|..+++|..|.+.+|.+..+....|..+..++.+.+..|.+-. .++++.+..
T Consensus 138 gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----dCnL~wla~- 211 (498)
T KOG4237|consen 138 GLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----DCNLPWLAD- 211 (498)
T ss_pred hHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----ccccchhhh-
Confidence 66666666666666665555666666666666666666664444566666666666666665320 111221111
Q ss_pred eccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccc-cCccce-eeeccCCccCCcCcccccCCcceEEeeccce
Q 001253 396 QLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICR-NTSLIF-LNLETNKLTGSIPTGVTRCKSLVQLRLGGNS 473 (1114)
Q Consensus 396 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-~~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 473 (1114)
+....|..++++.-..-..+.++++..+.+..|.. +..+.. +....+.........|..+++|+.|+|++|+
T Consensus 212 ------~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~ 285 (498)
T KOG4237|consen 212 ------DLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNK 285 (498)
T ss_pred ------HHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCc
Confidence 11122333444444444455555555444443322 122221 2222223332233468888999999999999
Q ss_pred eeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeeccccccccccc--
Q 001253 474 FTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIP-- 551 (1114)
Q Consensus 474 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-- 551 (1114)
++++.+.+|.++..+++|.|..|+|...-...|.++..|+.|+|.+|+|+...|.+|..+..|.+|+|-.|.+.-..-
T Consensus 286 i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~ 365 (498)
T KOG4237|consen 286 ITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLA 365 (498)
T ss_pred cchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchH
Confidence 998888899999999999999999987777788889999999999999998888899988899999888887642110
Q ss_pred ---cccc-----------ccccceEEECccccccC---CCchhhhhcccCCeeeccCccCCCccccccccccccccc-cc
Q 001253 552 ---LEIF-----------SCKMLQRLDLSWNKFVG---ALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTEL-QM 613 (1114)
Q Consensus 552 ---~~~~-----------~l~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L-~l 613 (1114)
+++. +-..++.++++.+.+.. ..|++.+-.+ .+..-..++-+.+. .-
T Consensus 366 wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~---------------s~~cP~~c~c~~tVvRc 430 (498)
T KOG4237|consen 366 WLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLT---------------SSPCPPPCTCLDTVVRC 430 (498)
T ss_pred HHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCC---------------CCCCCCCcchhhhhHhh
Confidence 1100 01123334444333321 1111111000 00011122333333 23
Q ss_pred CCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccC
Q 001253 614 GGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYN 689 (1114)
Q Consensus 614 s~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N 689 (1114)
|++.+. .+|..+..-. .+|.|.+|.++. +|.+ .+.+| .+|||+|+|+..-.-+|.+++.|.+|-+|||
T Consensus 431 Snk~lk-~lp~~iP~d~---telyl~gn~~~~-vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 431 SNKLLK-LLPRGIPVDV---TELYLDGNAITS-VPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred cccchh-hcCCCCCchh---HHHhcccchhcc-cCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 333333 4444333222 257777888773 4655 56677 7888888888777777888888888888886
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-25 Score=220.28 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=200.3
Q ss_pred CCCCCCHHHHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEE
Q 001253 795 PKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874 (1114)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 874 (1114)
...++++.++.. .-+|.+...|..|+|+|+ |..+++|++.... ......++|.+|.-.++-+.||||.+++
T Consensus 183 r~~gid~~~lnl-------~tkl~e~hsgelwrgrwq-gndivakil~vr~-~t~risrdfneefp~lrifshpnilpvl 253 (448)
T KOG0195|consen 183 RYTGIDVSSLNL-------ITKLAESHSGELWRGRWQ-GNDIVAKILNVRE-VTARISRDFNEEFPALRIFSHPNILPVL 253 (448)
T ss_pred cccCcchhhhhh-------hhhhccCCCccccccccc-Ccchhhhhhhhhh-cchhhcchhhhhCcceeeecCCchhhhh
Confidence 344555554433 347899999999999998 6778888876443 3345567899999999999999999999
Q ss_pred eEEEecCceEEEEecCCCCCHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEE
Q 001253 875 GFCYHQGSNLLMYEYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 953 (1114)
Q Consensus 875 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 953 (1114)
+.|.......++..||+.|+|+..+++... ..+..++.+++.++|+|++|||+. .+-|.---+..+.|++|++.+++|
T Consensus 254 gacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltari 332 (448)
T KOG0195|consen 254 GACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARI 332 (448)
T ss_pred hhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhe
Confidence 999999999999999999999999996544 578889999999999999999997 444555578899999999998877
Q ss_pred e--eccCceecCCCCCCccccccccccccCccccccCCCC---cccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 001253 954 G--DFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVT---EKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRN 1028 (1114)
Q Consensus 954 ~--DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~ 1028 (1114)
. |--++.. .....-.|.||+||.+...+.+ .++|+|||++++||+.|+..||.....-+
T Consensus 333 smad~kfsfq--------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme-------- 396 (448)
T KOG0195|consen 333 SMADTKFSFQ--------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME-------- 396 (448)
T ss_pred ecccceeeee--------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh--------
Confidence 4 2222211 1122346789999999876644 47999999999999999999998655311
Q ss_pred HHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
.++.-.....+...++.....+.+++.-|++.||.+||.+..++-.|++++
T Consensus 397 --------cgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 397 --------CGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred --------hhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 112112222334456666778899999999999999999999999999864
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=274.71 Aligned_cols=345 Identities=24% Similarity=0.274 Sum_probs=232.5
Q ss_pred cccccCcccchhhhccc------ccCCCCCCCccccc-cccceeccccccccccCCCCCCCCccceeeccccccCCCCcc
Q 001253 168 KEIGKLSALSQLVAYSN------NISGSLPPTLGNLK-RLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPK 240 (1114)
Q Consensus 168 ~~~~~l~~L~~L~l~~n------~i~~~~p~~l~~l~-~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 240 (1114)
.+|.+|++|+.|.+..+ ++...+|..+..++ +|+.|++.++.+. .+|..+ ...+|++|+|++|++. .+|.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 34455555555555433 23334566666553 5777777777765 667666 4578888888888877 6777
Q ss_pred cccccccccEEEecCCcccCccccccccccccchhhcccccccCCchhhhcCCCccceeeecccccccccCccccccccc
Q 001253 241 EIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSA 320 (1114)
Q Consensus 241 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 320 (1114)
.+..+++|+.|+|+++...+.+|. ++.+++|+.|+|++|.....+|..++.+++|++|++++|.....+|..+ ++++|
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL 706 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL 706 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence 777888888888887654445563 7777888888888877777778788888888888888765444666554 56777
Q ss_pred cccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCC
Q 001253 321 LEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDN 400 (1114)
Q Consensus 321 ~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 400 (1114)
+.|++++|...+.+|.. ..+|+.|++++|.+.. +|..+ .+++|++|+++++.... +..
T Consensus 707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~-l~~---------------- 764 (1153)
T PLN03210 707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEK-LWE---------------- 764 (1153)
T ss_pred CEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-cccccccccccccchhh-ccc----------------
Confidence 77777776554444432 2345566666666543 23222 34555555555433211 100
Q ss_pred cccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCc
Q 001253 401 SLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPS 480 (1114)
Q Consensus 401 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 480 (1114)
.+....+..+...++|+.|+|++|...+.+|..+.++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|.
T Consensus 765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~ 843 (1153)
T PLN03210 765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD 843 (1153)
T ss_pred cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc
Confidence 1111112222334678888888887777788888888888888888875544677665 688889999988765555554
Q ss_pred hhhccccccEeecccccCCCCccccccccccCcEEEecC-ceeccCCCccccCCCCcceeeccccc
Q 001253 481 DLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSD-NYFTGELPREVGNLSNLVTFNVSSNF 545 (1114)
Q Consensus 481 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~ 545 (1114)
. ..+|++|+|++|.|+ .+|.++..+++|+.|+|++ |+++ .+|..+..+++|+.+++++|.
T Consensus 844 ~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 844 I---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred c---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 3 367889999999998 6788899999999999988 5565 577788889999999988774
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=273.93 Aligned_cols=337 Identities=21% Similarity=0.246 Sum_probs=209.0
Q ss_pred CCCCCCccceeeccccc------cCCCCcccccccc-cccEEEecCCcccCccccccccccccchhhcccccccCCchhh
Q 001253 217 EIGGCESLQYLGLAQNQ------LSGEIPKEIGMLK-YLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKE 289 (1114)
Q Consensus 217 ~l~~l~~L~~L~Ls~N~------l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~ 289 (1114)
+|.++++|+.|.+..+. +...+|..+..++ +|+.|++.++.++ .+|..+ ...+|++|++++|++. .++..
T Consensus 553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~ 629 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDG 629 (1153)
T ss_pred HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccc
Confidence 34445555555544332 1122344444432 3555555555544 334433 3445555555555432 34444
Q ss_pred hcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCC
Q 001253 290 LGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLT 369 (1114)
Q Consensus 290 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 369 (1114)
+..+++|++|+|+++.....+|. ++.+++|+.|++++|.....+|..+..+++|+.|++++|..-..+|..+ ++++|+
T Consensus 630 ~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~ 707 (1153)
T PLN03210 630 VHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLY 707 (1153)
T ss_pred cccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCC
Confidence 44555555555555433334442 4445555555555554444555555555555555555543333334333 455666
Q ss_pred EEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccc-------cCCCCccccccCccce
Q 001253 370 KLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHL-------TGKIPRHICRNTSLIF 442 (1114)
Q Consensus 370 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-------~~~~~~~~~~~~~L~~ 442 (1114)
.|++++|.....+|.. .++|++|++++|.+. .+|..+ .+++|++|+++++.. ....+..+...++|+.
T Consensus 708 ~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~ 782 (1153)
T PLN03210 708 RLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTR 782 (1153)
T ss_pred EEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchh
Confidence 6666665443344422 345566666666654 233333 355666666655322 1122222334578999
Q ss_pred eeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCcee
Q 001253 443 LNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYF 522 (1114)
Q Consensus 443 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 522 (1114)
|+|++|...+.+|..++++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|.. ..+|+.|+|++|.|
T Consensus 783 L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i 858 (1153)
T PLN03210 783 LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGI 858 (1153)
T ss_pred eeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCC
Confidence 9999998888899999999999999999986555788776 7899999999998655456653 46899999999999
Q ss_pred ccCCCccccCCCCcceeeccc-ccccccccccccccccceEEECcccc
Q 001253 523 TGELPREVGNLSNLVTFNVSS-NFLTGRIPLEIFSCKMLQRLDLSWNK 569 (1114)
Q Consensus 523 ~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~ 569 (1114)
+ .+|.++..+++|+.|+|++ |.+. .+|..+..++.|+.|++++|.
T Consensus 859 ~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 859 E-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred c-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 8 6899999999999999999 4555 688888999999999999874
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=252.97 Aligned_cols=263 Identities=30% Similarity=0.356 Sum_probs=157.4
Q ss_pred ccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeee
Q 001253 366 KNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNL 445 (1114)
Q Consensus 366 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L 445 (1114)
..-..|+|+.|.++ .+|..+. ++|+.|++.+|+++. +|. ..++|++|+|++|+|+.
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts----------------- 256 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS----------------- 256 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-----------------
Confidence 34567888888887 4555543 356666666666653 232 12445555555555552
Q ss_pred ccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccC
Q 001253 446 ETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGE 525 (1114)
Q Consensus 446 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 525 (1114)
+|.. .++|+.|++++|.++ .+|..+ .+|+.|++++|+|+ .+|.. +++|+.|+|++|+|++
T Consensus 257 --------LP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~- 316 (788)
T PRK15387 257 --------LPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS- 316 (788)
T ss_pred --------ccCc---ccccceeeccCCchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-
Confidence 2221 234455555555544 233221 34555555666555 23331 3456666666666663
Q ss_pred CCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCccccccccc
Q 001253 526 LPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNL 605 (1114)
Q Consensus 526 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 605 (1114)
+|.. ..+|+.|++++|.|+ .+|.. ..+|+.|+|++|+|+ .+|.. ..+|+.|++++|+|+ .+|...
T Consensus 317 Lp~l---p~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~-~LP~l~--- 381 (788)
T PRK15387 317 LPAL---PSELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPALP--- 381 (788)
T ss_pred CCCC---cccccccccccCccc-ccccc---ccccceEecCCCccC-CCCCC---Ccccceehhhccccc-cCcccc---
Confidence 3332 124556666666665 34431 135667777777776 34432 235666777777777 355432
Q ss_pred ccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEE
Q 001253 606 SRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCN 685 (1114)
Q Consensus 606 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ 685 (1114)
.+|+.|++++|+|++ +|... +.|+ .|++|+|+|++ +|.. ..+|+.|+|++|+|+ .+|.++.++++|..|+
T Consensus 382 ~~L~~LdLs~N~Lt~-LP~l~---s~L~-~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~Ld 451 (788)
T PRK15387 382 SGLKELIVSGNRLTS-LPVLP---SELK-ELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 451 (788)
T ss_pred cccceEEecCCcccC-CCCcc---cCCC-EEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEE
Confidence 457777778887773 55433 3455 57788888875 4643 246788999999998 7888899999999999
Q ss_pred eccCcccCCCCC
Q 001253 686 FSYNNLTGPIPS 697 (1114)
Q Consensus 686 ls~N~l~g~ip~ 697 (1114)
|++|+|+|.+|.
T Consensus 452 Ls~N~Ls~~~~~ 463 (788)
T PRK15387 452 LEGNPLSERTLQ 463 (788)
T ss_pred CCCCCCCchHHH
Confidence 999999988775
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=210.79 Aligned_cols=278 Identities=20% Similarity=0.270 Sum_probs=220.7
Q ss_pred hcCCcCCceecccCCeEEEEEEe-CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVL-RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 885 (1114)
.-+|+++++||+|.||+++.|+. -++++||||.-....+ ..+++.|.+..+.+. .++|..++-+..++.+-.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 35799999999999999999993 4799999998655444 345778888888884 6899998888788888899
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-----CCeEEeeccCce
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK-----FEAHVGDFGLAK 960 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~DfG~a~ 960 (1114)
|+|.+ |.+|+|++..++..++.+++..+|+|++.-++|+|++ .+|+|||||+|+||... ..+.++|||+|+
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 99998 5699999999999999999999999999999999999 99999999999999743 358999999999
Q ss_pred ecCCCCCCc------cccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 001253 961 VIDMPQSKS------MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS 1034 (1114)
Q Consensus 961 ~~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1034 (1114)
.+.++.... .....||.+||+-....+.+-+.+-|+-|+|=++...+-|..||.+......-.++ +.+.+.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY--eKIGe~- 254 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY--EKIGET- 254 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH--HHhccc-
Confidence 887665432 34567999999999999999999999999999999999999999988765432222 111110
Q ss_pred cccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCCcc
Q 001253 1035 LVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDSDQ 1104 (1114)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~ 1104 (1114)
.....+...++..+ .++..-++..-+.+-.+-|..+-+...+.++-.+.+.-++..+||+...
T Consensus 255 ----Kr~T~i~~Lc~g~P---~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 255 ----KRSTPIEVLCEGFP---EEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred ----cccCCHHHHHhcCH---HHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 00001110111222 3455555555567788999999999999999999999999999998655
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=213.59 Aligned_cols=169 Identities=22% Similarity=0.203 Sum_probs=130.2
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcccc
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 972 (1114)
|+|.++++.....+++.++..++.|+++||+|||+. + ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 689999986667799999999999999999999998 5 999999999999999 99998754321
Q ss_pred ccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccH
Q 001253 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTV 1052 (1114)
Q Consensus 973 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1114)
..|++.|||||++.+..++.++|||||||++|||++|+.||............+........ .. ......
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~---~~~~~~ 133 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-------PR---DRSNLE 133 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-------cc---ccccHH
Confidence 25889999999999999999999999999999999999999654332222222211111100 00 001111
Q ss_pred HHH--HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1053 SHM--ITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1053 ~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
... ..+.+++.+||+.+|.+||++.|+++.+..+..
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 122 258999999999999999999999998877643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=228.27 Aligned_cols=276 Identities=21% Similarity=0.264 Sum_probs=211.1
Q ss_pred CCcCCceecccCCeEEEEEEeCCC--cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC----CceeeEEeEE-EecCc
Q 001253 810 NFDERFVIGRGACGTVYRAVLRTG--HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH----RNIVKLYGFC-YHQGS 882 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~ 882 (1114)
+|.+.++||+|+||.||.|..... +.+|+|.......... ..+..|..++..+.. +++..+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 799999999999999999997643 4788888776543321 146678888887762 6899999988 47778
Q ss_pred eEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-----CCeEEeec
Q 001253 883 NLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK-----FEAHVGDF 956 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~Df 956 (1114)
.|+||+.+ |.+|.++..... ..++..+..+++.|++.+|+++|+. |++||||||.|+++... ..+.+.||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 89999988 569999986554 7899999999999999999999999 99999999999999865 46999999
Q ss_pred cCce--ecCCCCC------Cc-cccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 001253 957 GLAK--VIDMPQS------KS-MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR 1027 (1114)
Q Consensus 957 G~a~--~~~~~~~------~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~ 1027 (1114)
|+|+ .+..... .. ...+.||.+|+++....+...+.+.|+||++.++.|+..|..||.............+
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 9998 3211111 11 2345699999999999999999999999999999999999999976554333222211
Q ss_pred HHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCCccc
Q 001253 1028 NFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDSDQK 1105 (1114)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~~ 1105 (1114)
. ........ .....+. .+.++...+-..+...+|....+...+++...+.+.....++||+....
T Consensus 252 ~-~~~~~~~~---------~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~~ 316 (322)
T KOG1164|consen 252 D-PRKLLTDR---------FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKLR 316 (322)
T ss_pred H-hhhhcccc---------ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccccc
Confidence 1 11100000 0111222 3445555555588999999999999999999998888889999987654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=271.49 Aligned_cols=195 Identities=15% Similarity=0.191 Sum_probs=140.2
Q ss_pred cCCC-CceeeEEeEE-------EecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 001253 864 KIRH-RNIVKLYGFC-------YHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935 (1114)
Q Consensus 864 ~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 935 (1114)
.++| +||+.++++| ...+.++.+|||++ ++|.++++.....+++.++..++.||++||+|||++ +|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 3445 5788888877 22345678899885 499999986666799999999999999999999998 9999
Q ss_pred cCCCCCCeEECC-------------------CCCeEEeeccCceecCCCC---------------CCccccccccccccC
Q 001253 936 RDIKSNNILLDD-------------------KFEAHVGDFGLAKVIDMPQ---------------SKSMSAIAGSYGYIA 981 (1114)
Q Consensus 936 ~Dlk~~Nill~~-------------------~~~~kl~DfG~a~~~~~~~---------------~~~~~~~~g~~~y~a 981 (1114)
|||||+|||++. ++.+|++|||+++...... ........||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 4456666666665321100 001112468889999
Q ss_pred ccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHH
Q 001253 982 PEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKI 1061 (1114)
Q Consensus 982 PE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 1061 (1114)
||++.+..++.++|||||||++|||++|..|+.... ......... ..++ ...........+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~------~~~~-------~~~~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHR------VLPP-------QILLNWPKEASF 244 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHh------hcCh-------hhhhcCHHHHHH
Confidence 999999999999999999999999999888764211 111111100 0000 011112345678
Q ss_pred HhhccCCCCCCCCCHHHHHH
Q 001253 1062 AMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1062 i~~cl~~dP~~RPs~~evl~ 1081 (1114)
+.+||+++|.+||++.|+++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 88999999999999999975
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=251.68 Aligned_cols=268 Identities=29% Similarity=0.343 Sum_probs=170.7
Q ss_pred ccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEee
Q 001253 343 GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLS 422 (1114)
Q Consensus 343 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 422 (1114)
+-..|++++|.++. +|..+. ++|+.|++++|+|+. +|. .+++|++|++++|+|+.. |.. .++|+.|+|+
T Consensus 202 ~~~~LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSL-PVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCCc-CCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcc-cCc---ccccceeecc
Confidence 46689999999994 565665 489999999999995 554 358999999999999854 532 4678888999
Q ss_pred cccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCc
Q 001253 423 DNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPI 502 (1114)
Q Consensus 423 ~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 502 (1114)
+|+|+ .+|..+ ++|+.|++++|+++. +|.. .++|+.|+|++|+|++ +|... .+|+.|++++|+|++ +
T Consensus 271 ~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-L 337 (788)
T PRK15387 271 SNPLT-HLPALP---SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-L 337 (788)
T ss_pred CCchh-hhhhch---hhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-c
Confidence 99887 344322 457777788887773 4432 3567777777777663 33321 245556666666652 3
Q ss_pred cccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcc
Q 001253 503 PTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLF 582 (1114)
Q Consensus 503 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 582 (1114)
|.. ..+|+.|+|++|+|++ +|.. .++|+.|++++|+|+ .+| .. ..
T Consensus 338 P~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP------------------------~l---~~ 382 (788)
T PRK15387 338 PTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLP------------------------AL---PS 382 (788)
T ss_pred ccc---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCc------------------------cc---cc
Confidence 321 1345555555555552 3321 123444445555444 233 22 13
Q ss_pred cCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhc
Q 001253 583 QLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLL 662 (1114)
Q Consensus 583 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 662 (1114)
+|+.|++++|+|++ +|... ++|+.|++++|+|++ +|... ..|+ .|+|++|+|+ .+|..++++++|+.|+|
T Consensus 383 ~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Lss-IP~l~---~~L~-~L~Ls~NqLt-~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 383 GLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLTS-LPMLP---SGLL-SLSVYRNQLT-RLPESLIHLSSETTVNL 452 (788)
T ss_pred ccceEEecCCcccC-CCCcc---cCCCEEEccCCcCCC-CCcch---hhhh-hhhhccCccc-ccChHHhhccCCCeEEC
Confidence 45555666665552 34322 456677777777763 55433 3455 5778888887 46888888888888888
Q ss_pred cCcccccCCCCcccccc
Q 001253 663 NNNHLSGEIPGSFVNLS 679 (1114)
Q Consensus 663 s~N~l~g~ip~~~~~l~ 679 (1114)
++|+|+|.+|..+..+.
T Consensus 453 s~N~Ls~~~~~~L~~l~ 469 (788)
T PRK15387 453 EGNPLSERTLQALREIT 469 (788)
T ss_pred CCCCCCchHHHHHHHHh
Confidence 88888888887765443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=203.64 Aligned_cols=281 Identities=19% Similarity=0.246 Sum_probs=216.8
Q ss_pred HHhcCCcCCceecccCCeEEEEEE-eCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC-CceeeEEeEEEecCce
Q 001253 806 VATDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH-RNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~ 883 (1114)
+...+|.++++||.|+||.+|.|. ..+|+.||||+-...... ..+..|.++.+.+++ ..|..+..+..++..-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 345789999999999999999999 458999999997655442 346678889988876 5677777777888888
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC---CCeEEeeccCce
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK---FEAHVGDFGLAK 960 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfG~a~ 960 (1114)
.+|||.+ |.+|++++.-+...++..+++..|-|++.-++|+|.+ +++||||||+|+|+.-+ ..+.++|||+|+
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9999998 5699999988888999999999999999999999999 99999999999999643 468999999998
Q ss_pred ecCCCCC------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 001253 961 VIDMPQS------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS 1034 (1114)
Q Consensus 961 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1034 (1114)
.+.+... .......||.+|.+-....+..-+.+.|+-|+|.++..+--|..||.+........++ +.+.+..
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy--EkI~EkK 240 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY--EKISEKK 240 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH--HHHHHhh
Confidence 7643332 2234567999999988888777888999999999999999999999877654432221 1111111
Q ss_pred cccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCCccc
Q 001253 1035 LVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDSDQK 1105 (1114)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~~ 1105 (1114)
. ...+...+. ..+.++.-.+..|-..--++-|...-+.+.++-+.+...+..+--+||+.-..
T Consensus 241 ~-----s~~ie~LC~---G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkq 303 (341)
T KOG1163|consen 241 M-----STPIEVLCK---GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQ 303 (341)
T ss_pred c-----CCCHHHHhC---CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHH
Confidence 0 111110011 12235667778888888889999999988888887777777777888875443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=220.77 Aligned_cols=168 Identities=23% Similarity=0.201 Sum_probs=130.6
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC--CCcEEEEEEecccCC--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR--TGHTVAVKKLASNRE--GNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
...++|++.++||+|+||+||+|+++ +++.||||++..... ......+.+.+|++++++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34578999999999999999999875 577789998764321 122335668999999999999999853322 24
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeEECCCCCeEEeeccCce
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDI-KSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~DfG~a~ 960 (1114)
..|+||||++|++|... ... . ...++.++++||+|+|+. ||+|||| ||+|||++.++.+||+|||+|+
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred CcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 67999999999999732 211 1 145788999999999998 9999999 9999999999999999999999
Q ss_pred ecCCCCC-------CccccccccccccCcccccc
Q 001253 961 VIDMPQS-------KSMSAIAGSYGYIAPEYAYT 987 (1114)
Q Consensus 961 ~~~~~~~-------~~~~~~~g~~~y~aPE~~~~ 987 (1114)
.+..... ....+..+++.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 7643321 11235678889999998864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-21 Score=235.42 Aligned_cols=183 Identities=26% Similarity=0.455 Sum_probs=87.6
Q ss_pred cceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecc
Q 001253 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELD 494 (1114)
Q Consensus 415 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 494 (1114)
.|+.|+|++|++. .+|..+. .+|+.|++++|+|+ .+|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+++
T Consensus 242 ~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls 312 (754)
T PRK15370 242 TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQ 312 (754)
T ss_pred cccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhc
Confidence 4555555555555 3343332 24555566655555 3444332 35556666666555 2333322 245556666
Q ss_pred cccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCC
Q 001253 495 QNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGAL 574 (1114)
Q Consensus 495 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 574 (1114)
+|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+
T Consensus 313 ~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~L 382 (754)
T PRK15370 313 SNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NL 382 (754)
T ss_pred CCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CC
Confidence 666652 333221 455566666666553 444332 45555555555555 3444331 34555555555555 33
Q ss_pred chhhhhcccCCeeeccCccCCCcccccc----cccccccccccCCCcCC
Q 001253 575 PREIGSLFQLELLKLSENELSGSIPVQI----GNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 575 p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~L~ls~N~l~ 619 (1114)
|..+.. .|+.|++++|+|+ .+|..+ +.++++..|++.+|+|+
T Consensus 383 P~~l~~--sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 383 PENLPA--ALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CHhHHH--HHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 443321 3555555555554 333322 22244444555555444
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-21 Score=234.62 Aligned_cols=204 Identities=25% Similarity=0.406 Sum_probs=97.5
Q ss_pred cceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecc
Q 001253 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELD 494 (1114)
Q Consensus 415 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 494 (1114)
+|++|++++|+|+ .+|..+. ++|+.|+|++|++. .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|+++
T Consensus 221 nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls 291 (754)
T PRK15370 221 NIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVY 291 (754)
T ss_pred CCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECC
Confidence 4555566666555 2333322 24566666666665 3444332 34555555555554 3343332 244455555
Q ss_pred cccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCC
Q 001253 495 QNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGAL 574 (1114)
Q Consensus 495 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 574 (1114)
+|+|+ + +|..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|.+++ +
T Consensus 292 ~N~Lt------------------------~-LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-L 340 (754)
T PRK15370 292 DNSIR------------------------T-LPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-L 340 (754)
T ss_pred CCccc------------------------c-Ccccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-C
Confidence 55444 2 232221 23445555555554 2333221 345555555555542 4
Q ss_pred chhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCcccc--
Q 001253 575 PREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELG-- 652 (1114)
Q Consensus 575 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~-- 652 (1114)
|..+. ++|+.|++++|+|+ .+|..+. ++|+.|++++|+|+ .+|..+. ..|+ .|++++|+|++ +|..+.
T Consensus 341 P~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~-~LdLs~N~L~~-LP~sl~~~ 410 (754)
T PRK15370 341 PASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQ-IMQASRNNLVR-LPESLPHF 410 (754)
T ss_pred Chhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHH-HHhhccCCccc-CchhHHHH
Confidence 43332 35555555555555 3444332 35555556555555 3444433 2344 45666666653 243332
Q ss_pred --chhhhHhhhccCcccc
Q 001253 653 --NLILLEYLLLNNNHLS 668 (1114)
Q Consensus 653 --~l~~L~~L~Ls~N~l~ 668 (1114)
.++.+..|+|.+|+|+
T Consensus 411 ~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 411 RGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred hhcCCCccEEEeeCCCcc
Confidence 2345566666666665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-19 Score=205.34 Aligned_cols=262 Identities=32% Similarity=0.406 Sum_probs=202.6
Q ss_pred CcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCC-ceeeEEeEEEecCceEEEEec
Q 001253 811 FDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR-NIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~ 889 (1114)
|.....||.|+||.||++... ..+|+|.+.............+.+|+..++.+.|+ +++++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999987 78999999877665544567789999999999988 799999999777778999999
Q ss_pred CCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-CeEEeeccCceecCCCC
Q 001253 890 MARGSLGELLHGAS--STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~ 966 (1114)
+.++++.+++.... ..+.......+..|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999998777444 2789999999999999999999999 899999999999999998 79999999998654333
Q ss_pred CC-----ccccccccccccCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 001253 967 SK-----SMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038 (1114)
Q Consensus 967 ~~-----~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1114)
.. ......|+..|+|||.+.+ ..+....|+||+|++++++++|..||........... ....+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~-- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ-TLKIILELPTP-- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHH-HHHHHHhcCCc--
Confidence 22 3456789999999999987 5788899999999999999999999764443101111 11111111100
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
....... ..........+.+++.+|+..+|..|.++.+....
T Consensus 234 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLS--PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccC--ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000 00002223467889999999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-21 Score=230.83 Aligned_cols=255 Identities=21% Similarity=0.245 Sum_probs=188.5
Q ss_pred CCceecccCCeEEEEEEeC-CCcEEEEEEecc---cCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 813 ERFVIGRGACGTVYRAVLR-TGHTVAVKKLAS---NREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 813 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
..+++|.|++|.|+.+... ..+.++.|.+.. ...........+..|+-+-..+.|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4568999999988888754 344455554431 111111112225567777888999999888877777666666699
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC-
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS- 967 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 967 (1114)
|+++ +|..++... ..++..++-.++.|+..|+.|+|.. |+.|||+|++|+++..+|.+||+|||.+..+..+..
T Consensus 402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 999999733 4788899999999999999999999 999999999999999999999999999987765444
Q ss_pred --CccccccccccccCccccccCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 968 --KSMSAIAGSYGYIAPEYAYTMKVTE-KCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 968 --~~~~~~~g~~~y~aPE~~~~~~~~~-~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
......+|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||......++..... .+...... .
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-------~~~~~~~~--~ 547 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-------NYSDQRNI--F 547 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------cccccccc--c
Confidence 3456788999999999999999987 5899999999999999999997655443322000 00000000 0
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
................++.+++++||.+|.|+++|++
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000111223345677899999999999999999875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-20 Score=193.12 Aligned_cols=175 Identities=14% Similarity=0.135 Sum_probs=138.2
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHH------HHHHHHHHhcCCCCceeeEEeEEEe
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNS------FRAEILTLGKIRHRNIVKLYGFCYH 879 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~ 879 (1114)
...++|+..+++|.|+||.||.+.. ++..+|||++.......+...+. +++|+..+.+++||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999766 57789999998766555443333 6899999999999999999988664
Q ss_pred c--------CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCe
Q 001253 880 Q--------GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEA 951 (1114)
Q Consensus 880 ~--------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 951 (1114)
. +..++||||++|.+|.++.. .+. ....+++.++..+|+. |++|||++|.||+++.++ +
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence 3 35789999999999988742 222 2455899999999999 999999999999999988 9
Q ss_pred EEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHH
Q 001253 952 HVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 1007 (1114)
Q Consensus 952 kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~ 1007 (1114)
+++|||.++........ ..+.....+..++|+|++|+++....
T Consensus 174 ~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988754311111 11344555778999999999986654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.7e-20 Score=187.91 Aligned_cols=143 Identities=17% Similarity=0.136 Sum_probs=110.6
Q ss_pred CceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhh-----------------------HHHHHHHHHHHhcCCCCce
Q 001253 814 RFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNV-----------------------DNSFRAEILTLGKIRHRNI 870 (1114)
Q Consensus 814 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~ni 870 (1114)
...||+|+||+||+|...+|+.||||+++......... ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999998889999999997653221110 1122358999999987776
Q ss_pred eeEEeEEEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCeEECCCC
Q 001253 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYL-HHDCKPRIFHRDIKSNNILLDDKF 949 (1114)
Q Consensus 871 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~~Nill~~~~ 949 (1114)
.....+.. ...++||||++++++..... ....++......++.|++.+|+|+ |+. ||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CC
Confidence 44333222 23489999999987765432 235788999999999999999999 677 999999999999998 47
Q ss_pred CeEEeeccCceecC
Q 001253 950 EAHVGDFGLAKVID 963 (1114)
Q Consensus 950 ~~kl~DfG~a~~~~ 963 (1114)
.++|+|||+|...+
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.8e-21 Score=224.44 Aligned_cols=254 Identities=21% Similarity=0.192 Sum_probs=184.2
Q ss_pred CCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCCh-hhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 810 NFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNN-NVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
+|...+.+|.+.|=+|.+|+++.|. |+||++.+...... +...+...|++ ...++|||++++..+-..+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5667788999999999999999887 99999987653221 11222223444 566799999999888777888899999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC--CCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID--MPQ 966 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~--~~~ 966 (1114)
|+.. +|+|.+. -+..+...+.+.|+.|++.|+..+|.. ||+|||||.+|||++.-..+.|+||...+..- .+.
T Consensus 102 yvkh-nLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9977 9999997 345788888999999999999999999 99999999999999999999999999776432 222
Q ss_pred CCccc----cccccccccCccccccC----------C-CCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHH
Q 001253 967 SKSMS----AIAGSYGYIAPEYAYTM----------K-VTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFI 1030 (1114)
Q Consensus 967 ~~~~~----~~~g~~~y~aPE~~~~~----------~-~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 1030 (1114)
+.... +......|.|||.+... . .+++.||||+||+++|+++ |++||.-. .+..+-
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr---- 248 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYR---- 248 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHh----
Confidence 22222 22344579999987531 1 5678999999999999998 67777411 111111
Q ss_pred hcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1031 RNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
+.+... ...-+....+ ..++.++..|++.||++|.+|++.++.-+...
T Consensus 249 ~~~~~~---~e~~Le~Ied------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 249 SGNADD---PEQLLEKIED------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred ccCccC---HHHHHHhCcC------ccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 100000 0000000011 14678999999999999999999998865543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=3e-19 Score=190.11 Aligned_cols=234 Identities=20% Similarity=0.245 Sum_probs=154.4
Q ss_pred CCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC----------CceeeEEeEEE
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH----------RNIVKLYGFCY 878 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~ 878 (1114)
.+...+.||.|+++.||.+++. +|+.+|+|++...........+++++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3556678999999999999987 689999999987776555567778877766655432 12333333322
Q ss_pred e---------cC--------ceEEEEecCCCCCHHHHhc---cCCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 001253 879 H---------QG--------SNLLMYEYMARGSLGELLH---GASS---TLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935 (1114)
Q Consensus 879 ~---------~~--------~~~lv~E~~~~gsL~~~l~---~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 935 (1114)
. .. ..+++|+-+.+ +|.+++. .... ......+..+..|+++.+++||+. |++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 1 11 22678888855 9988864 1121 244556677889999999999999 9999
Q ss_pred cCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccccccccccCcccccc--------CCCCcccchHHHHHHHHHHH
Q 001253 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT--------MKVTEKCDIYSYGVVLLELL 1007 (1114)
Q Consensus 936 ~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~ 1007 (1114)
+||+|+|++++.+|.++|+||+.....+.. ......+..|.+||.... ..++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999988764421 111345578999997644 34788999999999999999
Q ss_pred hCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCC
Q 001253 1008 TGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDR 1073 (1114)
Q Consensus 1008 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1073 (1114)
+|+.||.......... + .+.. + . .....+..+|..+++++|++|
T Consensus 245 C~~lPf~~~~~~~~~~-~------------~f~~------C--~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE-W------------DFSR------C--R-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG-G------------GGTT------S--S----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc-c------------cchh------c--C-CcCHHHHHHHHHHccCCcccC
Confidence 9999997543222100 0 0101 1 1 344568889999999999988
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-21 Score=178.92 Aligned_cols=186 Identities=35% Similarity=0.570 Sum_probs=162.0
Q ss_pred CCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcc
Q 001253 96 PNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSA 175 (1114)
Q Consensus 96 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 175 (1114)
+.+.++++++.|-||+|.++ .+|+.++.+.+|++|++++|+++ ..|.+++.+++|++|+++-|++. .+|..|+.++.
T Consensus 27 ~gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~ 103 (264)
T KOG0617|consen 27 PGLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPA 103 (264)
T ss_pred ccccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCch
Confidence 44678889999999999997 78889999999999999999999 58889999999999999999998 89999999999
Q ss_pred cchhhhcccccCC-CCCCCccccccccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEec
Q 001253 176 LSQLVAYSNNISG-SLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILW 254 (1114)
Q Consensus 176 L~~L~l~~n~i~~-~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 254 (1114)
|+.|++.+|++.. .+|..|..+..|+.|.+++|.+. .+|..++++++|+.|.+.+|.+- .+|++++.++.|++|.+.
T Consensus 104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq 181 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ 181 (264)
T ss_pred hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence 9999999999965 58999999999999999999998 89999999999999999999988 799999999999999999
Q ss_pred CCcccCcccccccccc---ccchhhcccccccCCch
Q 001253 255 GNQLSGVIPKELGNCT---SLETLALYDNKQVGQLP 287 (1114)
Q Consensus 255 ~N~l~~~~p~~l~~l~---~L~~L~Ls~N~~~~~~p 287 (1114)
+|+++ .+|++++++. +=+.+.+.+|.....+.
T Consensus 182 gnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIa 216 (264)
T KOG0617|consen 182 GNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPIA 216 (264)
T ss_pred cceee-ecChhhhhhhhhhhHHHHhhhhCCCCChHH
Confidence 99999 6777777653 22344455555444333
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-19 Score=188.66 Aligned_cols=196 Identities=23% Similarity=0.293 Sum_probs=139.1
Q ss_pred CCCceeeEEeEEEe---------------------------cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHH
Q 001253 866 RHRNIVKLYGFCYH---------------------------QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGA 918 (1114)
Q Consensus 866 ~h~niv~l~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 918 (1114)
+|||||++.++|.+ ....|+||...+. +|.+++. ....+......+..|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~--~~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW--TRHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh--cCCCchHHHHHHHHHH
Confidence 59999999988743 1234899998876 9999996 3346667778888999
Q ss_pred HHHHHHHHhCCCCCeEecCCCCCCeEE--CCCC--CeEEeeccCceecCC-----CCCCccccccccccccCccccccCC
Q 001253 919 AEGLSYLHHDCKPRIFHRDIKSNNILL--DDKF--EAHVGDFGLAKVIDM-----PQSKSMSAIAGSYGYIAPEYAYTMK 989 (1114)
Q Consensus 919 ~~~L~~LH~~~~~~ivH~Dlk~~Nill--~~~~--~~kl~DfG~a~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~ 989 (1114)
++|+.|||.+ ||.|||+|.+|||+ |+|+ .+.++|||++-.-+. +.........|.-.-||||+....+
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999 99999999999998 4444 468999998753221 1111222345778899999886543
Q ss_pred C------CcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHh
Q 001253 990 V------TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAM 1063 (1114)
Q Consensus 990 ~------~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 1063 (1114)
- -.|+|.|+.|.+.||+++...||+.... ...+ .+. .++ . ..+..+......+.+++.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~-~r~-Yqe---------~---qLPalp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLD-TRT-YQE---------S---QLPALPSRVPPVARQLVF 491 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccch--heec-hhh-hhh---------h---hCCCCcccCChHHHHHHH
Confidence 1 2489999999999999999999985221 0000 000 000 0 002223344456788999
Q ss_pred hccCCCCCCCCCHHHHHHHH
Q 001253 1064 LCTNISPFDRPTMREVVLML 1083 (1114)
Q Consensus 1064 ~cl~~dP~~RPs~~evl~~L 1083 (1114)
..++.||++|+++.-....+
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999987666555
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=174.95 Aligned_cols=188 Identities=15% Similarity=0.070 Sum_probs=140.5
Q ss_pred cCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhh-HHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEEEEec
Q 001253 812 DERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNV-DNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 812 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
.+...|++|+||+||.+.. .+.+++.+.+.......... ...+++|+++++++. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3456899999999997766 57888888776554432211 224789999999995 4789998886 346999999
Q ss_pred CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 890 MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDI-KSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
++|.+|.+.... ....++.|++++++++|+. ||+|||| ||.||+++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998765421 1234678999999999999 9999999 799999999999999999999865432210
Q ss_pred ----c--------cccccccccccCccccccC-CCC-cccchHHHHHHHHHHHhCCCCCCC
Q 001253 969 ----S--------MSAIAGSYGYIAPEYAYTM-KVT-EKCDIYSYGVVLLELLTGRAPVQP 1015 (1114)
Q Consensus 969 ----~--------~~~~~g~~~y~aPE~~~~~-~~~-~~~DvwslGvil~el~tg~~p~~~ 1015 (1114)
. ......++.|++|+...-. ..+ .+.+.++-|..+|.++||+.+...
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0112356778888754322 222 567899999999999999988654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=179.89 Aligned_cols=142 Identities=19% Similarity=0.177 Sum_probs=112.5
Q ss_pred CceecccCCeEEEEEEeCCCcEEEEEEecccCCCChh-----------------------hHHHHHHHHHHHhcCCCCce
Q 001253 814 RFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNN-----------------------VDNSFRAEILTLGKIRHRNI 870 (1114)
Q Consensus 814 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~ni 870 (1114)
.+.||+|+||+||+|+..+|+.||||++......... ....++.|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999888999999999865321100 01224578899999999887
Q ss_pred eeEEeEEEecCceEEEEecCCCCCHHHH-hccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCC
Q 001253 871 VKLYGFCYHQGSNLLMYEYMARGSLGEL-LHGASSTLDWQTRFMIALGAAEGLSYLHH-DCKPRIFHRDIKSNNILLDDK 948 (1114)
Q Consensus 871 v~l~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~ 948 (1114)
.....+... ..++||||++|+++... +. ...++..+...++.|++.++.++|+ . ||+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 554444332 34899999998855433 43 3457788899999999999999999 7 999999999999999 8
Q ss_pred CCeEEeeccCceecC
Q 001253 949 FEAHVGDFGLAKVID 963 (1114)
Q Consensus 949 ~~~kl~DfG~a~~~~ 963 (1114)
+.++|+|||+|+...
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8e-21 Score=176.94 Aligned_cols=166 Identities=33% Similarity=0.574 Sum_probs=126.8
Q ss_pred cccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcc
Q 001253 458 VTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLV 537 (1114)
Q Consensus 458 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 537 (1114)
+..+...+.|.||+|+++ .+|..++.+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 344556667777777777 66777788888888888888887 77888888888888888888887 7888888888888
Q ss_pred eeeccccccc-ccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCC
Q 001253 538 TFNVSSNFLT-GRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGN 616 (1114)
Q Consensus 538 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 616 (1114)
.|||++|.+. ..+|..|+.++.|+.|+|+.|.+. .+|..++++++|+.|.+.+|.+- ++|..++.+++|++|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 8888888876 356777888888888888888887 77777788878877777777777 67777777777777777777
Q ss_pred cCCCCCChhhcCc
Q 001253 617 SFSGGIPAELGSL 629 (1114)
Q Consensus 617 ~l~~~~p~~~~~l 629 (1114)
+++ .+|++++++
T Consensus 184 rl~-vlppel~~l 195 (264)
T KOG0617|consen 184 RLT-VLPPELANL 195 (264)
T ss_pred eee-ecChhhhhh
Confidence 776 555555443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-19 Score=204.03 Aligned_cols=227 Identities=25% Similarity=0.275 Sum_probs=181.8
Q ss_pred eecccCCeEEEEEE----eCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEEEEecC
Q 001253 816 VIGRGACGTVYRAV----LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLMYEYM 890 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 890 (1114)
++|+|+||.|+.++ .+.|.-+|.|+.++......... ....|..++...+ ||.+|++...++.+...+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 37999999999876 23577899999876654433222 4556788888887 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcc
Q 001253 891 ARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 970 (1114)
Q Consensus 891 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 970 (1114)
.||++...+... ..++..........++-+++++|+. +++|||+|++||+++.+|++++.|||.++..-...
T Consensus 80 rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred ccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999999988744 3556666666677888899999998 99999999999999999999999999998642111
Q ss_pred ccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcc
Q 001253 971 SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEK 1050 (1114)
Q Consensus 971 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1114)
..+||..|||||++. ....++|.||||++++||++|..||.. +..+.. +......
T Consensus 152 -~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------~~~~~I--------------l~~~~~~ 206 (612)
T KOG0603|consen 152 -IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------DTMKRI--------------LKAELEM 206 (612)
T ss_pred -hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------HHHHHH--------------hhhccCC
Confidence 118999999999998 567899999999999999999999974 112211 1122445
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCH
Q 001253 1051 TVSHMITVLKIAMLCTNISPFDRPTM 1076 (1114)
Q Consensus 1051 ~~~~~~~l~~li~~cl~~dP~~RPs~ 1076 (1114)
+.+....+.+++.+++..+|..|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 66677788889999999999999755
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-18 Score=193.50 Aligned_cols=220 Identities=24% Similarity=0.393 Sum_probs=168.4
Q ss_pred HhcCCCCceeeEEeEEEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 001253 862 LGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSN 941 (1114)
Q Consensus 862 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 941 (1114)
++.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+......+++.-...+.++++.||+|+|.. +-.+|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 3567999999999999999999999999999999999998778899999999999999999999987 23399999999
Q ss_pred CeEECCCCCeEEeeccCceecCC-CCCCccccccccccccCccccccCC-------CCcccchHHHHHHHHHHHhCCCCC
Q 001253 942 NILLDDKFEAHVGDFGLAKVIDM-PQSKSMSAIAGSYGYIAPEYAYTMK-------VTEKCDIYSYGVVLLELLTGRAPV 1013 (1114)
Q Consensus 942 Nill~~~~~~kl~DfG~a~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DvwslGvil~el~tg~~p~ 1013 (1114)
|++++....+|++|||+...... ..........-..-|.|||.+.... .+.++||||||++++|+++++.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999999876532 1111122223445799999887531 466799999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1014 QPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
+......+..+.+.. +.. .......+.+. ...+....+..++.+||..+|++||+++++-..++.+.+..
T Consensus 159 ~~~~~~~~~~eii~~-~~~--~~~~~~rP~i~----~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILR-VKK--GGSNPFRPSIE----LLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccCChHHHHHH-HHh--cCCCCcCcchh----hhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 875544443222222 221 00011111111 01133336889999999999999999999999999987654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.3e-20 Score=209.32 Aligned_cols=279 Identities=25% Similarity=0.278 Sum_probs=133.5
Q ss_pred ccccccccCC-CCCchhhhcccccceeecccccccCc----ccccccccccCCEEEcccccccccccCccccccceeeee
Q 001253 322 EIDFSENSLI-GEIPVELSKILGLELLYLFENKLTGV----IPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQ 396 (1114)
Q Consensus 322 ~L~ls~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 396 (1114)
.|+|..+.+. ......+..+.+|+.++++++.++.. ++..+...++|++|+++++.+.+ .+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~---------- 70 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL---------- 70 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH----------
Confidence 3566666665 33444555666677777777666432 23334455556666666665542 00000
Q ss_pred ccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCc---cceeeeccCCccC----CcCcccccC-CcceEEe
Q 001253 397 LFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTS---LIFLNLETNKLTG----SIPTGVTRC-KSLVQLR 468 (1114)
Q Consensus 397 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~ 468 (1114)
..++..+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+
T Consensus 71 -------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~ 143 (319)
T cd00116 71 -------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLV 143 (319)
T ss_pred -------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEE
Confidence 011122233344444444444444333333333322 5555555554442 112223333 5555555
Q ss_pred eccceeecc----CCchhhccccccEeecccccCCCC----ccccccccccCcEEEecCceeccC----CCccccCCCCc
Q 001253 469 LGGNSFTGS----FPSDLCKLANLSTVELDQNQFSGP----IPTEIGNCNALQRLHLSDNYFTGE----LPREVGNLSNL 536 (1114)
Q Consensus 469 L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L 536 (1114)
+++|.+++. ++..+..+.+|++|++++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+++|
T Consensus 144 L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L 223 (319)
T cd00116 144 LGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSL 223 (319)
T ss_pred cCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCC
Confidence 555555521 223344445566666666665531 222333445666666666665432 22334455566
Q ss_pred ceeecccccccccccccccc-----cccceEEECccccccC----CCchhhhhcccCCeeeccCccCCCc----cccccc
Q 001253 537 VTFNVSSNFLTGRIPLEIFS-----CKMLQRLDLSWNKFVG----ALPREIGSLFQLELLKLSENELSGS----IPVQIG 603 (1114)
Q Consensus 537 ~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~ 603 (1114)
++|++++|.+++.....+.. .+.|+.|++++|.++. .+...+..+++|+++++++|.++.. +...+.
T Consensus 224 ~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~ 303 (319)
T cd00116 224 EVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLL 303 (319)
T ss_pred CEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHh
Confidence 66666666655322222211 2566666666666652 1233344445666666666666633 222333
Q ss_pred cc-ccccccccCCCcC
Q 001253 604 NL-SRLTELQMGGNSF 618 (1114)
Q Consensus 604 ~l-~~L~~L~ls~N~l 618 (1114)
.. +.|++||+.+|++
T Consensus 304 ~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 304 EPGNELESLWVKDDSF 319 (319)
T ss_pred hcCCchhhcccCCCCC
Confidence 33 4566666666543
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5e-18 Score=204.96 Aligned_cols=199 Identities=22% Similarity=0.270 Sum_probs=165.3
Q ss_pred HHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC---CCceeeEEeEEEe
Q 001253 803 DLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR---HRNIVKLYGFCYH 879 (1114)
Q Consensus 803 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 879 (1114)
+..+..+.|.+.+.||+|+||+||+|...+|+.||+|+-+....+.-.+..++ +.+++ -+-|..+..++.-
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~------~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQV------MERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHH------HHhhchhhhcchHHHHHHHcc
Confidence 34456678999999999999999999988899999999988877765444433 33443 2345555555566
Q ss_pred cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-------CCCCeE
Q 001253 880 QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD-------DKFEAH 952 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-------~~~~~k 952 (1114)
.+..++|+||.+.|+|.+++. ..+.++|.....++.|+++.++.||.. +|||+||||+|.|+. +...++
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence 778899999999999999998 667899999999999999999999999 999999999999994 234589
Q ss_pred EeeccCceecCC-CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCC
Q 001253 953 VGDFGLAKVIDM-PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRA 1011 (1114)
Q Consensus 953 l~DfG~a~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~ 1011 (1114)
|+|||.+..+.. +........++|-.+-.+|+..+.++++..|-|.++-+++-|+.|+.
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999976542 23345667789999999999999999999999999999999999973
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-19 Score=205.89 Aligned_cols=277 Identities=23% Similarity=0.221 Sum_probs=177.7
Q ss_pred eeeecccccc-cccCccccccccccccccccccCCCC----CchhhhcccccceeecccccccC------cccccccccc
Q 001253 298 YLYIYRNELN-GTIPREIGKLSSALEIDFSENSLIGE----IPVELSKILGLELLYLFENKLTG------VIPVELTTLK 366 (1114)
Q Consensus 298 ~L~L~~n~l~-~~~p~~l~~l~~L~~L~ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~------~~~~~~~~l~ 366 (1114)
.|+|..+.++ ...+..+..+..|++|+++++.++.. ++..+...+.++.++++++.+.+ ..+..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5788888887 44556677888899999999998653 45556677789999999998873 2234566677
Q ss_pred cCCEEEcccccccccccCccccccc---eeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCcccccc-Cccce
Q 001253 367 NLTKLDLSINSLTGTIPLGFQYLTN---LIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIF 442 (1114)
Q Consensus 367 ~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-~~L~~ 442 (1114)
+|+.|++++|.+.+..+..+..+.+ |++|++++|++.+... ..+...+..+ ++|+.
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~--------------------~~l~~~l~~~~~~L~~ 141 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGL--------------------RLLAKGLKDLPPALEK 141 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHH--------------------HHHHHHHHhCCCCceE
Confidence 8888888888776544444444333 5555555554432100 0112223333 55666
Q ss_pred eeeccCCccCC----cCcccccCCcceEEeeccceeecc----CCchhhccccccEeecccccCCCC----ccccccccc
Q 001253 443 LNLETNKLTGS----IPTGVTRCKSLVQLRLGGNSFTGS----FPSDLCKLANLSTVELDQNQFSGP----IPTEIGNCN 510 (1114)
Q Consensus 443 L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~ 510 (1114)
|++++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++. ++..+..++
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~ 221 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence 66666665532 233445556677777777776632 233444556788888888877643 234456677
Q ss_pred cCcEEEecCceeccCCCcccc-----CCCCcceeecccccccc----cccccccccccceEEECccccccCC----Cchh
Q 001253 511 ALQRLHLSDNYFTGELPREVG-----NLSNLVTFNVSSNFLTG----RIPLEIFSCKMLQRLDLSWNKFVGA----LPRE 577 (1114)
Q Consensus 511 ~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 577 (1114)
+|++|++++|.+++.....+. ..+.|+.|++++|.++. .+...+..+++|+.+++++|+++.. +...
T Consensus 222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~ 301 (319)
T cd00116 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES 301 (319)
T ss_pred CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence 888888888888753232222 23688899999988862 2334455668899999999999855 3334
Q ss_pred hhhc-ccCCeeeccCccC
Q 001253 578 IGSL-FQLELLKLSENEL 594 (1114)
Q Consensus 578 ~~~l-~~L~~L~L~~N~l 594 (1114)
+... +.|++|++.+|.+
T Consensus 302 ~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 302 LLEPGNELESLWVKDDSF 319 (319)
T ss_pred HhhcCCchhhcccCCCCC
Confidence 4444 6788999888864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.1e-16 Score=163.62 Aligned_cols=135 Identities=19% Similarity=0.229 Sum_probs=104.3
Q ss_pred cCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-----CCCceeeEEeEEEecC---c
Q 001253 812 DERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-----RHRNIVKLYGFCYHQG---S 882 (1114)
Q Consensus 812 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~ 882 (1114)
.....||+|+||.||. +. ++.. +||++...... ..+.+.+|+.+++.+ +||||++++|+++++. .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 3456899999999996 43 4444 79988654332 246789999999999 5799999999998864 3
Q ss_pred eE-EEEec--CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCeEECC----CCCeEEe
Q 001253 883 NL-LMYEY--MARGSLGELLHGASSTLDWQTRFMIALGAAEGL-SYLHHDCKPRIFHRDIKSNNILLDD----KFEAHVG 954 (1114)
Q Consensus 883 ~~-lv~E~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~ 954 (1114)
.+ +|+|| +.+|+|.+++++. .+++. ..++.+++.++ +|||++ +|+||||||+||+++. ++.++|+
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 33 78999 5579999999743 35555 35567778777 999999 9999999999999974 3479999
Q ss_pred eccCc
Q 001253 955 DFGLA 959 (1114)
Q Consensus 955 DfG~a 959 (1114)
||+-+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-16 Score=169.16 Aligned_cols=146 Identities=18% Similarity=0.152 Sum_probs=113.6
Q ss_pred cCCcCCceecccCCeEEEEEE--eCCCcEEEEEEecccCCCC---------------------hhhHHHHHHHHHHHhcC
Q 001253 809 DNFDERFVIGRGACGTVYRAV--LRTGHTVAVKKLASNREGN---------------------NNVDNSFRAEILTLGKI 865 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l 865 (1114)
..|++.+.||+|+||.||+|+ ..+|+.||+|+++...... ......+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358888999999999999998 4589999999997543210 00123467899999999
Q ss_pred CCC--ceeeEEeEEEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCCC
Q 001253 866 RHR--NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR-IFHRDIKSNN 942 (1114)
Q Consensus 866 ~h~--niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~N 942 (1114)
.+. .+.+++++ ...++||||++++++...... ....+..+...++.|++.+++++|.. + ++||||||+|
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 753 34444432 235899999999888776532 23456666788999999999999998 8 9999999999
Q ss_pred eEECCCCCeEEeeccCceecC
Q 001253 943 ILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 943 ill~~~~~~kl~DfG~a~~~~ 963 (1114)
|+++ ++.++++|||.|...+
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999988644
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=5e-16 Score=162.14 Aligned_cols=144 Identities=19% Similarity=0.106 Sum_probs=111.9
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCCh-------------------hhHHHHHHHHHHHhcCC
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNN-------------------NVDNSFRAEILTLGKIR 866 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~ 866 (1114)
.....|.+.+.||+|+||.||+|..++|+.||||++........ .....+..|...+..+.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 33344888899999999999999988899999999765431100 01123567888888887
Q ss_pred CC--ceeeEEeEEEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 001253 867 HR--NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNIL 944 (1114)
Q Consensus 867 h~--niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nil 944 (1114)
|+ .+++.++ ....++||||++|++|.++... .....++.+++.++.++|+. +++||||||+||+
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nil 157 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNIL 157 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEE
Confidence 77 3444443 2456899999999999876431 33567889999999999998 9999999999999
Q ss_pred ECCCCCeEEeeccCceecC
Q 001253 945 LDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 945 l~~~~~~kl~DfG~a~~~~ 963 (1114)
+++++.++|+|||++....
T Consensus 158 l~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EcCCCcEEEEECCccccCC
Confidence 9999999999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.4e-16 Score=163.08 Aligned_cols=137 Identities=20% Similarity=0.285 Sum_probs=115.6
Q ss_pred ceecccCCeEEEEEEeCCCcEEEEEEecccCCCChh-----hHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEec
Q 001253 815 FVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNN-----VDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEY 889 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 889 (1114)
+.||+|++|.||+|.+ .|..|++|+.......... ....+.+|+..+..++|++++....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 5788999987654332211 124577899999999999988888888778888999999
Q ss_pred CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 890 MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
++|++|.+++.... + .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986322 2 7889999999999999998 999999999999999 78999999998874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=160.15 Aligned_cols=133 Identities=19% Similarity=0.278 Sum_probs=108.6
Q ss_pred eecccCCeEEEEEEeCCCcEEEEEEecccCCCCh-----hhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecC
Q 001253 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNN-----NVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYM 890 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 890 (1114)
.||+|+||+||+|.+. |..|++|+........+ .....+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999964 78999999765432211 11355778999999999887666555666677789999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 891 ARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 891 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
+|++|.+++..... .++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998863211 7889999999999998 999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.3e-16 Score=188.37 Aligned_cols=155 Identities=32% Similarity=0.485 Sum_probs=120.0
Q ss_pred cCCCcchHHHHHHhHhhccCCCCCCCCCCCCCCCC--CccceEEEecCCC--ccEEEEEeecCCCcCcccCCCCCCCCcc
Q 001253 29 KGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTP--CGWIGVNCTTNDF--GAVVFSLNLTKMNLSGYLSPNIGGLVHL 104 (1114)
Q Consensus 29 ~~~~~~~~~~ll~~k~~~~~~~~~~~~W~~~~~~~--C~w~gv~C~~~~~--~~~v~~l~l~~~~l~g~~~~~l~~l~~L 104 (1114)
.++.++|.+||+++|+++.++.. .+|+++.+.| |.|.||+|+.+.. ..+|+.|+|+++++.|.+|+.++.+++|
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 35567899999999999865542 4897632211 2799999964321 2368889999999999888888888999
Q ss_pred CEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccC-cccchhhhcc
Q 001253 105 TALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKL-SALSQLVAYS 183 (1114)
Q Consensus 105 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~l~~ 183 (1114)
+.|+|++|++.|.+|..++.+++|++|+|++|.++|.+|..++++++|++|+|++|+++|.+|..++.+ .++..+++.+
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~ 524 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD 524 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecC
Confidence 999999998888888888888889999998888888888888888888888888888888888777653 3444444444
Q ss_pred cc
Q 001253 184 NN 185 (1114)
Q Consensus 184 n~ 185 (1114)
|.
T Consensus 525 N~ 526 (623)
T PLN03150 525 NA 526 (623)
T ss_pred Cc
Confidence 43
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.8e-15 Score=180.59 Aligned_cols=140 Identities=19% Similarity=0.227 Sum_probs=113.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCC-----ChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREG-----NNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
...|...+.||+|+||+||+|.+.. ..+++|+....... .....+.+.+|+++++.++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3445677899999999999999864 44555543322111 11123567889999999999999988888877778
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
.++||||+++++|.+++. ....++.++++++.|+|+. +++|||+||+||++ +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999885 3567899999999999998 99999999999999 678999999999985
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.7e-16 Score=185.29 Aligned_cols=210 Identities=23% Similarity=0.293 Sum_probs=145.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
..+|..++.|..|+||.||..+++ +.+++|.|+ .+... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhhc--cccccCCccee---------------
Confidence 367899999999999999999987 567788844 22111 1110 22233344444
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|+-...++. .+.++... +.+++|+|+- +|+|||+||+|.+|+.-|++|++|||+++..-+..
T Consensus 136 ------gDc~tllk~-~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ------GDCATLLKN-IGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ------chhhhhccc-CCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 455555552 22333222 6789999998 99999999999999999999999999987432211
Q ss_pred C--------------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc
Q 001253 967 S--------------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN 1032 (1114)
Q Consensus 967 ~--------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1032 (1114)
. -....++||+.|.|||++....|...+|.|++|+|+||.+-|+.||.+....+ .+..++..
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee----lfg~visd 273 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE----LFGQVISD 273 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH----HHhhhhhh
Confidence 1 11234689999999999999999999999999999999999999997543322 22222222
Q ss_pred CCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001253 1033 NSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTM 1076 (1114)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1076 (1114)
..+ +. +.......++.+++.+.++.+|..|--.
T Consensus 274 ~i~--------wp---E~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 274 DIE--------WP---EEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hcc--------cc---ccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 110 10 1122223467888999999999999543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.3e-16 Score=174.44 Aligned_cols=172 Identities=23% Similarity=0.351 Sum_probs=129.5
Q ss_pred ceEEEEecCCCCCHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 882 SNLLMYEYMARGSLGELLHG--ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
+.|+.|++++..+|.+|+.+ .....++.....++.|++.|++| + +.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 57899999999999999963 34477888999999999999999 5 8999999999999999999999999999
Q ss_pred eecCCCC-----CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 960 KVIDMPQ-----SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 960 ~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
....... ...++..+||..||+||.+.+..|+.++||||+|++++|++. =..++.... .
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-------t-------- 468 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-------T-------- 468 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-------h--------
Confidence 8664333 335567789999999999999999999999999999999987 222222110 0
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1079 (1114)
+..+.+..+. +......+.-+.++.+++.+.|.+||++.++
T Consensus 469 --~~d~r~g~ip---~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 469 --LTDIRDGIIP---PEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --hhhhhcCCCC---hHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 0111111111 0111111233467889999999999955443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1e-14 Score=151.09 Aligned_cols=139 Identities=22% Similarity=0.219 Sum_probs=99.3
Q ss_pred CceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHH---------------------HHHHHHHHhcCCCC--ce
Q 001253 814 RFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNS---------------------FRAEILTLGKIRHR--NI 870 (1114)
Q Consensus 814 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~--ni 870 (1114)
.+.||+|+||+||+|...+|+.||||++............. ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987643322111111 13455555555433 24
Q ss_pred eeEEeEEEecCceEEEEecCCCCCHHH-HhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCC
Q 001253 871 VKLYGFCYHQGSNLLMYEYMARGSLGE-LLHGASSTLDWQTRFMIALGAAEGLSYLHH-DCKPRIFHRDIKSNNILLDDK 948 (1114)
Q Consensus 871 v~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~ 948 (1114)
.+.+++ ...++||||++++.+.. .+.... .. .+...++.+++.++.++|. . +|+|||+||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence 444433 24689999999954321 111111 11 5677899999999999998 7 999999999999999 8
Q ss_pred CCeEEeeccCceecC
Q 001253 949 FEAHVGDFGLAKVID 963 (1114)
Q Consensus 949 ~~~kl~DfG~a~~~~ 963 (1114)
+.++++|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.5e-14 Score=142.57 Aligned_cols=135 Identities=21% Similarity=0.192 Sum_probs=114.4
Q ss_pred CCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC--CceeeEEeEEEecCceEEEEecC
Q 001253 813 ERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH--RNIVKLYGFCYHQGSNLLMYEYM 890 (1114)
Q Consensus 813 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~ 890 (1114)
+.+.||+|.++.||+++..+ ..+++|+...... ...+..|+..++.++| .+++++++++..++..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 35689999999999999864 7899999865432 3467889999999976 58999998888888899999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 891 ARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 891 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
+++.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus 76 ~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 98777654 5567778899999999999986445799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.6e-13 Score=146.43 Aligned_cols=138 Identities=17% Similarity=0.168 Sum_probs=107.1
Q ss_pred Cceec-ccCCeEEEEEEeCCCcEEEEEEecccCC----------CChhhHHHHHHHHHHHhcCCCCce--eeEEeEEEec
Q 001253 814 RFVIG-RGACGTVYRAVLRTGHTVAVKKLASNRE----------GNNNVDNSFRAEILTLGKIRHRNI--VKLYGFCYHQ 880 (1114)
Q Consensus 814 ~~~lG-~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 880 (1114)
...|| .|+.|+||.+... +..+|||.+..... ........+.+|+.++.+++|+++ ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999876 78899998854211 111234567889999999998774 6777765433
Q ss_pred Cc----eEEEEecCCC-CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEee
Q 001253 881 GS----NLLMYEYMAR-GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 955 (1114)
Q Consensus 881 ~~----~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 955 (1114)
.. .++||||++| .+|.+++.. ..++.. .+.+++.++.++|+. ||+||||||.|||++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence 22 2599999997 699998863 234443 356889999999999 999999999999999999999999
Q ss_pred ccCcee
Q 001253 956 FGLAKV 961 (1114)
Q Consensus 956 fG~a~~ 961 (1114)
||.++.
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998875
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4e-15 Score=164.03 Aligned_cols=178 Identities=34% Similarity=0.542 Sum_probs=115.5
Q ss_pred cceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecc
Q 001253 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELD 494 (1114)
Q Consensus 415 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 494 (1114)
.-...||+.|++. .+|..++.+..|+.+.|.+|.+. .+|..+.++..|.+|+|+.|+++ ..|..++.|+ |+.|-++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS 151 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence 3345666666666 56666666666666666666666 56666666666666666666666 5666666655 6666666
Q ss_pred cccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCC
Q 001253 495 QNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGAL 574 (1114)
Q Consensus 495 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 574 (1114)
+|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|.++.. -.|..||+|.|+++ .+
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis-~i 226 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS-YL 226 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCcee-ec
Confidence 66666 56666666666667777777666 56666666666666666666666 56666653 34666666666666 66
Q ss_pred chhhhhcccCCeeeccCccCCCcccccc
Q 001253 575 PREIGSLFQLELLKLSENELSGSIPVQI 602 (1114)
Q Consensus 575 p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 602 (1114)
|-.|.+|..|++|-|.+|.|. +.|..+
T Consensus 227 Pv~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 227 PVDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred chhhhhhhhheeeeeccCCCC-CChHHH
Confidence 666666666666666666666 445444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.2e-14 Score=173.55 Aligned_cols=254 Identities=24% Similarity=0.274 Sum_probs=189.6
Q ss_pred cCCcCCceecccCCeEEEEEEeC--CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR--TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 885 (1114)
..|...+.||+|+|+.|-.+... ....+|+|.+.... ...........|..+-+.+. |+|++.+++...+.+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 45777788999999999988864 34556667665443 22223444556777777776 9999999999999999999
Q ss_pred EEecCCCCCHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCeEECCCC-CeEEeeccCceec
Q 001253 886 MYEYMARGSLGELL-HGASSTLDWQTRFMIALGAAEGLSYLH-HDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVI 962 (1114)
Q Consensus 886 v~E~~~~gsL~~~l-~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~~ 962 (1114)
++||..++++.+-+ +......+.........|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999999988 543336666777788999999999999 76 999999999999999999 9999999999876
Q ss_pred CC--CCCCccccccc-cccccCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCC-CHHHHHHHHHhcCCccc
Q 001253 963 DM--PQSKSMSAIAG-SYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPVQPLDQGG-DLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 963 ~~--~~~~~~~~~~g-~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 1037 (1114)
.. .........+| ++.|+|||...+.. .....|+||.|+++.-+.+|..|+....... ....|....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-------- 247 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-------- 247 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc--------
Confidence 54 22333445678 99999999988854 4568899999999999999999987554322 122222110
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV 1080 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1080 (1114)
................++..+++..+|..|.+.+++.
T Consensus 248 ------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 ------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ------cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 0000111122233566778888889999999888764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.6e-15 Score=163.60 Aligned_cols=181 Identities=30% Similarity=0.484 Sum_probs=143.1
Q ss_pred cCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEE
Q 001253 437 NTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLH 516 (1114)
Q Consensus 437 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 516 (1114)
++--...||+.|++. ++|..+..+..|+.+.|..|.|. .+|..++++..|++|||+.|+++ ..|..+..|+ |+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 344456788888887 67888888888888888888887 78888888888888888888887 6777776665 78888
Q ss_pred ecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCC
Q 001253 517 LSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSG 596 (1114)
Q Consensus 517 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 596 (1114)
+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+..|+.|.+..|++. .+|++++.| .|..||+|.|+++
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis- 224 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS- 224 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-
Confidence 8888887 67778887788888888888887 77888888888888888888887 667777744 5778888888888
Q ss_pred cccccccccccccccccCCCcCCCCCChhhc
Q 001253 597 SIPVQIGNLSRLTELQMGGNSFSGGIPAELG 627 (1114)
Q Consensus 597 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 627 (1114)
.+|..|.+|..|++|.|.+|+|. ..|..+.
T Consensus 225 ~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 225 YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 78888888888888888888887 5565543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.4e-14 Score=170.93 Aligned_cols=112 Identities=36% Similarity=0.583 Sum_probs=69.3
Q ss_pred ccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEec
Q 001253 608 LTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFS 687 (1114)
Q Consensus 608 L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls 687 (1114)
++.|+|++|.++|.+|..++.+++|+ .|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|+.++++++|+.|+|+
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~-~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCC-EEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 45556666666666666666666665 56666666666666666666666666666666666666666666666666666
Q ss_pred cCcccCCCCCc--ccccccccccccCCCCCCCCCC
Q 001253 688 YNNLTGPIPSS--QTFQNMSVNSFSGSKGLCGGPL 720 (1114)
Q Consensus 688 ~N~l~g~ip~~--~~~~~~~~~~~~~n~~lc~~p~ 720 (1114)
+|+++|.+|.. ..+.......+.+|..+|+.|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence 66666666642 1111222345677888888653
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.6e-13 Score=158.26 Aligned_cols=204 Identities=36% Similarity=0.498 Sum_probs=143.2
Q ss_pred EEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCC-cceEEeeccceeeccCCchhhccccccEeecccc
Q 001253 418 VVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCK-SLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQN 496 (1114)
Q Consensus 418 ~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 496 (1114)
.++++.|.+. .....+...+.++.|++.+|.++ .++....... +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4555555553 12223333456677777777776 4555555553 7777777777777 55567777788888888888
Q ss_pred cCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCch
Q 001253 497 QFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPR 576 (1114)
Q Consensus 497 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 576 (1114)
+++ .+|...+.++.|+.|++++|+++ .+|.....+..|++|++++|.+. .++..+..+.++..|.+++|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 887 55665557778888888888887 56665555666888888888544 56667777888888888888876 4467
Q ss_pred hhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcc
Q 001253 577 EIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLS 630 (1114)
Q Consensus 577 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 630 (1114)
.++.++++++|++++|+++ .++. ++.+.+++.|++++|.++..+|.......
T Consensus 250 ~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~~~ 301 (394)
T COG4886 250 SIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIALLLL 301 (394)
T ss_pred hhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhhhccch
Confidence 7788888888888888888 4444 78888888888888888866665544433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.8e-13 Score=158.02 Aligned_cols=180 Identities=36% Similarity=0.524 Sum_probs=100.9
Q ss_pred ccCcEEEecCceeccCCCccccCCC-CcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeee
Q 001253 510 NALQRLHLSDNYFTGELPREVGNLS-NLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLK 588 (1114)
Q Consensus 510 ~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 588 (1114)
+.++.|++.+|.++ .+|.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|+++ .+|...+.++.|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 44444444444444 3333344342 4555555555554 34444445555555555555554 4444444555555555
Q ss_pred ccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccc
Q 001253 589 LSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLS 668 (1114)
Q Consensus 589 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 668 (1114)
+++|+++ .+|.....+..|++|++++|++. .++..+.++..+. .+.+++|++... |..++.+..|++|++++|+++
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~-~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS-GLELSNNKLEDL-PESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhccccc-ccccCCceeeec-cchhccccccceecccccccc
Confidence 5555555 44444444444666666666433 4455555566555 455666665543 556667777777777777777
Q ss_pred cCCCCccccccccceEEeccCcccCCCCCc
Q 001253 669 GEIPGSFVNLSSLLGCNFSYNNLTGPIPSS 698 (1114)
Q Consensus 669 g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~ 698 (1114)
.++. +..+.+++.|++++|.++...|..
T Consensus 269 -~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 269 -SISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred -cccc-ccccCccCEEeccCccccccchhh
Confidence 4444 777777777777777777766643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.9e-12 Score=150.44 Aligned_cols=143 Identities=21% Similarity=0.226 Sum_probs=101.2
Q ss_pred ceecccCCeEEEEEEeCCCcEEEEEEecccCCCCh---------------------------h----------hHHHHHH
Q 001253 815 FVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNN---------------------------N----------VDNSFRA 857 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---------------------------~----------~~~~~~~ 857 (1114)
+.||.|++|.||+|++++|+.||||+.++.....- . .+-+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999865421100 0 0012455
Q ss_pred HHHHHhcCC-----CCceeeEEeEEEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHH-HHHHHHhCCCC
Q 001253 858 EILTLGKIR-----HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE-GLSYLHHDCKP 931 (1114)
Q Consensus 858 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~~~~ 931 (1114)
|+..+.+++ ++++.-..-+....+..++||||++|+++.++........ .+..++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~--- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD--- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC---
Confidence 665555552 3443322222233456799999999999988765322222 23456666665 46788887
Q ss_pred CeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 932 ~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|++|+|++|.||+++++++++++|||++..+.
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.7e-12 Score=131.13 Aligned_cols=199 Identities=22% Similarity=0.315 Sum_probs=137.9
Q ss_pred HHhcCCCCceeeEEeEEEecC-----ceEEEEecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 001253 861 TLGKIRHRNIVKLYGFCYHQG-----SNLLMYEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932 (1114)
Q Consensus 861 ~l~~l~h~niv~l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 932 (1114)
-+-.+.|-|+|+++.|+.+.. +..++.|||+.|++..++++ +...+......+++.||..||.|||+. .|.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 344557999999999986543 46899999999999999973 445788888999999999999999984 889
Q ss_pred eEecCCCCCCeEECCCCCeEEeeccCceecCCC----CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh
Q 001253 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP----QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 1008 (1114)
Q Consensus 933 ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t 1008 (1114)
|+|+++.-+-|++..+|-+|+.--.-.. .... .........+-++|.|||.-.....+.++|||+||+...||..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999888874221111 0000 0011122346789999998877778889999999999999988
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1009 GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1009 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+...-............+...+ ...-++ .=..++.+|++..|..||+|++++.
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i------~~len~--------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVI------IGLENG--------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhhhhe------eeccCc--------------cccCcCcccccCCCCCCcchhhhhc
Confidence 7643211111000000000000 000000 0124677999999999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.4e-12 Score=141.70 Aligned_cols=250 Identities=23% Similarity=0.208 Sum_probs=182.5
Q ss_pred cCCcCCceecc--cCCeEEEEEEe--C-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCc
Q 001253 809 DNFDERFVIGR--GACGTVYRAVL--R-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 809 ~~~~~~~~lG~--G~~g~Vy~~~~--~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 882 (1114)
..|.....+|. |.+|.||.++. + ++..+|+|+-+........... =.+|+...+.+ .|++.++.+..++.++.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~-k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKR-KLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccccc-ccchhhcccccCccccccccCcccccCCc
Confidence 44667778999 99999999997 3 6889999985544432222222 23466666666 48999998889999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCeEECCC-CCeEEeecc
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE----GLSYLHHDCKPRIFHRDIKSNNILLDDK-FEAHVGDFG 957 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG 957 (1114)
.|+-+|++. .++..+.+.....++.........+..+ |+.++|+. +++|-|+||.||.+..+ ...+++|||
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 999999996 5999988866666788888888888888 99999998 99999999999999999 889999999
Q ss_pred CceecCCCCCCc----cccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 958 LAKVIDMPQSKS----MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 958 ~a~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
+...+....... .....|...|++||...+ -++.++|+|++|.+..+..++..+...... ..|..
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----~~W~~------ 337 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN----SSWSQ------ 337 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC----CCccc------
Confidence 998776443211 122257889999997654 478899999999999999998766543311 01100
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. +..+ .+.+........+...+..+++.+|..|++++.+..
T Consensus 338 --~----r~~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 --L----RQGY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --c----cccc-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 0000 111111122234555888999999999999887643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.8e-11 Score=141.66 Aligned_cols=144 Identities=17% Similarity=0.233 Sum_probs=95.0
Q ss_pred cCCcCCceecccCCeEEEEEEeCC-CcEEEEEEecccCCCC---------------------------h----hhHH---
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRT-GHTVAVKKLASNREGN---------------------------N----NVDN--- 853 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~---------------------------~----~~~~--- 853 (1114)
.+|+. +.||+|++|.||+|++++ |+.||||+.++..... . +..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999987 9999999997652110 0 1111
Q ss_pred ---HHHHHHHHHhcCC----CCceeeEEeEEEe-cCceEEEEecCCCCCHHHHhccCCCCCC-----HHHHHHHHHHHHH
Q 001253 854 ---SFRAEILTLGKIR----HRNIVKLYGFCYH-QGSNLLMYEYMARGSLGELLHGASSTLD-----WQTRFMIALGAAE 920 (1114)
Q Consensus 854 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~l~-----~~~~~~i~~~i~~ 920 (1114)
+|.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++-.-.....+ ......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 2344554444442 3333443344432 5677899999999999875321111222 2222223333
Q ss_pred HHHHHHhCCCCCeEecCCCCCCeEECCCC----CeEEeeccCceecC
Q 001253 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKF----EAHVGDFGLAKVID 963 (1114)
Q Consensus 921 ~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfG~a~~~~ 963 (1114)
+... |++|+|+||.||+++.++ +++++|||++..++
T Consensus 276 ----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3345 999999999999999988 99999999998753
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.4e-12 Score=130.14 Aligned_cols=129 Identities=26% Similarity=0.334 Sum_probs=80.9
Q ss_pred cccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEE
Q 001253 485 LANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLD 564 (1114)
Q Consensus 485 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 564 (1114)
...|+++||++|.|+ .+-++..-+|+++.|++|+|.|..+ +.+..+++|+.||||+|.++ .+..+-.++-+++.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 345666777777766 4555556667777777777777632 22666777777777777776 4444445566777777
Q ss_pred CccccccCCCchhhhhcccCCeeeccCccCCCcc-cccccccccccccccCCCcCC
Q 001253 565 LSWNKFVGALPREIGSLFQLELLKLSENELSGSI-PVQIGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 565 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~ 619 (1114)
|++|.+... ..++.+.+|..||+++|+|.... ...+++++-|+.+.|.+|++.
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 777776522 34566677777777777766221 234566666666666666665
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.9e-12 Score=129.67 Aligned_cols=130 Identities=32% Similarity=0.367 Sum_probs=67.5
Q ss_pred CCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccc
Q 001253 533 LSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQ 612 (1114)
Q Consensus 533 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 612 (1114)
...|+.+|||+|.|+ .+..+..-.+.++.|++|+|.+... ..+..+++|..||||+|.++ .+..+-.++.+.++|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 344555555555555 4444444455555555555555422 22555555556666666555 3334444455556666
Q ss_pred cCCCcCCCCCChhhcCcchhhHHhhcccccccccC-CccccchhhhHhhhccCccccc
Q 001253 613 MGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLI-PPELGNLILLEYLLLNNNHLSG 669 (1114)
Q Consensus 613 ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g 669 (1114)
|++|.+.. -..++++-+|. .||+++|++.... -..+|+|+-|+.|.|-+|+|++
T Consensus 359 La~N~iE~--LSGL~KLYSLv-nLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 359 LAQNKIET--LSGLRKLYSLV-NLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhhhHhh--hhhhHhhhhhe-eccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 66665531 11234444444 4555555544322 2456666666666666666663
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.3e-11 Score=121.12 Aligned_cols=130 Identities=20% Similarity=0.120 Sum_probs=95.9
Q ss_pred ceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCcee-eEEeEEEecCceEEEEecCCCC
Q 001253 815 FVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV-KLYGFCYHQGSNLLMYEYMARG 893 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~g 893 (1114)
+.++.|.++.||+++.. ++.|++|+....... ...+..|+..++.+.+.+++ +++.+ ..+..++||||++|.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~ 76 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGS 76 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCC
Confidence 56899999999999976 788999997654321 22456788888888655444 44433 334568999999998
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 894 SLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC--KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 894 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
++.+.- ......+.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 77 ~l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 776430 111345678999999999872 12369999999999999 66899999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.8e-10 Score=131.79 Aligned_cols=166 Identities=19% Similarity=0.272 Sum_probs=127.0
Q ss_pred eCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCCCCCHHHHhccCCCCCCHH
Q 001253 830 LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQ 909 (1114)
Q Consensus 830 ~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~ 909 (1114)
..++.+|.|++.+.... .......+-++.++.+|||+|+++++.++.++..|+|+|.+. -|..+++. +...
T Consensus 34 k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHH
Confidence 33788999998875544 234556778889999999999999999999999999999886 46666653 3356
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccccccccccCccccccCC
Q 001253 910 TRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMK 989 (1114)
Q Consensus 910 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 989 (1114)
.....+.||+.||.|||..| +++|++|....|+|++.|..||++|..+........ ......---.|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 67788899999999999765 899999999999999999999999998875431111 111112223466666543222
Q ss_pred CCcccchHHHHHHHHHHHhC
Q 001253 990 VTEKCDIYSYGVVLLELLTG 1009 (1114)
Q Consensus 990 ~~~~~DvwslGvil~el~tg 1009 (1114)
-..|.|.||+++||++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.1e-10 Score=115.23 Aligned_cols=139 Identities=14% Similarity=0.119 Sum_probs=100.8
Q ss_pred ceecccCCeEEEEEEeCC-------CcEEEEEEecccCC----------CC---------hhhHHHHH----HHHHHHhc
Q 001253 815 FVIGRGACGTVYRAVLRT-------GHTVAVKKLASNRE----------GN---------NNVDNSFR----AEILTLGK 864 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~----------~~---------~~~~~~~~----~E~~~l~~ 864 (1114)
..||.|.-+.||.|...+ +..+|||+.+.... ++ ....+.+. +|++.+++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999998553 47999998864321 01 11122333 78888888
Q ss_pred CCC--CceeeEEeEEEecCceEEEEecCCCCCHH-HHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCC
Q 001253 865 IRH--RNIVKLYGFCYHQGSNLLMYEYMARGSLG-ELLHGASSTLDWQTRFMIALGAAEGLSYL-HHDCKPRIFHRDIKS 940 (1114)
Q Consensus 865 l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL~-~~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~ 940 (1114)
+.. -++.+++++ ...++||||+.++.+. ..+++ ..++..+...+..+++.+|..+ |.. ++||+|+++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 853 456666654 4678999999875332 22321 2344556677888999999998 777 999999999
Q ss_pred CCeEECCCCCeEEeeccCceecC
Q 001253 941 NNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 941 ~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
.||+++ ++.+.++|||.|...+
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4689999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.2e-11 Score=133.25 Aligned_cols=184 Identities=24% Similarity=0.258 Sum_probs=119.3
Q ss_pred hccccccEeecccccCCCCcc--ccccccccCcEEEecCceeccC--CCccccCCCCcceeeccccccccccccc-cccc
Q 001253 483 CKLANLSTVELDQNQFSGPIP--TEIGNCNALQRLHLSDNYFTGE--LPREVGNLSNLVTFNVSSNFLTGRIPLE-IFSC 557 (1114)
Q Consensus 483 ~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l 557 (1114)
.++.+|+++.|.+..+. ..+ .....|++++.||||+|-|... +-.-...|++|+.|+|+.|++.-..... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 35667777777777765 333 3566788888888888877632 2233456888888888888886222211 1246
Q ss_pred ccceEEECccccccCC-CchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCC-ChhhcCcchhhHH
Q 001253 558 KMLQRLDLSWNKFVGA-LPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGI-PAELGSLSSLQIA 635 (1114)
Q Consensus 558 ~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~-p~~~~~l~~L~~~ 635 (1114)
+.|+.|.|+.|.|+.. +-.....+|+|+.|+|+.|...+.-......+..|++|||++|++-... -...+.++.|. .
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~-~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLN-Q 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchh-h
Confidence 7888888888888732 2223346688888888888644444555566778888888888886332 13456777777 5
Q ss_pred hhcccccccccC-Ccc-----ccchhhhHhhhccCcccc
Q 001253 636 LNLSYNNLSGLI-PPE-----LGNLILLEYLLLNNNHLS 668 (1114)
Q Consensus 636 L~Ls~N~l~~~~-p~~-----~~~l~~L~~L~Ls~N~l~ 668 (1114)
|+++.+.++..- |.. .....+|++|++++|++.
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 777777776542 221 134456667777776664
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.4e-11 Score=143.75 Aligned_cols=242 Identities=27% Similarity=0.237 Sum_probs=122.7
Q ss_pred cCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeec
Q 001253 367 NLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLE 446 (1114)
Q Consensus 367 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls 446 (1114)
.++.+++..|.|.. +-..+..+++|..|++.+|+|..... .+..+.+|++|+|++|+|+...+ +..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchheeccccccccccc--hhhccchhhheec
Confidence 33444444444442 22223444445555555554442221 14455666666666666654322 3334446666777
Q ss_pred cCCccCCcCcccccCCcceEEeeccceeeccCC-chhhccccccEeecccccCCCCccccccccccCcEEEecCceeccC
Q 001253 447 TNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFP-SDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGE 525 (1114)
Q Consensus 447 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 525 (1114)
+|.|+. ...+..++.|+.+++++|++...-+ . ...+.+++.+++++|.+.. ...+..+..+..+++..|.++..
T Consensus 149 ~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~ 223 (414)
T KOG0531|consen 149 GNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKL 223 (414)
T ss_pred cCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceec
Confidence 776663 2334456667777777777663333 1 4556667777777776652 23344444555556666666532
Q ss_pred CCccccCCC--CcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCc---ccc
Q 001253 526 LPREVGNLS--NLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGS---IPV 600 (1114)
Q Consensus 526 ~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~p~ 600 (1114)
-+ +..+. .|+.+++++|++. .++..+..+..+..|++++|++... ..+...+.+..+.++.|.+... ...
T Consensus 224 ~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (414)
T KOG0531|consen 224 EG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQE 298 (414)
T ss_pred cC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcc
Confidence 21 11122 2666666666665 3334445556666666666666533 1233334455555555554421 111
Q ss_pred c-ccccccccccccCCCcCCCCC
Q 001253 601 Q-IGNLSRLTELQMGGNSFSGGI 622 (1114)
Q Consensus 601 ~-~~~l~~L~~L~ls~N~l~~~~ 622 (1114)
. .....+++.+++.+|++....
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
T KOG0531|consen 299 YITSAAPTLVTLTLELNPIRKIS 321 (414)
T ss_pred ccccccccccccccccCcccccc
Confidence 1 334445555555555554433
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-09 Score=106.46 Aligned_cols=133 Identities=25% Similarity=0.317 Sum_probs=103.6
Q ss_pred eecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhH-----HHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecC
Q 001253 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVD-----NSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYM 890 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 890 (1114)
.+++|+-+.+|.+.+. |.++++|.-.+.....++.. ..-.+|+.++.+++--.|....=+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999876 55677776655544333322 23457888888887666665555667788889999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 891 ARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 891 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
+|..|.+.+... ...++..+-+-+.-||.. ||+|+|+.++||.+..+. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888743 245666777778889998 999999999999998775 99999999875
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4e-12 Score=133.40 Aligned_cols=183 Identities=25% Similarity=0.299 Sum_probs=94.3
Q ss_pred cCccceEEEeecccccCCCCccc----cccCccceeeeccCCccCCcCc-------------ccccCCcceEEeecccee
Q 001253 412 AYSQLWVVDLSDNHLTGKIPRHI----CRNTSLIFLNLETNKLTGSIPT-------------GVTRCKSLVQLRLGGNSF 474 (1114)
Q Consensus 412 ~l~~L~~L~Ls~N~l~~~~~~~~----~~~~~L~~L~Ls~N~l~~~~p~-------------~~~~l~~L~~L~L~~N~l 474 (1114)
..++|++||||+|.|....++.| .....|++|+|.+|.+...--. -...-+.|+++..++|++
T Consensus 90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrl 169 (382)
T KOG1909|consen 90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRL 169 (382)
T ss_pred cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccc
Confidence 44578888888888775554433 3446778888888877521111 122334566666666666
Q ss_pred ecc----CCchhhccccccEeecccccCCCC----ccccccccccCcEEEecCceeccC----CCccccCCCCcceeecc
Q 001253 475 TGS----FPSDLCKLANLSTVELDQNQFSGP----IPTEIGNCNALQRLHLSDNYFTGE----LPREVGNLSNLVTFNVS 542 (1114)
Q Consensus 475 ~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls 542 (1114)
... +...|...+.|+.+.+++|.|... +...|..+++|+.|||.+|-|+.. +...+..+++|+.|+++
T Consensus 170 en~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~ 249 (382)
T KOG1909|consen 170 ENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLG 249 (382)
T ss_pred ccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccc
Confidence 421 122344445566666666655411 122344555566666666655421 22233344444555555
Q ss_pred cccccccccccccccccceEEECccccccCCCchhhh-----hcccCCeeeccCccCCC----ccccccccccccccccc
Q 001253 543 SNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIG-----SLFQLELLKLSENELSG----SIPVQIGNLSRLTELQM 613 (1114)
Q Consensus 543 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l 613 (1114)
++.+ ...-...|. ..++|++|.|.+|.++. .+...+...+.|..|+|
T Consensus 250 dcll------------------------~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnL 305 (382)
T KOG1909|consen 250 DCLL------------------------ENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNL 305 (382)
T ss_pred cccc------------------------ccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcC
Confidence 4444 433222221 23455555555555551 12223444566666666
Q ss_pred CCCcC
Q 001253 614 GGNSF 618 (1114)
Q Consensus 614 s~N~l 618 (1114)
++|.+
T Consensus 306 ngN~l 310 (382)
T KOG1909|consen 306 NGNRL 310 (382)
T ss_pred Ccccc
Confidence 66666
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.5e-09 Score=113.09 Aligned_cols=273 Identities=14% Similarity=0.104 Sum_probs=169.7
Q ss_pred cCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHH-hcCCCCceeeEEeE------EEecC-ce
Q 001253 812 DERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTL-GKIRHRNIVKLYGF------CYHQG-SN 883 (1114)
Q Consensus 812 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~------~~~~~-~~ 883 (1114)
...+.||+|+.+.+|-.-. -...+.|++.......+ .+ .+..+ +.-.||-+-.-+.+ .-+++ ..
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~---aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQ---AQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHH---HH---HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 3456799999999996532 12346788876554321 11 12222 33356643221111 11222 35
Q ss_pred EEEEecCCCCCHHH-Hhc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeecc
Q 001253 884 LLMYEYMARGSLGE-LLH-----GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~-~l~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 957 (1114)
.+.|..+++..--. +.. +......|+-.+++++.+|.+.+.||.. |.+-+|+.++|+|+++++.|.+.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 68888887753222 221 1223678999999999999999999999 99999999999999999999999866
Q ss_pred CceecCCCCCCccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCCCCHHHHHHHHHh
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTG-RAPVQPLDQGGDLVTWVRNFIR 1031 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~ 1031 (1114)
.-... .........+|...|.+||.-. +..-+...|.|.+||++++++.| ++||.+.....+...-.+..+.
T Consensus 163 sfqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 163 SFQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred ceeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 44332 2333444567999999999654 44566789999999999999886 9999876533221111111111
Q ss_pred cCCcccccccc--cccCCCcccHH-HHHHHHHHHhhccCC--CCCCCCCHHHHHHHHHhhhccCCCccccc
Q 001253 1032 NNSLVSGMLDA--RLNLQDEKTVS-HMITVLKIAMLCTNI--SPFDRPTMREVVLMLSESNRRQGHFEFSP 1097 (1114)
Q Consensus 1032 ~~~~~~~~~~~--~~~~~~~~~~~-~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~i~~~~~~~~~~~ 1097 (1114)
.+.+....... ........+-+ -...+..+..+|+.. .+.-|||++..+..|.++...-.++-...
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a 311 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSA 311 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcc
Confidence 22222221111 11111111111 123456667788875 36689999999999888876666554444
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3e-11 Score=140.92 Aligned_cols=197 Identities=30% Similarity=0.366 Sum_probs=78.5
Q ss_pred cccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcc
Q 001253 458 VTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLV 537 (1114)
Q Consensus 458 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 537 (1114)
+..+++|+.|++.+|+|. .+...+..+.+|++|++++|+|+... .+..++.|+.|++++|.|+. ...+..++.|+
T Consensus 91 l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~ 165 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISD--ISGLESLKSLK 165 (414)
T ss_pred cccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhheeccCcchh--ccCCccchhhh
Confidence 333444444444444444 12212334444444444444444221 12333334444444444441 12233344444
Q ss_pred eeeccccccccccccc-ccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccc--cccccccC
Q 001253 538 TFNVSSNFLTGRIPLE-IFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLS--RLTELQMG 614 (1114)
Q Consensus 538 ~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~ls 614 (1114)
.+++++|++.. +... ...+..++.+++++|.+... ..+..+..+..+++..|.++-.-+. ..+. .|+.++++
T Consensus 166 ~l~l~~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~l--~~~~~~~L~~l~l~ 240 (414)
T KOG0531|consen 166 LLDLSYNRIVD-IENDELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEGL--NELVMLHLRELYLS 240 (414)
T ss_pred cccCCcchhhh-hhhhhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccCc--ccchhHHHHHHhcc
Confidence 44444444442 1111 23344444444444444311 1222223333334444444421111 1111 24555555
Q ss_pred CCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccc
Q 001253 615 GNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLS 668 (1114)
Q Consensus 615 ~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 668 (1114)
+|++. .++..+..+..+. .|++++|+++.. ..+.....+..+.++.|.+.
T Consensus 241 ~n~i~-~~~~~~~~~~~l~-~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 241 GNRIS-RSPEGLENLKNLP-VLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred cCccc-ccccccccccccc-ccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 55554 2223333444444 345555554432 12333444555555555544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3e-11 Score=143.48 Aligned_cols=279 Identities=22% Similarity=0.253 Sum_probs=189.0
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
...+.+.+.+.+-+|+++.++.+.-. .|...++|+............+....+-.+.-..++|.++...-.+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567778888999999999988744 45455555543322211111222223333333345677776655555667889
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+|++|..++++...++..+ ..+..........+..+.+|||+. .+.|||++|.|.+...++..+++|||.......
T Consensus 881 L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 9999999999999998544 344444444555677889999997 699999999999999999999999983321110
Q ss_pred C-------------------------C-----CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 001253 965 P-------------------------Q-----SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQ 1014 (1114)
Q Consensus 965 ~-------------------------~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~ 1014 (1114)
- . ........||+.|.+||...+......+|.|+.|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0 011234579999999999999999999999999999999999999997
Q ss_pred CCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcc
Q 001253 1015 PLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFE 1094 (1114)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 1094 (1114)
...... .++... .....+ ...+.+..+.+.+++.+.+..+|.+|-.|.. ....-++..
T Consensus 1037 a~tpq~----~f~ni~----------~~~~~~-p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~-------~~e~k~~~~ 1094 (1205)
T KOG0606|consen 1037 AETPQQ----IFENIL----------NRDIPW-PEGPEEGSYEAQDLINRLLTEEPTQRLGAKG-------AAEVKGHPF 1094 (1205)
T ss_pred Ccchhh----hhhccc----------cCCCCC-CCCccccChhhhhhhhhhhccCchhccCccc-------ccccccCCc
Confidence 544321 111111 111111 2234445566778888999999999987762 123456778
Q ss_pred cccCCCCCcccccccc
Q 001253 1095 FSPMDHDSDQKLENEF 1110 (1114)
Q Consensus 1095 ~~~~~~~~~~~~~~~~ 1110 (1114)
+.+++|+..+...-++
T Consensus 1095 ~~~~~~~~l~~q~~~~ 1110 (1205)
T KOG0606|consen 1095 FQDVDWENLALQKAEF 1110 (1205)
T ss_pred cCCCCccccccccCcc
Confidence 8889999877665443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-10 Score=143.65 Aligned_cols=299 Identities=24% Similarity=0.235 Sum_probs=180.2
Q ss_pred CCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCC--cccccccccccccccceeccccccccCCCCcccccCcc
Q 001253 98 IGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNR--LEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSA 175 (1114)
Q Consensus 98 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~--l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 175 (1114)
.......+...+-+|.+. .++... .++.|++|-+.+|. +....++.|..++.|++|||++|.=-+.+|.+++.|-+
T Consensus 519 ~~~~~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~ 596 (889)
T KOG4658|consen 519 VKSWNSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVH 596 (889)
T ss_pred ccchhheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhh
Confidence 444567788888888774 344433 34479999999996 55444455888999999999999877799999999999
Q ss_pred cchhhhcccccCCCCCCCccccccccceeccccccccccCCCCCCCCccceeeccccccC--CCCcccccccccccEEEe
Q 001253 176 LSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLS--GEIPKEIGMLKYLTDVIL 253 (1114)
Q Consensus 176 L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~L 253 (1114)
|++|++++..+. .+|..+++|++|.+|++..+.-...+|.....|++|++|.+...... ...-..+..+++|+.+..
T Consensus 597 LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 597 LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred hhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 999999999998 89999999999999999998766666777778999999999776522 233344455555555555
Q ss_pred cCCcccCccccccccccccchh----hcccccccCCchhhhcCCCccceeeecccccccccCcccccccccccccccccc
Q 001253 254 WGNQLSGVIPKELGNCTSLETL----ALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENS 329 (1114)
Q Consensus 254 ~~N~l~~~~p~~l~~l~~L~~L----~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~ 329 (1114)
..... .+-..+..++.|..+ .+.. ......+..++.+.+|+.|.+.++.+............ .++
T Consensus 676 ~~~s~--~~~e~l~~~~~L~~~~~~l~~~~-~~~~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~---~~~----- 744 (889)
T KOG4658|consen 676 TISSV--LLLEDLLGMTRLRSLLQSLSIEG-CSKRTLISSLGSLGNLEELSILDCGISEIVIEWEESLI---VLL----- 744 (889)
T ss_pred ecchh--HhHhhhhhhHHHHHHhHhhhhcc-cccceeecccccccCcceEEEEcCCCchhhcccccccc---hhh-----
Confidence 43332 111223444444432 2222 22334555677778888888877776532222211111 111
Q ss_pred CCCCCchhhhcccccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCC-CCC
Q 001253 330 LIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGG-IPQ 408 (1114)
Q Consensus 330 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~ 408 (1114)
.++++..+...++... ..+.+....++|+.|.+..+.....+......+..+..+.+..+.+.+. .-.
T Consensus 745 ----------~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~ 813 (889)
T KOG4658|consen 745 ----------CFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLC 813 (889)
T ss_pred ----------hHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeee
Confidence 0111222222222111 1112222346677777776665544444445555555544555555443 233
Q ss_pred CCCcCccceEEEe
Q 001253 409 RLGAYSQLWVVDL 421 (1114)
Q Consensus 409 ~~~~l~~L~~L~L 421 (1114)
..+.++++..+.+
T Consensus 814 ~l~~l~~i~~~~l 826 (889)
T KOG4658|consen 814 SLGGLPQLYWLPL 826 (889)
T ss_pred cCCCCceeEeccc
Confidence 3444444444433
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.5e-09 Score=104.56 Aligned_cols=145 Identities=21% Similarity=0.229 Sum_probs=108.6
Q ss_pred CCceecccCCeEEEEEEeCCCcEEEEEEecccCCCCh-----hhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 813 ERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNN-----NVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 813 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
....|-+|+-+.|+++.+. |+.+.||.-......-+ -..+...+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567899999999999997 88888886554433222 22345678999998887555555555667777778999
Q ss_pred ecCCC-CCHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC---CeEEeeccCcee
Q 001253 888 EYMAR-GSLGELLHGASST-LDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF---EAHVGDFGLAKV 961 (1114)
Q Consensus 888 E~~~~-gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfG~a~~ 961 (1114)
||++| .++.+++...... .+.+.....+..|-+.+.-||.. +++|+|+..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4778877643332 23333367888999999999999 999999999999997655 358999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.6e-10 Score=131.51 Aligned_cols=251 Identities=20% Similarity=0.184 Sum_probs=177.4
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC--CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCc
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR--TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 882 (1114)
....+|..+..||.|.|+.||+...+ ++..|++|...............+ .|+.+...+ .|.+++.....+.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCcccccc
Confidence 34578999999999999999998854 678999998876655443322222 355555555 58888887777777777
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-CCeEEeeccCcee
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK-FEAHVGDFGLAKV 961 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG~a~~ 961 (1114)
.|+--||+++++...... -...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+..
T Consensus 341 ~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 889999999998877662 334677888899999999999999988 99999999999999886 7889999999874
Q ss_pred cCCCCCCcccccccccccc--CccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 962 IDMPQSKSMSAIAGSYGYI--APEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
+.. .. ....+..+++ +|+......+..+.|++|||..+.|.+++..--..... ...++
T Consensus 417 ~~~---~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~------------ 476 (524)
T KOG0601|consen 417 LAF---SS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIR------------ 476 (524)
T ss_pred cce---ec-ccccccccccccchhhccccccccccccccccccccccccCcccCccccc----ceeee------------
Confidence 221 11 1122333444 55566677788999999999999999998643221111 00000
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
.... ...+ .....+..+.+.+..+++..||.+.++....+..
T Consensus 477 -~~~~---p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 477 -SGDT---PNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -cccc---cCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0000 0111 1114566778889999999999998876554443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.6e-11 Score=128.93 Aligned_cols=89 Identities=19% Similarity=0.278 Sum_probs=44.0
Q ss_pred hhccccccEeecccccCCCC----ccccccccccCcEEEecCceeccCCCccc-----cCCCCcceeecccccccc----
Q 001253 482 LCKLANLSTVELDQNQFSGP----IPTEIGNCNALQRLHLSDNYFTGELPREV-----GNLSNLVTFNVSSNFLTG---- 548 (1114)
Q Consensus 482 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~---- 548 (1114)
|..++.|+.|||..|.|+.. +...+..+++|+.|+++++.++..-..+| ...++|+.|.|.+|.++.
T Consensus 209 l~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~ 288 (382)
T KOG1909|consen 209 LEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAAL 288 (382)
T ss_pred HHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHH
Confidence 34444555555555554421 22334444555555555555543222222 124566666666666652
Q ss_pred cccccccccccceEEECccccc
Q 001253 549 RIPLEIFSCKMLQRLDLSWNKF 570 (1114)
Q Consensus 549 ~~p~~~~~l~~L~~L~Ls~N~l 570 (1114)
.+...+...+.|..|+|++|++
T Consensus 289 ~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 289 ALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHHhcchhhHHhcCCcccc
Confidence 1222333456677777777776
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.9e-09 Score=114.99 Aligned_cols=143 Identities=19% Similarity=0.240 Sum_probs=110.9
Q ss_pred ceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC--CceeeEEeEEEec---CceEEEEec
Q 001253 815 FVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH--RNIVKLYGFCYHQ---GSNLLMYEY 889 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~E~ 889 (1114)
+.|+.|.++.||+++..+|+.+++|+....... .....+..|+++++.+++ ..+.+++.+.... +..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568999999999999877789999997654431 123457889999999875 3456677776553 256899999
Q ss_pred CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 001253 890 MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC---------------------------------------- 929 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------- 929 (1114)
++|.++.+.+.. ..++..+...++.++++++.+||+..
T Consensus 82 i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 82 VDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred eCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 999888876532 35677788888888888888888521
Q ss_pred -------------CCCeEecCCCCCCeEECC--CCCeEEeeccCcee
Q 001253 930 -------------KPRIFHRDIKSNNILLDD--KFEAHVGDFGLAKV 961 (1114)
Q Consensus 930 -------------~~~ivH~Dlk~~Nill~~--~~~~kl~DfG~a~~ 961 (1114)
...++|+|+++.||+++. ++.+.++||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999998 66789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.8e-11 Score=127.49 Aligned_cols=138 Identities=25% Similarity=0.240 Sum_probs=78.9
Q ss_pred CCCcCccceEEEeecccccCCCC--ccccccCccceeeeccCCccCCcCcc-cccCCcceEEeeccceeecc-CCchhhc
Q 001253 409 RLGAYSQLWVVDLSDNHLTGKIP--RHICRNTSLIFLNLETNKLTGSIPTG-VTRCKSLVQLRLGGNSFTGS-FPSDLCK 484 (1114)
Q Consensus 409 ~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~~~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~-~p~~~~~ 484 (1114)
....+++++.||||+|-|....+ .....+++|+.|+|+.|++.-..... -..++.|+.|.|++|.++-. +...+..
T Consensus 141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~ 220 (505)
T KOG3207|consen 141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT 220 (505)
T ss_pred hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence 34456666677777776654322 23445677777777777776322221 12456677777777777521 2222345
Q ss_pred cccccEeecccccCCCCccccccccccCcEEEecCceeccCCC--ccccCCCCcceeeccccccc
Q 001253 485 LANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELP--REVGNLSNLVTFNVSSNFLT 547 (1114)
Q Consensus 485 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~ 547 (1114)
+++|+.|+|..|..-..-......+..|+.|||++|++.. .+ ...+.++.|+.|+++.+.+.
T Consensus 221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~ 284 (505)
T KOG3207|consen 221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIA 284 (505)
T ss_pred CCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhhhccccCcc
Confidence 6677777777774332333344455667777777776652 33 34555666666666666665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.6e-10 Score=113.42 Aligned_cols=102 Identities=25% Similarity=0.229 Sum_probs=29.0
Q ss_pred cccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccc-cCCCCcceeecccccccccc-cccccccccceE
Q 001253 485 LANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRI-PLEIFSCKMLQR 562 (1114)
Q Consensus 485 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~ 562 (1114)
+.+|+.|+|++|+|+.. +.+..++.|++|++++|+|+. +...+ ..+++|+.|+|++|+|...- -..+..+++|+.
T Consensus 41 l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~ 117 (175)
T PF14580_consen 41 LDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV 117 (175)
T ss_dssp -TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred hcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence 34444444444444421 123444455555555555542 22222 23445555555555544210 122334556666
Q ss_pred EECccccccCCC---chhhhhcccCCeeec
Q 001253 563 LDLSWNKFVGAL---PREIGSLFQLELLKL 589 (1114)
Q Consensus 563 L~Ls~N~l~~~~---p~~~~~l~~L~~L~L 589 (1114)
|+|.+|.++..- ...+..+|+|+.||-
T Consensus 118 L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 118 LSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred eeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 666666655321 113445566665543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=5e-10 Score=111.41 Aligned_cols=121 Identities=27% Similarity=0.308 Sum_probs=36.8
Q ss_pred ccceeeeccCCccCCcCcccc-cCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccc-cccccCcEEE
Q 001253 439 SLIFLNLETNKLTGSIPTGVT-RCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEI-GNCNALQRLH 516 (1114)
Q Consensus 439 ~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ 516 (1114)
++++|+|++|+|+. + +.++ .+.+|+.|+|++|.|+.. +.+..+++|++|++++|+|+. +++.+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence 44555555555552 2 2233 355566666666666522 235556666666666666663 32223 3466666666
Q ss_pred ecCceeccCC-CccccCCCCcceeecccccccccccc----cccccccceEEEC
Q 001253 517 LSDNYFTGEL-PREVGNLSNLVTFNVSSNFLTGRIPL----EIFSCKMLQRLDL 565 (1114)
Q Consensus 517 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L 565 (1114)
|++|+|...- -..+..+++|+.|+|.+|.++.. +. -+..+++|+.||-
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 6666665321 13455667777777777776622 21 2345777777764
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.5e-10 Score=82.06 Aligned_cols=40 Identities=48% Similarity=0.934 Sum_probs=31.0
Q ss_pred cchHHHHHHhHhhcc-CCCCCCCCCCCCC-CCCCccceEEEe
Q 001253 33 NIEGQILLLIKSKLV-DNSNYLGNWNPND-STPCGWIGVNCT 72 (1114)
Q Consensus 33 ~~~~~~ll~~k~~~~-~~~~~~~~W~~~~-~~~C~w~gv~C~ 72 (1114)
++|++||++||+++. +|.+.+++|+.+. .+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999998 5678999999874 789999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.3e-09 Score=135.38 Aligned_cols=201 Identities=21% Similarity=0.316 Sum_probs=130.0
Q ss_pred CCccceeeccccccCCCCcccccccccccEEEecCCc--ccCccccccccccccchhhcccccccCCchhhhcCCCccce
Q 001253 221 CESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQ--LSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKY 298 (1114)
Q Consensus 221 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~--l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~ 298 (1114)
....+...+-+|++. .++...... +|++|-+..|. +....+..|..++.|+.|||++|.-.+.+|+.++.|-+|++
T Consensus 522 ~~~~rr~s~~~~~~~-~~~~~~~~~-~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 522 WNSVRRMSLMNNKIE-HIAGSSENP-KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hhheeEEEEeccchh-hccCCCCCC-ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 356777777777776 444444333 68888888886 55444455778999999999998888889999999999999
Q ss_pred eeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeeccccccc--CcccccccccccCCEEEcccc
Q 001253 299 LYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLT--GVIPVELTTLKNLTKLDLSIN 376 (1114)
Q Consensus 299 L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N 376 (1114)
|+|++..+. .+|..++++..|.+|++..+.....+|.....+.+|++|.+...... ...-..+.++.+|+.+.....
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~ 678 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITIS 678 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecc
Confidence 999999988 78889999999999999888766666666777888888888766522 222233445555555555333
Q ss_pred cccccccCcccccccee----eeeccCCcccCCCCCCCCcCccceEEEeeccccc
Q 001253 377 SLTGTIPLGFQYLTNLI----MLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLT 427 (1114)
Q Consensus 377 ~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 427 (1114)
.. .+-..+..+..|. .+.+..+.. ...+..+..+.+|+.|.+.++.+.
T Consensus 679 s~--~~~e~l~~~~~L~~~~~~l~~~~~~~-~~~~~~~~~l~~L~~L~i~~~~~~ 730 (889)
T KOG4658|consen 679 SV--LLLEDLLGMTRLRSLLQSLSIEGCSK-RTLISSLGSLGNLEELSILDCGIS 730 (889)
T ss_pred hh--HhHhhhhhhHHHHHHhHhhhhccccc-ceeecccccccCcceEEEEcCCCc
Confidence 22 1111223333332 222222111 123344455566666666665554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.7e-08 Score=100.92 Aligned_cols=129 Identities=26% Similarity=0.326 Sum_probs=84.1
Q ss_pred EEEEEEeCCCcEEEEEEecccCCC-----------------------ChhhHHHHHHHHHHHhcCCCC--ceeeEEeEEE
Q 001253 824 TVYRAVLRTGHTVAVKKLASNREG-----------------------NNNVDNSFRAEILTLGKIRHR--NIVKLYGFCY 878 (1114)
Q Consensus 824 ~Vy~~~~~~g~~vavK~~~~~~~~-----------------------~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 878 (1114)
.||.|...+|..+|||+.+..... ........++|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999988999999988643211 011223467899999999765 466666442
Q ss_pred ecCceEEEEecCC--CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCeEECCCCCeEEee
Q 001253 879 HQGSNLLMYEYMA--RGSLGELLHGASSTLDWQTRFMIALGAAEGLSY-LHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 955 (1114)
Q Consensus 879 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 955 (1114)
..++||||++ |..+..+.... ++......++.+++..+.. +|.. |++|+|+.+.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEe
Confidence 4579999999 65554444311 1133455667777775555 4677 99999999999999988 999999
Q ss_pred ccCceecC
Q 001253 956 FGLAKVID 963 (1114)
Q Consensus 956 fG~a~~~~ 963 (1114)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99998643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.8e-07 Score=102.42 Aligned_cols=166 Identities=20% Similarity=0.300 Sum_probs=127.1
Q ss_pred CeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe----cCceEEEEecCCCC-CH
Q 001253 822 CGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH----QGSNLLMYEYMARG-SL 895 (1114)
Q Consensus 822 ~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~~~g-sL 895 (1114)
..+.|++... ||..|+.|+++..+...... ...-+++++++.|+|+|++.+++.. +...++||+|.++. +|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 4578999865 89999999996555443211 2345678999999999999998863 44678999999864 77
Q ss_pred HHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 896 GELLHGA--------------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 896 ~~~l~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
.++-... +...++...+.++.|++.||.++|+. |+..+-+.+++|+++.+.+++|+..|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 7764311 22467888999999999999999999 999999999999999999999998887766
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCC
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRA 1011 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~ 1011 (1114)
...+.. |-+. -..+-|.=.+|.++..+.||..
T Consensus 443 l~~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 443 LQEDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ecCCCC---------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 543221 1111 1235688999999999999964
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.9e-09 Score=83.90 Aligned_cols=59 Identities=32% Similarity=0.468 Sum_probs=29.6
Q ss_pred cccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeeccccc
Q 001253 487 NLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNF 545 (1114)
Q Consensus 487 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 545 (1114)
+|++|++++|+|+...+..|.++++|++|++++|+|+...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34445555555544444445555555555555555554444455555555555555554
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=7.9e-08 Score=99.33 Aligned_cols=140 Identities=24% Similarity=0.165 Sum_probs=98.3
Q ss_pred CcCCceecccCCeEEEEEEeCCCcEEEEEEecccCC-------------------CChhhHHHHHHHHHHHhcCCCC--c
Q 001253 811 FDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNRE-------------------GNNNVDNSFRAEILTLGKIRHR--N 869 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-------------------~~~~~~~~~~~E~~~l~~l~h~--n 869 (1114)
..+..+||.|.-+.||.|....|.++|||.=+.... +-.......++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 445678999999999999999999999995322111 1112233456788899888654 6
Q ss_pred eeeEEeEEEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 001253 870 IVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF 949 (1114)
Q Consensus 870 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 949 (1114)
|.+.+++ +...+||||++|--|...- ++......++..|++-+.-+-.. |+||+|+.+-||++++||
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence 6666654 3557999999996555432 12233333444444444444455 999999999999999999
Q ss_pred CeEEeeccCceecC
Q 001253 950 EAHVGDFGLAKVID 963 (1114)
Q Consensus 950 ~~kl~DfG~a~~~~ 963 (1114)
.+.++||-.+...+
T Consensus 240 ~~~vIDwPQ~v~~~ 253 (304)
T COG0478 240 DIVVIDWPQAVPIS 253 (304)
T ss_pred CEEEEeCcccccCC
Confidence 99999999887543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.7e-07 Score=99.63 Aligned_cols=142 Identities=18% Similarity=0.120 Sum_probs=99.8
Q ss_pred eecccCCeEEEEEEeCCCcEEEEEEecccCCCC--------hhhHHHHHHHHHHHhcCCCC--ceeeEEeEEEe-----c
Q 001253 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGN--------NNVDNSFRAEILTLGKIRHR--NIVKLYGFCYH-----Q 880 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~-----~ 880 (1114)
.+-+.....|++..+. |+.|.||......... ......+.+|...+.++... .+++++++.+. .
T Consensus 29 ~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 4444444557777664 7899999774332110 01112367888888777432 33444555543 2
Q ss_pred CceEEEEecCCCC-CHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-------CCCe
Q 001253 881 GSNLLMYEYMARG-SLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD-------KFEA 951 (1114)
Q Consensus 881 ~~~~lv~E~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-------~~~~ 951 (1114)
...++|||++++. +|.+++... ....+......++.+++..+.-||.. ||+|+|+++.|||++. ++.+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceE
Confidence 3468999999986 899988532 23456677788999999999999999 9999999999999975 4689
Q ss_pred EEeeccCcee
Q 001253 952 HVGDFGLAKV 961 (1114)
Q Consensus 952 kl~DfG~a~~ 961 (1114)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998863
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.1e-09 Score=95.93 Aligned_cols=136 Identities=25% Similarity=0.333 Sum_probs=101.3
Q ss_pred cceEEECccccccCCCchhhhhc---ccCCeeeccCccCCCcccccc-cccccccccccCCCcCCCCCChhhcCcchhhH
Q 001253 559 MLQRLDLSWNKFVGALPREIGSL---FQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSGGIPAELGSLSSLQI 634 (1114)
Q Consensus 559 ~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 634 (1114)
.+..+||+++.+- .+++....+ ..|...+|++|.+. ..|..| ..++.++.|+|++|.|+ .+|.++..++.|+
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr- 103 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALR- 103 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhh-
Confidence 4556677777664 455554443 45666688888887 444444 45568889999999998 8888899999998
Q ss_pred HhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCCccc
Q 001253 635 ALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQT 700 (1114)
Q Consensus 635 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~~~ 700 (1114)
.||++.|.|..+ |..+..|.+|-+||..+|.+. +||..+..-+.....++.+++|.+..|.+.|
T Consensus 104 ~lNl~~N~l~~~-p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq 167 (177)
T KOG4579|consen 104 SLNLRFNPLNAE-PRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ 167 (177)
T ss_pred hcccccCccccc-hHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence 799999999865 778888999999999999988 6666544444555567788999998887644
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.3e-08 Score=81.73 Aligned_cols=60 Identities=32% Similarity=0.467 Sum_probs=37.4
Q ss_pred cceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCcee
Q 001253 463 SLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYF 522 (1114)
Q Consensus 463 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 522 (1114)
+|++|++++|+++...+..|..+++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455666666666655555666666666666666666655556666666666666666654
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.3e-09 Score=124.07 Aligned_cols=125 Identities=32% Similarity=0.379 Sum_probs=59.4
Q ss_pred ccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccc-cccccccceEEECc
Q 001253 488 LSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPL-EIFSCKMLQRLDLS 566 (1114)
Q Consensus 488 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls 566 (1114)
|.+.+.+.|.+. ..-..+.-++.|+.|||++|+++... .+..+++|++|||++|++. .+|. ....+. |+.|.++
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence 444444444444 33334444445555555555554221 3444455555555555554 2332 111222 5555555
Q ss_pred cccccCCCchhhhhcccCCeeeccCccCCCcccc-cccccccccccccCCCcCC
Q 001253 567 WNKFVGALPREIGSLFQLELLKLSENELSGSIPV-QIGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 567 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~ 619 (1114)
+|.++.. ..+.+|.+|+.||+++|-|++.-.- .++.|..|+.|+|.||++-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 5555422 2345555555566666655543211 1334555666666666654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.3e-07 Score=108.18 Aligned_cols=144 Identities=22% Similarity=0.262 Sum_probs=97.3
Q ss_pred ceecccCCeEEEEEEeCCCcEEEEEEecccCCCC---------------------------hh----------hHHHHHH
Q 001253 815 FVIGRGACGTVYRAVLRTGHTVAVKKLASNREGN---------------------------NN----------VDNSFRA 857 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---------------------------~~----------~~~~~~~ 857 (1114)
..|+.++-|.||+|++++|+.||||+.++..... .. .+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999999999999999987653210 00 1113455
Q ss_pred HHHHHhcCC-----CCceeeEEeEEEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 001253 858 EILTLGKIR-----HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932 (1114)
Q Consensus 858 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 932 (1114)
|+..+.+++ .|.+.-..=|.+..+...++|||++|-.+.+...-.....+.........++. +..+-.. |
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~d---g 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRD---G 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhc---C
Confidence 555555553 34443333334446778999999999988888532234455333332222221 2222233 9
Q ss_pred eEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 933 ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++|+|..|.||+++.+|++.+.|||+...++
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999998664
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.6e-09 Score=121.68 Aligned_cols=126 Identities=27% Similarity=0.294 Sum_probs=68.4
Q ss_pred cceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCc-cccCCCCcceeec
Q 001253 463 SLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPR-EVGNLSNLVTFNV 541 (1114)
Q Consensus 463 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L 541 (1114)
.|...+.+.|++. ....++.-++.|+.|+|++|+++.. +.+..|++|++|||++|++. .+|. ...++ +|+.|++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence 4555555566555 4455555556666666666666532 25555666666666666665 2332 12222 2666666
Q ss_pred ccccccccccccccccccceEEECccccccCCC-chhhhhcccCCeeeccCccCC
Q 001253 542 SSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGAL-PREIGSLFQLELLKLSENELS 595 (1114)
Q Consensus 542 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 595 (1114)
++|.++ . -..+.++++|+.|||++|-|.+.- -.-++.|..|+.|+|.+|.+-
T Consensus 240 rnN~l~-t-L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALT-T-LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHH-h-hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 666665 1 123445666666666666665431 122345566666666666554
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.2e-06 Score=89.86 Aligned_cols=155 Identities=22% Similarity=0.186 Sum_probs=99.6
Q ss_pred CHHHHHHHhcCCcCCc---eecccCCeEEEEEEeCCCcEEEEEEecccCCCChh---------------------hHHHH
Q 001253 800 TFKDLVVATDNFDERF---VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNN---------------------VDNSF 855 (1114)
Q Consensus 800 ~~~~~~~~~~~~~~~~---~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~---------------------~~~~~ 855 (1114)
+.+.+........+.. .|..|.-+.||+|...++..+|||+++........ ...-.
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3344433334444333 56677788999999888999999999755332111 00112
Q ss_pred HHHHHHHhcCC--CCceeeEEeEEEecCceEEEEecCCCC-CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 001253 856 RAEILTLGKIR--HRNIVKLYGFCYHQGSNLLMYEYMARG-SLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932 (1114)
Q Consensus 856 ~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 932 (1114)
++|..-|+++. +-.+.+.+++. .-.+||||+... .-.-.|++. .++..+...+..++++.+.-|-..+ +
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a--~ 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEA--G 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhc--C
Confidence 34555565553 33444554443 347999999763 111122211 2333356677778888888877632 9
Q ss_pred eEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 933 ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
+||+|++.-|||+. ++.+.++|||.|....
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8899999999998755
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.8e-06 Score=84.74 Aligned_cols=140 Identities=16% Similarity=0.084 Sum_probs=103.4
Q ss_pred ecccCCeEEEEEEeCCCcEEEEEEecccCCCC---hhhHHHHHHHHHHHhcCCC--CceeeEEeEEE-ec----CceEEE
Q 001253 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGN---NNVDNSFRAEILTLGKIRH--RNIVKLYGFCY-HQ----GSNLLM 886 (1114)
Q Consensus 817 lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~-~~----~~~~lv 886 (1114)
-|+|+-+.|+..... |..+-+|+-....... +.....|.+|...+.++.. -.+.++. ++. .. -..++|
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367888999997766 5578899865221111 2346678999999988853 2255554 332 11 135799
Q ss_pred EecCCC-CCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC--eEEeeccCcee
Q 001253 887 YEYMAR-GSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE--AHVGDFGLAKV 961 (1114)
Q Consensus 887 ~E~~~~-gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DfG~a~~ 961 (1114)
+|-++| -+|.+++... -...+...+..+..+++..+.-||.. |+.|+|+.++||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998864 3898888643 23567788889999999999999999 9999999999999987677 99999997764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.8e-06 Score=87.84 Aligned_cols=105 Identities=21% Similarity=0.247 Sum_probs=82.8
Q ss_pred HHHHHHHHHHhcCCC--CceeeEEeEEEecC----ceEEEEecCCCC-CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH
Q 001253 853 NSFRAEILTLGKIRH--RNIVKLYGFCYHQG----SNLLMYEYMARG-SLGELLHGASSTLDWQTRFMIALGAAEGLSYL 925 (1114)
Q Consensus 853 ~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~L 925 (1114)
....+|...+..+.. -.+.+++++.+... ..++|+|++++. +|.+++..... .+......++.++++.++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 346678877777743 23556666665532 348999999985 79999874332 66677889999999999999
Q ss_pred HhCCCCCeEecCCCCCCeEECCCC---CeEEeeccCcee
Q 001253 926 HHDCKPRIFHRDIKSNNILLDDKF---EAHVGDFGLAKV 961 (1114)
Q Consensus 926 H~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfG~a~~ 961 (1114)
|.. ||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 999999999999999887 899999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1114 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-60 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-59 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-52 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-28 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-06 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 4e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 4e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 4e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 8e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-06 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 9e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-05 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 633 bits (1636), Expect = 0.0
Identities = 226/748 (30%), Positives = 331/748 (44%), Gaps = 71/748 (9%)
Query: 35 EGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNCTT--------------------- 73
E L+ K L D N L +W+ ++ PC + GV C
Sbjct: 13 EIHQLISFKDVLPDK-NLLPDWS-SNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVS 70
Query: 74 ----------------NDFGAVVFS---------LNLTKMNLSGYLSP--NIGGLVHLTA 106
+ V L+L++ +LSG ++ ++G L
Sbjct: 71 SSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKF 130
Query: 107 LDLSFNQLSRNIPKEIG-NCSSLEVLNLNNNRLEAHIPKEL---GNLSSLTILNIYNNRI 162
L++S N L G +SLEVL+L+ N + L L I N+I
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190
Query: 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCE 222
SG + + L L SNN S +P LG+ L+ N +SG I C
Sbjct: 191 SGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCT 247
Query: 223 SLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKEL-GNCTSLETLALYDNK 281
L+ L ++ NQ G IP LK L + L N+ +G IP L G C +L L L N
Sbjct: 248 ELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH 305
Query: 282 QVGQLPKELGSIGSLKYLYIYRNELNGTIPRE-IGKLSSALEIDFSENSLIGEIPVELSK 340
G +P GS L+ L + N +G +P + + K+ +D S N GE+P L+
Sbjct: 306 FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTN 365
Query: 341 ILG-LELLYLFENKLTGVIPVEL--TTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQL 397
+ L L L N +G I L L +L L N TG IP + L+ L L
Sbjct: 366 LSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHL 425
Query: 398 FDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTG 457
N L G IP LG+ S+L + L N L G+IP+ + +L L L+ N LTG IP+G
Sbjct: 426 SFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG 485
Query: 458 VTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHL 517
++ C +L + L N TG P + +L NL+ ++L N FSG IP E+G+C +L L L
Sbjct: 486 LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL 545
Query: 518 SDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWN--KFVGALP 575
+ N F G +P + S + ++NF+ G+ + I + M + + N +F G
Sbjct: 546 NTNLFNGTIPAAMFKQSGKI----AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS 601
Query: 576 REIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIA 635
++ L ++ G N + L M N SG IP E+GS+ L I
Sbjct: 602 EQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFI- 660
Query: 636 LNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPI 695
LNL +N++SG IP E+G+L L L L++N L G IP + L+ L + S NNL+GPI
Sbjct: 661 LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI 720
Query: 696 PSSQTFQNMSVNSFSGSKGLCGGPLQNC 723
P F+ F + GLCG PL C
Sbjct: 721 PEMGQFETFPPAKFLNNPGLCGYPLPRC 748
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 367 bits (945), Expect = e-118
Identities = 121/292 (41%), Positives = 173/292 (59%), Gaps = 12/292 (4%)
Query: 799 FTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAE 858
F+ ++L VA+DNF + ++GRG G VY+ L G VAVK+L E + F+ E
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL--KEERTQGGELQFQTE 77
Query: 859 ILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHG---ASSTLDWQTRFMIA 915
+ + HRN+++L GFC LL+Y YMA GS+ L + LDW R IA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 916 LGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAG 975
LG+A GL+YLH C P+I HRD+K+ NILLD++FEA VGDFGLAK++D + +A+ G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 976 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPV----QPLDQGGDLVTWVRNFIR 1031
+ G+IAPEY T K +EK D++ YGV+LLEL+TG+ D L+ WV+ ++
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 1032 NNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
L ++D LQ + ++++A+LCT SP +RP M EVV ML
Sbjct: 258 EKKL-EALVDVD--LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 376 bits (968), Expect = e-117
Identities = 100/674 (14%), Positives = 197/674 (29%), Gaps = 80/674 (11%)
Query: 33 NIEGQILLLIKSKLVDNSNYLGN-WNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLS 91
+ I L ++ + + L W+ + G ++ N
Sbjct: 15 DAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQP----GANWNFNKELDMWG 70
Query: 92 GYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLE----AHIPKELG 147
++ +T L L S +P IG + LEVL L ++ + PK +
Sbjct: 71 AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGIS 130
Query: 148 NLSSLTILNIYNNRISGPFPKEIGKL--SALSQLVAYSNNISGSLPPTLGNLKRLKSFRA 205
S F + S L + S+ S+ + +
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQ 190
Query: 206 GQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKE 265
N I+ + + L+ + + E E + Q +
Sbjct: 191 LSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLK 244
Query: 266 LGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNEL--------NGTIPREIGKL 317
N L + +Y+ + +LP L ++ ++ + + N + +
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVG 304
Query: 318 SSALEIDFSENSLI-GEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSIN 376
I N+L + L K+ L +L N+L G +P + L L+L+ N
Sbjct: 305 EKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYN 363
Query: 377 SLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYS--QLWVVDLSDNHLTG------ 428
+T + + L N L IP A S + +D S N +
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF 422
Query: 429 -KIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLAN 487
+ + ++ +NL N+++ + L + L GN T P +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSL---- 477
Query: 488 LSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPRE--VGNLSNLVTFNVSSNF 545
N L + L N T L + L LV ++S N
Sbjct: 478 ------------KDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNS 524
Query: 546 LTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNL 605
+ P + + L+ + N P I
Sbjct: 525 FSK-FPTQPLNSSTLKGFGIRNQ------------------RDAQGNRTLREWPEGITLC 565
Query: 606 SRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNN 665
LT+LQ+G N + ++ ++ + L++ N + + I +L +
Sbjct: 566 PSLTQLQIGSNDIR-KVNEKI--TPNISV-LDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
Query: 666 HLSGEIPGSFVNLS 679
+++
Sbjct: 622 KTQDIRGCDALDIK 635
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 5e-71
Identities = 68/429 (15%), Positives = 136/429 (31%), Gaps = 57/429 (13%)
Query: 289 ELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLY 348
L S G + L + +G +P IG+L+ LE+L
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTE------------------------LEVLA 111
Query: 349 LFENKLTG----VIPVELTTLKNLTKLDLSINSLTGTIP--LGFQYLTNLIMLQLFDNSL 402
L + P ++ + + T + ++LI + +
Sbjct: 112 LGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQ 171
Query: 403 VGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCK 462
I + + + N++T + + + R T L + + C+
Sbjct: 172 QKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI-----CE 225
Query: 463 SLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYF 522
+ + L +L+ VE+ +PT + +Q ++++ N
Sbjct: 226 AWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285
Query: 523 T--------GELPREVGNLSNLVTFNVSSN-FLTGRIPLEIFSCKMLQRLDLSWNKFVGA 573
+ + + + N T + + K L L+ +N+ G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG- 344
Query: 574 LPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPA--ELGSLSS 631
GS +L L L+ N+++ G ++ L N IP + S+S
Sbjct: 345 KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSV 403
Query: 632 LQIALNLSYNNLSGL-------IPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGC 684
+ ++ SYN + + + P I + + L+NN +S F S L
Sbjct: 404 MSA-IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462
Query: 685 NFSYNNLTG 693
N N LT
Sbjct: 463 NLMGNMLTE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-37
Identities = 30/240 (12%), Positives = 69/240 (28%), Gaps = 13/240 (5%)
Query: 472 NSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTG----ELP 527
+ + L ++ + L+ SG +P IG L+ L L + P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 528 REVGNLSNLVTFNVSSNFLTGRIPLEIFSCKM--LQRLDLSWNKFVGALPREIGSLFQLE 585
+ + + L + ++ + ++ + +
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 586 LLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSG 645
+ N ++ + + L++L + MG + F E N Y
Sbjct: 187 QIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN------ENSEYAQQYK 239
Query: 646 LIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMS 705
+ NL L + + N ++P L + N + N +Q ++
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 360 bits (926), Expect = e-111
Identities = 140/659 (21%), Positives = 228/659 (34%), Gaps = 38/659 (5%)
Query: 102 VHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNR 161
V D S +L++ +P ++ +++ VLNL +N+L S LT L++ N
Sbjct: 4 VSHEVADCSHLKLTQ-VPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 162 ISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGC 221
IS P+ KL L L N +S T L N I +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 222 ESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELG--NCTSLETLALYD 279
++L L L+ N LS L+ L +++L N++ + +EL +SL+ L L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 280 NKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIG---KLSSALEIDFSENSLIGEIPV 336
N+ P +IG L L++ +L ++ ++ +S + S + L
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 337 ELS--KILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIM 394
K L +L L N L V L L L N++ L N+
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 395 LQLFDN---------SLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNL 445
L L + SL L +++ DN + G +L +L+L
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360
Query: 446 ETNKLTGSIPTGVT----RCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGP 501
+ + T T L L L N + L +L ++L N+
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420
Query: 502 IP-TEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTG--RIPLEIFSCK 558
+ E + ++LS N + + +L + L P +
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
Query: 559 MLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELS--------GSIPVQIGNLSRLTE 610
L LDLS N + L +LE+L L N L+ G + LS L
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540
Query: 611 LQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGE 670
L + N F L L+I ++L NNL+ L N + L+ L L N ++
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKI-IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSV 599
Query: 671 IPGSF-VNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPS 728
F +L + +N S F N + + L L C PP
Sbjct: 600 EKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYL--CNTPPH 656
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-104
Identities = 120/620 (19%), Positives = 212/620 (34%), Gaps = 36/620 (5%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141
LNLT L + N LT+LD+ FN +S+ P+ L+VLNL +N L
Sbjct: 29 VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQL 88
Query: 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLK 201
K ++LT L++ +N I K L L N +S + T L+ L+
Sbjct: 89 SDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQ 148
Query: 202 SFRAGQNLISGSLPSEIG--GCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLS 259
N I E+ SL+ L L+ NQ+ P + L + L QL
Sbjct: 149 ELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208
Query: 260 GVIPKELG---NCTSLETLALYDNKQVGQLPKELGSIG--SLKYLYIYRNELNGTIPREI 314
+ ++L TS+ L+L +++ + +L L + N LN
Sbjct: 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
Query: 315 GKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFEN---------KLTGVIPVELTTL 365
L N++ L + + L L + L + L
Sbjct: 269 AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328
Query: 366 KNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLG----AYSQLWVVDL 421
K L L++ N + G F L NL L L ++ A+S L +++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 422 SDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTGSFPS 480
+ N ++ L L+L N++ + +++ ++ L N + +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN 448
Query: 481 DLCKLANLSTVELDQNQFSG--PIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVT 538
+ +L + L + P+ L L LS+N + L L
Sbjct: 449 SFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI 508
Query: 539 FNVSSNFLT--------GRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLS 590
++ N L G + L L+L N F LF+L+++ L
Sbjct: 509 LDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568
Query: 591 ENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELG-SLSSLQIALNLSYNNLSGLIPP 649
N L+ N L L + N + G + +L L++ +N
Sbjct: 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE-LDMRFNPFDCTCES 627
Query: 650 ELGNLILLEYLLLNNNHLSG 669
+ ++ + ++
Sbjct: 628 IAW---FVNWINETHTNIPE 644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-44
Identities = 66/319 (20%), Positives = 102/319 (31%), Gaps = 16/319 (5%)
Query: 81 FSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEA 140
+++ +L + L L L++ N + +L+ L+L+N+
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367
Query: 141 HIPKELG----NLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLG 195
S L ILN+ N+IS L L L N I L
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
Query: 196 NLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSG--EIPKEIGMLKYLTDVIL 253
L+ + N + SLQ L L + L P L+ LT + L
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 254 WGNQLSGVIPKELGNCTSLETLALYDNK--------QVGQLPKELGSIGSLKYLYIYRNE 305
N ++ + L LE L L N G L + L L + N
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547
Query: 306 LNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVEL-TT 364
+ L ID N+L + + L+ L L +N +T V
Sbjct: 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
Query: 365 LKNLTKLDLSINSLTGTIP 383
+NLT+LD+ N T
Sbjct: 608 FRNLTELDMRFNPFDCTCE 626
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-105
Identities = 106/294 (36%), Positives = 153/294 (52%), Gaps = 17/294 (5%)
Query: 799 FTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASN-REGNNNVDNSFRA 857
DL AT+NFD +F+IG G G VY+ VLR G VA+K+ +G F
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE----EFET 84
Query: 858 EILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASS---TLDWQTRFMI 914
EI TL RH ++V L GFC + +L+Y+YM G+L L+G+ ++ W+ R I
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 915 ALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAI 973
+GAA GL YLH I HRD+KS NILLD+ F + DFG++K ++ Q+ + +
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201
Query: 974 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD--LVTWVRNFIR 1031
G+ GYI PEY ++TEK D+YS+GVVL E+L R+ + L W
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 1032 NNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
N L ++D L D+ + A+ C +S DRP+M +V+ L
Sbjct: 262 NGQL-EQIVDPN--LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 327 bits (842), Expect = e-104
Identities = 105/297 (35%), Positives = 149/297 (50%), Gaps = 18/297 (6%)
Query: 799 FTFKDLVVATDNFDERF------VIGRGACGTVYRAVLRTGHTVAVKKLASNREGN-NNV 851
F+F +L T+NFDER +G G G VY+ + TVAVKKLA+ + +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEEL 73
Query: 852 DNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASST--LDWQ 909
F EI + K +H N+V+L GF L+Y YM GSL + L T L W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 910 TRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969
R IA GAA G+++LH + HRDIKS NILLD+ F A + DFGLA+ +
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 970 MS-AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRN 1028
M+ I G+ Y+APE ++T K DIYS+GVVLLE++TG V + L+
Sbjct: 191 MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249
Query: 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ +D ++N D +V M +A C + RP +++V +L E
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVEAMY---SVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = 1e-93
Identities = 117/589 (19%), Positives = 198/589 (33%), Gaps = 36/589 (6%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI 162
LDLSFN L + L+VL+L+ ++ +LS L+ L + N I
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLI-SGSLPSEIGGC 221
LS+L +LVA N++ +G+LK LK NLI S LP
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 222 ESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILW----GNQLSGVIPKELGNCTSLETLAL 277
+L++L L+ N++ ++ +L + + L N ++ + P L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTL 207
Query: 278 YDNKQVGQLPKE-LGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPV 336
+N + K + + L+ + E E F +++L G
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE----------KFDKSALEG---- 253
Query: 337 ELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQ 396
L + E + + I L N++ L ++ + L+
Sbjct: 254 -LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLE 310
Query: 397 LFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLT--GSI 454
L + +L + + L+ G SL FL+L N L+ G
Sbjct: 311 LVNCKFGQFPTLKLKSLKR-----LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 365
Query: 455 PTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEI-GNCNALQ 513
SL L L N S+ L L ++ + + + L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424
Query: 514 RLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFS-CKMLQRLDLSWNKFVG 572
L +S + LS+L ++ N +IF+ + L LDLS +
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 573 ALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSL 632
P SL L++L +S N L+ L L N EL S
Sbjct: 485 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 544
Query: 633 QIALNLSYNNLSGLIPPE--LGNLILLEYLLLNNNHLSGEIPGSFVNLS 679
LNL+ N+ + + L + LL+ + P +
Sbjct: 545 LAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 1e-86
Identities = 116/605 (19%), Positives = 190/605 (31%), Gaps = 68/605 (11%)
Query: 124 NCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYS 183
++ + N + IP L S L++ N + L L
Sbjct: 6 VVPNITYQCMELNFYK--IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 184 NNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIG 243
I +L L + N I G SLQ L + L+ IG
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 244 MLKYLTDVILWGNQLSGV-IPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIY 302
LK L ++ + N + +P+ N T+LE L L NK +L + + L
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN-- 179
Query: 303 RNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTG-VIPVE 361
L +D S N + I K + L L L N + V+
Sbjct: 180 ------------------LSLDLSLNP-MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
Query: 362 LTTLKNLTKLDLSINSLTGTIPLG---FQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWV 418
+ L L L + L L L L + + L
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL---------------- 264
Query: 419 VDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSF 478
++ I T++ +L + + + L L F
Sbjct: 265 --AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ-- 318
Query: 479 PSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDN--YFTGELPREVGNLSNL 536
L S L G + +L+ L LS N F G + ++L
Sbjct: 319 ---FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 537 VTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREI-GSLFQLELLKLSENELS 595
++S N + + + L+ LD + + SL L L +S
Sbjct: 376 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 596 GSIPVQIGNLSRLTELQMGGNSFSGGIPAE-LGSLSSLQIALNLSYNNLSGLIPPELGNL 654
+ LS L L+M GNSF + L +L L+LS L L P +L
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF-LDLSQCQLEQLSPTAFNSL 493
Query: 655 ILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIP-------SSQTFQNMSVN 707
L+ L +++N+ + L+SL ++S N++ SS F N++ N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 708 SFSGS 712
F+ +
Sbjct: 554 DFACT 558
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-36
Identities = 52/301 (17%), Positives = 101/301 (33%), Gaps = 9/301 (2%)
Query: 81 FSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEA 140
++ + L L + L+F + SLE L+L+ N L
Sbjct: 302 YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361
Query: 141 H--IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNL 197
+ +SL L++ N + L L L +N+ +L
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 198 KRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEI-GMLKYLTDVILWGN 256
+ L + G SL+ L +A N +I L+ LT + L
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 257 QLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGK 316
QL + P + +SL+ L + N + SL+ L N + + +E+
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 540
Query: 317 LSSALE-IDFSENSLIGEIPVE--LSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDL 373
S+L ++ ++N + L I L + ++ P + + + L++
Sbjct: 541 FPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNI 599
Query: 374 S 374
+
Sbjct: 600 T 600
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = 4e-90
Identities = 103/662 (15%), Positives = 184/662 (27%), Gaps = 98/662 (14%)
Query: 42 IKSKLVDNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGL 101
S ++N+ + NWN N W +
Sbjct: 288 YYSGTINNTIHSLNWNFNKE-LDMWGDQPGVD------------------------LDNN 322
Query: 102 VHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNR 161
+T L L+ +P IG + L+VL+ + + + +R
Sbjct: 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHR 382
Query: 162 ISGPFPKEIG------KLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLP 215
I + K LS L Q N + + N I+ +
Sbjct: 383 IRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FIS 441
Query: 216 SEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETL 275
I LQ + A + + + D + N L +
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDV 496
Query: 276 ALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIP 335
LY+ + QLP L + L+ L I N + + +
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKADWTR--------------LA 541
Query: 336 VELSKILGLELLYLFENKLTGV-IPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIM 394
+ +++ Y+ N L L + L LD N + + F L
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTD 599
Query: 395 LQLFDNSLVGGIPQRLGAY-SQLWVVDLSDNHLTGKIPR--HICRNTSLIFLNLETNKLT 451
L+L N + IP+ A+ Q+ + S N L IP + + ++ NK+
Sbjct: 600 LKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIG 657
Query: 452 G-----SIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFS------- 499
S + + + L N + +ST+ L N +
Sbjct: 658 SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSL 717
Query: 500 GPIPTEIGNCNALQRLHLSDNYFTGELPRE--VGNLSNLVTFNVSSNFLTGRIPLEIFSC 557
P N L + L N T L + L L +VS N + P + +
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS 775
Query: 558 KMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNS 617
L+ + N + P I L +LQ+G N
Sbjct: 776 SQLKAFGIRHQ------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSND 817
Query: 618 FSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVN 677
+ +L L I L+++ N + + I +L + +
Sbjct: 818 IR-KVDEKL--TPQLYI-LDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG 873
Query: 678 LS 679
+
Sbjct: 874 IE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 1e-74
Identities = 75/611 (12%), Positives = 164/611 (26%), Gaps = 109/611 (17%)
Query: 107 LDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPF 166
+ + ++ N + L+L + +P +G L+ L +L+ + +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 167 PKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQ 225
+ + I L +RL Q+ I+ + E+ +
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDS 421
Query: 226 YLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQ 285
+ L Q+ N+++ I K + T L+
Sbjct: 422 RISLKDTQIG-----------------NLTNRITF-ISKAIQRLTKLQ------------ 451
Query: 286 LPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLE 345
+Y + + + + S + L
Sbjct: 452 ------------IIYFANSPFTYDNIAVDW-----EDANSDYAKQYENEELSWSNLKDLT 494
Query: 346 LLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGG 405
+ L+ +P L L L L+++ N L +
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR--------------- 539
Query: 406 IPQRLGAYSQLWVVDLSDNHLTG-KIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSL 464
+ ++ + + N+L + + L L+ NK+ + L
Sbjct: 540 LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKL 597
Query: 465 VQLRLGGNSFTGSFPSDLCKLA-NLSTVELDQNQFSG-PIPTEIGNCNALQRLHLSDNYF 522
L+L N P D C + + N+ P + + + S N
Sbjct: 598 TDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKI 656
Query: 523 TGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLF 582
R + ++ + + LS+N+ +
Sbjct: 657 GS-EGRNIS------------------CSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697
Query: 583 QLELLKLSENELS-------GSIPVQIGNLSRLTELQMGGNSFSGGIPAEL--GSLSSLQ 633
+ + LS N ++ N LT + + N + + + +L L
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLS 756
Query: 634 IALNLSYNNLSGLIPPELGNLILLEYL------LLNNNHLSGEIPGSFVNLSSLLGCNFS 687
+++SYN S P + N L+ N + + P SL+
Sbjct: 757 N-MDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814
Query: 688 YNNLTGPIPSS 698
N++ +
Sbjct: 815 SNDIRK-VDEK 824
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 4e-62
Identities = 66/452 (14%), Positives = 148/452 (32%), Gaps = 41/452 (9%)
Query: 284 GQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILG 343
Q +L + G + L + G +P IG+L+ + F +S + + L
Sbjct: 313 DQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELT 372
Query: 344 LELLYLFENKLTGVIP-VELTTLKNLTKLDLSINSLTG---TIPLGFQYLTNLIMLQLFD 399
++ ++++ + L + L DL +++ P+ +L Q+ +
Sbjct: 373 PDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGN 432
Query: 400 NS-LVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV 458
+ + I + + ++L ++ +++ T N + K +
Sbjct: 433 LTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEELSW 487
Query: 459 TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGP---------IPTEIGNC 509
+ K L + L P L L L ++ + N+ + +
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTG 547
Query: 510 NALQRLHLSDNYFTGELPREV--GNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSW 567
+Q ++ N E P + L + N + + + L L L +
Sbjct: 548 PKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LE-AFGTNVKLTDLKLDY 604
Query: 568 NKFVGALPREIGSLF-QLELLKLSENELSGSIP--VQIGNLSRLTELQMGGNSFSGGIPA 624
N+ +P + + Q+E L S N+L IP ++ + + N
Sbjct: 605 NQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662
Query: 625 ELGSLSSLQ----IALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLS-------GEIPG 673
S+ + + LSYN + + ++L+NN ++ G
Sbjct: 663 ISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDG 722
Query: 674 SFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMS 705
++ N L + +N LT + +
Sbjct: 723 NYKNTYLLTTIDLRFNKLTS-LSDDFRATTLP 753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 222 bits (566), Expect = 3e-60
Identities = 83/547 (15%), Positives = 152/547 (27%), Gaps = 86/547 (15%)
Query: 12 LFSASILAIICLLVHQTKGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNC 71
+ + + + + + L D N NP ++
Sbjct: 366 FGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISL 425
Query: 72 TTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLS---------------- 115
G + N ++S I L L + + + +
Sbjct: 426 KDTQIGNL--------TNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYA 477
Query: 116 ---RNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGP------- 165
N N L + L N +P L +L L LNI NR
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 166 --FPKEIGKLSALSQLVAYSNNISGSLPP--TLGNLKRLKSFRAGQNLISGSLPSEIGGC 221
+ + NN+ P +L + +L N + G
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH--LEAFGTN 594
Query: 222 ESLQYLGLAQNQLSGEIPKEIG-MLKYLTDVILWGNQLSGVIPK-ELGNCTSLETLALYD 279
L L L NQ+ EIP++ + + N+L + + + ++
Sbjct: 595 VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSY 653
Query: 280 NKQVGQLPKELGSIG------SLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSL--- 330
N ++G + + + + + NE+ S I S N +
Sbjct: 654 N-KIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSI 712
Query: 331 ----IGEIPVELSKILGLELLYLFENKLTGVIP-VELTTLKNLTKLDLSINSLTGTIPLG 385
+ L + L NKLT + TTL L+ +D+S N + + P
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQ 771
Query: 386 FQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNL 445
+ L + D N + + P I SLI L +
Sbjct: 772 PLNSSQLKAFGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQI 813
Query: 446 ETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTE 505
+N + + + L L + N + +C L ++ +
Sbjct: 814 GSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ-----D 865
Query: 506 IGNCNAL 512
I C+AL
Sbjct: 866 IRGCDAL 872
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-29
Identities = 38/302 (12%), Positives = 80/302 (26%), Gaps = 16/302 (5%)
Query: 419 VDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSF 478
V + I + L+ + + + + +
Sbjct: 257 VPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQP 315
Query: 479 PSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVT 538
DL ++ + L G +P IG L+ L + T
Sbjct: 316 GVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375
Query: 539 FNVSSNFLTGRIP-LEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSG- 596
+ + + + + L DL + E+ + + + L + ++
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNL 433
Query: 597 -----SIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPEL 651
I I L++L + + F+ A N Y
Sbjct: 434 TNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWED------ANSDYAKQYENEELSW 487
Query: 652 GNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSG 711
NL L + L N ++P +L L N + N + ++ + +G
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTG 547
Query: 712 SK 713
K
Sbjct: 548 PK 549
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 3e-88
Identities = 82/309 (26%), Positives = 124/309 (40%), Gaps = 31/309 (10%)
Query: 420 DLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGS--IPTGVTRCKSLVQLRLGG-NSFTG 476
D + G + + + L+L L IP+ + L L +GG N+ G
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91
Query: 477 SFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNL 536
P + KL L + + SG IP + L L S N +G LP + +L NL
Sbjct: 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 537 VTFNVSSNFLTGRIPLEIFSCKMLQR-LDLSWNKFVGALPREIGSLFQLELLKLSENELS 595
V N ++G IP S L + +S N+ G +P +L L + LS N L
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLE 210
Query: 596 GSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLI 655
G V G+ ++ + NS + + ++G +L L+L N + G +P L L
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG-LDLRNNRIYGTLPQGLTQLK 268
Query: 656 LLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGL 715
L L N S+NNL G IP Q V++++ +K L
Sbjct: 269 FLHSL------------------------NVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
Query: 716 CGGPLQNCT 724
CG PL CT
Sbjct: 305 CGSPLPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 6e-80
Identities = 83/306 (27%), Positives = 136/306 (44%), Gaps = 9/306 (2%)
Query: 35 EGQILLLIKSKLVDNSNYLGNWNPN-DSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSG- 92
+ Q LL IK L N L +W P D W+GV C T+ V +L+L+ +NL
Sbjct: 7 DKQALLQIKKDL-GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 93 -YLSPNIGGLVHLTALDLS-FNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLS 150
+ ++ L +L L + N L IP I + L L + + + IP L +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 151 SLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSF-RAGQNL 209
+L L+ N +SG P I L L + N ISG++P + G+ +L + +N
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185
Query: 210 ISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNC 269
++G +P +L ++ L++N L G+ G K + L N L+ + ++G
Sbjct: 186 LTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLS 243
Query: 270 TSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENS 329
+L L L +N+ G LP+ L + L L + N L G IP + G L ++ N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 330 LIGEIP 335
+ P
Sbjct: 303 CLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 2e-69
Identities = 86/299 (28%), Positives = 134/299 (44%), Gaps = 11/299 (3%)
Query: 262 IPKELGNCTSL----ETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGT--IPREIG 315
I K+LGN T+L T + +G L + L + L IP +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 316 KLSSALEIDFS-ENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLS 374
L + N+L+G IP ++K+ L LY+ ++G IP L+ +K L LD S
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 375 INSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVV-DLSDNHLTGKIPRH 433
N+L+GT+P L NL+ + N + G IP G++S+L+ +S N LTGKIP
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 434 ICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVEL 493
N +L F++L N L G K+ ++ L NS + NL+ ++L
Sbjct: 194 FA-NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDL 251
Query: 494 DQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPL 552
N+ G +P + L L++S N GE+P+ GNL ++N PL
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPL 309
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 3e-82
Identities = 125/621 (20%), Positives = 199/621 (32%), Gaps = 42/621 (6%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141
+ N + L+ + + L+ SFN L +L L+L ++
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLK 201
+ L L + N + + AL L IS L N K L+
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 202 SFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILW--GNQLS 259
S G N IS + E L+ L N + +++ L+ T++ L GN ++
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 260 GVIPKELGNCTSLETLALYDNKQVGQLPKELG--SIGSLKYLYIYRNELNGTIPREIGKL 317
G I + ++L + + + K L +I SL + P L
Sbjct: 193 G-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 318 S--SALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSI 375
S I+ ++ GL+ L L L+ +P L L L KL LS
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSA 310
Query: 376 NSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQR-LGAYSQLWVVDLSDNHLT--GKIPR 432
N + +L L + N+ + L L +DLS + +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 433 HICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFP-SDLCKLANLSTV 491
+ + L LNL N+ C L L L S L L +
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 492 ELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIP 551
L + ALQ L+L N+F ++ +L L
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL--------------- 475
Query: 552 LEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTEL 611
L+ L LS+ SL + + LS N L+ S + +L + L
Sbjct: 476 ------GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-L 528
Query: 612 QMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEI 671
+ N S +P+ L LS + +NL N L N+ LE+ N L
Sbjct: 529 NLASNHISIILPSLLPILSQQRT-INLRQNPLDCTC----SNIYFLEWYKENMQKLEDTE 583
Query: 672 PGSFVNLSSLLGCNFSYNNLT 692
N L G S L+
Sbjct: 584 DTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 3e-78
Identities = 105/607 (17%), Positives = 198/607 (32%), Gaps = 84/607 (13%)
Query: 107 LDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPF 166
+ L+ IP + +S E L + N L L +LT L++ +I
Sbjct: 17 YNCENLGLNE-IPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 167 PKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQY 226
L LV +N + L K LK Q IS + ++L+
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 227 LGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQL 286
L L N +S + + L + N + + +++ + L
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL----------- 182
Query: 287 PKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELS--KILGL 344
L + N++ I + ++F + I L I L
Sbjct: 183 -----------SLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSL 230
Query: 345 ELLYLFENKLTGVIPVELTTLK--NLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSL 402
L + + P L ++ ++L + F + L L
Sbjct: 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQEL------- 283
Query: 403 VGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCK 462
DL+ HL+ ++P + ++L L L NK +
Sbjct: 284 -----------------DLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFP 325
Query: 463 SLVQLRLGGNSFTGSFPSD-LCKLANLSTVELDQNQ--FSGPIPTEIGNCNALQRLHLSD 519
SL L + GN+ + L L NL ++L + S ++ N + LQ L+LS
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY 385
Query: 520 NYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFS-CKMLQRLDLSWNKFVGALPREI 578
N L +++ L + F +L+ L+LS + + +
Sbjct: 386 NEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF 445
Query: 579 GSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNL 638
L L+ L L N + +L L L++ L L
Sbjct: 446 DGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI----------------------LVL 483
Query: 639 SYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSS 698
S+ +LS + +L ++ ++ L++N L+ + +L + N + N+++ +PS
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPS- 541
Query: 699 QTFQNMS 705
+S
Sbjct: 542 -LLPILS 547
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 1e-77
Identities = 75/314 (23%), Positives = 124/314 (39%), Gaps = 37/314 (11%)
Query: 798 GFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRA 857
++L + V RG G V++A L VAVK + S++
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK------QSWQN 65
Query: 858 E--ILTLGKIRHRNIVKLYGFCYHQGSN----LLMYEYMARGSLGELLHGASSTLDWQTR 911
E + +L ++H NI++ G S L+ + +GSL + L + + W
Sbjct: 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNEL 123
Query: 912 FMIALGAAEGLSYLHHD-------CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964
IA A GL+YLH D KP I HRDIKS N+LL + A + DFGLA +
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 965 PQSK-SMSAIAGSYGYIAPEYA-----YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018
+S G+ Y+APE + + D+Y+ G+VL EL +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP-- 241
Query: 1019 GGDLVTWVRNFIRNNSLVSGMLDA------RLNLQDE-KTVSHMITVLKIAMLCTNISPF 1071
+ + I + + M + R L+D + + M + + C +
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 1072 DRPTMREVVLMLSE 1085
R + V +++
Sbjct: 302 ARLSAGCVGERITQ 315
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 5e-75
Identities = 120/613 (19%), Positives = 203/613 (33%), Gaps = 68/613 (11%)
Query: 92 GYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSS 151
G L+P I + ++T +LS+ +P +I SS + ++L+ N L+ N S
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 152 LTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLIS 211
L L++ I K L LS L+ N I P + L L++ A + ++
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 212 GSLPSEIGGCESLQYLGLAQNQLSG-EIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCT 270
IG +L+ L +A N + ++P L L V L N + + +L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 271 SLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSL 330
+ L + N ++ I + + E+ N
Sbjct: 178 ENPQV--------------------NLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFN 216
Query: 331 IGEIPVELSKIL-GLELLYLFENKLTGVIPVE------LTTLKNLTK--LDLSINSLTGT 381
I + L GL + L + +E + L ++T L+ +
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSD 276
Query: 382 IPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLI 441
+ F L N+ + L S+ + + + + + + L + L
Sbjct: 277 DIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLK 331
Query: 442 FLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGP 501
L L NK SI SL L L N+ + FSG
Sbjct: 332 SLTLTMNKG--SISFKKVALPSLSYLDLSRNALS----------------------FSGC 367
Query: 502 IPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIF-SCKML 560
N+L+ L LS N + L L + + L F S + L
Sbjct: 368 CSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426
Query: 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFS 619
LD+S+ L L LK++ N + + N + LT L +
Sbjct: 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE 486
Query: 620 GGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLS 679
+L LQ+ LN+S+NNL L L L L + N +
Sbjct: 487 QISWGVFDTLHRLQL-LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK 545
Query: 680 SLLGCNFSYNNLT 692
SL N + N++
Sbjct: 546 SLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-19
Identities = 29/143 (20%), Positives = 44/143 (30%), Gaps = 5/143 (3%)
Query: 563 LDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGI 622
K +P +I S + + LS N L N S L L +
Sbjct: 16 YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72
Query: 623 PAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLL 682
L L L L+ N + P L LE L+ L+ L +L
Sbjct: 73 DKAWHGLHHLSN-LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 683 GCNFSYNNLTGPIPSSQTFQNMS 705
N ++N + F N++
Sbjct: 132 KLNVAHNFIHS-CKLPAYFSNLT 153
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-65
Identities = 77/284 (27%), Positives = 121/284 (42%), Gaps = 37/284 (13%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVD----NSFRAEILTLGKIRHRNI 870
IG+G G V++ L VA+K L F+ E+ + + H NI
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
VKLYG H ++M E++ G L L + + W + + L A G+ Y+ +
Sbjct: 86 VKLYGLM-HNPPRMVM-EFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QN 142
Query: 931 PRIFHRDIKSNNILLDDKFE-----AHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE-- 983
P I HRD++S NI L E A V DFGL++ S+S + G++ ++APE
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPETI 198
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043
A TEK D YS+ ++L +LTG P G + ++ R
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK--IKFINMIREEG--------LR 248
Query: 1044 LNLQDE--KTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ ++ + ++I LC + P RP +V LSE
Sbjct: 249 PTIPEDCPPRLRNVIE------LCWSGDPKKRPHFSYIVKELSE 286
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-64
Identities = 86/308 (27%), Positives = 136/308 (44%), Gaps = 41/308 (13%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
V+GRGA G V +A R VA+K++ S E +F E+ L ++ H NIVKLYG
Sbjct: 15 VVGRGAFGVVCKAKWR-AKDVAIKQIESESE-----RKAFIVELRQLSRVNHPNIVKLYG 68
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGA--SSTLDWQTRFMIALGAAEGLSYLHHDCKPRI 933
C + L+M EY GSL +LHGA L ++G++YLH +
Sbjct: 69 ACLNPVC-LVM-EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 934 FHRDIKSNNILLDDKFE-AHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
HRD+K N+LL + DFG A I M+ GS ++APE +E
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 993 KCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDE--K 1050
KCD++S+G++L E++T R P + + W + N + R L K
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---VHNGT--------RPPLIKNLPK 231
Query: 1051 TVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE-------SNRRQGHFEFSPMDHDSD 1103
+ ++T C + P RP+M E+V +++ ++ + + D
Sbjct: 232 PIESLMT------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGED 285
Query: 1104 QKLENEFQ 1111
++E
Sbjct: 286 GRVEPYVD 293
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-64
Identities = 94/310 (30%), Positives = 151/310 (48%), Gaps = 29/310 (9%)
Query: 778 PLQDKQLSSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVA 837
P+ D + +T + + +G D+ + + + + IG G+ GTV+RA G VA
Sbjct: 9 PMSDYDIPTTENLYFQGAMDG---DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVA 64
Query: 838 VKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGE 897
VK L ++ + N F E+ + ++RH NIV G + ++ EY++RGSL
Sbjct: 65 VKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 898 LLH--GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 955
LLH GA LD + R +A A+G++YLH+ P I HR++KS N+L+D K+ V D
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 956 FGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQP 1015
FGL+++ S + AG+ ++APE EK D+YS+GV+L EL T + P
Sbjct: 183 FGLSRLKAS-TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241
Query: 1016 LDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDE--KTVSHMITVLKIAMLCTNISPFDR 1073
L+ +V V G RL + V+ +I C P+ R
Sbjct: 242 LN-PAQVVAAV-----------GFKCKRLEIPRNLNPQVAAIIE------GCWTNEPWKR 283
Query: 1074 PTMREVVLML 1083
P+ ++ +L
Sbjct: 284 PSFATIMDLL 293
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 3e-64
Identities = 75/340 (22%), Positives = 122/340 (35%), Gaps = 49/340 (14%)
Query: 799 FTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAE 858
+ + DN +IGRG G VY+ L VAVK + +F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANR------QNFINE 55
Query: 859 --ILTLGKIRHRNIVKLYGFCYHQGSN-----LLMYEYMARGSLGELLHGASSTLDWQTR 911
I + + H NI + ++ LL+ EY GSL + L T DW +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSS 113
Query: 912 FMIALGAAEGLSYLHHD------CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-- 963
+A GL+YLH + KP I HRD+ S N+L+ + + DFGL+ +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 964 -----MPQSKSMSAIAGSYGYIAPEYA-------YTMKVTEKCDIYSYGVVLLELLTGRA 1011
+ + + G+ Y+APE ++ D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 1012 PVQPLDQG-------GDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAML 1064
+ P + V F LVS R E + + V +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE-KQRPKF-PEAWKENSLAVRSLKET 291
Query: 1065 ---CTNISPFDRPTMREVVLMLSE-SNRRQGHFEFSPMDH 1100
C + R T + ++E + + SP H
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 6e-61
Identities = 79/281 (28%), Positives = 122/281 (43%), Gaps = 35/281 (12%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKL-ASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
+IG G G VYRA G VAVK E + + R E ++H NI+ L
Sbjct: 14 IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
G C + + L+ E+ G L +L G + A+ A G++YLH + I
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 935 HRDIKSNNILLDDKFEAH--------VGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY 986
HRD+KS+NIL+ K E + DFGLA+ + + AG+Y ++APE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH---RTTKMSAAGAYAWMAPEVIR 187
Query: 987 TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046
++ D++SYGV+L ELLTG P + +D G + V M L +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAYGV-----------AMNKLALPI 235
Query: 1047 QDE--KTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ + ++ C N P RP+ ++ L+
Sbjct: 236 PSTCPEPFAKLME------DCWNPDPHSRPSFTNILDQLTT 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-60
Identities = 57/274 (20%), Positives = 103/274 (37%), Gaps = 31/274 (11%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+ G +++ + G+ + VK L R+ + F E L H N++ + G
Sbjct: 17 KLNENHSGELWKGRWQ-GNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 876 FCYHQGSNLLMY--EYMARGSLGELLH-GASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
C + +M GSL +LH G + +D AL A G+++LH +P
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPL 133
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE---YAYTMK 989
I + S ++++D+ A + + S + ++APE
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 990 VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDE 1049
D++S+ V+L EL+T P L ++ V + R +
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKV-----------ALEGLRPTIPPG 235
Query: 1050 KTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
H+ ++KI C N P RP +V +L
Sbjct: 236 -ISPHVSKLMKI---CMNEDPAKRPKFDMIVPIL 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-60
Identities = 74/276 (26%), Positives = 119/276 (43%), Gaps = 29/276 (10%)
Query: 817 IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876
IG G+ GTVY+ VAVK L +F+ E+ L K RH NI+ G+
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 877 CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHR 936
++ ++ SL LH + + + + IA A G+ YLH I HR
Sbjct: 89 STAPQLAIVT-QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 937 DIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAIAGSYGYIAPE---YAYTMKVTE 992
D+KSNNI L + +GDFGLA S ++GS ++APE + +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 993 KCDIYSYGVVLLELLTGRAP---VQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDE 1049
+ D+Y++G+VL EL+TG+ P + DQ + + + SL + R N
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQ----IIEM---VGRGSLSPDLSKVRSNCPKR 257
Query: 1050 KTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ ++ C +RP+ ++ + E
Sbjct: 258 --------MKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 4e-59
Identities = 66/332 (19%), Positives = 126/332 (37%), Gaps = 39/332 (11%)
Query: 777 APLQDKQLSSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTV 836
P + L S S + ++ + + + +IG+G G VY V
Sbjct: 1 GPEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EV 58
Query: 837 AVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLG 896
A++ + R+ N + +F+ E++ + RH N+V G C ++ +L
Sbjct: 59 AIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 897 ELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 956
++ A LD IA +G+ YLH I H+D+KS N+ D+ + + DF
Sbjct: 118 SVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDF 173
Query: 957 GLAKVID----MPQSKSMSAIAGSYGYIAPE---------YAYTMKVTEKCDIYSYGVVL 1003
GL + + + G ++APE + ++ D+++ G +
Sbjct: 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233
Query: 1004 LELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAM 1063
EL P + Q + + W + +++ + E + I +
Sbjct: 234 YELHAREWPFK--TQPAEAIIWQ---MGTGMK---PNLSQIGMGKE--------ISDILL 277
Query: 1064 LCTNISPFDRPTMREVVLML---SESNRRQGH 1092
C +RPT +++ ML + NRR H
Sbjct: 278 FCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-58
Identities = 105/527 (19%), Positives = 188/527 (35%), Gaps = 75/527 (14%)
Query: 93 YLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSL 152
+++P L + L+ +P E N S + E + P G +
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 153 TILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISG 212
+ + + +L + +S SLP +L+ L A N ++
Sbjct: 61 AVSRLRDCLDRQ-----------AHELELNNLGLS-SLPELPPHLESL---VASCNSLT- 104
Query: 213 SLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSL 272
LP +SL LS P L + + NQL +P EL N + L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFL 155
Query: 273 ETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIG 332
+ + + +N + +LP SL+++ N+L +P E+ L I NSL
Sbjct: 156 KIIDVDNN-SLKKLPDLP---PSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK- 208
Query: 333 EIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNL 392
++P LE + N L EL L LT + N L T+P +L
Sbjct: 209 KLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDL---PPSL 259
Query: 393 IMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTG 452
L + DN L +P+ L +D+S+N + + +L +LN +N++
Sbjct: 260 EALNVRDNYLT-DLPELPQ---SLTFLDVSENIFS-GLSELP---PNLYYLNASSNEIR- 310
Query: 453 SIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNAL 512
S+ SL +L + N P+ +L L N + +P N L
Sbjct: 311 SLC---DLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLAE-VPELPQN---L 359
Query: 513 QRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVG 572
++LH+ N E P ++ +L ++ L +P + L++L + N
Sbjct: 360 KQLHVEYNPLR-EFPDIPESVEDL----RMNSHLA-EVPELPQN---LKQLHVETNPLR- 409
Query: 573 ALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS 619
P S +E L+++ + +L + +
Sbjct: 410 EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-38
Identities = 74/349 (21%), Positives = 126/349 (36%), Gaps = 51/349 (14%)
Query: 344 LELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLV 403
L+ + LT +PVE +K+ T+ + + P G + + +L D
Sbjct: 13 LQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD- 70
Query: 404 GGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKS 463
Q ++L++ L+ +P L L N LT +P KS
Sbjct: 71 ----------RQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQSLKS 115
Query: 464 LVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFT 523
L+ + + P L + + NQ +P E+ N + L+ + + +N
Sbjct: 116 LLVDNNNLKALSDLPP-------LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK 166
Query: 524 GELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQ 583
+LP +L + +N L +P E+ + L + N L +
Sbjct: 167 -KLPDLPPSLEFI---AAGNNQLE-ELP-ELQNLPFLTAIYADNNS----LKKLPDLPLS 216
Query: 584 LELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNL 643
LE + N L +P ++ NL LT + N +P SL +L N+ N L
Sbjct: 217 LESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDLPPSLEAL----NVRDNYL 269
Query: 644 SGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692
+ L P +L L+ + LS P NL L N S N +
Sbjct: 270 TDL-PELPQSLTFLDVSENIFSGLSELPP----NLYYL---NASSNEIR 310
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 33/135 (24%), Positives = 54/135 (40%), Gaps = 19/135 (14%)
Query: 575 PREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQI 634
PR + + F E L + L+ +PV+ N+ TE + + P G + +
Sbjct: 5 PRNVSNTFLQEPL-RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 635 A------------LNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLL 682
+ L L+ LS L P + LE L+ + N L+ E+P +L SLL
Sbjct: 63 SRLRDCLDRQAHELELNNLGLSSL-PELPPH---LESLVASCNSLT-ELPELPQSLKSLL 117
Query: 683 GCNFSYNNLTGPIPS 697
N + L+ P
Sbjct: 118 VDNNNLKALSDLPPL 132
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 11/80 (13%), Positives = 27/80 (33%), Gaps = 4/80 (5%)
Query: 84 NLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIP 143
++ + ++ +L+ +L L + N L P + +E L +N+ R+
Sbjct: 378 SVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPYE 433
Query: 144 KELGNLSSLTILNIYNNRIS 163
L ++
Sbjct: 434 FAHETTDKLEDDVFEHHHHH 453
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-58
Identities = 68/312 (21%), Positives = 115/312 (36%), Gaps = 36/312 (11%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
V+G+G G + R TG + +K+L R F E+ + + H N++K
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKEL--IRFDEETQRT-FLKEVKVMRCLEHPNVLKFI 73
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
G Y + EY+ G+L ++ S W R A A G++YLH I
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVID-------------MPQSKSMSAIAGSYGYIA 981
HRD+ S+N L+ + V DFGLA+++ P K + G+ ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 982 PEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041
PE EK D++S+G+VL E++ +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP-------------RTMDFGLNVR 237
Query: 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR-QGHFEFSPMDH 1100
L+ + I + C ++ P RP+ ++ L GH P
Sbjct: 238 GFLDRYCPPNCPP--SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLE 295
Query: 1101 DSDQKLENEFQS 1112
D+ ++
Sbjct: 296 QLDRGFWETYRR 307
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-58
Identities = 95/496 (19%), Positives = 187/496 (37%), Gaps = 37/496 (7%)
Query: 80 VFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLE 139
+ S +T+ + L L ++ + + + L + ++
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59
Query: 140 AHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKR 199
+ L++LT +N NN+++ P + L+ L ++ +N I+ L NL
Sbjct: 60 --SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTN 113
Query: 200 LKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLS 259
L N I+ + +L L L+ N +S + L L + GNQ++
Sbjct: 114 LTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVT 168
Query: 260 GVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSS 319
+ P L N T+LE L + NK L + +L+ L N+++ P +G L++
Sbjct: 169 DLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTN 222
Query: 320 ALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLT 379
E+ + N L L+ + L L L N+++ + P L+ L LT+L L N ++
Sbjct: 223 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
Query: 380 GTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTS 439
PL LT L L+L +N L P + L + L N+++ P + T
Sbjct: 279 NISPLA--GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTK 332
Query: 440 LIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFS 499
L L NK++ + + ++ L G N + P L L ++ + L+ ++
Sbjct: 333 LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388
Query: 500 GPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKM 559
N + + P + + + +++ N + ++
Sbjct: 389 NAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSY-TNEVSYTFSQ 445
Query: 560 LQRLDLSWNKFVGALP 575
+ F G +
Sbjct: 446 PVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-56
Identities = 112/551 (20%), Positives = 201/551 (36%), Gaps = 91/551 (16%)
Query: 147 GNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAG 206
G L S TI + I+ F L+ + V N++ + +L ++ + +A
Sbjct: 1 GPLGSATITQ--DTPINQIFT--DTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQAD 54
Query: 207 QNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKEL 266
+ I + +L + + NQL+ P + L L D+++ NQ++ + P L
Sbjct: 55 RLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--L 108
Query: 267 GNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFS 326
N T+L L L++N+ I + + L++
Sbjct: 109 ANLTNLTGLTLFNNQ-----------ITDID---------------PLKNLTN------- 135
Query: 327 ENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGF 386
L L L N ++ + L+ L +L +L N +T PL
Sbjct: 136 -----------------LNRLELSSNTISDISA--LSGLTSLQQLSFG-NQVTDLKPLA- 174
Query: 387 QYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLE 446
LT L L + N + L + L + ++N ++ P + T+L L+L
Sbjct: 175 -NLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLN 229
Query: 447 TNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEI 506
N+L + +L L L N + + L L L+ ++L NQ S P +
Sbjct: 230 GNQLKD--IGTLASLTNLTDLDLANNQISNL--APLSGLTKLTELKLGANQISNISP--L 283
Query: 507 GNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLS 566
AL L L++N + NL NL + N ++ P+ S LQRL
Sbjct: 284 AGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFY 339
Query: 567 WNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAEL 626
NK + +L + L N++S P + NL+R+T+L + +++ P
Sbjct: 340 NNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNY 394
Query: 627 GSLSSLQIALNLSYNNLSGLIPP-ELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCN 685
+ S+ N N LI P + + + N S S+ S +
Sbjct: 395 KANVSI---PNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSY-TFSQPVTIG 450
Query: 686 FSYNNLTGPIP 696
+G +
Sbjct: 451 KGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-55
Identities = 109/496 (21%), Positives = 191/496 (38%), Gaps = 37/496 (7%)
Query: 104 LTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRIS 163
L + ++ + I + L + + +L +T L I
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59
Query: 164 GPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCES 223
+ L+ L+Q+ +N ++ + P L NL +L N I+ + + +
Sbjct: 60 S--IDGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIAD--ITPLANLTN 113
Query: 224 LQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQV 283
L L L NQ++ P + L L + L N +S + L TSL+ L+ +
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTD 169
Query: 284 GQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILG 343
K L ++ +L+ L I N++ + + KL++ + + N + P L +
Sbjct: 170 ---LKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTN 222
Query: 344 LELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLV 403
L+ L L N+L + L +L NLT LDL+ N ++ PL LT L L+L N +
Sbjct: 223 LDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQIS 278
Query: 404 GGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKS 463
P L + L ++L++N L P I +L +L L N ++ P V+
Sbjct: 279 NISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTK 332
Query: 464 LVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFT 523
L +L N + S L L N++ + NQ S P + N + +L L+D +T
Sbjct: 333 LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388
Query: 524 GELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQ 583
N+S T + L P I D++WN + Q
Sbjct: 389 NAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSY-TNEVSYTFSQ 445
Query: 584 LELLKLSENELSGSIP 599
+ SG++
Sbjct: 446 PVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-52
Identities = 99/451 (21%), Positives = 171/451 (37%), Gaps = 36/451 (7%)
Query: 249 TDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNG 308
+ I ++ + L + + + L R +
Sbjct: 5 SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI-- 58
Query: 309 TIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNL 368
+ L++ +I+FS N L P L + L + + N++ + P L L NL
Sbjct: 59 KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNL 114
Query: 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTG 428
T L L N +T PL LTNL L+L N++ L + L + N +T
Sbjct: 115 TGLTLFNNQITDIDPLK--NLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTD 169
Query: 429 KIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANL 488
P + T+L L++ +NK++ + + + +L L N + P L L NL
Sbjct: 170 LKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNL 223
Query: 489 STVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTG 548
+ L+ NQ + + L L L++N + P + L+ L + +N ++
Sbjct: 224 DELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN 279
Query: 549 RIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRL 608
PL L L+L+ N+ I +L L L L N +S P + +L++L
Sbjct: 280 ISPLA--GLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKL 333
Query: 609 TELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLS 668
L N S + L +L+++ L+ +N +S L P L NL + L LN+ +
Sbjct: 334 QRLFFYNNKVSD--VSSLANLTNINW-LSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388
Query: 669 GEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQ 699
N+S L P S
Sbjct: 389 NAPVNYKANVSIPNTVKNVTGALIAPATISD 419
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-51
Identities = 99/430 (23%), Positives = 171/430 (39%), Gaps = 35/430 (8%)
Query: 271 SLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSL 330
L + + + + Q+ ++ + + + T+ L + +
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 331 IGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLT 390
+ + + L + N+LT + P L L L + ++ N + PL LT
Sbjct: 59 --KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLT 112
Query: 391 NLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKL 450
NL L LF+N + P L + L ++LS N ++ + TSL L+ N++
Sbjct: 113 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG-NQV 167
Query: 451 TGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCN 510
T P + +L +L + N + S L KL NL ++ NQ S P +G
Sbjct: 168 TDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILT 221
Query: 511 ALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKF 570
L L L+ N + +L+NL ++++N ++ PL L L L N+
Sbjct: 222 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQI 277
Query: 571 VGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLS 630
P + L L L+L+EN+L P I NL LT L + N+ S P + SL+
Sbjct: 278 SNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLT 331
Query: 631 SLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNN 690
LQ L N +S + L NL + +L +N +S P NL+ + +
Sbjct: 332 KLQR-LFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 386
Query: 691 LTGPIPSSQT 700
T + +
Sbjct: 387 WTNAPVNYKA 396
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 6e-56
Identities = 73/295 (24%), Positives = 117/295 (39%), Gaps = 35/295 (11%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAE--ILTLGKIRHRNIVKL 873
+G+G G V+R + G VAVK +S E S+ E + +RH NI+
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGF 67
Query: 874 YGFCYHQGSNLLMY----EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD- 928
+ Y GSL + L +TLD + I L A GL++LH +
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 929 ----CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID---MPQSKSMSAIAGSYGYIA 981
KP I HRD+KS NIL+ + + D GLA + + G+ Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 982 PE------YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG----GDLVTWVRNFIR 1031
PE ++ DI+++G+VL E+ ++ D+V +F
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 1032 NNSLVSGMLDARLNLQDEKTVSHMITVL-KIAMLCTNISPFDRPTMREVVLMLSE 1085
+V R N+ + +T L K+ C +P R T + L++
Sbjct: 246 MRKVVCVD-QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 7e-56
Identities = 71/295 (24%), Positives = 114/295 (38%), Gaps = 35/295 (11%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFR--AEILTLGKIRHRNIVKL 873
IG+G G V+ R G VAVK + E S+ EI +RH NI+
Sbjct: 44 QIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGF 96
Query: 874 YGFCYHQGSN----LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH--- 926
+ L+ +Y GSL + L S+TLD ++ +A + GL +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 927 --HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID---MPQSKSMSAIAGSYGYIA 981
KP I HRD+KS NIL+ + D GLA + G+ Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 982 PE------YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG----GDLVTWVRNFIR 1031
PE + D+YS+G++L E+ +++ DLV ++
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 1032 NNSLVSGMLDARLNLQDE-KTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+V R + + + + + K+ C +P R T V L++
Sbjct: 275 MREIVCIK-KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-55
Identities = 77/301 (25%), Positives = 121/301 (40%), Gaps = 35/301 (11%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAE--ILTLGKIRHRNIVKL 873
IG+G G V+R R G VAVK +S E S+ E I +RH NI+
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGF 101
Query: 874 YGFCYHQGSN----LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD- 928
L+ +Y GSL + L+ T+ + +AL A GL++LH +
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 929 ----CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID---MPQSKSMSAIAGSYGYIA 981
KP I HRD+KS NIL+ + D GLA D + + G+ Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 982 PE------YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG----GDLVTWVRNFIR 1031
PE + ++ DIY+ G+V E+ + + DLV +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 1032 NNSLVSGMLDARLNLQDEKTVSHMITVL-KIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090
+V R N+ + + V+ KI C + R T + LS+ ++++
Sbjct: 280 MRKVVCEQ-KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338
Query: 1091 G 1091
G
Sbjct: 339 G 339
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 6e-53
Identities = 107/527 (20%), Positives = 190/527 (36%), Gaps = 34/527 (6%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI 162
LDLSFN L + L+VL+L+ ++ +LS L+ L + N I
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLI-SGSLPSEIGGC 221
LS+L +LVA N++ +G+LK LK NLI S LP
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 222 ESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILW----GNQLSGVIPKELGNCTSLETLAL 277
+L++L L+ N++ ++ +L + + L N ++ I L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTL 207
Query: 278 YDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVE 337
+N + K I L L ++R L + + ++ + S + +
Sbjct: 208 RNNFDSLNVMK--TCIQGLAGLEVHRLVLG--------EFRNEGNLEKFDKSALEGLCNL 257
Query: 338 LSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQL 397
+ L L + + + + L N++ L ++ + L+L
Sbjct: 258 TIEEFRLAYLDYYLDDIIDL----FNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLEL 311
Query: 398 FDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLT--GSIP 455
+ +L L + + N SL FL+L N L+ G
Sbjct: 312 VNCKFGQFPTLKL---KSLKRLTFTSNKGGNAFSEVDL--PSLEFLDLSRNGLSFKGCCS 366
Query: 456 TGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEI-GNCNALQR 514
SL L L N + S+ L L ++ + + + L
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 515 LHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSC-KMLQRLDLSWNKFVGA 573
L +S + LS+L ++ N +IF+ + L LDLS +
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 574 LPREIGSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFS 619
P SL L++L ++ N+L S+P I L+ L ++ + N +
Sbjct: 486 SPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 6e-52
Identities = 102/568 (17%), Positives = 177/568 (31%), Gaps = 74/568 (13%)
Query: 130 VLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGS 189
IP L S L++ N + L L I
Sbjct: 11 TYQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 190 LPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLT 249
+L L L L N + L L
Sbjct: 68 EDGAYQSLS------------------------HLSTLILTGNPIQSLALGAFSGLSSLQ 103
Query: 250 DVILWGNQLSGVIPKELGNCTSLETLALYDNK-QVGQLPKELGSIGSLKYLYIYRNELNG 308
++ L+ + +G+ +L+ L + N Q +LP+ ++ +L++L + N++
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 309 TIPREIGKLSS----ALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIP-VELT 363
++ L L +D S N + I K + L L L N + + +
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNP-MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 364 TLKNLTKLDLSINSLTGTIPL------GFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLW 417
L L L + L + L NL + + L
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL--------------- 267
Query: 418 VVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGS 477
++ I T++ +L + + + + L L F
Sbjct: 268 ------DYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDF-SYNFGWQHLELVNCKFG-Q 318
Query: 478 FPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFT--GELPREVGNLSN 535
FP+ KL +L + N+ + +L+ L LS N + G + ++
Sbjct: 319 FPTL--KLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 536 LVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREI-GSLFQLELLKLSENEL 594
L ++S N + + + L+ LD + + SL L L +S
Sbjct: 375 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 595 SGSIPVQIGNLSRLTELQMGGNSFSGGIPAE-LGSLSSLQIALNLSYNNLSGLIPPELGN 653
+ LS L L+M GNSF + L +L L+LS L L P +
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF-LDLSQCQLEQLSPTAFNS 492
Query: 654 LILLEYLLLNNNHLSGEIPGSFVNLSSL 681
L L+ L + +N L G F L+SL
Sbjct: 493 LSSLQVLNMASNQLKSVPDGIFDRLTSL 520
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-42
Identities = 92/484 (19%), Positives = 149/484 (30%), Gaps = 49/484 (10%)
Query: 237 EIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKE-LGSIGS 295
+IP + ++ L N L + + L+ L L ++ + S+
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC-EIQTIEDGAYQSLSH 77
Query: 296 LKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLT 355
L L + N + LSS ++ E +L + + L+ L + N +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 356 GV-IPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYS 414
+P + L NL LDLS N + + L + +L L
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL----------------- 180
Query: 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNS 473
+DLS N + I + L L L N + ++ L RL
Sbjct: 181 ---SLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236
Query: 474 FTGS------FPSDLCKLANLSTVELDQNQ---FSGPIPTEIGNCNALQRLHLSDNYFTG 524
F S L L NL+ E + I + L
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE- 295
Query: 525 ELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQL 584
+ N + + K L+RL + NK A L L
Sbjct: 296 RVKDFSYN-FGWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSL 349
Query: 585 ELLKLSENELS--GSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNN 642
E L LS N LS G + L L + N + + L L+ L+ ++N
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEH-LDFQHSN 407
Query: 643 LSGLIPPE-LGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTF 701
L + +L L YL +++ H G F LSSL + N+ F
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD-IF 466
Query: 702 QNMS 705
+
Sbjct: 467 TELR 470
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-51
Identities = 137/700 (19%), Positives = 228/700 (32%), Gaps = 110/700 (15%)
Query: 100 GLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKE-LGNLSSLTILNIY 158
L L LSFN + L++L L + I KE NL +L IL++
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 159 NNRISGPFPKEIGKLSALSQLVAYSNNISGSLPP--TLGNLKRLKSFRAGQNLISG-SLP 215
+++I P L L +L Y +S ++ NLK L +N I L
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 216 SEIGGCESLQYLGLAQNQLSGEIPKEIGML--KYLTDVILWGNQLSGVIPKELGNC---- 269
G SL+ + + NQ+ E+ L K L+ L N L + + G C
Sbjct: 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201
Query: 270 --TSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSE 327
LE L + N + N ++ + + + F
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNF------------SNAISKSQAFSLILAHHIMGAGFGF 249
Query: 328 NSLIGEIPVELSKIL---GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPL 384
++ I + L + L L + + TLK+L L+L+ N +
Sbjct: 250 HN-IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE 308
Query: 385 GFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLN 444
F L N L V++LS N L + + F
Sbjct: 309 AFYGLDN------------------------LQVLNLSYNLLG-----ELYSSN---FYG 336
Query: 445 LETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPT 504
L + + L N L L T++L N T
Sbjct: 337 L----------------PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----T 375
Query: 505 EIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKM--LQR 562
I ++ + LS N LP+ + + ++S N L + + F ++ LQ
Sbjct: 376 TIHFIPSIPDIFLSGNKLV-TLPKINLTANLI---HLSENRLEN-LDILYFLLRVPHLQI 430
Query: 563 LDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPVQI-----GNLSRLTELQMGGN 616
L L+ N+F + LE L L EN L + ++ LS L L + N
Sbjct: 431 LILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHN 490
Query: 617 SFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFV 676
+ P L++L+ L+L+ N L+ L LE L ++ N L P FV
Sbjct: 491 YLNSLPPGVFSHLTALRG-LSLNSNRLTVL--SHNDLPANLEILDISRNQLLAPNPDVFV 547
Query: 677 NLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQPPSSLP----- 731
+LS L + ++N S ++ + + + G P P S
Sbjct: 548 SLSVL---DITHNKFICECELSTFINWLNHTNVT----IAGPPADIYCVYPDSFSGVSLF 600
Query: 732 -FPSGTNSPTARLGKLVAIIAAAIGGVSLVLITVIIYFLR 770
+ L L + + + I+ +
Sbjct: 601 SLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTK 640
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-37
Identities = 80/397 (20%), Positives = 130/397 (32%), Gaps = 22/397 (5%)
Query: 324 DFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIP 383
+ +L ++P L+ E L L N + V L+ L L+L TI
Sbjct: 10 FYRFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 384 LG-FQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGK-IPRHICRN-TSL 440
F+ L NL +L L + + P L+ + L L+ + RN +L
Sbjct: 66 KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL 125
Query: 441 IFLNLETNKLTG-SIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLA--NLSTVELDQNQ 497
L+L N++ + + SL + N +L L LS L N
Sbjct: 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANS 185
Query: 498 FSGPIPTEIGNC-NALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFS 556
+ + G C N + + L +G N + SN ++ +
Sbjct: 186 LYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLIL 238
Query: 557 CKMLQRLDLSWNKFVGALPREIGSLFQ--LELLKLSENELSGSIPVQIGNLSRLTELQMG 614
+ ++ L + + L LS + L L L +
Sbjct: 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298
Query: 615 GNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGS 674
N + L +LQ+ LNLSYN L L L + Y+ L NH++ +
Sbjct: 299 YNKINKIADEAFYGLDNLQV-LNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQT 357
Query: 675 FVNLSSLLGCNFSYNNLTG-PIPSSQTFQNMSVNSFS 710
F L L + N LT S +S N
Sbjct: 358 FKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-36
Identities = 109/601 (18%), Positives = 199/601 (33%), Gaps = 108/601 (17%)
Query: 82 SLNLTKMNLSGYLSPN--IGGLVHLTALDLSFNQLSR-NIPKEIGNCSSLEVLNLNNNRL 138
L L LS + + L LT LDLS NQ+ + G +SL+ ++ ++N++
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 139 EAHIPKELGNLS--SLTILNIYNNRI-SGPFPKEIGKLSALSQLVAYSNNISGSLPPTLG 195
EL L +L+ ++ N + S ++ +V ++S G
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS-------G 213
Query: 196 NLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWG 255
N + N IS S + + G + + + +
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQ--------------- 257
Query: 256 NQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIG 315
N +G+ +S+ L L + ++ LK L + N++N
Sbjct: 258 NTFAGLAR------SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311
Query: 316 KLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSI 375
L + L++L L N L + L + +DL
Sbjct: 312 GLDN------------------------LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 376 NSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHIC 435
N + F++L L L DL DN LT I
Sbjct: 348 NHIAIIQDQTFKFLEKLQTL------------------------DLRDNALT-----TIH 378
Query: 436 RNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTG-SFPSDLCKLANLSTVELD 494
S+ + L NKL ++P + + L N L ++ +L + L+
Sbjct: 379 FIPSIPDIFLSGNKLV-TLPKINL---TANLIHLSENRLENLDILYFLLRVPHLQILILN 434
Query: 495 QNQFSG-PIPTEIGNCNALQRLHLSDNYFTGELPREV-----GNLSNLVTFNVSSNFLTG 548
QN+FS +L++L L +N E+ LS+L ++ N+L
Sbjct: 435 QNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN- 493
Query: 549 RIPLEIFSC-KMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSR 607
+P +FS L+ L L+ N+ L LE+L +S N+L + +
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDV--FVS 548
Query: 608 LTELQMGGNSFSGGIPAE--LGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNN 665
L+ L + N F + L+ + + ++ + P + L +
Sbjct: 549 LSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCD 608
Query: 666 H 666
Sbjct: 609 E 609
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-31
Identities = 70/349 (20%), Positives = 126/349 (36%), Gaps = 33/349 (9%)
Query: 371 LDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKI 430
+LT +P Q L L L N + QL +++L + I
Sbjct: 9 AFYRFCNLT-QVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 431 PRHICRN-TSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTGSF--PSDLCKLA 486
+ RN +L L+L ++K+ + L +LRL + + L
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
Query: 487 NLSTVELDQNQFSG-PIPTEIGNCNALQRLHLSDNYFTGELPREVGNLS--NLVTFNVSS 543
L+ ++L +NQ + G N+L+ + S N E+ L L F++++
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 544 NFLTGRIPLEIFSCKM------LQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGS 597
N L R+ ++ C L+ LD+S N + +++ N +S S
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT------------VDITGNFSNAISKS 231
Query: 598 IPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQI-ALNLSYNNLSGLIPPELGNLIL 656
+ + G ++ L+ + L+LS+ + L L
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
Query: 657 LEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMS 705
L+ L L N ++ +F L +L N SYN L + SS F +
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE-LYSS-NFYGLP 338
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-23
Identities = 70/327 (21%), Positives = 121/327 (37%), Gaps = 24/327 (7%)
Query: 80 VFSLNLTKMNLSGYLSPNIGGLVH--LTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNR 137
+ N+ GL + LDLS + + L+VLNL N+
Sbjct: 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK 301
Query: 138 LEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNL 197
+ + L +L +LN+ N + + L ++ + N+I+ T L
Sbjct: 302 INKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFL 361
Query: 198 KRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQ 257
++L++ N + + I S+ + L+ N+L +PK + L N+
Sbjct: 362 EKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKINLTANLI---HLSENR 412
Query: 258 LSGV-IPKELGNCTSLETLALYDNKQVGQLPKE--LGSIGSLKYLYIYRNELNGTIPREI 314
L + I L L+ L L N + + SL+ L++ N L E+
Sbjct: 413 LENLDILYFLLRVPHLQILILNQN-RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETEL 471
Query: 315 -----GKLSSALEIDFSENSLIGEIPVELSKILG-LELLYLFENKLTGVIPVELTTLKNL 368
LS + + N + +P + L L L L N+LT + +L NL
Sbjct: 472 CWDVFEGLSHLQVLYLNHNY-LNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANL 528
Query: 369 TKLDLSINSLTGTIPLGFQYLTNLIML 395
LD+S N L P F L+ L +
Sbjct: 529 EILDISRNQLLAPNPDVFVSLSVLDIT 555
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-49
Identities = 89/574 (15%), Positives = 180/574 (31%), Gaps = 73/574 (12%)
Query: 124 NCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYS 183
+C + V + + IP L +++ L++ N+I+ ++ + L L+ S
Sbjct: 3 SCDASGVCDGRSRSF-TSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 184 NNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIG 243
+ I+ +L L+ N +S S G SL+YL L N +
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLG---- 114
Query: 244 MLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKE-LGSIGSLKYLYIY 302
+ N T+L+TL + + + ++ + + SL L I
Sbjct: 115 ------------------VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
Query: 303 RNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVEL 362
L + + + + L L ++ ++ +
Sbjct: 157 ALSLRNYQSQSLKSIRD------------------------IHHLTLHLSESAFLLEIFA 192
Query: 363 TTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLS 422
L ++ L+L +L ++ + +L L
Sbjct: 193 DILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILE 252
Query: 423 DNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDL 482
+ + T + ++ G ++ +L + +
Sbjct: 253 LSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306
Query: 483 CKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPRE---VGNLSNLVTF 539
L + + ++ ++ + + +L+ L LS+N E + G +L T
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366
Query: 540 NVSSNFLT--GRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGS 597
+S N L + + + K L LD+S N F +P ++ L LS +
Sbjct: 367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-V 424
Query: 598 IPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILL 657
+ L L + N+ L L L +S N L L P+ +L
Sbjct: 425 VKT--CIPQTLEVLDVSNNNLD-SFSLFLPRLQE----LYISRNKLKTL--PDASLFPVL 475
Query: 658 EYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNL 691
+ ++ N L G F L+SL N
Sbjct: 476 LVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-49
Identities = 94/524 (17%), Positives = 184/524 (35%), Gaps = 30/524 (5%)
Query: 104 LTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRIS 163
D + IP + ++++ L+L+ N++ +L ++L +L + ++RI+
Sbjct: 7 SGVCDGRSRSFTS-IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 164 GPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISG-SLPSEIGGC 221
L +L L N++S SL G L LK N + S
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 222 ESLQYLGLAQNQLSGEIPKE-IGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
+LQ L + + EI + L L ++ + L + L + + L L+ +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 281 KQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSK 340
+ L + S++YL + L + + + ++
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 341 ILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDN 400
+L L L +++ E D + + LG + L +
Sbjct: 243 LLKLLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 401 SLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLTGSI---PT 456
L + ++ + + ++ + +P ++ SL FL+L N +
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSA 355
Query: 457 GVTRCKSLVQLRLGGNSFT--GSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQR 514
SL L L N L L NL+++++ +N F P+P ++
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF 414
Query: 515 LHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGAL 574
L+LS + L +VS+N L L + LQ L +S NK L
Sbjct: 415 LNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TL 466
Query: 575 PREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSF 618
P + L ++K+S N+L L+ L ++ + N +
Sbjct: 467 P-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-48
Identities = 95/496 (19%), Positives = 181/496 (36%), Gaps = 39/496 (7%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKE-LGNLSSLTILNIYNNR 161
+ +LDLSFN+++ ++ C++L+VL L ++R+ I + +L SL L++ +N
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNH 85
Query: 162 ISGPFPKEIGKLSALSQLVAYSNNISG-SLPPTLGNLKRLKSFR-AGQNLISGSLPSEIG 219
+S G LS+L L N + NL L++ R S +
Sbjct: 86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145
Query: 220 GCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYD 279
G SL L + L + + ++ + + L ++ + ++ +S+ L L D
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205
Query: 280 NKQVGQLPKELGSIGSLKYLYIYRNELNG----------TIPREIGKLSSALEIDFSENS 329
L + + + R I +LS D + N
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
Query: 330 LIGEIPVELSKI--------LGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGT 381
L P E + + + L++ + L + + L+ + ++ + + +
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325
Query: 382 IPLGFQYLTNLIMLQLFDNSLVGGIPQR---LGAYSQLWVVDLSDNHLT--GKIPRHICR 436
Q+L +L L L +N +V + GA+ L + LS NHL K +
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 437 NTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQN 496
+L L++ N +P + + L L + + L +++ N
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNN 441
Query: 497 QFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIF- 555
+ LQ L++S N LP L+ +S N L +P IF
Sbjct: 442 NLDS-FSLFLPR---LQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQLK-SVPDGIFD 494
Query: 556 SCKMLQRLDLSWNKFV 571
LQ++ L N +
Sbjct: 495 RLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-34
Identities = 64/391 (16%), Positives = 133/391 (34%), Gaps = 16/391 (4%)
Query: 309 TIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNL 368
+IP + ++ +D S N + +L L++L L +++ + +L +L
Sbjct: 19 SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVG-GIPQRLGAYSQLWVVDLSDNHLT 427
LDLS N L+ F L++L L L N G+ + L + + +
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136
Query: 428 GKIPRHICRN-TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLA 486
+I R TSL L ++ L + + + L L + L+
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
Query: 487 NLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFL 546
++ +EL + + + + + L L+ + + + +
Sbjct: 197 SVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV 256
Query: 547 TGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLS 606
+ + L + S + V L + + L + + L + L
Sbjct: 257 E----FDDCTLNGLGDFNPSESDVVSELGKV--ETVTIRRLHIPQFYLFYDLSTVYSLLE 310
Query: 607 RLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPE---LGNLILLEYLLLN 663
++ + + + + L SL+ L+LS N + G L+ L+L+
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEF-LDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369
Query: 664 NNHLS--GEIPGSFVNLSSLLGCNFSYNNLT 692
NHL + + L +L + S N
Sbjct: 370 QNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-33
Identities = 64/403 (15%), Positives = 139/403 (34%), Gaps = 30/403 (7%)
Query: 82 SLNLTKMNLSGYLSPN-IGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEA 140
+L + + + GL L L++ L + + + + L L+ +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 141 HIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRL 200
+ LSS+ L + + ++ + S + + S + L +L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246
Query: 201 KSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILW--GNQL 258
I E C ++ ++ E+G ++ +T L L
Sbjct: 247 ------LRYILELSEVEFDDCTLNGLGDFNPSES--DVVSELGKVETVTIRRLHIPQFYL 298
Query: 259 SGVIPKELGNCTSLETLALYDNKQVGQLPKELGS-IGSLKYLYIYRNELNGTIPRE---I 314
+ ++ + + ++ +V +P + SL++L + N + +
Sbjct: 299 FYDLSTVYSLLEKVKRITVENS-KVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 315 GKLSSALEIDFSENSL--IGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLD 372
G S + S+N L + + L + L L + N +P + + L+
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416
Query: 373 LSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPR 432
LS + + L +L + +N+L L +L + +S N L +P
Sbjct: 417 LSSTGIR-VVKTC--IPQTLEVLDVSNNNL-DSFSLFL---PRLQELYISRNKLK-TLPD 468
Query: 433 HICRNTSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSF 474
L+ + + N+L S+P G+ R SL ++ L N +
Sbjct: 469 ASL-FPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-32
Identities = 64/388 (16%), Positives = 119/388 (30%), Gaps = 17/388 (4%)
Query: 324 DFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIP 383
D S IP L+ ++ L L NK+T + +L NL L L + + TI
Sbjct: 11 DGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIE 66
Query: 384 LG-FQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLI 441
F L +L L L DN L G S L ++L N + N T+L
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126
Query: 442 FLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSG 500
L + + I SL +L + S L + ++ + L ++ +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 501 PIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKML 560
+ ++++ L L D + + + L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246
Query: 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSG 620
R L ++ E L + +E + + L +
Sbjct: 247 LRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300
Query: 621 GIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEI---PGSFVN 677
+ L ++ + + + + + +L LE+L L+ N + E
Sbjct: 301 DLSTVYSLLEKVKR-ITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359
Query: 678 LSSLLGCNFSYNNLTGPIPSSQTFQNMS 705
SL S N+L + + +
Sbjct: 360 WPSLQTLVLSQNHLRSMQKTGEILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 51/300 (17%), Positives = 93/300 (31%), Gaps = 30/300 (10%)
Query: 418 VVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGS 477
V D T IP + ++ L+L NK+T + C +L L L +
Sbjct: 9 VCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65
Query: 478 FPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTG-ELPREVGNLSNL 536
L +L ++L N S + G ++L+ L+L N + + NL+NL
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125
Query: 537 VTFNVSSNFLTGRIPLEIFS-CKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELS 595
T + + I F+ L L++ + + S+ + L L +E +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 596 GSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLI 655
+ + LS + L L NL+ L
Sbjct: 186 FLLEIFADILSSVRYL-------------------------ELRDTNLARFQFSPLPVDE 220
Query: 656 LLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGL 715
+ + S SF L LL + + + + + + L
Sbjct: 221 VSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSEL 280
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 176 bits (450), Expect = 5e-49
Identities = 73/417 (17%), Positives = 144/417 (34%), Gaps = 75/417 (17%)
Query: 104 LTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRIS 163
L +++ P + + L + + L S+T L + +++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 164 GPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCES 223
+ I L+ L L N I+ S +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITD--------------------------ISPLSNLVK 89
Query: 224 LQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQV 283
L L + N+++ + L L ++ L + +S + P L N T + +L L N
Sbjct: 90 LTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGAN-HN 144
Query: 284 GQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILG 343
L ++ L YL + +++ P I L+
Sbjct: 145 LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTD------------------------ 178
Query: 344 LELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLV 403
L L L N++ + P L +L +L +N +T P+ +T L L++ +N +
Sbjct: 179 LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVA--NMTRLNSLKIGNNKIT 234
Query: 404 GGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKS 463
P L SQL +++ N ++ + T L LN+ +N+++ + +
Sbjct: 235 DLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQ 288
Query: 464 LVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDN 520
L L L N + L NL+T+ L QN + P + + + + ++
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 176 bits (450), Expect = 6e-49
Identities = 75/373 (20%), Positives = 148/373 (39%), Gaps = 28/373 (7%)
Query: 296 LKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLT 355
L +N P L+ + + S+ + ++ + L + K+
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 356 GVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQ 415
+ +E L NL L+L+ N +T PL L L L + N + L +
Sbjct: 58 SIQGIEY--LTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 416 LWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFT 475
L + L++++++ P + T + LNL N S + ++ L L + +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK 168
Query: 476 GSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSN 535
+ + L +L ++ L+ NQ P + + +L N T P V N++
Sbjct: 169 DV--TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 536 LVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELS 595
L + + +N +T PL + L L++ N+ + L +L++L + N++S
Sbjct: 223 LNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 596 GSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLI 655
+ NLS+L L + N +G L++L L LS N+++ + P L +L
Sbjct: 279 DISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT-LFLSQNHITDIRP--LASLS 333
Query: 656 LLEYLLLNNNHLS 668
++ N +
Sbjct: 334 KMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-49
Identities = 83/370 (22%), Positives = 144/370 (38%), Gaps = 49/370 (13%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141
L K +++ L +T L ++ +++ + I ++LE LNLN N++
Sbjct: 26 RAVLQKASVTD--VVTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDI 81
Query: 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLK 201
P L NL LT L I N+I+ + L+ L +L +NIS L NL ++
Sbjct: 82 SP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD--ISPLANLTKMY 135
Query: 202 SFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGV 261
S G N S S + L YL + ++++ P I L L + L NQ+ +
Sbjct: 136 SLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI 192
Query: 262 IPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSAL 321
P L + TSL Y N+ + ++ L L I N++ P + LS
Sbjct: 193 SP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LANLSQ-- 244
Query: 322 EIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGT 381
L L + N+++ + + L L L++ N ++
Sbjct: 245 ----------------------LTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISDI 280
Query: 382 IPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLI 441
L L+ L L L +N L + +G + L + LS NH+T P + + +
Sbjct: 281 SVLN--NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMD 336
Query: 442 FLNLETNKLT 451
+ +
Sbjct: 337 SADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-48
Identities = 85/394 (21%), Positives = 147/394 (37%), Gaps = 51/394 (12%)
Query: 176 LSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLS 235
+ L I+ P +L + ++ ES+ L +A +++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 236 GEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGS 295
+ I L L + L GNQ++ + P L N L L + NK L ++ +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTN 111
Query: 296 LKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLT 355
L+ LY+ + ++ P + L+ ++ N + ++ LS + GL L + E+K+
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168
Query: 356 GVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQ 415
V P + L +L L L+ N + PL LT+L
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISPLA--SLTSLHYF-------------------- 204
Query: 416 LWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFT 475
N +T P + T L L + NK+T P + L L +G N +
Sbjct: 205 ----TAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256
Query: 476 GSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSN 535
+ + L L + + NQ S + N + L L L++N E +G L+N
Sbjct: 257 D--INAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312
Query: 536 LVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNK 569
L T +S N +T PL S + D +
Sbjct: 313 LTTLFLSQNHITDIRPLA--SLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-46
Identities = 81/354 (22%), Positives = 147/354 (41%), Gaps = 26/354 (7%)
Query: 343 GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSL 402
G L + + P L + L S+T + L ++ L + +
Sbjct: 1 GAATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKV 56
Query: 403 VGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCK 462
Q + + L ++L+ N +T P + L L + TNK+T + +
Sbjct: 57 AS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLT 110
Query: 463 SLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYF 522
+L +L L ++ + S L L + ++ L N + + N L L ++++
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKV 167
Query: 523 TGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLF 582
+ NL++L + +++ N + PL S L N+ P + ++
Sbjct: 168 KD--VTPIANLTDLYSLSLNYNQIEDISPLA--SLTSLHYFTAYVNQITDITP--VANMT 221
Query: 583 QLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNN 642
+L LK+ N+++ P + NLS+LT L++G N S I A + L+ L++ LN+ N
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-INA-VKDLTKLKM-LNVGSNQ 276
Query: 643 LSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIP 696
+S + L NL L L LNNN L E L++L S N++T P
Sbjct: 277 ISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-45
Identities = 74/369 (20%), Positives = 143/369 (38%), Gaps = 27/369 (7%)
Query: 248 LTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELN 307
+ ++ + P + L + S+ L + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 308 GTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKN 367
+I I L++ ++ + N + P LS ++ L LY+ NK+T + L L N
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNLTN 111
Query: 368 LTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLT 427
L +L L+ ++++ PL LT + L L N + L + L + ++++ +
Sbjct: 112 LRELYLNEDNISDISPLA--NLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168
Query: 428 GKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLAN 487
P I T L L+L N++ P + SL N T + + +
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI--TPVANMTR 222
Query: 488 LSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLT 547
L+++++ N+ + P + N + L L + N + V +L+ L NV SN ++
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS 278
Query: 548 GRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSR 607
L + L L L+ N+ IG L L L LS+N ++ P + +LS+
Sbjct: 279 DISVLN--NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334
Query: 608 LTELQMGGN 616
+
Sbjct: 335 MDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-13
Identities = 33/162 (20%), Positives = 55/162 (33%), Gaps = 13/162 (8%)
Query: 536 LVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELS 595
T + P R L + L + L ++ +++
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 596 GSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLI 655
SI I L+ L L + GN + P L +L L L + N ++ L NL
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTN-LYIGTNKIT--DISALQNLT 110
Query: 656 LLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPS 697
L L LN +++S P NL+ + N N+ +
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-47
Identities = 46/294 (15%), Positives = 99/294 (33%), Gaps = 18/294 (6%)
Query: 84 NLTKMNLSGYLSP-NIGGLVHLTALDLSFNQLSRNIPKEIGNCSS--LEVLNLNNNRLEA 140
+ + + S + + L + + + + L L + L
Sbjct: 37 RHYNADRNRWHSAWRQANSNNPQIETRTGRAL-KATADLLEDATQPGRVALELRSVPLP- 94
Query: 141 HIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRL 200
P + LS L + I + P + + + L L N + +LP ++ +L RL
Sbjct: 95 QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRL 152
Query: 201 KSFRAGQNLISGSLPSEIGGCE---------SLQYLGLAQNQLSGEIPKEIGMLKYLTDV 251
+ LP + + +LQ L L + +P I L+ L +
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSL 211
Query: 252 ILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIP 311
+ + LS + + + LE L L + P G LK L + T+P
Sbjct: 212 KIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270
Query: 312 REIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTL 365
+I +L+ ++D + +P ++++ ++ + + +
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-47
Identities = 59/319 (18%), Positives = 100/319 (31%), Gaps = 28/319 (8%)
Query: 365 LKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDN 424
L ++ L+ D + R + + +
Sbjct: 11 SSGRENLYFQGSTALRPYH---DVLSQWQRHYNADRNRWH-SAWRQANSNNPQIETRTGR 66
Query: 425 HLTGKIPRHI--CRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDL 482
L + + L L + L P R L + + P +
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 483 CKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVS 542
+ A L T+ L +N +P I + N L+ L + ELP + +
Sbjct: 124 QQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTD-------- 174
Query: 543 SNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQI 602
E LQ L L W +LP I +L L+ LK+ + LS ++ I
Sbjct: 175 -------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAI 225
Query: 603 GNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLL 662
+L +L EL + G + P G + L+ L L + +P ++ L LE L L
Sbjct: 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKR-LILKDCSNLLTLPLDIHRLTQLEKLDL 284
Query: 663 NNNHLSGEIPGSFVNLSSL 681
+P L +
Sbjct: 285 RGCVNLSRLPSLIAQLPAN 303
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 2e-46
Identities = 60/348 (17%), Positives = 110/348 (31%), Gaps = 26/348 (7%)
Query: 308 GTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKN 367
G+ S + F ++ + LS+ + Y + N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQ---WQRHYNADRNRWH-SAWRQANSNN 57
Query: 368 LTKLDLSINSLTGTIP-LGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHL 426
+ +L T L + L+L L P + S L + + L
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGL 116
Query: 427 TGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLA 486
++P + + L L L N L ++P + L +L + P L
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST- 173
Query: 487 NLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFL 546
E LQ L L LP + NL NL + + ++ L
Sbjct: 174 --------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218
Query: 547 TGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLS 606
+ + I L+ LDL + P G L+ L L + ++P+ I L+
Sbjct: 219 SA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277
Query: 607 RLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNL 654
+L +L + G +P+ + L + I + + + + L
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCI-ILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-45
Identities = 53/265 (20%), Positives = 95/265 (35%), Gaps = 21/265 (7%)
Query: 82 SLNLTKMNLSGY-----LSPNIGGLVH--LTALDLSFNQLSRNIPKEIGNCSSLEVLNLN 134
+ N ++ + + AL+L L + P + S L+ + ++
Sbjct: 54 NSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTID 112
Query: 135 NNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTL 194
L +P + + L L + N + P I L+ L +L + LP L
Sbjct: 113 AAGLME-LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPL 170
Query: 195 GN---------LKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGML 245
+ L L+S R I SLP+ I ++L+ L + + LS + I L
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHL 228
Query: 246 KYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNE 305
L ++ L G P G L+ L L D + LP ++ + L+ L +
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288
Query: 306 LNGTIPREIGKLSSALEIDFSENSL 330
+P I +L + I +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 54/321 (16%), Positives = 101/321 (31%), Gaps = 23/321 (7%)
Query: 104 LTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRIS 163
L + R + + N N ++ I +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK 69
Query: 164 GPFPKEIGKLS--ALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGC 221
+ + L S + P L L+ + LP +
Sbjct: 70 A-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF 126
Query: 222 ESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNC---------TSL 272
L+ L LA+N L +P I L L ++ + +P+ L + +L
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 273 ETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIG 332
++L L + LP + ++ +LK L I + L+ + I L E+D + +
Sbjct: 186 QSLRLEWT-GIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243
Query: 333 EIPVELSKILGLELLYLFE-NKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTN 391
P L+ L L + + L +P+++ L L KLDL +P L
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
Query: 392 LIMLQLFDNSLVGGIPQRLGA 412
++ + + R A
Sbjct: 303 NCIILVPPHLQAQLDQHRPVA 323
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 47/334 (14%), Positives = 100/334 (29%), Gaps = 29/334 (8%)
Query: 121 EIGNCSSLEVLNLNN-NRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQL 179
+ S E L L L + +
Sbjct: 7 HHHHSSGRENLYFQGSTALRP-YHDVLSQWQRHYNADRNRWH----SAWRQANSNNPQIE 61
Query: 180 VAYSNNISGSLPPTLGNLKR--LKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGE 237
+ + L + + + + P + LQ++ + L E
Sbjct: 62 TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 238 IPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLK 297
+P + L + L N L +P + + L L++ ++ +LP+ L
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA------ 171
Query: 298 YLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGV 357
+ E L + + + +P ++ + L+ L + + L+
Sbjct: 172 ---------STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA- 220
Query: 358 IPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLW 417
+ + L L +LDL + P F L L L D S + +P + +QL
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE 280
Query: 418 VVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLT 451
+DL ++P I + + + + +
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-41
Identities = 50/348 (14%), Positives = 97/348 (27%), Gaps = 29/348 (8%)
Query: 212 GSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTS 271
GS + L + + + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 272 LETLALYDNKQVGQLPKELG--SIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENS 329
+ + + L + L + L P + +LS +
Sbjct: 58 PQIETR-TGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 330 LIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYL 389
L+ E+P + + GLE L L N L +P + +L L +L + +P
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 390 TNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNK 449
L + L + +P I +L L + +
Sbjct: 174 D---------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217
Query: 450 LTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVEL-DQNQFSGPIPTEIGN 508
L+ ++ + L +L L G + ++P A L + L D + +P +I
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHR 275
Query: 509 CNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFS 556
L++L L LP + L V + +
Sbjct: 276 LTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVA 323
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 52/314 (16%), Positives = 100/314 (31%), Gaps = 28/314 (8%)
Query: 387 QYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLE 446
+ + L ++ + L + + + D + H + +
Sbjct: 9 HHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NNPQIETRT 64
Query: 447 TNKLTGSIPTGVTRCKS--LVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPT 504
L + + V L L FP +L++L + +D +P
Sbjct: 65 GRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPD 121
Query: 505 EIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLD 564
+ L+ L L+ N LP + +L+ L ++ + +P + S
Sbjct: 122 TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD------ 174
Query: 565 LSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPA 624
E L L+ L+L + S+P I NL L L++ + S +
Sbjct: 175 ---------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGP 223
Query: 625 ELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGC 684
+ L L+ L+L PP G L+ L+L + +P L+ L
Sbjct: 224 AIHHLPKLEE-LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282
Query: 685 NFSYNNLTGPIPSS 698
+ +PS
Sbjct: 283 DLRGCVNLSRLPSL 296
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 44/228 (19%), Positives = 80/228 (35%), Gaps = 20/228 (8%)
Query: 84 NLTKMNLSG----YLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNL-NNNRL 138
+L M + L + L L L+ N L +P I + + L L++ L
Sbjct: 105 HLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPEL 163
Query: 139 EAHIPKELGN---------LSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGS 189
+P+ L + L +L L + I P I L L L ++ +S +
Sbjct: 164 TE-LPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-A 220
Query: 190 LPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLA-QNQLSGEIPKEIGMLKYL 248
L P + +L +L+ + P GG L+ L L + L +P +I L L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQL 279
Query: 249 TDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSL 296
+ L G +P + + + + + Q + +
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 20/148 (13%), Positives = 39/148 (26%), Gaps = 23/148 (15%)
Query: 571 VGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSG---------- 620
+G+ E L + + R +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60
Query: 621 ---------GIPAELGSLSSLQ-IALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGE 670
L + +AL L L P + L L+++ ++ L E
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLM-E 118
Query: 671 IPGSFVNLSSLLGCNFSYNNLTGPIPSS 698
+P + + L + N L +P+S
Sbjct: 119 LPDTMQQFAGLETLTLARNPLRA-LPAS 145
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 2e-44
Identities = 75/464 (16%), Positives = 153/464 (32%), Gaps = 31/464 (6%)
Query: 83 LNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHI 142
+T +L L+ ++ LDLS N LS+ ++ + LE+LNL++N L
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73
Query: 143 PKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKS 202
+L +LS+L L++ NN + E+ ++ L A +NNIS K +
Sbjct: 74 L-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKNI-- 125
Query: 203 FRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSG-EIPKEIGMLKYLTDVILWGNQLSGV 261
N I+ + G +QYL L N++ + L + L N +
Sbjct: 126 -YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183
Query: 262 IPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSAL 321
+ ++ L+TL L N ++ + E S + ++ + N+L I + + +
Sbjct: 184 VKGQV-VFAKLKTLDLSSN-KLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 322 EIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGT 381
D N + + + + + + T
Sbjct: 241 HFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-- 297
Query: 382 IPLGFQYLTNLIMLQLFDNSL-------VGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHI 434
L + LI L+ +++L + ++ +D + +
Sbjct: 298 -DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQV 355
Query: 435 CRN-TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVEL 493
+ I L + L + G L + + L +
Sbjct: 356 TLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRA 414
Query: 494 DQNQFS-GPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNL 536
++ + + NA++ + + T +L E L L
Sbjct: 415 IVKRYEEMYVEQQSVQNNAIRDWDMYQHKET-QLAEENARLKKL 457
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-43
Identities = 69/462 (14%), Positives = 143/462 (30%), Gaps = 23/462 (4%)
Query: 213 SLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSL 272
++ + + + L + + ++ L GN LS + +L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 273 ETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIG 332
E L L N + + +L S+ +L+ L + N + E+ S + + N+ I
Sbjct: 61 ELLNLSSN-VLYETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN-IS 112
Query: 333 EIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG--FQYLT 390
+ + G + +YL NK+T + ++ + LDL +N + T+
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSD 169
Query: 391 NLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKL 450
L L L N + + ++ ++L +DLS N L + + +++L NKL
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 451 TGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCN 510
I + ++L L GN F D N + + C
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 511 ALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTG----RIPLEIFSCKMLQRLDLS 566
H L L + G R+ E + + +D
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344
Query: 567 WNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAEL 626
++ + + L+ + L + + L +
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHAT 403
Query: 627 GSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLS 668
S LQ+ + + + + + + +
Sbjct: 404 EEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-41
Identities = 74/517 (14%), Positives = 152/517 (29%), Gaps = 48/517 (9%)
Query: 101 LVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNN 160
++ + L + + + +++ L+L+ N L +L + L +LN+ +N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 161 RISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGG 220
+ + LS L L +N + L +++ A N IS + G
Sbjct: 69 VLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG- 119
Query: 221 CESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKEL-GNCTSLETLALYD 279
+ + + LA N+++ + G + + L N++ V EL + +LE L L
Sbjct: 120 -QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 280 NKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELS 339
N + + ++ LK L + N+L + E +
Sbjct: 179 N-FIYDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAG-------------------- 215
Query: 340 KILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFD 399
+ + L NKL +I L +NL DL N L + N + +
Sbjct: 216 ----VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAK 269
Query: 400 NSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGS----IP 455
++ Q + + R +L GS +
Sbjct: 270 QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLE 329
Query: 456 TGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRL 515
++ + + T+E + + L
Sbjct: 330 CERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGT 389
Query: 516 HLSDNYFTGELPREVGNLSNLVTFNVSSN-FLTGRIPLEIFSCKMLQRLDLSWNKFVGAL 574
EL S L + + + ++ D+ +K L
Sbjct: 390 LQQAV-GQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHK-ETQL 447
Query: 575 PREIGSLFQL-ELLKLSENELSGSIPVQIGNLSRLTE 610
E L +L L+ + ++ + L
Sbjct: 448 AEENARLKKLNGEADLALASANATLQELVVREQNLAS 484
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 47/374 (12%), Positives = 108/374 (28%), Gaps = 56/374 (14%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSR-NIPKEIGNCSSLEVLNLNNNRLEA 140
++ L ++ + G + LDL N++ N + + +LE LNL N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 141 HIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRL 200
+ ++ + L L++ +N+++
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA------------------------------------- 204
Query: 201 KSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLS- 259
+ E + ++ L N+L I K + + L L GN
Sbjct: 205 ------------FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251
Query: 260 GVIPKELGNCTSLETLALYDNKQV-GQLPKELGSIGSLKYLYIYRNELNGTIPREIGKL- 317
G + ++T+A K++ GQ +E Y +L + L
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALK 311
Query: 318 SSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINS 377
+ + S + E + + + VI + L+ +
Sbjct: 312 RKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKA 371
Query: 378 LTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN 437
L + G + L + + + + + + +N
Sbjct: 372 LDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQN 431
Query: 438 TSLIFLNLETNKLT 451
++ ++ +K T
Sbjct: 432 NAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 35/192 (18%), Positives = 69/192 (35%), Gaps = 12/192 (6%)
Query: 502 IPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQ 561
I N N + ++D+ L + N+ ++S N L+ ++ L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 562 RLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGG 621
L+LS N ++ SL L L L+ N + ++ + L N+ S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 622 IPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSG-EIPGSFVNLSS 680
+ + + L+ N ++ L + G ++YL L N + + +
Sbjct: 114 VSCS--RGQGKKN-IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 681 LLGCNFSYNNLT 692
L N YN +
Sbjct: 171 LEHLNLQYNFIY 182
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 13/76 (17%), Positives = 27/76 (35%), Gaps = 1/76 (1%)
Query: 621 GIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSS 680
I + + +I ++ ++L + + ++ L L+ N LS +
Sbjct: 1 AIHEIKQNGNRYKI-EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 681 LLGCNFSYNNLTGPIP 696
L N S N L +
Sbjct: 60 LELLNLSSNVLYETLD 75
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-42
Identities = 79/388 (20%), Positives = 136/388 (35%), Gaps = 52/388 (13%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI 162
L++ + L+ +P + + L + +N L +P L L + N++
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQL 93
Query: 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCE 222
+ P L LS +N LP L +L N ++ SLP
Sbjct: 94 TS-LPVLPPGLLELSIF----SNPLTHLPALPSGLCKL---WIFGNQLT-SLPVLPP--- 141
Query: 223 SLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQ 282
LQ L ++ NQL+ +P L L + NQL+ +P L+ L++ DN Q
Sbjct: 142 GLQELSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSG---LQELSVSDN-Q 192
Query: 283 VGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKIL 342
+ LP L L+ Y N L ++P L E+ S N L +PV S+
Sbjct: 193 LASLPTL---PSELYKLWAYNNRLT-SLPALPSGLK---ELIVSGNRL-TSLPVLPSE-- 242
Query: 343 GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSL 402
L+ L + N+LT +P+ + L L + N LT +P +L++ + L N L
Sbjct: 243 -LKELMVSGNRLTS-LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296
Query: 403 VGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFL--NLETNKLTGSIPTGVTR 460
Q ++ + + + L +
Sbjct: 297 SERTLQA---LREITSAPGYSGPII-RFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352
Query: 461 CKSLVQLRLGGNSFTGSFPSDLCKLANL 488
N+ +F L +L+
Sbjct: 353 ADRWHMFGQEDNA--DAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-41
Identities = 79/335 (23%), Positives = 124/335 (37%), Gaps = 45/335 (13%)
Query: 351 ENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRL 410
+ V + L++ + LT T+P ++ L + DN+L +P
Sbjct: 25 RGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALP 80
Query: 411 GAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLG 470
+L +++S N LT +P L + L L +L +
Sbjct: 81 P---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIF 129
Query: 471 GNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV 530
GN T S P L LS + NQ + +P L +L +N T LP
Sbjct: 130 GNQLT-SLPVLPPGLQELS---VSDNQLAS-LPALPSE---LCKLWAYNNQLT-SLPMLP 180
Query: 531 GNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLS 590
L L +VS N L +P L +L N+ +LP L + L +S
Sbjct: 181 SGLQEL---SVSDNQLA-SLPTLPSE---LYKLWAYNNRLT-SLPALPSGL---KELIVS 229
Query: 591 ENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPE 650
N L+ S+PV L EL + GN + +P L SL ++ N L+ L P
Sbjct: 230 GNRLT-SLPVLPSEL---KELMVSGNRLTS-LPMLPSGLLSL----SVYRNQLTRL-PES 279
Query: 651 LGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCN 685
L +L + L N LS + ++S G +
Sbjct: 280 LIHLSSETTVNLEGNPLSERTLQALREITSAPGYS 314
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-40
Identities = 82/382 (21%), Positives = 146/382 (38%), Gaps = 48/382 (12%)
Query: 117 NIPKEIGNC--SSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLS 174
+ +++ C + VLN+ + L +P L +T L I +N ++ P +L
Sbjct: 29 AVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPALPPELR 84
Query: 175 ALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQL 234
L N ++ SLP L L F LP+ L L + NQL
Sbjct: 85 TLE---VSGNQLT-SLPVLPPGLLELSIFSNPLT----HLPALP---SGLCKLWIFGNQL 133
Query: 235 SGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIG 294
+ +P L+ L+ + NQL+ +P L Y+N Q+ LP
Sbjct: 134 T-SLPVLPPGLQELS---VSDNQLA-SLPALPSELCKLW---AYNN-QLTSLPML---PS 181
Query: 295 SLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKL 354
L+ L + N+L ++P +L L N L +P S GL+ L + N+L
Sbjct: 182 GLQELSVSDNQLA-SLPTLPSELYK-LWA--YNNRLT-SLPALPS---GLKELIVSGNRL 233
Query: 355 TGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYS 414
T +PV + L +L +S N LT ++P+ + L+ L ++ N L +P+ L S
Sbjct: 234 TS-LPVLPS---ELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLS 284
Query: 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSF 474
V+L N L+ + + + TS + + + + ++L +
Sbjct: 285 SETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA--DWL 342
Query: 475 TGSFPSDLCKLANLSTVELDQN 496
+ + + N
Sbjct: 343 VPAREGEPAPADRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-39
Identities = 78/394 (19%), Positives = 126/394 (31%), Gaps = 74/394 (18%)
Query: 269 CTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSEN 328
L + ++ + LP L + + L I N L ++P +L +
Sbjct: 39 NNGNAVLNVGES-GLTTLPDCLPA--HITTLVIPDNNLT-SLPALPPELRT--------- 85
Query: 329 SLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQY 388
L + N+LT +PV L L+ + L
Sbjct: 86 ------------------LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL------- 119
Query: 389 LTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETN 448
+ L L +F N L +P +L +SDN L +P L L N
Sbjct: 120 PSGLCKLWIFGNQL-TSLPVLPPGLQEL---SVSDNQLA-SLPALPS---ELCKLWAYNN 171
Query: 449 KLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGN 508
+LT S+P + L +L + N S P+ +L L N+ + +P
Sbjct: 172 QLT-SLPMLPS---GLQELSVSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLPALPSG 222
Query: 509 CNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWN 568
L+ L +S N T LP L L VS N LT +P+ L L + N
Sbjct: 223 ---LKELIVSGNRLT-SLPVLPSELKEL---MVSGNRLT-SLPMLPSG---LLSLSVYRN 271
Query: 569 KFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGS 628
+ LP + L + L N LS + ++ F +
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330
Query: 629 LSSLQIALNLSYNNLSGLIPPELGNLILLEYLLL 662
+L +A L+P G + +
Sbjct: 331 TRALHLAAADW------LVPAREGEPAPADRWHM 358
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-39
Identities = 84/412 (20%), Positives = 144/412 (34%), Gaps = 48/412 (11%)
Query: 134 NNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPT 193
+ R + +LN+ + ++ P + ++ LV NN++ SLP
Sbjct: 24 SRGRAAVVQKMRACLNNGNAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLT-SLPAL 79
Query: 194 LGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVIL 253
L+ L N ++ SLP G L L L + +
Sbjct: 80 PPELRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWI 128
Query: 254 WGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPRE 313
+GNQL+ +P L+ L++ DN Q+ LP L L+ Y N+L ++P
Sbjct: 129 FGNQLT-SLPVLPPG---LQELSVSDN-QLASLPAL---PSELCKLWAYNNQLT-SLPML 179
Query: 314 IGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDL 373
L E+ S+N L +P S+ L L+ + N+LT +P + L +L +
Sbjct: 180 PSGLQ---ELSVSDNQLA-SLPTLPSE---LYKLWAYNNRLT-SLPALPS---GLKELIV 228
Query: 374 SINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRH 433
S N LT ++P+ + L L + N L +P L + + N LT ++P
Sbjct: 229 SGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPES 279
Query: 434 ICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVEL 493
+ +S +NLE N L+ R + G + +
Sbjct: 280 LIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH-LA 337
Query: 494 DQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNF 545
+ E + DN + LS F + F
Sbjct: 338 AADWLVPAREGEPAPADRWHMFGQEDN--ADAFSLFLDRLSETENFIKDAGF 387
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 9e-39
Identities = 83/360 (23%), Positives = 131/360 (36%), Gaps = 48/360 (13%)
Query: 343 GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSL 402
G +L + E+ LT +P L ++T L + N+LT ++P L L++ N L
Sbjct: 41 GNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLP---ALPPELRTLEVSGNQL 93
Query: 403 VGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCK 462
+P +L + HL + L L + N+LT S+P
Sbjct: 94 TS-LPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLPVLPP--- 141
Query: 463 SLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYF 522
L +L + N S P+ +L L NQ + +P LQ L +SDN
Sbjct: 142 GLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLTS-LPMLPSG---LQELSVSDNQL 193
Query: 523 TGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLF 582
LP L L +N LT +P L+ L +S N+ +LP
Sbjct: 194 A-SLPTLPSELYKL---WAYNNRLT-SLPALPSG---LKELIVSGNRL-TSLPVLPS--- 241
Query: 583 QLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNN 642
+L+ L +S N L+ S+P+ L L + N + +P L LSS +NL N
Sbjct: 242 ELKELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLTR-LPESLIHLSSETT-VNLEGNP 295
Query: 643 LSGLIPPELGNLILLEYL---LLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQ 699
LS L + ++ + P L P P+ +
Sbjct: 296 LSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADR 355
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-38
Identities = 74/369 (20%), Positives = 121/369 (32%), Gaps = 70/369 (18%)
Query: 84 NLTKMNLSG----YLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLE 139
++T + + L L L++S NQL+ ++P L + + L
Sbjct: 62 HITTLVIPDNNLTSLPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP 117
Query: 140 AHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKR 199
A S L L I+ N+++ P L LS S+N SLP L +
Sbjct: 118 A-------LPSGLCKLWIFGNQLTS-LPVLPPGLQELS----VSDNQLASLPALPSELCK 165
Query: 200 LKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLS 259
L A N ++ SLP LQ L ++ NQL+ +P L L + N+L+
Sbjct: 166 LW---AYNNQLT-SLPMLPS---GLQELSVSDNQLA-SLPTLPSELYKLW---AYNNRLT 214
Query: 260 GVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSS 319
+P L+ L + N ++ LP LK L + N L ++P L S
Sbjct: 215 -SLPALPSG---LKELIVSGN-RLTSLPVL---PSELKELMVSGNRLT-SLPMLPSGLLS 265
Query: 320 ALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLT 379
L ++ N+LT +P L L + T ++L N L+
Sbjct: 266 ---------------------------LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
Query: 380 GTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTS 439
+ +T+ L + + L
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH--LAAADWLVPAREGEPAPADR 355
Query: 440 LIFLNLETN 448
E N
Sbjct: 356 WHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 6e-09
Identities = 27/130 (20%), Positives = 46/130 (35%), Gaps = 10/130 (7%)
Query: 84 NLTKMNLSG----YLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLE 139
L ++ +SG L GL+ L + NQL+R +P+ + + SS +NL N L
Sbjct: 242 ELKELMVSGNRLTSLPMLPSGLLSL---SVYRNQLTR-LPESLIHLSSETTVNLEGNPLS 297
Query: 140 AHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKR 199
+ L ++S + R + AL A + + + R
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA--DWLVPAREGEPAPADR 355
Query: 200 LKSFRAGQNL 209
F N
Sbjct: 356 WHMFGQEDNA 365
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
IGRG+ TVY+ + T VA +L +R+ + F+ E L ++H NIV+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 875 GFCYHQGS-----NLLMYEYMARGSLGELL--HGASSTLDWQTRFMIALGAAEGLSYLHH 927
L+ E M G+L L + + +GL +LH
Sbjct: 92 DSWESTVKGKKCIVLVT-ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH- 146
Query: 928 DCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY 986
P I HRD+K +NI + +GD GLA + +K++ G+ ++APE Y
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPEM-Y 202
Query: 987 TMKVTEKCDIYSYGVVLLELLTGRAP 1012
K E D+Y++G+ +LE+ T P
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 54/302 (17%), Positives = 99/302 (32%), Gaps = 17/302 (5%)
Query: 365 LKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDN 424
++ +SL + Q N+ L L N L L +++L +++LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 425 HLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCK 484
L + + ++L L+L N + + G S+ L N+ +
Sbjct: 69 VLY-ETL-DLESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNNIS-RVSCSR-- 118
Query: 485 LANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTG-ELPREVGNLSNLVTFNVSS 543
+ L N+ + + G + +Q L L N + L N+
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 544 NFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIG 603
NF+ + ++ L+ LDLS NK + E S + + L N+L I +
Sbjct: 179 NFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 604 NLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLN 663
L + GN F G + S Q ++ + L +
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 664 NN 665
Sbjct: 293 AY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-36
Identities = 59/298 (19%), Positives = 114/298 (38%), Gaps = 24/298 (8%)
Query: 83 LNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHI 142
+T +L L+ ++ LDLS N LS+ ++ + LE+LNL++N L
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73
Query: 143 PKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKS 202
+L +LS+L L++ NN + E+ ++ L A +NNIS K +
Sbjct: 74 L-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKNIY- 126
Query: 203 FRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSG-EIPKEIGMLKYLTDVILWGNQLSGV 261
N I+ + G +QYL L N++ + L + L N +
Sbjct: 127 --LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183
Query: 262 IPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSAL 321
+ ++ L+TL L N ++ + E S + ++ + N+L I + + +
Sbjct: 184 VKGQV-VFAKLKTLDLSSN-KLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 322 EIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLT 379
D N L + ++ V + L + + ++ +L
Sbjct: 241 HFDLRGNGF---------HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 59/318 (18%), Positives = 116/318 (36%), Gaps = 19/318 (5%)
Query: 213 SLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSL 272
++ + + + L + + ++ L GN LS + +L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 273 ETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIG 332
E L L N + + +L S+ +L+ L + N + +E+ S + + N+ I
Sbjct: 61 ELLNLSSN-VLYETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNN-IS 112
Query: 333 EIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG--FQYLT 390
+ + G + +YL NK+T + ++ + LDL +N + T+
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSD 169
Query: 391 NLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKL 450
L L L N + + ++ ++L +DLS N L + + +++L NKL
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 451 TGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCN 510
I + ++L L GN F D N + + + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKK-LTGQNEEEC 283
Query: 511 ALQRLHLSDNYFTGELPR 528
+ L Y +LP
Sbjct: 284 TVPTLGHYGAYCCEDLPA 301
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-35
Identities = 53/292 (18%), Positives = 111/292 (38%), Gaps = 18/292 (6%)
Query: 438 TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQ 497
+ + L ++ + ++ +L L GN + +DL L + L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 498 FSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSC 557
+ + + + L+ L L++NY E+ ++ T + ++N ++ R+
Sbjct: 70 LYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG-- 119
Query: 558 KMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSG-SIPVQIGNLSRLTELQMGGN 616
+ + + L+ NK + G +++ L L NE+ + + L L + N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 617 SFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFV 676
+ ++ + L+ L+LS N L+ + PE + + ++ L NN L I +
Sbjct: 180 FIYD-VKGQV-VFAKLKT-LDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 677 NLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGS--KGLCGGPLQNCTQP 726
+L + N +N V + + K L G + CT P
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 59/356 (16%), Positives = 102/356 (28%), Gaps = 42/356 (11%)
Query: 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRL 200
I + N + I + ++ + + +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLK-------------------------QALASLRQSAWNV 36
Query: 201 KSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSG 260
K N +S +++ L+ L L+ N L E ++ L L + L N +
Sbjct: 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ- 93
Query: 261 VIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSA 320
EL S+ETL +N + ++ G K +Y+ N++ + G S
Sbjct: 94 ----ELLVGPSIETLHAANN-NISRVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 321 LEIDFSENSLIG-EIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLT 379
+D N + + LE L L N + + L LDLS N L
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA 204
Query: 380 GTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTS 439
+ FQ + + L +N LV I + L L DL N + +
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKN 261
Query: 440 LIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQ 495
+ + C G +L L
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 42/209 (20%), Positives = 80/209 (38%), Gaps = 14/209 (6%)
Query: 485 LANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSN 544
++ + + + + ++ L LS N + ++ + L N+SSN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 545 FLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGN 604
L L++ S L+ LDL+ N +E+ +E L + N +S +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS--CSR 118
Query: 605 LSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPEL-GNLILLEYLLLN 663
+ + N + + G S +Q L+L N + + EL + LE+L L
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQY-LDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 664 NNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692
N + ++ G V + L + S N L
Sbjct: 178 YNFIY-DVKGQ-VVFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 35/192 (18%), Positives = 69/192 (35%), Gaps = 12/192 (6%)
Query: 502 IPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQ 561
I N N + ++D+ L + N+ ++S N L+ ++ L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 562 RLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGG 621
L+LS N ++ SL L L L+ N + ++ + L N+ S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 622 IPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSG-EIPGSFVNLSS 680
+ + + L+ N ++ L + G ++YL L N + + +
Sbjct: 114 VSCSR--GQGKKN-IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 681 LLGCNFSYNNLT 692
L N YN +
Sbjct: 171 LEHLNLQYNFIY 182
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 27/171 (15%), Positives = 65/171 (38%), Gaps = 6/171 (3%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSR-NIPKEIGNCSSLEVLNLNNNRLEA 140
++ L ++ + G + LDL N++ N + + +LE LNL N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 141 HIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRL 200
+ ++ + L L++ +N+++ E + ++ + +N + + L + L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 201 KSFRAGQNLIS-GSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTD 250
+ F N G+L + +Q + + +E + L
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 31/131 (23%), Positives = 60/131 (45%), Gaps = 10/131 (7%)
Query: 573 ALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSL 632
A+ + + ++ K++++ L ++ + + EL + GN S A+L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 633 QIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692
++ LNLS N L +L +L L L LNNN++ E+ S+ + + NN++
Sbjct: 61 EL-LNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS 112
Query: 693 GPIPSSQTFQN 703
+ S Q
Sbjct: 113 R-VSCS-RGQG 121
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-39
Identities = 67/391 (17%), Positives = 132/391 (33%), Gaps = 26/391 (6%)
Query: 334 IPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLI 393
I L +++ E TL N + +++ +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 394 MLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLTG 452
+L L D + + + + N + +P H+ +N L L LE N L+
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 453 SIPTGV-TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNA 511
S+P G+ L L + N+ +L ++L N+ + + + +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPS 187
Query: 512 LQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFV 571
L ++S N + + + + S N + + + L L L N
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV--ELTILKLQHNNLT 239
Query: 572 GALPREIGSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSGGIPAELGSLS 630
+ + L + LS NEL I + RL L + N + +
Sbjct: 240 D--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 631 SLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNN 690
+L++ L+LS+N+L + LE L L++N + + L +L S+N+
Sbjct: 296 TLKV-LDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL---TLSHND 350
Query: 691 LTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQ 721
F+N++ + + C Q
Sbjct: 351 WD-CNSLRALFRNVARPAVDDADQHCKIDYQ 380
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-37
Identities = 78/373 (20%), Positives = 140/373 (37%), Gaps = 35/373 (9%)
Query: 83 LNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNRLEAH 141
+++ Y L + + + + + +P + + +E+LNLN+ ++E
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE-E 83
Query: 142 IPKE-LGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKR 199
I ++ L + N I P + L+ LV N++S SLP N +
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPK 142
Query: 200 LKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQL 258
L + N + + + SLQ L L+ N+L+ + + ++ L + N L
Sbjct: 143 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL 198
Query: 259 SGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLS 318
S L ++E L N + + + L L + N L T +
Sbjct: 199 S-----TLAIPIAVEELDASHN-SINVVRGPVNV--ELTILKLQHNNL--TDTAWLLNYP 248
Query: 319 SALEIDFSENSLIGEIPVE-LSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINS 377
+E+D S N + +I K+ LE LY+ N+L + + + L LDLS N
Sbjct: 249 GLVEVDLSYNE-LEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 306
Query: 378 LTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN 437
L + L L L NS+V + L + L + LS N C +
Sbjct: 307 LL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-------CNS 355
Query: 438 TSLIFLNLETNKL 450
+F N+ +
Sbjct: 356 LRALFRNVARPAV 368
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 83/395 (21%), Positives = 144/395 (36%), Gaps = 28/395 (7%)
Query: 118 IPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALS 177
I + ++++ + + E L++ I+ N+ + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 178 QLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQLS 235
L I + ++ G N I LP + L L L +N LS
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
Query: 236 GEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIG 294
+P+ I LT + + N L + TSL+ L L N ++ + L I
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN-RLTHVD--LSLIP 186
Query: 295 SLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKL 354
SL + + N L+ + + E+D S NS I + ++ L +L L N L
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNS-INVVRGPVNV--ELTILKLQHNNL 238
Query: 355 TGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDNSLVGGIPQRLGAY 413
T L L ++DLS N L I F + L L + +N LV +
Sbjct: 239 TD-TAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294
Query: 414 SQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNS 473
L V+DLS NHL + R+ + L L L+ N + ++ +L L L N
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHND 350
Query: 474 FTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGN 508
+ + L N++ +D I ++ +
Sbjct: 351 WDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-34
Identities = 66/418 (15%), Positives = 128/418 (30%), Gaps = 48/418 (11%)
Query: 189 SLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEI-GMLKY 247
+ L E + + + + + ++P + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 248 LTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKE-LGSIGSLKYLYIYRNEL 306
+ + L Q+ + +++ L + N + LP ++ L L + RN+L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN-AIRYLPPHVFQNVPLLTVLVLERNDL 129
Query: 307 NGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLK 366
+ ++PR I L L + N L +
Sbjct: 130 S-SLPRGI-----------------------FHNTPKLTTLSMSNNNLERIEDDTFQATT 165
Query: 367 NLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHL 426
+L L LS N LT + L + +L + N L L + +D S N +
Sbjct: 166 SLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSI 217
Query: 427 TGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLA 486
+ + L L L+ N LT + LV++ L N K+
Sbjct: 218 N-VVRGPVNVE--LTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272
Query: 487 NLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFL 546
L + + N+ + L+ L LS N+ + R L + N +
Sbjct: 273 RLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 330
Query: 547 TGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGN 604
+ L L+ L LS N + R + + + + + I Q+ +
Sbjct: 331 V-TLKLSTHH--TLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-32
Identities = 61/316 (19%), Positives = 122/316 (38%), Gaps = 23/316 (7%)
Query: 381 TIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TS 439
I QY + + + + +V ++ + K+P + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 440 LIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQF 498
+ LNL ++ I T ++ +L +G N+ P + L+ + L++N
Sbjct: 71 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129
Query: 499 SGPIPTEI-GNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIFS 556
S +P I N L L +S+N + + ++L +SSN LT + L +
Sbjct: 130 SS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLI- 185
Query: 557 CKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGN 616
L ++S+N + +E L S N ++ + + LT L++ N
Sbjct: 186 -PSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHN 236
Query: 617 SFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFV 676
+ + L + L ++LSYN L ++ + LE L ++NN L +
Sbjct: 237 NLT-DTAW-LLNYPGLVE-VDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ 292
Query: 677 NLSSLLGCNFSYNNLT 692
+ +L + S+N+L
Sbjct: 293 PIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 53/258 (20%), Positives = 92/258 (35%), Gaps = 26/258 (10%)
Query: 453 SIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEI-GNCNA 511
I + + + + + F + L N V + +P + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQ 70
Query: 512 LQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIFS-CKMLQRLDLSWNK 569
++ L+L+D E+ + + N + +P +F +L L L N
Sbjct: 71 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 128
Query: 570 FVGALPREI-GSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSGGIPAELG 627
+LPR I + +L L +S N L I + L LQ+ N + + L
Sbjct: 129 LS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LS 183
Query: 628 SLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFS 687
+ SL N+SYN LS L I +E L ++N ++ V L+ L
Sbjct: 184 LIPSLFH-ANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQ 234
Query: 688 YNNLTGPIPSSQTFQNMS 705
+NNLT + N
Sbjct: 235 HNNLT----DTAWLLNYP 248
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 18/138 (13%), Positives = 41/138 (29%), Gaps = 3/138 (2%)
Query: 568 NKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELG 627
+ + + + + L+ + ++ A L
Sbjct: 7 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLD 66
Query: 628 SLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFS 687
S +++ LNL+ + + ++ L + N + P F N+ L
Sbjct: 67 SFRQVEL-LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125
Query: 688 YNNLTGPIPSSQTFQNMS 705
N+L+ +P F N
Sbjct: 126 RNDLSS-LPRG-IFHNTP 141
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-37
Identities = 68/278 (24%), Positives = 106/278 (38%), Gaps = 35/278 (12%)
Query: 816 VIGRGACGTVYRAVLRTGHT-VAVKKLASNREGNNNVD-NSFRAEILTLGKIRHRNIVKL 873
IGRG G V+ LR +T VAVK RE F E L + H NIV+L
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSC---RETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 874 YGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRI 933
G C + ++ E + G L + L +T + AA G+ YL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCC 234
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEYAYTM 988
HRD+ + N L+ +K + DFG+++ + A +G + APE
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEA----DGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 989 KVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047
+ + + D++S+G++L E + G +P L R F+ G L
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPNLS-----NQQTREFVEKG----GRLPCPELCP 341
Query: 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
D V ++ C P RP+ + L
Sbjct: 342 DA--------VFRLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 76/308 (24%), Positives = 120/308 (38%), Gaps = 35/308 (11%)
Query: 816 VIGRGACGTVYRAVLR-----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
+G+G G+V TG VAVK+L + + F+ EI L + I
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALHSDFI 86
Query: 871 VKLYGFCYHQGSNLLMY--EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
VK G Y G L EY+ G L + L + LD + + +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-- 144
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APE 983
R HRD+ + NIL++ + + DFGLAK++ + + + G APE
Sbjct: 145 -SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY---YVVREPGQSPIFWYAPE 200
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042
+ + D++S+GVVL EL T P + ++ R+ + L+ +L+
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE-LLEE 259
Query: 1043 --RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML------SESNRRQGHFE 1094
RL + V ++ LC SP DRP+ + L S
Sbjct: 260 GQRL----PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTA 315
Query: 1095 FSPMDHDS 1102
H S
Sbjct: 316 HPEGKHHS 323
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-36
Identities = 68/415 (16%), Positives = 134/415 (32%), Gaps = 31/415 (7%)
Query: 325 FSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPL 384
I L +++ E TL N + +++
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 69
Query: 385 GFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFL 443
+ +L L D + + + + N + +P H+ +N L L
Sbjct: 70 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL 128
Query: 444 NLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPI 502
LE N L+ S+P G+ L L + N+ +L ++L N+ + +
Sbjct: 129 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-V 186
Query: 503 PTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQR 562
+ +L ++S N + + + + S N + + + L
Sbjct: 187 D--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV--ELTI 236
Query: 563 LDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSGG 621
L L N + + L + LS NEL I + RL L + N
Sbjct: 237 LKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-A 292
Query: 622 IPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSL 681
+ + +L++ L+LS+N+L + LE L L++N + + L +L
Sbjct: 293 LNLYGQPIPTLKV-LDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL 350
Query: 682 LGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQN-----CTQPPSSLP 731
S+N+ F+N++ + + C Q C +
Sbjct: 351 ---TLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYL 401
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-36
Identities = 102/604 (16%), Positives = 196/604 (32%), Gaps = 58/604 (9%)
Query: 83 LNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNRLEAH 141
+++ Y L + + + + + +P + + +E+LNLN+ ++E
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEI 90
Query: 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRL 200
++ L + N I P + L+ LV N++S SLP N +L
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 149
Query: 201 KSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLS 259
+ N + + + SLQ L L+ N+L+ + + ++ L + N LS
Sbjct: 150 TTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS 205
Query: 260 GVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSS 319
L ++E L N + + + L L + N L T +
Sbjct: 206 -----TLAIPIAVEELDASHN-SINVVRGPVNV--ELTILKLQHNNL--TDTAWLLNYPG 255
Query: 320 ALEIDFSENSLIGEIPVE-LSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSL 378
+E+D S N + +I K+ LE LY+ N+L + + + L LDLS N L
Sbjct: 256 LVEVDLSYNE-LEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 313
Query: 379 TGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNT 438
+ L L L NS+V + L + L + LS N C +
Sbjct: 314 L-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-------CNSL 362
Query: 439 SLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQF 498
+F N+ + + CK QL G P + +
Sbjct: 363 RALFRNVARPAVDDADQH----CKIDYQLEHGLCCKESDKP-----YLDRLLQYIALTSV 413
Query: 499 SGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIP------- 551
+ G C+A ++ + + L N L +
Sbjct: 414 VEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQI 473
Query: 552 --------LEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIG 603
L L+R L + + L+ + + + + +
Sbjct: 474 QQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEAD 533
Query: 604 NLSRLTE-LQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLL 662
+ TE L+ + + + + L+ +L + L + N
Sbjct: 534 AKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKNRNPDTRRVSHH 593
Query: 663 NNNH 666
+++H
Sbjct: 594 HHHH 597
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-35
Identities = 105/580 (18%), Positives = 189/580 (32%), Gaps = 45/580 (7%)
Query: 109 LSFNQLSRN-----IPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRIS 163
+N R I + ++++ + + E L++ I+ N+ +
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 164 GPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GGC 221
+ + L I + ++ G N I LP +
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNV 122
Query: 222 ESLQYLGLAQNQLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
L L L +N LS +P+ I LT + + N L + TSL+ L L N
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181
Query: 281 KQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSK 340
++ + L I SL + + N L+ + + E+D S NS I + ++
Sbjct: 182 -RLTHVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS-INVVRGPVNV 232
Query: 341 ILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFD 399
L +L L N LT L L ++DLS N L I F + L L + +
Sbjct: 233 --ELTILKLQHNNLTD-TAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISN 287
Query: 400 NSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVT 459
N LV + L V+DLS NHL + R+ + L L L+ N + ++
Sbjct: 288 NRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST- 343
Query: 460 RCKSLVQLRLGGNSFTG-SFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQR---- 514
+L L L N + S + +A + + DQ+ C +
Sbjct: 344 -HHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLD 402
Query: 515 ---LHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFV 571
+++ ++ R G S T N + + ++L+ N+
Sbjct: 403 RLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELR 462
Query: 572 GALPREIGSLFQ----LELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELG 627
+ + Q L+ L + + L+R + F+ +
Sbjct: 463 AEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSS--DNLNKVFTHLKERQAF 520
Query: 628 SLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHL 667
L Q + E N+ L + L
Sbjct: 521 KLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQ 560
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-36
Identities = 87/484 (17%), Positives = 167/484 (34%), Gaps = 41/484 (8%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI 162
T L++S N +S +I + S L +L +++NR++ L L++ +N++
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 163 SG-PFPKEIGKLSALSQLVAYSNNISGSLPPT--LGNLKRLKSFRAGQNLISGSLPSEIG 219
L L N +LP GN+ +LK + S I
Sbjct: 82 VKISC----HPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 220 GCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYD 279
+ L + + + L+ L + + + + L
Sbjct: 137 HLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL-- 192
Query: 280 NKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELS 339
+ + + + L + I+ + NS I ++L
Sbjct: 193 ------ELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR--ILQLV 244
Query: 340 KILGLELLYLFENKLTGVIPVEL-----TTLKNLTKLDLSINSLTGTIPLGFQYLTNLIM 394
+ + KL G + T+LK L+ + + ++ +N+ +
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 395 LQLFDN---SLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLT 451
+ + P ++ S +D S+N LT + + T L L L+ N+L
Sbjct: 305 KNFTVSGTRMVHMLCPSKI---SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 452 GSIP--TGVTRC-KSLVQLRLGGNSFTGSFPSDLC-KLANLSTVELDQNQFSGPIPTEIG 507
+ +T KSL QL + NS + C +L ++ + N + I +
Sbjct: 362 -ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP 420
Query: 508 NCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIF-SCKMLQRLDLS 566
++ L L N +P++V L L NV+SN L +P IF LQ++ L
Sbjct: 421 --PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLH 476
Query: 567 WNKF 570
N +
Sbjct: 477 TNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-35
Identities = 81/476 (17%), Positives = 166/476 (34%), Gaps = 26/476 (5%)
Query: 213 SLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSL 272
+P ++ + L ++QN +S +I L L +I+ N++ + L
Sbjct: 14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 273 ETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPR--EIGKLSSALEIDFSENSL 330
E L L N ++ ++ +LK+L + N + +P E G +S + S L
Sbjct: 72 EYLDLSHN-KLVKIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL 127
Query: 331 IGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLT 390
+ ++ + ++L + + L++ L I T ++
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVS 185
Query: 391 NLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKL 450
+ L +++ + +Y + L N + + T F+ +
Sbjct: 186 VKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVW 245
Query: 451 TGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCN 510
++ S+ ++L G F L LS ++ + F P +
Sbjct: 246 HTTV-----WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFS 300
Query: 511 ALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIF-SCKMLQRLDLSWNK 569
+ + + + +S + + S+N LT E L+ L L N+
Sbjct: 301 NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQMNQ 359
Query: 570 FVGALPREIG---SLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSGGIPAE 625
L + + L+ L +S+N +S L L M N + I
Sbjct: 360 LK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418
Query: 626 LGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSL 681
L +++ L+L N + + P ++ L L+ L + +N L G F L+SL
Sbjct: 419 L--PPRIKV-LDLHSNKIKSI-PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSL 470
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-34
Identities = 90/528 (17%), Positives = 179/528 (33%), Gaps = 64/528 (12%)
Query: 105 TALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISG 164
+D S N L +PK++ +LN++ N + ++ +LS L IL I +NRI
Sbjct: 3 FLVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 165 PFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESL 224
L L N + + + L
Sbjct: 60 LDISVFKFNQELEYLDLSHNKL--------------------VKISCHPTVN-------L 92
Query: 225 QYLGLAQNQL-SGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQV 283
++L L+ N + I KE G + L + L L + + + L +
Sbjct: 93 KHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152
Query: 284 GQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILG 343
++ + ++ I +D S ++ + +L
Sbjct: 153 --EKEDPEGLQDFNTESLHIVFPTNKEFHFI--------LDVSVKTVANLELSNIKCVLE 202
Query: 344 LELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLV 403
F + L + + L ++ + NS L + T + + + L
Sbjct: 203 DNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR--ILQLVWHTTVWYFSISNVKLQ 260
Query: 404 GGIPQRLGAYS-----QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV 458
G + R YS L + + + +++ N + +
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR-MVHMLC 319
Query: 459 -TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIG---NCNALQR 514
++ + L N T + + L L T+ L NQ + +LQ+
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQ 378
Query: 515 LHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIFSC--KMLQRLDLSWNKFV 571
L +S N + + + +L++ N+SSN + IF C ++ LDL NK
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSN----ILTDTIFRCLPPRIKVLDLHSNKIK 434
Query: 572 GALPREIGSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSF 618
++P+++ L L+ L ++ N+L S+P I L+ L ++ + N +
Sbjct: 435 -SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 78/395 (19%), Positives = 132/395 (33%), Gaps = 27/395 (6%)
Query: 323 IDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTI 382
+D S+N LI +P +LS+ +L + +N ++ + ++ +L L L +S N +
Sbjct: 5 VDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 383 PLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTG-KIPRHICRNTSLI 441
F++ L L L N LV L +DLS N I + + L
Sbjct: 62 ISVFKFNQELEYLDLSHNKLVKISCHPT---VNLKHLDLSFNAFDALPICKEFGNMSQLK 118
Query: 442 FLNLETNKLTGSIPTGVTRCKSL-VQLRLGGNSFTGSFPSDLCKLA--NLSTVELDQNQF 498
FL L T L S + V L LG P L +L V +F
Sbjct: 119 FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF 178
Query: 499 SGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRI-------- 550
+ + L+ ++ + + L+ L T SN I
Sbjct: 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
Query: 551 -PLEIFSCKMLQRLDLSWNKFVGALPREIG-----SLFQLELLKLSENELSGSIPVQIGN 604
L++ + +S K G L SL L + ++ +
Sbjct: 239 RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEI 298
Query: 605 LSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNN 664
S + + +S L+ S N L+ + G+L LE L+L
Sbjct: 299 FSNMNIKNFTVSGTRMVHMLCPSKISPFLH-LDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 665 NHLS--GEIPGSFVNLSSLLGCNFSYNNLTGPIPS 697
N L +I + SL + S N+++
Sbjct: 358 NQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 50/198 (25%), Positives = 78/198 (39%), Gaps = 5/198 (2%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
++GRG G VY A VA+K ++ + + E T G+++ ++V ++
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
F G + + L +L L I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALDAAHAA---GAT 156
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
HRD+K NIL+ A++ DFG+A + + G+ Y+APE T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRA 216
Query: 995 DIYSYGVVLLELLTGRAP 1012
DIY+ VL E LTG P
Sbjct: 217 DIYALTCVLYECLTGSPP 234
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
D +R V+G+G G VY L +A+K++ E ++ EI ++
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLK 77
Query: 867 HRNIVKLYGFCYHQGS-NLLMYEYMARGSLGELL---HGASSTLDWQTRFMIA--LGAAE 920
H+NIV+ G G + M E + GSL LL G + F L E
Sbjct: 78 HKNIVQYLGSFSENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL---E 133
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYG 978
GL YLH + +I HRDIK +N+L++ + DFG +K + + + G+
Sbjct: 134 GLKYLHDN---QIVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTET-FTGTLQ 188
Query: 979 YIAPE------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y+APE Y DI+S G ++E+ TG+ P
Sbjct: 189 YMAPEIIDKGPRGYGKAA----DIWSLGCTIIEMATGKPP 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 57/197 (28%), Positives = 83/197 (42%), Gaps = 5/197 (2%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G TVY A VA+K + F E+ ++ H+NIV +
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
L+ EY+ +L E + + L T +G+ + H RI H
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHDM---RIVH 134
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCD 995
RDIK NIL+D + DFG+AK + + + G+ Y +PE A E D
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194
Query: 996 IYSYGVVLLELLTGRAP 1012
IYS G+VL E+L G P
Sbjct: 195 IYSIGIVLYEMLVGEPP 211
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 71/285 (24%), Positives = 114/285 (40%), Gaps = 28/285 (9%)
Query: 816 VIGRGACGTVYRAVL-----RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
+G G G V TG VAVK L GN+ D + EI L + H NI
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEIEILRNLYHENI 85
Query: 871 VKLYGFCYHQGSNLLM--YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
VK G C G N + E++ GSL E L + ++ + + A+ +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG-- 143
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APE 983
+ HRD+ + N+L++ + + +GDFGL K I ++ APE
Sbjct: 144 -SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI---ETDKEYYTVKDDRDSPVFWYAPE 199
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042
K D++S+GV L ELLT + P+ ++ + LV+ L
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN-TLKE 258
Query: 1043 --RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
RL + V ++ C P +R + + ++
Sbjct: 259 GKRL----PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 76/286 (26%), Positives = 115/286 (40%), Gaps = 30/286 (10%)
Query: 816 VIGRGACGTVYRAVLR-----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
+G+G G+V TG VAVKKL + F EI L ++H NI
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 871 VKLYGFCYHQGSNLLMY--EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
VK G CY G L EY+ GSL + L +D +G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-- 131
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID------MPQSKSMSAIAGSYGYIAP 982
R HRD+ + NIL++++ +GDFGL KV+ + S I + AP
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----WYAP 186
Query: 983 EYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041
E K + D++S+GVVL EL T P + ++ + + +L
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 1042 A--RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
RL + + I C N + RP+ R++ L + +
Sbjct: 247 NNGRL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-34
Identities = 78/306 (25%), Positives = 116/306 (37%), Gaps = 10/306 (3%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI 162
LDL N++ E + LE L LN N + A P NL +L L + +NR+
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92
Query: 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEI-GGC 221
LS L++L N I L +L LKS G N + + G
Sbjct: 93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGL 151
Query: 222 ESLQYLGLAQNQLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
SL+ L L + L+ IP E L L + L ++ + L+ L +
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 281 KQVGQLPKELGSIGSLKYLYIYRNELNGTIPRE-IGKLSSALEIDFSENSLIGEIPVE-L 338
+ + +L L I L +P + L ++ S N I I L
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNP-ISTIEGSML 268
Query: 339 SKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQL 397
++L L+ + L +L V P L L L++S N LT T+ F + NL L L
Sbjct: 269 HELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLIL 327
Query: 398 FDNSLV 403
N L
Sbjct: 328 DSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-33
Identities = 72/381 (18%), Positives = 132/381 (34%), Gaps = 66/381 (17%)
Query: 318 SSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINS 377
+ + + +P + LL L +N++ + E + +L +L+L+ N
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67
Query: 378 LTGTIPLG-FQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICR 436
++ + G F L NL L L N L IP +
Sbjct: 68 VS-AVEPGAFNNLFNLRTL------------------------GLRSNRLK-LIPLGVFT 101
Query: 437 N-TSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELD 494
++L L++ NK+ + + +L L +G N +
Sbjct: 102 GLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV----------------YIS 144
Query: 495 QNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLE 553
FSG N+L++L L T +P E +L L+ + + I
Sbjct: 145 HRAFSG--------LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDY 194
Query: 554 IFS-CKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIP-VQIGNLSRLTEL 611
F L+ L++S ++ + L L ++ L+ ++P + + +L L L
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFL 253
Query: 612 QMGGNSFSGGIPAE-LGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGE 670
+ N S I L L LQ + L L+ + P L L L ++ N L+
Sbjct: 254 NLSYNPIST-IEGSMLHELLRLQ-EIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTL 311
Query: 671 IPGSFVNLSSLLGCNFSYNNL 691
F ++ +L N L
Sbjct: 312 EESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 73/342 (21%), Positives = 123/342 (35%), Gaps = 40/342 (11%)
Query: 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTG 428
+ +P G T +L L N + ++ L ++L++N ++
Sbjct: 14 RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS- 69
Query: 429 KIPRHICRN-TSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTGSFPSDLCKLA 486
+ N +L L L +N+L IP GV T +L +L + N
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV----------- 117
Query: 487 NLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNF 545
L F L+ L + DN + L++L +
Sbjct: 118 -----ILLDYMFQD--------LYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCN 163
Query: 546 LTGRIPLEIFS-CKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGN 604
LT IP E S L L L L++L++L++S ++
Sbjct: 164 LT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
Query: 605 LSRLTELQMGGNSFSGGIPAE-LGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLN 663
LT L + + + +P + L L+ LNLSYN +S + L L+ L+ + L
Sbjct: 223 GLNLTSLSITHCNLTA-VPYLAVRHLVYLRF-LNLSYNPISTIEGSMLHELLRLQEIQLV 280
Query: 664 NNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMS 705
L+ P +F L+ L N S N LT + S F ++
Sbjct: 281 GGQLAVVEPYAFRGLNYLRVLNVSGNQLTT-LEES-VFHSVG 320
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 69/377 (18%), Positives = 124/377 (32%), Gaps = 65/377 (17%)
Query: 105 TALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISG 164
A+ + +P+ I + +L+L NR++ E + L L + N +S
Sbjct: 14 RAVLCHRKRFVA-VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS- 69
Query: 165 PFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GGCE 222
++ P NL L++ N + +P + G
Sbjct: 70 ------------------------AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLS 104
Query: 223 SLQYLGLAQNQLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNK 281
+L L +++N++ + + L L + + N L + + SLE L L
Sbjct: 105 NLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC- 162
Query: 282 QVGQLPKE-LGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSK 340
+ +P E L + L L + +N +L ++ S + +
Sbjct: 163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
Query: 341 ILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFD 399
L L L + LT V + + L L L+LS N ++ TI L L +
Sbjct: 223 GLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEI---- 277
Query: 400 NSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLTGSIPTGV 458
L L + + R L LN+ N+LT ++ V
Sbjct: 278 --------------------QLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESV 315
Query: 459 -TRCKSLVQLRLGGNSF 474
+L L L N
Sbjct: 316 FHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-27
Identities = 66/315 (20%), Positives = 122/315 (38%), Gaps = 12/315 (3%)
Query: 213 SLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSL 272
++P I + L L +N++ E +L ++ L N +S V P N +L
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 273 ETLALYDNKQVGQLPKE-LGSIGSLKYLYIYRNELNGTIPREI-GKLSSALEIDFSENSL 330
TL L N ++ +P + +L L I N++ + + L + ++ +N
Sbjct: 83 RTLGLRSN-RLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDND- 139
Query: 331 IGEIPVE-LSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYL 389
+ I S + LE L L + LT + L+ L L L L ++ F+ L
Sbjct: 140 LVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199
Query: 390 TNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETN 448
L +L++ + + L + ++ +LT +P R+ L FLNL N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYN 258
Query: 449 KLTGSIPTGV-TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIG 507
++ +I + L +++L G P L L + + NQ + +
Sbjct: 259 PIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFH 317
Query: 508 NCNALQRLHLSDNYF 522
+ L+ L L N
Sbjct: 318 SVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 50/258 (19%), Positives = 96/258 (37%), Gaps = 15/258 (5%)
Query: 84 NLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNR 137
NL + L + + GL +LT LD+S N++ + + + +L+ L + +N
Sbjct: 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDND 139
Query: 138 LEAHIPKE-LGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGN 196
L +I L+SL L + ++ + + L L L NI+ +
Sbjct: 140 L-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKR 198
Query: 197 LKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKE-IGMLKYLTDVILWG 255
L RLK ++ +L L + L+ +P + L YL + L
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSY 257
Query: 256 NQLSGVIPKELGNCTSLETLALYDNKQVGQLPKE-LGSIGSLKYLYIYRNELNGTIPREI 314
N +S + L L+ + L Q+ + + L+ L + N+L T+ +
Sbjct: 258 NPISTIEGSMLHELLRLQEIQLVGG-QLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESV 315
Query: 315 -GKLSSALEIDFSENSLI 331
+ + + N L
Sbjct: 316 FHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 25/130 (19%), Positives = 53/130 (40%), Gaps = 6/130 (4%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKE-IGNCSSLEVLNLNNNRLEA 140
L ++ ++PN ++LT+L ++ L+ +P + + L LNL+ N +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPIS- 261
Query: 141 HIPKE-LGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLK 198
I L L L + + +++ P L+ L L N ++ +L ++
Sbjct: 262 TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVG 320
Query: 199 RLKSFRAGQN 208
L++ N
Sbjct: 321 NLETLILDSN 330
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
+ F + IG+G+ G V++ + RT VA+K + + E + + EI L +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCD 78
Query: 867 HRNIVKLYGFCYHQGSNL--LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSY 924
+ K YG Y + + L +M EY+ GS +LL LD I +GL Y
Sbjct: 79 SPYVTKYYG-SYLKDTKLWIIM-EYLGGGSALDLLE--PGPLDETQIATILREILKGLDY 134
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
LH + + HRDIK+ N+LL + E + DFG+A + Q K + + + ++APE
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEV 190
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
K DI+S G+ +EL G P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 76/286 (26%), Positives = 115/286 (40%), Gaps = 30/286 (10%)
Query: 816 VIGRGACGTVYRAVL-----RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
+G+G G+V TG VAVKKL + F EI L ++H NI
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 871 VKLYGFCYHQGSNLLM--YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
VK G CY G L EY+ GSL + L +D +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-- 162
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID------MPQSKSMSAIAGSYGYIAP 982
R HRD+ + NIL++++ +GDFGL KV+ + S I + AP
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----WYAP 217
Query: 983 EYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041
E K + D++S+GVVL EL T P + ++ + + +L
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 1042 A--RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
RL + + I C N + RP+ R++ L + +
Sbjct: 278 NNGRL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-34
Identities = 40/339 (11%), Positives = 80/339 (23%), Gaps = 51/339 (15%)
Query: 777 APLQDKQLSSTVSDIYFPPKEGFTFKDLVV-ATDNFDERFVIGRGACGTVYRAV-LRTGH 834
A + + V+ +P T L+ + G V+ +
Sbjct: 29 ALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE 88
Query: 835 TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFC----------------- 877
A+K E + + ++ + +
Sbjct: 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148
Query: 878 --------YHQGSNLLMYEYMARGSLGELLHG------ASSTLDWQTRFMIALGAAEGLS 923
+ +N L+ A L L ++ +
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAA 208
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
L + H +N+ + +GD A + Y E
Sbjct: 209 NLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASSVPVTYAPRE 261
Query: 984 Y--AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041
+ A T T + + G+ + + P + G +W R +R S
Sbjct: 262 FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-SWKRPSLRVPGTDSLAFG 320
Query: 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV 1080
+ L D V +I L + R E +
Sbjct: 321 SCTPLPDF--VKTLIG----RFLNFD--RRRRLLPLEAM 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-34
Identities = 78/431 (18%), Positives = 155/431 (35%), Gaps = 66/431 (15%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141
S + + + L LT+LD + ++ ++ I + L L +N +
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITT- 78
Query: 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLK 201
+L ++LT L +N+++ ++ L+ L+ L +N ++ L + L
Sbjct: 79 --LDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLT 130
Query: 202 SFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGV 261
+N ++ + + L L N+ ++ + LT + N+++ +
Sbjct: 131 YLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL 185
Query: 262 IPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSAL 321
++ L L N + +L L L +L N+L
Sbjct: 186 ---DVSQNKLLNRLNCDTN-NITKLD--LNQNIQLTFLDCSSNKLT-------------- 225
Query: 322 EIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGT 381
EID + + L N LT ++++TL LT L L
Sbjct: 226 EIDVTPLT-------------QLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-E 268
Query: 382 IPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLI 441
I L + T LI Q + + + +QL+++D +T ++ + +N L+
Sbjct: 269 IDLT--HNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLV 321
Query: 442 FLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGP 501
+L L +LT + V+ L L F S + K+ L+ + Q
Sbjct: 322 YLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTIT- 375
Query: 502 IPTEIGNCNAL 512
+P E N+L
Sbjct: 376 MPKETLTNNSL 386
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-33
Identities = 74/467 (15%), Positives = 158/467 (33%), Gaps = 45/467 (9%)
Query: 248 LTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELN 307
+ ++ +L +L +++ + + + + L L N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNS-SITDMT-GIEKLTGLTKLICTSNNIT 77
Query: 308 GTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKN 367
T+ + + ++ + N L ++++ + L L NKLT ++++
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT---KLDVSQNPL 128
Query: 368 LTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLT 427
LT L+ + N+LT + + T L L N + + + +QL +D S N +T
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 428 GKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLAN 487
++ + +N L LN +TN +T + + + L L N T D+ L
Sbjct: 184 -ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQ 234
Query: 488 LSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLT 547
L+ + N + + + + L LH E+ + + + L+ F
Sbjct: 235 LTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKI 288
Query: 548 GRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSR 607
L++ L LD L + +L L L+ EL+ + + + ++
Sbjct: 289 --KELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTK 340
Query: 608 LTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHL 667
L L +G + +L + + L N L + +
Sbjct: 341 LKSLSCVNAHIQD-FS-SVGKIPALNN-NFEAEGQTITMPKETLTNNSLTIAVSPDLLDQ 397
Query: 668 SG---EIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSG 711
G I + ++ NL+ P+ + G
Sbjct: 398 FGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVG 444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 86/419 (20%), Positives = 164/419 (39%), Gaps = 43/419 (10%)
Query: 128 LEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNIS 187
++A L++LT L+ +N+ I+ I KL+ L++L+ SNNI+
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT 77
Query: 188 GSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKY 247
+L L L N ++ +L + L YL N+L+ ++ +
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 248 LTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELN 307
LT + N L+ + ++ + T L L + NK++ +L + L L N++
Sbjct: 129 LTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 308 GTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKN 367
+ + + ++ N++ ++L++ + L L NKLT +++T L
Sbjct: 184 -ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLTE---IDVTPLTQ 234
Query: 368 LTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLT 427
LT D S+N LT + + L+ L L L+ I L +QL
Sbjct: 235 LTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKI 288
Query: 428 GKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLAN 487
++ + NT L L+ + +T + +++ LV L L T D+
Sbjct: 289 KELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL--DVSHNTK 340
Query: 488 LSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFL 546
L ++ +G AL ++ +P+E ++L T VS + L
Sbjct: 341 LKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSL-TIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-32
Identities = 64/369 (17%), Positives = 137/369 (37%), Gaps = 41/369 (11%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141
L T N++ + ++ +LT L N+L+ N+ + + L LN + N+L
Sbjct: 68 KLICTSNNIT---TLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-- 119
Query: 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLK 201
++ LT LN N ++ ++ + L++L + N L + +L
Sbjct: 120 -KLDVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLT 173
Query: 202 SFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGV 261
+ N I+ L + + L L N ++ ++ + LT + N+L+ +
Sbjct: 174 TLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI 227
Query: 262 IPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSAL 321
++ T L N + +L + ++ L L+ + +L I + + +
Sbjct: 228 ---DVTPLTQLTYFDCSVN-PLTELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLI 278
Query: 322 EIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGT 381
I E+ +++ L LL +T ++L+ L L L+ LT
Sbjct: 279 YFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-E 332
Query: 382 IPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLI 441
+ + + T L L + + +G L ++ +P+ N SL
Sbjct: 333 LDVS--HNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLT 387
Query: 442 FLNLETNKL 450
+ + + L
Sbjct: 388 -IAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-22
Identities = 61/328 (18%), Positives = 109/328 (33%), Gaps = 36/328 (10%)
Query: 70 NCTTNDFGAVVFSL--NLTKMNLSGYL--SPNIGGLVHLTALDLSFNQLSRNIPKEIGNC 125
NC TN + S LT +N + ++ LT LD N+ + +
Sbjct: 112 NCDTNKLTKLDVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQ 169
Query: 126 SSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNN 185
+ L L+ + N++ ++ L LN N I+ ++ + L+ L SN
Sbjct: 170 TQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNK 223
Query: 186 ISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGML 245
++ + + L +L F N ++ L + L L Q L EI +
Sbjct: 224 LT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHN 274
Query: 246 KYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNE 305
L G + + ++ + T L L + +L L L YLY+ E
Sbjct: 275 TQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAA-GITELD--LSQNPKLVYLYLNNTE 329
Query: 306 LNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTL 365
L + + + + I + + KI L + E + + LT
Sbjct: 330 LT-ELD--VSHNTKLKSLSCVNAH-IQDFS-SVGKIPALNNNFEAEGQTITMPKETLTNN 384
Query: 366 K-----NLTKLDLSINSLTGTIPLGFQY 388
+ LD N + G Y
Sbjct: 385 SLTIAVSPDLLDQFGNPMNIEPGDGGVY 412
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-17
Identities = 42/258 (16%), Positives = 85/258 (32%), Gaps = 26/258 (10%)
Query: 84 NLTKMNLSG-YL-SPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141
L ++N + ++ + LT LD S N+L+ I + + L + + N L
Sbjct: 192 LLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-E 247
Query: 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLK 201
+ + LS LT L+ + ++ + L A L + + +L
Sbjct: 248 LD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLY 300
Query: 202 SFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGV 261
I+ L + L YL L +L+ E+ + L + +
Sbjct: 301 LLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF 354
Query: 262 IPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYL----YIYRNELNGTIPREIGKL 317
+G +L + + + +PKE + SL + + I G +
Sbjct: 355 --SSVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGV 411
Query: 318 SSALEIDFSENSLIGEIP 335
+ +L + P
Sbjct: 412 YDQATNTITWENLSTDNP 429
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG G G V+ VA+K + REG + ++ F E + K+ H +V+LYG
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEED-FIEEAEVMMKLSHPKLVQLYG 70
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
C Q L+ E+M G L + L +T + L EG++YL + + H
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI---APEYAYTMKVTE 992
RD+ + N L+ + V DFG+ + + ++ G+ + +PE + +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 993 KCDIYSYGVVLLELLT-GRAP 1012
K D++S+GV++ E+ + G+ P
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIP 205
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-34
Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 24/205 (11%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+GRG+ G V+R +TG AVKK+ ++ E++ + IV LYG
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKV--------RLEVFRVEELVACAGLSSPRIVPLYG 117
Query: 876 FCYHQGS-NLLMYEYMARGSLGELL--HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
N+ M E + GSLG+L+ G L A EGL YLH R
Sbjct: 118 AVREGPWVNIFM-ELLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLHTR---R 170
Query: 933 IFHRDIKSNNILLDDK-FEAHVGDFGLAKVIDMPQSK----SMSAIAGSYGYIAPEYAYT 987
I H D+K++N+LL A + DFG A + + I G+ ++APE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAP 1012
K DI+S ++L +L G P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-34
Identities = 66/281 (23%), Positives = 109/281 (38%), Gaps = 35/281 (12%)
Query: 810 NFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHR 868
+F + V+G GA GT+ + VAVK++ E + D E+ L + H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI--LPECFSFADR----EVQLLRESDEHP 78
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
N+++ + + + E A +L E + + GL++LH
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 929 CKPRIFHRDIKSNNILLDDKFE-----AHVGDFGLAKVIDMPQS--KSMSAIAGSYGYIA 981
I HRD+K +NIL+ A + DFGL K + + + S + G+ G+IA
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 982 PEY---AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038
PE T DI+S G V +++ + P G + N +
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--PF---GKSLQRQANILLGA----C 245
Query: 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
LD L EK + L M+ + P RP+ + V
Sbjct: 246 SLDC---LHPEKHEDVIARELIEKMIAMD--PQKRPSAKHV 281
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 55/297 (18%), Positives = 107/297 (36%), Gaps = 45/297 (15%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
++G+GA V+R + TG A+K N + E L K+ H+NIVKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 875 GFCYHQGSNLLMY---EYMARGSLGELL--HGASSTLDWQT--RFMIALGAAEGLSYLHH 927
+ + E+ GSL +L + L + + G+++L
Sbjct: 74 AI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV--VGGMNHLR- 129
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
+ I HR+IK NI+ + + DFG A+ ++ + ++ G+ Y+ P+
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPD 185
Query: 984 --------YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN-- 1033
+ K D++S GV TG P +P + + I
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 1034 ---SLVSGMLDARLNLQDE--------KTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
S V + ++ + + + ++T + +L + +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD--QEKCWGFDQF 300
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 62/312 (19%), Positives = 110/312 (35%), Gaps = 58/312 (18%)
Query: 802 KDLVVATDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLA-SNREGNNNVDNSFRAEI 859
+++ ++ +G G V L GH A+K++ ++ + E
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA----QREA 77
Query: 860 LTLGKIRHRNIVKLYGFCYHQGSN-----LLMYEYMARGSLGELLHGASSTLDWQTRF-- 912
H NI++L +C + LL+ + RG+L + D
Sbjct: 78 DMHRLFNHPNILRLVAYCLRERGAKHEAWLLL-PFFKRGTLWNEI---ERLKDKGNFLTE 133
Query: 913 ----MIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968
+ LG GL +H HRD+K NILL D+ + + D G +
Sbjct: 134 DQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 969 SMSAIA--------GSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPL 1016
S A+ + Y APE ++ + + E+ D++S G VL ++ G P +
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMV 249
Query: 1017 DQGGDLVTWVRN---FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDR 1073
Q GD V I + S L ++ +M+ + P R
Sbjct: 250 FQKGDSVALAVQNQLSIPQSPRHSSAL------------WQLLN----SMMTVD--PHQR 291
Query: 1074 PTMREVVLMLSE 1085
P + ++ L
Sbjct: 292 PHIPLLLSQLEA 303
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 33/217 (15%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKIRHRN--IVK 872
IG G V++ + A+K + N E +N +S+R EI L K++ + I++
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 873 LYGFCYHQGS-NLLMYEYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHDCK 930
LY + ++M E L L S + + + E + +H +
Sbjct: 93 LYDYEITDQYIYMVM-EC-GNIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIH---Q 145
Query: 931 PRIFHRDIKSNNILLDD---KFEAHVGDFGLAKVI-DMPQSKSMSAIAGSYGYIAPE--- 983
I H D+K N L+ D K + DFG+A + S + G+ Y+ PE
Sbjct: 146 HGIVHSDLKPANFLIVDGMLK----LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 984 --------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
K++ K D++S G +L + G+ P
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-33
Identities = 101/517 (19%), Positives = 177/517 (34%), Gaps = 60/517 (11%)
Query: 125 CSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSN 184
+++ +N L H+PK+L L++ N IS +I LS L L N
Sbjct: 30 NELESMVDYSNRNL-THVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHN 86
Query: 185 NISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGM 244
I SL + L+YL ++ N+L I
Sbjct: 87 RIR-SLDF--HVFLFNQD---------------------LEYLDVSHNRLQ-NIS--CCP 119
Query: 245 LKYLTDVILWGNQLSGV-IPKELGNCTSLETLALYDNK-QVGQLPKELGSIGSLKYLYIY 302
+ L + L N + + KE GN T L L L K + L S L +
Sbjct: 120 MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLV 179
Query: 303 RNELNGTIPREIGKL-SSALEIDFSENSLIGEI-PVELSKILGLELLYLFENKLTGVIPV 360
+ G + ++ L + F NSL + ++ + L+L + N +
Sbjct: 180 SYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLM 239
Query: 361 ELT-------TLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAY 413
TL N+T + F + + L +++ ++ I + Y
Sbjct: 240 TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTY 299
Query: 414 SQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTG----SIPTGV-TRCKSLVQLR 468
S+ + L H+ ++ +F + L+ I S L
Sbjct: 300 SETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLN 359
Query: 469 LGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFT----G 524
N FT S L L T+ L +N + L D
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSH 418
Query: 525 ELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSC--KMLQRLDLSWNKFVGALPREIGSLF 582
R +++ N+SSN LTG + F C ++ LDL N+ ++P+++ L
Sbjct: 419 AYDRTCAWAESILVLNLSSNMLTGSV----FRCLPPKVKVLDLHNNRI-MSIPKDVTHLQ 473
Query: 583 QLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSF 618
L+ L ++ N+L S+P + L+ L + + N +
Sbjct: 474 ALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 80/484 (16%), Positives = 154/484 (31%), Gaps = 61/484 (12%)
Query: 100 GLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIY 158
L L L LS N++ ++ + LE L++++NRL+ +I ++SL L++
Sbjct: 74 FLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLS 129
Query: 159 NNRI-SGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSE 217
N P KE G L+ L+ L + + +L + +E
Sbjct: 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETE 189
Query: 218 IGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGV-------IPKELGNCT 270
+ L L + S + + L + L +L+ EL
Sbjct: 190 SLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGP 249
Query: 271 SLETLALYDNKQVGQLPKELGSI---GSLKYLYIYRNELNGTIPREIGKLSSALEIDFSE 327
+L + L + + +L ++YL IY + I RE S
Sbjct: 250 TLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSE-------- 301
Query: 328 NSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQ 387
+ + L + ++ + + LSI+ +
Sbjct: 302 -----------TALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPP 350
Query: 388 YLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLET 447
++ L N + Q +L + L N L + ++ L
Sbjct: 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLD 409
Query: 448 NKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIG 507
L S+ + ++ + L N +G + +
Sbjct: 410 VSLN-SLNSHA--YDRTCAW-----------------AESILVLNLSSNMLTGSVFRCLP 449
Query: 508 NCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIF-SCKMLQRLDLS 566
++ L L +N +P++V +L L NV+SN L +P +F LQ + L
Sbjct: 450 --PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505
Query: 567 WNKF 570
N +
Sbjct: 506 DNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 86/505 (17%), Positives = 164/505 (32%), Gaps = 64/505 (12%)
Query: 213 SLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSL 272
+P ++ + L L+QN +S +I L L + L N++ + L
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDL 102
Query: 273 ETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPR--EIGKLSSALEIDFSENSL 330
E L + N ++ + + SL++L + N+ + +P E G L+
Sbjct: 103 EYLDVSHN-RLQNIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTK----------- 147
Query: 331 IGEIPVELSKILGLELLYLFENKLTGVIPVELTTLK-NLTKLDLSINSLTGTIPLGFQYL 389
L L L K + + + L + LDL + G Q
Sbjct: 148 -------------LTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP 194
Query: 390 TNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNK 449
N +L L + Q + + L + LS+ L + + + S +
Sbjct: 195 -NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLN 253
Query: 450 LTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNC 509
+T L + F + + + + I E
Sbjct: 254 VT------------LQHIETTWKCSVKLFQFF--WPRPVEYLNIYNLTITERIDREEFTY 299
Query: 510 -----NALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLD 564
+L H+ + F + + +S + + S L+
Sbjct: 300 SETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLN 359
Query: 565 LSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSF----SG 620
+ N F ++ + +L +L+ L L N L + ++ L+ S S
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSH 418
Query: 621 GIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSS 680
S+ + LNLS N L+G + L ++ L L+NN + IP +L +
Sbjct: 419 AYDRTCAWAESILV-LNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQA 474
Query: 681 LLGCNFSYNNLTGPIPSSQTFQNMS 705
L N + N L +P F ++
Sbjct: 475 LQELNVASNQLKS-VPDG-VFDRLT 497
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 30/223 (13%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
D+++ + VIG GA V A VA+K++ N E + EI + + H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHH 72
Query: 868 RNIVKLYGFCYHQGSNL--LMYEYMARGSLGELLHGASSTLDWQTRFM----IALGAAE- 920
NIV Y + L +M + ++ GS+ +++ + + ++ + IA E
Sbjct: 73 PNIVSYYT-SFVVKDELWLVM-KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 921 --GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG----LAKVIDMPQSKSMSAIA 974
GL YLH + HRD+K+ NILL + + DFG LA D+ ++K
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 975 GSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
G+ ++APE Y K DI+S+G+ +EL TG AP
Sbjct: 188 GTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAP 226
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G G V R + VA+K + +EG+ + D F E + + H +V+LYG
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDE-FIEEAKVMMNLSHEKLVQLYG 86
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
C Q ++ EYMA G L L Q + E + YL + H
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 143
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI---APEYAYTMKVTE 992
RD+ + N L++D+ V DFGL++ + ++ GS + PE K +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 993 KCDIYSYGVVLLELLT-GRAP 1012
K DI+++GV++ E+ + G+ P
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMP 221
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 13/209 (6%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
+ + IG G+ G G +K++ +R + + S R E+ L ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR-EVAVLANMKH 82
Query: 868 RNIVKLYGFCYHQGS-NLLMYEYMARGSLGELLHGASSTL---DWQTRFMIALGAAEGLS 923
NIV+ GS ++M +Y G L + ++ L D + + + L
Sbjct: 83 PNIVQYRESFEENGSLYIVM-DYCEGGDLFKRINAQKGVLFQEDQILDWFVQI--CLALK 139
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
++H +I HRDIKS NI L +GDFG+A+V++ + + I G+ Y++PE
Sbjct: 140 HVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPE 195
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
K DI++ G VL EL T +
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
+ FD +G G+ G+VY+A+ TG VA+K++ + EI + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCD 82
Query: 867 HRNIVKLYGFCYHQGSNL--LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSY 924
++VK YG Y + ++L +M EY GS+ +++ + TL I +GL Y
Sbjct: 83 SPHVVKYYG-SYFKNTDLWIVM-EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
LH R HRDIK+ NILL+ + A + DFG+A + +K + I + ++APE
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEV 196
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ DI+S G+ +E+ G+ P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 66/327 (20%), Positives = 130/327 (39%), Gaps = 44/327 (13%)
Query: 781 DKQLSSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVK 839
D+Q + ++ KD D+F++ +G G G V++ + +G +A K
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
Query: 840 KLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL--LMYEYMARGSLGE 897
+ + E + N E+ L + IV YG ++ + M E+M GSL +
Sbjct: 65 LI--HLEIKPAIRNQIIRELQVLHECNSPYIVGFYG-AFYSDGEISICM-EHMDGGSLDQ 120
Query: 898 LLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957
+L A + +++ +GL+YL K I HRD+K +NIL++ + E + DFG
Sbjct: 121 VLKKAGRIPEQILGK-VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLD 1017
++ + + S G+ Y++PE + + DI+S G+ L+E+ GR P+ P D
Sbjct: 178 VSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234
Query: 1018 QGGDLVTWVRNFIRNNSLVSGMLD--ARLNLQDEKTVSHMITVLKIAML----------- 1064
+ + + + R + + + ++
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294
Query: 1065 -------------CTNISPFDRPTMRE 1078
C +P +R +++
Sbjct: 295 GVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
++++ + IG G+ G + G + K+L E+ L +++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKH 64
Query: 868 RNIVKLYGFCYHQGSNLL---MYEYMARGSLGELLHGASST---------LDW--QTRFM 913
NIV+ Y + + L M EY G L ++ + L Q
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVM-EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ---- 119
Query: 914 IALGAAEGLSYLH--HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 971
+ L L H D + HRD+K N+ LD K +GDFGLA++++ S + +
Sbjct: 120 LTLA----LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT 175
Query: 972 AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ G+ Y++PE M EK DI+S G +L EL P
Sbjct: 176 FV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 811 FDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI 865
+R+ ++G G V+ A LR VAVK L ++ + + FR E +
Sbjct: 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 866 RHRNIVKLYGFCYHQGSNLLMY----EYMARGSLGELLHGASSTLDWQTRFMIALGAAEG 921
H IV +Y + + EY+ +L +++H + + + A +
Sbjct: 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQA 128
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK--SMSAIAGSYGY 979
L++ H + I HRD+K NI++ V DFG+A+ I + +A+ G+ Y
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 980 IAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
++PE A V + D+YS G VL E+LTG P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G G V + + VAVK + +EG+ + D F E T+ K+ H +VK YG
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMI---KEGSMSEDE-FFQEAQTMMKLSHPKLVKFYG 70
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
C + ++ EY++ G L L L+ + EG+++L + H
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIH 127
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI---APEYAYTMKVTE 992
RD+ + N L+D V DFG+ + + + G+ + APE + K +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 993 KCDIYSYGVVLLELLT-GRAP 1012
K D++++G+++ E+ + G+ P
Sbjct: 185 KSDVWAFGILMWEVFSLGKMP 205
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 73/286 (25%), Positives = 115/286 (40%), Gaps = 32/286 (11%)
Query: 816 VIGRGACGTVYRAVLR-----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
+G G G V TG VAVK L ++ + ++ EI L + H +I
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG--WKQEIDILRTLYHEHI 95
Query: 871 VKLYGFCYHQGSNLLM--YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
+K G C G+ L EY+ GSL + L ++ + A EG++YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP--RHSIGLAQLLLFAQQICEGMAYLH-- 151
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM------PQSKSMSAIAGSYGYIAP 982
HRD+ + N+LLD+ +GDFGLAK + + S + + AP
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAP 206
Query: 983 EYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041
E K D++S+GV L ELLT + P + +L+ + + L +L+
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE-LLE 265
Query: 1042 A--RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
RL + V + C RPT ++ +L
Sbjct: 266 RGERL----PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-33
Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 25/213 (11%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKIRH--RNIVK 872
IG G V++ + A+K + N E +N +S+R EI L K++ I++
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 873 LYGFCYHQGS-NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
LY + ++M E L L ++D R E + +H +
Sbjct: 74 LYDYEITDQYIYMVM-EC-GNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---QH 127
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM-SAIAGSYGYIAPE------- 983
I H D+K N L+ D + DFG+A + + + + G+ Y+ PE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 984 ----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
K++ K D++S G +L + G+ P
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 64/297 (21%), Positives = 112/297 (37%), Gaps = 68/297 (22%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
+F E +IG G G V++A G T +K++ N E E+ L K+ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-------KAEREVKALAKLDH 63
Query: 868 RNIVKLYGF---------------CYHQGSNL--LMYEYMARGSLGELLHGASST-LDWQ 909
NIV G + L M E+ +G+L + + LD
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM-EFCDKGTLEQWIEKRRGEKLDKV 122
Query: 910 TRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969
+ +G+ Y+H ++ +RD+K +NI L D + +GDFGL +
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--NDGK 177
Query: 970 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNF 1029
+ G+ Y++PE + ++ D+Y+ G++L ELL + T +R+
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH---VCDTAFETSKFFTDLRDG 234
Query: 1030 IRNN-------SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
I ++ +L+ +L + P DRP E+
Sbjct: 235 IISDIFDKKEKTLLQKLL--------------------------SKKPEDRPNTSEI 265
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-32
Identities = 57/308 (18%), Positives = 110/308 (35%), Gaps = 45/308 (14%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
++G+GA V+R + TG A+K N + E L K+ H+NIVKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 875 GFCYHQGSNLLMY---EYMARGSLGELL--HGASSTLDWQT--RFMIALGAAEGLSYLHH 927
+ + E+ GSL +L + L + + G+++L
Sbjct: 74 AI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV--VGGMNHLR- 129
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
+ I HR+IK NI+ + + DFG A+ ++ + ++ G+ Y+ P+
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPD 185
Query: 984 --------YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN-- 1033
+ K D++S GV TG P +P + + I
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 1034 ---SLVSGMLDARLNLQDE--------KTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082
S V + ++ + + + ++T + +L + +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD--QEKCWGFDQFFAE 303
Query: 1083 LSESNRRQ 1090
S+ R
Sbjct: 304 TSDILHRM 311
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 71/285 (24%), Positives = 111/285 (38%), Gaps = 43/285 (15%)
Query: 816 VIGRGACGTVYRAVLRTG----HTVAVKKLASNREGNNNVD-NSFRAEILTLGKIRHRNI 870
VIGRG G VY L AVK L + + + F E + + H N+
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 871 VKLYGFCYHQGSNLLM-YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
+ L G C + L+ YM G L + + + L A+G+ YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA--- 145
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEY 984
+ HRD+ + N +LD+KF V DFGLA+ + + S + + A E
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVKWMALES 203
Query: 985 AYTMKVTEKCDIYSYGVVLLELLT-GRAP---VQPLDQGGDLVTWVRNFIRNNSLVSGML 1040
T K T K D++S+GV+L EL+T G P V D + ++ L
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQG----RRL 251
Query: 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
D + ++ + C + RP+ E+V +S
Sbjct: 252 LQPEYCPDP--------LYEVMLKCWHPKAEMRPSFSELVSRISA 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 35/230 (15%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
+F+E V+G+GA G V +A A+KK+ E + + +E++ L +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI----LSEVMLLASLN 60
Query: 867 HRNIVKLYGF----------CYHQGSNLLMY---EYMARGSLGELLHGASSTLDWQTRFM 913
H+ +V+ Y ++ EY G+L +L+H + +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 914 IALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID---------- 963
+ E LSY+H I HRD+K NI +D+ +GDFGLAK +
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 964 ---MPQSKSMSAIAGSYGYIAPE-YAYTMKVTEKCDIYSYGVVLLELLTG 1009
S ++++ G+ Y+A E T EK D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 64/298 (21%), Positives = 110/298 (36%), Gaps = 52/298 (17%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
+F+ +GRG G V+ A A+K++ E+ L K+ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLEH 62
Query: 868 RNIVKLYGFCYHQGSN-------------LLMYEYMARGSLGELLHGASSTLDWQTRFM- 913
IV+ + + + + M + + +L + ++G + + +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQM-QLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 914 -IALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID--------- 963
I L AE + +LH + HRD+K +NI VGDFGL +D
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 964 --MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD 1021
MP + G+ Y++PE + + K DI+S G++L ELL P +
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PFSTQME 232
Query: 1022 LVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
V + + +RN L Q M+ ML + P +RP +
Sbjct: 233 RVRTLTD-VRNLKF------PPLFTQKYPCEYVMVQ----DMLSPS--PMERPEAINI 277
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 33/217 (15%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKIRH--RNIVK 872
IG G V++ + A+K + N E +N +S+R EI L K++ I++
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 873 LYGFCYHQGS-NLLMYEYMARGSLGELLHGASSTLDWQTRF----MIALGAAEGLSYLHH 927
LY + ++M E L L S W+ + M+ E + +H
Sbjct: 121 LYDYEITDQYIYMVM-EC-GNIDLNSWLKKKKSIDPWERKSYWKNML-----EAVHTIHQ 173
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAIAGSYGYIAPE--- 983
I H D+K N L+ D + DFG+A + S + G+ Y+ PE
Sbjct: 174 H---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 984 --------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
K++ K D++S G +L + G+ P
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 70/293 (23%), Positives = 108/293 (36%), Gaps = 39/293 (13%)
Query: 816 VIGRGACGTVYRAVLRTGHT----VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
+G G+ G V R VAVK L + + F E+ + + HRN++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
+LYG ++ E GSL + L T A+ AEG+ YL
Sbjct: 85 RLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SK 140
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEYAY 986
R HRD+ + N+LL + +GDFGL + + + + + APE
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH---YVMQEHRKVPFAWCAPESLK 197
Query: 987 TMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA--- 1042
T + D + +GV L E+ T G+ P L N S + +D
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---------------NGSQILHKIDKEGE 242
Query: 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEF 1095
RL + + + + C P DRPT + L E+ EF
Sbjct: 243 RL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRAEF 291
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G+G+ VYRA + TG VA+K + + + E+ +++H +I++LY
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 876 FCYHQGSNL-LMYEYMARGSLGELLHGASSTLD-WQTR-FMIALGAAEGLSYLHHDCKPR 932
+ + + L+ E G + L + R FM + G+ YLH
Sbjct: 79 -YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI--ITGMLYLH---SHG 132
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
I HRD+ +N+LL + DFGLA + MP K + + G+ YI+PE A
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGL 191
Query: 993 KCDIYSYGVVLLELLTGRAP 1012
+ D++S G + LL GR P
Sbjct: 192 ESDVWSLGCMFYTLLIGRPP 211
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 17/213 (7%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
+ ++ +G GA G VY+A TG A K + + ++ + EI L
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELE-DYIVEIEILATCD 74
Query: 867 HRNIVKLYGFCYHQGSNL--LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSY 924
H IVKL G Y+ L ++ E+ G++ ++ L ++ E L++
Sbjct: 75 HPYIVKLLG-AYYHDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
LH RI HRD+K+ N+L+ + + + DFG++ K S I Y ++APE
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY-WMAPEV 188
Query: 985 AYTMKVTE-----KCDIYSYGVVLLELLTGRAP 1012
+ + K DI+S G+ L+E+ P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-32
Identities = 53/208 (25%), Positives = 78/208 (37%), Gaps = 30/208 (14%)
Query: 816 VIGRGACGTVYRAV-LR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKL 873
I G G +Y A+ G V +K L G+ AE L ++ H +IV++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVH--SGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 874 YGFCYHQGSN------LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
+ F H + ++M EY+ SL L L LSYLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVM-EYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHS 200
Query: 928 DCKPRIFHRDIKSNNILLDD---KFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
+ + D+K NI+L + K + D G I+ S + G+ G+ APE
Sbjct: 201 I---GLVYNDLKPENIMLTEEQLK----LIDLGAVSRIN-----SFGYLYGTPGFQAPEI 248
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
T T DIY+ G L L
Sbjct: 249 VRT-GPTVATDIYTVGRTLAALTLDLPT 275
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 63/284 (22%), Positives = 106/284 (37%), Gaps = 39/284 (13%)
Query: 813 ERFVIGRGACGTVYRAVLRTGH---TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN 869
+G G G+V + V R VA+K L E + + E + ++ +
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE--MMREAQIMHQLDNPY 71
Query: 870 IVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
IV+L G C + L+M E G L + L G + + + G+ YL
Sbjct: 72 IVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEY 984
+ HRD+ + N+LL ++ A + DFGL+K + + A S G APE
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL---GADDSYYTARSAGKWPLKWYAPEC 184
Query: 985 AYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA- 1042
K + + D++SYGV + E L+ G+ P + + V ++
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---------------KGPEVMAFIEQG 229
Query: 1043 -RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
R+ E + + C DRP V +
Sbjct: 230 KRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-32
Identities = 48/222 (21%), Positives = 80/222 (36%), Gaps = 26/222 (11%)
Query: 808 TDNFDERFVIGRGAC--GTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGK 864
++ VIG+G TV A TG V V+++ N V + E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTF-LQGELHVSKL 82
Query: 865 IRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELL-HGASSTLDWQTRFMIALGAAEGL 922
H NIV + + L ++ +MA GS +L+ ++ I G + L
Sbjct: 83 FNHPNIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-- 980
Y+HH HR +K+++IL+ + ++ + + +
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 981 ----APE------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+PE Y K DIYS G+ EL G P
Sbjct: 199 LPWLSPEVLQQNLQGY----DAKSDIYSVGITACELANGHVP 236
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 69/291 (23%), Positives = 114/291 (39%), Gaps = 58/291 (19%)
Query: 816 VIGRGACGTVYRAVLRTGH-----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
V+G GA GTVY+ + VA+K+L N + E + + + ++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE--ILDEAYVMASVDNPHV 79
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
+L G C L+ + M G L + + + Q + A+G++YL
Sbjct: 80 CRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGY----------- 979
R+ HRD+ + N+L+ + DFGLAK++ A Y
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG----------AEEKEYHAEGGKVPIKW 185
Query: 980 IAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038
+A E T + D++SYGV + EL+T G P + S +S
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---------------PASEISS 230
Query: 1039 MLDA--RLNLQDEKTVS-HMITVLKIAML-CTNISPFDRPTMREVVLMLSE 1085
+L+ RL T+ +MI M C I RP RE+++ S+
Sbjct: 231 ILEKGERLPQPPICTIDVYMI------MRKCWMIDADSRPKFRELIIEFSK 275
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-32
Identities = 78/361 (21%), Positives = 135/361 (37%), Gaps = 41/361 (11%)
Query: 739 PTARLGKLVAIIAAAIGGVSLVLITVIIYFLRQPVEVVAPLQDKQLSSTVSDIYFPPKEG 798
+ G LV + + G+ + + + E + + + P+
Sbjct: 19 ASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN--TVHIDLSALNPELV 76
Query: 799 FTFKDLVVATDNFDERF--VIGRGACGTVYRAVLRTGH----TVAVKKLASNREGNNNVD 852
+ +V+ + F VIGRG G VY L AVK L + +
Sbjct: 77 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGE 133
Query: 853 -NSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM-YEYMARGSLGELLHGASSTLDWQT 910
+ F E + + H N++ L G C + L+ YM G L + + +
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 193
Query: 911 RFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 970
L A+G+ +L + HRD+ + N +LD+KF V DFGLA+ DM +
Sbjct: 194 LIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFD 248
Query: 971 SAIAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVT 1024
S + + A E T K T K D++S+GV+L EL+T G P ++
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TF 303
Query: 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084
+ ++ L D + ++ + C + RP+ E+V +S
Sbjct: 304 DITVYLLQG----RRLLQPEYCPDP--------LYEVMLKCWHPKAEMRPSFSELVSRIS 351
Query: 1085 E 1085
Sbjct: 352 A 352
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-32
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 816 VIGRGACGTVYRAVLRTGHT-VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
+G G G VY V + VAVK L +E V+ F E + +I+H N+V+L
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEE-FLKEAAVMKEIKHPNLVQLL 282
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRI 933
G C + ++ E+M G+L + L + + +A + + YL K
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEK 993
HR++ + N L+ + V DFGL++++ + + + APE K + K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 994 CDIYSYGVVLLELLT-GRAP 1012
D++++GV+L E+ T G +P
Sbjct: 400 SDVWAFGVLLWEIATYGMSP 419
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-32
Identities = 62/245 (25%), Positives = 94/245 (38%), Gaps = 48/245 (19%)
Query: 799 FTFKDLV-----VATDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVK-----KLAS 843
F F DL V + + +G GACG V A R T VA++ K A
Sbjct: 116 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAI 175
Query: 844 NREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYM----------ARG 893
+ + EI L K+ H I+K+ F + +++ E M
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK 234
Query: 894 SLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH- 952
L E +Q + YLH + I HRD+K N+LL + E
Sbjct: 235 RLKE---ATCKLYFYQM--------LLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCL 280
Query: 953 --VGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE---YAYTMKVTEKCDIYSYGVVLLELL 1007
+ DFG +K++ ++ M + G+ Y+APE T D +S GV+L L
Sbjct: 281 IKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
Query: 1008 TGRAP 1012
+G P
Sbjct: 339 SGYPP 343
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-31
Identities = 70/286 (24%), Positives = 107/286 (37%), Gaps = 33/286 (11%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
+G G G V R + TG VA+K+ +E + + EI + K+ H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 875 ------GFCYHQGSNLLMYEYMARGSLGELL--HGASSTLDWQT--RFMIALGAAEGLSY 924
LL EY G L + L L + + +A L Y
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRY 136
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAIAGSYGYIA 981
LH + RI HRD+K NI+L + + D G AK ++ Q + + G+ Y+A
Sbjct: 137 LH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYLA 191
Query: 982 PEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRN----FIRNNSLVS 1037
PE K T D +S+G + E +TG P P Q VR I ++
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 1038 GMLDARLNLQDEKTVSHMITVLKI----AMLCTNISPFDRPTMREV 1079
G + L +S ++ ML + R T +
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWH--QRQRGTDPQN 295
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 66/272 (24%), Positives = 116/272 (42%), Gaps = 27/272 (9%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G+G G V+ VA+K L + G + + F E + K+RH +V+LY
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA 246
Query: 876 FCYHQGSNLLMYEYMARGSLGELL-HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+ ++ EYM++GSL + L L +A A G++Y+ +
Sbjct: 247 VVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
HRD+++ NIL+ + V DFGLA++I+ + + + APE A + T K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 995 DIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVS 1053
D++S+G++L EL T GR P + +++ V R + +
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYR--------MPCPPECPES---- 409
Query: 1054 HMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ + C P +RPT + L +
Sbjct: 410 ----LHDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 86/427 (20%), Positives = 145/427 (33%), Gaps = 48/427 (11%)
Query: 71 CTTNDFGAVVF--SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSL 128
+ G + L ++ P + H+ +DLS N ++ L
Sbjct: 6 SECSVIGYNAICINRGLHQV-------PEL--PAHVNYVDLSLNSIAELNETSFSRLQDL 56
Query: 129 EVLNLNNNRLEAHIPKEL-GNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNI- 186
+ L + I LSSL IL + N+ L+ L L N+
Sbjct: 57 QFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLD 116
Query: 187 SGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQLSGEIPKEI-- 242
L L L+ N I P+ L L N++ I +E
Sbjct: 117 GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLL 175
Query: 243 -GMLKYLTDVILWGNQLSGVIPKELG--------NCTSLETLALYDNKQVGQLPKELGSI 293
K+ T + L L + LG TS+ TL L N + K
Sbjct: 176 NFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA 235
Query: 294 GSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENK 353
+ + + D + G + G++ L ++K
Sbjct: 236 IAGTKIQSLILSNS---YNMGSSFGHTNFKDPDNFTFKG------LEASGVKTCDLSKSK 286
Query: 354 LTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDN---SLVGGIPQR 409
+ ++ + +L +L L+ N + I F LT+L+ L L N S+ + +
Sbjct: 287 IFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFEN 345
Query: 410 LGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLTGSIPTGV-TRCKSLVQL 467
L +L V+DLS NH+ + +L L L+TN+L S+P G+ R SL ++
Sbjct: 346 L---DKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKI 400
Query: 468 RLGGNSF 474
L N +
Sbjct: 401 WLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-30
Identities = 68/365 (18%), Positives = 120/365 (32%), Gaps = 28/365 (7%)
Query: 344 LELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDNSL 402
+ + L N + + + L++L L + + I F+ L++LI+L+L N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 403 VGGIPQRLGAYSQLWVVDLSDNHLTG-KIPRHICRN-TSLIFLNLETNKLTGSIPTGV-T 459
+ + L V+ L+ +L G + + + TSL L L N + P
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151
Query: 460 RCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELD----------QNQFSGPIPTEIGNC 509
+ L L N DL L +
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 510 NALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNK 569
++ L LS N F + + + + + S D
Sbjct: 212 TSITTLDLSGNGFKESMA---KRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 570 FVGALPREIGSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSGGIPAE-LG 627
F G ++ LS++++ ++ + + + L +L + N + I
Sbjct: 269 FKGLEAS------GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINK-IDDNAFW 320
Query: 628 SLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFS 687
L+ L LNLS N L + NL LE L L+ NH+ SF+ L +L
Sbjct: 321 GLTHLLK-LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALD 379
Query: 688 YNNLT 692
N L
Sbjct: 380 TNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 81/423 (19%), Positives = 155/423 (36%), Gaps = 73/423 (17%)
Query: 223 SLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKEL-GNCTSLETLALYDNK 281
+ Y+ L+ N ++ L+ L + + VI +SL L L N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN- 89
Query: 282 QVGQLPKE-LGSIGSLKYLYIYRNELNGT-IPREI-GKLSSALEIDFSENSLIGEIPVEL 338
Q QL + +L+ L + + L+G + L+S
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS------------------- 130
Query: 339 SKILGLELLYLFENKLTGVIPVEL-TTLKNLTKLDLSINSLTGTIPLGFQYLT--NLIML 395
LE+L L +N + + P ++ LDL+ N + + +L
Sbjct: 131 -----LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL 185
Query: 396 QLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIP 455
+L +L D+++ L + + +NTS+ L+L N S+
Sbjct: 186 RLSSITLQ----------------DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA 229
Query: 456 TGVTRCKSLVQLR-------------LGGNSFTGSFPSDLCKL--ANLSTVELDQNQFSG 500
+ +++ G +F L + + T +L +++
Sbjct: 230 KRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA 289
Query: 501 PIPTEI-GNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIF-SC 557
+ + + L++L L+ N ++ L++L+ N+S NFL I +F +
Sbjct: 290 -LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENL 346
Query: 558 KMLQRLDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGG 615
L+ LDLS+N AL + L L+ L L N+L S+P I L+ L ++ +
Sbjct: 347 DKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHT 404
Query: 616 NSF 618
N +
Sbjct: 405 NPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 79/395 (20%), Positives = 136/395 (34%), Gaps = 44/395 (11%)
Query: 295 SLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILG-LELLYLFENK 353
+ Y+ + N + +L + + + I + L L +L L N+
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 354 LTGVIPVELTTLKNLTKLDLSINSLTGT-IPLG-FQYLTNLIMLQLFDNSLV----GGIP 407
+ L NL L L+ +L G + F+ LT+L ML L DN++
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 408 QRLGAYSQLWVVDLSDNHLTGKIPRHI---CRNTSLIFLNLETNKLT-------GSIPTG 457
+ + V+DL+ N + I + L L + L G G
Sbjct: 151 LNM---RRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCG 206
Query: 458 V-TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLH 516
+ S+ L L GN F S + I + I + +
Sbjct: 207 NPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT-----------KIQSLILSNSYNMGSS 255
Query: 517 LSDNYFTGELPREVGNL--SNLVTFNVSSNFLTGRIPLEIFS-CKMLQRLDLSWNKFVGA 573
F L S + T ++S + + + +FS L++L L+ N+
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-K 313
Query: 574 LPREI-GSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSGGIPAEL-GSLS 630
+ L L L LS+N L SI ++ NL +L L + N + + L
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLP 371
Query: 631 SLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNN 665
+L+ L L N L + L L+ + L+ N
Sbjct: 372 NLKE-LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-11
Identities = 37/225 (16%), Positives = 61/225 (27%), Gaps = 33/225 (14%)
Query: 501 PIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIF-SCKM 559
+P + + LS N L +L V I F
Sbjct: 27 ELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 560 LQRLDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSF 618
L L L +N+F+ L L LE+L L++ L + LT L+M
Sbjct: 81 LIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLD-GAVLSGNFFKPLTSLEM----- 133
Query: 619 SGGIPAELGSLSSLQIALNLSYNNLSGLIPPEL-GNLILLEYLLLNNNHLSGEIPGSFVN 677
L L NN+ + P N+ L L N + +N
Sbjct: 134 -----------------LVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLN 176
Query: 678 LSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQN 722
+++T + + + + L
Sbjct: 177 FQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSG 221
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
F + IG G+ G VY A +R VA+KK++ + + +N E+ L K+R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 867 HRNIVKLYGFCYHQGSNL--LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSY 924
H N ++ G CY + +M EY GS +LL L + GA +GL+Y
Sbjct: 113 HPNTIQYRG-CYLREHTAWLVM-EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
LH + HRD+K+ NILL + +GDFG A ++ + + S + Y ++APE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPY-WMAPEV 221
Query: 985 AYTMKVTE---KCDIYSYGVVLLELLTGRAP 1012
M + K D++S G+ +EL + P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 16/212 (7%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
NF IGRG VYRA L G VA+KK+ + EI L ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 868 RNIVKLYGFCYHQGS-NLLMYEYMARGSLGELLHGASSTLDWQTRF------MIALGAAE 920
N++K Y N+++ E G L ++ + +
Sbjct: 92 PNVIKYYASFIEDNELNIVL-ELADAGDLSRMIKHFKKQ---KRLIPERTVWKYFVQLCS 147
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI 980
L ++H R+ HRDIK N+ + +GD GL + + + S + G+ Y+
Sbjct: 148 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 203
Query: 981 APEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+PE + K DI+S G +L E+ ++P
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 20/208 (9%)
Query: 816 VIGRGACGTVYRAVLRTGH----TVAVKKLASNREGNNNVD-NSFRAEILTLGKIRHRNI 870
+IG G G V LR VA+K L + G F +E +G+ H NI
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKAL---KAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
++L G +++ EYM GSL L + G G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---D 169
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEYA 985
HRD+ + N+L+D V DFGL++V+ + +A + G I APE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 986 YTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
+ D++S+GVV+ E+L G P
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 48/200 (24%), Positives = 88/200 (44%), Gaps = 12/200 (6%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G+G + T A K + + + EI + H+++V +G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 876 FCYHQGSN--LLMYEYMARGSLGELLHGASSTLDWQTR-FMIALGAAEGLSYLHHDCKPR 932
+ +++ E R SL EL + + + R ++ + G YLH + R
Sbjct: 83 -FFEDNDFVFVVL-ELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH---RNR 135
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
+ HRD+K N+ L++ E +GDFGLA ++ + + G+ YIAPE +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 194
Query: 993 KCDIYSYGVVLLELLTGRAP 1012
+ D++S G ++ LL G+ P
Sbjct: 195 EVDVWSIGCIMYTLLVGKPP 214
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 50/296 (16%), Positives = 103/296 (34%), Gaps = 64/296 (21%)
Query: 816 VIGRGACGTVYRAVLRT--------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
+G+G +++ V R V +K L + + N SF + K+ H
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAASMMSKLSH 71
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
+++V YG C N+L+ E++ GSL L + ++ + +A A + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE- 130
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAH--------VGDFGLAKVIDMPQSKSMSAIAGSYGY 979
+ + H ++ + NILL + + + D G++ +
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL----------PKDILQ 178
Query: 980 I-----APE-YAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRN 1032
PE + D +S+G L E+ + G P+ L +
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL---------------D 223
Query: 1033 NSLVSGMLDA--RLNLQDEKTVSHMITVLKIAML-CTNISPFDRPTMREVVLMLSE 1085
+ + +L + + + C + P RP+ R ++ L+
Sbjct: 224 SQRKLQFYEDRHQLPAPKAAEL-ANL------INNCMDYEPDHRPSFRAIIRDLNS 272
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-31
Identities = 69/400 (17%), Positives = 139/400 (34%), Gaps = 43/400 (10%)
Query: 107 LDLSFNQLSRNIPKEIGNC----SSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI 162
+ +N +S + + + N N + + + L ++ + L + +
Sbjct: 15 QNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNL 71
Query: 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCE 222
S P + ++ L N + SLP +L+ L A N +S +LP
Sbjct: 72 SS-LPDNLPPQ--ITVLEITQNALI-SLPELPASLEYLD---ACDNRLS-TLPELPA--- 120
Query: 223 SLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQ 282
SL++L + NQL+ +P+ +L+Y+ NQL+ ++P+ + LE L++ +N Q
Sbjct: 121 SLKHLDVDNNQLT-MLPELPALLEYI---NADNNQLT-MLPELPTS---LEVLSVRNN-Q 171
Query: 283 VGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALE----IDFSENSLIGEIPVEL 338
+ LP+ SL+ L + N L ++P + + E EN I IP +
Sbjct: 172 LTFLPE---LPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENR-ITHIPENI 226
Query: 339 SKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLF 398
+ + L +N L+ I L+ + + N + L
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG-----QQNTLHRPLA 281
Query: 399 DNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV 458
D + SQ+W + H + ++ N + +
Sbjct: 282 DAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSG--FREQVAAWL 339
Query: 459 TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQF 498
+ + +LR + L+ L +
Sbjct: 340 EKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLL 379
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-30
Identities = 64/401 (15%), Positives = 130/401 (32%), Gaps = 42/401 (10%)
Query: 84 NLTKMNLSGYL------SPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNR 137
K L G + + L L+ LS +P + + VL + N
Sbjct: 35 KWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNA 91
Query: 138 LEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNL 197
L +P+ + L L+ +NR+S P+ L L +N ++ LP L
Sbjct: 92 LI-SLPELPAS---LEYLDACDNRLST-LPELPASLKHLD---VDNNQLT-MLPELPALL 142
Query: 198 KRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQ 257
+ + A N ++ LP SL+ L + NQL+ +P+ L+ L + N
Sbjct: 143 EYI---NADNNQLT-MLPELPT---SLEVLSVRNNQLT-FLPELPESLEAL---DVSTNL 191
Query: 258 LSGVIPKELGNCTSLET----LALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPRE 313
L +P E +N ++ +P+ + S+ + + N L+ I
Sbjct: 192 LES-LPAVPVRNHHSEETEIFFRCREN-RITHIPENILSLDPTCTIILEDNPLSSRIRES 249
Query: 314 IGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDL 373
+ + ++ + + + L +++ + + + +
Sbjct: 250 LSQQTAQPDYHGPRIYFSMSDGQQNTLH--RPLADAVTAWFPENKQSDVSQIWHAFEHEE 307
Query: 374 SINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRH 433
N+ + + + F V ++L A ++L +
Sbjct: 308 HANTFSAFLDR-LSDTVSARNTSGFREQ-VAAWLEKLSASAEL---RQQSFAVAADATES 362
Query: 434 ICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSF 474
+L + NL L G+ + L LG F
Sbjct: 363 CEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLGREMF 403
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-29
Identities = 52/289 (17%), Positives = 102/289 (35%), Gaps = 33/289 (11%)
Query: 420 DLSDNHLTG---KIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTG 476
+ N ++G + N+ + +L+L + +
Sbjct: 16 NSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC--LINQFSELQLNRLNLS- 72
Query: 477 SFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNL 536
S P +L ++ +E+ QN +P + L+ L DN + LP +L +L
Sbjct: 73 SLPDNLPP--QITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLKHL 125
Query: 537 VTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSG 596
+V +N LT +P +L+ ++ N+ LP SL E+L + N+L+
Sbjct: 126 ---DVDNNQLT-MLPELP---ALLEYINADNNQLT-MLPELPTSL---EVLSVRNNQLT- 173
Query: 597 SIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQ---IALNLSYNNLSGLIPPELGN 653
+P +L L + N +PA + I N ++ + P + +
Sbjct: 174 FLPELPESL---EALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRITHI-PENILS 228
Query: 654 LILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQ 702
L ++L +N LS I S ++ + + T
Sbjct: 229 LDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLH 277
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 63/343 (18%), Positives = 120/343 (34%), Gaps = 46/343 (13%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141
L L ++NLS L N+ +T L+++ N L ++P+ + LE L+ +NRL
Sbjct: 63 ELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-T 114
Query: 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKL-----------------SALSQLVAYSN 184
+P+ + L L++ NN+++ P+ L ++L L +N
Sbjct: 115 LPELPAS---LKHLDVDNNQLTM-LPELPALLEYINADNNQLTMLPELPTSLEVLSVRNN 170
Query: 185 NISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQ----YLGLAQNQLSGEIPK 240
++ LP +L+ L NL+ SLP+ + + +N+++ IP+
Sbjct: 171 QLT-FLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPE 224
Query: 241 EIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLY 300
I L +IL N LS I + L T+ ++ +
Sbjct: 225 NILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLAD 282
Query: 301 IYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPV 360
++ ++ A E + N+ LS + F ++
Sbjct: 283 AVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQVAAW--- 338
Query: 361 ELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLV 403
L L +L ++ + L L LV
Sbjct: 339 -LEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLV 380
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-24
Identities = 71/413 (17%), Positives = 140/413 (33%), Gaps = 43/413 (10%)
Query: 262 IPKELGNCTSLETLALYDNKQVGQLPKELGSI-GSLKYLYIYRNELNG--TIPREIGKLS 318
I + N SL + Y+ + S + + N ++ +E ++
Sbjct: 3 IMLPINNNFSLSQNSFYNTIS--GTYADYFSAWDKWEKQALPGENRNEAVSLLKEC-LIN 59
Query: 319 SALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSL 378
E+ + +L +P L + +L + +N L +P +L LD N L
Sbjct: 60 QFSELQLNRLNL-SSLPDNLPP--QITVLEITQNALI-SLPELPA---SLEYLDACDNRL 112
Query: 379 TGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNT 438
+ T+P + +L L + +N L +P+ L ++ +N LT +P T
Sbjct: 113 S-TLP---ELPASLKHLDVDNNQLTM-LPELPA---LLEYINADNNQLT-MLPELP---T 160
Query: 439 SLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVE----LD 494
SL L++ N+LT +P SL L + N S P+ + + E
Sbjct: 161 SLEVLSVRNNQLT-FLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCR 215
Query: 495 QNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEI 554
+N+ + IP I + + + L DN + + + + ++ + + +
Sbjct: 216 ENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQN 274
Query: 555 FSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMG 614
+ L +W P S E + + + LS +
Sbjct: 275 TLHRPLADAVTAW------FPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNT 328
Query: 615 GNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHL 667
F + A L LS+ L ++ + + L + L L
Sbjct: 329 S-GFREQVAAWLEKLSASA-ELRQQSFAVAADATESCEDRVALTWNNLRKTLL 379
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 61/200 (30%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG+G G V R G+ VAVK + + F AE + ++RH N+V+L G
Sbjct: 28 TIGKGEFGDVMLGDYR-GNKVAVKCI---KNDATAQA--FLAEASVMTQLRHSNLVQLLG 81
Query: 876 FCYHQGSNLLM-YEYMARGSLGELLH-GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRI 933
+ L + EYMA+GSL + L S L +L E + YL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEK 993
HRD+ + N+L+ + A V DFGL K Q + + APE K + K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTK 194
Query: 994 CDIYSYGVVLLELLT-GRAP 1012
D++S+G++L E+ + GR P
Sbjct: 195 SDVWSFGILLWEIYSFGRVP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 48/200 (24%), Positives = 88/200 (44%), Gaps = 12/200 (6%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G+G + T A K + + + EI + H+++V +G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 876 FCYHQGSN--LLMYEYMARGSLGELLHGASSTLDWQTR-FMIALGAAEGLSYLHHDCKPR 932
+ +++ E R SL EL + + + R ++ + G YLH + R
Sbjct: 109 -FFEDNDFVFVVL-ELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH---RNR 161
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
+ HRD+K N+ L++ E +GDFGLA ++ + + G+ YIAPE +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 220
Query: 993 KCDIYSYGVVLLELLTGRAP 1012
+ D++S G ++ LL G+ P
Sbjct: 221 EVDVWSIGCIMYTLLVGKPP 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 70/285 (24%), Positives = 109/285 (38%), Gaps = 43/285 (15%)
Query: 816 VIGRGACGTVYRAVLRTGH----TVAVKKLASNREGNNNVD-NSFRAEILTLGKIRHRNI 870
VIG+G G VY A+K L +F E L + + H N+
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSL---SRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 871 VKLYGFCYH-QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
+ L G +G ++ YM G L + + + L A G+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA--- 141
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEY 984
+ + HRD+ + N +LD+ F V DFGLA+ I + S + + A E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDIL--DREYYSVQQHRHARLPVKWTALES 199
Query: 985 AYTMKVTEKCDIYSYGVVLLELLT-GRAP---VQPLDQGGDLVTWVRNFIRNNSLVSGML 1040
T + T K D++S+GV+L ELLT G P + P D + +F+ L
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--------LTHFLAQG----RRL 247
Query: 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
D + ++ C P RPT R +V + +
Sbjct: 248 PQPEYCPDS--------LYQVMQQCWEADPAVRPTFRVLVGEVEQ 284
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-31
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G+G G V+ VA+K L + G + + F E + K+RH +V+LY
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA 329
Query: 876 FCYHQGSNLLMYEYMARGSLGELL-HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+ ++ EYM++GSL + L L +A A G++Y+ +
Sbjct: 330 VVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
HRD+++ NIL+ + V DFGLA++I+ + + + APE A + T K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 995 DIYSYGVVLLELLT-GRAP 1012
D++S+G++L EL T GR P
Sbjct: 446 DVWSFGILLTELTTKGRVP 464
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-31
Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG+G G V R G+ VAVK + ++ +F AE + ++RH N+V+L G
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 876 FCYHQGSNLLM-YEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRI 933
+ L + EYMA+GSL + L S L +L E + YL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 310
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEK 993
HRD+ + N+L+ + A V DFGL K Q + + APE K + K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTK 366
Query: 994 CDIYSYGVVLLELLT-GRAP 1012
D++S+G++L E+ + GR P
Sbjct: 367 SDVWSFGILLWEIYSFGRVP 386
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-31
Identities = 38/288 (13%), Positives = 75/288 (26%), Gaps = 45/288 (15%)
Query: 767 YFLRQPVEVVAPLQDKQLSST---VSDIYFPPKEGFTFKDLVVA-TDNFDERFVIGRGAC 822
F R P V + S+ VS + + F + + V+G+
Sbjct: 32 LFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDP 91
Query: 823 GTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR--------------- 866
A TG + V +N + E+L L +R
Sbjct: 92 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151
Query: 867 -------HRNIVKLYGFCYHQGSNLLMYEYM----ARGSLGELLH------GASSTLDWQ 909
K+ + ++ + + +L +L
Sbjct: 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 211
Query: 910 TRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969
R + L L+ LHH + H ++ +I+LD + + F
Sbjct: 212 ARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSP 268
Query: 970 MSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ A +T D ++ G+ + + P
Sbjct: 269 IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-31
Identities = 46/331 (13%), Positives = 88/331 (26%), Gaps = 63/331 (19%)
Query: 772 PVEVVAPLQDKQLSSTVSDIYFPPKEGFTFKDLVVATD-NFDERFVIGRGACGTVYRAV- 829
V + S VS + + F + + V+G+ A
Sbjct: 35 NVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATD 94
Query: 830 LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR----------------------- 866
TG + V +N + E+L L +R
Sbjct: 95 QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154
Query: 867 --HRNIVKLYGFCYHQGS-NLLMYEYMARGSLGELLH------GASSTLDWQTRFMIALG 917
+ ++++ + + +L +L R + L
Sbjct: 155 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQ 214
Query: 918 AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY 977
L+ LHH + H ++ +I+LD + + F + S
Sbjct: 215 VIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV-----SSVSR 266
Query: 978 GYIAPEY-----------AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWV 1026
G+ PE +T D ++ G+V+ + P+ D W+
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT-KDAALGGSEWI 325
Query: 1027 RNFIRNNS-----LVSGMLD----ARLNLQD 1048
+N L+ G L RL
Sbjct: 326 FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQ 356
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 816 VIGRGACGTVYRAVLRTGHT-VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
+G G G VY V + VAVK L +E V+ F E + +I+H N+V+L
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEE-FLKEAAVMKEIKHPNLVQLL 75
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRI 933
G C + ++ E+M G+L + L + + +A + + YL K
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEK 993
HRD+ + N L+ + V DFGL++++ + + + APE K + K
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 994 CDIYSYGVVLLELLT-GRAP 1012
D++++GV+L E+ T G +P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
++F+ +G+G G VY A ++ +A+K L + V++ R E+ +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 868 RNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH 926
NI++LYG+ +H + + L+ EY G++ L S + +T I A LSY H
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCH 126
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY 986
R+ HRDIK N+LL E + DFG + S + + G+ Y+ PE
Sbjct: 127 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIE 180
Query: 987 TMKVTEKCDIYSYGVVLLELLTGRAP 1012
EK D++S GV+ E L G+ P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G G V+ VAVK L ++G+ + D F AE + +++H+ +V+LY
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDA-FLAEANLMKQLQHQRLVRLYA 75
Query: 876 FCYHQGSNLLMYEYMARGSLGELL-HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+ ++ EYM GSL + L + L +A AEG++++ +
Sbjct: 76 VVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS---YGYIAPEYAYTMKVT 991
HRD+++ NIL+ D + DFGLA++I + +A G+ + APE T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 992 EKCDIYSYGVVLLELLT-GRAP 1012
K D++S+G++L E++T GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
+ IG+GA GTVY A+ + TG VA++++ N + + EIL + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIIN-EILVMRENK 75
Query: 867 HRNIVKLYGFCYHQGSNL--LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSY 924
+ NIV Y G L +M EY+A GSL +++ + +D + + L +
Sbjct: 76 NPNIVNYLD-SYLVGDELWVVM-EYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEF 131
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
LH + ++ HRDIKS+NILL + DFG I QSK + + Y ++APE
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEV 187
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
K DI+S G++ +E++ G P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-30
Identities = 77/402 (19%), Positives = 131/402 (32%), Gaps = 40/402 (9%)
Query: 695 IPSSQTFQNMS---VNSFSGSKGLCGGPLQNCTQPPSSLPFPSGTNSPTARLGKLVAIIA 751
IP F + + GL + C +S + + A L
Sbjct: 223 IPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQR 282
Query: 752 AAIGGVSLVLITVIIYFLRQPVEVVAPLQDKQLSSTVSDIYFPPKEGFTFKDLVVATDNF 811
S P+ S SD + K +
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLI--- 339
Query: 812 DERFVIGRGACGTVYRAVLRTG---HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
+G G G+V + V R VA+K L E + + E + ++ +
Sbjct: 340 -ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE--MMREAQIMHQLDNP 396
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
IV+L G C + L+M E G L + L G + + + G+ YL
Sbjct: 397 YIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL--- 452
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGY--IAPEYAY 986
+ HR++ + N+LL ++ A + DFGL+K + S + AG + APE
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512
Query: 987 TMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA--R 1043
K + + D++SYGV + E L+ G+ P + + V ++ R
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---------------KGPEVMAFIEQGKR 557
Query: 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ E + + C DRP V +
Sbjct: 558 M----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 57/219 (26%), Positives = 87/219 (39%), Gaps = 39/219 (17%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVK-----KLASNREGNNNVDNSFRAEILTLGKIRHRN 869
+G GACG V A R T VA+K K A + + EI L K+ H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 870 IVKLYGFCYHQGSNLLMYEYM----------ARGSLGELLHGASSTLDWQTRFMIALGAA 919
I+K+ F + +++ E M L E + +
Sbjct: 77 IIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKE--ATCK-------LYFYQM--L 124
Query: 920 EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAIAGS 976
+ YLH + I HRD+K N+LL + E + DFG +K++ ++ M + G+
Sbjct: 125 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGT 179
Query: 977 YGYIAPE---YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y+APE T D +S GV+L L+G P
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 62/239 (25%), Positives = 103/239 (43%), Gaps = 21/239 (8%)
Query: 780 QDKQLSSTVSDIYFPPKEGFTFKDLVVATD---NFDERFVIGRGACGTVYRAV-LRTGHT 835
S V+ F + +V D D IG G+ G V A +G
Sbjct: 17 NLYFQSGVVTHEQFKAA----LRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQ 72
Query: 836 VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL--LMYEYMARG 893
VAVK + + + F E++ + +H N+V++Y Y G L LM E++ G
Sbjct: 73 VAVKMM--DLRKQQRRELLFN-EVVIMRDYQHFNVVEMYK-SYLVGEELWVLM-EFLQGG 127
Query: 894 SLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 953
+L +++ L+ + + + L+YLH + HRDIKS++ILL +
Sbjct: 128 ALTDIVS--QVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKL 182
Query: 954 GDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
DFG I K S + Y ++APE + DI+S G++++E++ G P
Sbjct: 183 SDFGFCAQISKDVPKRKSLVGTPY-WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI- 865
F+ ++G G G VY+ ++TG A+K + + G+ + + EI L K
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDE--EEEIKQEINMLKKYS 78
Query: 866 RHRNIVKLYGFCYHQGSN--------LLMYEYMARGSLGELLHGASS-TLDWQTRFMIAL 916
HRNI YG + + + L+M E+ GS+ +L+ TL + I
Sbjct: 79 HHRNIATYYG-AFIKKNPPGMDDQLWLVM-EFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS 976
GLS+LH + ++ HRDIK N+LL + E + DFG++ +D + + I G+
Sbjct: 137 EILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GT 192
Query: 977 YGYIAPEYAYTMKVTE-----KCDIYSYGVVLLELLTGRAP 1012
++APE + + K D++S G+ +E+ G P
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 30/234 (12%)
Query: 793 FPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNV 851
P++ + F ++ + IGRGA G+V + V +G +AVK++ +
Sbjct: 11 ISPEQHWDFTA-----EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKE 63
Query: 852 DNSFRAEILTLGK-IRHRNIVKLYGFCYHQGSNL--LMYEYMARGSLGELLHGASSTLDW 908
++ + + IV+ YG + + M E M+ S + S L
Sbjct: 64 QKQLLMDLDVVMRSSDCPYIVQFYG-ALFREGDCWICM-ELMS-TSFDKFYKYVYSVL-- 118
Query: 909 QTRF------MIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962
I L + L++L + K I HRDIK +NILLD + DFG++ +
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 963 DMPQSKSMSAIAGSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
S + + AG Y+APE A + D++S G+ L EL TGR P
Sbjct: 177 V--DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 816 VIGRGACGTVYRAVLRTGH----TVAVKKLASNREGNNNVDNS-FRAEILTLGKIRHRNI 870
V+G G G V L+ +VA+K L + G F E +G+ H NI
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
++L G +++ EYM GSL L + + G A G+ YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---D 165
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEYA 985
HRD+ + NIL++ V DFGL +V++ +A G I +PE
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE---DDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 986 YTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
K T D++SYG+VL E+++ G P
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 816 VIGRGACGTVYRAVLRTGH-----TVAVKKLASNREGNNNVDNS-FRAEILTLGKIRHRN 869
VIG G G VY+ +L+T VA+K L + G F E +G+ H N
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 870 IVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC 929
I++L G +++ EYM G+L + L + G A G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--- 164
Query: 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEY 984
HRD+ + NIL++ V DFGL++V+ + + S G I APE
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEATYTTSGGKIPIRWTAPEA 221
Query: 985 AYTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
K T D++S+G+V+ E++T G P
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G G V+ A VAVK + + G+ +V+ F AE + ++H +VKL+
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEA-FLAEANVMKTLQHDKLVKLHA 250
Query: 876 FCYHQGSNLLMYEYMARGSLGELL-HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+ ++ E+MA+GSL + L S + AEG++++ +
Sbjct: 251 VVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI---APEYAYTMKVT 991
HRD+++ NIL+ + DFGLA+VI+ +A G+ I APE T
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 992 EKCDIYSYGVVLLELLT-GRAP 1012
K D++S+G++L+E++T GR P
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIP 385
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 49/237 (20%), Positives = 83/237 (35%), Gaps = 25/237 (10%)
Query: 783 QLSSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKL 841
+ S T+ + P +F +F +G G+ G V++ G AVK+
Sbjct: 36 EASETLQSPGYDPSRPESFFQ-----QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS 90
Query: 842 ASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY-EYMARGSLGELLH 900
S G + +H V+L + +G L + E SL +
Sbjct: 91 MSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ-AWEEGGILYLQTEL-CGPSLQQHCE 148
Query: 901 GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960
++L + L++LH + H D+K NI L + +GDFGL
Sbjct: 149 AWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV 205
Query: 961 VIDMPQSKSMSAIAGSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ + G Y+APE Y D++S G+ +LE+
Sbjct: 206 ELGTAG--AGEVQEGDPRYMAPELLQGSY------GTAADVFSLGLTILEVACNMEL 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 70/285 (24%), Positives = 112/285 (39%), Gaps = 48/285 (16%)
Query: 816 VIGRGACGTVYRAVLRTGH----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
++G G G VY V VAVK + +N F +E + + + H +IV
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK--FMSEAVIMKNLDHPHIV 76
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
KL G + ++ E G LG L ++L T + +L + ++YL
Sbjct: 77 KLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 132
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEYAY 986
HRDI NIL+ +GDFGL++ I+ S + +PE
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIE-----DEDYYKASVTRLPIKWMSPESIN 187
Query: 987 TMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA--R 1043
+ T D++ + V + E+L+ G+ P L N V G+L+ R
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWL---------------ENKDVIGVLEKGDR 232
Query: 1044 LNLQDE--KTVSHMITVLKIAML-CTNISPFDRPTMREVVLMLSE 1085
L D + + + M C + P DRP E+V LS+
Sbjct: 233 LPKPDLCPPVL-YTL------MTRCWDYDPSDRPRFTELVCSLSD 270
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-30
Identities = 66/301 (21%), Positives = 114/301 (37%), Gaps = 66/301 (21%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLY 874
++G G+ GTV G VAVK++ + + EI L + H N+++ Y
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALM----EIKLLTESDDHPNVIRYY 75
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFM------IALGAAEGLSYLHHD 928
+ E +L +L+ + + + + A G+++LH
Sbjct: 76 CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-- 132
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVG-------------DFGLAKVIDMPQS---KSMSA 972
+I HRD+K NIL+ DFGL K +D QS +++
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 973 IAGSYGYIAPE-------YAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVT 1024
+G+ G+ APE ++T DI+S G V +L+ G+ P
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP------------ 239
Query: 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIA------MLCTNISPFDRPTMRE 1078
F S S ++ +L + K H +++ A M+ + P RPT +
Sbjct: 240 ----FGDKYSRESNIIRGIFSLDEMKC-LHDRSLIAEATDLISQMIDHD--PLKRPTAMK 292
Query: 1079 V 1079
V
Sbjct: 293 V 293
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 66/297 (22%), Positives = 113/297 (38%), Gaps = 25/297 (8%)
Query: 333 EIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNL 392
++P +L LL L NK+T + + LKNL L L N ++ P F L L
Sbjct: 45 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 393 IMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLT 451
L L N L +P+ L + + +N +T K+ + + +I + L TN L
Sbjct: 103 ERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158
Query: 452 -GSIPTGV-TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEI-GN 508
I G K L +R+ + T + P L +L+ + LD N+ + +
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK-VDAASLKG 214
Query: 509 CNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSW 567
N L +L LS N + + N +L ++++N L ++P + K +Q + L
Sbjct: 215 LNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272
Query: 568 NKF------VGALPREIGSLFQLELLKLSENELS-GSIPVQI-GNLSRLTELQMGGN 616
N P + L N + I + +Q+G
Sbjct: 273 NNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 66/310 (21%), Positives = 127/310 (40%), Gaps = 24/310 (7%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI 162
HL + S L + +PK++ +L+L NN++ + NL +L L + NN+I
Sbjct: 32 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEI-GGC 221
S P L L +L N + LP + K L+ R +N I+ + + G
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 222 ESLQYLGLAQNQL-SGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYD 279
+ + L N L S I +K L+ + + ++ IP+ L SL L L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 201
Query: 280 NKQVGQLPKE-LGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVEL 338
N ++ ++ L + +L L + N ++ + E+ + N L+ ++P L
Sbjct: 202 N-KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 339 SKILGLELLYLFENKLTGV------IPVELTTLKNLTKLDLSINSLTGT-IPLG-FQYLT 390
+ ++++YL N ++ + P T + + + L N + I F+ +
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319
Query: 391 NLIMLQLFDN 400
+QL +
Sbjct: 320 VRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 59/288 (20%), Positives = 117/288 (40%), Gaps = 23/288 (7%)
Query: 295 SLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVE-LSKILGLELLYLFENK 353
L + N++ + L + + N I +I + ++ LE LYL +N+
Sbjct: 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK-ISKISPGAFAPLVKLERLYLSKNQ 111
Query: 354 LTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDNSL-VGGIPQR-L 410
L +P ++ K L +L + N +T + F L +I+++L N L GI
Sbjct: 112 LK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 411 GAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRL 469
+L + ++D ++T IP+ + + L L+L+ NK+T + +L +L L
Sbjct: 168 QGMKKLSYIRIADTNIT-TIPQGLPPS--LTELHLDGNKIT-KVDAASLKGLNNLAKLGL 223
Query: 470 GGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTG----- 524
NS + L +L + L+ N+ +P + + +Q ++L +N +
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSND 282
Query: 525 -ELPREVGNLSNLVTFNVSSNFLT-GRIPLEIFSC-KMLQRLDLSWNK 569
P ++ ++ SN + I F C + + L K
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 25/299 (8%)
Query: 418 VVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTG 476
VV SD L K+P+ + +T+L L+L+ NK+T I G K+L L L N +
Sbjct: 35 VVQCSDLGLE-KVPKDLPPDTAL--LDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISK 90
Query: 477 SFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSN 535
P L L + L +NQ +P ++ LQ L + +N T ++ + V L+
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQ 146
Query: 536 LVTFNVSSNFLT-GRIPLEIFS-CKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENE 593
++ + +N L I F K L + ++ +P+ G L L L N+
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNK 203
Query: 594 LSGSIPVQI-GNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELG 652
++ + L+ L +L + NS S L + L+ L+L+ N L +P L
Sbjct: 204 IT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE-LHLNNNKLV-KVPGGLA 260
Query: 653 NLILLEYLLLNNNHLSG------EIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMS 705
+ ++ + L+NN++S PG +S G + N + TF+ +
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 57/257 (22%), Positives = 92/257 (35%), Gaps = 38/257 (14%)
Query: 439 SLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQF 498
L + L +P + L L N T D L NL T+ L N+
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 499 SGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCK 558
S +S F L L +S N L +P ++ K
Sbjct: 89 S----------------KISPGAFAP--------LVKLERLYLSKNQLK-ELPEKMP--K 121
Query: 559 MLQRLDLSWNKFVGALPREI-GSLFQLELLKLSENEL-SGSIPVQI-GNLSRLTELQMGG 615
LQ L + N+ + + + L Q+ +++L N L S I + +L+ +++
Sbjct: 122 TLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180
Query: 616 NSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSF 675
+ + IP G SL L+L N ++ + L L L L L+ N +S GS
Sbjct: 181 TNITT-IPQ--GLPPSLTE-LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 236
Query: 676 VNLSSLLGCNFSYNNLT 692
N L + + N L
Sbjct: 237 ANTPHLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 50/262 (19%), Positives = 97/262 (37%), Gaps = 26/262 (9%)
Query: 84 NLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRL 138
NL + L +SP LV L L LS NQL +P+++ +L+ L ++ N +
Sbjct: 77 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEI 133
Query: 139 EAHIPKE-LGNLSSLTILNIYNNRI-SGPFPKEI-GKLSALSQLVAYSNNISGSLPPTLG 195
+ K L+ + ++ + N + S + LS + NI+ ++P G
Sbjct: 134 TK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--G 189
Query: 196 NLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILW 254
L N I+ + + G +L LGL+ N +S + +L ++ L
Sbjct: 190 LPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248
Query: 255 GNQLSGVIPKELGNCTSLETLALYDNK------QVGQLPKELGSIGSLKYLYIYRNELNG 308
N+L +P L + ++ + L++N P S + ++ N +
Sbjct: 249 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307
Query: 309 T-IPREI-GKLSSALEIDFSEN 328
I + +
Sbjct: 308 WEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 40/215 (18%), Positives = 80/215 (37%), Gaps = 23/215 (10%)
Query: 84 NLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQL-SRNIPKEI-GNCSSLEVLNLNNN 136
L ++ + + ++ GL + ++L N L S I L + + +
Sbjct: 122 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 137 RLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLG 195
+ IP+ L SLT L++ N+I+ + L+ L++L N+IS ++ +L
Sbjct: 182 NIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLA 237
Query: 196 NLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKE-------IGMLKYL 248
N L+ N + +P + + +Q + L N +S I
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASY 295
Query: 249 TDVILWGNQL--SGVIPKELGNCTSLETLALYDNK 281
+ V L+ N + + P + L + K
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 65/281 (23%), Positives = 112/281 (39%), Gaps = 39/281 (13%)
Query: 816 VIGRGACGTVYRAVLRTGH---TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVK 872
+G G GTV + + TVAVK L + D AE + ++ + IV+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE-LLAEANVMQQLDNPYIVR 82
Query: 873 LYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
+ G C + L+M E G L + L + + + + + G+ YL +
Sbjct: 83 MIGICEAESWMLVM-EMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE---ESN 137
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEYAYT 987
HRD+ + N+LL + A + DFGL+K + ++ A ++G APE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---YYKAQTHGKWPVKWYAPECINY 194
Query: 988 MKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA--RL 1044
K + K D++S+GV++ E + G+ P + + S V+ ML+ R+
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---------------KGSEVTAMLEKGERM 239
Query: 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ + LC +RP V L L
Sbjct: 240 ----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 21/207 (10%)
Query: 816 VIGRGACGTVYRAVLRTGH----TVAVKKLASNREGNNNVDNS-FRAEILTLGKIRHRNI 870
IG G G V++ + + VA+K + ++ F E LT+ + H +I
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
VKL G ++M E G L L +LD + + A + L+YL
Sbjct: 79 VKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 134
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID----MPQSKSMSAIAGSYGYIAPEYAY 986
R HRDI + N+L+ +GDFGL++ ++ SK I ++APE
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESIN 190
Query: 987 TMKVTEKCDIYSYGVVLLELLT-GRAP 1012
+ T D++ +GV + E+L G P
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 68/285 (23%), Positives = 117/285 (41%), Gaps = 46/285 (16%)
Query: 816 VIGRGACGTVYRAVLRTGH-----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
V+G GA GTVY+ + VA+K+L N + E + + + ++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE--ILDEAYVMASVDNPHV 79
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
+L G C L+ + M G L + + + Q + A+G++YL
Sbjct: 80 CRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEYA 985
R+ HRD+ + N+L+ + DFGLAK++ + + + G + A E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----EGGKVPIKWMALESI 191
Query: 986 YTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA-- 1042
T + D++SYGV + EL+T G P + S +S +L+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---------------PASEISSILEKGE 236
Query: 1043 RLNLQDEKTVS-HMITVLKIAML-CTNISPFDRPTMREVVLMLSE 1085
RL T+ +MI M+ C I RP RE+++ S+
Sbjct: 237 RLPQPPICTIDVYMI------MVKCWMIDADSRPKFRELIIEFSK 275
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 67/223 (30%), Positives = 96/223 (43%), Gaps = 36/223 (16%)
Query: 808 TDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTL 862
F ER+ ++G+G+ G V + R T AVK + N + + E+ L
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELL 75
Query: 863 GKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL-----HGASSTLDWQTRFMIALG 917
K+ H NI+KL+ S ++ E G GEL S D
Sbjct: 76 KKLDHPNIMKLFEILEDSSSFYIVGELYT-G--GELFDEIIKRKRFSEHDAARIIKQVFS 132
Query: 918 AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAIA 974
++Y+H K I HRD+K NILL+ K + + DFGL+ Q+ M
Sbjct: 133 G---ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI 184
Query: 975 GSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
G+ YIAPE Y EKCD++S GV+L LL+G P
Sbjct: 185 GTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPP 221
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
D+FD +G+G G VY A + +A+K L ++ V++ R EI +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 868 RNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH 926
NI+++Y + +H + LM E+ RG L + L + ++ + A+ L Y H
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCH 131
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE--- 983
+ ++ HRDIK N+L+ K E + DFG + S + G+ Y+ PE
Sbjct: 132 ---ERKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRTMCGTLDYLPPEMIE 185
Query: 984 -YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ KV D++ GV+ E L G P
Sbjct: 186 GKTHDEKV----DLWCAGVLCYEFLVGMPP 211
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 65/297 (21%), Positives = 105/297 (35%), Gaps = 26/297 (8%)
Query: 333 EIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNL 392
+P E+S LL L N ++ + + L++L L L N ++ F L L
Sbjct: 47 AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 393 IMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLT 451
L + N LV IP S L + + DN + K+P+ + ++ + + N L
Sbjct: 105 QKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 452 -GSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEI-GNC 509
G L LR+ T P DL L+ + LD N+ I E
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IELEDLLRY 216
Query: 510 NALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWN 568
+ L RL L N + L L ++ +N L+ R+P + K+LQ + L N
Sbjct: 217 SKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274
Query: 569 KF------VGALPREIGSLFQLELLKLSENELSGSIPVQIG---NLSRLTELQMGGN 616
+ L N + VQ ++ +Q G
Sbjct: 275 NITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP-YWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 67/300 (22%), Positives = 118/300 (39%), Gaps = 28/300 (9%)
Query: 418 VVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTG 476
VV SD L +P+ I + L+L+ N ++ + + L L L N +
Sbjct: 37 VVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISK 92
Query: 477 SFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSN 535
L L + + +N IP + ++L L + DN ++P+ V L N
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRN 148
Query: 536 LVTFNVSSNFLT-GRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENEL 594
+ + N L F L L +S K +P+ L L L N++
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKI 205
Query: 595 SGSIPVQI-GNLSRLTELQMGGNSFSGGIPAE-LGSLSSLQIALNLSYNNLSGLIPPELG 652
+I ++ S+L L +G N I L L +L+ L+L N LS +P L
Sbjct: 206 Q-AIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRE-LHLDNNKLS-RVPAGLP 261
Query: 653 NLILLEYLLLNNNHLSGEIP-------GSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMS 705
+L LL+ + L+ N+++ ++ G V + G + N + TF+ ++
Sbjct: 262 DLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 71/310 (22%), Positives = 114/310 (36%), Gaps = 25/310 (8%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI 162
HL + S L +PKEI +L+L NN + + L L L + NN+I
Sbjct: 34 HLRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCE 222
S K L L +L N++ +PP L L R N I G
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 223 SLQYLGLAQNQLSGEIPKEIGMLKYLTDVILW--GNQLSGVIPKELGNCTSLETLALYDN 280
++ + + N L E G L L +L+G IPK+L +L L L N
Sbjct: 148 NMNCIEMGGNPLE-NSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHLDHN 203
Query: 281 KQVGQLPKE-LGSIGSLKYLYIYRNELNGTIPREI-GKLSSALEIDFSENSLIGEIPVEL 338
++ + E L L L + N++ I L + E+ N L +P L
Sbjct: 204 -KIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260
Query: 339 SKILGLELLYLFENKLTGVIP------VELTTLKNLTKLDLSINSLT-GTIPLG-FQYLT 390
+ L+++YL N +T V + L N + + F+ +T
Sbjct: 261 PDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320
Query: 391 NLIMLQLFDN 400
+ + +Q +
Sbjct: 321 DRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 48/255 (18%), Positives = 85/255 (33%), Gaps = 35/255 (13%)
Query: 439 SLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQF 498
L + L ++P ++ L L N + EL ++ F
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS----------------ELRKDDF 74
Query: 499 SGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCK 558
L L L +N + + L L +S N L IP + S
Sbjct: 75 K--------GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSS- 124
Query: 559 MLQRLDLSWNKFVGALPREIGSLFQLELLKLSENEL-SGSIPVQIGNLSRLTELQMGGNS 617
L L + N+ L + +++ N L + + +L L++
Sbjct: 125 -LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183
Query: 618 FSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVN 677
+G IP +L +L L+L +N + + +L L L L +N + GS
Sbjct: 184 LTG-IPKDL--PETLNE-LHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239
Query: 678 LSSLLGCNFSYNNLT 692
L +L + N L+
Sbjct: 240 LPTLRELHLDNNKLS 254
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 70/322 (21%), Positives = 117/322 (36%), Gaps = 53/322 (16%)
Query: 816 VIGRGACGTVYRAVLRTGH-----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
V+G G GTV++ V V +K + + +L +G + H +I
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA--VTDHMLAIGSLDHAHI 77
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
V+L G C L+ +Y+ GSL + + L Q + A+G+ YL +
Sbjct: 78 VRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---E 133
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEYA 985
+ HR++ + N+LL + V DFG+A ++ + + S A E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY----SEAKTPIKWMALESI 189
Query: 986 YTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA-- 1042
+ K T + D++SYGV + EL+T G P L + V +L+
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL---------------RLAEVPDLLEKGE 234
Query: 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE-----------SNRRQG 1091
RL + I V + + C I RPT +E+ +
Sbjct: 235 RL----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGP 290
Query: 1092 HFEFSPMDHDSDQKLENEFQST 1113
P H K E +
Sbjct: 291 GIAPGPEPHGLTNKKLEEVELE 312
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 59/291 (20%), Positives = 109/291 (37%), Gaps = 46/291 (15%)
Query: 816 VIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
++G+G G+V A L+ + VAVK L ++ +++++ F E + + H ++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-FLREAACMKEFDHPHVA 88
Query: 872 KLYGFCYHQGSNLLMY------EYMARGSLGELL-----HGASSTLDWQTRFMIALGAAE 920
KL G + + +M G L L L QT + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-----MPQSKSMSAIAG 975
G+ YL HRD+ + N +L + V DFGL++ I S +
Sbjct: 149 GMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK- 204
Query: 976 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNS 1034
++A E T D++++GV + E++T G+ P ++ + N++
Sbjct: 205 ---WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-----NAEIYNYLIGG- 255
Query: 1035 LVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
L +E V + C + P RP+ + + L
Sbjct: 256 ---NRLKQPPECMEE--------VYDLMYQCWSADPKQRPSFTCLRMELEN 295
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 70/301 (23%), Positives = 111/301 (36%), Gaps = 67/301 (22%)
Query: 816 VIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKIRHRNI 870
++G G G+V L+ T VAVK + + ++ + F +E + H N+
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTM--KLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 871 VKLYGFCYHQGSNLLMY-----EYMARGSLGELL-----HGASSTLDWQTRFMIALGAAE 920
++L G C S + +M G L L + QT + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGY- 979
G+ YL HRD+ + N +L D V DFGL+K I +G Y Y
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY----------SGDY-YR 204
Query: 980 -----------IAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAP---VQPLDQGGDLVT 1024
IA E T K D++++GV + E+ T G P VQ +
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------- 257
Query: 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084
+ +++ + L + DE + +I C P DRPT + L L
Sbjct: 258 -MYDYLLHG----HRLKQPEDCLDE--------LYEIMYSCWRTDPLDRPTFSVLRLQLE 304
Query: 1085 E 1085
+
Sbjct: 305 K 305
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 52/227 (22%), Positives = 95/227 (41%), Gaps = 34/227 (14%)
Query: 804 LVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEI-LT 861
+ V D+ + +GRGA G V + +G +AVK++ N+ ++ ++
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDIS 59
Query: 862 LGKIRHRNIVKLYGFCYHQGSNL--LMYEYMARGSLGELLHGASSTLDWQTRF------M 913
+ + V YG + ++ M E M SL + +D
Sbjct: 60 MRTVDCPFTVTFYG-ALFREGDVWICM-ELMD-TSLDKFYK---QVIDKGQTIPEDILGK 113
Query: 914 IALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI 973
IA+ + L +LH + HRD+K +N+L++ + + DFG++ + +
Sbjct: 114 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDID 169
Query: 974 AGSYGYIAPE--------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
AG Y+APE Y++ K DI+S G+ ++EL R P
Sbjct: 170 AGCKPYMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 53/225 (23%), Positives = 99/225 (44%), Gaps = 18/225 (8%)
Query: 802 KDLVVATDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEIL 860
+ ++ + +G G CG V++ +TGH +AVK++ R GN + ++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLD 75
Query: 861 TLGK-IRHRNIVKLYGFCYHQGSNL--LMYEYMARGSLGELLHGASSTLDWQTRFMIALG 917
+ K IV+ +G + +++ M E M +L + + + +
Sbjct: 76 VVLKSHDCPYIVQCFG-TFITNTDVFIAM-ELMG-TCAEKLKKRMQGPIPERILGKMTVA 132
Query: 918 AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY 977
+ L YL + HRD+K +NILLD++ + + DFG++ + K+ AG
Sbjct: 133 IVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDRSAGCA 188
Query: 978 GYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLD 1017
Y+APE + D++S G+ L+EL TG+ P +
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-29
Identities = 62/265 (23%), Positives = 115/265 (43%), Gaps = 44/265 (16%)
Query: 770 RQPVEVVAPLQDKQLSSTVSDIYFPPKEGFTFKDLVVATDNFDERF------VIGRGACG 823
+ P++ K+ S+ DI PP F + + + + ++G G G
Sbjct: 45 NADLTERMPVKSKRTSALAVDIPAPPAP-FDHRIVTAKQGAVNSFYTVSKTEILGGGRFG 103
Query: 824 TVYRAVLR-TGHTVAVK----KLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCY 878
V++ TG +A K + ++E + EI + ++ H N+++LY +
Sbjct: 104 QVHKCEETATGLKLAAKIIKTRGMKDKE-------EVKNEISVMNQLDHANLIQLYDA-F 155
Query: 879 HQGSNL-LMYEYMARGSLGELL-----HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
+++ L+ EY+ G GEL + T FM + EG+ ++H +
Sbjct: 156 ESKNDIVLVMEYVD-G--GELFDRIIDESYNLTELDTILFMKQI--CEGIRHMH---QMY 207
Query: 933 IFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYGYIAPE---YAYT 987
I H D+K NIL ++ + DFGLA+ + + G+ ++APE Y +
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK--PREKLKVNFGTPEFLAPEVVNYDF- 264
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAP 1012
V+ D++S GV+ LL+G +P
Sbjct: 265 --VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 68/296 (22%), Positives = 118/296 (39%), Gaps = 57/296 (19%)
Query: 816 VIGRGACGTVYRAVLR------TGHTVAVKKL---ASNREGNNNVDNSFRAEILTLGKIR 866
+G+G+ G VY V + VA+K + AS RE F E + +
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-----FLNEASVMKEFN 86
Query: 867 HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL---------HGASSTLDWQTRFMIALG 917
++V+L G L++ E M RG L L + + +A
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 918 AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-----MPQSKSMSA 972
A+G++YL+ + HRD+ + N ++ + F +GDFG+ + I K +
Sbjct: 147 IADGMAYLN--ANKFV-HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQ--PLDQGGDLVTWVRNF 1029
+ +++PE T D++S+GVVL E+ T P Q +Q V F
Sbjct: 204 VR----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRF 252
Query: 1030 IRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ G+LD N D + ++ +C +P RP+ E++ + E
Sbjct: 253 VMEG----GLLDKPDNCPDM--------LFELMRMCWQYNPKMRPSFLEIISSIKE 296
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 48/237 (20%), Positives = 88/237 (37%), Gaps = 48/237 (20%)
Query: 810 NFDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGK 864
+ F IG G G+V++ V G A+K+ G+ + N+ R E+
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAV 66
Query: 865 I-RHRNIVKLYGFCYHQGSNLLMY-EYMARGSLGELL---HGASSTLDWQTRFMIALGAA 919
+ +H ++V+ + + + ++L+ EY GSL + + + S + L
Sbjct: 67 LGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 920 EGLSYLHHDCKPRIFHRDIKSNNILLD-------------------DKFEAHVGDFGLAK 960
GL Y+H + H DIK +NI + +K +GD G
Sbjct: 126 RGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 961 VIDMPQSKSMSAIAGSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
I PQ + G ++A E Y + K DI++ + ++
Sbjct: 183 RISSPQVE-----EGDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAEPL 230
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-28
Identities = 68/284 (23%), Positives = 110/284 (38%), Gaps = 46/284 (16%)
Query: 816 VIGRGACGTVYRAVLRTGH----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
IG G G V++ + + VA+K + + F E LT+ + H +IV
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHIV 454
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
KL G ++M E G L L +LD + + A + L+YL
Sbjct: 455 KLIGVITENPVWIIM-ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SK 510
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI-----APEYAY 986
R HRDI + N+L+ +GDFGL++ ++ + S G + APE
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-----DSTYYKASKGKLPIKWMAPESIN 565
Query: 987 TMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA--R 1043
+ T D++ +GV + E+L G P Q + N+ V G ++ R
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGV---------------KNNDVIGRIENGER 610
Query: 1044 LNLQDEKTVS-HMITVLKIAML-CTNISPFDRPTMREVVLMLSE 1085
L + + + + M C P RP E+ LS
Sbjct: 611 LPMPPNCPPTLYSL------MTKCWAYDPSRRPRFTELKAQLST 648
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-28
Identities = 54/255 (21%), Positives = 102/255 (40%), Gaps = 27/255 (10%)
Query: 771 QPVEVVAPLQDKQLSSTVSDIYFPPKEGFTFKDLVVATDNFDERF----VIGRGACGTVY 826
V D + Y + + + + V + + + +G GA G V+
Sbjct: 9 HHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVH 68
Query: 827 RAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL- 884
R V + TG K + + + + + EI + ++ H ++ L+ + +
Sbjct: 69 RCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDA-FEDKYEMV 124
Query: 885 LMYEYMARGSLGELL-----HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIK 939
L+ E+++ G GEL + +M EGL ++H + I H DIK
Sbjct: 125 LILEFLS-G--GELFDRIAAEDYKMSEAEVINYMRQA--CEGLKHMH---EHSIVHLDIK 176
Query: 940 SNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIY 997
NI+ + K + V DFGLA ++ + + + + APE V D++
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 998 SYGVVLLELLTGRAP 1012
+ GV+ LL+G +P
Sbjct: 235 AIGVLGYVLLSGLSP 249
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-28
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 35/221 (15%)
Query: 816 VIGRGACGTVYRAVLRTG---HTVAVKKLASNREGNNNVD-NSFRAEILTLGKI-RHRNI 870
VIG G G V +A ++ A+K++ +E + D F E+ L K+ H NI
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELL---------------HGASSTLDWQTRFMIA 915
+ L G C H+G L EY G+L + L + +STL Q A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 916 LGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAG 975
A G+ YL + + HRD+ + NIL+ + + A + DFGL++ ++ K+M +
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP- 204
Query: 976 SYGYI---APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
+ A E T D++SYGV+L E+++ G P
Sbjct: 205 ----VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 43/227 (18%)
Query: 808 TDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTL 862
+ F + + +G+GA V R V + TG A K + + + + E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARIC 59
Query: 863 GKIRHRNIVKLYGFCYHQGSNLLMYEYM----------ARGSLGELLHGASSTLDWQTRF 912
K++H NIV+L+ + + L+++ + AR E AS
Sbjct: 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--ADAS-------HC 110
Query: 913 MIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE-AHV--GDFGLAKVIDMPQSKS 969
+ + E ++Y H I HR++K N+LL K + A V DFGLA ++ S++
Sbjct: 111 IQQI--LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEA 163
Query: 970 MSAIAGSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
AG+ GY++PE Y ++ DI++ GV+L LL G P
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGVILYILLVGYPP 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 65/234 (27%), Positives = 100/234 (42%), Gaps = 45/234 (19%)
Query: 807 ATDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVK-----KLASNREGNNNVDNSFR 856
A F +++ VIGRG V R V R TGH AVK + E V + R
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 857 AEILTLGKIR-HRNIVKLYGFCYHQGSNL-LMYEYM----------ARGSLGELLHGASS 904
E L ++ H +I+ L Y S + L+++ M + +L E
Sbjct: 148 RETHILRQVAGHPHIITLIDS-YESSSFMFLVFDLMRKGELFDYLTEKVALSE--KETR- 203
Query: 905 TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964
M +L E +S+LH I HRD+K NILLDD + + DFG + ++
Sbjct: 204 ------SIMRSL--LEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE- 251
Query: 965 PQSKSMSAIAGSYGYIAPE------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ + + G+ GY+APE ++ D+++ GV+L LL G P
Sbjct: 252 -PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-28
Identities = 67/251 (26%), Positives = 104/251 (41%), Gaps = 32/251 (12%)
Query: 779 LQDKQLSSTVSDIYFPPKEGFTFKDLVVA--TDNFDERF----VIGRGACGTVYRAVLR- 831
+ S+ + + + + + + E + +G GA G V +
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 832 TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL-LMYEYM 890
T A+K + ++ E+ L + H NI+KLY F + N L+ E
Sbjct: 61 THVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDF-FEDKRNYYLVMECY 118
Query: 891 ARGSLGELLHGASSTLDWQTRF------MIALGAAEGLSYLHHDCKPRIFHRDIKSNNIL 944
G GEL + + +F +I G++YLH I HRD+K N+L
Sbjct: 119 K-G--GELFD----EIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLL 168
Query: 945 LDDKFEAH---VGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGV 1001
L+ K + + DFGL+ V + K M G+ YIAPE K EKCD++S GV
Sbjct: 169 LESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGV 225
Query: 1002 VLLELLTGRAP 1012
+L LL G P
Sbjct: 226 ILFILLAGYPP 236
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 62/227 (27%), Positives = 90/227 (39%), Gaps = 41/227 (18%)
Query: 808 TDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTL 862
D+ F +G GA G V+ R +G +K + +R AEI L
Sbjct: 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVL 74
Query: 863 GKIRHRNIVKLYGF-----CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRF----- 912
+ H NI+K++ + ++M E G GELL S
Sbjct: 75 KSLDHPNIIKIFEVFEDYHNMY----IVM-ETCE-G--GELLERIVSAQARGKALSEGYV 126
Query: 913 -MIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSK 968
+ L+Y H + H+D+K NIL D + DFGLA++ +
Sbjct: 127 AELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDE 181
Query: 969 SMSAIAGSYGYIAPE---YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ AG+ Y+APE T KCDI+S GVV+ LLTG P
Sbjct: 182 HSTNAAGTALYMAPEVFKRDV----TFKCDIWSAGVVMYFLLTGCLP 224
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 75/292 (25%), Positives = 105/292 (35%), Gaps = 53/292 (18%)
Query: 816 VIGRGACGTVYRAVLRTGH------TVAVKKLASNREGNNNVD-NSFRAEILTLGKIRHR 868
+G GA G VY + VAVK L E + D F E L + K H+
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALIISKFNHQ 93
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELL------HGASSTLDWQTRFMIALGAAEGL 922
NIV+ G ++ E MA G L L S+L +A A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 923 SYL--HHDCKPRIFHRDIKSNNILLDDKFEAHV---GDFGLAKVIDM-----PQSKSMSA 972
YL +H HRDI + N LL V GDFG+A+ I +M
Sbjct: 154 QYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208
Query: 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIR 1031
+ ++ PE T K D +S+GV+L E+ + G P V F+
Sbjct: 209 VK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----NQEVLEFVT 259
Query: 1032 NNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
+ G +D N V +I C P DRP ++ +
Sbjct: 260 SG----GRMDPPKNCPGP--------VYRIMTQCWQHQPEDRPNFAIILERI 299
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-28
Identities = 79/287 (27%), Positives = 119/287 (41%), Gaps = 43/287 (14%)
Query: 808 TDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTL 862
T F +R+ V+G+G+ G V + TG AVK ++ + S E+ L
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 863 GKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL-----HGASSTLDWQTRFMIALG 917
++ H NI+KLY F +G L+ E G GEL S +D L
Sbjct: 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYT-G--GELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 918 AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAIA 974
++Y+H + +I HRD+K N+LL+ K + + DFGL+ + SK M
Sbjct: 138 G---ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKI 189
Query: 975 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS 1034
G+ YIAPE EKCD++S GV+L LL+G P N
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF-----------NGAN---EYD 234
Query: 1035 LVSGMLDARLNLQDE--KTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
++ + + + K VS L ML P R + R+
Sbjct: 235 ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV--PSMRISARDA 279
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 27/223 (12%)
Query: 808 TDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVK----KLASNREGNNNVDNSFRAE 858
F++ + VIG+G V R + R TG AVK ++ G + D + E
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED--LKRE 76
Query: 859 ILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGA 918
++H +IV+L G +++E+M +L D + A+ +
Sbjct: 77 ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGA---DLCFEIVKRADAGFVYSEAVAS 133
Query: 919 A------EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKS 969
E L Y H + I HRD+K + +LL K + +G FG+A +
Sbjct: 134 HYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LV 189
Query: 970 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
G+ ++APE + D++ GV+L LL+G P
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-28
Identities = 66/231 (28%), Positives = 98/231 (42%), Gaps = 52/231 (22%)
Query: 808 TDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTL 862
F ER+ ++G+G+ G V + R T AVK + N + + E+ L
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELL 75
Query: 863 GKIRHRNIVKLYGF-----CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALG 917
K+ H NI+KL+ ++ ++ E G GEL +I
Sbjct: 76 KKLDHPNIMKLFEILEDSSSFY----IVG-ELYT-G--GELFD----------E-IIKRK 116
Query: 918 ------AA-------EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKV 961
AA G++Y+H I HRD+K NILL+ K + + DFGL+
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Q+ M G+ YIAPE EKCD++S GV+L LL+G P
Sbjct: 174 FQ--QNTKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 807 ATDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVK------KLASNREGNNNVDNSF 855
+T F E + ++GRG V R + + T AVK + + E + +
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 856 RAEILTLGKI-RHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELL-----HGASSTLDW 908
E+ L K+ H NI++L Y + L+++ M +G EL S +
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDT-YETNTFFFLVFDLMKKG---ELFDYLTEKVTLSEKE- 125
Query: 909 QTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968
+ M AL E + LH K I HRD+K NILLDD + DFG + +D +
Sbjct: 126 TRKIMRAL--LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGE 178
Query: 969 SMSAIAGSYGYIAPE------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ + G+ Y+APE ++ D++S GV++ LL G P
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 71/296 (23%), Positives = 111/296 (37%), Gaps = 58/296 (19%)
Query: 817 IGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
+G GA G V+ A VAVK L ++ F+ E L ++H +I
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQHEHI 79
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGELL---------------HGASSTLDWQTRFMIA 915
VK YG C ++++EYM G L + L A L IA
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 916 LGAAEGLSYL--HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI 973
A G+ YL H HRD+ + N L+ +GDFG+++ + +
Sbjct: 140 SQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVY----STDYYR 190
Query: 974 AGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVR 1027
G + + PE K T + D++S+GV+L E+ T G+ P L T V
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-----NTEVI 245
Query: 1028 NFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
I +L+ E V + + C P R ++E+ +L
Sbjct: 246 ECITQG----RVLERPRVCPKE--------VYDVMLGCWQREPQQRLNIKEIYKIL 289
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 66/227 (29%), Positives = 97/227 (42%), Gaps = 46/227 (20%)
Query: 808 TDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTL 862
T N + F V+G GA V+ R TG A+K + + D+S EI L
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVL 60
Query: 863 GKIRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALG---- 917
KI+H NIV L Y ++ L+ + ++ G GEL D ++ G
Sbjct: 61 KKIKHENIVTLEDI-YESTTHYYLVMQLVS-G--GELF-------DR----ILERGVYTE 105
Query: 918 --AA-------EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMP 965
A+ + YLH + I HRD+K N+L E + DFGL+K+
Sbjct: 106 KDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-- 160
Query: 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ MS G+ GY+APE ++ D +S GV+ LL G P
Sbjct: 161 -NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 73/296 (24%), Positives = 113/296 (38%), Gaps = 57/296 (19%)
Query: 816 VIGRGACGTVYRAVLRTG------HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN 869
+G GA G V+ A VAVK L +E + + F+ E L ++H++
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTMLQHQH 104
Query: 870 IVKLYGFCYHQGSNLLMYEYMARGSLGELL--------------HGASSTLDWQTRFMIA 915
IV+ +G C L+++EYM G L L A L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 916 LGAAEGLSYL--HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM-----PQSK 968
A G+ YL H HRD+ + N L+ +GDFG+++ I +
Sbjct: 165 SQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 219
Query: 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVR 1027
+M I ++ PE K T + D++S+GVVL E+ T G+ P L T
Sbjct: 220 TMLPIR----WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-----NTEAI 270
Query: 1028 NFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
+ I L+ E V I C P R ++++V L
Sbjct: 271 DCITQG----RELERPRACPPE--------VYAIMRGCWQREPQQRHSIKDVHARL 314
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 42/221 (19%), Positives = 82/221 (37%), Gaps = 31/221 (14%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKL--------------ASNREGNNNVDNSFRAEILT 861
+ +G + + A+KK +++ + + F+ E+
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 862 LGKIRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE 920
+ I++ + G + ++YEYM S+ + T F+
Sbjct: 97 ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 921 -------GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI 973
SY+H+ + I HRD+K +NIL+D + DFG ++ + K +
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKGS 210
Query: 974 AGSYGYIAPEYAYTMKVT--EKCDIYSYGVVLLELLTGRAP 1012
G+Y ++ PE+ K DI+S G+ L + P
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 58/258 (22%), Positives = 89/258 (34%), Gaps = 56/258 (21%)
Query: 808 TDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDN--SFRAEIL 860
+++ IG+G+ G V A+ T A+K + N+ N + + E+
Sbjct: 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 861 TLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSL-------GELLHGASSTLDWQTRFM 913
+ K+ H NI +LY + L+ E G L + G + +T+
Sbjct: 81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 914 IALGAA--------------------------------EGLSYLHHDCKPRIFHRDIKSN 941
L YLH I HRDIK
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPE 197
Query: 942 NILLDDKFEAHV--GDFGLAKVI---DMPQSKSMSAIAGSYGYIAPE--YAYTMKVTEKC 994
N L + DFGL+K + + M+ AG+ ++APE KC
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 995 DIYSYGVVLLELLTGRAP 1012
D +S GV+L LL G P
Sbjct: 258 DAWSAGVLLHLLLMGAVP 275
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 65/260 (25%), Positives = 99/260 (38%), Gaps = 40/260 (15%)
Query: 779 LQDKQLSSTVSDIYFPPKEGFTFKDLVV--ATDNFDERF----VIGRGACGTVYRAVLR- 831
+ S+ + + + V E + +G GA G V +
Sbjct: 1 MHHHHHHSSGRENLYFQGIAIN-PGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKN 59
Query: 832 TGHTVAVK-----KLASNREGNNNVDNS-----FRAEILTLGKIRHRNIVKLYGFCYHQG 881
A+K + R ++N + EI L + H NI+KL+ +
Sbjct: 60 GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119
Query: 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRF------MIALGAAEGLSYLHHDCKPRIFH 935
L+ E+ G GEL + + +F I G+ YLH I H
Sbjct: 120 YFYLVTEFYE-G--GELF----EQIINRHKFDECDAANIMKQILSGICYLHKH---NIVH 169
Query: 936 RDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTE 992
RDIK NILL++K + DFGL+ + + G+ YIAPE K E
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFS--KDYKLRDRLGTAYYIAPE-VLKKKYNE 226
Query: 993 KCDIYSYGVVLLELLTGRAP 1012
KCD++S GV++ LL G P
Sbjct: 227 KCDVWSCGVIMYILLCGYPP 246
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-27
Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 35/248 (14%)
Query: 782 KQLSSTVSDIYFPPKEGFTFKDLVVATDNFDERF----VIGRGACGTVYRAVLR-TGHTV 836
+SS + F + + + + + D+ + + +G GA G V+R R TG+
Sbjct: 126 GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNF 185
Query: 837 AVK----KLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMAR 892
A K S++E + R EI T+ +RH +V L+ +++YE+M+
Sbjct: 186 AAKFVMTPHESDKE-------TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS- 237
Query: 893 GSLGELL------HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD 946
G GEL H S + +M + +GL ++H + H D+K NI+
Sbjct: 238 G--GELFEKVADEHNKMSEDE-AVEYMRQV--CKGLCHMH---ENNYVHLDLKPENIMFT 289
Query: 947 DKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLL 1004
K + DFGL +D +S+ G+ + APE A V D++S GV+
Sbjct: 290 TKRSNELKLIDFGLTAHLD--PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSY 347
Query: 1005 ELLTGRAP 1012
LL+G +P
Sbjct: 348 ILLSGLSP 355
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 83/340 (24%), Positives = 123/340 (36%), Gaps = 54/340 (15%)
Query: 769 LRQPVEVVAPLQDKQLSSTVSDIYFPPKEGFTFKDL-VVATDNFDERFVIGRGACGTVYR 827
L+ P ++ L+ + + + Y + + DL V N +G GA G VY
Sbjct: 30 LQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYE 89
Query: 828 AVLR------TGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKIRHRNIVKLYGFCYHQ 880
+ + VAVK L E + D F E L + K H+NIV+ G
Sbjct: 90 GQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146
Query: 881 GSNLLMYEYMARGSLGELL------HGASSTLDWQTRFMIALGAAEGLSYL--HHDCKPR 932
++ E MA G L L S+L +A A G YL +H
Sbjct: 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH----- 201
Query: 933 IFHRDIKSNNILLDDKFEAHV---GDFGLAKVIDM-----PQSKSMSAIAGSYGYIAPEY 984
HRDI + N LL V GDFG+A+ I +M + ++ PE
Sbjct: 202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK----WMPPEA 257
Query: 985 AYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043
T K D +S+GV+L E+ + G P V F+ + G +D
Sbjct: 258 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----NQEVLEFVTSG----GRMDPP 308
Query: 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
N V +I C P DRP ++ +
Sbjct: 309 KNCPGP--------VYRIMTQCWQHQPEDRPNFAIILERI 340
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 67/299 (22%), Positives = 117/299 (39%), Gaps = 58/299 (19%)
Query: 816 VIGRGACGTVYRAVLR--------TGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKI- 865
+G G G V A TVAVK L ++ D + +E+ + I
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIG 144
Query: 866 RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL---------------HGASSTLDWQT 910
+H+NI+ L G C G ++ EY ++G+L E L + ++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 911 RFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 970
A G+ YL + HRD+ + N+L+ + + DFGLA+ I+
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN----NID 257
Query: 971 SAIAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVT 1024
+ G + APE + T + D++S+GV++ E+ T G +P G V
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-----GIPVE 312
Query: 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
+ ++ +D N +E + + C + P RPT +++V L
Sbjct: 313 ELFKLLKEG----HRMDKPANCTNE--------LYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 41/276 (14%), Positives = 82/276 (29%), Gaps = 32/276 (11%)
Query: 802 KDLVVATDNFDERFVIGRGACGTVYRAV------LRTGHTVAVKKLASNREGNNNVDNSF 855
+ + + ++G GA VY A + +K + N
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIG 114
Query: 856 RAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL----HGASSTLDWQTR 911
+ L +K Y Q ++L+ E + G+L + + +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 912 FMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG-----------DFGLAK 960
A+ + +H I H DIK +N +L + F D G +
Sbjct: 175 ISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 961 VIDM-PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
+ + P+ +A + G+ E + D + + +L G +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM--KVKNE 289
Query: 1020 GDLVTWVRNFIR--NNSLVSGMLDARLNLQDEKTVS 1053
G F R + + + LN+ D +
Sbjct: 290 GGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLP 325
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 810 NFDERF----VIGRGACGTVYRAVLR-TGHTVAVK-----KLASNREGNNNVDNSFRAEI 859
++ + +G G V + + TG A K +L+S+R G + + E+
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE--IEREV 59
Query: 860 LTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLH-----GASSTLDWQTRFMI 914
L +IRH NI+ L+ ++ +L+ E ++ G GEL + + + T+F+
Sbjct: 60 NILREIRHPNIITLHDIFENKTDVVLILELVS-G--GELFDFLAEKESLTEDE-ATQFLK 115
Query: 915 ALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMPQSKSM 970
+ +G+ YLH RI H D+K NI+L DK + + DFG+A I+
Sbjct: 116 QI--LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--AGNEF 168
Query: 971 SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
I G+ ++APE + + D++S GV+ LL+G +P
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 68/299 (22%), Positives = 111/299 (37%), Gaps = 57/299 (19%)
Query: 816 VIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKI-RH 867
+G GA G V A TVAVK L + + + + +E+ L + H
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSAHLTEREALMSELKVLSYLGNH 86
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELL-----------------HGASSTLDWQT 910
NIV L G C G L++ EY G L L LD +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 911 RFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 970
+ A+G+++L HRD+ + NILL + DFGLA+ I
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIK----NDS 199
Query: 971 SAIAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVT 1024
+ + + APE + T + D++SYG+ L EL + G +P +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
++ R + + + E + I C + P RPT +++V ++
Sbjct: 260 MIKEGFR--------MLSPEHAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 30/226 (13%)
Query: 805 VVATDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVK----KLASNREGNNNVDNSF 855
V +N D+ + +G G V + + TG A K + + + ++
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-I 61
Query: 856 RAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL-----HGASSTLDWQT 910
E+ L +I+H N++ L+ ++ +L+ E +A G GEL + + + T
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVA-G--GELFDFLAEKESLTEEE-AT 117
Query: 911 RFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMPQ 966
F+ + G+ YLH +I H D+K NI+L D+ + DFGLA ID
Sbjct: 118 EFLKQI--LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--F 170
Query: 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
I G+ ++APE + + D++S GV+ LL+G +P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 807 ATDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILT 861
A+ F + + +G+GA V R V + TG A K + + + + E
Sbjct: 23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARI 81
Query: 862 LGKIRHRNIVKLYGFCYHQGSNLLMYEYM----------ARGSLGELLHGASSTLDWQTR 911
K++H NIV+L+ + + L+++ + AR E AS
Sbjct: 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--ADAS-------H 132
Query: 912 FMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSK 968
+ + E ++Y H I HR++K N+LL K + + DFGLA ++ S+
Sbjct: 133 CIQQI--LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSE 185
Query: 969 SMSAIAGSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ AG+ GY++PE Y ++ DI++ GV+L LL G P
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGVILYILLVGYPP 229
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 67/301 (22%), Positives = 118/301 (39%), Gaps = 58/301 (19%)
Query: 816 VIGRGACGTVYRAVLR--------TGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKI- 865
+G GA G V A TVAVK L ++ D + +E+ + I
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIG 98
Query: 866 RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL---------------HGASSTLDWQT 910
+H+NI+ L G C G ++ EY ++G+L E L + ++
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 911 RFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 970
A G+ YL + HRD+ + N+L+ + + DFGLA+ I+
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN----NID 211
Query: 971 SAIAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVT 1024
+ G + APE + T + D++S+GV++ E+ T G +P + V
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----VE 266
Query: 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084
+ ++ +D N +E + + C + P RPT +++V L
Sbjct: 267 ELFKLLKEG----HRMDKPANCTNE--------LYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 1085 E 1085
Sbjct: 315 R 315
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 40/224 (17%)
Query: 808 TDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTL 862
+ ++ + IGRG+ G V AV + T A KK+ + + F+ EI +
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIM 60
Query: 863 GKIRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELL-----HGASSTLDWQTRFMIAL 916
+ H NI++LY + +++ L+ E G GEL D L
Sbjct: 61 KSLDHPNIIRLYET-FEDNTDIYLVMELCT-G--GELFERVVHKRVFRESDAARIMKDVL 116
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAI 973
A ++Y H K + HRD+K N L + DFGLA K M
Sbjct: 117 SA---VAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTK 168
Query: 974 AGSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
G+ Y++P+ Y +CD +S GV++ LL G P
Sbjct: 169 VGTPYYVSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPP 206
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 72/302 (23%), Positives = 114/302 (37%), Gaps = 60/302 (19%)
Query: 816 VIGRGACGTVYRAVLR------TGHTVAVKKL---ASNREGNNNVDNSFRAEILTLGKI- 865
+GRGA G V A T TVAVK L A++ E +E+ L I
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-----LMSELKILIHIG 88
Query: 866 RHRNIVKLYGFCYHQGSNLLM-YEYMARGSLGELL---------------HGASSTLDWQ 909
H N+V L G C G L++ E+ G+L L L +
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 910 TRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969
+ A+G+ +L + HRD+ + NILL +K + DFGLA+ I K
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY----KD 201
Query: 970 MSAIAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLV 1023
+ + APE + T + D++S+GV+L E+ + G +P + +
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
Query: 1024 TWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
++ + A E + + + C + P RPT E+V L
Sbjct: 262 RRLKE--------GTRMRAPDYTTPE--------MYQTMLDCWHGEPSQRPTFSELVEHL 305
Query: 1084 SE 1085
Sbjct: 306 GN 307
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 66/298 (22%), Positives = 105/298 (35%), Gaps = 59/298 (19%)
Query: 816 VIGRGACGTVYRAVLRTGH------TVAVKKLASNREGNNNVD-NSFRAEILTLGKIRHR 868
+G G VY+ L VA+K L ++ FR E + +++H
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKAEGPLREEFRHEAMLRARLQHP 72
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELL---------------HGASSTLDWQTRFM 913
N+V L G +++ Y + G L E L S L+
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 914 IALGAAEGLSYL--HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 971
+ A G+ YL HH + H+D+ + N+L+ DK + D GL + + +
Sbjct: 133 LVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVY----AADY 183
Query: 972 AIAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTW 1025
+ APE K + DI+SYGVVL E+ + G P
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQD 238
Query: 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
V IRN +L + V + + C N P RP +++ L
Sbjct: 239 VVEMIRNR----QVLPCPDDCPAW--------VYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 73/334 (21%), Positives = 127/334 (38%), Gaps = 62/334 (18%)
Query: 816 VIGRGACGTVYRAVLR--------TGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKI- 865
+G GA G V A VAVK L + D + +E+ + I
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDATEKDLSDLISEMEMMKMIG 132
Query: 866 RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL---------------HGASSTLDWQT 910
+H+NI+ L G C G ++ EY ++G+L E L H L +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 911 RFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 970
A A G+ YL + HRD+ + N+L+ + + DFGLA+ I
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHID 245
Query: 971 SAIAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVT 1024
+ G + APE + T + D++S+GV+L E+ T G +P + V
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----VE 300
Query: 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL--- 1081
+ ++ +D N +E + + C + P RPT +++V
Sbjct: 301 ELFKLLKEG----HRMDKPSNCTNE--------LYMMMRDCWHAVPSQRPTFKQLVEDLD 348
Query: 1082 -MLSESNRRQGHFEFSPMDHDSDQKLENEFQSTG 1114
+++ ++ ++ + HD D G
Sbjct: 349 RIVALTSNQEMGYYHHHHHHDYDIPTTENLYFNG 382
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 40/228 (17%)
Query: 808 TDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVK----KLASNREGNNNVDNSFRAE 858
++ + +G G V + + TG A K + + + E
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE-IERE 65
Query: 859 ILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYM----------ARGSLGELLHGASSTLDW 908
+ L ++ H NI+ L+ ++ +L+ E + + SL E A+
Sbjct: 66 VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--EEAT----- 118
Query: 909 QTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDM 964
F+ + +G++YLH +I H D+K NI+L DK + DFGLA I+
Sbjct: 119 --SFIKQI--LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
I G+ ++APE + + D++S GV+ LL+G +P
Sbjct: 171 -DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 68/295 (23%), Positives = 112/295 (37%), Gaps = 53/295 (17%)
Query: 816 VIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNS-FRAEILTLGKI-RH 867
+G GA G V A VAVK L + + + +E+ + + +H
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSHLGQH 109
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELL-------------HGASSTLDWQTRFMI 914
NIV L G C H G L++ EY G L L A+ST +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 915 ALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA 974
+ A+G+++L HRD+ + N+LL + A +GDFGLA+ I + I
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM----NDSNYIV 222
Query: 975 GSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRN 1028
+ APE + T + D++SYG++L E+ + G P + V++
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
+ + + I C + P RPT +++ L
Sbjct: 283 GYQ--------MAQPAFAPKN--------IYSIMQACWALEPTHRPTFQQICSFL 321
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 42/229 (18%)
Query: 806 VATDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEIL 860
+ F E + +G+GA V R V G A + + + + E
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-KLEREAR 62
Query: 861 TLGKIRHRNIVKLYGFCYHQGSNLLMYEYM----------ARGSLGELLHGASSTLDWQT 910
++H NIV+L+ +G + L+++ + AR E AS +
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE--ADASHCI---- 116
Query: 911 RFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQS 967
+ ++ E + + H + + HR++K N+LL K + + DFGLA ++ Q
Sbjct: 117 QQIL-----EAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ- 167
Query: 968 KSMSAIAGSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
++ AG+ GY++PE Y + D+++ GV+L LL G P
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPY----GKPVDLWACGVILYILLVGYPP 212
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 30/235 (12%)
Query: 794 PPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKK--LASNREGNNNV 851
+E F+ L+ + + + +G G G VY+A G VA+K+ L + EG +
Sbjct: 9 SGRENLYFQGLM---EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS- 64
Query: 852 DNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQT- 910
+ R EI L ++ H NIV L + + L++E+M + L ++L + L
Sbjct: 65 -TAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQI 121
Query: 911 -RFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969
++ L G+++ H RI HRD+K N+L++ + DFGLA+ +P +S
Sbjct: 122 KIYLYQL--LRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRS 175
Query: 970 MSAIAGSYGYIAPEY-----AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
+ + Y AP+ Y+ V DI+S G + E++TG+ PL G
Sbjct: 176 YTHEVVTLWYRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGK----PLFPG 222
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 68/309 (22%), Positives = 112/309 (36%), Gaps = 59/309 (19%)
Query: 802 KDLVVATDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEIL 860
+ + + R V+ G VY A + +G A+K+L SN + + E+
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVC 77
Query: 861 TLGKIR-HRNIVKLYGFCYHQGSN-------LLMYEYMARGSLGELLHGASSTLDWQTRF 912
+ K+ H NIV+ L+ + +G L E L S +
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES----RGPL 133
Query: 913 ------MIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966
I + ++H KP I HRD+K N+LL ++ + DFG A I
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 967 SKSMSAIA-----------GSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRA 1011
S SA + Y PE Y+ + EK DI++ G +L L +
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQH 251
Query: 1012 PVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPF 1071
P F + +++ + ++ T + L AML N P
Sbjct: 252 P----------------F--EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVN--PE 291
Query: 1072 DRPTMREVV 1080
+R ++ EVV
Sbjct: 292 ERLSIAEVV 300
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 29/222 (13%)
Query: 808 TDNFDERF-----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILT 861
+NF+ + +GRG V + + + TG A K L R G + EI
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAV 81
Query: 862 LGKIRHR-NIVKLYGFCYHQGSNLLMYEYMARGSLGELLH-------GASSTLDWQTRFM 913
L + ++ L+ + +L+ EY A G GE+ S D R +
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAA-G--GEIFSLCLPELAEMVSEND-VIRLI 137
Query: 914 IALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSM 970
+ EG+ YLH + I H D+K NILL + + DFG+++ I + +
Sbjct: 138 KQI--LEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--HACEL 190
Query: 971 SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
I G+ Y+APE +T D+++ G++ LLT +P
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 26/215 (12%)
Query: 810 NFDERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGK 864
E++ +GRG G V+R V + T K + V EI L
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILNI 57
Query: 865 IRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL-----HGASSTLDWQTRFMIALGAA 919
RHRNI+ L+ ++++E+++ G ++ ++ +
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFIS-G--LDIFERINTSAFELNEREIVSYVHQV--C 112
Query: 920 EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSY 977
E L +LH I H DI+ NI+ + + + +FG A+ + + + +
Sbjct: 113 EALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAP 167
Query: 978 GYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y APE V+ D++S G ++ LL+G P
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 51/228 (22%), Positives = 94/228 (41%), Gaps = 40/228 (17%)
Query: 808 TDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVK----KLASNREGNNNVDNSFRAE 858
++ + +G G V + + TG A K + + + + E
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-IERE 65
Query: 859 ILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYM----------ARGSLGELLHGASSTLDW 908
+ L ++ H N++ L+ ++ +L+ E + + SL E A+
Sbjct: 66 VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--EEAT----- 118
Query: 909 QTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDM 964
F+ + +G++YLH +I H D+K NI+L DK + DFGLA I+
Sbjct: 119 --SFIKQI--LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
I G+ ++APE + + D++S GV+ LL+G +P
Sbjct: 171 -DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 27/220 (12%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKK--LASNREGNNNVDNSFRAEILTLGKIR 866
+ + IG G G VY+A G T A+KK L EG + + R EI L +++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS--TTIR-EISILKELK 58
Query: 867 HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQT--RFMIALGAAEGLSY 924
H NIVKLY + + +L++E++ + L +LL L+ T F++ L G++Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQL--LNGIAY 115
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE- 983
H R+ HRD+K N+L++ + E + DFGLA+ +P + + + Y AP+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDV 171
Query: 984 ----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
Y+ + DI+S G + E++ G PL G
Sbjct: 172 LMGSKKYSTTI----DIWSVGCIFAEMVNGT----PLFPG 203
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 53/276 (19%), Positives = 109/276 (39%), Gaps = 19/276 (6%)
Query: 213 SLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSL 272
S+PS + E+++ L L+ N+++ ++ L ++L N ++ + + SL
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 273 ETLALYDNKQVGQLPKEL-GSIGSLKYLYIYRNELNGTIPREI-GKLSSALEIDFSENSL 330
E L L N + L + SL +L + N + L+ +
Sbjct: 103 EHLDLSYN-YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161
Query: 331 IGEIPVE-LSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQY 388
+I + + + LE L + + L P L +++N++ L L + +
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDV 220
Query: 389 LTNLIMLQLFDN--------SLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSL 440
+++ L+L D L G L V ++D L ++ + + + + L
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGL 279
Query: 441 IFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFT 475
+ L N+L S+P G+ R SL ++ L N +
Sbjct: 280 LELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 56/282 (19%), Positives = 107/282 (37%), Gaps = 23/282 (8%)
Query: 102 VHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNR 161
+ +LDLS N+++ ++ C +L+ L L +N + +L SL L++ N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 162 ISGPFPKEIGKLSALSQLVAYSNNISGSLPP--TLGNLKRLKSFRAGQNLISGSLPSEI- 218
+S LS+L+ L N +L +L +L+ R G + +
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 219 GGCESLQYLGLAQNQLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLAL 277
G L+ L + + L + ++ ++ +IL Q ++ + +S+E L L
Sbjct: 171 AGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229
Query: 278 YDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVE 337
D EL + + + K + + ++ SL ++
Sbjct: 230 RDTDLDTFHFSELSTGETNSLI----------------KKFTFRNVKITDESLF-QVMKL 272
Query: 338 LSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLT 379
L++I GL L N+L V L +L K+ L N
Sbjct: 273 LNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 52/278 (18%), Positives = 99/278 (35%), Gaps = 23/278 (8%)
Query: 418 VVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTG 476
+ S L IP + ++ L+L N++T I RC +L L L N
Sbjct: 35 ICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN- 89
Query: 477 SFPSDL-CKLANLSTVELDQNQFSGPIPTEI-GNCNALQRLHLSDNYFTGELPREV-GNL 533
+ D L +L ++L N S + + ++L L+L N + + +L
Sbjct: 90 TIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHL 148
Query: 534 SNLVTFNVSSNFLTGRIPLEIF-SCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSEN 592
+ L V + +I + F L+ L++ + P+ + S+ + L L
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208
Query: 593 ELSGSIPVQI-GNLSRLTELQMGGN--------SFSGGIPAELGSLSSLQIALNLSYNNL 643
+ + S + L++ S G L + + + ++ +L
Sbjct: 209 QHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN-VKITDESL 266
Query: 644 SGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSL 681
+ L + L L + N L G F L+SL
Sbjct: 267 FQ-VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSL 303
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 53/283 (18%), Positives = 98/283 (34%), Gaps = 29/283 (10%)
Query: 343 GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDN- 400
++ L L N++T + +L NL L L+ N + TI F L +L L L N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 401 --SLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLTGSIPTG 457
+L + L S L ++L N + + T L L + I
Sbjct: 112 LSNLSSSWFKPL---SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 458 V-TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLH 516
L +L + + P L + N+S + L Q + + ++++ L
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLE 228
Query: 517 LSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPR 576
L D E+ N T + + ++ + +
Sbjct: 229 LRDTDLDTFHFSELSTG----ETNSLIKKFT------------FRNVKITDESLF-QVMK 271
Query: 577 EIGSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSF 618
+ + L L+ S N+L S+P I L+ L ++ + N +
Sbjct: 272 LLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 58/300 (19%), Positives = 109/300 (36%), Gaps = 28/300 (9%)
Query: 108 DLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFP 167
S L+ +IP + +++ L+L+NNR+ +L +L L + +N I+
Sbjct: 37 KGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93
Query: 168 KEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GGCESLQ 225
L +L L N +S +L L L N + + LQ
Sbjct: 94 DSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQ 152
Query: 226 YLGLAQNQLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVG 284
L + +I ++ L +L ++ + + L PK L + ++ L L+ Q
Sbjct: 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK-QHI 211
Query: 285 QLPKEL-GSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILG 343
L + S++ L + +L+ E+ + L K
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNS----------------LIKKFT 255
Query: 344 LELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDNSL 402
+ + + L + L + L +L+ S N L ++P G F LT+L + L N
Sbjct: 256 FRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-21
Identities = 57/322 (17%), Positives = 96/322 (29%), Gaps = 53/322 (16%)
Query: 351 ENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRL 410
L IP LT + LDLS N +T Q NL L L N + I +
Sbjct: 40 SGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEE-- 93
Query: 411 GAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRL 469
++S L SL L+L N L+ ++ + SL L L
Sbjct: 94 DSFSSL---------------------GSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131
Query: 470 GGNSFTGSFPSDL-CKLANLSTVELDQNQFSGPIPTEI-GNCNALQRLHLSDNYFTGELP 527
GN + + L L L + + I + L+ L + +
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYE 190
Query: 528 REV-GNLSNLVTFNVSSNFLTGRIPLEIFSC-KMLQRLDLSWNKFVGALPREIGSLFQLE 585
+ ++ N+ + + ++ L+L
Sbjct: 191 PKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTD---------------- 233
Query: 586 LLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSG 645
L +ELS + +++ S + L +S L L S N L
Sbjct: 234 LDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLE-LEFSRNQLKS 291
Query: 646 LIPPELGNLILLEYLLLNNNHL 667
+ L L+ + L+ N
Sbjct: 292 VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 49/241 (20%), Positives = 86/241 (35%), Gaps = 26/241 (10%)
Query: 84 NLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNR 137
NL + L+ + + L L LDLS+N LS N+ SSL LNL N
Sbjct: 77 NLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNP 135
Query: 138 L----EAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPT 193
E + L L L + N + + K+ L+ L +L ++++ P +
Sbjct: 136 YKTLGETSLFSHLTKLQILRVGN--MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS 193
Query: 194 LGNLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQLSGEIPKEI--------GM 244
L +++ + L S++ L L L E+
Sbjct: 194 LKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
Query: 245 LKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKE-LGSIGSLKYLYIYR 303
+V + L + K L + L L N Q+ +P + SL+ ++++
Sbjct: 253 KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRN-QLKSVPDGIFDRLTSLQKIWLHT 310
Query: 304 N 304
N
Sbjct: 311 N 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 45/247 (18%), Positives = 91/247 (36%), Gaps = 22/247 (8%)
Query: 460 RCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSD 519
C + S S PS L + +++L N+ + +++ C LQ L L+
Sbjct: 29 SCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTS 85
Query: 520 NYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIFS-CKMLQRLDLSWNKFVGALPRE 577
N + + +L +L ++S N+L+ + F L L+L N +
Sbjct: 86 NGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETS 143
Query: 578 I-GSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSGGIPAE-LGSLSSLQI 634
+ L +L++L++ + I + L+ L EL++ + + L S+ ++
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS-YEPKSLKSIQNVSH 202
Query: 635 ALNLSYNNLSGLIPPE----LGNLILLE--YLLLNNNH---LSGEIPGSFVNLSSLLGCN 685
L L L+ ++ LE L+ H LS S + +
Sbjct: 203 -LILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVK 260
Query: 686 FSYNNLT 692
+ +L
Sbjct: 261 ITDESLF 267
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 47/241 (19%), Positives = 85/241 (35%), Gaps = 14/241 (5%)
Query: 464 LVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFT 523
V + S S + + IP+ + A++ L LS+N T
Sbjct: 9 WVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNS-IPSGL--TEAVKSLDLSNNRIT 65
Query: 524 GELPREV-GNLSNLVTFNVSSNFLTGRIPLEIFSC-KMLQRLDLSWNKFVGALPREI-GS 580
+ NL ++SN + I + FS L+ LDLS+N + L
Sbjct: 66 -YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY-LSNLSSSWFKP 122
Query: 581 LFQLELLKLSENELSGSIPVQI--GNLSRLTELQMGGNSFSGGIPAE-LGSLSSLQIALN 637
L L L L N ++ +L++L L++G I + L+ L+ L
Sbjct: 123 LSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE-ELE 180
Query: 638 LSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPS 697
+ ++L P L ++ + +L+L+ + SS+ +L S
Sbjct: 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFS 240
Query: 698 S 698
Sbjct: 241 E 241
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 25/137 (18%), Positives = 49/137 (35%), Gaps = 13/137 (9%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNRLEA 140
L + +L Y ++ + +++ L L Q + + SS+E L L + L+
Sbjct: 178 ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDLDT 236
Query: 141 HIPKEL--------GNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPP 192
EL + + I + + K + ++S L +L N + S+P
Sbjct: 237 FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPD 294
Query: 193 -TLGNLKRLKSFRAGQN 208
L L+ N
Sbjct: 295 GIFDRLTSLQKIWLHTN 311
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 26/198 (13%), Positives = 52/198 (26%), Gaps = 35/198 (17%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
G ++A+ VA+ + ++V + L L +I + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+ + L++ E++ GSL E+ + A H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA---GVA 151
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKC 994
+ + V G + + +
Sbjct: 152 LSIDHPSRVR--------VSIDGDVVL-------------AYPATMPD-------ANPQD 183
Query: 995 DIYSYGVVLLELLTGRAP 1012
DI G L LL R P
Sbjct: 184 DIRGIGASLYALLVNRWP 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 28/224 (12%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKK--LASNREGNNNVDNSFRAEILTLGKI 865
+++ IG G GTV++A T VA+K+ L + EG + ++ R EI L ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS--SALR-EICLLKEL 58
Query: 866 RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQT--RFMIALGAAEGLS 923
+H+NIV+L+ + L++E+ + L + + LD + F+ L +GL
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL--LKGLG 115
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
+ H + HRD+K N+L++ E + +FGLA+ +P + SA + Y P+
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPD 171
Query: 984 Y-----AYTMKVTEKCDIYSYGVVLLELLTGRAPVQP----LDQ 1018
Y+ + D++S G + EL P+ P DQ
Sbjct: 172 VLFGAKLYSTSI----DMWSAGCIFAELANAGRPLFPGNDVDDQ 211
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 63/235 (26%), Positives = 98/235 (41%), Gaps = 50/235 (21%)
Query: 816 VIGRGACGTVYRAVLR------TGHTVAVKKL---ASNREGNNNVDNSFRAEILTLGKIR 866
+G G G V +A TVAVK L AS E + +E L ++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-----LLSEFNVLKQVN 84
Query: 867 HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELL-----------------------HGAS 903
H +++KLYG C G LL+ EY GSL L H
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 904 STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963
L A ++G+ YL + ++ HRD+ + NIL+ + + + DFGL++ +
Sbjct: 145 RALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 964 MPQSKSMSAIAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAP 1012
+ S + S G I A E + T + D++S+GV+L E++T G P
Sbjct: 202 ----EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 58/233 (24%), Positives = 93/233 (39%), Gaps = 58/233 (24%)
Query: 808 TDNFDERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTL 862
+ F + + IG G+ R + + T AVK + ++ EI L
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEIL 69
Query: 863 GK-IRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELL-----------HGASSTLDWQ 909
+ +H NI+ L Y G + ++ E M +G GELL AS
Sbjct: 70 LRYGQHPNIITLKDV-YDDGKYVYVVTELM-KG--GELLDKILRQKFFSEREAS------ 119
Query: 910 TRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMP 965
+ + + + YLH + HRD+K +NIL D+ + DFG AK +
Sbjct: 120 -AVLFTI--TKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-A 172
Query: 966 QSKSMSAIAGSYGYIAPE------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
++ + + ++APE Y CDI+S GV+L +LTG P
Sbjct: 173 ENGLLMTPCYTANFVAPEVLERQGY------DAACDIWSLGVLLYTMLTGYTP 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 67/291 (23%), Positives = 114/291 (39%), Gaps = 67/291 (23%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKL 873
+G G+ + V + + AVK ++ E + + EI L H NIVKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCEGHPNIVKL 71
Query: 874 YGFCYHQGSNL-LMYEYMARGSLGELL-----------HGASSTLDWQTRFMIALGAAEG 921
+ +H + L+ E + G GEL AS + R +
Sbjct: 72 HEV-FHDQLHTFLVMELL-NG--GELFERIKKKKHFSETEASYIM----RKL-----VSA 118
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAIAGSYG 978
+S++H + HRD+K N+L D+ + + DFG A++ P ++ + +
Sbjct: 119 VSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPCFTLH 174
Query: 979 YIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS 1034
Y APE Y E CD++S GV+L +L+G+ P Q D+ + V +
Sbjct: 175 YAAPELLNQNGY----DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK--- 227
Query: 1035 LVSGMLDARLNLQDE--KTVS----HMITVLKIAMLCTNISPFDRPTMREV 1079
+ + + E K VS +I +L + P R M +
Sbjct: 228 ----IKKGDFSFEGEAWKNVSQEAKDLIQ----GLLTVD--PNKRLKMSGL 268
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 61/263 (23%), Positives = 103/263 (39%), Gaps = 19/263 (7%)
Query: 460 RCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSD 519
C S ++R T S P+ + ++ + +EL+ N+ L +L LS
Sbjct: 6 SC-SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSS 61
Query: 520 N--YFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPRE 577
N F G + ++L ++S N + + + L+ LD +
Sbjct: 62 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFS 120
Query: 578 I-GSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSGGIPAE-LGSLSSLQI 634
+ SL L L +S I LS L L+M GNSF + L +L
Sbjct: 121 VFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179
Query: 635 ALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT-- 692
L+LS L L P +L L+ L +++N+ + L+SL ++S N++
Sbjct: 180 -LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 238
Query: 693 -----GPIPSSQTFQNMSVNSFS 710
PSS F N++ N F+
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 61/282 (21%), Positives = 95/282 (33%), Gaps = 39/282 (13%)
Query: 319 SALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSL 378
S EI + L +P + L L NKL + L LTKL LS N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 379 T--GTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICR 436
+ G T+L L DLS N + + +
Sbjct: 65 SFKGCCSQSDFGTTSLKYL------------------------DLSFNGVI-TMSSNFLG 99
Query: 437 NTSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQ 495
L L+ + + L V ++L+ L + +F L++L +++
Sbjct: 100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 159
Query: 496 NQFSGPIPTEI-GNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLE 553
N F +I L L LS +L +LS+L N+S N +
Sbjct: 160 NSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTF 217
Query: 554 IFSC-KMLQRLDLSWNKFVGALPREI--GSLFQLELLKLSEN 592
+ C LQ LD S N + ++ L L L++N
Sbjct: 218 PYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 53/305 (17%), Positives = 100/305 (32%), Gaps = 61/305 (20%)
Query: 105 TALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISG 164
T + + L+ +P I SS L L +N+L++ L+ LT L++ +N +S
Sbjct: 10 TEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS- 65
Query: 165 PFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESL 224
G + LK N + ++ S G E L
Sbjct: 66 ---------------------FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQL 103
Query: 225 QYLGLAQNQLSGEIPKEIGM---LKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNK 281
++L + L ++ E + L+ L + + +SLE L + N
Sbjct: 104 EHLDFQHSNLK-QMS-EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 161
Query: 282 QVGQLPKE-LGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSK 340
+ + +L +L + + +L ++
Sbjct: 162 FQENFLPDIFTELRNLTFLDLSQCQLE-------------------------QLSPTAFN 196
Query: 341 IL-GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYL-TNLIMLQL 397
L L++L + N + L +L LD S+N + T Q+ ++L L L
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNL 255
Query: 398 FDNSL 402
N
Sbjct: 256 TQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 48/255 (18%), Positives = 85/255 (33%), Gaps = 27/255 (10%)
Query: 69 VNCTTNDFGAV--VFSLNLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRN--IP 119
+ C + +V + T++ L L + L LT L LS N LS
Sbjct: 12 IRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71
Query: 120 KEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRIS-----GPFPKEIGKLS 174
+ +SL+ L+L+ N + + L L L+ ++ + F L
Sbjct: 72 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF----LSLR 126
Query: 175 ALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQN 232
L L + L L+ + N + +I +L +L L+Q
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 233 QLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKEL- 290
QL ++ L L + + N + SL+ L N + K+
Sbjct: 186 QLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN-HIMTSKKQEL 243
Query: 291 -GSIGSLKYLYIYRN 304
SL +L + +N
Sbjct: 244 QHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 48/237 (20%), Positives = 85/237 (35%), Gaps = 14/237 (5%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH--IPKELGNLSSLTILNIYNN 160
T L+L N+L + L L+L++N L + +SL L++ N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 161 RISGPFPKEIGKLSALSQLVAYSNNISGSLPP--TLGNLKRLKSFRAGQNLISGSLPSEI 218
+ L L L +N+ + +L+ L + I
Sbjct: 89 GVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI 145
Query: 219 -GGCESLQYLGLAQNQLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLA 276
G SL+ L +A N +I L+ LT + L QL + P + +SL+ L
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205
Query: 277 LYDNKQVGQLPKE-LGSIGSLKYLYIYRNELNGTIPREI-GKLSSALE-IDFSENSL 330
+ N L + SL+ L N + T ++ S+L ++ ++N
Sbjct: 206 MSHN-NFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 55/306 (17%), Positives = 108/306 (35%), Gaps = 60/306 (19%)
Query: 125 CSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSN 184
CS E+ N+ L + +P + SS T L + +N++ KL+ L++L SN
Sbjct: 7 CSGTEI-RCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN 62
Query: 185 NIS--GSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEI 242
+S G + LK N + ++ S G E L++L + L ++ E
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMS-EF 119
Query: 243 GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKE-LGSIGSLKYLYI 301
+ L +L L + + SL+ L +
Sbjct: 120 SVFLSLR---------------------NLIYLDISHT-HTRVAFNGIFNGLSSLEVLKM 157
Query: 302 YRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVE 361
N +I +++ L L L + +L + P
Sbjct: 158 AGNSFQENFLPDI-----------------------FTELRNLTFLDLSQCQLEQLSPTA 194
Query: 362 LTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDNSLVGGIPQRL--GAYSQLWV 418
+L +L L++S N+ ++ ++ L +L +L N ++ ++ S L
Sbjct: 195 FNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAF 252
Query: 419 VDLSDN 424
++L+ N
Sbjct: 253 LNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 38/186 (20%), Positives = 64/186 (34%), Gaps = 13/186 (6%)
Query: 84 NLTKMNLSG----YLSPNIGGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNRL 138
+L ++LS +S N GL L LD + L + + + +L L++++
Sbjct: 79 SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 139 EAHIPKE-LGNLSSLTILNIYNNRISGPFPKEI-GKLSALSQLVAYSNNISGSLPP-TLG 195
LSSL +L + N F +I +L L+ L + L P
Sbjct: 139 R-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFN 196
Query: 196 NLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEI--GMLKYLTDVIL 253
+L L+ N SLQ L + N + K+ L + L
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNL 255
Query: 254 WGNQLS 259
N +
Sbjct: 256 TQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 31/110 (28%), Positives = 49/110 (44%), Gaps = 8/110 (7%)
Query: 83 LNLTKMNLSGYLSPNI-GGLVHLTALDLSFNQLSRNIPKEIGNC-SSLEVLNLNNNRLEA 140
L + + P+I L +LT LDLS QL + N SSL+VLN+++N
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMSHNNF-F 212
Query: 141 HIPKE-LGNLSSLTILNIYNNRISGPFPKEI--GKLSALSQLVAYSNNIS 187
+ L+SL +L+ N I K+ S+L+ L N+ +
Sbjct: 213 SLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 63/244 (25%), Positives = 96/244 (39%), Gaps = 58/244 (23%)
Query: 807 ATDNFDERF---------VIGRGACGTVYRAVLR-TGHTVAVKKLA-SNREGNNNVDNSF 855
+TD+F RF V+G GA V + T AVK + + V
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV---- 57
Query: 856 RAEILTLGKIR-HRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELL-----------HGA 902
E+ L + + HRN+++L F + + L++E M RG G +L A
Sbjct: 58 FREVEMLYQCQGHRNVLELIEF-FEEEDRFYLVFEKM-RG--GSILSHIHKRRHFNELEA 113
Query: 903 SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLA 959
S + +A L +LH I HRD+K NIL + + + DF L
Sbjct: 114 SVVV-----QDVA----SALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161
Query: 960 KVID------MPQSKSMSAIAGSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLT 1008
I + + GS Y+APE ++CD++S GV+L LL+
Sbjct: 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221
Query: 1009 GRAP 1012
G P
Sbjct: 222 GYPP 225
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 809 DNFDERFVIGRGACGTVYRA-VLRTGHTVAVKKLA-SNREGNNNVDNSFRAEILTLGKIR 866
+ + + +G G TVY+ T + VA+K++ + EG + E+ L ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLK 58
Query: 867 HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQT--RFMIALGAAEGLSY 924
H NIV L+ + + S L++EY+ + L + L + ++ F+ L GL+Y
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL--LRGLAY 115
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
H ++ HRD+K N+L++++ E + DFGLA+ +P +K+ + Y P+
Sbjct: 116 CHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDNEVVTLWYRPPDI 171
Query: 985 -----AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
Y+ ++ D++ G + E+ TGR PL G
Sbjct: 172 LLGSTDYSTQI----DMWGVGCIFYEMATGR----PLFPG 203
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 63/263 (23%), Positives = 103/263 (39%), Gaps = 43/263 (16%)
Query: 771 QPVEVVAPLQDKQLSSTVSDIYFPPKEGFTFKDLVVA--TDNFDERF----VIGRGACGT 824
V++ Q S+V+ P + D + F +GRGA
Sbjct: 9 SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSI 68
Query: 825 VYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883
VYR + T A+K L + R EI L ++ H NI+KL + +
Sbjct: 69 VYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEI-FETPTE 122
Query: 884 L-LMYEYM----------ARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
+ L+ E + +G E A+ + + + E ++YLH +
Sbjct: 123 ISLVLELVTGGELFDRIVEKGYYSE--RDAADAV----KQI-----LEAVAYLH---ENG 168
Query: 933 IFHRDIKSNNILLDDKFE-AHV--GDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMK 989
I HRD+K N+L A + DFGL+K+++ M + G+ GY APE
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEILRGCA 226
Query: 990 VTEKCDIYSYGVVLLELLTGRAP 1012
+ D++S G++ LL G P
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEP 249
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 65/304 (21%), Positives = 110/304 (36%), Gaps = 62/304 (20%)
Query: 816 VIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKI-RH 867
V+G GA G V A VAVK L +E ++ + + +E+ + ++ H
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQLGSH 108
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELL----------------------HGASST 905
NIV L G C G L++EY G L L +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 906 LDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965
L ++ A A+G+ +L HRD+ + N+L+ + DFGLA+ I
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM-- 223
Query: 966 QSKSMSAIAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQG 1019
+ + + APE + T K D++SYG++L E+ + G P +
Sbjct: 224 --SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281
Query: 1020 GDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
+ ++N + +D +E + I C RP+ +
Sbjct: 282 ANFYKLIQNGFK--------MDQPFYATEE--------IYIIMQSCWAFDSRKRPSFPNL 325
Query: 1080 VLML 1083
L
Sbjct: 326 TSFL 329
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 73/312 (23%), Positives = 112/312 (35%), Gaps = 79/312 (25%)
Query: 816 VIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKIRHR 868
IG GA G V++A VAVK L +E + F+ E + + +
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDNP 110
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELL-----------------------HGASST 905
NIVKL G C L++EYMA G L E L
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 906 LDWQTRFMIALGAAEGLSYL--HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963
L + IA A G++YL HRD+ + N L+ + + DFGL++ I
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 964 -----MPQSKS------MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRA 1011
M PE + + T + D+++YGVVL E+ + G
Sbjct: 226 SADYYKADGNDAIPIRWM----------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 1012 PVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPF 1071
P + V ++R+ +L N E + + LC + P
Sbjct: 276 PYYGMA-----HEEVIYYVRDG----NILACPENCPLE--------LYNLMRLCWSKLPA 318
Query: 1072 DRPTMREVVLML 1083
DRP+ + +L
Sbjct: 319 DRPSFCSIHRIL 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 28/221 (12%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKK--LASNREGNNNVDNSFRAEILTLGKI 865
+ +++ IG G+ G V++ TG VA+KK + + + R EI L ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKK--IALR-EIRMLKQL 59
Query: 866 RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQT--RFMIALGAAEGLS 923
+H N+V L + L++EY ++ L + + ++
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT--LQAVN 116
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
+ H K HRD+K NIL+ + DFG A+++ P S + Y +PE
Sbjct: 117 FCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-SDYYDDEVATRWYRSPE 172
Query: 984 -----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
Y V D+++ G V ELL+G PL G
Sbjct: 173 LLVGDTQYGPPV----DVWAIGCVFAELLSGV----PLWPG 205
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKK--LASNREGNNNVDN-SFRAEILTLGKIRHRNIVK 872
+G G TVY+A T VA+KK L E + ++ + R EI L ++ H NI+
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIG 76
Query: 873 LYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQT--RFMIALGAAEGLSYLHHDCK 930
L H+ + L++++M L ++ S L +M+ +GL YLH
Sbjct: 77 LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT--LQGLEYLHQH-- 131
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY-----A 985
I HRD+K NN+LLD+ + DFGLAK P +++ + + Y APE
Sbjct: 132 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYRAPELLFGARM 189
Query: 986 YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
Y + V D+++ G +L ELL P G
Sbjct: 190 YGVGV----DMWAVGCILAELLLRV----PFLPG 215
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKK--LASNREGNNNVDNSFRAEILTLGKI 865
+ ++ ++G G+ G V + TG VA+KK + + + + R EI L ++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK--IAMR-EIKLLKQL 81
Query: 866 RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQT--RFMIALGAAEGLS 923
RH N+V L C + L++E++ ++ + L + LD+Q +++ + G+
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI--INGIG 138
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
+ H I HRDIK NIL+ + DFG A+ + P + + Y APE
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYDDEVATRWYRAPE 194
Query: 984 -----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
Y V D+++ G ++ E+ G PL G
Sbjct: 195 LLVGDVKYGKAV----DVWAIGCLVTEMFMGE----PLFPG 227
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 32/215 (14%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVK-----KLASNREGNNNVDNSFRAEILTLGKIRHRN 869
++G G+ G V + T AVK KL G NV + EI L ++RH+N
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANV----KKEIQLLRRLRHKN 67
Query: 870 IVKLYGFCYHQGSN---LLMYEYMARGSLGELL-HGASSTLD-WQTRF----MIALGAAE 920
+++L Y++ ++M EY + E+L Q +I
Sbjct: 68 VIQLVDVLYNEEKQKMYMVM-EY-CVCGMQEMLDSVPEKRFPVCQAHGYFCQLID----- 120
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA-GSYGY 979
GL YLH I H+DIK N+LL + G+A+ + + + GS +
Sbjct: 121 GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 980 IAPEYAYTMKVTE--KCDIYSYGVVLLELLTGRAP 1012
PE A + K DI+S GV L + TG P
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 72/231 (31%), Positives = 100/231 (43%), Gaps = 51/231 (22%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
VIG G+ G VY+A L +G VA+KK+ ++ N R E+ + K+ H NIV+L
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------R-ELQIMRKLDHCNIVRLR 113
Query: 875 GFCYHQGSNL------LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE-------- 920
F Y G L+ +Y+ E ++ +R L
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYV-----PETVY---RVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 921 --GLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY 977
L+Y+H I HRDIK N+LLD D + DFG AK + ++S I Y
Sbjct: 166 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRY 221
Query: 978 GYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023
Y APE YT + D++S G VL ELL G QP+ G V
Sbjct: 222 -YRAPELIFGATDYTSSI----DVWSAGCVLAELLLG----QPIFPGDSGV 263
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 55/304 (18%), Positives = 104/304 (34%), Gaps = 58/304 (19%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI 162
+ + + LS +P+ I S+ LNL N ++ +L L +L + N I
Sbjct: 55 QFSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GG 220
L++L+ L + N ++ +P L +L+ N I S+PS
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169
Query: 221 CESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
SL L L + +L + +L+ L L
Sbjct: 170 VPSLMRLDLGEL-----------------------KKLEYISEGAFEGLFNLKYLNLGMC 206
Query: 281 KQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSK 340
+ +P L + L+ L + N I
Sbjct: 207 -NIKDMP-NLTPLVGLEELEMSGNHFP-EIRPGS-----------------------FHG 240
Query: 341 ILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFD 399
+ L+ L++ ++++ + L +L +L+L+ N+L+ ++P F L L+ L L
Sbjct: 241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHH 299
Query: 400 NSLV 403
N
Sbjct: 300 NPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 69/283 (24%), Positives = 109/283 (38%), Gaps = 37/283 (13%)
Query: 413 YSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGG 471
+Q V + L+ ++P+ I ++ +LNL N + I L L+LG
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGR 108
Query: 472 NSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV- 530
N ++ ++ F+G +L L L DN+ T +P
Sbjct: 109 N--------------SIRQ--IEVGAFNG--------LASLNTLELFDNWLT-VIPSGAF 143
Query: 531 GNLSNLVTFNVSSNFLTGRIPLEIFS-CKMLQRLDLSWNKFVGALPREI-GSLFQLELLK 588
LS L + +N + IP F+ L RLDL K + + LF L+ L
Sbjct: 144 EYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLN 202
Query: 589 LSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIP 648
L + +P + L L EL+M GN F P LSSL+ L + + +S +
Sbjct: 203 LGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK-LWVMNSQVSLIER 259
Query: 649 PELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNL 691
L L L L +N+LS F L L+ + +N
Sbjct: 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 52/237 (21%), Positives = 89/237 (37%), Gaps = 12/237 (5%)
Query: 460 RCKS-LVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLS 518
C + ++ + P + +N + L +N + + L+ L L
Sbjct: 51 SCSNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107
Query: 519 DNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIFSC-KMLQRLDLSWNKFVGALPR 576
N ++ L++L T + N+LT IP F L+ L L N
Sbjct: 108 RNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSY 165
Query: 577 EIGSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSGGIPAELGSLSSLQIA 635
+ L L L E + I L L L +G + +P L L L+
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPN-LTPLVGLEE- 222
Query: 636 LNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692
L +S N+ + P L L+ L + N+ +S +F L+SL+ N ++NNL+
Sbjct: 223 LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-19
Identities = 56/251 (22%), Positives = 86/251 (34%), Gaps = 24/251 (9%)
Query: 69 VNCTTNDFGAV--VFSLNLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKE 121
V CT V N +NL + + L HL L L N + +
Sbjct: 59 VVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGA 118
Query: 122 IGNCSSLEVLNLNNNRLEAHIPKE-LGNLSSLTILNIYNNRIS----GPFPKEIGKLSAL 176
+SL L L +N L IP LS L L + NN I F ++ +L
Sbjct: 119 FNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIESIPSYAF----NRVPSL 173
Query: 177 SQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLS 235
+L + L LK G I +P+ + L+ L ++ N
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP 231
Query: 236 GEIPKE-IGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKE-LGSI 293
EI L L + + +Q+S + SL L L N + LP + +
Sbjct: 232 -EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN-NLSSLPHDLFTPL 289
Query: 294 GSLKYLYIYRN 304
L L+++ N
Sbjct: 290 RYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 56/257 (21%), Positives = 93/257 (36%), Gaps = 14/257 (5%)
Query: 367 NLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHL 426
+K+ + L+ +P G +N L L +N++ L V+ L N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 427 TGKIPRHICRN-TSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTGSFPSDLCK 484
+I SL L L N LT IP+G L +L L N +
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169
Query: 485 LANLSTVELDQNQFSGPIPTEI-GNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSS 543
+ +L ++L + + I L+ L+L ++P + L L +S
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSG 227
Query: 544 NFLTGRIPLEIFSC-KMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQI 602
N I F L++L + ++ L L L L+ N LS S+P +
Sbjct: 228 NHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDL 285
Query: 603 -GNLSRLTELQMGGNSF 618
L L EL + N +
Sbjct: 286 FTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 45/185 (24%), Positives = 69/185 (37%), Gaps = 16/185 (8%)
Query: 84 NLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNL-NNN 136
+L + L + L L L L N + IP SL L+L
Sbjct: 124 SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELK 182
Query: 137 RLEAHIPKE-LGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TL 194
+LE +I + L +L LN+ I + L L +L N+ + P +
Sbjct: 183 KLE-YISEGAFEGLFNLKYLNLGMCNIK--DMPNLTPLVGLEELEMSGNHFP-EIRPGSF 238
Query: 195 GNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEI-GMLKYLTDVIL 253
L LK + +S + G SL L LA N LS +P ++ L+YL ++ L
Sbjct: 239 HGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHL 297
Query: 254 WGNQL 258
N
Sbjct: 298 HHNPW 302
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 65/230 (28%), Positives = 96/230 (41%), Gaps = 50/230 (21%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
VIG G+ G V++A L VA+KK+ ++ N R E+ + ++H N+V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN------R-ELQIMRIVKHPNVVDLKA 99
Query: 876 FCYHQGSNL------LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE--------- 920
F Y G L+ EY+ E ++ + +
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYV-----PETVY---RASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 921 -GLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG 978
L+Y+H I HRDIK N+LLD + DFG AK++ ++S I Y
Sbjct: 152 RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPNVSYICSRY- 206
Query: 979 YIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023
Y APE YT + DI+S G V+ EL+ G QPL G +
Sbjct: 207 YRAPELIFGATNYTTNI----DIWSTGCVMAELMQG----QPLFPGESGI 248
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 56/304 (18%), Positives = 109/304 (35%), Gaps = 58/304 (19%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI 162
+ + L +P I ++ +LNL+ N+++ +L L IL + N I
Sbjct: 44 QFSKVICVRKNLRE-VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GG 220
L+ L+ L + N ++ ++P L +LK N I S+PS
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNR 158
Query: 221 CESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
SL+ L L + +LS + ++L L L
Sbjct: 159 IPSLRRLDLGEL-----------------------KRLSYISEGAFEGLSNLRYLNLAMC 195
Query: 281 KQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSK 340
+ ++P L + L L + N L+ I
Sbjct: 196 -NLREIP-NLTPLIKLDELDLSGNHLS-AIRPGS-----------------------FQG 229
Query: 341 ILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFD 399
++ L+ L++ ++++ + L++L +++L+ N+LT +P F L +L + L
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHH 288
Query: 400 NSLV 403
N
Sbjct: 289 NPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 59/252 (23%), Positives = 91/252 (36%), Gaps = 11/252 (4%)
Query: 443 LNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPI 502
+ L +P G++ + L L N + L +L ++L +N
Sbjct: 48 VICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIE 104
Query: 503 PTEIGNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIFS-CKML 560
L L L DN T +P LS L + +N + IP F+ L
Sbjct: 105 IGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSL 162
Query: 561 QRLDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS 619
+RLDL K + + L L L L+ L IP + L +L EL + GN S
Sbjct: 163 RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS 220
Query: 620 GGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLS 679
P L LQ L + + + + NL L + L +N+L+ F L
Sbjct: 221 AIRPGSFQGLMHLQK-LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279
Query: 680 SLLGCNFSYNNL 691
L + +N
Sbjct: 280 HLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 59/230 (25%), Positives = 89/230 (38%), Gaps = 13/230 (5%)
Query: 467 LRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGEL 526
+ + P + N + L +NQ + L+ L LS N+ +
Sbjct: 48 VICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TI 103
Query: 527 PREV-GNLSNLVTFNVSSNFLTGRIPLEIFSC-KMLQRLDLSWNKFVGALPREI-GSLFQ 583
L+NL T + N LT IP F L+ L L N ++P +
Sbjct: 104 EIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPS 161
Query: 584 LELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNN 642
L L L E + I LS L L + + IP L L L L+LS N+
Sbjct: 162 LRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLD-ELDLSGNH 218
Query: 643 LSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692
LS + P L+ L+ L + + + +F NL SL+ N ++NNLT
Sbjct: 219 LSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 54/247 (21%), Positives = 88/247 (35%), Gaps = 16/247 (6%)
Query: 69 VNCTTNDFGAV--VFSLNLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKE 121
V C + V S N +NL + N L HL L LS N +
Sbjct: 48 VICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGA 107
Query: 122 IGNCSSLEVLNLNNNRLEAHIPKE-LGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLV 180
++L L L +NRL IP LS L L + NN I ++ +L +L
Sbjct: 108 FNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD 166
Query: 181 AYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIP 239
+ L L+ + +P+ + L L L+ N LS I
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIR 223
Query: 240 KEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKE-LGSIGSLK 297
L +L + + +Q+ + N SL + L N + LP + + L+
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN-NLTLLPHDLFTPLHHLE 282
Query: 298 YLYIYRN 304
++++ N
Sbjct: 283 RIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-14
Identities = 43/185 (23%), Positives = 70/185 (37%), Gaps = 16/185 (8%)
Query: 84 NLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNL-NNN 136
NL + L + L L L L N + IP SL L+L
Sbjct: 113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELK 171
Query: 137 RLEAHIPKE-LGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TL 194
RL +I + LS+L LN+ + + L L +L N++S ++ P +
Sbjct: 172 RLS-YISEGAFEGLSNLRYLNLAMCNLR--EIPNLTPLIKLDELDLSGNHLS-AIRPGSF 227
Query: 195 GNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEI-GMLKYLTDVIL 253
L L+ Q+ I + +SL + LA N L+ +P ++ L +L + L
Sbjct: 228 QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHL 286
Query: 254 WGNQL 258
N
Sbjct: 287 HHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 22/70 (31%), Positives = 32/70 (45%), Gaps = 2/70 (2%)
Query: 636 LNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPI 695
LNL N + + +L LE L L+ NH+ G+F L++L N LT I
Sbjct: 69 LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT-I 127
Query: 696 PSSQTFQNMS 705
P + F +S
Sbjct: 128 P-NGAFVYLS 136
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 32/225 (14%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKK--LASNREGNNNVDNSFRAEILTLGKI 865
D + +G G G VY+A+ T TVA+K+ L EG + R E+ L ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG--TAIR-EVSLLKEL 90
Query: 866 RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTR-FMIALGAAEGLSY 924
+HRNI++L +H L++EY L + + + F+ L G+++
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL--INGVNF 147
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVG-----DFGLAKVIDMPQSKSMSAIAGSYGY 979
H R HRD+K N+LL + DFGLA+ +P + + + Y
Sbjct: 148 CHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFTHEIITLWY 203
Query: 980 IAPEY-----AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
PE Y+ V DI+S + E+L PL G
Sbjct: 204 RPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT----PLFPG 240
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 55/219 (25%), Positives = 83/219 (37%), Gaps = 48/219 (21%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKL 873
V+G G G V R TG A+K L + + R E+ + +IV +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK--------ARQEVDHHWQASGGPHIVCI 87
Query: 874 YGFC---YHQGSNLLM-YEYMARGSLGELL-------------HGASSTLDWQTRFMIAL 916
+H LL+ E M G GEL A+ + R +
Sbjct: 88 LDVYENMHHGKRCLLIIMECM-EG--GELFSRIQERGDQAFTEREAAEIM----RDI--- 137
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAI 973
+ +LH I HRD+K N+L K + + DFG AK ++
Sbjct: 138 --GTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---QNALQTP 189
Query: 974 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ Y+APE K + CD++S GV++ LL G P
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 62/221 (28%), Positives = 94/221 (42%), Gaps = 28/221 (12%)
Query: 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGK 864
+ D F + V+GRG G V+ ++ TG A KKL R E L K
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 865 IRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALG---AAE 920
+ R IV L + + ++L L+ M G G++ + + + F A+
Sbjct: 242 VHSRFIVSLA-YAFETKTDLCLVMTIMN-G--GDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 921 ---GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAG 975
GL +LH + I +RD+K N+LLDD + +V D GLA AG
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDD--DGNVRISDLGLAV-ELKAGQTKTKGYAG 351
Query: 976 SYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ G++APE Y V D ++ GV L E++ R P
Sbjct: 352 TPGFMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-23
Identities = 67/220 (30%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGK 864
V + F + V+G+G G V +R TG A KKL R + E L K
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 865 IRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLH--GASSTLDWQTRFMIALGAAE- 920
+ R +V L + Y L L+ M G L ++ G + + + F AAE
Sbjct: 241 VNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY----AAEI 295
Query: 921 --GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGS 976
GL LH + RI +RD+K NILLDD H+ D GLA +P+ +++ G+
Sbjct: 296 CCGLEDLH---RERIVYRDLKPENILLDD--HGHIRISDLGLAV--HVPEGQTIKGRVGT 348
Query: 977 YGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
GY+APE YT D ++ G +L E++ G++P
Sbjct: 349 VGYMAPEVVKNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-22
Identities = 53/237 (22%), Positives = 95/237 (40%), Gaps = 44/237 (18%)
Query: 809 DNFD-ERFVIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGK 864
D F+ E +GRG G VY+A + A+K++ G + S EI L +
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTG---ISMSACREIALLRE 74
Query: 865 IRHRNIVKLYGFCYHQGSNLLM--YEYMARGSLGELLHGASSTLDWQTRFMIALGAA--- 919
++H N++ L + ++Y L ++ ++ + + G
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 920 -----EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMPQSKSM 970
+G+ YLH + + HRD+K NIL+ + + D G A++ + P K +
Sbjct: 134 LYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP-LKPL 189
Query: 971 SAIAGS---YGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
+ + + Y APE YT + DI++ G + ELLT P+
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE----PIFHC 238
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 44/292 (15%), Positives = 117/292 (40%), Gaps = 20/292 (6%)
Query: 97 NIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILN 156
L + + + ++ + + + L+ + I + L++L L
Sbjct: 14 PDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLE 69
Query: 157 IYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPS 216
+ +N+I+ P + L+ +++L N + ++ + L+ +K+ I+ +
Sbjct: 70 LKDNQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD--VT 123
Query: 217 EIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLA 276
+ G +LQ L L NQ++ I + L L + + Q+S + P L N + L TL
Sbjct: 124 PLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLK 179
Query: 277 LYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPV 336
DN ++ + L S+ +L +++ N+++ P + S+ + + ++ +
Sbjct: 180 ADDN-KISDIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVF 235
Query: 337 ELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQY 388
+ ++ ++ + P ++ +L+ N + + + +
Sbjct: 236 YNNNLVVPNVVKGPSGAP--IAPATISDNGTYASPNLTWNLTSFINNVSYTF 285
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 47/258 (18%), Positives = 102/258 (39%), Gaps = 18/258 (6%)
Query: 146 LGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRA 205
L++ + + ++ L ++ L A+ ++ ++ + L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 206 GQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKE 265
N I+ + + + L L+ N L I L+ + + L Q++ V P
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP-- 124
Query: 266 LGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDF 325
L ++L+ L L N Q+ + L + +L+YL I +++ P + LS +
Sbjct: 125 LAGLSNLQVLYLDLN-QITNIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180
Query: 326 SENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG 385
+N I +I L+ + L ++L N+++ V P L NL + L+ ++T
Sbjct: 181 DDNK-ISDIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFY 236
Query: 386 FQYLTNLIMLQLFDNSLV 403
L +++ + +
Sbjct: 237 NNNLVVPNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 48/201 (23%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 84 NLTKMNLSGYL---SPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEA 140
+T ++ G + L +L L+L NQ++ ++ + N + + L L+ N L+
Sbjct: 42 GITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK- 98
Query: 141 HIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRL 200
+ L S+ L++ + +I+ P + LS L L N I+ ++ P L L L
Sbjct: 99 -NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNL 153
Query: 201 KSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSG 260
+ G +S + + L L N++S +I + L L +V L NQ+S
Sbjct: 154 QYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISD 209
Query: 261 VIPKELGNCTSLETLALYDNK 281
V P L N ++L + L +
Sbjct: 210 VSP--LANTSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 57/279 (20%), Positives = 104/279 (37%), Gaps = 19/279 (6%)
Query: 362 LTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDL 421
L N K+ +++T T+ L + L F + + + L ++L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEG--VQYLNNLIGLEL 70
Query: 422 SDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSD 481
DN +T + + T + L L N L ++ + +S+ L L T +
Sbjct: 71 KDNQIT-DLA-PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITD--VTP 124
Query: 482 LCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNV 541
L L+NL + LD NQ + P + LQ L + + + P + NLS L T
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180
Query: 542 SSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQ 601
N ++ PL S L + L N+ P + + L ++ L+ ++
Sbjct: 181 DDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFY 236
Query: 602 IGNLSRL-TELQMGGNSFSGGIPAELGSLSSLQIALNLS 639
NL G + ++ G+ +S + NL+
Sbjct: 237 NNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLT 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 62/259 (23%), Positives = 99/259 (38%), Gaps = 22/259 (8%)
Query: 438 TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQ 497
+ I + + +T ++ + L G T + L NL +EL NQ
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 498 FSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSC 557
+ P + N + L LS N + L ++ T +++S +T PL
Sbjct: 75 ITDLAP--LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTPLA--GL 128
Query: 558 KMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNS 617
LQ L L N+ P + L L+ L + ++S P + NLS+LT L+ N
Sbjct: 129 SNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184
Query: 618 FSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVN 677
S I L SL +L ++L N +S + P L N L + L N ++ + N
Sbjct: 185 ISD-ISP-LASLPNLIE-VHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNN 239
Query: 678 LSSLLGCNFSYNNLTGPIP 696
L N PI
Sbjct: 240 LVVP---NVVKGPSGAPIA 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 49/188 (26%), Positives = 82/188 (43%), Gaps = 15/188 (7%)
Query: 84 NLTKMNLSG-YLS--PNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEA 140
+T++ LSG L I GL + LDL+ Q++ P + S+L+VL L+ N++
Sbjct: 86 KITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT- 142
Query: 141 HIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRL 200
+I L L++L L+I N ++S + LS L+ L A N IS + P L +L L
Sbjct: 143 NIS-PLAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNKIS-DISP-LASLPNL 197
Query: 201 KSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSG 260
N IS S + +L + L ++ + L V G +
Sbjct: 198 IEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVK--GPSGAP 253
Query: 261 VIPKELGN 268
+ P + +
Sbjct: 254 IAPATISD 261
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 51/234 (21%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLAS-----NREGNNNVDNSFRAEILTLGKIRHRN 869
+ G+G GTV + TG +VA+KK+ NRE + + L + H N
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--------LQ-IMQDLAVLHHPN 80
Query: 870 IVKLYGFCYHQGSN-------LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGA---- 918
IV+L + Y G ++ EY+ + LH + +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 919 ---AEGLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAIA 974
+ LH + HRDIK +N+L++ + DFG AK + P +++ I
Sbjct: 136 FQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYIC 193
Query: 975 GSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023
Y Y APE YT V DI+S G + E++ G +P+ +G +
Sbjct: 194 SRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLG----EPIFRGDNSA 238
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 32/230 (13%)
Query: 807 ATDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKK--LASNREGNNNVDNSFRAEI---L 860
AT ++ IG GA GTVY+A +GH VA+K + + G + S E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 861 TLGKIRHRNIVKLYGFCYHQGSNL-----LMYEYMAR--GSLGELLHGASSTLDWQTRFM 913
L H N+V+L C ++ L++E++ + + + + M
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 914 IALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI 973
GL +LH + I HRD+K NIL+ + DFGLA++ +++ +
Sbjct: 127 RQF--LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPV 179
Query: 974 AGSYGYIAPEY----AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
+ Y APE Y V D++S G + E+ + PL G
Sbjct: 180 VVTLWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRK----PLFCG 221
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-22
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 46/236 (19%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKK--LASNREGNNNVDNSFRAEILTLGKI 865
+++ IG+G G V++A +TG VA+KK + + +EG + R EI L +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT--ALR-EIKILQLL 73
Query: 866 RHRNIVKLYGFCYHQGSNL--------LMYEYMARGSLGELLHGASSTLDWQT--RFMIA 915
+H N+V L C + S L++++ L LL R M
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 916 LGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAG 975
L GL Y+H + +I HRD+K+ N+L+ + DFGLA+ + ++
Sbjct: 133 L--LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ----PN 183
Query: 976 SYG-------YIAPEY-----AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
Y Y PE Y + D++ G ++ E+ T P+ QG
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS----PIMQG 231
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-22
Identities = 61/229 (26%), Positives = 113/229 (49%), Gaps = 32/229 (13%)
Query: 805 VVATDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLA-SNREGNNNVDNSFRAEILTL 862
+ ++ F + +G G TVY+ + TG VA+K++ + EG + + R EI +
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS--TAIR-EISLM 57
Query: 863 GKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQT-------RFMIA 915
+++H NIV+LY + + L++E+M L + + + + F
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 916 LGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAG 975
L +GL++ H + +I HRD+K N+L++ + + +GDFGLA+ +P + S+
Sbjct: 117 L--LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-VNTFSSEVV 170
Query: 976 SYGYIAPEY-----AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
+ Y AP+ Y+ + DI+S G +L E++TG+ PL G
Sbjct: 171 TLWYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGK----PLFPG 211
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 55/218 (25%), Positives = 82/218 (37%), Gaps = 42/218 (19%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVK-----KLASNREGNNNVDNSFRAEILTLGKIRHRNI 870
+G GA G V+ AV V VK K+ + + EI L ++ H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 871 VKLYGFCYHQGSNLLMYEYMARGSLGEL-----LHG-----ASSTLDWQTRFMIALGAAE 920
+K+ +QG L+ E G +L H +S + Q
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG--LDLFAFIDRHPRLDEPLASYIFRQL--------VS 141
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI 980
+ YL I HRDIK NI++ + F + DFG A + + K G+ Y
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY--LERGKLFYTFCGTIEYC 196
Query: 981 APE------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
APE Y + +++S GV L L+ P
Sbjct: 197 APEVLMGNPYR-----GPELEMWSLGVTLYTLVFEENP 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 35/212 (16%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G GA G V AV T VAVK + + + + + + EI + H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 876 FCYHQGSNLLMY-EYMARGSLGELL-----HGASSTLDWQTRF--MIALGAAEGLSYLHH 927
+G+ ++ EY G GEL D Q F ++A G+ YLH
Sbjct: 73 -HRREGNIQYLFLEY-CSG--GELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHG 123
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAIAGSYGYIAPE--- 983
I HRDIK N+LLD++ + DFGLA V + + ++ + G+ Y+APE
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 984 ---YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ E D++S G+VL +L G P
Sbjct: 181 RREFH-----AEPVDVWSCGIVLTAMLAGELP 207
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG+G V A + TG VA+K + + ++ FR E+ + + H NIVKL+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 876 FCYHQGSNLLMYEYMARGSLGELL--HGASSTLDWQTRF--MIALGAAEGLSYLHHDCKP 931
+ + L+ EY + G + + L HG + +++F +++ + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-----AVQYCHQKR-- 134
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY----AYT 987
I HRD+K+ N+LLD + DFG + + A G+ Y APE Y
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAP 1012
+ D++S GV+L L++G P
Sbjct: 192 GP---EVDVWSLGVILYTLVSGSLP 213
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 56/219 (25%), Positives = 83/219 (37%), Gaps = 47/219 (21%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKL 873
V+G G G V + + T A+K L + R E+ + + +IV++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML-QDCP-------KARREVELHWRASQCPHIVRI 120
Query: 874 YGFC---YHQGSNLLM-YEYMARGSLGELL-------------HGASSTLDWQTRFMIAL 916
Y LL+ E + G GEL AS + I
Sbjct: 121 VDVYENLYAGRKCLLIVMECL-DG--GELFSRIQDRGDQAFTEREASEIM-----KSIG- 171
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAI 973
E + YLH I HRD+K N+L K + DFG AK S++
Sbjct: 172 ---EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTP 223
Query: 974 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ Y+APE K + CD++S GV++ LL G P
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 51/233 (21%), Positives = 87/233 (37%), Gaps = 14/233 (6%)
Query: 318 SSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINS 377
+ + L +PV + + ++L N+++ V +NLT L L N
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 378 LTGTIPLG-FQYLTNLIMLQLFDNSLVGGIPQR-LGAYSQLWVVDLSDNHLTGKIPRHIC 435
L I F L L L L DN+ + + +L + L L ++ +
Sbjct: 68 LA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLF 125
Query: 436 RN-TSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVEL 493
R +L +L L+ N L ++P +L L L GN + L +L + L
Sbjct: 126 RGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 494 DQNQFSGPIPTEI-GNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSN 544
QN+ + + + L L+L N + LP E L L ++ N
Sbjct: 185 HQNRVAH-VHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 57/235 (24%), Positives = 85/235 (36%), Gaps = 11/235 (4%)
Query: 435 CRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELD 494
C N + + L ++P G+ + ++ L GN + + NL+ + L
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 495 QNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLE 553
N + L++L LSDN + L L T ++ L +
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPG 123
Query: 554 IFS-CKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQI-GNLSRLTEL 611
+F LQ L L N L L L L N +S S+P + L L L
Sbjct: 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRL 182
Query: 612 QMGGNSFSGGIPAE-LGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNN 665
+ N + + L L L L NNLS L L L L+YL LN+N
Sbjct: 183 LLHQNRVAH-VHPHAFRDLGRLMT-LYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 11/214 (5%)
Query: 483 CKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVS 542
C T Q +P I A QR+ L N + NL +
Sbjct: 8 CYNEPKVTTSCPQQGLQA-VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 543 SNFLTGRIPLEIFSC-KMLQRLDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPV 600
SN L RI F+ +L++LDLS N + ++ L +L L L L +
Sbjct: 65 SNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP 122
Query: 601 QI-GNLSRLTELQMGGNSFSGGIPAE-LGSLSSLQIALNLSYNNLSGLIPPELGNLILLE 658
+ L+ L L + N+ +P + L +L L L N +S + L L+
Sbjct: 123 GLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTH-LFLHGNRISSVPERAFRGLHSLD 180
Query: 659 YLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692
LLL+ N ++ P +F +L L+ NNL+
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 9/206 (4%)
Query: 104 LTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNI-YNNRI 162
+ L N++S C +L +L L++N L L+ L L++ N ++
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GG 220
P L L L + L P L L+ N + +LP +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151
Query: 221 CESLQYLGLAQNQLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYD 279
+L +L L N++S +P+ L L ++L N+++ V P + L TL L+
Sbjct: 152 LGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 280 NKQVGQLPKE-LGSIGSLKYLYIYRN 304
N + LP E L + +L+YL + N
Sbjct: 211 N-NLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 53/277 (19%), Positives = 95/277 (34%), Gaps = 58/277 (20%)
Query: 131 LNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSL 190
+ L+A +P + ++ + ++ NRIS L+ L +SN ++ +
Sbjct: 16 TSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RI 71
Query: 191 PP-TLGNLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQLSGEIPKEIGMLKYL 248
L L+ N S+ G L L L + L E+ +
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL------ 124
Query: 249 TDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKE-LGSIGSLKYLYIYRNELN 307
+L+ L L DN + LP + +G+L +L+++ N ++
Sbjct: 125 -----------------FRGLAALQYLYLQDN-ALQALPDDTFRDLGNLTHLFLHGNRIS 166
Query: 308 GTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKN 367
++P + L+ L L +N++ V P L
Sbjct: 167 -SVPERA-----------------------FRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 368 LTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDNSLV 403
L L L N+L+ +P L L L+L DN V
Sbjct: 203 LMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 55/223 (24%), Positives = 85/223 (38%), Gaps = 14/223 (6%)
Query: 69 VNCTTNDFGAV--VFSLNLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKE 121
+C AV ++ L G ++ +LT L L N L+R
Sbjct: 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 122 IGNCSSLEVLNLNNNRLEAHIPKE-LGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLV 180
+ LE L+L++N + L L L++ + P L+AL L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 181 AYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQLSGEI 238
N + +LP T +L L N IS S+P G SL L L QN+++ +
Sbjct: 136 LQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HV 192
Query: 239 PKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
L L + L+ N LS + + L +L+ L L DN
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 84 NLTKMNLSG-----YLSPNI-GGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNN 136
L +++LS + P GL L L L L + + ++L+ L L +N
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDN 139
Query: 137 RLEAHIPKE-LGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TL 194
L+ +P + +L +LT L ++ NRIS + L +L +L+ + N ++ + P
Sbjct: 140 ALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAF 197
Query: 195 GNLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQL 234
+L RL + N +S +LP+E +LQYL L N
Sbjct: 198 RDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-21
Identities = 57/279 (20%), Positives = 97/279 (34%), Gaps = 25/279 (8%)
Query: 194 LGNLKRLKSFRAGQNLISGSLP-SEIGGCESLQYLGLAQNQLSGEIPKEIGML---KYLT 249
G + L+ + + ++I SL+ L + ++ I + L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 250 DVILWGNQLSGVIPKELGNCT--SLETLALYDNKQVGQLPKELGSIG-----SLKYLYIY 302
++ L +++G P L T L L L + L + LK L I
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIA 157
Query: 303 RNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILG----LELLYLFENKLT--- 355
+ ++ + +D S+N +GE + + L++L L +
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217
Query: 356 GVIPVELTTLKNLTKLDLSINSLTGTIP-LGFQYLTNLIMLQLFDNSLVGGIPQRLGAYS 414
GV L LDLS NSL + + L L L L +P+ L +
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--A 274
Query: 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGS 453
+L V+DLS N L P + L+L+ N S
Sbjct: 275 KLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 6e-21
Identities = 58/279 (20%), Positives = 90/279 (32%), Gaps = 25/279 (8%)
Query: 409 RLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLR 468
G S +++ D I ++ SL L + ++ I G R + L+
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 469 ---LGGNSFTGSFPSDLCKLANLSTVELDQNQFS----GPIPTEIGNC--NALQRLHLSD 519
L TG+ P L + L+ S E+ L+ L ++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 520 NYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKM----LQRLDLSWNKFVGALP 575
+ +V L T ++S N G L C + LQ L L
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM-ETPS 217
Query: 576 REIGSLF----QLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSGGIPAELGSLS 630
+L QL+ L LS N L + S+L L + +P L +
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PA 274
Query: 631 SLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSG 669
L + L+LSYN L P L + L L N
Sbjct: 275 KLSV-LDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 57/275 (20%), Positives = 95/275 (34%), Gaps = 28/275 (10%)
Query: 462 KSLVQLRLGGNSFTGSFP-SDLCKLANLSTVELDQNQFSGPIPT---EIGNCNALQRLHL 517
+SL L ++ +D+ K +L + + + I + + LQ L L
Sbjct: 43 RSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTL 102
Query: 518 SDNYFTGELPREVGNLS--NLVTFNVSSNFLTGRIP----LEIFSCKMLQRLDLSWNKFV 571
+ TG P + + +L N+ + R L+ + L+ L ++ +
Sbjct: 103 ENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL 162
Query: 572 GALPREIGSLFQLELLKLSENELSGSI-------PVQIGNLSRLTELQMGGNSFSGGIPA 624
++ L L LS+N G P++ L L G + SG A
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222
Query: 625 ELGSLSSLQIALNLSYNNLSGLIPPEL-GNLILLEYLLLNNNHLSGEIPGSFVNLSSLLG 683
+ LQ L+LS+N+L L L L+ L G LS L
Sbjct: 223 LAAARVQLQG-LDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL-- 279
Query: 684 CNFSYNNLTGPIPSSQTFQ-----NMSVNSFSGSK 713
+ SYN L PS ++ N F S+
Sbjct: 280 -DLSYNRLDR-NPSPDELPQVGNLSLKGNPFLDSE 312
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 51/277 (18%), Positives = 78/277 (28%), Gaps = 23/277 (8%)
Query: 266 LGNCTSLET-LALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKL---SSAL 321
G SLE L D + ++ SLK L + + I ++ S
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 322 EIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTT------LKNLTKLDLSI 375
E+ + G P L + G +L L ++ L L ++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 376 NSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIP----QRLGAYSQLWVVDLSDNHLT---G 428
+ L L L DN +G + L V+ L + + G
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 429 KIPRHICRNTSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTGSFPSDLCKLAN 487
L L+L N L + L L L P L A
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAK 275
Query: 488 LSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTG 524
LS ++L N+ P + L L N F
Sbjct: 276 LSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 58/331 (17%), Positives = 102/331 (30%), Gaps = 38/331 (11%)
Query: 63 PCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFN-QLSRNIPKE 121
PC +C+ N F + L GG L L + + +
Sbjct: 5 PCELDEESCSCN-FSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTD 63
Query: 122 IGNCSSLEVLNLNNNRLEAHIPK---ELGNLSSLTILNIYNNRISGPFPKEIGKLSALS- 177
I SL+ L + R+ + I + +S L L + N ++G P + + +
Sbjct: 64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123
Query: 178 QLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGE 237
++ N + L L++ L+ L +AQ
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLK-------------------PGLKVLSIAQAHSLNF 164
Query: 238 IPKEIGMLKYLTDVILWGNQLSGVIPKELGNC----TSLETLALYDNKQ---VGQLPKEL 290
+++ + L+ + L N G C +L+ LAL + G
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224
Query: 291 GSIGSLKYLYIYRNELNGTIPREIGKLSSALE-IDFSENSLIGEIPVELSKILGLELLYL 349
+ L+ L + N L S L ++ S L ++P L L +L L
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGLPA--KLSVLDL 281
Query: 350 FENKLTGVIPVELTTLKNLTKLDLSINSLTG 380
N+L L + L L N
Sbjct: 282 SYNRLDRNPS--PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 28/182 (15%), Positives = 52/182 (28%), Gaps = 15/182 (8%)
Query: 559 MLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSF 618
+L+R+D + + SL +L + +++ +S L EL +
Sbjct: 48 LLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEV 107
Query: 619 SGGIPAELGSLSSLQI-ALNLSYNNLSGL--IPPELGNLIL--LEYLLLNNNHLSGEIPG 673
+G P L + + LNL + + EL + L+ L + H
Sbjct: 108 TGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167
Query: 674 SFVNLSSLLGCNFSYNNLTGPIPSSQTFQ----------NMSVNSFSGSKGLCGGPLQNC 723
+L + S N G + G+C
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227
Query: 724 TQ 725
Q
Sbjct: 228 VQ 229
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 22/85 (25%), Positives = 38/85 (44%), Gaps = 6/85 (7%)
Query: 82 SLNLTKMNLSGYLSP-NIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEA 140
L+L+ +L + L +L+LSF L + +PK + + L VL+L+ NRL+
Sbjct: 232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLSYNRLD- 287
Query: 141 HIPKELGNLSSLTILNIYNNRISGP 165
P L + L++ N
Sbjct: 288 RNPSPDE-LPQVGNLSLKGNPFLDS 311
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-21
Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNR-EGNNNVDNSFRAEILTLGKIR 866
D+F+ IG+G+ G V T A+K + + N V N F+ E+ + +
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIMQGLE 73
Query: 867 HRNIVKLYGFCYHQGSNLLM-YEYMARGSLGELLHGASSTLDWQTRFMIA-LGAAEGLSY 924
H +V L+ + + ++ M + + G L L + + I L A L Y
Sbjct: 74 HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA--LDY 130
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE- 983
L RI HRD+K +NILLD+ H+ DF +A +P+ ++ +AG+ Y+APE
Sbjct: 131 LQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITTMAGTKPYMAPEM 185
Query: 984 ------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y+ V D +S GV ELL GR P
Sbjct: 186 FSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 35/212 (16%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G GA G V AV T VAVK + + + + + + EI + H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 876 FCYHQGSNLLMY-EYMARGSLGELL-----HGASSTLDWQTRF--MIALGAAEGLSYLHH 927
+G+ ++ EY G GEL D Q F ++A G+ YLH
Sbjct: 73 -HRREGNIQYLFLEY-CSG--GELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHG 123
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAIAGSYGYIAPE--- 983
I HRDIK N+LLD++ + DFGLA V + + ++ + G+ Y+APE
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 984 ---YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ E D++S G+VL +L G P
Sbjct: 181 RREFH-----AEPVDVWSCGIVLTAMLAGELP 207
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 7e-21
Identities = 63/219 (28%), Positives = 91/219 (41%), Gaps = 32/219 (14%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAE--ILTLGK- 864
++F +IGRG G VY TG A+K L R + E +L+L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 865 IRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE--- 920
IV + + +H L + + M G L L + RF AAE
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY----AAEIIL 303
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYG 978
GL ++H + +RD+K NILLD+ HV D GLA + + G++G
Sbjct: 304 GLEHMH---NRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSKKKPHAS---VGTHG 355
Query: 979 YIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y+APE AY D +S G +L +LL G +P
Sbjct: 356 YMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 60/282 (21%), Positives = 106/282 (37%), Gaps = 58/282 (20%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVK---KLASNREGNNNVDNSFRAEILTLGKIRHR--N 869
++G G G+VY + + VA+K K + G E++ L K+
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 870 IVKLYGFCYHQGSNLLMYEYMARGSLGELL-----HGASSTLDWQT--RFMIALGAAEGL 922
+++L + S +L+ E +L GA L + F + E +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPV--QDLFDFITERGA---LQEELARSFFWQV--LEAV 162
Query: 923 SYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIA 981
+ H + HRDIK NIL+D ++ E + DFG + + + G+ Y
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSP 216
Query: 982 PEY----AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS 1037
PE+ Y + ++S G++L +++ G P F + ++
Sbjct: 217 PEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIP----------------FEHDEEIIR 257
Query: 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
G + R + E H+I L P DRPT E+
Sbjct: 258 GQVFFRQRVSSE--CQHLIR----WCLALR--PSDRPTFEEI 291
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 58/290 (20%), Positives = 104/290 (35%), Gaps = 72/290 (24%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNR-EGNNNVDNSFRA--EILTLGKIR----H 867
++G+G GTV+ L VA+K + NR G + + +S E+ L K+ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELL-----HGASSTLD--------WQTRFMI 914
+++L + Q +L+ E +L G L Q
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGP---LGEGPSRCFFGQ----- 147
Query: 915 ALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAI 973
+ + H + HRDIK NIL+D + A + DFG + + +
Sbjct: 148 ---VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG---ALLHDEPYTDF 198
Query: 974 AGSYGYIAPEY----AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNF 1029
G+ Y PE+ Y ++S G++L +++ G P F
Sbjct: 199 DGTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIP----------------F 239
Query: 1030 IRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
R+ ++ L ++ + +I L P RP++ E+
Sbjct: 240 ERDQEILEAELHFPAHVSPD--CCALIR----RCLAPK--PSSRPSLEEI 281
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 55/229 (24%), Positives = 102/229 (44%), Gaps = 36/229 (15%)
Query: 809 DNFDERFVIGRGACGTVYRA--VLRTGHTVAVKK--LASNREGNNNVDNSFRAEI---LT 861
++ IG GA G V++A + G VA+K+ + + EG ++ R E+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL--STIR-EVAVLRH 67
Query: 862 LGKIRHRNIVKLY----GFCYHQGSNL-LMYEYMAR--GSLGELLHGASSTLDWQTRFMI 914
L H N+V+L+ + + L L++E++ + + + + + M
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 915 ALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIA 974
L GL +LH R+ HRD+K NIL+ + + DFGLA++ +++++
Sbjct: 128 QL--LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVV 180
Query: 975 GSYGYIAPEY----AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
+ Y APE +Y V D++S G + E+ + PL +G
Sbjct: 181 VTLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK----PLFRG 221
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 32/210 (15%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G G V TGH VAVK L + + +V + EI L RH +I+KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 876 FCYHQGSNLLMYEYMARGSL-------GELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
++ EY++ G L G + + L Q +++ + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ---ILS-----AVDYCH-- 128
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE----- 983
+ + HRD+K N+LLD A + DFGL+ + M + + GS Y APE
Sbjct: 129 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSCGSPNYAAPEVISGR 185
Query: 984 -YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
YA + DI+S GV+L LL G P
Sbjct: 186 LYA-----GPEVDIWSCGVILYALLCGTLP 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-20
Identities = 44/220 (20%), Positives = 80/220 (36%), Gaps = 38/220 (17%)
Query: 876 FCYHQGSNLLMY---EYMARGSLGELLH--GASSTLDWQTRFMIALGAAEGLSYLHHDCK 930
+ +Y + + +L + ++ + + I + AE + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182
Query: 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-----------MPQSKSMSAIAGSYGY 979
+ HRD+K +NI VGDFGL +D MP + + G+ Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 980 IAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039
++PE + + K DI+S G++L ELL + + + +RN
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-------IITDVRNLKFPLLF 295
Query: 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
Q M+ ML + P +RP ++
Sbjct: 296 ------TQKYPQEHMMVQ----DMLSPS--PTERPEATDI 323
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 62/227 (27%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 802 KDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEIL 860
K++ + D+F+ VIGRGA V ++ TG A+K + + FR E
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 861 TLGKIRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELL--HGASSTLDWQTRFMIALG 917
L R I +L+ F + + L L+ EY G L LL G + RF
Sbjct: 114 VLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFY---- 167
Query: 918 AAE---GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSA 972
AE + +H + HRDIK +NILLD H+ DFG + +
Sbjct: 168 LAEIVMAIDSVH---RLGYVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSLV 222
Query: 973 IAGSYGYIAPE-------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
G+ Y++PE T +CD ++ GV E+ G+ P
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.2 bits (236), Expect = 3e-20
Identities = 58/293 (19%), Positives = 107/293 (36%), Gaps = 19/293 (6%)
Query: 97 NIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILN 156
+L ++ + +S++ + NN+ ++ + + + L ++T L
Sbjct: 16 PDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLF 71
Query: 157 IYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPS 216
+ N+++ P + L L L N I L L +LK+LKS N IS +
Sbjct: 72 LNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING 126
Query: 217 EIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLA 276
+ L+ L L N+++ + L L + L NQ+S ++P L T L+ L
Sbjct: 127 -LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 181
Query: 277 LYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPV 336
L N + L + L + +L L ++ E L + ++ SL P
Sbjct: 182 LSKN-HISDL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPE 237
Query: 337 ELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSIN-SLTGTIPLGFQY 388
+S E + + V + +T T PL Y
Sbjct: 238 IISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVY 290
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 94.4 bits (234), Expect = 6e-20
Identities = 51/276 (18%), Positives = 105/276 (38%), Gaps = 20/276 (7%)
Query: 104 LTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRIS 163
+ + + P + NL + + L+S+ + N+ I
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 164 GPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCES 223
I L +++L N ++ + P L NLK L +N I L S + +
Sbjct: 57 SVQG--IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKK 110
Query: 224 LQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQV 283
L+ L L N +S +I + L L + L N+++ + L T L+TL+L DN Q+
Sbjct: 111 LKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDN-QI 165
Query: 284 GQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILG 343
+ L + L+ LY+ +N + + R + L + ++ + + S ++
Sbjct: 166 SDIV-PLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 344 LELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLT 379
+ + L P ++ + K ++ +
Sbjct: 223 PNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 93.6 bits (232), Expect = 1e-19
Identities = 52/254 (20%), Positives = 101/254 (39%), Gaps = 24/254 (9%)
Query: 152 LTILNIYNNRISGPFPKEIGKLSALSQLVA---YSNNISGSLPPTLGNLKRLKSFRAGQN 208
+ + I K+I A ++ + +++ T L + A +
Sbjct: 1 MGETITVSTPI-----KQIFPDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNS 53
Query: 209 LISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGN 268
I S+ I ++ L L N+L+ +I K + LK L + L N++ + L +
Sbjct: 54 DIK-SV-QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSS--LKD 107
Query: 269 CTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSEN 328
L++L+L N + + L + L+ LY+ N++ + +L+ + +N
Sbjct: 108 LKKLKSLSLEHN-GISDIN-GLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDN 163
Query: 329 SLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQY 388
I +I L+ + L+ LYL +N ++ + L LKNL L+L
Sbjct: 164 Q-ISDIV-PLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSN 219
Query: 389 LTNLIMLQLFDNSL 402
L ++ D SL
Sbjct: 220 LVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 92.9 bits (230), Expect = 2e-19
Identities = 48/219 (21%), Positives = 90/219 (41%), Gaps = 16/219 (7%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141
NL K +++ L + + + + + ++ + I ++ L LN N+L
Sbjct: 25 KDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-D 79
Query: 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLK 201
I K L NL +L L + N+I + L L L N IS + L +L +L+
Sbjct: 80 I-KPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLE 134
Query: 202 SFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGV 261
S G N I+ + + L L L NQ+S +I + L L ++ L N +S +
Sbjct: 135 SLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHISDL 190
Query: 262 IPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLY 300
+ L +L+ L L+ + + + ++ +
Sbjct: 191 --RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 227
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.4 bits (221), Expect = 2e-18
Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 84 NLTKMNLSG-YLS--PNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEA 140
++ ++ + + I L ++T L L+ N+L+ +I K + N +L L L+ N+++
Sbjct: 44 SIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK- 100
Query: 141 HIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRL 200
+ L +L L L++ +N IS + L L L +N I+ + L L +L
Sbjct: 101 DLS-SLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT-DITV-LSRLTKL 155
Query: 201 KSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSG 260
+ N IS + + G LQ L L++N +S ++ + + LK L + L+ +
Sbjct: 156 DTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLN 211
Query: 261 VIPKELGNCTSLETLALYDNK 281
N T+ D
Sbjct: 212 KPINHQSNLVVPNTVKNTDGS 232
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 87.5 bits (216), Expect = 9e-18
Identities = 45/254 (17%), Positives = 92/254 (36%), Gaps = 24/254 (9%)
Query: 344 LELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDN--- 400
+ + + P + K +L S+T + L ++ + ++
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK 56
Query: 401 SLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTR 460
S+ G + + + L+ N LT I + +L +L L+ NK+ + + +
Sbjct: 57 SVQG-----IQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIK-DL-SSLKD 107
Query: 461 CKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDN 520
K L L L N + + L L L ++ L N+ + + L L L DN
Sbjct: 108 LKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDN 163
Query: 521 YFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGS 580
+ ++ + L+ L +S N ++ L K L L+L + + +
Sbjct: 164 QIS-DIV-PLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSN 219
Query: 581 LFQLELLKLSENEL 594
L +K ++ L
Sbjct: 220 LVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 57.0 bits (137), Expect = 3e-08
Identities = 19/106 (17%), Positives = 40/106 (37%), Gaps = 7/106 (6%)
Query: 84 NLTKMNLSG-YLS--PNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEA 140
L + L ++ + L L L L NQ+S +I + + L+ L L+ N +
Sbjct: 132 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS- 188
Query: 141 HIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNI 186
+ L L +L +L +++ L + + ++
Sbjct: 189 -DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G+ G V A +T VA+K ++ +++ EI L +RH +I+KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 876 FCYHQGSNLLMYEY---------MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH 926
+++ EY + + + E Q +I + Y H
Sbjct: 77 VITTPTDIVMVIEYAGGELFDYIVEKKRMTE---DEGRRFFQQ---IIC-----AIEYCH 125
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE--- 983
+ +I HRD+K N+LLDD + DFGL+ + M + GS Y APE
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTSCGSPNYAAPEVIN 180
Query: 984 ---YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
YA + D++S G+VL +L GR P
Sbjct: 181 GKLYA-----GPEVDVWSCGIVLYVMLVGRLP 207
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-19
Identities = 67/210 (31%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
+G G G V TGH VAVK L + + +V R EI L RH +I+KLY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 876 FCYHQGSNLLMYEYMARGSL-------GELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
++ EY++ G L G L S L Q +++ G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ---ILS-----GVDYCH-- 133
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE----- 983
+ + HRD+K N+LLD A + DFGL+ + M + + GS Y APE
Sbjct: 134 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSCGSPNYAAPEVISGR 190
Query: 984 -YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
YA + DI+S GV+L LL G P
Sbjct: 191 LYA-----GPEVDIWSSGVILYALLCGTLP 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-19
Identities = 58/255 (22%), Positives = 92/255 (36%), Gaps = 46/255 (18%)
Query: 796 KEGFTFKDLVVATDNFDERF----VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNV 851
K +DL+ + I G+ G V V G VA+K++ N +
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRV-FNTVSDGRT 63
Query: 852 DNSF-------RA--EILTLGKIRHRNIVKLYGFCYHQGSNL-----LMYEYMARGSLGE 897
N R EI L H NI+ L H L+ E M L +
Sbjct: 64 VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQ 122
Query: 898 LLHGASSTL-DWQTRFMI--ALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG 954
++H + ++ + L GL LH + + HRD+ NILL D + +
Sbjct: 123 VIHDQRIVISPQHIQYFMYHIL---LGLHVLH---EAGVVHRDLHPGNILLADNNDITIC 176
Query: 955 DFGLAKVIDMPQSKSMSA-IAGSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLT 1008
DF LA+ + + + + Y APE +T V D++S G V+ E+
Sbjct: 177 DFNLAREDT--ADANKTHYVTHRW-YRAPELVMQFKGFTKLV----DMWSAGCVMAEMFN 229
Query: 1009 GRAPVQPLDQGGDLV 1023
+ L +G
Sbjct: 230 RK----ALFRGSTFY 240
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 29/227 (12%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRA--EILTLGK 864
+ IG GA G V A VA+KKL+ + N ++ RA E++ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKC 80
Query: 865 IRHRNIVKLYGFCYHQGSNL------LMYEYMARGSLGELLHGASSTLDWQTRFMI--AL 916
+ H+NI+ L Q S ++ E M +L +++ + +++ L
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQML 137
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGS 976
G+ +LH I HRD+K +NI++ + DFGLA+ S M+ +
Sbjct: 138 ---CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVT 189
Query: 977 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023
Y APE M E DI+S G ++ E++ G L G D +
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHI 232
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 27/181 (14%), Positives = 57/181 (31%), Gaps = 10/181 (5%)
Query: 101 LVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNN 160
L + + +SL + L N + + + ++ L I N
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNI 76
Query: 161 RISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGG 220
+ P I LS L +L +++ P L L L + S+ ++I
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 221 CESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
+ + L+ N +I + L L + + + + + + L L +
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
Query: 281 K 281
Sbjct: 192 T 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 24/164 (14%), Positives = 58/164 (35%), Gaps = 7/164 (4%)
Query: 98 IGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNI 157
+ LT + L+ ++ ++ I +++ L +NN + + LS+L L I
Sbjct: 40 EAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRI 95
Query: 158 YNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSE 217
++ + L++L+ L + S+ + L ++ S N +
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MP 154
Query: 218 IGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGV 261
+ L+ L + + + I L + + + G
Sbjct: 155 LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 32/158 (20%), Positives = 59/158 (37%), Gaps = 10/158 (6%)
Query: 84 NLTKMNLSGY----LSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLE 139
+LT + L+ L+ I ++ L ++ + N I S+LE L + +
Sbjct: 45 SLTYITLANINVTDLTG-IEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVT 101
Query: 140 AHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKR 199
+ L L+SLT+L+I ++ +I L ++ + N + P L L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPE 160
Query: 200 LKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGE 237
LKS + + I L L + G+
Sbjct: 161 LKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 29/178 (16%), Positives = 59/178 (33%), Gaps = 10/178 (5%)
Query: 131 LNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSL 190
L + ++SLT + + N ++ I + L + + +
Sbjct: 28 GLLGQSSTA---NITEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYN 82
Query: 191 PPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTD 250
P + L L+ R ++ + G SL L ++ + I +I L +
Sbjct: 83 P--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS 140
Query: 251 VILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNG 308
+ L N I L L++L + + V + + L LY + + G
Sbjct: 141 IDLSYNGAITDI-MPLKTLPELKSLNIQFD-GVHDY-RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-16
Identities = 20/181 (11%), Positives = 61/181 (33%), Gaps = 10/181 (5%)
Query: 148 NLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQ 207
+ + + + ++++L+ + + N++ L + +K
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75
Query: 208 NLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELG 267
+ + I G +L+ L + ++ + + L LT + + + I ++
Sbjct: 76 IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 268 NCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSE 327
+ ++ L N + + L ++ LK L I + ++ I ++
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 328 N 328
Sbjct: 191 Q 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 31/209 (14%), Positives = 61/209 (29%), Gaps = 31/209 (14%)
Query: 172 KLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQ 231
S + S + T + L ++ L + I +++ L +
Sbjct: 18 PDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 232 NQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELG 291
T+ + ++LE L + L
Sbjct: 76 IH--------------ATNY------------NPISGLSNLERLRIMGKDVTSDKIPNLS 109
Query: 292 SIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFE 351
+ SL L I + + +I +I L ID S N I +I L + L+ L +
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQF 168
Query: 352 NKLTGVIPVELTTLKNLTKLDLSINSLTG 380
+ + + L +L ++ G
Sbjct: 169 DGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 29/107 (27%), Positives = 46/107 (42%), Gaps = 3/107 (2%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141
L + +++ PN+ GL LT LD+S + +I +I + ++L+ N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISG 188
I L L L LNI + + I L+QL A+S I G
Sbjct: 152 I-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 34/209 (16%), Positives = 76/209 (36%), Gaps = 35/209 (16%)
Query: 462 KSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNY 521
K+ + LG +S + + +L+ + L + T I + ++ L +++ +
Sbjct: 23 KAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTDL--TGIEYAHNIKDLTINNIH 77
Query: 522 FTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSL 581
T P + LSNL + +T + L LD+S + ++ +I +L
Sbjct: 78 ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 582 FQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYN 641
++ + LS N I ++ L +L L+ LN+ ++
Sbjct: 136 PKVNSIDLSYNG-------AITDIM------------------PLKTLPELKS-LNIQFD 169
Query: 642 NLSGLIPPELGNLILLEYLLLNNNHLSGE 670
+ + + L L + + G+
Sbjct: 170 GVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 30/226 (13%), Positives = 69/226 (30%), Gaps = 55/226 (24%)
Query: 344 LELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLV 403
+ + + + +LT + L+ ++T + +Y N+ L
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGI--EYAHNIKDL-------- 71
Query: 404 GGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKS 463
+++ H T N ++ +
Sbjct: 72 ----------------TINNIHAT----------------NYN----------PISGLSN 89
Query: 464 LVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFT 523
L +LR+ G T +L L +L+ +++ + I T+I + + LS N
Sbjct: 90 LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
Query: 524 GELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNK 569
++ + L L + N+ + + +E L +L
Sbjct: 150 TDIM-PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 9e-13
Identities = 27/158 (17%), Positives = 55/158 (34%), Gaps = 7/158 (4%)
Query: 295 SLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKL 354
SL Y+ + + I + ++ + +S + LE L + +
Sbjct: 45 SLTYITLANINVTDLTG--IEYAHNIKDLTINNIH-ATNYN-PISGLSNLERLRIMGKDV 100
Query: 355 TGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYS 414
T L+ L +LT LD+S ++ +I L + + L N + I L
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLP 159
Query: 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTG 452
+L +++ + + I L L + + G
Sbjct: 160 ELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 25/161 (15%), Positives = 54/161 (33%), Gaps = 9/161 (5%)
Query: 532 NLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSE 591
+ + + + L + L+ I ++ L ++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 592 NELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPEL 651
+ P I LS L L++ G + L L+SL + L++S++ I ++
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL-LDISHSAHDDSILTKI 132
Query: 652 GNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692
L + + L+ N +I L L N ++ +
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 14/116 (12%), Positives = 42/116 (36%), Gaps = 5/116 (4%)
Query: 583 QLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNN 642
+ S + + ++ LT + + + + + +++ L ++ +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKD-LTINNIH 77
Query: 643 LSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSS 698
+ P + L LE L + ++ + + L+SL + S++ I +
Sbjct: 78 ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 6e-19
Identities = 63/224 (28%), Positives = 92/224 (41%), Gaps = 23/224 (10%)
Query: 802 KDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEIL 860
K + + ++F+ VIGRGA G V L+ A+K L FR E
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 861 TLGKIRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLD-WQTRFMIALGA 918
L + I L+ + + +NL L+ +Y G L LL L RF
Sbjct: 127 VLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY----L 181
Query: 919 AE---GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAI 973
AE + +H + HRDIK +NIL+D H+ DFG + + S
Sbjct: 182 AEMVIAIDSVH---QLHYVHRDIKPDNILMDM--NGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 974 AGSYGYIAPEYAYTMKVTEK-----CDIYSYGVVLLELLTGRAP 1012
G+ YI+PE M+ + CD +S GV + E+L G P
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 54/231 (23%), Positives = 88/231 (38%), Gaps = 47/231 (20%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVK-----KLASNREGNNNVDNSFRA------------- 857
IG+G+ G V A A+K KL
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 858 -----EILTLGKIRHRNIVKLYGFCYHQGSNLLMY---EYMARGSLGELL-HGASSTLDW 908
EI L K+ H N+VKL + +Y E + +G + E+ S +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPVMEVPTLKPLS--ED 137
Query: 909 QTRF----MIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964
Q RF +I G+ YLH+ +I HRDIK +N+L+ + + DFG++
Sbjct: 138 QARFYFQDLIK-----GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK- 188
Query: 965 PQSKSMSAIAGSYGYIAPEYAYTMKVT---EKCDIYSYGVVLLELLTGRAP 1012
+S G+ ++APE + + D+++ GV L + G+ P
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 60/226 (26%), Positives = 91/226 (40%), Gaps = 30/226 (13%)
Query: 802 KDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEIL 860
+DL + ++++ VIGRGA G V + T A+K L+ + F E
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 861 TLGKIRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAA 919
+ +V+L+ + + L ++ EYM G L L+ W RF A
Sbjct: 122 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-ARFY----TA 175
Query: 920 E---GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIA 974
E L +H HRD+K +N+LLD H+ DFG ++
Sbjct: 176 EVVLALDAIH---SMGFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 975 GSYGYIAPE--------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
G+ YI+PE Y +CD +S GV L E+L G P
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGR----ECDWWSVGVFLYEMLVGDTP 272
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLA-SNREGNNNVDNSFRAEILTLGKIR 866
++F ++G G+ TV A T A+K L + N V E + ++
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV-TRERDVMSRLD 88
Query: 867 HRNIVKLYGFCYHQGSNLLM-YEYMARGSLGELLHGASSTLDWQTRFMIALGAAE---GL 922
H VKLY F + L Y G L + + S + TRF AE L
Sbjct: 89 HPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY----TAEIVSAL 143
Query: 923 SYLH-HDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAK-VIDMPQSKSMSAIAGSYG 978
YLH I HRD+K NILL++ + H+ DFG AK + + ++ G+
Sbjct: 144 EYLHGKG----IIHRDLKPENILLNE--DMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 979 YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y++PE + D+++ G ++ +L+ G P
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 47/212 (22%), Positives = 76/212 (35%), Gaps = 18/212 (8%)
Query: 344 LELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDN-- 400
+ L L N L + + L LDLS + TI G +Q L++L L L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 401 -SLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLTGSIPTGV 458
SL G L S L + + +L + + +L LN+ N +
Sbjct: 89 QSLALGAFSGL---SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 459 -TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVE----LDQNQFSGPIPTEIGNCNALQ 513
+ +L L L N + +DL L + + L N + I L+
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLK 203
Query: 514 RLHLSDNYFTGELPREV-GNLSNLVTFNVSSN 544
L L N +P + L++L + +N
Sbjct: 204 ELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 53/220 (24%), Positives = 82/220 (37%), Gaps = 13/220 (5%)
Query: 477 SFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSN 535
P +L + ++L N + LQ L LS + +LS+
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 536 LVTFNVSSNFLTGRIPLEIFS-CKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENEL 594
L T ++ N + + L FS LQ+L IG L L+ L ++ N +
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 595 SGSIPVQ--IGNLSRLTELQMGGN---SFSGGIPAELGSLSSLQIALNLSYNNLSGLIPP 649
S + NL+ L L + N S L + L ++L+LS N ++ I P
Sbjct: 137 Q-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQP 194
Query: 650 ELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYN 689
I L+ L L+ N L G F L+SL N
Sbjct: 195 GAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 59/215 (27%), Positives = 86/215 (40%), Gaps = 20/215 (9%)
Query: 270 TSLETLALYDNKQVGQL-PKELGSIGSLKYLYIYRNELNGTIPREI-GKLSSALEIDFSE 327
S + L L N + L S L+ L + R E+ TI LS + +
Sbjct: 28 FSTKNLDLSFN-PLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85
Query: 328 N---SLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPL 384
N SL LS L+ L E L + + LK L +L+++ N + + L
Sbjct: 86 NPIQSLALGAFSGLSS---LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKL 141
Query: 385 G--FQYLTNLIMLQLFDN---SLVGGIPQRLGAYSQLWVV-DLSDNHLTGKIPRHICRNT 438
F LTNL L L N S+ + L L + DLS N + I +
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI 200
Query: 439 SLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGN 472
L L L+TN+L S+P G+ R SL ++ L N
Sbjct: 201 RLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 45/186 (24%), Positives = 71/186 (38%), Gaps = 17/186 (9%)
Query: 84 NLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNR 137
L ++LS + L HL+ L L+ N + ++ SSL+ L
Sbjct: 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETN 111
Query: 138 LEAHIPKELGNLSSLTILNIYNNRI-SGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLG 195
L + +G+L +L LN+ +N I S P+ L+ L L SN I S+ L
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLR 170
Query: 196 NLKRLKSFRA----GQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEI-GMLKYLTD 250
L ++ N ++ + L+ L L NQL +P I L L
Sbjct: 171 VLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQK 228
Query: 251 VILWGN 256
+ L N
Sbjct: 229 IWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 14/212 (6%)
Query: 102 VHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNR 161
LDLSFN L + L+VL+L+ ++ +LS L+ L + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 162 ISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSE--I 218
I LS+L +LVA N++ SL +G+LK LK NLI S
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYF 145
Query: 219 GGCESLQYLGLAQNQLSGEIPKEI-GMLKYLTDVI----LWGNQLSGVIPKELGNCTSLE 273
+L++L L+ N++ I +L + + L N ++ I L+
Sbjct: 146 SNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLK 203
Query: 274 TLALYDNKQVGQLPKE-LGSIGSLKYLYIYRN 304
LAL N Q+ +P + SL+ ++++ N
Sbjct: 204 ELALDTN-QLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 52/268 (19%), Positives = 90/268 (33%), Gaps = 66/268 (24%)
Query: 117 NIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSAL 176
N+P S + L+L+ N L + L +L++ I
Sbjct: 25 NLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ------------- 65
Query: 177 SQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQL 234
++ +L L + N I SL G SLQ L + L
Sbjct: 66 ------------TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNL 112
Query: 235 SGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNK-QVGQLPKELGSI 293
+ + + I G+ +L+ L + N Q +LP+ ++
Sbjct: 113 A-SLE-------------------NFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 294 GSLKYLYIYRNELNGTIPREI-GKLSS----ALEIDFSENSLIGEIPVELSKILGLELLY 348
+L++L + N++ +I L L +D S N + I K + L+ L
Sbjct: 149 TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNP-MNFIQPGAFKEIRLKELA 206
Query: 349 LFENKLTGVIPVELTTLKNLTKLDLSIN 376
L N+L V L +L K+ L N
Sbjct: 207 LDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 51/236 (21%), Positives = 77/236 (32%), Gaps = 27/236 (11%)
Query: 64 CGWIGVNCTTNDFGAV--VFSLNLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSR 116
I C +F + + ++LS +L L LDLS ++
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65
Query: 117 NIPKEI-GNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI----SGPFPKEIG 171
I + S L L L N +++ LSSL L + + P G
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI----G 121
Query: 172 KLSALSQLVAYSNNISGSLPP--TLGNLKRLKSFRAGQNLISGSLPSEI-GGCESLQY-- 226
L L +L N I S NL L+ N I S+ +
Sbjct: 122 HLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLN 179
Query: 227 --LGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
L L+ N ++ I L ++ L NQL V TSL+ + L+ N
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 13/160 (8%)
Query: 538 TFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGS 597
T+ +IP + + LDLS+N S +L++L LS E+ +
Sbjct: 11 TYQCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-T 66
Query: 598 IPVQI-GNLSRLTELQMGGN---SFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGN 653
I +LS L+ L + GN S + G + L SL L NL+ L +G+
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL----VAVETNLASLENFPIGH 122
Query: 654 LILLEYLLLNNNHL-SGEIPGSFVNLSSLLGCNFSYNNLT 692
L L+ L + +N + S ++P F NL++L + S N +
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 51/266 (19%), Positives = 89/266 (33%), Gaps = 71/266 (26%)
Query: 809 DNFDERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLG 863
+ +++ +G G+ G V +G A+KK+ + N R E+ +
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN------R-ELDIMK 55
Query: 864 KIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQT------------- 910
+ H NI+KL + Y G ++
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 911 ----------RFMIALGAAE-----------------GLSYLHHDCKPRIFHRDIKSNNI 943
+ + + + + ++H I HRDIK N+
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNL 172
Query: 944 LLD-DKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE-----YAYTMKVTEKCDIY 997
L++ + DFG AK + P S++ I + Y APE YT + D++
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLI-PSEPSVAYICSRF-YRAPELMLGATEYTPSI----DLW 226
Query: 998 SYGVVLLELLTGRAPVQPLDQGGDLV 1023
S G V EL+ G +PL G +
Sbjct: 227 SIGCVFGELILG----KPLFSGETSI 248
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 58/233 (24%), Positives = 80/233 (34%), Gaps = 47/233 (20%)
Query: 344 LELLYLFENKLTGV---IPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDN 400
+ + LT + +P + T L LS N L T L L L
Sbjct: 12 HLEVNCDKRNLTALPPDLPK------DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 401 SLVGGIPQRLGAYS---QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTG 457
L +L L +DLS N L +P +L L++ N+LT S+P G
Sbjct: 66 EL-----TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLG 118
Query: 458 V-TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLH 516
L +L L GN + P L L L++L
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPGL--LTPTP---------------------KLEKLS 154
Query: 517 LSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWN 568
L++N T ELP + L NL T + N L IP F +L L N
Sbjct: 155 LANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 47/208 (22%), Positives = 77/208 (37%), Gaps = 21/208 (10%)
Query: 104 LTALDLSFNQLSR---NIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNN 160
++ L+ ++P +L+L+ N L L + LT LN+
Sbjct: 12 HLEVNCDKRNLTALPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 161 RIS--GPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEI 218
++ G L L L N + SLP L L N ++ SLP
Sbjct: 66 ELTKLQVD----GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGA 119
Query: 219 -GGCESLQYLGLAQNQLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLA 276
G LQ L L N+L +P + L + L N L+ + L +L+TL
Sbjct: 120 LRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 277 LYDNKQVGQLPKELGSIGSLKYLYIYRN 304
L +N + +PK L + +++ N
Sbjct: 179 LQEN-SLYTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 57/233 (24%), Positives = 87/233 (37%), Gaps = 47/233 (20%)
Query: 248 LTDVILWGNQLSGV---IPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRN 304
+V L+ + +P L L +N L L L + R
Sbjct: 12 HLEVNCDKRNLTALPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 305 ELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTT 364
EL ++ V+ + L L L N+L +P+ T
Sbjct: 66 ELT-------------------------KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQT 98
Query: 365 LKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDN---SLVGGIPQRLGAYSQLWVVD 420
L LT LD+S N LT ++PLG + L L L L N +L G+ +L +
Sbjct: 99 LPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPT---PKLEKLS 154
Query: 421 LSDNHLTGKIPRHICRN-TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGN 472
L++N+LT ++P + +L L L+ N L +IP G L L GN
Sbjct: 155 LANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 15/215 (6%)
Query: 455 PTGVTRCK-SLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQ 513
P S +++ + T + P DL + + + L +N + L
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 514 RLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGA 573
+L+L T +L G L L T ++S N L +PL + L LD+S+N+ +
Sbjct: 59 QLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-S 114
Query: 574 LPREI-GSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSGGIPAEL-GSLS 630
LP L +L+ L L NEL ++P + +L +L + N+ + +PA L L
Sbjct: 115 LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLE 172
Query: 631 SLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNN 665
+L L L N+L IP LL + L+ N
Sbjct: 173 NLDT-LLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 50/182 (27%), Positives = 74/182 (40%), Gaps = 10/182 (5%)
Query: 102 VHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNR 161
T L LS N L + + L LNL+ L + G L L L++ +N+
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQ-VDGTLPVLGTLDLSHNQ 88
Query: 162 ISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-G 219
+ P L AL+ L N ++ SLP L L L+ N + +LP +
Sbjct: 89 LQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLT 145
Query: 220 GCESLQYLGLAQNQLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALY 278
L+ L LA N L+ E+P + L+ L ++L N L IPK L L+
Sbjct: 146 PTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLH 203
Query: 279 DN 280
N
Sbjct: 204 GN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 57/210 (27%), Positives = 84/210 (40%), Gaps = 35/210 (16%)
Query: 485 LANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSN 544
+A+ V D+ + +P ++ LHLS+N + + L N+
Sbjct: 9 VASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 545 FLTGRIPLEIFSC-KMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIG 603
LT L++ +L LDLS N+ +LP +L L +L +S N L+ S+P+ G
Sbjct: 66 ELTK---LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL--G 118
Query: 604 NLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLN 663
L L ELQ L L N L L P L LE L L
Sbjct: 119 ALRGLGELQE----------------------LYLKGNELKTLPPGLLTPTPKLEKLSLA 156
Query: 664 NNHLSGEIP-GSFVNLSSLLGCNFSYNNLT 692
NN+L+ E+P G L +L N+L
Sbjct: 157 NNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 27/216 (12%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLA-SNREGNNNVDNSFRAEILTLGKIR 866
+ F+ ++G+G G V + TG A+K L + V ++ E L R
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSR 206
Query: 867 HRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE---GL 922
H + L + + L + EY G L L + + RF AE L
Sbjct: 207 HPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY----GAEIVSAL 261
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYGYI 980
YLH + + +RD+K N++LD + H+ DFGL K + +M G+ Y+
Sbjct: 262 DYLHSEKN--VVYRDLKLENLMLDK--DGHIKITDFGLCKE-GIKDGATMKTFCGTPEYL 316
Query: 981 APE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
APE Y V D + GVV+ E++ GR P
Sbjct: 317 APEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 48/235 (20%), Positives = 95/235 (40%), Gaps = 16/235 (6%)
Query: 97 NIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILN 156
+ +L ++ + +S++ + NN+ ++ + + + L ++T L
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLF 74
Query: 157 IYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPS 216
+ N+++ P + L L L N + L L +LK+LKS N IS +
Sbjct: 75 LNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING 129
Query: 217 EIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLA 276
+ L+ L L N+++ + L L + L NQ+S ++P L T L+ L
Sbjct: 130 -LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184
Query: 277 LYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLI 331
L N + L + L + +L L ++ E L + ++ SL+
Sbjct: 185 LSKN-HISDL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 16/200 (8%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141
NL K +++ L + + + + + ++ + I ++ L LN N+L
Sbjct: 28 KDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-D 82
Query: 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLK 201
I K L NL +L L + N++ + L L L N IS + L +L +L+
Sbjct: 83 I-KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLE 137
Query: 202 SFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGV 261
S G N I+ + + L L L NQ+S +I + L L ++ L N +S +
Sbjct: 138 SLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHISDL 193
Query: 262 IPKELGNCTSLETLALYDNK 281
+ L +L+ L L+ +
Sbjct: 194 --RALAGLKNLDVLELFSQE 211
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 17/229 (7%)
Query: 84 NLTKMNLSG-YLS--PNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEA 140
++ ++ + + I L ++T L L+ N+L +I K + N +L L L+ N+++
Sbjct: 47 SIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKL-TDI-KPLANLKNLGWLFLDENKVKD 104
Query: 141 HIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRL 200
L +L L L++ +N IS + L L L +N I+ + L L +L
Sbjct: 105 LSS--LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT-DITV-LSRLTKL 158
Query: 201 KSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSG 260
+ N IS + + G LQ L L++N +S ++ + + LK L + L+ +
Sbjct: 159 DTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLN 214
Query: 261 VIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGT 309
N T+ D V P+ + G + + + T
Sbjct: 215 KPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 19/239 (7%)
Query: 168 KEIGKLSALSQLVA---YSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESL 224
K+I A ++ + +++ T L + A + I S+ I ++
Sbjct: 15 KQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNV 70
Query: 225 QYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVG 284
L L N+L+ +I K + LK L + L N++ + L + L++L+L N +
Sbjct: 71 TKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHN-GIS 125
Query: 285 QLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGL 344
+ L + L+ LY+ N++ T + +L+ + +N I +I L+ + L
Sbjct: 126 DIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQ-ISDIV-PLAGLTKL 180
Query: 345 ELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLV 403
+ LYL +N ++ + L LKNL L+L L ++ D SLV
Sbjct: 181 QNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 51/258 (19%), Positives = 103/258 (39%), Gaps = 18/258 (6%)
Query: 124 NCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYS 183
+ NL + + L+S+ + N+ I I L +++L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 184 NNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIG 243
N ++ + P L NLK L +N + L S + + L+ L L N +S +I +
Sbjct: 78 NKLT-DIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DIN-GLV 131
Query: 244 MLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYR 303
L L + L N+++ + L T L+TL+L DN Q+ + L + L+ LY+ +
Sbjct: 132 HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDN-QISDIV-PLAGLTKLQNLYLSK 187
Query: 304 NELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELT 363
N + + R + L + ++ + + S ++ + + L V P ++
Sbjct: 188 NHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIIS 243
Query: 364 TLKNLTKLDLSINSLTGT 381
+ K ++ + T
Sbjct: 244 DDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 47/221 (21%), Positives = 85/221 (38%), Gaps = 17/221 (7%)
Query: 480 SDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTF 539
A L + + + N++ ++ +++ + + L N+
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKL 73
Query: 540 NVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIP 599
++ N LT PL + K L L L NK + L +L+ L L N +S I
Sbjct: 74 FLNGNKLTDIKPLA--NLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DIN 128
Query: 600 VQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEY 659
+ +L +L L +G N + L L+ L L+L N +S ++P L L L+
Sbjct: 129 G-LVHLPQLESLYLGNNKITDITV--LSRLTKLDT-LSLEDNQISDIVP--LAGLTKLQN 182
Query: 660 LLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQT 700
L L+ NH+S ++ L +L + Q+
Sbjct: 183 LYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQS 221
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 55/252 (21%), Positives = 91/252 (36%), Gaps = 18/252 (7%)
Query: 296 LKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLT 355
+ + + + +L+S +I + + I + + + + L+L NKLT
Sbjct: 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD-IKSVQ-GIQYLPNVTKLFLNGNKLT 81
Query: 356 GVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQ 415
+ P L LKNL L L N + L + L L L L N + L Q
Sbjct: 82 DIKP--LANLKNLGWLFLDENKVKDLSSL--KDLKKLKSLSLEHNGISDING--LVHLPQ 135
Query: 416 LWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFT 475
L + L +N +T I + R T L L+LE N+++ I + L L L N +
Sbjct: 136 LESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS 191
Query: 476 GSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSN 535
L L NL +EL + N + +D P + + +
Sbjct: 192 D--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGD 247
Query: 536 LVTFNVSSNFLT 547
NV +
Sbjct: 248 YEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 50/321 (15%), Positives = 94/321 (29%), Gaps = 91/321 (28%)
Query: 347 LYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGI 406
+ + K +L S+T + L ++ +
Sbjct: 7 TITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQI----------- 51
Query: 407 PQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQ 466
+++ + + I ++ L L NKLT I + K+L
Sbjct: 52 -------------IANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGW 94
Query: 467 LRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGEL 526
L L N S L L L ++ L+ N S + + L+ L+L +N T
Sbjct: 95 LFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKITD-- 148
Query: 527 PREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLEL 586
+ L+ L T ++ N ++ D+ + L +L+
Sbjct: 149 ITVLSRLTKLDTLSLEDNQIS----------------DIV----------PLAGLTKLQN 182
Query: 587 LKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGL 646
L LS+N +S + L+ L L + L L
Sbjct: 183 LYLSKNHIS-----DLRALAGLKNLDV----------------------LELFSQECLNK 215
Query: 647 IPPELGNLILLEYLLLNNNHL 667
NL++ + + L
Sbjct: 216 PINHQSNLVVPNTVKNTDGSL 236
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-18
Identities = 56/212 (26%), Positives = 80/212 (37%), Gaps = 38/212 (17%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG G G T VAVK + + NV + EI+ +RH NIV+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV----QREIINHRSLRHPNIVRFKE 83
Query: 876 FCYHQGSNLLMYEYMARGSL-------GELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
++ EY + G L G + Q +++ G+SY H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ---LLS-----GVSYCHSM 135
Query: 929 CKPRIFHRDIKSNNILLDDKFEAH--VGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE--- 983
+I HRD+K N LLD + DFG +K + G+ YIAPE
Sbjct: 136 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGTPAYIAPEVLL 190
Query: 984 ---YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y + D++S GV L +L G P
Sbjct: 191 RQEYD-----GKIADVWSCGVTLYVMLVGAYP 217
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 5e-18
Identities = 59/218 (27%), Positives = 86/218 (39%), Gaps = 32/218 (14%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
++FD ++G+G G V + TG A+K L + E L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 868 RNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALG---AAE--- 920
+ L + + L + EY G L H L + F AE
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL--FFH-----LSRERVFTEERARFYGAEIVS 116
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYG 978
L YLH + +RDIK N++LD + H+ DFGL K + +M G+
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDK--DGHIKITDFGLCK-EGISDGATMKTFCGTPE 170
Query: 979 YIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y+APE Y V D + GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-18
Identities = 80/502 (15%), Positives = 155/502 (30%), Gaps = 119/502 (23%)
Query: 82 SLNLTKMNLSGYLSPNIG---------GLVHLTALDLSFNQLS----RNIPKEIGNCSSL 128
SL++ +++ + L + L L+ ++I + +L
Sbjct: 2 SLDIQSLDIQCE---ELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 58
Query: 129 EVLNLNNNRLEA----HIPKELGNLS-SLTILNIYNNRIS----GPFPKEIGKLSALSQL 179
LNL +N L + + L S + L++ N ++ G + L L +L
Sbjct: 59 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 180 VAYSNNISGSLPPTLGNLKR-----LKSFRAGQNLIS----GSLPSEIGGCESLQYLGLA 230
N + + L L+ + +S L S + + L ++
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 231 QNQLSGEIPKEIG-MLKY----LTDVILWGNQLS----GVIPKELGNCTSLETLALYDNK 281
N ++ + + LK L + L ++ + + + SL LAL NK
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238
Query: 282 QVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKI 341
LG +G + L + + + E + + +L ++
Sbjct: 239 --------LGDVG-MAELCPGLLHPSSRL----------RTLWIWECGITAKGCGDLCRV 279
Query: 342 LG----LELLYLFENKLT--GVI---PVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNL 392
L L+ L L N+L G L L L + S T + +++
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT---AACCSHFSSV 336
Query: 393 IMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICR-----NTSLIFLNLET 447
L L + +S+N L R +C+ + L L L
Sbjct: 337 -----------------LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 379
Query: 448 NKLT----GSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIP 503
++ S+ + SL +L L N + L +
Sbjct: 380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ--------------- 424
Query: 504 TEIGNCNALQRLHLSDNYFTGE 525
L++L L D Y++ E
Sbjct: 425 ----PGCLLEQLVLYDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 94/466 (20%), Positives = 155/466 (33%), Gaps = 91/466 (19%)
Query: 270 TSLETLALYDNK-QVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSAL------- 321
+++L + + + + L + + + + L +SSAL
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT---EARCKDISSALRVNPALA 59
Query: 322 EIDFSENSLIGEIPVELSKILG-----LELLYLFENKLT----GVIPVELTTLKNLTKLD 372
E++ N L + + L ++ L L LT GV+ L TL L +L
Sbjct: 60 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119
Query: 373 LSINSLTGTIPLGFQYL--------TNLIMLQLFDNSL----VGGIPQRLGAYSQLWVVD 420
LS N L G Q L L LQL SL + L A +
Sbjct: 120 LSDNLLGDA---GLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELT 176
Query: 421 LSDNHLTGKIPRHICR-----NTSLIFLNLETNKLT----GSIPTGVTRCKSLVQLRLGG 471
+S+N + R +C+ L L LE+ +T + V SL +L LG
Sbjct: 177 VSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS 236
Query: 472 NSFTGSFPSDLCKLA-----NLSTVELDQNQFSGP----IPTEIGNCNALQRLHLSDNYF 522
N ++LC L T+ + + + + + +L+ L L+ N
Sbjct: 237 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296
Query: 523 TGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLF 582
E L + L+ L + F A S+
Sbjct: 297 GDE---GARLLCETLLEP----------------GCQLESLWVKSCSFTAACCSHFSSVL 337
Query: 583 Q----LELLKLSENELSGSIPVQIG-----NLSRLTELQMGGNSFS----GGIPAELGSL 629
L L++S N L + ++ S L L + S + A L +
Sbjct: 338 AQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 397
Query: 630 SSLQIALNLSYNNLSGLIPPELGNLI-----LLEYLLLNNNHLSGE 670
SL+ L+LS N L +L + LLE L+L + + S E
Sbjct: 398 HSLRE-LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-15
Identities = 83/446 (18%), Positives = 145/446 (32%), Gaps = 80/446 (17%)
Query: 222 ESLQYLGLAQNQLSGEIPKEIG-MLKYLTDVILWGNQLS----GVIPKELGNCTSLETLA 276
+Q L + +LS E+ +L+ V L L+ I L +L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 277 LYDN----KQVGQLPKELGSIG-SLKYLYIYRNELNGTIPREIGKLSSAL-------EID 324
L N V + + L + ++ L + L G LSS L E+
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT---GAGCGVLSSTLRTLPTLQELH 119
Query: 325 FSENSLIGEIPVELSKIL-----GLELLYLFENKLT----GVIPVELTTLKNLTKLDLSI 375
S+N L L + L LE L L L+ + L + +L +S
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179
Query: 376 NSLTGTIPLGFQYL--------TNLIMLQLFDNSL----VGGIPQRLGAYSQLWVVDLSD 423
N + G + L L L+L + + + + + L + L
Sbjct: 180 NDINEA---GVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS 236
Query: 424 NHLTGKIPRHICR-----NTSLIFLNLETNKLT----GSIPTGVTRCKSLVQLRLGGNSF 474
N L +C ++ L L + +T G + + +SL +L L GN
Sbjct: 237 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296
Query: 475 TGSFPSDLCKL-----ANLSTVELDQNQFSG----PIPTEIGNCNALQRLHLSDNYFTGE 525
LC+ L ++ + F+ + + L L +S+N
Sbjct: 297 GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356
Query: 526 LPREVG-----NLSNLVTFNVSSNFLT----GRIPLEIFSCKMLQRLDLSWNKF--VGAL 574
RE+ S L ++ ++ + + + L+ LDLS N G
Sbjct: 357 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI- 415
Query: 575 PREIGSLFQ-----LELLKLSENELS 595
++ + LE L L + S
Sbjct: 416 -LQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 9e-18
Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 25/225 (11%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVD--NSFRAEILTLGK 864
+ IG GA G V A VA+KKL+ R N ++R E++ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYR-ELVLMKC 117
Query: 865 IRHRNIVKLYGFCYHQGSNL------LMYEYMARGSLGELLHGASSTLDWQTRFMIALGA 918
+ H+NI+ L Q + L+ E M +L +++ + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-LLYQM-- 173
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG 978
G+ +LH I HRD+K +NI++ + DFGLA+ S M+ +
Sbjct: 174 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY 228
Query: 979 YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023
Y APE M E DI+S G ++ E++ + L G D +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYI 269
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 58/240 (24%), Positives = 94/240 (39%), Gaps = 51/240 (21%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRA-----EILT 861
+ IG GA G V A VA+KK+ + ++ EI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-------SPFEHQTYCQRTLREIKI 78
Query: 862 LGKIRHRNIVKLYGFCYHQGSNL-----LMYEYMARGSLGELLHGASSTLDWQTRFMIAL 916
L + RH NI+ + ++ + M L +LL + D F+ +
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQI 137
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--MSAIA 974
GL Y+H + HRD+K +N+LL+ + + DFGLA+V D + ++
Sbjct: 138 --LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT--- 189
Query: 975 GSYGYI------APE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023
Y+ APE YT + DI+S G +L E+L+ R P+ G +
Sbjct: 190 ---EYVATRWYRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNR----PIFPGKHYL 238
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 53/261 (20%), Positives = 97/261 (37%), Gaps = 19/261 (7%)
Query: 435 CRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELD 494
C N + +K+T IP+ + R + ++LR +L +E+
Sbjct: 9 CSNRVF---LCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEIS 62
Query: 495 QNQFSGPIPTEI-GNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPL 552
QN I ++ N L + + + E NL NL +S+ + +P
Sbjct: 63 QNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPD 121
Query: 553 EIF-SCKMLQRLDLSWNKFVGALPREI--GSLFQLELLKLSENELSGSIPVQIGNLSRLT 609
LD+ N + + R G F+ +L L++N + I N ++L
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLD 180
Query: 610 ELQMGGNSFSGGIPAE-LGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLS 668
EL + N+ +P + S I L++S + L L NL L N
Sbjct: 181 ELNLSDNNNLEELPNDVFHGASGPVI-LDISRTRIHSLPSYGLENLKKLRARSTYNLK-- 237
Query: 669 GEIPGSFVNLSSLLGCNFSYN 689
++P + L +L+ + +Y
Sbjct: 238 -KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 8e-16
Identities = 52/255 (20%), Positives = 81/255 (31%), Gaps = 35/255 (13%)
Query: 455 PTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQR 514
+ C S + T PSDL N + + L++
Sbjct: 3 HHRICHC-SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 58
Query: 515 LHLSDNYFTGELPREV-GNLSNLVTFNVS-SNFLTGRIPLEIFS-CKMLQRLDLSWNKFV 571
+ +S N + +V NL L + +N L I E F LQ L +S
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK 117
Query: 572 GALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSS 631
Q LL + +N +I NSF G LS
Sbjct: 118 HLPDVHKIHSLQKVLLDIQDNINIHTIE---------------RNSFVG--------LSF 154
Query: 632 LQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIP-GSFVNLSSLLGCNFSYNN 690
+ L L+ N + + L E L +NN+L E+P F S + + S
Sbjct: 155 ESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTR 213
Query: 691 LTGPIPSSQTFQNMS 705
+ +PS +N+
Sbjct: 214 IH-SLPSY-GLENLK 226
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 48/338 (14%), Positives = 98/338 (28%), Gaps = 69/338 (20%)
Query: 123 GNCS-SLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVA 181
C S V +++ IP +L + L ++ L ++
Sbjct: 5 RICHCSNRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEI 61
Query: 182 YSNNISGSLPP-TLGNLKRLKSFR-AGQNLISGSLPSEI-GGCESLQYLGLAQNQLSGEI 238
N++ + NL +L R N + + E +LQYL ++ + +
Sbjct: 62 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HL 119
Query: 239 PKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKEL--GSIGSL 296
P + L + DN + + + G
Sbjct: 120 P-----------------------DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES 156
Query: 297 KYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTG 356
L++ +N + I + E++ S+N+ + E+P ++
Sbjct: 157 VILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDV------------------ 197
Query: 357 VIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQL 416
LD+S + G + L L ++ ++L +L
Sbjct: 198 -----FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL-------KKLPTLEKL 245
Query: 417 WVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSI 454
V L + LT P H C + E + +
Sbjct: 246 --VALMEASLTY--PSHCCAFANWRRQISELHPICNKS 279
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 34/231 (14%), Positives = 68/231 (29%), Gaps = 15/231 (6%)
Query: 69 VNCTTNDFGAV--VFSLNLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKE 121
C + + N ++ + G L +++S N + I +
Sbjct: 14 FLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73
Query: 122 I-GNCSSLEVLNLNNNRLEAHIPKE-LGNLSSLTILNIYNNRISGPFPKEIGKLSALSQL 179
+ N L + + +I E NL +L L I N I L
Sbjct: 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 133
Query: 180 VAYSNNISGSLPPTL--GNLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQLSG 236
N ++ G +N I + + G + + N L
Sbjct: 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE- 191
Query: 237 EIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQL 286
E+P ++ + + ++ + L N L + Y+ K++ L
Sbjct: 192 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL 242
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 48/281 (17%), Positives = 77/281 (27%), Gaps = 60/281 (21%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKE-LGNLSSLTILNIYNNR 161
+ L +L LE + ++ N + I + NL L + I
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA- 89
Query: 162 ISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-G 219
NN+ + P NL L+ I LP
Sbjct: 90 ----------------------NNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKI 125
Query: 220 GCESLQYLGLAQNQLSGEIPKEI--GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLAL 277
L + N I + G+ + L N + I N T L+ L L
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNL 184
Query: 278 YDNKQVGQLPKE-LGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPV 336
DN + +LP + L I R ++ ++P
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG---------------------- 221
Query: 337 ELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINS 377
L + L + K +P L L L + L+ S
Sbjct: 222 -LENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYPS 257
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 40/224 (17%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRA-----EILTLGKIRHRN 869
+G GA G+V A+ R+G VA+KKL + + A E+L L ++H N
Sbjct: 31 HVGSGAYGSVCSAIDKRSGEKVAIKKL------SRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 870 IVKLYGFCYHQGSNL------LMYEYMARGSLGELLHGASSTLDWQTRFMI--ALGAAEG 921
++ L S L+ +M L +++ + + ++++ L +G
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQML---KG 138
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA-IAGSYGYI 980
L Y+H + HRD+K N+ +++ E + DFGLA+ D M+ + + Y
Sbjct: 139 LKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRW-YR 190
Query: 981 APEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023
APE + M + DI+S G ++ E+LTG+ L +G D +
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKDYL 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-17
Identities = 66/248 (26%), Positives = 105/248 (42%), Gaps = 39/248 (15%)
Query: 794 PPKEGFT----FKDLVVATDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGN 848
P + GF K + + +G GA G V AV RTG VA+KKL
Sbjct: 6 PARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL------Y 59
Query: 849 NNVDNSFRA-----EILTLGKIRHRNIVKLYGFCYHQGSNL------LMYEYMARGSLGE 897
+ A E+ L +RH N++ L + L+ +M LG+
Sbjct: 60 RPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGK 118
Query: 898 LLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957
L+ D + + +GL Y+H I HRD+K N+ +++ E + DFG
Sbjct: 119 LMKHEKLGEDRIQFLVYQM--LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 173
Query: 958 LAKVIDMPQSKSMSA-IAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQP 1015
LA+ D M+ + + Y APE M+ T+ DI+S G ++ E++TG+
Sbjct: 174 LARQAD----SEMTGYVVTRW-YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK----T 224
Query: 1016 LDQGGDLV 1023
L +G D +
Sbjct: 225 LFKGSDHL 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 51/240 (21%), Positives = 76/240 (31%), Gaps = 70/240 (29%)
Query: 796 KEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNS 854
K G K + D V+G G G V + + T A+K L +
Sbjct: 5 KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-QDCP-------K 56
Query: 855 FRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMYEYM----ARGSLGELL-------HGA 902
R E+ + + +IV++ Y + G GEL A
Sbjct: 57 ARREVELHWRASQCPHIVRIVDV-YENLYAGRKCLLIVMECLDG--GELFSRIQDRGDQA 113
Query: 903 SSTLDWQTRFMIALGAA-------EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH--- 952
+ + A+ E + YLH I HRD+K N+L K
Sbjct: 114 FTERE----------ASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILK 160
Query: 953 VGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ DFG AK Y + CD++S GV++ LL G P
Sbjct: 161 LTDFGFAKET----------TGEKYD-------------KSCDMWSLGVIMYILLCGYPP 197
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 84.5 bits (208), Expect = 1e-16
Identities = 94/625 (15%), Positives = 179/625 (28%), Gaps = 196/625 (31%)
Query: 5 RISYSYRLFSASILAIICLLVHQTKGLVNIEGQILLLIKSKLVDNSNYLGNW-------N 57
+S + RLF LL Q + + ++L NY +
Sbjct: 60 AVSGTLRLF-------WTLLSKQEEMVQKFVEEVL---------RINY--KFLMSPIKTE 101
Query: 58 PNDSTPCGWIGVNCTTNDFGAV-VFS----------LNLTKMNLSGYLSPNIGGLVH--- 103
+ + + + VF+ L L + L L P L+
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE--LRPAKNVLIDGVL 159
Query: 104 ------LTALDLSFNQLSRNIPKEI-----GNCSSLEVLNLNNNRLEAHIPKELGNLSSL 152
+ ++ + +I NC+S E + +L I + S
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD- 218
Query: 153 TILNIYNNRISGPFPKEIGKLSALSQLVA---YSN------NISGSLPPTLGNLKRLKSF 203
+ + + + L +L+ Y N N+ N K +F
Sbjct: 219 -------HSSNIKLRIHSIQ-AELRRLLKSKPYENCLLVLLNVQ--------NAKAWNAF 262
Query: 204 RAGQNLISGSLPSEIGGCESL---QYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSG 260
NL C+ L ++ + + LS I + +
Sbjct: 263 ----NL----------SCKILLTTRFKQVT-DFLSAATTTHISL----------DHHSMT 297
Query: 261 VIPKELGNCTSLETLALYDNKQVGQLPKE--------LGSIG-SLK--------YLYIYR 303
+ P E L Y + + LP+E L I S++ + ++
Sbjct: 298 LTPDE-----VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC 352
Query: 304 NELNGTI--------PREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLT 355
++L I P E K+ L + F ++ IP + +L L ++ + +
Sbjct: 353 DKLTTIIESSLNVLEPAEYRKMFDRLSV-FPPSAH---IP---TILLSL----IWFDVIK 401
Query: 356 GVIPVELTTLKNLTKLDLSINSLTGTIP-LGFQYLTNLIMLQLFDNSLVG--GIPQRLGA 412
+ V + L + ++ T +IP + + L S+V IP+
Sbjct: 402 SDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF-- 459
Query: 413 YSQLWVVDLSDNHLTGKIPRHI------CRNT------SLIFLNLE--TNKLTGSIPTGV 458
DL +L HI + ++FL+ K+
Sbjct: 460 --DSD--DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKI---RHDST 512
Query: 459 TRCKS------LVQLRLGGNSFTGSFP------SDLCKLANLSTVELDQNQFSGPIPTEI 506
S L QL+ + P + + L L +E +N
Sbjct: 513 AWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI--LDFLPKIE--ENLICSK----- 563
Query: 507 GNCNALQR-LHLSDNYFTGELPREV 530
+ L+ L D E ++V
Sbjct: 564 -YTDLLRIALMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 9e-09
Identities = 108/611 (17%), Positives = 184/611 (30%), Gaps = 211/611 (34%)
Query: 415 QLWVVD-LSDNH--LTGKIPRHICRNTSLIFLNLET--NKLTGS----IPTGVTRCKSLV 465
Q +V + L N+ L I + R S++ ++L V+R + +
Sbjct: 80 QKFVEEVLRINYKFLMSPI-KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL 138
Query: 466 QLR----------------LGGNSFTGSFPSDLCK--LAN--LSTVELDQNQFSGPIP-T 504
+LR + G +G K +A + ++ Q + I
Sbjct: 139 KLRQALLELRPAKNVLIDGVLG---SG-------KTWVALDVCLSYKV-QCKMDFKIFWL 187
Query: 505 EIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSN-FLTGRIPLEIFSCKM-LQR 562
+ NCN+ + + L + N +S + I L I S + L+R
Sbjct: 188 NLKNCNS-----------PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 563 LDLSWNKFVGAL--------PREIGSL-FQLELLKLSENE-----LSGSIPVQIGNLSRL 608
L L + L + + ++L + + LS + I L
Sbjct: 237 L-LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI----SL 291
Query: 609 TELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPE--LGNLILL--------E 658
M + P E S L L+ +L P E N L +
Sbjct: 292 DHHSMT---LT---PDE--VKSLLLKYLDCRPQDL----PREVLTTNPRRLSIIAESIRD 339
Query: 659 YLLLNNN--HLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLC 716
L +N H++ + L++++ S N L P + F +SV
Sbjct: 340 GLATWDNWKHVNCD------KLTTIIES--SLNVLE-PAEYRKMFDRLSV---------- 380
Query: 717 GGPLQNCTQPPSSLPFPSGTNSPTARLGKL--------VAIIAAAIGGVSLV-------L 761
FP + PT L + V ++ + SLV
Sbjct: 381 ---------------FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST 425
Query: 762 ITV-IIYF-LRQPVEVVAPLQDKQLSSTVSDIYFPPKEGFTFKDLVVATDNFDERFV--I 817
I++ IY L+ +E + L ++ D Y PK F DL D+ F I
Sbjct: 426 ISIPSIYLELKVKLE-----NEYALHRSIVDHYNIPK-TFDSDDL--IPPYLDQYFYSHI 477
Query: 818 GRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLG----KIRHRNIVKL 873
G + H L + FR L KIRH +
Sbjct: 478 G-------H-------H------LKNIEHPER--MTLFRMVFLDFRFLEQKIRHDSTA-- 513
Query: 874 YGFCYHQGS--NLLM----YE-YMAR---------GSLGELLHGASSTLDWQTRFM---- 913
GS N L Y+ Y+ ++ + L L +++
Sbjct: 514 ---WNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENL-ICSKYTDLLR 569
Query: 914 IALGAAEGLSY 924
IAL A + +
Sbjct: 570 IALMAEDEAIF 580
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 1e-16
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 38/223 (17%)
Query: 809 DNFDERFVIGRGACGTVY----RAVLRTGHTVAVKKL--ASNREGNNNVDNSFRAEILTL 862
+ F+ V+G+G G V+ TG A+K L A + ++ +AE L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNIL 75
Query: 863 GKIRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALG---A 918
+++H IV L + + G L L+ EY+ G GEL L+ + FM
Sbjct: 76 EEVKHPFIVDLI-YAFQTGGKLYLILEYL-SG--GELFM----QLEREGIFMEDTACFYL 127
Query: 919 AE---GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAI 973
AE L +LH + I +RD+K NI+L+ + HV DFGL K +
Sbjct: 128 AEISMALGHLH---QKGIIYRDLKPENIMLNH--QGHVKLTDFGLCKE-SIHDGTVTHTF 181
Query: 974 AGSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
G+ Y+APE + V D +S G ++ ++LTG P
Sbjct: 182 CGTIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 58/204 (28%), Positives = 82/204 (40%), Gaps = 25/204 (12%)
Query: 352 NKLTGV---IPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDN---SLVGG 405
KLT + IP + KLDL N L+ F LT L +L L DN +L G
Sbjct: 26 KKLTAIPSNIPA------DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG 79
Query: 406 IPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLTGSIPTGV-TRCKS 463
I + L L + ++DN L +P + +L L L+ N+L S+P V
Sbjct: 80 IFKEL---KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTK 134
Query: 464 LVQLRLGGNSFTGSFPSDLC-KLANLSTVELDQNQFSGPIPTEI-GNCNALQRLHLSDNY 521
L L LG N S P + KL +L + L NQ +P L+ L L +N
Sbjct: 135 LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQ 192
Query: 522 FTGELPREV-GNLSNLVTFNVSSN 544
+P +L L + N
Sbjct: 193 LK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 17/185 (9%)
Query: 502 IPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIFSC-KM 559
IP + ++L L N + LP + L+ L ++ N L +P IF K
Sbjct: 35 IPAD------TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKN 86
Query: 560 LQRLDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNS 617
L+ L ++ NK ALP + L L L+L N+L S+P ++ +L++LT L +G N
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144
Query: 618 FSGGIPAEL-GSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFV 676
+P + L+SL+ L L N L + L L+ L L+NN L G+F
Sbjct: 145 LQS-LPKGVFDKLTSLKE-LRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202
Query: 677 NLSSL 681
+L L
Sbjct: 203 SLEKL 207
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 54/227 (23%), Positives = 89/227 (39%), Gaps = 47/227 (20%)
Query: 69 VNCTTNDFGAV---VFSLNLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPK 120
V+C++ A+ + + + K++L L L L L L+ N+L + +P
Sbjct: 21 VDCSSKKLTAIPSNIPA-DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPA 78
Query: 121 EI-GNCSSLEVLNLNNNRLEAHIPKEL-GNLSSLTILNIYNNRIS----GPFPKEIGKLS 174
I +LE L + +N+L+A +P + L +L L + N++ F L+
Sbjct: 79 GIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFD----SLT 133
Query: 175 ALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQL 234
L+ L N + SLP + F L SL+ L L NQL
Sbjct: 134 KLTYLSLGYNELQ-SLPKGV--------FD--------KLT-------SLKELRLYNNQL 169
Query: 235 SGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
+P+ L L + L NQL V + L+ L L +N
Sbjct: 170 K-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 53/185 (28%), Positives = 80/185 (43%), Gaps = 11/185 (5%)
Query: 486 ANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSN 544
A+ ++L N+ S L+ L+L+DN LP + L NL T V+ N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 545 FLTGRIPLEIFSC-KMLQRLDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPVQI 602
L +P+ +F L L L N+ +LP + SL +L L L NEL S+P +
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 603 -GNLSRLTELQMGGNSFSGGIPAEL-GSLSSLQIALNLSYNNLSGLIPPELGNLILLEYL 660
L+ L EL++ N +P L+ L+ L L N L + +L L+ L
Sbjct: 153 FDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKT-LKLDNNQLKRVPEGAFDSLEKLKML 210
Query: 661 LLNNN 665
L N
Sbjct: 211 QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 108 DLSFNQLSR---NIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRIS- 163
D S +L+ NIP + + L+L +N+L + K L+ L +L + +N++
Sbjct: 22 DCSSKKLTAIPSNIP------ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT 75
Query: 164 ---GPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI- 218
G F +L L L N + +LP L L R +N + SLP +
Sbjct: 76 LPAGIF----KELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVF 129
Query: 219 GGCESLQYLGLAQNQLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLAL 277
L YL L N+L +PK + L L ++ L+ NQL V T L+TL L
Sbjct: 130 DSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKL 188
Query: 278 YDNKQVGQLPKEL-GSIGSLKYLYIYRN 304
+N Q+ ++P+ S+ LK L + N
Sbjct: 189 DNN-QLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 52/182 (28%), Positives = 79/182 (43%), Gaps = 8/182 (4%)
Query: 223 SLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQ 282
+ L L N+LS K L L + L N+L + +LETL + DN +
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDN-K 96
Query: 283 VGQLPKEL-GSIGSLKYLYIYRNELNGTIPREI-GKLSSALEIDFSENSLIGEIPVEL-S 339
+ LP + + +L L + RN+L ++P + L+ + N L +P +
Sbjct: 97 LQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFD 154
Query: 340 KILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLF 398
K+ L+ L L+ N+L V L L L L N L +P G F L L MLQL
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQ 213
Query: 399 DN 400
+N
Sbjct: 214 EN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 49/160 (30%), Positives = 67/160 (41%), Gaps = 8/160 (5%)
Query: 535 NLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENEL 594
N + + SS LT IP I + ++LDL NK + L +L LL L++N+L
Sbjct: 17 NKNSVDCSSKKLT-AIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73
Query: 595 SGSIPVQI-GNLSRLTELQMGGNSFSGGIPAEL-GSLSSLQIALNLSYNNLSGLIPPELG 652
++P I L L L + N +P + L +L L L N L L P
Sbjct: 74 Q-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAE-LRLDRNQLKSLPPRVFD 130
Query: 653 NLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692
+L L YL L N L G F L+SL N L
Sbjct: 131 SLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK 170
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 41/207 (19%), Positives = 76/207 (36%), Gaps = 12/207 (5%)
Query: 343 GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDNS 401
+ L L E L + + L N++++ +SI+ + F L+ + +++ +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 402 LVGGIPQR-LGAYSQLWVVDLSDNHLTGKIP--RHICRNTSLIFLNLETNKLTGSIPTGV 458
+ I L L + + + L P + L + N SIP
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 459 TR--CKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEI--GNCNALQR 514
+ C + L+L N FT S L V L++N++ I + G +
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209
Query: 515 LHLSDNYFTGELPREV-GNLSNLVTFN 540
L +S T LP + +L L+ N
Sbjct: 210 LDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 35/221 (15%), Positives = 73/221 (33%), Gaps = 13/221 (5%)
Query: 479 PSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSNLV 537
S C+ + IP+ + Q L L + + +P NL N+
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQR-IPSLPPS---TQTLKLIETHLR-TIPSHAFSNLPNIS 58
Query: 538 TFNVSSNFLTGRIPLEIFS-CKMLQRLDLSWNKFVGALPREI-GSLFQLELLKLSENELS 595
VS + ++ F + +++ + + + + L L+ L + L
Sbjct: 59 RIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
Query: 596 GSIP--VQIGNLSRLTELQMGGNSFSGGIPAE-LGSLSSLQIALNLSYNNLSGLIPPELG 652
P ++ + L++ N + IP L + + L L N + +
Sbjct: 119 -MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFN 177
Query: 653 NLILLEYLLLNNNHLSGEIPGSFVNLSSLLGC-NFSYNNLT 692
L L N +L+ +F + S + S ++T
Sbjct: 178 GTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 37/242 (15%), Positives = 85/242 (35%), Gaps = 18/242 (7%)
Query: 433 HICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVE 492
C + + IP+ S L+L L N+S +
Sbjct: 6 PPCECHQEEDFRVTCKDIQ-RIPSLPP---STQTLKLIETHLRTIPSHAFSNLPNISRIY 61
Query: 493 LDQNQFSGPIPTEI-GNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRI 550
+ + + + N + + + + + + + L L + + L
Sbjct: 62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MF 120
Query: 551 P--LEIFSCKMLQRLDLSWNKFVGALPREI--GSLFQLELLKLSENELSGSIPVQIGNLS 606
P +++S + L+++ N ++ ++P G + LKL N + S+ N +
Sbjct: 121 PDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGT 179
Query: 607 RLTELQMGGNSFSGGIPAEL--GSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNN 664
+L + + N + I + G S + L++S +++ L L + L+ L+ N
Sbjct: 180 KLDAVYLNKNKYLTVIDKDAFGGVYSGPSL-LDVSQTSVTALPSKGLEH---LKELIARN 235
Query: 665 NH 666
Sbjct: 236 TW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 33/222 (14%), Positives = 70/222 (31%), Gaps = 19/222 (8%)
Query: 103 HLTALDLSFNQLSR--NIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNI-YN 159
++ + R ++P S + L L L NL +++ + + +
Sbjct: 12 QEEDFRVTCKDIQRIPSLP------PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID 65
Query: 160 NRISGPFPKEIGKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSE- 217
+ LS ++ + + + P L L LK + P
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLT 124
Query: 218 -IGGCESLQYLGLAQNQLSGEIPKEI--GMLKYLTDVILWGNQLSGVIPKELGNCTSLET 274
+ + L + N IP G+ + L+ N + + N T L+
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183
Query: 275 LALYDNKQVGQLPKEL--GSIGSLKYLYIYRNELNGTIPREI 314
+ L NK + + K+ G L + + + +P +
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 33/223 (14%), Positives = 73/223 (32%), Gaps = 14/223 (6%)
Query: 69 VNCTTNDFGAV-VFSLNLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKEI 122
T D + + + L + + L +++ + +S + + +
Sbjct: 16 FRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHS 75
Query: 123 -GNCSSLEVLNLNNNRLEAHIPKE-LGNLSSLTILNIYNNRISG-PFPKEIGKLSALSQL 179
N S + + + N R +I + L L L L I+N + P ++ L
Sbjct: 76 FYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFIL 135
Query: 180 VAYSNNISGSLPPTL--GNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGE 237
N S+P G + + N + S+ L + L +N+
Sbjct: 136 EITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTV 194
Query: 238 IPKEI--GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALY 278
I K+ G+ + + + ++ + K L + L +
Sbjct: 195 IDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 34/255 (13%), Positives = 71/255 (27%), Gaps = 34/255 (13%)
Query: 125 CSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSN 184
C E + ++ IP S L + + L +S++ +
Sbjct: 10 CHQEEDFRVTCKDIQR-IP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID 65
Query: 185 NISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQLSGEIPKEI 242
L + NL ++ + + L++LG+ L P
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLT 124
Query: 243 GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKEL--GSIGSLKYLY 300
+ + L + DN + +P G L
Sbjct: 125 K----------------------VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162
Query: 301 IYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKIL--GLELLYLFENKLTGVI 358
+Y N ++ + + ++N + I + + G LL + + +T +
Sbjct: 163 LYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALP 221
Query: 359 PVELTTLKNLTKLDL 373
L LK L +
Sbjct: 222 SKGLEHLKELIARNT 236
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 2e-16
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 37/221 (16%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREG----NNNVDNSFRAE--ILT 861
+F+ V+G+G+ G V + + T AVK L ++ +++V+ E +L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---KKDVVIQDDDVE-CTMVEKRVLA 396
Query: 862 LGKIRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE 920
L + + +L+ C+ L + EY+ G L + + F AAE
Sbjct: 397 L-PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY----AAE 450
Query: 921 ---GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAG 975
GL +L I +RD+K +N++LD E H+ DFG+ K ++ + G
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKE-NIWDGVTTKTFCG 504
Query: 976 SYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ YIAPE Y V D +++GV+L E+L G+AP
Sbjct: 505 TPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 42/227 (18%)
Query: 809 DNFDERFVIGRGACGTVY----RAVLRTGHTVAVKKL--ASNREGNNNVDNSFRAEILTL 862
+NF+ V+G GA G V+ + TG A+K L A+ + +++ R E L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-RTERQVL 112
Query: 863 GKIRHRN-IVKLYGFCYHQGSNL-LMYEYMARGSLGEL-LHGASSTLDWQTRFMIALG-- 917
IR +V L+ + + + L L+ +Y+ G GEL H L + RF
Sbjct: 113 EHIRQSPFLVTLH-YAFQTETKLHLILDYI-NG--GELFTH-----LSQRERFTEHEVQI 163
Query: 918 -AAE---GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMS 971
E L +LH K I +RDIK NILLD HV DFGL+K +++
Sbjct: 164 YVGEIVLALEHLH---KLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAY 218
Query: 972 AIAGSYGYIAPE------YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
G+ Y+AP+ + V D +S GV++ ELLTG +P
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 37/210 (17%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLY 874
+GRG V+ A+ + V VK L ++ R EI L +R NI+ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKR-EIKILENLRGGPNIITLA 97
Query: 875 GFCYHQGSN--LLMYEYMARGSLGELLHGASSTLDWQTRFMI--ALGAAEGLSYLHHDCK 930
S L++E++ +L + D+ RF + L + L Y H
Sbjct: 98 DIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDIRFYMYEIL---KALDYCH---S 148
Query: 931 PRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE------ 983
I HRD+K +N+++D + + + D+GLA+ + + S + PE
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH--PGQEYNVRVASRYFKGPELLVDYQ 206
Query: 984 -YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y Y++ D++S G +L ++ + P
Sbjct: 207 MYDYSL------DMWSLGCMLASMIFRKEP 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 56/239 (23%), Positives = 95/239 (39%), Gaps = 56/239 (23%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVD--NSFRAEILTLGKIRHRNIVK 872
+G G G V+ AV VA+KK+ + ++ R EI + ++ H NIVK
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALR-EIKIIRRLDHDNIVK 72
Query: 873 LY-------GFCYHQGSNL-------LMYEYMARGSLGELLHGASSTLDWQTRFMIALGA 918
++ +L ++ EYM L +L + FM L
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQL-- 129
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDMPQSKS--MSAIAG 975
GL Y+H + HRD+K N+ ++ + +GDFGLA+++D S +S
Sbjct: 130 LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS---- 182
Query: 976 SYGYI------APE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023
+ +P YT + D+++ G + E+LTG+ L G +
Sbjct: 183 --EGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK----TLFAGAHEL 231
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 4e-16
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 46/226 (20%)
Query: 809 DNFDERFVIGRGACGTVY----RAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILT--- 861
F+ V+G+G+ G V+ + A+K L ++ V + R
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL---KKATLKVRD--RVRTKMERD 78
Query: 862 -LGKIRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGEL-LHGASSTLDWQTRFMIALG- 917
L ++ H IVKL+ + + L L+ +++ RG G+L L + F
Sbjct: 79 ILVEVNHPFIVKLH-YAFQTEGKLYLILDFL-RG--GDLFTR-----LSKEVMFTEEDVK 129
Query: 918 --AAE---GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSM 970
AE L +LH I +RD+K NILLD+ E H+ DFGL+K + K
Sbjct: 130 FYLAELALALDHLH---SLGIIYRDLKPENILLDE--EGHIKLTDFGLSKE-SIDHEKKA 183
Query: 971 SAIAGSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ G+ Y+APE +T D +S+GV++ E+LTG P
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP 225
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-16
Identities = 58/235 (24%), Positives = 91/235 (38%), Gaps = 50/235 (21%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRA-----EILTLGKIRHRN 869
++G GA G V A TG VA+KK+ D A EI L +H N
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKI-------EPFDKPLFALRTLREIKILKHFKHEN 70
Query: 870 IVKLYGFCYHQGSNL-----LMYEYMARGSLGELLHGASSTLDWQTRFMI--ALGAAEGL 922
I+ ++ ++ E M L ++ + D ++ I L +
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLS-DDHIQYFIYQTL---RAV 125
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG---- 978
LH + HRD+K +N+L++ + V DFGLA++ID + + G
Sbjct: 126 KVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 979 -----YIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023
Y APE Y+ + D++S G +L EL R P+ G D
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR----PIFPGRDYR 229
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-15
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 29/217 (13%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAE--ILTLGKI 865
++F ++G+G+ G V+ A + T A+K L + ++ E +L+L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-W 75
Query: 866 RHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE---G 921
H + ++ + NL + EY+ G L + + F AAE G
Sbjct: 76 EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY----AAEIILG 130
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYGY 979
L +LH I +RD+K +NILLD + H+ DFG+ K +M + G+ Y
Sbjct: 131 LQFLH---SKGIVYRDLKLDNILLDK--DGHIKIADFGMCK-ENMLGDAKTNTFCGTPDY 184
Query: 980 IAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
IAPE Y V D +S+GV+L E+L G++P
Sbjct: 185 IAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 29/217 (13%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRA--EILTLGKIRHRNIVK 872
+G GA G+V A +TG VAVKKL+ + ++ ++ R E+ L ++H N++
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIG 92
Query: 873 LYGFCYHQGSNL------LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH 926
L S L+ M L ++ T D + + GL Y+H
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIH 149
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA-IAGSYGYIAPEYA 985
I HRD+K +N+ +++ E + DFGLA+ M+ +A + Y APE
Sbjct: 150 ---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD----EMTGYVATRW-YRAPEIM 201
Query: 986 YT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD 1021
M + DI+S G ++ ELLTGR L G D
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGR----TLFPGTD 234
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 66/220 (30%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAE--ILTLGKI 865
+F VIG+G+ G V A + AVK L + +E +L +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK-NV 96
Query: 866 RHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGEL---LHGASSTLDWQTRFMIALGAAE- 920
+H +V L+ F + L + +Y+ G GEL L L+ + RF AAE
Sbjct: 97 KHPFLVGLH-FSFQTADKLYFVLDYI-NG--GELFYHLQRERCFLEPRARFY----AAEI 148
Query: 921 --GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGS 976
L YLH I +RD+K NILLD + H+ DFGL K ++ + + S G+
Sbjct: 149 ASALGYLH---SLNIVYRDLKPENILLDS--QGHIVLTDFGLCKE-NIEHNSTTSTFCGT 202
Query: 977 YGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
Y+APE Y V D + G VL E+L G P
Sbjct: 203 PEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 54/254 (21%), Positives = 89/254 (35%), Gaps = 55/254 (21%)
Query: 808 TDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNS--FRAEILTLGK 864
D ++ R +IG G+ G V A VA+KK+ R + +D R EI L +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILR-EIAILNR 108
Query: 865 IRHRNIVKLYGFCYHQGSNL-----LMYEYMARGSLGELLHGASSTLDWQTRFMI--ALG 917
+ H ++VK+ + ++ E +L + + ++ L
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLL- 166
Query: 918 AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY 977
G+ Y+H I HRD+K N L++ V DFGLA+ +D P++ +
Sbjct: 167 --VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 978 G--------------------------YIAPE-----YAYTMKVTEKCDIYSYGVVLLEL 1006
Y APE YT + D++S G + EL
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----DVWSIGCIFAEL 277
Query: 1007 LTGRAPVQPLDQGG 1020
L
Sbjct: 278 LNMIKENVAYHADR 291
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 4e-15
Identities = 63/276 (22%), Positives = 100/276 (36%), Gaps = 56/276 (20%)
Query: 780 QDKQLSSTVSDIYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAV-LRTGHTVAV 838
SS ++YF + DN+ + +IGRG+ G VY A T VA+
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHV------PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAI 56
Query: 839 KKLASNREGNNNVD--NSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL-----LMYEYMA 891
KK+ NR + +D R EI L +++ I++LY ++ E
Sbjct: 57 KKV--NRMFEDLIDCKRILR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD 113
Query: 892 RGSLGELLHGASSTLDWQTRFMI--ALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF 949
L +L + + ++ L G +++H + I HRD+K N LL+
Sbjct: 114 S-DLKKLFKTPIFLTEEHIKTILYNLL---LGENFIH---ESGIIHRDLKPANCLLNQDC 166
Query: 950 EAHVGDFGLAKVIDMPQSKSMSAIAGSYG---------------------YIAPE----- 983
V DFGLA+ I+ + ++ Y APE
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019
YT + DI+S G + ELL
Sbjct: 227 ENYTKSI----DIWSTGCIFAELLNMLQSHINDPTN 258
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 34/185 (18%), Positives = 71/185 (38%), Gaps = 15/185 (8%)
Query: 97 NIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILN 156
GL + +L ++ + S ++ N +N+ ++ + + ++L L+
Sbjct: 14 PDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELH 69
Query: 157 IYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPS 216
+ +N+IS P + L+ L +L N + L RL N +
Sbjct: 70 LSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELRD--TD 122
Query: 217 EIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLA 276
+ ++L+ L + N+L I +G L L + L GN+++ L + +
Sbjct: 123 SLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWID 178
Query: 277 LYDNK 281
L K
Sbjct: 179 LTGQK 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 40/220 (18%), Positives = 87/220 (39%), Gaps = 17/220 (7%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141
NL K +++ + L + + + + ++ + ++L+ L+L++N++
Sbjct: 23 KQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISDL 78
Query: 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLK 201
P L +L+ L L++ NR+ + LS+L +N + L +LK L+
Sbjct: 79 SP--LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELR-DTDS-LIHLKNLE 131
Query: 202 SFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGV 261
N + S+ +G L+ L L N+++ + LK + + L G +
Sbjct: 132 ILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNE 187
Query: 262 IPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYI 301
K T+ D + + P + + GS +
Sbjct: 188 PVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCV 225
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 38/197 (19%), Positives = 73/197 (37%), Gaps = 21/197 (10%)
Query: 112 NQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIG 171
+++ P ++ NL + + LS + N N+ I +
Sbjct: 7 TPINQVFP--DPGLANAVKQNLGKQSVT-DL-VSQKELSGVQNFNGDNSNIQSLAG--MQ 60
Query: 172 KLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCE--SLQYLGL 229
+ L +L N IS L P L +L +L+ +N + + G L L L
Sbjct: 61 FFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFL 113
Query: 230 AQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKE 289
N+L + LK L + + N+L ++ LG + LE L L+ N ++
Sbjct: 114 DNNELRD--TDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGN-EITNT-GG 167
Query: 290 LGSIGSLKYLYIYRNEL 306
L + + ++ + +
Sbjct: 168 LTRLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 44/205 (21%), Positives = 75/205 (36%), Gaps = 16/205 (7%)
Query: 461 CKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDN 520
+ V+ LG S T +L+ + D + + L+ LHLS N
Sbjct: 18 LANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHLSHN 73
Query: 521 YFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGS 580
+ +L + +L+ L +V+ N L L L RL L N+ +
Sbjct: 74 QIS-DLS-PLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRDTDS--LIH 126
Query: 581 LFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSY 640
L LE+L + N+L SI +G LS+L L + GN + L L + ++L+
Sbjct: 127 LKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNW-IDLTG 181
Query: 641 NNLSGLIPPELGNLILLEYLLLNNN 665
L + + +
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDG 206
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 40/219 (18%), Positives = 72/219 (32%), Gaps = 16/219 (7%)
Query: 480 SDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTF 539
LAN L + + + + +Q + ++ L + +NL
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKEL 68
Query: 540 NVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIP 599
++S N ++ PL+ L+ L ++ N+ L L L NEL +
Sbjct: 69 HLSHNQISDLSPLK--DLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRDTDS 123
Query: 600 VQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEY 659
+ +L L L + N + LG LS L++ L+L N ++ L L + +
Sbjct: 124 --LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEV-LDLHGNEITNTGG--LTRLKKVNW 176
Query: 660 LLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSS 698
+ L E L P S
Sbjct: 177 IDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYIS 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 43/228 (18%), Positives = 82/228 (35%), Gaps = 19/228 (8%)
Query: 295 SLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKL 354
+ + + + + +LS + + I + + L+ L+L N++
Sbjct: 20 NAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNS-NIQSLA-GMQFFTNLKELHLSHNQI 75
Query: 355 TGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYS 414
+ + P L L L +L ++ N L + L L L +N L L
Sbjct: 76 SDLSP--LKDLTKLEELSVNRNRLKNLNGIP---SACLSRLFLDNNELRDTDS--LIHLK 128
Query: 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSF 474
L ++ + +N L I + + L L+L N++T + G+TR K + + L G
Sbjct: 129 NLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKC 184
Query: 475 TGSFPSDLCKLANLSTVE-LDQNQFSGPIPTEIGNCNALQRLHLSDNY 521
+L +TV+ D S P I N + +
Sbjct: 185 VNEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWEL 229
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-15
Identities = 67/220 (30%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAE--ILTLGKI 865
DNF+ V+G+G+ G V A ++ TG AVK L + ++ E IL+L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-R 81
Query: 866 RHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALG---AAE- 920
H + +L+ C+ L + E++ G L + H + RF A AAE
Sbjct: 82 NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFH-----IQKSRRFDEARARFYAAEI 133
Query: 921 --GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGS 976
L +LH I +RD+K +N+LLD E H DFG+ K + + + G+
Sbjct: 134 ISALMFLH---DKGIIYRDLKLDNVLLDH--EGHCKLADFGMCK-EGICNGVTTATFCGT 187
Query: 977 YGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
YIAPE Y V D ++ GV+L E+L G AP
Sbjct: 188 PDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-15
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNR-EGNNNVDNSFRAEILTLGKIR 866
D FD +G G+ G V + +G+ A+K L + ++++ E L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVN 99
Query: 867 HRNIVKLYGFCYHQGSNLLM-YEYMARGSLGELLHGASSTLDWQTRFMIALGAAE---GL 922
+VKL F + SNL M EY+A G + L + RF AA+
Sbjct: 100 FPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY----AAQIVLTF 154
Query: 923 SYLH-HDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYGY 979
YLH D + +RD+K N+L+D + ++ DFG AK + + G+
Sbjct: 155 EYLHSLD----LIYRDLKPENLLIDQ--QGYIQVTDFGFAKRVK----GRTWTLCGTPEA 204
Query: 980 IAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+APE Y V D ++ GV++ E+ G P
Sbjct: 205 LAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-15
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 43/224 (19%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREG----NNNVDNSFRAE--ILT 861
+F+ V+G+G+ G V + + T AVK L ++ +++V+ E +L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---KKDVVIQDDDVE-CTMVEKRVLA 75
Query: 862 LGKIRHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALG--- 917
L + + +L+ C+ L + EY+ G L + H + RF
Sbjct: 76 LP-GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYH-----IQQVGRFKEPHAVFY 126
Query: 918 AAE---GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSA 972
AAE GL +L I +RD+K +N++LD E H+ DFG+ K ++ +
Sbjct: 127 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKE-NIWDGVTTKT 180
Query: 973 IAGSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
G+ YIAPE Y V D +++GV+L E+L G+AP
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-15
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAE--ILTLGKI 865
+FD VIGRG+ V L+ T A+K + ++ + + E +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-S 67
Query: 866 RHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALG---AAE- 920
H +V L+ C+ S L + EY+ G G+L+ + Q + +AE
Sbjct: 68 NHPFLVGLH-SCFQTESRLFFVIEYV-NG--GDLMF----HMQRQRKLPEEHARFYSAEI 119
Query: 921 --GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGS 976
L+YLH + I +RD+K +N+LLD E H+ D+G+ K + + S G+
Sbjct: 120 SLALNYLH---ERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCK-EGLRPGDTTSTFCGT 173
Query: 977 YGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
YIAPE Y V D ++ GV++ E++ GR+P
Sbjct: 174 PNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 209
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 78.3 bits (192), Expect = 7e-15
Identities = 32/152 (21%), Positives = 65/152 (42%), Gaps = 7/152 (4%)
Query: 40 LLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGY-LS--P 96
LL + + + + L +P + + + + ++ ++L+ L+
Sbjct: 398 LLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLC 457
Query: 97 NIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILN 156
++ L+ +T LDLS N+L +P + LEVL ++N LE ++ + NL L L
Sbjct: 458 HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELL 514
Query: 157 IYNNRISG-PFPKEIGKLSALSQLVAYSNNIS 187
+ NNR+ + + L L N++
Sbjct: 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 76.7 bits (188), Expect = 2e-14
Identities = 32/225 (14%), Positives = 73/225 (32%), Gaps = 29/225 (12%)
Query: 94 LSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLE-------------VLNLNNNRLEA 140
+ L +LS + + + E+ +C L+ +L +
Sbjct: 341 WCRDSATDEQLFRCELSVEKSTV-LQSELESCKELQELEPENKWCLLTIILLMRALDPLL 399
Query: 141 HIPKELGNLSSLTILNIYN--------NRISGPFPKEIGKLSALSQLVAYSNNISGSLPP 192
+ + L S+L ++ ++ + + + L ++ ++
Sbjct: 400 YEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLC 457
Query: 193 TLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVI 252
L L + N + +LP + L+ L + N L + + L L +++
Sbjct: 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELL 514
Query: 253 LWGNQLSGV-IPKELGNCTSLETLALYDNKQVGQLPKELGSIGSL 296
L N+L + L +C L L L N + Q + +
Sbjct: 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGN-SLCQEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.9 bits (178), Expect = 3e-13
Identities = 53/285 (18%), Positives = 87/285 (30%), Gaps = 24/285 (8%)
Query: 407 PQRLGAYSQLWVVDLSDNHLTGKIPRH-----ICRNTSLIFLNLETNKLTGSIPTGVTRC 461
P S +W+ DL L ++P+H + S L ++
Sbjct: 290 PDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATD 348
Query: 462 KSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNY 521
+ L + L T S+L L +E + T I AL L
Sbjct: 349 EQLFRCELSVEKST-VLQSELESCKELQELEPENKWCL---LTIILLMRALDPLLYEKET 404
Query: 522 FTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSL 581
+ + + + + ++ L L+ + + L
Sbjct: 405 LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQL 462
Query: 582 FQLELLKLSENELSGSIPVQIGNLSRLTELQMGGN---SFSGGIPAELGSLSSLQIALNL 638
+ L LS N L ++P + L L LQ N + G + +L LQ L L
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG-----VANLPRLQE-LLL 515
Query: 639 SYNNLSGL-IPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLL 682
N L L + L L L N L + G L+ +L
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.2 bits (171), Expect = 2e-12
Identities = 41/267 (15%), Positives = 78/267 (29%), Gaps = 35/267 (13%)
Query: 109 LSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPK 168
+ ++ L L+ + + EL + L L N
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCL---LT 387
Query: 169 EIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLG 228
I + AL L+ + + R ++ ++ L
Sbjct: 388 IILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLH 447
Query: 229 LAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPK 288
LA L+ + + L +T + L N+L +P L LE L DN + +
Sbjct: 448 LAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDN-ALENVD- 502
Query: 289 ELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLY 348
+ ++ L+ L + N +L + I L L LL
Sbjct: 503 GVANLPRLQELLLCNN-----------RLQQSAAIQ------------PLVSCPRLVLLN 539
Query: 349 LFENKLTGVIPVE---LTTLKNLTKLD 372
L N L ++ L +++ +
Sbjct: 540 LQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.9 bits (165), Expect = 1e-11
Identities = 49/313 (15%), Positives = 95/313 (30%), Gaps = 24/313 (7%)
Query: 127 SLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNI 186
++ L + L S + L + + V +
Sbjct: 246 CCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLP 305
Query: 187 SGSLPPTLGNLKRLKSFRAGQNLIS--------GSLPSEIGGCESLQYLGLAQNQLSGEI 238
+ SL L + + + E L L+ + + +
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364
Query: 239 PKEIGMLKYLTDVIL---WGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGS 295
E+ K L ++ W ++ + L + Y + P +
Sbjct: 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD 424
Query: 296 LKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLT 355
L+ ++ N + ++ L + L + L ++L + L L N+L
Sbjct: 425 LRSKFLLENSVLKMEYADVRVL------HLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR 476
Query: 356 GVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVG-GIPQRLGAYS 414
+P L L+ L L S N+L + G L L L L +N L Q L +
Sbjct: 477 -ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCP 533
Query: 415 QLWVVDLSDNHLT 427
+L +++L N L
Sbjct: 534 RLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 52/328 (15%), Positives = 94/328 (28%), Gaps = 39/328 (11%)
Query: 386 FQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNL 445
+ + N D S Y + W++ ++ H H+ R + + +
Sbjct: 212 LELVQNAFFTDPNDQSA--------WFYHR-WLLGRAEPHDVLCCV-HVSREEACLSVCF 261
Query: 446 ETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTE 505
GS + L + + G L +L L+
Sbjct: 262 SRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVI 321
Query: 506 IGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDL 565
++ + L R+ L +S T + E+ SCK LQ L+
Sbjct: 322 WTGSDSQKECVLL-KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEP 379
Query: 566 SWN-------------KFVGALPREIGSLFQLELL--------KLSENELSGSIPVQIGN 604
+ + L+ + ++ V
Sbjct: 380 ENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKME 439
Query: 605 LSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNN 664
+ + L + + + L L + L+LS+N L +PP L L LE L ++
Sbjct: 440 YADVRVLHLAHKDLT--VLCHLEQLLLVTH-LDLSHNRLRA-LPPALAALRCLEVLQASD 495
Query: 665 NHLSGEIPGSFVNLSSLLGCNFSYNNLT 692
N L + G NL L N L
Sbjct: 496 NALE-NVDG-VANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 3e-10
Identities = 48/278 (17%), Positives = 81/278 (29%), Gaps = 40/278 (14%)
Query: 324 DFSENSLIGEIPVELSKILGLELLYLFENKL----TGVIPVELTTLKNLTKLDLSINSLT 379
D SL ++P +++ E L + T + L + +LS+ T
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST 362
Query: 380 GTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTS 439
+ + L L+ + + I + A L + +
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF------------- 408
Query: 440 LIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFS 499
+ L P L L NS +D+ L L +
Sbjct: 409 --------STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLH------LAHKDLT 454
Query: 500 GPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKM 559
+ + L LS N LP + L L S N L + + +
Sbjct: 455 VLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPR 509
Query: 560 LQRLDLSWNKFVGALP--REIGSLFQLELLKLSENELS 595
LQ L L N+ + + + S +L LL L N L
Sbjct: 510 LQELLLCNNR-LQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 51/248 (20%), Positives = 92/248 (37%), Gaps = 50/248 (20%)
Query: 812 DERFVI----GRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
D R+++ G G TV+ A + VA+K + ++ + EI L ++
Sbjct: 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE----AAEDEIKLLQRVN 73
Query: 867 -----------HRNIVKLYGFCYHQGSNL----LMYEYMARGSLGELL-----HGASSTL 906
+I+KL H+G N +++E + +L L+ G
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIY 132
Query: 907 DWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAH------VGDFGLAK 960
Q I+ GL Y+H C I H DIK N+L++ + D G A
Sbjct: 133 VKQ----ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA- 185
Query: 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG 1020
+ + + Y +PE DI+S ++ EL+TG L +
Sbjct: 186 ---CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG----DFLFEPD 238
Query: 1021 DLVTWVRN 1028
+ ++ ++
Sbjct: 239 EGHSYTKD 246
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAE--ILTLGKI 865
+FD VIGRG+ V L+ T A++ + ++ + + E +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-S 110
Query: 866 RHRNIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHGASSTLDWQTRFMIALG---AAE- 920
H +V L+ C+ S L + EY+ G G+L+ + Q + +AE
Sbjct: 111 NHPFLVGLH-SCFQTESRLFFVIEYV-NG--GDLMF----HMQRQRKLPEEHARFYSAEI 162
Query: 921 --GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGS 976
L+YLH + I +RD+K +N+LLD E H+ D+G+ K + + S G+
Sbjct: 163 SLALNYLH---ERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKE-GLRPGDTTSTFCGT 216
Query: 977 YGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
YIAPE Y V D ++ GV++ E++ GR+P
Sbjct: 217 PNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 252
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 4e-14
Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 33/217 (15%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLA-SNREGNNNVDNSFRAEILTLGKIR 866
+F +G G+ G V+ R G A+K L V+++ E L L +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIVT 64
Query: 867 HRNIVKLYGFCYHQGSNLLM-YEYMARGSLGELLHGASSTLDWQTRFMIALGAAE---GL 922
H I++++ + + M +Y+ G L LL + + +F AAE L
Sbjct: 65 HPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY----AAEVCLAL 119
Query: 923 SYLH-HDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYGY 979
YLH D I +RD+K NILLD H+ DFG AK + + G+ Y
Sbjct: 120 EYLHSKD----IIYRDLKPENILLDK--NGHIKITDFGFAKYVP----DVTYTLCGTPDY 169
Query: 980 IAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
IAPE Y + D +S+G+++ E+L G P
Sbjct: 170 IAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-14
Identities = 57/248 (22%), Positives = 100/248 (40%), Gaps = 70/248 (28%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEIL---TLGKIR----- 866
+G+GA G V++++ RTG VAVKK+ ++F+ T +I
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIF----------DAFQNSTDAQRTFREIMILTEL 65
Query: 867 --HRNIVKLYGFCYHQGSN--LLMYEYMARGS-LGELLHGASSTL-DWQTRFMI--ALGA 918
H NIV L L+++YM + L ++ ++ L ++++ +
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIR--ANILEPVHKQYVVYQLI-- 119
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG 978
+ + YLH + HRD+K +NILL+ + V DFGL++ + + +
Sbjct: 120 -KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 979 --------------------YIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRAPV 1013
Y APE YT + D++S G +L E+L G+
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILGEILCGK--- 228
Query: 1014 QPLDQGGD 1021
P+ G
Sbjct: 229 -PIFPGSS 235
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 7e-14
Identities = 62/243 (25%), Positives = 90/243 (37%), Gaps = 54/243 (22%)
Query: 805 VVATDNFDERFVI----GRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRA-- 857
V D+ R+ + G+G+ G V +A + VA+K + N R
Sbjct: 89 QVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-------RNEKRFHRQAA 141
Query: 858 -EILTLGKIRHR------NIVKLYGFCYHQG----------SNLLMYEYMARGSLGELLH 900
EI L +R + N++ + + NL YE + +
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNL--YELIKKNKF----Q 195
Query: 901 GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL--DDKFEAHVGDFGL 958
G S L R A + L LH K RI H D+K NILL + V DFG
Sbjct: 196 GFSLPL---VR-KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248
Query: 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018
+ + + + S Y APE + D++S G +L ELLTG PL
Sbjct: 249 S----CYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG----YPLLP 300
Query: 1019 GGD 1021
G D
Sbjct: 301 GED 303
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 60/271 (22%), Positives = 97/271 (35%), Gaps = 62/271 (22%)
Query: 789 SDIYFPPKEGFTFKDLVVATDNFDE---------------RFVI----GRGACGTVYRAV 829
++YF K+ V D +D+ R+ I G+G+ G V +A
Sbjct: 16 ENLYFQSMS-SHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAY 74
Query: 830 -LRTGHTVAVKKLASNREGNNNVDNSFRA---EILTLGKIRHR------NIVKLYGFCYH 879
VA+K + N E+ L + IV L
Sbjct: 75 DRVEQEWVAIKII-------KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127
Query: 880 QGSNLLMYEYMARGSLGELL-----HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+ L++E ++ +L +LL G S L TR A L +L + I
Sbjct: 128 RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNL---TR-KFAQQMCTALLFLATP-ELSII 181
Query: 935 HRDIKSNNILLDDKFEAHVGDFGLAKVID----MPQSKSMSAIAGSYGYIAPEYAYTMKV 990
H D+K NILL + + + K++D + + S Y +PE M
Sbjct: 182 HCDLKPENILLCNPKRSAI------KIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPY 235
Query: 991 TEKCDIYSYGVVLLELLTGRAPVQPLDQGGD 1021
D++S G +L+E+ TG PL G +
Sbjct: 236 DLAIDMWSLGCILVEMHTGE----PLFSGAN 262
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 32/134 (23%), Positives = 61/134 (45%), Gaps = 12/134 (8%)
Query: 347 LYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDN---SL 402
+ L +N + + P + K L ++DLS N ++ + FQ L +L L L+ N L
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 403 VGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLTGSIPTGV-TR 460
+ + L L ++ L+ N + + ++ +L L+L NKL +I G +
Sbjct: 96 PKSLFEGL---FSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSP 150
Query: 461 CKSLVQLRLGGNSF 474
+++ + L N F
Sbjct: 151 LRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 37/169 (21%), Positives = 64/169 (37%), Gaps = 40/169 (23%)
Query: 117 NIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRIS----GPFPKEIGK 172
N+P ++ + L N ++ P L +++ NN+IS F
Sbjct: 29 NLP------ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAF----QG 78
Query: 173 LSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQN 232
L +L+ LV Y N I+ LP +L F L SLQ L L N
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSL--------FE--------GLF-------SLQLLLLNAN 114
Query: 233 QLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
+++ + + L L + L+ N+L + +++T+ L N
Sbjct: 115 KIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 36/156 (23%), Positives = 58/156 (37%), Gaps = 21/156 (13%)
Query: 352 NKLTGV---IPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDNSLVG--- 404
LT + +P +T++ L N++ IP G F L + L +N +
Sbjct: 21 KGLTEIPTNLPE------TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAP 73
Query: 405 GIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLTGSIPTGV-TRCK 462
Q L + + L L N +T ++P+ + SL L L NK+ +
Sbjct: 74 DAFQGLRSLNSLV---LYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLH 128
Query: 463 SLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQF 498
+L L L N L + T+ L QN F
Sbjct: 129 NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 32/131 (24%), Positives = 54/131 (41%), Gaps = 6/131 (4%)
Query: 105 TALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISG 164
T + L N + P L ++L+NN++ P L SL L +Y N+I+
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 165 PFPKEI-GKLSALSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GGC 221
PK + L +L L+ +N I+ L +L L N + ++
Sbjct: 95 -LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPL 151
Query: 222 ESLQYLGLAQN 232
++Q + LAQN
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 36/151 (23%), Positives = 55/151 (36%), Gaps = 30/151 (19%)
Query: 253 LWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKEL-GSIGSLKYLYIYRNELNGTIP 311
L N + + P L + L +N Q+ +L + + SL L +Y N++ +P
Sbjct: 39 LEQNTIKVIPPGAFSPYKKLRRIDLSNN-QISELAPDAFQGLRSLNSLVLYGNKIT-ELP 96
Query: 312 REI-GKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTK 370
+ + L S L+LL L NK+ + L NL
Sbjct: 97 KSLFEGLFS------------------------LQLLLLNANKINCLRVDAFQDLHNLNL 132
Query: 371 LDLSINSLTGTIPLG-FQYLTNLIMLQLFDN 400
L L N L TI G F L + + L N
Sbjct: 133 LSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 32/123 (26%), Positives = 50/123 (40%), Gaps = 5/123 (4%)
Query: 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFS 619
+ L N P +L + LS N++S + L L L + GN +
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 620 GGIPAEL-GSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNL 678
+P L L SLQ+ L L+ N ++ L +L L L L +N L G+F L
Sbjct: 94 E-LPKSLFEGLFSLQL-LLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 679 SSL 681
++
Sbjct: 152 RAI 154
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 33/167 (19%), Positives = 58/167 (34%), Gaps = 37/167 (22%)
Query: 502 IPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIFSC-KM 559
+P I + L N +P L ++S+N ++ + + F +
Sbjct: 30 LPETI------TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 560 LQRLDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSF 618
L L L NK LP+ + LF L+LL L+ N+++ + V L L +
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRV--DAFQDLHNLNL----- 132
Query: 619 SGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNN 665
L+L N L + L ++ + L N
Sbjct: 133 -----------------LSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 27/108 (25%), Positives = 54/108 (50%), Gaps = 9/108 (8%)
Query: 84 NLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNR 137
L +++LS L+P+ GL L +L L N+++ +PK + SL++L LN N+
Sbjct: 57 KLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANK 115
Query: 138 LEAHIPKEL-GNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSN 184
+ + + +L +L +L++Y+N++ L A+ + N
Sbjct: 116 IN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 35/154 (22%), Positives = 60/154 (38%), Gaps = 21/154 (13%)
Query: 69 VNCTTNDFGAV--VFSLNLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKE 121
V+C + +T++ L + P L +DLS NQ+ + +
Sbjct: 16 VDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPD 74
Query: 122 I-GNCSSLEVLNLNNNRLEAHIPKEL-GNLSSLTILNIYNNRIS----GPFPKEIGKLSA 175
SL L L N++ +PK L L SL +L + N+I+ F L
Sbjct: 75 AFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAF----QDLHN 129
Query: 176 LSQLVAYSNNISGSLPP-TLGNLKRLKSFRAGQN 208
L+ L Y N + ++ T L+ +++ QN
Sbjct: 130 LNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 15/57 (26%), Positives = 23/57 (40%)
Query: 636 LNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692
+ L N + + P L + L+NN +S P +F L SL N +T
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 60/311 (19%), Positives = 96/311 (30%), Gaps = 59/311 (18%)
Query: 344 LELLYLFENKLT--GVIPV--ELTTLKNLTKLDLSINSLT--GTIPLG--FQYLTNLIML 395
+E L + +T V L ++ ++ LS N++ L +L +
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 396 QLFDNSL----------VGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICR----NTSLI 441
+ D + + Q L +L V LSDN + +T L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 442 FLNLETNKLT-------------GSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKL--- 485
L L N L ++ L + G N + K
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 486 -ANLSTVELDQNQF-----SGPIPTEIGNCNALQRLHLSDNYFTGE----LPREVGNLSN 535
L TV++ QN + + C L+ L L DN FT L + + N
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245
Query: 536 LVTFNVSSNFLTGR------IPLEIFSCKMLQRLDLSWNKF----VGALPREIGS-LFQL 584
L ++ L+ R LQ L L +N+ V L I + L
Sbjct: 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 305
Query: 585 ELLKLSENELS 595
L+L+ N S
Sbjct: 306 LFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 48/329 (14%), Positives = 96/329 (29%), Gaps = 71/329 (21%)
Query: 104 LTALDLSFNQLS----RNIPKEIGNCSSLEVLNLNNNRLE----AHIPKELGNLSSLTIL 155
+ L + ++ +++ + S++ + L+ N + + + + + L I
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 156 NIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISG--- 212
+ + L L Q L +L + R N
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQ--------------ALLKCPKLHTVRLSDNAFGPTAQ 111
Query: 213 -SLPSEIGGCESLQYLGLAQNQLSGE-------------IPKEIGMLKYLTDVILWGNQL 258
L + L++L L N L + + K+ L +I N+L
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
Query: 259 SGV----IPKELGNCTSLETLALYDNKQVGQ------LPKELGSIGSLKYLYIYRNELNG 308
K + L T+ + N + L + L LK L + N
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQN-GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT- 229
Query: 309 TIPREIGKLSSAL-------EIDFSENSLIGEIPVELSKILG------LELLYLFENKLT 355
L+ AL E+ ++ L + L+ L L N++
Sbjct: 230 --HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
Query: 356 GVIPVEL-----TTLKNLTKLDLSINSLT 379
L + +L L+L+ N +
Sbjct: 288 LDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 60/414 (14%), Positives = 110/414 (26%), Gaps = 113/414 (27%)
Query: 127 SLEVLNLNNNRLEA----HIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAY 182
S+E +L + + + L S+ + + N I + + +
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN--------- 55
Query: 183 SNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEI 242
+ + K L+ L L +
Sbjct: 56 -----------IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ-ALLKC---------- 93
Query: 243 GMLKYLTDVILWGNQLS--GVIP--KELGNCTSLETLALYDNKQVGQLPKELGSIGSLKY 298
L V L N P L T LE L L++N LG
Sbjct: 94 ---PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG--------LGPQA---- 138
Query: 299 LYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLT--G 356
K++ AL+ L + N+L
Sbjct: 139 ---------------GAKIARALQELAVNKKAKN--------APPLRSIICGRNRLENGS 175
Query: 357 VIPV--ELTTLKNLTKLDLSINSLT-----GTIPLGFQYLTNLIMLQLFDNSL----VGG 405
+ + + L + + N + + G Y L +L L DN+
Sbjct: 176 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 235
Query: 406 IPQRLGAYSQLWVVDLSDNHLTGKIPRHI------CRNTSLIFLNLETNKLTGSIPTGV- 458
+ L ++ L + L+D L+ + + N L L L+ N++ V
Sbjct: 236 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE---LDAVR 292
Query: 459 -------TRCKSLVQLRLGGNSFT--GSFPSDLCKL----ANLSTVELDQNQFS 499
+ L+ L L GN F+ ++ ++ ELD +
Sbjct: 293 TLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEEL 346
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 43/220 (19%), Positives = 65/220 (29%), Gaps = 41/220 (18%)
Query: 103 HLTALDLSFNQLS----RNIPKEIGNCSSLEVLNLNNNRL-------------EAHIPKE 145
L + LS N + + + LE L L+NN L E + K+
Sbjct: 95 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKK 154
Query: 146 LGNLSSLTILNIYNNRISGPFPKEIGKL----SALSQLVAYSNNI-----SGSLPPTLGN 196
N L + NR+ KE K L + N I L L
Sbjct: 155 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY 214
Query: 197 LKRLKSFRAGQNLISG----SLPSEIGGCESLQYLGLAQNQLSGEIPKEIG-MLKY---- 247
+ LK N + +L + +L+ LGL LS +
Sbjct: 215 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI 274
Query: 248 -LTDVILWGNQLSGVIPKELG-----NCTSLETLALYDNK 281
L + L N++ + L L L L N+
Sbjct: 275 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 48/197 (24%), Positives = 68/197 (34%), Gaps = 43/197 (21%)
Query: 502 IPTEIGNCNALQRLHLSDNYFTGELPREV--GNLSNLVTFNVSSNFLTGRIPLEIFS-CK 558
+P+ L LS N + L E L+NL + +S N L I E F
Sbjct: 37 LPSYT------ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 559 MLQRLDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNS 617
L+ LDLS N L + L LE+L L N + + N+
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVD---------------RNA 131
Query: 618 FSGGIPAELGSLSSLQIALNLSYNNLSGLIPPE----LGNLILLEYLLLNNNHLSGEIPG 673
F ++ LQ L LS N +S P E L L L L++N L
Sbjct: 132 FED--------MAQLQK-LYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLT 181
Query: 674 SFVNLSSLLGCNFSYNN 690
L + + +N
Sbjct: 182 DLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 8e-12
Identities = 42/185 (22%), Positives = 69/185 (37%), Gaps = 27/185 (14%)
Query: 64 CGWIGVNCTTNDFGAV-------VFSLNLTKMNLSGYLSPNI--GGLVHLTALDLSFNQL 114
C ++C+ V L+L+ NLS L L +L +L LS N L
Sbjct: 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL 76
Query: 115 SRNIPKEI-GNCSSLEVLNLNNNRLEAHIPKE-LGNLSSLTILNIYNNRIS----GPFPK 168
+ I E +L L+L++N L + + +L +L +L +YNN I F
Sbjct: 77 NF-ISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFE- 133
Query: 169 EIGKLSALSQLVAYSNNISGSLPP----TLGNLKRLKSFRAGQNLISGSLPSEIGGCESL 224
++ L +L N IS P L +L N + +++ +
Sbjct: 134 ---DMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW 189
Query: 225 QYLGL 229
GL
Sbjct: 190 VKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 39/171 (22%), Positives = 63/171 (36%), Gaps = 16/171 (9%)
Query: 542 SSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREI--GSLFQLELLKLSENELSGSIP 599
S L +P + S LDLS N L E L L L LS N L+ I
Sbjct: 26 SKQQLP-NVPQSLPSY--TALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FIS 80
Query: 600 VQI-GNLSRLTELQMGGNSFSGGIPAE-LGSLSSLQIALNLSYNNLSGLIPPELGNLILL 657
+ + L L + N + L +L++ L L N++ + ++ L
Sbjct: 81 SEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEV-LLLYNNHIVVVDRNAFEDMAQL 138
Query: 658 EYLLLNNNHLSGEIPGSFVN---LSSLLGCNFSYNNLTGPIPSSQTFQNMS 705
+ L L+ N +S + L L+ + S N L +P + Q +
Sbjct: 139 QKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK-LPLT-DLQKLP 187
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 40/189 (21%), Positives = 66/189 (34%), Gaps = 36/189 (19%)
Query: 223 SLQYLGLAQNQLSGEIPKEI--GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
L L+ N LS + E L L ++L N L+ + + +L L L N
Sbjct: 40 YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98
Query: 281 KQVGQLPKE-LGSIGSLKYLYIYRNELNGTIPREI-GKLSSALEIDFSENSLIGEIPVEL 338
+ L + + +L+ L +Y N + + R ++
Sbjct: 99 -HLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQ------------------- 137
Query: 339 SKILGLELLYLFENKLTGVIP---VELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIM- 394
L+ LYL +N+++ + L L LDLS N L Q L +
Sbjct: 138 -----LQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKN 192
Query: 395 -LQLFDNSL 402
L L +N L
Sbjct: 193 GLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 42/187 (22%), Positives = 64/187 (34%), Gaps = 42/187 (22%)
Query: 367 NLTKLDLSINSLTGTIPLG--FQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDN 424
LDLS N+L+ + LTNL L L N L I A+ +
Sbjct: 40 YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISS--EAFVPV-------- 87
Query: 425 HLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFT----GSFP 479
+L +L+L +N L ++ + + ++L L L N +F
Sbjct: 88 -------------PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFE 133
Query: 480 SDLCKLANLSTVELDQNQFSGPIPTEI----GNCNALQRLHLSDNYFTGELPREVGNLSN 535
+A L + L QNQ S P E+ L L LS N ++ L
Sbjct: 134 ----DMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPA 188
Query: 536 LVTFNVS 542
V +
Sbjct: 189 WVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 32/159 (20%), Positives = 55/159 (34%), Gaps = 12/159 (7%)
Query: 295 SLKYLYIYRNELNGTIPREI--GKLSSALEIDFSENSLIGEIPVE-LSKILGLELLYLFE 351
L + N L + E +L++ + S N + I E + L L L
Sbjct: 40 YTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDLSS 97
Query: 352 NKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDNSLVGGIPQR- 409
N L + + L+ L L L N + + F+ + L L L N + P
Sbjct: 98 NHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155
Query: 410 ---LGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNL 445
+L ++DLS N L + + + + L
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 23/90 (25%), Positives = 39/90 (43%), Gaps = 12/90 (13%)
Query: 84 NLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKEI----GNCSSLEVLNLN 134
L + L + N + L L LS NQ+SR P E+ L +L+L+
Sbjct: 113 ALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLS 171
Query: 135 NNRLEAHIPKELGNLSSLT--ILNIYNNRI 162
+N+L+ +L L + L ++NN +
Sbjct: 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 22/163 (13%)
Query: 344 LELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDNSL 402
++ + + + V ++ L N+ L L N L + + LTNL L L N L
Sbjct: 43 IDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLH---DISALKELTNLTYLILTGNQL 97
Query: 403 V---GGIPQRLGAYSQLWVVDLSDNHLTGKIPRHIC-RNTSLIFLNLETNKLTGSIPTGV 458
G+ +L + L + L +N L +P + + T+L +LNL N+L S+P GV
Sbjct: 98 QSLPNGVFDKL---TNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGV 152
Query: 459 -TRCKSLVQLRLGGNSFTGSFPS---DLCKLANLSTVELDQNQ 497
+ +L +L L N S P D KL L + L QNQ
Sbjct: 153 FDKLTNLTELDLSYNQLQ-SLPEGVFD--KLTQLKDLRLYQNQ 192
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 53/232 (22%), Positives = 84/232 (36%), Gaps = 48/232 (20%)
Query: 63 PCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLS------PNIGGLVHLTALDLSFNQLSR 116
I N V L ++ + I L ++ L L N+L
Sbjct: 18 FAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKL-- 75
Query: 117 NIPKEIG---NCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI----SGPFPKE 169
+I ++L L L N+L++ L++L L + N++ G F
Sbjct: 76 ---HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVF--- 129
Query: 170 IGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGL 229
KL+ L+ L N + SLP G +L +L L L
Sbjct: 130 -DKLTNLTYLNLAHNQLQ-SLPK--GVFDKLT---------------------NLTELDL 164
Query: 230 AQNQLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
+ NQL +P+ + L L D+ L+ NQL V TSL+ + L+DN
Sbjct: 165 SYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 52/187 (27%), Positives = 77/187 (41%), Gaps = 44/187 (23%)
Query: 223 SLQYLGLAQNQLSGEIPKEIGM---LKYLTDVILWGNQLSGVIPKELGNCTSLETLALYD 279
+++YL L N+L +I L LT +IL GNQL + T+L+ L L +
Sbjct: 64 NVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118
Query: 280 NKQVGQLPKEL-GSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVEL 338
N Q+ LP + + +L YL + N+L KL++
Sbjct: 119 N-QLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTN------------------- 158
Query: 339 SKILGLELLYLFENKLTGVIPV----ELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLI 393
L L L N+L +P +LT L L L N L ++P G F LT+L
Sbjct: 159 -----LTELDLSYNQLQ-SLPEGVFDKLT---QLKDLRLYQNQLK-SVPDGVFDRLTSLQ 208
Query: 394 MLQLFDN 400
+ L DN
Sbjct: 209 YIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 45/187 (24%), Positives = 74/187 (39%), Gaps = 23/187 (12%)
Query: 513 QRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVG 572
+ +L T + + L+++ +++ + I ++ L L NK
Sbjct: 22 IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKL-- 75
Query: 573 ALPREIG---SLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGN---SFSGGIPAE 625
+I L L L L+ N+L S+P + L+ L EL + N S G+ +
Sbjct: 76 ---HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDK 131
Query: 626 LGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIP-GSFVNLSSLLGC 684
L +L+ L NL++N L L L L L L+ N L +P G F L+ L
Sbjct: 132 LTNLTYL----NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDL 186
Query: 685 NFSYNNL 691
N L
Sbjct: 187 RLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 36/134 (26%), Positives = 58/134 (43%), Gaps = 7/134 (5%)
Query: 560 LQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS 619
+ ++ + + + ++ I L + L L N+L I + L+ LT L + GN
Sbjct: 43 IDQIIANNSD-IKSVQ-GIQYLPNVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQLQ 98
Query: 620 GGIPAEL-GSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNL 678
+P + L++L+ L L N L L L L YL L +N L G F L
Sbjct: 99 S-LPNGVFDKLTNLKE-LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKL 156
Query: 679 SSLLGCNFSYNNLT 692
++L + SYN L
Sbjct: 157 TNLTELDLSYNQLQ 170
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 33/158 (20%), Positives = 60/158 (37%), Gaps = 16/158 (10%)
Query: 538 TFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGS 597
T VS+ P + + + +L + L ++ + + +++ S
Sbjct: 2 TITVSTPIKQI-FPDDA-FAE-TIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIK-S 55
Query: 598 IPVQIGNLSRLTELQMGGNSFSGGIPAELG---SLSSLQIALNLSYNNLSGLIPPELGNL 654
+ I L + L +GGN ++ L++L L L+ N L L L
Sbjct: 56 VQG-IQYLPNVRYLALGGNKLH-----DISALKELTNLTY-LILTGNQLQSLPNGVFDKL 108
Query: 655 ILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692
L+ L+L N L G F L++L N ++N L
Sbjct: 109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ 146
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.1 bits (160), Expect = 2e-11
Identities = 45/263 (17%), Positives = 73/263 (27%), Gaps = 58/263 (22%)
Query: 796 KEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVD--- 852
K F + T+ IG G G V++ + VA+K +A N
Sbjct: 8 KGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 853 --NSFRAEILTLGKI---------RHRNIVKLYGFCYHQGSN----LLMYEYMA--RGSL 895
EI+ ++ R + L QGS L +++ +GS
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 896 GE----------------------LLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRI 933
+ L + T I L+ R
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRF 183
Query: 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEK 993
HRD+ N+LL + K +P S G YT+ E+
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP----------SCGLQVSIIDYTLSRLER 233
Query: 994 --CDIYSYGVVLLELLTGRAPVQ 1014
++ + +L TG Q
Sbjct: 234 DGIVVFCDVSMDEDLFTGDGDYQ 256
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 49/133 (36%), Positives = 68/133 (51%), Gaps = 11/133 (8%)
Query: 345 ELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDN--- 400
++LYL +N++T + P +L NL +L L N L +P+G F LT L +L L N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 401 SLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-T 459
L + RL +L+ + N LT ++PR I R T L L L+ N+L SIP G
Sbjct: 102 VLPSAVFDRLVHLKELF---MCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFD 156
Query: 460 RCKSLVQLRLGGN 472
R SL L GN
Sbjct: 157 RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 41/137 (29%), Positives = 54/137 (39%), Gaps = 17/137 (12%)
Query: 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDN---SLVGGIPQRLGAYSQLWVVDLSDNH 425
L L N +T P F L NL L L N +L G+ L + L L N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLD---LGTNQ 99
Query: 426 LTGKIPRHIC-RNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFT----GSFPS 480
LT +P + R L L + NKLT +P G+ R L L L N G+F
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 481 DLCKLANLSTVELDQNQ 497
L++L+ L N
Sbjct: 158 ----LSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 38/168 (22%), Positives = 68/168 (40%), Gaps = 39/168 (23%)
Query: 117 NIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI----SGPFPKEIGK 172
IP ++ ++L L++N++ P +L +L L + +N++ G F
Sbjct: 37 GIP------TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF----DS 86
Query: 173 LSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQN 232
L+ L+ L +N ++ LP RL L+ L + N
Sbjct: 87 LTQLTVLDLGTNQLT-VLPS--AVFDRLVH---------------------LKELFMCCN 122
Query: 233 QLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
+L+ E+P+ I L +LT + L NQL + +SL L+ N
Sbjct: 123 KLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 38/125 (30%), Positives = 57/125 (45%), Gaps = 10/125 (8%)
Query: 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGN--- 616
Q L L N+ P SL L+ L L N+L ++PV + +L++LT L +G N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 617 SFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFV 676
+ L L+ L + N L+ +P + L L +L L+ N L G+F
Sbjct: 102 VLPSAV---FDRLVHLKE-LFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFD 156
Query: 677 NLSSL 681
LSSL
Sbjct: 157 RLSSL 161
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 41/128 (32%), Positives = 57/128 (44%), Gaps = 7/128 (5%)
Query: 492 ELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRI 550
L NQ + P + L+ L+L N LP V +L+ L ++ +N LT +
Sbjct: 46 YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VL 103
Query: 551 PLEIF-SCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQI-GNLSRL 608
P +F L+ L + NK LPR I L L L L +N+L SIP LS L
Sbjct: 104 PSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSL 161
Query: 609 TELQMGGN 616
T + GN
Sbjct: 162 THAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 41/150 (27%), Positives = 62/150 (41%), Gaps = 29/150 (19%)
Query: 253 LWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKEL-GSIGSLKYLYIYRNELNGTIP 311
L NQ++ + P + +L+ L L N Q+G LP + S+ L L + N+L
Sbjct: 47 LHDNQITKLEPGVFDSLINLKELYLGSN-QLGALPVGVFDSLTQLTVLDLGTNQLTVLPS 105
Query: 312 REIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKL 371
+L L+ L++ NKLT +P + L +LT L
Sbjct: 106 AVFDRLVH------------------------LKELFMCCNKLTE-LPRGIERLTHLTHL 140
Query: 372 DLSINSLTGTIPLG-FQYLTNLIMLQLFDN 400
L N L +IP G F L++L LF N
Sbjct: 141 ALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 36/133 (27%), Positives = 57/133 (42%), Gaps = 25/133 (18%)
Query: 270 TSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENS 329
T+ + L L+DN+ P S+ +LK LY+ N+L +
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL---------------------GA 78
Query: 330 LIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYL 389
L + L++ L +L L N+LT + L +L +L + N LT +P G + L
Sbjct: 79 LPVGVFDSLTQ---LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERL 134
Query: 390 TNLIMLQLFDNSL 402
T+L L L N L
Sbjct: 135 THLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 20/60 (33%), Positives = 32/60 (53%), Gaps = 1/60 (1%)
Query: 101 LVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNN 160
LVHL L + N+L+ +P+ I + L L L+ N+L++ LSSLT ++ N
Sbjct: 111 LVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 30/143 (20%), Positives = 50/143 (34%), Gaps = 14/143 (9%)
Query: 69 VNCTTNDFGAV-------VFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSR---NI 118
V+C + +V L L ++ L++L L L NQL +
Sbjct: 24 VDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV 83
Query: 119 PKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQ 178
+ L VL+L N+L L L L + N+++ P+ I +L+ L+
Sbjct: 84 FDSLTQ---LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTH 139
Query: 179 LVAYSNNISGSLPPTLGNLKRLK 201
L N + L L
Sbjct: 140 LALDQNQLKSIPHGAFDRLSSLT 162
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 46/209 (22%), Positives = 75/209 (35%), Gaps = 20/209 (9%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH-RNIVKLY 874
IG G+ G +Y + G VA+K E E ++ I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGGVGIPTIR 71
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
N+++ E + SL +L + S +T ++A + Y+H
Sbjct: 72 WCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FI 127
Query: 935 HRDIKSNNILL---DDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIA-PEYA--YTM 988
HRD+K +N L+ ++ DFGLAK ++ + YA T
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 187
Query: 989 KVTEKC---DIYSYGVVLLELLTGRAPVQ 1014
E+ D+ S G VL+ G P Q
Sbjct: 188 LGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 38/159 (23%), Positives = 61/159 (38%), Gaps = 28/159 (17%)
Query: 353 KLTGV---IPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDN---SLVGG 405
KL + IP +L L+ N T G F+ L L + +N + G
Sbjct: 22 KLNKIPEHIPQ------YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEG 75
Query: 406 IPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLTGSIPTGV-TRCKS 463
+ S + + L+ N L + + + SL L L +N++T + S
Sbjct: 76 AFEGA---SGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSS 130
Query: 464 LVQLRLGGNSFT----GSFPSDLCKLANLSTVELDQNQF 498
+ L L N T G+F + L +LST+ L N F
Sbjct: 131 VRLLSLYDNQITTVAPGAFDT----LHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 30/124 (24%), Positives = 51/124 (41%), Gaps = 6/124 (4%)
Query: 561 QRLDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSF 618
L L+ N+F I L QL + S N+++ I S + E+ + N
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93
Query: 619 SGGIPAEL-GSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVN 677
+ ++ L SL+ L L N ++ + L + L L +N ++ PG+F
Sbjct: 94 EN-VQHKMFKGLESLKT-LMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT 151
Query: 678 LSSL 681
L SL
Sbjct: 152 LHSL 155
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 36/164 (21%), Positives = 63/164 (38%), Gaps = 17/164 (10%)
Query: 124 NCSSLEVLNLNNNRLEA---HIPKELGNLSSLTILNIYNNRISGPFPKEI-GKLSALSQL 179
C V + +N +L HIP L + NN + I KL L ++
Sbjct: 10 RCEGTTV-DCSNQKLNKIPEHIP------QYTAELRLNNNEFTVLEATGIFKKLPQLRKI 62
Query: 180 VAYSNNISGSLPP-TLGNLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQLSGE 237
+N I+ + + N + ++ ++ G ESL+ L L N+++
Sbjct: 63 NFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-C 119
Query: 238 IPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
+ + L + + L+ NQ++ V P SL TL L N
Sbjct: 120 VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 31/136 (22%), Positives = 51/136 (37%), Gaps = 9/136 (6%)
Query: 270 TSLETLALYDNKQVGQLPKE--LGSIGSLKYLYIYRNELNGTIPREI-GKLSSALEIDFS 326
L L +N + L + L+ + N++ I S EI +
Sbjct: 32 QYTAELRLNNN-EFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLT 89
Query: 327 ENSLIGEIPVEL-SKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG 385
N L + ++ + L+ L L N++T V L ++ L L N +T T+ G
Sbjct: 90 SNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147
Query: 386 -FQYLTNLIMLQLFDN 400
F L +L L L N
Sbjct: 148 AFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 36/154 (23%), Positives = 57/154 (37%), Gaps = 23/154 (14%)
Query: 64 CGWIGVNCTTNDFGAV-------VFSLNLTKMNLSGYLSPNIG--GLVHLTALDLSFNQL 114
C V+C+ + L L + L L L ++ S N++
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTV-LEATGIFKKLPQLRKINFSNNKI 69
Query: 115 SRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRIS----GPFPKEI 170
+ S + + L +NRLE K L SL L + +NRI+ F
Sbjct: 70 TDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSF---- 125
Query: 171 GKLSALSQLVAYSNNISGSLPP----TLGNLKRL 200
LS++ L Y N I+ ++ P TL +L L
Sbjct: 126 IGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTL 158
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 28/108 (25%), Positives = 51/108 (47%), Gaps = 9/108 (8%)
Query: 84 NLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNR 137
L K+N S + G + + L+ N+L N+ ++ SL+ L L +NR
Sbjct: 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNR 116
Query: 138 LEAHIPKEL-GNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSN 184
+ + + LSS+ +L++Y+N+I+ P L +LS L +N
Sbjct: 117 ITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 32/167 (19%), Positives = 57/167 (34%), Gaps = 36/167 (21%)
Query: 502 IPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIF-SCKM 559
IP L L++N FT + L L N S+N +T I F
Sbjct: 30 IPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82
Query: 560 LQRLDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSF 618
+ + L+ N+ + ++ L L+ L L N ++ + + L+ +++
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGN--DSFIGLSSVRL----- 133
Query: 619 SGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNN 665
L+L N ++ + P L L L L N
Sbjct: 134 -----------------LSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 35/132 (26%), Positives = 54/132 (40%), Gaps = 11/132 (8%)
Query: 299 LYIYRNELNGTIPREI-GKLSSALEIDFSENSLIGEIPVE-LSKILGLELLYLFENKLTG 356
L + NE I KL +I+FS N I +I G+ + L N+L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNK-ITDIEEGAFEGASGVNEILLTSNRLEN 95
Query: 357 VIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDN---SLVGGIPQRLGA 412
V L++L L L N +T + F L+++ +L L+DN ++ G L +
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154
Query: 413 YSQLWVVDLSDN 424
S L L N
Sbjct: 155 LSTLN---LLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 18/93 (19%), Positives = 41/93 (44%), Gaps = 3/93 (3%)
Query: 223 SLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQ 282
L+ + + N+++ + +++L N+L V K SL+TL L N +
Sbjct: 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSN-R 116
Query: 283 VGQLPKEL-GSIGSLKYLYIYRNELNGTIPREI 314
+ + + + S++ L +Y N++ T+
Sbjct: 117 ITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 50/257 (19%), Positives = 82/257 (31%), Gaps = 64/257 (24%)
Query: 805 VVATDNFDERFVI----GRGACGTVYRAV--LRTGHTVAVKKLASNREGNNNVDNSFRA- 857
D ER+ I G G G V + R VA+K + NV A
Sbjct: 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-------RNVGKYREAA 63
Query: 858 --EILTLGKIRHR------NIVKLYGFCYHQ----------GSNLLMYEYMARGSLGELL 899
EI L KI+ + V + + G N +E++ +
Sbjct: 64 RLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNT--FEFLKENNF---- 117
Query: 900 HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959
R +A L +LH + ++ H D+K NIL + + + +
Sbjct: 118 QPYPLPH---VR-HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKS 170
Query: 960 -----------KVID----MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLL 1004
+V D + + I + Y PE + + CD++S G +L
Sbjct: 171 CEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILF 230
Query: 1005 ELLTGRAPVQPLDQGGD 1021
E G L Q +
Sbjct: 231 EYYRG----FTLFQTHE 243
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 39/159 (24%), Positives = 62/159 (38%), Gaps = 16/159 (10%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH-RNIVKLY 874
IG G G + L T VA+K E + E ++ I ++Y
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVY 71
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
F N ++ E + SL +L T +T MIA+ + Y+H +
Sbjct: 72 YFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LI 127
Query: 935 HRDIKSNNILL-----DDKFEAHVGDFGLAKVIDMPQSK 968
+RD+K N L+ + H+ DF LAK P++K
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 51/170 (30%), Positives = 71/170 (41%), Gaps = 14/170 (8%)
Query: 309 TIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNL 368
++P I + L++ L + L L L N+L + L L
Sbjct: 28 SVPSGIPADTEKLDLQS--TGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 369 TKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDN---SLVGGIPQRLGAYSQLWVVDLSDN 424
L L+ N L ++PLG F +LT L L L N SL G+ RL +L L+ N
Sbjct: 86 GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR---LNTN 141
Query: 425 HLTGKIPRHICRN-TSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGN 472
L IP T+L L+L TN+L S+P G R L + L GN
Sbjct: 142 QLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 47/170 (27%), Positives = 66/170 (38%), Gaps = 18/170 (10%)
Query: 117 NIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSAL 176
IP + E L+L + L L+ LT LN+ N++ L+ L
Sbjct: 32 GIP------ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 177 SQLVAYSNNISGSLPP----TLGNLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQ 231
L +N ++ SLP L L +L G N + SLPS + L+ L L
Sbjct: 86 GTLGLANNQLA-SLPLGVFDHLTQLDKL---YLGGNQLK-SLPSGVFDRLTKLKELRLNT 140
Query: 232 NQLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
NQL IP L L + L NQL V L+T+ L+ N
Sbjct: 141 NQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 43/173 (24%), Positives = 71/173 (41%), Gaps = 13/173 (7%)
Query: 449 KLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGN 508
L S+P+G+ +L L + L L+ + LD NQ + + +
Sbjct: 25 SLD-SVPSGIPA--DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFD 80
Query: 509 C-NALQRLHLSDNYFTGELPREV-GNLSNLVTFNVSSNFLTGRIPLEIF-SCKMLQRLDL 565
L L L++N LP V +L+ L + N L +P +F L+ L L
Sbjct: 81 DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRL 138
Query: 566 SWNKFVGALPREI-GSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGN 616
+ N+ ++P L L+ L LS N+L S+P L +L + + GN
Sbjct: 139 NTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 42/171 (24%), Positives = 62/171 (36%), Gaps = 29/171 (16%)
Query: 513 QRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSC-KMLQRLDLSWNKFV 571
++L L L+ L N+ N L + +F L L L+ N+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 572 GALPREI-GSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLS 630
+LP + L QL+ L L N+L S+P G RLT+L+
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPS--GVFDRLTKLKE----------------- 135
Query: 631 SLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSL 681
L L+ N L + L L+ L L+ N L G+F L L
Sbjct: 136 -----LRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKL 181
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 40/150 (26%), Positives = 58/150 (38%), Gaps = 13/150 (8%)
Query: 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGN--- 616
++LDL L +L L L N+L ++ + +L+ L L + N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 617 SFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIP-GSF 675
S G+ L L L L N L L L L+ L LN N L IP G+F
Sbjct: 97 SLPLGVFDHLTQLDKL----YLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
Query: 676 VNLSSLLGCNFSYNNLTGPIPSSQTFQNMS 705
L++L + S N L +P F +
Sbjct: 152 DKLTNLQTLSLSTNQLQS-VPHG-AFDRLG 179
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 46/177 (25%), Positives = 64/177 (36%), Gaps = 34/177 (19%)
Query: 253 LWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKEL-GSIGSLKYLYIYRNELNGTIP 311
L L+ + T L L L N Q+ L + + L L + N+L
Sbjct: 42 LQSTGLATLSDATFRGLTKLTWLNLDYN-QLQTLSAGVFDDLTELGTLGLANNQL----- 95
Query: 312 REIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKL 371
SL + L++ L+ LYL N+L + L L +L
Sbjct: 96 ----------------ASLPLGVFDHLTQ---LDKLYLGGNQLKSLPSGVFDRLTKLKEL 136
Query: 372 DLSINSLTGTIPLG-FQYLTNLIMLQLFDN---SLVGGIPQRLGAYSQLWVVDLSDN 424
L+ N L +IP G F LTNL L L N S+ G RLG + L N
Sbjct: 137 RLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT---LFGN 189
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 42/189 (22%), Positives = 74/189 (39%), Gaps = 29/189 (15%)
Query: 903 SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962
L + + A+G+ +L + HRD+ + NILL +K + DFGLA+ I
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 963 DMPQSKSMSAIAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPL 1016
K + + APE + T + D++S+GV+L E+ + G +P +
Sbjct: 244 ----YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299
Query: 1017 DQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTM 1076
+ ++ R + A E + + + C + P RPT
Sbjct: 300 KIDEEFCRRLKEGTR--------MRAPDYTTPE--------MYQTMLDCWHGEPSQRPTF 343
Query: 1077 REVVLMLSE 1085
E+V L
Sbjct: 344 SELVEHLGN 352
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 35/128 (27%), Positives = 56/128 (43%), Gaps = 13/128 (10%)
Query: 816 VIGRGACGTVYRAVL------RTGHTVAVKKLASNREGNNNVD-NSFRAEILTLGKI-RH 867
+GRGA G V A T TVAVK L +EG + + + +E+ L I H
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHH 85
Query: 868 RNIVKLYGFCYHQGSNLLM-YEYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYL 925
N+V L G C G L++ E+ G+L L + + ++T+ + + +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 926 HHDCKPRI 933
D K R+
Sbjct: 146 PVDLKRRL 153
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 59/332 (17%), Positives = 107/332 (32%), Gaps = 56/332 (16%)
Query: 103 HLTALDLSFNQLSRNIPKEIG-----NCSSLEVLNLNNNRLEAHIPKELG-----NLSSL 152
+T+LDLS N L E+ +S+ LNL+ N L EL +++
Sbjct: 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82
Query: 153 TILNIYNNRISGPFPKEIGKL-----SALSQLVAYSNNISGS----LPPTLGNL-KRLKS 202
T LN+ N +S E+ K ++ L N+ S NL + S
Sbjct: 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS 142
Query: 203 FRAGQNLISGSLPSEIGGC-----ESLQYLGLAQNQLSGEIPKEIG-MLKY----LTDVI 252
N + E+ ++ L L N L+ + E+ L +T +
Sbjct: 143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLD 202
Query: 253 LWGNQLSGVIPKELG-----NCTSLETLALYDNK----QVGQLPKELGSIGSLKYLYIYR 303
L N L EL + +L L N + L S+ L+ +Y+
Sbjct: 203 LSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDY 262
Query: 304 NELNGTIPREIGKLSSAL-------EIDFSENSLIGEIPVELSKIL-----GLELLYLFE 351
+ + + L +A +D + + + +S ++ ++ L
Sbjct: 263 DIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLN 322
Query: 352 NKLTGV-----IPVELTTLKNLTKLDLSINSL 378
L +L L + + L
Sbjct: 323 QCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 57/324 (17%), Positives = 101/324 (31%), Gaps = 68/324 (20%)
Query: 367 NLTKLDLSINSLTGTIPLGFQYL--------TNLIMLQLFDNSL----VGGIPQRLGAY- 413
++T L+LS NSL L N+ L L N L + + L A
Sbjct: 52 SVTSLNLSGNSLG---FKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP 108
Query: 414 SQLWVVDLSDNHLTGKIPRHICR-----NTSLIFLNLETNKLTGSIPTGVTR-------- 460
+ V+DL N + K + S+ LNL N L
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG---IKSSDELIQILAAI 165
Query: 461 CKSLVQLRLGGNSFTGSFPSDLCKL-----ANLSTVELDQNQFSGPIPTEIG-----NCN 510
++ L L GN+ ++L K A++++++L N E+ N
Sbjct: 166 PANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPN 225
Query: 511 ALQRLHLSDNYFTGE----LPREVGNLSNLVTFNVSSNFLT--GRIPLEIF-----SCKM 559
+ L+L N G L +L +L T + + + + + + +
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQK 285
Query: 560 LQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS 619
+ +D + + + I +L + K L N + + N
Sbjct: 286 IILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLL--------NQCLIFAQKHQTNIED 337
Query: 620 GGIPAELGSLSSLQIALNLSYNNL 643
IP EL + L
Sbjct: 338 LNIPDEL-------RESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 57/374 (15%), Positives = 111/374 (29%), Gaps = 84/374 (22%)
Query: 124 NCSSLEVLNLNNNRLEAHIPKELG-----NLSSLTILNIYNNRISGPFPKEIGKL----- 173
+ L+L+ N L + EL +S+T LN+ N + E+ ++
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79
Query: 174 SALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQ 233
+ ++ L N +S + + +L + ++ L L N
Sbjct: 80 ANVTSLNLSGNFLSY----------------KSSDELVKTLAAI---PFTITVLDLGWND 120
Query: 234 LSGEIPKEIG-MLKY----LTDVILWGNQLSGVIPKELG-----NCTSLETLALYDN--- 280
S + E +T + L GN L EL ++ +L L N
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
Query: 281 -KQVGQLPKELGSI-GSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVEL 338
K +L K L SI S+ L + N L + +L+
Sbjct: 181 SKNCAELAKFLASIPASVTSLDLSANLLG---LKSYAELAYIFS---------------- 221
Query: 339 SKILGLELLYLFENKLTGV----IPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIM 394
S + L L N L G + + +LK+L + L + + + L
Sbjct: 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALG---- 277
Query: 395 LQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSI 454
++ +VD + + I + + L
Sbjct: 278 -------------AAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQC 324
Query: 455 PTGVTRCKSLVQLR 468
+ ++ ++
Sbjct: 325 LIFAQKHQTNIEDL 338
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 48/211 (22%), Positives = 74/211 (35%), Gaps = 22/211 (10%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH-RNIVKLY 874
IG G+ G ++ L VA+K E + R E T + I +Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 72
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
F N+L+ + + SL +LL +T M A + +H +
Sbjct: 73 YFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LV 128
Query: 935 HRDIKSNNILLDDKFEA-----HVGDFGLAKVIDMPQSKSMSAIAGSYGYIA-PEYA--Y 986
+RDIK +N L+ +V DFG+ K P +K Y
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 188
Query: 987 TMKVTEKC---DIYSYGVVLLELLTGRAPVQ 1014
T E+ D+ + G V + L G P Q
Sbjct: 189 THLGREQSRRDDLEALGHVFMYFLRGSLPWQ 219
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 50/209 (23%), Positives = 79/209 (37%), Gaps = 20/209 (9%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLY 874
IG G+ G +Y ++T VA+K E E ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQGGTGIPNVR 69
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
F N+L+ + + SL +L + S L +T M+A + ++H
Sbjct: 70 WFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FL 125
Query: 935 HRDIKSNNILL---DDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIA-PEYA--YTM 988
HRDIK +N L+ + ++ DFGLAK + + YA T
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTH 185
Query: 989 KVTEKC---DIYSYGVVLLELLTGRAPVQ 1014
E+ D+ S G VL+ L G P Q
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 7e-10
Identities = 52/280 (18%), Positives = 86/280 (30%), Gaps = 78/280 (27%)
Query: 809 DNFDERFVI----GRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLG 863
D F+ R+ + G G TV+ + ++ VA+K + S + EI L
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----EIRLLK 88
Query: 864 KIR--------HRNIVKLYGFCYHQGSN----LLMYEYMARGSLGELLHGASS-TLDWQT 910
+R +V+L G N +++E + L + + ++ L
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPC 147
Query: 911 RFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL------------------------- 945
I +GL YLH C+ I H DIK NILL
Sbjct: 148 VKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205
Query: 946 ------------------------DDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIA 981
+K + + D G A + ++ + Y +
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----YRS 261
Query: 982 PEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD 1021
E DI+S + EL TG +P
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 23/83 (27%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 97 NIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILN 156
++ G+ +L L L N + + I +LE L ++ N++ + + L +L +L
Sbjct: 65 SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLY 121
Query: 157 IYNNRISGPFPKEIGKLSALSQL 179
+ NN+I+ EI KL+AL +L
Sbjct: 122 MSNNKITN--WGEIDKLAALDKL 142
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 36/164 (21%), Positives = 61/164 (37%), Gaps = 19/164 (11%)
Query: 102 VHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNR 161
L + + + + + L L+ N +E I L + +L IL++ N
Sbjct: 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNL 81
Query: 162 ISGPFPKEIGKLSALSQ----LVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSE 217
I K+I L A++ L N I+ SL + L L+ N I+ E
Sbjct: 82 I-----KKIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN--WGE 132
Query: 218 I---GGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQL 258
I + L+ L LA N L + + +Y +V+ L
Sbjct: 133 IDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 31/130 (23%), Positives = 51/130 (39%), Gaps = 13/130 (10%)
Query: 347 LYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSL--VG 404
L+ + + L+TLK L LS N++ I + NL +L L N + +
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIE 86
Query: 405 GIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLT--GSIPTGVTRCK 462
+ L + +S N + + I + +L L + NK+T G I +
Sbjct: 87 NLDAVAD---TLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALD 140
Query: 463 SLVQLRLGGN 472
L L L GN
Sbjct: 141 KLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 27/133 (20%), Positives = 50/133 (37%), Gaps = 7/133 (5%)
Query: 440 LIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFS 499
+ L+ + + ++ K+ L L N+ S L + NL + L +N
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK 83
Query: 500 GPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFS-CK 558
I + L+ L +S N L + L NL +S+N +T ++ +
Sbjct: 84 K-IENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALD 140
Query: 559 MLQRLDLSWNKFV 571
L+ L L+ N
Sbjct: 141 KLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 34/161 (21%), Positives = 55/161 (34%), Gaps = 23/161 (14%)
Query: 321 LEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTG 380
+E+ I ++ LS + + L L N + + L+ ++NL L L N +
Sbjct: 28 VELHGMIPP-IEKMDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNLIK- 83
Query: 381 TIPLGFQYLTNLIMLQLFDN---SLVGGIPQRLGAYSQLWVVDLSDNHLTG-KIPRHICR 436
I L L + N SL G + L V+ +S+N +T +
Sbjct: 84 KIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEIDKLAA 138
Query: 437 NTSLIFLNLETNKLTGSIPTG----------VTRCKSLVQL 467
L L L N L V R +L +L
Sbjct: 139 LDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 37/128 (28%), Positives = 55/128 (42%), Gaps = 29/128 (22%)
Query: 347 LYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDNSLVGG 405
LYL N+ T ++P EL+ K+LT +DLS N ++ T+ F +T L+ L L N L
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL-RC 92
Query: 406 IPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-TRCKSL 464
IP + L SL L+L N ++ +P G +L
Sbjct: 93 IPP--RTFDGL---------------------KSLRLLSLHGNDIS-VVPEGAFNDLSAL 128
Query: 465 VQLRLGGN 472
L +G N
Sbjct: 129 SHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 37/166 (22%), Positives = 59/166 (35%), Gaps = 57/166 (34%)
Query: 116 RNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSA 175
+ IP+++ L L+ N+ +PKEL N LT++++ NNRIS
Sbjct: 27 KGIPRDV------TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS------------ 67
Query: 176 LSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLS 235
+L + + L L L+ N+L
Sbjct: 68 -------------TLSN--QSFSNMT---------------------QLLTLILSYNRLR 91
Query: 236 GEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
IP LK L + L GN +S V + ++L LA+ N
Sbjct: 92 -CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 28/98 (28%), Positives = 40/98 (40%), Gaps = 8/98 (8%)
Query: 331 IGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYL 389
+P ELS L L+ L N+++ + + + L L LS N L IP F L
Sbjct: 43 FTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGL 101
Query: 390 TNLIMLQLFDN---SLVGGIPQRLGAYSQLWVVDLSDN 424
+L +L L N + G L A S L + N
Sbjct: 102 KSLRLLSLHGNDISVVPEGAFNDLSALSHLA---IGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 213 SLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSL 272
LP I + L L NQ + +PKE+ K+LT + L N++S + + N T L
Sbjct: 24 VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 273 ETLALYDNKQVGQLPKEL-GSIGSLKYLYIYRNELNGTIPR 312
TL L N ++ +P + SL+ L ++ N+++ +P
Sbjct: 81 LTLILSYN-RLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPE 119
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 33/90 (36%), Positives = 44/90 (48%), Gaps = 10/90 (11%)
Query: 100 GLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKEL-GNLSSLTILNIY 158
HLT +DLS N++S + N + L L L+ NRL IP L SL +L+++
Sbjct: 52 NYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLH 110
Query: 159 NNRIS----GPFPKEIGKLSALSQLVAYSN 184
N IS G F LSALS L +N
Sbjct: 111 GNDISVVPEGAF----NDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 25/72 (34%), Positives = 34/72 (47%), Gaps = 8/72 (11%)
Query: 621 GIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSS 680
GIP ++ L L N + L+P EL N L + L+NN +S SF N++
Sbjct: 28 GIPRDVTEL-------YLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQ 79
Query: 681 LLGCNFSYNNLT 692
LL SYN L
Sbjct: 80 LLTLILSYNRLR 91
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 26/105 (24%), Positives = 45/105 (42%), Gaps = 8/105 (7%)
Query: 418 VVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGS 477
VV S+ L +P+ I R+ + L L+ N+ T +P ++ K L + L N + +
Sbjct: 14 VVRCSNKGLK-VLPKGIPRDVTE--LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-T 68
Query: 478 FPSDLC-KLANLSTVELDQNQFSGPIPTEI-GNCNALQRLHLSDN 520
+ + L T+ L N+ IP +L+ L L N
Sbjct: 69 LSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGN 112
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 57/256 (22%), Positives = 92/256 (35%), Gaps = 58/256 (22%)
Query: 805 VVATDNFDERFVI----GRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRA-- 857
+ F++ G G G V + AVK + N+ R+
Sbjct: 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-------RNIKKYTRSAK 79
Query: 858 -EILTLGKIRHR-----NIVKLYGFCYHQGSNLLMYEYMARGSLGELL-----HGASSTL 906
E L KI++ NIVK +G + L++E + SL E++ +G
Sbjct: 80 IEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIED 138
Query: 907 DWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA------- 959
+ + + + L+YL K + H D+K NILLDD +
Sbjct: 139 ---IK-LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 960 ----------KVID----MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLE 1005
K+ID +S +I + Y APE + D++S+G VL E
Sbjct: 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
Query: 1006 LLTGRAPVQPLDQGGD 1021
L TG L + +
Sbjct: 252 LYTG----SLLFRTHE 263
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 32/179 (17%), Positives = 69/179 (38%), Gaps = 28/179 (15%)
Query: 806 VATDNFDERFV----IGRGACGTVYRAVLRTGHTVAVK-----KLASNREG--------- 847
+ TD + IG+G G +Y A + + +V K+ + G
Sbjct: 28 IITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFY 87
Query: 848 NNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS----NLLMYEYMARGSLGELLHGAS 903
+ + K+++ + K +G H + ++ + L ++ +
Sbjct: 88 QRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANA 146
Query: 904 STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD--DKFEAHVGDFGLAK 960
+T ++L + L Y+H H DIK++N+LL+ + + ++ D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 34/180 (18%), Positives = 60/180 (33%), Gaps = 28/180 (15%)
Query: 805 VVATDNFDERFV----IGRGACGTVYRAV---------LRTGHTVAVKKLASNREGNNNV 851
V TD ++ R G +Y A ++K A + N
Sbjct: 34 TVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQ 93
Query: 852 DNSFRA-------EILTLGKIRHRNIVKLYGFCYHQGS-NLLMYEYMARGSLGELLHGAS 903
+ RA + L I GF HQ L+ + R SL L +
Sbjct: 94 NFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSP 152
Query: 904 S-TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL--DDKFEAHVGDFGLAK 960
L ++ +A + L +LH + H ++ + NI + +D+ + + +G A
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 45/134 (33%), Positives = 62/134 (46%), Gaps = 12/134 (8%)
Query: 345 ELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDN--- 400
L L N L + L +LT+L L N L ++P G F LT+L L L N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 401 SLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHIC-RNTSLIFLNLETNKLTGSIPTGV- 458
SL G+ +L +QL + L+ N L +P + + T L L L N+L S+P GV
Sbjct: 90 SLPNGVFDKL---TQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVF 144
Query: 459 TRCKSLVQLRLGGN 472
R SL + L N
Sbjct: 145 DRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 50/157 (31%), Positives = 65/157 (41%), Gaps = 34/157 (21%)
Query: 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDN---SLVGGIPQRLGAYSQLWVVDLSDNH 425
T LDL NSL F LT+L L L N SL G+ +L + + L LS N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN---LSTNQ 87
Query: 426 LTGKIPRHIC-RNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCK 484
L +P + + T L L L TN+L S+P GV F D K
Sbjct: 88 LQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGV---------------F------D--K 122
Query: 485 LANLSTVELDQNQFSGPIPTEI-GNCNALQRLHLSDN 520
L L + L QNQ +P + +LQ + L DN
Sbjct: 123 LTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 36/122 (29%), Positives = 46/122 (37%), Gaps = 3/122 (2%)
Query: 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGN-LSRLTELQMGGNSFS 619
LDL N L L L L N+L S+P + N L+ LT L + N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 620 GGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLS 679
L+ L+ L L+ N L L L L+ L L N L G F L+
Sbjct: 90 SLPNGVFDKLTQLKE-LALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT 148
Query: 680 SL 681
SL
Sbjct: 149 SL 150
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 41/154 (26%), Positives = 57/154 (37%), Gaps = 36/154 (23%)
Query: 253 LWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKEL-GSIGSLKYLYIYRNELNGTIP 311
L N L + TSL L L N ++ LP + + SL YL + N+L
Sbjct: 35 LETNSLKSLPNGVFDELTSLTQLYLGGN-KLQSLPNGVFNKLTSLTYLNLSTNQLQSLPN 93
Query: 312 REIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPV----ELTTLKN 367
KL+ L+ L L N+L +P +LT
Sbjct: 94 GVFDKLTQ------------------------LKELALNTNQLQ-SLPDGVFDKLT---Q 125
Query: 368 LTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDN 400
L L L N L ++P G F LT+L + L DN
Sbjct: 126 LKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 8/135 (5%)
Query: 486 ANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGN-LSNLVTFNVSSN 544
A + ++L+ N +L +L+L N LP V N L++L N+S+N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 545 FLTGRIPLEIF-SCKMLQRLDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPVQI 602
L +P +F L+ L L+ N+ +LP + L QL+ L+L +N+L S+P +
Sbjct: 87 QLQ-SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGV 143
Query: 603 -GNLSRLTELQMGGN 616
L+ L + + N
Sbjct: 144 FDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 45/177 (25%), Positives = 62/177 (35%), Gaps = 50/177 (28%)
Query: 105 TALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISG 164
T LDL N L +SL L L N+L++ L+SLT LN+ N++
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 165 PFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESL 224
SLP G +L L
Sbjct: 90 ------------------------SLPN--GVFDKLT---------------------QL 102
Query: 225 QYLGLAQNQLSGEIPKEI-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
+ L L NQL +P + L L D+ L+ NQL V TSL+ + L+DN
Sbjct: 103 KELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 50/238 (21%), Positives = 84/238 (35%), Gaps = 50/238 (21%)
Query: 809 DNFDERFVI----GRGACGTVYRAV--LRTGHTVAVKKLASNREGNNNVDNSFRA---EI 859
D R+ I G GA G V + G VAVK + NVD A EI
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSEI 62
Query: 860 LTLGKIRHR------NIVKLYGFCYHQGSNLLMYEYMARGSLGELL-----HGASSTLDW 908
L + V++ + H G +++E + S + +
Sbjct: 63 QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDH-- 119
Query: 909 QTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA--------- 959
R +A + +++LH ++ H D+K NIL + +
Sbjct: 120 -IR-KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 960 --KVID----MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRA 1011
KV+D + S + + Y APE + ++ CD++S G +L+E G
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 2e-08
Identities = 19/91 (20%), Positives = 36/91 (39%), Gaps = 4/91 (4%)
Query: 96 PNIGGLVHLTALDLSFNQLSRNIPKE-IGNCSSLEVLNLNNNRLEAHIPKE-LGNLSSLT 153
++ G +LT L + Q +++ + L L + + L + + L+
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLS 83
Query: 154 ILNIYNNRISGPFPKEIGKLSALSQLVAYSN 184
LN+ N + K + LS L +LV N
Sbjct: 84 RLNLSFNALESLSWKTVQGLS-LQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 27/149 (18%), Positives = 40/149 (26%), Gaps = 14/149 (9%)
Query: 597 SIPVQIGNLSRLTELQMGGNSFSGGIPAE-LGSLSSLQIALNLSYNNLSGLIPPE-LGNL 654
+ LTEL + + L L L+ L + + L + P+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN-LTIVKSGLR-FVAPDAFHFT 79
Query: 655 ILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT---------GPIPSSQTFQNMS 705
L L L+ N L + L SL S N L
Sbjct: 80 PRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQ 138
Query: 706 VNSFSGSKGLCGGPLQNCTQPPSSLPFPS 734
G L P +C P + P+
Sbjct: 139 KLQCHGQGPLAHMPNASCGVPTLKVQVPN 167
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 16/82 (19%), Positives = 27/82 (32%), Gaps = 2/82 (2%)
Query: 112 NQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKE-LGNLSSLTILNIYNNRISGPFPKEI 170
+ + + +L L + N + H+ L L L L I + + P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 171 GKLSALSQLVAYSNNISGSLPP 192
LS+L N + SL
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSW 97
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 4e-05
Identities = 20/108 (18%), Positives = 37/108 (34%), Gaps = 5/108 (4%)
Query: 322 EIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVE-LTTLKNLTKLDLSINSLTG 380
+ + + + + L L LY+ + + + L L L L + + L
Sbjct: 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR- 69
Query: 381 TIPLG-FQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLT 427
+ F + L L L N+L + + L + LS N L
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 5e-05
Identities = 20/96 (20%), Positives = 34/96 (35%), Gaps = 2/96 (2%)
Query: 213 SLPSEIGGCESLQYLGLAQNQLSGEIPKE-IGMLKYLTDVILWGNQLSGVIPKELGNCTS 271
+ G E+L L + Q + + L L ++ + + L V P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 272 LETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELN 307
L L L N + L + SL+ L + N L+
Sbjct: 82 LSRLNLSFN-ALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 6e-05
Identities = 19/111 (17%), Positives = 34/111 (30%), Gaps = 3/111 (2%)
Query: 509 CNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFS-CKMLQRLDLSW 567
+ L + + + + NL + + + L L+ L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 568 NKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSF 618
+ P +L L LS N L S+ + L EL + GN
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 24/136 (17%), Positives = 39/136 (28%), Gaps = 25/136 (18%)
Query: 269 CTSLETLALY-DNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSE 327
C + L L +L LYI + +
Sbjct: 5 CCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRD------------- 51
Query: 328 NSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQ 387
L + L L + ++ L V P L++L+LS N+L ++
Sbjct: 52 ----------LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTV 100
Query: 388 YLTNLIMLQLFDNSLV 403
+L L L N L
Sbjct: 101 QGLSLQELVLSGNPLH 116
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 21/85 (24%), Positives = 32/85 (37%), Gaps = 8/85 (9%)
Query: 97 NIGGLVHLTALDLSFNQLSR--NIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTI 154
L L L+ N+PK + L+ L L++NR+ + +LT
Sbjct: 37 LTDEFEELEFLSTINVGLTSIANLPK----LNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92
Query: 155 LNIYNNRISGPFPKEIGKLSALSQL 179
LN+ N+I I L L L
Sbjct: 93 LNLSGNKIKD--LSTIEPLKKLENL 115
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 21/84 (25%), Positives = 41/84 (48%), Gaps = 4/84 (4%)
Query: 84 NLTKMNLSG-YLS--PNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEA 140
L ++ L+ N+ L L L+LS N++S + C +L LNL+ N+++
Sbjct: 43 ELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD 102
Query: 141 -HIPKELGNLSSLTILNIYNNRIS 163
+ L L +L L+++N ++
Sbjct: 103 LSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 28/105 (26%), Positives = 42/105 (40%), Gaps = 9/105 (8%)
Query: 103 HLTALDLSFNQLSRNIPKEIGN---CSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYN 159
+ L L ++ N K G LE L+ N L I L L+ L L + +
Sbjct: 18 DVKELVLDNSRS--NEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 160 NRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFR 204
NR+SG K L+ L N I T+ LK+L++ +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLK 116
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 26/135 (19%), Positives = 48/135 (35%), Gaps = 28/135 (20%)
Query: 124 NCSSLEVLNLNNNRL-EAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAY 182
S ++ L L+N+R E + L L+ N ++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT------------------- 55
Query: 183 SNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSG-EIPKE 241
+I+ L L +LK N +SG L C +L +L L+ N++ +
Sbjct: 56 --SIAN-----LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP 108
Query: 242 IGMLKYLTDVILWGN 256
+ L+ L + L+
Sbjct: 109 LKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 27/119 (22%), Positives = 47/119 (39%), Gaps = 14/119 (11%)
Query: 484 KLANLSTVELDQNQFS-GPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLS---NLVTF 539
+++ + LD ++ + G + L+ L + T + NL L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKL 69
Query: 540 NVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLK---LSENELS 595
+S N ++G + + C L L+LS NK I L +LE LK L E++
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI--KDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 28/108 (25%), Positives = 46/108 (42%), Gaps = 4/108 (3%)
Query: 321 LEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTG 380
L +D S ++ G++ + LE L LT + L L L KL+LS N ++G
Sbjct: 22 LVLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLTSIAN--LPKLNKLKKLELSDNRVSG 78
Query: 381 TIPLGFQYLTNLIMLQLFDNSLVG-GIPQRLGAYSQLWVVDLSDNHLT 427
+ + + NL L L N + + L L +DL + +T
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 30/110 (27%), Positives = 47/110 (42%), Gaps = 8/110 (7%)
Query: 295 SLKYLYIYRNELNGTIPREIGKLSSALE-IDFSENSLIGEIPVELSKILGLELLYLFENK 353
+K L + + N + LE + + I L K+ L+ L L +N+
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG-LTSIAN-LPKLNKLKKLELSDNR 75
Query: 354 LTGVIPVELTTLKNLTKLDLS---INSLTGTIPLGFQYLTNLIMLQLFDN 400
++G + V NLT L+LS I L+ PL + L NL L LF+
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPL--KKLENLKSLDLFNC 123
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 50/240 (20%), Positives = 94/240 (39%), Gaps = 15/240 (6%)
Query: 426 LTGKIPRHICRNTSLIFLNLETNKLT-GSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCK 484
+ + ++L + + ++ +++C L L L G + + L K
Sbjct: 81 FMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK 140
Query: 485 LANLSTVELDQ-NQFSGPIPTEIG-NCNALQRLHLSDNY-FTGELPREV--GNLSNLVTF 539
+NL + L + FS + +C+ L L+LS + FT + + +
Sbjct: 141 NSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQL 200
Query: 540 NVS--SNFLTGR-IPLEIFSCKMLQRLDLSWNKFVG-ALPREIGSLFQLELLKLSE-NEL 594
N+S L + + C L LDLS + + +E L L+ L LS ++
Sbjct: 201 NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDI 260
Query: 595 SGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNL 654
+++G + L LQ+ G G + +L LQI N S + + + P +GN
Sbjct: 261 IPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI--NCS--HFTTIARPTIGNK 316
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 46/243 (18%), Positives = 91/243 (37%), Gaps = 19/243 (7%)
Query: 56 WNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNI--------GGLVHLTAL 107
W S W ++ T + V L++ ++ + + +
Sbjct: 39 WYRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHM 98
Query: 108 DLSFNQLS-RNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYN-NRISGP 165
DLS + + + + CS L+ L+L RL I L S+L LN+ + S
Sbjct: 99 DLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF 158
Query: 166 FPKEIGK-LSALSQL-VAYSNNIS-----GSLPPTLGNLKRLKSFRAGQNLISGSLPSEI 218
+ + S L +L +++ + + ++ + +L +NL L + +
Sbjct: 159 ALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLV 218
Query: 219 GGCESLQYLGLAQ-NQLSGEIPKEIGMLKYLTDVILWG-NQLSGVIPKELGNCTSLETLA 276
C +L +L L+ L + +E L YL + L + ELG +L+TL
Sbjct: 219 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ 278
Query: 277 LYD 279
++
Sbjct: 279 VFG 281
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 40/231 (17%), Positives = 80/231 (34%), Gaps = 10/231 (4%)
Query: 366 KNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNH 425
+ + + + + F M V + L S+L + L
Sbjct: 70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 129
Query: 426 LTGKIPRHICRNTSLIFLNLE-TNKLT-GSIPTGVTRCKSLVQLRLGG------NSFTGS 477
L+ I + +N++L+ LNL + + ++ T ++ C L +L L +
Sbjct: 130 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 189
Query: 478 FPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYF-TGELPREVGNLSNL 536
+ L+ +N + T + C L L LSD+ + +E L+ L
Sbjct: 190 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 249
Query: 537 VTFNVSS-NFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLEL 586
++S + LE+ L+ L + G L +L L++
Sbjct: 250 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 22/85 (25%), Positives = 33/85 (38%), Gaps = 8/85 (9%)
Query: 97 NIGGLVHLTALDLSFNQLSR--NIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTI 154
V+L L L L N+PK L+ L L+ NR+ + L +LT
Sbjct: 44 LTAEFVNLEFLSLINVGLISVSNLPK----LPKLKKLELSENRIFGGLDMLAEKLPNLTH 99
Query: 155 LNIYNNRISGPFPKEIGKLSALSQL 179
LN+ N++ + L L L
Sbjct: 100 LNLSGNKLKD--ISTLEPLKKLECL 122
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 22/85 (25%), Positives = 41/85 (48%), Gaps = 6/85 (7%)
Query: 84 NLTKMNLSG-YLS--PNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLE- 139
NL ++L L N+ L L L+LS N++ + +L LNL+ N+L+
Sbjct: 50 NLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD 109
Query: 140 -AHIPKELGNLSSLTILNIYNNRIS 163
+ + + L L L L+++N ++
Sbjct: 110 ISTL-EPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 25/140 (17%), Positives = 50/140 (35%), Gaps = 13/140 (9%)
Query: 125 CSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYS- 183
S +++ + + L + N +N K G + L S
Sbjct: 2 SSGSSGMDMKRRIHLELRNRTPAAVRELVLDNCKSNDG-----KIEGLTAEFVNLEFLSL 56
Query: 184 --NNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLS--GEIP 239
+ S+ L L +LK +N I G L +L +L L+ N+L +
Sbjct: 57 INVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL- 113
Query: 240 KEIGMLKYLTDVILWGNQLS 259
+ + L+ L + L+ +++
Sbjct: 114 EPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 31/108 (28%), Positives = 48/108 (44%), Gaps = 4/108 (3%)
Query: 321 LEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTG 380
L +D +++ G+I ++ + LE L L L V L L L KL+LS N + G
Sbjct: 29 LVLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLISVSN--LPKLPKLKKLELSENRIFG 85
Query: 381 TIPLGFQYLTNLIMLQLFDNSLVG-GIPQRLGAYSQLWVVDLSDNHLT 427
+ + + L NL L L N L + L L +DL + +T
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 22/109 (20%), Positives = 39/109 (35%), Gaps = 8/109 (7%)
Query: 95 SPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTI 154
+ V LDL ++ I + ++ ++N + L L
Sbjct: 12 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKT 68
Query: 155 LNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSF 203
L + NNRI L L++L+ +N++ LG+L L S
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDPLASL 112
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 26/152 (17%), Positives = 45/152 (29%), Gaps = 32/152 (21%)
Query: 107 LDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPF 166
+ L+ + + + N L+L ++ I L ++ +N I
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR--- 55
Query: 167 PKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQY 226
+ G L+RLK+ N I L
Sbjct: 56 ------------------KLDG-----FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92
Query: 227 LGLAQNQLS--GEIPKEIGMLKYLTDVILWGN 256
L L N L G++ + LK LT + + N
Sbjct: 93 LILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 21/85 (24%), Positives = 32/85 (37%), Gaps = 6/85 (7%)
Query: 84 NLTKMNLSGYLSPNIGG---LVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLE- 139
++ S + G L L L ++ N++ R L L L NN L
Sbjct: 43 QFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 102
Query: 140 -AHIPKELGNLSSLTILNIYNNRIS 163
+ L +L SLT L I N ++
Sbjct: 103 LGDL-DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 28/123 (22%), Positives = 46/123 (37%), Gaps = 5/123 (4%)
Query: 330 LIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYL 389
LI + + + + L L K+ VI TL +D S N + + GF L
Sbjct: 8 LIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLL 63
Query: 390 TNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTG-KIPRHICRNTSLIFLNLETN 448
L L + +N + A L + L++N L + SL +L + N
Sbjct: 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
Query: 449 KLT 451
+T
Sbjct: 124 PVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 26/140 (18%), Positives = 48/140 (34%), Gaps = 34/140 (24%)
Query: 265 ELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEID 324
+ N L L K I ++ L ++ + ID
Sbjct: 14 QYTNAVRDRELDLRGYK-----------IPVIENLGATLDQFD--------------AID 48
Query: 325 FSENSLIGEIPVE-LSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLS---INSLTG 380
FS+N + ++ + L+ L + N++ + L +LT+L L+ + L
Sbjct: 49 FSDNEIR---KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 105
Query: 381 TIPLGFQYLTNLIMLQLFDN 400
PL L +L L + N
Sbjct: 106 LDPL--ASLKSLTYLCILRN 123
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 33/131 (25%), Positives = 49/131 (37%), Gaps = 29/131 (22%)
Query: 347 LYLFENKLTGVIPVEL-TTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDNSLVG 404
L L +N+L + L L +L KL+L N LT I F+ +++ LQL +N +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI-K 91
Query: 405 GIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-TRCKS 463
I + L L LNL N+++ + G S
Sbjct: 92 EISN--KMFLGL---------------------HQLKTLNLYDNQIS-CVMPGSFEHLNS 127
Query: 464 LVQLRLGGNSF 474
L L L N F
Sbjct: 128 LTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 7/108 (6%)
Query: 297 KYLYIYRNELNGTIPREI-GKLSSALEIDFSENSLIGEIPVEL-SKILGLELLYLFENKL 354
L + NEL + G+L ++++ N L I ++ L L ENK+
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKI 90
Query: 355 TGVIPVEL-TTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDN 400
I ++ L L L+L N ++ + G F++L +L L L N
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 27/108 (25%), Positives = 44/108 (40%), Gaps = 11/108 (10%)
Query: 179 LVAYSNNISGSLPPT--LGNLKRLKSFRAGQNLISGSLPSEI-GGCESLQYLGLAQNQLS 235
L+ N + + G L L +N ++ + G +Q L L +N++
Sbjct: 34 LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 236 GEIPKEIGM---LKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
EI M L L + L+ NQ+S V+P + SL +L L N
Sbjct: 92 -EISN--KMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 24/86 (27%), Positives = 41/86 (47%), Gaps = 13/86 (15%)
Query: 84 NLTKMNLSG----YLSPNI-GGLVHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNR 137
+L K+ L + PN G H+ L L N++ I ++ L+ LNL +N+
Sbjct: 55 HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQ 113
Query: 138 LEAHIPKELG---NLSSLTILNIYNN 160
+ + G +L+SLT LN+ +N
Sbjct: 114 ISC-VMP--GSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 10/90 (11%)
Query: 100 GLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKEL-GNLSSLTILNIY 158
L HL L+L NQL+ P S ++ L L N+++ I ++ L L LN+Y
Sbjct: 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLY 110
Query: 159 NNRIS----GPFPKEIGKLSALSQLVAYSN 184
+N+IS G F L++L+ L SN
Sbjct: 111 DNQISCVMPGSF----EHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 28/122 (22%), Positives = 44/122 (36%), Gaps = 26/122 (21%)
Query: 561 QRLDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS 619
L L+ N+ + G L L L+L N+L+ I + +Q
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEP--NAFEGASHIQE------ 82
Query: 620 GGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLS 679
L L N + + L L+ L L +N +S +PGSF +L+
Sbjct: 83 ----------------LQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 680 SL 681
SL
Sbjct: 127 SL 128
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 27/105 (25%), Positives = 43/105 (40%), Gaps = 7/105 (6%)
Query: 420 DLSDNHLTGKIPRHICRN-TSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTGS 477
L+DN L + L+ L L+ N+LT I + +L+LG N
Sbjct: 35 LLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-E 92
Query: 478 FPSDLC-KLANLSTVELDQNQFSGPIPTEI-GNCNALQRLHLSDN 520
+ + L L T+ L NQ S + + N+L L+L+ N
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 31/161 (19%), Positives = 60/161 (37%), Gaps = 21/161 (13%)
Query: 817 IGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFR-----------AEILTLGK 864
IG G G +Y A A + + N + + + + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 865 IRHRNIVKLYGFCYHQGSNLLMYEYMARGSLG---ELLHGASSTLDWQTRFMIALGAAEG 921
+ + I YG + Y +M LG + + G + T T + + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGR-SYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDV 163
Query: 922 LSYLHHDCKPRIFHRDIKSNNILLD--DKFEAHVGDFGLAK 960
L Y+H + H DIK+ N+LL + + ++ D+GL+
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 41/130 (31%), Positives = 56/130 (43%), Gaps = 28/130 (21%)
Query: 345 ELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG-FQYLTNLIMLQLFDNSLV 403
L L NKL + L LTKL LS N + ++P G F LT L +L L +N L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKL- 88
Query: 404 GGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-TRCK 462
+P G + +L T L L L+TN+L S+P G+ R
Sbjct: 89 QSLPN--GVFDKL---------------------TQLKELALDTNQLK-SVPDGIFDRLT 124
Query: 463 SLVQLRLGGN 472
SL ++ L N
Sbjct: 125 SLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 37/124 (29%), Positives = 50/124 (40%), Gaps = 22/124 (17%)
Query: 405 GIP---QRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-TR 460
GIP RL +L N L + T L L+L N++ S+P GV +
Sbjct: 25 GIPSSATRL---------ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDK 74
Query: 461 CKSLVQLRLGGNSFTGSFPS---DLCKLANLSTVELDQNQFSGPIPTEI-GNCNALQRLH 516
L L L N S P+ D KL L + LD NQ +P I +LQ++
Sbjct: 75 LTKLTILYLHENKLQ-SLPNGVFD--KLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIW 130
Query: 517 LSDN 520
L N
Sbjct: 131 LHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 34/121 (28%), Positives = 45/121 (37%), Gaps = 25/121 (20%)
Query: 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSG 620
RL+L NK L QL L LS+N++ S+P G +LT+L +
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPD--GVFDKLTKLTI------- 80
Query: 621 GIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSS 680
L L N L L L L+ L L+ N L G F L+S
Sbjct: 81 ---------------LYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTS 125
Query: 681 L 681
L
Sbjct: 126 L 126
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 41/160 (25%), Positives = 61/160 (38%), Gaps = 36/160 (22%)
Query: 125 CSSLEVLNLNNNRLEA---HIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVA 181
CS E+ N+ L + IP SS T L + +N++ KL+ L++L
Sbjct: 7 CSGTEI-RCNSKGLTSVPTGIP------SSATRLELESNKLQSLPHGVFDKLTQLTKLSL 59
Query: 182 YSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKE 241
N I SLP G +L L L L +N+L +P
Sbjct: 60 SQNQIQ-SLPD--GVFDKLTK---------------------LTILYLHENKLQ-SLPNG 94
Query: 242 I-GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDN 280
+ L L ++ L NQL V TSL+ + L+ N
Sbjct: 95 VFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 62/388 (15%), Positives = 120/388 (30%), Gaps = 41/388 (10%)
Query: 219 GGCESLQYLGLAQ-NQLSGEIPKEIGM-LKYLTDVILWGNQLSGVIPKELG----NCTSL 272
+ L+ L L + + + + I + + +++ + S K L + TSL
Sbjct: 135 ARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194
Query: 273 ETLALYDNKQVGQLPKELGSIG----SLKYLYIYRNEL--NGTIPREIGKLSSALEIDFS 326
E L Y + PK+L +I SL + + E+ + L +
Sbjct: 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLN 254
Query: 327 ENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLG- 385
E+ + E + L L L L +P+ + KLDL L
Sbjct: 255 EDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTL 313
Query: 386 FQYLTNLIMLQLFDN-------SLVGGIPQ----RLGAYSQLWVVDLSDNHLTGKIPRHI 434
Q NL +L+ + L Q R+ + ++ + ++ + +
Sbjct: 314 IQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373
Query: 435 CRN-TSLIFLNLETNKLT-GSIPTGVTRCKSLVQLRL---------GGNSFTGSFPSDLC 483
+ L ++ + + +T S+ + T K+L RL S L
Sbjct: 374 AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLI 433
Query: 484 KLANLSTVEL--DQNQFSGPIPTEIG-NCNALQRLHLSDNYFTGE-LPREVGNLSNLVTF 539
L Q + + IG ++ + L + E L NL
Sbjct: 434 GCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKL 493
Query: 540 NVSSNFLTGRIPLEIF-SCKMLQRLDLS 566
+ + R L+ L +
Sbjct: 494 EMRGCCFSERAIAAAVTKLPSLRYLWVQ 521
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 49/336 (14%), Positives = 97/336 (28%), Gaps = 56/336 (16%)
Query: 365 LKNLTKLDLSINSLT--GTIPLGFQYLTNLIMLQLFDNSLVG--GIPQRLGAYSQLWVVD 420
L+ L + ++ L +L L+L S G+ + ++ +
Sbjct: 111 LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLL 170
Query: 421 LSDN---HLTGKIPRHICRN-TSLIFLNLETNKLTG----SIPTGVTRCKSLVQLRLGGN 472
+ ++ GK + ++ TSL LN + + T C+SLV +++G
Sbjct: 171 MEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDF 230
Query: 473 SFT--GSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV 530
F L L+++ + L RL LS +P
Sbjct: 231 EILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILF 289
Query: 531 GNLSNLVTFNVSSNFLTGRIPLEIFS-------------------------CKMLQRLDL 565
+ + ++ L + CK L+RL +
Sbjct: 290 PFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRI 349
Query: 566 SWNKFVGALPREIGSL------------FQLELLKLSENELSGSIPVQIG----NLSRLT 609
+ E G + +LE + + ++++ IG NL
Sbjct: 350 ERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFR 409
Query: 610 ELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSG 645
+ + +P + G S L L
Sbjct: 410 LVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYL 445
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 65/403 (16%), Positives = 125/403 (31%), Gaps = 47/403 (11%)
Query: 104 LTALDLSF-NQLSRNIPKEIG-NCSSLEVLNLNNNRLEAHIPKELG----NLSSLTILNI 157
L L L + + + I +C ++ L + + K L + +SL +LN
Sbjct: 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNF 199
Query: 158 YNNRISGPFPKEIGKLSA----LSQL-VAYSNNISG-SLPPTLGNLKRLKSFRAGQNLIS 211
Y + PK++ ++ L + V + NL+ +++
Sbjct: 200 YMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGM 259
Query: 212 GSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVIL-WGNQLSGVIPKELGNCT 270
+ L LGL+ + +P + + L + + + C
Sbjct: 260 PEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCP 318
Query: 271 SLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSL 330
+LE L + L LK L I R + E G +S I ++
Sbjct: 319 NLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGC- 377
Query: 331 IGEIPVELSKILGLELLYLFENKLT--GVIPVELTTLKNLTKLDLS----INSLTGT--- 381
LE + ++ + +T + + T LKNL L +T
Sbjct: 378 -----------QELEYMAVYVSDITNESLESI-GTYLKNLCDFRLVLLDREERITDLPLD 425
Query: 382 --IPLGFQYLTNLIMLQLFDNSLVGGI----PQRLGAY-SQLWVVDLSDNHLTGKIPRHI 434
+ L + GG+ +G Y + + L + +
Sbjct: 426 NGVRSLLIGCKKLRRFAFYLRQ--GGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEF 483
Query: 435 CRN-TSLIFLNLETNKLT-GSIPTGVTRCKSLVQLRLGGNSFT 475
R +L L + + +I VT+ SL L + G +
Sbjct: 484 SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.0 bits (118), Expect = 3e-06
Identities = 20/152 (13%), Positives = 44/152 (28%), Gaps = 18/152 (11%)
Query: 462 KSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCN--ALQRLHL-- 517
++ L T + NL ++E+ + +I + L++L L
Sbjct: 169 DAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYV 228
Query: 518 -SDNYFTGELPREV------GNLSNLVTFNVSSNFLTGRIPLEIFSCKM---LQRLDLSW 567
++Y NL + + + L+ +D+S
Sbjct: 229 GVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA 288
Query: 568 NKF----VGALPREIGSLFQLELLKLSENELS 595
L + + L+ + + N LS
Sbjct: 289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 2e-05
Identities = 23/189 (12%), Positives = 55/189 (29%), Gaps = 25/189 (13%)
Query: 524 GELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGS--- 580
+L + + L + + + L+ L++ ++ +I
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 581 --LFQLELLKLSENELSGSIPVQI------GNLSRLTELQMGGNSFSGGIPAELGS---L 629
L +L L E+ L L + + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 630 SSLQIALNLSYNNLSG----LIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCN 685
L+ +++S L+ L+ + + L+++ + N+LS E+ L L
Sbjct: 279 PQLET-MDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKE---LQKSLPMK 334
Query: 686 FSYNNLTGP 694
++
Sbjct: 335 IDVSDSQEY 343
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 2e-04
Identities = 28/181 (15%), Positives = 56/181 (30%), Gaps = 22/181 (12%)
Query: 262 IPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLS--- 318
+ L L L + + K + LK L I L ++ +I
Sbjct: 164 LSPVLDAMPLLNNLKIKGTNNLSIGKKPRPN---LKSLEIISGGLPDSVVEDILGSDLPN 220
Query: 319 -SALEIDFSENSLIGEIPVE-LSKILG------LELLYLFENKLTGVIPVELTT---LKN 367
L + + + + L+ L + + + V+ L
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280
Query: 368 LTKLDLSINSLTGT----IPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSD 423
L +D+S LT + + +L + + N L + + L S +D+SD
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK-SLPMKIDVSD 339
Query: 424 N 424
+
Sbjct: 340 S 340
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 4e-04
Identities = 14/105 (13%), Positives = 33/105 (31%), Gaps = 9/105 (8%)
Query: 75 DFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNC---SSLEVL 131
G + + S + +L L + + + + LE +
Sbjct: 227 YVGVEDYGFDGDMNVFRPLFSKD--RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284
Query: 132 NLNNNRLE----AHIPKELGNLSSLTILNIYNNRISGPFPKEIGK 172
+++ L + + + L +N+ N +S KE+ K
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 64/358 (17%), Positives = 114/358 (31%), Gaps = 57/358 (15%)
Query: 266 LGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNG-TIPREIGKLSSALEID 324
+ N +LE K + L L +L+ + E E+ LSS +++
Sbjct: 22 IKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLF-FHYEFQNQRFSAEV--LSSLRQLN 78
Query: 325 FSENSLIGEIPVELSKILG-----LELLYLFENKLT--GVIPVELTTLKNLTKLDLSINS 377
+ + ++ +LG L+ + L +L G+ + L KL L +NS
Sbjct: 79 LAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTL-LPVFLRARKLGLQLNS 137
Query: 378 LTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICR- 436
L + L +L L + Q+ + LS+N LT +
Sbjct: 138 LGPE---ACKDLRDL----LLHDQ------------CQITTLRLSNNPLTAAGVAVLMEG 178
Query: 437 ---NTSLIFLNLETNKLT----GSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKL---- 485
NTS+ L+L L + + R + L +L + N + L +
Sbjct: 179 LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREH 238
Query: 486 ANLSTVELDQNQFSGP----IPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNV 541
+L + L N+ S + G R+ +S T LS +
Sbjct: 239 PSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLN 298
Query: 542 SSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQ----LELLKLSENELS 595
S + + LE L DL ++ P L + + L
Sbjct: 299 SWDRARVQRHLE------LLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 47/304 (15%), Positives = 93/304 (30%), Gaps = 53/304 (17%)
Query: 103 HLTALDLSFNQLSRNIPKEIG-----NCSSLEVLNLNNNRLEAHIPKELGN-LSSLTILN 156
L L+L+ +++ + +L+ +NL + +L+ + L L
Sbjct: 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLG 132
Query: 157 IYNNRISGPFPKEIGKL-----SALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLIS 211
+ N + K++ L ++ L +N ++ AG ++
Sbjct: 133 LQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTA----------------AGVAVLM 176
Query: 212 GSLPSEIGGCESLQYLGLAQNQLSGEIPKEIG-MLKY---LTDVILWGNQLSGV----IP 263
L S+ +L L L E + + L L ++ + N +
Sbjct: 177 EGLAG----NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALA 232
Query: 264 KELGNCTSLETLALYDNK----QVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSS 319
+ SLE L LY N+ L G+ + + E LS
Sbjct: 233 RAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSE 292
Query: 320 ALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVE----LTTLKNLTKLDLSI 375
+ NS + + L L L L +++ + P L + L +
Sbjct: 293 VQR---NLNSW---DRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQL 346
Query: 376 NSLT 379
S
Sbjct: 347 GSSG 350
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 48/233 (20%), Positives = 76/233 (32%), Gaps = 26/233 (11%)
Query: 454 IPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLA----NLSTVELDQ-NQFSGPIPTEIG- 507
I + L ++RL T L +A N + L FS I
Sbjct: 97 IEAMSSSYTWLEEIRLKRMVVTDD---CLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAA 153
Query: 508 NCNALQRLHLSDNYFTGE----LPREVGNLSNLVTFNVSS-NFLTGRIPLEIF--SCKML 560
C L+ L L ++ L ++LV+ N+S LE C L
Sbjct: 154 TCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNL 213
Query: 561 QRLDLSWNKFVGALPREIGSLFQLELLKLS------ENELSGSIPVQIGNLSRLTELQMG 614
+ L L+ + L + QLE L ++ + V + L L
Sbjct: 214 KSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGF 273
Query: 615 GNSFSGGIPAELGSLSSLQIALNLSYNNLS--GLIPPELGNLILLEYLLLNNN 665
++ +PA S L LNLSY + L+ L L+ L + +
Sbjct: 274 WDAVPAYLPAVYSVCSRLTT-LNLSYATVQSYDLVKL-LCQCPKLQRLWVLDY 324
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 71/453 (15%), Positives = 134/453 (29%), Gaps = 82/453 (18%)
Query: 70 NCTTNDFGAVVFSL---NLTKMNLSGYLSPNIGGLVH-------LTALDLSFNQLSRNIP 119
D + + N + LS + GL L LDL + +
Sbjct: 114 RMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSG 173
Query: 120 KEIG----NCSSLEVLNLNNNRLE------AHIPKELGNLSSLTILNIYNNRISGPFPKE 169
+ +SL LN++ E + NL SL + +
Sbjct: 174 HWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQR 233
Query: 170 IGKLSALSQLVAYSNNISG----SLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQ 225
+L L Y+ + L L K L+ + + LP+ C L
Sbjct: 234 APQLEELG-TGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLT 292
Query: 226 YLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQ 285
L L+ + ++ L C L+ L + D +
Sbjct: 293 TLNLSYATVQSYDLVKL-----------------------LCQCPKLQRLWVLDYIEDAG 329
Query: 286 LPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKIL-GL 344
L + L+ L ++ +E + +E L V +S L
Sbjct: 330 LEVLASTCKDLRELRVFPSE----------PFVMEPNVALTEQGL-----VSVSMGCPKL 374
Query: 345 ELLYLFENKLTGVIPVELTT-LKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLV 403
E + F ++T + + N+T+ L I + L L
Sbjct: 375 ESVLYFCRQMTNAALITIARNRPNMTRFRLCI-------------IEPKAPDYLTLEPLD 421
Query: 404 GGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLTG-SIPTGVTRC 461
G + L + LS LT K+ +I + L++ + + ++ C
Sbjct: 422 IGFGAIVEHCKDLRRLSLS-GLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGC 480
Query: 462 KSLVQLRLGGNSFTG-SFPSDLCKLANLSTVEL 493
SL +L + F + ++ KL + ++ +
Sbjct: 481 DSLRKLEIRDCPFGDKALLANASKLETMRSLWM 513
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 76/527 (14%), Positives = 146/527 (27%), Gaps = 99/527 (18%)
Query: 84 NLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLE---- 139
+ + L G LV + + + + LE + L +
Sbjct: 67 KVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSS----SYTWLEEIRLKRMVVTDDCL 122
Query: 140 AHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKR 199
I K N L + + S L+ + A T NLK
Sbjct: 123 ELIAKSFKNFKVLVLSSCEG--FST---------DGLAAIAA-----------TCRNLKE 160
Query: 200 LK-SFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQL 258
L ++ L SL L ++ + ++ L
Sbjct: 161 LDLRESDVDDVSGHWLSHFPDTYTSLVSLNIS------------CLASEVSFSALE---- 204
Query: 259 SGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLS 318
+ + C +L++L L + +L L L+ L
Sbjct: 205 -----RLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAE----------- 248
Query: 319 SALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSL 378
+ + V LS L L F + + +P + LT L+LS ++
Sbjct: 249 -------VRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATV 301
Query: 379 TGT-IPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSD---------NHLTG 428
+ L L + D G+ L + + LT
Sbjct: 302 QSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTE 361
Query: 429 KIPRHICRN-TSLIFLNLETNKLTG-SIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLA 486
+ + L + ++T ++ T ++ + RL C +
Sbjct: 362 QGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRL-------------CIIE 408
Query: 487 NLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVG-NLSNLVTFNVSSNF 545
+ L + +C L+RL LS T ++ +G + +V+
Sbjct: 409 PKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGL-LTDKVFEYIGTYAKKMEMLSVAFAG 467
Query: 546 LTGRIPLEIF-SCKMLQRLDLSWNKFVG-ALPREIGSLFQLELLKLS 590
+ + C L++L++ F AL L + L +S
Sbjct: 468 DSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMS 514
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 70/489 (14%), Positives = 154/489 (31%), Gaps = 75/489 (15%)
Query: 83 LNLTKMNLSGYLSPNIGGLV----HLTALDLSFNQLSRNIPKEIG-NCSSLEVLNLNNNR 137
NL GY+ P I + L + L ++ + + I + + +VL L++
Sbjct: 82 FNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE 141
Query: 138 L--EAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLG 195
+ +L L++ + + S + P T
Sbjct: 142 GFSTDGLAAIAATCRNLKELDLRESDVDDV-----------------SGHWLSHFPDTYT 184
Query: 196 NLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWG 255
+L L + +L + C +L+ L L + ++ + L ++
Sbjct: 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEEL---- 240
Query: 256 NQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIG 315
G T+ +Y L L L+ L + + + +P +
Sbjct: 241 ---------GTGGYTAEVRPDVYSG-----LSVALSGCKELRCLSGFWDAVPAYLP-AVY 285
Query: 316 KLSSALE-IDFSENSLIGEIPVELSKIL-GLELLYLFEN-KLTGVIPVELTTLKNLTKLD 372
+ S L ++ S ++ V+L L+ L++ + + G+ + +T K+L +L
Sbjct: 286 SVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVL-ASTCKDLRELR 344
Query: 373 LSINSLTGTIPLGFQYLTNLIMLQLFDN-----SLVGGIPQRLGAYSQLWVVDLSDN--- 424
+ + LT ++ + S++ + +++
Sbjct: 345 VF--PSEPFVMEPNVALTEQGLVSVSMGCPKLESVL------------YFCRQMTNAALI 390
Query: 425 HLTGKIPR----HICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPS 480
+ P +C L L V CK L +L L G F
Sbjct: 391 TIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEY 450
Query: 481 DLCKLANLSTVELDQNQFSGPIPTEIG-NCNALQRLHLSDNYFTGE-LPREVGNLSNLVT 538
+ + + S + C++L++L + D F + L L + +
Sbjct: 451 IGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRS 510
Query: 539 FNVSSNFLT 547
+SS ++
Sbjct: 511 LWMSSCSVS 519
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1114 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.81 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.68 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.68 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.66 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.57 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.53 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.48 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.47 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.38 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.35 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.27 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.26 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.26 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.15 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.15 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.99 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.88 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.86 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.81 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.8 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.79 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.75 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.56 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.47 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.33 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.26 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.26 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.26 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.2 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.75 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.64 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.6 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.59 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.58 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.49 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.08 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.02 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.96 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.89 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.75 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.69 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.68 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.62 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.26 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.21 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.19 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.85 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.83 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.5 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.36 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.37 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-96 Score=928.19 Aligned_cols=682 Identities=32% Similarity=0.500 Sum_probs=643.3
Q ss_pred cCCCcchHHHHHHhHhhccCCCCCCCCCCCCCCCCCccceEEEecCCCccEEEEEeecCCCcCcc---cCCCCCCCCccC
Q 001253 29 KGLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGY---LSPNIGGLVHLT 105 (1114)
Q Consensus 29 ~~~~~~~~~~ll~~k~~~~~~~~~~~~W~~~~~~~C~w~gv~C~~~~~~~~v~~l~l~~~~l~g~---~~~~l~~l~~L~ 105 (1114)
..+.++|++|||+||+++.||. .+++|+. +.+||.|.||+|+ .++|++|+|+++++.|. +++++++|++|+
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~-~l~~W~~-~~~~C~w~gv~C~----~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~ 80 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCR----DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTT-SSTTCCT-TSCGGGSTTEEEE----TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred ccCCHHHHHHHHHHHhhCCCcc-cccCCCC-CCCCcCCcceEEC----CCcEEEEECCCCCcCCccCccChhHhccCccc
Confidence 3446789999999999999988 9999984 4679999999997 26899999999999999 999999999999
Q ss_pred EEEecCCcccCCCCcccCCCCCCCEEEccCCCccccccc--ccccccccceeccccccccCCCCccc-ccCcccchhhhc
Q 001253 106 ALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPK--ELGNLSSLTILNIYNNRISGPFPKEI-GKLSALSQLVAY 182 (1114)
Q Consensus 106 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~ 182 (1114)
.++++.|.+. .+|+.|+.+++|++|+|++|.++|.+|. .++++++|++|+|++|++.+.+|..+ .++++|++|+++
T Consensus 81 ~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls 159 (768)
T 3rgz_A 81 SLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159 (768)
T ss_dssp EEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred ccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence 9999999885 4778999999999999999999999998 99999999999999999999999887 899999999999
Q ss_pred ccccCCCCCCC---ccccccccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCccc
Q 001253 183 SNNISGSLPPT---LGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLS 259 (1114)
Q Consensus 183 ~n~i~~~~p~~---l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 259 (1114)
+|++++..|.. +.++++|++|++++|.+.+..|. ..+++|++|+|++|++++.+|. ++.+++|++|++++|+++
T Consensus 160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~ 236 (768)
T 3rgz_A 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLS 236 (768)
T ss_dssp SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCC
T ss_pred CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCC
Confidence 99999988887 89999999999999999977664 8899999999999999988887 999999999999999999
Q ss_pred CccccccccccccchhhcccccccCCchhhhcCCCccceeeecccccccccCcccccc-ccccccccccccCCCCCchhh
Q 001253 260 GVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKL-SSALEIDFSENSLIGEIPVEL 338 (1114)
Q Consensus 260 ~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~ls~N~l~~~~~~~l 338 (1114)
+.+|..++++++|++|++++|.+.+.+|.. .+++|++|+|++|.+.+.+|..+... ++|++|++++|++.+.+|..+
T Consensus 237 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~ 314 (768)
T 3rgz_A 237 GDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314 (768)
T ss_dssp SCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGG
T ss_pred CcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHH
Confidence 999999999999999999999999888875 89999999999999999999998876 999999999999999999999
Q ss_pred hcccccceeecccccccCccccc-ccccccCCEEEcccccccccccCcccccc-ceeeeeccCCcccCCCCCCCCc--Cc
Q 001253 339 SKILGLELLYLFENKLTGVIPVE-LTTLKNLTKLDLSINSLTGTIPLGFQYLT-NLIMLQLFDNSLVGGIPQRLGA--YS 414 (1114)
Q Consensus 339 ~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~--l~ 414 (1114)
..+++|+.|++++|++++.+|.. +..+++|++|+|++|++++.+|..+..++ +|++|++++|++.+.+|..+.. ++
T Consensus 315 ~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 394 (768)
T 3rgz_A 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394 (768)
T ss_dssp GGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTC
T ss_pred hcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccC
Confidence 99999999999999999777765 99999999999999999999999999998 9999999999999999888877 88
Q ss_pred cceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecc
Q 001253 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELD 494 (1114)
Q Consensus 415 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 494 (1114)
+|++|++++|++++.+|..+..+++|++|++++|++++.+|..+..+++|++|++++|++++.+|..+..+++|++|+++
T Consensus 395 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 474 (768)
T 3rgz_A 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474 (768)
T ss_dssp CCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred CccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCC
Q 001253 495 QNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGAL 574 (1114)
Q Consensus 495 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 574 (1114)
+|++++.+|..+.++++|++|+|++|++++.+|.+++.+++|++|+|++|++++.+|..+..+++|+.|+|++|+++|.+
T Consensus 475 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~i 554 (768)
T 3rgz_A 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBC
T ss_pred CCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred chhhhhccc----------------------------------------------CCeeeccCccCCCcccccccccccc
Q 001253 575 PREIGSLFQ----------------------------------------------LELLKLSENELSGSIPVQIGNLSRL 608 (1114)
Q Consensus 575 p~~~~~l~~----------------------------------------------L~~L~L~~N~l~~~~p~~~~~l~~L 608 (1114)
|..+..... ++.++++.|.++|.+|..++.+++|
T Consensus 555 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L 634 (768)
T 3rgz_A 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634 (768)
T ss_dssp CGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC
T ss_pred ChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccc
Confidence 988765433 3345566688899999999999999
Q ss_pred cccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEecc
Q 001253 609 TELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSY 688 (1114)
Q Consensus 609 ~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~ 688 (1114)
+.|||++|+|+|.+|.++++++.|+ .|+|++|+++|.+|..|+++++|++||||+|+|+|.||..|.++++|+.||+|+
T Consensus 635 ~~LdLs~N~l~g~ip~~l~~l~~L~-~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~ 713 (768)
T 3rgz_A 635 MFLDMSYNMLSGYIPKEIGSMPYLF-ILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713 (768)
T ss_dssp CEEECCSSCCBSCCCGGGGGCTTCC-EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCS
T ss_pred cEEECcCCcccccCCHHHhccccCC-EEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcC
Confidence 9999999999999999999999999 799999999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCcccccccccccccCCCCCCCCCCCCC
Q 001253 689 NNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNC 723 (1114)
Q Consensus 689 N~l~g~ip~~~~~~~~~~~~~~~n~~lc~~p~~~~ 723 (1114)
|+++|.||.+++|++++..+|.||+++||.|+..|
T Consensus 714 N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C 748 (768)
T 3rgz_A 714 NNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRC 748 (768)
T ss_dssp SEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCC
T ss_pred CcccccCCCchhhccCCHHHhcCCchhcCCCCcCC
Confidence 99999999999999999999999999999998655
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-77 Score=754.82 Aligned_cols=604 Identities=33% Similarity=0.466 Sum_probs=561.9
Q ss_pred EeecCCCcCcccC--CCCCCCCccCEEEecCCcccCCCCc--ccCCCCCCCEEEccCCCccccccccc-ccccccceecc
Q 001253 83 LNLTKMNLSGYLS--PNIGGLVHLTALDLSFNQLSRNIPK--EIGNCSSLEVLNLNNNRLEAHIPKEL-GNLSSLTILNI 157 (1114)
Q Consensus 83 l~l~~~~l~g~~~--~~l~~l~~L~~L~Ls~n~l~~~~p~--~~~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~L 157 (1114)
|++.++...|.++ +.++.+++|++|||++|.++|.+|. .++++++|++|+|++|.+.+.+|..+ .++++|++|+|
T Consensus 79 L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L 158 (768)
T 3rgz_A 79 LESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158 (768)
T ss_dssp CCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEEC
T ss_pred ccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEEC
Confidence 3444444455444 8899999999999999999999998 99999999999999999998888876 89999999999
Q ss_pred ccccccCCCCcc---cccCcccchhhhcccccCCCCCCCccccccccceeccccccccccCCCCCCCCccceeecccccc
Q 001253 158 YNNRISGPFPKE---IGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQL 234 (1114)
Q Consensus 158 ~~N~l~~~~p~~---~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 234 (1114)
++|++++..|.. +.++++|++|++++|.+++.+|. .++++|++|++++|.+.+.+|. ++++++|++|+|++|++
T Consensus 159 s~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l 235 (768)
T 3rgz_A 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKL 235 (768)
T ss_dssp CSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCC
T ss_pred CCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcC
Confidence 999999888887 88999999999999999987764 8899999999999999988887 99999999999999999
Q ss_pred CCCCcccccccccccEEEecCCcccCccccccccccccchhhcccccccCCchhhhcCC-CccceeeecccccccccCcc
Q 001253 235 SGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSI-GSLKYLYIYRNELNGTIPRE 313 (1114)
Q Consensus 235 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l-~~L~~L~L~~n~l~~~~p~~ 313 (1114)
++.+|..++.+++|++|++++|++++.+|.. .+++|++|++++|.+.+.+|..+..+ ++|++|+|++|++.+.+|..
T Consensus 236 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~ 313 (768)
T 3rgz_A 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF 313 (768)
T ss_dssp CSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGG
T ss_pred CCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchH
Confidence 9999999999999999999999999888875 89999999999999999999998875 99999999999999999999
Q ss_pred ccccccccccccccccCCCCCchh-hhcccccceeecccccccCcccccccccc-cCCEEEcccccccccccCcccc--c
Q 001253 314 IGKLSSALEIDFSENSLIGEIPVE-LSKILGLELLYLFENKLTGVIPVELTTLK-NLTKLDLSINSLTGTIPLGFQY--L 389 (1114)
Q Consensus 314 l~~l~~L~~L~ls~N~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~--l 389 (1114)
++.+++|++|++++|.+.+.+|.. +.++++|+.|++++|++++.+|..+..++ +|++|++++|++++.+|..+.. +
T Consensus 314 ~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~ 393 (768)
T 3rgz_A 314 FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393 (768)
T ss_dssp GGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTT
T ss_pred HhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhccc
Confidence 999999999999999999888876 99999999999999999999999999988 9999999999999999988877 8
Q ss_pred cceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEee
Q 001253 390 TNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRL 469 (1114)
Q Consensus 390 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 469 (1114)
++|++|++++|++.+.+|..+..+++|++|+|++|++++.+|..+..+++|++|++++|++++.+|..+..+++|++|++
T Consensus 394 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 473 (768)
T 3rgz_A 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473 (768)
T ss_dssp CCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred CCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEe
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeeccccccccc
Q 001253 470 GGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGR 549 (1114)
Q Consensus 470 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 549 (1114)
++|++++.+|..+..+++|++|+|++|++++.+|.+++.+++|++|+|++|+++|.+|..++++++|+.|++++|+++|.
T Consensus 474 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ 553 (768)
T 3rgz_A 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT 553 (768)
T ss_dssp CSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESB
T ss_pred cCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccc----------------------------------------------eEEECccccccCCCchhhhhccc
Q 001253 550 IPLEIFSCKML----------------------------------------------QRLDLSWNKFVGALPREIGSLFQ 583 (1114)
Q Consensus 550 ~p~~~~~l~~L----------------------------------------------~~L~Ls~N~l~~~~p~~~~~l~~ 583 (1114)
+|..++.+..+ +.++++.|.+.|.+|..++.+++
T Consensus 554 ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~ 633 (768)
T 3rgz_A 554 IPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633 (768)
T ss_dssp CCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBC
T ss_pred CChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhcccc
Confidence 99887664433 33455668889999999999999
Q ss_pred CCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhcc
Q 001253 584 LELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLN 663 (1114)
Q Consensus 584 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 663 (1114)
|++|||++|+++|.+|..++++++|+.|+|++|+|+|.+|..++++++|+ .||||+|+++|.+|..++++++|++||||
T Consensus 634 L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~-~LdLs~N~l~g~ip~~l~~l~~L~~L~ls 712 (768)
T 3rgz_A 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN-ILDLSSNKLDGRIPQAMSALTMLTEIDLS 712 (768)
T ss_dssp CCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC-EEECCSSCCEECCCGGGGGCCCCSEEECC
T ss_pred ccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCC-EEECCCCcccCcCChHHhCCCCCCEEECc
Confidence 99999999999999999999999999999999999999999999999999 79999999999999999999999999999
Q ss_pred CcccccCCCCccccccccceEEeccCc-ccC
Q 001253 664 NNHLSGEIPGSFVNLSSLLGCNFSYNN-LTG 693 (1114)
Q Consensus 664 ~N~l~g~ip~~~~~l~~l~~l~ls~N~-l~g 693 (1114)
+|+|+|.||.. ..+..+....+.+|+ |+|
T Consensus 713 ~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 713 NNNLSGPIPEM-GQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp SSEEEEECCSS-SSGGGSCGGGGCSCTEEES
T ss_pred CCcccccCCCc-hhhccCCHHHhcCCchhcC
Confidence 99999999975 445566667788886 666
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-65 Score=643.29 Aligned_cols=619 Identities=21% Similarity=0.197 Sum_probs=444.8
Q ss_pred eecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceecccccccc
Q 001253 84 NLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRIS 163 (1114)
Q Consensus 84 ~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~ 163 (1114)
++++++++ .+|..+. +++++|+|++|++++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|+++
T Consensus 10 ~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 86 (680)
T 1ziw_A 10 DCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86 (680)
T ss_dssp ECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC
T ss_pred ECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC
Confidence 33444454 3555554 67899999999998777778888999999999999988888888888999999999999888
Q ss_pred CCCCcccccCcccchhhhcccccCCCCCCCccccccccceeccccccccccCCCCCCCCccceeeccccccCCCCccccc
Q 001253 164 GPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIG 243 (1114)
Q Consensus 164 ~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 243 (1114)
+..+..|+++++|++|++++|++++..|.+|+++++|++|++++|.+++..|..++++++|++|+|++|++++..+..++
T Consensus 87 ~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 166 (680)
T 1ziw_A 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELD 166 (680)
T ss_dssp CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHG
T ss_pred ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhh
Confidence 55555788888888888888888877777888888888888888888877777788888888888888888766666554
Q ss_pred --ccccccEEEecCCcccCccccccccccccchhhcccccccCCchhhhc---CCCccceeeecccccccccCccccccc
Q 001253 244 --MLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELG---SIGSLKYLYIYRNELNGTIPREIGKLS 318 (1114)
Q Consensus 244 --~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~---~l~~L~~L~L~~n~l~~~~p~~l~~l~ 318 (1114)
.+++|++|++++|++++..|..+..+++|+.|++++|.+.......+. ..++|++|++++|.+.+..|..+..++
T Consensus 167 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~ 246 (680)
T 1ziw_A 167 IFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246 (680)
T ss_dssp GGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGG
T ss_pred ccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccC
Confidence 447788888888888877777777777888887777765433222221 236677777777777666666666554
Q ss_pred c--ccccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeee
Q 001253 319 S--ALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQ 396 (1114)
Q Consensus 319 ~--L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 396 (1114)
. |++|++++|.+.+..|..+..+++|+.|++++|++++..|..|..+++|++|++++|...+.++.
T Consensus 247 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~------------ 314 (680)
T 1ziw_A 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL------------ 314 (680)
T ss_dssp GSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC----------------
T ss_pred cCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccc------------
Confidence 3 66666666666555555555555555555555555555555555555555555555443321110
Q ss_pred ccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCC--cCcccccC--CcceEEeeccc
Q 001253 397 LFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGS--IPTGVTRC--KSLVQLRLGGN 472 (1114)
Q Consensus 397 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~--~p~~~~~l--~~L~~L~L~~N 472 (1114)
+.+.......|..+++|++|++++|++++..+..|..+++|++|++++|.+... ....+..+ ++|+.|++++|
T Consensus 315 ---~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n 391 (680)
T 1ziw_A 315 ---ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKN 391 (680)
T ss_dssp -----CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTS
T ss_pred ---ccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCC
Confidence 000001112455666777777777777766666666777777777777664322 12223322 57888888888
Q ss_pred eeeccCCchhhccccccEeecccccCCCCcc-ccccccccCcEEEecCceeccCCCccccCCCCcceeeccccccc--cc
Q 001253 473 SFTGSFPSDLCKLANLSTVELDQNQFSGPIP-TEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLT--GR 549 (1114)
Q Consensus 473 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~ 549 (1114)
++++..|..|..+++|++|+|++|++++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.++ +.
T Consensus 392 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 471 (680)
T 1ziw_A 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471 (680)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTC
T ss_pred CCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccccccc
Confidence 8887778888888888888888888876554 67788888888888888888777888888888888888888876 46
Q ss_pred ccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCccc--------ccccccccccccccCCCcCCCC
Q 001253 550 IPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIP--------VQIGNLSRLTELQMGGNSFSGG 621 (1114)
Q Consensus 550 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--------~~~~~l~~L~~L~ls~N~l~~~ 621 (1114)
+|..+..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+ ..+.++++|+.|+|++|+|+..
T Consensus 472 ~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i 551 (680)
T 1ziw_A 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551 (680)
T ss_dssp SSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCC
T ss_pred CCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCC
Confidence 77788888888888888888887777778888888888888888885422 2378899999999999999955
Q ss_pred CChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccc-cccccceEEeccCcccCCCCC-cc
Q 001253 622 IPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFV-NLSSLLGCNFSYNNLTGPIPS-SQ 699 (1114)
Q Consensus 622 ~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~l~~l~ls~N~l~g~ip~-~~ 699 (1114)
.+..|..+++|+ .|+|++|++++..+..|.++++|+.|+|++|+|++.+|..|. .+++|+.+++++|+|.|.++. .+
T Consensus 552 ~~~~~~~l~~L~-~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~ 630 (680)
T 1ziw_A 552 PVEVFKDLFELK-IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW 630 (680)
T ss_dssp CTTTTTTCTTCC-EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSS
T ss_pred CHHHcccccCcc-eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHH
Confidence 556789999998 799999999988788889999999999999999999988888 899999999999999999986 44
Q ss_pred ccccccccc--cc--CCCCCCCCCCC
Q 001253 700 TFQNMSVNS--FS--GSKGLCGGPLQ 721 (1114)
Q Consensus 700 ~~~~~~~~~--~~--~n~~lc~~p~~ 721 (1114)
-..++.... +. .....|..|..
T Consensus 631 ~~~~~~~~~~~~~~~~~~~~C~~p~~ 656 (680)
T 1ziw_A 631 FVNWINETHTNIPELSSHYLCNTPPH 656 (680)
T ss_dssp EECCSSCC------------------
T ss_pred HHHHHHhcCcccccccCCcEECCchH
Confidence 434443321 11 23446776653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-64 Score=627.45 Aligned_cols=598 Identities=21% Similarity=0.201 Sum_probs=430.8
Q ss_pred CccceEEEe-------cCCCccEEEEEeecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCC
Q 001253 64 CGWIGVNCT-------TNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNN 136 (1114)
Q Consensus 64 C~w~gv~C~-------~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 136 (1114)
|.+.-|.|+ +.+.+..++.|+|+++++++..+..++++++|++|+|++|.+++..|..++++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 444445554 3344556899999999999988888999999999999999999999999999999999999999
Q ss_pred CcccccccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccceeccccccccccCC
Q 001253 137 RLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPS 216 (1114)
Q Consensus 137 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 216 (1114)
.+++..+..|+++++|++|+|++|++++..|..|+++++|++|++++|.+++..|..++++++|++|++++|.+++..+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99976666899999999999999999988889999999999999999999999999999999999999999999987776
Q ss_pred CCC--CCCccceeeccccccCCCCcccccccccccEEEecCCcccCccccccc---cccccchhhcccccccCCchhhhc
Q 001253 217 EIG--GCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELG---NCTSLETLALYDNKQVGQLPKELG 291 (1114)
Q Consensus 217 ~l~--~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~---~l~~L~~L~Ls~N~~~~~~p~~~~ 291 (1114)
.+. .+++|++|++++|++++..|..+..+++|+.|++.+|.+.+.....+. ..++|+.|++++|.+.+..|..|.
T Consensus 164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~ 243 (680)
T 1ziw_A 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243 (680)
T ss_dssp HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence 654 568999999999999998999999999999999999998754333222 347899999999999999999999
Q ss_pred CCCc--cceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccCc-----cc----c
Q 001253 292 SIGS--LKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGV-----IP----V 360 (1114)
Q Consensus 292 ~l~~--L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-----~~----~ 360 (1114)
.++. |++|+|++|++.+..|..++.+++|++|++++|.+.+..|..+..+++|+.|++++|...+. +| .
T Consensus 244 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~ 323 (680)
T 1ziw_A 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323 (680)
T ss_dssp GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTT
T ss_pred ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChh
Confidence 8865 99999999999988889999999999999999999999999999999999999998765532 12 2
Q ss_pred cccccccCCEEEcccccccccccCccccccceeeeeccCCcccCC--CCCCCCcC--ccceEEEeecccccCCCCccccc
Q 001253 361 ELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGG--IPQRLGAY--SQLWVVDLSDNHLTGKIPRHICR 436 (1114)
Q Consensus 361 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~ 436 (1114)
.|..+++|++|++++|.+++..+..|..+++|++|++++|.+... ....|..+ ++|++|++++|++++..|..|..
T Consensus 324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 403 (680)
T 1ziw_A 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403 (680)
T ss_dssp TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence 566677777777777777776666677777777777777654321 11222222 34555555555555544555555
Q ss_pred cCccceeeeccCCccCCcC-cccccCCcceEEeeccceeeccCCchhhccccccEeecccccCC--CCccccccccccCc
Q 001253 437 NTSLIFLNLETNKLTGSIP-TGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFS--GPIPTEIGNCNALQ 513 (1114)
Q Consensus 437 ~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~ 513 (1114)
+++|++|++++|++++.+| ..+..+++|++|++++|++.+..+..|..+++|+.|++++|.++ +.+|..|.++++|+
T Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~ 483 (680)
T 1ziw_A 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483 (680)
T ss_dssp CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence 5555555555555544333 34444555555555555554444444444555555555555443 23444444444445
Q ss_pred EEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCcc
Q 001253 514 RLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENE 593 (1114)
Q Consensus 514 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 593 (1114)
.|+|++|+|++..+..|.++++|++|+|++|++++..+..+ .+..+..+..+++|++|+|++|+
T Consensus 484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----------------~~~~~~~~~~l~~L~~L~L~~N~ 547 (680)
T 1ziw_A 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHAN----------------PGGPIYFLKGLSHLHILNLESNG 547 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTS----------------TTSCCCTTTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhc----------------cCCcchhhcCCCCCCEEECCCCC
Confidence 55554444444444444444444444444444442111000 00011235666677777777777
Q ss_pred CCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCcccc-chhhhHhhhccCcccccCCC
Q 001253 594 LSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELG-NLILLEYLLLNNNHLSGEIP 672 (1114)
Q Consensus 594 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~ip 672 (1114)
++...+..|.++++|+.|+|++|+|++..+..|..+++|+ .|+|++|+|++..|..++ .+++|+.|+|++|++....+
T Consensus 548 l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK-SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC-EEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCC-EEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 7644344567777777777777777755555566777776 577777777777666666 67788888888888887665
Q ss_pred --Cccccc
Q 001253 673 --GSFVNL 678 (1114)
Q Consensus 673 --~~~~~l 678 (1114)
.+|..+
T Consensus 627 ~~~~~~~~ 634 (680)
T 1ziw_A 627 SIAWFVNW 634 (680)
T ss_dssp CCSSEECC
T ss_pred cHHHHHHH
Confidence 344443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=580.58 Aligned_cols=563 Identities=21% Similarity=0.191 Sum_probs=381.5
Q ss_pred CEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhccc
Q 001253 105 TALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSN 184 (1114)
Q Consensus 105 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n 184 (1114)
+.++.++..++ .+|..+.. ++++|+|++|.+++..|..|+++++|++|+|++|++++..|.+|+++++|++|++++|
T Consensus 15 ~~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 91 (606)
T 3t6q_A 15 KTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91 (606)
T ss_dssp TEEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred ceEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCC
Confidence 68999998886 68877754 7899999999999888889999999999999999998777777877777777777777
Q ss_pred ccCCCCCCCccccccccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCcccc
Q 001253 185 NISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPK 264 (1114)
Q Consensus 185 ~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 264 (1114)
++++..|.+|+++++|++|++++|.+++..|..++++++|++|+|++|++++..+..+..+++|++|++++|.+++..|.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 171 (606)
T 3t6q_A 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171 (606)
T ss_dssp CCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHH
T ss_pred cccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChh
Confidence 77766666777777777777776666655566666666666666666666643323333356666666666666555455
Q ss_pred ccccccccc--hhhcccccccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhccc
Q 001253 265 ELGNCTSLE--TLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKIL 342 (1114)
Q Consensus 265 ~l~~l~~L~--~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~ 342 (1114)
.++.+++|+ .|++++|.+.+..|..+.. .+|++|++++|. .++..+..+.
T Consensus 172 ~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-------------------------~~L~~L~l~~~~---~~~~~~~~l~ 223 (606)
T 3t6q_A 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDS-------------------------AVFQSLNFGGTQ---NLLVIFKGLK 223 (606)
T ss_dssp HHHTTTTCCSEEEECTTCCCCEECTTTTTT-------------------------CEEEEEECTTCS---CHHHHHHHTT
T ss_pred hhhhhcccceeEEecCCCccCccChhHhhh-------------------------ccccccccCCch---hHHHHhhhcc
Confidence 555555555 4455555444444433322 344444444443 2223333333
Q ss_pred ccceeecccccccCcccccccccccCCEEEcccccccccccCcccccc--ceeeeeccCCcccCCCCCCCCcCccceEEE
Q 001253 343 GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLT--NLIMLQLFDNSLVGGIPQRLGAYSQLWVVD 420 (1114)
Q Consensus 343 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 420 (1114)
++....+.-+.+. .+...+++ +..|..+. +|+.|++++|.+.+..+..|..+++|++|+
T Consensus 224 ~~~l~~l~~~~~~-----------~~~~~~i~--------~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 284 (606)
T 3t6q_A 224 NSTIQSLWLGTFE-----------DMDDEDIS--------PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284 (606)
T ss_dssp TCEEEEEECCCCT-----------TSCCCCCC--------GGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEE
T ss_pred ccchhheechhhc-----------cccccccC--------hhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEe
Confidence 3222222211111 11111111 11122221 455555555555555555556666666666
Q ss_pred eecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCc-hhhccccccEeecccccCC
Q 001253 421 LSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPS-DLCKLANLSTVELDQNQFS 499 (1114)
Q Consensus 421 Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~ 499 (1114)
+++|+++ .+|..+..+++|++|++++|++++..|..+..+++|++|++++|.+.+.+|. .+..+++|++|++++|+++
T Consensus 285 l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 363 (606)
T 3t6q_A 285 LTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363 (606)
T ss_dssp CTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCC
T ss_pred ccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccc
Confidence 6666665 4555566666666666666666655566666666666677766666654444 3666777777777777776
Q ss_pred CCc--cccccccccCcEEEecCceeccCCCccccCCCCcceeeccccccccccccc-ccccccceEEECccccccCCCch
Q 001253 500 GPI--PTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLE-IFSCKMLQRLDLSWNKFVGALPR 576 (1114)
Q Consensus 500 ~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~ 576 (1114)
+.. |..+..+++|++|++++|++++..|..|..+++|++|++++|++++..|.. +..+++|+.|++++|.+++..|.
T Consensus 364 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 443 (606)
T 3t6q_A 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443 (606)
T ss_dssp EEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTT
T ss_pred cccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHH
Confidence 554 566777777777777777777777777777777777777777777655544 66777888888888888777777
Q ss_pred hhhhcccCCeeeccCccCCCc---ccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccc
Q 001253 577 EIGSLFQLELLKLSENELSGS---IPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGN 653 (1114)
Q Consensus 577 ~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~ 653 (1114)
.++.+++|++|++++|++++. .+..+..+++|+.|++++|++++.+|..+..+++|+ .|+|++|++++.+|..+.+
T Consensus 444 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~l~~ 522 (606)
T 3t6q_A 444 LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN-HVDLSHNRLTSSSIEALSH 522 (606)
T ss_dssp TTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCC-EEECCSSCCCGGGGGGGTT
T ss_pred HHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCC-EEECCCCccCcCChhHhCc
Confidence 788888888888888888752 235678888888888888888888888888888888 7899999999988999999
Q ss_pred hhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCCccccccccccc---ccCCCCCCCCCC
Q 001253 654 LILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNS---FSGSKGLCGGPL 720 (1114)
Q Consensus 654 l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~---~~~n~~lc~~p~ 720 (1114)
++.| +|||++|++++.+|..|..+++|+.+++++|+|.|.++..+...++.... .......|..|.
T Consensus 523 l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~w~~~~~~~~~~~~~~~C~~p~ 591 (606)
T 3t6q_A 523 LKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCENPP 591 (606)
T ss_dssp CCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHHHHHHHHHCGGGEECGGGCBEEESG
T ss_pred cccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHHHHHHHHhCcccccCCCCCeeCCch
Confidence 9999 99999999999999999999999999999999999998765555443221 112234676654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-58 Score=589.15 Aligned_cols=541 Identities=21% Similarity=0.169 Sum_probs=363.1
Q ss_pred CEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCC-CcccccCcccchhhhcc
Q 001253 105 TALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPF-PKEIGKLSALSQLVAYS 183 (1114)
Q Consensus 105 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~ 183 (1114)
+..|.++++++ .+|. -.++|++|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |.+|+++++|++|++++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 57888999997 5776 4588999999999999888999999999999999999665555 77788888888888888
Q ss_pred cccCCCCCCCccccccccceeccccccccccCCC--CCCCCccceeeccccccCCCCc-ccccccccccEEEecCCcccC
Q 001253 184 NNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSE--IGGCESLQYLGLAQNQLSGEIP-KEIGMLKYLTDVILWGNQLSG 260 (1114)
Q Consensus 184 n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~--l~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~ 260 (1114)
|++.+..|.+|+++++|++|++++|.+++..|.. ++++++|++|+|++|++++..+ ..|+.+++|++|+|++|.+++
T Consensus 83 N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162 (844)
T ss_dssp CCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred CcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence 8888777888888888888888888887766654 7788888888888888876544 567788888888888888877
Q ss_pred ccccccccc--cccchhhcccccccCCchhhhcCCCc------cceeeecccccccccCcccccc---cccccccccccc
Q 001253 261 VIPKELGNC--TSLETLALYDNKQVGQLPKELGSIGS------LKYLYIYRNELNGTIPREIGKL---SSALEIDFSENS 329 (1114)
Q Consensus 261 ~~p~~l~~l--~~L~~L~Ls~N~~~~~~p~~~~~l~~------L~~L~L~~n~l~~~~p~~l~~l---~~L~~L~ls~N~ 329 (1114)
..|..+..+ ++|+.|+++.|.+.+..|..++.+.+ |++|++++|.+.+.+|..+... .++..++++.+.
T Consensus 163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~ 242 (844)
T 3j0a_A 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242 (844)
T ss_dssp CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred eCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence 777777766 67777777777777766666555544 6666666666665555544332 233333333222
Q ss_pred CCCCCchhhhcccccceeecccccccCccccccccc--ccCCEEEcccccccccccCccccccceeeeeccCCcccCCCC
Q 001253 330 LIGEIPVELSKILGLELLYLFENKLTGVIPVELTTL--KNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIP 407 (1114)
Q Consensus 330 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 407 (1114)
... ....+.+.......|..+ ++|+.|+|++|.+.+..+..|..+++|+.|++++|++.+..+
T Consensus 243 ~~~---------------~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~ 307 (844)
T 3j0a_A 243 MGA---------------GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD 307 (844)
T ss_dssp CBC---------------SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECT
T ss_pred ccc---------------cccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCCh
Confidence 110 011222322223333332 455555555555555555555555555555555555554444
Q ss_pred CCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhcccc
Q 001253 408 QRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLAN 487 (1114)
Q Consensus 408 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 487 (1114)
..|..+++|++|+|++|++++.. |..+..+++|++|++++|++.+..+..|..+++
T Consensus 308 ~~~~~l~~L~~L~Ls~N~l~~~~------------------------~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 363 (844)
T 3j0a_A 308 EAFYGLDNLQVLNLSYNLLGELY------------------------SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363 (844)
T ss_dssp TTTTTCSSCCEEEEESCCCSCCC------------------------SCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCC
T ss_pred HHhcCCCCCCEEECCCCCCCccC------------------------HHHhcCCCCCCEEECCCCCCCccChhhhcCCCC
Confidence 44555555555555555554444 444444555555555555554444444555555
Q ss_pred ccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccc-cccccccccceEEECc
Q 001253 488 LSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRI-PLEIFSCKMLQRLDLS 566 (1114)
Q Consensus 488 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls 566 (1114)
|++|+|++|.+++. ..+++|+.|++++|+++ .+|.. ..+++.|++++|++++.- +..+..+++|+.|+|+
T Consensus 364 L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls 434 (844)
T 3j0a_A 364 LQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILN 434 (844)
T ss_dssp CCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEE
T ss_pred CCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCC
Confidence 55555555555421 12455666666666665 33332 345566666666665321 1123356677777777
Q ss_pred cccccCCCch-hhhhcccCCeeeccCccCC-----CcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhccc
Q 001253 567 WNKFVGALPR-EIGSLFQLELLKLSENELS-----GSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSY 640 (1114)
Q Consensus 567 ~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~ 640 (1114)
+|++++..+. .+..+++|++|+|++|.++ +..+..|.++++|+.|+|++|+|++.+|..|..+++|+ .|+|++
T Consensus 435 ~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~ 513 (844)
T 3j0a_A 435 QNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR-GLSLNS 513 (844)
T ss_dssp SCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCS-EEEEES
T ss_pred CCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhh-eeECCC
Confidence 7777654332 3445677778888888776 34456788899999999999999988888899999998 799999
Q ss_pred ccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCCcccccc
Q 001253 641 NNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQN 703 (1114)
Q Consensus 641 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~~~~~~ 703 (1114)
|+|++..|..+. ++|+.|||++|+|+|.+|..|. +|+.+++++|++.|.++..+...+
T Consensus 514 N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~~~~f~~~ 571 (844)
T 3j0a_A 514 NRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECELSTFINW 571 (844)
T ss_dssp CCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSSSCCSHHHH
T ss_pred CCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCCcccccccHHHHHH
Confidence 999988777776 7899999999999999998865 788999999999999987544443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-58 Score=566.57 Aligned_cols=537 Identities=19% Similarity=0.187 Sum_probs=347.0
Q ss_pred cCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCC
Q 001253 86 TKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGP 165 (1114)
Q Consensus 86 ~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 165 (1114)
++.++. .+|..+.. ++++|||++|.|++..|.+|+++++|++|+|++|.+.+..|..|+++++|++|+|++|++++.
T Consensus 20 ~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 96 (606)
T 3t6q_A 20 ENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM 96 (606)
T ss_dssp TTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEE
T ss_pred CCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCccccc
Confidence 333443 34554543 689999999999988899999999999999999999998899999999999999999999988
Q ss_pred CCcccccCcccchhhhcccccCCCCCCCccccccccceeccccccccccCCCCCCCCccceeeccccccCCCCccccccc
Q 001253 166 FPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGML 245 (1114)
Q Consensus 166 ~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 245 (1114)
.|..|+++++|++|++++|.+++..|..++++++|++|++++|.+.+..+..+.++++|++|+|++|++++..|..++.+
T Consensus 97 ~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 176 (606)
T 3t6q_A 97 AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSL 176 (606)
T ss_dssp CTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTT
T ss_pred ChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhh
Confidence 89999999999999999999998778999999999999999999997555556669999999999999998888899999
Q ss_pred cccc--EEEecCCcccCccccccccccccchhhcccccccCCchhhhcCCCccceeeecccccccccCcccccccccccc
Q 001253 246 KYLT--DVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEI 323 (1114)
Q Consensus 246 ~~L~--~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 323 (1114)
++|+ .|++++|.+++..|..+.. .+|+.|++++|. .++..+..+.+++...+..+.+.+ +...
T Consensus 177 ~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~-----------~~~~ 241 (606)
T 3t6q_A 177 QQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFED-----------MDDE 241 (606)
T ss_dssp TTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTT-----------SCCC
T ss_pred cccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhcc-----------cccc
Confidence 9999 9999999999877766554 689999999986 556666666666555554333221 1111
Q ss_pred ccccccCCCCCchhhhccc--ccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCc
Q 001253 324 DFSENSLIGEIPVELSKIL--GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNS 401 (1114)
Q Consensus 324 ~ls~N~l~~~~~~~l~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 401 (1114)
+++ +..+..+. +|+.|++++|.+++..+..|..+++|++|++++|.++ .+|..+..+++|++|++++|.
T Consensus 242 ~i~--------~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~ 312 (606)
T 3t6q_A 242 DIS--------PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANK 312 (606)
T ss_dssp CCC--------GGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCC
T ss_pred ccC--------hhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCC
Confidence 111 11222222 5666666666666666666666666666666666666 455556666666666666666
Q ss_pred ccCCCCCCCCcCccceEEEeecccccCCCCc-cccccCccceeeeccCCccCCc--CcccccCCcceEEeeccceeeccC
Q 001253 402 LVGGIPQRLGAYSQLWVVDLSDNHLTGKIPR-HICRNTSLIFLNLETNKLTGSI--PTGVTRCKSLVQLRLGGNSFTGSF 478 (1114)
Q Consensus 402 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~ 478 (1114)
+.+..|..+..+++|++|++++|.+.+.+|. .+..+++|++|++++|++++.. +..+..+++|++|++++|++.+..
T Consensus 313 l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 392 (606)
T 3t6q_A 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLK 392 (606)
T ss_dssp CSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEEC
T ss_pred cCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCC
Confidence 6555555555555555555555555544333 2445555555555555555433 444445555555555555555444
Q ss_pred CchhhccccccEeecccccCCCCccc-cccccccCcEEEecCceeccCCCccccCCCCcceeeccccccccccccccccc
Q 001253 479 PSDLCKLANLSTVELDQNQFSGPIPT-EIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSC 557 (1114)
Q Consensus 479 p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 557 (1114)
|..+..+++|++|++++|++++..|. .+.++++|++|++++|.+++..|..+..+++|++|++++|++++...
T Consensus 393 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~------ 466 (606)
T 3t6q_A 393 TEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI------ 466 (606)
T ss_dssp TTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEE------
T ss_pred HHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCcccc------
Confidence 44455555555555555555443332 24444555555555555544444444444444444444444443110
Q ss_pred ccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhh
Q 001253 558 KMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALN 637 (1114)
Q Consensus 558 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~ 637 (1114)
..+..+..+++|++|++++|++++..|..|+++++|+.|+|++|++++.+|..+..++.| .|+
T Consensus 467 ---------------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L--~L~ 529 (606)
T 3t6q_A 467 ---------------QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI--YLN 529 (606)
T ss_dssp ---------------CSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC--EEE
T ss_pred ---------------ccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc--EEE
Confidence 112334444555555555555554444455555555555555555555555555555555 255
Q ss_pred cccccccccCCccccchhhhHhhhccCcccccCCC
Q 001253 638 LSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIP 672 (1114)
Q Consensus 638 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip 672 (1114)
|++|++++.+|..+..+++|+.|+|++|++++..+
T Consensus 530 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 530 LASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred CcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 55555555555555555555555555555555443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-58 Score=567.58 Aligned_cols=562 Identities=19% Similarity=0.160 Sum_probs=409.0
Q ss_pred CCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccceeccc
Q 001253 128 LEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQ 207 (1114)
Q Consensus 128 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~ 207 (1114)
.++++.+++.++ .+|..+. ++|++|+|++|++++..+..|+++++|++|++++|++++..|.+|+++++|++|++++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~ 89 (606)
T 3vq2_A 13 NITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTG 89 (606)
T ss_dssp TTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCC
Confidence 467888888888 4666554 7888999999998877777888888888888888888877777888888888888888
Q ss_pred cccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccC-ccccccccccccchhhcccccccCCc
Q 001253 208 NLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSG-VIPKELGNCTSLETLALYDNKQVGQL 286 (1114)
Q Consensus 208 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~~~~~~ 286 (1114)
|.+++..|..|+++++|++|+|++|++++..+..++.+++|++|++++|.+++ .+|..++++++|++|++++|.+.+..
T Consensus 90 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~ 169 (606)
T 3vq2_A 90 NPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169 (606)
T ss_dssp CCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred CcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence 88887778888888888888888888876666778888888888888888775 45777777777888888777777776
Q ss_pred hhhhcCCCccc----eeeecccccccccCccccccccccccccccccCC-CCCchhhhcccccceeecccccccCccccc
Q 001253 287 PKELGSIGSLK----YLYIYRNELNGTIPREIGKLSSALEIDFSENSLI-GEIPVELSKILGLELLYLFENKLTGVIPVE 361 (1114)
Q Consensus 287 p~~~~~l~~L~----~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 361 (1114)
|..|+.+++|+ +|++++|.+.+..+..+.. .+|++|++++|.+. +..|..+.++++|+.+++..+.+.+..
T Consensus 170 ~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~-~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~--- 245 (606)
T 3vq2_A 170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG-IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER--- 245 (606)
T ss_dssp TTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSC---
T ss_pred hhhhhhhhccccccceeeccCCCcceeCcccccC-ceeeeeeccCCccchhHHHHHhccccccccccccccccccCC---
Confidence 76666665554 6777777776443333333 36777777777665 344555666666666665544433210
Q ss_pred ccccccCCEEEcccccccccccCccccccceeeeec-cCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCcc
Q 001253 362 LTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQL-FDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSL 440 (1114)
Q Consensus 362 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L-~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L 440 (1114)
.+.. +....+..+..+ .++.+.+ ..|.+.+.+|. +..+++|+.|++++|.+. .+| .+..+++|
T Consensus 246 -----~l~~-------~~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L 309 (606)
T 3vq2_A 246 -----NLEI-------FEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKW 309 (606)
T ss_dssp -----CCSC-------CCGGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCC
T ss_pred -----cccc-------cChHHhhhhhhc-cHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccC
Confidence 0000 001111112222 3455555 55666666665 666777777777777775 344 66666777
Q ss_pred ceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCC--ccccccccccCcEEEec
Q 001253 441 IFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGP--IPTEIGNCNALQRLHLS 518 (1114)
Q Consensus 441 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls 518 (1114)
++|++++|++ +.+| .+ .+++|++|++++|+..+.+ .+..+++|++|++++|++++. +|..+..+++|++|+|+
T Consensus 310 ~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~ 384 (606)
T 3vq2_A 310 QSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384 (606)
T ss_dssp SEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECC
T ss_pred CEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECC
Confidence 7777777777 4566 34 7777777777777544333 456777777777777777755 36777778888888888
Q ss_pred CceeccCCCccccCCCCcceeeccccccccccc-ccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCC-
Q 001253 519 DNYFTGELPREVGNLSNLVTFNVSSNFLTGRIP-LEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSG- 596 (1114)
Q Consensus 519 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~- 596 (1114)
+|.+++ +|..+..+++|+.|++++|++++..| ..+..+++|+.|++++|++++..|..++.+++|++|++++|++++
T Consensus 385 ~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 463 (606)
T 3vq2_A 385 FNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463 (606)
T ss_dssp SCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCc
Confidence 888774 55777788888888888888876666 567778888888888888887788888888888888888888887
Q ss_pred cccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccc
Q 001253 597 SIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFV 676 (1114)
Q Consensus 597 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 676 (1114)
.+|..++.+++|++|+|++|++++.+|..+..+++|+ .|+|++|++++.+|..|+++++|+.|||++|+|+ .+|..+.
T Consensus 464 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~ 541 (606)
T 3vq2_A 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ-LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQ 541 (606)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC-EEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGG
T ss_pred chHHhhccCCCCCEEECCCCcCCccChhhhcccccCC-EEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHh
Confidence 4788888889999999999999888888888999998 7999999999998999999999999999999999 6777799
Q ss_pred ccc-ccceEEeccCcccCCCCCccccccccccc---ccCCCCCCCCCC
Q 001253 677 NLS-SLLGCNFSYNNLTGPIPSSQTFQNMSVNS---FSGSKGLCGGPL 720 (1114)
Q Consensus 677 ~l~-~l~~l~ls~N~l~g~ip~~~~~~~~~~~~---~~~n~~lc~~p~ 720 (1114)
.++ +|+.|++++|+|.|.+|..+..+++.... .......|..|.
T Consensus 542 ~l~~~L~~l~l~~N~~~c~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~ 589 (606)
T 3vq2_A 542 HFPKSLAFFNLTNNSVACICEHQKFLQWVKEQKQFLVNVEQMTCATPV 589 (606)
T ss_dssp GSCTTCCEEECCSCCCCCSSTTHHHHTTTTTSSSSBSSGGGCCCC---
T ss_pred hhcccCcEEEccCCCcccCCccHHHHHHHHcCcccccCCccceeCCCh
Confidence 997 59999999999999999876555654321 112234566554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-57 Score=556.86 Aligned_cols=533 Identities=20% Similarity=0.192 Sum_probs=365.4
Q ss_pred EeecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccc
Q 001253 83 LNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI 162 (1114)
Q Consensus 83 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l 162 (1114)
++.++++++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++
T Consensus 16 ~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l 92 (606)
T 3vq2_A 16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92 (606)
T ss_dssp EECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred eEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence 455555555 3455444 7899999999999988888999999999999999999988899999999999999999999
Q ss_pred cCCCCcccccCcccchhhhcccccCCCCCCCccccccccceecccccccc-ccCCCCCCCCccceeeccccccCCCCccc
Q 001253 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISG-SLPSEIGGCESLQYLGLAQNQLSGEIPKE 241 (1114)
Q Consensus 163 ~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 241 (1114)
++..|..|+++++|++|++++|.+++..|..++++++|++|++++|.+.+ .+|..++++++|++|+|++|++++..|..
T Consensus 93 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~ 172 (606)
T 3vq2_A 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172 (606)
T ss_dssp CCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTT
T ss_pred cccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhh
Confidence 98889999999999999999999998887899999999999999999986 67999999999999999999999888888
Q ss_pred cccccccc----EEEecCCcccCccccccccccccchhhccccccc-CCchhhhcCCCccceeeecccccccccCccccc
Q 001253 242 IGMLKYLT----DVILWGNQLSGVIPKELGNCTSLETLALYDNKQV-GQLPKELGSIGSLKYLYIYRNELNGTIPREIGK 316 (1114)
Q Consensus 242 l~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 316 (1114)
++.+++|+ +|++++|.+++..+..+... +|++|++++|.+. +..|..+.++++|+.+++..+.+.+...
T Consensus 173 ~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~----- 246 (606)
T 3vq2_A 173 LQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERN----- 246 (606)
T ss_dssp THHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCC-----
T ss_pred hhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCc-----
Confidence 88888775 79999999996655555544 8999999999876 4577888999999999887766542110
Q ss_pred cccccccccccccCCCCCchhhhcccccceeec-ccccccCcccccccccccCCEEEcccccccccccCccccccceeee
Q 001253 317 LSSALEIDFSENSLIGEIPVELSKILGLELLYL-FENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIML 395 (1114)
Q Consensus 317 l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L-~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 395 (1114)
+..+ ....+..+..+ .++.+++ ..|.+.+..|. +..+++|+.|++++|.+.. +| .+..+++|++|
T Consensus 247 ---l~~~-------~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L 312 (606)
T 3vq2_A 247 ---LEIF-------EPSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSL 312 (606)
T ss_dssp ---CSCC-------CGGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEE
T ss_pred ---cccc-------ChHHhhhhhhc-cHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEE
Confidence 0000 00011111111 2344444 44455554444 5555666666666666542 33 55555566666
Q ss_pred eccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCC--cCcccccCCcceEEeeccce
Q 001253 396 QLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGS--IPTGVTRCKSLVQLRLGGNS 473 (1114)
Q Consensus 396 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~ 473 (1114)
++++|.+ +.+| .+ .+++|++|++++|+..+.. .+..+++|++|++++|++++. .|..+..+++|++|++++|.
T Consensus 313 ~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~ 387 (606)
T 3vq2_A 313 SIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG 387 (606)
T ss_dssp EEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCS
T ss_pred EcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCc
Confidence 6666666 4444 23 5566666666666433222 344556666666666666543 25555666666666666666
Q ss_pred eeccCCchhhccccccEeecccccCCCCcc-ccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccc-ccc
Q 001253 474 FTGSFPSDLCKLANLSTVELDQNQFSGPIP-TEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTG-RIP 551 (1114)
Q Consensus 474 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p 551 (1114)
+++ +|..+..+++|++|++++|++++..| ..+.++++|++|++++|++++..|..+.++++|++|++++|.+++ .+|
T Consensus 388 l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 466 (606)
T 3vq2_A 388 AII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS 466 (606)
T ss_dssp EEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEEC
T ss_pred ccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchH
Confidence 653 44556666666666666666665555 456666666666666666666666666666666666666666665 245
Q ss_pred ccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcc-
Q 001253 552 LEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLS- 630 (1114)
Q Consensus 552 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~- 630 (1114)
..+..+++|+.|+|++|++++..|..++.+++|++|+|++|++++..|..+.++++|+.|++++|+|+ .+|..+..+.
T Consensus 467 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~ 545 (606)
T 3vq2_A 467 NVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPK 545 (606)
T ss_dssp SCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCT
T ss_pred HhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcc
Confidence 55666666666666666666666666666666666666666666666666666666666666666666 4555566554
Q ss_pred hhhHHhhccccccccc
Q 001253 631 SLQIALNLSYNNLSGL 646 (1114)
Q Consensus 631 ~L~~~L~Ls~N~l~~~ 646 (1114)
+|+ .|++++|.+.+.
T Consensus 546 ~L~-~l~l~~N~~~c~ 560 (606)
T 3vq2_A 546 SLA-FFNLTNNSVACI 560 (606)
T ss_dssp TCC-EEECCSCCCCCS
T ss_pred cCc-EEEccCCCcccC
Confidence 355 566666666654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-58 Score=563.82 Aligned_cols=502 Identities=21% Similarity=0.251 Sum_probs=376.7
Q ss_pred chHHHHHHhHhhccCC-CCC-------CCCCCCCCCCCCcc---ceEEEecCCCccEEEEEeecCCCcCcccCCCCCCCC
Q 001253 34 IEGQILLLIKSKLVDN-SNY-------LGNWNPNDSTPCGW---IGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLV 102 (1114)
Q Consensus 34 ~~~~~ll~~k~~~~~~-~~~-------~~~W~~~~~~~C~w---~gv~C~~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~ 102 (1114)
.|++||.+||.++.++ +.. ..+|+.+ .+||.| .||+|+.. ++|++|+|++++++|.+|+++++|+
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~---~~V~~L~L~~~~l~g~lp~~l~~L~ 105 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSN---GRVTGLSLEGFGASGRVPDAIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTT---CCEEEEECTTSCCEEEECGGGGGCT
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCC---CCEEEEEecCcccCCcCChHHhcCc
Confidence 5899999999998544 222 3489864 679999 99999753 6799999999999999999999999
Q ss_pred ccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCccccc-Ccccchhhh
Q 001253 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGK-LSALSQLVA 181 (1114)
Q Consensus 103 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~l 181 (1114)
+|++|||++|++.. .+..++.. .+...+|... +.+|+ +++++|.+.+.+|..+.. +..+..+++
T Consensus 106 ~L~~L~Ls~N~~~~-~~~~~~~~-----------~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l 170 (636)
T 4eco_A 106 ELEVLALGSHGEKV-NERLFGPK-----------GISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDP 170 (636)
T ss_dssp TCCEEESCCGGGGG-TCCSBSTT-----------SBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCT
T ss_pred cceEEECcCCcccc-CCcccccc-----------ccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCc
Confidence 99999999997631 11111110 0011234333 56666 777777777777766663 344444544
Q ss_pred cccccCCCCCCCccccccccceecc--ccccccccCCCCCCCCccceeeccccccCCC-----------------Ccccc
Q 001253 182 YSNNISGSLPPTLGNLKRLKSFRAG--QNLISGSLPSEIGGCESLQYLGLAQNQLSGE-----------------IPKEI 242 (1114)
Q Consensus 182 ~~n~i~~~~p~~l~~l~~L~~L~l~--~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-----------------~p~~l 242 (1114)
....+.. .....++.+.+. .|.+++ +|.+++++++|++|+|++|++++. +|..+
T Consensus 171 ~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l 243 (636)
T 4eco_A 171 QQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDL 243 (636)
T ss_dssp TSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCC
T ss_pred ccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhh
Confidence 4333321 112233333333 467776 777777777777777777777764 77777
Q ss_pred c--ccccccEEEecCCcccCccccccccccccchhhccccc-ccC-CchhhhcCC------CccceeeecccccccccCc
Q 001253 243 G--MLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNK-QVG-QLPKELGSI------GSLKYLYIYRNELNGTIPR 312 (1114)
Q Consensus 243 ~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-~~~-~~p~~~~~l------~~L~~L~L~~n~l~~~~p~ 312 (1114)
+ .+++|++|+|++|++.+.+|..++++++|++|++++|+ +.+ .+|..++.+ ++|++|++++|+++ .+|.
T Consensus 244 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~ 322 (636)
T 4eco_A 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPV 322 (636)
T ss_dssp CGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCC
T ss_pred hhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCc
Confidence 7 78888888888888887888888888888888888887 776 777777766 88888888888888 7887
Q ss_pred --cccccccccccccccccCCCCCchhhhcccccceeecccccccCccccccccccc-CCEEEcccccccccccCccccc
Q 001253 313 --EIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKN-LTKLDLSINSLTGTIPLGFQYL 389 (1114)
Q Consensus 313 --~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l 389 (1114)
.++.+++|++|++++|++.|.+| .+..+++|+.|++++|+++ .+|..+..+++ |++|++++|.++ .+|..+..+
T Consensus 323 ~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~ 399 (636)
T 4eco_A 323 ETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAK 399 (636)
T ss_dssp HHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTT
T ss_pred hhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhc
Confidence 78888888888888888887888 8888888888899888888 66777888888 999999999998 677777765
Q ss_pred c--ceeeeeccCCcccCCCCCCCC-------cCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCccc-c
Q 001253 390 T--NLIMLQLFDNSLVGGIPQRLG-------AYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGV-T 459 (1114)
Q Consensus 390 ~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~-~ 459 (1114)
+ +|++|++++|.+.+..|..+. .+++|++|+|++|+++...+..+..+++|++|+|++|+++ .+|..+ .
T Consensus 400 ~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~ 478 (636)
T 4eco_A 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLK 478 (636)
T ss_dssp CSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSE
T ss_pred ccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhc
Confidence 5 899999999999988888888 7789999999999999544445556899999999999999 555543 3
Q ss_pred cC-------CcceEEeeccceeeccCCchhh--ccccccEeecccccCCCCccccccccccCcEEEecC------ceecc
Q 001253 460 RC-------KSLVQLRLGGNSFTGSFPSDLC--KLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSD------NYFTG 524 (1114)
Q Consensus 460 ~l-------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~ 524 (1114)
.. ++|++|+|++|+++ .+|..+. .+++|++|+|++|+|++ +|..+.++++|++|+|++ |++.+
T Consensus 479 ~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~ 556 (636)
T 4eco_A 479 DENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLR 556 (636)
T ss_dssp ETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCC
T ss_pred cccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccc
Confidence 33 39999999999999 7888887 99999999999999997 899999999999999955 55555
Q ss_pred CCCccccCCCCcceeecccccccccccccccccccceEEECcccccc
Q 001253 525 ELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFV 571 (1114)
Q Consensus 525 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 571 (1114)
.+|..+.++++|+.|+|++|++ +.+|..+. ++|+.|+|++|++.
T Consensus 557 ~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 557 EWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp CCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred cChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence 6666666666666666666666 35555544 45666666666554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-57 Score=563.43 Aligned_cols=505 Identities=20% Similarity=0.176 Sum_probs=351.0
Q ss_pred CCCcchHHHHHHhHhhccCCCCCCCCCCCCC----CCC--Ccc------------ceEEEecCCCccEEEEEeecCCCcC
Q 001253 30 GLVNIEGQILLLIKSKLVDNSNYLGNWNPND----STP--CGW------------IGVNCTTNDFGAVVFSLNLTKMNLS 91 (1114)
Q Consensus 30 ~~~~~~~~~ll~~k~~~~~~~~~~~~W~~~~----~~~--C~w------------~gv~C~~~~~~~~v~~l~l~~~~l~ 91 (1114)
++..+|++||++||+++.|| +|+.++ .+| |.| .||+|+. .++|+.|+|+++++.
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~---~~~V~~L~Ls~~~L~ 336 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN---NGRVTGLSLAGFGAK 336 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT---TSCEEEEECTTTCCE
T ss_pred ccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC---CCCEEEEECccCCCC
Confidence 44457999999999999776 897654 345 999 9999976 368999999999999
Q ss_pred cccCCCCCCCCccCEEEe-cCCcccCCCCcccCCCC-CCCEE--------------E-ccCCCcccc-----------cc
Q 001253 92 GYLSPNIGGLVHLTALDL-SFNQLSRNIPKEIGNCS-SLEVL--------------N-LNNNRLEAH-----------IP 143 (1114)
Q Consensus 92 g~~~~~l~~l~~L~~L~L-s~n~l~~~~p~~~~~l~-~L~~L--------------~-L~~n~l~~~-----------~p 143 (1114)
|.+|+++++|++|++||| ++|.++|..|....... .+... + .....+.+. .+
T Consensus 337 G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~ 416 (876)
T 4ecn_A 337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416 (876)
T ss_dssp EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence 999999999999999999 99988877543211110 00000 0 000000000 00
Q ss_pred cccccccccceecccc--ccccCCCCcccccCcccchhhhcccccCC-----------------CCCCCcc--ccccccc
Q 001253 144 KELGNLSSLTILNIYN--NRISGPFPKEIGKLSALSQLVAYSNNISG-----------------SLPPTLG--NLKRLKS 202 (1114)
Q Consensus 144 ~~l~~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~l~~n~i~~-----------------~~p~~l~--~l~~L~~ 202 (1114)
-.......++.+.++. |++++ +|..|+++++|++|++++|++++ .+|+.++ ++++|++
T Consensus 417 i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~ 495 (876)
T 4ecn_A 417 IKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495 (876)
T ss_dssp CCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred cccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence 0011122333333333 55554 55555555555555555555555 3777766 7777777
Q ss_pred eeccccccccccCCCCCCCCccceeeccccc-cCC-CCcccccccc-------cccEEEecCCcccCcccc--ccccccc
Q 001253 203 FRAGQNLISGSLPSEIGGCESLQYLGLAQNQ-LSG-EIPKEIGMLK-------YLTDVILWGNQLSGVIPK--ELGNCTS 271 (1114)
Q Consensus 203 L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~p~~l~~l~-------~L~~L~L~~N~l~~~~p~--~l~~l~~ 271 (1114)
|++++|.+.+.+|..|+++++|++|+|++|+ ++| .+|..++.++ +|++|+|++|+++ .+|. .++++++
T Consensus 496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~ 574 (876)
T 4ecn_A 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVK 574 (876)
T ss_dssp EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTT
T ss_pred EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCC
Confidence 7777777777777777777777777777776 776 6776666655 7777777777777 6666 7777777
Q ss_pred cchhhcccccccCCchhhhcCCCccceeeecccccccccCcccccccc-ccccccccccCCCCCchhhhcccc--cceee
Q 001253 272 LETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSS-ALEIDFSENSLIGEIPVELSKILG--LELLY 348 (1114)
Q Consensus 272 L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~-L~~L~ls~N~l~~~~~~~l~~l~~--L~~L~ 348 (1114)
|+.|+|++|.+. .+| .|+.+++|++|+|++|++. .+|..+..+++ |++|++++|.+. .+|..+..+.. |+.|+
T Consensus 575 L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~ 650 (876)
T 4ecn_A 575 LGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVD 650 (876)
T ss_dssp CCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEE
T ss_pred CCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEE
Confidence 777777777766 666 6777777777777777777 67777777777 777777777776 56666655543 77777
Q ss_pred cccccccCccccc---cc--ccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCC-------cCccc
Q 001253 349 LFENKLTGVIPVE---LT--TLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLG-------AYSQL 416 (1114)
Q Consensus 349 L~~N~l~~~~~~~---~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-------~l~~L 416 (1114)
|++|++++.+|.. +. .+++|+.|+|++|.++...+..+..+++|+.|+|++|++....+..+. ++++|
T Consensus 651 Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L 730 (876)
T 4ecn_A 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730 (876)
T ss_dssp CCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGC
T ss_pred CcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCc
Confidence 7777777655432 22 234788888888888844333445778888888888888733333333 23489
Q ss_pred eEEEeecccccCCCCcccc--ccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecc
Q 001253 417 WVVDLSDNHLTGKIPRHIC--RNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELD 494 (1114)
Q Consensus 417 ~~L~Ls~N~l~~~~~~~~~--~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 494 (1114)
++|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+ +++
T Consensus 731 ~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------------------~ls 790 (876)
T 4ecn_A 731 TTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------------------DAE 790 (876)
T ss_dssp CEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB------------------CTT
T ss_pred cEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC------------------Ccc
Confidence 99999999999 6788877 88999999999999997 78888899999999998876 566
Q ss_pred cccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECcccccc
Q 001253 495 QNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFV 571 (1114)
Q Consensus 495 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 571 (1114)
+|++.+.+|..|.++++|+.|+|++|+| +.+|..+. ++|+.|+|++|++....+..+.....+..+.|.+|++.
T Consensus 791 ~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 791 GNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp CCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred cccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 7777777777777777777777777777 46666655 57777777777776545555555555666667777654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=554.75 Aligned_cols=533 Identities=21% Similarity=0.201 Sum_probs=404.7
Q ss_pred eeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccceecccccccccc-CCCCCCCCccceeecccc
Q 001253 154 ILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSL-PSEIGGCESLQYLGLAQN 232 (1114)
Q Consensus 154 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~-p~~l~~l~~L~~L~Ls~N 232 (1114)
..+.+++.++ .+|. -.++|++|++++|.+++..|..|.++++|++|++++|...+.+ |.+|+++++|++|+|++|
T Consensus 8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 4566666676 4554 3466777777777777666777777777777777777544444 666777777777777777
Q ss_pred ccCCCCcccccccccccEEEecCCcccCccccc--cccccccchhhcccccccCCch-hhhcCCCccceeeecccccccc
Q 001253 233 QLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKE--LGNCTSLETLALYDNKQVGQLP-KELGSIGSLKYLYIYRNELNGT 309 (1114)
Q Consensus 233 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~--l~~l~~L~~L~Ls~N~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~ 309 (1114)
.+++..|..|+.+++|++|+|++|.+++.+|.. ++++++|++|+|++|.+.+..+ ..|+++++|++|+|++|.+.+.
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 777666677777777777777777776655544 6667777777777776665543 4566677777777777766666
Q ss_pred cCcccccc--ccccccccccccCCCCCchhhhcccc------cceeecccccccCccccccccc---ccCCEEEcccccc
Q 001253 310 IPREIGKL--SSALEIDFSENSLIGEIPVELSKILG------LELLYLFENKLTGVIPVELTTL---KNLTKLDLSINSL 378 (1114)
Q Consensus 310 ~p~~l~~l--~~L~~L~ls~N~l~~~~~~~l~~l~~------L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l 378 (1114)
.|..+..+ ++|+.|++++|.+.+..|..+..+.+ |+.|++++|.+++..+..+... .+++.|+++.+.+
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~ 243 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred CHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence 66666655 56666666666666655555444433 5555555555554444443322 3444555443322
Q ss_pred cccccCccccccceeeeeccCCcccCCCCCCCCcC--ccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCc
Q 001253 379 TGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAY--SQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPT 456 (1114)
Q Consensus 379 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~ 456 (1114)
.. .+..+.+.+.....|..+ ++|+.|+|++|.+.+..+..|..+++|+.|+|++|++++..|.
T Consensus 244 ~~---------------~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~ 308 (844)
T 3j0a_A 244 GA---------------GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE 308 (844)
T ss_dssp BC---------------SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTT
T ss_pred cc---------------cccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChH
Confidence 21 112334444444555554 7899999999999988899999999999999999999988899
Q ss_pred ccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCc
Q 001253 457 GVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNL 536 (1114)
Q Consensus 457 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 536 (1114)
.|..+++|++|+|++|++++..|..|..+++|++|++++|++++..+..|.++++|++|+|++|.+++. ..+++|
T Consensus 309 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L 383 (844)
T 3j0a_A 309 AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSI 383 (844)
T ss_dssp TTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSC
T ss_pred HhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCc
Confidence 999999999999999999988899999999999999999999988888999999999999999999853 238899
Q ss_pred ceeecccccccccccccccccccceEEECccccccCCC-chhhhhcccCCeeeccCccCCCcccc-cccccccccccccC
Q 001253 537 VTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGAL-PREIGSLFQLELLKLSENELSGSIPV-QIGNLSRLTELQMG 614 (1114)
Q Consensus 537 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls 614 (1114)
+.|++++|+++ .+|.. ..+++.|++++|++++.. +..++.+++|++|+|++|++++..+. .+..+++|+.|+|+
T Consensus 384 ~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls 459 (844)
T 3j0a_A 384 PDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG 459 (844)
T ss_dssp SEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEE
T ss_pred chhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCC
Confidence 99999999998 66654 567999999999999653 33466899999999999999965543 45678999999999
Q ss_pred CCcCC-----CCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccC
Q 001253 615 GNSFS-----GGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYN 689 (1114)
Q Consensus 615 ~N~l~-----~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N 689 (1114)
+|.++ +..|..|..+++|+ .|+|++|+|++.+|..|..+++|+.|||++|+|++.+|..+. ++|+.||+++|
T Consensus 460 ~N~l~~~~~~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N 536 (844)
T 3j0a_A 460 ENMLQLAWETELCWDVFEGLSHLQ-VLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRN 536 (844)
T ss_dssp SCCCSSSCCSCCCSSCSSCBCCEE-CCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEE
T ss_pred CCccccccccccchhhhcCccccc-EEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCC
Confidence 99997 55567789999999 799999999999999999999999999999999998888876 89999999999
Q ss_pred cccCCCCCcccccccccccccCCCCCCCCC
Q 001253 690 NLTGPIPSSQTFQNMSVNSFSGSKGLCGGP 719 (1114)
Q Consensus 690 ~l~g~ip~~~~~~~~~~~~~~~n~~lc~~p 719 (1114)
+++|.+|. .|..+....+.+|+-.|+.+
T Consensus 537 ~l~~~~~~--~~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 537 QLLAPNPD--VFVSLSVLDITHNKFICECE 564 (844)
T ss_dssp CCCCCCSC--CCSSCCEEEEEEECCCCSSS
T ss_pred cCCCCChh--HhCCcCEEEecCCCcccccc
Confidence 99999885 35566666677888777544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=512.60 Aligned_cols=535 Identities=19% Similarity=0.174 Sum_probs=378.1
Q ss_pred ceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccceeccccccccccCCCCCCCCccceeecccc
Q 001253 153 TILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQN 232 (1114)
Q Consensus 153 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N 232 (1114)
+..+.++..++ .+|..+. +++++|++++|++++..+.+|.++++|++|++++|.+++..|..|+++++|++|+|++|
T Consensus 10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 86 (570)
T 2z63_A 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (570)
T ss_dssp TEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred cEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCC
Confidence 44556665665 4555443 35666777777776666666666777777777777666666666666667777777777
Q ss_pred ccCCCCcccccccccccEEEecCCcccCccccccccccccchhhcccccccC-CchhhhcCCCccceeeecccccccccC
Q 001253 233 QLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVG-QLPKELGSIGSLKYLYIYRNELNGTIP 311 (1114)
Q Consensus 233 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p 311 (1114)
++++..|..|+.+++|++|++++|++++..+..++++++|++|++++|.+.+ .+|..|+++++|++|++++|++.+..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~ 166 (570)
T 2z63_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (570)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECG
T ss_pred cCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecH
Confidence 6665555666666666666666666665544456666666666666666555 356666666666666666666665555
Q ss_pred ccccccccc----cccccccccCCCCCchhhhcccccceeecccccccC-cccccccccccCCEEEcccccccccccCcc
Q 001253 312 REIGKLSSA----LEIDFSENSLIGEIPVELSKILGLELLYLFENKLTG-VIPVELTTLKNLTKLDLSINSLTGTIPLGF 386 (1114)
Q Consensus 312 ~~l~~l~~L----~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 386 (1114)
..++.+.+| ++|++++|.+.+..+..+... +|+.|++++|.... ..+..+..+++++.+++..+.+..
T Consensus 167 ~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~------ 239 (570)
T 2z63_A 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN------ 239 (570)
T ss_dssp GGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCC------
T ss_pred HHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccC------
Confidence 555555555 455555555555444444433 45555555543321 123333444444444433222210
Q ss_pred ccccceeeeeccCCcccCCCCCCCCcCc--cceEEEeecc-cccCCCCccccccCccceeeeccCCccCCcCcccccCCc
Q 001253 387 QYLTNLIMLQLFDNSLVGGIPQRLGAYS--QLWVVDLSDN-HLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKS 463 (1114)
Q Consensus 387 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N-~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~ 463 (1114)
.+.+.......+..+. .++.+++++| .+.+..|..+..+++|+.|++++|.++ .+|..+..+ +
T Consensus 240 ------------~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~ 305 (570)
T 2z63_A 240 ------------EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-G 305 (570)
T ss_dssp ------------CSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-C
T ss_pred ------------chhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-C
Confidence 0011111222233332 3566777777 777777788888888888888888887 577777777 8
Q ss_pred ceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCC--CccccCCCCcceeec
Q 001253 464 LVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGEL--PREVGNLSNLVTFNV 541 (1114)
Q Consensus 464 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L 541 (1114)
|++|++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++++.. |..+.++++|++|++
T Consensus 306 L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l 380 (570)
T 2z63_A 306 WQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380 (570)
T ss_dssp CSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEEC
T ss_pred ccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEEC
Confidence 888888888887 5555 4678888888888888766655 67888999999999888654 677888889999999
Q ss_pred ccccccccccccccccccceEEECccccccCCCc-hhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCC-
Q 001253 542 SSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALP-REIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS- 619 (1114)
Q Consensus 542 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~- 619 (1114)
++|.+++ +|..+..+++|+.|++++|++++..| ..+..+++|++|++++|.+.+..|..+.++++|++|++++|+++
T Consensus 381 ~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 459 (570)
T 2z63_A 381 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459 (570)
T ss_dssp CSCSEEE-EEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCcccc-ccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCcc
Confidence 9999884 44458888999999999999987765 56888999999999999999888889999999999999999997
Q ss_pred CCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCCcc
Q 001253 620 GGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQ 699 (1114)
Q Consensus 620 ~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~~ 699 (1114)
+.+|..+..+++|+ .|+|++|++++..|..|+++++|++|+|++|++++.+|..|.++++|+.|++++|+++|.+|..+
T Consensus 460 ~~~p~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 460 NFLPDIFTELRNLT-FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp GEECSCCTTCTTCC-EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred ccchhhhhcccCCC-EEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence 57889999999998 79999999999999999999999999999999999999999999999999999999999999876
Q ss_pred cc-cccccc--cccCCCCCCCCC
Q 001253 700 TF-QNMSVN--SFSGSKGLCGGP 719 (1114)
Q Consensus 700 ~~-~~~~~~--~~~~n~~lc~~p 719 (1114)
.+ .|+... ...+.. .|+.|
T Consensus 539 ~~~~wl~~~~~~~~~~~-~C~~~ 560 (570)
T 2z63_A 539 YLSRWLNKNSQKEQGSA-KCSGS 560 (570)
T ss_dssp HHHHHHHHTGGGEESCC-BBTTT
T ss_pred HHHHHHHhccccCCCch-hhCCC
Confidence 66 555432 233333 67665
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=501.63 Aligned_cols=512 Identities=20% Similarity=0.201 Sum_probs=308.6
Q ss_pred eecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceecccccccc
Q 001253 84 NLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRIS 163 (1114)
Q Consensus 84 ~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~ 163 (1114)
+.++.+++. +|..+. +++++|||++|++++..+.+|+.+++|++|+|++|.+++..|..|+++++|++|+|++|+++
T Consensus 13 ~c~~~~l~~-ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~ 89 (570)
T 2z63_A 13 QCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89 (570)
T ss_dssp ECCSSCCSS-CCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred EeCCCCccc-cCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCC
Confidence 334444442 444432 46899999999998888888999999999999999999877888999999999999999998
Q ss_pred CCCCcccccCcccchhhhcccccCCCCCCCccccccccceecccccccc-ccCCCCCCCCccceeeccccccCCCCcccc
Q 001253 164 GPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISG-SLPSEIGGCESLQYLGLAQNQLSGEIPKEI 242 (1114)
Q Consensus 164 ~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l 242 (1114)
+..|..|+++++|++|++++|++++..+..++++++|++|++++|.+.+ .+|..++++++|++|++++|++++..|..+
T Consensus 90 ~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~ 169 (570)
T 2z63_A 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169 (570)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGG
T ss_pred ccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHc
Confidence 7777888899999999999988886666678888888888888888876 468888888888888888888887677778
Q ss_pred cccccc----cEEEecCCcccCccccccccccccchhhcccccccC-CchhhhcCCCccceeeecccccccccCcccccc
Q 001253 243 GMLKYL----TDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVG-QLPKELGSIGSLKYLYIYRNELNGTIPREIGKL 317 (1114)
Q Consensus 243 ~~l~~L----~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 317 (1114)
+.+++| +.|++++|.+++..|..+..+ +|+.|++++|.... .++..+..+++++.+.+....+.. .
T Consensus 170 ~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~--------~ 240 (570)
T 2z63_A 170 RVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN--------E 240 (570)
T ss_dssp HHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCC--------C
T ss_pred cchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccC--------c
Confidence 888777 788888888887777666655 78888888775332 355667777777776665443321 0
Q ss_pred ccccccccccccCCCCCchhhhccc--ccceeecccc-cccCcccccccccccCCEEEcccccccccccCccccccceee
Q 001253 318 SSALEIDFSENSLIGEIPVELSKIL--GLELLYLFEN-KLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIM 394 (1114)
Q Consensus 318 ~~L~~L~ls~N~l~~~~~~~l~~l~--~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 394 (1114)
..+..+ . ...+..+. .++.+++.++ .+.+..+..+..+++|+.|++++|.++ .+|..+..+ +|++
T Consensus 241 ~~l~~~--~--------~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~ 308 (570)
T 2z63_A 241 GNLEKF--D--------KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQH 308 (570)
T ss_dssp SSCEEC--C--------TTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSE
T ss_pred hhhhhc--c--------hhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccE
Confidence 111110 0 11111111 2444555555 455555555556666666666666655 344444444 5555
Q ss_pred eeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeecccee
Q 001253 395 LQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSF 474 (1114)
Q Consensus 395 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 474 (1114)
|++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++++..
T Consensus 309 L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~-------------------- 363 (570)
T 2z63_A 309 LELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKG-------------------- 363 (570)
T ss_dssp EEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEE--------------------
T ss_pred EeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccc--------------------
Confidence 555555554 2222 2344555555555555443332 33444555555555444322
Q ss_pred eccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCC-ccccCCCCcceeeccccccccccccc
Q 001253 475 TGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELP-REVGNLSNLVTFNVSSNFLTGRIPLE 553 (1114)
Q Consensus 475 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~ 553 (1114)
..|..+..+++|++|++++|++++..+. +..+++|++|++++|.+++..| ..+.++++|++|++++|.+++..|..
T Consensus 364 --~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 440 (570)
T 2z63_A 364 --CCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440 (570)
T ss_dssp --EEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTT
T ss_pred --cccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhh
Confidence 0134444444455555555544432222 4445555555555555544333 33444555555555555554444444
Q ss_pred ccccccceEEECcccccc-CCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchh
Q 001253 554 IFSCKMLQRLDLSWNKFV-GALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSL 632 (1114)
Q Consensus 554 ~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 632 (1114)
+..+++|+.|+|++|+++ +.+|..+..+++|++|++++|++++..|..+.++++|++|++++|++++.+|..+..+++|
T Consensus 441 ~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 520 (570)
T 2z63_A 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL 520 (570)
T ss_dssp TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred hhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCC
Confidence 444555555555555554 3344455555555555555555554445555555555555555555554444445555555
Q ss_pred hHHhhcccccccccCC
Q 001253 633 QIALNLSYNNLSGLIP 648 (1114)
Q Consensus 633 ~~~L~Ls~N~l~~~~p 648 (1114)
+ .|++++|.+++..|
T Consensus 521 ~-~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 521 Q-KIWLHTNPWDCSCP 535 (570)
T ss_dssp C-EEECCSSCBCCCTT
T ss_pred c-EEEecCCcccCCCc
Confidence 5 45555555555443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=502.53 Aligned_cols=468 Identities=21% Similarity=0.274 Sum_probs=392.4
Q ss_pred CccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhh
Q 001253 102 VHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVA 181 (1114)
Q Consensus 102 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 181 (1114)
.+++.|+|++|+++|.+|++|++|++|++|+|++|.+.. .+..++... +...+|... +..|+ +++
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~-~~~~~~~~~-----------~~~~~~~~~--~~~l~-l~l 145 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKV-NERLFGPKG-----------ISANMSDEQ--KQKMR-MHY 145 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGG-TCCSBSTTS-----------BCTTCCHHH--HHHHH-THH
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCcccc-CCccccccc-----------cccCchHHH--HHHHH-hhH
Confidence 467899999999988899999999999999998887642 111122110 112455555 67787 999
Q ss_pred cccccCCCCCCCccc-cccccceeccccccccccCCCCCCCCccceeecc--ccccCCCCcccccccccccEEEecCCcc
Q 001253 182 YSNNISGSLPPTLGN-LKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLA--QNQLSGEIPKEIGMLKYLTDVILWGNQL 258 (1114)
Q Consensus 182 ~~n~i~~~~p~~l~~-l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls--~N~l~~~~p~~l~~l~~L~~L~L~~N~l 258 (1114)
++|.+.+.+|..+.. +.++..+++....+.. .....++.+.+. .|+++| +|..|+.+++|++|+|++|.+
T Consensus 146 ~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l 218 (636)
T 4eco_A 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218 (636)
T ss_dssp HHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCC
T ss_pred HHhhhccCchhhHHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcc
Confidence 999999999988874 4455555555444431 222344445554 689998 999999999999999999999
Q ss_pred cCc-----------------cccccc--cccccchhhcccccccCCchhhhcCCCccceeeecccc-ccc-ccCcccccc
Q 001253 259 SGV-----------------IPKELG--NCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNE-LNG-TIPREIGKL 317 (1114)
Q Consensus 259 ~~~-----------------~p~~l~--~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~-l~~-~~p~~l~~l 317 (1114)
++. +|..++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L 298 (636)
T 4eco_A 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298 (636)
T ss_dssp CGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHH
T ss_pred ccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhh
Confidence 986 899999 99999999999999999999999999999999999998 998 899999887
Q ss_pred ------ccccccccccccCCCCCch--hhhcccccceeecccccccCcccccccccccCCEEEcccccccccccCccccc
Q 001253 318 ------SSALEIDFSENSLIGEIPV--ELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYL 389 (1114)
Q Consensus 318 ------~~L~~L~ls~N~l~~~~~~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 389 (1114)
++|++|++++|+++ .+|. .+.++++|+.|++++|+++|.+| .|..+++|++|+|++|+++ .+|..|..+
T Consensus 299 ~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 375 (636)
T 4eco_A 299 ADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGF 375 (636)
T ss_dssp HHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEE
T ss_pred hccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhh
Confidence 99999999999999 8888 89999999999999999998888 9999999999999999999 888899999
Q ss_pred cc-eeeeeccCCcccCCCCCCCCcCc--cceEEEeecccccCCCCcccc-------ccCccceeeeccCCccCCcCcccc
Q 001253 390 TN-LIMLQLFDNSLVGGIPQRLGAYS--QLWVVDLSDNHLTGKIPRHIC-------RNTSLIFLNLETNKLTGSIPTGVT 459 (1114)
Q Consensus 390 ~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~-------~~~~L~~L~Ls~N~l~~~~p~~~~ 459 (1114)
++ |++|++++|.+. .+|..+...+ +|++|++++|++++.+|..+. .+++|++|++++|++++..+..+.
T Consensus 376 ~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~ 454 (636)
T 4eco_A 376 TEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454 (636)
T ss_dssp CTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHH
T ss_pred cccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHc
Confidence 99 999999999999 7788887755 999999999999999999888 888999999999999954444456
Q ss_pred cCCcceEEeeccceeeccCCchhhc-c-------ccccEeecccccCCCCcccccc--ccccCcEEEecCceeccCCCcc
Q 001253 460 RCKSLVQLRLGGNSFTGSFPSDLCK-L-------ANLSTVELDQNQFSGPIPTEIG--NCNALQRLHLSDNYFTGELPRE 529 (1114)
Q Consensus 460 ~l~~L~~L~L~~N~l~~~~p~~~~~-l-------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~ 529 (1114)
.+++|++|+|++|+++ .+|..+.. . ++|++|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..
T Consensus 455 ~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~ 531 (636)
T 4eco_A 455 TGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQ 531 (636)
T ss_dssp TTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCG
T ss_pred cCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChh
Confidence 6999999999999999 66655433 3 29999999999999 7888887 99999999999999997 8999
Q ss_pred ccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCccccccccccccc
Q 001253 530 VGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLT 609 (1114)
Q Consensus 530 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 609 (1114)
+.++++|+.|+|++|+ ++++|++.+.+|..++.+++|++|+|++|++ +.+|..+. ++|+
T Consensus 532 ~~~l~~L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~ 590 (636)
T 4eco_A 532 PLNSSTLKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNIS 590 (636)
T ss_dssp GGGCSSCCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCC
T ss_pred hhcCCCCCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCC
Confidence 9999999999998876 5667777777777777777788888888887 46776655 6788
Q ss_pred ccccCCCcCC
Q 001253 610 ELQMGGNSFS 619 (1114)
Q Consensus 610 ~L~ls~N~l~ 619 (1114)
.|||++|++.
T Consensus 591 ~L~Ls~N~l~ 600 (636)
T 4eco_A 591 VLDIKDNPNI 600 (636)
T ss_dssp EEECCSCTTC
T ss_pred EEECcCCCCc
Confidence 8888888665
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=446.87 Aligned_cols=266 Identities=27% Similarity=0.398 Sum_probs=211.4
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
++..++|++.++||+|+||+||+|+++. .||||+++.... .....+.|.+|+.++++++|||||+++|++.+ +..|
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 3455788899999999999999999763 699999875443 34456789999999999999999999998864 5689
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+|||||++|+|.++++.....+++.++..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 99999999999999987777899999999999999999999998 999999999999999999999999999987543
Q ss_pred CC-CCccccccccccccCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 965 PQ-SKSMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 965 ~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.. .......+||+.|||||++.+ .+|+.++|||||||++|||+||+.||...... ..+...+..+..
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~----~~~~~~~~~~~~----- 255 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR----DQIIFMVGRGYA----- 255 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----HHHHHHHHTTCC-----
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH----HHHHHHHhcCCC-----
Confidence 22 233456789999999999864 45899999999999999999999999754432 222222222111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
.+.. ...+......+.+++.+||+.||++||||+||++.|+.++..
T Consensus 256 ~p~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 256 SPDL---SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCCS---TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCCc---ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 1111 111222345688999999999999999999999999988643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=490.95 Aligned_cols=492 Identities=19% Similarity=0.211 Sum_probs=351.0
Q ss_pred CCccceEEEecCCCccEEEEEeecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCccccc
Q 001253 63 PCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHI 142 (1114)
Q Consensus 63 ~C~w~gv~C~~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 142 (1114)
.|.|.|| |+.. +++++ .+|+.+. ++|++|+|++|++++..|.+|+.+++|++|+|++|.+++..
T Consensus 3 ~C~~~~~-c~~~------------~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~ 66 (549)
T 2z81_A 3 SCDASGV-CDGR------------SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66 (549)
T ss_dssp EECTTSE-EECT------------TSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEEC
T ss_pred cCCCCce-EECC------------CCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccC
Confidence 4999999 9653 23344 4566554 78999999999999888899999999999999999999888
Q ss_pred ccccccccccceeccccccccCCCCcccccCcccchhhhcccccCC-CCCCCccccccccceeccccccccccC-CCCCC
Q 001253 143 PKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISG-SLPPTLGNLKRLKSFRAGQNLISGSLP-SEIGG 220 (1114)
Q Consensus 143 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~-~~p~~l~~l~~L~~L~l~~n~l~~~~p-~~l~~ 220 (1114)
|..|+++++|++|+|++|++++..|..|+++++|++|++++|.+++ ..|..++++++|++|++++|.+.+.+| ..+++
T Consensus 67 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~ 146 (549)
T 2z81_A 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146 (549)
T ss_dssp TTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTT
T ss_pred hhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhc
Confidence 8899999999999999999998777779999999999999999986 456788888888888888887444444 67888
Q ss_pred CCccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhhcccccccCCc--hh-hhcCCCccc
Q 001253 221 CESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQL--PK-ELGSIGSLK 297 (1114)
Q Consensus 221 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~--p~-~~~~l~~L~ 297 (1114)
+++|++|++++|++++..|..++.+++|++|++++|.+....+..+..+++|++|++++|.+.+.. |. ....+++|+
T Consensus 147 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~ 226 (549)
T 2z81_A 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226 (549)
T ss_dssp CCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCC
T ss_pred ccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhccc
Confidence 888888888888888778888888888888888888876432223356777888888877776642 21 223466777
Q ss_pred eeeecccccccccCcc----ccccccccccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCCEEEc
Q 001253 298 YLYIYRNELNGTIPRE----IGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDL 373 (1114)
Q Consensus 298 ~L~L~~n~l~~~~p~~----l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 373 (1114)
+|++++|.+.+..+.. +..+++|+.+++++|.+.+..... ......+..+.+|+.|++
T Consensus 227 ~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~------------------~~~~~~~~~l~~L~~L~l 288 (549)
T 2z81_A 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN------------------PSESDVVSELGKVETVTI 288 (549)
T ss_dssp EEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCC------------------CCTTTCCCCCTTCCEEEE
T ss_pred ceeccccccchhHHHHHHHHhhhhcccccccccccccccccccc------------------ccchhhhhhhcccccccc
Confidence 7777777776543322 234455555555555544321000 000112344555666666
Q ss_pred ccccccccc-----cCccccccceeeeeccCCcccCCCCCCC-CcCccceEEEeecccccCCCC---ccccccCccceee
Q 001253 374 SINSLTGTI-----PLGFQYLTNLIMLQLFDNSLVGGIPQRL-GAYSQLWVVDLSDNHLTGKIP---RHICRNTSLIFLN 444 (1114)
Q Consensus 374 s~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~---~~~~~~~~L~~L~ 444 (1114)
+++.+.... +..+...++|++|++++|.+. .+|..+ ..+++|++|+|++|++++.+| ..+..+++|++|+
T Consensus 289 ~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~ 367 (549)
T 2z81_A 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV 367 (549)
T ss_dssp ESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEE
T ss_pred cccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEE
Confidence 666554211 111233455666667666665 334333 456777777777777766543 2356667777777
Q ss_pred eccCCccCCcC--cccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCcee
Q 001253 445 LETNKLTGSIP--TGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYF 522 (1114)
Q Consensus 445 Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 522 (1114)
+++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++|++|++++|+++ .+|..+ .++|++|+|++|+|
T Consensus 368 Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l 443 (549)
T 2z81_A 368 LSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNL 443 (549)
T ss_dssp CTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCC
T ss_pred ccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchh--cCCceEEECCCCCh
Confidence 77777765332 34677778888888888777 57777777788888888888877 344333 25788888888888
Q ss_pred ccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCccc
Q 001253 523 TGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIP 599 (1114)
Q Consensus 523 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 599 (1114)
++.+ ..+++|++|+|++|+++ .+|. ...+++|+.|+|++|++++.+|..+..+++|++|++++|.+.+..|
T Consensus 444 ~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 444 DSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp SCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred hhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 8643 46788888888888888 6775 4568889999999999988888888889999999999999887655
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=490.52 Aligned_cols=488 Identities=20% Similarity=0.189 Sum_probs=319.1
Q ss_pred hhcccccCCCCCCCccccccccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCccc
Q 001253 180 VAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLS 259 (1114)
Q Consensus 180 ~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 259 (1114)
+.++|.++ .+|..+. ++|++|++++|.+++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|+++
T Consensus 11 ~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~ 87 (549)
T 2z81_A 11 DGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87 (549)
T ss_dssp ECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred ECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccC
Confidence 44556666 5666554 56777777777777666777777777777777777777666667777777777777777777
Q ss_pred CccccccccccccchhhcccccccC-CchhhhcCCCccceeeecccccccccC-ccccccccccccccccccCCCCCchh
Q 001253 260 GVIPKELGNCTSLETLALYDNKQVG-QLPKELGSIGSLKYLYIYRNELNGTIP-REIGKLSSALEIDFSENSLIGEIPVE 337 (1114)
Q Consensus 260 ~~~p~~l~~l~~L~~L~Ls~N~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~ls~N~l~~~~~~~ 337 (1114)
+..|..++++++|++|++++|.+.+ ..|..++.+++|++|++++|.+.+.+| ..+..+++|++|++++|.+.+..|..
T Consensus 88 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 167 (549)
T 2z81_A 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS 167 (549)
T ss_dssp SCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTT
T ss_pred ccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhh
Confidence 6666667777777777777776665 345566677777777777776433443 45666666666666666666666666
Q ss_pred hhcccccceeecccccccCcccccccccccCCEEEcccccccccc--c-CccccccceeeeeccCCcccCCCCCCCCcCc
Q 001253 338 LSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTI--P-LGFQYLTNLIMLQLFDNSLVGGIPQRLGAYS 414 (1114)
Q Consensus 338 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 414 (1114)
+..+++|+.|++++|.+.......+..+++|++|++++|++++.. + .....+++|+.|++++|.+.+..+..
T Consensus 168 l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~----- 242 (549)
T 2z81_A 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE----- 242 (549)
T ss_dssp TTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHH-----
T ss_pred hhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHH-----
Confidence 666666666666666665433333344566666666666665431 1 11223444445555554444322111
Q ss_pred cceEEEeecccccCCCCccccccCccceeeeccCCccCCc------CcccccCCcceEEeeccceeecc-----CCchhh
Q 001253 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSI------PTGVTRCKSLVQLRLGGNSFTGS-----FPSDLC 483 (1114)
Q Consensus 415 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~------p~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~ 483 (1114)
++..+..+++|+.|++++|.+.+.. ...+..+.+|+.|++.++.+... ++..+.
T Consensus 243 ---------------l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~ 307 (549)
T 2z81_A 243 ---------------LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307 (549)
T ss_dssp ---------------HHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHH
T ss_pred ---------------HHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhh
Confidence 1112233344555555555444311 12234455666666666654421 222234
Q ss_pred ccccccEeecccccCCCCccccc-cccccCcEEEecCceeccCCC---ccccCCCCcceeeccccccccccc--cccccc
Q 001253 484 KLANLSTVELDQNQFSGPIPTEI-GNCNALQRLHLSDNYFTGELP---REVGNLSNLVTFNVSSNFLTGRIP--LEIFSC 557 (1114)
Q Consensus 484 ~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l 557 (1114)
...+|+.|++++|+++ .+|..+ ..+++|++|+|++|++++.+| ..++.+++|++|+|++|++++..+ ..+..+
T Consensus 308 ~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l 386 (549)
T 2z81_A 308 LLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386 (549)
T ss_dssp HSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC
T ss_pred hcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcC
Confidence 4566777777777776 455554 467777777777777776553 336677777777787777764322 346677
Q ss_pred ccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhh
Q 001253 558 KMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALN 637 (1114)
Q Consensus 558 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~ 637 (1114)
++|+.|+|++|+++ .+|..+..+++|++|++++|+++ .+|..+ .++|++|+|++|+|++.+ ..+++|+ .|+
T Consensus 387 ~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~-~L~ 457 (549)
T 2z81_A 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQ-ELY 457 (549)
T ss_dssp TTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCC-EEE
T ss_pred CCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchh--cCCceEEECCCCChhhhc----ccCChhc-EEE
Confidence 77888888888777 56777777778888888888877 344433 257888888888888643 4667777 688
Q ss_pred cccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCCccccc
Q 001253 638 LSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQ 702 (1114)
Q Consensus 638 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~~~~~ 702 (1114)
|++|+|+ .+|. .+.+++|++|||++|+|++.+|+.|..+++|+.|++++|+|.|.+|....+.
T Consensus 458 Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~l~ 520 (549)
T 2z81_A 458 ISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 520 (549)
T ss_dssp CCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHHHHHH
T ss_pred CCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccHHHHH
Confidence 8888888 4565 5678899999999999999999999999999999999999999999644443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=447.03 Aligned_cols=259 Identities=26% Similarity=0.439 Sum_probs=213.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
.++|.+.++||+|+||+||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 367888999999999999999864 4778999999753 3344678999999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 001253 882 SNLLMYEYMARGSLGELLHGA------------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF 949 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 949 (1114)
..|+|||||++|+|.++++.. ...++|.++..++.|||+||+|||++ +|+||||||+|||+++++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence 999999999999999999743 24799999999999999999999998 999999999999999999
Q ss_pred CeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHH
Q 001253 950 EAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVR 1027 (1114)
Q Consensus 950 ~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~ 1027 (1114)
.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+.+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~----~~~~~ 241 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NEVIE 241 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence 9999999999865432222 2234579999999999999999999999999999999999 8999975432 22222
Q ss_pred HHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1028 NFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
. +..+.. . +.+.....++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 242 ~-i~~~~~--------~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 C-ITQGRV--------L----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp H-HHHTCC--------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-HHcCCC--------C----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 2 222111 0 11122335688999999999999999999999999998664
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=489.75 Aligned_cols=592 Identities=22% Similarity=0.202 Sum_probs=352.8
Q ss_pred CCCCCCCCCCCCCCCCCccceEEEecCCCccEEEEEeecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCC
Q 001253 48 DNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSS 127 (1114)
Q Consensus 48 ~~~~~~~~W~~~~~~~C~w~gv~C~~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~ 127 (1114)
|+...+++|+... |..|....|.... . ..+.++.+++ .+|+.+. +.+++||||+|+|++..|.+|+++++
T Consensus 8 ~~~~~~~~~~~~~--p~~~~~c~~~~~~--~---~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~ 77 (635)
T 4g8a_A 8 DDDDKLAAANSSI--PESWEPCVEVVPN--I---TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPE 77 (635)
T ss_dssp -------------------CCSEEEETT--T---EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred CCcchhhcccCCC--CCCCCCccccCCC--C---EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCC
Confidence 4455677887543 3445554443321 1 2355555665 3455442 36899999999998777788999999
Q ss_pred CCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccceeccc
Q 001253 128 LEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQ 207 (1114)
Q Consensus 128 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~ 207 (1114)
|++|+|++|.|++..|++|++|++|++|+|++|+|++..+..|.++++|++|++++|++++..+..|+++++|++|++++
T Consensus 78 L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~ 157 (635)
T 4g8a_A 78 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 157 (635)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecccc
Confidence 99999999999987788899999999999999999866667788888888888888888866666777777777777777
Q ss_pred ccccc-ccCCCCCCCCccceeeccccccCCCCccccccccccc----EEEecCCcccCccccccccccccchhhcccccc
Q 001253 208 NLISG-SLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLT----DVILWGNQLSGVIPKELGNCTSLETLALYDNKQ 282 (1114)
Q Consensus 208 n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~ 282 (1114)
|.+.+ ..|..++.+++|++|+|++|++++..|..+..+++++ .++++.|.++...+. ......++.|++.+|..
T Consensus 158 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~-~~~~~~~~~l~l~~n~~ 236 (635)
T 4g8a_A 158 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLHKLTLRNNFD 236 (635)
T ss_dssp SCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTT-TTTTCEEEEEEEESCCS
T ss_pred CccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcc-cccchhhhhhhhhcccc
Confidence 77754 3456666777777777777777766666666555433 566666666643333 33333455566655543
Q ss_pred cCC-chhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccCccccc
Q 001253 283 VGQ-LPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVE 361 (1114)
Q Consensus 283 ~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 361 (1114)
... .+..+..+..++...+..+..... ..+.......
T Consensus 237 ~~~~~~~~~~~l~~l~~~~l~~~~~~~~------------------------------------------~~l~~~~~~~ 274 (635)
T 4g8a_A 237 SLNVMKTCIQGLAGLEVHRLVLGEFRNE------------------------------------------GNLEKFDKSA 274 (635)
T ss_dssp SHHHHHHHHHTTTTCEEEEEEEECCTTS------------------------------------------CCCSCCCTTT
T ss_pred cccccchhhcCCcccccccccccccccc------------------------------------------cccccccccc
Confidence 322 223344445444444433222100 0001111112
Q ss_pred ccccccCCEEEccccccc---ccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccC
Q 001253 362 LTTLKNLTKLDLSINSLT---GTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNT 438 (1114)
Q Consensus 362 ~~~l~~L~~L~Ls~N~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 438 (1114)
+..+..+..+++..+... ...+..+..+.+++.+.+.+|.+.... .+.....|+.|++++|.+.+..+. .+.
T Consensus 275 ~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~ 349 (635)
T 4g8a_A 275 LEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLK 349 (635)
T ss_dssp TGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC---BCT
T ss_pred cccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcc---cch
Confidence 222233333333332221 112223333444444444444443222 123344566666666666543322 234
Q ss_pred ccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEec
Q 001253 439 SLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLS 518 (1114)
Q Consensus 439 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 518 (1114)
.|+.++++.|.+... .....+++|+.|++++|.+... +..+..+..+.+|+.|+++
T Consensus 350 ~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~----------------------~~~~~~~~~~~~L~~L~~~ 405 (635)
T 4g8a_A 350 SLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFK----------------------GCCSQSDFGTISLKYLDLS 405 (635)
T ss_dssp TCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEE----------------------EECCHHHHSCSCCCEEECC
T ss_pred hhhhcccccccCCCC--cccccccccccchhhccccccc----------------------cccccchhhhhhhhhhhcc
Confidence 455555555555422 1223445555555555544311 1223333444555555555
Q ss_pred CceeccCCCccccCCCCcceeeccccccccccc-ccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCC-C
Q 001253 519 DNYFTGELPREVGNLSNLVTFNVSSNFLTGRIP-LEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELS-G 596 (1114)
Q Consensus 519 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~ 596 (1114)
.|.+.+ .+..+..+++|+.+++++|......+ ..+..+++++.+++++|.+.+..|..+..++.|++|+|++|.+. +
T Consensus 406 ~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~ 484 (635)
T 4g8a_A 406 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 484 (635)
T ss_dssp SCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGG
T ss_pred cccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccc
Confidence 555542 33445555555555555555443333 23445666666666666666666666666777777777776533 3
Q ss_pred cccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccc
Q 001253 597 SIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFV 676 (1114)
Q Consensus 597 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 676 (1114)
..|..|..+++|++|||++|+|++.+|..|.++++|+ .|+|++|+|++..|..|+++++|++|||++|+|++.+|+.|.
T Consensus 485 ~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~-~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 563 (635)
T 4g8a_A 485 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 563 (635)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC-EEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTT
T ss_pred cCchhhhhccccCEEECCCCccCCcChHHHcCCCCCC-EEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHH
Confidence 4667777778888888888888877788888888887 688888888888888889999999999999999999999999
Q ss_pred cc-cccceEEeccCcccCCCCCccccccccccc---ccCCCCCCCCCCCCC
Q 001253 677 NL-SSLLGCNFSYNNLTGPIPSSQTFQNMSVNS---FSGSKGLCGGPLQNC 723 (1114)
Q Consensus 677 ~l-~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~---~~~n~~lc~~p~~~~ 723 (1114)
.+ ++|+.|++++|+|+|.+...+-.+|+.... .......|..|....
T Consensus 564 ~l~~~L~~L~L~~Np~~C~C~~~~~~~wl~~~~~~~~~~~~~~C~~P~~~~ 614 (635)
T 4g8a_A 564 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 614 (635)
T ss_dssp CCCTTCCEEECTTCCBCCSGGGHHHHHHHHHTTTTBSCGGGCBBCSSTTTT
T ss_pred hhhCcCCEEEeeCCCCcccCCcHHHHHHHHhCCCccCCCCCceeCCchHHC
Confidence 98 689999999999999988655444443221 112235687765433
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=447.62 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=207.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
.++|.+.++||+|+||+||+|+++ +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+++
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357888899999999999999864 4788999999743 3345678999999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 001253 882 SNLLMYEYMARGSLGELLHGAS--------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 947 (1114)
..|+|||||++|+|.++++... ..++|.++..++.|||+||+|||+. +|+||||||+|||+++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence 9999999999999999997532 3589999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHH
Q 001253 948 KFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTW 1025 (1114)
Q Consensus 948 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~ 1025 (1114)
++.+||+|||+|+....... ......+||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+.
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~----~~~ 269 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN----TEA 269 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH----HHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH----HHH
Confidence 99999999999987643322 23345679999999999999999999999999999999999 8999975432 222
Q ss_pred HHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
+.. +..+. ++ +.+.....++.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 270 ~~~-i~~g~--------~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 270 IDC-ITQGR--------EL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHH-HHHTC--------CC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHH-HHcCC--------CC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 222 22111 11 11222335688999999999999999999999999998654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=443.66 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=211.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
.+++..++||+|+||+||+|++. +++.||||+++..... ...++|.+|+.++++++|||||+++|+|.+++.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 45777889999999999999973 4678999999755432 346789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 001253 883 NLLMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 947 (1114)
.++|||||++|+|.++++... ..++|.++..++.|||+||+|||++ +||||||||+|||+++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence 999999999999999996432 3689999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeccCceecCCCC-CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHH
Q 001253 948 KFEAHVGDFGLAKVIDMPQ-SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTW 1025 (1114)
Q Consensus 948 ~~~~kl~DfG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~ 1025 (1114)
++++||+|||+|+...... .......+||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~----~~- 255 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QD- 255 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----HH-
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH----HH-
Confidence 9999999999998654322 223445689999999999999999999999999999999998 8999975432 22
Q ss_pred HHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
+...+..+.. . +.+......+.++|.+||+.||++||||+||++.|+.+
T Consensus 256 ~~~~i~~~~~--------~----~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 VVEMIRNRQV--------L----PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHTTCC--------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHcCCC--------C----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2222322211 1 11222345688999999999999999999999999875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=484.83 Aligned_cols=476 Identities=19% Similarity=0.181 Sum_probs=330.1
Q ss_pred eeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhhcccccccCCchhhhcCCCccceeeecccc
Q 001253 226 YLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNE 305 (1114)
Q Consensus 226 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~ 305 (1114)
+|++++|+++ .+|..+. ++|++|++++|++++..|..|.++++|++|+|++|++.+..|..|+.+++|++|+|++|+
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 3445555554 3444333 445555555555554444445555555555555555554445555555555555555555
Q ss_pred cccccCccccccccccccccccccCCC-CCchhhhcccccceeecccccccCcccccccccccC--CEEEcccccc--cc
Q 001253 306 LNGTIPREIGKLSSALEIDFSENSLIG-EIPVELSKILGLELLYLFENKLTGVIPVELTTLKNL--TKLDLSINSL--TG 380 (1114)
Q Consensus 306 l~~~~p~~l~~l~~L~~L~ls~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~Ls~N~l--~~ 380 (1114)
++ .+|.. .+++|++|++++|.+.+ .+|..++++++|+.|++++|++++ ..+..+++| ++|++++|.+ .+
T Consensus 81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~ 154 (520)
T 2z7x_B 81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEK 154 (520)
T ss_dssp CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSS
T ss_pred ee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccc
Confidence 55 34433 45555666666666554 345566666666666666666654 345555566 7777777777 66
Q ss_pred cccCcccccc-ceeeeeccCCcccCCCCC-CCCcCccceEEEeeccc-------ccCCCCccccccCccceeeeccCCcc
Q 001253 381 TIPLGFQYLT-NLIMLQLFDNSLVGGIPQ-RLGAYSQLWVVDLSDNH-------LTGKIPRHICRNTSLIFLNLETNKLT 451 (1114)
Q Consensus 381 ~~~~~~~~l~-~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~-------l~~~~~~~~~~~~~L~~L~Ls~N~l~ 451 (1114)
..|..+..+. +...+++++|.+.+.++. .+..+++|+.|++++|. +.+.+| .+..+++|+.|++++|.++
T Consensus 155 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~ 233 (520)
T 2z7x_B 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETT 233 (520)
T ss_dssp CCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEE
T ss_pred cccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccC
Confidence 6666666655 344566777776665443 46677788888888876 555555 6777788888888888776
Q ss_pred CCcCcccc---cCCcceEEeeccceeeccCCchh-----hccccccEeecccccCCCCcc-cccccc---ccCcEEEecC
Q 001253 452 GSIPTGVT---RCKSLVQLRLGGNSFTGSFPSDL-----CKLANLSTVELDQNQFSGPIP-TEIGNC---NALQRLHLSD 519 (1114)
Q Consensus 452 ~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~Ls~ 519 (1114)
+..+..+. ..++|++|++++|+++|.+|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~ 311 (520)
T 2z7x_B 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSG 311 (520)
T ss_dssp HHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEES
T ss_pred HHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCC
Confidence 53322221 24578888888888888888887 7888888888888888 344 555554 6788889988
Q ss_pred ceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccC--CCchhhhhcccCCeeeccCccCCCc
Q 001253 520 NYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVG--ALPREIGSLFQLELLKLSENELSGS 597 (1114)
Q Consensus 520 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~ 597 (1114)
|.+.+.. .+..+++|++|++++|++++.+|..+..+++|+.|+|++|++++ .+|..++.+++|++|++++|++++.
T Consensus 312 n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~ 389 (520)
T 2z7x_B 312 TRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD 389 (520)
T ss_dssp SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCC
T ss_pred Ccccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcc
Confidence 8876432 12678888999999999988788888889999999999999886 5667888999999999999999975
Q ss_pred cccc-ccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccc
Q 001253 598 IPVQ-IGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFV 676 (1114)
Q Consensus 598 ~p~~-~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 676 (1114)
+|.. +..+++|++|++++|++++.+|..+. ++|+ .|+|++|+++ .+|..+..+++|++|||++|+|++..+..|.
T Consensus 390 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~-~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~ 465 (520)
T 2z7x_B 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIK-VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFD 465 (520)
T ss_dssp GGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCC-EEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTT
T ss_pred cccchhccCccCCEEECcCCCCCcchhhhhc--ccCC-EEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhc
Confidence 6654 78889999999999999888887765 5777 7999999999 6788888999999999999999954444499
Q ss_pred cccccceEEeccCcccCCCCCccc-cccccccc-ccCCCCCCCCC
Q 001253 677 NLSSLLGCNFSYNNLTGPIPSSQT-FQNMSVNS-FSGSKGLCGGP 719 (1114)
Q Consensus 677 ~l~~l~~l~ls~N~l~g~ip~~~~-~~~~~~~~-~~~n~~lc~~p 719 (1114)
.+++|+.|++++|+++|.++..+. ..++.... .......|+.|
T Consensus 466 ~l~~L~~L~l~~N~~~c~c~~~~~~~~~~~~~~~~~~~~~~C~~p 510 (520)
T 2z7x_B 466 RLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSAKCSGS 510 (520)
T ss_dssp TCTTCCEEECCSSCBCCCHHHHHHHHHHHHHTTTTEESCCBBTTT
T ss_pred cCCcccEEECcCCCCcccCCchHHHHHHHHhccccCCCCCCcCCc
Confidence 999999999999999999886544 22332221 12234567765
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=439.05 Aligned_cols=269 Identities=20% Similarity=0.273 Sum_probs=222.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+.+ +|+.||||++.+.........+.+.+|++++++++|||||++++++++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999976 79999999997654323334677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC-
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ- 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 966 (1114)
||++||+|.+++++ ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999974 35799999999999999999999999 99999999999999999999999999999875332
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+..+..... .+ .
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~-~~---------~- 252 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EGLIFAKIIKL-EY---------D- 252 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHT-CC---------C-
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcC-CC---------C-
Confidence 234557799999999999999999999999999999999999999997432 23333332222 11 1
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCCc
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDSD 1103 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~ 1103 (1114)
.+.....++.+++.+||+.||++|||++|++.. ..+ ..+.++..+||+.-
T Consensus 253 ---~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~-~~i---~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 253 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPL---KAHPFFESVTWENL 302 (311)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH-HHH---HTSGGGTTCCCTTG
T ss_pred ---CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC-HHH---HCCCCcCCCCHHHh
Confidence 111223467899999999999999999986432 111 24678889999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=437.43 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=209.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+.|++.++||+|+||+||+|+++ +|+.||||++....... .+.+.+|+.+++.++|||||+++++|.+++..|+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56899999999999999999986 79999999997654432 345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|||+||+|.++++. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+... .
T Consensus 151 Ey~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 224 (346)
T 4fih_A 151 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-V 224 (346)
T ss_dssp CCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-S
T ss_pred eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC-C
Confidence 99999999999974 4699999999999999999999999 9999999999999999999999999999976532 2
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+.++....... +.
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~~~-------~~---- 289 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMIRDNLP-------PR---- 289 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHSSC-------CC----
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHHcCCC-------CC----
Confidence 33456789999999999999999999999999999999999999997432 2233332222110 01
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.........++.+++.+||+.||++|||++|+++
T Consensus 290 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111223456889999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=441.54 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=205.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+++ +|+.||||++...... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 68999999999999999999976 7999999999766543 334667899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 888 EYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+||+|.++++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.... .
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-T 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH-H
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC-C
Confidence 999999999999744 34679999999999999999999999 999999999999999999999999999987532 1
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||... ...+.+....... +.
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~----~~~~~~~~i~~~~-~~---------- 243 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG----SMKNLVLKIISGS-FP---------- 243 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHTC-CC----------
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc----CHHHHHHHHHcCC-CC----------
Confidence 12234568999999999999999999999999999999999999999743 3333333333221 10
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+.....++.+++.+||+.||++|||++|+++
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122346889999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=443.38 Aligned_cols=272 Identities=25% Similarity=0.388 Sum_probs=222.2
Q ss_pred CCHHHHHHHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC-Ccee
Q 001253 799 FTFKDLVVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH-RNIV 871 (1114)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv 871 (1114)
+..+++++..++|++.++||+|+||+||+|++. +++.||||++..... ....+.|.+|+.++++++| ||||
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEE
Confidence 445667788899999999999999999999964 246899999975443 2345679999999999965 8999
Q ss_pred eEEeEEEec-CceEEEEecCCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 001253 872 KLYGFCYHQ-GSNLLMYEYMARGSLGELLHGA---------------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935 (1114)
Q Consensus 872 ~l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 935 (1114)
+++|+|.+. +..|+|||||++|+|.++++.. ...+++.++..++.|||+||+|||++ +|||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Ceec
Confidence 999999764 5689999999999999999742 23589999999999999999999999 9999
Q ss_pred cCCCCCCeEECCCCCeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCC
Q 001253 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPV 1013 (1114)
Q Consensus 936 ~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~ 1013 (1114)
|||||+|||+++++.+||+|||+|+........ .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 999999999999999999999999976433332 3345679999999999999999999999999999999998 89999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 001253 1014 QPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1091 (1114)
........+...+.+ +. ++ ..+.....++.++|.+||+.||++||||+||++.|+++.+...
T Consensus 289 ~~~~~~~~~~~~i~~----g~--------~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 289 PGVKIDEEFCRRLKE----GT--------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp TTCCCSHHHHHHHHH----TC--------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHc----CC--------CC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 865543333222222 11 11 1112223468899999999999999999999999999876543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=434.38 Aligned_cols=254 Identities=25% Similarity=0.294 Sum_probs=209.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+.|+..++||+|+||+||+|+++ +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..|+||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888889999999999999986 799999999975432 236999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-CeEEeeccCceecCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~ 966 (1114)
|||+||+|.++++.. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++ ++||+|||+|+.+....
T Consensus 130 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred eccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999999743 4799999999999999999999998 999999999999999988 69999999999765322
Q ss_pred C----CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 967 S----KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 967 ~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.............. ....
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~------- 274 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS----EPPP------- 274 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH----SCCG-------
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc----CCCC-------
Confidence 1 122346899999999999999999999999999999999999999986554443332221 1110
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
. ...+......+.+++.+||+.||++|||+.|+++.+.++...
T Consensus 275 -~---~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 275 -I---REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp -G---GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -c---hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 0 011122345688999999999999999999999998887554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=480.83 Aligned_cols=483 Identities=21% Similarity=0.212 Sum_probs=274.2
Q ss_pred CccCEEEecCCcccCCCCcccCCCCCCCEEEc-cCCCcccccccccccc----ccc--ceeccccc-cccCCCCcccccC
Q 001253 102 VHLTALDLSFNQLSRNIPKEIGNCSSLEVLNL-NNNRLEAHIPKELGNL----SSL--TILNIYNN-RISGPFPKEIGKL 173 (1114)
Q Consensus 102 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L-~~n~l~~~~p~~l~~l----~~L--~~L~L~~N-~l~~~~p~~~~~l 173 (1114)
.+++.|+|++|+++|.+|++|++|++|++|+| ++|.++|..|-..... +.+ +.+..... .+....|. ..+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~--~~~ 400 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR--LNL 400 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGG--GGS
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcc--hhh
Confidence 57889999999999999999999999999999 8888887644221111 110 11110000 00000000 011
Q ss_pred cccchhhhcccccCCCCCCCccccccccceeccc--cccccccCCCCCCCCccceeeccccccCC---------------
Q 001253 174 SALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQ--NLISGSLPSEIGGCESLQYLGLAQNQLSG--------------- 236 (1114)
Q Consensus 174 ~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~--n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--------------- 236 (1114)
..+....+..+.. ..+....+...++.+.+.. |.+++ +|..|+++++|++|+|++|++++
T Consensus 401 s~l~~~~l~~~~~--~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~ 477 (876)
T 4ecn_A 401 SDLLQDAINRNPE--MKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYA 477 (876)
T ss_dssp CHHHHHHHHTCTT--SCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHH
T ss_pred hHHHHHHhhhCcc--ccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccc
Confidence 1111111111110 0111112223334444433 55555 55566666666666666666665
Q ss_pred --CCccccc--ccccccEEEecCCcccCccccccccccccchhhccccc-ccC-CchhhhcCCC-------ccceeeecc
Q 001253 237 --EIPKEIG--MLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNK-QVG-QLPKELGSIG-------SLKYLYIYR 303 (1114)
Q Consensus 237 --~~p~~l~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-~~~-~~p~~~~~l~-------~L~~L~L~~ 303 (1114)
.+|..++ .+++|++|+|++|.+.+.+|..|+++++|+.|+|++|+ +.+ .+|..++.++ +|++|+|++
T Consensus 478 ~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~ 557 (876)
T 4ecn_A 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557 (876)
T ss_dssp HHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCS
T ss_pred cccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeC
Confidence 3666665 66666666666666666666666666666666666665 555 5666555544 677777777
Q ss_pred cccccccCc--cccccccccccccccccCCCCCchhhhcccccceeecccccccCccccccccccc-CCEEEcccccccc
Q 001253 304 NELNGTIPR--EIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKN-LTKLDLSINSLTG 380 (1114)
Q Consensus 304 n~l~~~~p~--~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~ 380 (1114)
|++. .+|. .++.+++|++|++++|++. .+| .+..+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|.++
T Consensus 558 N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~- 632 (876)
T 4ecn_A 558 NNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK- 632 (876)
T ss_dssp SCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-
T ss_pred CcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-
Confidence 7666 6666 6666666666666666666 555 6666666666666666666 55556666666 666666666666
Q ss_pred cccCccccccc--eeeeeccCCcccCCCCCCC---C--cCccceEEEeecccccCCCCccc-cccCccceeeeccCCccC
Q 001253 381 TIPLGFQYLTN--LIMLQLFDNSLVGGIPQRL---G--AYSQLWVVDLSDNHLTGKIPRHI-CRNTSLIFLNLETNKLTG 452 (1114)
Q Consensus 381 ~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~Ls~N~l~~~~~~~~-~~~~~L~~L~Ls~N~l~~ 452 (1114)
.+|..+..++. |+.|++++|++.+.+|... . ..++|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+|+
T Consensus 633 ~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~- 710 (876)
T 4ecn_A 633 YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT- 710 (876)
T ss_dssp SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-
T ss_pred cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-
Confidence 55555555543 6666666666665544322 1 2235666666666666 334333 35566666666666666
Q ss_pred CcCccccc--------CCcceEEeeccceeeccCCchhh--ccccccEeecccccCCCCccccccccccCcEEEecCcee
Q 001253 453 SIPTGVTR--------CKSLVQLRLGGNSFTGSFPSDLC--KLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYF 522 (1114)
Q Consensus 453 ~~p~~~~~--------l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 522 (1114)
.+|..+.. +++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+.++++|+.|+|++|+
T Consensus 711 ~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~- 787 (876)
T 4ecn_A 711 SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR- 787 (876)
T ss_dssp CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB-
T ss_pred ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC-
Confidence 34443322 125666666666665 4555554 55666666666666654 45555566666666665532
Q ss_pred ccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccc
Q 001253 523 TGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQI 602 (1114)
Q Consensus 523 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 602 (1114)
++++|++.+.+|..+..+++|+.|+|++|++ +.+|..+. ++|+.|+|++|++....+..+
T Consensus 788 -----------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~ 847 (876)
T 4ecn_A 788 -----------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSV 847 (876)
T ss_dssp -----------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGG
T ss_pred -----------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHc
Confidence 1233555556666666666666666666666 45555544 466666666666665444555
Q ss_pred cccccccccccCCCcCC
Q 001253 603 GNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 603 ~~l~~L~~L~ls~N~l~ 619 (1114)
.....+..+.|++|++.
T Consensus 848 ~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 848 CPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp HHHHHTTCCEEECCTTS
T ss_pred cccccchheeecCCCcc
Confidence 44445555566666554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=466.84 Aligned_cols=459 Identities=19% Similarity=0.214 Sum_probs=278.0
Q ss_pred CEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhccc
Q 001253 105 TALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSN 184 (1114)
Q Consensus 105 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n 184 (1114)
++||+++|+++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|++++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 45666666665 4665554 66677777777666655566666666666666666666555555555555555555555
Q ss_pred ccCCCCCCCccccccccceecccccccc-ccCCCCCCCCccceeeccccccCCCCcccccccccc--cEEEecCCcc--c
Q 001253 185 NISGSLPPTLGNLKRLKSFRAGQNLISG-SLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYL--TDVILWGNQL--S 259 (1114)
Q Consensus 185 ~i~~~~p~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L--~~L~L~~N~l--~ 259 (1114)
+++ .+|.. .+++|++|++++|.+++ .+|..++++++|++|+|++|++++ ..++.+++| ++|++++|.+ +
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 555 33333 44445555555554443 234455555555555555555543 233444444 5555555544 3
Q ss_pred CccccccccccccchhhcccccccCCchhhhcCCCccceeeecccccccccCc-ccccccccccccccccc-------CC
Q 001253 260 GVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPR-EIGKLSSALEIDFSENS-------LI 331 (1114)
Q Consensus 260 ~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~ls~N~-------l~ 331 (1114)
+..|..+..++. +...+++++|.+.+.++. .+..+++|+.|++++|. +.
T Consensus 154 ~~~~~~l~~l~~-----------------------~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~ 210 (520)
T 2z7x_B 154 KEDPEGLQDFNT-----------------------ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL 210 (520)
T ss_dssp SCCTTTTTTCCE-----------------------EEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHH
T ss_pred cccccccccccc-----------------------ceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceee
Confidence 344444433321 122334444444333322 23344444444444443 22
Q ss_pred CCCchhhhcccccceeecccccccCccccccc---ccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCC
Q 001253 332 GEIPVELSKILGLELLYLFENKLTGVIPVELT---TLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQ 408 (1114)
Q Consensus 332 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 408 (1114)
+.+| .+..+++|+.|++++|.+++..+..+. ..++|++|++++|++++.+|..+...
T Consensus 211 ~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~------------------- 270 (520)
T 2z7x_B 211 SILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY------------------- 270 (520)
T ss_dssp HHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCC-------------------
T ss_pred cchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhc-------------------
Confidence 2222 334444444444444444332111110 12345555555555554444433000
Q ss_pred CCCcCccceEEEeecccccCCCC-cccccc---CccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhc
Q 001253 409 RLGAYSQLWVVDLSDNHLTGKIP-RHICRN---TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCK 484 (1114)
Q Consensus 409 ~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 484 (1114)
....+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.+.. .+..+++|++|++++|++++..|..++.
T Consensus 271 ~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 346 (520)
T 2z7x_B 271 SGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGH 346 (520)
T ss_dssp CSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCC
T ss_pred ccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhcc
Confidence 005566666666666666 333 344333 56777777777766322 1256777888888888888777888888
Q ss_pred cccccEeecccccCCC--CccccccccccCcEEEecCceeccCCCc-cccCCCCcceeecccccccccccccccccccce
Q 001253 485 LANLSTVELDQNQFSG--PIPTEIGNCNALQRLHLSDNYFTGELPR-EVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQ 561 (1114)
Q Consensus 485 l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 561 (1114)
+++|++|++++|++++ .+|..+..+++|++|+|++|++++.+|. .+..+++|++|++++|++++.+|..+. ++|+
T Consensus 347 l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~ 424 (520)
T 2z7x_B 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIK 424 (520)
T ss_dssp CSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCC
T ss_pred CCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCC
Confidence 8888888888888876 4567788888888888888888874554 477888888888888888877776654 7899
Q ss_pred EEECccccccCCCchhhhhcccCCeeeccCccCCCccccc-ccccccccccccCCCcCCCCCC
Q 001253 562 RLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQ-IGNLSRLTELQMGGNSFSGGIP 623 (1114)
Q Consensus 562 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~p 623 (1114)
.|+|++|+++ .+|..+..+++|++|+|++|+++ .+|.. +..+++|++|++++|++++..+
T Consensus 425 ~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 425 VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp EEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred EEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence 9999999998 78888888999999999999999 45554 8889999999999999987544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=420.11 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=193.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+.+ +|+.||||++.+.........+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 79999999998766555555678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+ +|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.... .
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--G 165 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC--C
Confidence 999 57999998743 5799999999999999999999999 999999999999999999999999999987542 2
Q ss_pred CccccccccccccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
....+.+||+.|||||++.+..+ +.++||||+||++|||++|+.||... ......+..... .+ .
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~----~~~~~~~~i~~~-~~---------~- 230 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE----SIPVLFKNISNG-VY---------T- 230 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHT-CC---------C-
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHcC-CC---------C-
Confidence 33456789999999999998886 57999999999999999999999642 233333332221 11 1
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+......+.+++.+||+.||++|||++|+++
T Consensus 231 ---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 ---LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11112346789999999999999999999976
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=427.19 Aligned_cols=270 Identities=27% Similarity=0.337 Sum_probs=205.7
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC----ceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG----SNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 884 (1114)
++|.+.++||+|+||+||+|+++ |+.||||++..... ....++.|+..+.+++|||||+++++|.+++ ..|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 46888899999999999999985 89999999964321 1223445677778899999999999998764 579
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC-----KPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
+|||||++|+|.++++. ..++|..+.+++.|+++||+|||+++ .++|+||||||+|||+++++++||+|||+|
T Consensus 78 lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999999984 46899999999999999999999762 458999999999999999999999999999
Q ss_pred eecCCCCCC---ccccccccccccCccccccC------CCCcccchHHHHHHHHHHHhCCCCCCCCC----------CCC
Q 001253 960 KVIDMPQSK---SMSAIAGSYGYIAPEYAYTM------KVTEKCDIYSYGVVLLELLTGRAPVQPLD----------QGG 1020 (1114)
Q Consensus 960 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslGvil~el~tg~~p~~~~~----------~~~ 1020 (1114)
+........ .....+||+.|||||++.+. .++.++|||||||++|||+||+.||.... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 876533221 22346799999999998754 46789999999999999999987664322 112
Q ss_pred CHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 001253 1021 DLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1091 (1114)
.....+...+..... ++.+.. .....+....+.+++.+||+.||++||||+||++.|+++.+..+
T Consensus 236 ~~~~~~~~~~~~~~~-----rp~~p~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKL-----RPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CCHHHHHHHHTTSCC-----CCCCCG-GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred chHHHHHHHHhcccC-----CCCCCc-cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 222233332222111 111110 11233456678999999999999999999999999999976543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=439.01 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=209.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.+.|++.++||+|+||+||+|+++ +|+.||||++....... .+.+.+|+.+++.++|||||+++++|.+++..|+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 367999999999999999999986 79999999997654332 45588999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
||||+||+|.++++. ..+++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 227 mEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~- 300 (423)
T 4fie_A 227 MEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 300 (423)
T ss_dssp EECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-
T ss_pred EeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC-
Confidence 999999999999974 4699999999999999999999999 9999999999999999999999999999976532
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+.++...... ...+
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~~-------~~~~-- 367 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMIRDNL-------PPRL-- 367 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHSC-------CCCC--
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHHcCC-------CCCC--
Confidence 234456789999999999999999999999999999999999999996432 223333222211 1111
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.........+.+++.+||+.||++|||++|+++
T Consensus 368 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111122346889999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=422.52 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=199.5
Q ss_pred cCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe----cCceEEE
Q 001253 812 DERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH----QGSNLLM 886 (1114)
Q Consensus 812 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 886 (1114)
+..++||+|+||+||+|+++ +++.||+|++...... ....+.|.+|+.++++++|||||+++++|.+ ++..|+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 56678999999999999976 7899999999765443 3345679999999999999999999999875 3457999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCCeEEeeccCceecCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+||+|.+++++ ...+++..+..++.||++||+|||++ .++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-- 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-- 183 (290)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC--
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC--
Confidence 999999999999974 35789999999999999999999998 123999999999999984 7999999999998642
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.....+.+||+.|||||++.+ +|+.++|||||||++|||+||+.||..... ... +...+..+.. ...
T Consensus 184 -~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~---~~~-~~~~i~~~~~-----~~~-- 250 (290)
T 3fpq_A 184 -ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQ-IYRRVTSGVK-----PAS-- 250 (290)
T ss_dssp -TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---HHH-HHHHHTTTCC-----CGG--
T ss_pred -CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc---HHH-HHHHHHcCCC-----CCC--
Confidence 233456789999999998865 699999999999999999999999964332 222 2222222111 000
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+.....++.+++.+||+.||++|||++|+++
T Consensus 251 ----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 ----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112235789999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=424.57 Aligned_cols=264 Identities=25% Similarity=0.281 Sum_probs=205.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
++|++.+.||+|+||+||+|+.. +++.||||++.+....... ...+.+|+.++++++|||||++++++.+++..|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 57999999999999999999863 5789999999765432211 335778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||++||+|.+++++ ...+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 103 ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999974 34799999999999999999999999 999999999999999999999999999986532
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
......+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+......... .
T Consensus 179 -~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~----~~~~~~~i~~~~----------~ 243 (304)
T 3ubd_A 179 -HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD----RKETMTMILKAK----------L 243 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCC----------C
T ss_pred -CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC----HHHHHHHHHcCC----------C
Confidence 2233456789999999999999999999999999999999999999997432 233333322211 1
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHH-HHHHHHhhhccCCCcccccCCCCC
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMRE-VVLMLSESNRRQGHFEFSPMDHDS 1102 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-vl~~L~~i~~~~~~~~~~~~~~~~ 1102 (1114)
. .+.....++.+++.+||+.||++|||+.. .++++ ..+.++..+||+.
T Consensus 244 ~----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~ei------l~Hp~f~~idw~~ 292 (304)
T 3ubd_A 244 G----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEI------KRHSFFSTIDWNK 292 (304)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHH------HTSGGGTTCCHHH
T ss_pred C----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHH------HcCccccCCCHHH
Confidence 1 11122346889999999999999999631 11111 1355666777653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=462.53 Aligned_cols=523 Identities=20% Similarity=0.152 Sum_probs=403.1
Q ss_pred eEEEec-------CCCccEEEEEeecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCccc
Q 001253 68 GVNCTT-------NDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEA 140 (1114)
Q Consensus 68 gv~C~~-------~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~ 140 (1114)
.|.|+. .+.+..++.|+|++|++++..+.+|.++++|++|||++|+|++..|.+|.+|++|++|+|++|+|++
T Consensus 35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~ 114 (635)
T 4g8a_A 35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 114 (635)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC
Confidence 466743 3445568999999999998888899999999999999999998788899999999999999999998
Q ss_pred ccccccccccccceeccccccccCCCCcccccCcccchhhhcccccCC-CCCCCccccccccceeccccccccccCCCCC
Q 001253 141 HIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISG-SLPPTLGNLKRLKSFRAGQNLISGSLPSEIG 219 (1114)
Q Consensus 141 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~-~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~ 219 (1114)
..++.|.++++|++|+|++|++++..+..|+++++|++|++++|.+++ .+|..++++++|++|++++|.+++..|..+.
T Consensus 115 l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~ 194 (635)
T 4g8a_A 115 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 194 (635)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGH
T ss_pred CCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccccc
Confidence 788889999999999999999998777889999999999999999976 4688999999999999999999998888887
Q ss_pred CCCccc----eeeccccccCCCCcccccccccccEEEecCCcccCc-cccccccccccchhhccccccc------CCchh
Q 001253 220 GCESLQ----YLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGV-IPKELGNCTSLETLALYDNKQV------GQLPK 288 (1114)
Q Consensus 220 ~l~~L~----~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~~~------~~~p~ 288 (1114)
.+.+++ .++++.|.++. ++........+..+++.+|..+.. .+..+..+..++...+..+... .....
T Consensus 195 ~L~~l~~~~~~~~ls~n~l~~-i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~ 273 (635)
T 4g8a_A 195 VLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 273 (635)
T ss_dssp HHHTCTTCCCEEECTTCCCCE-ECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTT
T ss_pred chhhhhhhhhhhhcccCcccc-cCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccc
Confidence 776654 68899999984 555555556788899999876643 3445667777776665433221 12222
Q ss_pred hhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccCcccccccccccC
Q 001253 289 ELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNL 368 (1114)
Q Consensus 289 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 368 (1114)
.+..+..+..+.+..+..... .......+....+++.+.+.++.+.... .+.....|
T Consensus 274 ~~~~~~~l~~~~l~~~~~~~~---------------------~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L 330 (635)
T 4g8a_A 274 ALEGLCNLTIEEFRLAYLDYY---------------------LDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGW 330 (635)
T ss_dssp TTGGGGGSEEEEEEEECCCSC---------------------EEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCC
T ss_pred ccccccchhhhhhhhhhhccc---------------------ccchhhhhhhhccccccccccccccccc--ccccchhh
Confidence 333344444444433322110 0112233444556666777766665443 24455677
Q ss_pred CEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccC--CCCccccccCccceeeec
Q 001253 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTG--KIPRHICRNTSLIFLNLE 446 (1114)
Q Consensus 369 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~~~~L~~L~Ls 446 (1114)
+.|++++|.+.+..+. .+..|+.+.+.+|.+... .....+++|++|++++|.+.. ..+..+..+.+|++|+++
T Consensus 331 ~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~ 405 (635)
T 4g8a_A 331 QHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLS 405 (635)
T ss_dssp SEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECC
T ss_pred hhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcc
Confidence 7888888877654433 345666777777766532 234467888888888888753 345666777888889988
Q ss_pred cCCccCCcCcccccCCcceEEeeccceeeccCC-chhhccccccEeecccccCCCCccccccccccCcEEEecCceec-c
Q 001253 447 TNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFP-SDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFT-G 524 (1114)
Q Consensus 447 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~ 524 (1114)
.|.+.. .+..+..+++|+.+++++|++....+ ..+..+.+++.++++.|++++..+..+..++.|+.|+|++|++. +
T Consensus 406 ~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~ 484 (635)
T 4g8a_A 406 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 484 (635)
T ss_dssp SCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGG
T ss_pred cccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccc
Confidence 888874 56667888899999998888775544 45778888999999999998888888888999999999988754 4
Q ss_pred CCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccc
Q 001253 525 ELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGN 604 (1114)
Q Consensus 525 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 604 (1114)
..|..|..+++|++|+|++|+|++..|..+.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..+..
T Consensus 485 ~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 564 (635)
T 4g8a_A 485 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 564 (635)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTC
T ss_pred cCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHh
Confidence 57788888999999999999998777888888999999999999998888888888999999999999999888888888
Q ss_pred c-ccccccccCCCcCCC
Q 001253 605 L-SRLTELQMGGNSFSG 620 (1114)
Q Consensus 605 l-~~L~~L~ls~N~l~~ 620 (1114)
+ ++|+.|+|++|++..
T Consensus 565 l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 565 FPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp CCTTCCEEECTTCCBCC
T ss_pred hhCcCCEEEeeCCCCcc
Confidence 7 679999999998874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=410.72 Aligned_cols=249 Identities=23% Similarity=0.383 Sum_probs=190.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC------
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG------ 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 881 (1114)
++|++.+.||+|+||+||+|+++ +|+.||||++.... .+...+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 46899999999999999999976 79999999997543 2344567889999999999999999999987654
Q ss_pred ------ceEEEEecCCCCCHHHHhccCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEE
Q 001253 882 ------SNLLMYEYMARGSLGELLHGASS--TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 953 (1114)
Q Consensus 882 ------~~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 953 (1114)
..|+||||+++|+|.++++.... ..++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence 36899999999999999985432 456777889999999999999999 9999999999999999999999
Q ss_pred eeccCceecCCCCC-----------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCH
Q 001253 954 GDFGLAKVIDMPQS-----------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDL 1022 (1114)
Q Consensus 954 ~DfG~a~~~~~~~~-----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~ 1022 (1114)
+|||+|+....... ....+.+||+.|||||++.+..|+.++||||+||++|||++ ||.... +.
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---~~ 233 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---ER 233 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---HH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---HH
Confidence 99999987643221 12345689999999999999999999999999999999996 664211 11
Q ss_pred HHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1023 VTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+.. +....+ ++..........+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~-~~~~~~------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTD-VRNLKF------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHH-HHTTCC------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHH-HhcCCC------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 111110 1122233345678999999999999999999875
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=449.82 Aligned_cols=459 Identities=19% Similarity=0.191 Sum_probs=290.8
Q ss_pred ceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhhcccccccCCchhhhcCCCccceeeeccc
Q 001253 225 QYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRN 304 (1114)
Q Consensus 225 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n 304 (1114)
+++++++|+++ .+|..+. ++|++|++++|.+++..|..|.++++|++|+|++|.+.+..|+.|+.+++|++|+|++|
T Consensus 34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 44444444444 2343332 44444444444444444444444444555555444444444444555555555555555
Q ss_pred ccccccCccccccccccccccccccCCC-CCchhhhcccccceeecccccccCcccccccccccC--CEEEcccccc--c
Q 001253 305 ELNGTIPREIGKLSSALEIDFSENSLIG-EIPVELSKILGLELLYLFENKLTGVIPVELTTLKNL--TKLDLSINSL--T 379 (1114)
Q Consensus 305 ~l~~~~p~~l~~l~~L~~L~ls~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~Ls~N~l--~ 379 (1114)
+++ .+|.. .+++|++|++++|++.+ .+|..+.++++|+.|++++|++++. .+..+++| ++|++++|.+ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 554 33433 45555555555555544 2344555555555555555555532 23333333 6666666666 5
Q ss_pred ccccCcccccc-ceeeeeccCCcccCCCCC-CCCcCccceEEEeeccc-----ccCCCCccccccCccceeeeccCCccC
Q 001253 380 GTIPLGFQYLT-NLIMLQLFDNSLVGGIPQ-RLGAYSQLWVVDLSDNH-----LTGKIPRHICRNTSLIFLNLETNKLTG 452 (1114)
Q Consensus 380 ~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~-----l~~~~~~~~~~~~~L~~L~Ls~N~l~~ 452 (1114)
+..|..|..+. ....+++++|.+.+.++. .+..+++|+.|++++|+ +.+ ....+..+++|+.|+++++.+.+
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECH
T ss_pred ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcH
Confidence 55555555443 122445566665554432 34456666667776664 221 12334555666666666665553
Q ss_pred Cc----CcccccCCcceEEeeccceeeccCCchh-----hccccccEeecccccCCCCcc-cccccc---ccCcEEEecC
Q 001253 453 SI----PTGVTRCKSLVQLRLGGNSFTGSFPSDL-----CKLANLSTVELDQNQFSGPIP-TEIGNC---NALQRLHLSD 519 (1114)
Q Consensus 453 ~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~Ls~ 519 (1114)
.. +..+ ..++|++|++++|.++|.+|..+ ..++.|+.++++.|.+ .+| ..+..+ .+|++|++++
T Consensus 264 ~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~ 340 (562)
T 3a79_B 264 KCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISD 340 (562)
T ss_dssp HHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEES
T ss_pred HHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccC
Confidence 21 1111 23477788888888777777766 6666777777777776 333 333322 5688888888
Q ss_pred ceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCC--CchhhhhcccCCeeeccCccCCCc
Q 001253 520 NYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGA--LPREIGSLFQLELLKLSENELSGS 597 (1114)
Q Consensus 520 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~ 597 (1114)
|.+.... ....+++|++|++++|++++.+|..+..+++|+.|+|++|++++. +|..++.+++|++|++++|++++.
T Consensus 341 n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~ 418 (562)
T 3a79_B 341 TPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSH 418 (562)
T ss_dssp SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSC
T ss_pred CCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCc
Confidence 8775321 125778888888888888877888888888888888888888863 356688888899999999988875
Q ss_pred ccc-cccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccc
Q 001253 598 IPV-QIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFV 676 (1114)
Q Consensus 598 ~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 676 (1114)
+|. .+..+++|++|++++|++++.+|..+. ++|+ .|+|++|+++ .+|..+..+++|+.|||++|+|++..+..|.
T Consensus 419 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~-~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~ 494 (562)
T 3a79_B 419 AYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVK-VLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFD 494 (562)
T ss_dssp CSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCS-EEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTT
T ss_pred cChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCC-EEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHh
Confidence 554 477888999999999999887777664 5676 6899999998 5677777999999999999999954444499
Q ss_pred cccccceEEeccCcccCCCCCccccc
Q 001253 677 NLSSLLGCNFSYNNLTGPIPSSQTFQ 702 (1114)
Q Consensus 677 ~l~~l~~l~ls~N~l~g~ip~~~~~~ 702 (1114)
.+++|+.|++++|+|.|.+|..+.++
T Consensus 495 ~l~~L~~L~l~~N~~~c~c~~~~~~~ 520 (562)
T 3a79_B 495 RLTSLQYIWLHDNPWDCTCPGIRYLS 520 (562)
T ss_dssp TCTTCCCEECCSCCBCCCHHHHHHHH
T ss_pred cCCCCCEEEecCCCcCCCcchHHHHH
Confidence 99999999999999999998765544
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=441.80 Aligned_cols=455 Identities=18% Similarity=0.154 Sum_probs=313.7
Q ss_pred EEEeecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccc
Q 001253 81 FSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNN 160 (1114)
Q Consensus 81 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N 160 (1114)
..++++++++++ +|..+. ++|++|+|++|.|++..|.+|+.+++|++|+|++|.+++..|+.|+++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 467889999986 776665 79999999999999888889999999999999999999988999999999999999999
Q ss_pred cccCCCCcccccCcccchhhhcccccCC-CCCCCccccccccceeccccccccccCCCCCCCCcc--ceeecccccc--C
Q 001253 161 RISGPFPKEIGKLSALSQLVAYSNNISG-SLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESL--QYLGLAQNQL--S 235 (1114)
Q Consensus 161 ~l~~~~p~~~~~l~~L~~L~l~~n~i~~-~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L--~~L~Ls~N~l--~ 235 (1114)
+++ .+|.. .+++|++|++++|++++ .+|..|+++++|++|++++|.+.+. .+..+++| ++|+|++|++ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 998 67766 89999999999999987 4568999999999999999998853 45555555 9999999999 8
Q ss_pred CCCcccccccc-cccEEEecCCcccCcccc-ccccccccchhhcccccc----cCCchhhhcCCCccceeeecccccccc
Q 001253 236 GEIPKEIGMLK-YLTDVILWGNQLSGVIPK-ELGNCTSLETLALYDNKQ----VGQLPKELGSIGSLKYLYIYRNELNGT 309 (1114)
Q Consensus 236 ~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~~----~~~~p~~~~~l~~L~~L~L~~n~l~~~ 309 (1114)
+..|..+..++ ..-.+++++|.+.+.++. .+.++++|+.|++++|.. .......+..+++|+.|++.++.+.+.
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~ 264 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHH
T ss_pred ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHH
Confidence 88888888765 222668888988876654 567888999999988842 112334577788888888888776532
Q ss_pred cCccc---cccccccccccccccCCCCCchhh-----hcccccceeecccccccCccccccccc---ccCCEEEcccccc
Q 001253 310 IPREI---GKLSSALEIDFSENSLIGEIPVEL-----SKILGLELLYLFENKLTGVIPVELTTL---KNLTKLDLSINSL 378 (1114)
Q Consensus 310 ~p~~l---~~l~~L~~L~ls~N~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l 378 (1114)
....+ ...++|++|++++|.+.+.+|..+ .+++.|+.+++..|.+ ......+..+ .+|++|++++|.+
T Consensus 265 ~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p~~~~~~~~~~~~L~~L~l~~n~~ 343 (562)
T 3a79_B 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFSKEALYSVFAEMNIKMLSISDTPF 343 (562)
T ss_dssp HHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSCHHHHHHHHHTCCCSEEEEESSCC
T ss_pred HHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-ecChhhhhhhhccCcceEEEccCCCc
Confidence 11110 112355566666666555555544 4444444444444443 1111111111 3344555555444
Q ss_pred cccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccC--CcCc
Q 001253 379 TGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTG--SIPT 456 (1114)
Q Consensus 379 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~--~~p~ 456 (1114)
. ... ....+++|++|++++|++++.+|..+..+++|++|++++|++++ .+|.
T Consensus 344 ~------------------------~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 397 (562)
T 3a79_B 344 I------------------------HMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL 397 (562)
T ss_dssp C------------------------CCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHH
T ss_pred c------------------------ccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchh
Confidence 3 211 11345556666666666665556666666666666666666664 2234
Q ss_pred ccccCCcceEEeeccceeeccCCc-hhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCC
Q 001253 457 GVTRCKSLVQLRLGGNSFTGSFPS-DLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSN 535 (1114)
Q Consensus 457 ~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 535 (1114)
.+..+++|++|++++|++++.+|. .+..+++|++|++++|++++.+|..+. ++|++|+|++|+|+ .+|..+..+++
T Consensus 398 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~ 474 (562)
T 3a79_B 398 MTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQA 474 (562)
T ss_dssp TTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCC
T ss_pred hhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCC
Confidence 566666666666666666653443 356667777777777777666555543 57777777777777 55665557777
Q ss_pred cceeeccccccccccccc-ccccccceEEECccccccCCCc
Q 001253 536 LVTFNVSSNFLTGRIPLE-IFSCKMLQRLDLSWNKFVGALP 575 (1114)
Q Consensus 536 L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p 575 (1114)
|++|+|++|+++ .+|.. +..+++|+.|+|++|.+.+..+
T Consensus 475 L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 475 LQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 777777777777 55555 6677777778888887776543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=403.88 Aligned_cols=266 Identities=23% Similarity=0.319 Sum_probs=203.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe------cC
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH------QG 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 881 (1114)
++|++.++||+|+||+||+|+++ +|+.||||+++..... ....+.+.+|+.+++.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 67999999999999999999986 7999999999765443 3335667889999999999999999999764 35
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..|+|||||+ |+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 7899999996 589999974 45799999999999999999999999 999999999999999999999999999986
Q ss_pred cCCC---CCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcc-
Q 001253 962 IDMP---QSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLV- 1036 (1114)
Q Consensus 962 ~~~~---~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 1036 (1114)
+... ......+.+||+.|||||++.+. .++.++||||+||++|||++|+.||.+....+.+. .+..........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~-~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ-LIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH-HHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHH-HHHHhcCCCChHH
Confidence 5422 12334567899999999998875 46899999999999999999999997543222111 111111111000
Q ss_pred -ccccc-------ccccCCCccc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1037 -SGMLD-------ARLNLQDEKT-----VSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1037 -~~~~~-------~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..... ..+......+ ......+.+++.+||..||++|||++|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 0000000001 112346789999999999999999999876
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=420.12 Aligned_cols=251 Identities=24% Similarity=0.240 Sum_probs=203.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCC---CChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNRE---GNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
++|++.++||+|+||+||+|+.+ +|+.||||++.+... .........+.++.+++.++|||||+++++|.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999986 799999999975432 12222223344567788889999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||++||+|.+++.. ...+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 269 lVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999974 35799999999999999999999999 999999999999999999999999999997643
Q ss_pred CCCCccccccccccccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
. ...+.+||+.|||||++. +..|+.++||||+||++|||++|+.||...... +.....+......
T Consensus 345 ~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-~~~~i~~~i~~~~---------- 410 (689)
T 3v5w_A 345 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEIDRMTLTMA---------- 410 (689)
T ss_dssp C---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-CHHHHHHHHHHCC----------
T ss_pred C---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhhcCCC----------
Confidence 2 335678999999999996 457999999999999999999999999754332 2223222222211
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPT-----MREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1081 (1114)
...+.....++.+++.+||+.||.+|++ ++||++
T Consensus 411 ----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1111223346889999999999999998 677653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=397.21 Aligned_cols=198 Identities=26% Similarity=0.374 Sum_probs=171.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCc
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 882 (1114)
.++|++.++||+|+||+||+|+.+ +++.||||++..... ...+.+|+++++.+ +|||||++++++.+.+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 478999999999999999999864 468899999865432 45678899999988 69999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-CCeEEeeccCcee
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK-FEAHVGDFGLAKV 961 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG~a~~ 961 (1114)
.|+||||+++|+|.++++ .+++.++..++.|++.||+|||++ ||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999999995 489999999999999999999999 99999999999999876 7999999999986
Q ss_pred cCCCCC---------------------------CccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCC
Q 001253 962 IDMPQS---------------------------KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPV 1013 (1114)
Q Consensus 962 ~~~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~ 1013 (1114)
...... ....+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 543211 122345799999999999875 4899999999999999999999999
Q ss_pred CCCC
Q 001253 1014 QPLD 1017 (1114)
Q Consensus 1014 ~~~~ 1017 (1114)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=413.28 Aligned_cols=421 Identities=23% Similarity=0.215 Sum_probs=216.5
Q ss_pred cccccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhh
Q 001253 197 LKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLA 276 (1114)
Q Consensus 197 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 276 (1114)
.+.|++|++++|.+ +.+|.+++++++|++|++++|+++|.+|.+++.+++|+.+++.+|.. .++++|+
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~ 77 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELE 77 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEE
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEE
Confidence 46777777777777 57777777777777777777777777777777776665544444321 3455566
Q ss_pred cccccccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccC
Q 001253 277 LYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTG 356 (1114)
Q Consensus 277 Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 356 (1114)
+++|.+.+ +|.. .++|++|++++|.+++ +|.. .++|++|++++|++.+. +.. .++|++|++++|++++
T Consensus 78 l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~ 145 (454)
T 1jl5_A 78 LNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK 145 (454)
T ss_dssp CTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS
T ss_pred ecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC
Confidence 66665444 2221 2566677777776664 5543 25666777777766642 211 1467777777777775
Q ss_pred cccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccc
Q 001253 357 VIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICR 436 (1114)
Q Consensus 357 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 436 (1114)
+| .|..+++|++|++++|++++ +|..+ .+|++|++++|++.+ +| .++.+++|++|++++|++++ +|...
T Consensus 146 -lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~-- 214 (454)
T 1jl5_A 146 -LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP-- 214 (454)
T ss_dssp -CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC--
T ss_pred -Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc--
Confidence 44 47777777777777777774 44332 467777777777765 34 46777777777777777764 33322
Q ss_pred cCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEE
Q 001253 437 NTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLH 516 (1114)
Q Consensus 437 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 516 (1114)
++|++|++++|+++ .+|. +..+++|++|++++|++++ +|.. +++|++|++++|++++ +|.. +++|++|+
T Consensus 215 -~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ 283 (454)
T 1jl5_A 215 -LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLD 283 (454)
T ss_dssp -TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred -CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEE
Confidence 46777777777776 4553 6677777777777777763 4432 3567777777777764 4433 36677777
Q ss_pred ecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCC
Q 001253 517 LSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSG 596 (1114)
Q Consensus 517 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 596 (1114)
+++|++++. |.. .++|++|++++|++++ ++.. .++|+.|++++|++++ +|.. +++|++|++++|+++
T Consensus 284 ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~- 350 (454)
T 1jl5_A 284 VSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA- 350 (454)
T ss_dssp CCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-
T ss_pred CcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-
Confidence 777777652 211 1467777777777763 2211 1467777777777764 4443 466777777777777
Q ss_pred cccccccccccccccccCCCcCCC--CCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCccccc--CCC
Q 001253 597 SIPVQIGNLSRLTELQMGGNSFSG--GIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSG--EIP 672 (1114)
Q Consensus 597 ~~p~~~~~l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g--~ip 672 (1114)
.+|. .+++|++|++++|++++ .+|.++.. |+.|++.|.+|.. +++|++||+++|+++| .+|
T Consensus 351 ~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~---------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP 415 (454)
T 1jl5_A 351 EVPE---LPQNLKQLHVEYNPLREFPDIPESVED---------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIP 415 (454)
T ss_dssp CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE---------EECCC--------------------------------
T ss_pred cccc---hhhhccEEECCCCCCCcCCCChHHHHh---------hhhcccccccccc---cCcCCEEECCCCcCCccccch
Confidence 3554 35667777777777776 56655433 3346666666653 3667788888888877 666
Q ss_pred CccccccccceEEeccCcccCCCCC
Q 001253 673 GSFVNLSSLLGCNFSYNNLTGPIPS 697 (1114)
Q Consensus 673 ~~~~~l~~l~~l~ls~N~l~g~ip~ 697 (1114)
.+ ++.|.+++|.+.+.+|.
T Consensus 416 ~s------l~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 416 ES------VEDLRMNSERVVDPYEF 434 (454)
T ss_dssp -------------------------
T ss_pred hh------HhheeCcCcccCCcccc
Confidence 54 34456677777776553
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=392.92 Aligned_cols=295 Identities=28% Similarity=0.437 Sum_probs=262.9
Q ss_pred CCCcchHHHHHHhHhhccCCCCCCCCCCCCCCCCCc--cceEEEecCCCccEEEEEeecCCCcCc--ccCCCCCCCCccC
Q 001253 30 GLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPCG--WIGVNCTTNDFGAVVFSLNLTKMNLSG--YLSPNIGGLVHLT 105 (1114)
Q Consensus 30 ~~~~~~~~~ll~~k~~~~~~~~~~~~W~~~~~~~C~--w~gv~C~~~~~~~~v~~l~l~~~~l~g--~~~~~l~~l~~L~ 105 (1114)
.|.++|++||++||+++.||. .+++|+.. .+||. |.||+|+.....++|+.|+|+++++.| .+|+.++++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 588999999999999998776 78999864 56898 999999764333679999999999999 8999999999999
Q ss_pred EEEecC-CcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhccc
Q 001253 106 ALDLSF-NQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSN 184 (1114)
Q Consensus 106 ~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n 184 (1114)
+|+|++ |++.+.+|..|+++++|++|+|++|.+++.+|..|.++++|++|+|++|++++.+|..+.++++|++|++++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 9999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCccccc-cccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCccc
Q 001253 185 NISGSLPPTLGNLK-RLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIP 263 (1114)
Q Consensus 185 ~i~~~~p~~l~~l~-~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 263 (1114)
++++.+|..+++++ +|++|++++|.+++.+|..+..++ |++|+|++|++++.+|..++.+++|+.|+|++|++++.+|
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 238 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecC
Confidence 99989999999988 899999999999988998888887 9999999999988888889999999999999999987666
Q ss_pred cccccccccchhhcccccccCCchhhhcCCCccceeeecccccccccCcccccccccccccccccc
Q 001253 264 KELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENS 329 (1114)
Q Consensus 264 ~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~ 329 (1114)
. +..+++|++|++++|.+.+.+|..|..+++|++|+|++|++++.+|.. +.+++|+.+++++|.
T Consensus 239 ~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 239 K-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp G-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred c-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 5 778888888888888888888888888888888888888888877775 777778888887776
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=405.76 Aligned_cols=425 Identities=23% Similarity=0.249 Sum_probs=206.2
Q ss_pred CCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccce
Q 001253 124 NCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSF 203 (1114)
Q Consensus 124 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L 203 (1114)
..++|++|++++|.+ +.+|.+|+++++|++|++++|++.|.+|.+++++++|+.+++..|.. .++++|
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 357788888888888 57888888888888888888888888888888888887777776542 456777
Q ss_pred eccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhhccccccc
Q 001253 204 RAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQV 283 (1114)
Q Consensus 204 ~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~ 283 (1114)
++++|.+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|++++|.+.
T Consensus 77 ~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~ 144 (454)
T 1jl5_A 77 ELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLE 144 (454)
T ss_dssp ECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCS
T ss_pred EecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCC
Confidence 777777764 3332 2567777777777775 5543 3667777777777764 2221 145666666666555
Q ss_pred CCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccCccccccc
Q 001253 284 GQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELT 363 (1114)
Q Consensus 284 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 363 (1114)
+ +| .|+.+++|++|++++|++++ +|..+ . +|+.|++++|++++. | .+.
T Consensus 145 ~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~------------------------~L~~L~L~~n~l~~l-~-~~~ 192 (454)
T 1jl5_A 145 K-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---P------------------------SLEFIAAGNNQLEEL-P-ELQ 192 (454)
T ss_dssp S-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---T------------------------TCCEEECCSSCCSSC-C-CCT
T ss_pred C-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---c------------------------cccEEECcCCcCCcC-c-ccc
Confidence 4 44 35566666666666666553 34322 2 444555555555442 2 345
Q ss_pred ccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCcccee
Q 001253 364 TLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFL 443 (1114)
Q Consensus 364 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L 443 (1114)
.+++|++|++++|++++ +|... ++|++|++++|.+. .+|. ++.+++|++|++++|++++ +|.. .++|++|
T Consensus 193 ~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L 262 (454)
T 1jl5_A 193 NLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEAL 262 (454)
T ss_dssp TCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEE
T ss_pred CCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEE
Confidence 55555555555555553 22211 35555555555555 3332 5555566666666666553 2321 2456666
Q ss_pred eeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCcccccccc-ccCcEEEecCcee
Q 001253 444 NLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNC-NALQRLHLSDNYF 522 (1114)
Q Consensus 444 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l 522 (1114)
++++|++++ +|.. .++|++|++++|++++. |.. .++|+.|++++|++++ ++ .+ ++|++|++++|++
T Consensus 263 ~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l 329 (454)
T 1jl5_A 263 NVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKL 329 (454)
T ss_dssp ECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCC
T ss_pred ECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcc
Confidence 666666664 3332 25666666666666642 111 1466777777777763 22 22 4677777777777
Q ss_pred ccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccC--CCchhhhhcccCCeeeccCccCCCcccc
Q 001253 523 TGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVG--ALPREIGSLFQLELLKLSENELSGSIPV 600 (1114)
Q Consensus 523 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 600 (1114)
++ +|.. +++|++|++++|+++ .+|. .+++|+.|++++|++++ .+|.+++. |+.|.+.|.+|.
T Consensus 330 ~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~ 393 (454)
T 1jl5_A 330 IE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPE 393 (454)
T ss_dssp SC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC-------
T ss_pred cc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhccccccccc
Confidence 75 4443 467777777777777 4565 35777777777777776 56655543 234566666665
Q ss_pred cccccccccccccCCCcCCC--CCChhhcCcchhhHHhhcccccccccCCccccc
Q 001253 601 QIGNLSRLTELQMGGNSFSG--GIPAELGSLSSLQIALNLSYNNLSGLIPPELGN 653 (1114)
Q Consensus 601 ~~~~l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~ 653 (1114)
. +++|+.|++++|++++ .+|.++. .|.+++|.+.+.+|.+...
T Consensus 394 ~---~~~L~~L~ls~N~l~~~~~iP~sl~-------~L~~~~~~~~~~~~~~~~~ 438 (454)
T 1jl5_A 394 L---PQNLKQLHVETNPLREFPDIPESVE-------DLRMNSERVVDPYEFAHET 438 (454)
T ss_dssp -------------------------------------------------------
T ss_pred c---cCcCCEEECCCCcCCccccchhhHh-------heeCcCcccCCccccCHHH
Confidence 3 4678888888888876 6665432 3556777777776655544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=418.49 Aligned_cols=251 Identities=26% Similarity=0.340 Sum_probs=211.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+.+ +|+.||+|++..... ...+.+.+|+.+++.++|||||+++++|.+++..|+||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999986 799999999975432 33567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC--CCeEEeeccCceecCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK--FEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DfG~a~~~~~~ 965 (1114)
|||+||+|.+++......+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~-- 308 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-- 308 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC--
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc--
Confidence 99999999999986667899999999999999999999999 99999999999999854 899999999999865
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
........+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. ..+..+..... .+ .
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~----~~~~~~~i~~~-~~---------~ 374 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDETLRNVKSC-DW---------N 374 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHHTT-CC---------C
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHHhC-CC---------C
Confidence 3344456789999999999999999999999999999999999999997433 22223222221 11 1
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
............+.+||.+||+.||.+|||+.|+++
T Consensus 375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111223346789999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=385.97 Aligned_cols=290 Identities=41% Similarity=0.757 Sum_probs=238.7
Q ss_pred CCCCCCHHHHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEE
Q 001253 795 PKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874 (1114)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 874 (1114)
....+++.++....++|++.+.||+|+||+||+|+.++|+.||||++........ ...+.+|+.+++.++||||++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCC
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceE
Confidence 3456888999999999999999999999999999988899999999976543322 23588999999999999999999
Q ss_pred eEEEecCceEEEEecCCCCCHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCe
Q 001253 875 GFCYHQGSNLLMYEYMARGSLGELLHGAS---STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEA 951 (1114)
Q Consensus 875 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 951 (1114)
+++...+..++||||+++|+|.++++... ..+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999997543 359999999999999999999999877799999999999999999999
Q ss_pred EEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCC----CCCCCCHHHHHH
Q 001253 952 HVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQP----LDQGGDLVTWVR 1027 (1114)
Q Consensus 952 kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~----~~~~~~~~~~~~ 1027 (1114)
||+|||+++..............||+.|+|||++.+..++.++||||+||++|||++|+.||.. .........|+.
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 9999999997754444445556799999999999988999999999999999999999999962 223334445544
Q ss_pred HHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1028 NFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
........ ....+.... ..........+.+++.+||+.||.+|||++|+++.|++....
T Consensus 254 ~~~~~~~~-~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 254 GLLKEKKL-EALVDVDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp TTTSSCCS-TTSSCTTCT--TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HHhhchhh-hhhcChhhc--cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 43333222 222222222 344566778899999999999999999999999999985433
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=408.05 Aligned_cols=385 Identities=22% Similarity=0.232 Sum_probs=256.6
Q ss_pred eeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccCcc-cccccccccCCEEEcccc
Q 001253 298 YLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVI-PVELTTLKNLTKLDLSIN 376 (1114)
Q Consensus 298 ~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N 376 (1114)
.++.+++.++ .+|. +. +++++|++++|.+.+..|..+.++++|++|++++|.+.+.+ +..|..+++|++|+|++|
T Consensus 14 ~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n 89 (455)
T 3v47_A 14 NAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89 (455)
T ss_dssp EEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred ccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence 4555555554 4444 21 45666666666666555556666666666666666654332 345556666666666666
Q ss_pred cccccccCccccccceeeeeccCCcccCCCCC--CCCcCccceEEEeecccccCCCCcc-ccccCccceeeeccCCccCC
Q 001253 377 SLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQ--RLGAYSQLWVVDLSDNHLTGKIPRH-ICRNTSLIFLNLETNKLTGS 453 (1114)
Q Consensus 377 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~~L~~L~Ls~N~l~~~ 453 (1114)
++++..|..|..+++|++|++++|++.+..+. .+..+++|++|+|++|++++..|.. +..+++|++|++++|++++.
T Consensus 90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 169 (455)
T 3v47_A 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSI 169 (455)
T ss_dssp TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCC
T ss_pred ccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccccc
Confidence 66655555566666666666666665543322 2555555556666655555554443 45555555555555555555
Q ss_pred cCcccccC--CcceEEeeccceeeccCCchh--------hccccccEeecccccCCCCcccccccc---ccCcEEEecCc
Q 001253 454 IPTGVTRC--KSLVQLRLGGNSFTGSFPSDL--------CKLANLSTVELDQNQFSGPIPTEIGNC---NALQRLHLSDN 520 (1114)
Q Consensus 454 ~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~--------~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~N 520 (1114)
.+..+..+ .+|+.|++++|.+.+..+..+ ..+++|++|++++|++++..|..+..+ ++|+.|++++|
T Consensus 170 ~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~ 249 (455)
T 3v47_A 170 CEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249 (455)
T ss_dssp CTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTC
T ss_pred ChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccc
Confidence 55555444 455555555555553333221 133445555555555544444444332 44444554444
Q ss_pred eeccCCCccccCCCCcceeecccccccccccccccc--cccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcc
Q 001253 521 YFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFS--CKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSI 598 (1114)
Q Consensus 521 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 598 (1114)
.+.+... ..+.+.+..+..+.. .++|+.|++++|++++.+|..++.+++|++|+|++|++++..
T Consensus 250 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 315 (455)
T 3v47_A 250 YNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKID 315 (455)
T ss_dssp TTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEEC
T ss_pred ccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccC
Confidence 4332110 011122112222222 368999999999999999999999999999999999999888
Q ss_pred cccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccc
Q 001253 599 PVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNL 678 (1114)
Q Consensus 599 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l 678 (1114)
|..|.++++|++|+|++|++++..|..+..+++|+ .|+|++|++++..|..|+.+++|++|+|++|+|++.++..|..+
T Consensus 316 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 394 (455)
T 3v47_A 316 DNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLE-VLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL 394 (455)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCC-EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred hhHhcCcccCCEEECCCCccCCcChhHhcCcccCC-EEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccC
Confidence 99999999999999999999988899999999999 79999999999999999999999999999999999888889999
Q ss_pred cccceEEeccCcccCCCCCcccc
Q 001253 679 SSLLGCNFSYNNLTGPIPSSQTF 701 (1114)
Q Consensus 679 ~~l~~l~ls~N~l~g~ip~~~~~ 701 (1114)
++|+.|++++|+++|.+|.-..+
T Consensus 395 ~~L~~L~l~~N~l~~~~~~~~~l 417 (455)
T 3v47_A 395 TSLQKIWLHTNPWDCSCPRIDYL 417 (455)
T ss_dssp TTCCEEECCSSCBCCCTTTTHHH
T ss_pred CcccEEEccCCCcccCCCcchHH
Confidence 99999999999999999965444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=401.10 Aligned_cols=364 Identities=18% Similarity=0.211 Sum_probs=187.5
Q ss_pred ccccEEEecCCcccCccccccccccccchhhcccccccCCc-hhhhcCCCccceeeecccccccccCccccccccccccc
Q 001253 246 KYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQL-PKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEID 324 (1114)
Q Consensus 246 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 324 (1114)
++|++|+|++|.+++..|..|+++++|++|++++|.+.+.+ +..|..+++|++|+|++|++.+..|..++.+++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 34444444444444444444555555555555555444333 23345555555555555555544455555555555555
Q ss_pred cccccCCCCCchh--hhcccccceeecccccccCccccc-ccccccCCEEEcccccccccccCccccc--cceeeeeccC
Q 001253 325 FSENSLIGEIPVE--LSKILGLELLYLFENKLTGVIPVE-LTTLKNLTKLDLSINSLTGTIPLGFQYL--TNLIMLQLFD 399 (1114)
Q Consensus 325 ls~N~l~~~~~~~--l~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~ 399 (1114)
+++|.+.+.++.. +..+++|+.|+|++|++++..|.. +..+++|++|++++|.+++..+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 5555554433333 555556666666666666555544 5666666666666666666666655554 4566666666
Q ss_pred CcccCCCCCCC--------CcCccceEEEeecccccCCCCcccccc---CccceeeeccCCccCCcCcccccCCcceEEe
Q 001253 400 NSLVGGIPQRL--------GAYSQLWVVDLSDNHLTGKIPRHICRN---TSLIFLNLETNKLTGSIPTGVTRCKSLVQLR 468 (1114)
Q Consensus 400 N~l~~~~~~~~--------~~l~~L~~L~Ls~N~l~~~~~~~~~~~---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 468 (1114)
|.+.+..+..+ ..+++|++|++++|++++..|..+... ++|+.|++++|.+.+..
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~-------------- 255 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS-------------- 255 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------
Confidence 66655444332 234566666666666665555554443 55566666655544321
Q ss_pred eccceeeccCCchhhcc--ccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccc
Q 001253 469 LGGNSFTGSFPSDLCKL--ANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFL 546 (1114)
Q Consensus 469 L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 546 (1114)
+..+.+.+..+..+..+ ++|++|++++|++++.+|..+..+++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 335 (455)
T 3v47_A 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335 (455)
T ss_dssp TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCcc
Confidence 11112222222222222 3455555555555555555555555555555555555555555555555555555555555
Q ss_pred cccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCC
Q 001253 547 TGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIP 623 (1114)
Q Consensus 547 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 623 (1114)
++..|..+..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|++++|++++..|
T Consensus 336 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 336 GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 54444444555555555555555554445555555555555555555554333344455555555555555544433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=375.62 Aligned_cols=282 Identities=38% Similarity=0.635 Sum_probs=231.4
Q ss_pred CHHHHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 001253 800 TFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH 879 (1114)
Q Consensus 800 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 879 (1114)
.+.++....++|+..+.||+|+||+||+|++++|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 33444456789999999999999999999988899999999875533 235678999999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeec
Q 001253 880 QGSNLLMYEYMARGSLGELLHGAS---STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 956 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 956 (1114)
++..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999997543 3589999999999999999999998 9999999999999999999999999
Q ss_pred cCceecCCCC-CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC--CCHHHHHHHHHhcC
Q 001253 957 GLAKVIDMPQ-SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG--GDLVTWVRNFIRNN 1033 (1114)
Q Consensus 957 G~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~ 1033 (1114)
|+++...... ........||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....|........
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 9998654222 22234456999999999999999999999999999999999999999754432 23444544433333
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
... ...++... ..........+.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus 264 ~~~-~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 264 QLE-QIVDPNLA--DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CCC-SSSSSSCT--TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cHH-HhcChhhc--cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 222 22233222 3345667788999999999999999999999999999986543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=371.96 Aligned_cols=260 Identities=24% Similarity=0.423 Sum_probs=214.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|+++ +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 367999999999999999999986 6899999998543 334567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++|+|.++++.....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999987777899999999999999999999999 99999999999999999999999999998764322
Q ss_pred CC-------------ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCC-HHHHHHHHHhc
Q 001253 967 SK-------------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD-LVTWVRNFIRN 1032 (1114)
Q Consensus 967 ~~-------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~-~~~~~~~~~~~ 1032 (1114)
.. ......||+.|+|||++.+..++.++||||+|+++|||++|..|+........ ...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 21 11256799999999999999999999999999999999999999875432211 00001111110
Q ss_pred CCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1033 NSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
. .+......+.+++.+||+.||++|||++|+++.|++++..
T Consensus 243 ----------~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 243 ----------Y------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ----------T------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------c------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 0011123578899999999999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=368.16 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=208.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|++. +|+.||||++....... .+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 368999999999999999999964 78999999997654433 56688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 169 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 169 (297)
T ss_dssp EECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred EECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc-
Confidence 9999999999999743 689999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............. .
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~-------~--- 235 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIATNGTP-------E--- 235 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHHCSC-------C---
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCC-------C---
Confidence 2334456899999999999999999999999999999999999999964332 2222221111110 0
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.+++.+||+.||++|||++|+++
T Consensus 236 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 -LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1112223346889999999999999999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=365.51 Aligned_cols=261 Identities=22% Similarity=0.370 Sum_probs=216.5
Q ss_pred HhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
..++|++.+.||+|+||+||+|+++++..||+|++...... .+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 35789999999999999999999998889999999765432 45688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999999986666799999999999999999999999 99999999999999999999999999998765443
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..... .............
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~~~~~---------- 224 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN----SEVVLKVSQGHRL---------- 224 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHHHTTCCC----------
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh----HHHHHHHHcCCCC----------
Confidence 333344567788999999999899999999999999999999 9999964332 2222221111100
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1091 (1114)
..+......+.+++.+||+.||++|||++|+++.|+++..+..
T Consensus 225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 225 ---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp ---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred ---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 0011122468899999999999999999999999999977643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=366.17 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=216.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.++|++.+.||+|+||+||+|++.+++.||+|++...... .+++.+|+.++++++||||+++++++.+++..++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 4689999999999999999999988999999999765432 456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.++++.....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 99999999999987777899999999999999999999999 999999999999999999999999999986543322
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.......+++.|+|||++.+..++.++||||+|+++|||++ |+.||.... .............
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~----~~~~~~~~~~~~~------------ 225 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTGFR------------ 225 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTTCC------------
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC----HHHHHHHHhcCcc------------
Confidence 23344567889999999999999999999999999999999 999996433 2222222221100
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
...+......+.+++.+||+.||++|||++|+++.|+++...
T Consensus 226 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 -LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 011111234688999999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=373.26 Aligned_cols=276 Identities=20% Similarity=0.244 Sum_probs=226.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... .+.+.+|+.+++++ +||||+++++++..++..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 467999999999999999999974 789999999875543 23477899999999 99999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC-----eEEeeccCce
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE-----AHVGDFGLAK 960 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~DfG~a~ 960 (1114)
||||+ +++|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999 8899999987667899999999999999999999999 9999999999999998887 9999999998
Q ss_pred ecCCCCCC------ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 001253 961 VIDMPQSK------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS 1034 (1114)
Q Consensus 961 ~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1034 (1114)
.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~- 236 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-DTLKERYQKIGDTK- 236 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-SSHHHHHHHHHHHH-
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-ccHHHHHHHHHhhh-
Confidence 76433321 12456899999999999999999999999999999999999999986543 33333322211110
Q ss_pred cccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCCc
Q 001253 1035 LVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDSD 1103 (1114)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~ 1103 (1114)
..............+.+++.+||+.||.+||+++++++.|+++..+.+......+||+..
T Consensus 237 ---------~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 296 (330)
T 2izr_A 237 ---------RATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGK 296 (330)
T ss_dssp ---------HHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTTS
T ss_pred ---------ccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCCC
Confidence 000000000001278899999999999999999999999999999998888889999843
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=361.95 Aligned_cols=284 Identities=35% Similarity=0.585 Sum_probs=232.7
Q ss_pred CCCCHHHHHHHhcCCcCC------ceecccCCeEEEEEEeCCCcEEEEEEecccCC-CChhhHHHHHHHHHHHhcCCCCc
Q 001253 797 EGFTFKDLVVATDNFDER------FVIGRGACGTVYRAVLRTGHTVAVKKLASNRE-GNNNVDNSFRAEILTLGKIRHRN 869 (1114)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~n 869 (1114)
..++++++..++++|... ++||+|+||+||+|+. +++.||||++..... ......+.+.+|+.+++.++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 457888999999888877 8999999999999997 488999999976543 23344677899999999999999
Q ss_pred eeeEEeEEEecCceEEEEecCCCCCHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 001253 870 IVKLYGFCYHQGSNLLMYEYMARGSLGELLHGA--SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947 (1114)
Q Consensus 870 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 947 (1114)
|+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 999999999999999999999999999998632 34689999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 001253 948 KFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWV 1026 (1114)
Q Consensus 948 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~ 1026 (1114)
++.+||+|||+++........ ......|++.|+|||++.+ .++.++||||+|+++|+|++|+.||...........+.
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999876432222 2334579999999998765 48899999999999999999999998766555444444
Q ss_pred HHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1027 RNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
+.............+..+ ...+......+.+++.+||+.||.+|||++|+++.|+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHTTSCCHHHHSCSSC---SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHhhhhhhhhhhhccccc---cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 443333332233323322 23345566789999999999999999999999999999854
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=365.34 Aligned_cols=276 Identities=20% Similarity=0.232 Sum_probs=226.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... .+.+.+|+..++.+ +|++++++++++.+....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 467999999999999999999974 789999999865443 23477899999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC-----eEEeeccCce
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE-----AHVGDFGLAK 960 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~DfG~a~ 960 (1114)
||||+ +++|.++++.....+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999 8899999987777899999999999999999999998 9999999999999987776 9999999998
Q ss_pred ecCCCCC------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 001253 961 VIDMPQS------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS 1034 (1114)
Q Consensus 961 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1034 (1114)
....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||........ ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~- 237 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKYERIGEKK- 237 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHHHHHHHHHH-
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-HHHHHHHHhhc-
Confidence 7654332 123456799999999999999999999999999999999999999986543322 22221111100
Q ss_pred cccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCC
Q 001253 1035 LVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDS 1102 (1114)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~ 1102 (1114)
. .... ..........+.+++.+||+.||++||++++|++.|+++..+.+.....++||+.
T Consensus 238 ~-----~~~~---~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 238 Q-----STPL---RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp H-----HSCH---HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred c-----CccH---HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 0 0000 0000112346889999999999999999999999999999999999999999964
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=368.49 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=213.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|++. +++.||+|++...........+.+.+|+..+++++||||+++++++.+++..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 368999999999999999999976 7899999999877666666677899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999999743 4689999999999999999999999 99999999999999999999999999998765433
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
........||+.|+|||.+.+..++.++||||+|+++|||++|+.||.... .............. ...
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~----~~~~~~~~~~~~~~-----~~~--- 233 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET----AVSIAIKHIQDSVP-----NVT--- 233 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC----HHHHHHHHHSSCCC-----CHH---
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhhccCC-----Ccc---
Confidence 334445679999999999999999999999999999999999999996433 22222222221100 000
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhhccC
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRP-TMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~ 1090 (1114)
..........+.+++.+|++.||.+|| +++++.+.|+++....
T Consensus 234 -~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 234 -TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 001111234688999999999999998 9999999999985543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=371.31 Aligned_cols=266 Identities=32% Similarity=0.449 Sum_probs=207.8
Q ss_pred HHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 803 DLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 803 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
++.+..++|++.++||+|+||+||+|+++ |+.||||++..... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 33455688999999999999999999885 88999999976543 33445678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEECCCCCeEEeeccC
Q 001253 883 NLLMYEYMARGSLGELLHGASS--TLDWQTRFMIALGAAEGLSYLHHDCKPR--IFHRDIKSNNILLDDKFEAHVGDFGL 958 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~DfG~ 958 (1114)
.++||||+++|+|.++++.... .+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999985432 489999999999999999999998 8 99999999999999999999999999
Q ss_pred ceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 001253 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038 (1114)
Q Consensus 959 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1114)
++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+..........
T Consensus 186 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~~~~~~~~---- 256 (309)
T 3p86_A 186 SRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP----AQVVAAVGFKCK---- 256 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH----HHHHHHHHHSCC----
T ss_pred Ccccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcCC----
Confidence 9864322 2223456799999999999999999999999999999999999999975432 222222111110
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
. ...+......+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 257 ----~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 ----R----LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ----C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ----C----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 0 1111222346889999999999999999999999999987653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=376.23 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=213.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC--------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR--------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCY 878 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 878 (1114)
.++|++.+.||+|+||+||+|++. ++..||||+++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 478999999999999999999862 35679999997543 233456789999999999 8999999999999
Q ss_pred ecCceEEEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 001253 879 HQGSNLLMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNI 943 (1114)
Q Consensus 879 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni 943 (1114)
+.+..|+||||+++|+|.++++... ..+++.++..++.|+++||+|||+. +|+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence 9999999999999999999997543 3589999999999999999999999 999999999999
Q ss_pred EECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 001253 944 LLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGD 1021 (1114)
Q Consensus 944 ll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~ 1021 (1114)
+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-~~ 313 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EE 313 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GG
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-HH
Confidence 999999999999999987653322 22334567889999999999999999999999999999999 9999975432 12
Q ss_pred HHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1022 LVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
.... +..+.. ...+......+.+++.+||+.||++||++.|+++.|+++...
T Consensus 314 ~~~~----~~~~~~------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 314 LFKL----LKEGHR------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp HHHH----HHTTCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----HhcCCC------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 2211 111110 111122334688999999999999999999999999998653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=369.27 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=214.5
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
.+..++|++.+.||+|+||+||+|+++++..||+|++...... .+++.+|+.++++++||||+++++++.+.+..+
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 3456789999999999999999999998889999999765432 456889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||+++++|.+++......+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999986566899999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
..........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..... ............
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~~~~~--------- 239 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAEHIAQGLR--------- 239 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHHHTTCC---------
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----hHHHHHHhcccC---------
Confidence 32222334457889999999999999999999999999999998 9999975432 222222111100
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
...+......+.+++.+||+.||++|||++|+++.|+++...
T Consensus 240 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 ----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 001111124688999999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=386.08 Aligned_cols=265 Identities=22% Similarity=0.252 Sum_probs=211.9
Q ss_pred HHHHHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 001253 801 FKDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH 879 (1114)
Q Consensus 801 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 879 (1114)
++++....++|++.++||+|+||+||+|+++ +++.||+|++.+.........+.+.+|..++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3444556789999999999999999999987 578999999975322111223347889999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 880 QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
++..|+||||+++|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 9999999999999999999987667899999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS 1034 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1034 (1114)
+.............+||+.|+|||++. ...++.++||||+||++|||++|+.||..... .+.........
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~- 297 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHK- 297 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTHH-
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh----hHHHHhhhhcc-
Confidence 876544444445568999999999987 56689999999999999999999999975332 22222221110
Q ss_pred cccccccccccCCCcccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 001253 1035 LVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFD--RPTMREVVL 1081 (1114)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1081 (1114)
..... +.........+.+++.+|+..+|++ ||+++|+++
T Consensus 298 -------~~~~~-p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 298 -------ERFQF-PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp -------HHCCC-CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred -------ccccC-CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 00000 0000112346788999999988888 999998875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=370.49 Aligned_cols=261 Identities=23% Similarity=0.376 Sum_probs=213.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.++|++.+.||+|+||+||+|+++ .+..||||+++... .....+.+.+|+.++++++||||+++++++.+++..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 467999999999999999999985 34569999997543 234456789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++|+|.++++.....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999999987777899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC--ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 964 MPQSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 964 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..... ......+|+.|+|||++.+..++.++||||+||++|||++ |+.||..... ............
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~~~~~~~~~~~------ 272 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----RDVISSVEEGYR------ 272 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHHHHHHHTTCC------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHcCCC------
Confidence 33222 2223456788999999998999999999999999999999 9999964332 222222111100
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
...+......+.+++.+||+.||++|||++|+++.|+++....
T Consensus 273 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 273 -------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 1111223346889999999999999999999999999986643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=368.65 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=208.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|++. +|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 367999999999999999999984 8999999999765443 33456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-- 166 (328)
T ss_dssp ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence 9999999999999743 4689999999999999999999999 999999999999999999999999999986542
Q ss_pred CCccccccccccccCccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVT-EKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.......+||+.|+|||++.+..++ .++||||+||++|||++|+.||.... ........... .+ .
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~-~~---------~ 232 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN----LKELRERVLRG-KY---------R 232 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-CC---------C
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhC-CC---------C
Confidence 2344567899999999999888775 79999999999999999999997432 22222222221 11 1
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+......+.+++.+||+.||.+|||++|+++
T Consensus 233 ----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 ----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11112346789999999999999999999876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=381.98 Aligned_cols=263 Identities=24% Similarity=0.366 Sum_probs=215.8
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
+..++|++.+.||+|+||+||+|+++ +++.||||+++... .....+.+.+|+.++++++||||+++++++..++..+
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 44578999999999999999999987 78999999987543 2233456889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||+++|+|.++++.....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999999986666799999999999999999999999 999999999999999999999999999986432
Q ss_pred CCCCc-cccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 965 PQSKS-MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 965 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
..... .....+++.|+|||++.+..++.++|||||||++|||++ |..||..... ..+...+..+..
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~~~------- 333 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----QQTREFVEKGGR------- 333 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----HHHHHHHHTTCC-------
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCCC-------
Confidence 21111 122346788999999998899999999999999999998 9999975432 222222322111
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
. ..+......+.+++.+||+.||++|||++++++.|+++.+++
T Consensus 334 -~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 334 -L----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp -C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 1 111122346889999999999999999999999999997654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=361.42 Aligned_cols=275 Identities=20% Similarity=0.257 Sum_probs=221.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC--ceE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG--SNL 884 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~ 884 (1114)
.++|++.++||+|+||+||+|+++ +|+.||||++....... ..+.+.+|+.++++++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 367999999999999999999987 68999999997544322 2566789999999999999999999998765 679
Q ss_pred EEEecCCCCCHHHHhccCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----CCCCCeEEeeccC
Q 001253 885 LMYEYMARGSLGELLHGASS--TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL----DDKFEAHVGDFGL 958 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfG~ 958 (1114)
+||||+++|+|.+++..... .+++.++..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999975432 489999999999999999999999 99999999999999 7888899999999
Q ss_pred ceecCCCCCCccccccccccccCccccc--------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 001253 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAY--------TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFI 1030 (1114)
Q Consensus 959 a~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 1030 (1114)
++..... .......||+.|+|||++. +..++.++||||+||++|||++|+.||............+....
T Consensus 163 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 163 ARELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp CEECCTT--CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred ceecCCC--CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 9876432 2334567999999999886 57789999999999999999999999976655444444554444
Q ss_pred hcCCcc--c---------ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1031 RNNSLV--S---------GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1031 ~~~~~~--~---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
...... . ..+.................+.+++.+||+.||++|||++|+++...+..-+
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 322110 0 0011122222334566777899999999999999999999999999876544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=369.71 Aligned_cols=254 Identities=23% Similarity=0.290 Sum_probs=208.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCCh---hhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNN---NVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999986 789999999986543221 2356789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC----CeEEeeccCc
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF----EAHVGDFGLA 959 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfG~a 959 (1114)
|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999974 45799999999999999999999999 999999999999998877 7999999999
Q ss_pred eecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
+.... .......+||+.|+|||++.+..++.++||||+||++|+|++|..||.... ........... .+
T Consensus 167 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~-~~---- 235 (361)
T 2yab_A 167 HEIED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANITAV-SY---- 235 (361)
T ss_dssp EECCT--TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHHTT-CC----
T ss_pred eEcCC--CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhc-CC----
Confidence 87653 223345679999999999999999999999999999999999999997532 22222222111 11
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||..||++|||+.|+++
T Consensus 236 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 -----DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001111122346889999999999999999999874
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=383.81 Aligned_cols=359 Identities=20% Similarity=0.205 Sum_probs=158.2
Q ss_pred CcccccccccccEEEecCCcccCccccccccccccchhhcccccccCCchhhhcCCCccceeeecccccccccCcccccc
Q 001253 238 IPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKL 317 (1114)
Q Consensus 238 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 317 (1114)
.+..++.+++|++|++++|.+++. | .++.+++|++|++++|.+.+. | ++.+++|++|++++|++++. | ++.+
T Consensus 34 ~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l 105 (457)
T 3bz5_A 34 DTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPL 105 (457)
T ss_dssp SEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTC
T ss_pred cccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCC
Confidence 333444444444444444444432 2 344444444444444443332 1 44444444444444444431 1 3344
Q ss_pred ccccccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeec
Q 001253 318 SSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQL 397 (1114)
Q Consensus 318 ~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 397 (1114)
++|++|++++|++++. + +..+++|+.|++++|++++. .+..+++|++|++++|...+.+ .+..+++|++|++
T Consensus 106 ~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l 177 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDC 177 (457)
T ss_dssp TTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEEC
T ss_pred CcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEEC
Confidence 4444444444444331 1 33344444444444444432 1344444444444444322222 2333334444444
Q ss_pred cCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeecc
Q 001253 398 FDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGS 477 (1114)
Q Consensus 398 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 477 (1114)
++|++++. | +..+++|+.|++++|++++. .+..+++|++|++++|++++
T Consensus 178 ------------------------s~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~- 226 (457)
T 3bz5_A 178 ------------------------SFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE- 226 (457)
T ss_dssp ------------------------CSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-
T ss_pred ------------------------CCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-
Confidence 44444331 1 33334444444444444432 14444444444444444443
Q ss_pred CCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeeccccccccccccccccc
Q 001253 478 FPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSC 557 (1114)
Q Consensus 478 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 557 (1114)
+| +..+++|+.|++++|++++.. ++.+++|+.|++++| +|+.|++++|.+.+.+| +..+
T Consensus 227 ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l 285 (457)
T 3bz5_A 227 ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGC 285 (457)
T ss_dssp CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTC
T ss_pred cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--cccc
Confidence 23 444445555555555554332 233444455544443 23344445555444444 2344
Q ss_pred ccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhh
Q 001253 558 KMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALN 637 (1114)
Q Consensus 558 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~ 637 (1114)
++|+.|++++|.+.+.+|. ..++|+.|++++| ++|++|++++|+|++. + ++.++.|+ .|+
T Consensus 286 ~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~-~L~ 345 (457)
T 3bz5_A 286 RKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLK-SLS 345 (457)
T ss_dssp TTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCS-EEE
T ss_pred ccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCc-EEE
Confidence 5555555555554444442 2233444443333 3445555555555542 2 44555554 455
Q ss_pred cccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCC
Q 001253 638 LSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPS 697 (1114)
Q Consensus 638 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~ 697 (1114)
+++|+|++. +.|+.|++++|.++|. .++..|..+++++|+++|.||.
T Consensus 346 l~~N~l~~l--------~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 346 CVNAHIQDF--------SSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp CCSSCCCBC--------TTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred CCCCCCCCc--------cccccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence 555555541 2344555555555554 2344455556666666666654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=375.57 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=203.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.++||+|+||+||+|+.+ +++.||+|++++.........+.+..|..+++++ +||||+++++++.+++..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999986 6889999999876544444445677899998877 89999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 131 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 9999999999999974 34789999999999999999999999 999999999999999999999999999986322
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC----CHHHHHHHHHhcCCccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG----DLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....+...+....
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------- 278 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------- 278 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-------
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-------
Confidence 2334456789999999999999999999999999999999999999996543211 11222222222111
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTM 1076 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1076 (1114)
. ..+......+.+++.+||+.||++||++
T Consensus 279 --~----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 --I----RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --C----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --c----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 1112233468899999999999999996
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=359.15 Aligned_cols=261 Identities=25% Similarity=0.344 Sum_probs=206.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhc--CCCCceeeEEeEEEec----C
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGK--IRHRNIVKLYGFCYHQ----G 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~ 881 (1114)
.++|++.+.||+|+||+||+|++ +|+.||||++.... ...+..|.+++.. ++||||+++++++... .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 47899999999999999999998 48999999986432 3344556655555 7999999999997653 4
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeEECCCCCeEE
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH--------HDCKPRIFHRDIKSNNILLDDKFEAHV 953 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~Nill~~~~~~kl 953 (1114)
..++||||+++|+|.++++ ...+++..+..++.|+++||+||| +. +|+||||||+||+++.++.+||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred eeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 5789999999999999996 357999999999999999999999 76 9999999999999999999999
Q ss_pred eeccCceecCCCCCCc---cccccccccccCccccccC------CCCcccchHHHHHHHHHHHhC----------CCCCC
Q 001253 954 GDFGLAKVIDMPQSKS---MSAIAGSYGYIAPEYAYTM------KVTEKCDIYSYGVVLLELLTG----------RAPVQ 1014 (1114)
Q Consensus 954 ~DfG~a~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslGvil~el~tg----------~~p~~ 1014 (1114)
+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998764332221 2345799999999999876 456799999999999999999 88887
Q ss_pred CCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1015 PLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
......................... . ...........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNI-----P-NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCC-----C-GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCC-----C-hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 6655444444444433322111110 0 0112334567899999999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=368.73 Aligned_cols=271 Identities=26% Similarity=0.338 Sum_probs=211.5
Q ss_pred HhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc----
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS---- 882 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 882 (1114)
..++|++.++||+|+||+||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.+...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3478999999999999999999987 8999999996532 223455678999999999999999999987553
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCeEecCCCCCCeEECCCCCeEEee
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC-------KPRIFHRDIKSNNILLDDKFEAHVGD 955 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlk~~Nill~~~~~~kl~D 955 (1114)
.++||||+++|+|.++++. ..+++..+..++.|+++||+|||+.+ .++|+||||||+||+++.++.+||+|
T Consensus 97 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 6999999999999999974 35999999999999999999999751 33899999999999999999999999
Q ss_pred ccCceecCCCCC-CccccccccccccCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCH-------
Q 001253 956 FGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYT-----MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDL------- 1022 (1114)
Q Consensus 956 fG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~------- 1022 (1114)
||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999987653322 22344679999999999886 35667899999999999999999999764432211
Q ss_pred ----HHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1023 ----VTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1023 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
...+......... .+... ...........+.+++.+||+.||++|||+.|+++.|+++++..
T Consensus 255 ~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKK-----RPVLR-DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SSCCHHHHHHHHTTSCC-----CCCCC-GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCchhhhhhhhhcccC-----CCCcc-ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111111110 01100 00112344567999999999999999999999999999987643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=367.30 Aligned_cols=251 Identities=21% Similarity=0.251 Sum_probs=209.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|+++ +++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 368999999999999999999986 68899999986432 2355688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC--CCCeEEeeccCceecCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD--KFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DfG~a~~~~~ 964 (1114)
|||+++|+|.+++......+++.++..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999999986666899999999999999999999999 9999999999999987 78999999999987642
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
........||+.|+|||++.+..++.++||||+||++|+|++|..||.... ....+........
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~---------- 220 (321)
T 1tki_A 157 --GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQQIIENIMNAEY---------- 220 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHTCC----------
T ss_pred --CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC----HHHHHHHHHcCCC----------
Confidence 233445679999999999998889999999999999999999999997533 2233333222111
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++|||+.|+++
T Consensus 221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000011122346889999999999999999999987
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=361.31 Aligned_cols=267 Identities=22% Similarity=0.358 Sum_probs=207.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.++|++.++||+|+||+||+|++++|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3789999999999999999999988999999999765432 233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++ ++.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....+.
T Consensus 99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 99986 88888887777899999999999999999999999 99999999999999999999999999998765322
Q ss_pred CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccc--cc-----
Q 001253 968 KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS--GM----- 1039 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~----- 1039 (1114)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........... +........... ..
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK-IFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH-HHHHHCCCCTTTSGGGTTSHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHHCCCChHHhhhhhccch
Confidence 23344578999999999876 5689999999999999999999999987655443333 322222111000 00
Q ss_pred -ccccccCCCcc-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1040 -LDARLNLQDEK-----TVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1040 -~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
........... ......++.+++.+||++||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000000 1112246789999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=367.44 Aligned_cols=250 Identities=22% Similarity=0.254 Sum_probs=207.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+.+ +|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 67999999999999999999986 79999999997653222223566888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... ..
T Consensus 85 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-~~ 159 (337)
T 1o6l_A 85 EYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DG 159 (337)
T ss_dssp ECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-TT
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc-CC
Confidence 99999999999974 34789999999999999999999999 999999999999999999999999999986432 22
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ............ ..
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~----------~~-- 223 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERLFELILMEE----------IR-- 223 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCC----------CC--
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC----HHHHHHHHHcCC----------CC--
Confidence 33456789999999999999999999999999999999999999997432 222222222211 11
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
.+......+.+++.+||+.||++|| +++|+++
T Consensus 224 --~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1112234678999999999999999 8999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=387.99 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=215.5
Q ss_pred HHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 803 DLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 803 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
++++..++|++.++||+|+||+||+|+++++..||||+++.... ..+.+.+|+.++++++||||+++++++. .+.
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 34556788999999999999999999998889999999976442 2567899999999999999999999986 667
Q ss_pred eEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 883 NLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
.++||||+++|+|.++++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 899999999999999997432 3688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.............+++.|+|||++....++.++|||||||++|||++ |+.||..... .+........ .
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----~~~~~~i~~~-~------ 402 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRALERG-Y------ 402 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHHT-C------
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcC-C------
Confidence 54322222233457789999999998999999999999999999999 9999975432 2222221111 0
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
+ ...+......+.++|.+||+.||++|||+++|++.|+++....
T Consensus 403 --~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 403 --R----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp --C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred --C----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 0 0111223346889999999999999999999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=360.32 Aligned_cols=261 Identities=22% Similarity=0.332 Sum_probs=212.9
Q ss_pred CCCCHHHHHHHhcC----------CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC
Q 001253 797 EGFTFKDLVVATDN----------FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI 865 (1114)
Q Consensus 797 ~~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l 865 (1114)
..++++++..+.+. |+..++||+|+||+||+|+.+ +|+.||||++...... ..+.+.+|+.+++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDY 99 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhC
Confidence 34677776665543 677789999999999999987 7999999999755433 256688999999999
Q ss_pred CCCceeeEEeEEEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE
Q 001253 866 RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL 945 (1114)
Q Consensus 866 ~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 945 (1114)
+||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999999973 4689999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHH
Q 001253 946 DDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTW 1025 (1114)
Q Consensus 946 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~ 1025 (1114)
+.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.... ....
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~----~~~~ 249 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS----PVQA 249 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHH
T ss_pred CCCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHH
Confidence 999999999999998764322 23345679999999999999999999999999999999999999996432 2222
Q ss_pred HHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
......... +.. .........+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~-------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 250 MKRLRDSPP-------PKL----KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHHSSC-------CCC----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhcCCC-------CCc----CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222222110 000 011122346889999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=377.95 Aligned_cols=260 Identities=22% Similarity=0.260 Sum_probs=208.7
Q ss_pred HHHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 803 DLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 803 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
++....++|++.++||+|+||+||+|+.+ +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 44455689999999999999999999987 68999999997532211112334778999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..|+||||++||+|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 99999999999999999974 3589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCccccccccccccCccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMK----VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1114)
............+||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... ............
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~--- 290 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMNHKN--- 290 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTHHH---
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh----hhHHHHHHhccc---
Confidence 6543333345678999999999998765 78999999999999999999999975332 222222221100
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFD--RPTMREVVL 1081 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1081 (1114)
.+. .+........+.+++.+|++.+|.+ ||+++|+++
T Consensus 291 -----~~~--~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 291 -----SLT--FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp -----HCC--CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred -----ccc--CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 000 0001112346789999999999988 999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=374.90 Aligned_cols=262 Identities=24% Similarity=0.413 Sum_probs=203.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.++|++.+.||+|+||+||+|+++ ++..||||+++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 468999999999999999999965 57789999997543 334466799999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++|+|.++++.....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999999987777899999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCc--cccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 964 MPQSKS--MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 964 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .+..+ .+....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----~~~~~-~i~~~~------ 267 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIK-AVDEGY------ 267 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----HHHHH-HHHTTE------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH-HHHcCC------
Confidence 332211 122345778999999999999999999999999999998 9999965432 22222 122110
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1091 (1114)
+ ...+......+.+++.+||+.||++||++.|+++.|+++....+
T Consensus 268 --~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 268 --R----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp --E----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred --C----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 0 01111223468899999999999999999999999999866543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=378.05 Aligned_cols=264 Identities=22% Similarity=0.233 Sum_probs=209.4
Q ss_pred HHHHHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 001253 801 FKDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH 879 (1114)
Q Consensus 801 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 879 (1114)
+++.....++|++.++||+|+||+||+|+.+ +|+.||+|++.+.........+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444456689999999999999999999986 799999999975432222223457889999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 880 QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
.+..|+||||+++|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhh
Confidence 9999999999999999999986666899999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccccccCccccc-------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAY-------TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN 1032 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1032 (1114)
+.............+||+.|+|||++. +..++.++||||+||++|||++|+.||..... .+........
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~ 285 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST----AETYGKIVHY 285 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTH
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH----HHHHHHHHhc
Confidence 876543333334568999999999987 35689999999999999999999999975432 2222221111
Q ss_pred CCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 001253 1033 NSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDR---PTMREVVL 1081 (1114)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 1081 (1114)
. ..... +.........+.+++.+||. +|++| |+++|+++
T Consensus 286 ~--------~~~~~-p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 286 K--------EHLSL-PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp H--------HHCCC-C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred c--------cCcCC-CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0 00000 00011123468899999999 99998 58888753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=359.00 Aligned_cols=275 Identities=19% Similarity=0.246 Sum_probs=218.6
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEE-EecCceE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFC-YHQGSNL 884 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~ 884 (1114)
..++|++.+.||+|+||+||+|++. +++.||||++...... +.+.+|+.+++.++|++++..+.++ ...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 3478999999999999999999974 7899999987654432 2477899999999988766666655 5667789
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---CCCCCeEEeeccCcee
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL---DDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfG~a~~ 961 (1114)
+||||+ +++|.+++......+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++.
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999999 8899999986677899999999999999999999999 99999999999999 7889999999999987
Q ss_pred cCCCCC------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCC--HHHHHHHHHhcC
Q 001253 962 IDMPQS------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD--LVTWVRNFIRNN 1033 (1114)
Q Consensus 962 ~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~ 1033 (1114)
...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ....+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 654322 123356799999999999999999999999999999999999999986543322 211111111100
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCC
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDS 1102 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~ 1102 (1114)
.. . .........+.+++.+||+.||++|||++|+++.|+++..+.+.....++||+.
T Consensus 238 ~~-~-----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 238 PI-E-----------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp CH-H-----------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred hh-h-----------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhh
Confidence 00 0 000111246889999999999999999999999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=368.74 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=207.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+.+ +++.||+|++...........+.+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67999999999999999999976 68999999997654322233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++... ..
T Consensus 95 e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~--~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RE 168 (384)
T ss_dssp CCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--TT
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc--CC
Confidence 99999999999984 45799999999999999999999999 99999999999999999999999999998764 23
Q ss_pred CccccccccccccCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ..............
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~~~~~~~~~----------- 236 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTV----------- 236 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT-SCHHHHHHHHHHCC-----------
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC-ccHHHHHHHHhhcc-----------
Confidence 34456789999999999864 4589999999999999999999999975433 22333333222211
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPT-MREVVL 1081 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 1081 (1114)
...+......+.+++.+||+.||.+||+ ++++.+
T Consensus 237 ---~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ---VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0111122346889999999999999998 666653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=357.12 Aligned_cols=274 Identities=19% Similarity=0.249 Sum_probs=222.2
Q ss_pred hcCCcCCceecccCCeEEEEEEe-CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEE-EecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVL-RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFC-YHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l 885 (1114)
.++|++.+.||+|+||+||+|++ .+|+.||||++..... .+.+.+|+.+++.++|++++..+.++ ...+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 46899999999999999999997 4789999999876543 23578899999999988766666655 55677899
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC---CCCCeEEeeccCceec
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD---DKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfG~a~~~ 962 (1114)
||||+ +++|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+||+|||+++..
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99999 8899999986677899999999999999999999999 999999999999994 8889999999999876
Q ss_pred CCCCCC------ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC--CHHHHHHHHHhcCC
Q 001253 963 DMPQSK------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG--DLVTWVRNFIRNNS 1034 (1114)
Q Consensus 963 ~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~ 1034 (1114)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 543321 2345679999999999999999999999999999999999999998654322 22222222111100
Q ss_pred cccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCC
Q 001253 1035 LVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDS 1102 (1114)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~ 1102 (1114)
. . .........+.+++.+||+.||++|||++++++.|+++....+.....++||+.
T Consensus 239 ~------~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 3uzp_A 239 I------E------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp H------H------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred h------H------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 0 0 000112246889999999999999999999999999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=373.69 Aligned_cols=288 Identities=16% Similarity=0.232 Sum_probs=220.2
Q ss_pred HhcCCcCCceecccCCeEEEEEEeCC------CcEEEEEEecccCCCChh--------hHHHHHHHHHHHhcCCCCceee
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLRT------GHTVAVKKLASNREGNNN--------VDNSFRAEILTLGKIRHRNIVK 872 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~ 872 (1114)
..++|++.++||+|+||+||+|+++. ++.||||++......... ....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999999864 478999998754321100 0112334556677889999999
Q ss_pred EEeEEEec----CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC--
Q 001253 873 LYGFCYHQ----GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD-- 946 (1114)
Q Consensus 873 l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-- 946 (1114)
+++++... ...|+||||+ +++|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 99998775 4579999999 8999999987767899999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeccCceecCCCCC------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 001253 947 DKFEAHVGDFGLAKVIDMPQS------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG 1020 (1114)
Q Consensus 947 ~~~~~kl~DfG~a~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~ 1020 (1114)
.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999987542211 11234569999999999999999999999999999999999999998544333
Q ss_pred CHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCC
Q 001253 1021 DLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDH 1100 (1114)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~ 1100 (1114)
......+...... ...+.+..+. .......+.+++.+||+.||++||++.++++.|+++....+.....++||
T Consensus 269 ~~~~~~~~~~~~~--~~~~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 341 (364)
T 3op5_A 269 KYVRDSKIRYREN--IASLMDKCFP-----AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL 341 (364)
T ss_dssp HHHHHHHHHHHHC--HHHHHHHHSC-----TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred HHHHHHHHHhhhh--HHHHHHHhcc-----cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence 3333332222110 1111111110 01113468899999999999999999999999999999999999999999
Q ss_pred CCccc
Q 001253 1101 DSDQK 1105 (1114)
Q Consensus 1101 ~~~~~ 1105 (1114)
+....
T Consensus 342 ~~~~~ 346 (364)
T 3op5_A 342 SVVEN 346 (364)
T ss_dssp -----
T ss_pred EeccC
Confidence 86553
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=374.10 Aligned_cols=271 Identities=25% Similarity=0.377 Sum_probs=218.5
Q ss_pred CCCHHHHHHHhcCCcCCceecccCCeEEEEEEe------CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCce
Q 001253 798 GFTFKDLVVATDNFDERFVIGRGACGTVYRAVL------RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNI 870 (1114)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 870 (1114)
.+...++.+..++|++.++||+|+||+||+|++ .+++.||||++..... ....+.+.+|+.+++++ +||||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcce
Confidence 345566777889999999999999999999984 2568999999975432 33356789999999999 78999
Q ss_pred eeEEeEEEecCc-eEEEEecCCCCCHHHHhccCCC---------------------------------------------
Q 001253 871 VKLYGFCYHQGS-NLLMYEYMARGSLGELLHGASS--------------------------------------------- 904 (1114)
Q Consensus 871 v~l~~~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------- 904 (1114)
+++++++.+.+. .++||||+++|+|.++++....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 999999987654 8999999999999999975432
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 905 --------------------TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 905 --------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
.+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 289999999999999999999999 999999999999999999999999999986543
Q ss_pred CCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 965 PQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 965 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||............+.. ...
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~------- 314 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTR------- 314 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH----TCC-------
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc----CCC-------
Confidence 222 23345678999999999999999999999999999999998 99999765433322222221 110
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
...+......+.+++.+||+.||++|||++|+++.|+++...
T Consensus 315 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 315 -----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 001111234688999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=373.28 Aligned_cols=271 Identities=25% Similarity=0.391 Sum_probs=219.4
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC--------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR--------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGF 876 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 876 (1114)
+..++|++.++||+|+||+||+|++. ++..||||+++... .....+.+.+|+++++++ +||||++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 34578999999999999999999962 34679999997653 233456788999999999 99999999999
Q ss_pred EEecCceEEEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 001253 877 CYHQGSNLLMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSN 941 (1114)
Q Consensus 877 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 941 (1114)
+..++..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence 999999999999999999999997543 3589999999999999999999999 9999999999
Q ss_pred CeEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 001253 942 NILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQG 1019 (1114)
Q Consensus 942 Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~ 1019 (1114)
||++++++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-- 298 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-- 298 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 99999999999999999987643322 23344567899999999999999999999999999999999 999996433
Q ss_pred CCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccC
Q 001253 1020 GDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPM 1098 (1114)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~ 1098 (1114)
..+..+ .+...... ..+......+.+++.+||+.||++|||++|+++.|+++.......+....
T Consensus 299 --~~~~~~-~~~~~~~~------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 299 --VEELFK-LLKEGHRM------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp --HHHHHH-HHHTTCCC------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred --HHHHHH-HHHcCCCC------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 222222 22221110 11112234688999999999999999999999999999887776666554
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=366.17 Aligned_cols=248 Identities=24% Similarity=0.327 Sum_probs=204.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|++. +|+.||||++...........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 67999999999999999999974 78999999997543222233457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+ +|+|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.... ..
T Consensus 89 E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~--~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DG 161 (336)
T ss_dssp CCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT--TS
T ss_pred ECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc--CC
Confidence 999 6799988864 34689999999999999999999999 99999999999999999999999999998654 22
Q ss_pred CccccccccccccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||....... ....+.....
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------------~~~~i~~~~~-- 225 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--------------LFKKVNSCVY-- 225 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--------------CBCCCCSSCC--
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--------------HHHHHHcCCC--
Confidence 33455689999999999988776 689999999999999999999997543211 1111111111
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+......+.+++.+||+.||.+|||++|+++
T Consensus 226 --~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 --VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112223346789999999999999999999976
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=378.89 Aligned_cols=352 Identities=23% Similarity=0.199 Sum_probs=283.4
Q ss_pred ccchhhcccccccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecc
Q 001253 271 SLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLF 350 (1114)
Q Consensus 271 ~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~ 350 (1114)
+++..........+..+..++.+++|++|++++|.+++ +| .++.+++|++|++++|++++. | +..+++|+.|+++
T Consensus 19 ~l~~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls 93 (457)
T 3bz5_A 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACD 93 (457)
T ss_dssp HHHHHHHHHTTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECC
T ss_pred HHHHHHHHhcCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECc
Confidence 33333333444444555567777778888888877774 34 577777888888888877764 3 7777888888888
Q ss_pred cccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCC
Q 001253 351 ENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKI 430 (1114)
Q Consensus 351 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 430 (1114)
+|++++. + +..+++|++|++++|++++. + +..+++|++|++++|++++. .++.+++|++|++++|+..+.+
T Consensus 94 ~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~ 164 (457)
T 3bz5_A 94 SNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL 164 (457)
T ss_dssp SSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC
T ss_pred CCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc
Confidence 8888875 2 77888888888888888863 3 78888888888888888874 2778889999999999665555
Q ss_pred CccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccc
Q 001253 431 PRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCN 510 (1114)
Q Consensus 431 ~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 510 (1114)
.+..+++|++|++++|++++ +| +..+++|+.|++++|++++. .+..+++|++|++++|++++ +| ++.++
T Consensus 165 --~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~ 233 (457)
T 3bz5_A 165 --DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLT 233 (457)
T ss_dssp --CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCT
T ss_pred --ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccC
Confidence 47788999999999999996 44 78889999999999999865 38888999999999999997 55 88899
Q ss_pred cCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeecc
Q 001253 511 ALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLS 590 (1114)
Q Consensus 511 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 590 (1114)
+|+.|++++|+|++.. ++.+++|+.|++++|. |+.|++++|.+.+.+| ++.+++|+.|+++
T Consensus 234 ~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls 294 (457)
T 3bz5_A 234 QLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVT 294 (457)
T ss_dssp TCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCT
T ss_pred CCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECC
Confidence 9999999999999754 4567888999988774 4578899999988887 5788999999999
Q ss_pred CccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccC
Q 001253 591 ENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGE 670 (1114)
Q Consensus 591 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 670 (1114)
+|...+.+|. ..++|+.|++++| ++|+ .|+|++|+|++. | ++++++|+.||+++|+|+|
T Consensus 295 ~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~-~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~- 353 (457)
T 3bz5_A 295 HNTQLYLLDC---QAAGITELDLSQN-------------PKLV-YLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD- 353 (457)
T ss_dssp TCTTCCEEEC---TTCCCSCCCCTTC-------------TTCC-EEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB-
T ss_pred CCcccceecc---CCCcceEechhhc-------------ccCC-EEECCCCccccc-c--cccCCcCcEEECCCCCCCC-
Confidence 9999988885 4567888888877 3566 699999999995 3 9999999999999999997
Q ss_pred CCCccccccccceEEeccCcccCC
Q 001253 671 IPGSFVNLSSLLGCNFSYNNLTGP 694 (1114)
Q Consensus 671 ip~~~~~l~~l~~l~ls~N~l~g~ 694 (1114)
++.|..|++++|+++|.
T Consensus 354 -------l~~L~~L~l~~n~l~g~ 370 (457)
T 3bz5_A 354 -------FSSVGKIPALNNNFEAE 370 (457)
T ss_dssp -------CTTGGGSSGGGTSEEEE
T ss_pred -------ccccccccccCCcEEec
Confidence 24677789999999997
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=356.29 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=215.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
.++|++.+.||+|+||+||+|++.+++.||+|++...... .+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 4689999999999999999999988899999999765432 457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.+++......+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 99999999999987777899999999999999999999999 999999999999999999999999999986543222
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.......+++.|+|||++.+..++.++||||+|+++|||++ |+.||.... .............
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~i~~~~~------------ 223 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTGFR------------ 223 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTTCC------------
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC----HHHHHHHHhcCCc------------
Confidence 22234467889999999998899999999999999999999 899986432 2222222211100
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
...+......+.+++.+||+.||++|||++|+++.|+++..+
T Consensus 224 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 224 -LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 001111234688999999999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=354.10 Aligned_cols=267 Identities=22% Similarity=0.348 Sum_probs=207.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+++ +|+.||||++...... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 57999999999999999999986 6899999999765543 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++ ++.+.+......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....+ .
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 155 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-V 155 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-C
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc-c
Confidence 99986 66666665667899999999999999999999999 9999999999999999999999999999876432 2
Q ss_pred CccccccccccccCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccc--cccc---
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS--GMLD--- 1041 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--- 1041 (1114)
.......||+.|+|||++.+.. ++.++||||+||++|||++|..||.......+....+........... ....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 3334567899999999998766 799999999999999999998886543332222222222221110000 0000
Q ss_pred -------ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 -------ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 -------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+...............+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000000111223456789999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=384.39 Aligned_cols=264 Identities=25% Similarity=0.399 Sum_probs=210.4
Q ss_pred HHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 803 DLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 803 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
.+.+..++|++.++||+|+||+||+|+++.+..||||+++..... .+.|.+|+.++++++||||+++++++.+ +.
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 344556889999999999999999999998888999999765432 4678999999999999999999999876 67
Q ss_pred eEEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 883 NLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
.++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 89999999999999999743 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.............+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .+.... +..+.
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~~~-i~~~~------ 398 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQ-VERGY------ 398 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHH-HHTTC------
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH----HHHHHH-HHcCC------
Confidence 65333333344567889999999999999999999999999999999 9999975432 222222 22111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1091 (1114)
+ ...+......+.+++.+||+.||++|||++++++.|+++.....
T Consensus 399 --~----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 399 --R----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp --C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred --C----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 0 01112233468899999999999999999999999999865543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.21 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=202.0
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCC----CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRT----GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
+..++|++.+.||+|+||+||+|++.. +..||+|++.... .....+.+.+|+.++++++||||+++++++. ++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 345789999999999999999999752 4579999986543 2344667889999999999999999999984 56
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..++||||+++|+|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 78999999999999999987666899999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.............+++.|+|||++.+..++.++||||+|+++|||++ |..||...... +....+ .....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-~~~~~i----~~~~~----- 235 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRI----ENGER----- 235 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHH----HTTCC-----
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-HHHHHH----HcCCC-----
Confidence 65433333344567889999999998999999999999999999997 99999754432 222111 11110
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
...+......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 236 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 236 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 011112234688999999999999999999999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=357.53 Aligned_cols=266 Identities=24% Similarity=0.386 Sum_probs=203.6
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
++|++.++||+|+||+||+|+.++|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 578999999999999999999988999999999755432 2234668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++ +|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....+. .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 9986 99999987667899999999999999999999999 99999999999999999999999999998764322 2
Q ss_pred ccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC---ccc----ccc
Q 001253 969 SMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS---LVS----GML 1040 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~----~~~ 1040 (1114)
......||+.|+|||++.+. .++.++||||+||++|||++|+.||............. ....... +.. ...
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF-RILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHHCCCChhhchhhhccccc
Confidence 23345789999999998764 58999999999999999999999997543222111111 1111100 000 000
Q ss_pred cccccCCC-----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 DARLNLQD-----EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 ~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
++...... .........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 001112346789999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=359.91 Aligned_cols=264 Identities=28% Similarity=0.426 Sum_probs=208.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ-- 880 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 880 (1114)
.++|++.++||+|+||+||+|+++ +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 478999999999999999999842 68899999987432 34456789999999999999999999998653
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 881 GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
...++||||+++|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 568999999999999999987666799999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCC--CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----------CC-CHHHHHH
Q 001253 961 VIDMPQS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ----------GG-DLVTWVR 1027 (1114)
Q Consensus 961 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~----------~~-~~~~~~~ 1027 (1114)
....... .......++..|+|||++.+..++.++||||+|+++|||++|..|+..... .. .....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 7643222 222334578889999999999999999999999999999999998853210 00 0000111
Q ss_pred HHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1028 NFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
..+.... + ...+......+.+++.+||+.||++|||++|+++.|+++...
T Consensus 243 ~~~~~~~--------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 243 ELLKNNG--------R----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHTTC--------C----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhccC--------c----CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1111110 0 111222335688999999999999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=361.22 Aligned_cols=253 Identities=25% Similarity=0.317 Sum_probs=207.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGN---NNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
++|++.+.||+|+||+||+|+.+ +|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 67999999999999999999986 68999999997654322 123567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC----CeEEeeccCce
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF----EAHVGDFGLAK 960 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfG~a~ 960 (1114)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999974 45799999999999999999999998 999999999999999887 79999999998
Q ss_pred ecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ............ .
T Consensus 167 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~~~~~~-~----- 234 (326)
T 2y0a_A 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANVSAVN-Y----- 234 (326)
T ss_dssp ECCTT--SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHHHTC-C-----
T ss_pred ECCCC--CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHHHhcC-C-----
Confidence 76422 23345679999999999999999999999999999999999999996432 222222221111 0
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++|||+.|+++
T Consensus 235 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 ----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ----CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000011112346789999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=376.65 Aligned_cols=255 Identities=26% Similarity=0.420 Sum_probs=210.5
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-ceE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG-SNL 884 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 884 (1114)
+..++|++.++||+|+||+||+|.++ |+.||||+++... ..+.|.+|+.++++++||||+++++++...+ ..|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 34578999999999999999999987 7899999997543 2467899999999999999999999987765 789
Q ss_pred EEEecCCCCCHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 885 LMYEYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
+||||+++|+|.++++.... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999999985543 479999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
.. .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... +....+ ..+.
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i----~~~~-------- 403 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRV----EKGY-------- 403 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-THHHHH----HTTC--------
T ss_pred cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH----HcCC--------
Confidence 21 223367889999999999999999999999999999998 99999765432 222222 1110
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
+ ...+......+.++|.+||+.||++|||+.|+++.|+++....
T Consensus 404 ~----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 404 K----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred C----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 0 1111223356889999999999999999999999999987653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=370.96 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=202.3
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 884 (1114)
..++|++.++||+|+||+||+|+.+ +|+.||||++.+.........+.+.+|..+++.+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999976 6899999999865332333356678899999988 7999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999999743 5689999999999999999999999 999999999999999999999999999985432
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+......... .
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~~~~i~~~~----------~ 241 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN----EDDLFEAILNDE----------V 241 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCC----------C
T ss_pred -CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC----HHHHHHHHHcCC----------C
Confidence 2233456789999999999999999999999999999999999999997533 222233222211 1
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTM------REVVL 1081 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 1081 (1114)
. .+......+.+++.+||+.||++||++ .|+++
T Consensus 242 ~----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 V----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred C----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1 111123467889999999999999998 66654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=358.22 Aligned_cols=247 Identities=22% Similarity=0.261 Sum_probs=196.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.++||+|+||+||+|+++ +|+.||||++.......... ..+..|+..+.++ +||||+++++++.+++..++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 368999999999999999999987 79999999987655443333 3344455544444 99999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+ +++|.+++......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 99999 5699999887677899999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... . ... +..... ..
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~-~~~-~~~~~~-----~~--- 271 (311)
T 3p1a_A 211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------G-WQQ-LRQGYL-----PP--- 271 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------H-HHH-HTTTCC-----CH---
T ss_pred --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------H-HHH-HhccCC-----Cc---
Confidence 23344579999999998876 79999999999999999999977764211 1 111 111110 00
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.........+.+++.+||++||++|||++|+++
T Consensus 272 ---~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 ---EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111122356889999999999999999999885
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=366.99 Aligned_cols=265 Identities=24% Similarity=0.383 Sum_probs=213.1
Q ss_pred HHHHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeE
Q 001253 804 LVVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGF 876 (1114)
Q Consensus 804 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 876 (1114)
+.+..++|++.+.||+|+||+||+|++. ++..||||++...... ...+.+.+|+.+++++ +||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4456688999999999999999999962 4568999999754322 2356788999999999 89999999999
Q ss_pred EEecCceEEEEecCCCCCHHHHhccCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 001253 877 CYHQGSNLLMYEYMARGSLGELLHGASS----------------------TLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934 (1114)
Q Consensus 877 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 934 (1114)
+...+..++||||+++|+|.+++..... .+++..+..++.|+++||+|||+. +|+
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 194 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 194 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 9999999999999999999999975432 378999999999999999999999 999
Q ss_pred ecCCCCCCeEECCCCCeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCC
Q 001253 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAP 1012 (1114)
Q Consensus 935 H~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p 1012 (1114)
||||||+||+++.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999999866433222 2334567889999999999999999999999999999998 9999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1013 VQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
|............ +..... ...+......+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 275 ~~~~~~~~~~~~~----~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 275 YPGIPVDANFYKL----IQNGFK------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp STTCCCSHHHHHH----HHTTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cccCCcHHHHHHH----HhcCCC------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 9765443322222 222110 011112234688999999999999999999999999998554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=373.42 Aligned_cols=260 Identities=26% Similarity=0.350 Sum_probs=210.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
.++|++.++||+|+||+||+|++. +++.||||+++... .......+.+|+.++++++||||+++++++.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 467999999999999999999953 46789999986433 2334557889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC---CeE
Q 001253 882 SNLLMYEYMARGSLGELLHGAS------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF---EAH 952 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~k 952 (1114)
..++||||+++|+|.++++... ..+++.++..++.|+++||+|||+. +|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999997432 4689999999999999999999999 999999999999999555 599
Q ss_pred EeeccCceecCCC-CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHH
Q 001253 953 VGDFGLAKVIDMP-QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFI 1030 (1114)
Q Consensus 953 l~DfG~a~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 1030 (1114)
|+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |..||.... ....... +
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~----~~~~~~~-i 299 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS----NQEVLEF-V 299 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHHH-H
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHH-H
Confidence 9999999754322 2223344568999999999999999999999999999999998 999996433 2222222 2
Q ss_pred hcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1031 RNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
..... ...+......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 300 ~~~~~------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 300 TSGGR------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HTTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HcCCC------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 22111 011112234688999999999999999999999999998654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=362.75 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=205.6
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 886 (1114)
++|++.+.||+|+||+||+|+.+ +++.||+|++.+.........+.+.+|..+++++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 67999999999999999999986 6899999999877655555566788999999887 899999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... .
T Consensus 89 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-P 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC-T
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC-C
Confidence 9999999999999743 4689999999999999999999999 999999999999999999999999999986432 2
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC----CHHHHHHHHHhcCCcccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG----DLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....+...+....
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-------- 235 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------- 235 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--------
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--------
Confidence 233456789999999999999999999999999999999999999997533211 11122222221111
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTM 1076 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1076 (1114)
.. .+......+.+++.+||+.||++||++
T Consensus 236 -~~----~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 -IR----IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -CC----CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -CC----CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 111223468899999999999999996
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=351.64 Aligned_cols=256 Identities=28% Similarity=0.471 Sum_probs=207.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhh----HHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNV----DNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
.++|++.+.||+|+||+||+|++. +++.||+|++.......... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999985 78999999997654433221 167889999999999999999999986544
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEECCCCC-----eEEee
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR--IFHRDIKSNNILLDDKFE-----AHVGD 955 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~-----~kl~D 955 (1114)
++||||+++|+|.+.+......+++..+..++.|++.||+|||+. + |+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999999987777899999999999999999999998 7 999999999999988776 99999
Q ss_pred ccCceecCCCCCCccccccccccccCcccc--ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 956 FGLAKVIDMPQSKSMSAIAGSYGYIAPEYA--YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 956 fG~a~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
||+++... .......||+.|+|||++ ....++.++||||+||++|||++|+.||...... ............
T Consensus 173 fg~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~ 246 (287)
T 4f0f_A 173 FGLSQQSV----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--KIKFINMIREEG 246 (287)
T ss_dssp CTTCBCCS----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC--HHHHHHHHHHSC
T ss_pred CCcccccc----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc--HHHHHHHHhccC
Confidence 99998533 233456799999999998 4556788999999999999999999999754432 222222222211
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
.. ...+......+.+++.+||+.||++|||++|+++.|+++
T Consensus 247 -~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 -LR-----------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -CC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -CC-----------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 10 111122234688999999999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=359.78 Aligned_cols=247 Identities=24% Similarity=0.311 Sum_probs=206.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+.+ +|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67999999999999999999986 79999999997653222223566788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 158 (318)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence 99999999999974 34689999999999999999999998 999999999999999999999999999987542
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ............ ..
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~~----------~~-- 221 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----TMKTYEKILNAE----------LR-- 221 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHCC----------CC--
T ss_pred -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCC----------CC--
Confidence 2345689999999999999999999999999999999999999997532 222333322211 11
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
.+......+.+++.+|++.||++|| +++|+++
T Consensus 222 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 --FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1111234688999999999999999 8888873
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=366.08 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=207.8
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999976 6899999999765443 33456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC---CeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF---EAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfG~a~~~~ 963 (1114)
|||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+++...
T Consensus 107 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp ECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999874 45789999999999999999999999 999999999999998654 59999999998764
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
. ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.... .......... +.+
T Consensus 183 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~----~~~~~~~i~~-~~~-------- 247 (362)
T 2bdw_A 183 D--SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKA-GAY-------- 247 (362)
T ss_dssp T--CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHH-TCC--------
T ss_pred C--CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHh-CCC--------
Confidence 2 223345689999999999999999999999999999999999999997433 2222222211 111
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++|||+.|+++
T Consensus 248 -~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 248 -DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0011111122346889999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=361.43 Aligned_cols=253 Identities=26% Similarity=0.371 Sum_probs=204.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+++ +++.||||++....... ..+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 68999999999999999999987 78999999996544322 2356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC-
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ- 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 966 (1114)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 85 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 85 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999999974 44699999999999999999999998 99999999999999999999999999998654222
Q ss_pred CCccccccccccccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
........||+.|+|||++.+..+ +.++||||+||++|||++|+.||.......... ..........
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~~~~~~~~~~--------- 228 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKTYL--------- 228 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH---HHHHTTCTTS---------
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHHhcccccC---------
Confidence 222345689999999999987775 778999999999999999999997544332211 1111111100
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
.........+.+++.+||+.||++|||++|+++.
T Consensus 229 ---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0111223467889999999999999999998763
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=384.36 Aligned_cols=349 Identities=17% Similarity=0.142 Sum_probs=224.1
Q ss_pred ceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecc
Q 001253 345 ELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDN 424 (1114)
Q Consensus 345 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 424 (1114)
+.++.+++.++.+ |..+. ++++.|+|++|+|++..+..|..+++|++|+|++|.+.+..|..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~i-p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFVAV-PEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCSSC-CSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCcC-CCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 4566666666643 43332 46777777777777666667777777777777777776666666666677777777776
Q ss_pred cccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccc
Q 001253 425 HLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPT 504 (1114)
Q Consensus 425 ~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 504 (1114)
++++..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 66655555566666666666666666655555666666666666666666655555566666666666666666555455
Q ss_pred cccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccC
Q 001253 505 EIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQL 584 (1114)
Q Consensus 505 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 584 (1114)
.|.++++|+.|+|++|.+++..+..|..+++|+.|++++|.+.+.+|.......+|+.|+|++|++++.
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~----------- 239 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAV----------- 239 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSC-----------
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccccc-----------
Confidence 555566666666666665555555555555555555555555545554444444555555555555433
Q ss_pred CeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccC
Q 001253 585 ELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNN 664 (1114)
Q Consensus 585 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 664 (1114)
.+..+.++++|+.|+|++|++++..+..|..+.+|+ .|+|++|++++..|..|.++++|+.|||++
T Consensus 240 -------------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 305 (477)
T 2id5_A 240 -------------PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQ-EIQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305 (477)
T ss_dssp -------------CHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCC-EEECCSSCCSEECTTTBTTCTTCCEEECCS
T ss_pred -------------CHHHhcCccccCeeECCCCcCCccChhhccccccCC-EEECCCCccceECHHHhcCcccCCEEECCC
Confidence 223444455555555555555544444555555555 566666666666677777788888888888
Q ss_pred cccccCCCCccccccccceEEeccCcccCCCCCcccccccccccccCCCCCCCCCCC
Q 001253 665 NHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQ 721 (1114)
Q Consensus 665 N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lc~~p~~ 721 (1114)
|+|++..+..|..+++|+.|++++|+|.|.++..|.+++.....+.++...|+.|..
T Consensus 306 N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~ 362 (477)
T 2id5_A 306 NQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEF 362 (477)
T ss_dssp SCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESGG
T ss_pred CcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCchH
Confidence 888887777888888999999999999988887766666555667777788887653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=374.03 Aligned_cols=254 Identities=21% Similarity=0.276 Sum_probs=206.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|..+ +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999976 7899999999765432 23356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC---CCCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD---DKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfG~a~~~~ 963 (1114)
|||+++|+|.+.+... ..+++..+..++.|+++||+|||+. +|+||||||+||+++ .++.+||+|||+++...
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999998743 5699999999999999999999999 999999999999998 56789999999998764
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
.. ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ........... .+
T Consensus 165 ~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~----~~~~~~~i~~~-~~-------- 230 (444)
T 3soa_A 165 GE-QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED----QHRLYQQIKAG-AY-------- 230 (444)
T ss_dssp TT-CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHT-CC--------
T ss_pred CC-CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHHhC-CC--------
Confidence 32 233345689999999999999999999999999999999999999996433 22222222211 11
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++|||+.|+++
T Consensus 231 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 -DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0011111122346889999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.16 Aligned_cols=264 Identities=27% Similarity=0.442 Sum_probs=201.8
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
+..++|++.++||+|+||+||+|+++ ..||+|+++.... .....+.+.+|+.++++++||||+++++++ .....++
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 44578999999999999999999875 3699999976544 334456789999999999999999999965 5567899
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+++++|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999999999987777899999999999999999999999 9999999999999999999999999999865422
Q ss_pred -CCCccccccccccccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 966 -QSKSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 966 -~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
.........||+.|+|||++. +..++.++||||+|+++|||++|+.||........ +...+.........
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~-- 247 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ----IIEMVGRGSLSPDL-- 247 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH----HHHHHHHTSCCCCT--
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH----HHHHhcccccCcch--
Confidence 222334567999999999986 66788899999999999999999999975443222 22222222111110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
..........+.+++.+||+.||.+|||++|+++.|+++.+
T Consensus 248 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 ------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 01111223468899999999999999999999999999854
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=382.92 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=214.9
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
+..++|++.++||+|+||+||+|+++ ++..||||+++..... .+.|.+|+.++++++||||++++++|.+.+..+
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 34577999999999999999999987 4889999999754332 567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 885 LMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
+||||+++|+|.++++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999999753 35689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
...........+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ...+. +....
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~~~~~----~~~~~-------- 436 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYEL----LEKDY-------- 436 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHH----HHTTC--------
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHH----HHcCC--------
Confidence 333233334457789999999999999999999999999999999 99999754422 22222 21110
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
+ ...+......+.++|.+||+.||++|||+.|+++.|+++..
T Consensus 437 ~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 437 R----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred C----CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 0 11112233468899999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=365.04 Aligned_cols=266 Identities=26% Similarity=0.427 Sum_probs=215.3
Q ss_pred HHHHHhcCCcCCceecccCCeEEEEEEeC-CC-----cEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEe
Q 001253 803 DLVVATDNFDERFVIGRGACGTVYRAVLR-TG-----HTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYG 875 (1114)
Q Consensus 803 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 875 (1114)
++....++|++.+.||+|+||+||+|++. ++ ..||+|++..... ....+.+.+|+.+++.+ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34456688999999999999999999975 22 4899999975542 23456788999999999 8999999999
Q ss_pred EEEecCceEEEEecCCCCCHHHHhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 001253 876 FCYHQGSNLLMYEYMARGSLGELLHGA-------------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNN 942 (1114)
Q Consensus 876 ~~~~~~~~~lv~E~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 942 (1114)
++.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 194 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN 194 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccce
Confidence 999999999999999999999998642 34679999999999999999999999 99999999999
Q ss_pred eEECCCCCeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 001253 943 ILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGG 1020 (1114)
Q Consensus 943 ill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~ 1020 (1114)
|+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999999999865433222 2234567889999999999999999999999999999998 999997654433
Q ss_pred CHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1021 DLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
.....+.. ... ...+......+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 275 ~~~~~~~~----~~~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 275 KFYKLVKD----GYQ------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHHH----TCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhc----CCC------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 22222221 100 001111234688999999999999999999999999988553
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=368.46 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=205.2
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCce
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 883 (1114)
...++|++.+.||+|+||+||+|+.+ +|+.||||+++..........+.+..|..+++.+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 44578999999999999999999986 6899999999765322122345677888888876 999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 9999999999999999743 4689999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .....+.......
T Consensus 170 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~~--------- 235 (345)
T 1xjd_A 170 L-GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHSIRMDNP--------- 235 (345)
T ss_dssp C-TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCC---------
T ss_pred c-CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC----HHHHHHHHHhCCC---------
Confidence 2 2233456789999999999999999999999999999999999999997433 2222222222110
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMR-EVV 1080 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 1080 (1114)
..+......+.+++.+||+.||++||++. |++
T Consensus 236 -----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 -----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 01111234678999999999999999997 554
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=367.53 Aligned_cols=276 Identities=21% Similarity=0.269 Sum_probs=222.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC--ceE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG--SNL 884 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~ 884 (1114)
.++|++.++||+|+||+||+|+++ +|+.||||++....... ..+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 367999999999999999999987 68999999997544322 2566788999999999999999999998765 679
Q ss_pred EEEecCCCCCHHHHhccCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----CCCCCeEEeeccC
Q 001253 885 LMYEYMARGSLGELLHGASS--TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL----DDKFEAHVGDFGL 958 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfG~ 958 (1114)
+||||+++|+|.++++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999975332 389999999999999999999999 99999999999999 7788899999999
Q ss_pred ceecCCCCCCccccccccccccCcccccc--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 001253 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAYT--------MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFI 1030 (1114)
Q Consensus 959 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 1030 (1114)
++.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........+.+....
T Consensus 163 a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 163 ARELED--DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp CEECCC--GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred ceEccC--CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 987642 223345679999999999865 5678899999999999999999999987665555555555544
Q ss_pred hcCCcc--cc---------cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1031 RNNSLV--SG---------MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1031 ~~~~~~--~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
...... .. .+.................+.+++.+||++||++||+++|+++.++++..+.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 432110 00 0111222223334567778899999999999999999999999999986553
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=366.47 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=208.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+.+ +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 67999999999999999999986 789999999875432 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC--CCCeEEeeccCceecCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD--KFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DfG~a~~~~~~ 965 (1114)
||+++|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~- 203 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 203 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC-
Confidence 99999999999986666899999999999999999999999 9999999999999974 57799999999987643
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..............
T Consensus 204 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~~~i~~~~~~---------- 268 (387)
T 1kob_A 204 -DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED----DLETLQNVKRCDWE---------- 268 (387)
T ss_dssp -TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHHHCCCC----------
T ss_pred -CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCC----------
Confidence 223345579999999999999999999999999999999999999997532 22223222221110
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
............+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 001111122346889999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=355.22 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=213.9
Q ss_pred HHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 804 LVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 804 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
+.+..++|++.+.||+|+||+||+|+.++++.||||++...... .+.+.+|+.+++.++||||+++++++. .+..
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 82 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI 82 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCc
Confidence 34556789999999999999999999988889999999754432 567889999999999999999999986 4568
Q ss_pred EEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 884 LLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
++||||+++++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||.++..
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 99999999999999997432 2689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 963 DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 963 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
............+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... .+..........
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~~~------- 228 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----PEVIQNLERGYR------- 228 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCC-------
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH----HHHHHHHhcccC-------
Confidence 5433333344567889999999998889999999999999999999 8999864332 222222211100
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
...+......+.+++.+||+.||++|||++++++.|+++...
T Consensus 229 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 229 ------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 001112234688999999999999999999999999998654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=367.49 Aligned_cols=264 Identities=27% Similarity=0.457 Sum_probs=214.3
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCY 878 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 878 (1114)
....++|++.+.||+|+||+||+|+++ +++.||||+++... .....+.+.+|+.++++++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 345688999999999999999999974 34889999997543 2344677899999999999999999999999
Q ss_pred ecCceEEEEecCCCCCHHHHhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 001253 879 HQGSNLLMYEYMARGSLGELLHGAS-----------------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935 (1114)
Q Consensus 879 ~~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 935 (1114)
+.+..++||||+++|+|.++++... ..+++.++..++.|+++||+|||+. +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 9999999999999999999997532 5789999999999999999999999 9999
Q ss_pred cCCCCCCeEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCC
Q 001253 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPV 1013 (1114)
Q Consensus 936 ~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~ 1013 (1114)
|||||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999986532221 22334568899999999999999999999999999999999 99999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1014 QPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
.... ..+... .+..+... ..+......+.+++.+||+.||++|||+.|+++.|+++..+.
T Consensus 278 ~~~~----~~~~~~-~~~~~~~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 278 YGMA----HEEVIY-YVRDGNIL------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTSC----HHHHHH-HHHTTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCC----hHHHHH-HHhCCCcC------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 6432 222222 22222110 011122346889999999999999999999999999986643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=359.65 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=216.5
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEe------CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVL------RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFC 877 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 877 (1114)
....++|++.+.||+|+||+||+|++ .+++.||||++..... ....+.+.+|+.+++++ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 34457899999999999999999985 2568999999975433 23356788999999999 999999999999
Q ss_pred EecCceEEEEecCCCCCHHHHhccCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 001253 878 YHQGSNLLMYEYMARGSLGELLHGASS-----------------TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKS 940 (1114)
Q Consensus 878 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 940 (1114)
.+++..++||||+++|+|.+++..... .+++..+..++.|+++||+|||+. +|+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence 999999999999999999999975432 489999999999999999999999 999999999
Q ss_pred CCeEECCCCCeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 001253 941 NNILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQ 1018 (1114)
Q Consensus 941 ~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~ 1018 (1114)
+||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999999999876533322 2234567889999999999999999999999999999999 9999976554
Q ss_pred CCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1019 GGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
.......+.. .. . ...+......+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 254 ~~~~~~~~~~----~~------~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 254 DSKFYKMIKE----GF------R------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SHHHHHHHHH----TC------C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHhcc----CC------C------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 3322222221 10 0 001112234688999999999999999999999999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=365.31 Aligned_cols=270 Identities=23% Similarity=0.378 Sum_probs=217.3
Q ss_pred CCHHHHHHHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceee
Q 001253 799 FTFKDLVVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVK 872 (1114)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 872 (1114)
+..+++.+..++|++.+.||+|+||+||+|+++ +++.||||++..... ......+.+|+.+++.++||||++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEee
Confidence 344455567789999999999999999999865 367899999875432 233556889999999999999999
Q ss_pred EEeEEEecCceEEEEecCCCCCHHHHhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 001253 873 LYGFCYHQGSNLLMYEYMARGSLGELLHGAS---------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNI 943 (1114)
Q Consensus 873 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni 943 (1114)
+++++.+.+..++||||+++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NI 169 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC 169 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceE
Confidence 9999999999999999999999999986421 4578999999999999999999999 999999999999
Q ss_pred EECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 001253 944 LLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGD 1021 (1114)
Q Consensus 944 ll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~ 1021 (1114)
+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||....
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 245 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---- 245 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC----
Confidence 999999999999999986542221 12233467889999999999999999999999999999999 888886432
Q ss_pred HHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1022 LVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
....... +...... ..+......+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 246 ~~~~~~~-~~~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 246 NEQVLRF-VMEGGLL------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp HHHHHHH-HHTTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HHHHHHH-HHcCCcC------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 2222222 2221110 011122346889999999999999999999999999986643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=366.02 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=205.8
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 884 (1114)
..++|++.++||+|+||+||+|+.+ +|+.||+|++.+.........+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3478999999999999999999987 5889999999765322223356678899999888 8999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||++||+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999999743 4689999999999999999999999 999999999999999999999999999986432
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .....+...... .
T Consensus 174 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~~~~i~~~~----------~ 238 (353)
T 2i0e_A 174 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----EDELFQSIMEHN----------V 238 (353)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCC----------C
T ss_pred -CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC----HHHHHHHHHhCC----------C
Confidence 2233456789999999999999999999999999999999999999997432 222333322211 1
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPT-----MREVVL 1081 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1081 (1114)
. .+......+.+++.+||+.||++||+ ++|+++
T Consensus 239 ~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred C----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 11122346889999999999999996 455553
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=352.05 Aligned_cols=257 Identities=29% Similarity=0.447 Sum_probs=196.8
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCC-hhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGN-NNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|++. |+.||||++....... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 367999999999999999999986 8999999987654322 23356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC--------CCCeEEeeccC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD--------KFEAHVGDFGL 958 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--------~~~~kl~DfG~ 958 (1114)
|||+++++|.++++ ...+++..+..++.|+++||+|||+....+|+||||||+||+++. ++.+||+|||+
T Consensus 85 ~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 85 MEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999999996 457899999999999999999999982122999999999999986 77899999999
Q ss_pred ceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 001253 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038 (1114)
Q Consensus 959 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1114)
++...... .....|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... .......... ...
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~-~~~-- 232 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG----LAVAYGVAMN-KLA-- 232 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH----HHHHHHHHTS-CCC--
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHhhhcC-CCC--
Confidence 98654222 2345799999999999999999999999999999999999999975332 1111111111 110
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
...+......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 233 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 ---------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111122234688999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=363.74 Aligned_cols=252 Identities=24% Similarity=0.311 Sum_probs=199.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|+.+ +++.||||++...... .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 468999999999999999999987 7899999999765433 35578999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC--eEEeeccCceecCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE--AHVGDFGLAKVIDM 964 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DfG~a~~~~~ 964 (1114)
|||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||+++...
T Consensus 95 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~- 169 (361)
T 3uc3_A 95 MEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 169 (361)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc-
Confidence 999999999999974 34689999999999999999999998 9999999999999987765 9999999998532
Q ss_pred CCCCccccccccccccCccccccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEK-CDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
.........||+.|+|||++.+..++.+ +||||+||++|+|++|+.||............++.........
T Consensus 170 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~------- 241 (361)
T 3uc3_A 170 -LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI------- 241 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC-------
T ss_pred -ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC-------
Confidence 2223345579999999999988887665 8999999999999999999987766666666555543321100
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.........+.+++.+||+.||++|||+.|+++
T Consensus 242 -----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 242 -----PDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp -----CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred -----CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 011112246789999999999999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=367.37 Aligned_cols=275 Identities=16% Similarity=0.193 Sum_probs=219.8
Q ss_pred hcCCcCCceecccCCeEEEEEEeCC---------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceee------
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRT---------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVK------ 872 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 872 (1114)
.++|++.+.||+|+||+||+|++.. ++.||||++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3689999999999999999999763 789999998754 23778999999999999887
Q ss_pred ---------EEeEEEe-cCceEEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 001253 873 ---------LYGFCYH-QGSNLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSN 941 (1114)
Q Consensus 873 ---------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 941 (1114)
+++++.. ++..++||||+ +++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 6777776 67889999999 89999999854 35799999999999999999999999 9999999999
Q ss_pred CeEECCCC--CeEEeeccCceecCCCCC------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCC
Q 001253 942 NILLDDKF--EAHVGDFGLAKVIDMPQS------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPV 1013 (1114)
Q Consensus 942 Nill~~~~--~~kl~DfG~a~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~ 1013 (1114)
||+++.++ .+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 899999999986542211 1223457999999999999999999999999999999999999999
Q ss_pred CCCCCCCC-HHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCC
Q 001253 1014 QPLDQGGD-LVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGH 1092 (1114)
Q Consensus 1014 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 1092 (1114)
........ .............. +.+. ..........+.+++.+||+.||++|||++|+++.|+++....+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGP---FVGP-----CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCC---EECT-----TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccCCcCHHHHHHHHHhccCChhh---hhhh-----ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 76542222 22222222221110 0000 000011124688999999999999999999999999999999999
Q ss_pred cccccCCCCC
Q 001253 1093 FEFSPMDHDS 1102 (1114)
Q Consensus 1093 ~~~~~~~~~~ 1102 (1114)
...+++||+.
T Consensus 341 ~~~~~~dw~~ 350 (352)
T 2jii_A 341 SPYDPIGLPM 350 (352)
T ss_dssp CTTSCCCCCC
T ss_pred CcCccccCcC
Confidence 9999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=351.74 Aligned_cols=264 Identities=22% Similarity=0.255 Sum_probs=206.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|++. +++.||+|++...........+.+.+|+.++++++||||+++++++..++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 68999999999999999999976 78999999998766555555678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.++++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 114 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 114 RLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp ECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 999999999999743 4689999999999999999999999 999999999999999999999999999987654333
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......|++.|+|||++.+..++.++||||+|+++|||++|+.||.... .......+.......
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~---------- 254 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-----LSVMGAHINQAIPRP---------- 254 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH-----HHHHHHHHHSCCCCG----------
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch-----HHHHHHHhccCCCCc----------
Confidence 33445679999999999999999999999999999999999999997432 222223222211100
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhhccCC
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRP-TMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~~ 1091 (1114)
..........+.+++.+||+.||++|| +++++++.|+++.....
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 001111223588899999999999999 99999999998865543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=367.02 Aligned_cols=255 Identities=22% Similarity=0.302 Sum_probs=205.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCC--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNRE--GNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
.++|++.+.||+|+||+||+|+.+ +|+.||||++..... ......+.+.+|+.+++.++||||+++++++.+++..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 367999999999999999999976 789999999864321 11123567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC---eEEeeccC
Q 001253 885 LMYEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE---AHVGDFGL 958 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfG~ 958 (1114)
+||||+++|+|.+.+.. ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999888753 234689999999999999999999999 9999999999999987654 99999999
Q ss_pred ceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 001253 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038 (1114)
Q Consensus 959 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1114)
++..... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......... .+
T Consensus 180 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~i~~~-~~--- 249 (351)
T 3c0i_A 180 AIQLGES-GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-----ERLFEGIIKG-KY--- 249 (351)
T ss_dssp CEECCTT-SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-----HHHHHHHHHT-CC---
T ss_pred eeEecCC-CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-----HHHHHHHHcC-CC---
Confidence 9876532 222345679999999999999999999999999999999999999997522 1222222221 11
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++|||+.|+++
T Consensus 250 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 ------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000112346889999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=369.15 Aligned_cols=253 Identities=23% Similarity=0.254 Sum_probs=198.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHH-HhcCCCCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILT-LGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.++||+|+||+||+|+.+ +++.||+|++.+...........+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999987 688999999987654433334556667766 577899999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||++||+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~- 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE- 191 (373)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc-
Confidence 9999999999999974 34688999999999999999999999 999999999999999999999999999986432
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .....+...... ..
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~~~~i~~~~----------~~ 257 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----TAEMYDNILNKP----------LQ 257 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB----HHHHHHHHHHSC----------CC
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhcc----------cC
Confidence 2233456789999999999999999999999999999999999999997533 222233322211 11
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1083 (1114)
. +......+.+++.+||+.||.+||++.+.++.+
T Consensus 258 ~----~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 258 L----KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp C----CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred C----CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 1 111234678999999999999999986544444
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=359.50 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=214.4
Q ss_pred HHhcCCcCCceecccCCeEEEEEEe------CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVL------RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH 879 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 879 (1114)
...++|++.+.||+|+||+||+|++ .+++.||||++.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 3457899999999999999999986 245789999997543 23445678899999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 001253 880 QGSNLLMYEYMARGSLGELLHGAS-----------------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHR 936 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 936 (1114)
.+..++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence 999999999999999999997533 2489999999999999999999999 99999
Q ss_pred CCCCCCeEECCCCCeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCC
Q 001253 937 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQ 1014 (1114)
Q Consensus 937 Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~ 1014 (1114)
||||+||++++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876433221 2234467889999999999899999999999999999999 999997
Q ss_pred CCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1015 PLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
..... ..... +..... ...+......+.+++.+||+.||++||++.|+++.|+++..+
T Consensus 255 ~~~~~-~~~~~----~~~~~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 255 GIPPE-RLFNL----LKTGHR------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TCCGG-GHHHH----HHTTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHH-HHHHH----hhcCCc------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 54432 22221 121110 011112234688999999999999999999999999998654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=358.31 Aligned_cols=262 Identities=24% Similarity=0.400 Sum_probs=217.3
Q ss_pred HHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 804 LVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 804 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
+.+..++|++.+.||+|+||+||+|+++ +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++.
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3345688999999999999999999987 588999999975432 35678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 883 NLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999999753 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.............+++.|+|||++.+..++.++||||+|+++|+|++ |..||...... .....+ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~~~~~----~~~~------ 229 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELL----EKDY------ 229 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHH----HTTC------
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH----hccC------
Confidence 65444344445567889999999999999999999999999999999 99998754322 222211 1110
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
. ...+......+.+++.+||+.||++|||++|+++.|+++...
T Consensus 230 --~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 230 --R----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp --C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --C----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 111112234688999999999999999999999999988654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=361.50 Aligned_cols=258 Identities=24% Similarity=0.427 Sum_probs=203.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcE----EEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHT----VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
.++|++.++||+|+||+||+|++. +++. ||+|++..... ....+.+.+|+.++++++||||+++++++.++.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 367999999999999999999975 4443 57887754332 233567899999999999999999999998754
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.++|+||+++|+|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 7899999999999999987777899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 963 DMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 963 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ...... +.....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~----~~~~~~----- 237 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSI----LEKGER----- 237 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHH----HHTTCC-----
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-HHHHHH----HHcCCC-----
Confidence 533322 2234457889999999999999999999999999999999 9999975432 222222 211110
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
...+......+.+++.+||+.||++||+++|+++.|+++..
T Consensus 238 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 238 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01112223468899999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=361.75 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=190.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|+++ +++.||||++..... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 478999999999999999999987 688999999975432 35678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD---KFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG~a~~~~ 963 (1114)
|||+++|+|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 127 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 127 LELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp ECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999999974 34689999999999999999999999 9999999999999975 8899999999998654
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+..... ..
T Consensus 203 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~i~~~-~~-------- 268 (349)
T 2w4o_A 203 H--QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD---QFMFRRILNC-EY-------- 268 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH---HHHHHHHHTT-CC--------
T ss_pred c--ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc---HHHHHHHHhC-CC--------
Confidence 2 22334567999999999999999999999999999999999999999754321 1122222221 11
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++|||+.|+++
T Consensus 269 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 -YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001111122346889999999999999999999876
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=350.11 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=187.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+.. +|+.||||++...........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 57999999999999999999975 78999999997543322233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.+++......+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH- 166 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-
Confidence 99999999999987667899999999999999999999999 99999999999999999999999999998764322
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......|++.|+|||++.+..++.++||||+|+++|||++|+.||......... .. .......
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~----------~~~~~~~-- 230 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----NK----------VVLADYE-- 230 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSSCCC--
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----HH----------HhhcccC--
Confidence 2223457999999999999989999999999999999999999999754432211 00 0001111
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+......+.+++.+||+.||++|||++|+++
T Consensus 231 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 --MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11122346789999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=362.60 Aligned_cols=247 Identities=19% Similarity=0.236 Sum_probs=206.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+.+ +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67999999999999999999986 78999999997653322233567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC---
Confidence 999999999999743 4689999999999999999999999 999999999999999999999999999987542
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ........... . ..
T Consensus 194 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~i~~~-~---------~~-- 256 (350)
T 1rdq_E 194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQIYEKIVSG-K---------VR-- 256 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-C---------CC--
T ss_pred -CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC----HHHHHHHHHcC-C---------CC--
Confidence 2345679999999999999999999999999999999999999997432 22222222221 1 11
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPT-----MREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1081 (1114)
.+......+.+++.+||+.||++||+ ++|+++
T Consensus 257 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11122346889999999999999998 777764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=362.65 Aligned_cols=268 Identities=23% Similarity=0.372 Sum_probs=198.2
Q ss_pred HHHHHhcCCcCCceecccCCeEEEEEEeCC-C---cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 001253 803 DLVVATDNFDERFVIGRGACGTVYRAVLRT-G---HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCY 878 (1114)
Q Consensus 803 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 878 (1114)
++.+..++|++.+.||+|+||+||+|+++. + ..||||+++...... ...+.+.+|+.++++++||||+++++++.
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 334456789999999999999999999763 3 279999997654333 33567889999999999999999999998
Q ss_pred ecCce------EEEEecCCCCCHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 001253 879 HQGSN------LLMYEYMARGSLGELLHGA-----SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947 (1114)
Q Consensus 879 ~~~~~------~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 947 (1114)
..... ++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcC
Confidence 77655 9999999999999998532 22689999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHH
Q 001253 948 KFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTW 1025 (1114)
Q Consensus 948 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~ 1025 (1114)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||+||++|||++ |+.||....... ..
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~-- 249 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IY-- 249 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HH--
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-HH--
Confidence 99999999999986543222 22234457889999999999999999999999999999999 899997544322 11
Q ss_pred HHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 001253 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1091 (1114)
........ ...+......+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 250 -~~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 250 -NYLIGGNR-------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp -HHHHTTCC-------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred -HHHhcCCC-------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 11111110 01111223468899999999999999999999999999966443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=356.45 Aligned_cols=266 Identities=21% Similarity=0.390 Sum_probs=191.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|+.+ +|+.||+|++...... ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 467999999999999999999976 6899999999765432 2245678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 887 YEYMARGSLGELLHGA-----SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
|||+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 999985 999988632 24689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC--cccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS--LVSG 1038 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 1038 (1114)
...+. .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ...+.+...... ....
T Consensus 158 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 158 FGIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-LKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp TTSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCTTTCGG
T ss_pred cCCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhHhhh
Confidence 64322 22345578999999999876 4689999999999999999999999975443211 111212111100 0000
Q ss_pred c-----ccccccCCCc----------ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1039 M-----LDARLNLQDE----------KTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1039 ~-----~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. .......... ........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000000000 00112346889999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=348.74 Aligned_cols=253 Identities=20% Similarity=0.317 Sum_probs=208.1
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--CceEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLLM 886 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 886 (1114)
++|++.+.||+|+||+||+|+++ ++.||||++...... ....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 67999999999999999999987 889999999765433 34456789999999999999999999999887 778999
Q ss_pred EecCCCCCHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHDCKPR--IFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|||+++|+|.++++.... .+++..+..++.|+++||+|||+. + ++||||||+||+++.++.++++|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999986544 589999999999999999999998 7 9999999999999999999999999876432
Q ss_pred CCCCCccccccccccccCccccccCCCCc---ccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTE---KCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.....||+.|+|||++.+..++. ++||||+|+++|||++|+.||..... .............
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~----- 229 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN----MEIGMKVALEGLR----- 229 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH----HHHHHHHHHSCCC-----
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh----HHHHHHHHhcCCC-----
Confidence 12346899999999998765554 79999999999999999999974332 2222222222110
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
...+......+.+++.+||+.||++|||++|+++.|+++..
T Consensus 230 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 -------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 01111223468899999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=359.27 Aligned_cols=265 Identities=24% Similarity=0.394 Sum_probs=213.7
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC--------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR--------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFC 877 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 877 (1114)
..++|++.+.||+|+||+||+|++. +++.||||++.... .....+.+.+|+.+++++ +||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 4588999999999999999999863 46789999997543 233456788999999999 899999999999
Q ss_pred EecCceEEEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 001253 878 YHQGSNLLMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNN 942 (1114)
Q Consensus 878 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 942 (1114)
.+.+..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 99999999999999999999997543 2489999999999999999999999 99999999999
Q ss_pred eEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 001253 943 ILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGG 1020 (1114)
Q Consensus 943 ill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~ 1020 (1114)
|+++.++.+||+|||+++....... .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||....
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--- 264 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--- 264 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---
Confidence 9999999999999999987653322 12233467889999999998889999999999999999999 999996432
Q ss_pred CHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCc
Q 001253 1021 DLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHF 1093 (1114)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 1093 (1114)
..+..+. +..... ...+......+.+++.+||+.||.+|||+.|+++.|+++.......
T Consensus 265 -~~~~~~~-~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 265 -VEELFKL-LKEGHR------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp -HHHHHHH-HHHTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred -HHHHHHH-HhcCCC------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 2222222 211110 0111122346889999999999999999999999999997654443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=352.41 Aligned_cols=272 Identities=25% Similarity=0.336 Sum_probs=211.0
Q ss_pred HHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhc--CCCCceeeEEeEEEec-
Q 001253 804 LVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGK--IRHRNIVKLYGFCYHQ- 880 (1114)
Q Consensus 804 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~- 880 (1114)
.....++|++.++||+|+||+||+|+++ ++.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3345578999999999999999999987 8999999986432 2334445555554 4899999999999887
Q ss_pred ---CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeEECCCCCeE
Q 001253 881 ---GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC-----KPRIFHRDIKSNNILLDDKFEAH 952 (1114)
Q Consensus 881 ---~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~k 952 (1114)
...++||||+++|+|.++++. ..+++..+..++.|++.||+|||+.+ .++|+||||||+||+++.++.+|
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 678999999999999999974 36899999999999999999999752 34899999999999999999999
Q ss_pred EeeccCceecCCCCCC---ccccccccccccCccccccCCCCcc------cchHHHHHHHHHHHhC----------CCCC
Q 001253 953 VGDFGLAKVIDMPQSK---SMSAIAGSYGYIAPEYAYTMKVTEK------CDIYSYGVVLLELLTG----------RAPV 1013 (1114)
Q Consensus 953 l~DfG~a~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~------~DvwslGvil~el~tg----------~~p~ 1013 (1114)
|+|||+++........ ......||+.|+|||++.+..++.+ +|||||||++|||++| +.||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999999865432221 1234579999999999987766665 9999999999999999 7777
Q ss_pred CCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1014 QPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
......................... .. ...........+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPS-----FP-NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCC-----CC-GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhhcCCCCchhhhHHHHhhhccCcc-----cc-ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 6655444444444443332221111 00 01112356678999999999999999999999999999987654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=353.14 Aligned_cols=264 Identities=23% Similarity=0.347 Sum_probs=204.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce---
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN--- 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 883 (1114)
.++|++.+.||+|+||+||+|++. +++.||||++.............+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 368999999999999999999974 7899999999877666666667889999999999999999999998876544
Q ss_pred -EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 884 -LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 884 -~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
|+||||+++++|.++++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 9999999999999999743 4689999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCC--CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 963 DMPQS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 963 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.... .................
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~-- 240 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS----PVSVAYQHVREDPIPPS-- 240 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHCCCCCHH--
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCCCCCcc--
Confidence 43222 22334579999999999999999999999999999999999999996433 22222222222111100
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHHHHhhhcc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMR-EVVLMLSESNRR 1089 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~L~~i~~~ 1089 (1114)
.........+.+++.+||+.||++||++. ++.+.+.++...
T Consensus 241 --------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 241 --------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp --------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred --------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 00111234688999999999999999554 556677666443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=351.64 Aligned_cols=264 Identities=22% Similarity=0.316 Sum_probs=205.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|+.. +|+.||||++...........+.+.+|+.++++++||||+++++++..++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 367999999999999999999975 7899999999875555555667889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|||+++++|.+++.. ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999863 355789999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
... .......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......+. +.......
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~-~~~~~~~~------ 257 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKK-IEQCDYPP------ 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C--CHHHHHHH-HHTTCSCC------
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch--hHHHHHHH-hhcccCCC------
Confidence 222 223345789999999999999999999999999999999999999974332 22222222 22111100
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
.........+.+++.+||+.||++|||++|+++.|++++..
T Consensus 258 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 258 -----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp -----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00111234688999999999999999999999999998664
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=370.96 Aligned_cols=280 Identities=20% Similarity=0.247 Sum_probs=224.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC-CceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH-RNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.++||+|+||+||+|++. +++.||||++...... ..+..|+++++.++| +++..+..++...+..++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 468999999999999999999974 7899999998755442 236789999999987 566666667777888899
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---CCCCCeEEeeccCceec
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL---DDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfG~a~~~ 962 (1114)
||||+ +++|.+++......+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.+
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99999 8899999987677899999999999999999999999 99999999999999 58899999999999876
Q ss_pred CCCCCC------ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 001253 963 DMPQSK------SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLV 1036 (1114)
Q Consensus 963 ~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1114)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~i~~~-~~~ 234 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEK-KVA 234 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH-HHHHHHHHH-HHH
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH-HHHHHHhhc-ccc
Confidence 543321 223567999999999999999999999999999999999999999865543322 222211111 000
Q ss_pred cccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCCcccc
Q 001253 1037 SGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDSDQKL 1106 (1114)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~~~ 1106 (1114)
..+ . ........++.+++.+||+.||++||++.+|++.|+++..+.+..++..+||+.....
T Consensus 235 ~~~-~-------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~ 296 (483)
T 3sv0_A 235 TSI-E-------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (483)
T ss_dssp SCH-H-------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-
T ss_pred ccH-H-------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccc
Confidence 000 0 0001112468899999999999999999999999999999999999999998755443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=375.62 Aligned_cols=255 Identities=25% Similarity=0.310 Sum_probs=210.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|+.+ +|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999986 7999999999764322222356678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 887 YEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|||++||+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~- 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence 99999999999997543 3599999999999999999999999 999999999999999999999999999987642
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||.............+..... .
T Consensus 339 -~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~----------- 405 (576)
T 2acx_A 339 -GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-P----------- 405 (576)
T ss_dssp -TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-C-----------
T ss_pred -CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-c-----------
Confidence 223345689999999999999999999999999999999999999998655433333332222211 1
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
...+......+.+++.+||+.||++|| +++|+++
T Consensus 406 --~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 --EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 011112234688999999999999999 7788864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=351.98 Aligned_cols=263 Identities=25% Similarity=0.378 Sum_probs=209.0
Q ss_pred hcCCcCCceecccCCeEEEEEEe-----CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--
Q 001253 808 TDNFDERFVIGRGACGTVYRAVL-----RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ-- 880 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 880 (1114)
.++|++.++||+|+||+||+|++ .+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 36689999999999999999994 36899999999765432 2356789999999999999999999999876
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 881 GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
...++||||+++|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 568999999999999999976667899999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC--CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC----------CCCCHHHHHHH
Q 001253 961 VIDMPQS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLD----------QGGDLVTWVRN 1028 (1114)
Q Consensus 961 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~----------~~~~~~~~~~~ 1028 (1114)
....... .......||..|+|||++.+..++.++||||+|+++|||++|+.|+.... ........+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 7653332 22334568889999999999999999999999999999999998864211 00111111111
Q ss_pred HHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
...... ....+......+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 255 ~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGK------------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTC------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccC------------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111 01112223356889999999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=347.77 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=211.5
Q ss_pred hcCCcCCc-eecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERF-VIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.++|.+.+ .||+|+||+||+|+++ ++..||||+++... .....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 35676666 8999999999999864 57889999997653 234466788999999999999999999999 55678
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++++|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999999987677899999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCC--ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 964 MPQSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 964 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..... ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..... .+.. ..+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~-~~i~~~~~----- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVM-AFIEQGKR----- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHHH-HHHHTTCC-----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----HHHH-HHHhcCCc-----
Confidence 33221 1233457899999999998889999999999999999998 9999975432 1111 12222110
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
...+......+.+++.+||+.||++||++.|+++.|+++...
T Consensus 232 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 232 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111122334688999999999999999999999999998443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=371.95 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=207.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|.+.+.||+|+||+||+|+++ +|+.||||++...........+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67999999999999999999986 79999999997653322233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... .
T Consensus 96 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~--~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--G 169 (476)
T ss_dssp ECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT--T
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc--c
Confidence 99999999999974 45799999999999999999999998 999999999999999999999999999987643 2
Q ss_pred CccccccccccccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... ....+.... +.+ .
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~-~~~---------~- 234 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV----PTLFKKICD-GIF---------Y- 234 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS----HHHHHHHHT-TCC---------C-
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH----HHHHHHHhc-CCc---------C-
Confidence 33445689999999999988775 6899999999999999999999974332 222222221 111 1
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+......+.+++.+||+.||++|||++|+++
T Consensus 235 ---~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 ---TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 01112246789999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=358.20 Aligned_cols=272 Identities=25% Similarity=0.386 Sum_probs=218.6
Q ss_pred CCHHHHHHHhcCCcCCceecccCCeEEEEEEe------CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCcee
Q 001253 799 FTFKDLVVATDNFDERFVIGRGACGTVYRAVL------RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIV 871 (1114)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 871 (1114)
+....+....++|++.+.||+|+||+||+|++ .+++.||||++..... ....+.+.+|+.+++++ +||||+
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv 94 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVV 94 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCee
Confidence 34455666778999999999999999999984 2568999999975432 33456788999999999 799999
Q ss_pred eEEeEEEecC-ceEEEEecCCCCCHHHHhccCCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 001253 872 KLYGFCYHQG-SNLLMYEYMARGSLGELLHGASS---------------TLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935 (1114)
Q Consensus 872 ~l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 935 (1114)
++++++...+ ..++||||+++|+|.+++..... .+++..+..++.|+++||+|||+. +|+|
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H 171 (316)
T 2xir_A 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 171 (316)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9999998755 58999999999999999985443 289999999999999999999999 9999
Q ss_pred cCCCCCCeEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCC
Q 001253 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPV 1013 (1114)
Q Consensus 936 ~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~ 1013 (1114)
|||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||+|+++|||++ |+.||
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987643322 22334568899999999999999999999999999999998 99999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 001253 1014 QPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1091 (1114)
............+.. ... . ..+......+.+++.+||+.||.+|||+.|+++.|+++.....
T Consensus 252 ~~~~~~~~~~~~~~~----~~~--------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 252 PGVKIDEEFCRRLKE----GTR--------M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TTCCCSHHHHHHHHH----TCC--------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cccchhHHHHHHhcc----Ccc--------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 765433222222211 110 0 0111123468899999999999999999999999999876543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=349.14 Aligned_cols=264 Identities=25% Similarity=0.320 Sum_probs=211.7
Q ss_pred CCcCCceecccCCeEEEEEEeC-C---CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce-E
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-T---GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN-L 884 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~ 884 (1114)
.|+..++||+|+||+||+|++. + +..||+|++.... .....+.+.+|+.++++++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 4666789999999999999864 2 2379999987533 233456788999999999999999999999876655 9
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||+.+|+|.+++......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999999987777899999999999999999999999 999999999999999999999999999986532
Q ss_pred CC---CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 965 PQ---SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 965 ~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
.. ........+++.|+|||.+.+..++.++||||+|+++|||++|..|+............+.. ...
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~----~~~------ 246 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ----GRR------ 246 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT----TCC------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc----CCC------
Confidence 21 12233456889999999999999999999999999999999976665443333333322221 110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcc
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFE 1094 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 1094 (1114)
...+......+.+++.+||+.||.+|||++|+++.|+++..+.....
T Consensus 247 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 247 ------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred ------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 01111123468899999999999999999999999999977655443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=364.01 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=202.2
Q ss_pred cCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecC
Q 001253 812 DERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYM 890 (1114)
Q Consensus 812 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 890 (1114)
...+.||+|+||+||+|+.. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 33568999999999999975 789999999976432 33567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE--CCCCCeEEeeccCceecCCCCCC
Q 001253 891 ARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL--DDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 891 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill--~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
++|+|.+++......+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||+++..... .
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~ 243 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--E 243 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--C
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--c
Confidence 99999999976666799999999999999999999999 99999999999999 67789999999999976432 2
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+......... ...
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~----------~~~ 309 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN----DAETLNNILACRWD----------LED 309 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHTCCC----------SCS
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccCC----------CCh
Confidence 3344579999999999999899999999999999999999999997543 22333333322110 011
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhh
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSES 1086 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1086 (1114)
.........+.+++.+||+.||.+|||+.|+++ .+++.
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 111122346889999999999999999999987 55443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.82 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=197.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCC-----------------------hhhHHHHHHHHHHHh
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGN-----------------------NNVDNSFRAEILTLG 863 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~ 863 (1114)
.++|++.+.||+|+||+||+|+.+ +++.||||++....... ....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999975 68999999997653211 112346889999999
Q ss_pred cCCCCceeeEEeEEEe--cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 001253 864 KIRHRNIVKLYGFCYH--QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSN 941 (1114)
Q Consensus 864 ~l~h~niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 941 (1114)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 9999999999999987 567899999999999998765 35799999999999999999999999 9999999999
Q ss_pred CeEECCCCCeEEeeccCceecCCCCCCccccccccccccCccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 001253 942 NILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMK---VTEKCDIYSYGVVLLELLTGRAPVQPLDQ 1018 (1114)
Q Consensus 942 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslGvil~el~tg~~p~~~~~~ 1018 (1114)
||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++||||+||++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~- 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER- 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred HEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc-
Confidence 9999999999999999998764322 2234567999999999997665 4778999999999999999999996432
Q ss_pred CCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1019 GGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
........... ... . .........+.+++.+||+.||++|||+.|+++
T Consensus 245 ---~~~~~~~~~~~-~~~-------~----~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 ---IMCLHSKIKSQ-ALE-------F----PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ---HHHHHHHHHHC-CCC-------C----CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---HHHHHHHHhcc-cCC-------C----CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 22222221111 110 0 001112246889999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=356.19 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=199.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC------
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG------ 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 881 (1114)
++|++.+.||+|+||+||+|+++ +|+.||||++..... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 67999999999999999999987 799999999975443 234577899999999999999999999986543
Q ss_pred ---------------------------------------------------ceEEEEecCCCCCHHHHhccCCC--CCCH
Q 001253 882 ---------------------------------------------------SNLLMYEYMARGSLGELLHGASS--TLDW 908 (1114)
Q Consensus 882 ---------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~--~l~~ 908 (1114)
..++||||+++|+|.++++.... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 27899999999999999985432 4567
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC-----------Cccccccccc
Q 001253 909 QTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-----------KSMSAIAGSY 977 (1114)
Q Consensus 909 ~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-----------~~~~~~~g~~ 977 (1114)
..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78899999999999999999 999999999999999999999999999987654321 2234457999
Q ss_pred cccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHH
Q 001253 978 GYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMIT 1057 (1114)
Q Consensus 978 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1114)
.|+|||++.+..++.++||||+||++|||++|..|+.. ....... ..... ...........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~------~~~~~~~-~~~~~------------~~~~~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME------RVRIITD-VRNLK------------FPLLFTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH------HHHHHHH-HHTTC------------CCHHHHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH------HHHHHHH-hhccC------------CCcccccCChh
Confidence 99999999999999999999999999999998766421 1111111 11110 01122334456
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1058 VLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1058 l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+.+++.+||+.||++|||++|+++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 789999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=352.31 Aligned_cols=255 Identities=31% Similarity=0.485 Sum_probs=200.6
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
++|++.+.||+|+||+||+|+++ ++.||||++... ...+.+.+|+.++++++||||+++++++. +..++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEE
Confidence 67899999999999999999986 789999998643 23567899999999999999999999876 45899999
Q ss_pred cCCCCCHHHHhccCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC-eEEeeccCceecCCC
Q 001253 889 YMARGSLGELLHGASS--TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE-AHVGDFGLAKVIDMP 965 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~DfG~a~~~~~~ 965 (1114)
|+++|+|.++++.... .+++..+..++.|+++||+|||+....+|+||||||+||+++.++. +||+|||+++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9999999999985443 5789999999999999999999932238999999999999998886 799999999865322
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......... .....
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~-~~~~~---------- 222 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG--PAFRIMWAV-HNGTR---------- 222 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS--SHHHHHHHH-HTTCC----------
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc--cHHHHHHHH-hcCCC----------
Confidence 2334699999999999999999999999999999999999999975432 222221111 11110
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
..........+.+++.+||+.||++|||++|+++.|+++....
T Consensus 223 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 223 --PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp --CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred --CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 0111112346789999999999999999999999999986654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=362.56 Aligned_cols=276 Identities=18% Similarity=0.220 Sum_probs=210.1
Q ss_pred hcCCcCCceeccc--CCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 808 TDNFDERFVIGRG--ACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 808 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
.++|++.++||+| +||+||+|+++ +|+.||||++...... ....+.+.+|+.+++.++|||||++++++.+++..|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 4789999999999 99999999987 7999999999765443 344667889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 885 LMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999754 35799999999999999999999999 99999999999999999999999999986542
Q ss_pred CCC------CCccccccccccccCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC--
Q 001253 964 MPQ------SKSMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN-- 1033 (1114)
Q Consensus 964 ~~~------~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-- 1033 (1114)
... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||............+.......
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 111 112233478999999999987 6799999999999999999999999976554433322221111000
Q ss_pred --------------------Cccccccc--c----cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHh
Q 001253 1034 --------------------SLVSGMLD--A----RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM--LSE 1085 (1114)
Q Consensus 1034 --------------------~~~~~~~~--~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~ 1085 (1114)
...+.... . ...............+.+++.+||+.||++|||++|+++- +++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 00000000 0 0000001112233568899999999999999999999853 444
Q ss_pred hh
Q 001253 1086 SN 1087 (1114)
Q Consensus 1086 i~ 1087 (1114)
+.
T Consensus 340 ~~ 341 (389)
T 3gni_B 340 IK 341 (389)
T ss_dssp C-
T ss_pred Hh
Confidence 43
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=348.66 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=208.4
Q ss_pred HhcCCcCCceecccCCeEEEEEEeCC----CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLRT----GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
..++|++.+.||+|+||+||+|++.. +..||+|++.... .....+.+.+|+.+++.++||||+++++++.+ +.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 34789999999999999999998642 3469999987653 23346778999999999999999999999865 45
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.++||||+++++|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 7899999999999999987667799999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 963 DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 963 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
............+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... .....+.. . ..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-~~~~~~~~---~-~~------ 232 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIGVLEK---G-DR------ 232 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-GHHHHHHH---T-CC------
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-HHHHHHhc---C-CC------
Confidence 5433333344567889999999998999999999999999999998 99999754332 22222111 1 00
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
. ..+......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 233 --~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 233 --L----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp --C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --C----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0 01111234688999999999999999999999999998553
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=359.85 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=206.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+.|+..+.||+|+||+||+|+.. +|+.||||++...........+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 56889999999999999999974 78999999998665555555677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||++ |++.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence 9998 588888875567899999999999999999999999 999999999999999999999999999986532
Q ss_pred CccccccccccccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ....+......... ..
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~----~~~~~~~~~~~~~~-------~~ 273 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHIAQNESP-------AL 273 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHSCCC-------CC
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCC-------CC
Confidence 23457999999999984 5678999999999999999999999996433 22233332222110 00
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
........+.+++.+||+.||++|||++|+++.
T Consensus 274 -----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 -----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -----CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 011122457889999999999999999999764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=352.27 Aligned_cols=257 Identities=19% Similarity=0.326 Sum_probs=205.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CC-------cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TG-------HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH 879 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 879 (1114)
.++|++.+.||+|+||+||+|+++ ++ ..||+|++..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 468999999999999999999975 33 4799999865432 335678999999999999999999999999
Q ss_pred cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC--------e
Q 001253 880 QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE--------A 951 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--------~ 951 (1114)
++..++||||+++|+|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999987666699999999999999999999999 9999999999999998887 9
Q ss_pred EEeeccCceecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 001253 952 HVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFI 1030 (1114)
Q Consensus 952 kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 1030 (1114)
||+|||.+.... ......|++.|+|||++.+ ..++.++||||+|+++|||++|..|+..... ...... ..
T Consensus 161 kl~Dfg~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~-~~ 231 (289)
T 4fvq_A 161 KLSDPGISITVL-----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD---SQRKLQ-FY 231 (289)
T ss_dssp EECCCCSCTTTS-----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHH-HH
T ss_pred eeccCccccccc-----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc---hHHHHH-Hh
Confidence 999999987542 1234568899999999987 6789999999999999999996555432222 111111 11
Q ss_pred hcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCc
Q 001253 1031 RNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHF 1093 (1114)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 1093 (1114)
....... .. ....+.+++.+||+.||++|||++|+++.|+++....+..
T Consensus 232 ~~~~~~~----------~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 232 EDRHQLP----------AP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp HTTCCCC----------CC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred hccCCCC----------CC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 1111000 00 1224778999999999999999999999999997655443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=352.48 Aligned_cols=275 Identities=26% Similarity=0.336 Sum_probs=217.6
Q ss_pred CCHHHHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhc--CCCCceeeEEeE
Q 001253 799 FTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGK--IRHRNIVKLYGF 876 (1114)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~ 876 (1114)
..+.......++|++.+.||+|+||+||+|+++ |+.||||++.... .+.+.+|++++.. ++||||++++++
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAA 104 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence 344444556689999999999999999999985 8999999986432 4556778888776 789999999999
Q ss_pred EEecC----ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeE
Q 001253 877 CYHQG----SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH--------HDCKPRIFHRDIKSNNIL 944 (1114)
Q Consensus 877 ~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~Nil 944 (1114)
+.... ..++||||+++|+|.++++. ..+++.++..++.|++.||+||| +. +|+||||||+||+
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 98876 78999999999999999974 36899999999999999999999 66 9999999999999
Q ss_pred ECCCCCeEEeeccCceecCCCCCC---ccccccccccccCccccccC------CCCcccchHHHHHHHHHHHhC------
Q 001253 945 LDDKFEAHVGDFGLAKVIDMPQSK---SMSAIAGSYGYIAPEYAYTM------KVTEKCDIYSYGVVLLELLTG------ 1009 (1114)
Q Consensus 945 l~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslGvil~el~tg------ 1009 (1114)
++.++.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999876533321 23445799999999998765 334689999999999999999
Q ss_pred ----CCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1010 ----RAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1010 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
+.||............+...+...... +.... ..........+.+++.+||+.||++|||+.|+++.|++
T Consensus 260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-----PNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-----CCCCG-GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccccCccccCcCcccHHHHHHHHHHHHhC-----CCCcc-cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 778876554443333333333222111 11100 01223556689999999999999999999999999999
Q ss_pred hhccCC
Q 001253 1086 SNRRQG 1091 (1114)
Q Consensus 1086 i~~~~~ 1091 (1114)
+....+
T Consensus 334 i~~~~~ 339 (342)
T 1b6c_B 334 LSQQEG 339 (342)
T ss_dssp HHHTTC
T ss_pred HHHHhc
Confidence 977654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=360.02 Aligned_cols=262 Identities=27% Similarity=0.401 Sum_probs=201.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC--CC--cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe-cCce
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR--TG--HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH-QGSN 883 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 883 (1114)
..|+..++||+|+||+||+|++. ++ ..||||++.... .....+.+.+|+.++++++||||+++++++.. ++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35777889999999999999964 22 468999986533 23346778999999999999999999998754 5578
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++|+|.++++.....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999999987777899999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCC---CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 964 MPQS---KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 964 ~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||..... .+....+. .+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-~~~~~~~~----~~~~---- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLL----QGRR---- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-SCHHHHHH----TTCC----
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-HHHHHHHH----cCCC----
Confidence 3221 12234467889999999999999999999999999999999 6667764433 33322221 1110
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCC
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGH 1092 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 1092 (1114)
. ..+......+.+++.+||+.||++|||++|+++.|+++......
T Consensus 315 ----~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 315 ----L----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp ----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 0 01111234688999999999999999999999999999765443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=371.97 Aligned_cols=251 Identities=23% Similarity=0.299 Sum_probs=208.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|+.+ +|+.||+|++.+.........+.+..|+.++++++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999986 7999999999765432223356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHGA---SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|||++||+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999998743 34699999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.............+......
T Consensus 341 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~---------- 409 (543)
T 3c4z_A 341 AGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA---------- 409 (543)
T ss_dssp TTC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC----------
T ss_pred CCC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc----------
Confidence 322 223456899999999999999999999999999999999999999986654444444433322221
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTM 1076 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1076 (1114)
. ..+......+.+++.+||+.||++||++
T Consensus 410 ~----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 V----TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp C----CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred c----CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 0 1111223467889999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=385.47 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=214.8
Q ss_pred HHHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 802 KDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 802 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
+.+++..++|++.++||+|+||+||+|+++.+..||||+++..... .+.|.+|+.++++++||||+++++++.+ +
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 3344566889999999999999999999998888999999765432 4678999999999999999999999876 6
Q ss_pred ceEEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 882 SNLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
..|+||||+++|+|.++++.. ...+++.++..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 789999999999999999743 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
..............++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+... .+..+.
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----~~~~~-~i~~~~----- 481 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLD-QVERGY----- 481 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----HHHHH-HHHTTC-----
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH-HHHcCC-----
Confidence 654221112233457789999999999999999999999999999999 8999975432 22222 222211
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
+. ..+......+.++|.+||+.||++|||+++|++.|+++....
T Consensus 482 ---~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 482 ---RM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ---CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ---CC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 00 111122346889999999999999999999999999986543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=356.81 Aligned_cols=259 Identities=25% Similarity=0.425 Sum_probs=203.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcE----EEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHT----VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
.++|++.++||+|+||+||+|++. +++. ||+|.+..... ....+.+.+|+.++++++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 468999999999999999999975 4544 57777654332 233677899999999999999999999998754
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.++|+||+.+|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 7899999999999999987777899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 963 DMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 963 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..... .......+|+.|+|||++.+..++.++||||+||++|||++ |+.||...... ..... +....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~----~~~~~------ 236 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSI----LEKGE------ 236 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHH----HHTTC------
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHH----HHcCC------
Confidence 43222 22234457889999999999999999999999999999999 99999754432 22221 11111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
. ...+......+.+++.+||+.||.+||++.|+++.|+++...
T Consensus 237 --~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 --R----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --C----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --C----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0 011112234688999999999999999999999999998643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=347.46 Aligned_cols=260 Identities=26% Similarity=0.386 Sum_probs=206.6
Q ss_pred cCCcCCceecccCCeEEEEEEeCC----CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEE-ecCce
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRT----GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCY-HQGSN 883 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~ 883 (1114)
.+|++.++||+|+||+||+|++.+ +..||+|++.... .....+.+.+|+.++++++||||+++++++. .++..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 568889999999999999999652 2358999987533 3334567889999999999999999999865 45678
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++|+|.++++.....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccc
Confidence 999999999999999987777899999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCC---CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 964 MPQS---KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTG-RAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 964 ~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
.... .......+|+.|+|||.+.+..++.++||||+|+++|||++| .+||... ...+....+.. ...
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-~~~~~~~~~~~---~~~----- 250 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQ---GRR----- 250 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS-CTTTHHHHHHT---TCC-----
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhc---CCC-----
Confidence 3221 223345678899999999999999999999999999999995 4555433 33333222211 100
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
...+......+.+++.+||+.||++|||++|+++.|+++....
T Consensus 251 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 251 --------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0001112246889999999999999999999999999987643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=369.87 Aligned_cols=264 Identities=23% Similarity=0.303 Sum_probs=198.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-----
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG----- 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 881 (1114)
.++|++.++||+|+||+||+|++. +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 478999999999999999999976 789999999976532 3344567889999999999999999999997553
Q ss_pred -ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 882 -SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 882 -~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
..|+||||+++ ++.+.+. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred CeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 46999999987 5666665 2489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH------------
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRN------------ 1028 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~------------ 1028 (1114)
.... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+.+...++.
T Consensus 213 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 213 TAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred ecCC--CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 7542 23345578999999999999999999999999999999999999999754422211111110
Q ss_pred ------HHhcCCccccc-----ccc-cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1029 ------FIRNNSLVSGM-----LDA-RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1029 ------~~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+.......... ... ...............+.+++.+||++||++|||++|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01000000000 000 000001111222567899999999999999999999886
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=352.96 Aligned_cols=254 Identities=23% Similarity=0.286 Sum_probs=208.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCCh---hhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNN---NVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 367999999999999999999986 689999999986543321 2356789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC----CeEEeeccCc
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF----EAHVGDFGLA 959 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfG~a 959 (1114)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999974 45789999999999999999999999 999999999999999888 7999999999
Q ss_pred eecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
+..... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... ........... ..
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~i~~~-~~---- 235 (321)
T 2a2a_A 167 HEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANITSV-SY---- 235 (321)
T ss_dssp EECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHHTT-CC----
T ss_pred eecCcc--ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHhc-cc----
Confidence 876532 22345579999999999999999999999999999999999999996432 22222222211 10
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++|||+.|+++
T Consensus 236 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 -----DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -----CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -----ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000011112346889999999999999999999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=365.71 Aligned_cols=347 Identities=24% Similarity=0.365 Sum_probs=190.7
Q ss_pred cccccccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccch
Q 001253 195 GNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLET 274 (1114)
Q Consensus 195 ~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 274 (1114)
..+++|+.|++.++.+. .+| .+..+++|++|+|++|.+++. |. ++.+++|++|++++|++++..+ ++++++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 34677888888888776 344 367778888888888888754 33 7788888888888888876544 777778888
Q ss_pred hhcccccccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccc
Q 001253 275 LALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKL 354 (1114)
Q Consensus 275 L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l 354 (1114)
|++++|.+.+..+ +..+++|++|++++|.+.+ ++ .+..+++|++|+++ |.+.+.. .+.++++|+.|++++|.+
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l 189 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKV 189 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcC
Confidence 8887777665533 7777777777777777763 22 35566666666664 3333221 144445555555555554
Q ss_pred cCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccc
Q 001253 355 TGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHI 434 (1114)
Q Consensus 355 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 434 (1114)
++. ..+..+++|++|++++|.+++..+ +. .+++|++|++++|++++. ..+
T Consensus 190 ~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~------------------------~l~~L~~L~l~~n~l~~~--~~l 239 (466)
T 1o6v_A 190 SDI--SVLAKLTNLESLIATNNQISDITP--LG------------------------ILTNLDELSLNGNQLKDI--GTL 239 (466)
T ss_dssp CCC--GGGGGCTTCSEEECCSSCCCCCGG--GG------------------------GCTTCCEEECCSSCCCCC--GGG
T ss_pred CCC--hhhccCCCCCEEEecCCccccccc--cc------------------------ccCCCCEEECCCCCcccc--hhh
Confidence 432 124444444444444444443332 33 344444444444444422 233
Q ss_pred cccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcE
Q 001253 435 CRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQR 514 (1114)
Q Consensus 435 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 514 (1114)
..+++|++|++++|++++..+ +..+++|++|++++|++++..+ +..+++|++|++++|++++..+ +..+++|+.
T Consensus 240 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 313 (466)
T 1o6v_A 240 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTY 313 (466)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSE
T ss_pred hcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCE
Confidence 444445555555555443322 4444555555555555543222 4445555555555555554332 445555555
Q ss_pred EEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccC
Q 001253 515 LHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENEL 594 (1114)
Q Consensus 515 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 594 (1114)
|+|++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|.+
T Consensus 314 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~ 387 (466)
T 1o6v_A 314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387 (466)
T ss_dssp EECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEE
T ss_pred EECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcc
Confidence 5555555554333 44455555555555555432 234445555555555555554443 45555555555555555
Q ss_pred CC
Q 001253 595 SG 596 (1114)
Q Consensus 595 ~~ 596 (1114)
++
T Consensus 388 ~~ 389 (466)
T 1o6v_A 388 TN 389 (466)
T ss_dssp EC
T ss_pred cC
Confidence 53
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=364.64 Aligned_cols=346 Identities=27% Similarity=0.381 Sum_probs=197.8
Q ss_pred CCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccce
Q 001253 124 NCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSF 203 (1114)
Q Consensus 124 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L 203 (1114)
.+++|+.|++++|.+.. +|+ +..+++|++|+|++|++++..| +.++++|++|++++|.+++..| +.++++|++|
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L 117 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HhccccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence 35667777777777764 443 6667777777777777764332 6666666666666666654333 5555555555
Q ss_pred eccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhhccccccc
Q 001253 204 RAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQV 283 (1114)
Q Consensus 204 ~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~ 283 (1114)
++++|.+.+..+ +.++++|++|++++|++++ ++ .++.+++|++|+++ |.+.+.
T Consensus 118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~---------------------- 170 (466)
T 1o6v_A 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDL---------------------- 170 (466)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCC----------------------
T ss_pred ECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCc----------------------
Confidence 555555543222 4455555555555555542 22 24444444444443 223222
Q ss_pred CCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccCccccccc
Q 001253 284 GQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELT 363 (1114)
Q Consensus 284 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 363 (1114)
.+ ++.+++|++|++++|.+.+. ..+..+++|++|++++|.+.+..| +..+++|+.|++++|++++. ..+.
T Consensus 171 --~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~ 240 (466)
T 1o6v_A 171 --KP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA 240 (466)
T ss_dssp --GG--GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGG
T ss_pred --hh--hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhh
Confidence 11 44444455555555544421 124444455555555555444333 44455555555555555543 2455
Q ss_pred ccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCcccee
Q 001253 364 TLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFL 443 (1114)
Q Consensus 364 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L 443 (1114)
.+++|++|++++|.+++..+ +..+++|++|++++|.+.+..+ +..+++|++|+|++|++++..+ +..+++|++|
T Consensus 241 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 314 (466)
T 1o6v_A 241 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYL 314 (466)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEE
T ss_pred cCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEE
Confidence 56666666666666665443 5566666666666666655433 5566666666666666665433 5566667777
Q ss_pred eeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceec
Q 001253 444 NLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFT 523 (1114)
Q Consensus 444 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 523 (1114)
++++|++++..| +..+++|++|++++|++++. ..+..+++|++|++++|++++..| +..+++|+.|++++|.++
T Consensus 315 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp ECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred ECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 777777665544 56667777777777776643 356667777777777777766655 666777777777777776
Q ss_pred c
Q 001253 524 G 524 (1114)
Q Consensus 524 ~ 524 (1114)
+
T Consensus 389 ~ 389 (466)
T 1o6v_A 389 N 389 (466)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=384.70 Aligned_cols=267 Identities=24% Similarity=0.324 Sum_probs=210.4
Q ss_pred hcCCcCCc-eecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERF-VIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.+++.+.+ +||+|+||+||+|.++ ++..||||+++..... ...+.+.+|+.++++++|||||++++++.. +..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 34455555 7999999999999864 4667999999765332 236779999999999999999999999976 568
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++|+|.+++......+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999999987777899999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCC--ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 964 MPQSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 964 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... + +...+..+..
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~-~~~~i~~~~~----- 557 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----E-VMAFIEQGKR----- 557 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----H-HHHHHHTTCC-----
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----H-HHHHHHcCCC-----
Confidence 32221 1223346789999999999999999999999999999998 99999764431 1 1222222111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCccccc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSP 1097 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~ 1097 (1114)
. ..+......+.++|.+||+.||++||+++++++.|+++..........+
T Consensus 558 ---~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~ 607 (613)
T 2ozo_A 558 ---M----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607 (613)
T ss_dssp ---C----CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCS
T ss_pred ---C----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCc
Confidence 1 1112233568899999999999999999999999999866554444333
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=356.53 Aligned_cols=272 Identities=25% Similarity=0.343 Sum_probs=211.0
Q ss_pred hcCCcCCceecccCCeEEEEEEe-----CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEE--ec
Q 001253 808 TDNFDERFVIGRGACGTVYRAVL-----RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCY--HQ 880 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~ 880 (1114)
.++|++.+.||+|+||+||+|++ .+++.||||++.... ....+.+.+|+.++++++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 37899999999999999999994 368899999997543 334567899999999999999999999987 44
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 881 GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
...++||||+++++|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 568899999999999999986556799999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCCC--ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----------CCCHHHHHHH
Q 001253 961 VIDMPQSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ----------GGDLVTWVRN 1028 (1114)
Q Consensus 961 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~----------~~~~~~~~~~ 1028 (1114)
........ ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... .......+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76433221 22345688899999999999999999999999999999999999853221 0011111111
Q ss_pred HHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCccccc
Q 001253 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSP 1097 (1114)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~ 1097 (1114)
....+. ....+......+.+++.+||+.||++|||++|+++.|+++..........+
T Consensus 256 ~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 312 (327)
T 3lxl_A 256 LLEEGQ------------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312 (327)
T ss_dssp HHHTTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----------
T ss_pred Hhhccc------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccc
Confidence 111110 011122334568899999999999999999999999999966555444333
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=360.20 Aligned_cols=275 Identities=15% Similarity=0.197 Sum_probs=205.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChh--------hHHHHHHHHHHHhcCCCCceeeEEe
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNN--------VDNSFRAEILTLGKIRHRNIVKLYG 875 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~ 875 (1114)
.++|++.+.||+|+||+||+|++. ++..||||++......... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999986 5788999998765331110 1233567888899999999999999
Q ss_pred EEEe----cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC--
Q 001253 876 FCYH----QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-- 949 (1114)
Q Consensus 876 ~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-- 949 (1114)
++.. ....|+||||+ +++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 9988 67889999999 899999998544 799999999999999999999999 999999999999999887
Q ss_pred CeEEeeccCceecCCCC------CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHH
Q 001253 950 EAHVGDFGLAKVIDMPQ------SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023 (1114)
Q Consensus 950 ~~kl~DfG~a~~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~ 1023 (1114)
.+||+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 99999999998764221 112245579999999999999999999999999999999999999996433222222
Q ss_pred HHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcc
Q 001253 1024 TWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFE 1094 (1114)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 1094 (1114)
...+...... ..... .... . .......+.+++.+||+.||++||+++++++.|++.....+..+
T Consensus 271 ~~~~~~~~~~-~~~~~-~~~~---~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d 334 (345)
T 2v62_A 271 QTAKTNLLDE-LPQSV-LKWA---P--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLD 334 (345)
T ss_dssp HHHHHHHHHT-TTHHH-HHHS---C--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCC
T ss_pred HHHHHhhccc-ccHHH-Hhhc---c--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCC
Confidence 2222211110 00000 0000 0 00122368899999999999999999999999999765443333
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=355.09 Aligned_cols=263 Identities=25% Similarity=0.419 Sum_probs=207.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeCC-----CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRT-----GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
.++|+..+.||+|+||+||+|+++. +..||||++.... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 3678888999999999999998652 2469999997543 23345678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.++||||+++|+|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999999987777899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC--ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 963 DMPQSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 963 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
...... ......+|+.|+|||++.+..++.++||||+||++|||++ |+.||..... ...... +..+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~~~~~~-~~~~~~---- 268 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMKA-INDGFR---- 268 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHH-HHTTCC----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----HHHHHH-HHCCCc----
Confidence 432221 1223356789999999999999999999999999999999 9999964332 222222 221110
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCC
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGH 1092 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 1092 (1114)
...+......+.+++.+||+.||++||++.|+++.|+++......
T Consensus 269 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 269 --------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 011112234688999999999999999999999999998665443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.10 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=207.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|.++ +|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 478999999999999999999976 6899999999765543 33456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC---eEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE---AHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfG~a~~~~ 963 (1114)
|||+++++|.+.+... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||.+....
T Consensus 84 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999888743 5689999999999999999999999 9999999999999987655 9999999998764
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
. ........|++.|+|||++.+..++.++||||+|+++|+|++|+.||.... ........... ..
T Consensus 160 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~~~~~-~~-------- 224 (284)
T 3kk8_A 160 D--SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRLYAQIKAG-AY-------- 224 (284)
T ss_dssp S--SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHT-CC--------
T ss_pred c--CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc----hhHHHHHHHhc-cc--------
Confidence 2 233345679999999999999999999999999999999999999996433 22222221111 11
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++|||+.|+++
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 -DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0001111122346889999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=357.90 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=204.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcE----EEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHT----VAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
++|++.++||+|+||+||+|++. +++. ||+|++...... ...+.+.+|+.++++++||||+++++++. ++..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 67999999999999999999975 4443 788877544322 12345678999999999999999999986 5678
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++|+|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999999987666899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 964 MPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 964 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
.... .......|++.|+|||++.+..++.++||||+||++|||++ |+.||...... .... .+......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~----~~~~~~~~----- 236 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EVPD----LLEKGERL----- 236 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-HHHH----HHHTTCBC-----
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-HHHH----HHHcCCCC-----
Confidence 3332 22345568889999999999999999999999999999999 99999754322 1111 12211110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
. .+......+.+++.+||+.||++|||++|+++.|+++..
T Consensus 237 ---~----~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 237 ---A----QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---C----CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---C----CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 011112247789999999999999999999999998854
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=355.44 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=203.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCCh-----hhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNN-----NVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
.++|++.+.||+|+||+||+|+++ +++.||||++........ ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 468999999999999999999975 789999999986643221 12335678999999999999999999999999
Q ss_pred ceEEEEecCCCC-CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 882 SNLLMYEYMARG-SLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 882 ~~~lv~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
..++||||+.+| +|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 999999999777 99999974 34699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccccccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
.... ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||......
T Consensus 179 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------------- 236 (335)
T 3dls_A 179 YLER--GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------------- 236 (335)
T ss_dssp ECCT--TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------------
T ss_pred ECCC--CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------------
Confidence 7643 233345679999999999988877 78999999999999999999999642210
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
...... .+......+.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 VEAAIH----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTTCCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HhhccC----CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111 111123468899999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=348.13 Aligned_cols=250 Identities=27% Similarity=0.392 Sum_probs=204.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|+++ +++.||+|++.............+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999976 6789999999765433333456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-- 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence 9999999999999743 4689999999999999999999998 999999999999999999999999999865432
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... .............
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~------------ 224 (279)
T 3fdn_A 162 -SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQETYKRISRVEF------------ 224 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHTCC------------
T ss_pred -ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc----HHHHHHHHHhCCC------------
Confidence 22344579999999999999999999999999999999999999996432 2222222211110
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
..+......+.+++.+||+.||++|||++|+++.
T Consensus 225 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111123457889999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=350.97 Aligned_cols=266 Identities=23% Similarity=0.336 Sum_probs=201.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|++. +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 57999999999999999999986 689999999876543 3344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++++|.++++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 82 e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 82 EYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp ECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 99999999998873 45689999999999999999999999 99999999999999999999999999998764322
Q ss_pred CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH-----------hcCCc
Q 001253 968 KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFI-----------RNNSL 1035 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~ 1035 (1114)
.......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||.......... .+.... ....+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY-LIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCSCCHHHHHHHHTCGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhcccccccccccccccc
Confidence 22345579999999999876 668999999999999999999999997544322111 111111 11111
Q ss_pred ccccccccccCCCc---ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1036 VSGMLDARLNLQDE---KTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1036 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
......+....... ........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 11110000000000 00122346889999999999999999999885
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=354.21 Aligned_cols=251 Identities=24% Similarity=0.287 Sum_probs=196.0
Q ss_pred hcCCcCCceecccCCeEEEEEEe----CCCcEEEEEEecccCCC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 808 TDNFDERFVIGRGACGTVYRAVL----RTGHTVAVKKLASNREG-NNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
.++|++.++||+|+||+||+|+. .+|+.||+|+++..... .......+.+|+.+++.++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999997 47899999999765321 12234557789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999999974 34688999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 963 DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 963 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ............
T Consensus 172 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~~--------- 237 (327)
T 3a62_A 172 IHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN----RKKTIDKILKCK--------- 237 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHTC---------
T ss_pred ccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHhCC---------
Confidence 322 222345679999999999999999999999999999999999999997433 222333322211
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
.. .+......+.+++.+||+.||++|| ++.|+++
T Consensus 238 -~~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 -LN----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -CC----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -CC----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11 1111234688999999999999999 7777765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=350.81 Aligned_cols=269 Identities=23% Similarity=0.328 Sum_probs=201.1
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCC--ChhhHHHHHHHHHHHhcC---CCCceeeEEeEEEe
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREG--NNNVDNSFRAEILTLGKI---RHRNIVKLYGFCYH 879 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~ 879 (1114)
...++|++.++||+|+||+||+|+++ +|+.||||++...... .......+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34578999999999999999999974 7899999999754321 112234566777777666 49999999999987
Q ss_pred cC-----ceEEEEecCCCCCHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEE
Q 001253 880 QG-----SNLLMYEYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 953 (1114)
Q Consensus 880 ~~-----~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 953 (1114)
.. ..++||||+++ +|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 65 47899999975 99999975443 499999999999999999999999 9999999999999999999999
Q ss_pred eeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 954 GDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 954 ~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
+|||+++... .........||+.|+|||++.+..++.++||||+||++|||++|+.||........... +.+.....
T Consensus 162 ~Dfg~a~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-i~~~~~~~ 238 (308)
T 3g33_A 162 ADFGLARIYS--YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK-IFDLIGLP 238 (308)
T ss_dssp CSCSCTTTST--TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH-HHHHHCCC
T ss_pred eeCccccccC--CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCC
Confidence 9999998654 22334556899999999999999999999999999999999999999975433221111 11111110
Q ss_pred C---cccccc--cccccCCCcc-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1034 S---LVSGML--DARLNLQDEK-----TVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1034 ~---~~~~~~--~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. +..... ...+...... ..+....+.+++.+||++||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0 000000 0000000000 1122346889999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=356.28 Aligned_cols=247 Identities=23% Similarity=0.351 Sum_probs=181.1
Q ss_pred CceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEEEEecCC
Q 001253 814 RFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLMYEYMA 891 (1114)
Q Consensus 814 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~ 891 (1114)
.++||+|+||+||+|+++ +++.||||++... ....+.+|+.+++.++ ||||+++++++.++...|+||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 378999999999999986 7899999999643 2456788999999997 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC---CeEEeeccCceecCCCCCC
Q 001253 892 RGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF---EAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 892 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfG~a~~~~~~~~~ 968 (1114)
+|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+++.... ...
T Consensus 90 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~-~~~ 164 (325)
T 3kn6_A 90 GGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQ 164 (325)
T ss_dssp SCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCC-CCC
Confidence 99999999853 5799999999999999999999999 999999999999998765 899999999987542 223
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC---CCHHHHHHHHHhcCCccccccccccc
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG---GDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....+.... +..+. ..
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~---------~~ 234 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGD---------FS 234 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTC---------CC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCC---------CC
Confidence 334567899999999999999999999999999999999999999754421 122222222 22211 11
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
............+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 111111223457889999999999999999998863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=374.00 Aligned_cols=251 Identities=21% Similarity=0.244 Sum_probs=198.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|+.+ +|+.||||++.............+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999976 7899999999865333333345677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|||+++|+|.+++.. ...+++..+..++.|+++||+|||+ . +|+||||||+|||++.++.+||+|||+|+....
T Consensus 227 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK- 301 (446)
T ss_dssp ECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC-
Confidence 999999999999974 3478999999999999999999998 7 999999999999999999999999999985432
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ............ ..
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~----------~~ 367 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELILMEE----------IR 367 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCC----------CC
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----HHHHHHHHHhCC----------CC
Confidence 2233455789999999999999999999999999999999999999996433 222222222211 01
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
.+......+.+++.+||+.||.+|| +++|+++
T Consensus 368 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 ----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1111234688999999999999999 9999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=358.16 Aligned_cols=207 Identities=27% Similarity=0.332 Sum_probs=179.7
Q ss_pred CCHHHHHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-----CCceee
Q 001253 799 FTFKDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-----HRNIVK 872 (1114)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 872 (1114)
+++++.....++|++.++||+|+||+||+|++. +++.||||++... ....+.+..|+.+++.++ ||||++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 344444455689999999999999999999985 7899999999642 233456778999998886 999999
Q ss_pred EEeEEEecCceEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC----
Q 001253 873 LYGFCYHQGSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD---- 947 (1114)
Q Consensus 873 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---- 947 (1114)
+++++...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence 999999999999999999 889999997543 4689999999999999999999999 9999999999999975
Q ss_pred ---------------------CCCeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHH
Q 001253 948 ---------------------KFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLEL 1006 (1114)
Q Consensus 948 ---------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el 1006 (1114)
++.+||+|||+|+.... ......||+.|+|||++.+..++.++||||+||++|||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 78999999999987432 22345799999999999999999999999999999999
Q ss_pred HhCCCCCCCCC
Q 001253 1007 LTGRAPVQPLD 1017 (1114)
Q Consensus 1007 ~tg~~p~~~~~ 1017 (1114)
++|+.||....
T Consensus 253 l~g~~pf~~~~ 263 (360)
T 3llt_A 253 YTGSLLFRTHE 263 (360)
T ss_dssp HHSSCSCCCSS
T ss_pred HHCCCCCCCCc
Confidence 99999997543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=353.49 Aligned_cols=251 Identities=23% Similarity=0.294 Sum_probs=202.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.+.||+|+||+||+|+.+ +|+.||||++...... ..+|++++.++ +||||+++++++.+++..|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 467999999999999999999986 6899999999765432 24577777777 79999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC----CCeEEeeccCcee
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK----FEAHVGDFGLAKV 961 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~DfG~a~~ 961 (1114)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++.++ +.+||+|||+++.
T Consensus 94 v~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 94 VTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999999974 35799999999999999999999999 99999999999998543 3599999999987
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+....... +.+
T Consensus 170 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~-~~~------ 240 (342)
T 2qr7_A 170 LRAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGS-GKF------ 240 (342)
T ss_dssp CBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHH-CCC------
T ss_pred CcCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHcc-CCc------
Confidence 64332 233456799999999999988899999999999999999999999975332 233333332222 111
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++|||+.|+++
T Consensus 241 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 ---SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111223346889999999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.53 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=204.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|+++ ++..||+|++....... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 367999999999999999999986 57899999997654433 56788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---CCCCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL---DDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfG~a~~~~ 963 (1114)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 85 MELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999998874 34689999999999999999999999 99999999999999 788999999999998764
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
. ........||+.|+|||++.+. ++.++||||+|+++|||++|+.||..... .......... ..
T Consensus 161 ~--~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~-~~-------- 224 (277)
T 3f3z_A 161 P--GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD----SEVMLKIREG-TF-------- 224 (277)
T ss_dssp T--TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHC-CC--------
T ss_pred C--ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhC-CC--------
Confidence 2 2334456799999999988664 89999999999999999999999975332 2222221111 10
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++|||+.|+++
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 -TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000112346889999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=348.37 Aligned_cols=262 Identities=26% Similarity=0.388 Sum_probs=208.7
Q ss_pred CCcCCceecccCCeEEEEEEeC-----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec--Cc
Q 001253 810 NFDERFVIGRGACGTVYRAVLR-----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--GS 882 (1114)
Q Consensus 810 ~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 882 (1114)
.|++.++||+|+||+||+|.++ +++.||||++.... .....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 3499999999999999998753 68899999997553 234466789999999999999999999999874 56
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 79999999999999999743 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC---------C-CHHHHHHHHH
Q 001253 963 DMPQS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG---------G-DLVTWVRNFI 1030 (1114)
Q Consensus 963 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~---------~-~~~~~~~~~~ 1030 (1114)
..... .......+|+.|+|||++.+..++.++||||+|+++|||++|+.||...... + .....+...+
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 53322 1223456888999999999989999999999999999999999998632110 0 0000111111
Q ss_pred hcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1031 RNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
.... ....+......+.+++.+||+.||++|||++|+++.|+++..+.
T Consensus 265 ~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 265 ERGE------------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HTTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hccc------------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 1110 01112223357889999999999999999999999999986543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=359.90 Aligned_cols=251 Identities=23% Similarity=0.269 Sum_probs=192.0
Q ss_pred cCCcCC-ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHH-hcCCCCceeeEEeEEEe----cC
Q 001253 809 DNFDER-FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTL-GKIRHRNIVKLYGFCYH----QG 881 (1114)
Q Consensus 809 ~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~ 881 (1114)
++|.+. ++||+|+||+||+|+++ +|+.||||++.. ...+.+|+.++ +..+||||+++++++.. ..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 456665 68999999999999976 789999999853 23466788776 44589999999999876 56
Q ss_pred ceEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCCeEEeecc
Q 001253 882 SNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD---KFEAHVGDFG 957 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG 957 (1114)
..|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 7899999999999999998543 4699999999999999999999998 9999999999999997 7899999999
Q ss_pred CceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1114)
+++.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .+..+.+
T Consensus 210 ~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~-~i~~~~~-- 284 (400)
T 1nxk_A 210 FAKETTS--HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-RIRMGQY-- 284 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH-HHHHTCC--
T ss_pred cccccCC--CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH-HHHcCcc--
Confidence 9987542 2233456899999999999999999999999999999999999999976543221111111 1111111
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
.............+.+++.+||+.||++|||+.|+++-
T Consensus 285 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 -------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00011111223468899999999999999999999873
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=356.24 Aligned_cols=260 Identities=24% Similarity=0.271 Sum_probs=203.6
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCC--CChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNRE--GNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
....++|++.+.||+|+||+||+|+++ +++.||+|++..... ......+.+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 345688999999999999999999975 788999999975421 12234567899999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccC---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 001253 882 SNLLMYEYMARGSLGELLHGA---------------------------------------SSTLDWQTRFMIALGAAEGL 922 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~~L 922 (1114)
..++||||+++|+|.+++... ...+++..+..++.|+++||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998521 11235777888999999999
Q ss_pred HHHHhCCCCCeEecCCCCCCeEECCCC--CeEEeeccCceecCCCCC---CccccccccccccCcccccc--CCCCcccc
Q 001253 923 SYLHHDCKPRIFHRDIKSNNILLDDKF--EAHVGDFGLAKVIDMPQS---KSMSAIAGSYGYIAPEYAYT--MKVTEKCD 995 (1114)
Q Consensus 923 ~~LH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~DfG~a~~~~~~~~---~~~~~~~g~~~y~aPE~~~~--~~~~~~~D 995 (1114)
+|||+. +|+||||||+||+++.++ .+||+|||+++.+..... .......||+.|+|||++.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 899999999987543221 22345679999999999875 67889999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCC
Q 001253 996 IYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPT 1075 (1114)
Q Consensus 996 vwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1075 (1114)
|||+||++|||++|+.||..... .+........... ............+.+++.+||+.||.+||+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVND----ADTISQVLNKKLC----------FENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCC----------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHCCCCCCCCCh----HHHHHHHHhcccc----------cCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 99999999999999999975432 2233332222111 111111122346889999999999999999
Q ss_pred HHHHHH
Q 001253 1076 MREVVL 1081 (1114)
Q Consensus 1076 ~~evl~ 1081 (1114)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=354.41 Aligned_cols=272 Identities=24% Similarity=0.327 Sum_probs=202.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHH--HHHHhcCCCCceeeEEeEEEe-----c
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAE--ILTLGKIRHRNIVKLYGFCYH-----Q 880 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~~-----~ 880 (1114)
.++|++.+.||+|+||+||+|++ +++.||||++.... ...+..| +..+..++||||+++++++.. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 36899999999999999999987 48999999996432 2233334 444556899999999986643 2
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCeEECCCCCeEEe
Q 001253 881 GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC------KPRIFHRDIKSNNILLDDKFEAHVG 954 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlk~~Nill~~~~~~kl~ 954 (1114)
...++||||+++|+|.++++.. ..++..+..++.|+++||+|||+.+ .++|+||||||+||+++.++.+||+
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred ceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 2568999999999999999743 4589999999999999999999862 2389999999999999999999999
Q ss_pred eccCceecCCCC-------CCccccccccccccCcccccc-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 001253 955 DFGLAKVIDMPQ-------SKSMSAIAGSYGYIAPEYAYT-------MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG 1020 (1114)
Q Consensus 955 DfG~a~~~~~~~-------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~ 1020 (1114)
|||+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998764321 122234579999999999876 456779999999999999999987765443322
Q ss_pred CHHH-------------HHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1021 DLVT-------------WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1021 ~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
.... .......... ..+.+.............+.+++.+||+.||++|||++|+++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSC-----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccc-----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 2111 1111111111 011111112223345667999999999999999999999999999997
Q ss_pred ccCCCc
Q 001253 1088 RRQGHF 1093 (1114)
Q Consensus 1088 ~~~~~~ 1093 (1114)
....+-
T Consensus 318 ~~~~~~ 323 (336)
T 3g2f_A 318 MIWERN 323 (336)
T ss_dssp HCCCC-
T ss_pred HHHHhc
Confidence 655443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.79 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=210.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGN---NNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.++|++.+.||+|+||+||+|+.+ +|+.||+|+++...... ....+.+.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 367999999999999999999987 78999999997654322 12356789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC----CeEEeeccCc
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF----EAHVGDFGLA 959 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfG~a 959 (1114)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++ .+||+|||.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999974 34689999999999999999999999 999999999999999877 8999999999
Q ss_pred eecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
...... .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.... ........... ..
T Consensus 160 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~---- 228 (283)
T 3bhy_A 160 HKIEAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET----KQETLTNISAV-NY---- 228 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHTT-CC----
T ss_pred eeccCC--CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc----hHHHHHHhHhc-cc----
Confidence 876422 22344579999999999999999999999999999999999999997533 22222221111 10
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhhhccC
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSESNRRQ 1090 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~~~ 1090 (1114)
.............+.+++.+||+.||++|||+.|+++ .+++++.+.
T Consensus 229 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 229 -----DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp -----CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred -----CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 0000011112346889999999999999999999997 567765554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=361.24 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=196.4
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCC-----ChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREG-----NNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ 880 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 880 (1114)
..++|.+.++||+|+||+||+|+++ +++.||||++...... .......+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4578999999999999999999976 6899999999764321 1112234788999999999999999999985 4
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC---CeEEeecc
Q 001253 881 GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF---EAHVGDFG 957 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfG 957 (1114)
+..|+||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence 557999999999999999874 45799999999999999999999999 999999999999997544 59999999
Q ss_pred CceecCCCCCCccccccccccccCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS 1034 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1034 (1114)
+|+... ........+||+.|+|||++.+ ..++.++||||+||++|||++|+.||............+.. ..
T Consensus 288 ~a~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~----~~ 361 (419)
T 3i6u_A 288 HSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS----GK 361 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT----TC
T ss_pred cceecC--CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc----CC
Confidence 998754 2233445689999999999853 56888999999999999999999999865554444333322 11
Q ss_pred cccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1035 LVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+ .............+.+++.+||+.||++|||++|+++
T Consensus 362 ~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 362 Y---------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp C---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C---------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1 0000111122346889999999999999999999886
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=339.53 Aligned_cols=250 Identities=26% Similarity=0.330 Sum_probs=198.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+.+ +++.||+|++....... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 67999999999999999999976 68999999997665332 2567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---CCCCCeEEeeccCcee
Q 001253 888 EYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL---DDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 888 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfG~a~~ 961 (1114)
||+++|+|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999998853 236799999999999999999999999 99999999999999 4567899999999986
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
... ........|++.|+|||++. ..++.++||||+|+++|||++|+.||.... ..............
T Consensus 177 ~~~--~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~----~~~~~~~~~~~~~~------ 243 (285)
T 3is5_A 177 FKS--DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEVQQKATYKEPN------ 243 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHCCCC------
T ss_pred cCC--cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC----HHHHHhhhccCCcc------
Confidence 542 22334567999999999875 568999999999999999999999997433 22222221111110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...... .....+.+++.+||+.||++|||++|+++
T Consensus 244 --~~~~~~---~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 --YAVECR---PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CCC--C---CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --cccccC---cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 01246789999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=353.63 Aligned_cols=278 Identities=22% Similarity=0.330 Sum_probs=200.6
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
...++|++.++||+|+||+||+|++. +++.||||++...... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999976 7899999999755432 223456778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE-----CCCCCeEEeeccCc
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL-----DDKFEAHVGDFGLA 959 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-----~~~~~~kl~DfG~a 959 (1114)
+||||+++ +|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||++
T Consensus 110 lv~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99999985 999999744 4689999999999999999999999 99999999999999 45556999999999
Q ss_pred eecCCCCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcc--
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLV-- 1036 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 1036 (1114)
+..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||............... .......
T Consensus 185 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~ 262 (329)
T 3gbz_A 185 RAFGIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV-LGLPDDTTW 262 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH-HCCCCTTTS
T ss_pred cccCCc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH-hCCCchhhh
Confidence 876432 2233445789999999999874 4899999999999999999999999754322212111111 1110000
Q ss_pred ccc-----ccccccCCCcc------cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCC
Q 001253 1037 SGM-----LDARLNLQDEK------TVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHD 1101 (1114)
Q Consensus 1037 ~~~-----~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~ 1101 (1114)
... +.......... .......+.+++.+||+.||++|||++|+++ +.++...+|+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~----------hp~f~~~~~~ 328 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE----------HPYFSHNDFD 328 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT----------SGGGSSSCSC
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC----------CcccCCCCCC
Confidence 000 00000000000 0112356889999999999999999999874 4566666665
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=352.16 Aligned_cols=264 Identities=26% Similarity=0.446 Sum_probs=209.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcE--EEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHT--VAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 884 (1114)
++|++.+.||+|+||+||+|+++ ++.. ||+|++...... ...+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch--HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 67999999999999999999975 5664 499998754322 2345688999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 001253 885 LMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF 949 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 949 (1114)
+||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence 9999999999999997543 4789999999999999999999999 999999999999999999
Q ss_pred CeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHH
Q 001253 950 EAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRN 1028 (1114)
Q Consensus 950 ~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~ 1028 (1114)
.+||+|||+++.... ........+++.|+|||++.+..++.++||||+|+++|||++ |+.||.... .......
T Consensus 180 ~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~----~~~~~~~ 253 (327)
T 1fvr_A 180 VAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAELYEK 253 (327)
T ss_dssp CEEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHH
T ss_pred eEEEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc----HHHHHHH
Confidence 999999999974321 122233457889999999998889999999999999999998 999996433 2222221
Q ss_pred HHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccc
Q 001253 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFS 1096 (1114)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~ 1096 (1114)
+..+. . ...+......+.+++.+||+.||.+|||++|+++.|+++..........
T Consensus 254 -~~~~~--------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 308 (327)
T 1fvr_A 254 -LPQGY--------R----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 308 (327)
T ss_dssp -GGGTC--------C----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCC
T ss_pred -hhcCC--------C----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcccc
Confidence 11110 0 0111122346889999999999999999999999999997766555433
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=357.80 Aligned_cols=256 Identities=23% Similarity=0.261 Sum_probs=207.6
Q ss_pred cCCcCCceecccCCeEEEEEEe----CCCcEEEEEEecccCCC-ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCc
Q 001253 809 DNFDERFVIGRGACGTVYRAVL----RTGHTVAVKKLASNREG-NNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 882 (1114)
++|++.++||+|+||+||+|+. .+|+.||||+++..... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6799999999999999999997 37899999998754311 111234466799999999 69999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999743 4689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccccccCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 963 DMPQSKSMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 963 ~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
...........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............+.......
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 283 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------ 283 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC------
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC------
Confidence 4333334445689999999999985 44788999999999999999999999866555555554444333211
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVVLM 1082 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1082 (1114)
..+......+.+++.+||+.||++|| +++|+++.
T Consensus 284 --------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 284 --------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11112234678899999999999999 99998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=350.34 Aligned_cols=266 Identities=24% Similarity=0.357 Sum_probs=201.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC--CCc--EEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR--TGH--TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.++|++.++||+|+||+||+|+++ +++ .||||+++..........+.+.+|+.++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 468999999999999999999863 333 68999998765544555678999999999999999999999998754 8
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++++|.+++......+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 999999999999999986666799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCC--ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 964 MPQSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 964 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..... ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||.... ..............
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~~~~~~~~----- 243 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN----GSQILHKIDKEGER----- 243 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTSCCC-----
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC----HHHHHHHHHccCCC-----
Confidence 33221 1233467889999999998889999999999999999999 999997543 22233322222110
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHF 1093 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 1093 (1114)
...+......+.+++.+||+.||++|||+.++++.|+++.......
T Consensus 244 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 289 (291)
T 1u46_A 244 -------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA 289 (291)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred -------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchhh
Confidence 0111122346889999999999999999999999999987655443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=345.84 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=209.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|+++ +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367999999999999999999987 6889999999876655555667889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++.. ...+++.++..++.|+++||+|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999999874 34789999999999999999999999 99999999999999999999999999998764222
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.......|++.|+|||.+.+..++.++||||+|+++|||++|+.||.... ..+....... ... .
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~-~~~---------~- 233 (294)
T 2rku_A 170 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKETYLRIKK-NEY---------S- 233 (294)
T ss_dssp -CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHT-TCC---------C-
T ss_pred -cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhh-ccC---------C-
Confidence 22344679999999999999899999999999999999999999996433 2222222111 110 0
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+......+.+++.+||+.||++|||++|+++
T Consensus 234 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 234 ---IPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 01112246788999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=349.05 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=208.7
Q ss_pred CCCHHHHHHHhcCCcCC-ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEE
Q 001253 798 GFTFKDLVVATDNFDER-FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLY 874 (1114)
Q Consensus 798 ~~~~~~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~ 874 (1114)
...++......++|.+. +.||+|+||+||+|+.+ +|+.||+|++....... .....+.+|+.+++.++ ||||++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 34455555666788887 88999999999999976 68999999998654432 33567889999999994 69999999
Q ss_pred eEEEecCceEEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCC
Q 001253 875 GFCYHQGSNLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD---KFE 950 (1114)
Q Consensus 875 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~ 950 (1114)
+++.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999999998643 45799999999999999999999999 9999999999999998 789
Q ss_pred eEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 001253 951 AHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFI 1030 (1114)
Q Consensus 951 ~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 1030 (1114)
+||+|||+++..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ........
T Consensus 173 ~kL~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~ 246 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN----QETYLNIS 246 (327)
T ss_dssp EEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH
T ss_pred EEEeeCccccccCCc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHHH
Confidence 999999999876422 233456799999999999999999999999999999999999999965332 22222211
Q ss_pred hcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1031 RNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
... ..............+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 247 QVN----------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HTC----------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcc----------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 110 00011111223346889999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.78 Aligned_cols=267 Identities=24% Similarity=0.392 Sum_probs=203.6
Q ss_pred HHHHHHhcCCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEE
Q 001253 802 KDLVVATDNFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFC 877 (1114)
Q Consensus 802 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 877 (1114)
+++.+..++|++.+.||+|+||+||+|++. ++..||+|++...... ....+.+.+|+.++++++||||+++++++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 344456688999999999999999999864 3458999998765432 33456788999999999999999999999
Q ss_pred EecC-----ceEEEEecCCCCCHHHHhc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 001253 878 YHQG-----SNLLMYEYMARGSLGELLH-----GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947 (1114)
Q Consensus 878 ~~~~-----~~~lv~E~~~~gsL~~~l~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 947 (1114)
.+.+ ..++||||+++|+|.+++. .....+++..+..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence 8755 3499999999999999984 2345799999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHH
Q 001253 948 KFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTW 1025 (1114)
Q Consensus 948 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~ 1025 (1114)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ....
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~- 260 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-EMYD- 260 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHH-
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-HHHH-
Confidence 99999999999986543222 22234467889999999999999999999999999999999 88888654332 1111
Q ss_pred HHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1026 VRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
..... .. ...+......+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 261 --~~~~~-~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 261 --YLLHG-HR------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp --HHHTT-CC------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHcC-CC------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 00 011122234688999999999999999999999999998664
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=339.56 Aligned_cols=253 Identities=26% Similarity=0.375 Sum_probs=206.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|+.+ +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 367999999999999999999986 7899999999755432 2356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 84 LEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999999974 45789999999999999999999998 99999999999999999999999999998653222
Q ss_pred -CCccccccccccccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 967 -SKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 967 -~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
........|++.|+|||++.+..+ +.++||||+|+++|||++|+.||.......... ..........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~-------- 228 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKTYL-------- 228 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH---HHHHTTCTTS--------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHhhhccccc--------
Confidence 122345679999999999987765 779999999999999999999997654332211 1111111100
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.........+.+++.+||+.||++|||++|+++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001122346788999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=345.76 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=201.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec-CceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ-GSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|+++ |+.||||++.... ..+.+.+|+.++++++||||+++++++... +..++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 478999999999999999999986 8899999987543 256788999999999999999999997654 478999
Q ss_pred EecCCCCCHHHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 887 YEYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|||+++++|.+++..... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999999974332 378999999999999999999999 9999999999999999999999999999864322
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
.....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..... .+.. .. +..+. .
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~---~~-~~~~~--------~- 232 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVV---PR-VEKGY--------K- 232 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GGHH---HH-HTTTC--------C-
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HHHH---HH-HhcCC--------C-
Confidence 223457889999999999999999999999999999998 9999975432 1111 11 11110 0
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
...+......+.+++.+||+.||++|||+.|+++.|+++...+
T Consensus 233 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 233 ---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 1111122346889999999999999999999999999987654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=364.96 Aligned_cols=248 Identities=16% Similarity=0.155 Sum_probs=194.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHH---HHHhcCCCCceeeEE-------eE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEI---LTLGKIRHRNIVKLY-------GF 876 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 876 (1114)
.++|++.+.||+|+||+||+|+++ +|+.||||++...........+.+.+|+ +.+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467999999999999999999974 7999999999876555555567899999 555666899999998 66
Q ss_pred EEecCc-----------------eEEEEecCCCCCHHHHhccCCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 001253 877 CYHQGS-----------------NLLMYEYMARGSLGELLHGASS------TLDWQTRFMIALGAAEGLSYLHHDCKPRI 933 (1114)
Q Consensus 877 ~~~~~~-----------------~~lv~E~~~~gsL~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 933 (1114)
+.+.+. .|+||||+ +|+|.+++..... .+++..+..++.|+++||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 665542 78999999 5799999974321 233688889999999999999999 99
Q ss_pred EecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccccccccccCccccccC-----------CCCcccchHHHHHH
Q 001253 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM-----------KVTEKCDIYSYGVV 1002 (1114)
Q Consensus 934 vH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DvwslGvi 1002 (1114)
+||||||+|||++.++.+||+|||+|+... .......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999998633 23345567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH-
Q 001253 1003 LLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL- 1081 (1114)
Q Consensus 1003 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~- 1081 (1114)
+|||++|+.||........ ...+... .. .....+.+++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~--------------~~~~~~~----~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG--------------SEWIFRS----CK----NIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------CC--------------SGGGGSS----CC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCcccccccc--------------hhhhhhh----cc----CCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999965432111 0111010 01 11246889999999999999999999985
Q ss_pred -HHHhh
Q 001253 1082 -MLSES 1086 (1114)
Q Consensus 1082 -~L~~i 1086 (1114)
.++++
T Consensus 361 p~f~~~ 366 (377)
T 3byv_A 361 PEYEQL 366 (377)
T ss_dssp HHHHHH
T ss_pred hHHHHH
Confidence 44444
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=347.46 Aligned_cols=260 Identities=22% Similarity=0.344 Sum_probs=207.2
Q ss_pred HhcCCcCCc-eecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc
Q 001253 807 ATDNFDERF-VIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 807 ~~~~~~~~~-~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 882 (1114)
..++|++.+ .||+|+||+||+|.+. +++.||||++..... .....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 346788888 9999999999999643 568899999976543 233456789999999999999999999999 5677
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 89999999999999999853 4689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCc--cccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 963 DMPQSKS--MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 963 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
....... .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..... .. +...+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~-~~~~~~~~~~---- 238 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SE-VTAMLEKGER---- 238 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HH-HHHHHHTTCC----
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----HH-HHHHHHcCCC----
Confidence 5333211 222346789999999998889999999999999999999 9999975332 11 2222222111
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
...+......+.+++.+||+.||.+||++.|+++.|+++-..
T Consensus 239 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 239 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 011122234688999999999999999999999999998543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=351.80 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=210.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|.+.+.||+|+||+||+|++. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367999999999999999999986 6889999999876655555677889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999999999874 35789999999999999999999999 99999999999999999999999999998764222
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||.... ........... .. ..
T Consensus 196 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~-~~---------~~ 260 (335)
T 2owb_A 196 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKETYLRIKKN-EY---------SI 260 (335)
T ss_dssp -CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHT-CC---------CC
T ss_pred -ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC----HHHHHHHHhcC-CC---------CC
Confidence 23345679999999999999999999999999999999999999996432 22222221111 10 00
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+......+.+++.+||+.||++|||++|+++
T Consensus 261 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 ----PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112235788999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=349.27 Aligned_cols=264 Identities=21% Similarity=0.302 Sum_probs=207.5
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe----cC
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH----QG 881 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~ 881 (1114)
..++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 4578999999999999999999974 78999999986532 3346678899999999999999999999873 34
Q ss_pred ceEEEEecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccC
Q 001253 882 SNLLMYEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 958 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~ 958 (1114)
..++||||+++|+|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 67899999999999999874 456799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCC--------ccccccccccccCccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCC-CCHHHHH
Q 001253 959 AKVIDMPQSK--------SMSAIAGSYGYIAPEYAYTMK---VTEKCDIYSYGVVLLELLTGRAPVQPLDQG-GDLVTWV 1026 (1114)
Q Consensus 959 a~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslGvil~el~tg~~p~~~~~~~-~~~~~~~ 1026 (1114)
+......... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... ......+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 260 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence 8764321111 012345799999999987554 688999999999999999999999532211 1111111
Q ss_pred HHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCC
Q 001253 1027 RNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGH 1092 (1114)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 1092 (1114)
. .. .. ..........+.+++.+||+.||.+|||++|+++.|+++......
T Consensus 261 ~----~~----------~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 261 Q----NQ----------LS--IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp H----CC--------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred h----cc----------CC--CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 1 10 00 011112234688999999999999999999999999998765443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=351.72 Aligned_cols=268 Identities=19% Similarity=0.324 Sum_probs=199.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+.+ +++.||||++........ ...+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc--chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 57899999999999999999986 789999999975443211 123456999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++ +|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....+ .
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~ 154 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP-T 154 (324)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC-c
Confidence 99985 99999987777899999999999999999999999 9999999999999999999999999999865422 2
Q ss_pred CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc-
Q 001253 968 KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN- 1045 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1045 (1114)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....+........ ...+.....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~--~~~~~~~~~~ 231 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPT--EETWPGILSN 231 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC--TTTSTTGGGC
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC--hHhchhhhcc
Confidence 23344578999999999876 568999999999999999999999997543221 1222222211100 000000000
Q ss_pred ---------CC-C----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhh
Q 001253 1046 ---------LQ-D----EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSES 1086 (1114)
Q Consensus 1046 ---------~~-~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1086 (1114)
.. . .........+.+++.+||+.||++|||++|+++ .+.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 00 0 001122346789999999999999999999987 44444
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=371.67 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=209.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|+.+ +|+.||||++...........+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999986 7899999999766544444567789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---CCCCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL---DDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfG~a~~~~ 963 (1114)
|||+.+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.+.
T Consensus 105 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999999874 45789999999999999999999999 99999999999999 567899999999998764
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
. ........||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... .....+.... +.+
T Consensus 181 ~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~-~~~-------- 244 (484)
T 3nyv_A 181 A--SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN----EYDILKKVEK-GKY-------- 244 (484)
T ss_dssp C--CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHH-CCC--------
T ss_pred c--ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHc-CCC--------
Confidence 2 233455679999999999876 69999999999999999999999997533 2222222222 111
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....+........+.+++.+||+.||++|||+.|+++
T Consensus 245 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 245 -TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1111111223456889999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=358.11 Aligned_cols=268 Identities=24% Similarity=0.347 Sum_probs=193.4
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecC--c
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQG--S 882 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 882 (1114)
..++|++.++||+|+||+||+|+++ +|+.||||++...... ....+.+.+|+.+++.+. ||||+++++++...+ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3478999999999999999999976 7899999999754332 334556778999999997 999999999997654 6
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.|+||||+++ +|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 86 ~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYMET-DLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCSE-EHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEecccCc-CHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 8999999985 99999974 4789999999999999999999999 9999999999999999999999999999865
Q ss_pred CCC--------------------CCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 001253 963 DMP--------------------QSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD 1021 (1114)
Q Consensus 963 ~~~--------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~ 1021 (1114)
... ........+||+.|+|||++.+ ..++.++||||+||++|||++|+.||........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 321 1122344689999999999986 6789999999999999999999999975442221
Q ss_pred HHHHHHHHHhcCCcc----------ccccc--------ccccCCCcc------------cHHHHHHHHHHHhhccCCCCC
Q 001253 1022 LVTWVRNFIRNNSLV----------SGMLD--------ARLNLQDEK------------TVSHMITVLKIAMLCTNISPF 1071 (1114)
Q Consensus 1022 ~~~~~~~~~~~~~~~----------~~~~~--------~~~~~~~~~------------~~~~~~~l~~li~~cl~~dP~ 1071 (1114)
+...+ +.+...... ..... ......... .......+.+++.+||+.||+
T Consensus 240 ~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 240 LERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 11111 111110000 00000 000000000 001234688999999999999
Q ss_pred CCCCHHHHHHH
Q 001253 1072 DRPTMREVVLM 1082 (1114)
Q Consensus 1072 ~RPs~~evl~~ 1082 (1114)
+|||++|+++-
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=348.60 Aligned_cols=264 Identities=28% Similarity=0.438 Sum_probs=210.7
Q ss_pred hcCCcCCceecccCCeEEEEEEe-----CCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-
Q 001253 808 TDNFDERFVIGRGACGTVYRAVL-----RTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG- 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 881 (1114)
.++|++.+.||+|+||+||+|++ .+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 46799999999999999999984 368899999997542 234567899999999999999999999987654
Q ss_pred -ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 882 -SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 882 -~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
..++||||+++++|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 78999999999999999987767899999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCCC--ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC----------CCCC-HHHHHH
Q 001253 961 VIDMPQSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLD----------QGGD-LVTWVR 1027 (1114)
Q Consensus 961 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~----------~~~~-~~~~~~ 1027 (1114)
........ ......++..|+|||.+.+..++.++||||+|+++|||++|..|+.... .... ....+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 76533221 1223457788999999998889999999999999999999999875321 0000 001111
Q ss_pred HHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1028 NFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
..+.... + ...+......+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 274 ~~~~~~~--------~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 274 ELLKNNG--------R----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHTTC--------C----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhhcCC--------C----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111110 0 111122335688999999999999999999999999998653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=354.69 Aligned_cols=265 Identities=23% Similarity=0.355 Sum_probs=200.2
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-----
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG----- 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 881 (1114)
.++|++.+.||+|+||+||+|++. +|+.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 367999999999999999999975 799999999965443 3344567889999999999999999999997653
Q ss_pred -ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 882 -SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 882 -~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
..|+||||+ +++|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 7799999974 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc-CCcccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN-NSLVSG 1038 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1038 (1114)
.... .....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+...... +.....
T Consensus 177 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 177 QADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----LDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp ECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHH
T ss_pred cccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhcCCCCHH
Confidence 7542 2345678999999999887 6799999999999999999999999975432 2222211110 000000
Q ss_pred ccc--------------ccccCC--CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhhh
Q 001253 1039 MLD--------------ARLNLQ--DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSESN 1087 (1114)
Q Consensus 1039 ~~~--------------~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 1087 (1114)
... +..... ..........+.+++.+||+.||++|||++|+++ .+++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 000 000000 0011122356889999999999999999999987 455543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=352.83 Aligned_cols=268 Identities=24% Similarity=0.318 Sum_probs=200.8
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGN--NNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
..++|++.+.||+|+||+||+|+++ +|+.||||++....... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3478999999999999999999976 68999999997543321 11234678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++ +|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999987 89999987777899999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
.. ........||+.|+|||++.+. .++.++||||+||++|||++|..||........+...+.. .... ....+..
T Consensus 164 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~-~~~~--~~~~~~~ 239 (346)
T 1ua2_A 164 SP-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET-LGTP--TEEQWPD 239 (346)
T ss_dssp SC-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH-HCCC--CTTTSSS
T ss_pred CC-cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH-cCCC--Chhhhhh
Confidence 32 2233456799999999998764 4889999999999999999999998754322211111111 1110 0000000
Q ss_pred c--------ccCCCccc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1043 R--------LNLQDEKT-----VSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1043 ~--------~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
. .......+ ......+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00000001 1223578899999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=352.90 Aligned_cols=253 Identities=15% Similarity=0.202 Sum_probs=206.7
Q ss_pred HHhcCCcCCceecccCCeEEEEEE------eCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC---CCceeeEEeE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAV------LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR---HRNIVKLYGF 876 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~ 876 (1114)
...++|++.++||+|+||+||+|+ ..+++.||||++.... ..++..|+.++++++ |+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 455789999999999999999994 3468899999986432 445777888888776 8999999999
Q ss_pred EEecCceEEEEecCCCCCHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-----
Q 001253 877 CYHQGSNLLMYEYMARGSLGELLHG----ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD----- 947 (1114)
Q Consensus 877 ~~~~~~~~lv~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~----- 947 (1114)
+..++..|+||||+++|+|.++++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999974 345799999999999999999999998 9999999999999998
Q ss_pred ------CCCeEEeeccCceecCC-CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 001253 948 ------KFEAHVGDFGLAKVIDM-PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG 1020 (1114)
Q Consensus 948 ------~~~~kl~DfG~a~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~ 1020 (1114)
++.+||+|||+|+.+.. .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999986532 22334456689999999999999999999999999999999999999986432211
Q ss_pred CHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHHhhhcc
Q 001253 1021 DLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDR-PTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~i~~~ 1089 (1114)
. .....+. ... ....+.+++..|++.+|.+| |+++++.+.|+++..+
T Consensus 293 --------------~---~~~~~~~--~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 --------------C---KPEGLFR--RLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------------E---EECSCCT--TCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------------e---eechhcc--ccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0 0011111 111 13356688999999999998 6899999999888654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=343.53 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=208.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+.. +++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999986 67899999997543322233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~--- 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--- 166 (284)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS---
T ss_pred EeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc---
Confidence 999999999999743 4689999999999999999999998 999999999999999999999999999976532
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.... ........... . ..
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~-~---------~~-- 230 (284)
T 2vgo_A 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS----HTETHRRIVNV-D---------LK-- 230 (284)
T ss_dssp SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHTT-C---------CC--
T ss_pred cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC----HhHHHHHHhcc-c---------cC--
Confidence 22344579999999999999999999999999999999999999996433 22222222211 1 11
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhh
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSES 1086 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1086 (1114)
.+......+.+++.+||+.||.+||+++|+++ .++..
T Consensus 231 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 231 --FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred --CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 11112346789999999999999999999986 44443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=350.17 Aligned_cols=253 Identities=21% Similarity=0.318 Sum_probs=198.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC--CceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH--RNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.+.||+|+||+||+|..++++.||||++..... .....+.+.+|+.++++++| |||+++++++.+++..++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 467999999999999999999998899999999976543 33445678899999999986 999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|||+ .+++|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 87 v~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9995 57799999985 45789999999999999999999999 999999999999997 678999999999876433
Q ss_pred CCC-ccccccccccccCcccccc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 966 QSK-SMSAIAGSYGYIAPEYAYT-----------MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 966 ~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
... .....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .............
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~~~~~~~ 237 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---NQISKLHAIIDPN 237 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC---SHHHHHHHHHCTT
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh---hHHHHHHHHhcCC
Confidence 222 2345679999999999865 678899999999999999999999996432 2222222222211
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
.. . ..+......+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~--------~----~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 238 HE--------I----EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp SC--------C----CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc--------c----CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 10 0 0111112357899999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=357.69 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=200.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC--CCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR--HRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.+.||+|+||+||+|..++++.||||++..... .....+.+.+|+.++++++ ||||+++++++..++..|+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 356999999999999999999988899999999976543 3344677899999999996 5999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||| +.+++|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+|||++ ++.+||+|||+++.+...
T Consensus 134 v~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 999 5677999999854 4788999999999999999999998 999999999999995 579999999999876433
Q ss_pred CC-CccccccccccccCcccccc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 966 QS-KSMSAIAGSYGYIAPEYAYT-----------MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 966 ~~-~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
.. ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+...+...
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~~~~~~~ 284 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---NQISKLHAIIDPN 284 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC---CHHHHHHHHHCTT
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh---HHHHHHHHHhCcc
Confidence 22 12345679999999999865 368899999999999999999999996432 2222333322211
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
.. ...... ....+.+++.+||+.||.+|||+.|+++.
T Consensus 285 ~~--------~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 285 HE--------IEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp SC--------CCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc--------CCCCcc----chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 10 000011 12367899999999999999999999853
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=342.65 Aligned_cols=250 Identities=27% Similarity=0.389 Sum_probs=207.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.+.|++.+.||+|+||+||+|+.. +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 367999999999999999999975 7899999999765432 2356789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred EEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999999973 5789999999999999999999999 99999999999999999999999999998764322
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ...... +..... ..
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~-~~~~~~------~~--- 238 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVLFL-IPKNNP------PT--- 238 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHH-HHHSCC------CC---
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----HHHHHH-hhcCCC------CC---
Confidence 233456799999999999999999999999999999999999999964331 122211 111110 00
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
........+.+++.+||+.||++|||+.|+++.
T Consensus 239 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 ---LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ---CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ---CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 011122358899999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=349.45 Aligned_cols=267 Identities=24% Similarity=0.397 Sum_probs=203.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 67999999999999999999986 689999999875543 3344566889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||++++++.++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... .
T Consensus 104 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-G 178 (331)
T ss_dssp ECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC-c
Confidence 9999999988876 345799999999999999999999999 9999999999999999999999999999865432 2
Q ss_pred CccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH----------HHHhcCCcc
Q 001253 968 KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR----------NFIRNNSLV 1036 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~----------~~~~~~~~~ 1036 (1114)
.......|++.|+|||++.+. .++.++||||+||++|||++|+.||.............. .........
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 233455799999999998875 689999999999999999999999975443222211111 011111111
Q ss_pred cccccccccCCCc---ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1037 SGMLDARLNLQDE---KTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1037 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.....+....... ........+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111110000 01122457889999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=347.55 Aligned_cols=259 Identities=21% Similarity=0.274 Sum_probs=201.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEe--cCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYH--QGSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~ 883 (1114)
.++|++.++||+|+||+||+|+.. +++.||||++.... .+.+.+|+.++++++ ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 378999999999999999999975 78999999986422 466889999999997 9999999999987 5678
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-CeEEeeccCceec
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVI 962 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~~ 962 (1114)
++||||+++++|.++++ .+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+++..
T Consensus 109 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999999986 488999999999999999999999 999999999999999776 8999999999876
Q ss_pred CCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc-
Q 001253 963 DMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML- 1040 (1114)
Q Consensus 963 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1040 (1114)
... .......|++.|+|||++.+ ..++.++||||+||++|||++|+.||.......+....+..........+.+.
T Consensus 182 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 182 HPG--QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp CTT--CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC--CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 432 23345579999999999877 67899999999999999999999999654332221111111111000000000
Q ss_pred -----cc------------cc--cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 -----DA------------RL--NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 -----~~------------~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
++ .. .............+.+++.+||++||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 00 0000111113457889999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=348.60 Aligned_cols=257 Identities=23% Similarity=0.311 Sum_probs=197.3
Q ss_pred cCCcCC-ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEE
Q 001253 809 DNFDER-FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 809 ~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 885 (1114)
+.|++. ++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+++..|+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 567774 78999999999999965 789999999976533 2356788999999885 79999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC---eEEeeccCceec
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE---AHVGDFGLAKVI 962 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfG~a~~~ 962 (1114)
||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||+++..
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999999743 4689999999999999999999999 9999999999999998776 999999999765
Q ss_pred CCCCC------CccccccccccccCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCH---------
Q 001253 963 DMPQS------KSMSAIAGSYGYIAPEYAYT-----MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDL--------- 1022 (1114)
Q Consensus 963 ~~~~~------~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~--------- 1022 (1114)
..... ......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 12234569999999999875 56889999999999999999999999765432200
Q ss_pred -HHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1023 -VTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1023 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+...+.... ..............+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~i~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGK---------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCC---------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccC---------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 011111111111 10000000112346889999999999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=367.39 Aligned_cols=322 Identities=21% Similarity=0.185 Sum_probs=290.3
Q ss_pred cccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCC
Q 001253 321 LEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDN 400 (1114)
Q Consensus 321 ~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 400 (1114)
..++.++++++ .+|..+. .+++.|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 46788888887 5565553 58999999999999998999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCc
Q 001253 401 SLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPS 480 (1114)
Q Consensus 401 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 480 (1114)
++.+..+..|..+++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 99988888899999999999999999999999999999999999999999988899999999999999999999977777
Q ss_pred hhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccc
Q 001253 481 DLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKML 560 (1114)
Q Consensus 481 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 560 (1114)
.+..+++|+.|+|++|++++..+..|..+++|+.|++++|.+.+.+|.......+|++|+|++|++++..+..+..+++|
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 250 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence 89999999999999999998888899999999999999999888888877777899999999999995444577889999
Q ss_pred eEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhccc
Q 001253 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSY 640 (1114)
Q Consensus 561 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~ 640 (1114)
+.|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+ .|+|++
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~l~~ 329 (477)
T 2id5_A 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE-TLILDS 329 (477)
T ss_dssp CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCC-EEECCS
T ss_pred CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccC-EEEccC
Confidence 9999999999988888899999999999999999988888899999999999999999876666777777777 677777
Q ss_pred cccccc
Q 001253 641 NNLSGL 646 (1114)
Q Consensus 641 N~l~~~ 646 (1114)
|.+++.
T Consensus 330 N~l~c~ 335 (477)
T 2id5_A 330 NPLACD 335 (477)
T ss_dssp SCEECS
T ss_pred CCccCc
Confidence 777654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=356.13 Aligned_cols=255 Identities=11% Similarity=0.045 Sum_probs=186.6
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHH---HHhcCCCCceeeEE-------eEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEIL---TLGKIRHRNIVKLY-------GFC 877 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~~ 877 (1114)
.+|++.++||+|+||+||+|++. +|+.||||++...........+.+.+|+. .++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 56889999999999999999976 78999999998876555555667788854 5555 799988755 555
Q ss_pred EecC-----------------ceEEEEecCCCCCHHHHhccCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeE
Q 001253 878 YHQG-----------------SNLLMYEYMARGSLGELLHGASSTLDWQTR------FMIALGAAEGLSYLHHDCKPRIF 934 (1114)
Q Consensus 878 ~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~iv 934 (1114)
...+ ..|+||||++ |+|.++++.....+++..+ ..++.|+++||+|||+. +|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 4433 3799999999 7999999854445566666 78889999999999999 999
Q ss_pred ecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccccccccccCcccccc--CCCCcccchHHHHHHHHHHHhCCCC
Q 001253 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRAP 1012 (1114)
Q Consensus 935 H~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~p 1012 (1114)
||||||+|||++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987532 1224457799999999987 7799999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1013 VQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
|......... .+ .. ............ ..........+.+++.+||+.||++|||+.|+++
T Consensus 293 f~~~~~~~~~-~~-----~~-~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKG-SW-----KR-PSLRVPGTDSLA--FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTT-CC-----CB-CCTTSCCCCSCC--CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCccccc-ch-----hh-hhhhhccccccc--hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9765322100 00 00 000000011111 1111123457889999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=382.00 Aligned_cols=247 Identities=22% Similarity=0.275 Sum_probs=204.3
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 884 (1114)
..++|++.++||+|+||+||+|+++ +++.||||++++.........+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999976 6889999999864322222345677899999887 7999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||+++|+|.++++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 419 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999999999843 4689999999999999999999999 999999999999999999999999999986432
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+..+..... . .
T Consensus 495 -~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~----~~~~~~~i~~~-~---------~ 559 (674)
T 3pfq_A 495 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----EDELFQSIMEH-N---------V 559 (674)
T ss_dssp -TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHSS-C---------C
T ss_pred -CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC----HHHHHHHHHhC-C---------C
Confidence 2334456789999999999999999999999999999999999999997533 22233322221 1 1
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTM 1076 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1076 (1114)
..+......+.+++.+||+.||++||++
T Consensus 560 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 560 ----AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ----CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1112233468899999999999999997
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=350.99 Aligned_cols=260 Identities=26% Similarity=0.373 Sum_probs=206.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
.++|++.+.||+|+||+||+|++. +++.||||++.... .......+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 478999999999999999999842 57789999996433 2344567889999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCCeE
Q 001253 882 SNLLMYEYMARGSLGELLHGAS------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD---KFEAH 952 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~k 952 (1114)
..|+||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999997543 3589999999999999999999999 9999999999999994 44699
Q ss_pred EeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHH
Q 001253 953 VGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFI 1030 (1114)
Q Consensus 953 l~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 1030 (1114)
|+|||+++....... .......|++.|+|||++.+..++.++||||||+++|||++ |+.||.... ...... .+
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~----~~~~~~-~~ 258 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS----NQEVLE-FV 258 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHH-HH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC----HHHHHH-HH
Confidence 999999975532222 22334568899999999999999999999999999999998 899986432 222222 22
Q ss_pred hcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1031 RNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
...... ..+......+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus 259 ~~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 259 TSGGRM------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HTTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCCCC------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 221110 01112234688999999999999999999999999988654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=344.15 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=202.8
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
..++|++.+.||+|+||+||+|+++ +|+.||+|++..... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4578999999999999999999986 689999999976432 4568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+++++|.+++......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999999975567899999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
........|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ............ ...
T Consensus 179 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~-------~~~- 245 (314)
T 3com_A 179 -MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP----MRAIFMIPTNPP-------PTF- 245 (314)
T ss_dssp -BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSCC-------CCC-
T ss_pred -ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCCC-------ccc-
Confidence 2233455799999999999999999999999999999999999999974332 122211111110 000
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+......+.+++.+||+.||.+|||+.|+++
T Consensus 246 ---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111122346889999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=352.68 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=206.7
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCC-----hhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGN-----NNVDNSFRAEILTLGKI-RHRNIVKLYGFC 877 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 877 (1114)
....++|++.+.||+|+||.||+|+++ +|+.||||++....... ....+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344578999999999999999999986 79999999997654321 12245678899999999 799999999999
Q ss_pred EecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeecc
Q 001253 878 YHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957 (1114)
Q Consensus 878 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 957 (1114)
...+..|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecC
Confidence 999999999999999999999974 34689999999999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCCCccccccccccccCcccccc------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHh
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYT------MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIR 1031 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1031 (1114)
++..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .....+....
T Consensus 246 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~i~~ 319 (365)
T 2y7j_A 246 FSCHLEP--GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR----QILMLRMIME 319 (365)
T ss_dssp TCEECCT--TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHH
T ss_pred cccccCC--CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHh
Confidence 9987653 233345689999999998863 358889999999999999999999996432 1222222111
Q ss_pred cCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1032 NNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.... ............+.+++.+||+.||++|||+.|+++
T Consensus 320 -~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 320 -GQYQ---------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -TCCC---------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CCCC---------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1110 000000112346889999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=349.71 Aligned_cols=267 Identities=21% Similarity=0.343 Sum_probs=204.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec-------
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ------- 880 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 880 (1114)
++|++.++||+|+||+||+|+++ +|+.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 68999999999999999999985 78999999987654432 2345677899999999999999999999873
Q ss_pred -CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 881 -GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 881 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
+..++||||+++ ++.+.+......+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 467999999986 88888876667899999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCC---CCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 001253 960 KVIDMPQ---SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL 1035 (1114)
Q Consensus 960 ~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1114)
+.+.... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....+.........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCh
Confidence 8764222 223345678999999999876 458999999999999999999999997543211 12222222111000
Q ss_pred --cccccc----cccc--CCCcccH-H------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1036 --VSGMLD----ARLN--LQDEKTV-S------HMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1036 --~~~~~~----~~~~--~~~~~~~-~------~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...... .... ....... . ....+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000000 0000 0000000 0 1245789999999999999999999886
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=345.39 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=200.8
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCC-----ChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREG-----NNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
.++|++.+.||+|+||+||+|+++ +++.||||++...... .......+.+|+.++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 468999999999999999999976 6899999999754321 1122345789999999999999999999987654
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC---eEEeeccC
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE---AHVGDFGL 958 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfG~ 958 (1114)
.|+||||+++++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 8999999999999999874 45789999999999999999999999 9999999999999987664 99999999
Q ss_pred ceecCCCCCCccccccccccccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 001253 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL 1035 (1114)
Q Consensus 959 a~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1114)
++.... ........||+.|+|||++. ...++.++||||+||++|+|++|+.||............+.. ...
T Consensus 164 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~ 237 (322)
T 2ycf_A 164 SKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS----GKY 237 (322)
T ss_dssp CEECCC--CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH----TCC
T ss_pred ceeccc--ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh----Ccc
Confidence 987542 22234557999999999874 566889999999999999999999999866554444443332 110
Q ss_pred ccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1036 VSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++||++.|+++
T Consensus 238 ---------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 238 ---------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0000011112346889999999999999999999884
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=348.31 Aligned_cols=279 Identities=21% Similarity=0.365 Sum_probs=206.2
Q ss_pred HHHHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec
Q 001253 801 FKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ 880 (1114)
Q Consensus 801 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 880 (1114)
.+++.+..++|++.+.||+|+||+||+|+++. .||+|++....... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 34444556889999999999999999999863 49999987654322 2234577899999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 881 GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
+..++||||+++++|.+++......+++..+..++.|++.||+|||+. +++||||||+||+++ ++.+||+|||+++
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 999999999999999999987767899999999999999999999999 999999999999998 6799999999987
Q ss_pred ecCCCC----CCccccccccccccCcccccc---------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 001253 961 VIDMPQ----SKSMSAIAGSYGYIAPEYAYT---------MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR 1027 (1114)
Q Consensus 961 ~~~~~~----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~ 1027 (1114)
...... ........|++.|+|||++.+ ..++.++||||||+++|||++|+.||..... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~ 253 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIW 253 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH----HHHHH
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH
Confidence 643211 122334569999999999874 4578899999999999999999999964332 22222
Q ss_pred HHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCC
Q 001253 1028 NFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDS 1102 (1114)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~ 1102 (1114)
.. ..... +... .......+.+++.+||+.||++|||+.|+++.|+++..+..+...+..+|..
T Consensus 254 ~~-~~~~~------~~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~ 316 (319)
T 2y4i_B 254 QM-GTGMK------PNLS-----QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316 (319)
T ss_dssp HH-HTTCC------CCCC-----CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------------
T ss_pred Hh-ccCCC------CCCC-----cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccccc
Confidence 21 11110 0000 0011235788999999999999999999999999999888777666666653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=366.78 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=199.6
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+.+ +++.||+|++........ ....+.+|+.+++.++||||+++++++.+....|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 789999999976543222 2466889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC---CCeEEeeccCceecCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK---FEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfG~a~~~~~ 964 (1114)
||+++|+|.+.+... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.. +.+||+|||+++....
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999988643 4689999999999999999999999 99999999999999764 4599999999987653
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
.......+||+.|+|||++. ..++.++||||+||++|+|++|+.||..... ....+..... .+
T Consensus 192 --~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~-~~--------- 254 (494)
T 3lij_A 192 --QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD----QEILRKVEKG-KY--------- 254 (494)
T ss_dssp --TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHT-CC---------
T ss_pred --CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhC-CC---------
Confidence 23344567999999999876 4699999999999999999999999975332 2222222221 11
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0011111122346889999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.25 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=198.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|+++ +|+.||||++...........+.+.+|+..++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999987 7999999999765332233456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 164 (276)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence 9999999999999743 4689999999999999999999999 9999999999999999999999999999875422
Q ss_pred CCccccccccccccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.......|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||.... .....+..... .. .
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~-~~---------~ 229 (276)
T 2h6d_A 165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH----VPTLFKKIRGG-VF---------Y 229 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-CC---------C
T ss_pred -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHhhcC-cc---------c
Confidence 22334578999999999987765 689999999999999999999996432 22222221111 10 0
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+......+.+++.+||+.||++|||++|+++
T Consensus 230 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 230 ----IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 01112245788999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=367.47 Aligned_cols=253 Identities=25% Similarity=0.326 Sum_probs=202.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCC----------hhhHHHHHHHHHHHhcCCCCceeeEEeE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGN----------NNVDNSFRAEILTLGKIRHRNIVKLYGF 876 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 876 (1114)
.++|++.++||+|+||+||+|+.+ +++.||||++....... ....+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 478999999999999999999986 68899999997654321 1335678899999999999999999999
Q ss_pred EEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC---CeEE
Q 001253 877 CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF---EAHV 953 (1114)
Q Consensus 877 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl 953 (1114)
+.++...|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999988643 4689999999999999999999999 999999999999998776 6999
Q ss_pred eeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 954 GDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 954 ~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
+|||+++.... ........||+.|+|||++. ..++.++||||+||++|+|++|+.||.... ....+......
T Consensus 191 ~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~- 262 (504)
T 3q5i_A 191 VDFGLSSFFSK--DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN----DQDIIKKVEKG- 262 (504)
T ss_dssp CCCTTCEECCT--TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-
T ss_pred EECCCCEEcCC--CCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcC-
Confidence 99999987643 23345567999999999887 469999999999999999999999997533 22222222221
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+. ............+.+++.+||++||.+|||++|+++
T Consensus 263 ~~~---------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 263 KYY---------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCC---------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC---------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 110 000001112346889999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=366.78 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=203.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.++||+|+||+||+|+.+ +++.||||++....... .....+.+|+.++++++||||+++++++.+....|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 367999999999999999999986 78999999997543222 2256788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC---CCCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD---DKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfG~a~~~~ 963 (1114)
|||+++|+|.+.+... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+++...
T Consensus 100 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999988643 4789999999999999999999999 999999999999995 45679999999998654
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
. .......+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... .....+.... +.+
T Consensus 176 ~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~-~~~-------- 239 (486)
T 3mwu_A 176 Q--NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EYDILKRVET-GKY-------- 239 (486)
T ss_dssp C--C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHH-TCC--------
T ss_pred C--CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHh-CCC--------
Confidence 2 233345679999999999876 59999999999999999999999997533 2222222222 111
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....+........+.+++.+||+.||++|||+.|+++
T Consensus 240 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 240 -AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111111223356889999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=351.67 Aligned_cols=259 Identities=23% Similarity=0.296 Sum_probs=194.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC------
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG------ 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 881 (1114)
++|++.+.||+|+||+||+|+.. +++.||||++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 68999999999999999999976 789999999976543 3344567889999999999999999999997655
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..|+||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 67999999986 7888886 3589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc---------
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN--------- 1032 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------- 1032 (1114)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+......
T Consensus 177 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 177 AGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHC-CCCCCHHHH
T ss_pred ccc--ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHHH
Confidence 542 2233456799999999999999999999999999999999999999975432 1122211111
Q ss_pred -------------CCccc-----ccccc-cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1033 -------------NSLVS-----GMLDA-RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1033 -------------~~~~~-----~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..... ..... ...............+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000 00000 000001112233567899999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=343.72 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=203.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++....... .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 467999999999999999999986 78999999997544322 45688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE---CCCCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL---DDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfG~a~~~~ 963 (1114)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 85 MQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp ECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999998643 4689999999999999999999999 99999999999999 788999999999997543
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
........|++.|+|||++.+..++.++||||+|+++|||++|+.||.... ........... ..
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~i~~~-~~-------- 224 (304)
T 2jam_A 161 ---NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET----ESKLFEKIKEG-YY-------- 224 (304)
T ss_dssp ---CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHC-CC--------
T ss_pred ---CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHcC-CC--------
Confidence 222344579999999999999999999999999999999999999996432 22222222211 11
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++|||+.|+++
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 225 -EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001111122346889999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=340.18 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=200.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe----cCce
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH----QGSN 883 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 883 (1114)
+.|++.+.||+|+||+||+|.+. ++..||+|++...... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 45788889999999999999976 6889999999765443 3446778899999999999999999999875 3457
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEEC-CCCCeEEeeccCce
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR--IFHRDIKSNNILLD-DKFEAHVGDFGLAK 960 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~DfG~a~ 960 (1114)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+||+++ +++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999999743 5689999999999999999999998 7 99999999999998 78999999999997
Q ss_pred ecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
... ........|++.|+|||++.+ .++.++||||+|+++|+|++|+.||..... ....... ......
T Consensus 181 ~~~---~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~-~~~~~~----- 247 (290)
T 1t4h_A 181 LKR---ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYRR-VTSGVK----- 247 (290)
T ss_dssp GCC---TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---HHHHHHH-HTTTCC-----
T ss_pred ccc---ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc---HHHHHHH-HhccCC-----
Confidence 543 223345579999999998764 589999999999999999999999975432 2222222 111110
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.. ..+......+.+++.+||+.||.+|||++|+++
T Consensus 248 ~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 PA------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CG------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00 011111246889999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=354.31 Aligned_cols=274 Identities=21% Similarity=0.254 Sum_probs=202.9
Q ss_pred HHHHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCC--------hhhHHHHHHHHHHHhcCCCCceee
Q 001253 801 FKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGN--------NNVDNSFRAEILTLGKIRHRNIVK 872 (1114)
Q Consensus 801 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~ 872 (1114)
++++....++|++.+.||+|+||+||+|+..+|+.||||++....... ....+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456677889999999999999999999998889999999997654332 122367899999999999999999
Q ss_pred EEeEEEec-----CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC
Q 001253 873 LYGFCYHQ-----GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD 947 (1114)
Q Consensus 873 l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 947 (1114)
+++++... ...|+||||++ |+|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcC
Confidence 99998543 35799999998 589998886777899999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeccCceecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 001253 948 KFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWV 1026 (1114)
Q Consensus 948 ~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~ 1026 (1114)
++.+||+|||+++... .........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......... ..+
T Consensus 170 ~~~~kl~Dfg~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~i 246 (362)
T 3pg1_A 170 NNDITICDFNLAREDT--ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL-NKI 246 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHH
T ss_pred CCCEEEEecCcccccc--cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH-HHH
Confidence 9999999999998543 2223345579999999999877 67899999999999999999999999754321111 111
Q ss_pred HHHHhcCCccc----------ccccccccCCC-----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1027 RNFIRNNSLVS----------GMLDARLNLQD-----EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1027 ~~~~~~~~~~~----------~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
........... ........... .........+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111110000 00000000000 011122346889999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=351.62 Aligned_cols=264 Identities=24% Similarity=0.303 Sum_probs=192.9
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEe----
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYH---- 879 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~---- 879 (1114)
....+|++.++||+|+||+||+|++. +++.||||++.... ....+.+.+|+.+++++. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 44578999999999999999999975 78999999986543 234567889999999996 9999999999953
Q ss_pred ----cCceEEEEecCCCCCHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEECCCCCe
Q 001253 880 ----QGSNLLMYEYMARGSLGELLHG--ASSTLDWQTRFMIALGAAEGLSYLHHDCKPR--IFHRDIKSNNILLDDKFEA 951 (1114)
Q Consensus 880 ----~~~~~lv~E~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~ 951 (1114)
....++||||++ |+|.+++.. ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence 334789999996 599998864 345799999999999999999999998 7 9999999999999999999
Q ss_pred EEeeccCceecCCCCCC-----------ccccccccccccCcccc---ccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 001253 952 HVGDFGLAKVIDMPQSK-----------SMSAIAGSYGYIAPEYA---YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLD 1017 (1114)
Q Consensus 952 kl~DfG~a~~~~~~~~~-----------~~~~~~g~~~y~aPE~~---~~~~~~~~~DvwslGvil~el~tg~~p~~~~~ 1017 (1114)
||+|||+++........ ......||+.|+|||++ .+..++.++|||||||++|||++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999999876432221 11245699999999998 56778899999999999999999999996432
Q ss_pred CCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccc
Q 001253 1018 QGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFS 1096 (1114)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~ 1096 (1114)
.. ..... .... .........+.+++.+||+.||++|||+.|+++.|+++..........
T Consensus 258 ~~----~~~~~--------------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 258 KL----RIVNG--------------KYSI--PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp --------------------------CCC--CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred HH----HhhcC--------------cccC--CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 21 11111 0000 000011124778999999999999999999999999997765544333
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=340.38 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=205.5
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe------
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH------ 879 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 879 (1114)
..++|++.+.||+|+||+||+|++. +++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 3467999999999999999999987 79999999997543 235689999999999999999999864
Q ss_pred ----------cCceEEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC
Q 001253 880 ----------QGSNLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK 948 (1114)
Q Consensus 880 ----------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 948 (1114)
....++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 34579999999999999999743 35789999999999999999999999 99999999999999999
Q ss_pred CCeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 001253 949 FEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRN 1028 (1114)
Q Consensus 949 ~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~ 1028 (1114)
+.+||+|||++...... .......|++.|+|||++.+..++.++||||+|+++|||++|..|+... ......
T Consensus 159 ~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~~~~~ 230 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKND--GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------SKFFTD 230 (284)
T ss_dssp TEEEECCCTTCEESSCC--SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------HHHHHH
T ss_pred CCEEECcchhheecccc--ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------HHHHHH
Confidence 99999999999876532 2234457999999999999999999999999999999999999886421 111111
Q ss_pred HHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 001253 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQ 1090 (1114)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1090 (1114)
...... . .. ....+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 231 -~~~~~~-----~------~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 231 -LRDGII-----S------DI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -HHTTCC-----C------TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -hhcccc-----c------cc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 111110 0 11 1235778999999999999999999999999986653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=360.85 Aligned_cols=195 Identities=27% Similarity=0.411 Sum_probs=156.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec-----Cc
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ-----GS 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 882 (1114)
++|++.++||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 68999999999999999999976 789999999975443 333456788999999999999999999998543 46
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.|+||||++ |+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 132 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEeccc-cchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 899999985 599999974 45799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--------------------------CccccccccccccCcccc-ccCCCCcccchHHHHHHHHHHHhC
Q 001253 963 DMPQS--------------------------KSMSAIAGSYGYIAPEYA-YTMKVTEKCDIYSYGVVLLELLTG 1009 (1114)
Q Consensus 963 ~~~~~--------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslGvil~el~tg 1009 (1114)
..... ......+||+.|+|||++ .+..++.++||||+||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 43221 123456789999999986 566799999999999999999993
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=337.18 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=198.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|....+||+|+||+||+|++. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 44566679999999999999975 688999999976533 23567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCCeEEeeccCceecCC
Q 001253 888 EYMARGSLGELLHGAS--STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~~~~~ 964 (1114)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||.++....
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999997543 3567889999999999999999999 9999999999999987 89999999999987643
Q ss_pred CCCCccccccccccccCccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMK--VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
. ........|++.|+|||++.+.. ++.++||||||+++|||++|+.||....... ....+...... .
T Consensus 176 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~-------~- 244 (295)
T 2clq_A 176 I-NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAMFKVGMFKV-------H- 244 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--HHHHHHHHHCC-------C-
T ss_pred C-CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--HHHHhhccccc-------c-
Confidence 2 22234557999999999987644 7899999999999999999999996433211 11111111100 0
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.+++.+||+.||++||++.|+++
T Consensus 245 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 -----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111122346789999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=342.55 Aligned_cols=255 Identities=23% Similarity=0.380 Sum_probs=204.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe--cCceEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH--QGSNLL 885 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 885 (1114)
++|++.+.||+|+||+||+|+.+ +|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 67999999999999999999986 7899999999765432 3446678899999999999999999998854 567899
Q ss_pred EEecCCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEecCCCCCCeEECCCCCeEEeecc
Q 001253 886 MYEYMARGSLGELLHGA---SSTLDWQTRFMIALGAAEGLSYLHHDCKPR-----IFHRDIKSNNILLDDKFEAHVGDFG 957 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlk~~Nill~~~~~~kl~DfG 957 (1114)
||||+++++|.+++... ...+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999642 34589999999999999999999998 7 9999999999999999999999999
Q ss_pred CceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1114)
.++..... ........|++.|+|||++.+..++.++||||+|+++|||++|+.||..... ...... +..+...
T Consensus 162 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~-i~~~~~~- 234 (279)
T 2w5a_A 162 LARILNHD-TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELAGK-IREGKFR- 234 (279)
T ss_dssp HHHHC----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH-HHHTCCC-
T ss_pred hheeeccc-cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH----HHHHHH-Hhhcccc-
Confidence 99865422 1222345789999999999998999999999999999999999999975431 222222 2221110
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1085 (1114)
..+......+.+++.+||+.||++||++.|+++.+..
T Consensus 235 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 -----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 0111223468899999999999999999999986544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=352.25 Aligned_cols=262 Identities=21% Similarity=0.245 Sum_probs=197.1
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec---
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ--- 880 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 880 (1114)
....++|++.++||+|+||+||+|++. +|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 345688999999999999999999975 7999999998755332 23699999999999999999998543
Q ss_pred -----------------------------------CceEEEEecCCCCCHHHHhc---cCCCCCCHHHHHHHHHHHHHHH
Q 001253 881 -----------------------------------GSNLLMYEYMARGSLGELLH---GASSTLDWQTRFMIALGAAEGL 922 (1114)
Q Consensus 881 -----------------------------------~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~L 922 (1114)
...++||||+++ +|.+.+. .....+++..+..++.|+++||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 337899999985 8877765 2456899999999999999999
Q ss_pred HHHHhCCCCCeEecCCCCCCeEEC-CCCCeEEeeccCceecCCCCCCccccccccccccCccccccC-CCCcccchHHHH
Q 001253 923 SYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYG 1000 (1114)
Q Consensus 923 ~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG 1000 (1114)
+|||+. +|+||||||+||+++ .++.+||+|||+|+.... ........||+.|+|||++.+. .++.++||||+|
T Consensus 155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP--SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCT--TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCC--CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 999998 999999999999997 688999999999987642 2233455789999999998765 489999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc----------CCcccccccccccCCC---cccHHHHHHHHHHHhhccC
Q 001253 1001 VVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN----------NSLVSGMLDARLNLQD---EKTVSHMITVLKIAMLCTN 1067 (1114)
Q Consensus 1001 vil~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~ 1067 (1114)
|++|||++|+.||......+.+...++. ... ..+.... -+...... ..+......+.+++.+||+
T Consensus 230 ~il~ell~g~~pf~~~~~~~~~~~i~~~-~g~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQLVRIIQI-MGTPTKEQMIRMNPHYTEVR-FPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHH-HCCCCHHHHHHHCTTC--CC-CCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHHHHHHhCccccccc-CCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 9999999999999754432222222211 110 0000000 00000000 0111233468899999999
Q ss_pred CCCCCCCCHHHHHH
Q 001253 1068 ISPFDRPTMREVVL 1081 (1114)
Q Consensus 1068 ~dP~~RPs~~evl~ 1081 (1114)
.||++|||+.|+++
T Consensus 308 ~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 308 YEPDLRINPYEAMA 321 (383)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999984
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=354.03 Aligned_cols=200 Identities=29% Similarity=0.394 Sum_probs=168.8
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec-----C
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ-----G 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 881 (1114)
.++|++.++||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.++++++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 368999999999999999999976 688999999975533 333456788999999999999999999999776 5
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..|+||||+++ +|.++++. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 104 ~~~lv~e~~~~-~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 104 ELYIVLEIADS-DLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp CEEEEEECCSE-EHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecCCc-CHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 68999999975 99999974 45799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC---------------------CccccccccccccCcccc-ccCCCCcccchHHHHHHHHHHHhCCCCC
Q 001253 962 IDMPQS---------------------KSMSAIAGSYGYIAPEYA-YTMKVTEKCDIYSYGVVLLELLTGRAPV 1013 (1114)
Q Consensus 962 ~~~~~~---------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslGvil~el~tg~~p~ 1013 (1114)
...... ......+||+.|+|||++ ....++.++||||+||++|||++|..||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 643221 123567899999999986 5667999999999999999999865444
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=374.43 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=200.1
Q ss_pred ceecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCC
Q 001253 815 FVIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMA 891 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 891 (1114)
++||+|+||+||+|.++ +++.||||+++.... .....+++.+|+.++++++|||||++++++.. +..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 47999999999999753 567899999976543 23345779999999999999999999999964 56889999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC--Cc
Q 001253 892 RGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS--KS 969 (1114)
Q Consensus 892 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--~~ 969 (1114)
+|+|.++++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+..... ..
T Consensus 453 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 453 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999974 45789999999999999999999999 999999999999999999999999999987643322 22
Q ss_pred cccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 970 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 970 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... . .+...+..+.. .
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~-~~~~~i~~~~~------------~ 591 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----S-EVTAMLEKGER------------M 591 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----H-HHHHHHHTTCC------------C
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----H-HHHHHHHcCCC------------C
Confidence 233457889999999999999999999999999999998 9999975432 1 12222222111 0
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
..+......+.++|.+||+.||++||++++|++.|+++.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111223356889999999999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=348.47 Aligned_cols=201 Identities=28% Similarity=0.476 Sum_probs=176.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|+++ +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 468999999999999999999987 78999999997653 334467789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.++++.. ..+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 110 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp ECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999999743 46899999999999999999999831 7999999999999999999999999999754321
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPL 1016 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~ 1016 (1114)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 223457999999999999999999999999999999999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=345.25 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=200.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|+++ +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 378999999999999999999987 6899999998755332 256788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.+++......+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999999876667899999999999999999999999 9999999999999999999999999987643211
Q ss_pred CCccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
........|++.|+|||++. +..++.++||||+|+++|||++|+.||..... .............
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~------ 240 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAKSDPP------ 240 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSCCC------
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH----HHHHHHHhccCCc------
Confidence 11123456899999999883 66788999999999999999999999975432 2222222221110
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. ...+......+.+++.+||+.||++|||+.|+++
T Consensus 241 -~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 -T----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -C----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -c----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 0011122346889999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=349.31 Aligned_cols=263 Identities=19% Similarity=0.267 Sum_probs=206.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhh--------------HHHHHHHHHHHhcCCCCceeeE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNV--------------DNSFRAEILTLGKIRHRNIVKL 873 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l 873 (1114)
.++|++.+.||+|+||+||+|++ +|+.||||++.......... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999999 89999999997654322211 1778999999999999999999
Q ss_pred EeEEEecCceEEEEecCCCCCHHHH------hccC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEE
Q 001253 874 YGFCYHQGSNLLMYEYMARGSLGEL------LHGA-SSTLDWQTRFMIALGAAEGLSYLHH-DCKPRIFHRDIKSNNILL 945 (1114)
Q Consensus 874 ~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill 945 (1114)
++++.+.+..++||||+++|+|.++ +... ...+++..+..++.|++.||+|||+ . +++||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998 6532 5689999999999999999999998 7 99999999999999
Q ss_pred CCCCCeEEeeccCceecCCCCCCccccccccccccCccccccC-CCCc-ccchHHHHHHHHHHHhCCCCCCCCCCCCCHH
Q 001253 946 DDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM-KVTE-KCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023 (1114)
Q Consensus 946 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~DvwslGvil~el~tg~~p~~~~~~~~~~~ 1023 (1114)
+.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||+|+++|||++|+.||.......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--- 259 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--- 259 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH---
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH---
Confidence 99999999999999875422 33456799999999999877 6666 9999999999999999999997554322
Q ss_pred HHHHHHHhcCCcccccccccc-cCC-----CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1024 TWVRNFIRNNSLVSGMLDARL-NLQ-----DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..... +.............. ... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ELFNN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHH-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22222 221111000000000 000 0000223346889999999999999999999886
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=354.31 Aligned_cols=198 Identities=25% Similarity=0.314 Sum_probs=172.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC------CCCceeeEEeEEEec
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI------RHRNIVKLYGFCYHQ 880 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~ 880 (1114)
..+|++.++||+|+||+||+|++. +++.||||++.... ...+.+.+|+.+++.+ .|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 467999999999999999999976 68999999996432 2345667788877766 577999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC--eEEeecc
Q 001253 881 GSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE--AHVGDFG 957 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DfG 957 (1114)
+..++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999997 58999887544 4699999999999999999999999 9999999999999999987 9999999
Q ss_pred CceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLD 1017 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~ 1017 (1114)
+|+.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 248 ~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 248 SSCYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCEETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9986432 2334579999999999999999999999999999999999999997654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=376.11 Aligned_cols=260 Identities=24% Similarity=0.368 Sum_probs=208.7
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
+..++|++.+.||+|+||+||+|++. .+..||||++.... .....+.+.+|+.++++++||||+++++++. ++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 44578999999999999999999975 24579999986533 2344567899999999999999999999985 46
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..++||||+++|+|.++++.....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence 78999999999999999987666899999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.............+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .+........ ..
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----~~~~~~i~~~-~~----- 610 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIGRIENG-ER----- 610 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHHT-CC-----
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHcC-CC-----
Confidence 65443333344567889999999999999999999999999999997 9999975432 2222221111 10
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
. ..+......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 611 ---~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 611 ---L----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---C----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0 1111223468899999999999999999999999999854
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=337.01 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=198.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.+.||+|+||+||+|+++ +++.||+|++........ ....+.+|+..+..+ +||||+++++++.+++..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 467999999999999999999987 799999999986654433 355677899999888 99999999999999999999
Q ss_pred EEecCCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC--------------
Q 001253 886 MYEYMARGSLGELLHGA---SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK-------------- 948 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-------------- 948 (1114)
||||+++++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999743 25689999999999999999999999 99999999999999844
Q ss_pred -----CCeEEeeccCceecCCCCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCH
Q 001253 949 -----FEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDL 1022 (1114)
Q Consensus 949 -----~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~ 1022 (1114)
..+||+|||.+....... ...||+.|+|||++.+. .++.++||||+||++|||++|.+|+... ..
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~ 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQ 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HH
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hH
Confidence 479999999998764322 23589999999999765 5668999999999999999998776422 11
Q ss_pred HHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1023 VTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. .. +..+.. ...+......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~---~~-~~~~~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 W---HE-IRQGRL------------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp H---HH-HHTTCC------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H---HH-HHcCCC------------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 11 111111 0011112346889999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=346.05 Aligned_cols=262 Identities=27% Similarity=0.387 Sum_probs=187.4
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.+..++|++.+.||+|+||+||+|++. +++.||||++...... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 345688999999999999999999965 7899999998654322 2245688899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeec
Q 001253 884 LLMYEYMARGSLGELLHG-------ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 956 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 956 (1114)
++||||+++++|.+++.. ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999999863 345689999999999999999999999 9999999999999999999999999
Q ss_pred cCceecCCCC----CCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHh
Q 001253 957 GLAKVIDMPQ----SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIR 1031 (1114)
Q Consensus 957 G~a~~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1031 (1114)
|++....... ........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||........ ......
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~ 241 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV----LMLTLQ 241 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----HHHHHT
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH----HHHHhc
Confidence 9997654221 112234579999999999876 5689999999999999999999999976443221 111111
Q ss_pred cCCc--ccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1032 NNSL--VSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1032 ~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.... .....+. .........+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 NDPPSLETGVQDK------EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SSCCCTTC-----------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCCccccccccc------hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1110 0000000 001112246789999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=346.14 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=197.2
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEe---
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYH--- 879 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 879 (1114)
....++|++.+.||+|+||+||+|++. +|+.||||++...... .+.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 345688999999999999999999985 7899999999754432 45688899999998 79999999999987
Q ss_pred ---cCceEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEee
Q 001253 880 ---QGSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 955 (1114)
Q Consensus 880 ---~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 955 (1114)
.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 457899999999999999997543 4789999999999999999999999 999999999999999999999999
Q ss_pred ccCceecCCCCCCccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 001253 956 FGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFI 1030 (1114)
Q Consensus 956 fG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 1030 (1114)
||++....... .......|++.|+|||++. +..++.++||||+||++|+|++|+.||..... ........
T Consensus 173 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~ 247 (326)
T 2x7f_A 173 FGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRALFLIP 247 (326)
T ss_dssp CTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHH
T ss_pred CcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhh
Confidence 99998654221 2234457999999999987 56788999999999999999999999964332 12222211
Q ss_pred hcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1031 RNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.... +.. ........+.+++.+||+.||++||+++|+++
T Consensus 248 ~~~~-------~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPA-------PRL-----KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCC-------CCC-----SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCcc-------ccC-----CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1110 000 01111246889999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=337.73 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=205.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCC------hhhHHHHHHHHHHHhcCC-CCceeeEEeEEEe
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGN------NNVDNSFRAEILTLGKIR-HRNIVKLYGFCYH 879 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 879 (1114)
.++|++.+.||+|+||+||+|+++ +|+.||||++....... ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999986 68999999997654221 123456788999999995 9999999999999
Q ss_pred cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 880 QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
++..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999999974 34789999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccccccCccccc------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAY------TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
..... ........|++.|+|||++. ...++.++||||+|+++|||++|+.||.... .....+.....
T Consensus 172 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~- 244 (298)
T 1phk_A 172 CQLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK----QMLMLRMIMSG- 244 (298)
T ss_dssp EECCT--TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHT-
T ss_pred hhcCC--CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc----HHHHHHHHhcC-
Confidence 87642 22334567999999999885 4568889999999999999999999996432 22222222221
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.. .............+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NY---------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CC---------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Cc---------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 0001111223346889999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=334.78 Aligned_cols=259 Identities=21% Similarity=0.327 Sum_probs=193.2
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
..++|++.+.||+|+||+||+|+.. +|+.||||++...... ....+.+.++...++.++||||+++++++.+++..++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3578999999999999999999975 7899999999765432 2223445556666888999999999999999999999
Q ss_pred EEecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 886 MYEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
||||+++ +|.+++.. ....+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9999985 88887753 4568999999999999999999999842 8999999999999999999999999999875
Q ss_pred CCCCCCccccccccccccCcccc----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 001253 963 DMPQSKSMSAIAGSYGYIAPEYA----YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038 (1114)
Q Consensus 963 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1114)
... .......||+.|+|||++ .+..++.++||||+|+++|||++|+.||.... .....+..........
T Consensus 161 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~-- 233 (290)
T 3fme_A 161 VDD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG---TPFQQLKQVVEEPSPQ-- 233 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS---CHHHHHHHHHHSCCCC--
T ss_pred ccc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC---chHHHHHHHhccCCCC--
Confidence 432 223344799999999996 56678999999999999999999999996432 2223333333321110
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhh
Q 001253 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSES 1086 (1114)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1086 (1114)
.........+.+++.+||+.||++|||+.|+++ .++..
T Consensus 234 ----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 234 ----------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ----------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ----------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 001112346889999999999999999999987 44443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=348.25 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=185.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec------
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ------ 880 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 880 (1114)
.++|++.+.||+|+||+||+|++. +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 368999999999999999999975 789999999975433 233456788999999999999999999999754
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 881 GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
...|+||||+ +++|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred CeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 5679999999 6799999874 5799999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc--cc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL--VS 1037 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 1037 (1114)
.... .....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||........+ ..+......... ..
T Consensus 181 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l-~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 181 HTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLK 255 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHT
T ss_pred cccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHH
Confidence 6532 2345679999999999887 67899999999999999999999999754422111 111111111000 00
Q ss_pred cccc-------ccccCCCccc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1038 GMLD-------ARLNLQDEKT-----VSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1038 ~~~~-------~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+.. ..+....... ......+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000 0000000000 112346889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=350.21 Aligned_cols=260 Identities=25% Similarity=0.313 Sum_probs=196.2
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc------
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS------ 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 882 (1114)
.+|++.++||+|+||+||+|++..+..||+|++....... .+|+.+++.++||||+++++++...+.
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~-------~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-------NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC-------CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH-------HHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 6799999999999999999999877779999987544322 369999999999999999999965443
Q ss_pred eEEEEecCCCCCHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCCeEEeeccCc
Q 001253 883 NLLMYEYMARGSLGELLH--GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLA 959 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfG~a 959 (1114)
.++||||++++.+..... .....+++..+..++.|+++||+|||+. +|+||||||+||+++ .++.+||+|||+|
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 789999998854443332 2356799999999999999999999999 999999999999999 7999999999999
Q ss_pred eecCCCCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc---
Q 001253 960 KVIDMPQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL--- 1035 (1114)
Q Consensus 960 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 1035 (1114)
+..... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||........+...++. ......
T Consensus 190 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~-~g~p~~~~~ 266 (394)
T 4e7w_A 190 KILIAG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV-LGTPSREQI 266 (394)
T ss_dssp EECCTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH-HCCCCHHHH
T ss_pred ccccCC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCCHHHH
Confidence 876422 233456789999999998765 5899999999999999999999999764432222222221 100000
Q ss_pred ---ccccccccccCCCc------ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1036 ---VSGMLDARLNLQDE------KTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1036 ---~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
........+..... ........+.+++.+||+.||.+|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000000000000 01113347889999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=337.20 Aligned_cols=251 Identities=26% Similarity=0.450 Sum_probs=194.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe-------
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH------- 879 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 879 (1114)
.++|++.+.||+|+||+||+|+.. +|+.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 467999999999999999999975 7899999999643 2335678899999999999999999999865
Q ss_pred ------cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEE
Q 001253 880 ------QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 953 (1114)
Q Consensus 880 ------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 953 (1114)
.+..|+||||+++|+|.++++.....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 3467999999999999999987666788999999999999999999999 9999999999999999999999
Q ss_pred eeccCceecCCCC-------------CCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001253 954 GDFGLAKVIDMPQ-------------SKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019 (1114)
Q Consensus 954 ~DfG~a~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~ 1019 (1114)
+|||+++...... ........|++.|+|||++.+. .++.++||||+||++|||++ ||....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 9999998654221 1223445799999999998764 68999999999999999998 543211
Q ss_pred CCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1020 GDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+....... +... ...............+.+++.+||+.||.+|||+.|+++
T Consensus 233 -~~~~~~~~-~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 -ERVNILKK-LRSV---------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHHHH-HHST---------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hHHHHHHh-cccc---------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11122222 1111 011111122233346789999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=351.02 Aligned_cols=264 Identities=27% Similarity=0.333 Sum_probs=197.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC------
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG------ 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 881 (1114)
.+|++.++||+|+||+||+|+++ +|+.||||++...... ..+|+++++.++||||+++++++...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------HHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 56899999999999999999986 6899999998754322 236999999999999999999985422
Q ss_pred ceEEEEecCCCCCHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-CCeEEeecc
Q 001253 882 SNLLMYEYMARGSLGELLH---GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK-FEAHVGDFG 957 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfG 957 (1114)
..++||||+++ ++.+.+. .....+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 35799999987 6666654 3456899999999999999999999998 99999999999999965 568999999
Q ss_pred CceecCCCCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHH-------
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNF------- 1029 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~------- 1029 (1114)
+++..... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+.+.+.++..
T Consensus 203 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 203 SAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp TCEECCTT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhhcccC--CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99875422 223456789999999998765 79999999999999999999999997644322222222210
Q ss_pred Hh--cCCcccccccccccCCCc---ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhh
Q 001253 1030 IR--NNSLVSGMLDARLNLQDE---KTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSES 1086 (1114)
Q Consensus 1030 ~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1086 (1114)
+. ...+.. ...+....... ........+.+++.+||+.||.+|||+.|+++ .++++
T Consensus 281 ~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 281 IREMNPNYTE-FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHCSCCCC-CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhhChhhhh-hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 00 000000 00000000000 01122357889999999999999999999985 34444
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=345.17 Aligned_cols=263 Identities=20% Similarity=0.230 Sum_probs=201.8
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC--------CCceeeEEeEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR--------HRNIVKLYGFCY 878 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~ 878 (1114)
.++|++.++||+|+||+||+|+.. +++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 478999999999999999999975 6889999999643 233567888999998885 788999999997
Q ss_pred ----ecCceEEEEecCCCCCHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC----
Q 001253 879 ----HQGSNLLMYEYMARGSLGELL-HGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF---- 949 (1114)
Q Consensus 879 ----~~~~~~lv~E~~~~gsL~~~l-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---- 949 (1114)
.....++||||+.+ ++.+.+ ......+++..+..++.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred ecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 45578999999955 555554 444467999999999999999999999853 799999999999999775
Q ss_pred ---------------------------------------------CeEEeeccCceecCCCCCCccccccccccccCccc
Q 001253 950 ---------------------------------------------EAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984 (1114)
Q Consensus 950 ---------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~ 984 (1114)
.+||+|||.++..... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999875422 334579999999999
Q ss_pred cccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCH--HHHHH---HHHhc--------CCccccccccc--------
Q 001253 985 AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDL--VTWVR---NFIRN--------NSLVSGMLDAR-------- 1043 (1114)
Q Consensus 985 ~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~--~~~~~---~~~~~--------~~~~~~~~~~~-------- 1043 (1114)
+.+..++.++|||||||++|||++|+.||......... ...+. ..... ..+........
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999765433211 11111 11110 11110000000
Q ss_pred ---------ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 ---------LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+......+......+.+++.+||+.||++|||++|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00011224556678999999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=342.06 Aligned_cols=265 Identities=23% Similarity=0.291 Sum_probs=203.1
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec-----C
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ-----G 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 881 (1114)
.++|++.++||+|+||+||+|++. +++.||||++.... .....+.+.+|+.++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 368999999999999999999976 78899999997533 233456788999999999999999999999765 3
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..|+||||+++ +|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 67999999985 99999974 4689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--CccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccc-
Q 001253 962 IDMPQS--KSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS- 1037 (1114)
Q Consensus 962 ~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 1037 (1114)
...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||............ ...........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~ 256 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI-LGILGSPSQEDL 256 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH-HHHHCSCCHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH-HHHhCCCCHHHH
Confidence 643222 12345689999999998754 45899999999999999999999999765433322222 21111100000
Q ss_pred -cc-------ccccccCCCcc-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1038 -GM-------LDARLNLQDEK-----TVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1038 -~~-------~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.. ........... .......+.+++.+||++||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00000000000 1112346889999999999999999999986
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=367.40 Aligned_cols=335 Identities=17% Similarity=0.151 Sum_probs=216.8
Q ss_pred cccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEe
Q 001253 342 LGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDL 421 (1114)
Q Consensus 342 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 421 (1114)
.+++.+++++|.++.+.+..|..+++|++|+|++|.+++..|..|..+++|++|+|++|.+.+..|..|+
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~---------- 120 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ---------- 120 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTT----------
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHc----------
Confidence 3455555555555555444555555555555555555555444555555555555555555444444444
Q ss_pred ecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCC
Q 001253 422 SDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGP 501 (1114)
Q Consensus 422 s~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 501 (1114)
.+++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|..+++|++|+|++|++++.
T Consensus 121 --------------~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 121 --------------NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 186 (597)
T ss_dssp --------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred --------------CCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence 444555555555555433333345555555555555555555555555555566666666655543
Q ss_pred ccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhc
Q 001253 502 IPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSL 581 (1114)
Q Consensus 502 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 581 (1114)
. ++.+++|+.|++++|.+++ +...++|+.|++++|.++ .++..+ .++|+.|+|++|.+++ +..++.+
T Consensus 187 ~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~-~~~~~~--~~~L~~L~L~~n~l~~--~~~l~~l 253 (597)
T 3oja_B 187 D---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNY 253 (597)
T ss_dssp C---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCC-EEECSC--CSCCCEEECCSSCCCC--CGGGGGC
T ss_pred C---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccc-cccccc--CCCCCEEECCCCCCCC--ChhhccC
Confidence 1 3445566666666666653 223345667777777666 333322 2567777777777775 3567777
Q ss_pred ccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhh
Q 001253 582 FQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLL 661 (1114)
Q Consensus 582 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 661 (1114)
++|+.|+|++|.+++..|..|+.+++|+.|+|++|++++ +|..+..+++|+ .|+|++|.++ .+|..++.+++|++|+
T Consensus 254 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~-~L~Ls~N~l~-~i~~~~~~l~~L~~L~ 330 (597)
T 3oja_B 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLK-VLDLSHNHLL-HVERNQPQFDRLENLY 330 (597)
T ss_dssp TTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCC-EEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred CCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCc-EEECCCCCCC-ccCcccccCCCCCEEE
Confidence 778888888888777777777778888888888888775 566667777777 6888888888 4577788888999999
Q ss_pred ccCcccccCCCCccccccccceEEeccCcccCCCCCcccccccccccccCCCCCCCCCC
Q 001253 662 LNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPL 720 (1114)
Q Consensus 662 Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lc~~p~ 720 (1114)
|++|+|++.. +..+++|+.|++++|+|+|.++. ..+..+....+.++...|+.+.
T Consensus 331 L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~~ 385 (597)
T 3oja_B 331 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDY 385 (597)
T ss_dssp CCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTTC
T ss_pred CCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcch
Confidence 9999998663 56778999999999999997643 4567777777888999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=345.95 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=198.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce---
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN--- 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 883 (1114)
.++|.+.+.||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 368999999999999999999976 789999999976543 334456788999999999999999999999877654
Q ss_pred ---EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 884 ---LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 884 ---~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
++||||++ ++|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999998 48988885 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc-ccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL-VSG 1038 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1038 (1114)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .+.+......... ...
T Consensus 193 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 193 HADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTGVPGTE 264 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCHH
T ss_pred cccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCcHH
Confidence 6532 2344578999999999887 7789999999999999999999999975432 2222221110000 000
Q ss_pred ccc-----------ccccCCCc-----ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1039 MLD-----------ARLNLQDE-----KTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1039 ~~~-----------~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
... ........ ........+.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000 00000000 01122457889999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=328.51 Aligned_cols=257 Identities=23% Similarity=0.314 Sum_probs=201.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCC-ChhhHHHHHHHHHHHhcCCCCceeeEEeEEE--ecCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREG-NNNVDNSFRAEILTLGKIRHRNIVKLYGFCY--HQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 883 (1114)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... .....+.+.+|+.+++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999975 7899999999754321 1233567899999999999999999999984 45578
Q ss_pred EEEEecCCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 884 LLMYEYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
++||||++++ +.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999986 7776653 345799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-CCccccccccccccCccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 963 DMPQ-SKSMSAIAGSYGYIAPEYAYTMK--VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 963 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
.... ........|++.|+|||++.+.. ++.++||||+|+++|||++|+.||.... ........... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~i~~~-~~---- 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN----IYKLFENIGKG-SY---- 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHC-CC----
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHHHHhcC-CC----
Confidence 4322 22234557999999999987644 4779999999999999999999997432 22222222111 11
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhh
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSES 1086 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1086 (1114)
.. +......+.+++.+||+.||.+|||++|+++ .+++.
T Consensus 231 -----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 -----AI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp -----CC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred -----CC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 11 1112346789999999999999999999986 34443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=348.42 Aligned_cols=264 Identities=20% Similarity=0.318 Sum_probs=182.7
Q ss_pred cCCcC-CceecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe--cCc
Q 001253 809 DNFDE-RFVIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH--QGS 882 (1114)
Q Consensus 809 ~~~~~-~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 882 (1114)
+.|++ .++||+|+||+||+|+++ +++.||||++..... ...+.+|+.++++++||||+++++++.. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 44665 458999999999999976 578999999975433 3457789999999999999999999965 667
Q ss_pred eEEEEecCCCCCHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE----CCCCC
Q 001253 883 NLLMYEYMARGSLGELLHG--------ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL----DDKFE 950 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~ 950 (1114)
.|+||||+++ +|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence 8999999976 88887752 122589999999999999999999999 99999999999999 67889
Q ss_pred eEEeeccCceecCCCCC--CccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCC-----CH
Q 001253 951 AHVGDFGLAKVIDMPQS--KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG-----DL 1022 (1114)
Q Consensus 951 ~kl~DfG~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~-----~~ 1022 (1114)
+||+|||+|+....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ..
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999999987643221 233456899999999999874 58999999999999999999999997544210 01
Q ss_pred HHHHHHHHhc-CCcccccccccccCC--------------Cccc---------HHHHHHHHHHHhhccCCCCCCCCCHHH
Q 001253 1023 VTWVRNFIRN-NSLVSGMLDARLNLQ--------------DEKT---------VSHMITVLKIAMLCTNISPFDRPTMRE 1078 (1114)
Q Consensus 1023 ~~~~~~~~~~-~~~~~~~~~~~~~~~--------------~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~e 1078 (1114)
...+...+.. +......+....... .... ......+.+++.+||+.||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 1111111110 000000000000000 0000 001346789999999999999999999
Q ss_pred HHH
Q 001253 1079 VVL 1081 (1114)
Q Consensus 1079 vl~ 1081 (1114)
+++
T Consensus 331 ~L~ 333 (405)
T 3rgf_A 331 AMQ 333 (405)
T ss_dssp HHT
T ss_pred Hhc
Confidence 986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=332.21 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=204.4
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
..++|++.+.||+|+||+||+|+.+ +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 3478999999999999999999986 78999999997654332 235678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC---CCeEEeeccCceec
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK---FEAHVGDFGLAKVI 962 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfG~a~~~ 962 (1114)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||++...
T Consensus 99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999988643 4689999999999999999999999 99999999999999764 46999999999865
Q ss_pred CCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 963 DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 963 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
... .......|++.|+|||.+.+ .++.++||||+|+++|+|++|+.||.... .....+.... +...
T Consensus 175 ~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~-~~~~------ 240 (287)
T 2wei_A 175 QQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EYDILKRVET-GKYA------ 240 (287)
T ss_dssp CCC--SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHH-CCCC------
T ss_pred cCC--CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHc-CCCC------
Confidence 422 22334568999999998876 48999999999999999999999997533 2222222221 1111
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
............+.+++.+||+.||++|||+.|+++
T Consensus 241 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 ---FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 001111122346889999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=337.24 Aligned_cols=254 Identities=21% Similarity=0.283 Sum_probs=174.9
Q ss_pred cCCcCCc-eecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe----cCc
Q 001253 809 DNFDERF-VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH----QGS 882 (1114)
Q Consensus 809 ~~~~~~~-~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~ 882 (1114)
++|++.+ +||+|+||+||+|+++ +|+.||||++.... ....+....++.++||||+++++++.. +..
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 7899855 6999999999999987 79999999986421 122233344667799999999999976 445
Q ss_pred eEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCCeEEeeccC
Q 001253 883 NLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD---KFEAHVGDFGL 958 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG~ 958 (1114)
.++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 799999999999999998554 4799999999999999999999999 9999999999999986 45599999999
Q ss_pred ceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 001253 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038 (1114)
Q Consensus 959 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1114)
++.... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||............ ......
T Consensus 178 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~------ 247 (336)
T 3fhr_A 178 AKETTQ---NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-KRRIRL------ 247 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceeccc---cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH-HHhhhc------
Confidence 986542 2234457899999999998888999999999999999999999999754432211111 111110
Q ss_pred cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHh
Q 001253 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSE 1085 (1114)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1085 (1114)
................+.+++.+||+.||++|||++|+++ .+++
T Consensus 248 ---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 248 ---GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ---cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 0111111111223346889999999999999999999997 4444
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=343.18 Aligned_cols=201 Identities=24% Similarity=0.322 Sum_probs=171.7
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CC-----ceeeEEeEEEe
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HR-----NIVKLYGFCYH 879 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~ 879 (1114)
..++|++.++||+|+||+||+|+++ +++.||||++.... .....+..|+.+++.++ |+ +|+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3578999999999999999999976 68899999996432 23456777888887774 44 59999999999
Q ss_pred cCceEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC--CCCCeEEeec
Q 001253 880 QGSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD--DKFEAHVGDF 956 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Df 956 (1114)
.+..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||++ ..+|+||||||+|||++ .++.+||+||
T Consensus 128 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999999975 9999987543 5689999999999999999999953 23899999999999995 5778999999
Q ss_pred cCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 001253 957 GLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLD 1017 (1114)
Q Consensus 957 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~ 1017 (1114)
|+|+..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999876422 234579999999999999999999999999999999999999997544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=337.60 Aligned_cols=267 Identities=21% Similarity=0.324 Sum_probs=200.2
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC--CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC---CCCceeeEEeEEE---
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR--TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI---RHRNIVKLYGFCY--- 878 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 878 (1114)
..++|++.+.||+|+||+||+|++. +|+.||+|++........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4578999999999999999999983 688999999975543221 122355677666655 8999999999987
Q ss_pred --ecCceEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEee
Q 001253 879 --HQGSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 955 (1114)
Q Consensus 879 --~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 955 (1114)
.....++||||++ |+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 59999987543 3589999999999999999999999 999999999999999999999999
Q ss_pred ccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC--
Q 001253 956 FGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN-- 1033 (1114)
Q Consensus 956 fG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-- 1033 (1114)
||+++.... ........|++.|+|||++.+..++.++||||+||++|||++|+.||.......... .+.......
T Consensus 164 fg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG-KILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCCCCG
T ss_pred CcccccccC--CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHHcCCCCc
Confidence 999986532 223345678999999999999999999999999999999999999997543221111 111111110
Q ss_pred -Cccccccccc--c-----cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1034 -SLVSGMLDAR--L-----NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1034 -~~~~~~~~~~--~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+......+. . .............+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 0 0000011122346789999999999999999999984
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=343.64 Aligned_cols=268 Identities=23% Similarity=0.289 Sum_probs=190.5
Q ss_pred HHHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 803 DLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 803 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
......++|++.+.||+|+||+||+|+++ +|+.||||++...... ...+.+|+..++.++||||+++++++...+
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 34556689999999999999999999986 7899999998654433 234566788888899999999999997644
Q ss_pred c-------eEEEEecCCCCCHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCeEECC-C
Q 001253 882 S-------NLLMYEYMARGSLGELLH---GASSTLDWQTRFMIALGAAEGLSYLH--HDCKPRIFHRDIKSNNILLDD-K 948 (1114)
Q Consensus 882 ~-------~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlk~~Nill~~-~ 948 (1114)
. .++||||+++ ++.+.+. .....+++..+..++.|++.|++||| +. +|+||||||+||+++. +
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence 3 7899999987 5544433 24567899999999999999999999 77 9999999999999996 8
Q ss_pred CCeEEeeccCceecCCCCCCccccccccccccCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 001253 949 FEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVR 1027 (1114)
Q Consensus 949 ~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~ 1027 (1114)
+.+||+|||+++.... ........||+.|+|||++.+.. ++.++||||+||++|||++|+.||............++
T Consensus 169 ~~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSP--SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp TEEEECCCTTCBCCCT--TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcEEEeeCCCceecCC--CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 9999999999987643 22334557899999999987654 89999999999999999999999976443222222221
Q ss_pred HHHhcCC-----------ccccccc-ccc---cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1028 NFIRNNS-----------LVSGMLD-ARL---NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1028 ~~~~~~~-----------~~~~~~~-~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. ..... ....... ... .............+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 247 V-LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp H-HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred H-cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1 10000 0000000 000 0000111123457899999999999999999999986
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=345.20 Aligned_cols=335 Identities=16% Similarity=0.128 Sum_probs=215.7
Q ss_pred ccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeee
Q 001253 366 KNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNL 445 (1114)
Q Consensus 366 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L 445 (1114)
++++.|++++|.++...+..|..+++|++|++++|.+.+..+..|..+++|++|+|++|++++..|..|..+++|++|++
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 44444455444444333333444444555555555544444445555555555555555555555555555555555555
Q ss_pred ccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccC
Q 001253 446 ETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGE 525 (1114)
Q Consensus 446 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 525 (1114)
++|+++...+..+..+++|++|++++|++++..|..+..+++|++|++++|++++. .+..+++|+.|++++|.+++.
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc
Confidence 55555533333345566666666666666655555566666666666666666543 244556666677776666532
Q ss_pred CCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCccccccccc
Q 001253 526 LPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNL 605 (1114)
Q Consensus 526 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 605 (1114)
...++|+.|++++|.++ .+|... .++|+.|++++|++++. ..+..+++|++|++++|.+++..|..|..+
T Consensus 202 -----~~~~~L~~L~l~~n~l~-~~~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l 271 (390)
T 3o6n_A 202 -----AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKM 271 (390)
T ss_dssp -----ECCSSCSEEECCSSCCC-EEECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTC
T ss_pred -----CCCCcceEEECCCCeee-eccccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcccc
Confidence 22346777777777776 334332 36777777777777753 467777778888888888877777777778
Q ss_pred ccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEE
Q 001253 606 SRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCN 685 (1114)
Q Consensus 606 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ 685 (1114)
++|+.|+|++|++++ +|..+..+++|+ .|+|++|++++ +|..++.+++|++|+|++|+|++. | +..+++|+.|+
T Consensus 272 ~~L~~L~L~~n~l~~-~~~~~~~l~~L~-~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~ 345 (390)
T 3o6n_A 272 QRLERLYISNNRLVA-LNLYGQPIPTLK-VLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLT 345 (390)
T ss_dssp SSCCEEECCSSCCCE-EECSSSCCTTCC-EEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEE
T ss_pred ccCCEEECCCCcCcc-cCcccCCCCCCC-EEECCCCccee-cCccccccCcCCEEECCCCcccee-C--chhhccCCEEE
Confidence 888888888888774 566666777777 68888888874 466788888999999999999865 3 67788999999
Q ss_pred eccCcccCCCCCcccccccccccccCCCCCCCCCC
Q 001253 686 FSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPL 720 (1114)
Q Consensus 686 ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lc~~p~ 720 (1114)
+++|+|.|.... ..+..+....+.++...|+.|.
T Consensus 346 l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~~ 379 (390)
T 3o6n_A 346 LSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDY 379 (390)
T ss_dssp CCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTTC
T ss_pred cCCCCccchhHH-HHHHHHHhhcccccCceecccc
Confidence 999999986432 3455666666778888887654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=338.79 Aligned_cols=261 Identities=20% Similarity=0.294 Sum_probs=202.6
Q ss_pred hcCCcCCceecccCCeEEEEEEe-C-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCC------ceeeEEeEEEe
Q 001253 808 TDNFDERFVIGRGACGTVYRAVL-R-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR------NIVKLYGFCYH 879 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~ 879 (1114)
.++|++.+.||+|+||+||+|.+ + +++.||||++... ....+.+.+|+.+++.++|+ +++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 36899999999999999999997 3 6889999998643 23356688899998888765 49999999999
Q ss_pred cCceEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-----------
Q 001253 880 QGSNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD----------- 947 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~----------- 947 (1114)
.+..++||||+ +++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999999 789999987544 3689999999999999999999999 9999999999999987
Q ss_pred --------CCCeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001253 948 --------KFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019 (1114)
Q Consensus 948 --------~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~ 1019 (1114)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 67899999999987432 223457999999999999999999999999999999999999999754321
Q ss_pred CCHHHHHHHHHhcCCc--------ccccccc-------------------cccCCCcccHHHHHHHHHHHhhccCCCCCC
Q 001253 1020 GDLVTWVRNFIRNNSL--------VSGMLDA-------------------RLNLQDEKTVSHMITVLKIAMLCTNISPFD 1072 (1114)
Q Consensus 1020 ~~~~~~~~~~~~~~~~--------~~~~~~~-------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 1072 (1114)
. ....+......... ....... ...............+.+++.+||+.||.+
T Consensus 241 ~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 241 E-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp H-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred H-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 1 11112211110000 0000000 000001112344567899999999999999
Q ss_pred CCCHHHHHH
Q 001253 1073 RPTMREVVL 1081 (1114)
Q Consensus 1073 RPs~~evl~ 1081 (1114)
|||++|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=341.12 Aligned_cols=265 Identities=23% Similarity=0.318 Sum_probs=200.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec-----C
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ-----G 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 881 (1114)
.++|++.+.||+|+||+||+|+++ +|+.||||++.... .......+.+|+.++++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 378999999999999999999986 78999999996432 333456678999999999999999999998764 5
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..++||||+++ +|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 88 ~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 88 EVYIIQELMQT-DLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp CEEEEECCCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEeccCc-cHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 78999999984 99999874 4689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---------ccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHh
Q 001253 962 IDMPQSK---------SMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIR 1031 (1114)
Q Consensus 962 ~~~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1031 (1114)
....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... ..+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~ 240 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL-LLIFGIIG 240 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhC
Confidence 6432211 1233578999999998764 67899999999999999999999999754321111 11111111
Q ss_pred cCCccc---cccc-------ccccCCCc-----ccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1032 NNSLVS---GMLD-------ARLNLQDE-----KTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1032 ~~~~~~---~~~~-------~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...... .... ........ ........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 100000 0000 00000000 01122356889999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=339.22 Aligned_cols=263 Identities=21% Similarity=0.325 Sum_probs=201.4
Q ss_pred CCCCHHHHHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC--CCceeeEE
Q 001253 797 EGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR--HRNIVKLY 874 (1114)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~ 874 (1114)
..+.+..+.+..++|++.+.||+|+||+||+|++++++.||||++..... .....+.+.+|+.++++++ ||||++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEE
Confidence 33444445556688999999999999999999998899999999976543 2344577889999999997 59999999
Q ss_pred eEEEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEe
Q 001253 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG 954 (1114)
Q Consensus 875 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 954 (1114)
+++..++..++||| +.+++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++ +.+||+
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEEC
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEe
Confidence 99999999999999 5577999999854 4789999999999999999999999 9999999999999964 899999
Q ss_pred eccCceecCCCCC-CccccccccccccCcccccc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCH
Q 001253 955 DFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYT-----------MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDL 1022 (1114)
Q Consensus 955 DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~ 1022 (1114)
|||+++....... .......|++.|+|||++.+ ..++.++||||+|+++|||++|+.||..... .
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~ 245 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---Q 245 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS---H
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH---H
Confidence 9999987643222 12234579999999999875 4688899999999999999999999964322 2
Q ss_pred HHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1023 VTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
............. .. .+......+.+++.+||+.||++||+++|+++
T Consensus 246 ~~~~~~~~~~~~~--------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 246 ISKLHAIIDPNHE--------IE----FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHHHCTTSC--------CC----CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcccc--------cC----CcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 2222222221110 00 01111246889999999999999999999986
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=337.47 Aligned_cols=258 Identities=29% Similarity=0.488 Sum_probs=156.5
Q ss_pred ccceeeeccCCccC--CcCcccccCCcceEEeecc-ceeeccCCchhhccccccEeecccccCCCCccccccccccCcEE
Q 001253 439 SLIFLNLETNKLTG--SIPTGVTRCKSLVQLRLGG-NSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRL 515 (1114)
Q Consensus 439 ~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 515 (1114)
+++.|+|++|.+++ .+|..+..+++|++|+|++ |.+.+.+|..|+.+++|++|+|++|++++.+|..|.++++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 45566666666655 5555555555555555553 55555555555555555555555555555555555555555555
Q ss_pred EecCceeccCCCccccCCCCcceeecccccccccccccccccc-cceEEECccccccCCCchhhhhcccCCeeeccCccC
Q 001253 516 HLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCK-MLQRLDLSWNKFVGALPREIGSLFQLELLKLSENEL 594 (1114)
Q Consensus 516 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 594 (1114)
+|++|+|++.+|..|..+++|++|+|++|++++.+|..+..++ +|+.|+|++|++++.+|..+..
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~-------------- 196 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN-------------- 196 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG--------------
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhC--------------
Confidence 5555555555555555555555555555555555555555544 4555555555555444444444
Q ss_pred CCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCc
Q 001253 595 SGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGS 674 (1114)
Q Consensus 595 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~ 674 (1114)
++ |+.|++++|++++.+|..+..++.|+ .|+|++|++++.+|. +..+++|++|+|++|+|+|.+|.+
T Consensus 197 ----------l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~ 263 (313)
T 1ogq_A 197 ----------LN-LAFVDLSRNMLEGDASVLFGSDKNTQ-KIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQG 263 (313)
T ss_dssp ----------CC-CSEEECCSSEEEECCGGGCCTTSCCS-EEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGG
T ss_pred ----------Cc-ccEEECcCCcccCcCCHHHhcCCCCC-EEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChH
Confidence 43 55555555555545555555555555 455555555555444 556667777788888887777877
Q ss_pred cccccccceEEeccCcccCCCCCcccccccccccccCCCCCCCCCCCCC
Q 001253 675 FVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNC 723 (1114)
Q Consensus 675 ~~~l~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lc~~p~~~~ 723 (1114)
|.++++|+.|++++|+++|.+|....+..+....+.+|+.+||.|++.|
T Consensus 264 l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~~C 312 (313)
T 1ogq_A 264 LTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp GGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred HhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCCCC
Confidence 8788888888888888888888777777777777788888888877544
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=342.29 Aligned_cols=352 Identities=19% Similarity=0.166 Sum_probs=218.0
Q ss_pred CCCCCCCCCCCCCccceEEEecCCCccEEEEEeecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEE
Q 001253 52 YLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVL 131 (1114)
Q Consensus 52 ~~~~W~~~~~~~C~w~gv~C~~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 131 (1114)
.+++|.+...+||.|.+..|...+ +.+............-..+.+++.|++++|.++...+..+..+++|++|
T Consensus 2 ~~~~~~~~~~C~~~~~~~~c~~~~-------~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L 74 (390)
T 3o6n_A 2 NVKPRQPEYKCIDSNLQYDCVFYD-------VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 74 (390)
T ss_dssp -----CCEECBCC------EEEES-------CEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEE
T ss_pred CcCCCCCccceehhhhhhccceee-------eeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEE
Confidence 367898754433456666664322 1112222222333334457889999999999875444457889999999
Q ss_pred EccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccceeccccccc
Q 001253 132 NLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLIS 211 (1114)
Q Consensus 132 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~ 211 (1114)
+|++|.+++..+..|+.+++|++|+|++|++++..|..|+++++|++|++++|+++...+..|.++++|++|++++|.+.
T Consensus 75 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~ 154 (390)
T 3o6n_A 75 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 154 (390)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccC
Confidence 99999999877788999999999999999999877888888888888888888888544445678888888888888888
Q ss_pred cccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhhcccccccCCchhhhc
Q 001253 212 GSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELG 291 (1114)
Q Consensus 212 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~ 291 (1114)
+..|..+.++++|++|++++|++++. .++.+++|+.|++++|.+++ +...++|++|++++|.+... |..
T Consensus 155 ~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~-- 223 (390)
T 3o6n_A 155 RIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGP-- 223 (390)
T ss_dssp BCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--
T ss_pred ccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeec-ccc--
Confidence 77777788888888888888888743 35666777777787777763 22334566666666654433 211
Q ss_pred CCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCCEE
Q 001253 292 SIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKL 371 (1114)
Q Consensus 292 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 371 (1114)
..++|++|++++|.+. +. ..+..+++|+.|++++|.+++..|..|..+++|++|
T Consensus 224 ~~~~L~~L~l~~n~l~------------------------~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 277 (390)
T 3o6n_A 224 VNVELTILKLQHNNLT------------------------DT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 277 (390)
T ss_dssp CCSSCCEEECCSSCCC------------------------CC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEE
T ss_pred ccccccEEECCCCCCc------------------------cc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEE
Confidence 1245555555555554 22 234444555555555555555555555555555555
Q ss_pred EcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCcc
Q 001253 372 DLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLT 451 (1114)
Q Consensus 372 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~ 451 (1114)
+|++|++++ +|..+..+++|++|++++|++. .+|..+..+++|++|+|++|+++.. + +..+++|++|++++|.+.
T Consensus 278 ~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 278 YISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp ECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEE
T ss_pred ECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCcc
Confidence 555555553 3334445555555555555555 2333445555666666666666533 2 444556666666666665
Q ss_pred C
Q 001253 452 G 452 (1114)
Q Consensus 452 ~ 452 (1114)
.
T Consensus 353 ~ 353 (390)
T 3o6n_A 353 C 353 (390)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=338.96 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=197.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc-----
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS----- 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 882 (1114)
++|.+.+.||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 67899999999999999999976 789999999976543 33445678899999999999999999999987654
Q ss_pred -eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 883 -NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 883 -~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
.|+||||++ ++|.+++. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999998 48888875 3589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhc---CC--c
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN---NS--L 1035 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~--~ 1035 (1114)
... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+...... .. +
T Consensus 176 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 176 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH----HHHHHHHHHHHCBCCHHH
T ss_pred CCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCHHH
Confidence 432 2234578999999999876 6789999999999999999999999975432 2222221110 00 0
Q ss_pred ------------ccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1036 ------------VSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1036 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+..................+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000000111223457889999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=333.79 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=179.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHH-HHhcCCCCceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEIL-TLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.+.||+|+||+||+|+.+ +|+.||||++..... ......+..|+. +++.++||||+++++++.+++..++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 478999999999999999999986 789999999976533 222344555555 7788899999999999999999999
Q ss_pred EEecCCCCCHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 886 MYEYMARGSLGELLHG----ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
||||+++ +|.+++.. ....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++.
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 9999986 88877752 356789999999999999999999984 2799999999999999999999999999986
Q ss_pred cCCCCCCccccccccccccCcccc----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYA----YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1114)
.... .......|++.|+|||++ .+..++.++||||||+++|||++|+.||.......+ .+ . ....
T Consensus 176 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~----~--~~~~ 244 (327)
T 3aln_A 176 LVDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---QL----T--QVVK 244 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------C--CCCC
T ss_pred cccc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---HH----H--HHhc
Confidence 5422 222334799999999998 466789999999999999999999999975332110 00 0 0000
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.................+.+++.+||+.||++|||+.|+++
T Consensus 245 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 ---GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00000011111122346889999999999999999999976
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=329.98 Aligned_cols=261 Identities=22% Similarity=0.342 Sum_probs=193.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEE--------
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCY-------- 878 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-------- 878 (1114)
.++|++.+.||+|+||+||+|+++ +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 368999999999999999999987 58999999986442 344567889999999999999999999874
Q ss_pred ------ecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCCe
Q 001253 879 ------HQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD-DKFEA 951 (1114)
Q Consensus 879 ------~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~ 951 (1114)
+....++||||++ |+|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+||+++ +++.+
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3457799999998 599999973 5689999999999999999999999 999999999999997 56799
Q ss_pred EEeeccCceecCCCC--CCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 001253 952 HVGDFGLAKVIDMPQ--SKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRN 1028 (1114)
Q Consensus 952 kl~DfG~a~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~ 1028 (1114)
||+|||+++...... ........+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||..... ......
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~ 236 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE----LEQMQL 236 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence 999999998754221 122334567999999998865 6789999999999999999999999975432 222222
Q ss_pred HHhcCCcccc------------cccccccCCC----cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1029 FIRNNSLVSG------------MLDARLNLQD----EKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1029 ~~~~~~~~~~------------~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.......... .......... .........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 2111100000 0000000000 001122356889999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=336.91 Aligned_cols=261 Identities=20% Similarity=0.299 Sum_probs=199.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CC-cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCc------eeeEEeEEEe
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TG-HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN------IVKLYGFCYH 879 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~ 879 (1114)
.++|++.+.||+|+||+||+|+.. ++ +.||+|++... ....+.+.+|+.+++.++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 478999999999999999999975 44 68999999643 233566788999999887665 9999999999
Q ss_pred cCceEEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEE-------------
Q 001253 880 QGSNLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILL------------- 945 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill------------- 945 (1114)
.+..++||||++ +++.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||++
T Consensus 94 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 94 HGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999995 5666666543 35799999999999999999999998 99999999999999
Q ss_pred ------CCCCCeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001253 946 ------DDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQG 1019 (1114)
Q Consensus 946 ------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~ 1019 (1114)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5678999999999986432 223457999999999999999999999999999999999999999754322
Q ss_pred CCHHHHHHHHHhcCC--------cccccccccc-------------------cCCCcccHHHHHHHHHHHhhccCCCCCC
Q 001253 1020 GDLVTWVRNFIRNNS--------LVSGMLDARL-------------------NLQDEKTVSHMITVLKIAMLCTNISPFD 1072 (1114)
Q Consensus 1020 ~~~~~~~~~~~~~~~--------~~~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~ 1072 (1114)
. ....+........ .......... .............+.+++.+||+.||++
T Consensus 246 ~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 246 E-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp H-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred H-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 1 1111221111100 0000000000 0001112233557889999999999999
Q ss_pred CCCHHHHHH
Q 001253 1073 RPTMREVVL 1081 (1114)
Q Consensus 1073 RPs~~evl~ 1081 (1114)
|||++|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=331.80 Aligned_cols=253 Identities=21% Similarity=0.333 Sum_probs=185.5
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|+++ +|+.||||++...... ....+.+.++..+++.++||||+++++++.+++..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 367899999999999999999986 7899999999765432 22234455566678888999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
|||+ ++.+..+.......+++..+..++.|+++||+|||+ . +++||||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999 557777766555679999999999999999999998 5 8999999999999999999999999999765422
Q ss_pred CCCccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.......|++.|+|||++. ...++.++||||+|+++|||++|+.||..... ....+.........
T Consensus 179 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~----- 248 (318)
T 2dyl_A 179 --KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT---DFEVLTKVLQEEPP----- 248 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHHHHHHHHSCCC-----
T ss_pred --ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc---cHHHHHHHhccCCC-----
Confidence 2233457999999999984 55688999999999999999999999975332 22333333332111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
... ........+.+++.+||+.||.+||+++|+++
T Consensus 249 --~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 --LLP----GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CCC----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCC----ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000 00112246889999999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=336.63 Aligned_cols=244 Identities=21% Similarity=0.359 Sum_probs=199.2
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCCh---hhHHHHHHHHHHHhcCC--CCceeeEEeEEEec
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNN---NVDNSFRAEILTLGKIR--HRNIVKLYGFCYHQ 880 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 880 (1114)
..++|++.+.||+|+||+||+|++. +++.||||++........ ...+.+.+|+.++++++ ||||+++++++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4578999999999999999999975 789999999976543221 11234667899999996 59999999999999
Q ss_pred CceEEEEecCCC-CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCCeEEeeccC
Q 001253 881 GSNLLMYEYMAR-GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGL 958 (1114)
Q Consensus 881 ~~~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfG~ 958 (1114)
+..++||||+.+ ++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++ +++.+||+|||+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999999986 899999974 35789999999999999999999998 999999999999999 789999999999
Q ss_pred ceecCCCCCCccccccccccccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 001253 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 959 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1114)
++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... . ......
T Consensus 197 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~----~~~~~~--- 260 (320)
T 3a99_A 197 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E----IIRGQV--- 260 (320)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHCCC---
T ss_pred ccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------h----hhcccc---
Confidence 9876422 2334579999999999987766 678999999999999999999996321 1 111110
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.... .....+.+++.+||+.||++|||++|+++
T Consensus 261 -------~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 -------FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -------CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------cccc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001 11236789999999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=336.07 Aligned_cols=263 Identities=20% Similarity=0.266 Sum_probs=199.7
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-----------CCceeeEEe
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-----------HRNIVKLYG 875 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~ 875 (1114)
.++|++.+.||+|+||+||+|++. +++.||||++.... ...+.+.+|+.++++++ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 368999999999999999999975 78999999986432 23566788999888876 899999999
Q ss_pred EEEecC----ceEEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC----
Q 001253 876 FCYHQG----SNLLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD---- 946 (1114)
Q Consensus 876 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---- 946 (1114)
++...+ ..++||||+ +++|.+++... ...+++..+..++.|++.||+|||+++ +|+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 998654 679999999 88999999753 346999999999999999999999852 899999999999994
Q ss_pred --CCCCeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC--CH
Q 001253 947 --DKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG--DL 1022 (1114)
Q Consensus 947 --~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~--~~ 1022 (1114)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999875422 234579999999999999999999999999999999999999997543211 11
Q ss_pred HHHHHHHHh---c--------CCccccccc-----------------ccccCCCcccHHHHHHHHHHHhhccCCCCCCCC
Q 001253 1023 VTWVRNFIR---N--------NSLVSGMLD-----------------ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRP 1074 (1114)
Q Consensus 1023 ~~~~~~~~~---~--------~~~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1074 (1114)
...+..... . ......... .........+......+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 111111111 0 000000000 000111123455677899999999999999999
Q ss_pred CHHHHHH
Q 001253 1075 TMREVVL 1081 (1114)
Q Consensus 1075 s~~evl~ 1081 (1114)
|++|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=342.05 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=189.8
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 884 (1114)
+...+|+..++||+|+||+||.....+|+.||||++...... .+.+|+.+++.+ +|||||++++++.+....|
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 345679999999999999976655667999999999654321 245799999998 7999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-----CCCeEEeeccCc
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD-----KFEAHVGDFGLA 959 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~DfG~a 959 (1114)
+||||+++ +|.+++........+..+..++.|+++||+|||+. +|+||||||+||+++. ...+||+|||+|
T Consensus 95 lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 95 IAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99999975 99999986665666667789999999999999999 9999999999999953 335889999999
Q ss_pred eecCCCCC--CccccccccccccCccccc---cCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 960 KVIDMPQS--KSMSAIAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 960 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
+....... .......||+.|+|||++. ...++.++||||+||++|||++ |..||..... ..........
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~~~~~~~~~ 245 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQANILLGAC 245 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HHHHHHTTCC
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HHHHHHhccC
Confidence 87643221 2334567999999999997 4567889999999999999999 8899853221 1111111110
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. ... ..........+.+++.+||+.||.+|||++|+++
T Consensus 246 ~---------~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 S---------LDC-LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C---------CTT-SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C---------ccc-cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 000 1112233456789999999999999999999983
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=356.95 Aligned_cols=271 Identities=24% Similarity=0.295 Sum_probs=205.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe------cC
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH------QG 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 881 (1114)
++|++.++||+|+||+||+|+++ +|+.||||++.... .....+.+.+|+.++++++||||+++++++.. .+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 68999999999999999999975 68999999987543 33446678899999999999999999998765 66
Q ss_pred ceEEEEecCCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC---eEEeec
Q 001253 882 SNLLMYEYMARGSLGELLHGAS--STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE---AHVGDF 956 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Df 956 (1114)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 7799999999999999998543 2688999999999999999999998 9999999999999997765 999999
Q ss_pred cCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHH---HhcC
Q 001253 957 GLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNF---IRNN 1033 (1114)
Q Consensus 957 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~ 1033 (1114)
|.++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...|.... ....
T Consensus 169 G~a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~---~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 169 GYAKELDQG--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ---PVQWHGKVREKSNEH 243 (676)
T ss_dssp CCCCBTTSC--CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH---HHHSSTTCC------
T ss_pred ccccccccc--cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc---hhhhhhhhhcccchh
Confidence 999876432 233456799999999999999999999999999999999999999965321 11110000 0000
Q ss_pred Cccccccc------ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHH-----HHHHHHhhhcc
Q 001253 1034 SLVSGMLD------ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMRE-----VVLMLSESNRR 1089 (1114)
Q Consensus 1034 ~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~i~~~ 1089 (1114)
........ ................+.+++.+||++||++|||++| ..+.++++...
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000001 1111112223345667999999999999999999988 55666666443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.50 Aligned_cols=240 Identities=11% Similarity=0.065 Sum_probs=189.9
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.++|++.+.||+|+||+||+|++. +|+.||||++...........+.+.+|+..+++++||||+++++++.+++..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999986 5899999999877665555667899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||++|++|.++++.. ....++..++.|++.||+|||+. +|+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 9999999999999632 35667889999999999999999 99999999999999999999997443
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
|++| ++.++|||||||++|||++|+.||........... ...........
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-----------~~~~~~~~~~~ 224 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----------AERDTAGQPIE 224 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------CCBCTTSCBCC
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------HHHHhccCCCC
Confidence 3333 67899999999999999999999976543221100 00000000000
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCc
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHF 1093 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 1093 (1114)
...........+.+++.+||+.||++| |+.|+++.|+++.....+.
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~ 270 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRT 270 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-----
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCcc
Confidence 000111233468899999999999999 9999999999987665443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=331.20 Aligned_cols=246 Identities=20% Similarity=0.301 Sum_probs=190.8
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCCh---hhHHHHHHHHHHHhcC----CCCceeeEEeE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNN---NVDNSFRAEILTLGKI----RHRNIVKLYGF 876 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~niv~l~~~ 876 (1114)
....++|++.+.||+|+||+||+|++. +++.||||++........ .....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344578999999999999999999975 789999999976543211 1122355688888888 89999999999
Q ss_pred EEecCceEEEEec-CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCCeEEe
Q 001253 877 CYHQGSNLLMYEY-MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVG 954 (1114)
Q Consensus 877 ~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~ 954 (1114)
+...+..++|||| +.+++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++ .++.+||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence 9999999999999 789999999974 34689999999999999999999999 999999999999999 88999999
Q ss_pred eccCceecCCCCCCccccccccccccCccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcC
Q 001253 955 DFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVT-EKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033 (1114)
Q Consensus 955 DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1033 (1114)
|||+++..... ......|++.|+|||++.+..+. .++||||+|+++|||++|+.||.... .. ...
T Consensus 183 dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~----~~~- 248 (312)
T 2iwi_A 183 DFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EI----LEA- 248 (312)
T ss_dssp CCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH----HHT-
T ss_pred EcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HH----hhh-
Confidence 99999876432 23455799999999998877664 58999999999999999999996321 11 111
Q ss_pred CcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1034 SLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
... .+......+.+++.+||+.||++|||++|+++
T Consensus 249 ---------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 249 ---------ELH----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ---------CCC----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------ccC----CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011 11112346789999999999999999999986
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=355.79 Aligned_cols=350 Identities=18% Similarity=0.153 Sum_probs=231.5
Q ss_pred CCCCCCCCCCCCCCC-c---cceEEEecCCCccEEEEEeecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCC
Q 001253 50 SNYLGNWNPNDSTPC-G---WIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNC 125 (1114)
Q Consensus 50 ~~~~~~W~~~~~~~C-~---w~gv~C~~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l 125 (1114)
...+++|.+. ++|| . |.++.|+. .+ +. ..........-..+.+++.|++++|.++...+..++.+
T Consensus 6 ~~~l~~~~~~-~~C~~~~~~~~c~~~~~-----~i---~~--~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l 74 (597)
T 3oja_B 6 RYNVKPRQPE-YKCIDSNLQYDCVFYDV-----HI---DM--QTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 74 (597)
T ss_dssp -----CCCSE-ECCCCC--CCSEEECSC-----EE---CS--SCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHC
T ss_pred cccccCCCCC-CcCcccCcCceeEecCc-----ee---cc--cccccccCcccccCCCceEEEeeCCCCCCcCHHHHccC
Confidence 3457899875 4455 3 65555531 11 11 11111122223356788999999999876555567889
Q ss_pred CCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccceec
Q 001253 126 SSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRA 205 (1114)
Q Consensus 126 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l 205 (1114)
++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|++++|.+++..+..|+++++|++|++
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 99999999999999888888999999999999999998877777888888888888888888555555677888888888
Q ss_pred cccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhhcccccccCC
Q 001253 206 GQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQ 285 (1114)
Q Consensus 206 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~ 285 (1114)
++|.+.+..|..|+++++|++|+|++|.+++. .++.+++|+.|++++|.+++ +...++|+.|++++|.+...
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~ 226 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV 226 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEE
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccc
Confidence 88887777777777777788888887777743 24556677777777776663 22334455555555544322
Q ss_pred chhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccCccccccccc
Q 001253 286 LPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTL 365 (1114)
Q Consensus 286 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 365 (1114)
.+ .+ .++|+.|++++|.+++ +..+..+++|+.|+|++|.+++..|..|..+
T Consensus 227 ~~-------------------------~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 277 (597)
T 3oja_B 227 RG-------------------------PV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKM 277 (597)
T ss_dssp EC-------------------------SC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTC
T ss_pred cc-------------------------cc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCc
Confidence 11 11 1345555555555543 2445566666666666666666666666666
Q ss_pred ccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeee
Q 001253 366 KNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNL 445 (1114)
Q Consensus 366 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L 445 (1114)
++|+.|+|++|.+++ +|..+..+++|+.|+|++|.+. .+|..+..+++|++|+|++|.|++.. +..+++|+.|++
T Consensus 278 ~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l 352 (597)
T 3oja_B 278 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTL 352 (597)
T ss_dssp SSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEEC
T ss_pred cCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEe
Confidence 777777777777664 3555566677777777777766 45555666777777777777776542 455677888888
Q ss_pred ccCCccC
Q 001253 446 ETNKLTG 452 (1114)
Q Consensus 446 s~N~l~~ 452 (1114)
++|.+.+
T Consensus 353 ~~N~~~~ 359 (597)
T 3oja_B 353 SHNDWDC 359 (597)
T ss_dssp CSSCEEH
T ss_pred eCCCCCC
Confidence 8888764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=339.22 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=186.8
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+.|...++||+|+||+||.+...+|+.||||++.... .+.+.+|+.+++++ +||||+++++++.+++..|+||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 4456668899999999987777789999999986532 34567899999876 8999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCC------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC-------------
Q 001253 888 EYMARGSLGELLHGASST------LDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK------------- 948 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~------l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~------------- 948 (1114)
||++ |+|.+++...... .++..+..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence 9996 5999999754321 12334577999999999999999 99999999999999754
Q ss_pred CCeEEeeccCceecCCCCCC---ccccccccccccCcccccc-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 001253 949 FEAHVGDFGLAKVIDMPQSK---SMSAIAGSYGYIAPEYAYT-------MKVTEKCDIYSYGVVLLELLT-GRAPVQPLD 1017 (1114)
Q Consensus 949 ~~~kl~DfG~a~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~t-g~~p~~~~~ 1017 (1114)
+.+||+|||+++........ ......||+.|+|||++.+ ..++.++||||+||++|||++ |+.||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999976533221 2234579999999999875 668999999999999999999 999996432
Q ss_pred CCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1018 QGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.. .... ... ... .... ...........+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~--~~~i----~~~-~~~----~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SR--ESNI----IRG-IFS----LDEM--KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TH--HHHH----HHT-CCC----CCCC--TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hh--HHHH----hcC-CCC----cccc--cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 21 1111 111 000 0000 11123445668899999999999999999999985
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=329.96 Aligned_cols=284 Identities=20% Similarity=0.241 Sum_probs=192.7
Q ss_pred hcCCCcchHHHHHHhHhhc-cCCCCCCCCCC---CCCCCCCccceEEEecC------CCccEEEEEeecCCCcCcccCCC
Q 001253 28 TKGLVNIEGQILLLIKSKL-VDNSNYLGNWN---PNDSTPCGWIGVNCTTN------DFGAVVFSLNLTKMNLSGYLSPN 97 (1114)
Q Consensus 28 ~~~~~~~~~~~ll~~k~~~-~~~~~~~~~W~---~~~~~~C~w~gv~C~~~------~~~~~v~~l~l~~~~l~g~~~~~ 97 (1114)
..++..+|++||++||+++ .|+.+.+++|. ....++|.|.|++|... ....+|+.|+|+++++. .+|+.
T Consensus 21 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~ 99 (328)
T 4fcg_A 21 GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ 99 (328)
T ss_dssp --CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred ccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence 3467789999999999998 57777889994 34566899999999531 00123445555555554 44445
Q ss_pred CCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccc
Q 001253 98 IGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALS 177 (1114)
Q Consensus 98 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 177 (1114)
++.+++|++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..|+++++|++|+|++|++.+.+|..++..
T Consensus 100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~---- 173 (328)
T 4fcg_A 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST---- 173 (328)
T ss_dssp GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE----
T ss_pred hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc----
Confidence 555555555555555554 45555555555555555555555 345455555555555555554444444443320
Q ss_pred hhhhcccccCCCCCCCccccccccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCc
Q 001253 178 QLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQ 257 (1114)
Q Consensus 178 ~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 257 (1114)
..+..+.++++|++|++++|.++ .+|..++++++|++|+|++|+++ .+|..++.+++|++|+|++|.
T Consensus 174 -----------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~ 240 (328)
T 4fcg_A 174 -----------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCT 240 (328)
T ss_dssp -----------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCT
T ss_pred -----------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCc
Confidence 01122334778888888888877 67777888888888888888887 466678888888888888888
Q ss_pred ccCccccccccccccchhhcccccccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCC
Q 001253 258 LSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLI 331 (1114)
Q Consensus 258 l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~ 331 (1114)
+.+.+|..++++++|++|++++|.+.+.+|..++.+++|++|+|++|++.+.+|..++.+++++.+++..+.+.
T Consensus 241 ~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 241 ALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred chhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 88888888888888888888888888888888888888888888888888888888888888888888776554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=323.36 Aligned_cols=306 Identities=25% Similarity=0.350 Sum_probs=173.3
Q ss_pred hcccccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceE
Q 001253 339 SKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWV 418 (1114)
Q Consensus 339 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 418 (1114)
..+++|+.|++++|.+... + .+..+++|++|++++|.+++..+ |..+ ++|++
T Consensus 41 ~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l------------------------~~L~~ 92 (347)
T 4fmz_A 41 EELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNL------------------------VKLTN 92 (347)
T ss_dssp HHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTC------------------------TTCCE
T ss_pred hhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcC------------------------CcCCE
Confidence 3445555555555555432 1 24445555555555555553322 4444 44555
Q ss_pred EEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccC
Q 001253 419 VDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQF 498 (1114)
Q Consensus 419 L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 498 (1114)
|++++|.+++. ..+..+++|++|++++|++++..+ +..+++|++|++++|..... +..+..+++|++|++++|.+
T Consensus 93 L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~ 167 (347)
T 4fmz_A 93 LYIGTNKITDI--SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKV 167 (347)
T ss_dssp EECCSSCCCCC--GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCC
T ss_pred EEccCCcccCc--hHHcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCc
Confidence 55555544432 234455555555555555553222 55555555555555543322 22355556666666666665
Q ss_pred CCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhh
Q 001253 499 SGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREI 578 (1114)
Q Consensus 499 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 578 (1114)
.+..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +
T Consensus 168 ~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~ 239 (347)
T 4fmz_A 168 KDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--L 239 (347)
T ss_dssp CCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred CCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--h
Confidence 53332 5556666666666666653322 5556666666666666653322 5556666666666666664322 5
Q ss_pred hhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhH
Q 001253 579 GSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLE 658 (1114)
Q Consensus 579 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~ 658 (1114)
..+++|++|++++|.+++. ..+..+++|+.|++++|++++. +.+..+++|+ .|+|++|++++..|..++.+++|+
T Consensus 240 ~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~-~L~L~~n~l~~~~~~~l~~l~~L~ 314 (347)
T 4fmz_A 240 ANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLN-SLFLNNNQLGNEDMEVIGGLTNLT 314 (347)
T ss_dssp TTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCS-EEECCSSCCCGGGHHHHHTCTTCS
T ss_pred hcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCC-EEECcCCcCCCcChhHhhccccCC
Confidence 6666666666666666642 3456666666666666666643 3466666666 577777777766666677777777
Q ss_pred hhhccCcccccCCCCccccccccceEEeccCccc
Q 001253 659 YLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692 (1114)
Q Consensus 659 ~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~ 692 (1114)
+|+|++|++++.+| +..+++|+.|++++|+++
T Consensus 315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 77777777776666 667777777777777653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=317.09 Aligned_cols=307 Identities=23% Similarity=0.334 Sum_probs=208.6
Q ss_pred hcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCC
Q 001253 290 LGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLT 369 (1114)
Q Consensus 290 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 369 (1114)
+..+++|++|++++|.+. .+| .+..+++|++|++++|.+.+..+ +..+++|+.|++++|.++.. ..+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCS
T ss_pred chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCC
Confidence 345566666777666665 233 36666666777777766664333 66677777777777777653 2467777777
Q ss_pred EEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCC
Q 001253 370 KLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNK 449 (1114)
Q Consensus 370 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~ 449 (1114)
+|++++|.+++..+ +..+++|++|++++|.....++. +..+++|++|++++|.+.+..+ +..+++|++|++++|.
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~ 188 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence 77777777775433 66777777777777755544333 6677777777777777765443 6677777777777777
Q ss_pred ccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCcc
Q 001253 450 LTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPRE 529 (1114)
Q Consensus 450 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 529 (1114)
+.+..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|++++..+ +..+++|++|++++|.+++. ..
T Consensus 189 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~ 260 (347)
T 4fmz_A 189 IEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NA 260 (347)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GG
T ss_pred cccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hh
Confidence 774333 6677777777777777774433 6777777777777777775443 77777777777777777743 45
Q ss_pred ccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCccccccccccccc
Q 001253 530 VGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLT 609 (1114)
Q Consensus 530 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 609 (1114)
+..+++|+.|++++|.+++ + ..+..+++|+.|++++|++++..|..++.+++|++|++++|++++..| +..+++|+
T Consensus 261 ~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 336 (347)
T 4fmz_A 261 VKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMD 336 (347)
T ss_dssp GTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCS
T ss_pred HhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccc
Confidence 6777777777777777774 3 346667777777777777777777777777777777777777776555 66777777
Q ss_pred ccccCCCcCC
Q 001253 610 ELQMGGNSFS 619 (1114)
Q Consensus 610 ~L~ls~N~l~ 619 (1114)
+|++++|+|+
T Consensus 337 ~L~l~~N~i~ 346 (347)
T 4fmz_A 337 SADFANQVIK 346 (347)
T ss_dssp EESSSCC---
T ss_pred eeehhhhccc
Confidence 7777777764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=351.06 Aligned_cols=240 Identities=24% Similarity=0.315 Sum_probs=195.8
Q ss_pred hcCCcCCceecccCCeEEEEEEeC--CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc---
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR--TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS--- 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 882 (1114)
.++|++.++||+|+||+||+|+++ +|+.||||++.... .......+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 378999999999999999999986 68999999986532 33445678899999999999999999999988766
Q ss_pred --eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 883 --NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 883 --~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
.|+||||++|++|.+++.. .+++.++..++.|+++||+|||+. +|+||||||+||+++.+ .+||+|||+++
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred ceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999998863 789999999999999999999999 99999999999999986 99999999998
Q ss_pred ecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||....... +
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------~- 284 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------L- 284 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------C-
T ss_pred hcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc------------------c-
Confidence 76432 345799999999998765 4889999999999999999988876322110 0
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhh
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRP-TMREVVLMLSES 1086 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i 1086 (1114)
. ...........+.+++.+||+.||++|| +++++.+.+..+
T Consensus 285 ----~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 ----P-EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ----C-TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----c-ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 0111122335688999999999999999 567777777665
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=331.14 Aligned_cols=241 Identities=17% Similarity=0.174 Sum_probs=180.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC-Cce---------e------
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH-RNI---------V------ 871 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni---------v------ 871 (1114)
.+|...++||+|+||+||+|++. +|+.||||++...........+.+++|+.+++.++| ++. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45778889999999999999965 799999999985555444456779999999999977 211 1
Q ss_pred e------EEeEEEe-----cCceEEEEecCCCCCHHHHhc------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 001253 872 K------LYGFCYH-----QGSNLLMYEYMARGSLGELLH------GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934 (1114)
Q Consensus 872 ~------l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 934 (1114)
. +..++.. ....+++|+++ +++|.++++ .....+++..+..++.|+++||+|||+. +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 1 1111111 12356777766 569999984 2344678889999999999999999999 999
Q ss_pred ecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccccccccccCcccc----------ccCCCCcccchHHHHHHHH
Q 001253 935 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYA----------YTMKVTEKCDIYSYGVVLL 1004 (1114)
Q Consensus 935 H~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~DvwslGvil~ 1004 (1114)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999875422 345577 999999999 5566888999999999999
Q ss_pred HHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 001253 1005 ELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV 1080 (1114)
Q Consensus 1005 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1080 (1114)
||++|+.||........ . ...+...... ...+.+++.+||+.||++||++.|++
T Consensus 309 elltg~~Pf~~~~~~~~--------------~----~~~~~~~~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG--------------S----EWIFRSCKNI----PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHSSCCCCTTGGGSC--------------S----GGGGSSCCCC----CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHCCCCCCCcchhhh--------------H----HHHHhhcccC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999975432111 1 1111111111 24688999999999999999977764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=309.76 Aligned_cols=229 Identities=22% Similarity=0.284 Sum_probs=178.6
Q ss_pred cCCcCC-ceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHH-hcCCCCceeeEEeEEEe----cC
Q 001253 809 DNFDER-FVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTL-GKIRHRNIVKLYGFCYH----QG 881 (1114)
Q Consensus 809 ~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~ 881 (1114)
++|.+. +.||+|+||+||+|+.+ +++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 567776 77999999999999975 789999999853 23466788877 66699999999999987 66
Q ss_pred ceEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCCeEEeecc
Q 001253 882 SNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD---KFEAHVGDFG 957 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG 957 (1114)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 7899999999999999998543 4799999999999999999999999 9999999999999998 7889999999
Q ss_pred CceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1114)
++.... +..++.++||||+||++|||++|+.||........ ......
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~~~~~~ 212 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------SPGMKT 212 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCSCC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------hHHHHH
Confidence 987542 13467889999999999999999999965432110 000111
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....................+.+++.+||+.||++|||+.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11111111110001123457889999999999999999999987
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=310.39 Aligned_cols=288 Identities=20% Similarity=0.256 Sum_probs=163.3
Q ss_pred cCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeec
Q 001253 367 NLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLE 446 (1114)
Q Consensus 367 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls 446 (1114)
+++.+++++|.++ .+|..+. ++|++|++++|.+.+..+..|..+++|++|+|++|++++..|..|..+++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4666666666665 3343331 345555555555554444445555555555555555554444444444445555554
Q ss_pred cCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceec--c
Q 001253 447 TNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFT--G 524 (1114)
Q Consensus 447 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~ 524 (1114)
+|+++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|.++ +
T Consensus 111 ~n~l~-------------------------~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 163 (332)
T 2ft3_A 111 KNHLV-------------------------EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSG 163 (332)
T ss_dssp SSCCC-------------------------SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGG
T ss_pred CCcCC-------------------------ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCC
Confidence 44444 3333332 45555555555555444444555555555555555553 2
Q ss_pred CCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccc
Q 001253 525 ELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGN 604 (1114)
Q Consensus 525 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 604 (1114)
..|..+..+ +|++|++++|+++ .+|..+. ++|+.|++++|++++..|..+..+++|++|+|++|++++..+..+..
T Consensus 164 ~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 239 (332)
T 2ft3_A 164 FEPGAFDGL-KLNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239 (332)
T ss_dssp SCTTSSCSC-CCSCCBCCSSBCS-SCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGG
T ss_pred CCcccccCC-ccCEEECcCCCCC-ccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhC
Confidence 445555555 5555555555555 3444333 45566666666665555555666666666666666666555555666
Q ss_pred cccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccc------hhhhHhhhccCcccc--cCCCCccc
Q 001253 605 LSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGN------LILLEYLLLNNNHLS--GEIPGSFV 676 (1114)
Q Consensus 605 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~--g~ip~~~~ 676 (1114)
+++|++|+|++|+++ .+|..+..++.|+ .|+|++|++++..+..|.. ...|+.|++++|+++ +..|..|.
T Consensus 240 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~-~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~ 317 (332)
T 2ft3_A 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQ-VVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317 (332)
T ss_dssp CTTCCEEECCSSCCC-BCCTTGGGCTTCC-EEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGT
T ss_pred CCCCCEEECCCCcCe-ecChhhhcCccCC-EEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccc
Confidence 666666666666665 5555566666665 5666666666555555543 246888899999888 67888888
Q ss_pred cccccceEEeccCc
Q 001253 677 NLSSLLGCNFSYNN 690 (1114)
Q Consensus 677 ~l~~l~~l~ls~N~ 690 (1114)
.+++|+.+++++|+
T Consensus 318 ~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 318 CVTDRLAIQFGNYK 331 (332)
T ss_dssp TBCCSTTEEC----
T ss_pred ccchhhhhhccccc
Confidence 99999999998874
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=307.96 Aligned_cols=296 Identities=18% Similarity=0.195 Sum_probs=192.5
Q ss_pred ccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeee
Q 001253 366 KNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNL 445 (1114)
Q Consensus 366 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~L 445 (1114)
.+++.++++++.++ .+|..+. +++++|++++|++.+..+..|..+++|++|+|++|++++..|..|..+++|++|++
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 46888888888887 4554442 56777888888777766667777777777777777777766777777777777777
Q ss_pred ccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCC--CccccccccccCcEEEecCceec
Q 001253 446 ETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSG--PIPTEIGNCNALQRLHLSDNYFT 523 (1114)
Q Consensus 446 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~ 523 (1114)
++|+++ .+|..+. ++|++|++++|++++..+..+..+++|++|++++|+++. ..+..+.++++|++|++++|+++
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 777777 3454443 567777777777776666666777777777777777642 55566666677777777777666
Q ss_pred cCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCccccccc
Q 001253 524 GELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIG 603 (1114)
Q Consensus 524 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 603 (1114)
. +|..+. ++|++|++++|++++..|..+..+++|+.|+|++|++++..+..+..+++|++|+|++|+++ .+|..+.
T Consensus 185 ~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 260 (330)
T 1xku_A 185 T-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260 (330)
T ss_dssp S-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT
T ss_pred c-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhc
Confidence 3 444332 56666666666666555556666666666666666666555556666666666666666666 5555666
Q ss_pred ccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCccccc--CCCCcccccccc
Q 001253 604 NLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSG--EIPGSFVNLSSL 681 (1114)
Q Consensus 604 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g--~ip~~~~~l~~l 681 (1114)
.+++|++|++++|+|++..+..|..... ......|+.|++++|++.. ..|..|..+.++
T Consensus 261 ~l~~L~~L~l~~N~i~~~~~~~f~~~~~-------------------~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l 321 (330)
T 1xku_A 261 DHKYIQVVYLHNNNISAIGSNDFCPPGY-------------------NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321 (330)
T ss_dssp TCSSCCEEECCSSCCCCCCTTSSSCSSC-------------------CTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCG
T ss_pred cCCCcCEEECCCCcCCccChhhcCCccc-------------------ccccccccceEeecCcccccccCccccccccce
Confidence 6666666666666666444333322100 0112456778888888763 566778888888
Q ss_pred ceEEeccCc
Q 001253 682 LGCNFSYNN 690 (1114)
Q Consensus 682 ~~l~ls~N~ 690 (1114)
+.+++++|+
T Consensus 322 ~~l~L~~N~ 330 (330)
T 1xku_A 322 AAVQLGNYK 330 (330)
T ss_dssp GGEEC----
T ss_pred eEEEecccC
Confidence 888888874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-33 Score=321.05 Aligned_cols=245 Identities=14% Similarity=0.144 Sum_probs=187.7
Q ss_pred HhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCC-----ChhhHHHHHHHHHHHhcCC---------CCceee
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREG-----NNNVDNSFRAEILTLGKIR---------HRNIVK 872 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~niv~ 872 (1114)
..++|++.++||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346799999999999999999998 5899999999876432 2233467888999888885 777777
Q ss_pred EEeEEE-----------------e-------------cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHH
Q 001253 873 LYGFCY-----------------H-------------QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGL 922 (1114)
Q Consensus 873 l~~~~~-----------------~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L 922 (1114)
+.+++. + .+..|+||||+++|++.+.+.+ ..+++..+..++.|++.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 777643 2 6788999999999977666642 5689999999999999999
Q ss_pred HHHH-hCCCCCeEecCCCCCCeEECCCC--------------------CeEEeeccCceecCCCCCCccccccccccccC
Q 001253 923 SYLH-HDCKPRIFHRDIKSNNILLDDKF--------------------EAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIA 981 (1114)
Q Consensus 923 ~~LH-~~~~~~ivH~Dlk~~Nill~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~a 981 (1114)
+||| +. +|+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccC
Confidence 9999 88 999999999999999887 899999999997642 23479999999
Q ss_pred ccccccCCCCcccchHHHHHH-HHHHHhCCCCCCCCCCCCCHHHHHHHH-HhcCCcccccccccccCCCcccHHHHHHHH
Q 001253 982 PEYAYTMKVTEKCDIYSYGVV-LLELLTGRAPVQPLDQGGDLVTWVRNF-IRNNSLVSGMLDARLNLQDEKTVSHMITVL 1059 (1114)
Q Consensus 982 PE~~~~~~~~~~~DvwslGvi-l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1059 (1114)
||++.+.. +.++||||+|++ .+++++|..||... .+.....+. ...... . ..............+.
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----~~~~~~~~~~~~~~~~-----~--~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV----LWLHYLTDKMLKQMTF-----K--TKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----HHHHHHHHHHHHTCCC-----S--SCCCSHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch----hhhhHHHHhhhhhhcc-----C--cccchhhhhhcCHHHH
Confidence 99998776 899999998777 77888999988421 000111111 111000 0 0111222345667899
Q ss_pred HHHhhccCCCCCCCCCHHHHH
Q 001253 1060 KIAMLCTNISPFDRPTMREVV 1080 (1114)
Q Consensus 1060 ~li~~cl~~dP~~RPs~~evl 1080 (1114)
+++.+||+.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999976 898887
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=304.51 Aligned_cols=266 Identities=20% Similarity=0.267 Sum_probs=121.9
Q ss_pred CCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeecc
Q 001253 368 LTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLET 447 (1114)
Q Consensus 368 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~ 447 (1114)
|+.|+|++|.+++..+..|..+++|++|++++|++.+..|..|..+++|++|+|++|+++ .+|..+. ++|++|++++
T Consensus 56 l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~ 132 (332)
T 2ft3_A 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHD 132 (332)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCS
T ss_pred CeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCC
Confidence 333333333333333333333333333333333333333333333444444444444443 2222222 3444444444
Q ss_pred CCccCCcCcccccCCcceEEeeccceee--ccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccC
Q 001253 448 NKLTGSIPTGVTRCKSLVQLRLGGNSFT--GSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGE 525 (1114)
Q Consensus 448 N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 525 (1114)
|++++..+..+..+++|++|++++|.++ +..|..+..+ +|++|++++|++++ +|..+. ++|++|+|++|++++.
T Consensus 133 n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~ 208 (332)
T 2ft3_A 133 NRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAI 208 (332)
T ss_dssp SCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCC
T ss_pred CccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCcc
Confidence 4444333333444444444444444443 2334444444 45555555555542 333222 4455555555555544
Q ss_pred CCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccc-
Q 001253 526 LPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGN- 604 (1114)
Q Consensus 526 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~- 604 (1114)
.+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|..+..+++|++|++++|++++..+..|..
T Consensus 209 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~ 287 (332)
T 2ft3_A 209 ELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV 287 (332)
T ss_dssp CTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCS
T ss_pred CHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccc
Confidence 4455555555555555555555444444555555555555555555 44555555555555555555555444444332
Q ss_pred -----cccccccccCCCcCC--CCCChhhcCcchhhHHhhccccc
Q 001253 605 -----LSRLTELQMGGNSFS--GGIPAELGSLSSLQIALNLSYNN 642 (1114)
Q Consensus 605 -----l~~L~~L~ls~N~l~--~~~p~~~~~l~~L~~~L~Ls~N~ 642 (1114)
..+|+.|++++|++. +..|..|..++.|+ .++|++|+
T Consensus 288 ~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~-~l~l~~n~ 331 (332)
T 2ft3_A 288 GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRL-AIQFGNYK 331 (332)
T ss_dssp SCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCST-TEEC----
T ss_pred ccccccccccceEeecCcccccccCcccccccchhh-hhhccccc
Confidence 244566666666665 44555566666665 46666553
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=300.68 Aligned_cols=288 Identities=20% Similarity=0.248 Sum_probs=198.6
Q ss_pred ccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEee
Q 001253 343 GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLS 422 (1114)
Q Consensus 343 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 422 (1114)
+++.++++++.++. +|..+. ++|+.|+|++|++++..+..|..+++|++|++++|++.+..|..|..+++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCccc-cCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 45555555555553 233332 456667777777666655566666777777777777766666667777777777777
Q ss_pred cccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeec--cCCchhhccccccEeecccccCCC
Q 001253 423 DNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTG--SFPSDLCKLANLSTVELDQNQFSG 500 (1114)
Q Consensus 423 ~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~ 500 (1114)
+|+++ .+|..+. ++|++|++++|++++..+..+..+++|++|++++|.+.. ..+..+..+++|++|++++|+++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 77776 3444433 577777777777776666667777788888888887753 667777888888888888888873
Q ss_pred CccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhh
Q 001253 501 PIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGS 580 (1114)
Q Consensus 501 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 580 (1114)
+|..+. ++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|..+..
T Consensus 186 -l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 186 -IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp -CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred -CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 555443 77888888888888777788888888888888888888666667778888888888888887 77778888
Q ss_pred cccCCeeeccCccCCCcccccccc------cccccccccCCCcCCC--CCChhhcCcchhhHHhhcccc
Q 001253 581 LFQLELLKLSENELSGSIPVQIGN------LSRLTELQMGGNSFSG--GIPAELGSLSSLQIALNLSYN 641 (1114)
Q Consensus 581 l~~L~~L~L~~N~l~~~~p~~~~~------l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~~L~Ls~N 641 (1114)
+++|++|++++|++++..+..|.. ...|+.|++++|++.. ..|..|..+..++ .++|++|
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~-~l~L~~N 329 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA-AVQLGNY 329 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGG-GEEC---
T ss_pred CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccccccccee-EEEeccc
Confidence 888888888888888666665543 3566777777777652 2333444444444 3444443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-35 Score=349.98 Aligned_cols=383 Identities=20% Similarity=0.124 Sum_probs=205.8
Q ss_pred CccceeeccccccCCCCccc-ccccccccEEEecCCcccC----ccccccccccccchhhcccccccCCchhhhc-CCC-
Q 001253 222 ESLQYLGLAQNQLSGEIPKE-IGMLKYLTDVILWGNQLSG----VIPKELGNCTSLETLALYDNKQVGQLPKELG-SIG- 294 (1114)
Q Consensus 222 ~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~-~l~- 294 (1114)
++|++|+|++|+++...... +..+++|++|++++|.+++ .++..+..+++|++|++++|.+....+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 35666666666665332222 5556666666666666653 2344555556666666666665544333332 233
Q ss_pred ---ccceeeeccccccc----ccCccccccccccccccccccCCCCCchhhhc-----ccccceeecccccccCcc----
Q 001253 295 ---SLKYLYIYRNELNG----TIPREIGKLSSALEIDFSENSLIGEIPVELSK-----ILGLELLYLFENKLTGVI---- 358 (1114)
Q Consensus 295 ---~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~-----l~~L~~L~L~~N~l~~~~---- 358 (1114)
+|++|+|++|+++. .+|..+..+++|++|++++|.+.+..+..+.. .++|+.|++++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 46666666666652 34555555666666666666554433333222 234666666666555432
Q ss_pred cccccccccCCEEEcccccccccccCcccc-ccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCC----CCcc
Q 001253 359 PVELTTLKNLTKLDLSINSLTGTIPLGFQY-LTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGK----IPRH 433 (1114)
Q Consensus 359 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~ 433 (1114)
+..+..+++|++|++++|.+++..+..+.. +. ...++|++|+|++|.+++. ++..
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~--------------------~~~~~L~~L~L~~n~l~~~~~~~l~~~ 222 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLK--------------------DSPCQLEALKLESCGVTSDNCRDLCGI 222 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHH--------------------HSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHh--------------------cCCCCceEEEccCCCCcHHHHHHHHHH
Confidence 333444556666666666655433222211 00 0122444444444444432 2344
Q ss_pred ccccCccceeeeccCCccCCc-----CcccccCCcceEEeeccceeecc----CCchhhccccccEeecccccCCCCccc
Q 001253 434 ICRNTSLIFLNLETNKLTGSI-----PTGVTRCKSLVQLRLGGNSFTGS----FPSDLCKLANLSTVELDQNQFSGPIPT 504 (1114)
Q Consensus 434 ~~~~~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~ 504 (1114)
+..+++|++|++++|++++.. +..+..+++|++|++++|++++. ++..+..+++|++|++++|.+++..+.
T Consensus 223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 302 (461)
T 1z7x_W 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence 444455555555555554321 11122355666666666666543 455555566666666666666543333
Q ss_pred cccc-----cccCcEEEecCceeccC----CCccccCCCCcceeecccccccccccccccc-----cccceEEECccccc
Q 001253 505 EIGN-----CNALQRLHLSDNYFTGE----LPREVGNLSNLVTFNVSSNFLTGRIPLEIFS-----CKMLQRLDLSWNKF 570 (1114)
Q Consensus 505 ~~~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l 570 (1114)
.+.. .++|++|+|++|.+++. ++..+..+++|++|+|++|.+++..+..+.. .++|+.|+|++|++
T Consensus 303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i 382 (461)
T 1z7x_W 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence 3322 25677777777776644 3455556677777777777776544443332 56777777777777
Q ss_pred cC----CCchhhhhcccCCeeeccCccCCCccccccc-----ccccccccccCCCcCCCCCCh
Q 001253 571 VG----ALPREIGSLFQLELLKLSENELSGSIPVQIG-----NLSRLTELQMGGNSFSGGIPA 624 (1114)
Q Consensus 571 ~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~ls~N~l~~~~p~ 624 (1114)
++ .+|..+..+++|++|++++|++++.-...+. ...+|+.|++.+|.+....+.
T Consensus 383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~ 445 (461)
T 1z7x_W 383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED 445 (461)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHH
T ss_pred ChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHH
Confidence 75 5677777777888888888877743111111 123456666666655533333
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-34 Score=344.88 Aligned_cols=357 Identities=23% Similarity=0.162 Sum_probs=252.5
Q ss_pred cccccEEEecCCcccCccccc-cccccccchhhcccccccC----CchhhhcCCCccceeeecccccccccCcccc-ccc
Q 001253 245 LKYLTDVILWGNQLSGVIPKE-LGNCTSLETLALYDNKQVG----QLPKELGSIGSLKYLYIYRNELNGTIPREIG-KLS 318 (1114)
Q Consensus 245 l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~~~~----~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~ 318 (1114)
+++|++|+|++|+++...... +..+++|++|++++|.+.. .++..+..+++|++|+|++|.+.+..+..+. .++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 356778888888877544333 6667777777777777654 2455566667777777777766543332222 122
Q ss_pred cccccccccccCCCCCchhhhcccccceeecccccccC----cccccccccccCCEEEcccccccccccCccc-----cc
Q 001253 319 SALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTG----VIPVELTTLKNLTKLDLSINSLTGTIPLGFQ-----YL 389 (1114)
Q Consensus 319 ~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l 389 (1114)
. ...+|++|++++|+++. .++..+..+++|++|+|++|.+++..+..+. ..
T Consensus 82 ~--------------------~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~ 141 (461)
T 1z7x_W 82 T--------------------PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141 (461)
T ss_dssp S--------------------TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred h--------------------CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCC
Confidence 0 00035555555555442 2344555555666666666655533332221 13
Q ss_pred cceeeeeccCCcccCCC----CCCCCcCccceEEEeecccccCCCCccccc-----cCccceeeeccCCccCC----cCc
Q 001253 390 TNLIMLQLFDNSLVGGI----PQRLGAYSQLWVVDLSDNHLTGKIPRHICR-----NTSLIFLNLETNKLTGS----IPT 456 (1114)
Q Consensus 390 ~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----~~~L~~L~Ls~N~l~~~----~p~ 456 (1114)
++|++|++++|++.+.. +..+..+++|++|+|++|.+++..+..+.. .++|++|++++|.+++. ++.
T Consensus 142 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 221 (461)
T 1z7x_W 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred CcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHH
Confidence 45666666666665432 344556678888888888887654444443 56999999999999974 577
Q ss_pred ccccCCcceEEeeccceeeccCC-----chhhccccccEeecccccCCCC----ccccccccccCcEEEecCceeccCCC
Q 001253 457 GVTRCKSLVQLRLGGNSFTGSFP-----SDLCKLANLSTVELDQNQFSGP----IPTEIGNCNALQRLHLSDNYFTGELP 527 (1114)
Q Consensus 457 ~~~~l~~L~~L~L~~N~l~~~~p-----~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p 527 (1114)
.+..+++|++|++++|.+++... ..+..+++|++|++++|++++. ++..+..+++|++|+|++|.+++..+
T Consensus 222 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~ 301 (461)
T 1z7x_W 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301 (461)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHH
Confidence 78889999999999999986432 2233588999999999999854 67778889999999999999986555
Q ss_pred ccccC-----CCCcceeeccccccccc----ccccccccccceEEECccccccCCCchhhhh-----cccCCeeeccCcc
Q 001253 528 REVGN-----LSNLVTFNVSSNFLTGR----IPLEIFSCKMLQRLDLSWNKFVGALPREIGS-----LFQLELLKLSENE 593 (1114)
Q Consensus 528 ~~~~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~ 593 (1114)
..+.. .++|++|++++|.+++. ++..+..+++|+.|+|++|++++..+..+.. .++|++|+|++|+
T Consensus 302 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence 44443 36999999999999865 5666777899999999999998776666654 6799999999999
Q ss_pred CCC----cccccccccccccccccCCCcCCCC
Q 001253 594 LSG----SIPVQIGNLSRLTELQMGGNSFSGG 621 (1114)
Q Consensus 594 l~~----~~p~~~~~l~~L~~L~ls~N~l~~~ 621 (1114)
+++ .+|..+..+++|++|++++|++++.
T Consensus 382 i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp CCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred CChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 996 7888899999999999999999864
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=298.86 Aligned_cols=276 Identities=20% Similarity=0.170 Sum_probs=145.3
Q ss_pred eeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccce
Q 001253 394 MLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNS 473 (1114)
Q Consensus 394 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 473 (1114)
..++++|.++. +|..+. ++|++|+|++|++++..+..+..+++|++|++++|++++..|..+..+++|++|+|++|+
T Consensus 35 ~c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 111 (353)
T 2z80_A 35 ICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111 (353)
T ss_dssp EEECCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeeCCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCc
Confidence 34555555542 222221 245555555555554444445555555555555555554444445555555555555555
Q ss_pred eeccCCchhhccccccEeecccccCCCCcc-ccccccccCcEEEecCc-eeccCCCccccCCCCcceeeccccccccccc
Q 001253 474 FTGSFPSDLCKLANLSTVELDQNQFSGPIP-TEIGNCNALQRLHLSDN-YFTGELPREVGNLSNLVTFNVSSNFLTGRIP 551 (1114)
Q Consensus 474 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 551 (1114)
+++..+..+..+++|++|++++|++++..+ ..+.++++|++|++++| .+++..+..|.++++|++|++++|++++..|
T Consensus 112 l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 191 (353)
T 2z80_A 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191 (353)
T ss_dssp CSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred CCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCH
Confidence 543333334445555555555555543222 24444555555555554 2443334444455555555555555544444
Q ss_pred ccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhc---C
Q 001253 552 LEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELG---S 628 (1114)
Q Consensus 552 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~---~ 628 (1114)
..+..+++|+.|++++|+++. +|. ..+..+++|+.|++++|++++..+..+. .
T Consensus 192 ~~l~~l~~L~~L~l~~n~l~~-~~~-----------------------~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~ 247 (353)
T 2z80_A 192 KSLKSIQNVSHLILHMKQHIL-LLE-----------------------IFVDVTSSVECLELRDTDLDTFHFSELSTGET 247 (353)
T ss_dssp TTTTTCSEEEEEEEECSCSTT-HHH-----------------------HHHHHTTTEEEEEEESCBCTTCCCC------C
T ss_pred HHHhccccCCeecCCCCcccc-chh-----------------------hhhhhcccccEEECCCCccccccccccccccc
Confidence 444445555555555554432 222 2223344444455555544443332221 1
Q ss_pred cchhhHHhhcccccccc----cCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCC
Q 001253 629 LSSLQIALNLSYNNLSG----LIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPS 697 (1114)
Q Consensus 629 l~~L~~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~ 697 (1114)
...++ .++|++|.+++ .+|..+..+++|++|||++|+|++..+..|.++++|+.|++++|++.|.+|.
T Consensus 248 ~~~l~-~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 248 NSLIK-KFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp CCCCC-EEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred cchhh-ccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 22232 34455555444 3577888899999999999999954444468999999999999999999884
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=290.64 Aligned_cols=256 Identities=23% Similarity=0.198 Sum_probs=147.9
Q ss_pred cceEEeeccceeeccCCchhhccccccEeecccccCCCC--ccccccccccCcEEEecCceeccCCCccccCCCCcceee
Q 001253 463 SLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGP--IPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFN 540 (1114)
Q Consensus 463 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 540 (1114)
+|++|+|++|+++...+..|.++++|++|+|++|+++.. .|..+..+++|++|+|++|.++ .+|..+..+++|++|+
T Consensus 29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~ 107 (306)
T 2z66_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 107 (306)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEE
T ss_pred CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEE
Confidence 344444444444422222334444444444444444411 1333444445555555555544 2344444555555555
Q ss_pred ccccccccccc-ccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCC-cccccccccccccccccCCCcC
Q 001253 541 VSSNFLTGRIP-LEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSG-SIPVQIGNLSRLTELQMGGNSF 618 (1114)
Q Consensus 541 Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l 618 (1114)
+++|++++..+ ..+..+++|+.|++++|.+++..|..+..+++|++|++++|.+++ .+|..+..+++|++|++++|++
T Consensus 108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l 187 (306)
T 2z66_A 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187 (306)
T ss_dssp CTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred CCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCc
Confidence 55555543222 244455555555555555555555555555666666666666654 4556666666666666666666
Q ss_pred CCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCcccccc-ccceEEeccCcccCCCCC
Q 001253 619 SGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLS-SLLGCNFSYNNLTGPIPS 697 (1114)
Q Consensus 619 ~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~-~l~~l~ls~N~l~g~ip~ 697 (1114)
++..|..+..+++|+ .|+|++|++++..+..+..+++|++|||++|++++.+|..+..++ +|+.|++++|+++|.++.
T Consensus 188 ~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~ 266 (306)
T 2z66_A 188 EQLSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 266 (306)
T ss_dssp CEECTTTTTTCTTCC-EEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGG
T ss_pred CCcCHHHhcCCCCCC-EEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccCh
Confidence 665666666666666 567777777666666677778888888888888888888888884 888888888888887765
Q ss_pred cccccccccc---cccCCCCCCCCCC
Q 001253 698 SQTFQNMSVN---SFSGSKGLCGGPL 720 (1114)
Q Consensus 698 ~~~~~~~~~~---~~~~n~~lc~~p~ 720 (1114)
.+..+++... ....+...|..|.
T Consensus 267 ~~~~~~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 267 QSFLQWIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp HHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred HHHHHHHHhhhhhhccccccccCCch
Confidence 5444444322 2234455666554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=280.22 Aligned_cols=249 Identities=23% Similarity=0.249 Sum_probs=176.1
Q ss_pred CEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCC--CCccccccCccceeeec
Q 001253 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGK--IPRHICRNTSLIFLNLE 446 (1114)
Q Consensus 369 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~~~~L~~L~Ls 446 (1114)
+.++.+++.++ .+|..+. ++|++|++++|++....+..|..+++|++|+|++|+++.. .+..+..+++|++|+++
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 34555555555 3333221 4556666666666544444566666677777777766532 24555667777777777
Q ss_pred cCCccCCcCcccccCCcceEEeeccceeeccCC-chhhccccccEeecccccCCCCccccccccccCcEEEecCceecc-
Q 001253 447 TNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFP-SDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTG- 524 (1114)
Q Consensus 447 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~- 524 (1114)
+|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|++++..|..+..+++|++|+|++|.+++
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 77777 456667777888888888888875544 567777888888888888877777777778888888888888875
Q ss_pred CCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccc
Q 001253 525 ELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGN 604 (1114)
Q Consensus 525 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 604 (1114)
..|..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+++|++|+|++|++++..|..+..
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence 56777777888888888888887666777777778888888888887666667777778888888888887777777777
Q ss_pred cc-cccccccCCCcCCCC
Q 001253 605 LS-RLTELQMGGNSFSGG 621 (1114)
Q Consensus 605 l~-~L~~L~ls~N~l~~~ 621 (1114)
++ +|++|+|++|++++.
T Consensus 246 ~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 246 FPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CCTTCCEEECTTCCEECS
T ss_pred hhccCCEEEccCCCeecc
Confidence 73 777788887777654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-31 Score=329.05 Aligned_cols=381 Identities=17% Similarity=0.110 Sum_probs=180.9
Q ss_pred CCCCCCccceeecccccc---CCCCccccc------------ccccccEEEecCCcccCccccccccc--cccchhhccc
Q 001253 217 EIGGCESLQYLGLAQNQL---SGEIPKEIG------------MLKYLTDVILWGNQLSGVIPKELGNC--TSLETLALYD 279 (1114)
Q Consensus 217 ~l~~l~~L~~L~Ls~N~l---~~~~p~~l~------------~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~Ls~ 279 (1114)
.+..+++|++|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..++.. .+|++|+|++
T Consensus 68 ~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~ 147 (592)
T 3ogk_B 68 LSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDK 147 (592)
T ss_dssp HHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEES
T ss_pred HHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcC
Confidence 344566777777766432 123333332 45566666666666555444444442 2356666555
Q ss_pred ccccC--CchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecccccccC-
Q 001253 280 NKQVG--QLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTG- 356 (1114)
Q Consensus 280 N~~~~--~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~- 356 (1114)
|.... .++.....+++|++|+|++|.+.+..+.+ ++..+..+++|+.|++++|.+++
T Consensus 148 ~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~--------------------l~~~~~~~~~L~~L~L~~n~~~~~ 207 (592)
T 3ogk_B 148 CSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKW--------------------LHELAQHNTSLEVLNFYMTEFAKI 207 (592)
T ss_dssp CEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHH--------------------HHHHHHHCCCCCEEECTTCCCSSC
T ss_pred CCCcCHHHHHHHHhhCCCCCEEECccccccCcchhH--------------------HHHHHhcCCCccEEEeeccCCCcc
Confidence 54110 11222234555555555555554331110 11222333444444444444431
Q ss_pred ---cccccccccccCCEEEcccccccccccCccccccceeeeeccCCccc---CCCCCCCCcCccceEEEeecccccCCC
Q 001253 357 ---VIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLV---GGIPQRLGAYSQLWVVDLSDNHLTGKI 430 (1114)
Q Consensus 357 ---~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~---~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 430 (1114)
..+..+..+++|+.|+|++|.+.+ ++..+..+++|++|++++.... +..+..+..+++|+.|+++++.. +.+
T Consensus 208 ~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l 285 (592)
T 3ogk_B 208 SPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEM 285 (592)
T ss_dssp CHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTG
T ss_pred CHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHH
Confidence 112223344555555555555443 3344444555555555432211 12233444555666666655422 244
Q ss_pred CccccccCccceeeeccCCccCCcC-cccccCCcceEEeeccceeeccCCchhhccccccEeecc-----------cccC
Q 001253 431 PRHICRNTSLIFLNLETNKLTGSIP-TGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELD-----------QNQF 498 (1114)
Q Consensus 431 ~~~~~~~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-----------~N~l 498 (1114)
|..+..+++|++|+|++|.+++... ..+..+++|++|+++++-..+.++..+..+++|++|+++ .|.+
T Consensus 286 ~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~ 365 (592)
T 3ogk_B 286 PILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLV 365 (592)
T ss_dssp GGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCC
T ss_pred HHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCcc
Confidence 5555555666666666666543222 224556666666666322222233333455666666666 2444
Q ss_pred CCC-ccccccccccCcEEEecCceeccCCCccccC-CCCcceeecc----ccccccc-----ccccccccccceEEECcc
Q 001253 499 SGP-IPTEIGNCNALQRLHLSDNYFTGELPREVGN-LSNLVTFNVS----SNFLTGR-----IPLEIFSCKMLQRLDLSW 567 (1114)
Q Consensus 499 ~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~Ls~ 567 (1114)
++. ++..+..+++|++|+++.|++++..+..++. +++|+.|+++ .|.+++. ++..+..+++|+.|+|++
T Consensus 366 ~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~ 445 (592)
T 3ogk_B 366 SQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYL 445 (592)
T ss_dssp CHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEEC
T ss_pred CHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEec
Confidence 422 1222334566666666666665544444443 5566666664 4455432 222234455666666653
Q ss_pred c--cccCCCchhhhh-cccCCeeeccCccCCC-cccccccccccccccccCCCcCC
Q 001253 568 N--KFVGALPREIGS-LFQLELLKLSENELSG-SIPVQIGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 568 N--~l~~~~p~~~~~-l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~ 619 (1114)
| .+++..+..++. +++|++|+|++|++++ .++..+..+++|+.|++++|+|+
T Consensus 446 ~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~ 501 (592)
T 3ogk_B 446 RQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501 (592)
T ss_dssp CGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred CCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence 2 244443334433 4556666666655553 22333345555555555555554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-31 Score=327.10 Aligned_cols=394 Identities=14% Similarity=0.078 Sum_probs=263.8
Q ss_pred CCCccceeeccccccCCCCccccccc--ccccEEEecCCc-ccC-ccccccccccccchhhcccccccCC----chhhhc
Q 001253 220 GCESLQYLGLAQNQLSGEIPKEIGML--KYLTDVILWGNQ-LSG-VIPKELGNCTSLETLALYDNKQVGQ----LPKELG 291 (1114)
Q Consensus 220 ~l~~L~~L~Ls~N~l~~~~p~~l~~l--~~L~~L~L~~N~-l~~-~~p~~l~~l~~L~~L~Ls~N~~~~~----~p~~~~ 291 (1114)
.+++|++|+|++|.+++..+..++.. ++|++|+|++|. ++. .++....++++|++|+|++|.+.+. ++..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 45677777777777765555666553 347777777765 221 1222234667777778877776655 444455
Q ss_pred CCCccceeeecccccc----cccCccccccccccccccccccCCCCCchhhhcccccceeeccccccc---Ccccccccc
Q 001253 292 SIGSLKYLYIYRNELN----GTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLT---GVIPVELTT 364 (1114)
Q Consensus 292 ~l~~L~~L~L~~n~l~----~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~---~~~~~~~~~ 364 (1114)
.+++|++|++++|.++ +.++..+..+++|++|++++|.+.+ ++..+..+++|+.|+++.+... ...+..+..
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 268 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVF 268 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhc
Confidence 6777888888877775 2344445667777777777777764 5667777778888887753322 223345667
Q ss_pred cccCCEEEcccccccccccCccccccceeeeeccCCcccCCCC-CCCCcCccceEEEeecccccC-CCCccccccCccce
Q 001253 365 LKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIP-QRLGAYSQLWVVDLSDNHLTG-KIPRHICRNTSLIF 442 (1114)
Q Consensus 365 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~~~~L~~ 442 (1114)
+++|+.|+++++... .+|..+..+++|++|++++|.+.+... ..+..+++|++|+++ +.+.. .++..+..+++|++
T Consensus 269 ~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~ 346 (592)
T 3ogk_B 269 PRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKR 346 (592)
T ss_dssp CTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCE
T ss_pred cccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCE
Confidence 778888888876433 566677788888888888888654333 335678888888888 44433 33444456788888
Q ss_pred eeec-----------cCCccCCc-CcccccCCcceEEeeccceeeccCCchhhc-cccccEeecc----cccCCCC----
Q 001253 443 LNLE-----------TNKLTGSI-PTGVTRCKSLVQLRLGGNSFTGSFPSDLCK-LANLSTVELD----QNQFSGP---- 501 (1114)
Q Consensus 443 L~Ls-----------~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~---- 501 (1114)
|+++ .|.+++.. +.....+++|++|+++.|.+++..+..+.. +++|+.|+++ .|.+++.
T Consensus 347 L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~ 426 (592)
T 3ogk_B 347 LRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN 426 (592)
T ss_dssp EEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHH
T ss_pred EEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHH
Confidence 8888 35666432 222445788999999888888777777765 8889999885 6778754
Q ss_pred -ccccccccccCcEEEecCc--eeccCCCcccc-CCCCcceeecccccccc-cccccccccccceEEECccccccCC-Cc
Q 001253 502 -IPTEIGNCNALQRLHLSDN--YFTGELPREVG-NLSNLVTFNVSSNFLTG-RIPLEIFSCKMLQRLDLSWNKFVGA-LP 575 (1114)
Q Consensus 502 -~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p 575 (1114)
++..+.++++|++|+|++| .+++..+..+. .+++|++|+|++|.+++ .++..+..+++|+.|+|++|.+++. ++
T Consensus 427 ~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 506 (592)
T 3ogk_B 427 GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIA 506 (592)
T ss_dssp HHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHH
T ss_pred HHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHH
Confidence 3444677888999999743 36655444444 37889999999998875 3444556788899999999988654 34
Q ss_pred hhhhhcccCCeeeccCccCCCcccccc-cccccccccccCCC
Q 001253 576 REIGSLFQLELLKLSENELSGSIPVQI-GNLSRLTELQMGGN 616 (1114)
Q Consensus 576 ~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ls~N 616 (1114)
..+..+++|++|+|++|+++..-...+ ..++.+....+..+
T Consensus 507 ~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 507 AAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp HHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred HHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 445678889999999998885533222 24555554444433
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=293.66 Aligned_cols=258 Identities=21% Similarity=0.177 Sum_probs=190.3
Q ss_pred ceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCc
Q 001253 441 IFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDN 520 (1114)
Q Consensus 441 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 520 (1114)
..++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 34555555555 3444433 45666666666666666666666667777777777766666666677777777777777
Q ss_pred eeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCC-chhhhhcccCCeeeccCccCCCccc
Q 001253 521 YFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGAL-PREIGSLFQLELLKLSENELSGSIP 599 (1114)
Q Consensus 521 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p 599 (1114)
+|++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|+..+.+ +..|..+++|++|+|++|+++ .+|
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc
Confidence 776555556777777777777777776444455666777777777774333333 346777778888888888877 445
Q ss_pred ccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCcccccc
Q 001253 600 VQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLS 679 (1114)
Q Consensus 600 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~ 679 (1114)
.+..+++|+.|+|++|+|++..|..|..+++|+ .|+|++|++++..|..|.++++|++|||++|+|++..+..|..++
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ-KLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCC-EEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred -ccCCCcccCEEECCCCccCccChhhhccCccCC-EEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 467788888888888888888888888888888 799999999999899999999999999999999999999999999
Q ss_pred ccceEEeccCcccCCCCCccccccc
Q 001253 680 SLLGCNFSYNNLTGPIPSSQTFQNM 704 (1114)
Q Consensus 680 ~l~~l~ls~N~l~g~ip~~~~~~~~ 704 (1114)
+|+.|+|++|+|.|.+...+...++
T Consensus 280 ~L~~L~L~~Np~~CdC~l~~l~~~~ 304 (440)
T 3zyj_A 280 HLERIHLHHNPWNCNCDILWLSWWI 304 (440)
T ss_dssp TCCEEECCSSCEECSSTTHHHHHHH
T ss_pred CCCEEEcCCCCccCCCCchHHHHHH
Confidence 9999999999999988765443333
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=295.72 Aligned_cols=257 Identities=23% Similarity=0.204 Sum_probs=190.4
Q ss_pred ceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCc
Q 001253 441 IFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDN 520 (1114)
Q Consensus 441 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 520 (1114)
..++.+++.++ .+|..+. +++++|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 34555555555 3444332 45666666666666666666666777777777777776666666777777777777777
Q ss_pred eeccCCCccccCCCCcceeecccccccccccccccccccceEEECccc-cccCCCchhhhhcccCCeeeccCccCCCccc
Q 001253 521 YFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWN-KFVGALPREIGSLFQLELLKLSENELSGSIP 599 (1114)
Q Consensus 521 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 599 (1114)
+|++..+..|.++++|++|+|++|++++..+..+..+++|+.|+|++| .+....+..|..+++|++|+|++|++++ +|
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~ 212 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP 212 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc
Confidence 777666666777777777777777776444445666777777777773 3333333457777888888888888874 34
Q ss_pred ccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCcccccc
Q 001253 600 VQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLS 679 (1114)
Q Consensus 600 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~ 679 (1114)
.+..+++|++|+|++|+|++..|..|..+++|+ .|+|++|++++..|..|..+++|+.|||++|+|++.++..|..++
T Consensus 213 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 213 -NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLK-KLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp -CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCC-EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred -cccccccccEEECcCCcCcccCcccccCccCCC-EEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 477788888888888888888888888888888 799999999999899999999999999999999998889999999
Q ss_pred ccceEEeccCcccCCCCCcccccc
Q 001253 680 SLLGCNFSYNNLTGPIPSSQTFQN 703 (1114)
Q Consensus 680 ~l~~l~ls~N~l~g~ip~~~~~~~ 703 (1114)
+|+.|++++|+|.|.+...+...+
T Consensus 291 ~L~~L~L~~Np~~CdC~~~~l~~~ 314 (452)
T 3zyi_A 291 YLVELHLHHNPWNCDCDILWLAWW 314 (452)
T ss_dssp TCCEEECCSSCEECSTTTHHHHHH
T ss_pred CCCEEEccCCCcCCCCCchHHHHH
Confidence 999999999999999886544333
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=281.46 Aligned_cols=233 Identities=23% Similarity=0.298 Sum_probs=167.7
Q ss_pred CccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEe
Q 001253 438 TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHL 517 (1114)
Q Consensus 438 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 517 (1114)
++++.|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++++++|++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 45666677766666 55666666666666666666666 56666666666666666666666 55666666666666666
Q ss_pred cCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCc
Q 001253 518 SDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGS 597 (1114)
Q Consensus 518 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 597 (1114)
++|++.+.+|..+... .++..+..+++|+.|+|++|+++ .+|..++.+++|++|+|++|++++
T Consensus 158 ~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~- 220 (328)
T 4fcg_A 158 RACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA- 220 (328)
T ss_dssp EEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-
T ss_pred CCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-
Confidence 6665555555544320 01122334777778888888777 677777778888888888888874
Q ss_pred ccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCcccc
Q 001253 598 IPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVN 677 (1114)
Q Consensus 598 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~ 677 (1114)
+|..++.+++|++|+|++|++.+.+|..++.+++|+ .|+|++|++.+.+|..++++++|++|||++|++.|.+|.++.+
T Consensus 221 l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~-~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK-RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC-EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC-EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence 555677788888888888888888888888888887 6888888888888888888888889999999999999999999
Q ss_pred ccccceEEeccCcc
Q 001253 678 LSSLLGCNFSYNNL 691 (1114)
Q Consensus 678 l~~l~~l~ls~N~l 691 (1114)
+++|+.++++.|.+
T Consensus 300 L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 300 LPANCIILVPPHLQ 313 (328)
T ss_dssp SCTTCEEECCGGGS
T ss_pred ccCceEEeCCHHHH
Confidence 99999988887654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=285.64 Aligned_cols=269 Identities=22% Similarity=0.204 Sum_probs=142.7
Q ss_pred eecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccc
Q 001253 347 LYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHL 426 (1114)
Q Consensus 347 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 426 (1114)
.++++|.++.+ |..+. ++|++|++++|.+++..+..|..+++|++|++++|++.+..+..|..+++|++|+|++|++
T Consensus 36 c~~~~~~l~~i-P~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (353)
T 2z80_A 36 CKGSSGSLNSI-PSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112 (353)
T ss_dssp EECCSTTCSSC-CTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eeCCCCCcccc-ccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcC
Confidence 44555555532 32222 3566666666666655555566666666666666666655555666666666666666666
Q ss_pred cCCCCccccccCccceeeeccCCccCCcC-cccccCCcceEEeeccc-eeeccCCchhhccccccEeecccccCCCCccc
Q 001253 427 TGKIPRHICRNTSLIFLNLETNKLTGSIP-TGVTRCKSLVQLRLGGN-SFTGSFPSDLCKLANLSTVELDQNQFSGPIPT 504 (1114)
Q Consensus 427 ~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 504 (1114)
++..+..+..+++|++|++++|++++..+ ..+..+++|++|++++| .+.+..+..+..+++|++|++++|++++..|.
T Consensus 113 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 192 (353)
T 2z80_A 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192 (353)
T ss_dssp SSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred CcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHH
Confidence 64444445566666666666666663322 24556666666666666 34444455555666666666666666555555
Q ss_pred cccccccCcEEEecCceeccCCCccccCCCCcceeeccccccccccccccc---ccccceEEECccccccC----CCchh
Q 001253 505 EIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIF---SCKMLQRLDLSWNKFVG----ALPRE 577 (1114)
Q Consensus 505 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~p~~ 577 (1114)
.+..+++|++|++++|+++...+..+..+++|+.|++++|.+++..+..+. ....++.++|++|.+++ .+|..
T Consensus 193 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~ 272 (353)
T 2z80_A 193 SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKL 272 (353)
T ss_dssp TTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHH
T ss_pred HHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHH
Confidence 566666666666666665432222333455555566665555543322221 13344445555544443 23444
Q ss_pred hhhcccCCeeeccCccCCCccccc-ccccccccccccCCCcCC
Q 001253 578 IGSLFQLELLKLSENELSGSIPVQ-IGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 578 ~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~ 619 (1114)
+..+++|++|++++|+++ .+|.. |.++++|++|+|++|++.
T Consensus 273 l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~ 314 (353)
T 2z80_A 273 LNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314 (353)
T ss_dssp HHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred HhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCcc
Confidence 455555555555555555 23322 344455555555555444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-30 Score=289.27 Aligned_cols=249 Identities=20% Similarity=0.214 Sum_probs=182.7
Q ss_pred ccccCccceeeeccCCccCCcCcccccCCcceEEeecccee-eccCCchhh-------ccccccEeecccccCCCCcccc
Q 001253 434 ICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSF-TGSFPSDLC-------KLANLSTVELDQNQFSGPIPTE 505 (1114)
Q Consensus 434 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~ 505 (1114)
++..++|++|++++|.+ .+|..+... |+.|+|++|.+ ...+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 44556677777777777 456555443 77777777777 345555554 5777788888888877777776
Q ss_pred c--cccccCcEEEecCceeccCCCccccCC-----CCcceeecccccccccccccccccccceEEECccccccCC--Cch
Q 001253 506 I--GNCNALQRLHLSDNYFTGELPREVGNL-----SNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGA--LPR 576 (1114)
Q Consensus 506 ~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~ 576 (1114)
+ ..+++|++|+|++|+|++. |..++.+ ++|++|+|++|++++..|..+..+++|+.|+|++|++.+. .|.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 5 7777888888888887765 6666666 7788888888888766667777778888888888877654 334
Q ss_pred hh--hhcccCCeeeccCccCCC--ccc-ccccccccccccccCCCcCCCCCC-hhhcCcchhhHHhhcccccccccCCcc
Q 001253 577 EI--GSLFQLELLKLSENELSG--SIP-VQIGNLSRLTELQMGGNSFSGGIP-AELGSLSSLQIALNLSYNNLSGLIPPE 650 (1114)
Q Consensus 577 ~~--~~l~~L~~L~L~~N~l~~--~~p-~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~~L~Ls~N~l~~~~p~~ 650 (1114)
.+ +.+++|++|+|++|++++ .++ ..+.++++|++|+|++|++++.+| ..+..+++|+ .|+|++|+|+ .+|..
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~-~L~Ls~N~l~-~ip~~ 271 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN-SLNLSFTGLK-QVPKG 271 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCC-EEECTTSCCS-SCCSS
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCC-EEECCCCccC-hhhhh
Confidence 44 677788888888888773 122 334567788888888888887665 4556677887 6888888888 66777
Q ss_pred ccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccC
Q 001253 651 LGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTG 693 (1114)
Q Consensus 651 ~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g 693 (1114)
+. ++|++|||++|+|++. |. +..+++|+.|++++|++++
T Consensus 272 ~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 272 LP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred cc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 76 7889999999999977 65 8889999999999998876
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=269.81 Aligned_cols=237 Identities=20% Similarity=0.192 Sum_probs=126.9
Q ss_pred CccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeeccccc-CCCCccccccccccCcEEE
Q 001253 438 TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQ-FSGPIPTEIGNCNALQRLH 516 (1114)
Q Consensus 438 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~ 516 (1114)
++|++|++++|.+++..+..+..+++|++|++++|.+++..|..|..+++|++|++++|+ ++...|..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 345555555555554444445555555555555555554445555555555555555554 4444455555555555555
Q ss_pred ecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCC
Q 001253 517 LSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSG 596 (1114)
Q Consensus 517 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 596 (1114)
|++|++++..|..|.++++|++|++++|++++..+..+..+++|+.|+|++|++++..+..+..+++|++|++++|++++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 55555555555555555555555555555553333334455555555555555554444445555555555555555555
Q ss_pred cccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccc
Q 001253 597 SIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFV 676 (1114)
Q Consensus 597 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 676 (1114)
..|..+.++++|+.|++++|++++..+..+..+++|+ .|+|++|.+++..+.. .-+..++.++.+.|.+.+..|+.+.
T Consensus 192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ-YLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC-EEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGT
T ss_pred cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccC-EEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhC
Confidence 5555555555555555555555554444455555555 4555555555432211 2223455555666666666665543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-29 Score=282.53 Aligned_cols=251 Identities=21% Similarity=0.201 Sum_probs=125.7
Q ss_pred ceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecc
Q 001253 345 ELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDN 424 (1114)
Q Consensus 345 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 424 (1114)
+..+++.+.+.......+..+++|++|+|++|.+++..|..|..+++|++|++++|++.+..+
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~----------------- 75 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD----------------- 75 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-----------------
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-----------------
Confidence 334444444443333334444445555555555544444444444444444444444433222
Q ss_pred cccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccc
Q 001253 425 HLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPT 504 (1114)
Q Consensus 425 ~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 504 (1114)
+..+++|++|++++|++++.. ..++|++|++++|++++..+.. +++|++|++++|++++..+.
T Consensus 76 ---------~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~ 138 (317)
T 3o53_A 76 ---------LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDL 138 (317)
T ss_dssp ---------ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGB
T ss_pred ---------hhhcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccch
Confidence 333344444444444443211 1244555555555554333222 34555566666666555555
Q ss_pred cccccccCcEEEecCceeccCCCcccc-CCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhccc
Q 001253 505 EIGNCNALQRLHLSDNYFTGELPREVG-NLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQ 583 (1114)
Q Consensus 505 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 583 (1114)
.+..+++|++|+|++|++++..+..+. .+++|++|+|++|.+++ ++.. ..+++|+.|+|++|++++ +|..+..+++
T Consensus 139 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~-~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~ 215 (317)
T 3o53_A 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQ-VVFAKLKTLDLSSNKLAF-MGPEFQSAAG 215 (317)
T ss_dssp CTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EECC-CCCTTCCEEECCSSCCCE-ECGGGGGGTT
T ss_pred hhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-cccc-cccccCCEEECCCCcCCc-chhhhcccCc
Confidence 555666666666666666655444442 45666666666666653 2222 235666666666666663 3344666666
Q ss_pred CCeeeccCccCCCcccccccccccccccccCCCcCC-CCCChhhcCcchhh
Q 001253 584 LELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS-GGIPAELGSLSSLQ 633 (1114)
Q Consensus 584 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~ 633 (1114)
|++|+|++|+++ .+|..+..+++|+.|++++|++. +.+|..+..++.|+
T Consensus 216 L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~ 265 (317)
T 3o53_A 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265 (317)
T ss_dssp CSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHH
T ss_pred ccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccce
Confidence 666666666666 35555666666666666666665 33444444443333
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.6e-28 Score=265.99 Aligned_cols=205 Identities=20% Similarity=0.137 Sum_probs=86.8
Q ss_pred ceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCC-ccCCcCcccccCCcceEEee
Q 001253 391 NLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNK-LTGSIPTGVTRCKSLVQLRL 469 (1114)
Q Consensus 391 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L 469 (1114)
+|++|++++|.+.+..+..|..+++|++|+|++|++++..|..|..+++|++|++++|+ ++...|..+..+++|++|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 33344444444333333334444444444444444443334444444444444444443 33333344444444444444
Q ss_pred ccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeeccccccccc
Q 001253 470 GGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGR 549 (1114)
Q Consensus 470 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 549 (1114)
++|++++..|..+..+++|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 44444433344444444444444444444433333344444444444444444433333344444444444444444433
Q ss_pred ccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCC
Q 001253 550 IPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELS 595 (1114)
Q Consensus 550 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 595 (1114)
.|..+..+++|+.|+|++|++++..+..+..+++|++|++++|.+.
T Consensus 193 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 238 (285)
T 1ozn_A 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred CHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCcc
Confidence 3444444444444444444444333333444444444444444333
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-29 Score=282.34 Aligned_cols=265 Identities=19% Similarity=0.170 Sum_probs=165.6
Q ss_pred eeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccce
Q 001253 394 MLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNS 473 (1114)
Q Consensus 394 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 473 (1114)
.++++++.+.......+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+ +..+++|++|++++|+
T Consensus 14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~ 91 (317)
T 3o53_A 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY 91 (317)
T ss_dssp EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSE
T ss_pred EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCc
Confidence 33444444443333334455666777777777776666677777777777777777775443 7777777888888777
Q ss_pred eeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeeccccccccccccc
Q 001253 474 FTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLE 553 (1114)
Q Consensus 474 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 553 (1114)
+++.. ..++|++|++++|++++..+.. +++|++|++++|++++..+..+..+++|++|+|++|.+++..+..
T Consensus 92 l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 163 (317)
T 3o53_A 92 VQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163 (317)
T ss_dssp EEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGG
T ss_pred ccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHH
Confidence 77432 2367777777777777554433 456777777777777666666777777777777777776555555
Q ss_pred cc-ccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchh
Q 001253 554 IF-SCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSL 632 (1114)
Q Consensus 554 ~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 632 (1114)
+. .+++|+.|+|++|++++. |. ...+++|++|+|++|++++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|
T Consensus 164 ~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L 239 (317)
T 3o53_A 164 LAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239 (317)
T ss_dssp GGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTC
T ss_pred HhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCC
Confidence 53 466677777777776643 22 2235666666666666663 3444666666666666666666 355556666666
Q ss_pred hHHhhccccccc-ccCCccccchhhhHhhhcc-CcccccCCCC
Q 001253 633 QIALNLSYNNLS-GLIPPELGNLILLEYLLLN-NNHLSGEIPG 673 (1114)
Q Consensus 633 ~~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~g~ip~ 673 (1114)
+ .|+|++|.++ +.+|..++.+++|+.|+++ .+.++|..|.
T Consensus 240 ~-~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 240 E-HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp C-EEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred C-EEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 5 5666666666 5555556666666666666 3445554443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=273.83 Aligned_cols=254 Identities=23% Similarity=0.197 Sum_probs=146.5
Q ss_pred ccccccccccccccccCCCCCchhhhcccccceeeccccccc-Cccccccc-------ccccCCEEEcccccccccccCc
Q 001253 314 IGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLT-GVIPVELT-------TLKNLTKLDLSINSLTGTIPLG 385 (1114)
Q Consensus 314 l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~ 385 (1114)
++..++|+.|++++|.+ .+|..+... |+.|+|++|+++ ...+..+. .+++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 45566777777777777 566655544 777777777774 33444333 5667777777777777666655
Q ss_pred c--ccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCc
Q 001253 386 F--QYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKS 463 (1114)
Q Consensus 386 ~--~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~ 463 (1114)
+ ..+++|++|++++|++.+. |..++.+.. ...++|++|++++|++++..|..+..+++
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~-------------------~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQ-------------------WLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHT-------------------TCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHH-------------------hhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 4 5555555555555555544 444443300 00044555555555555444445555555
Q ss_pred ceEEeeccceeecc--CCchh--hccccccEeecccccCCCC---ccccccccccCcEEEecCceeccCCC-ccccCCCC
Q 001253 464 LVQLRLGGNSFTGS--FPSDL--CKLANLSTVELDQNQFSGP---IPTEIGNCNALQRLHLSDNYFTGELP-REVGNLSN 535 (1114)
Q Consensus 464 L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~ 535 (1114)
|++|+|++|++.+. .|..+ ..+++|++|+|++|+|++. ....+.++++|++|+|++|+|++..| ..+..+++
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 254 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTT
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCC
Confidence 55555555554433 22222 5556666666666666521 11233455666666666666665553 34455666
Q ss_pred cceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCC
Q 001253 536 LVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSG 596 (1114)
Q Consensus 536 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 596 (1114)
|++|+|++|+|+ .+|..+. ++|+.|||++|++++. |. +..+++|++|+|++|.+++
T Consensus 255 L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 255 LNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 777777777776 5666555 6677777777777654 44 6677777777777777664
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=287.29 Aligned_cols=266 Identities=28% Similarity=0.355 Sum_probs=120.2
Q ss_pred CCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeecc
Q 001253 368 LTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLET 447 (1114)
Q Consensus 368 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~ 447 (1114)
++.|++++|.++ .+|..+. ++|++|++++|+++. +|. .+++|++|+|++|+|++ +|. .+++|++|++++
T Consensus 42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 110 (622)
T 3g06_A 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFS 110 (622)
T ss_dssp CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECS
T ss_pred CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcC
Confidence 444444444444 2333222 344444444444432 222 23445555555555542 222 334455555555
Q ss_pred CCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCC
Q 001253 448 NKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELP 527 (1114)
Q Consensus 448 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 527 (1114)
|++++ +|. .+++|+.|++++|++++ +|.. +++|++|+|++|++++ +|. .+++|+.|++++|+|++ +|
T Consensus 111 N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~ 177 (622)
T 3g06_A 111 NPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP 177 (622)
T ss_dssp CCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC
T ss_pred CcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc
Confidence 55543 222 33445555555555542 3322 2455555555555552 222 12445555555555553 33
Q ss_pred ccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCccccccccccc
Q 001253 528 REVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSR 607 (1114)
Q Consensus 528 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 607 (1114)
..+++|+.|++++|.++ .+|.. +++|+.|++++|.++ .+|.. +++|+.|+|++|+|++ +| ..+++
T Consensus 178 ---~~~~~L~~L~Ls~N~l~-~l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~ 242 (622)
T 3g06_A 178 ---MLPSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSE 242 (622)
T ss_dssp ---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTT
T ss_pred ---ccCCCCcEEECCCCCCC-CCCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCc
Confidence 23345555555555555 23322 244555555555555 23321 2445555555555553 33 23345
Q ss_pred ccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccc
Q 001253 608 LTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNL 678 (1114)
Q Consensus 608 L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l 678 (1114)
|+.|+|++|+|+ .+|. .+++|+ .|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|..+..+
T Consensus 243 L~~L~Ls~N~L~-~lp~---~~~~L~-~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 243 LKELMVSGNRLT-SLPM---LPSGLL-SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp CCEEECCSSCCS-CCCC---CCTTCC-EEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred CcEEECCCCCCC-cCCc---ccccCc-EEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence 555555555555 2333 233333 3445555544 334445555555555555555555555444443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=277.11 Aligned_cols=227 Identities=19% Similarity=0.148 Sum_probs=125.4
Q ss_pred ceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeec
Q 001253 391 NLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLG 470 (1114)
Q Consensus 391 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 470 (1114)
++++|+|++|++.+..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..+..+++|++|+|+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 34444444444444444444445555555555555554444455555555555555555554444445555555555555
Q ss_pred cceeeccCCchhhccccccEeeccc-ccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeeccccccccc
Q 001253 471 GNSFTGSFPSDLCKLANLSTVELDQ-NQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGR 549 (1114)
Q Consensus 471 ~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 549 (1114)
+|++++..+..|..+++|++|++++ |.+....+..|.++++|++|+|++|+|++ +| .+..+++|+.|+|++|++++.
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEE
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCccc
Confidence 5555544444555556666666655 33333333345566666666666666653 22 355555666666666666655
Q ss_pred ccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCC
Q 001253 550 IPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 550 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 619 (1114)
.|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 5555555666666666666666555556666666666666666666555555566666666666666654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-27 Score=275.90 Aligned_cols=246 Identities=20% Similarity=0.190 Sum_probs=137.8
Q ss_pred CEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccC
Q 001253 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETN 448 (1114)
Q Consensus 369 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N 448 (1114)
..++.+++.++ .+|..+. ++++.|+|++|++.+..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 34444444444 2333222 34444555555554444455555555555555555555555555555555666666666
Q ss_pred CccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeeccc-ccCCCCccccccccccCcEEEecCceeccCCC
Q 001253 449 KLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQ-NQFSGPIPTEIGNCNALQRLHLSDNYFTGELP 527 (1114)
Q Consensus 449 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 527 (1114)
++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++ |.+....+..|.++++|++|+|++|+|+ .+|
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc
Confidence 65544444555666666666666666555555566666666666665 3333333335566666666666666665 233
Q ss_pred ccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCccccccccccc
Q 001253 528 REVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSR 607 (1114)
Q Consensus 528 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 607 (1114)
.+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 280 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence 2555566666666666666555555555666666666666666555555666666666666666666555555566666
Q ss_pred ccccccCCCcCC
Q 001253 608 LTELQMGGNSFS 619 (1114)
Q Consensus 608 L~~L~ls~N~l~ 619 (1114)
|+.|+|++|++.
T Consensus 281 L~~L~L~~Np~~ 292 (440)
T 3zyj_A 281 LERIHLHHNPWN 292 (440)
T ss_dssp CCEEECCSSCEE
T ss_pred CCEEEcCCCCcc
Confidence 666666666654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-28 Score=291.18 Aligned_cols=236 Identities=22% Similarity=0.158 Sum_probs=109.5
Q ss_pred CccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEee
Q 001253 413 YSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVE 492 (1114)
Q Consensus 413 l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 492 (1114)
+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|.|++..+ .++|++|+
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~ 105 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLH 105 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence 3455555555555555555555555555555555555554333 4555555555555555543221 14444444
Q ss_pred cccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccC
Q 001253 493 LDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVG 572 (1114)
Q Consensus 493 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 572 (1114)
+++|.|++..+. .+++|+.|+|++|.|++.. |..+..+++|+.|+|++|.+++
T Consensus 106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~------------------------~~~~~~l~~L~~L~Ls~N~l~~ 158 (487)
T 3oja_A 106 AANNNISRVSCS---RGQGKKNIYLANNKITMLR------------------------DLDEGCRSRVQYLDLKLNEIDT 158 (487)
T ss_dssp CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGG------------------------GBCGGGGSSEEEEECTTSCCCE
T ss_pred CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCC------------------------chhhcCCCCCCEEECCCCCCCC
Confidence 444444433322 1233444444444444433 4444444444444444444444
Q ss_pred CCchhhh-hcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccc
Q 001253 573 ALPREIG-SLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPEL 651 (1114)
Q Consensus 573 ~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~ 651 (1114)
.+|..+. .+++|++|+|++|.+++..+ +..+++|+.|+|++|+|++ +|+.+..+++|+ .|+|++|+|++ +|..+
T Consensus 159 ~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~-~L~Ls~N~l~~-lp~~l 233 (487)
T 3oja_A 159 VNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVT-WISLRNNKLVL-IEKAL 233 (487)
T ss_dssp EEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCS-EEECTTSCCCE-ECTTC
T ss_pred cChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCcc-EEEecCCcCcc-cchhh
Confidence 4444443 34444444444444443311 1234444444444444443 222244444444 34444444443 24444
Q ss_pred cchhhhHhhhccCcccc-cCCCCccccccccceEEec
Q 001253 652 GNLILLEYLLLNNNHLS-GEIPGSFVNLSSLLGCNFS 687 (1114)
Q Consensus 652 ~~l~~L~~L~Ls~N~l~-g~ip~~~~~l~~l~~l~ls 687 (1114)
+.+++|+.|+|++|+++ +.+|..+..++.|+.++++
T Consensus 234 ~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred ccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 44455555555555554 4444445555555444443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=279.74 Aligned_cols=268 Identities=29% Similarity=0.326 Sum_probs=185.2
Q ss_pred ccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEee
Q 001253 343 GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLS 422 (1114)
Q Consensus 343 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 422 (1114)
+++.|++++|.++ .+|..+. ++|++|+|++|.|+. +|. .+++|++|+|++|++++ +|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence 4556666666665 3343333 566666666666663 333 35666666776666653 333 45677777777
Q ss_pred cccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCc
Q 001253 423 DNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPI 502 (1114)
Q Consensus 423 ~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 502 (1114)
+|++++. |. .+++|+.|++++|++++ +|.. +++|++|+|++|++++ +|. .+.+|+.|++++|+|++ +
T Consensus 110 ~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l 176 (622)
T 3g06_A 110 SNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-L 176 (622)
T ss_dssp SCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-C
T ss_pred CCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-C
Confidence 7777643 33 44677777777777774 4443 3777788888887774 443 24567888888888874 4
Q ss_pred cccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcc
Q 001253 503 PTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLF 582 (1114)
Q Consensus 503 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 582 (1114)
| ..+++|+.|+|++|+|++ +|.. +++|+.|++++|.++ .+|.. +++|+.|+|++|+|++ +| ..++
T Consensus 177 ~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~ 241 (622)
T 3g06_A 177 P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPS 241 (622)
T ss_dssp C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCT
T ss_pred c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCC
Confidence 4 446778888888888874 4432 467888888888887 55543 4778888888888885 55 4557
Q ss_pred cCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchh
Q 001253 583 QLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLI 655 (1114)
Q Consensus 583 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~ 655 (1114)
+|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+.++++|+ .|+|++|.+++.+|..+..++
T Consensus 242 ~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~-~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 242 ELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSET-TVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp TCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTC-EEECCSCCCCHHHHHHHHHHH
T ss_pred cCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccC-EEEecCCCCCCcCHHHHHhcc
Confidence 8888888888888 4555 5678888888888888 7788888888888 688888888888777665544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=282.88 Aligned_cols=238 Identities=21% Similarity=0.179 Sum_probs=200.0
Q ss_pred ccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccC
Q 001253 382 IPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRC 461 (1114)
Q Consensus 382 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 461 (1114)
+......+++|++|+|++|.+.+..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|.|++.. ..
T Consensus 26 l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~ 98 (487)
T 3oja_A 26 LASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VG 98 (487)
T ss_dssp HHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----EC
T ss_pred HHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CC
Confidence 33344556699999999999999999999999999999999999997766 889999999999999999543 33
Q ss_pred CcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCcccc-CCCCcceee
Q 001253 462 KSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVG-NLSNLVTFN 540 (1114)
Q Consensus 462 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ 540 (1114)
++|++|++++|.+++..+. .+++|+.|+|++|+|++..|..++.+++|+.|+|++|.|++..|..+. .+++|+.|+
T Consensus 99 ~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~ 175 (487)
T 3oja_A 99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (487)
T ss_dssp TTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence 8999999999999976654 357899999999999999999999999999999999999998888886 799999999
Q ss_pred cccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCC-
Q 001253 541 VSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS- 619 (1114)
Q Consensus 541 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~- 619 (1114)
|++|.+++. |. ...+++|+.|+|++|++++ +|..+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++.
T Consensus 176 Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 176 LQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp CTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred cCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence 999999955 33 3358899999999999986 44558888999999999999984 6777888888888888888886
Q ss_pred CCCChhhcCcchhh
Q 001253 620 GGIPAELGSLSSLQ 633 (1114)
Q Consensus 620 ~~~p~~~~~l~~L~ 633 (1114)
+.+|..+..++.|.
T Consensus 252 ~~~~~~~~~l~~L~ 265 (487)
T 3oja_A 252 GTLRDFFSKNQRVQ 265 (487)
T ss_dssp HHHHHHHTTCHHHH
T ss_pred cchHHHHHhCCCCc
Confidence 44444444444443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=287.69 Aligned_cols=188 Identities=16% Similarity=0.086 Sum_probs=133.3
Q ss_pred eecccCCeEEEEEEeC-CCcEEEEEEecccCCC-------ChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceEEE
Q 001253 816 VIGRGACGTVYRAVLR-TGHTVAVKKLASNREG-------NNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 816 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 886 (1114)
..+.|++|.+..++.. .|+.||+|++...... .+...++|.+|+++++++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3567777777776633 6899999999765322 123345689999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||++|++|.+++... ..++.. .|+.||++||+|+|++ |||||||||+|||+++++.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~- 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD- 392 (569)
T ss_dssp EECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC-
Confidence 9999999999999844 456654 4789999999999999 9999999999999999999999999999876432
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p 1012 (1114)
.....+.+||+.|||||++.+. +..++|+|++|++++++.++..+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 2334567899999999998764 67789999999998887665433
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-26 Score=250.34 Aligned_cols=234 Identities=21% Similarity=0.215 Sum_probs=153.6
Q ss_pred eeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCcee
Q 001253 443 LNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYF 522 (1114)
Q Consensus 443 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 522 (1114)
.+..+..++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 334444444 3444332 3566666666666655555666666666666666666655555666666677777777766
Q ss_pred ccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCC-CchhhhhcccCCeeeccCccCCCccccc
Q 001253 523 TGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGA-LPREIGSLFQLELLKLSENELSGSIPVQ 601 (1114)
Q Consensus 523 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 601 (1114)
++..+..|.++++|++|++++|.+++..+..+..+++|+.|++++|++++. +|..+..+++|++|++++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 168 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence 666666666666666666666666654444566666666666666666642 4666666666666666666666555555
Q ss_pred ccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCcccccccc
Q 001253 602 IGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSL 681 (1114)
Q Consensus 602 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l 681 (1114)
+..+++|+.+++ .|++++|++++..+..+.. .+|+.|+|++|+|++.++..|..+++|
T Consensus 169 ~~~l~~L~~l~l---------------------~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L 226 (276)
T 2z62_A 169 LRVLHQMPLLNL---------------------SLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSL 226 (276)
T ss_dssp GHHHHTCTTCCE---------------------EEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSC
T ss_pred hhhhhhccccce---------------------eeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccc
Confidence 555555442221 3667777777665554444 379999999999998888888999999
Q ss_pred ceEEeccCcccCCCCCcccc
Q 001253 682 LGCNFSYNNLTGPIPSSQTF 701 (1114)
Q Consensus 682 ~~l~ls~N~l~g~ip~~~~~ 701 (1114)
+.|++++|++.|.+|.-..+
T Consensus 227 ~~L~l~~N~~~c~c~~l~~l 246 (276)
T 2z62_A 227 QKIWLHTNPWDCSCPRIDYL 246 (276)
T ss_dssp CEEECCSSCBCCCTTTTHHH
T ss_pred cEEEccCCcccccCCchHHH
Confidence 99999999999999854333
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=243.96 Aligned_cols=217 Identities=25% Similarity=0.297 Sum_probs=128.7
Q ss_pred CCCccceEEEecCCCccEEEEEeecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccc
Q 001253 62 TPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141 (1114)
Q Consensus 62 ~~C~w~gv~C~~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 141 (1114)
++|.|.|+.|+... .++.+++++++++. +|..+. ++++.|+|++|++++..+..|+.+++|++|+|++|.++..
T Consensus 3 ~~C~~~~~~C~c~~---~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i 76 (270)
T 2o6q_A 3 ALCKKDGGVCSCNN---NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL 76 (270)
T ss_dssp CCBGGGTCSBEEET---TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCC
T ss_pred ccCCCCCCCCEeCC---CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCee
Confidence 47999999997642 12345666666663 444433 4566666666666655555666666666666666666654
Q ss_pred cccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccceeccccccccccCCCCCCC
Q 001253 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGC 221 (1114)
Q Consensus 142 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l 221 (1114)
.+..|.++++|++|+|++|++++..+..|.++++ |++|++++|.+++..+..|..+
T Consensus 77 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~------------------------L~~L~l~~n~l~~~~~~~~~~l 132 (270)
T 2o6q_A 77 PAGIFKELKNLETLWVTDNKLQALPIGVFDQLVN------------------------LAELRLDRNQLKSLPPRVFDSL 132 (270)
T ss_dssp CTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSS------------------------CCEEECCSSCCCCCCTTTTTTC
T ss_pred ChhhhcCCCCCCEEECCCCcCCcCCHhHcccccC------------------------CCEEECCCCccCeeCHHHhCcC
Confidence 4444566666666666666665444444444444 4555555555554444455555
Q ss_pred CccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhhcccccccCCchhhhcCCCccceeee
Q 001253 222 ESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYI 301 (1114)
Q Consensus 222 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L 301 (1114)
++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|.++++|++|++++|.+.+..+..|..+++|++|+|
T Consensus 133 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 212 (270)
T 2o6q_A 133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212 (270)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEe
Confidence 55555566666555444444555666666666666666554555666666666666666665555555666677777777
Q ss_pred ccccccc
Q 001253 302 YRNELNG 308 (1114)
Q Consensus 302 ~~n~l~~ 308 (1114)
++|.+..
T Consensus 213 ~~N~~~c 219 (270)
T 2o6q_A 213 QENPWDC 219 (270)
T ss_dssp CSSCBCC
T ss_pred cCCCeeC
Confidence 7776653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-28 Score=300.54 Aligned_cols=134 Identities=19% Similarity=0.208 Sum_probs=77.9
Q ss_pred cccccEeecccccCCCCcccccc-ccccCcEEEec--C----ceeccC-----CCccccCCCCcceeecccccccccccc
Q 001253 485 LANLSTVELDQNQFSGPIPTEIG-NCNALQRLHLS--D----NYFTGE-----LPREVGNLSNLVTFNVSSNFLTGRIPL 552 (1114)
Q Consensus 485 l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 552 (1114)
+++|+.|.++.|++++..+..+. .+++|+.|+|+ + |.+++. ++..+..+++|+.|+|++ .+++..+.
T Consensus 371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 55666666666666544444443 35666666666 3 344421 111244566677777765 55544444
Q ss_pred cccc-cccceEEECccccccCCCchhh-hhcccCCeeeccCccCCCcccc-cccccccccccccCCCcCC
Q 001253 553 EIFS-CKMLQRLDLSWNKFVGALPREI-GSLFQLELLKLSENELSGSIPV-QIGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 553 ~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~ 619 (1114)
.+.. +++|+.|+|++|.+++..+..+ ..+++|++|+|++|.+++.... .+..+++|+.|++++|+++
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 4444 6677777777777765544444 5567777777777777543332 3345677777777777764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-28 Score=303.01 Aligned_cols=170 Identities=16% Similarity=0.072 Sum_probs=82.1
Q ss_pred eeeccccccCCCCcccccccccccEEEecCCcccC---cccc------------ccccccccchhhcccccccCCchhhh
Q 001253 226 YLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSG---VIPK------------ELGNCTSLETLALYDNKQVGQLPKEL 290 (1114)
Q Consensus 226 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~---~~p~------------~l~~l~~L~~L~Ls~N~~~~~~p~~~ 290 (1114)
.++++..... .....+..+++|++|+++++.... ..|. ....+++|++|+|++|.+.+..+..+
T Consensus 47 ~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l 125 (594)
T 2p1m_B 47 KVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELI 125 (594)
T ss_dssp EEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHH
T ss_pred EEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHH
Confidence 4555444322 233445677889999998875321 1111 12345566666666666555555555
Q ss_pred c-CCCccceeeeccc-ccccc-cCccccccccccccccccccCCCCCchhhh----cccccceeeccccc--ccCc-ccc
Q 001253 291 G-SIGSLKYLYIYRN-ELNGT-IPREIGKLSSALEIDFSENSLIGEIPVELS----KILGLELLYLFENK--LTGV-IPV 360 (1114)
Q Consensus 291 ~-~l~~L~~L~L~~n-~l~~~-~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~----~l~~L~~L~L~~N~--l~~~-~~~ 360 (1114)
. .+++|++|+|++| .++.. ++..+..+++|++|++++|.+++..+..+. .+++|+.|++++|. ++.. .+.
T Consensus 126 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~ 205 (594)
T 2p1m_B 126 AKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALER 205 (594)
T ss_dssp HHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHH
T ss_pred HHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHH
Confidence 4 4566666666666 33321 233333555566666665555544333332 33355555555554 1100 011
Q ss_pred cccccccCCEEEcccc-cccccccCccccccceeeeec
Q 001253 361 ELTTLKNLTKLDLSIN-SLTGTIPLGFQYLTNLIMLQL 397 (1114)
Q Consensus 361 ~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L 397 (1114)
.+..+++|++|+|++| .+.+ ++..+..+++|++|++
T Consensus 206 l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l 242 (594)
T 2p1m_B 206 LVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGT 242 (594)
T ss_dssp HHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEEC
T ss_pred HHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEccc
Confidence 1122355555555555 2222 3444444445555543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=242.78 Aligned_cols=228 Identities=21% Similarity=0.174 Sum_probs=145.9
Q ss_pred ccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEec
Q 001253 439 SLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLS 518 (1114)
Q Consensus 439 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 518 (1114)
.+..+++..+.+.+. .....+++|+.|++++|.++. + ..+..+++|++|++++|++++. ..+..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC
Confidence 344445555555432 224455666666666666652 2 2356666666666666666642 356666667777777
Q ss_pred CceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcc
Q 001253 519 DNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSI 598 (1114)
Q Consensus 519 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 598 (1114)
+|++++..+..|.++++|++|+|++|++++..+..+..+++|+.|+|++|++++..+..++.+++|++|++++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP 173 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence 77666666666666666777777777666544445566667777777777766555555666677777777777777665
Q ss_pred cccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccc
Q 001253 599 PVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNL 678 (1114)
Q Consensus 599 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l 678 (1114)
+..++.+++|+.|++++|++++..|..+..+++|+ .|+|++|.+++..| +|++|+++.|+++|.+|.+++.+
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~l~~N~~~~~~~-------~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQ-YIWLHDNPWDCTCP-------GIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC-EEECCSSCBCCCTT-------TTHHHHHHHHHTGGGBBCTTSCB
T ss_pred HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCC-EEEccCCCccccCc-------HHHHHHHHHHhCCCcccCccccc
Confidence 55666677777777777777766666666677776 57777776665433 57777788888888888776655
Q ss_pred cc
Q 001253 679 SS 680 (1114)
Q Consensus 679 ~~ 680 (1114)
..
T Consensus 246 ~~ 247 (272)
T 3rfs_A 246 AP 247 (272)
T ss_dssp CG
T ss_pred CC
Confidence 43
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-25 Score=242.09 Aligned_cols=209 Identities=22% Similarity=0.246 Sum_probs=148.9
Q ss_pred ccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEE
Q 001253 436 RNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRL 515 (1114)
Q Consensus 436 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 515 (1114)
.+++|+.|++++|.++. + ..+..+++|++|++++|++++. ..+..+++|++|++++|++++..+..|.++++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 114 (272)
T 3rfs_A 39 ELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKEL 114 (272)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred cccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEE
Confidence 34555555555555552 2 2355666666666666666642 356677777777777777776666667777777777
Q ss_pred EecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCC
Q 001253 516 HLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELS 595 (1114)
Q Consensus 516 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 595 (1114)
+|++|++++..+..|+.+++|++|++++|++++..+..+..+++|+.|++++|++++..+..++.+++|++|++++|+++
T Consensus 115 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 115 VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 77777777666666777777777777777777555555667777888888888887666666777888888888888888
Q ss_pred CcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhh
Q 001253 596 GSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLIL 656 (1114)
Q Consensus 596 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~ 656 (1114)
+..|..+..+++|+.|++++|++.+..| .|+ .|+++.|+++|.+|..++.+..
T Consensus 195 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~-------~l~-~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 195 SVPDGVFDRLTSLQYIWLHDNPWDCTCP-------GIR-YLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCCTT-------TTH-HHHHHHHHTGGGBBCTTSCBCG
T ss_pred ccCHHHHhCCcCCCEEEccCCCccccCc-------HHH-HHHHHHHhCCCcccCcccccCC
Confidence 7777777888888888888888876544 455 5778888888888888877654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=238.38 Aligned_cols=206 Identities=24% Similarity=0.195 Sum_probs=135.2
Q ss_pred CccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEe
Q 001253 438 TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHL 517 (1114)
Q Consensus 438 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 517 (1114)
++|++|++++|++++..+..+..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 35666666666666555556666666777777777666655666677777777777777777666666777777777777
Q ss_pred cCceeccCCCccccCCCCcceeeccccccccc-ccccccccccceEEECccccccCCCchhhhhcccCC----eeeccCc
Q 001253 518 SDNYFTGELPREVGNLSNLVTFNVSSNFLTGR-IPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLE----LLKLSEN 592 (1114)
Q Consensus 518 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~~N 592 (1114)
++|++++..+..+..+++|++|++++|.+++. +|..+..+++|+.|+|++|++++..+..+..+.+|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 77777766665677777777777777777642 567777777777777877777766667777777766 6777777
Q ss_pred cCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccc
Q 001253 593 ELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSG 645 (1114)
Q Consensus 593 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~ 645 (1114)
.+++..+..+. ..+|+.|+|++|++++..+..+..+++|+ .|+|++|.+++
T Consensus 188 ~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~-~L~l~~N~~~c 238 (276)
T 2z62_A 188 PMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQ-KIWLHTNPWDC 238 (276)
T ss_dssp CCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCC-EEECCSSCBCC
T ss_pred cccccCccccC-CCcccEEECCCCceeecCHhHhccccccc-EEEccCCcccc
Confidence 77754444333 33566666666666644444445555554 45555555443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.3e-25 Score=242.20 Aligned_cols=207 Identities=27% Similarity=0.284 Sum_probs=145.4
Q ss_pred hccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceE
Q 001253 483 CKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQR 562 (1114)
Q Consensus 483 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 562 (1114)
.++++++++++++|+++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|.+++ ++.. ..+++|+.
T Consensus 7 ~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~ 81 (290)
T 1p9a_G 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGT 81 (290)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCE
T ss_pred cccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCE
Confidence 34455555555555555 3343332 456666666666665555666666666666666666663 3322 45666777
Q ss_pred EECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhccccc
Q 001253 563 LDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNN 642 (1114)
Q Consensus 563 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~ 642 (1114)
|+|++|+++ .+|..+..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+ .|+|++|+
T Consensus 82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~ 159 (290)
T 1p9a_G 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE-KLSLANNN 159 (290)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC-EEECTTSC
T ss_pred EECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCC-EEECCCCc
Confidence 777777776 5666667777777777777777766666777777777777777777766666677777777 67888888
Q ss_pred ccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCC
Q 001253 643 LSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPS 697 (1114)
Q Consensus 643 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~ 697 (1114)
|++..+..|..+++|+.|+|++|+|+ .+|..+....+|+.+++++|+|.|.+..
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~~ 213 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCcc
Confidence 88766667788888999999999998 6778888888999999999999987643
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=237.20 Aligned_cols=206 Identities=23% Similarity=0.249 Sum_probs=140.4
Q ss_pred ccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECcc
Q 001253 488 LSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSW 567 (1114)
Q Consensus 488 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 567 (1114)
.+++++++|+++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.++...+..+..+++|++|+|++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 445555555555 3343332 3455666666666554445556666666666666666532222334566666666666
Q ss_pred ccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccC
Q 001253 568 NKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLI 647 (1114)
Q Consensus 568 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~ 647 (1114)
|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+ .|+|++|++++..
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLK-ELRLYNNQLKRVP 173 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC-EEECCSSCCSCCC
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccc-eeEecCCcCcEeC
Confidence 666655555566666677777777777666666667777777777777777765555677777777 6777777777776
Q ss_pred CccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCC
Q 001253 648 PPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPS 697 (1114)
Q Consensus 648 p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~ 697 (1114)
+..|.++++|++|+|++|+|++..+..|..+++|+.|++++|+|.|.++.
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 223 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG 223 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence 77788888999999999999988888899999999999999999998873
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.4e-25 Score=262.02 Aligned_cols=188 Identities=19% Similarity=0.233 Sum_probs=149.6
Q ss_pred cCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChh-----hHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 812 DERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNN-----VDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 812 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
...++||+|+||+||+|+.. ++.+|+|+.......... ..+.+.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 44568999999999999554 789999987664433221 234578999999999999999776777778888999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++++|.++++. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+|+......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999984 568999999999999999 9999999999999999 99999999999865322
Q ss_pred CCc------cccccccccccCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCC
Q 001253 967 SKS------MSAIAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRAPVQ 1014 (1114)
Q Consensus 967 ~~~------~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~p~~ 1014 (1114)
... .....||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 111 235689999999999986 668888999999999888888877764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-25 Score=257.87 Aligned_cols=260 Identities=18% Similarity=0.204 Sum_probs=140.0
Q ss_pred eecccccccCcccccccccccCCEEEccccccccccc----Ccccccc-ceeeeeccCCcccCCCCCCCCcCccceEEEe
Q 001253 347 LYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIP----LGFQYLT-NLIMLQLFDNSLVGGIPQRLGAYSQLWVVDL 421 (1114)
Q Consensus 347 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 421 (1114)
+.+++|.+++.+|..+...++|++|||++|.+++..+ ..|..++ +|++|+|++|.+.+..+..+..+
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~-------- 74 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQI-------- 74 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHH--------
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHH--------
Confidence 4566666666666655555557777777777665544 4444444 45555555555544433333332
Q ss_pred ecccccCCCCccccc-cCccceeeeccCCccCCcCccccc----C-CcceEEeeccceeeccCCchhhc-----cccccE
Q 001253 422 SDNHLTGKIPRHICR-NTSLIFLNLETNKLTGSIPTGVTR----C-KSLVQLRLGGNSFTGSFPSDLCK-----LANLST 490 (1114)
Q Consensus 422 s~N~l~~~~~~~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~ 490 (1114)
+.. .++|++|+|++|++++..+..+.. + ++|++|+|++|++++..+..+.. .++|++
T Consensus 75 ------------l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~ 142 (362)
T 3goz_A 75 ------------LAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS 142 (362)
T ss_dssp ------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCE
T ss_pred ------------HhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeE
Confidence 000 044445555555544433332222 2 45555555555555444333332 135666
Q ss_pred eecccccCCCCcc----ccccccc-cCcEEEecCceeccCCCcccc----CC-CCcceeeccccccccc----ccccccc
Q 001253 491 VELDQNQFSGPIP----TEIGNCN-ALQRLHLSDNYFTGELPREVG----NL-SNLVTFNVSSNFLTGR----IPLEIFS 556 (1114)
Q Consensus 491 L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----~p~~~~~ 556 (1114)
|+|++|++++..+ ..+..++ +|++|+|++|+|++..+..+. .. ++|++|+|++|.+++. ++..+..
T Consensus 143 L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~ 222 (362)
T 3goz_A 143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS 222 (362)
T ss_dssp EECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred EEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence 6666666653322 2233333 666666666666655444333 23 4666666666666642 3444444
Q ss_pred -cccceEEECccccccCCCchh----hhhcccCCeeeccCccCCCc-------ccccccccccccccccCCCcCCCCCCh
Q 001253 557 -CKMLQRLDLSWNKFVGALPRE----IGSLFQLELLKLSENELSGS-------IPVQIGNLSRLTELQMGGNSFSGGIPA 624 (1114)
Q Consensus 557 -l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~ls~N~l~~~~p~ 624 (1114)
.++|+.|+|++|++++..+.. +..+++|++|+|++|.+.+. ++..+.++++|+.||+++|++.+..+.
T Consensus 223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~ 302 (362)
T 3goz_A 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI 302 (362)
T ss_dssp SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCH
T ss_pred CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchH
Confidence 346777777777776554433 34456777777777774432 233566777788888888887755444
Q ss_pred hh
Q 001253 625 EL 626 (1114)
Q Consensus 625 ~~ 626 (1114)
.+
T Consensus 303 ~~ 304 (362)
T 3goz_A 303 PI 304 (362)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-25 Score=255.88 Aligned_cols=225 Identities=20% Similarity=0.184 Sum_probs=129.7
Q ss_pred eeccCCcccCCCCCCCCcCccceEEEeecccccCCCC----ccccccC-ccceeeeccCCccCCcCcccccC-----Ccc
Q 001253 395 LQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIP----RHICRNT-SLIFLNLETNKLTGSIPTGVTRC-----KSL 464 (1114)
Q Consensus 395 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L 464 (1114)
+.++.|.+++.+|..+...++|++|||++|.+++..+ ..+..++ +|++|+|++|++++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4566677776666666555667777777777765555 5555565 67777777777666555555554 666
Q ss_pred eEEeeccceeeccCCchhhcc-----ccccEeecccccCCCCccccccc-----cccCcEEEecCceeccCCC----ccc
Q 001253 465 VQLRLGGNSFTGSFPSDLCKL-----ANLSTVELDQNQFSGPIPTEIGN-----CNALQRLHLSDNYFTGELP----REV 530 (1114)
Q Consensus 465 ~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~~p----~~~ 530 (1114)
++|+|++|++++..+..++.. ++|++|+|++|+|++..+..+.. .++|++|+|++|+|++..+ ..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 667776666665555544433 56666666666666554444332 2466666666666664322 223
Q ss_pred cCCC-Ccceeecccccccccccccccc----c-ccceEEECccccccCC----Cchhhhhc-ccCCeeeccCccCCCccc
Q 001253 531 GNLS-NLVTFNVSSNFLTGRIPLEIFS----C-KMLQRLDLSWNKFVGA----LPREIGSL-FQLELLKLSENELSGSIP 599 (1114)
Q Consensus 531 ~~l~-~L~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~L~~N~l~~~~p 599 (1114)
..++ +|++|+|++|++++..+..+.. + ++|+.|||++|.+++. ++..+..+ ++|++|+|++|.+++..+
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 242 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence 3343 6666666666666444433332 2 4666666666666542 33344442 356666666666664333
Q ss_pred ----ccccccccccccccCCCcCC
Q 001253 600 ----VQIGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 600 ----~~~~~l~~L~~L~ls~N~l~ 619 (1114)
..+..+++|+.|+|++|++.
T Consensus 243 ~~l~~~~~~l~~L~~L~L~~n~l~ 266 (362)
T 3goz_A 243 ENLKLLKDSLKHLQTVYLDYDIVK 266 (362)
T ss_dssp HHHHHTTTTTTTCSEEEEEHHHHT
T ss_pred HHHHHHHhcCCCccEEEeccCCcc
Confidence 22344556666666666644
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-23 Score=227.39 Aligned_cols=175 Identities=22% Similarity=0.155 Sum_probs=91.0
Q ss_pred eEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccc
Q 001253 417 WVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQN 496 (1114)
Q Consensus 417 ~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 496 (1114)
++|+|++|+|++..+..|..+++|++|+|++|+|++..+. ..+++|++|+|++|+++ .+|..+..+++|++|+|++|
T Consensus 34 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N 110 (290)
T 1p9a_G 34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN 110 (290)
T ss_dssp CEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSS
T ss_pred CEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCC
Confidence 3333333333333333344444444444444444422111 34445555555555554 44445555555555555555
Q ss_pred cCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCch
Q 001253 497 QFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPR 576 (1114)
Q Consensus 497 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 576 (1114)
+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+++ .+|.
T Consensus 111 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~ 189 (290)
T 1p9a_G 111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189 (290)
T ss_dssp CCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCT
T ss_pred cCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccCh
Confidence 555554555555556666666666665555555555566666666666665322223344566666666666665 4555
Q ss_pred hhhhcccCCeeeccCccCC
Q 001253 577 EIGSLFQLELLKLSENELS 595 (1114)
Q Consensus 577 ~~~~l~~L~~L~L~~N~l~ 595 (1114)
.+..+.+|+.|+|++|.+.
T Consensus 190 ~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 190 GFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp TTTTTCCCSEEECCSCCBC
T ss_pred hhcccccCCeEEeCCCCcc
Confidence 5555566666666666655
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-24 Score=239.00 Aligned_cols=226 Identities=18% Similarity=0.155 Sum_probs=117.3
Q ss_pred ccceeeeccCCccCCcCc---ccccCCcceEEeeccceeeccCCchh--hccccccEeecccccCCCCcc----cccccc
Q 001253 439 SLIFLNLETNKLTGSIPT---GVTRCKSLVQLRLGGNSFTGSFPSDL--CKLANLSTVELDQNQFSGPIP----TEIGNC 509 (1114)
Q Consensus 439 ~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l 509 (1114)
.++.|.+.++.++...-. .+..+++|++|++++|.+++..|..+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 455566665555421100 01123445555555555555555555 555555555555555554333 223345
Q ss_pred ccCcEEEecCceeccCCCccccCCCCcceeeccccccccc--ccccccccccceEEECccccccCCCchhhhhcccCCee
Q 001253 510 NALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGR--IPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELL 587 (1114)
Q Consensus 510 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 587 (1114)
++|++|+|++|+|++..+..|+.+++|++|+|++|++.+. ++. +..++.+++|++|
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----------------------~~~~~~l~~L~~L 202 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMA----------------------ALCPHKFPAIQNL 202 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHT----------------------TSCTTSSCCCCSC
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhH----------------------HHhhhcCCCCCEE
Confidence 5555555555555554445555555555555555554321 111 1112344445555
Q ss_pred eccCccCCCcccc----cccccccccccccCCCcCCCCCChhhcCc---chhhHHhhcccccccccCCccccchhhhHhh
Q 001253 588 KLSENELSGSIPV----QIGNLSRLTELQMGGNSFSGGIPAELGSL---SSLQIALNLSYNNLSGLIPPELGNLILLEYL 660 (1114)
Q Consensus 588 ~L~~N~l~~~~p~----~~~~l~~L~~L~ls~N~l~~~~p~~~~~l---~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L 660 (1114)
+|++|+++ .++. .++++++|++|||++|+|++.+|..+..+ ++|+ .|+|++|+|+ .+|..+. ++|+.|
T Consensus 203 ~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~-~L~Ls~N~l~-~lp~~~~--~~L~~L 277 (310)
T 4glp_A 203 ALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALN-SLNLSFAGLE-QVPKGLP--AKLRVL 277 (310)
T ss_dssp BCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCC-CEECCSSCCC-SCCSCCC--SCCSCE
T ss_pred ECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCC-EEECCCCCCC-chhhhhc--CCCCEE
Confidence 55555554 1221 13444555555555555555545444444 3555 4666666666 3455553 567778
Q ss_pred hccCcccccCCCCccccccccceEEeccCcccC
Q 001253 661 LLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTG 693 (1114)
Q Consensus 661 ~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g 693 (1114)
||++|+|++. |. +..+++|+.|++++|+++.
T Consensus 278 ~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 278 DLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp ECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred ECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 8888888764 32 5667788888888887764
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-25 Score=259.37 Aligned_cols=242 Identities=19% Similarity=0.230 Sum_probs=157.9
Q ss_pred cCcccccCCcceEEeeccceeeccCCc----hhhccccccEeecccc---cCCCCccccc-------cccccCcEEEecC
Q 001253 454 IPTGVTRCKSLVQLRLGGNSFTGSFPS----DLCKLANLSTVELDQN---QFSGPIPTEI-------GNCNALQRLHLSD 519 (1114)
Q Consensus 454 ~p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~Ls~ 519 (1114)
++..+..+++|++|+|++|++.+..+. .+..+++|++|+|++| ++++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 334444555555555555555543222 2445555566655553 3333344333 4566666666666
Q ss_pred ceecc----CCCccccCCCCcceeeccccccccccccccc----cc---------ccceEEECcccccc-CCCc---hhh
Q 001253 520 NYFTG----ELPREVGNLSNLVTFNVSSNFLTGRIPLEIF----SC---------KMLQRLDLSWNKFV-GALP---REI 578 (1114)
Q Consensus 520 N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l---------~~L~~L~Ls~N~l~-~~~p---~~~ 578 (1114)
|+|++ .+|..+..+++|++|+|++|.+++..+..+. .+ ++|+.|+|++|+++ +.+| ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 66665 3555666666666666666666533332222 23 67777777777776 3344 356
Q ss_pred hhcccCCeeeccCccCC--C---cccccccccccccccccCCCcCC----CCCChhhcCcchhhHHhhccccccccc---
Q 001253 579 GSLFQLELLKLSENELS--G---SIPVQIGNLSRLTELQMGGNSFS----GGIPAELGSLSSLQIALNLSYNNLSGL--- 646 (1114)
Q Consensus 579 ~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~ls~N~l~----~~~p~~~~~l~~L~~~L~Ls~N~l~~~--- 646 (1114)
..+++|++|+|++|+++ | ..|..+..+++|+.|+|++|.|+ +.+|..+..+++|+ .|+|++|++++.
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~-~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR-ELGLNDCLLSARGAA 262 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC-EEECTTCCCCHHHHH
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcC-EEECCCCCCchhhHH
Confidence 66777777777777776 2 34446677777888888888775 56677777777777 688888887765
Q ss_pred -CCccc--cchhhhHhhhccCccccc----CCCCcc-ccccccceEEeccCcccCCCC
Q 001253 647 -IPPEL--GNLILLEYLLLNNNHLSG----EIPGSF-VNLSSLLGCNFSYNNLTGPIP 696 (1114)
Q Consensus 647 -~p~~~--~~l~~L~~L~Ls~N~l~g----~ip~~~-~~l~~l~~l~ls~N~l~g~ip 696 (1114)
+|..+ +.+++|++|+|++|+|++ .+|..+ .++++|+.|++++|++++..|
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 45555 347889999999999998 588877 668999999999999988665
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=8.2e-24 Score=236.89 Aligned_cols=203 Identities=19% Similarity=0.181 Sum_probs=150.8
Q ss_pred ccceEEEeecccccCCCCc---cccccCccceeeeccCCccCCcCccc--ccCCcceEEeeccceeeccCC----chhhc
Q 001253 414 SQLWVVDLSDNHLTGKIPR---HICRNTSLIFLNLETNKLTGSIPTGV--TRCKSLVQLRLGGNSFTGSFP----SDLCK 484 (1114)
Q Consensus 414 ~~L~~L~Ls~N~l~~~~~~---~~~~~~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~ 484 (1114)
..++.+.+.++.++...-. .+...++|++|++++|++++..|..+ ..+++|++|+|++|++++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 3577888888877532111 12334679999999999999999988 899999999999999997655 44567
Q ss_pred cccccEeecccccCCCCccccccccccCcEEEecCceeccC--C--CccccCCCCcceeeccccccccccccc----ccc
Q 001253 485 LANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGE--L--PREVGNLSNLVTFNVSSNFLTGRIPLE----IFS 556 (1114)
Q Consensus 485 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~ 556 (1114)
+++|++|+|++|++++..|..|+.+++|++|||++|++.+. + +..+..+++|++|+|++|+++ .++.. +..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 99999999999999998899999999999999999998652 2 233478889999999999987 33331 345
Q ss_pred cccceEEECccccccCCCchhhhhc---ccCCeeeccCccCCCcccccccccccccccccCCCcCCC
Q 001253 557 CKMLQRLDLSWNKFVGALPREIGSL---FQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSG 620 (1114)
Q Consensus 557 l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 620 (1114)
+++|+.|||++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNR 286 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCC
Confidence 6777777777777776666666555 46666666666666 4455443 456666666666553
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-24 Score=243.46 Aligned_cols=250 Identities=20% Similarity=0.216 Sum_probs=162.3
Q ss_pred ceEEEeecccccCCCCcccccc--CccceeeeccCCccCCcCcccccCCcceEEeeccceeecc-CCchhhccccccEee
Q 001253 416 LWVVDLSDNHLTGKIPRHICRN--TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGS-FPSDLCKLANLSTVE 492 (1114)
Q Consensus 416 L~~L~Ls~N~l~~~~~~~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ 492 (1114)
++.+++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|++++|.+++. +|..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 345666666554 3444444 6677777777777755444 44677777777777777655 666777777777777
Q ss_pred cccccCCCCccccccccccCcEEEecCc-eeccC-CCccccCCCCcceeecccc-ccccc-ccccccccc-cceEEECcc
Q 001253 493 LDQNQFSGPIPTEIGNCNALQRLHLSDN-YFTGE-LPREVGNLSNLVTFNVSSN-FLTGR-IPLEIFSCK-MLQRLDLSW 567 (1114)
Q Consensus 493 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~-~L~~L~Ls~ 567 (1114)
|++|++++..|..+..+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|+.|+|++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 7777777667777777777777777777 56642 5555667777777777777 77643 455566677 777777777
Q ss_pred c--ccc-CCCchhhhhcccCCeeeccCcc-CCCcccccccccccccccccCCCcCCCCCCh---hhcCcchhhHHhhccc
Q 001253 568 N--KFV-GALPREIGSLFQLELLKLSENE-LSGSIPVQIGNLSRLTELQMGGNSFSGGIPA---ELGSLSSLQIALNLSY 640 (1114)
Q Consensus 568 N--~l~-~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~---~~~~l~~L~~~L~Ls~ 640 (1114)
| .++ +.+|..+..+++|++|++++|. +++..+..+.++++|+.|++++|. +..|. .+.++++|+ .|++++
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l~~~~~L~-~L~l~~ 281 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPETLLELGEIPTLK-TLQVFG 281 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGGGGGGGGGCTTCC-EEECTT
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHHHHHHHhcCCCCC-EEeccC
Confidence 7 444 3456666777777777777777 666666677777777777777775 22232 355555665 466665
Q ss_pred ccccccCCccccchh-hhHhhhccCcccccCCCCccc
Q 001253 641 NNLSGLIPPELGNLI-LLEYLLLNNNHLSGEIPGSFV 676 (1114)
Q Consensus 641 N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~ 676 (1114)
| ++ ...+..+. .|+.|++++|+++|..|..++
T Consensus 282 ~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 282 I-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp S-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred c-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence 5 22 22334442 356666666666666665544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7e-23 Score=221.71 Aligned_cols=191 Identities=22% Similarity=0.260 Sum_probs=133.4
Q ss_pred CCCccceEEEecCCCccEEEEEeecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccc
Q 001253 62 TPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141 (1114)
Q Consensus 62 ~~C~w~gv~C~~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 141 (1114)
+||.|.|++|... ...+++++++++. +|+.+. ++++.|+|++|++++..+..|+.+++|++|+|++|.+++.
T Consensus 3 ~Cp~~~gC~C~~~-----~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 74 (251)
T 3m19_A 3 TCETVTGCTCNEG-----KKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL 74 (251)
T ss_dssp -CHHHHSSEEEGG-----GTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCC
T ss_pred cCCCCCceEcCCC-----CeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCcc
Confidence 3789999999642 1246777777763 454444 5778888888888777777788888888888888888877
Q ss_pred cccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccceeccccccccccCCCCCCC
Q 001253 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGC 221 (1114)
Q Consensus 142 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l 221 (1114)
.|..|.++++|++|+|++|++++..+..|..+++|++|++++|++++..+..|.++++|++|++++|.+++..+..|.++
T Consensus 75 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 154 (251)
T 3m19_A 75 SAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKL 154 (251)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcC
Confidence 77777888888888888888876666666777777777777777775555556666666666666666665555566666
Q ss_pred CccceeeccccccCCCCcccccccccccEEEecCCcccC
Q 001253 222 ESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSG 260 (1114)
Q Consensus 222 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 260 (1114)
++|++|+|++|++++..+..+..+++|+.|+|++|.+++
T Consensus 155 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred cCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 666666666666665555556666666666666666654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-24 Score=252.16 Aligned_cols=244 Identities=17% Similarity=0.216 Sum_probs=140.3
Q ss_pred ccccccccccCCEEEccccccccccc----CccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCcc
Q 001253 358 IPVELTTLKNLTKLDLSINSLTGTIP----LGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRH 433 (1114)
Q Consensus 358 ~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 433 (1114)
++..+..+++|++|+|++|.+++..+ ..+..+++|++|+|++|.+. ++++.+|..
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~---------------------~l~~~~~~~ 82 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG---------------------RVKDEIPEA 82 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTT---------------------SCGGGSHHH
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccC---------------------ccccchhHH
Confidence 44556667778888888887775433 23445555555555554322 222222222
Q ss_pred -------ccccCccceeeeccCCccC----CcCcccccCCcceEEeeccceeeccCCchhh----cc---------cccc
Q 001253 434 -------ICRNTSLIFLNLETNKLTG----SIPTGVTRCKSLVQLRLGGNSFTGSFPSDLC----KL---------ANLS 489 (1114)
Q Consensus 434 -------~~~~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~ 489 (1114)
+..+++|++|+|++|++++ .+|..+..+++|++|+|++|.+++..+..+. .+ ++|+
T Consensus 83 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~ 162 (386)
T 2ca6_A 83 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR 162 (386)
T ss_dssp HHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred HHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCc
Confidence 2445566666666666654 2455556666666666666666543333333 22 6677
Q ss_pred EeecccccCC-CCcc---ccccccccCcEEEecCceec--c---CCCccccCCCCcceeeccccccc----ccccccccc
Q 001253 490 TVELDQNQFS-GPIP---TEIGNCNALQRLHLSDNYFT--G---ELPREVGNLSNLVTFNVSSNFLT----GRIPLEIFS 556 (1114)
Q Consensus 490 ~L~L~~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~ 556 (1114)
+|+|++|+++ +.+| ..+..+++|++|+|++|+|+ | ..|..+..+++|+.|+|++|.++ +.+|..+..
T Consensus 163 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~ 242 (386)
T 2ca6_A 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242 (386)
T ss_dssp EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred EEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHcc
Confidence 7777777765 3333 34556667777777777665 2 23335666666667777666664 455656666
Q ss_pred cccceEEECccccccCC----Cchhhhh--cccCCeeeccCccCCC----cccccc-cccccccccccCCCcCCCCC
Q 001253 557 CKMLQRLDLSWNKFVGA----LPREIGS--LFQLELLKLSENELSG----SIPVQI-GNLSRLTELQMGGNSFSGGI 622 (1114)
Q Consensus 557 l~~L~~L~Ls~N~l~~~----~p~~~~~--l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~ls~N~l~~~~ 622 (1114)
+++|+.|+|++|++++. +|..+.. +++|++|+|++|.+++ .+|..+ .++++|+.|++++|++++..
T Consensus 243 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred CCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 66666666666666644 3444422 5666666666666665 355554 44566666666666665443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.3e-24 Score=240.56 Aligned_cols=221 Identities=21% Similarity=0.270 Sum_probs=115.8
Q ss_pred CCEEEcccccccccccCccccc--cceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCC-CCccccccCccceee
Q 001253 368 LTKLDLSINSLTGTIPLGFQYL--TNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGK-IPRHICRNTSLIFLN 444 (1114)
Q Consensus 368 L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~~~~L~~L~ 444 (1114)
++.+|+++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. ++..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 555666665554 2333444 4555555555555544443 23456666666666666543 455555556666666
Q ss_pred eccCCccCCcCcccccCCcceEEeeccc-eeec-cCCchhhccccccEeecccc-cCCCC-ccccccccc-cCcEEEecC
Q 001253 445 LETNKLTGSIPTGVTRCKSLVQLRLGGN-SFTG-SFPSDLCKLANLSTVELDQN-QFSGP-IPTEIGNCN-ALQRLHLSD 519 (1114)
Q Consensus 445 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~Ls~ 519 (1114)
+++|.+++..+..+..+++|++|++++| .+++ .++..+..+++|++|++++| .+++. ++..+..++ +|++|+|++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 6666665555555555666666666666 4543 24444555566666666666 55532 344455555 566666665
Q ss_pred c--eec-cCCCccccCCCCcceeeccccc-ccccccccccccccceEEECcccc-ccCCCchhhhhcccCCeeeccCc
Q 001253 520 N--YFT-GELPREVGNLSNLVTFNVSSNF-LTGRIPLEIFSCKMLQRLDLSWNK-FVGALPREIGSLFQLELLKLSEN 592 (1114)
Q Consensus 520 N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N 592 (1114)
| .++ +.+|..+..+++|+.|++++|. +++..+..+..+++|+.|++++|. ++......+..+++|+.|++++|
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 5 233 2334444455555555555555 444444455555555555555553 11111113444455555555554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-22 Score=215.99 Aligned_cols=196 Identities=17% Similarity=0.200 Sum_probs=130.5
Q ss_pred cceEEEeecccccCCCCccccccCccceeeeccCC-ccCCcCcccccCCcceEEeecc-ceeeccCCchhhccccccEee
Q 001253 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNK-LTGSIPTGVTRCKSLVQLRLGG-NSFTGSFPSDLCKLANLSTVE 492 (1114)
Q Consensus 415 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ 492 (1114)
+|++|+|++|++++..+..|..+++|++|++++|+ +++..+..|..+++|++|++++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 56666666666665555566666666666666665 6544445666667777777776 667655556666777777777
Q ss_pred cccccCCCCccccccccccCc---EEEecCc-eeccCCCccccCCCCcc-eeecccccccccccccccccccceEEECcc
Q 001253 493 LDQNQFSGPIPTEIGNCNALQ---RLHLSDN-YFTGELPREVGNLSNLV-TFNVSSNFLTGRIPLEIFSCKMLQRLDLSW 567 (1114)
Q Consensus 493 L~~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 567 (1114)
+++|++++ +|. |..+++|+ +|++++| ++++..+..|.++++|+ .|++++|+++ .+|...+..++|+.|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence 77777764 454 66666666 7777777 77766666677777777 7777777777 5665555556777777777
Q ss_pred cc-ccCCCchhhhhc-ccCCeeeccCccCCCcccccccccccccccccCCC
Q 001253 568 NK-FVGALPREIGSL-FQLELLKLSENELSGSIPVQIGNLSRLTELQMGGN 616 (1114)
Q Consensus 568 N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 616 (1114)
|+ +++..+..|..+ ++|++|++++|++++ +|.. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence 74 765556667777 777777777777773 3332 4556666666654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=226.26 Aligned_cols=192 Identities=24% Similarity=0.325 Sum_probs=89.8
Q ss_pred ccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEE
Q 001253 436 RNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRL 515 (1114)
Q Consensus 436 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 515 (1114)
.+++|++|++++|.++. ++ .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++. + .+..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L 112 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTL 112 (308)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEE
T ss_pred HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEE
Confidence 34555555555555553 22 34555555555555555553222 55555555555555555432 2 34455555555
Q ss_pred EecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCC
Q 001253 516 HLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELS 595 (1114)
Q Consensus 516 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 595 (1114)
+|++|++++. + .+..+++|++|++++|++++. +. +..+++|+.|+|++|++++. +. +..+++|+.|++++|+++
T Consensus 113 ~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 113 DLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp ECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccC
Confidence 5555555432 2 144555555555555555422 21 44445555555555554432 21 444444555555555444
Q ss_pred CcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhccccccc
Q 001253 596 GSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLS 644 (1114)
Q Consensus 596 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~ 644 (1114)
+..+ +..+++|+.|+|++|++++..| +..+++|+ .|+|++|.++
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~-~L~l~~N~i~ 230 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLF-IVTLTNQTIT 230 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCC-EEEEEEEEEE
T ss_pred cChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCC-EEEccCCeee
Confidence 3222 4444444444444444443221 34444443 3444444443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.8e-22 Score=215.13 Aligned_cols=180 Identities=20% Similarity=0.220 Sum_probs=132.5
Q ss_pred ccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEec
Q 001253 439 SLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLS 518 (1114)
Q Consensus 439 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 518 (1114)
..+.++++++.++ .+|..+. ++++.|+|++|++++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4556666666666 4555443 467777777777776666677777777777777777777777777777777777777
Q ss_pred CceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcc
Q 001253 519 DNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSI 598 (1114)
Q Consensus 519 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 598 (1114)
+|+|++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..+..|+.+++|++|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 77777766677777777888888888777544445567778888888888887666667777888888888888888766
Q ss_pred cccccccccccccccCCCcCCCC
Q 001253 599 PVQIGNLSRLTELQMGGNSFSGG 621 (1114)
Q Consensus 599 p~~~~~l~~L~~L~ls~N~l~~~ 621 (1114)
+..+..+++|+.|+|++|++.+.
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHHhCCCCCCEEEeeCCceeCC
Confidence 66777888888888888888754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.5e-22 Score=213.73 Aligned_cols=178 Identities=21% Similarity=0.167 Sum_probs=82.1
Q ss_pred cCCEEEcccccccccccCccccccceeeeeccCCc-ccCCCCCCCCcCccceEEEeec-ccccCCCCccccccCccceee
Q 001253 367 NLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNS-LVGGIPQRLGAYSQLWVVDLSD-NHLTGKIPRHICRNTSLIFLN 444 (1114)
Q Consensus 367 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~~~L~~L~ 444 (1114)
+|++|++++|++++..+..|..+++|++|++++|+ +....+..|..+++|++|+|++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45555555555554444445455555555555553 4433344444555555555554 555544444444455555555
Q ss_pred eccCCccCCcCcccccCCcce---EEeeccc-eeeccCCchhhcccccc-EeecccccCCCCccccccccccCcEEEecC
Q 001253 445 LETNKLTGSIPTGVTRCKSLV---QLRLGGN-SFTGSFPSDLCKLANLS-TVELDQNQFSGPIPTEIGNCNALQRLHLSD 519 (1114)
Q Consensus 445 Ls~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 519 (1114)
+++|++++ +|. +..+++|+ +|++++| ++++..+..|..+++|+ +|++++|+++ .+|......++|+.|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence 55555543 333 44444444 5555555 44443334444444444 4444444444 2222211124444444444
Q ss_pred ce-eccCCCccccCC-CCcceeeccccccc
Q 001253 520 NY-FTGELPREVGNL-SNLVTFNVSSNFLT 547 (1114)
Q Consensus 520 N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~ 547 (1114)
|+ +++..+..|.++ ++|+.|++++|+++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 42 443333444444 44444444444444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=224.48 Aligned_cols=209 Identities=25% Similarity=0.368 Sum_probs=115.8
Q ss_pred eeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCce
Q 001253 442 FLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNY 521 (1114)
Q Consensus 442 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 521 (1114)
.+.+..+.+++.+ ....+++|++|++++|.++. +| .+..+++|++|+|++|++++..+ +..+++|++|+|++|+
T Consensus 23 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~ 96 (308)
T 1h6u_A 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (308)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc
Confidence 3344555554322 23455666666666666653 33 45666666666666666664333 5666666666666666
Q ss_pred eccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCccccc
Q 001253 522 FTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQ 601 (1114)
Q Consensus 522 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 601 (1114)
+++. + .+..+++|++|++++|++++ ++. +..+++|+.|++++|++++..+ ++.+++|++|++++|++++..+
T Consensus 97 l~~~-~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-- 168 (308)
T 1h6u_A 97 LKNV-S-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-- 168 (308)
T ss_dssp CSCC-G-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred CCCc-h-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--
Confidence 6532 2 45555666666666666553 222 4555555555555555553322 4455555555555555553222
Q ss_pred ccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCcccccccc
Q 001253 602 IGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSL 681 (1114)
Q Consensus 602 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l 681 (1114)
+..+++|+.|++++| ++++..+ +..+++|++|+|++|++++..| +..+++|
T Consensus 169 l~~l~~L~~L~l~~n-------------------------~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L 219 (308)
T 1h6u_A 169 LANLSKLTTLKADDN-------------------------KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219 (308)
T ss_dssp GTTCTTCCEEECCSS-------------------------CCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTC
T ss_pred hcCCCCCCEEECCCC-------------------------ccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCC
Confidence 444445555555554 4444322 5556666677777777765543 6667777
Q ss_pred ceEEeccCcccC
Q 001253 682 LGCNFSYNNLTG 693 (1114)
Q Consensus 682 ~~l~ls~N~l~g 693 (1114)
+.|++++|++++
T Consensus 220 ~~L~l~~N~i~~ 231 (308)
T 1h6u_A 220 FIVTLTNQTITN 231 (308)
T ss_dssp CEEEEEEEEEEC
T ss_pred CEEEccCCeeec
Confidence 777777777765
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-21 Score=223.36 Aligned_cols=224 Identities=18% Similarity=0.149 Sum_probs=106.8
Q ss_pred cceEEeeccceeeccCCchhhccccccEeecccccCCCCcc-ccccccccCcE-EEecCceeccCCCccccCCCCcceee
Q 001253 463 SLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIP-TEIGNCNALQR-LHLSDNYFTGELPREVGNLSNLVTFN 540 (1114)
Q Consensus 463 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~ 540 (1114)
++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|++ ++++.|+|+...|..|.++++|++|+
T Consensus 31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~ 110 (350)
T 4ay9_X 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 110 (350)
T ss_dssp TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEE
T ss_pred CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccc
Confidence 34444444444443333344444444444444444433222 23444444332 33344444444444444455555555
Q ss_pred cccccccccccccccccccceEEECcc-ccccCCCchhhhhcc-cCCeeeccCccCCCcccccccccccccccccCC-Cc
Q 001253 541 VSSNFLTGRIPLEIFSCKMLQRLDLSW-NKFVGALPREIGSLF-QLELLKLSENELSGSIPVQIGNLSRLTELQMGG-NS 617 (1114)
Q Consensus 541 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~-N~ 617 (1114)
+++|++++..+..+....++..|++++ |++....+..|..+. .++.|+|++|+|+ .+|.......+|++|++++ |.
T Consensus 111 l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~ 189 (350)
T 4ay9_X 111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNN 189 (350)
T ss_dssp EEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTT
T ss_pred ccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCc
Confidence 555554433333333444444455433 334333333344332 3555555555555 2333333344555666553 33
Q ss_pred CCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCccc
Q 001253 618 FSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692 (1114)
Q Consensus 618 l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~ 692 (1114)
++...+..|..+++|+ .|+||+|+|+...+..|.+|++|+.+++ ++++ .+| .+.++++|+.++++++.-+
T Consensus 190 l~~i~~~~f~~l~~L~-~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~~~c 259 (350)
T 4ay9_X 190 LEELPNDVFHGASGPV-ILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYPSHC 259 (350)
T ss_dssp CCCCCTTTTTTEECCS-EEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCHHHH
T ss_pred ccCCCHHHhccCcccc-hhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCCccc
Confidence 3322223455666665 5666666666554445555555555544 3344 455 3677888888888765443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=8.9e-22 Score=215.88 Aligned_cols=163 Identities=16% Similarity=0.065 Sum_probs=126.2
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCCh---------------hhHHHHHHHHHHHhcCCCCce
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNN---------------NVDNSFRAEILTLGKIRHRNI 870 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~ni 870 (1114)
.....|++.+.||+|+||.||+|++.+|+.||+|+++....... .....+.+|+.++++++ |
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence 34455777799999999999999998899999999965432111 12456889999999999 4
Q ss_pred eeEEeEEEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCC
Q 001253 871 VKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFE 950 (1114)
Q Consensus 871 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 950 (1114)
+++.+++.. +..|+||||++||+|.+ +.. .....++.|+++||+|||+. +|+||||||+|||++ ++.
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTE
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCc
Confidence 666665543 56799999999999998 531 22446999999999999998 999999999999999 999
Q ss_pred eEEeeccCceecCCCCCCccccccccccccCcccccc----------CCCCcccchHH
Q 001253 951 AHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT----------MKVTEKCDIYS 998 (1114)
Q Consensus 951 ~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~----------~~~~~~~Dvws 998 (1114)
+||+|||+|+.. ..|+|||++.. ..+...+|+|.
T Consensus 231 vkl~DFG~a~~~--------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 231 IWIIDFPQSVEV--------------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEECCCTTCEET--------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEEEECCCCeEC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999999742 34788997643 34455556654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.5e-21 Score=218.35 Aligned_cols=238 Identities=16% Similarity=0.138 Sum_probs=128.8
Q ss_pred ccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCCEEEccccccccccc-Cccccccceee-eeccC
Q 001253 322 EIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIP-LGFQYLTNLIM-LQLFD 399 (1114)
Q Consensus 322 ~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~-L~L~~ 399 (1114)
.++.++++++ .+|..+ .++++.|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| ..|.+++++.+ +.+..
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 3555555555 444443 2356677777777776656667777777777777777654443 45666666544 44555
Q ss_pred CcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeecc-CCccCCcCcccccCC-cceEEeeccceeecc
Q 001253 400 NSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLET-NKLTGSIPTGVTRCK-SLVQLRLGGNSFTGS 477 (1114)
Q Consensus 400 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~-N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~ 477 (1114)
|++....|..|..+++|++|++++|+++...+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~- 168 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE- 168 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-
T ss_pred CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-
Confidence 666666666666666666666666666655555555555666666643 445533334444443 45566666666653
Q ss_pred CCchhhccccccEeeccc-ccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccc
Q 001253 478 FPSDLCKLANLSTVELDQ-NQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFS 556 (1114)
Q Consensus 478 ~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 556 (1114)
+|.......+|++|++++ |.++.+.++.|.++++|++|||++|+|+...+..|.++++|+.+++ +.++ .+| .+.+
T Consensus 169 i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~ 244 (350)
T 4ay9_X 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEK 244 (350)
T ss_dssp ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTT
T ss_pred CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-Cchh
Confidence 333333344556666543 4444333344556666666666666665433333433333333322 1222 333 2444
Q ss_pred cccceEEECcc
Q 001253 557 CKMLQRLDLSW 567 (1114)
Q Consensus 557 l~~L~~L~Ls~ 567 (1114)
+++|+.+++++
T Consensus 245 l~~L~~l~l~~ 255 (350)
T 4ay9_X 245 LVALMEASLTY 255 (350)
T ss_dssp CCSCCEEECSC
T ss_pred CcChhhCcCCC
Confidence 45555555543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=3e-21 Score=202.42 Aligned_cols=185 Identities=25% Similarity=0.288 Sum_probs=120.8
Q ss_pred CCccceEEEecCCCccEEEEEeecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCccccc
Q 001253 63 PCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHI 142 (1114)
Q Consensus 63 ~C~w~gv~C~~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 142 (1114)
.|.|.+|.|+.... . .+|..+ .++|++|+|++|++++..+..++.+++|++|+|++|.+++..
T Consensus 6 ~C~~~~v~c~~~~l--------------~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 68 (208)
T 2o6s_A 6 SCSGTTVECYSQGR--------------T-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLP 68 (208)
T ss_dssp EEETTEEECCSSCC--------------S-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred EECCCEEEecCCCc--------------c-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccC
Confidence 48999999975321 1 123322 347888888888888666666788888888888888888666
Q ss_pred ccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccceeccccccccccCCCCCCCC
Q 001253 143 PKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCE 222 (1114)
Q Consensus 143 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~ 222 (1114)
+..|..+++|++|+|++|++++..+..|.++++|++|++++|+++ +..+..+..++
T Consensus 69 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~------------------------~~~~~~~~~l~ 124 (208)
T 2o6s_A 69 NGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ------------------------SLPDGVFDKLT 124 (208)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC------------------------CCCTTTTTTCT
T ss_pred hhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCc------------------------ccCHhHhccCC
Confidence 666778888888888888777544444555555555555555554 33344455555
Q ss_pred ccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhhcccccccCCchhhhcCCCc
Q 001253 223 SLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGS 295 (1114)
Q Consensus 223 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~ 295 (1114)
+|++|+|++|++++..+..+..+++|++|++++|.+.+ .+++|+.|+++.|.+.+.+|.+++.++.
T Consensus 125 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 125 QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred cCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 66666666666664444445666666666666665543 2346777777777777777777666554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=6.7e-22 Score=236.45 Aligned_cols=210 Identities=25% Similarity=0.374 Sum_probs=128.4
Q ss_pred CCCCCCCCCCCCC-----ccceE-EEecCCCccEEEEEeecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCC
Q 001253 52 YLGNWNPNDSTPC-----GWIGV-NCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNC 125 (1114)
Q Consensus 52 ~~~~W~~~~~~~C-----~w~gv-~C~~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l 125 (1114)
.+.+|..+ .++| .|.|+ .|... .++.|+|+++++++ +|+.+. ++|++|+|++|+|+ .+| ..+
T Consensus 32 ~l~~W~~~-~~~~~~~~~~~~~l~~C~~~----~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l 99 (571)
T 3cvr_A 32 AWDKWEKQ-ALPGENRNEAVSLLKECLIN----QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELP 99 (571)
T ss_dssp HHHHHHTT-CCTTCCHHHHHHHHHHHHHT----TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCC
T ss_pred HHHHHhcc-CCccccccchhhhccccccC----CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---ccc
Confidence 34567553 4467 79999 78642 36677888888776 666553 67788888888776 566 446
Q ss_pred CCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccceec
Q 001253 126 SSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRA 205 (1114)
Q Consensus 126 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l 205 (1114)
++|++|+|++|.|++ +|. |.+ +|++|+|++|+|++ +|. .+++|+.|++++|++++ +|. .+
T Consensus 100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l-------- 159 (571)
T 3cvr_A 100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LP-------- 159 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CC--------
T ss_pred CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cC--------
Confidence 777777777777776 565 554 77777777777764 444 45556666666665553 333 23
Q ss_pred cccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCcccccccccccc-------chhhcc
Q 001253 206 GQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSL-------ETLALY 278 (1114)
Q Consensus 206 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-------~~L~Ls 278 (1114)
++|++|+|++|++++ +|. |. ++|+.|+|++|+|+ .+|. +.. +| +.|+|+
T Consensus 160 ----------------~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls 215 (571)
T 3cvr_A 160 ----------------TSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCR 215 (571)
T ss_dssp ----------------TTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECC
T ss_pred ----------------CCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecC
Confidence 445555555555543 343 33 45555555555555 3333 332 44 666666
Q ss_pred cccccCCchhhhcCCCccceeeecccccccccCccccccc
Q 001253 279 DNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLS 318 (1114)
Q Consensus 279 ~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 318 (1114)
+|.+. .+|..+..+++|++|+|++|.+++.+|..+..+.
T Consensus 216 ~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp SSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred CCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 66655 3555566667777777777777766666665544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=6.7e-21 Score=199.75 Aligned_cols=133 Identities=20% Similarity=0.183 Sum_probs=55.5
Q ss_pred cccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECc
Q 001253 487 NLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLS 566 (1114)
Q Consensus 487 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 566 (1114)
+|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 33444444444443333334444444444444444443333333444444444444444442222223334444444444
Q ss_pred cccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCC
Q 001253 567 WNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 567 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 619 (1114)
+|++++..+..+..+++|++|++++|++++..+..+..+++|+.|++++|++.
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 44444333333444444444444444444333333444444444444444443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.7e-21 Score=230.04 Aligned_cols=167 Identities=26% Similarity=0.363 Sum_probs=86.8
Q ss_pred ccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEec
Q 001253 439 SLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLS 518 (1114)
Q Consensus 439 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 518 (1114)
+|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.. +|++|+|++|+|++ +|. .+++|+.|+|+
T Consensus 81 ~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 148 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINAD 148 (571)
T ss_dssp TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCC
Confidence 3444444444444 233 223445555555555543 333 332 55555555555554 333 34555555555
Q ss_pred CceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccC-------CeeeccC
Q 001253 519 DNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQL-------ELLKLSE 591 (1114)
Q Consensus 519 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~L~~ 591 (1114)
+|+|++ +|. .+++|+.|+|++|+|++ +|. +. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++
T Consensus 149 ~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~ 216 (571)
T 3cvr_A 149 NNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRE 216 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCS
T ss_pred CCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCC
Confidence 555553 333 34555555555555553 444 33 55566666666555 4444 332 44 6666666
Q ss_pred ccCCCcccccccccccccccccCCCcCCCCCChhhcCcc
Q 001253 592 NELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLS 630 (1114)
Q Consensus 592 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 630 (1114)
|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+.
T Consensus 217 N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp SCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred Ccce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 6666 4566666666666666666666666666655543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.3e-21 Score=204.76 Aligned_cols=179 Identities=21% Similarity=0.207 Sum_probs=126.3
Q ss_pred eeecccccccccccccccccccceEEECccccccCCCc-hhhhhcccCCeeeccCccCCCcccccccccccccccccCCC
Q 001253 538 TFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALP-REIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGN 616 (1114)
Q Consensus 538 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 616 (1114)
.+++++|.++ .+|..+. ..++.|+|++|++++..| ..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4444444444 3443332 234556666666654433 34566667777777777777666666777777777777777
Q ss_pred cCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCC
Q 001253 617 SFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIP 696 (1114)
Q Consensus 617 ~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip 696 (1114)
+|++..|..|..+++|+ .|+|++|+|++..|..|..+++|++|+|++|+|++.+|..|..+++|+.|++++|+|+|.++
T Consensus 92 ~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLK-TLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCC-EEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCC-EEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 77776677777777777 68888888888888888889999999999999999999999999999999999999999998
Q ss_pred CcccccccccccccCCCCCCCCCC
Q 001253 697 SSQTFQNMSVNSFSGSKGLCGGPL 720 (1114)
Q Consensus 697 ~~~~~~~~~~~~~~~n~~lc~~p~ 720 (1114)
..+...++...........|+.|.
T Consensus 171 l~~l~~~~~~~~~~~~~~~C~~P~ 194 (220)
T 2v70_A 171 LAWLGEWLRKKRIVTGNPRCQKPY 194 (220)
T ss_dssp GHHHHHHHHHSCCBCCCCEEEESG
T ss_pred hHHHHHHHHhcCccccCCccCCCh
Confidence 766555554333322334676654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=6.4e-21 Score=201.39 Aligned_cols=179 Identities=22% Similarity=0.248 Sum_probs=121.3
Q ss_pred eeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCc
Q 001253 538 TFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNS 617 (1114)
Q Consensus 538 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 617 (1114)
.+++++|.++ .+|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3444444444 3443332 355555666666555445556666666666666666665556666666666777777777
Q ss_pred CCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCC
Q 001253 618 FSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPS 697 (1114)
Q Consensus 618 l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~ 697 (1114)
|++..+..|..+++|+ .|+|++|+|++..|..|..+++|++|+|++|+|++..++.|..+++|+.|++++|+|.|.++.
T Consensus 92 l~~l~~~~f~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l 170 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQ-LLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL 170 (220)
T ss_dssp CCCCCTTTTTTCTTCC-EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred CCccCHhHccCCCCCC-EEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence 7655555566677776 677777777777778888888899999999999988888899999999999999999998876
Q ss_pred cccccccccccccCCCCCCCCCC
Q 001253 698 SQTFQNMSVNSFSGSKGLCGGPL 720 (1114)
Q Consensus 698 ~~~~~~~~~~~~~~n~~lc~~p~ 720 (1114)
.+...++...........|..|.
T Consensus 171 ~~l~~~l~~~~~~~~~~~C~~P~ 193 (220)
T 2v9t_B 171 KWLADYLHTNPIETSGARCTSPR 193 (220)
T ss_dssp HHHHHHHHHCCCBCSCCBEEESG
T ss_pred HHHHHHHHhCCCCccCCCcCCch
Confidence 55444444434444445676654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.6e-21 Score=239.13 Aligned_cols=240 Identities=21% Similarity=0.230 Sum_probs=107.6
Q ss_pred CCCcchHHHHHHhHhhcc-CCCCCCCCCCCCCCCCCccceEEEecCCCccEEEEEeecCCCcCcccCCCCCCCCccCEEE
Q 001253 30 GLVNIEGQILLLIKSKLV-DNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALD 108 (1114)
Q Consensus 30 ~~~~~~~~~ll~~k~~~~-~~~~~~~~W~~~~~~~C~w~gv~C~~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~ 108 (1114)
+....++++|+++..... +....-++|.......+.|.+++++. .+++.++|.++++.+. +. ..++.++
T Consensus 128 s~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~----~~~~~l~L~~n~~~~~-~~-----~~l~~l~ 197 (727)
T 4b8c_D 128 SLVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST----PLTPKIELFANGKDEA-NQ-----ALLQHKK 197 (727)
T ss_dssp ----CCCHHHHHHHHHHHHHHTTC--------------------------------------------------------
T ss_pred hccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC----CccceEEeeCCCCCcc-hh-----hHhhcCc
Confidence 455678999999998864 23344567865555567999998865 3577888888777662 22 2345556
Q ss_pred ecCCcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhcccccCC
Q 001253 109 LSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISG 188 (1114)
Q Consensus 109 Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~ 188 (1114)
|+.|.|.+ ++++.|.+. ..|..|..+++|++|+|++|++. .+|..+.++++|++|+|++|.|+
T Consensus 198 Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~- 260 (727)
T 4b8c_D 198 LSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT- 260 (727)
T ss_dssp ---------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-
T ss_pred cCcccccC--------------cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-
Confidence 66655542 233444444 34555666666666666666665 55555556666666666666666
Q ss_pred CCCCCccccccccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCcccccccc
Q 001253 189 SLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGN 268 (1114)
Q Consensus 189 ~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 268 (1114)
.+|..|++|++|++|+|++|.|+ .+|..|++|++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+..
T Consensus 261 ~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 261 ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTE 338 (727)
T ss_dssp CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHH
T ss_pred ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhh
Confidence 56666666667777777777766 56777777777777777777776 66777777777777777777777777776665
Q ss_pred ccc-cchhhcccccccCCchhhhcCCCccceeeeccc
Q 001253 269 CTS-LETLALYDNKQVGQLPKELGSIGSLKYLYIYRN 304 (1114)
Q Consensus 269 l~~-L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n 304 (1114)
+.. +..|+|++|.+.+.+|. .|+.|++++|
T Consensus 339 ~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n 369 (727)
T 4b8c_D 339 KSVTGLIFYLRDNRPEIPLPH------ERRFIEINTD 369 (727)
T ss_dssp HHHHHHHHHHHHCCCCCCCCC------C---------
T ss_pred cchhhhHHhhccCcccCcCcc------ccceeEeecc
Confidence 432 23467777777776664 3455556555
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-20 Score=235.19 Aligned_cols=192 Identities=24% Similarity=0.293 Sum_probs=124.7
Q ss_pred ecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECcccccc
Q 001253 492 ELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFV 571 (1114)
Q Consensus 492 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 571 (1114)
+++.|++. ..|..+..++.|+.|+|++|.|. .+|..+.++++|++|+|++|.|+ .+|..+..+++|+.|+|++|+|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 45556665 66777888888888888888887 66767778889999999999998 88888888999999999999998
Q ss_pred CCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccc
Q 001253 572 GALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPEL 651 (1114)
Q Consensus 572 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~ 651 (1114)
.+|..|+.+++|++|+|++|.|+ .+|..|+++++|+.|+|++|+|++.+|..+..+......++|++|.++|.+|..
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~- 360 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE- 360 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc-
Confidence 77999999999999999999997 778889999999999999999999999988876655546899999999998875
Q ss_pred cchhhhHhhhccCc--------ccccCCCCccccccccceEEeccCcccCC
Q 001253 652 GNLILLEYLLLNNN--------HLSGEIPGSFVNLSSLLGCNFSYNNLTGP 694 (1114)
Q Consensus 652 ~~l~~L~~L~Ls~N--------~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ 694 (1114)
|+.|++++| .|++.++..+.++..+....+++|-+++.
T Consensus 361 -----l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~ 406 (727)
T 4b8c_D 361 -----RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQH 406 (727)
T ss_dssp ----------------------------------------------CCCGG
T ss_pred -----cceeEeecccccccccCCccccccchhhcccccceeeeeccccccc
Confidence 556777777 56666666667777777788888877653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.9e-22 Score=238.49 Aligned_cols=202 Identities=21% Similarity=0.179 Sum_probs=143.5
Q ss_pred CCcceEEeeccceeeccCCchhhccccccEeeccccc-------------CCCCccccccccccCcEEE-ecCceeccCC
Q 001253 461 CKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQ-------------FSGPIPTEIGNCNALQRLH-LSDNYFTGEL 526 (1114)
Q Consensus 461 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~~~~ 526 (1114)
+++|+.|+|++|+++ .+|..++.+++|++|++++|. +.+.+|..++++++|+.|+ ++.|.+.
T Consensus 348 ~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~--- 423 (567)
T 1dce_A 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD--- 423 (567)
T ss_dssp TTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH---
T ss_pred CccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc---
Confidence 444444445554444 444455555555555544443 4556777788888888888 6777653
Q ss_pred CccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccc
Q 001253 527 PREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLS 606 (1114)
Q Consensus 527 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 606 (1114)
+|..+.+++|.++. +|. ..|+.|+|++|+|++ +|. ++.+++|+.|+|++|+|+ .+|..+++++
T Consensus 424 --------~L~~l~l~~n~i~~-l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 486 (567)
T 1dce_A 424 --------DLRSKFLLENSVLK-MEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALR 486 (567)
T ss_dssp --------HHHHHHHHHHHHHH-HHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred --------hhhhhhhhcccccc-cCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCC
Confidence 46677777887773 332 247888888888885 565 888888888888888888 7788888888
Q ss_pred cccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccC-CccccchhhhHhhhccCcccccCCCCc---cccccccc
Q 001253 607 RLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLI-PPELGNLILLEYLLLNNNHLSGEIPGS---FVNLSSLL 682 (1114)
Q Consensus 607 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~ip~~---~~~l~~l~ 682 (1114)
+|+.|+|++|+|++ +| .++.+++|+ .|+|++|+|++.+ |..++.+++|+.|+|++|+|++.+|.. +..+++|+
T Consensus 487 ~L~~L~Ls~N~l~~-lp-~l~~l~~L~-~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~ 563 (567)
T 1dce_A 487 CLEVLQASDNALEN-VD-GVANLPRLQ-ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 563 (567)
T ss_dssp TCCEEECCSSCCCC-CG-GGTTCSSCC-EEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCS
T ss_pred CCCEEECCCCCCCC-Cc-ccCCCCCCc-EEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccC
Confidence 88888888888886 56 788888887 6888888888877 888888888888888888888776543 23367777
Q ss_pred eEEe
Q 001253 683 GCNF 686 (1114)
Q Consensus 683 ~l~l 686 (1114)
.||+
T Consensus 564 ~L~l 567 (567)
T 1dce_A 564 SILT 567 (567)
T ss_dssp EEEC
T ss_pred ccCC
Confidence 7764
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-19 Score=219.99 Aligned_cols=170 Identities=22% Similarity=0.302 Sum_probs=83.6
Q ss_pred CccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEe
Q 001253 438 TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHL 517 (1114)
Q Consensus 438 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 517 (1114)
++|+.|++++|.+.. ++ .+..+++|+.|+|++|++++..| +..+++|+.|+|++|+|++ +| .+..+++|+.|+|
T Consensus 43 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~L 116 (605)
T 1m9s_A 43 NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSL 116 (605)
T ss_dssp TTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEe
Confidence 344444444444442 22 24444444444444444443222 4445555555555555542 12 3455555555555
Q ss_pred cCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCc
Q 001253 518 SDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGS 597 (1114)
Q Consensus 518 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 597 (1114)
++|+|++. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++..| +..+++|+.|+|++|+|++.
T Consensus 117 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 117 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp TTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred cCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC
Confidence 55555432 2345555555555555555532 344455555555555555554433 55555555555555555532
Q ss_pred ccccccccccccccccCCCcCCCC
Q 001253 598 IPVQIGNLSRLTELQMGGNSFSGG 621 (1114)
Q Consensus 598 ~p~~~~~l~~L~~L~ls~N~l~~~ 621 (1114)
..+..+++|+.|+|++|++++.
T Consensus 191 --~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 191 --RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp --GGGTTCTTCSEEECCSEEEECC
T ss_pred --hHHccCCCCCEEEccCCcCcCC
Confidence 2355555566666666655543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=8.8e-19 Score=186.26 Aligned_cols=157 Identities=25% Similarity=0.318 Sum_probs=105.5
Q ss_pred CCCccceEEEecCCCccEEEEEeecCCCcCcccCCCCCCCCccCEEEecCCcccCCCCcccCCCCCCCEEEccCCCcccc
Q 001253 62 TPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141 (1114)
Q Consensus 62 ~~C~w~gv~C~~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 141 (1114)
+.|+|.+|.|+.... +.+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|.++..
T Consensus 17 ~~Cs~~~v~c~~~~l---------------~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i 79 (229)
T 3e6j_A 17 CSCSGTTVDCRSKRH---------------ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL 79 (229)
T ss_dssp CEEETTEEECTTSCC---------------SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CEEeCCEeEccCCCc---------------CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCc
Confidence 369999999965321 13344333 6788888888888887788888888888888888888766
Q ss_pred cccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccceeccccccccccCCCCCCC
Q 001253 142 IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGC 221 (1114)
Q Consensus 142 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l 221 (1114)
.+..|..+++|++|+|++|+|++..+..|..+++|++|++++|+++ .+|.. +..+
T Consensus 80 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~------------------------~~~l 134 (229)
T 3e6j_A 80 PVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRG------------------------IERL 134 (229)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTT------------------------GGGC
T ss_pred ChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcc------------------------cccC
Confidence 6666788888888888888887555555566666666666666555 44444 4445
Q ss_pred CccceeeccccccCCCCcccccccccccEEEecCCcccC
Q 001253 222 ESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSG 260 (1114)
Q Consensus 222 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 260 (1114)
++|++|+|++|++++..+..+..+++|+.|+|++|.+.+
T Consensus 135 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 135 THLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 555555555555554444445555555566666665553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.3e-19 Score=196.94 Aligned_cols=149 Identities=28% Similarity=0.307 Sum_probs=68.0
Q ss_pred cccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcE
Q 001253 435 CRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQR 514 (1114)
Q Consensus 435 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 514 (1114)
..+++|++|++++|++++..+ +..+++|++|++++|++++ + ..+..+++|++|++++|++++. ..+..+++|+.
T Consensus 65 ~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~ 138 (291)
T 1h6t_A 65 QYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLES 138 (291)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-G-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCE
T ss_pred hcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-C-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCE
Confidence 333444444444444443222 4444444444444444442 1 1244444455555555544432 23444555555
Q ss_pred EEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccC
Q 001253 515 LHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENEL 594 (1114)
Q Consensus 515 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 594 (1114)
|+|++|++++. ..+..+++|+.|++++|++++..+ +..+++|+.|+|++|++++ +| .+..+++|+.|++++|++
T Consensus 139 L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i 212 (291)
T 1h6t_A 139 LYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQEC 212 (291)
T ss_dssp EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEE
T ss_pred EEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcc
Confidence 55555555432 344445555555555555543222 4445555555555555543 22 245555555555555555
Q ss_pred C
Q 001253 595 S 595 (1114)
Q Consensus 595 ~ 595 (1114)
+
T Consensus 213 ~ 213 (291)
T 1h6t_A 213 L 213 (291)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=7.6e-19 Score=212.60 Aligned_cols=190 Identities=23% Similarity=0.272 Sum_probs=106.9
Q ss_pred cccccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeecc
Q 001253 319 SALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLF 398 (1114)
Q Consensus 319 ~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 398 (1114)
.+..+.++.+.+.+..+ +..+.+|+.|++++|.+.... .+..+++|+.|+|++|+|++..+ +..+++|+.|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 34444555554443322 345556666666666665432 35666666667776666665444 5666666666666
Q ss_pred CCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccC
Q 001253 399 DNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSF 478 (1114)
Q Consensus 399 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 478 (1114)
+|.+.+. ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+|++..
T Consensus 96 ~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~ 169 (605)
T 1m9s_A 96 ENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 169 (605)
T ss_dssp SSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCG
T ss_pred CCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCch
Confidence 6666542 2455666666666666666542 2355556666666666666543 34555556666666666555443
Q ss_pred CchhhccccccEeecccccCCCCccccccccccCcEEEecCceecc
Q 001253 479 PSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTG 524 (1114)
Q Consensus 479 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 524 (1114)
| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.+++
T Consensus 170 ~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 170 P--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp G--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred h--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 3 55555566666666655532 235555556666666665554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=5.4e-19 Score=195.27 Aligned_cols=171 Identities=27% Similarity=0.355 Sum_probs=87.3
Q ss_pred cccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccce
Q 001253 363 TTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIF 442 (1114)
Q Consensus 363 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 442 (1114)
..+++|+.|++++|.+++. + .+..+++|++|++++|++.+..+ +..+++|++|+|++|++++. ..+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCE
Confidence 3455566666666655532 2 24555555555555555554333 45555555555555555531 12455555555
Q ss_pred eeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCcee
Q 001253 443 LNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYF 522 (1114)
Q Consensus 443 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 522 (1114)
|++++|++++. ..+..+++|+.|++++|++++. ..+..+++|++|++++|++++..| +..+++|+.|+|++|+|
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 55555555532 2344555555555555555532 345555555555555555554333 55555555555555555
Q ss_pred ccCCCccccCCCCcceeeccccccc
Q 001253 523 TGELPREVGNLSNLVTFNVSSNFLT 547 (1114)
Q Consensus 523 ~~~~p~~~~~l~~L~~L~Ls~N~l~ 547 (1114)
++ ++ .+..+++|+.|++++|+++
T Consensus 191 ~~-l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 191 SD-LR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp CB-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred CC-Ch-hhccCCCCCEEECcCCccc
Confidence 53 22 2445555555555555544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=7.1e-19 Score=200.98 Aligned_cols=156 Identities=22% Similarity=0.135 Sum_probs=75.7
Q ss_pred ceEEeeccceeeccCCchhh-ccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecc
Q 001253 464 LVQLRLGGNSFTGSFPSDLC-KLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVS 542 (1114)
Q Consensus 464 L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 542 (1114)
++.|+|++|+|++..+..+. .+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 120 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence 44555555555544444444 45555555555555554444445555555555555555554444445555555555555
Q ss_pred cccccccccccccccccceEEECccccccCCCchhh---hhcccCCeeeccCccCCCccccccccccc--ccccccCCCc
Q 001253 543 SNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREI---GSLFQLELLKLSENELSGSIPVQIGNLSR--LTELQMGGNS 617 (1114)
Q Consensus 543 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~ls~N~ 617 (1114)
+|+|++..|..+..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++..+..+..++. ++.|+|++|+
T Consensus 121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~ 200 (361)
T 2xot_A 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP 200 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence 555554444444455555555555555553222222 33445555555555555333334444443 2455555555
Q ss_pred CC
Q 001253 618 FS 619 (1114)
Q Consensus 618 l~ 619 (1114)
+.
T Consensus 201 ~~ 202 (361)
T 2xot_A 201 LE 202 (361)
T ss_dssp EE
T ss_pred cc
Confidence 54
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=5.4e-19 Score=187.92 Aligned_cols=154 Identities=27% Similarity=0.257 Sum_probs=103.6
Q ss_pred eeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCc
Q 001253 538 TFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNS 617 (1114)
Q Consensus 538 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 617 (1114)
.++.++++++ .+|..+. ++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 23 ~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 23 TVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 3444444444 3443332 455555666666655555556666666666666666654444455666666666666666
Q ss_pred CCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCC
Q 001253 618 FSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIP 696 (1114)
Q Consensus 618 l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip 696 (1114)
|++..+..|..+++|+ .|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|++++|++.|.++
T Consensus 100 l~~l~~~~~~~l~~L~-~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLK-ELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCCCCTTTTTTCTTCC-EEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCccChhHhCcchhhC-eEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 6655555566666666 5777777776 457777788888889999999988877888889999999999999998887
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-18 Score=198.19 Aligned_cols=176 Identities=22% Similarity=0.225 Sum_probs=142.7
Q ss_pred eEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccc-cCCcceEEeeccceeeccCCchhhccccccEeeccc
Q 001253 417 WVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVT-RCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQ 495 (1114)
Q Consensus 417 ~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 495 (1114)
+.+++++|.++ .+|..+. +.++.|+|++|+|++..+..+. .+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 46777777776 3454443 3577888888888876666676 888888888888888877778888888999999999
Q ss_pred ccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccc----cccccceEEECcccccc
Q 001253 496 NQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEI----FSCKMLQRLDLSWNKFV 571 (1114)
Q Consensus 496 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~ 571 (1114)
|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|+ .+|..+ ..+++|+.|+|++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 9998777778888999999999999998888888999999999999999998 455554 46899999999999999
Q ss_pred CCCchhhhhccc--CCeeeccCccCCC
Q 001253 572 GALPREIGSLFQ--LELLKLSENELSG 596 (1114)
Q Consensus 572 ~~~p~~~~~l~~--L~~L~L~~N~l~~ 596 (1114)
+..+..+..++. |+.|+|++|.+..
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred ccCHHHhhhccHhhcceEEecCCCccC
Confidence 766678888887 4899999999873
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.7e-18 Score=181.19 Aligned_cols=114 Identities=20% Similarity=0.195 Sum_probs=50.9
Q ss_pred cccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCe
Q 001253 507 GNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLEL 586 (1114)
Q Consensus 507 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 586 (1114)
..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|++++..|..|..+++|++
T Consensus 54 ~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 133 (220)
T 2v70_A 54 KKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRL 133 (220)
T ss_dssp GGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSE
T ss_pred ccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCE
Confidence 33333333344434333333333444444444444444444333333334444444444444444444444444444555
Q ss_pred eeccCccCCCcccccccccccccccccCCCcCCC
Q 001253 587 LKLSENELSGSIPVQIGNLSRLTELQMGGNSFSG 620 (1114)
Q Consensus 587 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 620 (1114)
|+|++|++++..|..|..+++|+.|+|++|++.+
T Consensus 134 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 134 LSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp EECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred EECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 5555555554444455555555555555555544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=4.2e-19 Score=183.13 Aligned_cols=158 Identities=26% Similarity=0.348 Sum_probs=116.4
Q ss_pred eEEECccccccCCCchhhhhcccCCeeeccCccCCCcccc-cccccccccccccCCCcCCCCCChhhcCcchhhHHhhcc
Q 001253 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPV-QIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLS 639 (1114)
Q Consensus 561 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls 639 (1114)
+.+++++|.++ .+|..+.. +|++|++++|++++..+. .|+.+++|++|+|++|+|++.+|..|..+++|+ .|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ-ELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCC-EEECC
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCC-EEECC
Confidence 45666666664 44544432 666666666666654443 366777777777777777777777777777777 67788
Q ss_pred cccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCCcccccccccccccCCCCCCCCC
Q 001253 640 YNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGP 719 (1114)
Q Consensus 640 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lc~~p 719 (1114)
+|+|++..|..|+++++|++|+|++|+|++.+|..|..+++|+.|++++|+|+|.+|..+...++....+.++...|+.|
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 88888877778888888999999999999998999999999999999999999988876555555555566667778877
Q ss_pred CCC
Q 001253 720 LQN 722 (1114)
Q Consensus 720 ~~~ 722 (1114)
...
T Consensus 167 ~~l 169 (192)
T 1w8a_A 167 SKV 169 (192)
T ss_dssp TTT
T ss_pred hHH
Confidence 543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-18 Score=180.91 Aligned_cols=132 Identities=23% Similarity=0.238 Sum_probs=64.9
Q ss_pred ccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECcc
Q 001253 488 LSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSW 567 (1114)
Q Consensus 488 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 567 (1114)
|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..+..+++|+.|+|++
T Consensus 34 l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 113 (220)
T 2v9t_B 34 ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNA 113 (220)
T ss_dssp CCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCC
Confidence 34444444444433333444444444444444444444444444444444444444444422222233445555555555
Q ss_pred ccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCC
Q 001253 568 NKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 568 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 619 (1114)
|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 114 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 114 NKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 5555444555555555555555555555554555555666666666666654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.2e-20 Score=223.45 Aligned_cols=217 Identities=18% Similarity=0.108 Sum_probs=128.8
Q ss_pred CCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhcccccCCCCCCCccccccccc
Q 001253 123 GNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKS 202 (1114)
Q Consensus 123 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n~i~~~~p~~l~~l~~L~~ 202 (1114)
..+++|+.|+|++|.++ .+|..+++|++|+.|++++|.....+| . .+..+++.+.+|..++++++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~----------~-ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTII----------L-LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHH----------H-HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHH----------H-HHHhcccccCCHHHHHHHHhccc
Confidence 55677777777777776 567777777777777776654110000 0 01111234455556666666666
Q ss_pred ee-ccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhhccccc
Q 001253 203 FR-AGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNK 281 (1114)
Q Consensus 203 L~-l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 281 (1114)
|+ ++.|.+ .+|+.+.+++|.++. +|. ..|+.|+|++|+|++ +|. ++++++|+.|+|++|.
T Consensus 414 L~~l~~n~~-----------~~L~~l~l~~n~i~~-l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 414 VDPMRAAYL-----------DDLRSKFLLENSVLK-MEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp HCGGGHHHH-----------HHHHHHHHHHHHHHH-HHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred Ccchhhccc-----------chhhhhhhhcccccc-cCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence 66 454443 245555556665552 221 135666666666664 344 6666666666666666
Q ss_pred ccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCC-chhhhcccccceeecccccccCcccc
Q 001253 282 QVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEI-PVELSKILGLELLYLFENKLTGVIPV 360 (1114)
Q Consensus 282 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~~~ 360 (1114)
+. .+|..|+.+++|++|+|++|+|++ +| .++.+++|++|++++|++++.. |..+..+++|+.|+|++|.+++.++.
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 55 556666666666666666666664 45 6666666777777777666665 66677777777777777777765442
Q ss_pred ---cccccccCCEEEc
Q 001253 361 ---ELTTLKNLTKLDL 373 (1114)
Q Consensus 361 ---~~~~l~~L~~L~L 373 (1114)
.+..+++|+.|++
T Consensus 552 ~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 552 QERLAEMLPSVSSILT 567 (567)
T ss_dssp TTHHHHHCTTCSEEEC
T ss_pred HHHHHHHCcccCccCC
Confidence 2334677777764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=9.5e-19 Score=190.10 Aligned_cols=169 Identities=20% Similarity=0.261 Sum_probs=99.0
Q ss_pred CccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEe
Q 001253 438 TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHL 517 (1114)
Q Consensus 438 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 517 (1114)
.++..+++++|.+++. + .+..+++|++|++++|+++ .+| .+..+++|++|+|++|+|++..+ +..+++|+.|+|
T Consensus 19 ~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 3455555666665532 2 3555666666666666665 333 45566666666666666664433 666666666666
Q ss_pred cCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCc
Q 001253 518 SDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGS 597 (1114)
Q Consensus 518 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 597 (1114)
++|+|++ +|.. .. ++|+.|+|++|++++ ++ .+..+++|+.|+|++|++++. + .+..+++|++|+|++|++++.
T Consensus 93 ~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 93 NRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 6666664 2222 22 566666666666663 22 455666666666666666643 2 466666666666666666644
Q ss_pred ccccccccccccccccCCCcCCCC
Q 001253 598 IPVQIGNLSRLTELQMGGNSFSGG 621 (1114)
Q Consensus 598 ~p~~~~~l~~L~~L~ls~N~l~~~ 621 (1114)
..+..+++|+.|++++|++++.
T Consensus 166 --~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 --GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp --TTSTTCCCCCEEEEEEEEEECC
T ss_pred --HHhccCCCCCEEeCCCCcccCC
Confidence 4556666666666666666544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=8.4e-18 Score=174.29 Aligned_cols=154 Identities=16% Similarity=0.236 Sum_probs=88.2
Q ss_pred ccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcce
Q 001253 459 TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVT 538 (1114)
Q Consensus 459 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 538 (1114)
..+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..+..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44555555555555555 334 4555556666666666544 1234556666666666666666555566666666666
Q ss_pred eecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcC
Q 001253 539 FNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSF 618 (1114)
Q Consensus 539 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 618 (1114)
|++++|++++..|..+..+++|+.|+|++|++.+.+| .+..+++|++|++++|++++ ++ .+..+++|+.|++++|++
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC--
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCccc
Confidence 6666666665555556666666666666665222344 46666666666666666663 23 555666666666666665
Q ss_pred C
Q 001253 619 S 619 (1114)
Q Consensus 619 ~ 619 (1114)
.
T Consensus 194 ~ 194 (197)
T 4ezg_A 194 G 194 (197)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=5e-18 Score=184.41 Aligned_cols=169 Identities=19% Similarity=0.245 Sum_probs=95.7
Q ss_pred cccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEe
Q 001253 342 LGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDL 421 (1114)
Q Consensus 342 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 421 (1114)
.++..+++++|.+++.. .+..+++|++|++++|.++. ++ .+..+++|++|++++|++.+..+ +..+++|++|+|
T Consensus 19 ~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 34445555555555332 34555666666666666653 23 45555556666666655554433 555666666666
Q ss_pred ecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCC
Q 001253 422 SDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGP 501 (1114)
Q Consensus 422 s~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 501 (1114)
++|++++. |... . ++|++|++++|++++. ..+..+++|++|+|++|++++. + .+..+++|++|+|++|++++.
T Consensus 93 ~~N~l~~l-~~~~-~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 93 NRNRLKNL-NGIP-S-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CSSCCSCC-TTCC-C-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCCccCCc-Cccc-c-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 66666542 2211 1 5666666666666642 2356666666666666666643 2 456666666666666666644
Q ss_pred ccccccccccCcEEEecCceeccC
Q 001253 502 IPTEIGNCNALQRLHLSDNYFTGE 525 (1114)
Q Consensus 502 ~p~~~~~l~~L~~L~Ls~N~l~~~ 525 (1114)
..+..+++|+.|++++|.+++.
T Consensus 166 --~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 --GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp --TTSTTCCCCCEEEEEEEEEECC
T ss_pred --HHhccCCCCCEEeCCCCcccCC
Confidence 4556666666666666666643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.6e-18 Score=186.13 Aligned_cols=139 Identities=22% Similarity=0.197 Sum_probs=107.8
Q ss_pred CcCCceecccCCeEEEEEEe-CCCcE--EEEEEecccCCCC---------------------hhhHHHHHHHHHHHhcCC
Q 001253 811 FDERFVIGRGACGTVYRAVL-RTGHT--VAVKKLASNREGN---------------------NNVDNSFRAEILTLGKIR 866 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~ 866 (1114)
|++.+.||+|+||.||+|.+ .+|+. ||||+++...... ......+.+|+..+++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66788999999999999998 67889 9999976542110 011235788999999998
Q ss_pred CCce--eeEEeEEEecCceEEEEecCCC-C----CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCC
Q 001253 867 HRNI--VKLYGFCYHQGSNLLMYEYMAR-G----SLGELLHGASSTLDWQTRFMIALGAAEGLSYLH-HDCKPRIFHRDI 938 (1114)
Q Consensus 867 h~ni--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dl 938 (1114)
|+++ +.++++ +..++||||+.+ | +|.++... .++..+..++.|++.|++||| +. +|+||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA---ELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence 8754 334432 367899999942 4 77776542 234567789999999999999 87 9999999
Q ss_pred CCCCeEECCCCCeEEeeccCceec
Q 001253 939 KSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 939 k~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
||+|||+++ .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999864
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.4e-17 Score=170.87 Aligned_cols=150 Identities=15% Similarity=0.240 Sum_probs=87.0
Q ss_pred CccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEe
Q 001253 438 TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHL 517 (1114)
Q Consensus 438 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 517 (1114)
++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..+..+++|++|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 34444444444444 233 3445555555555555443 2234555666666666666666555566666666666666
Q ss_pred cCceeccCCCccccCCCCcceeeccccc-ccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCC
Q 001253 518 SDNYFTGELPREVGNLSNLVTFNVSSNF-LTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELS 595 (1114)
Q Consensus 518 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 595 (1114)
++|++++..|..+..+++|++|++++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|++|++++|++.
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 6666665556666666666666666666 44 444 46666777777777777764 33 5667777777777777765
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-16 Score=164.61 Aligned_cols=132 Identities=28% Similarity=0.343 Sum_probs=79.1
Q ss_pred cEeecccccCCCCccccccccccCcEEEecCceeccCCCc-cccCCCCcceeecccccccccccccccccccceEEECcc
Q 001253 489 STVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPR-EVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSW 567 (1114)
Q Consensus 489 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 567 (1114)
+.+++++|+++ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..+..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 44555555554 34443322 555666666666544433 355566666666666666655555566666666666666
Q ss_pred ccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCC
Q 001253 568 NKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIP 623 (1114)
Q Consensus 568 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 623 (1114)
|+|++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 66665555556666666666666666666666666677777777777777765543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.7e-17 Score=170.90 Aligned_cols=157 Identities=24% Similarity=0.269 Sum_probs=108.6
Q ss_pred eEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhccc
Q 001253 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSY 640 (1114)
Q Consensus 561 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~ 640 (1114)
+.+++++|.++ .+|..+. ++|++|+|++|+++ .+|..|.++++|+.|+|++|+|++..|..|..++.|+ .|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~-~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL-TLILSY 87 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCC-EEECCS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCC-EEECCC
Confidence 34555555555 3444332 35666666666665 4556666666667777777777666666677777776 577777
Q ss_pred ccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCCcccccccccccccCCCCCCCCCC
Q 001253 641 NNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPL 720 (1114)
Q Consensus 641 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lc~~p~ 720 (1114)
|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|++++|+|.|.+...+-..++...........|..|.
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~~~~~~~~~~~~C~~P~ 167 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVKSEYKEPGIARCAGPG 167 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHHHHSSCCCSCCBEEESG
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHHHhccCCCCCcCcCCch
Confidence 77777777788888899999999999998878889999999999999999999887654444443332333445777665
Q ss_pred CC
Q 001253 721 QN 722 (1114)
Q Consensus 721 ~~ 722 (1114)
..
T Consensus 168 ~l 169 (193)
T 2wfh_A 168 EM 169 (193)
T ss_dssp GG
T ss_pred HH
Confidence 43
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.7e-17 Score=183.45 Aligned_cols=290 Identities=15% Similarity=0.103 Sum_probs=127.6
Q ss_pred ccccchhhcccccccCCchhhhcC-CCccceeeecccccc--cccCccccccccccccccccccCCCCCchhhhc-----
Q 001253 269 CTSLETLALYDNKQVGQLPKELGS-IGSLKYLYIYRNELN--GTIPREIGKLSSALEIDFSENSLIGEIPVELSK----- 340 (1114)
Q Consensus 269 l~~L~~L~Ls~N~~~~~~p~~~~~-l~~L~~L~L~~n~l~--~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~----- 340 (1114)
+.++++|.++++ +....-..+.. +++|+.|+|++|++. ...+..+ +.+..+.+..|.+ .+..|..
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhccccccc
Confidence 567777777765 22222223333 677888888888776 1111111 1122233333321 1233444
Q ss_pred ---ccccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccce
Q 001253 341 ---ILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLW 417 (1114)
Q Consensus 341 ---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 417 (1114)
+++|+.++|.+ .++.+.+.+|..+++|+.|++++|.+....+..|.++.++..+.+..+...
T Consensus 97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~-------------- 161 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAY-------------- 161 (329)
T ss_dssp EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHH--------------
T ss_pred ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhh--------------
Confidence 55555555555 555555555555555555555555555444555555444444444332110
Q ss_pred EEEeecccccCCCCccccccCccc-eeeeccCC-ccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeeccc
Q 001253 418 VVDLSDNHLTGKIPRHICRNTSLI-FLNLETNK-LTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQ 495 (1114)
Q Consensus 418 ~L~Ls~N~l~~~~~~~~~~~~~L~-~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 495 (1114)
..........|.++..|+ .+.+.... +...+...-....++..+.+.++-...........+++|+.|+|++
T Consensus 162 ------~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~ 235 (329)
T 3sb4_A 162 ------RFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISK 235 (329)
T ss_dssp ------HTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTT
T ss_pred ------hccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCC
Confidence 000111112222222332 22222110 0000000001123344444443321111111111245555555555
Q ss_pred ccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcc-eeecccccccccccccccccccceEEECccccccCCC
Q 001253 496 NQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLV-TFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGAL 574 (1114)
Q Consensus 496 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 574 (1114)
|+++.+.+..|.+|++|+.|+|++| ++.+.+.+|.++++|+ .+++.+ .++..-+..|.+|++|+.|++++|+++...
T Consensus 236 n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~ 313 (329)
T 3sb4_A 236 TNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLG 313 (329)
T ss_dssp BCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEEC
T ss_pred CCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccc
Confidence 5555444445555555555555555 4444455555555555 555555 444233344445555555555555555444
Q ss_pred chhhhhcccCCeee
Q 001253 575 PREIGSLFQLELLK 588 (1114)
Q Consensus 575 p~~~~~l~~L~~L~ 588 (1114)
+..|.++++|+.++
T Consensus 314 ~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 314 DELFGNGVPSKLIY 327 (329)
T ss_dssp TTTTCTTCCCCEEE
T ss_pred hhhhcCCcchhhhc
Confidence 44555555555443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.66 E-value=5.8e-17 Score=182.69 Aligned_cols=296 Identities=13% Similarity=0.054 Sum_probs=174.1
Q ss_pred CCCcccccc--cccccEEEecCCcccCcccccccc-ccccchhhccccccc--CCchhhhcCCCccceeeeccccccccc
Q 001253 236 GEIPKEIGM--LKYLTDVILWGNQLSGVIPKELGN-CTSLETLALYDNKQV--GQLPKELGSIGSLKYLYIYRNELNGTI 310 (1114)
Q Consensus 236 ~~~p~~l~~--l~~L~~L~L~~N~l~~~~p~~l~~-l~~L~~L~Ls~N~~~--~~~p~~~~~l~~L~~L~L~~n~l~~~~ 310 (1114)
|.++..+.. +.++++|.++++ +....-..+.. +++|+.|||++|++. ...+. .++.++.+.+..|.+.
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I~--- 85 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFVP--- 85 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEEC---
T ss_pred CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---cccccccccccccccC---
Confidence 445555553 778999999875 22222233444 788999999999987 22222 2233566666666432
Q ss_pred Cccccc--------cccccccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCCEEEcccccc----
Q 001253 311 PREIGK--------LSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSL---- 378 (1114)
Q Consensus 311 p~~l~~--------l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l---- 378 (1114)
+..|.. +++|++|++.+ ++....+.+|..+++|+.+++.+|.+..+.+.+|..+.++..+.++.+..
T Consensus 86 ~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~ 164 (329)
T 3sb4_A 86 AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFK 164 (329)
T ss_dssp TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTS
T ss_pred HHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcc
Confidence 345666 99999999999 88877788899999999999999999988899999988888887776432
Q ss_pred cccccCcccccccee-eeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcc
Q 001253 379 TGTIPLGFQYLTNLI-MLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTG 457 (1114)
Q Consensus 379 ~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~ 457 (1114)
.......|.++..|+ .+.+....- ++..+ ...-....+++.+.+.++-........
T Consensus 165 ~~i~~~~f~~~~~L~~~i~~~~~~~---l~~~~--------------------~~~~~~~~~~~~l~~~~~l~~~~~~~l 221 (329)
T 3sb4_A 165 NRWEHFAFIEGEPLETTIQVGAMGK---LEDEI--------------------MKAGLQPRDINFLTIEGKLDNADFKLI 221 (329)
T ss_dssp TTTTTSCEEESCCCEEEEEECTTCC---HHHHH--------------------HHTTCCGGGCSEEEEEECCCHHHHHHH
T ss_pred ccccccccccccccceeEEecCCCc---HHHHH--------------------hhcccCccccceEEEeeeecHHHHHHH
Confidence 223344455555555 333322110 00000 000001123333333333111000000
Q ss_pred cccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCc-EEEecCceeccCCCccccCCCCc
Q 001253 458 VTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQ-RLHLSDNYFTGELPREVGNLSNL 536 (1114)
Q Consensus 458 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L 536 (1114)
...+++|+.|+|++|+++...+..|.++.+|++|+|.+| ++.+.+..|.++++|+ .+++.+ .++.+.+.+|.++++|
T Consensus 222 ~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L 299 (329)
T 3sb4_A 222 RDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNL 299 (329)
T ss_dssp HHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTE
T ss_pred HHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccC
Confidence 112455666666666555455555666666666666665 5545555566666666 666666 4554555666666666
Q ss_pred ceeecccccccccccccccccccceEEE
Q 001253 537 VTFNVSSNFLTGRIPLEIFSCKMLQRLD 564 (1114)
Q Consensus 537 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 564 (1114)
+.+++++|.++..-+..|.++++|+.++
T Consensus 300 ~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 300 RYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CEEEeCCCccCccchhhhcCCcchhhhc
Confidence 6666666666643344555566666654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8.3e-16 Score=154.78 Aligned_cols=132 Identities=22% Similarity=0.177 Sum_probs=61.8
Q ss_pred CcceEEeeccceee-ccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceee
Q 001253 462 KSLVQLRLGGNSFT-GSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFN 540 (1114)
Q Consensus 462 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 540 (1114)
++|++|++++|+++ +.+|..+..+++|++|++++|++++. ..+..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34444444444444 34444444444455555555544433 4444455555555555555544444444455555555
Q ss_pred cccccccccc-cccccccccceEEECccccccCCCc---hhhhhcccCCeeeccCccCC
Q 001253 541 VSSNFLTGRI-PLEIFSCKMLQRLDLSWNKFVGALP---REIGSLFQLELLKLSENELS 595 (1114)
Q Consensus 541 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~ 595 (1114)
|++|.+++.. +..+..+++|+.|++++|++++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 5555554211 1344444555555555555543322 24444445555555554444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-15 Score=153.63 Aligned_cols=132 Identities=20% Similarity=0.168 Sum_probs=87.1
Q ss_pred ccceEEEeeccccc-CCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEee
Q 001253 414 SQLWVVDLSDNHLT-GKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVE 492 (1114)
Q Consensus 414 ~~L~~L~Ls~N~l~-~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 492 (1114)
++|++|+|++|+++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 45666666666665 45565566666666666666666644 5566677777777777777665666666677777777
Q ss_pred cccccCCCCc-cccccccccCcEEEecCceeccCCC---ccccCCCCcceeeccccccc
Q 001253 493 LDQNQFSGPI-PTEIGNCNALQRLHLSDNYFTGELP---REVGNLSNLVTFNVSSNFLT 547 (1114)
Q Consensus 493 L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~ 547 (1114)
|++|+|++.. +..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 7777776432 2566677777777777777765443 36666777777777777665
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.8e-16 Score=175.68 Aligned_cols=141 Identities=11% Similarity=0.071 Sum_probs=102.0
Q ss_pred CcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCC-----------hhhHH--------HHHHHHHHHhcCCCCcee
Q 001253 811 FDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGN-----------NNVDN--------SFRAEILTLGKIRHRNIV 871 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-----------~~~~~--------~~~~E~~~l~~l~h~niv 871 (1114)
|++.+.||+|+||.||+|...+|+.||||+++...... ..... ...+|...+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 88999999999999999999999999999986432110 00011 123456666666544432
Q ss_pred eEEeEEEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC--
Q 001253 872 KLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-- 949 (1114)
Q Consensus 872 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-- 949 (1114)
...-+.. ...++||||++|+.+.++... .....++.|++.+|.|+|+. |||||||||.|||+++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECS
T ss_pred CCeeeec--cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCc
Confidence 1111111 234799999999888776531 12356788999999999998 999999999999998876
Q ss_pred --------CeEEeeccCceecC
Q 001253 950 --------EAHVGDFGLAKVID 963 (1114)
Q Consensus 950 --------~~kl~DfG~a~~~~ 963 (1114)
.+.|+||+.+....
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 38999999988644
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-15 Score=150.22 Aligned_cols=126 Identities=21% Similarity=0.167 Sum_probs=58.4
Q ss_pred cceEEeeccceee-ccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeec
Q 001253 463 SLVQLRLGGNSFT-GSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNV 541 (1114)
Q Consensus 463 ~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 541 (1114)
+|+.|++++|.++ +.+|..+..+++|++|++++|++++. ..+..+++|++|+|++|++++.+|..+..+++|++|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 3444444444444 34444444444444444444444433 34444455555555555554444444444445555555
Q ss_pred cccccccc-ccccccccccceEEECccccccCCCc---hhhhhcccCCeeecc
Q 001253 542 SSNFLTGR-IPLEIFSCKMLQRLDLSWNKFVGALP---REIGSLFQLELLKLS 590 (1114)
Q Consensus 542 s~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~ 590 (1114)
++|++++. .+..+..+++|+.|++++|++++..+ ..+..+++|++|+++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 55554431 12344445555555555555543333 244444555554443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.1e-15 Score=150.47 Aligned_cols=127 Identities=21% Similarity=0.211 Sum_probs=69.0
Q ss_pred ccccEeecccccCC-CCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEE
Q 001253 486 ANLSTVELDQNQFS-GPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLD 564 (1114)
Q Consensus 486 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 564 (1114)
++|+.|++++|+++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45666666666665 55555556666666666666666543 4455555555555555555544454444455555555
Q ss_pred CccccccCC-CchhhhhcccCCeeeccCccCCCccc---ccccccccccccccC
Q 001253 565 LSWNKFVGA-LPREIGSLFQLELLKLSENELSGSIP---VQIGNLSRLTELQMG 614 (1114)
Q Consensus 565 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~ls 614 (1114)
+++|++++. .+..++.+++|++|++++|.+++..+ ..+..+++|+.||++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555532 22445555555555555555554333 244555555555544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=1e-15 Score=155.61 Aligned_cols=133 Identities=23% Similarity=0.244 Sum_probs=91.4
Q ss_pred eEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhccc
Q 001253 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSY 640 (1114)
Q Consensus 561 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~ 640 (1114)
+.+++++|+++ .+|..+. ++|++|++++|++++..+..|..+++|++|++++|+|++..+..+..++.|+ .|+|++
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT-ILYLHE 85 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCC-EEECCS
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccC-EEECCC
Confidence 44555555554 3333222 4566666666666655455556666666666666666655555566666666 577777
Q ss_pred ccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCC
Q 001253 641 NNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPS 697 (1114)
Q Consensus 641 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~ 697 (1114)
|++++..+..++.+++|++|+|++|+|++.++..|..+++|+.|++++|++.|.+|.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 777766666677888888888888888877777778889999999999999988874
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=8.6e-15 Score=150.66 Aligned_cols=126 Identities=23% Similarity=0.322 Sum_probs=71.2
Q ss_pred eeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCce
Q 001253 442 FLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNY 521 (1114)
Q Consensus 442 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 521 (1114)
.+++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4555555555 3443332 35566666666665 455556666666666666666665555556666666666666666
Q ss_pred eccCCCccccCCCCcceeecccccccccccccccccccceEEECcccccc
Q 001253 522 FTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFV 571 (1114)
Q Consensus 522 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 571 (1114)
|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|.+.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 66555555666666666666666665333333445555555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=8e-15 Score=148.93 Aligned_cols=132 Identities=20% Similarity=0.209 Sum_probs=82.4
Q ss_pred cEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccc
Q 001253 489 STVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWN 568 (1114)
Q Consensus 489 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 568 (1114)
+.+++++|+++ .+|..+ .++|+.|++++|++++..+..|..+++|++|++++|++++..+..+..+++|+.|+|++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 45556666655 333322 246666666666666555555666666666666666666443444556666777777777
Q ss_pred cccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCC
Q 001253 569 KFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIP 623 (1114)
Q Consensus 569 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 623 (1114)
++++..+..+..+++|++|++++|++++..+..+..+++|+.|+|++|++.+..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 7765555556667777777777777775555555667777777777777765443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.8e-16 Score=164.42 Aligned_cols=132 Identities=22% Similarity=0.232 Sum_probs=68.5
Q ss_pred hhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccc
Q 001253 481 DLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKML 560 (1114)
Q Consensus 481 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 560 (1114)
.+..+++|++|+|++|++++ +| .+..+++|++|+|++|+|+ .+|..+..+++|++|+|++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 45555555555555555553 33 4555555555555555555 344444444555555555555552 33 34455555
Q ss_pred eEEECccccccCCCc-hhhhhcccCCeeeccCccCCCccccc----------ccccccccccccCCCcCC
Q 001253 561 QRLDLSWNKFVGALP-REIGSLFQLELLKLSENELSGSIPVQ----------IGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 561 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~~L~~L~ls~N~l~ 619 (1114)
+.|+|++|++++..+ ..+..+++|++|++++|.+++.+|.. +..+++|+.|| +|+++
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 555555555553221 34555555556666665555444332 45555555554 44443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.53 E-value=4.2e-14 Score=162.63 Aligned_cols=249 Identities=12% Similarity=0.061 Sum_probs=130.0
Q ss_pred cccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccc
Q 001253 357 VIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICR 436 (1114)
Q Consensus 357 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 436 (1114)
+...+|.+. +|+.+++..| ++.....+|.+. +|+.+.+.+ .+.......|..+.+|+.++|++|+++......|.
T Consensus 127 I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~- 201 (401)
T 4fdw_A 127 IPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV- 201 (401)
T ss_dssp ECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-
T ss_pred ehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-
Confidence 334444442 4555555444 443444444442 355555543 34434444555555555555555555533333333
Q ss_pred cCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEE
Q 001253 437 NTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLH 516 (1114)
Q Consensus 437 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 516 (1114)
..+|+.+.+..+ ++.....+|.++++|+.+++..| ++.....+|.+ .+|+.+.+ .|.++.+....|.+|++|+.++
T Consensus 202 ~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~ 277 (401)
T 4fdw_A 202 YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVT 277 (401)
T ss_dssp TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEE
T ss_pred ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEE
Confidence 355566665533 44344455666666666666554 34344445555 56666666 3445545556666666666666
Q ss_pred ecCceec-----cCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccC
Q 001253 517 LSDNYFT-----GELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSE 591 (1114)
Q Consensus 517 Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 591 (1114)
+.+|.+. .+.+.+|.++++|+.++|.+ .++..-...|.+|++|+.++|..| ++...+.+|.++ +|+.+++++
T Consensus 278 l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~ 354 (401)
T 4fdw_A 278 TYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEG 354 (401)
T ss_dssp EESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECC
T ss_pred eCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcC
Confidence 6666554 34455666666666666663 354233344445666666666433 443444555555 666666666
Q ss_pred ccCCCcccccccccc-cccccccCCCc
Q 001253 592 NELSGSIPVQIGNLS-RLTELQMGGNS 617 (1114)
Q Consensus 592 N~l~~~~p~~~~~l~-~L~~L~ls~N~ 617 (1114)
|.+....+..|.+++ +++.|++..|.
T Consensus 355 n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 355 TTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp SSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred CCCcccccccccCCCCCccEEEeCHHH
Confidence 665544444454442 44555554443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.52 E-value=8.3e-14 Score=160.11 Aligned_cols=113 Identities=12% Similarity=0.106 Sum_probs=57.3
Q ss_pred CcccccCCcceEEeeccceee-----ccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCcc
Q 001253 455 PTGVTRCKSLVQLRLGGNSFT-----GSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPRE 529 (1114)
Q Consensus 455 p~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 529 (1114)
..+|.++++|+.+.+.+|.+. ...+..|.++++|+.++|. |.++.+....|.+|++|+.++|..| ++.+.+.+
T Consensus 264 ~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~a 341 (401)
T 4fdw_A 264 SRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSA 341 (401)
T ss_dssp TTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTS
T ss_pred hhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHh
Confidence 344444444444444444332 2334455555555555555 3344444455555666666666443 44444555
Q ss_pred ccCCCCcceeecccccccccccccccccc-cceEEECccccc
Q 001253 530 VGNLSNLVTFNVSSNFLTGRIPLEIFSCK-MLQRLDLSWNKF 570 (1114)
Q Consensus 530 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l 570 (1114)
|.++ +|+.+++++|.+....+..+..++ .++.|++..+.+
T Consensus 342 F~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 342 FNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp SSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred CCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 6655 566666666655533333344442 455666655543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=1.8e-14 Score=146.11 Aligned_cols=131 Identities=17% Similarity=0.136 Sum_probs=67.3
Q ss_pred ccCCcceEEeeccceeeccCCchhhccc-cccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcc
Q 001253 459 TRCKSLVQLRLGGNSFTGSFPSDLCKLA-NLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLV 537 (1114)
Q Consensus 459 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 537 (1114)
..+.+|++|++++|+++ .+|. +..+. +|++|++++|+|++. ..+..+++|++|+|++|+|++..+..|..+++|+
T Consensus 16 ~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp ECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred CCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 34445555555555555 2232 22332 555555555555533 3455555566666666655544334445555555
Q ss_pred eeecccccccccccc--cccccccceEEECccccccCCCchh----hhhcccCCeeeccCccCC
Q 001253 538 TFNVSSNFLTGRIPL--EIFSCKMLQRLDLSWNKFVGALPRE----IGSLFQLELLKLSENELS 595 (1114)
Q Consensus 538 ~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~ 595 (1114)
+|+|++|+++ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|++|++++|.+.
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 5555555554 3443 4445555555555555555 33332 555555555555555443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=4.6e-16 Score=161.25 Aligned_cols=114 Identities=20% Similarity=0.196 Sum_probs=60.4
Q ss_pred cccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccC
Q 001253 433 HICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNAL 512 (1114)
Q Consensus 433 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 512 (1114)
.+..+++|++|++++|++++ +| .+..+++|++|++++|+++ .+|..+..+++|++|++++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 45555555555555555553 34 4555555555555555555 445555555555555555555553 33 35555556
Q ss_pred cEEEecCceeccCCC-ccccCCCCcceeeccccccccccc
Q 001253 513 QRLHLSDNYFTGELP-REVGNLSNLVTFNVSSNFLTGRIP 551 (1114)
Q Consensus 513 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p 551 (1114)
++|+|++|+|++..+ ..+..+++|++|++++|.+++.+|
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 666666665553221 245555555555555555554433
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.48 E-value=3.2e-14 Score=144.22 Aligned_cols=105 Identities=18% Similarity=0.168 Sum_probs=50.5
Q ss_pred cceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCc--cccCCCCcceee
Q 001253 463 SLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPR--EVGNLSNLVTFN 540 (1114)
Q Consensus 463 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~ 540 (1114)
+|++|+|++|.+++. ..+..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 444444444444432 34444444555555555554333333344555555555555553 2333 445555555555
Q ss_pred ccccccccccccc----ccccccceEEECcccccc
Q 001253 541 VSSNFLTGRIPLE----IFSCKMLQRLDLSWNKFV 571 (1114)
Q Consensus 541 Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~ 571 (1114)
+++|.++ .+|.. +..+++|+.||+++|.+.
T Consensus 120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 5555554 33432 445555555555555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.47 E-value=7.1e-13 Score=153.14 Aligned_cols=41 Identities=5% Similarity=0.165 Sum_probs=20.8
Q ss_pred CCCCccccccccceeccccccccccCCCCCCCCccceeeccc
Q 001253 190 LPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQ 231 (1114)
Q Consensus 190 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~ 231 (1114)
...+|.++++|+.+.+..+ +......+|.++++|+.++|.+
T Consensus 63 g~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~ 103 (394)
T 4fs7_A 63 GYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPD 103 (394)
T ss_dssp CTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCT
T ss_pred HHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCC
Confidence 3345555555555555432 4434444555555555555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.46 E-value=6.7e-13 Score=153.38 Aligned_cols=334 Identities=11% Similarity=0.037 Sum_probs=161.3
Q ss_pred cCCCCcccccccccccEEEecCCcccCccccccccccccchhhcccccccCCchhhhcCCCccceeeecccccccccCcc
Q 001253 234 LSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPRE 313 (1114)
Q Consensus 234 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 313 (1114)
++.....+|..+++|+.+.|.. .++.+-..+|.+|++|+.+++.++ +.......|..+.+|+.+.+..+ +......+
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence 3433345566777777777753 355444556777777777777554 33333445666666666555433 22112222
Q ss_pred ccccccccccccccccCCCCCchhhhcccccceeecccccccCcccccccccccCCEEEcccccccccccCcccccccee
Q 001253 314 IGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLI 393 (1114)
Q Consensus 314 l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 393 (1114)
|.....+.. ... +.+..+...+|.++++|+.+.+.++. .......|.++.+|+
T Consensus 136 F~~~~~~~~------------------------~~~--~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~ 188 (394)
T 4fs7_A 136 FKGCDFKEI------------------------TIP--EGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLK 188 (394)
T ss_dssp TTTCCCSEE------------------------ECC--TTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCC
T ss_pred eeccccccc------------------------ccC--ccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCce
Confidence 322221111 111 11111223445555555555554432 223444455555555
Q ss_pred eeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccce
Q 001253 394 MLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNS 473 (1114)
Q Consensus 394 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 473 (1114)
.+.+..| +.......|.....|+.+.+..+... +...+....+|+.+.+..+. +......+..+..|+.+.+..+.
T Consensus 189 ~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~ 264 (394)
T 4fs7_A 189 SIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNK 264 (394)
T ss_dssp BCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTT
T ss_pred EEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCc
Confidence 5555443 33233344444555554444443221 22222333455555554322 22233445555666666665554
Q ss_pred eeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeeccccccccccccc
Q 001253 474 FTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLE 553 (1114)
Q Consensus 474 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 553 (1114)
.. .....|.....++.+....+.+. ...|..+.+|+.+.+.++ ++.+...+|.++++|+.++|.++ ++..-...
T Consensus 265 ~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a 338 (394)
T 4fs7_A 265 LR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRS 338 (394)
T ss_dssp CE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred ce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHh
Confidence 33 44445555555555555544322 234555666666666544 44344555666666666666533 44222344
Q ss_pred ccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccc
Q 001253 554 IFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTE 610 (1114)
Q Consensus 554 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 610 (1114)
|.+|.+|+.+++..| ++.....+|.++.+|+.+++..+ ++ .+...|.++++|++
T Consensus 339 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 339 FRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp TTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred ccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 555666666666554 44344455666666666666543 22 22344555555554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=6.5e-14 Score=140.89 Aligned_cols=110 Identities=26% Similarity=0.260 Sum_probs=80.5
Q ss_pred CCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhcc
Q 001253 584 LELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLN 663 (1114)
Q Consensus 584 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 663 (1114)
.+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|..+++|+ .|+|++|+|++..|..|..+++|++|+|+
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~-~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLT-RLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCS-EEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCC-EEECCCCCcCccChhhccCCCCCCEEECC
Confidence 345555555555 3444442 5666677777777766666677777776 57777777777666677788888888888
Q ss_pred CcccccCCCCccccccccceEEeccCcccCCCCC
Q 001253 664 NNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPS 697 (1114)
Q Consensus 664 ~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~ 697 (1114)
+|+|++.+|..|.++++|+.|+|++|+|.|.++.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 8888888777888899999999999999888763
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.8e-13 Score=138.06 Aligned_cols=108 Identities=27% Similarity=0.302 Sum_probs=71.3
Q ss_pred CeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccC
Q 001253 585 ELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNN 664 (1114)
Q Consensus 585 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 664 (1114)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++.+|..|..+++|+ .|+|++|+|++..+..|.++++|++|||++
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQ-QLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCC-EEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCC-EEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 34455555554 3444332 4556666666666655566666666666 566666666665555567777788888888
Q ss_pred cccccCCCCccccccccceEEeccCcccCCCC
Q 001253 665 NHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIP 696 (1114)
Q Consensus 665 N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip 696 (1114)
|+|++.++..|..+++|+.|+|++|+|.+.++
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 88887666668888888888888888887665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.38 E-value=1.1e-12 Score=131.89 Aligned_cols=85 Identities=21% Similarity=0.153 Sum_probs=40.2
Q ss_pred cccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECc
Q 001253 487 NLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLS 566 (1114)
Q Consensus 487 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 566 (1114)
+|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..+..+++|+.|+|+
T Consensus 31 ~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 110 (170)
T 3g39_A 31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLL 110 (170)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeC
Confidence 34444444444444444444444444444444444444444444444455555555555543333334445555555555
Q ss_pred ccccc
Q 001253 567 WNKFV 571 (1114)
Q Consensus 567 ~N~l~ 571 (1114)
+|.++
T Consensus 111 ~N~~~ 115 (170)
T 3g39_A 111 NNPWD 115 (170)
T ss_dssp SSCBC
T ss_pred CCCCC
Confidence 55554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.3e-12 Score=131.69 Aligned_cols=103 Identities=22% Similarity=0.303 Sum_probs=43.2
Q ss_pred eeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCce
Q 001253 442 FLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNY 521 (1114)
Q Consensus 442 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 521 (1114)
.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 3444444443 2333222 344444444444444334444444444444444444443333333444444444444444
Q ss_pred eccCCCccccCCCCcceeeccccccc
Q 001253 522 FTGELPREVGNLSNLVTFNVSSNFLT 547 (1114)
Q Consensus 522 l~~~~p~~~~~l~~L~~L~Ls~N~l~ 547 (1114)
|++..+..|..+++|+.|+|++|.+.
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred cceeCHHHhccccCCCEEEeCCCCcc
Confidence 44333333444444444444444433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.6e-13 Score=156.10 Aligned_cols=136 Identities=20% Similarity=0.214 Sum_probs=68.2
Q ss_pred CcceEEeeccceeeccCCchh-hccccccEeecccccCCCCccccc-----cccccCcEEEecCceeccC----CCcccc
Q 001253 462 KSLVQLRLGGNSFTGSFPSDL-CKLANLSTVELDQNQFSGPIPTEI-----GNCNALQRLHLSDNYFTGE----LPREVG 531 (1114)
Q Consensus 462 ~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~ 531 (1114)
++|++|+|++|.++......+ ..+.+|++|+|++|+|+......+ ...++|++|+|++|.|+.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 345555555554433222222 123455555555555543222222 1235566666666665431 233334
Q ss_pred CCCCcceeeccccccccc----ccccccccccceEEECccccccCC----CchhhhhcccCCeeeccCccCCCc
Q 001253 532 NLSNLVTFNVSSNFLTGR----IPLEIFSCKMLQRLDLSWNKFVGA----LPREIGSLFQLELLKLSENELSGS 597 (1114)
Q Consensus 532 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~ 597 (1114)
..++|++|+|++|.|++. ++..+..+++|+.|+|++|.|+.. ++..+...++|++|+|++|.|+..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 555666666666666532 233444555666666666666542 223334456666666666666643
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-13 Score=157.33 Aligned_cols=144 Identities=18% Similarity=0.155 Sum_probs=93.6
Q ss_pred CccceeeeccCCccCCcCccc-ccCCcceEEeeccceeeccCCchhh-----ccccccEeecccccCCC----Ccccccc
Q 001253 438 TSLIFLNLETNKLTGSIPTGV-TRCKSLVQLRLGGNSFTGSFPSDLC-----KLANLSTVELDQNQFSG----PIPTEIG 507 (1114)
Q Consensus 438 ~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~----~~p~~~~ 507 (1114)
++|++|+|++|.++......+ ..+++|+.|+|++|.+++.....++ ..++|++|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 456666666666653222222 2345677777777777644444442 34668888888887763 2344456
Q ss_pred ccccCcEEEecCceeccC----CCccccCCCCcceeeccccccccc----ccccccccccceEEECccccccCCCchhhh
Q 001253 508 NCNALQRLHLSDNYFTGE----LPREVGNLSNLVTFNVSSNFLTGR----IPLEIFSCKMLQRLDLSWNKFVGALPREIG 579 (1114)
Q Consensus 508 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 579 (1114)
.+++|++|||++|.|++. ++..+...++|+.|+|++|.|+.. ++..+..+++|+.|||++|.|+......+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 677888888888888743 345566777888889998888743 334444578899999999998865555554
Q ss_pred hc
Q 001253 580 SL 581 (1114)
Q Consensus 580 ~l 581 (1114)
.+
T Consensus 261 ~~ 262 (372)
T 3un9_A 261 DL 262 (372)
T ss_dssp HC
T ss_pred HH
Confidence 43
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=2.3e-12 Score=146.21 Aligned_cols=108 Identities=22% Similarity=0.158 Sum_probs=71.6
Q ss_pred eeccCc-cCCCcccccccccccccccccCC-CcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccC
Q 001253 587 LKLSEN-ELSGSIPVQIGNLSRLTELQMGG-NSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNN 664 (1114)
Q Consensus 587 L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 664 (1114)
++++++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|..+++|+ .|+|++|+|++..|..|++|++|++|||++
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELR-NLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCS-EEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCC-EEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 455554 555 3455 55666666666664 666655556666666666 566666666666666777777777777777
Q ss_pred cccccCCCCccccccccceEEeccCcccCCCCCc
Q 001253 665 NHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSS 698 (1114)
Q Consensus 665 N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~ 698 (1114)
|+|++.+|..|..++ |+.|+|++|+|.+.+...
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~ 122 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALR 122 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGH
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCccH
Confidence 777766666666665 788888888888766543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.15 E-value=7e-10 Score=127.94 Aligned_cols=334 Identities=12% Similarity=0.095 Sum_probs=168.9
Q ss_pred CCccccc-cccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCcccccccccc
Q 001253 192 PTLGNLK-RLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCT 270 (1114)
Q Consensus 192 ~~l~~l~-~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 270 (1114)
.+|.+++ .|+.+.+..+ ++.+...+|.++++|+.+.++.|.-+ .++.+-..+|.++.
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~---------------------~l~~Ig~~aF~~c~ 114 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPS---------------------CVKKIGRQAFMFCS 114 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCC---------------------CCCEECTTTTTTCT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCC---------------------eeeEechhhchhcc
Confidence 3455442 3555555433 33344455555555555555444210 13323334566666
Q ss_pred ccchhhcccccccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeecc
Q 001253 271 SLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLF 350 (1114)
Q Consensus 271 ~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~ 350 (1114)
+|+.+.+..+ +.......|..+.+|+.+.+..+. .......+..+.+|+.+.+..+ +......+|.. .+|+.+.+.
T Consensus 115 ~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip 190 (394)
T 4gt6_A 115 ELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIP 190 (394)
T ss_dssp TCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEEC
T ss_pred cceeeccCCc-cceehhhhhhhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEEC
Confidence 6666665543 233334445666666666665332 2122334555555555555433 22122222322 345555554
Q ss_pred cccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCC
Q 001253 351 ENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKI 430 (1114)
Q Consensus 351 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 430 (1114)
.+- +.+...+|..+.+++......+.........+........-. ..+.....+..+.+. +.++...
T Consensus 191 ~~~-~~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~ip-~~v~~i~ 257 (394)
T 4gt6_A 191 AKV-TRIGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYAL-----------IRYPSQREDPAFKIP-NGVARIE 257 (394)
T ss_dssp TTC-CEECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEE-----------EECCTTCCCSEEECC-TTEEEEC
T ss_pred Ccc-cccccchhhhccccceecccccccccccceeecccccccccc-----------cccccccccceEEcC-CcceEcc
Confidence 332 223445555566666665554443311111111000000000 000111122223322 2233234
Q ss_pred CccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccc
Q 001253 431 PRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCN 510 (1114)
Q Consensus 431 ~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 510 (1114)
...|..+..|+.+.+..+... .....|.++++|+.+.+. +.++......|.++.+|+.+++..+ ++.+-...|.+|.
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 456666677777777655443 445667778888888875 4455455667888888888888754 5545567788888
Q ss_pred cCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECcccccc
Q 001253 511 ALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFV 571 (1114)
Q Consensus 511 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 571 (1114)
+|+.+.+..+ ++.+-..+|.++++|+.+++.+|.... ..+..+.+|+.+.+..|.+.
T Consensus 335 ~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 335 QLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp TCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred CCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 8888888765 665667788888888888888876541 35667788888888776553
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.15 E-value=5.7e-11 Score=134.68 Aligned_cols=89 Identities=19% Similarity=0.166 Sum_probs=42.0
Q ss_pred hhccccccEeeccc-ccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccc
Q 001253 482 LCKLANLSTVELDQ-NQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKML 560 (1114)
Q Consensus 482 ~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 560 (1114)
+..+++|++|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++ +|..++....|
T Consensus 27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~L 105 (347)
T 2ifg_A 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSL 105 (347)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC-CCSTTTCSCCC
T ss_pred CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccce-eCHHHcccCCc
Confidence 44444444444443 44444444445555555555555555554444445555555555555555542 22222222225
Q ss_pred eEEECcccccc
Q 001253 561 QRLDLSWNKFV 571 (1114)
Q Consensus 561 ~~L~Ls~N~l~ 571 (1114)
+.|+|++|.+.
T Consensus 106 ~~l~l~~N~~~ 116 (347)
T 2ifg_A 106 QELVLSGNPLH 116 (347)
T ss_dssp CEEECCSSCCC
T ss_pred eEEEeeCCCcc
Confidence 55555555554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.6e-10 Score=125.39 Aligned_cols=143 Identities=17% Similarity=0.085 Sum_probs=112.5
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+.|++...++.|+.+.||++... ++.+++|+........ ...+.+|+.+++.+. +..+.++++++.+.+..|+||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 56887888898999999999865 7899999987542221 224778999988884 677889999999888999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD--------------------------------------- 928 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------------------------------------- 928 (1114)
||++|.++.+.... ......++.+++++++.||+.
T Consensus 90 e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 90 SEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp ECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999876421 122346788999999999981
Q ss_pred -----------------CCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 929 -----------------CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 929 -----------------~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..+.++|+|+++.||+++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014699999999999998765667999998764
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.2e-09 Score=125.85 Aligned_cols=335 Identities=14% Similarity=0.091 Sum_probs=153.3
Q ss_pred ccCcccccccccc-ccchhhcccccccCCchhhhcCCCccceeeecccc---cccccCccccccccccccccccccCCCC
Q 001253 258 LSGVIPKELGNCT-SLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNE---LNGTIPREIGKLSSALEIDFSENSLIGE 333 (1114)
Q Consensus 258 l~~~~p~~l~~l~-~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~---l~~~~p~~l~~l~~L~~L~ls~N~l~~~ 333 (1114)
++.+-..+|.++. .|+.+.+.++ +......+|.++++|+.+.+..|. ++..-..+|..+.+|+.+.+..+ ++..
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I 128 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI 128 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence 3334445677774 5888888754 555566778888888888887764 33223345556666666555443 2323
Q ss_pred CchhhhcccccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcC
Q 001253 334 IPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAY 413 (1114)
Q Consensus 334 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 413 (1114)
....|....+|+.+.+..+ +..+....|..+.+|+.+.+..+ ++.....+|.+ .+|+.+.+..+-. ......|...
T Consensus 129 ~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~-~i~~~af~~c 204 (394)
T 4gt6_A 129 DSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT-RIGTNAFSEC 204 (394)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC-EECTTTTTTC
T ss_pred hhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCccc-ccccchhhhc
Confidence 3344555555555555432 23344445555555555555443 23233333432 3344444433211 1222333344
Q ss_pred ccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeec
Q 001253 414 SQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVEL 493 (1114)
Q Consensus 414 ~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 493 (1114)
..+.......+.... +...+..... ........+.....+..+.+. +.++..-..+|..+..|+.+.+
T Consensus 205 ~~l~~~~~~~~~~~~-~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~l 272 (394)
T 4gt6_A 205 FALSTITSDSESYPA-IDNVLYEKSA----------NGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKM 272 (394)
T ss_dssp TTCCEEEECCSSSCB-SSSCEEEECT----------TSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEEC
T ss_pred cccceeccccccccc-ccceeecccc----------cccccccccccccccceEEcC-CcceEcccceeeecccccEEec
Confidence 444444433332221 1111000000 000000001111222222222 2233233445556666666666
Q ss_pred ccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCC
Q 001253 494 DQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGA 573 (1114)
Q Consensus 494 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 573 (1114)
..+..+ +....|.++++|+.+.+.. .++.+...+|.++.+|+.++|..+ ++..-...|.+|.+|+.+.+..+ ++..
T Consensus 273 p~~~~~-I~~~aF~~c~~L~~i~l~~-~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I 348 (394)
T 4gt6_A 273 PDSVVS-IGTGAFMNCPALQDIEFSS-RITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKI 348 (394)
T ss_dssp CTTCCE-ECTTTTTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBC
T ss_pred ccccce-ecCcccccccccccccCCC-cccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEE
Confidence 544333 4445556666666666643 344344555666666666666543 33222334455666666666433 4433
Q ss_pred CchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCc
Q 001253 574 LPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNS 617 (1114)
Q Consensus 574 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 617 (1114)
-..+|.++.+|+.+++.+|.... ..+.....|+.+.+..|.
T Consensus 349 ~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 349 PESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp CGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC---------
T ss_pred hHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCC
Confidence 34555666666666665554321 234444555555554443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.99 E-value=7e-10 Score=120.11 Aligned_cols=129 Identities=17% Similarity=0.079 Sum_probs=97.4
Q ss_pred cccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCc--eeeEEeEEEecCceEEEEecCCCCCH
Q 001253 818 GRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN--IVKLYGFCYHQGSNLLMYEYMARGSL 895 (1114)
Q Consensus 818 G~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL 895 (1114)
+.|..+.||++...+|+.+++|+..... ...+..|+.+++.+++.+ +.+++++...++..++||||++|.++
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 4566799999987778889999976541 134678888888885434 55688888887888999999999888
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 001253 896 GELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC---------------------------------------------- 929 (1114)
Q Consensus 896 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------------- 929 (1114)
. .. ..+ ...++.++++.++.+|+..
T Consensus 103 ~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 103 L--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp T--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred C--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 4 22 112 2356778888888888741
Q ss_pred ---------CCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 930 ---------KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 930 ---------~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
.+.++|+|++|.||++++++.+.|+|||.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.88 E-value=4.7e-09 Score=119.41 Aligned_cols=143 Identities=15% Similarity=0.218 Sum_probs=107.4
Q ss_pred CCceecccCCeEEEEEEeCCCcEEEEEEec--ccCCCChhhHHHHHHHHHHHhcCC--CCceeeEEeEEEec---CceEE
Q 001253 813 ERFVIGRGACGTVYRAVLRTGHTVAVKKLA--SNREGNNNVDNSFRAEILTLGKIR--HRNIVKLYGFCYHQ---GSNLL 885 (1114)
Q Consensus 813 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~l 885 (1114)
..+.++.|.++.||+.... +..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+. +..|+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 3457899999999999876 4688899876 33211 11345778999998886 45688888888776 45899
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC------------------------------------ 929 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------ 929 (1114)
||||++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 119 vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999998775422 234678888999999999999999831
Q ss_pred -------------------CCCeEecCCCCCCeEECCCCC--eEEeeccCcee
Q 001253 930 -------------------KPRIFHRDIKSNNILLDDKFE--AHVGDFGLAKV 961 (1114)
Q Consensus 930 -------------------~~~ivH~Dlk~~Nill~~~~~--~kl~DfG~a~~ 961 (1114)
.+.++|+|+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999999875
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.86 E-value=4.8e-08 Score=111.90 Aligned_cols=109 Identities=16% Similarity=0.119 Sum_probs=57.4
Q ss_pred cccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccC
Q 001253 433 HICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNAL 512 (1114)
Q Consensus 433 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 512 (1114)
.|.....|+.+.+..+ ++......|..+.+|+.+.+..+ +.......|.++.+|+.+.+.++.++.+....|.++.+|
T Consensus 235 ~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L 312 (379)
T 4h09_A 235 AFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKL 312 (379)
T ss_dssp TTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTC
T ss_pred cccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCC
Confidence 3344444444444433 33233344555555555555433 332334455556666666666665554445566666666
Q ss_pred cEEEecCceeccCCCccccCCCCcceeecccc
Q 001253 513 QRLHLSDNYFTGELPREVGNLSNLVTFNVSSN 544 (1114)
Q Consensus 513 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 544 (1114)
+.++|..+ ++.+-..+|.++++|+.+.+..+
T Consensus 313 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 313 SSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred CEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 66666544 44444556666666666666544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.81 E-value=1.8e-09 Score=121.62 Aligned_cols=63 Identities=16% Similarity=0.189 Sum_probs=26.1
Q ss_pred CCCcceeeccccccccccccccc---ccccceEEECccccccCC----CchhhhhcccCCeeeccCccCC
Q 001253 533 LSNLVTFNVSSNFLTGRIPLEIF---SCKMLQRLDLSWNKFVGA----LPREIGSLFQLELLKLSENELS 595 (1114)
Q Consensus 533 l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 595 (1114)
+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.+.+. ++..+..+++|+.|+|++|.++
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 44455555555544422222221 244455555555544432 1222233344444444444444
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.80 E-value=2.4e-09 Score=120.52 Aligned_cols=158 Identities=16% Similarity=0.168 Sum_probs=96.4
Q ss_pred ccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhh--ccccccEeeccc--ccCCCC-----c
Q 001253 432 RHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLC--KLANLSTVELDQ--NQFSGP-----I 502 (1114)
Q Consensus 432 ~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~ 502 (1114)
..+..+|+|+.|+|++|.-. .++. + .+++|+.|+|..|.+.......++ .+++|+.|+|+. |...+. +
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l 242 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred HHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence 33444566666666665211 1222 2 266777777777766544333443 567777777753 221111 1
Q ss_pred cccc--cccccCcEEEecCceeccCCCccc---cCCCCcceeeccccccccc----ccccccccccceEEECccccccCC
Q 001253 503 PTEI--GNCNALQRLHLSDNYFTGELPREV---GNLSNLVTFNVSSNFLTGR----IPLEIFSCKMLQRLDLSWNKFVGA 573 (1114)
Q Consensus 503 p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ 573 (1114)
...+ ..+++|+.|+|++|.+.+..+..+ ..+++|++|+|+.|.+++. ++..+..+++|+.|+|++|.++..
T Consensus 243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 1122 257899999999998875433333 2478899999999999863 344445689999999999988754
Q ss_pred CchhhhhcccCCeeeccCcc
Q 001253 574 LPREIGSLFQLELLKLSENE 593 (1114)
Q Consensus 574 ~p~~~~~l~~L~~L~L~~N~ 593 (1114)
.-..+...- ...+++++|+
T Consensus 323 ~~~~l~~al-g~~~~~~~~~ 341 (362)
T 2ra8_A 323 MKKELQKSL-PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHHC-CSEEECCSBC
T ss_pred HHHHHHHHc-CCEEEecCCc
Confidence 333343311 3557777776
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.79 E-value=2.5e-09 Score=118.56 Aligned_cols=185 Identities=21% Similarity=0.163 Sum_probs=122.8
Q ss_pred CceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCc--eeeEEeEEEecC---ceEEEE
Q 001253 814 RFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRN--IVKLYGFCYHQG---SNLLMY 887 (1114)
Q Consensus 814 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~ 887 (1114)
.+.++.|....||++. +.+++|+.... .....+.+|+.+++.+. +.. +.+++......+ ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3568999999999863 56899986432 23456888999998873 322 444544443333 348999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD--------------------------------------- 928 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------------------------------------- 928 (1114)
||++|.++.+... ..++..++..++.++++.++.||+.
T Consensus 96 ~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 96 TKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp ECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred cccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9999988865332 2467778888888999988888861
Q ss_pred ----------------CCCCeEecCCCCCCeEECC--CCCeEEeeccCceecCCCCCCcccc--------------cccc
Q 001253 929 ----------------CKPRIFHRDIKSNNILLDD--KFEAHVGDFGLAKVIDMPQSKSMSA--------------IAGS 976 (1114)
Q Consensus 929 ----------------~~~~ivH~Dlk~~Nill~~--~~~~kl~DfG~a~~~~~~~~~~~~~--------------~~g~ 976 (1114)
..+.++|+|+++.||++++ ...+.++||+.+...+. ....... +...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHHH
Confidence 1246899999999999998 45678999999876431 1100000 0000
Q ss_pred ccccC-ccccccCCCCcccchHHHHHHHHHHHhCCCCC
Q 001253 977 YGYIA-PEYAYTMKVTEKCDIYSYGVVLLELLTGRAPV 1013 (1114)
Q Consensus 977 ~~y~a-PE~~~~~~~~~~~DvwslGvil~el~tg~~p~ 1013 (1114)
+++.. |+.... .....+.|++|.++|++.+|+.+|
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11112 222111 122368999999999999998765
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.75 E-value=2.8e-07 Score=105.56 Aligned_cols=132 Identities=15% Similarity=0.109 Sum_probs=63.3
Q ss_pred hhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccc
Q 001253 481 DLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKML 560 (1114)
Q Consensus 481 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 560 (1114)
.+....+|+.+.+..+ ++.+....|.++..|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++..-...+..+.+|
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence 3444444555544333 22233344455555555555444 33334445555555555555433 321222334445555
Q ss_pred eEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCC
Q 001253 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGN 616 (1114)
Q Consensus 561 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 616 (1114)
+.+++.++.++......|.++.+|+.+.|..+ ++.+-..+|.++++|+.+.+..+
T Consensus 289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred ccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 55555555555344445555555555555433 44333445666666666655443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.56 E-value=1.2e-10 Score=124.03 Aligned_cols=12 Identities=0% Similarity=-0.532 Sum_probs=10.1
Q ss_pred CCccceEEEecC
Q 001253 63 PCGWIGVNCTTN 74 (1114)
Q Consensus 63 ~C~w~gv~C~~~ 74 (1114)
.|.|.|+.|+.+
T Consensus 77 l~~~~g~i~~~~ 88 (267)
T 3rw6_A 77 LKAVNYKILDRE 88 (267)
T ss_dssp HHHTTSSCBCTT
T ss_pred HHhcCcEEECCC
Confidence 489999999865
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.33 E-value=8.1e-08 Score=102.26 Aligned_cols=16 Identities=25% Similarity=0.264 Sum_probs=8.1
Q ss_pred cceEEECccccccCCC
Q 001253 559 MLQRLDLSWNKFVGAL 574 (1114)
Q Consensus 559 ~L~~L~Ls~N~l~~~~ 574 (1114)
+|+.|+|++|.+.+.+
T Consensus 221 ~L~~L~L~~Npl~~~~ 236 (267)
T 3rw6_A 221 KLEELWLDGNSLCDTF 236 (267)
T ss_dssp CCSEEECTTSTTGGGC
T ss_pred CcceEEccCCcCcccc
Confidence 4555555555555433
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3e-06 Score=91.80 Aligned_cols=135 Identities=18% Similarity=0.151 Sum_probs=98.4
Q ss_pred eecccCCe-EEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEEEEecCCC
Q 001253 816 VIGRGACG-TVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 816 ~lG~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
.+..|..| .||+.... ++..+++|+-... ....+.+|...++.+. +--+.++++++.+.+..++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 45556665 69998865 4678999986532 2456788998888774 33477888899999999999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD-------------------------------------------- 928 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------------------- 928 (1114)
.++.+..... ......++.++++.++.||+.
T Consensus 105 ~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 105 KTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp EEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8887765421 122344566666777777652
Q ss_pred -----------CCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 929 -----------CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 929 -----------~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012489999999999999887778999998875
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.26 E-value=1.6e-07 Score=95.27 Aligned_cols=14 Identities=7% Similarity=-0.128 Sum_probs=7.1
Q ss_pred cccccccccCCCcC
Q 001253 605 LSRLTELQMGGNSF 618 (1114)
Q Consensus 605 l~~L~~L~ls~N~l 618 (1114)
.++|++|+|++|.+
T Consensus 150 n~~L~~L~L~~n~i 163 (185)
T 1io0_A 150 NTTLLKFGYHFTQQ 163 (185)
T ss_dssp CSSCCEEECCCSSH
T ss_pred CCCcCEEeccCCCC
Confidence 34455555555544
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.26 E-value=1.2e-07 Score=96.17 Aligned_cols=116 Identities=14% Similarity=0.138 Sum_probs=67.5
Q ss_pred chhhccccccEeecccc-cCCCC----ccccccccccCcEEEecCceeccC----CCccccCCCCcceeeccccccccc-
Q 001253 480 SDLCKLANLSTVELDQN-QFSGP----IPTEIGNCNALQRLHLSDNYFTGE----LPREVGNLSNLVTFNVSSNFLTGR- 549 (1114)
Q Consensus 480 ~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~- 549 (1114)
..+...+.|++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+..
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34555667777777777 76532 233445566777777777776532 223344445677777777776632
Q ss_pred ---ccccccccccceEEEC--ccccccCCC----chhhhhcccCCeeeccCccCC
Q 001253 550 ---IPLEIFSCKMLQRLDL--SWNKFVGAL----PREIGSLFQLELLKLSENELS 595 (1114)
Q Consensus 550 ---~p~~~~~l~~L~~L~L--s~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~ 595 (1114)
+...+...+.|+.|+| ++|.+.... ...+...+.|++|+|++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3344455566777777 666665432 223334466667777666664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=6.3e-06 Score=90.91 Aligned_cols=136 Identities=21% Similarity=0.174 Sum_probs=96.0
Q ss_pred CceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCC---ceeeEEeEEE-ecCceEEEEec
Q 001253 814 RFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR---NIVKLYGFCY-HQGSNLLMYEY 889 (1114)
Q Consensus 814 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E~ 889 (1114)
.+.++.|....||+. |+.+++|+... ......+.+|+.+++.+.+. .+.+++.++. ..+..++||||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 346888999999998 67789998532 12356788999999998642 3566666664 34567899999
Q ss_pred CCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 001253 890 MARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD----------------------------------------- 928 (1114)
Q Consensus 890 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------------- 928 (1114)
++|..+.+..- ..++..++..++.++++.|+.||+.
T Consensus 95 i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 95 VQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred cCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 99988776321 1234455555555555555555542
Q ss_pred ----------------CCCCeEecCCCCCCeEECC---CCC-eEEeeccCcee
Q 001253 929 ----------------CKPRIFHRDIKSNNILLDD---KFE-AHVGDFGLAKV 961 (1114)
Q Consensus 929 ----------------~~~~ivH~Dlk~~Nill~~---~~~-~kl~DfG~a~~ 961 (1114)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2336799999999999987 455 48999998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=4.7e-06 Score=94.34 Aligned_cols=84 Identities=5% Similarity=0.034 Sum_probs=55.2
Q ss_pred Ccee-cccCCeEEEEEEeC-------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-C--CceeeEEeEEEec--
Q 001253 814 RFVI-GRGACGTVYRAVLR-------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-H--RNIVKLYGFCYHQ-- 880 (1114)
Q Consensus 814 ~~~l-G~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 880 (1114)
.+.| +.|....+|+.... +++.+++|+..............+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3467 88999999998764 26789999865432000000123667888887774 2 3567777777655
Q ss_pred -CceEEEEecCCCCCHHH
Q 001253 881 -GSNLLMYEYMARGSLGE 897 (1114)
Q Consensus 881 -~~~~lv~E~~~~gsL~~ 897 (1114)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999876543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=9.7e-05 Score=84.75 Aligned_cols=78 Identities=12% Similarity=0.060 Sum_probs=49.2
Q ss_pred CceecccCCeEEEEEEeC-CCcEEEEEEecccCC----CChhhHHHHHHHHHHHhcCCC--C-ceeeEEeEEEecCceEE
Q 001253 814 RFVIGRGACGTVYRAVLR-TGHTVAVKKLASNRE----GNNNVDNSFRAEILTLGKIRH--R-NIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 814 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l 885 (1114)
.+.||.|..+.||+++.. +++.|+||....... ........+..|..+++.+.. | .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357999999999999865 468999998754321 000112345678888876632 3 34455543 4556789
Q ss_pred EEecCCCC
Q 001253 886 MYEYMARG 893 (1114)
Q Consensus 886 v~E~~~~g 893 (1114)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00015 Score=81.37 Aligned_cols=139 Identities=16% Similarity=0.244 Sum_probs=79.3
Q ss_pred ceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-----CCceeeEE-e--EEEecCceEEE
Q 001253 815 FVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-----HRNIVKLY-G--FCYHQGSNLLM 886 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv 886 (1114)
+.|+.|..+.||++...+| .+++|+.... ...+..|+.+++.+. .|.++... | +....+..++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 3466678899999987654 5899998652 122334455444442 34443310 0 12346678999
Q ss_pred EecCCCCCHH-----H------H---hcc----C--C-------CCCCHHHHH---------------------------
Q 001253 887 YEYMARGSLG-----E------L---LHG----A--S-------STLDWQTRF--------------------------- 912 (1114)
Q Consensus 887 ~E~~~~gsL~-----~------~---l~~----~--~-------~~l~~~~~~--------------------------- 912 (1114)
|||++|..+. + . +|. . . ....|....
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986542 1 1 111 1 0 011232110
Q ss_pred ----HHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 913 ----MIALGAAEGLSYLHH----------DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 913 ----~i~~~i~~~L~~LH~----------~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
.+...+..++++++. ...+.++|+|+++.||+++.++.+.++||+.+..
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111123345666653 1245899999999999998888999999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.64 E-value=7.1e-05 Score=86.53 Aligned_cols=77 Identities=14% Similarity=0.085 Sum_probs=48.1
Q ss_pred CCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccccc--cccccCccccccC---CCCcccchHHHHHHHH
Q 001253 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAG--SYGYIAPEYAYTM---KVTEKCDIYSYGVVLL 1004 (1114)
Q Consensus 930 ~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~---~~~~~~DvwslGvil~ 1004 (1114)
.+.++|+|+++.|||++.++ ++++||+.+.... +. ........ ...|++|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~-p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP-MG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC-HH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc-hH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 34899999999999999876 9999999988642 11 11111111 1346666554311 1122345567777888
Q ss_pred HHHhC
Q 001253 1005 ELLTG 1009 (1114)
Q Consensus 1005 el~tg 1009 (1114)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.60 E-value=2.3e-05 Score=77.12 Aligned_cols=84 Identities=13% Similarity=0.127 Sum_probs=48.5
Q ss_pred CccceeeccccccCCCCcccccccccccEEEecCCc-ccCccccccccc----cccchhhccccc-ccCCchhhhcCCCc
Q 001253 222 ESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQ-LSGVIPKELGNC----TSLETLALYDNK-QVGQLPKELGSIGS 295 (1114)
Q Consensus 222 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~l~~l----~~L~~L~Ls~N~-~~~~~p~~~~~l~~ 295 (1114)
..|++|||+++.++...-..+..+++|++|+|++|. |++.--..++.+ ++|++|+|++|. ++...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356777777776665445556666677777777763 554333344442 356666666653 44444444555666
Q ss_pred cceeeecccc
Q 001253 296 LKYLYIYRNE 305 (1114)
Q Consensus 296 L~~L~L~~n~ 305 (1114)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666666553
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00021 Score=78.28 Aligned_cols=136 Identities=23% Similarity=0.252 Sum_probs=91.8
Q ss_pred CceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC---CCceeeEEeEEEecCceEEEEecC
Q 001253 814 RFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR---HRNIVKLYGFCYHQGSNLLMYEYM 890 (1114)
Q Consensus 814 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~ 890 (1114)
.+.|+.|....+|+.... +..+++|+.... ....+..|+..++.+. ...+++++.++...+..++||||+
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 457999999999999864 678999987542 1456888988888774 357888888888888899999999
Q ss_pred CCCCHH--------HH---hccCCC---------------------CCCHHHHH---HHHH----------------HHH
Q 001253 891 ARGSLG--------EL---LHGASS---------------------TLDWQTRF---MIAL----------------GAA 919 (1114)
Q Consensus 891 ~~gsL~--------~~---l~~~~~---------------------~l~~~~~~---~i~~----------------~i~ 919 (1114)
++..+. +. ++.... .-+|.... ++.. .++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 997642 11 222111 12454332 1111 111
Q ss_pred HH-HHHHHh-CCCCCeEecCCCCCCeEECCCCCeEEeecc
Q 001253 920 EG-LSYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957 (1114)
Q Consensus 920 ~~-L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 957 (1114)
+. .+.|.. ...+.++|+|+.+.|++++.++ +.|+|++
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 223321 2257899999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00022 Score=77.68 Aligned_cols=80 Identities=23% Similarity=0.293 Sum_probs=57.1
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC---CceeeEEeEEEecCceEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH---RNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~l 885 (1114)
.+...+..+|.|..+.||+.+..+|+.|++|+........ ...|+.|+..++.+.- --+.+++++ +..++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~l 87 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTL 87 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec----cCceE
Confidence 3455667899999999999999999999999876443322 3357889888887742 134444443 23579
Q ss_pred EEecCCCCCH
Q 001253 886 MYEYMARGSL 895 (1114)
Q Consensus 886 v~E~~~~gsL 895 (1114)
||||++++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987643
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.49 E-value=3.8e-05 Score=75.57 Aligned_cols=82 Identities=10% Similarity=0.042 Sum_probs=38.1
Q ss_pred cCcEEEecCceeccCCCccccCCCCcceeeccccc-cccccccccccc----ccceEEECcccc-ccCCCchhhhhcccC
Q 001253 511 ALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNF-LTGRIPLEIFSC----KMLQRLDLSWNK-FVGALPREIGSLFQL 584 (1114)
Q Consensus 511 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L 584 (1114)
+|+.|||+++.|+..--..+.++++|+.|+|++|. +++.--..+..+ ++|+.|+|++|. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45566666655554333444555555555555553 443222222222 245555555542 443322334444445
Q ss_pred CeeeccCc
Q 001253 585 ELLKLSEN 592 (1114)
Q Consensus 585 ~~L~L~~N 592 (1114)
+.|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00014 Score=68.38 Aligned_cols=84 Identities=15% Similarity=0.139 Sum_probs=59.2
Q ss_pred Hhhccccccc-ccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCCccccccccccc--ccC
Q 001253 635 ALNLSYNNLS-GLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNS--FSG 711 (1114)
Q Consensus 635 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~~~~~~~~~~~--~~~ 711 (1114)
.++.+++.|+ ..+|..+. .+|++|||++|+|+...++.|..+++|+.|+|++|+|.+.+-..+...++.... ...
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~wl~~~~~~~~~ 89 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAGRPERAPY 89 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHHHHTSSCSGGG
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHHHHhCcccccc
Confidence 4677777776 34565543 268899999999998888899999999999999999999776544434433221 112
Q ss_pred CCCCCCCCC
Q 001253 712 SKGLCGGPL 720 (1114)
Q Consensus 712 n~~lc~~p~ 720 (1114)
....|..|.
T Consensus 90 ~~~~C~~P~ 98 (130)
T 3rfe_A 90 RDLRCVAPP 98 (130)
T ss_dssp TTCBCCBST
T ss_pred cCcEeCcCh
Confidence 345666554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0011 Score=72.61 Aligned_cols=137 Identities=13% Similarity=0.133 Sum_probs=74.8
Q ss_pred CceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCce-eeEEeEEEecCceEEEEecC-C
Q 001253 814 RFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI-VKLYGFCYHQGSNLLMYEYM-A 891 (1114)
Q Consensus 814 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~-~ 891 (1114)
.+.|+.|....+|++ +.+++|+........ .....|+.+++.+....+ .+++++ +.+.-++|+||+ +
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 568999999999999 568899876532211 113457766666642222 344433 344567999999 6
Q ss_pred CCCHHH--------H----------hccCCCCC----CH-HHHHHHHH--------------HHHHHH----HHHHh-CC
Q 001253 892 RGSLGE--------L----------LHGASSTL----DW-QTRFMIAL--------------GAAEGL----SYLHH-DC 929 (1114)
Q Consensus 892 ~gsL~~--------~----------l~~~~~~l----~~-~~~~~i~~--------------~i~~~L----~~LH~-~~ 929 (1114)
|.++.. . +|.....+ .. .....+.. .+.+.+ +.+.. ..
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 544421 0 11111100 11 11000000 011111 11111 12
Q ss_pred CCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 930 ~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.+.++|+|+.+.||+ ..++.+.++||..+...
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 346899999999999 56668899999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0017 Score=71.90 Aligned_cols=156 Identities=13% Similarity=0.105 Sum_probs=85.4
Q ss_pred CHHHHHHHhcCCcC-----CceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCc--eee
Q 001253 800 TFKDLVVATDNFDE-----RFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN--IVK 872 (1114)
Q Consensus 800 ~~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 872 (1114)
+.+++...-.+|.. .+.|+.|....+|+....+| .+++|+...... ...+..|+.+++.+.... +.+
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCCc
Confidence 34444433344554 24577788899999987655 688998865311 123455666666553211 233
Q ss_pred EEeE------EEecCceEEEEecCCCCCHHH-----H---------hcc----CCCC----C---CHHHHHH--------
Q 001253 873 LYGF------CYHQGSNLLMYEYMARGSLGE-----L---------LHG----ASST----L---DWQTRFM-------- 913 (1114)
Q Consensus 873 l~~~------~~~~~~~~lv~E~~~~gsL~~-----~---------l~~----~~~~----l---~~~~~~~-------- 913 (1114)
++.. ....+..+++|+|++|..+.. + ++. .... . .|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 123456789999999865321 0 111 0100 1 1222110
Q ss_pred ----HHHHHHHHHHHHHhC----CCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 914 ----IALGAAEGLSYLHHD----CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 914 ----i~~~i~~~L~~LH~~----~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
+...+.+.+++++.. ...+++|+|+.+.||++++++.+.++||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555532 234799999999999999876668999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0024 Score=71.09 Aligned_cols=139 Identities=17% Similarity=0.139 Sum_probs=72.0
Q ss_pred eecccCCeE-EEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC--CceeeEEeEEEecCceEEEEecCCC
Q 001253 816 VIGRGACGT-VYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH--RNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 816 ~lG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
.|+.|+... +|+....+|+.+++|....... ..+..|+.+++.+.. -.+.+++.+.. +.-+++||++++
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~ 96 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGD 96 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCS
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCC
Confidence 465565554 6677654467788876544321 113345666555532 23455665533 233789999987
Q ss_pred CCHHHHhccC---------------------C----CCCCHHHHH-------H-H------------HHHHHHHHHHHHh
Q 001253 893 GSLGELLHGA---------------------S----STLDWQTRF-------M-I------------ALGAAEGLSYLHH 927 (1114)
Q Consensus 893 gsL~~~l~~~---------------------~----~~l~~~~~~-------~-i------------~~~i~~~L~~LH~ 927 (1114)
..+.+++... . ..++..... . + ...+...++.+..
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 6665433210 0 011111100 0 0 0011122222211
Q ss_pred ---CCCCCeEecCCCCCCeEECCC----CCeEEeeccCceec
Q 001253 928 ---DCKPRIFHRDIKSNNILLDDK----FEAHVGDFGLAKVI 962 (1114)
Q Consensus 928 ---~~~~~ivH~Dlk~~Nill~~~----~~~kl~DfG~a~~~ 962 (1114)
...+.++|||+.+.||+++.+ +.+.++||+.+...
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123589999999999999875 67999999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0048 Score=68.38 Aligned_cols=140 Identities=14% Similarity=0.123 Sum_probs=81.9
Q ss_pred ceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCC--ceeeEEeE-----EEecCceEEEE
Q 001253 815 FVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR--NIVKLYGF-----CYHQGSNLLMY 887 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~ 887 (1114)
..++ |....||+....+|+.+++|+....... ...+..|..+++.+... .+++++.. ....+..++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 4577 8889999988777878999998643221 34566677777766321 23444432 22345668899
Q ss_pred ecCCCCCHH-----HH---------hc----cC----CCCCCHHHH----HHH---------------HHHHHHHHHHHH
Q 001253 888 EYMARGSLG-----EL---------LH----GA----SSTLDWQTR----FMI---------------ALGAAEGLSYLH 926 (1114)
Q Consensus 888 E~~~~gsL~-----~~---------l~----~~----~~~l~~~~~----~~i---------------~~~i~~~L~~LH 926 (1114)
||++|..+. .+ +| .. ....++... ..+ ...+.+.++.+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999885432 11 11 00 011222211 000 011112233332
Q ss_pred hC----CCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 927 HD----CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 927 ~~----~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
.. ....++|+|+++.||+++ + .+.++||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 21 234789999999999999 4 899999998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0034 Score=70.59 Aligned_cols=139 Identities=17% Similarity=0.206 Sum_probs=81.4
Q ss_pred ceecccCCeEEEEEEeC--------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEE
Q 001253 815 FVIGRGACGTVYRAVLR--------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 885 (1114)
+.+..|....+|++... +++.|++|+...... ....+.+|..+++.+. +.-..++++++.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~----~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ----GVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C----CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc----hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 46777888999999874 247899998633211 1345668888887774 3223566665543 39
Q ss_pred EEecCCCCCHHHH-----------------hccC----CCCCC--HHHHHHHHHHHH-------------------HHHH
Q 001253 886 MYEYMARGSLGEL-----------------LHGA----SSTLD--WQTRFMIALGAA-------------------EGLS 923 (1114)
Q Consensus 886 v~E~~~~gsL~~~-----------------l~~~----~~~l~--~~~~~~i~~~i~-------------------~~L~ 923 (1114)
||||++|.++..- +|.. ..... +.+..++..++. ..++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998654311 1111 11122 344444443332 1223
Q ss_pred HHH----hC-CCCCeEecCCCCCCeEECCC----CCeEEeeccCcee
Q 001253 924 YLH----HD-CKPRIFHRDIKSNNILLDDK----FEAHVGDFGLAKV 961 (1114)
Q Consensus 924 ~LH----~~-~~~~ivH~Dlk~~Nill~~~----~~~kl~DfG~a~~ 961 (1114)
.|. .. ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 21 23479999999999999876 7899999998874
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.00022 Score=71.58 Aligned_cols=15 Identities=13% Similarity=0.164 Sum_probs=7.7
Q ss_pred CCCCcceeecccccc
Q 001253 532 NLSNLVTFNVSSNFL 546 (1114)
Q Consensus 532 ~l~~L~~L~Ls~N~l 546 (1114)
.-+.|+.|+++.|.+
T Consensus 155 ~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 155 ENESLLRVGISFASM 169 (197)
T ss_dssp HCSSCCEEECCCCCH
T ss_pred hCCCcCeEeccCCCc
Confidence 334555555555544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0036 Score=72.05 Aligned_cols=72 Identities=19% Similarity=0.240 Sum_probs=48.2
Q ss_pred ceecccCCeEEEEEEeCC--------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCc-eeeEEeEEEecCceEE
Q 001253 815 FVIGRGACGTVYRAVLRT--------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN-IVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l 885 (1114)
+.|+.|....||++...+ ++.+++|+.... .. ...+..|..+++.+...+ ..++++.+.+ .+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 468889999999998753 578999998432 11 134557888887774323 3566665532 38
Q ss_pred EEecCCCCCH
Q 001253 886 MYEYMARGSL 895 (1114)
Q Consensus 886 v~E~~~~gsL 895 (1114)
||||++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999986443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.00053 Score=68.75 Aligned_cols=14 Identities=29% Similarity=0.591 Sum_probs=6.7
Q ss_pred ccCcEEEecCceec
Q 001253 510 NALQRLHLSDNYFT 523 (1114)
Q Consensus 510 ~~L~~L~Ls~N~l~ 523 (1114)
+.|+.|+|++|+|.
T Consensus 98 ~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 98 PSLRVLNVESNFLT 111 (197)
T ss_dssp SSCCEEECCSSBCC
T ss_pred CccCeEecCCCcCC
Confidence 44444555555444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.01 Score=68.49 Aligned_cols=73 Identities=15% Similarity=0.124 Sum_probs=47.0
Q ss_pred ceecccCCeEEEEEEeCC-CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCce-eeEEeEEEecCceEEEEecCCC
Q 001253 815 FVIGRGACGTVYRAVLRT-GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNI-VKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
+.|+.|....+|++...+ ++.+++|+........ -+..+|..+++.+...++ .++++++. + .+||||++|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 468889999999999874 4789999875432211 112568888887754333 56666652 2 369999987
Q ss_pred CCH
Q 001253 893 GSL 895 (1114)
Q Consensus 893 gsL 895 (1114)
.++
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0054 Score=69.28 Aligned_cols=73 Identities=11% Similarity=0.070 Sum_probs=43.1
Q ss_pred ceecccCCeEEEEEEeCC---------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCc-eeeEEeEEEecCceE
Q 001253 815 FVIGRGACGTVYRAVLRT---------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN-IVKLYGFCYHQGSNL 884 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~ 884 (1114)
..++.|....+|+....+ ++.+++|+....... ..+...|..+++.+...+ +.++++.. . -+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 467888889999998764 268888887543211 112356777777664223 34555443 2 37
Q ss_pred EEEecCCCCCH
Q 001253 885 LMYEYMARGSL 895 (1114)
Q Consensus 885 lv~E~~~~gsL 895 (1114)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999998543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.024 Score=62.89 Aligned_cols=32 Identities=19% Similarity=0.284 Sum_probs=28.7
Q ss_pred CCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 931 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 931 ~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
..++|+|+.+.||++++++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998888999999988753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.85 E-value=0.038 Score=55.50 Aligned_cols=102 Identities=18% Similarity=0.173 Sum_probs=68.0
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCccccc
Q 001253 894 SLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAI 973 (1114)
Q Consensus 894 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 973 (1114)
+|.++|+..+.++++++++.++.|.+++|.-.-....+ ..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-------------
Confidence 89999998889999999999999999998776321111 1333456899999999988753 1110
Q ss_pred cccccccCccccccCCCCcccchHHHHHHHHHHHhCCCC
Q 001253 974 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012 (1114)
Q Consensus 974 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p 1012 (1114)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122366788653 3456788899999999998874433
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.83 E-value=0.0095 Score=55.68 Aligned_cols=36 Identities=25% Similarity=0.226 Sum_probs=17.0
Q ss_pred cCcEEEecCceeccCCCccccCCCCcceeecccccc
Q 001253 511 ALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFL 546 (1114)
Q Consensus 511 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 546 (1114)
+|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 345555555555544444444444444444444443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.36 E-value=0.056 Score=61.53 Aligned_cols=73 Identities=7% Similarity=0.000 Sum_probs=46.9
Q ss_pred ceecccCCeEEEEEEeCC--------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEE
Q 001253 815 FVIGRGACGTVYRAVLRT--------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 885 (1114)
+.+..|....+|+....+ ++.|++|+....... .-+..+|..+++.+. +.-..++++.+ .-++
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~----~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~ 147 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK----FYDSKVELDVFRYLSNINIAPNIIADF----PEGR 147 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C----CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch----hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCE
Confidence 467778889999998763 578999986543221 112356777777664 22244555433 2378
Q ss_pred EEecCCCCCH
Q 001253 886 MYEYMARGSL 895 (1114)
Q Consensus 886 v~E~~~~gsL 895 (1114)
||||++|.++
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.37 E-value=0.17 Score=57.36 Aligned_cols=30 Identities=30% Similarity=0.410 Sum_probs=25.7
Q ss_pred CeEecCCCCCCeEE------CCCCCeEEeeccCcee
Q 001253 932 RIFHRDIKSNNILL------DDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 932 ~ivH~Dlk~~Nill------~~~~~~kl~DfG~a~~ 961 (1114)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1114 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-30 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-23 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-12 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 6e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 9e-66
Identities = 71/274 (25%), Positives = 114/274 (41%), Gaps = 23/274 (8%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG G+ GTVY+ VAVK L + +F+ E+ L K RH NI+ G
Sbjct: 15 RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHVNILLFMG 71
Query: 876 FCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935
+ ++ ++ SL LH + + IA A+G+ YLH I H
Sbjct: 72 YS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 936 RDIKSNNILLDDKFEAHVGDFGLAKVID-MPQSKSMSAIAGSYGYIAPEYAYTMK---VT 991
RD+KSNNI L + +GDFGLA V S ++GS ++APE +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 992 EKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKT 1051
+ D+Y++G+VL EL+TG+ P + + + L + R N
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPY----SNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA-- 241
Query: 1052 VSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ ++ C +RP +++ +
Sbjct: 242 ------MKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 2e-64
Identities = 61/281 (21%), Positives = 107/281 (38%), Gaps = 23/281 (8%)
Query: 805 VVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGK 864
V+ IG G G V+ VA+K + + F E + K
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMK 56
Query: 865 IRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSY 924
+ H +V+LYG C Q L++E+M G L + L +T + L EG+
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM-- 114
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
+ + + HRD+ + N L+ + V DFG+ + + Q S + + +PE
Sbjct: 115 -AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 173
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044
+ + K D++S+GV++ E+ + ++V + R
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------- 220
Query: 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
L + S V +I C P DRP ++ L+E
Sbjct: 221 -LYKPRLASTH--VYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 4e-63
Identities = 64/278 (23%), Positives = 113/278 (40%), Gaps = 25/278 (8%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
+ +G G G V+ VAVK L ++F AE + +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQ 68
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASST-LDWQTRFMIALGAAEGLSYLHH 927
+V+LY Q ++ EYM GSL + L S L +A AEG++++
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
HRD+++ NIL+ D + DFGLA++I+ + + + APE
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047
T K D++S+G++L E++T P +++ + R +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------MV 230
Query: 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ ++ LC P DRPT + +L +
Sbjct: 231 RPDNCPE--ELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 7e-62
Identities = 68/301 (22%), Positives = 130/301 (43%), Gaps = 35/301 (11%)
Query: 806 VATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGK 864
+ D+F++ +G G G V++ + +G +A K + + E + N E+ L +
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHE 60
Query: 865 IRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSY 924
IV YG Y G + E+M GSL ++L + + Q +++ +GL+Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTY 119
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
L +I HRD+K +NIL++ + E + DFG++ + + S G+ Y++PE
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPER 174
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLD------------QGGDLVTWVRNFIRN 1032
+ + DI+S G+ L+E+ GR P+ P D +G T R
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 1033 NSLVSGMLDARLNLQDEKTVSHMIT--------------VLKIAMLCTNISPFDRPTMRE 1078
L S +D+R + + + +++ C +P +R +++
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 1079 V 1079
+
Sbjct: 295 L 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 3e-61
Identities = 58/277 (20%), Positives = 102/277 (36%), Gaps = 23/277 (8%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
+ +G G G V R + VA+K + ++ F E + + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHE 59
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
+V+LYG C Q ++ EYMA G L L Q + E + YL
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES- 118
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM 988
+ HRD+ + N L++D+ V DFGL++ + + S + PE
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 989 KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048
K + K DI+++GV++ E+ + + + +R L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--------------LYR 222
Query: 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
S V I C + +RPT + ++ + +
Sbjct: 223 PHLASEK--VYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 6e-61
Identities = 67/303 (22%), Positives = 116/303 (38%), Gaps = 33/303 (10%)
Query: 802 KDLVVATDNFD-ERFVIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRA 857
K L + DN +G G G+V + V R VA+K L +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMR 58
Query: 858 EILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALG 917
E + ++ + IV+L G C + L+M E G L + L G + +
Sbjct: 59 EAQIMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 918 AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAIAG 975
+ G+ YL HRD+ + N+LL ++ A + DFGL+K + D + SA
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 976 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL 1035
+ APE K + + D++SYGV + E L+ +G +++ ++ R
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 230
Query: 1036 VSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML-----SESNRRQ 1090
++ E + + C DRP V + S +++ +
Sbjct: 231 ----MECPPECPPE--------LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
Query: 1091 GHF 1093
GH
Sbjct: 279 GHH 281
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 8e-61
Identities = 65/293 (22%), Positives = 116/293 (39%), Gaps = 25/293 (8%)
Query: 794 PPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDN 853
P +G + ++ +G+G G V+ VA+K L
Sbjct: 2 PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PE 57
Query: 854 SFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLD-WQTRF 912
+F E + K+RH +V+LY + ++ EYM++GSL + L G +
Sbjct: 58 AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLV 116
Query: 913 MIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 972
+A A G++Y+ HRD+++ NIL+ + V DFGLA++I+ + +
Sbjct: 117 DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173
Query: 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN 1032
+ APE A + T K D++S+G++L EL T P +++ V R
Sbjct: 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR- 232
Query: 1033 NSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ + + + C P +RPT + L +
Sbjct: 233 -------MPCPPECPES--------LHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (527), Expect = 1e-60
Identities = 69/312 (22%), Positives = 113/312 (36%), Gaps = 41/312 (13%)
Query: 791 IYFPPKEGFTFKDLVVATDNFDERF---------VIGRGACGTVYRAVLR----TGHTVA 837
I+ P FTF+D A F + VIG G G V L+ VA
Sbjct: 2 IFIDP---FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVA 58
Query: 838 VKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGE 897
+K L F +E +G+ H N++ L G +++ E+M GSL
Sbjct: 59 IKTL--KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 116
Query: 898 LLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957
L + G A G+ YL HRD+ + NIL++ V DFG
Sbjct: 117 FLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFG 173
Query: 958 LAKVID----MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPV 1013
L++ ++ P S + APE K T D++SYG+V+ E+++
Sbjct: 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233
Query: 1014 QPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDR 1073
D++ + R L ++ + ++ + C R
Sbjct: 234 YWDMTNQDVINAIEQDYR--------LPPPMDCPSA--------LHQLMLDCWQKDRNHR 277
Query: 1074 PTMREVVLMLSE 1085
P ++V L +
Sbjct: 278 PKFGQIVNTLDK 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 7e-60
Identities = 72/299 (24%), Positives = 117/299 (39%), Gaps = 29/299 (9%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYG 875
IG+G G V+R G VAVK +S E AEI +RH NI+
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIA 64
Query: 876 FCYHQGSNL----LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC-- 929
L+ +Y GSL + L+ T+ + +AL A GL++LH +
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 930 ---KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ---SKSMSAIAGSYGYIAPE 983
KP I HRD+KS NIL+ + D GLA D + + G+ Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 984 YAYTM------KVTEKCDIYSYGVVLLELLTGRAPVQPL-DQGGDLVTWVRNFIRNNSLV 1036
+ ++ DIY+ G+V E+ + D V + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 1037 SGMLDARLNLQ---DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGH 1092
+ + +L ++ + + KI C + R T + LS+ ++++G
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 4e-59
Identities = 75/295 (25%), Positives = 121/295 (41%), Gaps = 31/295 (10%)
Query: 801 FKDLVVATDNFDERF--VIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNS 854
+ +V+ + F VIGRG G VY L AVK L NR + +
Sbjct: 17 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQ 74
Query: 855 FRAEILTLGKIRHRNIVKLYGFCYH-QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFM 913
F E + + H N++ L G C +GS L++ YM G L + + +
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134
Query: 914 IALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS---M 970
L A+G+ + HRD+ + N +LD+KF V DFGLA+ + + S
Sbjct: 135 FGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 971 SAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFI 1030
+ ++A E T K T K D++S+GV+L EL+T AP P D+ ++
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 251
Query: 1031 RNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
R L + + ++ + C + RP+ E+V +S
Sbjct: 252 R--------------LLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-58
Identities = 63/287 (21%), Positives = 112/287 (39%), Gaps = 28/287 (9%)
Query: 806 VATDNFDERFVIGRGACGTVYRAVLRTGH-----TVAVKKLASNREGNNNVDNSFRAEIL 860
+ + VIG G G VY+ +L+T VA+K L F E
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAG 61
Query: 861 TLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE 920
+G+ H NI++L G +++ EYM G+L + L + G A
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAIAGSYG 978
G + + HRD+ + NIL++ V DFGL++V+ D + + S
Sbjct: 122 G---MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 979 YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038
+ APE K T D++S+G+V+ E++T +++ + + R
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR------- 231
Query: 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
L ++ + ++ M C RP ++V +L +
Sbjct: 232 -LPTPMDCPSA--------IYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 1e-57
Identities = 71/273 (26%), Positives = 112/273 (41%), Gaps = 26/273 (9%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
++F+ +G+G G VY A + + +A+K L + V++ R E+ +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
NI++LYG+ + L+ EY G++ L S D Q A LSY H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCH- 123
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
R+ HRDIK N+LL E + DFG + S + + G+ Y+ PE
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEG 178
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047
EK D++S GV+ E L G+ P F N + +R+
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPP----------------FEANTYQETYKRISRVEFT 222
Query: 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVV 1080
V+ + +P RP +REV+
Sbjct: 223 FPDFVTEG--ARDLISRLLKHNPSQRPMLREVL 253
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 1e-57
Identities = 70/279 (25%), Positives = 111/279 (39%), Gaps = 31/279 (11%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
IG+G G V R G+ VAVK + N+ +F AE + ++RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK-----NDATAQAFLAEASVMTQLRHS 60
Query: 869 NIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLH 926
N+V+L G + L ++ EYMA+GSL + L S L +L E + YL
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY 986
HRD+ + N+L+ + A V DFGL K Q + APE
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALR 173
Query: 987 TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046
K + K D++S+G++L E+ + P D+V V + +DA
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDAPDGC 225
Query: 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
V ++ C ++ RP+ ++ L
Sbjct: 226 PPA--------VYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (503), Expect = 2e-57
Identities = 62/287 (21%), Positives = 114/287 (39%), Gaps = 25/287 (8%)
Query: 801 FKDLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEI 859
+ + + + +G G G VY V + TVAVK L + F E
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEA 64
Query: 860 LTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASS-TLDWQTRFMIALGA 918
+ +I+H N+V+L G C + ++ E+M G+L + L + + +A
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG 978
+ + YL K HRD+ + N L+ + V DFGL++++ + +
Sbjct: 125 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181
Query: 979 YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038
+ APE K + K D++++GV+L E+ T P + S V
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------------DLSQVYE 227
Query: 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+L+ ++ + V ++ C +P DRP+ E+
Sbjct: 228 LLEKDYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 4e-57
Identities = 63/291 (21%), Positives = 114/291 (39%), Gaps = 31/291 (10%)
Query: 810 NFDERFVIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
+++ +G G GTV + + TVAVK L N + + + AE + ++
Sbjct: 9 TLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLD 66
Query: 867 HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH 926
+ IV++ G C + S +L+ E G L + L + + + + + G+ YL
Sbjct: 67 NPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLE 124
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAIAGSYGYIAPEY 984
HRD+ + N+LL + A + DFGL+K + D K+ + + APE
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044
K + K D++S+GV++ E + +G ++ + R +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--------MGCPA 233
Query: 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE---SNRRQGH 1092
E + + LC +RP V L L +GH
Sbjct: 234 GCPRE--------MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 276
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-56
Identities = 61/280 (21%), Positives = 110/280 (39%), Gaps = 27/280 (9%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
++++ + IG G+ G + + G + K+L +E+ L +++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKH 62
Query: 868 RNIVKLYGFCYHQGSNLLM--YEYMARGSLGELLHGASS---TLDWQTRFMIALGAAEGL 922
NIV+ Y + + L EY G L ++ + LD + + L
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 923 SYLH--HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYI 980
H D + HRD+K N+ LD K +GDFGLA++++ S A G+ Y+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYM 181
Query: 981 APEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040
+PE M EK DI+S G +L EL P Q L +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------------KELAGKIR 227
Query: 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV 1080
+ + + + ++ N+ + RP++ E++
Sbjct: 228 EGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEIL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (495), Expect = 3e-56
Identities = 72/315 (22%), Positives = 120/315 (38%), Gaps = 51/315 (16%)
Query: 801 FKDLVVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNS 854
L +N + IG GA G V++A VAVK L E + ++
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQAD 62
Query: 855 FRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHG------------- 901
F+ E + + + NIVKL G C L++EYMA G L E L
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 902 ----------ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEA 951
L + IA A G++YL + HRD+ + N L+ +
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVV 179
Query: 952 HVGDFGLAKVIDMPQ-SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGR 1010
+ DFGL++ I K+ A ++ PE + + T + D+++YGVVL E+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 1011 APVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISP 1070
+++ +VR+ L + + + + LC + P
Sbjct: 240 LQPYYGMAHEEVIYYVRDGNI--------------LACPENCP--LELYNLMRLCWSKLP 283
Query: 1071 FDRPTMREVVLMLSE 1085
DRP+ + +L
Sbjct: 284 ADRPSFCSIHRILQR 298
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (490), Expect = 2e-55
Identities = 71/280 (25%), Positives = 119/280 (42%), Gaps = 33/280 (11%)
Query: 809 DNFDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLG 863
D+ ++ F IG G+ G VY A +R VA+KK++ + + +N E+ L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 864 KIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLS 923
K+RH N ++ G + + L+ EY + +LL L + GA +GL+
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
YLH + HRD+K+ NILL + +GDFG A ++ ++ G+ ++APE
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPE 181
Query: 984 YAYTM---KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040
M + K D++S G+ +EL + P+ ++ L +N +L SG
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHW 239
Query: 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV 1080
C P DRPT ++
Sbjct: 240 SEYF--------------RNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 3e-55
Identities = 65/276 (23%), Positives = 113/276 (40%), Gaps = 30/276 (10%)
Query: 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN 869
FD IGRG+ TVY+ + T VA +L + + F+ E L ++H N
Sbjct: 13 FDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPN 69
Query: 870 IVKLYGFCYHQGSN----LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYL 925
IV+ Y +L+ E M G+L L + + +GL +L
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFL 128
Query: 926 HHDCKPRIFHRDIKSNNILLDDK-FEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
H P I HRD+K +NI + +GD GLA + +K+ + G+ ++APE
Sbjct: 129 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEM 184
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044
Y K E D+Y++G+ +LE+ T P + V + ++ S +
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE-- 241
Query: 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVV 1080
V +I C + +R ++++++
Sbjct: 242 -------------VKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-54
Identities = 70/296 (23%), Positives = 123/296 (41%), Gaps = 42/296 (14%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHT---VAVKKLASNREGNNNVDNSFRAEILTLGKI 865
++ + VIG G G V +A ++ A+K++ + + F E+ L K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKL 67
Query: 866 -RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHG---------------ASSTLDWQ 909
H NI+ L G C H+G L EY G+L + L +STL Q
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 910 TRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 969
A A G+ + + + HRD+ + NIL+ + + A + DFGL++ ++ K+
Sbjct: 128 QLLHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 970 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNF 1029
M ++A E T D++SYGV+L E+++ +L +
Sbjct: 185 MG--RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242
Query: 1030 IRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
R L+ LN DE V + C P++RP+ ++++ L+
Sbjct: 243 YR--------LEKPLNCDDE--------VYDLMRQCWREKPYERPSFAQILVSLNR 282
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 5e-54
Identities = 63/274 (22%), Positives = 104/274 (37%), Gaps = 26/274 (9%)
Query: 816 VIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIV 871
IG G G V++ + VA+K +++V F E LT+ + H +IV
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 872 KLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKP 931
KL G + ++ E G L L +LD + + A + L+YL
Sbjct: 72 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SK 127
Query: 932 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVT 991
R HRDI + N+L+ +GDFGL++ ++ S ++APE + T
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 992 EKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKT 1051
D++ +GV + E+L + D++ + N R L N
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--------LPMPPNCPPT-- 237
Query: 1052 VSHMITVLKIAMLCTNISPFDRPTMREVVLMLSE 1085
+ + C P RP E+ LS
Sbjct: 238 ------LYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 5e-54
Identities = 72/274 (26%), Positives = 113/274 (41%), Gaps = 24/274 (8%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
+++D +G GA G V AV R T VAVK + + + + + + EI + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNH 62
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
N+VK YG L EY + G L + + + G+ YLH
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP-QSKSMSAIAGSYGYIAPEYAY 986
I HRDIK N+LLD++ + DFGLA V + + ++ + G+ Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 987 TMKV-TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045
+ E D++S G+VL +L G P DQ D ++ +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE---LPWDQPSDSCQEYSDWKEK----------KTY 225
Query: 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
L K + L +L N P R T+ ++
Sbjct: 226 LNPWKKIDSAPLALLHKILVEN--PSARITIPDI 257
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-53
Identities = 68/320 (21%), Positives = 112/320 (35%), Gaps = 45/320 (14%)
Query: 791 IYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASN 844
+Y P + + +G GA G V A TVAVK L
Sbjct: 5 VYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--K 62
Query: 845 REGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHG-- 901
+ + +E+ L + H NIV L G C G L++ EY G L L
Sbjct: 63 PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122
Query: 902 ---------------ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD 946
LD + + A+G+++L HRD+ + NILL
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179
Query: 947 DKFEAHVGDFGLAKVIDMPQSKSMSA-IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLE 1005
+ DFGLA+ I + + ++APE + T + D++SYG+ L E
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239
Query: 1006 LLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLC 1065
L + G + + I+ + + + I C
Sbjct: 240 LFSLG---SSPYPGMPVDSKFYKMIKEG----------FRMLSPEHAPA--EMYDIMKTC 284
Query: 1066 TNISPFDRPTMREVVLMLSE 1085
+ P RPT +++V ++ +
Sbjct: 285 WDADPLKRPTFKQIVQLIEK 304
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-53
Identities = 67/324 (20%), Positives = 115/324 (35%), Gaps = 52/324 (16%)
Query: 791 IYFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASN 844
Y +E +N + V+G GA G V A VAVK L
Sbjct: 19 FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--K 76
Query: 845 REGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHG-- 901
+ +++ + +E+ + ++ H NIV L G C G L++EY G L L
Sbjct: 77 EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 136
Query: 902 --------------------ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSN 941
+ L ++ A A+G+ +L HRD+ +
Sbjct: 137 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193
Query: 942 NILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYG 1000
N+L+ + DFGLA+ I + ++APE + T K D++SYG
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 253
Query: 1001 VVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVL 1059
++L E+ + G P + + ++N + +D +E +
Sbjct: 254 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK--------MDQPFYATEE--------IY 297
Query: 1060 KIAMLCTNISPFDRPTMREVVLML 1083
I C RP+ + L
Sbjct: 298 IIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-53
Identities = 63/288 (21%), Positives = 104/288 (36%), Gaps = 25/288 (8%)
Query: 805 VVATDNFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREGNNNVDNSFRAEIL 860
++ + +G G+ G V R +VAVK L + + F E+
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 861 TLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE 920
+ + HRN+++LYG ++ E GSL + L T A+ AE
Sbjct: 64 AMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--MSAIAGSYG 978
G+ YL R HRD+ + N+LL + +GDFGL + + +
Sbjct: 123 GMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 979 YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038
+ APE T + D + +GV L E+ T Q G + + +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKIDKEG----- 231
Query: 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086
L + + + + C P DRPT + L E+
Sbjct: 232 -----ERLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 5e-53
Identities = 57/278 (20%), Positives = 103/278 (37%), Gaps = 28/278 (10%)
Query: 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR 866
D ++ +G GA G VY+A + T A K + + + EI L
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI---DTKSEEELEDYMVEIDILASCD 67
Query: 867 HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH 926
H NIVKL Y++ + ++ E+ A G++ ++ L ++ + L+YLH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY 986
+I HRD+K+ NIL + + DFG++ + + G+ ++APE
Sbjct: 128 ---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVM 183
Query: 987 TM-----KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041
K D++S G+ L+E+ P + + + ++
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPP----HHELNPMRVLLKIAKSE-------- 231
Query: 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
L S L N R T ++
Sbjct: 232 -PPTLAQPSRWSSNFKDFLKKCLEKN--VDARWTTSQL 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-52
Identities = 67/280 (23%), Positives = 122/280 (43%), Gaps = 29/280 (10%)
Query: 805 VVATDNFDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEI 859
+V+ + +++ IG+GA GTVY A+ + TG VA++++ ++ EI
Sbjct: 12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEI 68
Query: 860 LTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAA 919
L + + ++ NIV ++ EY+A GSL +++ + +D +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECL 126
Query: 920 EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGY 979
+ L +LH ++ HRDIKS+NILL + DFG I QSK S + G+ +
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYW 182
Query: 980 IAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039
+APE K DI+S G++ +E++ G P + + + N
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY----LNENPLRALYLIATNG------ 232
Query: 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
LQ+ + +S + L + R + +E+
Sbjct: 233 ---TPELQNPEKLSAIFRDFLNRCLDMD--VEKRGSAKEL 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-52
Identities = 72/317 (22%), Positives = 126/317 (39%), Gaps = 38/317 (11%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHT-----VAVKKLASNREGNNNVDNSFRAEILTLG 863
F + V+G GA GTVY+ + VA+K+L + + E +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMA 66
Query: 864 KIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLS 923
+ + ++ +L G C + L+ + M G L + + + Q + A+G++
Sbjct: 67 SVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 924 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAP 982
YL R+ HRD+ + N+L+ + DFGLAK++ + + ++A
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 983 EYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042
E T + D++SYGV + EL+T + P D S +S +L+
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDG------------IPASEISSILEK 228
Query: 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR-------RQGHFEF 1095
L + V I + C I RP RE+++ S+ R QG
Sbjct: 229 GERLPQPPICTID--VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 286
Query: 1096 ---SPMDHDSDQKLENE 1109
SP D + + L +E
Sbjct: 287 HLPSPTDSNFYRALMDE 303
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-51
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 6/206 (2%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
++F ++G G+ TV A L T A+K L N E + ++ H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
VKLY Y G L + + S + TRF AE +S L +
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT----AEIVSALEY 123
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS-MSAIAGSYGYIAPEYAY 986
I HRD+K NILL++ + DFG AKV+ ++ ++ G+ Y++PE
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 987 TMKVTEKCDIYSYGVVLLELLTGRAP 1012
+ D+++ G ++ +L+ G P
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 6e-51
Identities = 67/325 (20%), Positives = 124/325 (38%), Gaps = 40/325 (12%)
Query: 792 YFPPKEGFTFKDLVVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNR 845
YF + + + VA + +G+G+ G VY V + VA+K + N
Sbjct: 3 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NE 60
Query: 846 EGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLH----- 900
+ F E + + ++V+L G L++ E M RG L L
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 901 ----GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 956
+ +A A+G++YL+ + HRD+ + N ++ + F +GDF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 957 GLAKVI-DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQP 1015
G+ + I + + +++PE T D++S+GVVL E+ T
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237
Query: 1016 LDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPT 1075
++ +V G+LD N D + ++ +C +P RP+
Sbjct: 238 GLSNEQVLRFVME--------GGLLDKPDNCPDM--------LFELMRMCWQYNPKMRPS 281
Query: 1076 MREVVLMLS---ESNRRQGHFEFSP 1097
E++ + E R+ F +S
Sbjct: 282 FLEIISSIKEEMEPGFREVSFYYSE 306
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (450), Expect = 1e-49
Identities = 63/274 (22%), Positives = 112/274 (40%), Gaps = 25/274 (9%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
D++D +G GA G V+R TG+ A K + + E + + R EI T+ +RH
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRH 82
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
+V L+ +++YE+M+ G L E + + + +GL ++H
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH- 141
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYA 985
+ H D+K NI+ K + DFGL +D +S+ G+ + APE A
Sbjct: 142 --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVTTGTAEFAAPEVA 197
Query: 986 YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045
V D++S GV+ LL+G +P G+ +++ D ++
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFG-----GENDDETLRNVKSC-------DWNMD 245
Query: 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
+S +L + P R T+ +
Sbjct: 246 DSAFSGISEDGKDFIRKLLLAD--PNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (436), Expect = 1e-47
Identities = 61/298 (20%), Positives = 116/298 (38%), Gaps = 29/298 (9%)
Query: 789 SDIYFPPKEGFTFKDLVVATDNFDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLAS 843
Y + + + + V + + + +G GA G V+R V TG K + +
Sbjct: 5 DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 64
Query: 844 NREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGAS 903
+ + + EI + ++ H ++ L+ + +L+ E+++ G L + +
Sbjct: 65 PYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121
Query: 904 STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKV 961
+ A EGL ++H + I H DIK NI+ + K + V DFGLA
Sbjct: 122 YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178
Query: 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGD 1021
++ + + + + APE V D+++ GV+ LL+G +P G D
Sbjct: 179 LN--PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF----AGED 232
Query: 1022 LVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
+ ++N R D + +VS +L P R T+ +
Sbjct: 233 DLETLQNVKRC--------DWEFDEDAFSSVSPEAKDFIKNLLQKE--PRKRLTVHDA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 3e-47
Identities = 55/303 (18%), Positives = 100/303 (33%), Gaps = 31/303 (10%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
IG G+ G +Y + G VA+K + E ++ +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTI 68
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+C +G +M + SL +L + S +T ++A + Y+H
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFI 125
Query: 935 HRDIKSNNIL---LDDKFEAHVGDFGLAKVIDMPQSKSM------SAIAGSYGYIAPEYA 985
HRD+K +N L ++ DFGLAK ++ + G+ Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 986 YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045
++ + + D+ S G VL+ G P Q L + R + S +L
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDSDQK 1105
+ C ++ D+P + + RQG D +
Sbjct: 246 SE----------FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN---M 292
Query: 1106 LEN 1108
L+
Sbjct: 293 LKF 295
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (428), Expect = 5e-47
Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 9/205 (4%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
+F +G G+ G V+ R G A+K L E L L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
I++++G ++ +Y+ G L LL + + +F AE L +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA----AEVCLALEY 119
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
I +RD+K NILLD + DFG AK + + G+ YIAPE T
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVST 175
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAP 1012
+ D +S+G+++ E+L G P
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-46
Identities = 54/276 (19%), Positives = 102/276 (36%), Gaps = 30/276 (10%)
Query: 811 FDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI 865
E++ +GRG G V+R V + T K + + EI L
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIA 58
Query: 866 RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYL 925
RHRNI+ L+ ++++E+++ + E ++ ++ L+ + E L +L
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 926 HHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAIAGSYGYIAPE 983
H I H DI+ NI+ + + + +FG A+ + + + + Y APE
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPE 173
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043
V+ D++S G ++ LL+G P N ++ +++A
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------------NQQIIENIMNAE 219
Query: 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
+E I + R T E
Sbjct: 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (421), Expect = 1e-46
Identities = 67/286 (23%), Positives = 114/286 (39%), Gaps = 30/286 (10%)
Query: 810 NFDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGK 864
+ +R+ ++G G V+ A LR VAVK L ++ + + FR E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 865 IRHRNIVKLYGFCYHQGSNL----LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE 920
+ H IV +Y + ++ EY+ +L +++H + + + A +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQ 122
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS--KSMSAIAGSYG 978
L++ + I HRD+K NI++ V DFG+A+ I + +A+ G+
Sbjct: 123 ALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 979 YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038
Y++PE A V + D+YS G VL E+LTG P VR S
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRP-TMREVVLML 1083
L A L+ + + +P +R T E+ L
Sbjct: 240 GLSADLD--------------AVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 3e-46
Identities = 56/277 (20%), Positives = 100/277 (36%), Gaps = 24/277 (8%)
Query: 808 TDNFDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTL 862
++ + + V+G GA V A RT VA+K + ++ + S EI L
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI--AKKALEGKEGSMENEIAVL 61
Query: 863 GKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGL 922
KI+H NIV L G L+ + ++ G L + + + + + +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAV 120
Query: 923 SYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAP 982
YLH + LD+ + + DFGL+K+ D +S G+ GY+AP
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGYVAP 178
Query: 983 EYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042
E ++ D +S GV+ LL G P + ++ +
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPF----YDENDAKLFEQILKA--------EY 226
Query: 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
+ +S ++ + P R T +
Sbjct: 227 EFDSPYWDDISDSAKDFIRHLMEKD--PEKRFTCEQA 261
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-46
Identities = 68/302 (22%), Positives = 113/302 (37%), Gaps = 46/302 (15%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR--------TGHTVAVKKLASNREGNNNVDNSFRAEIL 860
D +G GA G V A VAVK L + + +E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEME 70
Query: 861 TLGKI-RHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLH---------------GASS 904
+ I +H+NI+ L G C G ++ EY ++G+L E L
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 905 TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964
L + A A G+ YL + HRD+ + N+L+ + + DFGLA+ I
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 965 PQSKSMS-AIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLV 1023
+ ++APE + T + D++S+GV+L E+ T P +L
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 1024 TWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLML 1083
++ R +D N +E + + C + P RPT +++V L
Sbjct: 248 KLLKEGHR--------MDKPSNCTNE--------LYMMMRDCWHAVPSQRPTFKQLVEDL 291
Query: 1084 SE 1085
Sbjct: 292 DR 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 9e-46
Identities = 73/301 (24%), Positives = 115/301 (38%), Gaps = 44/301 (14%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTL 862
D +GRGA G V A T TVAVK L ++ + +E+ L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKIL 70
Query: 863 GKIRHR-NIVKLYGFCYHQGSNL-LMYEYMARGSLGELLHG---------------ASST 905
I H N+V L G C G L ++ E+ G+L L
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 906 LDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DM 964
L + + A+G+ +L + HRD+ + NILL +K + DFGLA+ I
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVT 1024
P ++APE + T + D++S+GV+L E+ + A P G +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---GVKIDE 244
Query: 1025 WVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084
++ + R+ D T + + + C + P RPT E+V L
Sbjct: 245 EFCRRLKEGT--------RMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLG 292
Query: 1085 E 1085
Sbjct: 293 N 293
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 163 bits (414), Expect = 2e-45
Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 16/282 (5%)
Query: 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHR 868
+ + IG G G VY+A G T A+KK+ +E + + ++ EI L +++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHS 60
Query: 869 NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
NIVKLY + + +L++E++ L +LL L+ T L G++Y H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-- 117
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM 988
R+ HRD+K N+L++ + E + DFGLA+ +P K I + +
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 989 KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNF----------IRNNSLVSG 1038
K + DI+S G + E++ G + + L+ R +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 1039 MLDARLNLQDEKTVSHMITVLK-IAMLCTNISPFDRPTMREV 1079
L E + + + + P R T ++
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-45
Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 25/275 (9%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGK-IR 866
++F ++G+G+ G V+ A + T A+K L + ++ E L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 867 HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLH 926
H + ++ + + + EY+ G L + + D A GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFL- 119
Query: 927 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAY 986
I +RD+K +NILLD + DFG+ K + +K + G+ YIAPE
Sbjct: 120 --HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILL 176
Query: 987 TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046
K D +S+GV+L E+L G++P G + + IR + N
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFH-----GQDEEELFHSIRMD-----------NP 220
Query: 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081
+ + L + + P R +R +
Sbjct: 221 FYPRWLEKEAKDLLVKLFVRE--PEKRLGVRGDIR 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 163 bits (412), Expect = 3e-45
Identities = 52/296 (17%), Positives = 98/296 (33%), Gaps = 30/296 (10%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
IG G+ G ++ L VA+K + R E T + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNV 66
Query: 875 GFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIF 934
+ +G + ++ + SL +LL +T M A + +H +
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLV 123
Query: 935 HRDIKSNNILLDDKFEAHVG-----DFGLAKVIDMPQSKS------MSAIAGSYGYIAPE 983
+RDIK +N L+ + DFG+ K P +K ++G+ Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 984 YAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043
+ + + D+ + G V + L G P Q L + + R I + + +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER--IGEKKQSTPLRELC 241
Query: 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMD 1099
+E K N++ P + + S+ R E D
Sbjct: 242 AGFPEE--------FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (409), Expect = 6e-45
Identities = 68/287 (23%), Positives = 109/287 (37%), Gaps = 38/287 (13%)
Query: 811 FDERF----VIGRGACGTVYRAV-LRTGHTVAVKKL------ASNREGNNNVDNSFRAEI 859
F E + ++GRG V R + T AVK + + + E + + E+
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 860 LTLGKIR-HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGA 918
L K+ H NI++L L+++ M +G L + L TL + I
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRAL 119
Query: 919 AEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG 978
E + LH K I HRD+K NILLDD + DFG + +D + + + G+
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPS 174
Query: 979 YIAPEYAYTM------KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN 1032
Y+APE ++ D++S GV++ LL G P + +R +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF----WHRKQMLMLRMIMSG 230
Query: 1033 NSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
N + + S + L L P R T E
Sbjct: 231 N--------YQFGSPEWDDYSDTVKDLVSRFLVVQ--PQKRYTAEEA 267
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-43
Identities = 62/287 (21%), Positives = 114/287 (39%), Gaps = 32/287 (11%)
Query: 805 VVATDNFDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNS---FR 856
V +N D+ + +G G V + TG A K + R ++ S
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 857 AEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIAL 916
E+ L +I+H N++ L+ ++ +L+ E +A G L + L S + + +
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL-- 119
Query: 917 GAAEGLSYLHHDCKPRIFHRDIKSNNILLDD----KFEAHVGDFGLAKVIDMPQSKSMSA 972
+ L+ +++ +I H D+K NI+L D K + DFGLA ID
Sbjct: 120 --KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKN 175
Query: 973 IAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRN 1032
I G+ ++APE + + D++S GV+ LL+G +P GD +
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL-----GDTKQETLANVSA 230
Query: 1033 NSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
++ + S + +L + P R T+++
Sbjct: 231 -------VNYEFEDEYFSNTSALAKDFIRRLLVKD--PKKRMTIQDS 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-43
Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 16/283 (5%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
+NF + IG G G VY+A + TG VA+KK+ + E V ++ EI L ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNH 60
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
NIVKL + + L++E++ + + A + + +GL++ H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
+ HRD+K N+L++ + + DFGLA+ +P + +
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLV----SGMLDAR 1043
+ DI+S G + E++T RA + L R + +V + M D +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 1044 LNL-----QDEKTVSHMITVLKIAML--CTNISPFDRPTMREV 1079
+ QD V + ++L + P R + +
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 60/280 (21%), Positives = 105/280 (37%), Gaps = 23/280 (8%)
Query: 816 VIGRGACGTVYRAVLR-TGHTVAVKKL--ASNREGNNNVDNSFRAEILTLGKIRHRNIVK 872
+G G TVY+A + T VA+KK+ E + ++ + EI L ++ H NI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 873 LYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPR 932
L H+ + L++++M + + + + L L + +
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYML----MTLQGLEYLHQHW 120
Query: 933 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKV-T 991
I HRD+K NN+LLD+ + DFGLAK P ++ + + Y APE + ++
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYG 179
Query: 992 EKCDIYSYGVVLLELLTGRAPVQ---PLDQ---------GGDLVTWVRNFIRNNSLVSGM 1039
D+++ G +L ELL + LDQ W + +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
+ L + N P R T +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFN--PCARITATQA 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (403), Expect = 3e-43
Identities = 55/209 (26%), Positives = 83/209 (39%), Gaps = 12/209 (5%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILT---LGK 864
++F +IGRG G VY TG A+K L R + E + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 865 IRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSY 924
IV + + + + M G L L + RF A GL +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 122
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
+H+ + +RD+K NILLD+ + D GLA K A G++GY+APE
Sbjct: 123 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEV 176
Query: 985 AYT-MKVTEKCDIYSYGVVLLELLTGRAP 1012
+ D +S G +L +LL G +P
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-43
Identities = 60/291 (20%), Positives = 121/291 (41%), Gaps = 27/291 (9%)
Query: 811 FDERF----VIGRGACGTVYRAVLR--TGHTVAVKKLASNREGNNNVDNSFR--AEILTL 862
D+++ IG GA G V++A G VA+K++ ++ R A + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 863 GKIRHRNIVKLYGFCYHQGSN-----LLMYEYMARGSLGELLHGASSTLDWQTRFMIALG 917
H N+V+L+ C ++ L++E++ + L + +T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 918 AAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSY 977
GL +LH + HRD+K NIL+ + + DFGLA++ + ++++ +
Sbjct: 125 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTL 179
Query: 978 GYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQ---PLDQGGDLVTWVR-----NF 1029
Y APE D++S G + E+ + + +DQ G ++ + ++
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 1030 IRNNSLVSGMLDARLNLQDEKTVSHMITVLK-IAMLCTNISPFDRPTMREV 1079
R+ +L ++ EK V+ + + K + + C +P R +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-42
Identities = 52/286 (18%), Positives = 106/286 (37%), Gaps = 26/286 (9%)
Query: 813 ERF----VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
+++ IG G GTV++A R T VA+K++ + + + V +S EI L +++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
+NIV+L+ + L++E+ + + + + L L
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF----QLLKGLGF 116
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
+ HRD+K N+L++ E + +FGLA+ +P + + +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047
+ D++S G + EL P+ P + D + + + + + L
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT--EEQWPSMTKLP 234
Query: 1048 DEKTVSHMITVLKIAMLCTNIS--------------PFDRPTMREV 1079
D K + + ++ P R + E
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-41
Identities = 54/208 (25%), Positives = 79/208 (37%), Gaps = 6/208 (2%)
Query: 806 VATDNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGK 864
V ++FD ++G+G G V TG A+K L + E L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 865 IRHRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSY 924
RH + L + EY G L L + + RF AE +S
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG----AEIVSA 117
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEY 984
L + + +RDIK N++LD + DFGL K + M G+ Y+APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 985 AYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
D + GVV+ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 52/281 (18%), Positives = 102/281 (36%), Gaps = 42/281 (14%)
Query: 811 FDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNS---FRAEILTL 862
+ ++ ++G G G+VY + + VA+K + +R + + E++ L
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 863 GKIR--HRNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE 920
K+ +++L + S +L+ E L + E
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGY 979
+ + + HRDIK NIL+D ++ E + DFG ++ + G+ Y
Sbjct: 122 AVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVY 175
Query: 980 IAPEY-AYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG 1038
PE+ Y ++S G++L +++ G P F + ++ G
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----------------FEHDEEIIRG 219
Query: 1039 MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
+ R + E + C + P DRPT E+
Sbjct: 220 QVFFRQRVSSE--------CQHLIRWCLALRPSDRPTFEEI 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-41
Identities = 66/297 (22%), Positives = 105/297 (35%), Gaps = 36/297 (12%)
Query: 810 NFDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGK 864
+ R+ IG GA G V A VA+KK+ + + EI L +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLR 62
Query: 865 IRHRNIVKLYGFC----YHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAE 920
RH NI+ + Q ++ + ++ L +LL + L
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILR 120
Query: 921 GLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK--SMSAIAGSYG 978
GL Y+H + HRD+K +N+LL+ + + DFGLA+V D ++ +
Sbjct: 121 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 979 YIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAP---------------VQPLDQGGDL 1022
Y APE T+ DI+S G +L E+L+ R + DL
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 1023 VTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
+ RN L + + L ML N P R + +
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN--PHKRIEVEQA 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-40
Identities = 70/292 (23%), Positives = 106/292 (36%), Gaps = 32/292 (10%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
++ + VIG G+ G VY+A L +G VA+KK+ ++ E+ + K+ H
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDH 72
Query: 868 RNIVKLYGFCYHQGSN------LLMYEYMARGSLGELLHGASS--TLDWQTRFMIALGAA 919
NIV+L F Y G L+ +Y+ H + + TL +
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 920 EGLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYG 978
L+Y+H I HRDIK N+LLD D + DFG AK + ++S I Y
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYY 188
Query: 979 YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQ---PLDQ--------GGDLVTWVR 1027
T D++S G VL ELL G+ +DQ G +R
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 1028 NFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
N + + + +P R T E
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-39
Identities = 63/274 (22%), Positives = 103/274 (37%), Gaps = 33/274 (12%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKL 873
V+G G G V + RT A+K L + R E+ + + +IV++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--------ARREVELHWRASQCPHIVRI 70
Query: 874 YGFCYHQGSN----LLMYEYMARGSLGELLHGASS-TLDWQTRFMIALGAAEGLSYLHHD 928
+ + L++ E + G L + + I E + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-- 128
Query: 929 CKPRIFHRDIKSNNILLDDKFE---AHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYA 985
I HRD+K N+L K + DFG AK + S++ + Y+APE
Sbjct: 129 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL 185
Query: 986 YTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045
K + CD++S GV++ LL G P + G + ++ IR
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQY-------EFP 237
Query: 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
+ VS + +L +L T P R T+ E
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTE--PTQRMTITEF 269
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-38
Identities = 68/309 (22%), Positives = 116/309 (37%), Gaps = 36/309 (11%)
Query: 796 KEGFTFKDLVVATDNFDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNN 850
+ GF +++ + +G GA G V AV RTG VA+KKL +
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 851 VDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN------LLMYEYMARGSLGELLHGASS 904
E+ L +RH N++ L + L+ +M + H
Sbjct: 61 AKR-AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--- 116
Query: 905 TLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964
L + +GL Y+H I HRD+K N+ +++ E + DFGLA+ D
Sbjct: 117 KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172
Query: 965 PQSKSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQ----- 1018
M+ + Y APE M+ T+ DI+S G ++ E++TG+ + D
Sbjct: 173 ---SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229
Query: 1019 ------GGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAML--CTNISP 1070
G +V+ + + L +D ++ + L + +L +
Sbjct: 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289
Query: 1071 FDRPTMREV 1079
R T E
Sbjct: 290 EQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-38
Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 12/236 (5%)
Query: 806 VATDNFDERFVIGRGACGTVYRAVL----RTGHTVAVKKL-ASNREGNNNVDNSFRAEIL 860
V +NF+ V+G GA G V+ TG A+K L + R E
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 861 TLGKIRHR-NIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAA 919
L IR +V L+ + L+ +Y+ G L L + + + +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG---- 136
Query: 920 EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGY 979
E + L H K I +RDIK NILLD + DFGL+K +++ G+ Y
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 980 IAPEYAYTMK--VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNN 1033
+AP+ + D +S GV++ ELLTG +P + R +++
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-38
Identities = 54/301 (17%), Positives = 112/301 (37%), Gaps = 38/301 (12%)
Query: 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
+++ IG+G G V++A R TG VA+KK+ E + EI L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKH 68
Query: 868 RNIVKLYGFCY--------HQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAA 919
N+V L C +GS L++++ G L + + + ++
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ---- 124
Query: 920 EGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS---KSMSAIAGS 976
L+ L++ + +I HRD+K+ N+L+ + DFGLA+ + ++ + +
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 977 YGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPVQ-----------------PLDQ 1018
Y PE + D++ G ++ E+ T +Q +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 1019 GGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMRE 1078
V + + + + L+ + + ++ +L + P R +
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID-KLLVLD--PAQRIDSDD 301
Query: 1079 V 1079
Sbjct: 302 A 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 3e-37
Identities = 47/205 (22%), Positives = 77/205 (37%), Gaps = 9/205 (4%)
Query: 809 DNFDERFVIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH 867
D FD +G G+ G V +G+ A+K L + E L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 868 RNIVKLYGFCYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH 927
+VKL + ++ EY+A G + L A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLH- 158
Query: 928 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYT 987
+ +RD+K N+L+D + V DFG AK + + G+ +APE +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILS 212
Query: 988 MKVTEKCDIYSYGVVLLELLTGRAP 1012
+ D ++ GV++ E+ G P
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 135 bits (340), Expect = 3e-35
Identities = 60/315 (19%), Positives = 109/315 (34%), Gaps = 46/315 (14%)
Query: 795 PKEGFTFKDLVVATDNFDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNN 849
P+E + ++ VV N D + +GRG V+ A+ + V VK L ++
Sbjct: 18 PREYWDYESHVVEWGNQD-DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--- 73
Query: 850 NVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNL--LMYEYMARGSLGELLHGASSTL 906
+ EI L +R NI+ L S L++E++ +L TL
Sbjct: 74 ---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TL 126
Query: 907 DWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMP 965
+ L Y H I HRD+K +N+++D + + + D+GLA+
Sbjct: 127 TDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-- 181
Query: 966 QSKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVT 1024
+ + S + PE + D++S G +L ++ + P D +
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 1025 WVRNFI------------------RNNSLVSGMLDARLNLQDEKTVSHMITVLKIAML-- 1064
+ + R N ++ R H+++ + L
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301
Query: 1065 CTNISPFDRPTMREV 1079
R T RE
Sbjct: 302 LLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 6e-34
Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 19/227 (8%)
Query: 796 KEGFTFKDLVVATDNFDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNN 850
+ F ++L ER+ +G GA G+V A +TG VAVKKL+ + +
Sbjct: 1 RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 60
Query: 851 VDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS-----NLLMYEYMARGSLGELLHGASST 905
++R E+ L ++H N++ L S ++ + ++ L ++
Sbjct: 61 AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQK 117
Query: 906 LDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965
L + GL Y+H I HRD+K +N+ +++ E + DFGLA+ D
Sbjct: 118 LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAP 1012
+A + M + DI+S G ++ ELLTGR
Sbjct: 175 M---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 3e-33
Identities = 65/297 (21%), Positives = 106/297 (35%), Gaps = 45/297 (15%)
Query: 816 VIGRGACGTVYRAV-LRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLY 874
IG GA G V A VA+KKL S N E++ + + H+NI+ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 875 GFCYHQGSN------LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD 928
Q + L+ E M + D + + G+ +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLHSA 138
Query: 929 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTM 988
I HRD+K +NI++ + DFGLA+ S M+ + Y APE M
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 989 KVTEKCDIYSYGVVLLELLTGRAPVQ------------------PLDQGGDLVTWVRNFI 1030
E DI+S G ++ E++ + + L VRN++
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 1031 RNNSLVSGMLDARL--------NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREV 1079
N +G+ +L + + K + L ML + P R ++ +
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID--PAKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (306), Expect = 1e-30
Identities = 48/245 (19%), Positives = 92/245 (37%), Gaps = 29/245 (11%)
Query: 792 YFPPKEGFTFKDLVVATDNFDERF----VIGRGACGTVYRAV-LRTGHTVAVKKLASNRE 846
Y P +G +KD R+ +G G TV+ A + VA+K + ++
Sbjct: 1 YHPAFKGEPYKD---------ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV 51
Query: 847 GNNNVDNSFR-------AEILTLGKIRHRNIVKLYGFCYHQGSNL----LMYEYMARGSL 895
++ + A+ + +I+KL H+G N +++E + L
Sbjct: 52 YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLL 111
Query: 896 GELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVG 954
+ + I+ GL Y+H C I H DIK N+L++ ++
Sbjct: 112 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLI 169
Query: 955 DFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPV 1013
+A + + + + + Y +PE DI+S ++ EL+TG
Sbjct: 170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
Query: 1014 QPLDQ 1018
+P +
Sbjct: 230 EPDEG 234
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 111 bits (278), Expect = 1e-26
Identities = 76/383 (19%), Positives = 134/383 (34%), Gaps = 54/383 (14%)
Query: 317 LSSALEIDFSENSLIGEIPV-ELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSI 375
L+ ++ + ++ + +L ++ L+ L + G + L NLT+++ S
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 376 NSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHIC 435
N LT PL LT L+ + + +N + P + + +
Sbjct: 76 NQLTDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 436 RNTSLIFLN----LETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGS---------FPSDL 482
N + N + S+ + L + S L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 483 CKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVS 542
KL NL ++ NQ S P I L L L+ N + +L+NL +++
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 543 SNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALP--------------------REIGSLF 582
+N ++ PL L L L N+ P I +L
Sbjct: 250 NNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 583 QLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNN 642
L L L N +S P + +L++L L N S + L +L+++ L+ +N
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW-LSAGHNQ 362
Query: 643 LSGLIPPELGNLILLEYLLLNNN 665
+S L P L NL + L LN+
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 106 bits (264), Expect = 6e-25
Identities = 77/398 (19%), Positives = 131/398 (32%), Gaps = 35/398 (8%)
Query: 124 NCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYS 183
+ L + + + +L +T L I + L+ L+Q+ +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 184 NNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIG 243
N ++ P L NL +L N I+ P + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLT----LFNNQITDIDPLK 129
Query: 244 MLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYR 303
L L + L N +S + G +L + +L L
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTS--------LQQLSFGNQVTDLKPLANLTTLERLD 181
Query: 304 NELNGTIPREI-GKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVEL 362
N + KL++ + + N + P+ + L+ L L N+L L
Sbjct: 182 ISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTL 237
Query: 363 TTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLS 422
+L NLT LDL+ N ++ PL LT L L+L N + P
Sbjct: 238 ASLTNLTDLDLANNQISNLAPLSG--LTKLTELKLGANQISNISPLAGLTALTNL----E 291
Query: 423 DNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDL 482
N + I +L +L L N ++ P V+ L +L N + S L
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSL 347
Query: 483 CKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDN 520
L N++ + NQ S P + N + +L L+D
Sbjct: 348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.5 bits (244), Expect = 2e-22
Identities = 75/372 (20%), Positives = 141/372 (37%), Gaps = 52/372 (13%)
Query: 347 LYLFENKLTGVIPVELTTLKNLTKLDLS---INSLTGTIPLGFQYLTNLIMLQLFDNSLV 403
L + +T + T L +T L I S+ G +YL NL + +N L
Sbjct: 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLT 79
Query: 404 GGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKS 463
P L ++L + +++N + P N + + L + +
Sbjct: 80 DITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR- 136
Query: 464 LVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFT 523
+ + SD+ L+ L++++ + N L+RL +S N +
Sbjct: 137 --------LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188
Query: 524 GELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQ 583
+ L+NL + ++N ++ P + L L L+ N+ + SL
Sbjct: 189 D--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTN 242
Query: 584 LELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIA-------- 635
L L L+ N++S P + L++LTEL++G N S P + +
Sbjct: 243 LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI 300
Query: 636 -----------LNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGC 684
L L +NN+S + P + +L L+ L NN +S S NL+++
Sbjct: 301 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWL 356
Query: 685 NFSYNNLTGPIP 696
+ +N ++ P
Sbjct: 357 SAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 94.7 bits (234), Expect = 4e-21
Identities = 70/360 (19%), Positives = 127/360 (35%), Gaps = 33/360 (9%)
Query: 222 ESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNK 281
+ + L + + + L LT + NQL+ + P L N T L + + +N+
Sbjct: 44 DQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99
Query: 282 QVGQLPKELGSIGSLKYLYIYRNELNGTIPREIG---------KLSSALEIDFSENSLIG 332
P + + L+ + + +S + +
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQL 159
Query: 333 EIPVELSKILGLELL----YLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQY 388
+++ + L L L + L L NL L + N ++ PLG
Sbjct: 160 SFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL- 218
Query: 389 LTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETN 448
TNL L L N L L + + L +DL++N ++ P + T L L L N
Sbjct: 219 -TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 273
Query: 449 KLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGN 508
+++ P L N S + L NL+ + L N S P + +
Sbjct: 274 QISNISPL----AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSS 327
Query: 509 CNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWN 568
LQRL ++N + + NL+N+ + N ++ PL + + +L L+
Sbjct: 328 LTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 89.3 bits (220), Expect = 2e-19
Identities = 78/358 (21%), Positives = 140/358 (39%), Gaps = 37/358 (10%)
Query: 82 SLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAH 141
+L ++ + + L +LT ++ S NQL+ P + N + L + +NNN++
Sbjct: 48 TLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI 103
Query: 142 IPKELGNLSSLTILNIYNNRISGPFP---------------KEIGKLSALSQLVAYSNNI 186
P + L P +I LS L+ L S
Sbjct: 104 TPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGN 163
Query: 187 SGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLK 246
+ L NL L+ N +S S + +L+ L NQ+S P I
Sbjct: 164 QVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILT-- 219
Query: 247 YLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNEL 306
L ++ L GNQL L + T+L L L +N+ P L + L L + N++
Sbjct: 220 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 275
Query: 307 NGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLK 366
+ P + L++ ++ +EN E +S + L L L+ N ++ + P +++L
Sbjct: 276 SNISP--LAGLTALTNLELNEN--QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLT 329
Query: 367 NLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDN 424
L +L + N ++ LTN+ L N + P L +++ + L+D
Sbjct: 330 KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.9 bits (219), Expect = 3e-19
Identities = 68/388 (17%), Positives = 133/388 (34%), Gaps = 33/388 (8%)
Query: 229 LAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPK 288
L + ++ + + L +T + + + + +L + +N+ P
Sbjct: 29 LGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP- 83
Query: 289 ELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLY 348
L ++ L + + N++ P + + L + L L
Sbjct: 84 -LKNLTKLVDILMNNNQIADITPLANLT----NLTGLTLFNNQITDIDPLKNLTNLNRLE 138
Query: 349 LFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQ 408
L N ++ + + T + L L ++ ++ D S++ +
Sbjct: 139 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN 198
Query: 409 RLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLR 468
+ ++N ++ P I N L L+L N+L + +L L
Sbjct: 199 L-------ESLIATNNQISDITPLGILTN--LDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 469 LGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPR 528
L N + P L L L+ ++L NQ S P +L N E
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISP----LAGLTALTNLELNENQLEDIS 301
Query: 529 EVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLK 588
+ NL NL + N ++ P+ S LQRL + NK + +L + L
Sbjct: 302 PISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357
Query: 589 LSENELSGSIPVQIGNLSRLTELQMGGN 616
N++S P + NL+R+T+L +
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.5 bits (179), Expect = 4e-14
Identities = 50/207 (24%), Positives = 78/207 (37%), Gaps = 31/207 (14%)
Query: 49 NSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYL---SPNIGGLVHLT 105
N + + I N +D + NL +++L+G + L +LT
Sbjct: 185 NKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLT 244
Query: 106 ALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIP--------------------KE 145
LDL+ NQ+S P + + L L L N++ P
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302
Query: 146 LGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRA 205
+ NL +LT L +Y N IS P + L+ L +L +N +S +L NL + A
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 206 GQNLISGSLPSEIGGCESLQYLGLAQN 232
G N IS P + + LGL
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.5 bits (135), Expect = 9e-09
Identities = 62/365 (16%), Positives = 117/365 (32%), Gaps = 77/365 (21%)
Query: 420 DLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFP 479
L ++T + + + L + + SI GV +L Q+ N T P
Sbjct: 28 VLGKTNVTDTVSQTDL--DQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITP 83
Query: 480 -SDLCKLANLST---------------------------VELDQNQFSGPIPTEIGNCNA 511
+L KL ++ ++D + + + N
Sbjct: 84 LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNT 143
Query: 512 LQRLHLSDNYFTGELPREVGNLSNLVTFNVSS-------NFLTGRIPLEIFSCKMLQRLD 564
+ + + + +++L + + + L+ L
Sbjct: 144 ISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLI 203
Query: 565 LSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPA 624
+ N+ P I + L+ L L+ N+L + +L+ LT+L + N S P
Sbjct: 204 ATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP- 258
Query: 625 ELGSLSSLQIALNLSYNNLSGLIP--------------------PELGNLILLEYLLLNN 664
L L+ L L L N +S + P + NL L YL L
Sbjct: 259 -LSGLTKLTE-LKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF 316
Query: 665 NHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIP----SSQTFQNMSVNSFSGSKGLCGGPL 720
N++S P +L+ L F+ N ++ ++ + + N S PL
Sbjct: 317 NNISDISP--VSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLT-----PL 369
Query: 721 QNCTQ 725
N T+
Sbjct: 370 ANLTR 374
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 2e-04
Identities = 14/88 (15%), Positives = 33/88 (37%), Gaps = 9/88 (10%)
Query: 604 NLSRLTELQMGGNSFSGGIP-AELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLL 662
L+ + +G + + + +L +++L + + + L L +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTL----QADRLGIKSI--DGVEYLNNLTQINF 73
Query: 663 NNNHLSGEIPGSFVNLSSLLGCNFSYNN 690
+NN L+ P NL+ L+ + N
Sbjct: 74 SNNQLTDITP--LKNLTKLVDILMNNNQ 99
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 102 bits (253), Expect = 4e-24
Identities = 59/300 (19%), Positives = 105/300 (35%), Gaps = 15/300 (5%)
Query: 319 SALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSL 378
+ S+ L ++P +L LL L NK+T + + LKNL L L N +
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 379 TGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNT 438
+ P F L L L L N L + +L V + + + + +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 439 SLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQF 498
+ L K +G K L +R+ + T + P L +L+ + LD N+
Sbjct: 128 VV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGNKI 183
Query: 499 SGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCK 558
+ + N L +L LS N + + N +L ++++N L ++P + K
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 242
Query: 559 MLQRLDLSWNKF------VGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQ 612
+Q + L N P + L N + +Q +
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ-YWEIQPSTFRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.8 bits (229), Expect = 5e-21
Identities = 54/279 (19%), Positives = 97/279 (34%), Gaps = 13/279 (4%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI 162
LDL N+++ + N +L L L NN++ P L L L + N++
Sbjct: 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCE 222
K L L + S+ L + + SG G +
Sbjct: 92 KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGMK 150
Query: 223 SLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQ 282
L Y+ +A ++ IP+ G+ LT++ L GN+++ V L +L L L N
Sbjct: 151 KLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 283 VGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIG------EIPV 336
L + L+ L++ N+L +P + + N++ P
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 337 ELSKILGLELLYLFENKLT--GVIPVELTTLKNLTKLDL 373
+K + LF N + + P + + L
Sbjct: 267 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.6 bits (226), Expect = 1e-20
Identities = 62/299 (20%), Positives = 112/299 (37%), Gaps = 19/299 (6%)
Query: 418 VVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGS 477
VV SD L K+P+ + L+L+ NK+T K+L L L N +
Sbjct: 14 VVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 478 FPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSN-- 535
P L L + L +NQ +P ++ Q L + +N T L+
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTL--QELRVHENEITKVRKSVFNGLNQMI 127
Query: 536 LVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELS 595
+V + +G K L + ++ +P+ + L L L N+++
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGLPP--SLTELHLDGNKIT 184
Query: 596 GSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLI 655
+ L+ L +L + NS S L + L+ +L+ N L +P L +
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL-HLNNNKLVK-VPGGLADHK 242
Query: 656 LLEYLLLNNNHLSGEIPGSFV------NLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNS 708
++ + L+NN++S F +S G + N + TF+ + V +
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.6 bits (226), Expect = 1e-20
Identities = 54/288 (18%), Positives = 95/288 (32%), Gaps = 31/288 (10%)
Query: 358 IPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLW 417
+P +L + LDL N +T F+ L NL L L +N + P +L
Sbjct: 25 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 418 VVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGS 477
+ LS N L + L E K+ S+ G+ + + +L +G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGI 141
Query: 478 FPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLV 537
+ LS + + + IP G +L LHL N T + L+NL
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 538 TFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGS 597
+S N ++ + + L+ L L+ NK V
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-------------------------K 233
Query: 598 IPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSG 645
+P + + + + + N+ S + + S +L
Sbjct: 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.5 bits (223), Expect = 3e-20
Identities = 50/267 (18%), Positives = 93/267 (34%), Gaps = 13/267 (4%)
Query: 309 TIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNL 368
+P+++ +D N + + + L L L NK++ + P L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTG 428
+L LS N L + L L + + + + L + + + +G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSG 140
Query: 429 KIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANL 488
L ++ + +T +IP G+ SL +L L GN T + L L NL
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 489 STVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTG 548
+ + L N S + N L+ LHL++N P + + + + +N ++
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISA 256
Query: 549 ------RIPLEIFSCKMLQRLDLSWNK 569
P + L N
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 80.5 bits (197), Expect = 7e-17
Identities = 42/235 (17%), Positives = 82/235 (34%), Gaps = 7/235 (2%)
Query: 477 SFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNL 536
P DL + + ++L N+ + + N L L L +N + P L L
Sbjct: 24 KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 537 VTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSG 596
+S N L + + L+ + K ++ + + +EL + + SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL-GTNPLKSSG 140
Query: 597 SIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLIL 656
+ +L+ +++ + + SL+ L +L N ++ + L L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTEL----HLDGNKITKVDAASLKGLNN 196
Query: 657 LEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSG 711
L L L+ N +S GS N L + + N L + + V
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHN 251
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 69.3 bits (168), Expect = 4e-13
Identities = 37/179 (20%), Positives = 64/179 (35%), Gaps = 12/179 (6%)
Query: 538 TFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGS 597
S L ++P ++ LDL NK + +L L L L N++S
Sbjct: 14 VVQCSDLGLE-KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 598 IPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILL 657
P L +L L + N +P ++ L + N ++ + L +
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQE---LRVHENEITKVRKSVFNGLNQM 126
Query: 658 EYLLLNNNHL--SGEIPGSFVNLSSLLGCNFSYNNLT---GPIPSSQTFQNMSVNSFSG 711
+ L N L SG G+F + L + N+T +P S T ++ N +
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITK 185
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 68.1 bits (165), Expect = 8e-13
Identities = 34/204 (16%), Positives = 65/204 (31%), Gaps = 6/204 (2%)
Query: 534 SNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENE 593
+ ++ +N +T + + K L L L NK P L +LE L LS+N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 594 LSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGN 653
L L L + + L + ++ L + SG+
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE--LGTNPLKSSGIENGAFQG 148
Query: 654 LILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSK 713
+ L Y+ + + +++ G +L+ L + N +T +S ++ S
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASL-KGLNNLAKLGLSF 204
Query: 714 GLCGGPLQNCTQPPSSLPFPSGTN 737
L N
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNN 228
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.0 bits (131), Expect = 2e-08
Identities = 35/198 (17%), Positives = 66/198 (33%), Gaps = 10/198 (5%)
Query: 44 SKLVDNSNYLGNWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVH 103
+L + + + +V L + SG + G+
Sbjct: 92 KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151
Query: 104 LTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRIS 163
L+ + ++ ++ IP+ G SL L+L+ N++ L L++L L + N IS
Sbjct: 152 LSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 164 GPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISG------SLPSE 217
+ L +L +N + P L + K ++ N IS P
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 218 IGGCESLQYLGLAQNQLS 235
S + L N +
Sbjct: 268 NTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.1 bits (126), Expect = 8e-08
Identities = 22/105 (20%), Positives = 35/105 (33%), Gaps = 3/105 (2%)
Query: 622 IPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSL 681
+P +L + L+L N ++ + + NL L L+L NN +S PG+F L L
Sbjct: 25 VPKDLPP--DTAL-LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 682 LGCNFSYNNLTGPIPSSQTFQNMSVNSFSGSKGLCGGPLQNCTQP 726
S N L + + Q
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 100 bits (249), Expect = 1e-23
Identities = 74/270 (27%), Positives = 109/270 (40%), Gaps = 7/270 (2%)
Query: 459 TRCKSLVQLRLGGNSFTGSF--PSDLCKLANLSTVELDQN-QFSGPIPTEIGNCNALQRL 515
T+ + L L G + + PS L L L+ + + GPIP I L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 516 HLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALP 575
+++ +G +P + + LVT + S N L+G +P I S L + N+ GA+P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 576 REIGSLFQLEL-LKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQI 634
GS +L + +S N L+G IP NL+ S
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG---SDKNT 223
Query: 635 ALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGP 694
N ++G L L L NN + G +P L L N S+NNL G
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 695 IPSSQTFQNMSVNSFSGSKGLCGGPLQNCT 724
IP Q V++++ +K LCG PL CT
Sbjct: 284 IPQGGNLQRFDVSAYANNKCLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 98.3 bits (243), Expect = 8e-23
Identities = 70/305 (22%), Positives = 115/305 (37%), Gaps = 7/305 (2%)
Query: 35 EGQILLLIKSKLVDNSNYLGNWNPN-DSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGY 93
+ Q LL IK L + + L +W P D W+GV C T+ V +L+L+ +NL
Sbjct: 7 DKQALLQIKKDLGNPTT-LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 94 --LSPNIGGLVHLTALDLSFN-QLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLS 150
+ ++ L +L L + L IP I + L L + + + IP L +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 151 SLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLI 210
+L L+ N +SG P I L L + N ISG++P + G+ +L +
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR-N 184
Query: 211 SGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCT 270
+ + + T I ++G
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSK 244
Query: 271 SLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSL 330
+L L L +N+ G LP+ L + L L + N L G IP + G L ++ N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303
Query: 331 IGEIP 335
+ P
Sbjct: 304 LCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 96.0 bits (237), Expect = 6e-22
Identities = 69/273 (25%), Positives = 112/273 (41%), Gaps = 7/273 (2%)
Query: 355 TGVIPVELTTLKNLTKLDLSINSLTG--TIPLGFQYLTNLIMLQLFDN-SLVGGIPQRLG 411
GV+ T + LDLS +L IP L L L + +LVG IP +
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 412 AYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGG 471
+QL + ++ +++G IP + + +L+ L+ N L+G++P ++ +LV + G
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 472 NSFTGSFPSDLCKLANLST-VELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV 530
N +G+ P + L T + + +N+ +G IP N N +
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218
Query: 531 GNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLS 590
+ + ++ + K L LDL N+ G LP+ + L L L +S
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGK--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 591 ENELSGSIPVQIGNLSRLTELQMGGNSFSGGIP 623
N L G IP Q GNL R N G P
Sbjct: 277 FNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 85.2 bits (209), Expect = 2e-18
Identities = 68/259 (26%), Positives = 106/259 (40%), Gaps = 7/259 (2%)
Query: 415 QLWVVDLSDNHLTGK--IPRHICRNTSLIFLNLETN-KLTGSIPTGVTRCKSLVQLRLGG 471
++ +DLS +L IP + L FL + L G IP + + L L +
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 472 NSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVG 531
+ +G+ P L ++ L T++ N SG +P I + L + N +G +P G
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 532 NLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSE 591
+ S L T S F+ L +DLS N G GS + + L++
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 592 NELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPEL 651
N L+ + + + + N G +P L L L LN+S+NNL G I P+
Sbjct: 231 NSLAFDLGKVGLSKNLNGLD-LRNNRIYGTLPQGLTQLKFLHS-LNVSFNNLCGEI-PQG 287
Query: 652 GNLILLEYL-LLNNNHLSG 669
GNL + NN L G
Sbjct: 288 GNLQRFDVSAYANNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.1 bits (188), Expect = 1e-15
Identities = 66/266 (24%), Positives = 108/266 (40%), Gaps = 7/266 (2%)
Query: 291 GSIGSLKYLYIYRNELNG--TIPREIGKLSSALEIDFSEN-SLIGEIPVELSKILGLELL 347
+ L + L IP + L + +L+G IP ++K+ L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 348 YLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIP 407
Y+ ++G IP L+ +K L LD S N+L+GT+P L NL+ + N + G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 408 QRLGAYSQLWV-VDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQ 466
G++S+L+ + +S N LTGKIP + + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 467 LRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGEL 526
+ L K NL+ ++L N+ G +P + L L++S N GE+
Sbjct: 227 HLAKNSLAFDLGKVGLSK--NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 527 PREVGNLSNLVTFNVSSNFLTGRIPL 552
P + GNL ++N PL
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 63.6 bits (153), Expect = 3e-11
Identities = 18/63 (28%), Positives = 28/63 (44%), Gaps = 3/63 (4%)
Query: 108 DLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI--SGP 165
DL N++ +P+ + L LN++ N L IP + GNL + NN+ P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
Query: 166 FPK 168
P
Sbjct: 309 LPA 311
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.0 bits (238), Expect = 3e-23
Identities = 30/203 (14%), Positives = 59/203 (29%), Gaps = 31/203 (15%)
Query: 816 VIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNV-------DNSFRAEILTLGKIRHR 868
++G G V+ VK V D F + + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 869 NIVKLYGFC----YHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSY 924
+ KL G Y N ++ E + + + + E ++
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELID--------AKELYRVRVENPDEVLDMILEEVAK 118
Query: 925 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA--IAGSYGYIAP 982
+H I H D+ N+L+ + + DF + + + + + Y +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174
Query: 983 EYAYTMKVTEKCDIYSYGVVLLE 1005
Y + DI S +L+
Sbjct: 175 TYRT------EKDINSAIDRILQ 191
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (217), Expect = 1e-19
Identities = 50/278 (17%), Positives = 76/278 (27%), Gaps = 9/278 (3%)
Query: 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTG 428
L +P+G + L N + A L ++ L N L
Sbjct: 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70
Query: 429 KIPRHICRNTSLIFLNLETNKLTGSI-PTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLAN 487
L L+L N S+ P L L L P LA
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130
Query: 488 LSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLT 547
L + L N + L L L N + R L +L + N +
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 548 GRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSR 607
P L L L N + L L+ L+L++N +
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAW 249
Query: 608 LTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSG 645
L + + + +P L L+ N+L G
Sbjct: 250 LQKFRGSSSEVPCSLPQRLAGRD----LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.6 bits (210), Expect = 1e-18
Identities = 61/281 (21%), Positives = 94/281 (33%), Gaps = 9/281 (3%)
Query: 435 CRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELD 494
C N + + L ++P G+ + ++ L GN + + NL+ + L
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 495 QNQFSGPIPTEIGNCNALQRLHLSDNYFTGEL-PREVGNLSNLVTFNVSSNFLTGRIPLE 553
N + L++L LSDN + P L L T ++ L P
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124
Query: 554 IFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQM 613
LQ L L N L L L L N +S L L L +
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 614 GGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPG 673
N + P L L L NNLS L L L L+YL LN+N +
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTL-YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243
Query: 674 SFVNLSSLLGCNFSYNNLTGPIPSS---QTFQNMSVNSFSG 711
+ + L S + + +P + + ++ N G
Sbjct: 244 RPL-WAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (209), Expect = 1e-18
Identities = 58/280 (20%), Positives = 87/280 (31%), Gaps = 32/280 (11%)
Query: 318 SSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINS 377
+ + L +PV + + ++L N+++ V +NLT L L N
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 378 -------------------------LTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGA 412
L P F L L L L L P
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 413 YSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGN 472
+ L + L DN L +L L L N+++ SL +L L N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 473 SFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGN 532
P L L T+ L N S + ALQ L L+DN + + R
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPL 246
Query: 533 LSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVG 572
+ L F SS+ + +P + L+ N G
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (206), Expect = 3e-18
Identities = 56/265 (21%), Positives = 87/265 (32%), Gaps = 7/265 (2%)
Query: 237 EIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSL 296
+P I + L GN++S V C +L L L+ N + L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 297 KYLYIYRNELNGTI-PREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLT 355
+ L + N ++ P L + L P + L+ LYL +N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 356 GVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQ 415
+ L NLT L L N ++ F+ L +L L L N + P +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 416 LWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFT 475
L + L N+L+ + +L +L L N L + R +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP 261
Query: 476 GSFPSDLCKLANLSTVELDQNQFSG 500
S P +LA L N G
Sbjct: 262 CSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (206), Expect = 4e-18
Identities = 54/282 (19%), Positives = 96/282 (34%), Gaps = 8/282 (2%)
Query: 124 NCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYS 183
+ L+A +P + ++ + ++ NRIS L+ L +S
Sbjct: 9 YNEPKVTTSCPQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 184 NNISGSLPPTLGNLKRLKSFRAGQNLISGSL-PSEIGGCESLQYLGLAQNQLSGEIPKEI 242
N ++ L L+ N S+ P+ G L L L + L P
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF 125
Query: 243 GMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIY 302
L L + L N L + + +L L L+ N+ + + SL L ++
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 303 RNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVEL 362
+N + P L + + N+L L+ + L+ L L +N
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-R 244
Query: 363 TTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVG 404
L K S + + ++P Q L + +L N L G
Sbjct: 245 PLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (198), Expect = 3e-17
Identities = 52/255 (20%), Positives = 90/255 (35%), Gaps = 5/255 (1%)
Query: 103 HLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRI 162
+ L N++S C +L +L L++N L L+ L L++ +N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 163 SGP-FPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIGGC 221
P L L L + P L L+ N +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 222 ESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNK 281
+L +L L N++S + L L ++L N+++ V P + L TL L+ N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 282 QVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKI 341
+ L + +L+YL + N R + + S + + +P L+
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLA-- 269
Query: 342 LGLELLYLFENKLTG 356
G +L L N L G
Sbjct: 270 -GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (161), Expect = 2e-12
Identities = 41/181 (22%), Positives = 70/181 (38%), Gaps = 1/181 (0%)
Query: 88 MNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELG 147
L GL L L L L P ++L+ L L +N L+A
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 148 NLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQ 207
+L +LT L ++ NRIS + L +L +L+ + N ++ P +L RL +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 208 NLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELG 267
N +S + +LQYL L N + + +L +++ +P+ L
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLA 269
Query: 268 N 268
Sbjct: 270 G 270
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.8 bits (151), Expect = 4e-11
Identities = 48/290 (16%), Positives = 103/290 (35%), Gaps = 29/290 (10%)
Query: 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTG 428
LDL+ +L + G +I + + + + + ++ +DLS++ +
Sbjct: 3 QTLDLTGKNLHPDV-TGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEV 60
Query: 429 K-IPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQL--RLGGNSFTGSFPSDLCKL 485
+ + + + L L+LE +L+ I + + +LV+L + + L
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 486 ANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNF 545
+ L N ++ + + ++ L N
Sbjct: 121 SRLD------------------ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL 162
Query: 546 LTGRIPLEIFSCKMLQRLDLSWN-KFVGALPREIGSLFQLELLKLSE-NELSGSIPVQIG 603
+ + C L LDLS + +E L L+ L LS ++ +++G
Sbjct: 163 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 222
Query: 604 NLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGN 653
+ L LQ+ G G + +L LQI + ++ + + P +GN
Sbjct: 223 EIPTLKTLQVFGIVPDGTLQLLKEALPHLQI----NCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 43/247 (17%), Positives = 74/247 (29%), Gaps = 15/247 (6%)
Query: 80 VFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRN-IPKEIGNCSSLEVLNLNNNRL 138
V + + + L + +DLS + + + + + CS L+ L+L RL
Sbjct: 25 VIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83
Query: 139 EAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLK 198
I L S+L LN+ F + S + +
Sbjct: 84 SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 143
Query: 199 RLKSFRAGQNLISGSLPSEIGGCE---------SLQYLGLAQNQLSGEIPKEIGMLKYLT 249
S Q +SG + + L + +E L YL
Sbjct: 144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203
Query: 250 DVILWG-NQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNG 308
+ L + ELG +L+TL ++ G L +L +L I +
Sbjct: 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL---LKEALPHLQINCSHFTT 260
Query: 309 TIPREIG 315
IG
Sbjct: 261 IARPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 50/260 (19%), Positives = 83/260 (31%), Gaps = 15/260 (5%)
Query: 311 PREIGKLSSALEIDFS-ENSLIGEIPVELSKILGLELLYLFENKLTGV-IPVELTTLKNL 368
P G+L S I F S + + E ++ + L + + + L+ L
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73
Query: 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIP--------QRLGAYSQLWVVD 420
L L L+ I +NL+ L L S RL + W D
Sbjct: 74 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133
Query: 421 LSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGN-SFTGSFP 479
++ H+ + T L N + T V RC +LV L L +
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193
Query: 480 SDLCKLANLSTVELDQ-NQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVT 538
+ +L L + L + E+G L+ L + G L L +L
Sbjct: 194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL-- 251
Query: 539 FNVSSNFLTGRIPLEIFSCK 558
++ + T I + K
Sbjct: 252 -QINCSHFTTIARPTIGNKK 270
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 3e-07
Identities = 42/267 (15%), Positives = 85/267 (31%), Gaps = 12/267 (4%)
Query: 443 LNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSG-P 501
L+L L + + + ++ R + + ++L +
Sbjct: 5 LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVST 62
Query: 502 IPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVS--SNFLTGRIPLEIFSCKM 559
+ + C+ LQ L L + + + SNLV N+S S F + + SC
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 560 LQRLDL------SWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQM 613
L L+L + A+ ++ QL L +N + + L L +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 614 GGNSFSGGIPAELGSLSSLQIALNLSY-NNLSGLIPPELGNLILLEYLLLNNNHLSGEIP 672
+ + + L+LS ++ ELG + L+ L + G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 673 GSFVNLSSLLGCNFSYNNLTGPIPSSQ 699
L L + + P ++
Sbjct: 243 LLKEALPHLQINCSHFTTIARPTIGNK 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 0.002
Identities = 23/147 (15%), Positives = 47/147 (31%), Gaps = 4/147 (2%)
Query: 55 NWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQL 114
+W + + + V + + S + S + + L
Sbjct: 129 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML 188
Query: 115 SRNIPKEIGNCSSLEVLNLNN-NRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKL 173
+ +E + L+ L+L+ + ELG + +L L ++ G
Sbjct: 189 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK--- 245
Query: 174 SALSQLVAYSNNISGSLPPTLGNLKRL 200
AL L ++ + PT+GN K
Sbjct: 246 EALPHLQINCSHFTTIARPTIGNKKNQ 272
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.0 bits (149), Expect = 6e-11
Identities = 43/232 (18%), Positives = 69/232 (29%), Gaps = 31/232 (13%)
Query: 313 EIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLD 372
E+ K++S LE++ + +L +P +L K + T L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--------------------------DTTILH 37
Query: 373 LSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPR 432
LS N L T L L L L + + +P
Sbjct: 38 LSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ---SLPL 94
Query: 433 HICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVE 492
+L L++ N+LT + L +L L GN P L L +
Sbjct: 95 LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154
Query: 493 LDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSN 544
L N + + L L L +N +P+ L + N
Sbjct: 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (148), Expect = 9e-11
Identities = 48/210 (22%), Positives = 76/210 (36%), Gaps = 8/210 (3%)
Query: 71 CTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEV 130
C + + + +N K NL+ L P++ T L LS N L + + L
Sbjct: 4 CEVSKVASHL-EVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 131 LNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSL 190
LNL+ L L L L++ +N++ AL+ L N ++
Sbjct: 60 LNLDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLP 116
Query: 191 PPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTD 250
L L L+ N + P + L+ L LA N L+ + L+ L
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 251 VILWGNQLSGVIPKELGNCTSLETLALYDN 280
++L N L IPK L L+ N
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 1e-08
Identities = 48/211 (22%), Positives = 78/211 (36%), Gaps = 8/211 (3%)
Query: 481 DLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFN 540
++ K+A+ V D+ + +P ++ LHLS+N + + L N
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 541 VSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPV 600
+ LT L + + + L + + +L L +S N L+
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTV---LDVSFNRLTSLPLG 118
Query: 601 QIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYL 660
+ L L EL + GN +P L + + L+L+ NNL+ L L L L+ L
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 661 LLNNNHLSGEIPGSFVNLSSLLGCNFSYNNL 691
LL N L IP F L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 48/210 (22%), Positives = 76/210 (36%), Gaps = 7/210 (3%)
Query: 265 ELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEID 324
E+ S + D + + LP +L L++ N L + + +++
Sbjct: 5 EVSKVASHLEVNC-DKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 325 FSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPL 384
L +LG + +P+ TL LT LD+S N LT
Sbjct: 62 LDRAELTKLQVDGTLPVLG---TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 385 GFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLN 444
+ L L L L N L P L +L + L++N+LT + +L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 445 LETNKLTGSIPTGVTRCKSLVQLRLGGNSF 474
L+ N L +IP G L L GN +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 57.7 bits (138), Expect = 9e-10
Identities = 38/220 (17%), Positives = 71/220 (32%), Gaps = 18/220 (8%)
Query: 347 LYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGI 406
+ ++ +T + L +T L +T TI G QYL NLI L+L DN +
Sbjct: 24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLA 79
Query: 407 PQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQ 466
P + + + I T + T+ + + + +
Sbjct: 80 PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139
Query: 467 LRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGEL 526
+ G T + N + L L DN +
Sbjct: 140 QITNISPLAGLTNLQYL----------SIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189
Query: 527 PREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLS 566
P + +L NL+ ++ +N ++ PL + L + L+
Sbjct: 190 P--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 2e-07
Identities = 40/227 (17%), Positives = 72/227 (31%), Gaps = 19/227 (8%)
Query: 438 TSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQ 497
+ I + + +T ++ + L G T + L NL +EL NQ
Sbjct: 19 ANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 498 FSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSC 557
+ P + L + + + +T ++ +
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 558 KMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNS 617
+ + + G + S+ S + NLS+LT L+ N
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNA----------QVSDLTPLANLSKLTTLKADDNK 184
Query: 618 FSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNN 664
S P L SL +L ++L N +S + P L N L + L N
Sbjct: 185 ISDISP--LASLPNLIE-VHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 38/226 (16%), Positives = 71/226 (31%), Gaps = 18/226 (7%)
Query: 365 LKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDN 424
L N K+ +++T T+ L + L F + + + + L ++L DN
Sbjct: 18 LANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDN 73
Query: 425 HLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCK 484
+T P + + L+ K +I + + + + S+L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 485 LANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSN 544
L I +LS + NLS L T N
Sbjct: 134 L----------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 545 FLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLS 590
++ PL S L + L N+ P + + L ++ L+
Sbjct: 184 KISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 3e-06
Identities = 33/211 (15%), Positives = 69/211 (32%), Gaps = 22/211 (10%)
Query: 83 LNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHI 142
+ K N++ ++ L +T L ++ I + ++L L L +N++
Sbjct: 24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLA 79
Query: 143 PKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKS 202
P + + L+ + + ++ + L L +
Sbjct: 80 PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139
Query: 203 FRAGQNLI--------------SGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYL 248
+ + S + + L L N++S P + L L
Sbjct: 140 QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNL 197
Query: 249 TDVILWGNQLSGVIPKELGNCTSLETLALYD 279
+V L NQ+S V P L N ++L + L +
Sbjct: 198 IEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 26/227 (11%), Positives = 66/227 (29%), Gaps = 18/227 (7%)
Query: 148 NLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQ 207
L++ + + ++ + L ++ L A+ ++ ++ + L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 208 NLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELG 267
N I + L + + + + +
Sbjct: 73 NQI----------TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 268 NCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSE 327
+ + + Q+ G Y+ + + LS + +
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 328 NSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLS 374
N + P L+ + L ++L N+++ V P L NL + L+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 38/224 (16%), Positives = 67/224 (29%), Gaps = 25/224 (11%)
Query: 478 FPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLV 537
FP LAN + ++ + + + + + L T + V L+NL+
Sbjct: 13 FPDP--ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLI 66
Query: 538 TFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGS 597
+ N +T PL+ + L + K V A+ + +
Sbjct: 67 GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 598 IPVQIGNLSRLTELQMGGNSF--------------SGGIPAELGSLSSLQIALNLSYNNL 643
+ L + L +LS L N +
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA-DDNKI 185
Query: 644 SGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFS 687
S + P L +L L + L NN +S P N S+L +
Sbjct: 186 SDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 4e-05
Identities = 43/251 (17%), Positives = 79/251 (31%), Gaps = 43/251 (17%)
Query: 389 LTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETN 448
L N I + +++ + Q + L + L+
Sbjct: 18 LANAIKIAAGKSNVTDTVTQ-----ADL---------------------DGITTLSAFGT 51
Query: 449 KLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGN 508
+T +I GV +L+ L L N T P + + + I
Sbjct: 52 GVT-TIE-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSI 109
Query: 509 CNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWN 568
+ + L + + + L G L+ S Q DL+
Sbjct: 110 KTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP- 168
Query: 569 KFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGS 628
+ +L +L LK +N++S P + +L L E+ + N S P L +
Sbjct: 169 ---------LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LAN 215
Query: 629 LSSLQIALNLS 639
S+L I + L+
Sbjct: 216 TSNLFI-VTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 9e-05
Identities = 39/240 (16%), Positives = 79/240 (32%), Gaps = 22/240 (9%)
Query: 162 ISGPFP-KEIGKLSALSQLVA---YSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSE 217
I+ P I AL+ + +N++ ++ T +L + + A ++
Sbjct: 3 ITQPTAINVIFPDPALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EG 58
Query: 218 IGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLAL 277
+ +L L L NQ++ P + ++ + I T T
Sbjct: 59 VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQ 118
Query: 278 YDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVE 337
+ L + + L G + S +
Sbjct: 119 ITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQY----------LSIGNAQVSDLTP 168
Query: 338 LSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQL 397
L+ + L L +NK++ + P L +L NL ++ L N ++ PL +NL ++ L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTL 224
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.8 bits (135), Expect = 6e-09
Identities = 54/339 (15%), Positives = 95/339 (28%), Gaps = 28/339 (8%)
Query: 343 GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSL 402
L L L+ +P +L L S NSLT +P + +L L + +N+L
Sbjct: 39 QAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELP---ELPQSLKSLLVDNNNL 90
Query: 403 VGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCK 462
L + +S+N L +I ++ + +
Sbjct: 91 KALSDL----PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNS------LKKLPDLPP 140
Query: 463 SLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYF 522
SL + G N + + + +P + + A +
Sbjct: 141 SLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPEL 200
Query: 523 TGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLF 582
N + + + + F+ L
Sbjct: 201 QNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLS 260
Query: 583 QLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNN 642
+L N S I L EL + N +PA L L S+N+
Sbjct: 261 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLER----LIASFNH 315
Query: 643 LSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSL 681
L+ +P N L+ L + N L E P ++ L
Sbjct: 316 LAE-VPELPQN---LKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.4 bits (134), Expect = 9e-09
Identities = 21/113 (18%), Positives = 38/113 (33%), Gaps = 9/113 (7%)
Query: 64 CGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIG 123
++ V+ + + S + L L++S N+L +P
Sbjct: 246 LTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP 304
Query: 124 NCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSAL 176
LE L + N L +P+ N L L++ N + FP + L
Sbjct: 305 R---LERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 2e-07
Identities = 21/93 (22%), Positives = 33/93 (35%), Gaps = 9/93 (9%)
Query: 109 LSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPK 168
N S I SLE LN++NN+L +P L L N ++ P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPE 321
Query: 169 EIGKLSALSQLVAYSNNISGSLPPTLGNLKRLK 201
L L N + P +++ L+
Sbjct: 322 LPQNLKQLH---VEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 3e-07
Identities = 55/324 (16%), Positives = 91/324 (28%), Gaps = 25/324 (7%)
Query: 322 EIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGT 381
E++ + L +P LE L N LT +P +LK+L + ++ +L+
Sbjct: 42 ELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDL 96
Query: 382 IPLGFQYLTNLIMLQLFDNSLVGGIPQR---LGAYSQLWVVDLSDNHLTGKIPRHICRNT 438
PL + L+ + + +
Sbjct: 97 PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELP 156
Query: 439 SLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQF 498
L L T + L + + +L L L+T+ D N
Sbjct: 157 ELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLL 216
Query: 499 SGPIPTEIGNCNALQRLHL--------SDNYFTGELPREVGNLSNLVTFNVSSNFLTGRI 550
R + F LS L N + I
Sbjct: 217 KTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEI 276
Query: 551 PLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTE 610
L+ L++S NK + LP LE L S N L+ +P N L +
Sbjct: 277 RSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQN---LKQ 328
Query: 611 LQMGGNSFSGGIPAELGSLSSLQI 634
L + N P S+ L++
Sbjct: 329 LHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 24/80 (30%), Positives = 38/80 (47%), Gaps = 9/80 (11%)
Query: 629 LSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSY 688
SL+ LN+S N L +P L E L+ + NHL+ E+P NL L + Y
Sbjct: 283 PPSLEE-LNVSNNKLIE-LPALPPRL---ERLIASFNHLA-EVPELPQNLKQL---HVEY 333
Query: 689 NNLTGPIPSSQTFQNMSVNS 708
N L ++ +++ +NS
Sbjct: 334 NPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 7e-07
Identities = 21/104 (20%), Positives = 43/104 (41%), Gaps = 7/104 (6%)
Query: 55 NWNPNDSTPCGWIGVNCTTNDFGAVVFSL-NLTKMNLSG-YLSPNIGGLVHLTALDLSFN 112
++ P +N ++N+ ++ +L ++N+S L L L SFN
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERLIASFN 314
Query: 113 QLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILN 156
L+ +P+ N L+ L++ N L P ++ L + +
Sbjct: 315 HLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 23/91 (25%), Positives = 39/91 (42%), Gaps = 9/91 (9%)
Query: 207 QNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKEL 266
N S + S SL+ L ++ N+L E+P L+ L I N L+ +P+
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLAE-VPELP 323
Query: 267 GNCTSLETLALYDNKQVGQLPKELGSIGSLK 297
N L+ L + N + + P S+ L+
Sbjct: 324 QN---LKQLHVEYN-PLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 4e-05
Identities = 22/94 (23%), Positives = 35/94 (37%), Gaps = 9/94 (9%)
Query: 132 NLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLP 191
N I SL LN+ NN++ P + L +L+A N+++ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVP 320
Query: 192 PTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQ 225
NLK+L N + P E L+
Sbjct: 321 ELPQNLKQL---HVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 7e-05
Identities = 20/94 (21%), Positives = 36/94 (38%), Gaps = 10/94 (10%)
Query: 231 QNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKEL 290
N S EI + L ++ + N+L +P LE L N + ++P+
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFN-HLAEVPELP 323
Query: 291 GSIGSLKYLYIYRNELNGTIPREIGKLSSALEID 324
+ LK L++ N L P + L ++
Sbjct: 324 QN---LKQLHVEYNPLR-EFPDIPESVED-LRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 6e-04
Identities = 21/94 (22%), Positives = 33/94 (35%), Gaps = 9/94 (9%)
Query: 253 LWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPR 312
+ N S I SLE L + +N ++ +LP L+ L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNN-KLIELP---ALPPRLERLIASFNHLA-EVPE 321
Query: 313 EIGKLSSALEIDFSENSLIGEIPVELSKILGLEL 346
L ++ N L E P + L +
Sbjct: 322 LPQNLK---QLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (130), Expect = 3e-08
Identities = 17/80 (21%), Positives = 28/80 (35%), Gaps = 9/80 (11%)
Query: 103 HLTALDLSFNQLS----RNIPKEIGNCSSLEVLNLNNNRLEAHIPKELG-----NLSSLT 153
L L L+ +S ++ + SL L+L+NN L +L L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 154 ILNIYNNRISGPFPKEIGKL 173
L +Y+ S + L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 5e-08
Identities = 14/77 (18%), Positives = 30/77 (38%), Gaps = 5/77 (6%)
Query: 102 VHLTALDLSFNQLSRNIPKEI-GNCSSLEVLNLNNNRLE----AHIPKELGNLSSLTILN 156
+ + +LD+ +LS E+ +V+ L++ L I L +L LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 157 IYNNRISGPFPKEIGKL 173
+ +N + + +
Sbjct: 62 LRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 14/94 (14%), Positives = 32/94 (34%), Gaps = 15/94 (15%)
Query: 82 SLNLTKMNLSGY------LSPNIGGLVHLTALDLSFNQLS----RNIPKEIGNCSSLEVL 131
SL++ +++ + + L + L L+ ++I + +L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 132 NLNNNRLEAHIPKELG-----NLSSLTILNIYNN 160
NL +N L + + L++ N
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 9e-07
Identities = 20/87 (22%), Positives = 33/87 (37%), Gaps = 9/87 (10%)
Query: 124 NCSSLEVLNLNNNRLE----AHIPKELGNLSSLTILNIYNNRISGPFPKEIGK-----LS 174
S L VL L + + + + L SL L++ NN + ++ +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 175 ALSQLVAYSNNISGSLPPTLGNLKRLK 201
L QLV Y S + L L++ K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 1e-06
Identities = 15/89 (16%), Positives = 29/89 (32%), Gaps = 10/89 (11%)
Query: 367 NLTKLDLSINSLTGT-IPLGFQYLTNLIMLQLFDNSL----VGGIPQRLGAYSQLWVVDL 421
++ LD+ L+ L +++L D L I L L ++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 422 SDNHLTGKIPRHICR-----NTSLIFLNL 445
N L + + + + L+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 13/90 (14%), Positives = 24/90 (26%), Gaps = 5/90 (5%)
Query: 512 LQRLHLSDNYFTGE-LPREVGNLSNLVTFNVSSNFLTGR----IPLEIFSCKMLQRLDLS 566
+Q L + + + L + LT I + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 567 WNKFVGALPREIGSLFQLELLKLSENELSG 596
N+ + Q K+ + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 19/87 (21%), Positives = 29/87 (33%), Gaps = 13/87 (14%)
Query: 82 SLNLTKMNLSG----YLSPNIGGLVHLTALDLSFNQLSRNIPKEIG-----NCSSLEVLN 132
L L ++S L+ + L LDLS N L ++ LE L
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432
Query: 133 LNNNRLEAHIPKELGNLS----SLTIL 155
L + + L L SL ++
Sbjct: 433 LYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 2e-05
Identities = 14/91 (15%), Positives = 31/91 (34%), Gaps = 6/91 (6%)
Query: 584 LELLKLSENELSGSIPVQI-GNLSRLTELQMGGNSFSG----GIPAELGSLSSLQIALNL 638
++ L + ELS + ++ L + +++ + I + L +L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE-LNL 62
Query: 639 SYNNLSGLIPPELGNLILLEYLLLNNNHLSG 669
N L + + + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 14/85 (16%), Positives = 33/85 (38%), Gaps = 9/85 (10%)
Query: 508 NCNALQRLHLSDNYFTGE----LPREVGNLSNLVTFNVSSNFLTGRIPLEIFS-----CK 558
+ L+ L L+D + L + +L ++S+N L L++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 559 MLQRLDLSWNKFVGALPREIGSLFQ 583
+L++L L + + + +L +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 4e-05
Identities = 21/78 (26%), Positives = 32/78 (41%), Gaps = 10/78 (12%)
Query: 604 NLSRLTELQMGGNSFSG----GIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLI---- 655
S L L + S + A L + SL+ L+LS N L +L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE-LDLSNNCLGDAGILQLVESVRQPG 425
Query: 656 -LLEYLLLNNNHLSGEIP 672
LLE L+L + + S E+
Sbjct: 426 CLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 8e-05
Identities = 17/105 (16%), Positives = 31/105 (29%), Gaps = 23/105 (21%)
Query: 433 HICRNTSLIFLNLETNKLTG----SIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANL 488
+ L L L ++ S+ + SL +L L N + L +
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 489 STVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNL 533
L++L L D Y++ E+ + L
Sbjct: 424 -------------------PGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 15/83 (18%), Positives = 30/83 (36%), Gaps = 9/83 (10%)
Query: 532 NLSNLVTFNVSSNFLTGR----IPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQ---- 583
S L ++ ++ + + + L+ LDLS N A ++ +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 584 -LELLKLSENELSGSIPVQIGNL 605
LE L L + S + ++ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 15/75 (20%), Positives = 25/75 (33%), Gaps = 5/75 (6%)
Query: 223 SLQYLGLAQNQLSGEIPKEI-GMLKYLTDVILWGNQLSGV----IPKELGNCTSLETLAL 277
+Q L + +LS E+ +L+ V L L+ I L +L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 278 YDNKQVGQLPKELGS 292
N+ +
Sbjct: 63 RSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 2e-04
Identities = 10/76 (13%), Positives = 22/76 (28%), Gaps = 5/76 (6%)
Query: 535 NLVTFNVSSNFLTGRIPLEIFSC-KMLQRLDLSWNKF----VGALPREIGSLFQLELLKL 589
++ + ++ L+ E+ + Q + L + + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 590 SENELSGSIPVQIGNL 605
NEL +
Sbjct: 63 RSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 17/95 (17%), Positives = 30/95 (31%), Gaps = 16/95 (16%)
Query: 583 QLELLKLSENELSG----SIPVQIGNLSRLTELQMGGNSFSGGIPAELGS-----LSSLQ 633
L +L L++ ++S S+ + L EL + N +L L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 634 IALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLS 668
L L S + L+ L + L
Sbjct: 430 Q-LVLYDIYWSEEMED------RLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 6e-04
Identities = 10/83 (12%), Positives = 26/83 (31%), Gaps = 5/83 (6%)
Query: 416 LWVVDLSDNHLTGKIPRHICRN-TSLIFLNLETNKLTG----SIPTGVTRCKSLVQLRLG 470
+ +D+ L+ + + L+ LT I + + +L +L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 471 GNSFTGSFPSDLCKLANLSTVEL 493
N + + + ++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 6e-04
Identities = 20/78 (25%), Positives = 30/78 (38%), Gaps = 9/78 (11%)
Query: 344 LELLYLFENKLTGV----IPVELTTLKNLTKLDLSINSLTGTIPLGF-----QYLTNLIM 394
L +L+L + ++ + L +L +LDLS N L L Q L
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 395 LQLFDNSLVGGIPQRLGA 412
L L+D + RL A
Sbjct: 431 LVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 7e-04
Identities = 13/93 (13%), Positives = 27/93 (29%), Gaps = 10/93 (10%)
Query: 463 SLVQLRLGGNSFTGSFPSDLCK-LANLSTVELDQNQFSG----PIPTEIGNCNALQRLHL 517
+ L + + + ++L L V LD + I + + AL L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 518 SDNYFTGELPREVG-----NLSNLVTFNVSSNF 545
N V + ++ +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 9e-04
Identities = 13/68 (19%), Positives = 22/68 (32%), Gaps = 5/68 (7%)
Query: 636 LNLSYNNLSGLIPPEL-GNLILLEYLLLNNNHLSGE----IPGSFVNLSSLLGCNFSYNN 690
L++ LS EL L + + L++ L+ I + +L N N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 691 LTGPIPSS 698
L
Sbjct: 67 LGDVGVHC 74
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 16/79 (20%), Positives = 25/79 (31%), Gaps = 9/79 (11%)
Query: 386 FQYLTNLIMLQLFDNSL----VGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICR----- 436
Q + L +L L D + + L A L +DLS+N L +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 437 NTSLIFLNLETNKLTGSIP 455
L L L + +
Sbjct: 425 GCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 14/80 (17%), Positives = 26/80 (32%), Gaps = 9/80 (11%)
Query: 196 NLKRLKSFRAGQNLISG----SLPSEIGGCESLQYLGLAQNQLSGEIPKEIG-----MLK 246
L+ +S SL + + SL+ L L+ N L ++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 247 YLTDVILWGNQLSGVIPKEL 266
L ++L+ S + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.004
Identities = 15/70 (21%), Positives = 23/70 (32%), Gaps = 5/70 (7%)
Query: 322 EIDFSENSLIGEIPVELSKIL-GLELLYLFENKLTGV----IPVELTTLKNLTKLDLSIN 376
+D L EL +L +++ L + LT I L L +L+L N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 377 SLTGTIPLGF 386
L
Sbjct: 66 ELGDVGVHCV 75
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.3 bits (117), Expect = 1e-07
Identities = 23/108 (21%), Positives = 42/108 (38%), Gaps = 4/108 (3%)
Query: 130 VLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGS 189
VL+L + L + L L +T L++ +NR+ P + L L +++ S+N +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCL-EVLQASDNALEN 57
Query: 190 LPPTLGNLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGE 237
+ + + L + + C L L L N L E
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 6e-07
Identities = 26/123 (21%), Positives = 41/123 (33%), Gaps = 8/123 (6%)
Query: 561 QRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSG 620
+ L L+ + L + L LS N L P L+ L L++ S +
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNA 54
Query: 621 GIPAELGSLSSLQIALNLSYNNLSGLIPPE-LGNLILLEYLLLNNNHLSGEIPGSFVNLS 679
+ + L L N L + L + L L L N L + G L+
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLA 113
Query: 680 SLL 682
+L
Sbjct: 114 EML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 8e-07
Identities = 24/122 (19%), Positives = 43/122 (35%), Gaps = 6/122 (4%)
Query: 443 LNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPI 502
L+L LT + + + + L L N P+ L L L + + +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNALEN 57
Query: 503 PTEIGNCNALQRLHLSDNYFTG-ELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQ 561
+ N LQ L L +N + + + LV N+ N L ++ +ML
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 562 RL 563
+
Sbjct: 118 SV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 7e-06
Identities = 25/128 (19%), Positives = 49/128 (38%), Gaps = 12/128 (9%)
Query: 418 VVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGS 477
V+ L+ LT + H+ + + L+L N+L P + + L L+ +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALE 56
Query: 478 FPSDLCKLANLSTVELDQNQF-SGPIPTEIGNCNALQRLHLSDNYFTGE------LPREV 530
+ L L + L N+ + +C L L+L N E L +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 531 GNLSNLVT 538
++S+++T
Sbjct: 117 PSVSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 9e-06
Identities = 25/117 (21%), Positives = 44/117 (37%), Gaps = 27/117 (23%)
Query: 83 LNLTKMNLSGYLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSL-------------- 128
L+L +L+ ++ L+ +T LDLS N+L P + L
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 129 --------EVLNLNNNRLEA-HIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSAL 176
+ L L NNRL+ + L + L +LN+ N + +L+ +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.6 bits (102), Expect = 1e-05
Identities = 25/108 (23%), Positives = 44/108 (40%), Gaps = 7/108 (6%)
Query: 587 LKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGL 646
L L+ +L+ + + L +T L + N P +L++L+ L ++ +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALE 56
Query: 647 IPPELGNLILLEYLLLNNNHL-SGEIPGSFVNLSSLLGCNFSYNNLTG 693
+ NL L+ LLL NN L V+ L+ N N+L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 3e-04
Identities = 22/119 (18%), Positives = 37/119 (31%), Gaps = 7/119 (5%)
Query: 467 LRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGEL 526
L L T L +L ++ ++L N+ P + L+ L SDN
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 527 PREVGNLSNLVTFNVSSNFLTGRIPLEIFS-CKMLQRLDLSWNKFVGALPREIGSLFQL 584
L + +N L ++ C L L+L N L ++
Sbjct: 60 GVANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.002
Identities = 26/106 (24%), Positives = 37/106 (34%), Gaps = 26/106 (24%)
Query: 347 LYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIM------------ 394
L+L LT + L L +T LDLS N L P L L +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 395 ----------LQLFDNSLVGG-IPQRLGAYSQLWVVDLSDNHLTGK 429
L L +N L Q L + +L +++L N L +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.003
Identities = 22/95 (23%), Positives = 36/95 (37%), Gaps = 4/95 (4%)
Query: 287 PKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLEL 346
L + + +L + N L P + L + S+N+L V L +
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLPRL--QE 69
Query: 347 LYLFENKLTGVIPVE-LTTLKNLTKLDLSINSLTG 380
L L N+L ++ L + L L+L NSL
Sbjct: 70 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 5e-07
Identities = 41/197 (20%), Positives = 69/197 (35%), Gaps = 16/197 (8%)
Query: 347 LYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGI 406
L + +T + L ++ ++ + + + G QYL N+ L L N L
Sbjct: 29 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK 84
Query: 407 PQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQ 466
P + L + ++ + + I G+ L
Sbjct: 85 P-----LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN-GLVHLPQLES 138
Query: 467 LRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGEL 526
L LG N T +L L T+ L+ NQ S +P + LQ L+LS N+ +
Sbjct: 139 LYLGNNKITDITVL--SRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-- 192
Query: 527 PREVGNLSNLVTFNVSS 543
R + L NL + S
Sbjct: 193 LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 35/202 (17%), Positives = 65/202 (32%), Gaps = 25/202 (12%)
Query: 478 FPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLV 537
F D A L + + + N++ ++ +++ + L N+
Sbjct: 18 FSDD--AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVT 71
Query: 538 TFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFV---------------GALPREIGSLF 582
++ N LT PL LD + K + +I L
Sbjct: 72 KLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 583 QLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNN 642
L L+ + + + + + ++ I L L+ LQ L LS N+
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQN-LYLSKNH 189
Query: 643 LSGLIPPELGNLILLEYLLLNN 664
+S L L L L+ L L +
Sbjct: 190 ISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 32/203 (15%), Positives = 69/203 (33%), Gaps = 16/203 (7%)
Query: 100 GLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYN 159
+L ++ + + +S++ + NN+ +++ + + L ++T L +
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77
Query: 160 NRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIG 219
N+++ P L+ L + + +L + G
Sbjct: 78 NKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129
Query: 220 GCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYD 279
Q L + L L + L NQ+S ++P L T L+ L L
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 280 NKQVGQLPKELGSIGSLKYLYIY 302
N + L L + +L L ++
Sbjct: 188 N-HISDLR-ALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 37/202 (18%), Positives = 62/202 (30%), Gaps = 16/202 (7%)
Query: 389 LTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETN 448
I L S+ + Q + + + +++ + I ++ L L N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 449 KLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGN 508
KLT K L L+ G F + I G
Sbjct: 79 KLTD--------IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL 130
Query: 509 CNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWN 568
+ Q L + L+ L T ++ N ++ +PL LQ L LS N
Sbjct: 131 VHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKN 188
Query: 569 KFVGALPREIGSLFQLELLKLS 590
R + L L++L+L
Sbjct: 189 HISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 8/39 (20%), Positives = 19/39 (48%), Gaps = 2/39 (5%)
Query: 121 EIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYN 159
+ + L+ L L+ N + + L L +L +L +++
Sbjct: 173 PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 49.1 bits (115), Expect = 2e-06
Identities = 36/332 (10%), Positives = 89/332 (26%), Gaps = 36/332 (10%)
Query: 104 LTALDLSFNQLSRN----IPKEIGNCSSLEVLNLNNNRLEA----HIPKELGNLSSLTIL 155
+ L + ++ + + S++ + L+ N + + + + + L I
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 156 NIYNN---RISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISG 212
+ R+ P+ + L + + S + ++
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 213 SLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSL 272
L G +A+ + K+ L +I N+L KE
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 273 ETLALYDNKQVGQLPKELGSIGSLKYL-------------YIYRNELNGTIPREIGKLSS 319
L + E L+ L + + + + + +
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 320 ALEIDFSENSLIGEIPVELSKILG------LELLYLFENKLTGVIPVELTT-----LKNL 368
E+ ++ L + L+ L L N++ L T + +L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 369 TKLDLSINSLTGTIPLGFQYLTNLIMLQLFDN 400
L+L+ N + + + +
Sbjct: 305 LFLELNGNRFSE-EDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.0 bits (107), Expect = 2e-05
Identities = 54/336 (16%), Positives = 96/336 (28%), Gaps = 38/336 (11%)
Query: 295 SLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILG-------LELL 347
SLK I + ++ + + S EI S N++ E LS+ + E
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 348 YLFENKLTGVIPVELTTL----KNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLV 403
+F ++ IP L L KL S P + L + + L
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 404 GGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKS 463
L + + K + + N N +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 464 LVQLRLGGNSFTGSFPSDLCKLANLSTVEL---------DQNQFSGPIPTEIGNCNALQR 514
L +++ N L EL + S + + + L+
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 515 LHLSDNYFTGELPREVGN------LSNLVTFNVSSNFLTGRIPLEIFS-----CKMLQRL 563
L L+D + V + L T + N + + + L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 564 DLSWNKF--VGALPREIGSLFQL----ELLKLSENE 593
+L+ N+F + EI +F EL +L + E
Sbjct: 308 ELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDME 343
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 2e-04
Identities = 38/330 (11%), Positives = 85/330 (25%), Gaps = 24/330 (7%)
Query: 318 SSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTG----VIPVELTTLKNLTKLDL 373
+L++D + L + ++ + L N + + + + K+L +
Sbjct: 7 GKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 374 SINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRH 433
S + L L+ L L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLH--------TVRLSDNAFGPTAQEPLIDFLS 118
Query: 434 ICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVEL 493
++L+ + V + S +L N S E
Sbjct: 119 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 178
Query: 494 DQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLE 553
+ S + + R ++ L + N ++ + + +
Sbjct: 179 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238
Query: 554 IFSCKMLQRLDLSWNKFVGALPREIGSLF------QLELLKLSENELSGSIPVQI----- 602
+ S L+ L L+ + F L+ L+L NE+ +
Sbjct: 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 298
Query: 603 GNLSRLTELQMGGNSFSGGIPAELGSLSSL 632
+ L L++ GN F + + +
Sbjct: 299 EKMPDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 3e-04
Identities = 16/102 (15%), Positives = 30/102 (29%), Gaps = 18/102 (17%)
Query: 55 NWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQL 114
+ +C + GA +K+ L L L +N++
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI-----------GLQTLRLQYNEI 285
Query: 115 SRNIPKEI-----GNCSSLEVLNLNNNRL--EAHIPKELGNL 149
+ + + L L LN NR E + E+ +
Sbjct: 286 ELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 38/330 (11%), Positives = 87/330 (26%), Gaps = 22/330 (6%)
Query: 366 KNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSL----VGGIPQRLGAYSQLWVVDL 421
K+L ++ ++ ++ + L N++ + + + + L + +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 422 SDNH---LTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSF 478
SD + +IP + + + + + S + + L ++
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 479 PSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVT 538
L + ++ + + + N L+ + N +E
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 539 FNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSI 598
+ + I E +L+ L V L + S
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG------SSALAIALK 240
Query: 599 PVQIGNLSRLTELQMGGNSFSG-GIPAELGSLSSLQIALNLSYNNLSGLIPPEL-----G 652
L + + + LQ L L YN + L
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQT-LRLQYNEIELDAVRTLKTVIDE 299
Query: 653 NLILLEYLLLNNNHLSGEIPGSFVNLSSLL 682
+ L +L LN N S E + +
Sbjct: 300 KMPDLLFLELNGNRFSEE-DDVVDEIREVF 328
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 2e-06
Identities = 39/239 (16%), Positives = 73/239 (30%), Gaps = 9/239 (3%)
Query: 431 PRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLST 490
IC ++ +F + +K+T IP+ + ++ ++LR +L
Sbjct: 2 HHRICHCSNRVF-LCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 491 VELDQNQFSGPIPTEIGNCNALQRLHLSDNYF--TGELPREVGNLSNLVTFNVSSNFLTG 548
+E+ QN I ++ + + P NL NL +S+ +
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 549 RIPLEIFSCKMLQRLDLSW--NKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLS 606
+ LD+ N +G F+ +L L++N +
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 607 RLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNN 665
N+ S I L++S + L L NL L N
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVI-LDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.6 bits (111), Expect = 3e-06
Identities = 15/107 (14%), Positives = 26/107 (24%)
Query: 55 NWNPNDSTPCGWIGVNCTTNDFGAVVFSLNLTKMNLSGYLSPNIGGLVHLTALDLSFNQL 114
+ L L K + + G N L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 115 SRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNR 161
S +L+++ R+ + L NL L + YN +
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 35/237 (14%), Positives = 60/237 (25%), Gaps = 10/237 (4%)
Query: 418 VVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGS 477
V ++ +T +IP + RN I L KL + L ++ + N
Sbjct: 12 VFLCQESKVT-EIPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 478 FPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFT----GELPREVGNL 533
+D+ + + N +L + ++ +
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 534 SNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENE 593
L+ + N T + L L+ N EL N
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 594 LSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPE 650
L S L + L +L L+ S NL L E
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA---RSTYNLKKLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 38/224 (16%), Positives = 67/224 (29%), Gaps = 9/224 (4%)
Query: 351 ENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRL 410
E+K+T IP +L +N +L + L F +L +++ N ++ I +
Sbjct: 17 ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 73
Query: 411 GAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETN--KLTGSIPTGVTRCKSLVQLR 468
+ + L + + V L
Sbjct: 74 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 133
Query: 469 LGGNSFTGSFPSDLCKLANLSTVELD-QNQFSGPIPTEIGNCNALQRLHLSDNYFTGELP 527
+ N + + + +V L I N L L+LSDN ELP
Sbjct: 134 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELP 193
Query: 528 REV-GNLSNLVTFNVSSNFLTGRIPLEIFS-CKMLQRLDLSWNK 569
+V S V ++S + +P K L+ K
Sbjct: 194 NDVFHGASGPVILDISRTRIHS-LPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 34/230 (14%), Positives = 62/230 (26%), Gaps = 7/230 (3%)
Query: 319 SALEIDFSENSLIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSL 378
S E+ + EIP +L + L KL + + +L K+++S N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 379 TGTIPLGFQYLTNLIMLQLFD--NSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPR--HI 434
I + + N+L+ P+ L + +S+ +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 435 CRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELD 494
L+ + N T + V V L L N D
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 495 QNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSN 544
N + L +S + NL L + +
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.004
Identities = 22/86 (25%), Positives = 28/86 (32%), Gaps = 3/86 (3%)
Query: 107 LDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPF 166
L L+ N + E+ +NN LE S IL+I RI
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS-L 216
Query: 167 PKEIGKLSALSQLVAYSNNISGSLPP 192
P L L +L A S LP
Sbjct: 217 PSYG--LENLKKLRARSTYNLKKLPT 240
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 21/80 (26%), Positives = 34/80 (42%)
Query: 640 YNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQ 699
N + + L L+ L L +N +S +PGSF +L+SL N + N +
Sbjct: 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146
Query: 700 TFQNMSVNSFSGSKGLCGGP 719
+ + S +G CG P
Sbjct: 147 FAEWLRKKSLNGGAARCGAP 166
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 36/192 (18%), Positives = 67/192 (34%), Gaps = 25/192 (13%)
Query: 485 LANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSN 544
LA L + + + + + + L + V L+NL N S+N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNN 72
Query: 545 FLTGRIPLEIFSCKMLQRLDLSW----------------NKFVGALPREIGSLFQLELLK 588
LT PL+ + + ++ + F + L +
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 589 LSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIP 648
L + + S + L+ L +L N + P L +L++L+ L++S N +S +
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLER-LDISSNKVSDI-- 187
Query: 649 PELGNLILLEYL 660
L L LE L
Sbjct: 188 SVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 5e-05
Identities = 38/190 (20%), Positives = 62/190 (32%), Gaps = 16/190 (8%)
Query: 347 LYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGI 406
L + +T + T L +T L + +I G +YL NL + +N L
Sbjct: 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-- 76
Query: 407 PQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQ 466
+ L + + L + + I
Sbjct: 77 ------ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 467 LRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGEL 526
RL +S T S S L L +L + NQ + P + N L+RL +S N +
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD-- 186
Query: 527 PREVGNLSNL 536
+ L+NL
Sbjct: 187 ISVLAKLTNL 196
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 0.001
Identities = 31/200 (15%), Positives = 66/200 (33%), Gaps = 16/200 (8%)
Query: 100 GLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYN 159
L L ++ + + + + L + +++ + L++LT +N N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 160 NRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQNLISGSLPSEIG 219
N+++ P L L + + + + G L + +
Sbjct: 72 NQLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 220 GCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYD 279
L + + + L L + NQ++ + P L N T+LE L +
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 280 NKQVGQLPKELGSIGSLKYL 299
NK L + +L+ L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (98), Expect = 5e-05
Identities = 25/155 (16%), Positives = 45/155 (29%), Gaps = 4/155 (2%)
Query: 481 DLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREV-GNLSNLVTF 539
D C S + ++ + L L++ + L L L
Sbjct: 3 DACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 540 NVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIP 599
+ + L P L RL+LS+N +L + L+ L LS N L S
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 600 VQ-IGNLSRLTELQMGGNSFSGGIPAELGSLSSLQ 633
++ + + L + +
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 5e-04
Identities = 16/106 (15%), Positives = 29/106 (27%), Gaps = 3/106 (2%)
Query: 104 LTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKEL-GNLSSLTILNIYNNRI 162
+ L + + + + +L L + N + H+ L L L I + +
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 163 SGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNLKRLKSFRAGQN 208
P + S N SL L+ N
Sbjct: 69 RFVAPDAFHFTPR-LSRLNLSFNALESLSWKTVQGLSLQELVLSGN 113
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 6e-04
Identities = 22/150 (14%), Positives = 42/150 (28%), Gaps = 4/150 (2%)
Query: 221 CESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKEL-GNCTSLETLALYD 279
L ++ + + + LT++ + Q + L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 280 NKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLI-GEIPVEL 338
+ P L L + N ++ + + S E+ S N L L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124
Query: 339 SKILGLELLYLFENKLTGVIPVELTTLKNL 368
+ L + E KL L + N
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 8e-05
Identities = 28/135 (20%), Positives = 48/135 (35%), Gaps = 5/135 (3%)
Query: 479 PSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVT 538
+ K + S LD ++ N L+ + L N+ L++
Sbjct: 13 KLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLS 69
Query: 539 FNVSSNFLTGRIPLEIF--SCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSG 596
N+S+N L + L+ L+LS N+ + +LE L L N LS
Sbjct: 70 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
Query: 597 SIPVQIGNLSRLTEL 611
+ Q +S + E
Sbjct: 130 TFRDQSTYISAIRER 144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 2e-04
Identities = 23/125 (18%), Positives = 47/125 (37%), Gaps = 4/125 (3%)
Query: 81 FSLNLTKMNLSG-YLSPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLE 139
+ + ++L G P++ L+ + + + N L LNL+NNRL
Sbjct: 20 YDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLY 78
Query: 140 AH--IPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSNNISGSLPPTLGNL 197
+ + +L ILN+ N + + K L +L N++S + +
Sbjct: 79 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYI 138
Query: 198 KRLKS 202
++
Sbjct: 139 SAIRE 143
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 3e-04
Identities = 23/136 (16%), Positives = 50/136 (36%), Gaps = 6/136 (4%)
Query: 549 RIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRL 608
++ L + + L ++ + +L + ++ ++ + N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPEL 67
Query: 609 TELQMGGNSFSG--GIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNH 666
L + N + + + +L+I LNLS N L + + LE L L+ N
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKI-LNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 667 LSGEIPGSFVNLSSLL 682
LS +S++
Sbjct: 127 LSDTFRDQSTYISAIR 142
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 0.001
Identities = 23/127 (18%), Positives = 48/127 (37%), Gaps = 5/127 (3%)
Query: 331 IGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLT 390
+ ++ + +SK L L +L L+ +S+ T+ + + +
Sbjct: 9 VEQLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLRIIEENIP 65
Query: 391 NLIMLQLFDNSLVG--GIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETN 448
L+ L L +N L + + L +++LS N L + + L L L+ N
Sbjct: 66 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 125
Query: 449 KLTGSIP 455
L+ +
Sbjct: 126 SLSDTFR 132
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 27/142 (19%), Positives = 44/142 (30%), Gaps = 8/142 (5%)
Query: 330 LIGEIPVELSKILGLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYL 389
LI + + + + L L K+ VI TL +D S N + GF L
Sbjct: 7 LIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD--GFPLL 62
Query: 390 TNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTG----KIPRHICRNTSLIFLNL 445
L L + +N + A L + L++N L + T L L
Sbjct: 63 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122
Query: 446 ETNKLTGSIPTGVTRCKSLVQL 467
+ + + L
Sbjct: 123 PVTNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 2e-04
Identities = 23/137 (16%), Positives = 43/137 (31%), Gaps = 7/137 (5%)
Query: 95 SPNIGGLVHLTALDLSFNQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTI 154
+ V LDL ++ I + ++ ++N + L L
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKT 67
Query: 155 LNIYNNRISGPFPKEIGKLSALSQLVAYSNNISG----SLPPTLGNLKRLKSFRAGQNLI 210
L + NNRI L L++L+ +N++ +L +L L R
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 211 SGSLPSEIGGCESLQYL 227
I ++ L
Sbjct: 128 KHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 7e-04
Identities = 25/105 (23%), Positives = 38/105 (36%), Gaps = 6/105 (5%)
Query: 588 KLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLI 647
KL+ + + Q N R EL + G I +L ++ S N + L
Sbjct: 2 KLTAELIEQAA--QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDA-IDFSDNEIRKL- 56
Query: 648 PPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLT 692
L L+ LL+NNN + G L L + N+L
Sbjct: 57 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 40.1 bits (92), Expect = 6e-04
Identities = 27/172 (15%), Positives = 50/172 (29%), Gaps = 10/172 (5%)
Query: 326 SENSLIGEIPVELSKILGLELLYLFENKLTGVIPV------ELTTLKNLTKLDLSINSLT 379
++ + I + + + + +L G+IP L+TLK L LS N++
Sbjct: 2 AKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE 61
Query: 380 GTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTS 439
I + NL +L L N + + L A + + +
Sbjct: 62 -KIS-SLSGMENLRILSLGRN--LIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNL 117
Query: 440 LIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTV 491
+ + L L L GN + + V
Sbjct: 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1114 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.79 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.49 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.47 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.44 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.43 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.32 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.29 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.36 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.35 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.28 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.97 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.31 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.3 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.26 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.83 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.48 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.22 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.06 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.99 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=426.11 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=204.4
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
++|+..++||+|+||+||+|++++++.||||++...... .++|.+|++++++++|||||+++|+|.+++..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 578899999999999999999998899999998754332 5678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++|+|.+++......+++..+..++.|+|+||+|+|+. +|+||||||+|||+++++.+||+|||+|+........
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 9999999999987777899999999999999999999998 9999999999999999999999999999876544444
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
......||+.|+|||++.+..++.++|||||||++|||+|+..|+.... ...+.......... .
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~~~-------------~ 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFR-------------L 221 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC---CHHHHHHHHHHTCC-------------C
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC---CHHHHHHHHHhcCC-------------C
Confidence 4445679999999999999999999999999999999999655543322 22223322222110 0
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
..+.....++.+++.+||+.||++||||+||++.|+++..
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1111223468899999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=428.63 Aligned_cols=265 Identities=27% Similarity=0.417 Sum_probs=210.1
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
+..++|++.++||+|+||+||+|+++ ..||||+++..... ....+.|.+|+.++++++|||||++++++. ++..++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 44578999999999999999999875 36999999765443 344678999999999999999999999875 456899
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 965 (1114)
||||+++|+|.++++.....+++..+..++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999999987777899999999999999999999998 9999999999999999999999999999876432
Q ss_pred C-CCccccccccccccCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 966 Q-SKSMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 966 ~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
. ........||+.|||||++.+ ..|+.++|||||||++|||+||+.||....... .+...+..+.. .
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~~-----~ 228 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRGYL-----S 228 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHHTSC-----C
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH----HHHHHHhcCCC-----C
Confidence 2 233456689999999999864 358899999999999999999999997544322 22222222111 1
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
+... ..+......+.+++.+||+.||++||||+|+++.|+.+++.
T Consensus 229 p~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 229 PDLS---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CCGG---GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred Ccch---hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 1110 11122234688999999999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-48 Score=427.66 Aligned_cols=263 Identities=24% Similarity=0.377 Sum_probs=218.0
Q ss_pred HHHHHhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 803 DLVVATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 803 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
++++..++|++.++||+|+||+||+|+++ +|+.||||+++..... .++|.+|+.++++++|||||+++++|.+++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 34455688999999999999999999986 6889999998754432 567899999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 882 SNLLMYEYMARGSLGELLHG-ASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
..++||||+++|+|.+++.. ....+++..+..++.|+|+||+|||++ +|+||||||+|||+++++.+||+|||+|+
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 99999999999999999864 345899999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..............|++.|+|||++.+..++.++|||||||++|||++|..||..... ... +.+.+..+.
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~---~~~-~~~~i~~~~------ 233 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQ-VYELLEKDY------ 233 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH-HHHHHHTTC------
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch---HHH-HHHHHhcCC------
Confidence 7654444444455689999999999999999999999999999999998777653332 222 222222211
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
+ .+.+......+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 234 --~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 234 --R----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp --C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred --C----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0 11112233468899999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=423.05 Aligned_cols=261 Identities=25% Similarity=0.372 Sum_probs=213.1
Q ss_pred HHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 804 LVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 804 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
+++..++|++.++||+|+||+||+|++++++.||||++...... .+.|.+|+.++++++|||||++++++.+ +..
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~ 82 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence 34456789999999999999999999998899999999754332 5679999999999999999999998754 567
Q ss_pred EEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 884 LLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
++||||+++|+|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+|+..
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence 99999999999999886433 3689999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 963 DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 963 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
............||+.|||||++.+..++.++|||||||++|||+||..|+..... ..+.... +..+.
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~---~~~~~~~-i~~~~-------- 227 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVIQN-LERGY-------- 227 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHH-HHTTC--------
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC---HHHHHHH-HHhcC--------
Confidence 54444444556799999999999999999999999999999999997666543322 2222222 22211
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
+ ...+......+.+++.+||+.||++||||+||++.|+++-.
T Consensus 228 ~----~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 228 R----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 0 01111223468899999999999999999999999998643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=412.81 Aligned_cols=254 Identities=23% Similarity=0.372 Sum_probs=216.5
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
++|+..++||+|+||+||+|++++++.||||+++..... .++|.+|+.++++++||||++++|+|.+++..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 679999999999999999999998889999999865432 4678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+++|++.+++......+++..+.+++.|+|+||+|||+. +|+||||||+||++++++.+||+|||+|+........
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999999887777899999999999999999999998 9999999999999999999999999999876544444
Q ss_pred ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 969 SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .+ +...+..+.. .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----~~-~~~~i~~~~~--------~--- 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SE-TAEHIAQGLR--------L--- 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HH-HHHHHHTTCC--------C---
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH----HH-HHHHHHhCCC--------C---
Confidence 4555679999999999999999999999999999999998 7999865432 22 2222222111 0
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
..+......+.+++.+||+.||++|||++|+++.|.+|
T Consensus 221 -~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 -YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11112234688999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=416.46 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=209.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+++ +|+.||+|++.+.........+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999986 78999999997554333344677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred eecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence 99999999999974 34699999999999999999999999 999999999999999999999999999986542
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.......||+.|||||++.+..++.++||||+||++|||++|+.||.... ..+..+...+. .. .
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~~~~~i~~~-~~---------~-- 222 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQETYKRISRV-EF---------T-- 222 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHTT-CC---------C--
T ss_pred CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC----HHHHHHHHHcC-CC---------C--
Confidence 23345689999999999999999999999999999999999999996432 22233322221 11 1
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+......+.+++.+||+.||++|||++|+++
T Consensus 223 --~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11122346788999999999999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=417.34 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=209.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+++ +|+.||||++....... .+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 57999999999999999999975 79999999997654432 567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||++||+|.+++.+ ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+... .
T Consensus 97 Ey~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~ 170 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-Q 170 (293)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST-T
T ss_pred EecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc-c
Confidence 99999999999874 4699999999999999999999999 9999999999999999999999999999976432 2
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
......+||+.|||||++.+..++.++||||+||++|||++|+.||.... ..+.+..........
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~~~~~~~~~----------- 235 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN----PLRALYLIATNGTPE----------- 235 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHHCSCC-----------
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC----HHHHHHHHHhCCCCC-----------
Confidence 33456689999999999999999999999999999999999999996433 222333322221110
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...+......+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111223356889999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=415.69 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=204.7
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+++ +|+.||||++...... +..+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 57999999999999999999986 7999999999765432 22456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC-
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ- 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 966 (1114)
||+++|+|.++++. ...+++.++..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+|+......
T Consensus 83 Ey~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred eccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999999974 45799999999999999999999999 99999999999999999999999999998764322
Q ss_pred CCccccccccccccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.......+||+.|||||++.+..+ +.++||||+||++|||++|+.||........... .........
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---~~~~~~~~~--------- 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYL--------- 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH---HHHTTCTTS---------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH---HHhcCCCCC---------
Confidence 233456789999999999988876 5789999999999999999999975443222211 111111110
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.........+.+++.+||+.||++|||++|+++
T Consensus 227 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011122346778999999999999999999854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-47 Score=419.91 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=202.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CC---cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TG---HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
++|++.++||+|+||+||+|+++ ++ ..||||++..... ....+.|.+|+.++++++|||||+++|++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 56777889999999999999976 33 2588888765433 344567999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||+++|+|.+++......+++.++..++.|||+||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999987777899999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCC----ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 965 PQSK----SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 965 ~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
.... ......||+.|||||++.+..++.++|||||||++|||+| |+.||..... .+.+. .+..+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----~~~~~-~i~~~~----- 250 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN----QDVIN-AIEQDY----- 250 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHH-HHHTTC-----
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH----HHHHH-HHHcCC-----
Confidence 2221 1223468999999999999999999999999999999998 8999975432 22222 222211
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
+ .+.+......+.+++.+||+.||++||||+||++.|+++.+
T Consensus 251 ---~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 ---R----LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ---C----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---C----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 11122234568899999999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=420.30 Aligned_cols=270 Identities=20% Similarity=0.273 Sum_probs=217.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+++ +|+.||||++.+.....+...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999986 79999999997644323334567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC-
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ- 966 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 966 (1114)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999874 35799999999999999999999999 99999999999999999999999999999765332
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
.......+||+.|||||++.+..++.++||||+||++|||++|+.||.... .....+..... .+ .
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~i~~~-~~---------~- 228 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EYLIFQKIIKL-EY---------D- 228 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHTT-CC---------C-
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC----HHHHHHHHHcC-CC---------C-
Confidence 223445689999999999999999999999999999999999999997432 22222222221 11 1
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCCcc
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDSDQ 1104 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~ 1104 (1114)
.+......+.+++.+||+.||++|||++|+++.-. +. .+.++..++|+.-.
T Consensus 229 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~-i~---~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 229 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP-LK---AHPFFESVTWENLH 279 (288)
T ss_dssp ---CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH-HH---TSGGGTTCCCTTGG
T ss_pred ---CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH-HH---cCCccCCCCHHHhh
Confidence 11122346789999999999999999999765321 21 35678888987543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=417.71 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=207.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+.|++.++||+|+||+||+|+++ +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 57899999999999999999976 789999999975433 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|+|.+++......+++.++..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~ 164 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-I 164 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-H
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-c
Confidence 99999999999876667899999999999999999999999 9999999999999999999999999999864311 1
Q ss_pred CccccccccccccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
......+||+.|||||++. +..|+.++||||+||++|||++|+.||....... .+........ +
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~~~~i~~~~~-------~ 233 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----VLLKIAKSEP-------P 233 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHHHHHHSCC-------C
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----HHHHHHcCCC-------C
Confidence 2234568999999999984 5568899999999999999999999997554322 2222222111 0
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. ...+......+.+++.+||+.||++|||++|+++
T Consensus 234 ~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 T----LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C----CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C----CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 1112223456889999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=415.16 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=211.3
Q ss_pred hcCCcCCc-eecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERF-VIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.++|.+.. +||+|+||+||+|+++ ++..||||+++... .....+.|.+|++++++++|||||+++|++.+ +..
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 45677776 4999999999999875 35579999997543 23446779999999999999999999999865 568
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
|+||||+++|+|.+++......+++..+..++.|+|+||+|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999999887777899999999999999999999998 99999999999999999999999999999765
Q ss_pred CCCC--CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 964 MPQS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 964 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..... . +. ...+..+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~---~~-~~~i~~~~~----- 230 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-P---EV-MAFIEQGKR----- 230 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-H---HH-HHHHHTTCC-----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-H---HH-HHHHHcCCC-----
Confidence 3332 22234568999999999999999999999999999999998 8999975432 1 11 222222211
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
.+.+.....++.++|.+||+.||++||||.+|++.|+.+..
T Consensus 231 -------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 231 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11112233568899999999999999999999999987643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=413.90 Aligned_cols=262 Identities=24% Similarity=0.369 Sum_probs=207.9
Q ss_pred HHHHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 804 LVVATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 804 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
+++..++|++.+.||+|+||+||+|++++++.||||+++..... .+.|.+|+.++++++|||||++++++. ++..
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~ 86 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI 86 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCe
Confidence 33445789999999999999999999998889999999754432 467999999999999999999999985 4568
Q ss_pred EEEEecCCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 884 LLMYEYMARGSLGELLHGA-SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
++||||+++|++.+++... ...+++.++..++.||+.||+|||+. +|+||||||+|||+++++++||+|||+|+..
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhc
Confidence 9999999999999988743 34699999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 001253 963 DMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDA 1042 (1114)
Q Consensus 963 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1114)
............||+.|+|||++.+..++.++|||||||++|||++|..|+..... ..+.+.. +..+.
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~---~~~~~~~-i~~~~-------- 231 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQ-VERGY-------- 231 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHH-HHTTC--------
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC---HHHHHHH-HHhcC--------
Confidence 54444444556799999999999999999999999999999999997777654332 2222222 22111
Q ss_pred cccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1043 RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1043 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
+ .+.+.....++.+++.+||+.||++||+|++|+++|++....
T Consensus 232 ~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 232 R----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred C----CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 0 111222334688999999999999999999999999997654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=411.47 Aligned_cols=254 Identities=23% Similarity=0.387 Sum_probs=196.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe--cCceEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH--QGSNLL 885 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 885 (1114)
++|++.+.||+|+||+||+|+.+ +|+.||||++...... +...+.+.+|++++++++|||||++++++.+ .+..|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 68999999999999999999976 7899999999766543 3345678899999999999999999999865 456799
Q ss_pred EEecCCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 886 MYEYMARGSLGELLHG---ASSTLDWQTRFMIALGAAEGLSYLHHDC--KPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
||||+++|+|.+++.+ ....+++..+..++.|+++||+|||+.. ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999863 3457999999999999999999999862 1249999999999999999999999999998
Q ss_pred ecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..... .......+||+.|||||++.+..++.++||||+||++|||++|+.||.... ..+.... +..+...
T Consensus 163 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~----~~~~~~~-i~~~~~~---- 232 (269)
T d2java1 163 ILNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----QKELAGK-IREGKFR---- 232 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHH-HHHTCCC----
T ss_pred ecccC-CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC----HHHHHHH-HHcCCCC----
Confidence 76432 223345789999999999999999999999999999999999999997432 2222222 2222111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..+.....++.+++.+||+.||++|||++|+++
T Consensus 233 --------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 011122346889999999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=410.35 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=206.1
Q ss_pred cCCcCCceecccCCeEEEEEEeCCC-----cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTG-----HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
+.|+..++||+|+||+||+|.+++. ..||||++..... +....+|.+|+.++++++|||||+++|++.+.+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 5688889999999999999997632 4799999965433 33456789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+.+|++.+++......+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999999887778899999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCC--CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 964 MPQS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 964 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
.... .......||+.|||||++.+..++.++|||||||++|||++|..|+...... .+..+ .+..+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~---~~~~~-~i~~~~------- 230 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMK-AINDGF------- 230 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH-HHHTTC-------
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH---HHHHH-HHhccC-------
Confidence 3222 2233456899999999999999999999999999999999977666533322 22222 222211
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
+ .+.+......+.+++.+||+.||++||||+||++.|+++.+.
T Consensus 231 -~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 -R----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -C----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -C----CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 0 111222335688999999999999999999999999988653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=421.11 Aligned_cols=271 Identities=24% Similarity=0.403 Sum_probs=208.3
Q ss_pred HhcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 885 (1114)
..++|++.++||+|+||+||+|+++ +|+.||+|+++.... ....+.+.+|+.++++++|||||+++++|.+++..|+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4578999999999999999999976 789999999976533 2335678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
||||+++|+|.+++.+. ..+++..+..++.|+++||+|||+ + +|+||||||+|||+++++++||+|||+|+....
T Consensus 82 VmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999999743 468999999999999999999996 5 899999999999999999999999999986542
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC----------
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS---------- 1034 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 1034 (1114)
. ...+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.........+.........
T Consensus 158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2 234568999999999999999999999999999999999999999764432111110000000000
Q ss_pred --ccccccccc------------ccC--CCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhh
Q 001253 1035 --LVSGMLDAR------------LNL--QDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSES 1086 (1114)
Q Consensus 1035 --~~~~~~~~~------------~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1086 (1114)
......+.. ... ..........++.+++.+||+.||++|||++|+++ .+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 000000000 000 00000012346889999999999999999999987 45443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=417.37 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=209.4
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeCC-C-----cEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLRT-G-----HTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFC 877 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 877 (1114)
++..++|++.++||+|+||+||+|+++. + ..||||++...... .....+.+|+.+++++ +|||||++++++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 4556889999999999999999999752 2 36999998755432 2345788999999988 899999999999
Q ss_pred EecCceEEEEecCCCCCHHHHhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 001253 878 YHQGSNLLMYEYMARGSLGELLHGAS----------------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFH 935 (1114)
Q Consensus 878 ~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 935 (1114)
.+.+..|+||||+++|+|.++++... ..+++..+..++.|+++||+|||++ +|+|
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH 187 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 187 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 99999999999999999999997543 2489999999999999999999998 9999
Q ss_pred cCCCCCCeEECCCCCeEEeeccCceecCCCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCC
Q 001253 936 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPV 1013 (1114)
Q Consensus 936 ~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~ 1013 (1114)
|||||+||+++.++.+||+|||+|+........ ...+..||+.|||||++.+..++.++|||||||++|||+| |+.||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 999999999999999999999999876433322 2345678999999999999999999999999999999998 89999
Q ss_pred CCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 001253 1014 QPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLS 1084 (1114)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1084 (1114)
........+.+. +..+. + .+.+......+.++|.+||+.||++||||+||++.|.
T Consensus 268 ~~~~~~~~~~~~----~~~~~--------~----~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDANFYKL----IQNGF--------K----MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSHHHHHH----HHTTC--------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHHHHHH----HhcCC--------C----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 765543333222 22211 1 1111222346889999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-46 Score=412.00 Aligned_cols=252 Identities=25% Similarity=0.319 Sum_probs=192.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
.+.|++.+.||+|+||+||+|+++ +|+.||||++....... ..+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999986 78999999997654432 245678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC---CCCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD---DKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfG~a~~~~ 963 (1114)
|||++||+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||++. +++.+||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp ECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999999974 45799999999999999999999999 999999999999995 57899999999998754
Q ss_pred CCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
. .....+.+||+.|||||++.+..++.++||||+||++|||++|+.||.... ..+........ ..
T Consensus 162 ~--~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~i~~~-~~-------- 226 (307)
T d1a06a_ 162 P--GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----DAKLFEQILKA-EY-------- 226 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHTT-CC--------
T ss_pred C--CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC----HHHHHHHHhcc-CC--------
Confidence 2 233455789999999999999999999999999999999999999997432 22222222221 11
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++|||++|+++
T Consensus 227 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 -EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111111223346889999999999999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-46 Score=412.00 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=206.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
+.|+..++||+|+||+||+|+++ +|+.||||++...........+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999975 78999999998766655555677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+++|++..++. ....+++.++..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp ECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred EecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence 9999999987665 345799999999999999999999999 999999999999999999999999999986432
Q ss_pred CccccccccccccCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 968 KSMSAIAGSYGYIAPEYAYT---MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
.....||+.|||||++.+ ..|+.++||||+||++|||++|+.||.... ..+.+......... ..
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~----~~~~~~~i~~~~~~-------~~ 234 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHIAQNESP-------AL 234 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHSCCC-------CC
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC----HHHHHHHHHhCCCC-------CC
Confidence 234579999999999864 458999999999999999999999997432 22333332222110 00
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
........+.+++.+||+.||++|||++|+++
T Consensus 235 -----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 -----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 01112346889999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=405.16 Aligned_cols=249 Identities=23% Similarity=0.373 Sum_probs=200.2
Q ss_pred ceecccCCeEEEEEEeC---CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecCC
Q 001253 815 FVIGRGACGTVYRAVLR---TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYMA 891 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 891 (1114)
++||+|+||+||+|.++ +++.||||+++.... +....+.|.+|+.++++++|||||+++++|.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 47999999999999865 356899999976543 33446779999999999999999999999864 56789999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC--c
Q 001253 892 RGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK--S 969 (1114)
Q Consensus 892 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~ 969 (1114)
+|+|.++++. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+|+........ .
T Consensus 91 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 91 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999999974 45799999999999999999999998 9999999999999999999999999999876433222 2
Q ss_pred cccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCC
Q 001253 970 MSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQD 1048 (1114)
Q Consensus 970 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1114)
.....||+.|||||++.+..++.++|||||||++|||+| |+.||..... . .+...+..+.. .
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----~-~~~~~i~~~~~--------~---- 229 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----S-EVTAMLEKGER--------M---- 229 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----H-HHHHHHHTTCC--------C----
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----H-HHHHHHHcCCC--------C----
Confidence 234579999999999999999999999999999999998 8999975432 1 22223332211 1
Q ss_pred cccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 001253 1049 EKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSES 1086 (1114)
Q Consensus 1049 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1086 (1114)
+.+......+.+++.+||+.||++|||++||++.|+..
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11122335688999999999999999999999988875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-46 Score=401.72 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=198.7
Q ss_pred CcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe----cCceEE
Q 001253 811 FDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH----QGSNLL 885 (1114)
Q Consensus 811 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 885 (1114)
|+..++||+|+||+||+|+++ +++.||+|++...... ....+.+.+|++++++++|||||++++++.+ +...|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 356678999999999999986 7889999999765443 3345678999999999999999999999875 345789
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC-CCCCeEEeeccCceecCC
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfG~a~~~~~ 964 (1114)
||||+++|+|.++++. ...+++..+..++.|+++||+|||++ .++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 90 vmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~- 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 166 (270)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-
Confidence 9999999999999974 34789999999999999999999998 12399999999999996 57899999999998643
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARL 1044 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1114)
.......+||+.|||||++.+ +++.++||||+||++|||++|+.||..... .....+ .+..+.. ...
T Consensus 167 --~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~---~~~~~~-~i~~~~~-----~~~- 233 (270)
T d1t4ha_ 167 --ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYR-RVTSGVK-----PAS- 233 (270)
T ss_dssp --TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---HHHHHH-HHTTTCC-----CGG-
T ss_pred --CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc---HHHHHH-HHHcCCC-----Ccc-
Confidence 233456789999999998865 599999999999999999999999964332 222222 2222111 111
Q ss_pred cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1045 NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1045 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+.....++.+++.+||+.||++|||++|+++
T Consensus 234 -----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11112235789999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.9e-46 Score=416.55 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=210.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 68999999999999999999976 799999999975432 33567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC--CCCeEEeeccCceecCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD--KFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DfG~a~~~~~~ 965 (1114)
||++||+|.+++......+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+|+...
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~-- 177 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-- 177 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC--
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc--
Confidence 99999999999976667899999999999999999999999 9999999999999964 6789999999999765
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.........||+.|||||++.+..++.++||||+||++|||++|+.||.+.. ..+.++....... .
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~~~~~i~~~~~----------~ 243 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDETLRNVKSCDW----------N 243 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHTCC----------C
T ss_pred cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCC----------C
Confidence 3334456789999999999999999999999999999999999999996432 2333333222211 1
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
............+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111223346889999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-45 Score=413.47 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=210.6
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67999999999999999999975 799999999875432 23566889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEEC--CCCCeEEeeccCceecCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLD--DKFEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~DfG~a~~~~~~ 965 (1114)
||++||+|.+++......+++.++..++.||+.||+|||+. ||+||||||+|||++ .++.+||+|||+|+.+..
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~- 181 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 181 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC-
Confidence 99999999998886777899999999999999999999998 999999999999998 678999999999998652
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
........||+.|||||++.+..++.++||||+||++|||++|+.||.+.. ..+.+........ .
T Consensus 182 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~~~~~i~~~~~----------~ 246 (352)
T d1koba_ 182 -DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED----DLETLQNVKRCDW----------E 246 (352)
T ss_dssp -TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHHHHHCCC----------C
T ss_pred -CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCC----------C
Confidence 334456789999999999999999999999999999999999999996433 2233333222111 0
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
............+.+++.+||+.||.+|||++|+++
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111223346789999999999999999999976
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=403.72 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=208.9
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCC---hhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGN---NNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
++|++.++||+|+||+||+|+++ +|+.||||++.+..... ....+.+.+|+.++++++|||||++++++.+++..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 67999999999999999999985 79999999997654322 223577999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC----CeEEeeccCce
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF----EAHVGDFGLAK 960 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfG~a~ 960 (1114)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|++|||+|+
T Consensus 90 iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999743 4799999999999999999999999 999999999999998876 49999999998
Q ss_pred ecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+........ ..
T Consensus 166 ~~~~--~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~~i~~~-~~----- 233 (293)
T d1jksa_ 166 KIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETLANVSAV-NY----- 233 (293)
T ss_dssp ECTT--SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHTT-CC-----
T ss_pred hcCC--CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC----HHHHHHHHHhc-CC-----
Confidence 7642 233455689999999999999999999999999999999999999997432 22222222111 11
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.............+.+++.+||+.||++|||++|+++
T Consensus 234 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 ----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011111122346889999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=402.49 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=202.5
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCC----CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRT----GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG 881 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 881 (1114)
+..++|++.+.||+|+||+||+|++.. +..||||+++... .....+.+.+|+.++++++|||||++++++. ++
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 345789999999999999999999752 3568888885433 3344667999999999999999999999985 56
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..|+||||+++|++.+++......+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+|+.
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 78999999999999999887777899999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
.............||+.|+|||++.+..++.++|||||||++|||++ |..||..... .+.... +..+..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-~~~~~~----i~~~~~----- 227 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGR----IENGER----- 227 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHH----HHTTCC-----
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-HHHHHH----HHcCCC-----
Confidence 65444444556678999999999999999999999999999999998 8888875443 222222 222111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
.+.+......+.++|.+||+.||++|||++||++.|+++..
T Consensus 228 -------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 228 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11122233568899999999999999999999999998754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-46 Score=398.75 Aligned_cols=253 Identities=27% Similarity=0.427 Sum_probs=201.2
Q ss_pred HhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe-cCceEE
Q 001253 807 ATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH-QGSNLL 885 (1114)
Q Consensus 807 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 885 (1114)
..++|++.++||+|+||+||+|+++ |+.||||+++.... .+.+.+|++++++++||||++++|+|.+ .+..|+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 3467889999999999999999996 78999999965432 4678999999999999999999999865 456899
Q ss_pred EEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 886 MYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
||||+++|+|.+++.... ..+++..++.++.||++||+|||+. +|+||||||+||+++.++.+|++|||+++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999997433 3589999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
......+++.|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+ ..+. +
T Consensus 156 ----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~i----~~~~--------~ 218 (262)
T d1byga_ 156 ----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRV----EKGY--------K 218 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHH----TTTC--------C
T ss_pred ----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHHHHH----HcCC--------C
Confidence 2234468899999999999999999999999999999998 67776543 223333332 2111 0
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
.+.+......+.+++.+||+.||.+||||+|+++.|++++..
T Consensus 219 ----~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 219 ----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 111222334688999999999999999999999999998653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-45 Score=404.78 Aligned_cols=263 Identities=27% Similarity=0.446 Sum_probs=212.8
Q ss_pred HHHHHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeE
Q 001253 803 DLVVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGF 876 (1114)
Q Consensus 803 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 876 (1114)
+++...++|++.++||+|+||+||+|+++ +++.||||++.... .....++|.+|+.++++++||||++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 34445688999999999999999999964 45789999986543 33446779999999999999999999999
Q ss_pred EEecCceEEEEecCCCCCHHHHhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 001253 877 CYHQGSNLLMYEYMARGSLGELLHGAS-----------------------STLDWQTRFMIALGAAEGLSYLHHDCKPRI 933 (1114)
Q Consensus 877 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 933 (1114)
|...+..++||||+++|+|.++++... ..+++..+..++.|++.||+|||+. +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999986322 2488999999999999999999998 99
Q ss_pred EecCCCCCCeEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCC-C
Q 001253 934 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGR-A 1011 (1114)
Q Consensus 934 vH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~-~ 1011 (1114)
+||||||+|||++.++.+||+|||+|+....... .......|++.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986543222 2334567899999999999999999999999999999999986 5
Q ss_pred CCCCCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1012 PVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1012 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
||.... ..+... .+..+... +.+...+.++.+++.+||+.||++||||.||++.|+++.
T Consensus 242 p~~~~~----~~e~~~-~v~~~~~~------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMA----HEEVIY-YVRDGNIL------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSC----HHHHHH-HHHTTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCC----HHHHHH-HHHcCCCC------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 665332 222222 23322211 111222346889999999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=406.37 Aligned_cols=250 Identities=22% Similarity=0.252 Sum_probs=209.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|+++++||+|+||+||+|+.+ +|+.||||++.+.........+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 67999999999999999999975 79999999997654322333567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||++||+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++++|.+||+|||+|+.... ..
T Consensus 85 ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~-~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DG 159 (337)
T ss_dssp ECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-TT
T ss_pred eccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc-CC
Confidence 99999999999984 34789999999999999999999999 999999999999999999999999999986542 23
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+..+..... . ..
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~----~~~~~~~i~~~-~---------~~-- 223 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERLFELILME-E---------IR-- 223 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-C---------CC--
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC----HHHHHHHHhcC-C---------CC--
Confidence 34456789999999999999999999999999999999999999997533 22222222221 1 11
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRPT-----MREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1081 (1114)
.+.....++.+++.+||+.||++||+ +.|+++
T Consensus 224 --~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11122346789999999999999995 777765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=399.93 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=202.6
Q ss_pred hcCCcCCceecccCCeEEEEEEeC--CC--cEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR--TG--HTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
.++|++.+.||+|+||+||+|+++ ++ ..||||++.+.........++|.+|+.++++++|||||+++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 367999999999999999999864 23 3789999987766565667789999999999999999999999965 567
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++||||+++|++.+.+......+++..+..++.|+|+||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 899999999999999876667899999999999999999999998 99999999999999999999999999999865
Q ss_pred CCCCC--ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 964 MPQSK--SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 964 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+......+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~----~~~~~~~i~~~~~~----- 233 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN----GSQILHKIDKEGER----- 233 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTSCCC-----
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC----HHHHHHHHHhCCCC-----
Confidence 43322 2234568889999999999999999999999999999998 899996432 23333333332111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESN 1087 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1087 (1114)
.+.+...+..+.+++.+||+.||++||||+||++.|++.+
T Consensus 234 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 234 -------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 1111122346889999999999999999999999998863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.9e-44 Score=391.69 Aligned_cols=262 Identities=24% Similarity=0.351 Sum_probs=210.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCc----
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGS---- 882 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 882 (1114)
.++|++.+.||+|+||+||+|++. +|+.||||+++.....+....+.+.+|+.+++.++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999975 799999999988776666667789999999999999999999999987543
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.|+||||++||+|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+|||++.++.++++|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence 7899999999999998874 34789999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCC--CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 963 DMPQS--KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 963 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
..... ......+||+.|||||++.+..++.++||||+||++|||+||+.||... ...+.....+.........
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~~~~~~~~~~~~~~- 236 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD----SPVSVAYQHVREDPIPPSA- 236 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHCCCCCGGG-
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc----CHHHHHHHHHhcCCCCCch-
Confidence 32222 2344568999999999999999999999999999999999999999643 2333344444432221111
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhh
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRP-TMREVVLMLSESN 1087 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~ 1087 (1114)
.....+..+.+++.+||+.||.+|| |++++++.|.+++
T Consensus 237 ---------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 237 ---------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0111234688999999999999999 8999999998874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=403.31 Aligned_cols=269 Identities=25% Similarity=0.365 Sum_probs=205.5
Q ss_pred CHHHHHHHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceee
Q 001253 800 TFKDLVVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVK 872 (1114)
Q Consensus 800 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 872 (1114)
....+++..++|++.++||+|+||+||+|++. +++.||||+++.... ....+.+.+|...+.++ +|+|||.
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 44556667789999999999999999999964 346899999875433 23355677777777766 6899999
Q ss_pred EEeEEEec-CceEEEEecCCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 001253 873 LYGFCYHQ-GSNLLMYEYMARGSLGELLHGA---------------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHR 936 (1114)
Q Consensus 873 l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 936 (1114)
+++++... ...++||||+++|+|.++++.. ...+++.++..++.||++||+|||++ +|+||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHr 158 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 158 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCC
Confidence 99998765 4689999999999999999643 23589999999999999999999999 99999
Q ss_pred CCCCCCeEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCC-CCCC
Q 001253 937 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGR-APVQ 1014 (1114)
Q Consensus 937 Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~-~p~~ 1014 (1114)
||||+|||+++++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||++|. .||.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987543332 2334567999999999999999999999999999999999975 5776
Q ss_pred CCCCCCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1015 PLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
...........+ ..+.. . ..+.....++.+++.+||+.||++|||++|+++.|+++.++
T Consensus 239 ~~~~~~~~~~~~----~~~~~--------~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 239 GVKIDEEFCRRL----KEGTR--------M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp TCCCSHHHHHHH----HHTCC--------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHH----hcCCC--------C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 544332222222 22111 1 11112234688999999999999999999999999998654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.2e-45 Score=402.14 Aligned_cols=247 Identities=24% Similarity=0.311 Sum_probs=207.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+++ +|+.||||++++.........+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999985 79999999997553323333667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||++||++.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 156 (316)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc---
Confidence 99999999999874 44678889999999999999999998 999999999999999999999999999997642
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+..+...... ..
T Consensus 157 -~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~i~~~~----------~~-- 219 (316)
T d1fota_ 157 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN----TMKTYEKILNAE----------LR-- 219 (316)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHCC----------CC--
T ss_pred -ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC----HHHHHHHHHcCC----------CC--
Confidence 2345689999999999999999999999999999999999999997432 223333322221 11
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
.+......+.+++.+||+.||.+|| |++|+++
T Consensus 220 --~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 --FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1112234678999999999999996 8999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=398.75 Aligned_cols=257 Identities=25% Similarity=0.439 Sum_probs=205.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCc----EEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCce
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGH----TVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 883 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 883 (1114)
++|++.++||+|+||+||+|++. +|+ +||+|+++.... ....+.|.+|+.++++++|||||+++|+|.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 57999999999999999999975 444 688888865432 23367799999999999999999999999764 56
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
++++||+.+|+|.+++......+++..+..++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 788999999999999987788999999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCC-ccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 001253 964 MPQSK-SMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLD 1041 (1114)
Q Consensus 964 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1114)
..... ......||+.|||||++.+..++.++|||||||++|||+| |+.||..... ......+.. +.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~~~~~i~~----~~------- 230 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK----GE------- 230 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GGHHHHHHH----TC-------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHc----CC-------
Confidence 33322 2334568999999999999999999999999999999998 7888865432 223222222 11
Q ss_pred ccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1042 ARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1042 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
+ .+.+......+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 231 -~----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 231 -R----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -C----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -C----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1 11112233468899999999999999999999999988743
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-44 Score=405.43 Aligned_cols=247 Identities=19% Similarity=0.237 Sum_probs=207.7
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|+++++||+|+||+||+|+++ +|+.||||++.+.........+.+.+|+.+++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999986 79999999997543322333567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+.+|+|.+++... ..+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence 999999999999743 4789999999999999999999999 999999999999999999999999999997642
Q ss_pred CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccCC
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNLQ 1047 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1114)
......||+.|||||++.+..++.++||||+||++|||++|+.||... +............ .
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~~i~~~~----------~--- 255 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----QPIQIYEKIVSGK----------V--- 255 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCC----------C---
T ss_pred -ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc----CHHHHHHHHhcCC----------C---
Confidence 234568999999999999999999999999999999999999999643 2223333222221 1
Q ss_pred CcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1048 DEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1048 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
..+.....++.+++.+||+.||.+|+ |++|+++
T Consensus 256 -~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11112234688999999999999994 8999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.6e-44 Score=387.94 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=207.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCCh------hhHHHHHHHHHHHhcCC-CCceeeEEeEEEec
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNN------NVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQ 880 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 880 (1114)
++|++.+.||+|+||+||+|+.+ +|+.||||++........ ...+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999975 789999999986654321 22346788999999997 99999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 881 GSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 881 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
+..|+||||+++|+|.++++. ...+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999999974 44799999999999999999999998 99999999999999999999999999999
Q ss_pred ecCCCCCCccccccccccccCcccccc------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYT------MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS 1034 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1034 (1114)
.... .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... ....+..... .
T Consensus 159 ~~~~--~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----~~~~~~i~~~-~ 231 (277)
T d1phka_ 159 QLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----MLMLRMIMSG-N 231 (277)
T ss_dssp ECCT--TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHT-C
T ss_pred EccC--CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----HHHHHHHHhC-C
Confidence 8653 233355689999999998863 3468899999999999999999999975432 2222222221 1
Q ss_pred cccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1035 LVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
. ..........+.++.+++.+||+.||++|||++|+++
T Consensus 232 ~---------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 232 Y---------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp C---------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C---------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 1111122233457889999999999999999999854
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=398.79 Aligned_cols=250 Identities=21% Similarity=0.263 Sum_probs=208.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.+.||+|+||+||+|+++ +|+.||||+++.... ....+.+|+++++.++|||||++++++.+++..|+||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 67999999999999999999986 789999999975432 2456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC--CCeEEeeccCceecCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK--FEAHVGDFGLAKVIDMP 965 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DfG~a~~~~~~ 965 (1114)
||++||+|.+++......+++.++..++.||++||+|||+. +|+||||||+|||++.+ ..+||+|||+++...
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~-- 155 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-- 155 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc--
Confidence 99999999999987666899999999999999999999998 99999999999999854 589999999998754
Q ss_pred CCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 966 QSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 966 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.........|++.|+|||...+..++.++||||+||++|||++|+.||.... ..+..+...... ..
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~----~~~~~~~i~~~~----------~~ 221 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----NQQIIENIMNAE----------YT 221 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS----HHHHHHHHHHTC----------CC
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCC----------CC
Confidence 2333455679999999999999999999999999999999999999997533 222223222211 11
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
...........++.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111112346789999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=391.54 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=206.8
Q ss_pred CceecccCCeEEEEEEeCC----CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe-cCceEEEEe
Q 001253 814 RFVIGRGACGTVYRAVLRT----GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH-QGSNLLMYE 888 (1114)
Q Consensus 814 ~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E 888 (1114)
.++||+|+||+||+|++.. +..||||+++... .....++|.+|++++++++|||||+++|++.+ ++..++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4689999999999999753 2368999986432 34446789999999999999999999999876 457899999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC-
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS- 967 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 967 (1114)
|+++|+|.++++......++..+..++.|+|+||.|+|+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999999998777889999999999999999999998 999999999999999999999999999987643322
Q ss_pred --CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccc
Q 001253 968 --KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLN 1045 (1114)
Q Consensus 968 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1114)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......+...++. .+.. .
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~----~g~~--------~- 253 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----QGRR--------L- 253 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH----TTCC--------C-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH----cCCC--------C-
Confidence 222345789999999999999999999999999999999998888765443333333322 1111 0
Q ss_pred CCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1046 LQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1046 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
..+......+.++|.+||+.||++||+|.||++.|+++...
T Consensus 254 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 ---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11112234688999999999999999999999999999765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=396.03 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=205.6
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCc--EEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGH--TVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 884 (1114)
++|++.++||+|+||+||+|+++ +|. .||||++...... ...+.|.+|+++++++ +|||||+++++|.+++..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh--HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 67889999999999999999976 454 4778887543332 2355689999999998 7999999999999999999
Q ss_pred EEEecCCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC
Q 001253 885 LMYEYMARGSLGELLHGA---------------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF 949 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 949 (1114)
+||||+++|+|.++++.. ...+++..+..++.|||+||.|+|+. +|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence 999999999999999743 35789999999999999999999999 999999999999999999
Q ss_pred CeEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCC-CCCCCCCCCCHHHHHHH
Q 001253 950 EAHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRA-PVQPLDQGGDLVTWVRN 1028 (1114)
Q Consensus 950 ~~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~-p~~~~~~~~~~~~~~~~ 1028 (1114)
.+||+|||+|+... .........||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ..+...
T Consensus 165 ~~kl~DfG~a~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~----~~~~~~- 237 (309)
T d1fvra_ 165 VAKIADFGLSRGQE--VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAELYE- 237 (309)
T ss_dssp CEEECCTTCEESSC--EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHH-
T ss_pred ceEEcccccccccc--ccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC----HHHHHH-
Confidence 99999999998643 2222234568999999999999999999999999999999999765 554322 222222
Q ss_pred HHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 001253 1029 FIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1091 (1114)
.+..+. + .+.+......+.++|.+||+.||++||||+||++.|+++.....
T Consensus 238 ~i~~~~--------~----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 238 KLPQGY--------R----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HGGGTC--------C----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHhcC--------C----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 222111 1 11122233468899999999999999999999999999865443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.3e-44 Score=402.23 Aligned_cols=251 Identities=24% Similarity=0.236 Sum_probs=201.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHH---HHHHHHHhcCCCCceeeEEeEEEecCceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSF---RAEILTLGKIRHRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 884 (1114)
++|++.++||+|+||+||+|+++ +|+.||||++.+...........+ ..|+.+++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999976 799999999865432221222223 34577788889999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 964 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~ 964 (1114)
+||||++||+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 84 ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999974 35688999999999999999999999 999999999999999999999999999997643
Q ss_pred CCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 001253 965 PQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDAR 1043 (1114)
Q Consensus 965 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1114)
. .....+||+.|||||++.. ..|+.++||||+||++|||++|+.||..... .+.....+. .. ...
T Consensus 160 ~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~~~~-~~---------~~~ 225 (364)
T d1omwa3 160 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-KDKHEIDRM-TL---------TMA 225 (364)
T ss_dssp S---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-SCHHHHHHH-SS---------SCC
T ss_pred C---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh-cc---------cCC
Confidence 2 2345679999999999864 5689999999999999999999999975443 222222211 11 011
Q ss_pred ccCCCcccHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 001253 1044 LNLQDEKTVSHMITVLKIAMLCTNISPFDRPT-----MREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1081 (1114)
...+......+.++|.+||+.||++||| ++|+++
T Consensus 226 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111122346889999999999999999 677764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=389.46 Aligned_cols=270 Identities=27% Similarity=0.331 Sum_probs=205.9
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC----ceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG----SNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 884 (1114)
++|...++||+|+||+||+|+++ |+.||||++..... ....++.|+..+..++|||||++++++.+++ ..|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 56888899999999999999975 89999999864321 1222344666667889999999999998754 578
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDC-----KPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
+||||+++|+|.+++++ ..++|..+..++.|+|.||+|+|+.. .++|+||||||+|||+++++.+||+|||++
T Consensus 78 lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999984 36999999999999999999999731 349999999999999999999999999999
Q ss_pred eecCCCCC---CccccccccccccCccccccCC------CCcccchHHHHHHHHHHHhCCCCCCCCCCC----------C
Q 001253 960 KVIDMPQS---KSMSAIAGSYGYIAPEYAYTMK------VTEKCDIYSYGVVLLELLTGRAPVQPLDQG----------G 1020 (1114)
Q Consensus 960 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~------~~~~~DvwslGvil~el~tg~~p~~~~~~~----------~ 1020 (1114)
+....... .......||+.|+|||++.+.. ++.++|||||||++|||+||..||...... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 87653322 1234567999999999987543 677899999999999999998877432211 1
Q ss_pred CHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 001253 1021 DLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQG 1091 (1114)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1091 (1114)
............... ++.+. ......+....+.+++.+||+.||++||||.||++.|+++....+
T Consensus 236 ~~~~~~~~~~~~~~~-----~p~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKL-----RPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CCHHHHHHHHTTSCC-----CCCCC-GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHhcccc-----CCCCC-cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 122233332222111 11111 011233455678999999999999999999999999999987654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=394.76 Aligned_cols=250 Identities=22% Similarity=0.275 Sum_probs=199.8
Q ss_pred cCCcCCc-eecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhc-CCCCceeeEEeEEEe----cC
Q 001253 809 DNFDERF-VIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGK-IRHRNIVKLYGFCYH----QG 881 (1114)
Q Consensus 809 ~~~~~~~-~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~ 881 (1114)
++|++.. .||+|+||+||+|+++ +|+.||||++.. ...+.+|+.++.+ .+|||||+++++|.+ +.
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 6788765 5999999999999975 799999999853 2346789988655 489999999999976 35
Q ss_pred ceEEEEecCCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCCeEEeecc
Q 001253 882 SNLLMYEYMARGSLGELLHGAS-STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD---KFEAHVGDFG 957 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG 957 (1114)
..|+|||||+||+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+|||+++ ++.+||+|||
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 6799999999999999997543 4799999999999999999999999 9999999999999985 5679999999
Q ss_pred CceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1114)
+|+.... .......+||+.|||||++.+..|+.++||||+||++|||+||+.||........... +..
T Consensus 160 ~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-~~~--------- 227 (335)
T d2ozaa1 160 FAKETTS--HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKT--------- 227 (335)
T ss_dssp TCEECCC--CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeeccC--CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-HHH---------
Confidence 9987653 2334566899999999999999999999999999999999999999975443221111 111
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.+.................++.+++.+||+.||++|||+.|+++
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111111112222334567899999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-44 Score=394.66 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=213.2
Q ss_pred HHHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 001253 805 VVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGFC 877 (1114)
Q Consensus 805 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 877 (1114)
++..++|++.++||+|+||.||+|+++ +++.||||+++.... ......+.+|+.+++++ +|||||+++++|
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 345578999999999999999999862 467899999976543 33456788999999999 699999999999
Q ss_pred EecCceEEEEecCCCCCHHHHhccCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 001253 878 YHQGSNLLMYEYMARGSLGELLHGAS-----------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKS 940 (1114)
Q Consensus 878 ~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 940 (1114)
.+++..++||||+++|+|.++++... ..+++..+..++.||++||+|||++ +++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 99999999999999999999987432 2589999999999999999999999 999999999
Q ss_pred CCeEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCC-CCCCCCCC
Q 001253 941 NNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGR-APVQPLDQ 1018 (1114)
Q Consensus 941 ~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~-~p~~~~~~ 1018 (1114)
+||+++.++.+|++|||.++....... ......+||+.|+|||++.+..++.++|||||||++|||+|++ +||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654332 2334568999999999999999999999999999999999954 44544333
Q ss_pred CCCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1019 GGDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
.+.+.+.++. +. + ...+......+.++|.+||+.||++||||+||+++|+++..
T Consensus 254 ~~~~~~~i~~----~~--------~----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 254 DSKFYKMIKE----GF--------R----MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp SHHHHHHHHH----TC--------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhc----CC--------C----CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 2222222222 11 0 11111223468899999999999999999999999987643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=397.48 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=203.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHH-hcCCCCceeeEEeEEEecCceEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTL-GKIRHRNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv 886 (1114)
++|++.++||+|+||+||+|+++ +|+.||||++++.........+.+..|..++ +.++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999986 7999999999754322222244555666655 468999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 966 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 966 (1114)
|||+++|+|.++++. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.... .
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~-~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML-G 156 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-T
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc-c
Confidence 999999999999974 34689999999999999999999999 999999999999999999999999999986543 2
Q ss_pred CCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccccC
Q 001253 967 SKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGMLDARLNL 1046 (1114)
Q Consensus 967 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1114)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+..+..... ..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~----~~~~~~~i~~~-~~----------- 220 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHSIRMD-NP----------- 220 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHC-CC-----------
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC----HHHHHHHHHcC-CC-----------
Confidence 333455689999999999999999999999999999999999999997432 22222222111 11
Q ss_pred CCcccHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 001253 1047 QDEKTVSHMITVLKIAMLCTNISPFDRPTMR-EVVL 1081 (1114)
Q Consensus 1047 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 1081 (1114)
..+......+.+++.+||+.||++||++. |+++
T Consensus 221 --~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11112234688999999999999999995 6753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=392.06 Aligned_cols=264 Identities=23% Similarity=0.373 Sum_probs=213.7
Q ss_pred HHHHhcCCcCCceecccCCeEEEEEEeC------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEE
Q 001253 804 LVVATDNFDERFVIGRGACGTVYRAVLR------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFC 877 (1114)
Q Consensus 804 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 877 (1114)
+++..++|++.++||+|+||+||+|+++ +++.||||+++... .......|.+|+.++++++|||||++++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 3445688999999999999999999874 35789999997543 333456789999999999999999999999
Q ss_pred EecCceEEEEecCCCCCHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCC
Q 001253 878 YHQGSNLLMYEYMARGSLGELLHGA---------SSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDK 948 (1114)
Q Consensus 878 ~~~~~~~lv~E~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 948 (1114)
..++..++||||+++|+|.+++... ...+++..+..++.|+|+||+|||+. +|+||||||+|||++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC
Confidence 9999999999999999999998632 23579999999999999999999998 99999999999999999
Q ss_pred CCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCC-CCCCCCCCCCCHHHHH
Q 001253 949 FEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGR-APVQPLDQGGDLVTWV 1026 (1114)
Q Consensus 949 ~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~-~p~~~~~~~~~~~~~~ 1026 (1114)
+++||+|||+|+....... .......||+.|+|||.+.+..++.++||||||+++|||+||. .||... ...+..
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~----~~~~~~ 245 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----SNEQVL 245 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC----CHHHHH
Confidence 9999999999986643222 2234457899999999999999999999999999999999985 666432 223333
Q ss_pred HHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 001253 1027 RNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRR 1089 (1114)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1089 (1114)
.. +..+... +.+......+.+++.+||+.||++|||++||++.|++...+
T Consensus 246 ~~-i~~~~~~------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 246 RF-VMEGGLL------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HH-HHTTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HH-HHhCCCC------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 32 2221111 11112234688999999999999999999999999887543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=391.65 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=208.1
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeC--------CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcC-CCCceeeEEeE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLR--------TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKI-RHRNIVKLYGF 876 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 876 (1114)
+..++|++.+.||+|+||+||+|+.. ++..||||+++.... .....++.+|...+.++ +|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 44578999999999999999999853 134799999975443 33356788888888888 89999999999
Q ss_pred EEecCceEEEEecCCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 001253 877 CYHQGSNLLMYEYMARGSLGELLHGAS---------------STLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSN 941 (1114)
Q Consensus 877 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 941 (1114)
|.+++..++||||+++|+|.++++... ..+++.++..++.|++.||+|||+. +|+||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence 999999999999999999999997443 3589999999999999999999999 9999999999
Q ss_pred CeEECCCCCeEEeeccCceecCCCCC-CccccccccccccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 001253 942 NILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRAPVQPLDQG 1019 (1114)
Q Consensus 942 Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~p~~~~~~~ 1019 (1114)
|||++.++.+||+|||+++....... .......|++.|+|||.+.+..|+.++|||||||++|||++ |+.||.....
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~- 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-
Confidence 99999999999999999987653332 23345679999999999999999999999999999999998 6778764332
Q ss_pred CCHHHHHHHHHhcCCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 001253 1020 GDLVTWVRNFIRNNSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNR 1088 (1114)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1088 (1114)
..+...+..+... +.+......+.+++.+||+.||++||||.||++.|+++..
T Consensus 244 ----~~~~~~i~~~~~~------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 ----EELFKLLKEGHRM------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ----HHHHHHHHTTCCC------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcCCCC------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 2233333322111 1111223468899999999999999999999999998854
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=387.56 Aligned_cols=268 Identities=24% Similarity=0.346 Sum_probs=203.1
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+++ +|+.||||+++..... +...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 58999999999999999999975 7999999999755432 233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
||+.++.+..........+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+|||.|+....+ .
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~ 156 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-V 156 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-S
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC-c
Confidence 99987555555455566899999999999999999999999 9999999999999999999999999999876432 3
Q ss_pred CccccccccccccCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcc-ccc---cc-
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLV-SGM---LD- 1041 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~- 1041 (1114)
.......||+.|+|||...... ++.++||||+||++|+|++|+.||......+.+....+......... ... .+
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 3445568999999999877665 57899999999999999999999975432222222221111100000 000 00
Q ss_pred -ccccCCCcc-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1042 -ARLNLQDEK-----TVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1042 -~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
......... .......+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000000 1112246789999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=384.45 Aligned_cols=262 Identities=23% Similarity=0.269 Sum_probs=196.3
Q ss_pred CceecccCCeEEEEEEeC-CCcEEEEEEecccCCCC--hhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEecC
Q 001253 814 RFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGN--NNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYEYM 890 (1114)
Q Consensus 814 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 890 (1114)
.++||+|+||+||+|+++ +|+.||||+++...... +...+.+.+|+.++++++|||||++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999976 79999999997554321 122356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCCcc
Q 001253 891 ARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 970 (1114)
Q Consensus 891 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 970 (1114)
+++++..+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..... ....
T Consensus 83 ~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-~~~~ 157 (299)
T d1ua2a_ 83 ETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAY 157 (299)
T ss_dssp SEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCCC
T ss_pred cchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCC-cccc
Confidence 9977776664 556789999999999999999999999 9999999999999999999999999999876433 2333
Q ss_pred ccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcc---c---cccccc
Q 001253 971 SAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLV---S---GMLDAR 1043 (1114)
Q Consensus 971 ~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~ 1043 (1114)
...+||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.+.. +.+........ . ......
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~-i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR-IFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH-HHHhcCCCChhhccchhccchhhh
Confidence 45679999999999865 4579999999999999999999999975432221111 11211110000 0 000000
Q ss_pred ccCCCccc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1044 LNLQDEKT-----VSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1044 ~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
.......+ ......+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00001111 112346889999999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.7e-42 Score=375.87 Aligned_cols=274 Identities=19% Similarity=0.246 Sum_probs=223.3
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCC-CceeeEEeEEEecCceEE
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRH-RNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 885 (1114)
.++|++.++||+|+||+||+|++. +|+.||||++...... ..+++|++.++.++| +|++.+++++..+...++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 468999999999999999999976 7899999998654432 236678888888865 899999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-----CCCeEEeeccCce
Q 001253 886 MYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD-----KFEAHVGDFGLAK 960 (1114)
Q Consensus 886 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~DfG~a~ 960 (1114)
||||+ +++|.++++.....+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99999 5799999987777899999999999999999999999 9999999999999974 5789999999999
Q ss_pred ecCCCCC------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHH--HHHHHhc
Q 001253 961 VIDMPQS------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTW--VRNFIRN 1032 (1114)
Q Consensus 961 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~--~~~~~~~ 1032 (1114)
.+..... ......+||+.|||||++.+..++.++||||+||++|||++|+.||............ +......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 7653322 2234568999999999999999999999999999999999999999865543332221 1111110
Q ss_pred CCcccccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCC
Q 001253 1033 NSLVSGMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDS 1102 (1114)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~ 1102 (1114)
.. .. .+ ....+.++.+++..|++.+|++||+++.+.+.|+++..+.+..+..++||+.
T Consensus 235 ~~-~~-----~l------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~ 292 (293)
T d1csna_ 235 TP-LR-----EL------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 292 (293)
T ss_dssp SC-HH-----HH------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred CC-hH-----Hh------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCc
Confidence 00 00 00 0111235888999999999999999999999999999888888889999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-42 Score=380.99 Aligned_cols=266 Identities=23% Similarity=0.364 Sum_probs=202.7
Q ss_pred cCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEEe
Q 001253 809 DNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMYE 888 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 888 (1114)
++|++.++||+|+||+||+|++++|+.||||++..... .+...+.+.+|+.++++++|||||++++++.+++..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999999999999999976543 23335678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCCC
Q 001253 889 YMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 968 (1114)
Q Consensus 889 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 968 (1114)
|+.++.+..+.+ ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.|.....+. .
T Consensus 81 ~~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~ 155 (286)
T d1ob3a_ 81 HLDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (286)
T ss_dssp CCSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred eehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc-c
Confidence 998866666655 557899999999999999999999998 99999999999999999999999999998765332 2
Q ss_pred ccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC---ccccc----c
Q 001253 969 SMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS---LVSGM----L 1040 (1114)
Q Consensus 969 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~----~ 1040 (1114)
......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+...+..+. ..... +.... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI-LGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCTTTSTTGGGSTTC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHh-hCCCChhhccchhhhhhc
Confidence 33455799999999998754 5689999999999999999999999754322222221111 11000 00000 0
Q ss_pred cccccCC-----CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1041 DARLNLQ-----DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1041 ~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
....... ..........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 0011122346889999999999999999999873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=379.49 Aligned_cols=242 Identities=21% Similarity=0.363 Sum_probs=197.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChh---hHHHHHHHHHHHhcCC--CCceeeEEeEEEecCc
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNN---VDNSFRAEILTLGKIR--HRNIVKLYGFCYHQGS 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 882 (1114)
++|++.++||+|+||+||+|++. +|+.||||++......... ....+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 67999999999999999999976 7899999999765432211 1223567999999886 8999999999999999
Q ss_pred eEEEEecCCC-CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC-CCCeEEeeccCce
Q 001253 883 NLLMYEYMAR-GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAK 960 (1114)
Q Consensus 883 ~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG~a~ 960 (1114)
.++||||+.+ +++.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+|||++. ++.+||+|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccce
Confidence 9999999986 578888763 45789999999999999999999999 9999999999999985 4799999999998
Q ss_pred ecCCCCCCccccccccccccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTMKV-TEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGM 1039 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1114)
.... ....+..||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... +..+..
T Consensus 160 ~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~------ 220 (273)
T d1xwsa_ 160 LLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQ------ 220 (273)
T ss_dssp ECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCC------
T ss_pred eccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HHhhcc------
Confidence 7532 23456789999999999987765 567899999999999999999996321 111111
Q ss_pred ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1040 LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..... ..+.++.+++.+||+.||++|||++|+++
T Consensus 221 ----~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 ----VFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----CCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----cCCCC----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11111 12246789999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.6e-42 Score=377.54 Aligned_cols=276 Identities=19% Similarity=0.228 Sum_probs=213.7
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCc-eeeEEeEEEecCceEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN-IVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 886 (1114)
++|++.++||+|+||+||+|++. +|+.||||++...... +.+..|+++++.++|++ |+.+.+++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 57999999999999999999975 7899999998754432 24678999999998766 55555566777888999
Q ss_pred EecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECC---CCCeEEeeccCceecC
Q 001253 887 YEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDD---KFEAHVGDFGLAKVID 963 (1114)
Q Consensus 887 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG~a~~~~ 963 (1114)
|||++ +++.+.+......+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+|++|||+|+.+.
T Consensus 82 me~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 99995 477777766677899999999999999999999999 9999999999999864 5579999999999765
Q ss_pred CCCC------CccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 001253 964 MPQS------KSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVS 1037 (1114)
Q Consensus 964 ~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1114)
.... .......||+.|||||++.+..++.++|||||||++|||++|+.||.............+......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~---- 233 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM---- 233 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH----
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC----
Confidence 3322 223456899999999999999999999999999999999999999986554333222211100000
Q ss_pred ccccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCCCc
Q 001253 1038 GMLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHDSD 1103 (1114)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~ 1103 (1114)
.... .......+.++.+++.+||+.+|++||+++++.+.|+++..+.+.....++||+.-
T Consensus 234 ---~~~~---~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (299)
T d1ckia_ 234 ---STPI---EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 293 (299)
T ss_dssp ---HSCH---HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHG
T ss_pred ---CCCh---hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhh
Confidence 0000 00011122468899999999999999999999999999987777777778888643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=382.71 Aligned_cols=267 Identities=20% Similarity=0.293 Sum_probs=200.4
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-C-CcEEEEEEecccCCCChhhHHHHHHHHHHHhcC---CCCceeeEEeEEEe---
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-T-GHTVAVKKLASNREGNNNVDNSFRAEILTLGKI---RHRNIVKLYGFCYH--- 879 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--- 879 (1114)
.++|++.++||+|+||+||+|++. + ++.||||+++........ ...+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-HHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 478999999999999999999974 4 567999999765432211 22345666666555 89999999999863
Q ss_pred --cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeecc
Q 001253 880 --QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 957 (1114)
Q Consensus 880 --~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 957 (1114)
....+++|||++++++..........+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 3467899999999887777666677899999999999999999999999 99999999999999999999999999
Q ss_pred CceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC---
Q 001253 958 LAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS--- 1034 (1114)
Q Consensus 958 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 1034 (1114)
+++... .........||+.|||||++.+..|+.++||||+||++|||++|+.||........+.... .......
T Consensus 162 ~~~~~~--~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~ 238 (305)
T d1blxa_ 162 LARIYS--FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL-DVIGLPGEED 238 (305)
T ss_dssp SCCCCC--GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHHCCCCGGG
T ss_pred hhhhhc--ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH-HhhCCCchhc
Confidence 998643 2334456789999999999999999999999999999999999999997543222121111 1111100
Q ss_pred cccccc--cccc-----cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1035 LVSGML--DARL-----NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1035 ~~~~~~--~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+..... .... .............+.+++.+||++||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000 0000011122346788999999999999999999875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=4.2e-42 Score=384.01 Aligned_cols=295 Identities=27% Similarity=0.428 Sum_probs=264.1
Q ss_pred CCCcchHHHHHHhHhhccCCCCCCCCCCCCCCCCC--ccceEEEecCCCccEEEEEeecCCCcCc--ccCCCCCCCCccC
Q 001253 30 GLVNIEGQILLLIKSKLVDNSNYLGNWNPNDSTPC--GWIGVNCTTNDFGAVVFSLNLTKMNLSG--YLSPNIGGLVHLT 105 (1114)
Q Consensus 30 ~~~~~~~~~ll~~k~~~~~~~~~~~~W~~~~~~~C--~w~gv~C~~~~~~~~v~~l~l~~~~l~g--~~~~~l~~l~~L~ 105 (1114)
-|.++|++||++||+++.||. .+++|.. +.||| .|.||+|+.+....+|+.|+|+++++.| .+|+.+++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 489999999999999998874 6899985 45788 5999999876555689999999999998 5789999999999
Q ss_pred EEEecC-CcccCCCCcccCCCCCCCEEEccCCCcccccccccccccccceeccccccccCCCCcccccCcccchhhhccc
Q 001253 106 ALDLSF-NQLSRNIPKEIGNCSSLEVLNLNNNRLEAHIPKELGNLSSLTILNIYNNRISGPFPKEIGKLSALSQLVAYSN 184 (1114)
Q Consensus 106 ~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~n 184 (1114)
+|+|++ |+++|.+|++|++|++|++|+|++|++.+..|..+..+.+|+++++++|++.+.+|..++++++|+.+++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 999997 8999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCccccccc-cceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCccc
Q 001253 185 NISGSLPPTLGNLKRL-KSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIP 263 (1114)
Q Consensus 185 ~i~~~~p~~l~~l~~L-~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 263 (1114)
.+.+.+|..+.++..+ +.+.+++|++++..|..+..+..+ +++++++...+.+|..++.+++|+.+++++|.+++.+|
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~ 238 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999888876 788899999999888888876554 69999999998999999999999999999999987655
Q ss_pred cccccccccchhhcccccccCCchhhhcCCCccceeeecccccccccCcccccccccccccccccc
Q 001253 264 KELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENS 329 (1114)
Q Consensus 264 ~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~ 329 (1114)
.++.+++|+.|+|++|++.+.+|++|+++++|++|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus 239 -~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 239 -KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp -GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred -ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 688889999999999999888999999999999999999999888884 5777888888888876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=378.34 Aligned_cols=269 Identities=23% Similarity=0.320 Sum_probs=199.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC-----
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG----- 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 881 (1114)
.++|+++++||+|+||+||+|+++ +|+.||||+++.... .+...+.+.+|+.+++.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 368999999999999999999976 799999999976543 3344567889999999999999999999997655
Q ss_pred -ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCce
Q 001253 882 -SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 960 (1114)
Q Consensus 882 -~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~ 960 (1114)
..|+||||+ ++++.++.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+|+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 469999999 5588888763 4699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHH-------Hhc
Q 001253 961 VIDMPQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNF-------IRN 1032 (1114)
Q Consensus 961 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~ 1032 (1114)
.... .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||........+....+.. ...
T Consensus 170 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 170 QADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp ECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 7542 23456799999999998764 56899999999999999999999997543222111111100 000
Q ss_pred CCcc--cccc--cccccCC--CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhh
Q 001253 1033 NSLV--SGML--DARLNLQ--DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLM--LSESN 1087 (1114)
Q Consensus 1033 ~~~~--~~~~--~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~ 1087 (1114)
.... .... ....... ..........+.+++.+||..||++|||++|+++- ++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 0000 0000000 00011223467899999999999999999999873 55554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=369.79 Aligned_cols=266 Identities=21% Similarity=0.329 Sum_probs=197.0
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEe--------
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYH-------- 879 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 879 (1114)
++|+++++||+|+||+||+|+++ +|+.||||++...... +...+.+.+|+.++++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 78999999999999999999975 7999999998765433 2335668899999999999999999999855
Q ss_pred cCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCc
Q 001253 880 QGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 959 (1114)
Q Consensus 880 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a 959 (1114)
++..|+||||++++++.... .....++...+..++.|+++||+|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 34579999999886665544 4566889999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC---CccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCC-
Q 001253 960 KVIDMPQS---KSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNS- 1034 (1114)
Q Consensus 960 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 1034 (1114)
+....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ....+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhcCCCCh
Confidence 87653221 223445799999999998765 68999999999999999999999997533211 1111222221100
Q ss_pred -cccccccc----c---ccCCCccc------HHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 001253 1035 -LVSGMLDA----R---LNLQDEKT------VSHMITVLKIAMLCTNISPFDRPTMREVV 1080 (1114)
Q Consensus 1035 -~~~~~~~~----~---~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl 1080 (1114)
........ . ........ ......+.+++.+||++||++|||++|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 00000000 0 00000000 01123567899999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-40 Score=363.63 Aligned_cols=267 Identities=22% Similarity=0.327 Sum_probs=208.2
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecCceEEEE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLMY 887 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 887 (1114)
++|++.++||+|+||+||+|+++ +|+.||||+++.... .....+.+.+|+.+++.++||||+++++++.+....++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 57999999999999999999975 789999999976553 3344677889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecCCCCC
Q 001253 888 EYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 967 (1114)
Q Consensus 888 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 967 (1114)
|++.++++..+++ ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+|++|||.|+......
T Consensus 81 ~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~- 155 (292)
T d1unla_ 81 EFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp ECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred eeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence 9999999888876 456789999999999999999999998 99999999999999999999999999999765332
Q ss_pred CccccccccccccCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc---c--ccc--
Q 001253 968 KSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL---V--SGM-- 1039 (1114)
Q Consensus 968 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~--~~~-- 1039 (1114)
.......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||.......+....+......... . ...
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 2334456888999999987665 6899999999999999999999986433322222222221111000 0 000
Q ss_pred -----ccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1040 -----LDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1040 -----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
..................+.+++.+|+++||.+||||+|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000111112233356889999999999999999999865
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.8e-40 Score=367.71 Aligned_cols=268 Identities=21% Similarity=0.271 Sum_probs=203.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEec--CceE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQ--GSNL 884 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~ 884 (1114)
++|+++++||+|+||+||+|+++ +|+.||||+++... .+.+.+|+.+++.++ ||||+++++++... ...+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 68999999999999999999985 78999999986432 456889999999995 99999999999854 4689
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-CeEEeeccCceecC
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVID 963 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~a~~~~ 963 (1114)
+||||+++++|.++.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus 109 ~v~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EEEeecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999999987653 689999999999999999999999 999999999999998655 69999999998765
Q ss_pred CCCCCccccccccccccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH---------hcC
Q 001253 964 MPQSKSMSAIAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFI---------RNN 1033 (1114)
Q Consensus 964 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---------~~~ 1033 (1114)
.. ......+||+.|+|||.+.+. .++.++||||+||++|||++|+.||.......+....+.... ...
T Consensus 182 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PG--QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TT--CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CC--CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 32 334556799999999998765 479999999999999999999999976543222211111111 000
Q ss_pred Cccc-----ccccccc------cCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCcccccCCCC
Q 001253 1034 SLVS-----GMLDARL------NLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVLMLSESNRRQGHFEFSPMDHD 1101 (1114)
Q Consensus 1034 ~~~~-----~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~ 1101 (1114)
.... ....... ............++.+++.+||+.||++|||++|+++ +.+|..+.||
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~----------Hp~F~~v~~~ 328 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME----------HPYFYTVVKD 328 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT----------SGGGTTSCCC
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc----------CcccCCCCCC
Confidence 0000 0000000 0001111223356889999999999999999999875 4455555554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=370.25 Aligned_cols=255 Identities=24% Similarity=0.263 Sum_probs=208.4
Q ss_pred cCCcCCceecccCCeEEEEEEeC----CCcEEEEEEecccCCC-ChhhHHHHHHHHHHHhcCCC-CceeeEEeEEEecCc
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR----TGHTVAVKKLASNREG-NNNVDNSFRAEILTLGKIRH-RNIVKLYGFCYHQGS 882 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 882 (1114)
++|++.++||+|+||+||+|+.. +|+.||||+++..... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 5889999998754321 12224557789999999976 899999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceec
Q 001253 883 NLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 962 (1114)
Q Consensus 883 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~ 962 (1114)
.++||||+.+|+|.+++... ..+.+.....++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+|+.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999744 3567888999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccccccCccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 001253 963 DMPQSKSMSAIAGSYGYIAPEYAYTM--KVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSGML 1040 (1114)
Q Consensus 963 ~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1114)
............|++.|+|||.+.+. .++.++||||+||++|||++|+.||.............+......
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~------- 252 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------- 252 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-------
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC-------
Confidence 54444445567899999999998754 467899999999999999999999987766665555544433321
Q ss_pred cccccCCCcccHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 001253 1041 DARLNLQDEKTVSHMITVLKIAMLCTNISPFDRP-----TMREVVL 1081 (1114)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1081 (1114)
...+.....++.+++.+||++||++|| |++|+++
T Consensus 253 -------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111222345788999999999999999 4788864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=373.77 Aligned_cols=267 Identities=27% Similarity=0.313 Sum_probs=198.3
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec------C
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ------G 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 881 (1114)
-+|+..++||+|+||+||+|+++ +|+.||||++...... ..+|+.++++++||||++++++|... .
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 36888999999999999999986 7999999999765432 23699999999999999999998643 2
Q ss_pred ceEEEEecCCCCCHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCC-CeEEeeccC
Q 001253 882 SNLLMYEYMARGSLGELLH--GASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGL 958 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfG~ 958 (1114)
+.|+||||++++.+..+.+ .....+++.++..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence 4689999998765444432 3455799999999999999999999998 999999999999999775 899999999
Q ss_pred ceecCCCCCCccccccccccccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH-------HH
Q 001253 959 AKVIDMPQSKSMSAIAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRN-------FI 1030 (1114)
Q Consensus 959 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~-------~~ 1030 (1114)
++.... .....+.+|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.+...++. .+
T Consensus 170 a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 170 AKQLVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CEECCT--TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhhccC--CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 987643 233445689999999998875 56899999999999999999999999754432222221110 00
Q ss_pred h--cCCcccccccccccCC---CcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhhhc
Q 001253 1031 R--NNSLVSGMLDARLNLQ---DEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSESNR 1088 (1114)
Q Consensus 1031 ~--~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~ 1088 (1114)
. ...+...... ..... ..........+.+++.+||+.||++|||++|+++ .++++..
T Consensus 248 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 248 REMNPNYTEFKFP-QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHCC---CCCCC-CCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhccchhhcccc-ccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0 0000000000 00000 0011123346889999999999999999999985 3555533
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-40 Score=369.67 Aligned_cols=266 Identities=22% Similarity=0.293 Sum_probs=196.7
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEecC----ce
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQG----SN 883 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 883 (1114)
++|+++++||+|+||+||+|+++ +|+.||||++.... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999975 89999999997543 2334567889999999999999999999997654 23
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCceecC
Q 001253 884 LLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 963 (1114)
Q Consensus 884 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~~~ 963 (1114)
+++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 ~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 555666778999999974 3689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC--CCccccccccccccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCcccc--
Q 001253 964 MPQ--SKSMSAIAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSLVSG-- 1038 (1114)
Q Consensus 964 ~~~--~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1038 (1114)
... .......+||+.|+|||++. +..++.++||||+||++|||++|+.||......+.... .............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH-ILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH-HhhhccCCChhhhhh
Confidence 322 12234567999999999984 45678899999999999999999999975432111111 1111110000000
Q ss_pred -----ccc--ccccCCCcc-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 001253 1039 -----MLD--ARLNLQDEK-----TVSHMITVLKIAMLCTNISPFDRPTMREVVLM 1082 (1114)
Q Consensus 1039 -----~~~--~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1082 (1114)
... ......... .......+.+++.+||+.||.+|||++|+++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000000 01112467899999999999999999999863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=368.57 Aligned_cols=263 Identities=23% Similarity=0.306 Sum_probs=193.8
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec------C
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ------G 881 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 881 (1114)
++|++.++||+|+||+||+|+++ +|+.||||++...... ....+.+.+|+.++++++|||||++++++... .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 57999999999999999999986 7999999999766543 34456788999999999999999999999643 5
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..|+||||+.++.+ +.+. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+|++|||+++.
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eeEEEEeccchHHH-Hhhh---cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 77999999987544 4443 3589999999999999999999999 999999999999999999999999999886
Q ss_pred cCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHH---------------
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWV--------------- 1026 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~--------------- 1026 (1114)
.. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||............+
T Consensus 169 ~~--~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cc--cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 54 3334455679999999999999999999999999999999999999997543211111111
Q ss_pred ---HHHHhcCCcccc------cccccccCCCcccHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 001253 1027 ---RNFIRNNSLVSG------MLDARLNLQDEKTVSHMITVLKIAMLCTNISPFDRPTMREVVL 1081 (1114)
Q Consensus 1027 ---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1081 (1114)
+........... ...................+.+++.+|++.||++||||+|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111111100000 0001111111223445668899999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=368.41 Aligned_cols=271 Identities=22% Similarity=0.292 Sum_probs=201.0
Q ss_pred hcCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCceeeEEeEEEec-----C
Q 001253 808 TDNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRNIVKLYGFCYHQ-----G 881 (1114)
Q Consensus 808 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 881 (1114)
.++|++.++||+|+||+||+|+++ +|+.||||++...... ....+.+.+|+.++++++|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 468999999999999999999975 7999999999865443 33355688999999999999999999998643 3
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 882 SNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 882 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..+++|+|+.+|+|.++++. ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.|..
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred ceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 34667778889999999963 4699999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCccccccccccccCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHhcCCc-cc--
Q 001253 962 IDMPQSKSMSAIAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRAPVQPLDQGGDLVTWVRNFIRNNSL-VS-- 1037 (1114)
Q Consensus 962 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~-- 1037 (1114)
.. ....+..|++.|+|||...+.. ++.++||||+||++|+|++|+.||.+...........+. ...... ..
T Consensus 171 ~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~-~~~~~~~~~~~ 245 (348)
T d2gfsa1 171 TD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-VGTPGAELLKK 245 (348)
T ss_dssp CT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCHHHHTT
T ss_pred cC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCChHHhhh
Confidence 43 3345567999999999877654 688999999999999999999999754321111111111 000000 00
Q ss_pred ------ccccccccCCCcc-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhhhcc
Q 001253 1038 ------GMLDARLNLQDEK-----TVSHMITVLKIAMLCTNISPFDRPTMREVVL--MLSESNRR 1089 (1114)
Q Consensus 1038 ------~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~~ 1089 (1114)
............. .......+.+++.+||+.||++|||++|+++ .+++....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 0000000000000 0112346789999999999999999999987 56655443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-34 Score=329.42 Aligned_cols=262 Identities=19% Similarity=0.199 Sum_probs=189.5
Q ss_pred cCCcCCceecccCCeEEEEEEeC-CCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-----------CCceeeEEeE
Q 001253 809 DNFDERFVIGRGACGTVYRAVLR-TGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-----------HRNIVKLYGF 876 (1114)
Q Consensus 809 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~ 876 (1114)
++|+++++||+|+||+||+|+.+ +|+.||||+++... ...+.+.+|+++++.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 46999999999999999999975 79999999997532 22456678888887775 5789999998
Q ss_pred EEec--CceEEEEecCCCCCH--HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCC-
Q 001253 877 CYHQ--GSNLLMYEYMARGSL--GELLHGASSTLDWQTRFMIALGAAEGLSYLHH-DCKPRIFHRDIKSNNILLDDKFE- 950 (1114)
Q Consensus 877 ~~~~--~~~~lv~E~~~~gsL--~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~- 950 (1114)
+... ...+++|+++..+.. ..........+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcc
Confidence 8654 445666666655432 22233455688999999999999999999998 5 8999999999999986653
Q ss_pred -----eEEeeccCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCC--CHH
Q 001253 951 -----AHVGDFGLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRAPVQPLDQGG--DLV 1023 (1114)
Q Consensus 951 -----~kl~DfG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p~~~~~~~~--~~~ 1023 (1114)
++++|||.|..... .....+||+.|+|||++.+..++.++||||+||+++||++|+.||....... ...
T Consensus 166 ~~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cccceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 99999999986532 2345679999999999999999999999999999999999999997544221 111
Q ss_pred HHHHHHHh-----------cCCccc----------ccccc-------cccCCCcccHHHHHHHHHHHhhccCCCCCCCCC
Q 001253 1024 TWVRNFIR-----------NNSLVS----------GMLDA-------RLNLQDEKTVSHMITVLKIAMLCTNISPFDRPT 1075 (1114)
Q Consensus 1024 ~~~~~~~~-----------~~~~~~----------~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1075 (1114)
........ ...... .+... ...............+.+++.+|+++||++|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 11111100 000000 00000 000112234456678999999999999999999
Q ss_pred HHHHHH
Q 001253 1076 MREVVL 1081 (1114)
Q Consensus 1076 ~~evl~ 1081 (1114)
++|+++
T Consensus 322 a~e~L~ 327 (362)
T d1q8ya_ 322 AGGLVN 327 (362)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=4.2e-34 Score=318.70 Aligned_cols=258 Identities=31% Similarity=0.504 Sum_probs=176.1
Q ss_pred ceEEeeccceeec--cCCchhhccccccEeeccc-ccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceee
Q 001253 464 LVQLRLGGNSFTG--SFPSDLCKLANLSTVELDQ-NQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFN 540 (1114)
Q Consensus 464 L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 540 (1114)
++.|+|++|.+.+ .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|+|++..+..+..+.+|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence 4444444444443 3455555555555555554 555555555555666666666666666555555555556666666
Q ss_pred cccccccccccccccccccceEEECccccccCCCchhhhhcccC-CeeeccCccCCCcccccccccccccccccCCCcCC
Q 001253 541 VSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQL-ELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 541 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 619 (1114)
+++|.+.+.+|..+..++.|+.+++++|.+++.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+.
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 66666555556666666666666666666666666666655554 556666666666666666555433 4677777777
Q ss_pred CCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCCcc
Q 001253 620 GGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSSQ 699 (1114)
Q Consensus 620 ~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~~ 699 (1114)
|.+|..+..+..++ .+++++|.+++.+| .++.+++|+.|||++|+|+|.+|.+|+++++|+.|||++|+|+|.||..+
T Consensus 211 ~~~~~~~~~~~~l~-~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQ-KIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp ECCGGGCCTTSCCS-EEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cccccccccccccc-cccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 77777777777776 57777777777654 57777888889999999998899999999999999999999999999877
Q ss_pred cccccccccccCCCCCCCCCCCCCC
Q 001253 700 TFQNMSVNSFSGSKGLCGGPLQNCT 724 (1114)
Q Consensus 700 ~~~~~~~~~~~~n~~lc~~p~~~~~ 724 (1114)
.++.+....+.||+.+||.|++.|+
T Consensus 289 ~L~~L~~l~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred cCCCCCHHHhCCCccccCCCCCCCC
Confidence 8888888889999999999887663
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=6.9e-28 Score=276.53 Aligned_cols=342 Identities=24% Similarity=0.308 Sum_probs=175.5
Q ss_pred ccccccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchh
Q 001253 196 NLKRLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETL 275 (1114)
Q Consensus 196 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 275 (1114)
.+.+|++|+++++.|+. + +.++.+++|++|+|++|+|++ +| .++.+++|++|++++|++++.. .++++++|+.|
T Consensus 42 ~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L 115 (384)
T d2omza2 42 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGL 115 (384)
T ss_dssp HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccccccc--ccccccccccc
Confidence 44555566666665552 2 345566667777777777663 33 2666677777777777766432 26666667777
Q ss_pred hcccccccCCchhhhcCCCccceeeecccccccccCccccccccccccccccccCCCCCchhhhcccccceeeccccccc
Q 001253 276 ALYDNKQVGQLPKELGSIGSLKYLYIYRNELNGTIPREIGKLSSALEIDFSENSLIGEIPVELSKILGLELLYLFENKLT 355 (1114)
Q Consensus 276 ~Ls~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 355 (1114)
++++|.+.+..+ ......+..+....|.+....+................ .....+.............|...
T Consensus 116 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 188 (384)
T d2omza2 116 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV-----TDLKPLANLTTLERLDISSNKVS 188 (384)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESC-----CCCGGGTTCTTCCEEECCSSCCC
T ss_pred cccccccccccc--cccccccccccccccccccccccccccccccccccccc-----chhhhhccccccccccccccccc
Confidence 766665554332 23344555666666655422221111111111111100 11112222223333333333322
Q ss_pred CcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCcccc
Q 001253 356 GVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHIC 435 (1114)
Q Consensus 356 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 435 (1114)
....+..+++++.+++++|.+++..| +...++|++|++++| +++.. ..+.
T Consensus 189 --~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n------------------------~l~~~--~~l~ 238 (384)
T d2omza2 189 --DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGN------------------------QLKDI--GTLA 238 (384)
T ss_dssp --CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSS------------------------CCCCC--GGGG
T ss_pred --cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCC------------------------CCCCc--chhh
Confidence 12334445555555555555554332 233344444444444 44321 2334
Q ss_pred ccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEE
Q 001253 436 RNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRL 515 (1114)
Q Consensus 436 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 515 (1114)
.+++|+.|++++|++++..+ +..+++|++|++++|++++.. .+..++.++.++++.|++++. ..+..+++++.|
T Consensus 239 ~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L 312 (384)
T d2omza2 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYL 312 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEE
T ss_pred cccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeE
Confidence 44455555555555543222 444555555555555555322 244555666666666666532 235556666666
Q ss_pred EecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCc
Q 001253 516 HLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSEN 592 (1114)
Q Consensus 516 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 592 (1114)
++++|+|++.. .+..+++|++|++++|+|+ .++ .+..+++|++|++++|++++..| +.++++|++|+|++|
T Consensus 313 ~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 313 TLYFNNISDIS--PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp ECCSSCCSCCG--GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ECCCCCCCCCc--ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 66666666432 2556666666666666665 233 45666677777777777665433 666677777777766
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=8.6e-28 Score=275.75 Aligned_cols=189 Identities=26% Similarity=0.367 Sum_probs=90.6
Q ss_pred ccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEE
Q 001253 436 RNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRL 515 (1114)
Q Consensus 436 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 515 (1114)
.+++++.+++++|.+++..| +...++|++|++++|++++ ++.+..+++|+.|++++|++++..+ +..+++|++|
T Consensus 195 ~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L 268 (384)
T d2omza2 195 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 268 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEE
T ss_pred cccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--cchhhcccccchhccccCccCCCCc--ccccccCCEe
Confidence 33444444444444443222 2333444444454444442 1234444555555555555543322 4445555555
Q ss_pred EecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCC
Q 001253 516 HLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELS 595 (1114)
Q Consensus 516 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 595 (1114)
++++|++++.. .+..++.++.+++++|++++ ...+..+++++.|++++|++++.. .+..+++|++|++++|+|+
T Consensus 269 ~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~ 342 (384)
T d2omza2 269 KLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVS 342 (384)
T ss_dssp ECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCC
T ss_pred eccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCC
Confidence 55555554322 24445555555555555542 123444555555555555555332 2455555555555555555
Q ss_pred CcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccc
Q 001253 596 GSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYN 641 (1114)
Q Consensus 596 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N 641 (1114)
+ ++ .++++++|++|++++|+|++.+| +.++++|+ .|+|++|
T Consensus 343 ~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~-~L~L~~N 383 (384)
T d2omza2 343 D-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRIT-QLGLNDQ 383 (384)
T ss_dssp C-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCS-EEECCCE
T ss_pred C-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCC-EeeCCCC
Confidence 2 22 35555555555555555554433 55555555 4555555
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=2.2e-25 Score=246.60 Aligned_cols=243 Identities=21% Similarity=0.262 Sum_probs=106.6
Q ss_pred cCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeec
Q 001253 367 NLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLE 446 (1114)
Q Consensus 367 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls 446 (1114)
.++.+|=+++.++ .+|..+. +++++|+|++|+|+...+..|..+++|++|++++|.+....|..|..+++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3455666666665 3343332 345555555555554444455555555555555555554445555555555555555
Q ss_pred cCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCC--CCccccccccccCcEEEecCceecc
Q 001253 447 TNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFS--GPIPTEIGNCNALQRLHLSDNYFTG 524 (1114)
Q Consensus 447 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~ 524 (1114)
+|+++. +|..+ ...++.|++.+|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|.++
T Consensus 88 ~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~- 163 (305)
T d1xkua_ 88 KNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 163 (305)
T ss_dssp SSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred CCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-
Confidence 555552 33221 234444555555544333333444444444444444322 122233344444444444444443
Q ss_pred CCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccc
Q 001253 525 ELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGN 604 (1114)
Q Consensus 525 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 604 (1114)
.+|..+ +++|+.|++++|.+++..+..+..++.++.|++++|.+++..+..+..+++|++|+|++|+|+ .+|..|.+
T Consensus 164 ~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~ 240 (305)
T d1xkua_ 164 TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 240 (305)
T ss_dssp SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccc
Confidence 122211 233444444444444333333333444444444444444333333344444444444444443 23333333
Q ss_pred cccccccccCCCcCC
Q 001253 605 LSRLTELQMGGNSFS 619 (1114)
Q Consensus 605 l~~L~~L~ls~N~l~ 619 (1114)
+++|++|+|++|+|+
T Consensus 241 l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 241 HKYIQVVYLHNNNIS 255 (305)
T ss_dssp CSSCCEEECCSSCCC
T ss_pred ccCCCEEECCCCccC
Confidence 444444444444333
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=1.1e-24 Score=240.98 Aligned_cols=256 Identities=22% Similarity=0.264 Sum_probs=141.5
Q ss_pred ccceeecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEee
Q 001253 343 GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLS 422 (1114)
Q Consensus 343 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 422 (1114)
++++|+|++|+|+.+.+.+|.++++|++|++++|.+....|..|.++++|++|++++|++..
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~------------------ 93 (305)
T d1xkua_ 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE------------------ 93 (305)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB------------------
T ss_pred CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCc------------------
Confidence 44445555555544444444445555555555555544444444444444444444444442
Q ss_pred cccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceee--ccCCchhhccccccEeecccccCCC
Q 001253 423 DNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFT--GSFPSDLCKLANLSTVELDQNQFSG 500 (1114)
Q Consensus 423 ~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~ 500 (1114)
+|..+ ...+..|+++.|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|+++
T Consensus 94 -------l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~- 163 (305)
T d1xkua_ 94 -------LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 163 (305)
T ss_dssp -------CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred -------Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-
Confidence 22211 123444455555554433333444445555555554332 233445556666666666666665
Q ss_pred CccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhh
Q 001253 501 PIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGS 580 (1114)
Q Consensus 501 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 580 (1114)
.+|..+ +++|+.|++++|.+++..+..|.+++.+++|++++|.+++..+..+..+++|++|+|++|+|+ .+|.+|..
T Consensus 164 ~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~ 240 (305)
T d1xkua_ 164 TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 240 (305)
T ss_dssp SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccc
Confidence 333332 456666777777666666666666666777777777776555556666677777777777766 45666777
Q ss_pred cccCCeeeccCccCCCcccc------cccccccccccccCCCcCC-C-CCChhhcCc
Q 001253 581 LFQLELLKLSENELSGSIPV------QIGNLSRLTELQMGGNSFS-G-GIPAELGSL 629 (1114)
Q Consensus 581 l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~ls~N~l~-~-~~p~~~~~l 629 (1114)
+++|++|+|++|+|+..... ....+.+|+.|+|++|++. . ..|..|.-+
T Consensus 241 l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~ 297 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297 (305)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred ccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhccc
Confidence 77777777777777643222 2345667888888888875 2 334444443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=4.9e-25 Score=240.84 Aligned_cols=205 Identities=23% Similarity=0.195 Sum_probs=97.9
Q ss_pred cceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeec-cceeeccCCchhhccccccEeec
Q 001253 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLG-GNSFTGSFPSDLCKLANLSTVEL 493 (1114)
Q Consensus 415 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L 493 (1114)
.+++|+|++|+|+...+..|.+++.|++|++++|++....+..+..+..++.+... .|.++...|..|.++++|++|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 34555555555554444445555555555555555554444444444444444432 33344333444444555555555
Q ss_pred ccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCC
Q 001253 494 DQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGA 573 (1114)
Q Consensus 494 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 573 (1114)
++|.+....+..+..+.+|+.+++++|+|+++.+..|..+++|+.|++++|++++..+..+..+++|+.+++++|++++.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 55554444444444444455555555555444444444444455555555544433333444444444444444444444
Q ss_pred CchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCC
Q 001253 574 LPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 574 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 619 (1114)
.|..|..+++|++|++++|++.+..|..|+.+++|++|+|++|++.
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 4444444444444444444444444444444444444444444444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1e-24 Score=238.34 Aligned_cols=224 Identities=20% Similarity=0.164 Sum_probs=140.3
Q ss_pred eecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccc
Q 001253 347 LYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHL 426 (1114)
Q Consensus 347 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 426 (1114)
++.+++.++. +|..+. +++++|+|++|+|+...+..|.++++|++|++++|++....+.
T Consensus 16 v~c~~~~L~~-iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~------------------ 74 (284)
T d1ozna_ 16 TSCPQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA------------------ 74 (284)
T ss_dssp EECCSSCCSS-CCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT------------------
T ss_pred EEcCCCCCCc-cCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccc------------------
Confidence 4445555552 233332 3456666666666644444555555555555555555444444
Q ss_pred cCCCCccccccCccceeeec-cCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCcccc
Q 001253 427 TGKIPRHICRNTSLIFLNLE-TNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTE 505 (1114)
Q Consensus 427 ~~~~~~~~~~~~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 505 (1114)
.+...+.+..+... .|.++...+..+..+++|++|++++|.+....+..+....+|+.+++++|+|+++.+..
T Consensus 75 ------~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~ 148 (284)
T d1ozna_ 75 ------AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148 (284)
T ss_dssp ------TTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred ------cccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhH
Confidence 44444444444432 34444444555666666666666666666555556666666777777777776665666
Q ss_pred ccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCC
Q 001253 506 IGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLE 585 (1114)
Q Consensus 506 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 585 (1114)
|..+++|+.|++++|+|++..+.+|.++++|+.+++++|++++..|..+..+++|+.||+++|++.+..|..|+.+++|+
T Consensus 149 f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~ 228 (284)
T d1ozna_ 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred hccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccC
Confidence 77777777777777777766667777777777777777777766677777777777777777777766667777777777
Q ss_pred eeeccCccCCCc
Q 001253 586 LLKLSENELSGS 597 (1114)
Q Consensus 586 ~L~L~~N~l~~~ 597 (1114)
+|+|++|.+...
T Consensus 229 ~L~l~~N~l~C~ 240 (284)
T d1ozna_ 229 YLRLNDNPWVCD 240 (284)
T ss_dssp EEECCSSCEECS
T ss_pred EEEecCCCCCCC
Confidence 777777777643
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=5.5e-24 Score=229.73 Aligned_cols=205 Identities=27% Similarity=0.271 Sum_probs=156.2
Q ss_pred ccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEEC
Q 001253 486 ANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDL 565 (1114)
Q Consensus 486 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 565 (1114)
..+.+++.++++|+ .+|..+. ++|++|||++|+|++..+..|.++++|++|+|++|+|+ .+|. +..+++|++|+|
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~L 84 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDL 84 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEEC
T ss_pred CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccc
Confidence 34455566666666 3454443 45677777777777655566777777777777777776 4442 356777777777
Q ss_pred ccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccc
Q 001253 566 SWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSG 645 (1114)
Q Consensus 566 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~ 645 (1114)
++|+++ ..+..+..+++|++|++++|.+.+..+..+..+.+++.|++++|.+++..+..+..+..++ .+++++|+|++
T Consensus 85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~-~l~l~~N~l~~ 162 (266)
T d1p9ag_ 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE-KLSLANNNLTE 162 (266)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC-EEECTTSCCSC
T ss_pred cccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccch-hcccccccccc
Confidence 777776 4456677777888888888888777777777888888888888888877777777888887 68888888888
Q ss_pred cCCccccchhhhHhhhccCcccccCCCCccccccccceEEeccCcccCCCCCc
Q 001253 646 LIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSS 698 (1114)
Q Consensus 646 ~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~ 698 (1114)
..+..|..+++|++|||++|+|+ .+|+.+.++++|+.|+|++|+|.|.+-..
T Consensus 163 ~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~~ 214 (266)
T d1p9ag_ 163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEIL 214 (266)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGGH
T ss_pred cCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcchH
Confidence 88888899999999999999999 78888889999999999999999876543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=2.9e-22 Score=216.02 Aligned_cols=197 Identities=24% Similarity=0.215 Sum_probs=103.6
Q ss_pred ceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeeccc
Q 001253 416 LWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQ 495 (1114)
Q Consensus 416 L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 495 (1114)
+.++|.+++.++ .+|..+. +++++|+|++|+|++..+..|..+++|++|+|++|+|+. +| .++.+++|++|+|++
T Consensus 12 ~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~ 86 (266)
T d1p9ag_ 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSH 86 (266)
T ss_dssp CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCS
T ss_pred CeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccc
Confidence 334455555554 2333332 245555555555554434445555555555555555542 22 234455555555555
Q ss_pred ccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCc
Q 001253 496 NQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALP 575 (1114)
Q Consensus 496 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 575 (1114)
|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|++++..+
T Consensus 87 N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~ 165 (266)
T d1p9ag_ 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA 165 (266)
T ss_dssp SCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCT
T ss_pred cccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCc
Confidence 5555 334455555555556665555555555555555555555555555553333334445555555555555555555
Q ss_pred hhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCC
Q 001253 576 REIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 576 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 619 (1114)
..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 166 ~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 166 GLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 55555555555555555555 45555555555555555555553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=6e-22 Score=201.75 Aligned_cols=171 Identities=16% Similarity=0.134 Sum_probs=120.9
Q ss_pred cCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCC---------------hhhHHHHHHHHHHHhcCCCCceeeEEeE
Q 001253 812 DERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGN---------------NNVDNSFRAEILTLGKIRHRNIVKLYGF 876 (1114)
Q Consensus 812 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---------------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 876 (1114)
.+.++||+|+||+||+|++.+|+.||||+++...... .........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4568999999999999999899999999876432110 0112334568888999999999988765
Q ss_pred EEecCceEEEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEECCCCCeEEeec
Q 001253 877 CYHQGSNLLMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 956 (1114)
Q Consensus 877 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 956 (1114)
. ..+++|||++++.+.+ ++......++.|+++|++|||+. +|+||||||+|||++++ .++++||
T Consensus 83 ~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp E----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCC
T ss_pred c----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEEC
Confidence 3 3479999999865543 23344567899999999999998 99999999999999865 5899999
Q ss_pred cCceecCCCCCCccccccccccccCccccccCCCCcccchHHHHHH
Q 001253 957 GLAKVIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVV 1002 (1114)
Q Consensus 957 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvi 1002 (1114)
|.|+....+..... .......+ .| +..+.|+.++|+||..--
T Consensus 147 G~a~~~~~~~~~~~--l~rd~~~~-~~-~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 147 PQSVEVGEEGWREI--LERDVRNI-IT-YFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp TTCEETTSTTHHHH--HHHHHHHH-HH-HHHHHHCCCCCHHHHHHH
T ss_pred CCcccCCCCCcHHH--HHHHHHHH-HH-HHcCCCCCcccHHHHHHH
Confidence 99987542221110 00000000 11 224668899999996543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.79 E-value=3.3e-18 Score=192.30 Aligned_cols=53 Identities=25% Similarity=0.279 Sum_probs=26.5
Q ss_pred cccceeccccccccccCCCCCCCCccceeeccccccCCCCcccccccccccEEEecCCccc
Q 001253 199 RLKSFRAGQNLISGSLPSEIGGCESLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLS 259 (1114)
Q Consensus 199 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 259 (1114)
+|++|++++|.++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~ 91 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK 91 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc
Confidence 3555555555554 34432 234555555555555 444432 34455555555554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.77 E-value=7.2e-18 Score=189.55 Aligned_cols=95 Identities=26% Similarity=0.285 Sum_probs=56.1
Q ss_pred ccceeeccccccCCCCcccccccccccEEEecCCcccCccccccccccccchhhcccccccCCchhhhcCCCccceeeec
Q 001253 223 SLQYLGLAQNQLSGEIPKEIGMLKYLTDVILWGNQLSGVIPKELGNCTSLETLALYDNKQVGQLPKELGSIGSLKYLYIY 302 (1114)
Q Consensus 223 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~p~~~~~l~~L~~L~L~ 302 (1114)
+|++|||++|.++ .+|+. +++|++|+|++|+|+ .+|..+ .+|++|++++|.+... +.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-hhh---cccccccccc
Confidence 6788888888887 57753 457788888888888 456543 3566666666654421 110 1245666666
Q ss_pred ccccccccCccccccccccccccccccCC
Q 001253 303 RNELNGTIPREIGKLSSALEIDFSENSLI 331 (1114)
Q Consensus 303 ~n~l~~~~p~~l~~l~~L~~L~ls~N~l~ 331 (1114)
+|.+. .+|. ++.+++|++|++++|.+.
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred ccccc-cccc-hhhhccceeecccccccc
Confidence 66555 3332 344555555555555443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.4e-21 Score=226.87 Aligned_cols=161 Identities=18% Similarity=0.106 Sum_probs=81.1
Q ss_pred CCcceEEeeccceeecc----CCchhhccccccEeecccccCCCCccccc-----cccccCcEEEecCceeccCCCcc--
Q 001253 461 CKSLVQLRLGGNSFTGS----FPSDLCKLANLSTVELDQNQFSGPIPTEI-----GNCNALQRLHLSDNYFTGELPRE-- 529 (1114)
Q Consensus 461 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p~~-- 529 (1114)
...++.|++++|.+... ....+...+.++.+++++|.++......+ .....|+.+++++|.++......
T Consensus 254 ~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~ 333 (460)
T d1z7xw1 254 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 333 (460)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcc
Confidence 34455555555544322 11223344555555555555542111111 12345666666666655332222
Q ss_pred --ccCCCCcceeeccccccccc----cccccc-ccccceEEECccccccCC----CchhhhhcccCCeeeccCccCCCcc
Q 001253 530 --VGNLSNLVTFNVSSNFLTGR----IPLEIF-SCKMLQRLDLSWNKFVGA----LPREIGSLFQLELLKLSENELSGSI 598 (1114)
Q Consensus 530 --~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~ 598 (1114)
+...++|++|+|++|++++. ++..+. ..+.|++|+|++|+|+.. ++..+...++|++|+|++|+|+...
T Consensus 334 ~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g 413 (460)
T d1z7xw1 334 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413 (460)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHH
T ss_pred cccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHH
Confidence 23344566666666666532 222222 245577777777776532 3344455567777777777766432
Q ss_pred ccc----cc-ccccccccccCCCcCCCC
Q 001253 599 PVQ----IG-NLSRLTELQMGGNSFSGG 621 (1114)
Q Consensus 599 p~~----~~-~l~~L~~L~ls~N~l~~~ 621 (1114)
... +. +..+|+.|++++|.+...
T Consensus 414 ~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 414 ILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred HHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 222 21 233577777777777643
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=5.1e-19 Score=185.51 Aligned_cols=205 Identities=24% Similarity=0.321 Sum_probs=105.9
Q ss_pred ceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCc
Q 001253 441 IFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDN 520 (1114)
Q Consensus 441 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 520 (1114)
..++++.+++++.. .+..+.+|+.|++.+|+|+. + +.+..+++|++|++++|++++..| +..+++|+++++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 34555555555432 33445556666666665552 2 235555555555555555553322 455555555555555
Q ss_pred eeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccc
Q 001253 521 YFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPV 600 (1114)
Q Consensus 521 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 600 (1114)
.++. ++ .+..+++|+.+++++|...+. ..+...+.++.+.++++ .+....
T Consensus 96 ~~~~-i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~------------------------~~~~~~-- 145 (227)
T d1h6ua2 96 PLKN-VS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLN------------------------QITNIS-- 145 (227)
T ss_dssp CCSC-CG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSS------------------------CCCCCG--
T ss_pred cccc-cc-ccccccccccccccccccccc--chhccccchhhhhchhh------------------------hhchhh--
Confidence 5542 21 344455555555555544421 12233444444444444 444221
Q ss_pred cccccccccccccCCCcCCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhccCcccccCCCCccccccc
Q 001253 601 QIGNLSRLTELQMGGNSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLLNNNHLSGEIPGSFVNLSS 680 (1114)
Q Consensus 601 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~ 680 (1114)
.+.++++|+.|++++|.+++.. .+.++++|+ .|+|++|++++. | .++++++|++|+|++|+|++..| +.++++
T Consensus 146 ~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~-~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~ 218 (227)
T d1h6ua2 146 PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLT-TLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSN 218 (227)
T ss_dssp GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCC-EEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTT
T ss_pred hhccccccccccccccccccch--hhcccccce-ecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCC
Confidence 2334444555555555544221 144555555 455555555543 2 25666777777777777775433 677777
Q ss_pred cceEEecc
Q 001253 681 LLGCNFSY 688 (1114)
Q Consensus 681 l~~l~ls~ 688 (1114)
|+.|++++
T Consensus 219 L~~L~lsn 226 (227)
T d1h6ua2 219 LFIVTLTN 226 (227)
T ss_dssp CCEEEEEE
T ss_pred CCEEEeeC
Confidence 88877763
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4.6e-21 Score=224.46 Aligned_cols=188 Identities=20% Similarity=0.162 Sum_probs=109.3
Q ss_pred CccceEEEeecccccCC-----CCccccccCccceeeeccCCccCCc----CcccccCCcceEEeeccceeeccCCchhh
Q 001253 413 YSQLWVVDLSDNHLTGK-----IPRHICRNTSLIFLNLETNKLTGSI----PTGVTRCKSLVQLRLGGNSFTGSFPSDLC 483 (1114)
Q Consensus 413 l~~L~~L~Ls~N~l~~~-----~~~~~~~~~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 483 (1114)
...++.+++++|++... .+........++.|++++|.+.... ...+...+.++.+++++|.+.+.....+.
T Consensus 225 ~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~ 304 (460)
T d1z7xw1 225 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 304 (460)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred cccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhh
Confidence 34455555555544321 1222233445666666666655321 22234556677777777776533222221
Q ss_pred -----ccccccEeecccccCCCCcccc----ccccccCcEEEecCceeccC----CCcccc-CCCCcceeeccccccccc
Q 001253 484 -----KLANLSTVELDQNQFSGPIPTE----IGNCNALQRLHLSDNYFTGE----LPREVG-NLSNLVTFNVSSNFLTGR 549 (1114)
Q Consensus 484 -----~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~ 549 (1114)
....|+.+++++|.++...... +...++|++|||++|+|++. ++..+. ..+.|++|+|++|.|+..
T Consensus 305 ~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~ 384 (460)
T d1z7xw1 305 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 384 (460)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred ccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChH
Confidence 2346777777777776443222 33455788888888887642 233332 356688888888888632
Q ss_pred ----ccccccccccceEEECccccccCCCchhhh-----hcccCCeeeccCccCCCcccc
Q 001253 550 ----IPLEIFSCKMLQRLDLSWNKFVGALPREIG-----SLFQLELLKLSENELSGSIPV 600 (1114)
Q Consensus 550 ----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~~p~ 600 (1114)
++..+..+++|++|||++|+|+......+. ....|+.|++++|.+......
T Consensus 385 ~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~ 444 (460)
T d1z7xw1 385 SCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED 444 (460)
T ss_dssp HHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHH
T ss_pred HHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHH
Confidence 344455678888888888888754333332 223688888888888754443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=4.6e-18 Score=178.08 Aligned_cols=167 Identities=27% Similarity=0.352 Sum_probs=85.0
Q ss_pred cccccceeeeeccCCcccCCCCCCCCcCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcce
Q 001253 386 FQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLV 465 (1114)
Q Consensus 386 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 465 (1114)
+.++++|++|++++|++.+..+ +..+++|+++++++|.++. + ..+..+++|+.+++++|...+. ..+...+.++
T Consensus 59 l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~ 132 (227)
T d1h6ua2 59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQ 132 (227)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCC
T ss_pred HhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-c-cccccccccccccccccccccc--chhccccchh
Confidence 3333444444444443333221 3344444444444444442 1 1244445555555555554422 2244455555
Q ss_pred EEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeeccccc
Q 001253 466 QLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNF 545 (1114)
Q Consensus 466 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 545 (1114)
.+.++++.+... ..+...++|++|++++|.+++.. .++++++|++|+|++|++++. + .++++++|++|+|++|+
T Consensus 133 ~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 133 VLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQ 206 (227)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSC
T ss_pred hhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCc
Confidence 566655555422 23455556666666666665322 255666666666666666642 2 25666666666666666
Q ss_pred ccccccccccccccceEEECc
Q 001253 546 LTGRIPLEIFSCKMLQRLDLS 566 (1114)
Q Consensus 546 l~~~~p~~~~~l~~L~~L~Ls 566 (1114)
+++ ++ .+.++++|+.|+++
T Consensus 207 lt~-i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 207 ISD-VS-PLANTSNLFIVTLT 225 (227)
T ss_dssp CCB-CG-GGTTCTTCCEEEEE
T ss_pred CCC-Cc-ccccCCCCCEEEee
Confidence 663 33 25566666666665
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=5.1e-18 Score=172.45 Aligned_cols=130 Identities=28% Similarity=0.356 Sum_probs=86.5
Q ss_pred cEeecccccCCCCccccccccccCcEEEecCceecc-CCCccccCCCCcceeecccccccccccccccccccceEEECcc
Q 001253 489 STVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTG-ELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSW 567 (1114)
Q Consensus 489 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 567 (1114)
++++.++|+++ .+|..+. +++++|+|++|+|++ ..+..|.++++|+.|+|++|.+.+..+..+..+++|+.|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 35566666665 4454432 456667777776654 3345566667777777777777666666666677777777777
Q ss_pred ccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCC
Q 001253 568 NKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGG 621 (1114)
Q Consensus 568 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 621 (1114)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++...
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 777766666677777777777777777766666777777777777777777643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=9e-18 Score=170.58 Aligned_cols=128 Identities=23% Similarity=0.290 Sum_probs=76.1
Q ss_pred eeeeccCCccCCcCcccccCCcceEEeeccceeec-cCCchhhccccccEeecccccCCCCccccccccccCcEEEecCc
Q 001253 442 FLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTG-SFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDN 520 (1114)
Q Consensus 442 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 520 (1114)
.++.++|+++ .+|..+. +++++|+|++|+|++ ..+..|..+++|++|+|++|++.+..+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4555555555 3444432 455666666666653 23445566666666666666666666666666666666666666
Q ss_pred eeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccC
Q 001253 521 YFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVG 572 (1114)
Q Consensus 521 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 572 (1114)
+|++..|.+|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 6666556666666666666666666664444455556666666666666653
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.5e-17 Score=176.27 Aligned_cols=199 Identities=15% Similarity=0.080 Sum_probs=112.2
Q ss_pred ccceeecccccccCcccccccccccCCEEEcccccccccc-cCccccccceeeeeccC-CcccCCCCCCCCcCccceEEE
Q 001253 343 GLELLYLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTI-PLGFQYLTNLIMLQLFD-NSLVGGIPQRLGAYSQLWVVD 420 (1114)
Q Consensus 343 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ 420 (1114)
++++|+|++|+|+.+.+.+|.++++|++|++++|.+...+ +..|..+++++++.+.. |++....+..|..+++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 4566666666666555556666666777777766665433 34466666666665543 455555556666666666666
Q ss_pred eecccccCCCCc-cccccCccceeeeccCCccCCcCcccccCC-cceEEeeccceeeccCCchhhccccc-cEeeccccc
Q 001253 421 LSDNHLTGKIPR-HICRNTSLIFLNLETNKLTGSIPTGVTRCK-SLVQLRLGGNSFTGSFPSDLCKLANL-STVELDQNQ 497 (1114)
Q Consensus 421 Ls~N~l~~~~~~-~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~ 497 (1114)
+++|.+....+. .+..+..+..+..+++.+....+..+..++ .++.|++++|+++...+..+ ...++ +.+++++|+
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~ 188 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNN 188 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTT
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccc-cchhhhccccccccc
Confidence 666666533222 222344555555555566544444454443 56666666666664333333 33333 333456666
Q ss_pred CCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecc
Q 001253 498 FSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVS 542 (1114)
Q Consensus 498 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 542 (1114)
|+...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.
T Consensus 189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 664444456666666666666666665444556666666655553
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=4.7e-17 Score=172.27 Aligned_cols=199 Identities=13% Similarity=0.037 Sum_probs=104.4
Q ss_pred cceEEEeecccccCCCCccccccCccceeeeccCCccCCc-CcccccCCcceEEeecc-ceeeccCCchhhccccccEee
Q 001253 415 QLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSI-PTGVTRCKSLVQLRLGG-NSFTGSFPSDLCKLANLSTVE 492 (1114)
Q Consensus 415 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ 492 (1114)
++++|+|++|+|+...+..|.++++|++|++++|.+...+ +..|..++.++++.+.. |++....+..|.++++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 3445555555554333334455555555555555544322 22345555555555432 444444455555555666666
Q ss_pred cccccCCCCcc-ccccccccCcEEEecCceeccCCCccccCCC-CcceeecccccccccccccccccccceEE-ECcccc
Q 001253 493 LDQNQFSGPIP-TEIGNCNALQRLHLSDNYFTGELPREVGNLS-NLVTFNVSSNFLTGRIPLEIFSCKMLQRL-DLSWNK 569 (1114)
Q Consensus 493 L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~Ls~N~ 569 (1114)
+++|++....+ ..+..+..+..+..+++.+....+..|.+++ .++.|++++|+++ .++...+...+++.+ ++++|+
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~ 188 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNN 188 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTT
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-ccccccccchhhhccccccccc
Confidence 66665543222 1233444555555556566554455555543 5666666666666 444444455554443 455566
Q ss_pred ccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccC
Q 001253 570 FVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMG 614 (1114)
Q Consensus 570 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 614 (1114)
++...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.
T Consensus 189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 663333446666666666666666664444456666666666553
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=3.1e-17 Score=169.12 Aligned_cols=179 Identities=26% Similarity=0.333 Sum_probs=89.5
Q ss_pred ecccccccCcccccccccccCCEEEcccccccccccCccccccceeeeeccCCcccCCCCCCCCcCccceEEEeeccccc
Q 001253 348 YLFENKLTGVIPVELTTLKNLTKLDLSINSLTGTIPLGFQYLTNLIMLQLFDNSLVGGIPQRLGAYSQLWVVDLSDNHLT 427 (1114)
Q Consensus 348 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 427 (1114)
.+..+.+++.++. ..+.+|++|++++|.+++.. .+..+++|++|++++|++++.. .++.+++|++|++++|+|+
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccc
Confidence 4444444443332 23556666666666665322 2555566666666666555432 2345555666666666555
Q ss_pred CCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCcccccc
Q 001253 428 GKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIG 507 (1114)
Q Consensus 428 ~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 507 (1114)
+ ++ .+..+++|+.|++++|.+.. ...+..++.++.+++++|.+++ +..+..+++|+++++++|++++.. .+.
T Consensus 104 ~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~ 175 (210)
T d1h6ta2 104 D-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLA 175 (210)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGT
T ss_pred c-cc-cccccccccccccccccccc--cccccccccccccccccccccc--cccccccccccccccccccccccc--ccc
Confidence 3 22 34555555555555555542 1234455555555555555542 223444555555555555554321 144
Q ss_pred ccccCcEEEecCceeccCCCccccCCCCcceeecc
Q 001253 508 NCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVS 542 (1114)
Q Consensus 508 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 542 (1114)
++++|++|+|++|+|+. +| .+.++++|++|+|+
T Consensus 176 ~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 176 GLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp TCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred CCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 55555555555555542 22 34455555555544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=9.6e-17 Score=165.33 Aligned_cols=146 Identities=27% Similarity=0.295 Sum_probs=78.3
Q ss_pred ccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCc
Q 001253 434 ICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQ 513 (1114)
Q Consensus 434 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 513 (1114)
+..+++|++|++++|+|++.. .++.+++|++|++++|++++ +| .+..+++|+.|++++|.+.. + ..+.++++|+
T Consensus 64 l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~ 137 (210)
T d1h6ta2 64 IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLE 137 (210)
T ss_dssp GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCC
T ss_pred HhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccccccccccc-c-cccccccccc
Confidence 334444555555555544321 23445555555555555542 22 35555555566665555542 2 2355556666
Q ss_pred EEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccC
Q 001253 514 RLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSE 591 (1114)
Q Consensus 514 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 591 (1114)
.+++++|.+++ +..+..+++|+.+++++|++++ ++ .+.++++|+.|+|++|+++ .+| .+.++++|++|+|++
T Consensus 138 ~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 138 SLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp EEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred ccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 66666666553 2234556666666666666653 22 2555666666666666665 333 466666677666653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=5.1e-17 Score=165.95 Aligned_cols=140 Identities=29% Similarity=0.400 Sum_probs=63.0
Q ss_pred ccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcce
Q 001253 459 TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVT 538 (1114)
Q Consensus 459 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 538 (1114)
..+++|++|++++|++++..| ++++++|++|++++|.+.. ++ .+.++++|+.|++++|.+... ..+..+++|+.
T Consensus 59 ~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~ 132 (199)
T d2omxa2 59 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNR 132 (199)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSE
T ss_pred ccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccccccccccccc--cccchhhhhHH
Confidence 334444444444444432211 4444444444444444432 11 244444555555555444421 22444455555
Q ss_pred eecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccc
Q 001253 539 FNVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTE 610 (1114)
Q Consensus 539 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 610 (1114)
|++++|++. .++ .+..+++|+.|++++|++++. + .++++++|++|++++|+++. ++ .++++++|++
T Consensus 133 L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~ 198 (199)
T d2omxa2 133 LELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLES 198 (199)
T ss_dssp EECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSE
T ss_pred hhhhhhhhc-ccc-cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCc
Confidence 555555544 222 344455555555555555432 1 24555555555555555553 22 2444555544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=1.3e-16 Score=163.00 Aligned_cols=159 Identities=23% Similarity=0.361 Sum_probs=83.2
Q ss_pred cCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCccee
Q 001253 460 RCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTF 539 (1114)
Q Consensus 460 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 539 (1114)
.+.++++|++++|.++. + +.+..+++|++|++++|+|++..| ++++++|++|++++|.+.. ++ .+.++++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence 34455555555555542 2 234555566666666666654322 5556666666666665552 22 25555666666
Q ss_pred ecccccccccccccccccccceEEECccccccCCCchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCC
Q 001253 540 NVSSNFLTGRIPLEIFSCKMLQRLDLSWNKFVGALPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFS 619 (1114)
Q Consensus 540 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 619 (1114)
++++|.+... ..+..+++|+.|++++|++.. + +.+..+++|++|++++|++++. + .++++++|++|++++|+++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred cccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCC
Confidence 6666555421 224455566666666665542 2 2355555666666666665532 2 2555566666666666655
Q ss_pred CCCChhhcCcchh
Q 001253 620 GGIPAELGSLSSL 632 (1114)
Q Consensus 620 ~~~p~~~~~l~~L 632 (1114)
+ +| .++++++|
T Consensus 186 ~-i~-~l~~L~~L 196 (199)
T d2omxa2 186 D-IS-VLAKLTNL 196 (199)
T ss_dssp C-CG-GGGGCTTC
T ss_pred C-Cc-cccCCCCC
Confidence 3 22 24444444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=2.6e-15 Score=162.28 Aligned_cols=213 Identities=21% Similarity=0.208 Sum_probs=108.1
Q ss_pred cCCcceEEeeccceeecc-CCchhhccccccEeecccccCCCCccccccccccCcEEEecCc-eeccC-CCccccCCCCc
Q 001253 460 RCKSLVQLRLGGNSFTGS-FPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDN-YFTGE-LPREVGNLSNL 536 (1114)
Q Consensus 460 ~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L 536 (1114)
...+|++|++++|.+++. ++..+..+++|++|+|++|.+++..+..+..+++|++|+|+++ .++.. +...+.++++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 344566666666665532 2334455666666666666666555556666666666666663 34321 11122345666
Q ss_pred ceeecccc-ccccc-ccccccc-cccceEEECccc--cccCC-CchhhhhcccCCeeeccCc-cCCCccccccccccccc
Q 001253 537 VTFNVSSN-FLTGR-IPLEIFS-CKMLQRLDLSWN--KFVGA-LPREIGSLFQLELLKLSEN-ELSGSIPVQIGNLSRLT 609 (1114)
Q Consensus 537 ~~L~Ls~N-~l~~~-~p~~~~~-l~~L~~L~Ls~N--~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~ 609 (1114)
++|+++++ .++.. +...+.. +++|+.|+++++ .++.. +...+.++++|++|++++| .+++.....+.++++|+
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~ 203 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred cccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCC
Confidence 66666664 23211 1111222 355666666653 23321 2222345566666666664 35555555566666666
Q ss_pred ccccCC-CcCCCCCChhhcCcchhhHHhhcccccccccCCccccch-hhhHhhhccCcccccCCCCcccc
Q 001253 610 ELQMGG-NSFSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNL-ILLEYLLLNNNHLSGEIPGSFVN 677 (1114)
Q Consensus 610 ~L~ls~-N~l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~g~ip~~~~~ 677 (1114)
+|+|++ +.+++.....++++++|+ .|+++++ ++ +..+..+ ..+..|++..+++++..++++++
T Consensus 204 ~L~L~~C~~i~~~~l~~L~~~~~L~-~L~l~~~-~~---d~~l~~l~~~lp~L~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 204 HLSLSRCYDIIPETLLELGEIPTLK-TLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN 268 (284)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCC-EEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred EEECCCCCCCChHHHHHHhcCCCCC-EEeeeCC-CC---HHHHHHHHHhCccccccCccCCCCCCCccCc
Confidence 666666 345544444455555555 4555544 21 1122222 23444555666666555555443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=5e-15 Score=159.98 Aligned_cols=58 Identities=24% Similarity=0.334 Sum_probs=29.0
Q ss_pred ccceEEEeecccccCC-CCccccccCccceeeeccCCccCCcCcccccCCcceEEeecc
Q 001253 414 SQLWVVDLSDNHLTGK-IPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGG 471 (1114)
Q Consensus 414 ~~L~~L~Ls~N~l~~~-~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 471 (1114)
.+|++|||+++.+++. +...+..+++|++|+|++|.+++..+..+..+++|++|++++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 4555666665555432 222334445555555555555444444444555555555555
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=3.8e-14 Score=138.28 Aligned_cols=126 Identities=17% Similarity=0.118 Sum_probs=64.5
Q ss_pred ccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcce
Q 001253 459 TRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVT 538 (1114)
Q Consensus 459 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 538 (1114)
.+..++++|+|++|+|+ .++..+..+++|+.|+|++|+|+. + +.|..+++|++|++++|+|+...+..+..+++|+.
T Consensus 15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp ECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred cCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCcccccccccccc
Confidence 34445555555555555 334444455555555555555552 2 23555556666666666665444444445555666
Q ss_pred eeccccccccccc--ccccccccceEEECccccccCCC---chhhhhcccCCeee
Q 001253 539 FNVSSNFLTGRIP--LEIFSCKMLQRLDLSWNKFVGAL---PREIGSLFQLELLK 588 (1114)
Q Consensus 539 L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~ 588 (1114)
|++++|+++. ++ ..+..+++|+.|++++|.++... +..+..+++|++||
T Consensus 92 L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 92 LILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ceeccccccc-cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 6666665552 22 23445556666666666554221 12345555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=3.1e-15 Score=167.08 Aligned_cols=136 Identities=18% Similarity=0.229 Sum_probs=79.1
Q ss_pred cccccEeecccccCCCC----ccccccccccCcEEEecCceeccC-----CCccccCCCCcceeeccccccccc----cc
Q 001253 485 LANLSTVELDQNQFSGP----IPTEIGNCNALQRLHLSDNYFTGE-----LPREVGNLSNLVTFNVSSNFLTGR----IP 551 (1114)
Q Consensus 485 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p 551 (1114)
.+.|+.+++++|+++.. +...+..++.|+.|+|++|+|+.. +...+...++|+.|+|++|.++.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 34555666666655421 222334455666666666666421 233455566677777777766532 33
Q ss_pred ccccccccceEEECccccccCCCchhh----hh--cccCCeeeccCccCCCc----ccccc-cccccccccccCCCcCCC
Q 001253 552 LEIFSCKMLQRLDLSWNKFVGALPREI----GS--LFQLELLKLSENELSGS----IPVQI-GNLSRLTELQMGGNSFSG 620 (1114)
Q Consensus 552 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~--l~~L~~L~L~~N~l~~~----~p~~~-~~l~~L~~L~ls~N~l~~ 620 (1114)
..+..+++|+.|+|++|.+++.....+ .. .+.|++|++++|+|+.. +...+ .++++|+.|+|++|+|..
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 344566777777777777765433333 22 24577888888877632 22233 246778888888888863
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.44 E-value=2.9e-15 Score=167.26 Aligned_cols=44 Identities=14% Similarity=0.049 Sum_probs=28.0
Q ss_pred cccccccccCCEEEccccccccc----ccCccccccceeeeeccCCcc
Q 001253 359 PVELTTLKNLTKLDLSINSLTGT----IPLGFQYLTNLIMLQLFDNSL 402 (1114)
Q Consensus 359 ~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l 402 (1114)
...+....+|+.|+|++|.|... +...+...++|+.|+++++..
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~ 71 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCT
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcc
Confidence 34566677888888888887543 223345556666666666544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=1.6e-13 Score=127.14 Aligned_cols=87 Identities=25% Similarity=0.369 Sum_probs=37.5
Q ss_pred hhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccc-cccccccccc
Q 001253 482 LCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRI-PLEIFSCKML 560 (1114)
Q Consensus 482 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L 560 (1114)
+..+++|++|++++|+|+ .+|..++.+++|+.|++++|+|++ +| .++.+++|++|++++|+++... ...+..+++|
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L 92 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 92 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCC
Confidence 344444444444444444 233344444444444444444442 22 2444444444444444444211 1233444445
Q ss_pred eEEECcccccc
Q 001253 561 QRLDLSWNKFV 571 (1114)
Q Consensus 561 ~~L~Ls~N~l~ 571 (1114)
+.|++++|+++
T Consensus 93 ~~L~l~~N~i~ 103 (124)
T d1dcea3 93 VLLNLQGNSLC 103 (124)
T ss_dssp CEEECTTSGGG
T ss_pred CEEECCCCcCC
Confidence 55555555443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.43 E-value=1.2e-13 Score=127.84 Aligned_cols=102 Identities=24% Similarity=0.277 Sum_probs=63.5
Q ss_pred cEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeecccccccccccccccccccceEEECccc
Q 001253 489 STVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKMLQRLDLSWN 568 (1114)
Q Consensus 489 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 568 (1114)
+.|+|++|+|+ .++ .+.++++|++||+++|+|+ .+|..|+.+++|+.|++++|+|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 35667777776 333 3666777777777777776 45556666777777777777776 333 3566666666666666
Q ss_pred cccCCC-chhhhhcccCCeeeccCccCC
Q 001253 569 KFVGAL-PREIGSLFQLELLKLSENELS 595 (1114)
Q Consensus 569 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 595 (1114)
+++... ...+..+++|++|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 666332 234555666666666666655
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=6.9e-14 Score=136.45 Aligned_cols=109 Identities=15% Similarity=0.093 Sum_probs=48.1
Q ss_pred cCccceEEEeecccccCCCCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEe
Q 001253 412 AYSQLWVVDLSDNHLTGKIPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTV 491 (1114)
Q Consensus 412 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 491 (1114)
+..++++|||++|+|+. ++..+..+++|+.|+|++|+|+. + ..+..+++|++|++++|+++...+..+..+++|++|
T Consensus 16 n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccccc
Confidence 34455555555555552 23344444555555555555542 2 224444444455555444443333333444444444
Q ss_pred ecccccCCCCcc-ccccccccCcEEEecCceec
Q 001253 492 ELDQNQFSGPIP-TEIGNCNALQRLHLSDNYFT 523 (1114)
Q Consensus 492 ~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 523 (1114)
++++|+|+.... ..+..+++|++|++++|.++
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred eeccccccccccccccccccccchhhcCCCccc
Confidence 444444442110 22334444444444444443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.32 E-value=3.5e-14 Score=143.77 Aligned_cols=111 Identities=23% Similarity=0.214 Sum_probs=51.6
Q ss_pred chhhccccccEeecccccCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeeccccccccccccccccccc
Q 001253 480 SDLCKLANLSTVELDQNQFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLTGRIPLEIFSCKM 559 (1114)
Q Consensus 480 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 559 (1114)
..+..+++|++|+|++|+|+. ++ .+..+++|+.|+|++|+|+ .+|..+..+++|++|++++|+++ .++ .+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHH
T ss_pred hHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-ccccccc
Confidence 344455555555555555542 22 2445555555555555554 23333333344555555555554 222 2344455
Q ss_pred ceEEECccccccCCCc-hhhhhcccCCeeeccCccCC
Q 001253 560 LQRLDLSWNKFVGALP-REIGSLFQLELLKLSENELS 595 (1114)
Q Consensus 560 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 595 (1114)
|+.|+|++|+++.... ..+..+++|+.|+|++|.+.
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccchhccccccccccCCCccceeecCCCccc
Confidence 5555555555542211 23445555555555555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=4.1e-12 Score=122.71 Aligned_cols=105 Identities=18% Similarity=0.132 Sum_probs=65.6
Q ss_pred eEEeeccceeeccCCchhhccccccEeecccc-cCCCCccccccccccCcEEEecCceeccCCCccccCCCCcceeeccc
Q 001253 465 VQLRLGGNSFTGSFPSDLCKLANLSTVELDQN-QFSGPIPTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSS 543 (1114)
Q Consensus 465 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 543 (1114)
+.++.+++++. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34455555554 34555555566666666544 36555555666677777777777777666666677777777777777
Q ss_pred ccccccccccccccccceEEECcccccc
Q 001253 544 NFLTGRIPLEIFSCKMLQRLDLSWNKFV 571 (1114)
Q Consensus 544 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 571 (1114)
|+|+ .+|...+...+|+.|+|++|.+.
T Consensus 90 N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCc-ccChhhhccccccccccCCCccc
Confidence 7776 55555555556777777777764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.29 E-value=1e-13 Score=140.30 Aligned_cols=114 Identities=20% Similarity=0.207 Sum_probs=75.0
Q ss_pred CCccccccCccceeeeccCCccCCcCcccccCCcceEEeeccceeeccCCchhhccccccEeecccccCCCCcccccccc
Q 001253 430 IPRHICRNTSLIFLNLETNKLTGSIPTGVTRCKSLVQLRLGGNSFTGSFPSDLCKLANLSTVELDQNQFSGPIPTEIGNC 509 (1114)
Q Consensus 430 ~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 509 (1114)
++..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+ .+|..+..+++|++|++++|+|+. + ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 34556666677777777777763 33 4667777777777777776 455555556677777777777763 3 236677
Q ss_pred ccCcEEEecCceeccCCC-ccccCCCCcceeecccccccc
Q 001253 510 NALQRLHLSDNYFTGELP-REVGNLSNLVTFNVSSNFLTG 548 (1114)
Q Consensus 510 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 548 (1114)
++|+.|+|++|+|+.... ..+..+++|+.|+|++|.+..
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 777777777777764221 356677777777777777653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=1.7e-12 Score=125.45 Aligned_cols=112 Identities=20% Similarity=0.091 Sum_probs=79.3
Q ss_pred CCeeeccCccCCCcccccccccccccccccCCCc-CCCCCChhhcCcchhhHHhhcccccccccCCccccchhhhHhhhc
Q 001253 584 LELLKLSENELSGSIPVQIGNLSRLTELQMGGNS-FSGGIPAELGSLSSLQIALNLSYNNLSGLIPPELGNLILLEYLLL 662 (1114)
Q Consensus 584 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~l~~L~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 662 (1114)
.+.++.+++.+. ..|..+..+++|++|++++|+ |+...+..|.++++|+ .|+|++|+|++..|..|..+++|++|||
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~-~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELR-NLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCS-EEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccC-cceeeccccCCcccccccccccccceec
Confidence 344555555555 445556666667777776553 6655556677777777 6777777777777778888888899999
Q ss_pred cCcccccCCCCccccccccceEEeccCcccCCCCCc
Q 001253 663 NNNHLSGEIPGSFVNLSSLLGCNFSYNNLTGPIPSS 698 (1114)
Q Consensus 663 s~N~l~g~ip~~~~~l~~l~~l~ls~N~l~g~ip~~ 698 (1114)
++|+|+...++.|..+ .|+.|+|++|+|.+.+-..
T Consensus 88 s~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~ 122 (156)
T d2ifga3 88 SFNALESLSWKTVQGL-SLQELVLSGNPLHCSCALR 122 (156)
T ss_dssp CSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGH
T ss_pred cCCCCcccChhhhccc-cccccccCCCcccCCchHH
Confidence 9999996655566554 6999999999998766443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=1.7e-08 Score=97.53 Aligned_cols=69 Identities=17% Similarity=0.107 Sum_probs=33.1
Q ss_pred CchhhccccccEeecccccCCCCc--cccccccccCcEEEecCceeccCCCccccCCCCcceeeccccccc
Q 001253 479 PSDLCKLANLSTVELDQNQFSGPI--PTEIGNCNALQRLHLSDNYFTGELPREVGNLSNLVTFNVSSNFLT 547 (1114)
Q Consensus 479 p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 547 (1114)
+..+..+++|++|+|++|+|+... +..+..+++|+.|||++|+|+...+-.+....+|+.|++++|.+.
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 333445566666666666665321 233445555555555555555322212222334455555555444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.35 E-value=2.2e-08 Score=96.69 Aligned_cols=67 Identities=28% Similarity=0.303 Sum_probs=33.7
Q ss_pred ccccceEEECccccccCC--CchhhhhcccCCeeeccCccCCCcccccccccccccccccCCCcCCCCC
Q 001253 556 SCKMLQRLDLSWNKFVGA--LPREIGSLFQLELLKLSENELSGSIPVQIGNLSRLTELQMGGNSFSGGI 622 (1114)
Q Consensus 556 ~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 622 (1114)
.+++|++|+|++|+|+.. ++..+..+++|+.|+|++|.|+...+..+....+|+.|++++|+++...
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence 345555555555555432 2233455556666666666665332222233345566666666665443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.28 E-value=1.4e-06 Score=91.39 Aligned_cols=146 Identities=16% Similarity=0.075 Sum_probs=99.0
Q ss_pred HHhcCCcCCceecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceE
Q 001253 806 VATDNFDERFVIGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNL 884 (1114)
Q Consensus 806 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 884 (1114)
..-..|+.++..+-++.+.||+.... ++.+++|+........ ...+.+|...++.+. +--+.+++.+..+++..+
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 33456666655444556789998754 6678889886554332 223567777776663 334667778888888899
Q ss_pred EEEecCCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 001253 885 LMYEYMARGSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHHD------------------------------------ 928 (1114)
Q Consensus 885 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------ 928 (1114)
+||++++|.++.+..... . ....++.++++.++.||+.
T Consensus 87 lv~~~l~G~~~~~~~~~~---~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE---Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTC---S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEeccccccccccccc---c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999998886654311 1 1223455566666666642
Q ss_pred --------------------CCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 929 --------------------CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 929 --------------------~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012479999999999999876677999998874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.97 E-value=1e-05 Score=83.95 Aligned_cols=131 Identities=17% Similarity=0.089 Sum_probs=86.5
Q ss_pred eecccCC-eEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC--CCceeeEEeEEEecCceEEEEecCCC
Q 001253 816 VIGRGAC-GTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR--HRNIVKLYGFCYHQGSNLLMYEYMAR 892 (1114)
Q Consensus 816 ~lG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~ 892 (1114)
.+..|.. +.||+...+++..+++|........ .+..|...++.+. .-.+.+++.+..+++..++||||++|
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 4455554 6899999888888999987554322 2566777776653 23367778888888889999999998
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 001253 893 GSLGELLHGASSTLDWQTRFMIALGAAEGLSYLHH--------------------------------------------- 927 (1114)
Q Consensus 893 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~--------------------------------------------- 927 (1114)
.++.+.. .... ..+.++++.++-||+
T Consensus 91 ~~~~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 91 QDLLSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp EETTTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccccccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 6553311 1111 112223333333332
Q ss_pred ------C----CCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 928 ------D----CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 928 ------~----~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
. ..+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 123489999999999999876678999998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.31 E-value=2.8e-05 Score=74.57 Aligned_cols=38 Identities=13% Similarity=0.309 Sum_probs=17.5
Q ss_pred ccccEeecccc-cCCCC----ccccccccccCcEEEecCceec
Q 001253 486 ANLSTVELDQN-QFSGP----IPTEIGNCNALQRLHLSDNYFT 523 (1114)
Q Consensus 486 ~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 523 (1114)
+.|++|+|+++ .++.. +-..+...+.|++|+|++|.+.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence 55666666542 34321 1122334445555555555544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.30 E-value=0.00029 Score=77.59 Aligned_cols=78 Identities=13% Similarity=0.104 Sum_probs=48.1
Q ss_pred ceecccCCeEEEEEEeC-CCcEEEEEEecccCC----CChhhHHHHHHHHHHHhcCC-C--CceeeEEeEEEecCceEEE
Q 001253 815 FVIGRGACGTVYRAVLR-TGHTVAVKKLASNRE----GNNNVDNSFRAEILTLGKIR-H--RNIVKLYGFCYHQGSNLLM 886 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 886 (1114)
+.||.|....||++... +++.|+||.-..... .......+...|+..++.+. + ..+.+++. .+++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 46899999999999876 467899997543211 00111223445777776552 2 34555554 356677899
Q ss_pred EecCCCCC
Q 001253 887 YEYMARGS 894 (1114)
Q Consensus 887 ~E~~~~gs 894 (1114)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.26 E-value=5.3e-05 Score=72.63 Aligned_cols=39 Identities=10% Similarity=0.222 Sum_probs=17.4
Q ss_pred CCcceEEeeccc-eeecc----CCchhhccccccEeecccccCC
Q 001253 461 CKSLVQLRLGGN-SFTGS----FPSDLCKLANLSTVELDQNQFS 499 (1114)
Q Consensus 461 l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 499 (1114)
.++|++|+|+++ .+... +-..+...+.|++|+|++|.+.
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence 345555555542 23321 1122333445555555555554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.83 E-value=0.0018 Score=69.07 Aligned_cols=134 Identities=16% Similarity=0.156 Sum_probs=77.7
Q ss_pred CeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCc--eeeEEe-----EEEecCceEEEEecCCCCC
Q 001253 822 CGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN--IVKLYG-----FCYHQGSNLLMYEYMARGS 894 (1114)
Q Consensus 822 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~-----~~~~~~~~~lv~E~~~~gs 894 (1114)
--.||+++.++|+.|++|+..+.... .+++..|...+..+.... ++..+. .+..++..+.+++|++|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 45899999999999999998765432 455777887776664211 111111 2234566789999998753
Q ss_pred HH-----HH------h---c----c----CCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----CC
Q 001253 895 LG-----EL------L---H----G----ASSTLDWQ-------------------TRFMIALGAAEGLSYLHH----DC 929 (1114)
Q Consensus 895 L~-----~~------l---~----~----~~~~l~~~-------------------~~~~i~~~i~~~L~~LH~----~~ 929 (1114)
+. .+ + + . .....++. .+..+...+.+.++.+.. ..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 21 11 0 0 0 01111111 111122222223333322 22
Q ss_pred CCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 930 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 930 ~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
..+++|+|+.+.|||++++ ..++||+-++.
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4579999999999999754 45899998874
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.48 E-value=0.00023 Score=67.88 Aligned_cols=61 Identities=18% Similarity=0.182 Sum_probs=28.5
Q ss_pred cccceEEECccccccCC----CchhhhhcccCCeeec--cCccCCC----cccccccccccccccccCCCc
Q 001253 557 CKMLQRLDLSWNKFVGA----LPREIGSLFQLELLKL--SENELSG----SIPVQIGNLSRLTELQMGGNS 617 (1114)
Q Consensus 557 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--~~N~l~~----~~p~~~~~l~~L~~L~ls~N~ 617 (1114)
.+.++.+++++|.+... +...+...++|+.++| ++|.+.. .+...+...++|+.|+++.|.
T Consensus 73 ~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 73 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred cccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 44555555555555432 1123334445554333 3444442 123334455666666665554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.22 E-value=0.0004 Score=66.16 Aligned_cols=15 Identities=27% Similarity=0.600 Sum_probs=7.1
Q ss_pred cccCcEEEecCceec
Q 001253 509 CNALQRLHLSDNYFT 523 (1114)
Q Consensus 509 l~~L~~L~Ls~N~l~ 523 (1114)
.+.++.+++++|.+.
T Consensus 73 ~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 73 NNTLKSLNVESNFIS 87 (166)
T ss_dssp CSSCCEEECCSSCCC
T ss_pred cccchhhhhcccccc
Confidence 344455555554443
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.06 E-value=0.0072 Score=66.15 Aligned_cols=72 Identities=19% Similarity=0.224 Sum_probs=48.0
Q ss_pred ceecccCCeEEEEEEeCC--------CcEEEEEEecccCCCChhhHHHHHHHHHHHhcCC-CCceeeEEeEEEecCceEE
Q 001253 815 FVIGRGACGTVYRAVLRT--------GHTVAVKKLASNREGNNNVDNSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLL 885 (1114)
Q Consensus 815 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 885 (1114)
+.|+.|-.-.+|++...+ .+.|.+++.-. ... .....+|..+++.+. +.-..++++++. -.+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~----~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET----ESHLVAESVIFTLLSERHLGPKLYGIFS----GGR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC----HHHHHHHHHHHHHHHHTTSSSCEEEEET----TEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch----hhHHHHHHHHHHHHHhCCCCCeEEEEcC----Cce
Confidence 478889999999998753 24577766542 211 234567888888774 433456777664 268
Q ss_pred EEecCCCCCH
Q 001253 886 MYEYMARGSL 895 (1114)
Q Consensus 886 v~E~~~~gsL 895 (1114)
||||++|..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.99 E-value=0.0069 Score=64.00 Aligned_cols=157 Identities=13% Similarity=0.076 Sum_probs=81.7
Q ss_pred CCHHHHHHHhcCCcCCce-----ecccCCeEEEEEEeCCCcEEEEEEecccCCCChhhHHHHHHHHHHHhcCCCCc--ee
Q 001253 799 FTFKDLVVATDNFDERFV-----IGRGACGTVYRAVLRTGHTVAVKKLASNREGNNNVDNSFRAEILTLGKIRHRN--IV 871 (1114)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~-----lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv 871 (1114)
.+.+++.....+|.+.+. |..|.--+.|+.+..+| .+++|++..... .+++..|+.++..+...+ +.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp 76 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCP 76 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC-----HHHHHHHHHHHHhhhhcccccc
Confidence 345566666667776543 44677788999988765 489999865332 123455666666653221 11
Q ss_pred eEEe------EEEecCceEEEEecCCCCCHHHH--------------hc----cCC----CCCCHH--------------
Q 001253 872 KLYG------FCYHQGSNLLMYEYMARGSLGEL--------------LH----GAS----STLDWQ-------------- 909 (1114)
Q Consensus 872 ~l~~------~~~~~~~~~lv~E~~~~gsL~~~--------------l~----~~~----~~l~~~-------------- 909 (1114)
..+. +....+..+.++.++.+...... ++ ... ......
T Consensus 77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence 1111 11234456677777766433210 00 000 000000
Q ss_pred ----HHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEECCCCCeEEeeccCcee
Q 001253 910 ----TRFMIALGAAEGLSYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 961 (1114)
Q Consensus 910 ----~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG~a~~ 961 (1114)
.....+..+...+...+. ....++||+|+.+.||+++.+...-++||+.+..
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 011111122222222221 1245899999999999999987778999998874
|